PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mosca, L				Mosca, Lori			Sex, statins, and statistics	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE; PREVENTION; WOMEN; RISK		Columbia Univ, NewYork Presbyterian Hosp, Med Ctr, Div Cardiol, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital	Mosca, L (corresponding author), Columbia Univ, NewYork Presbyterian Hosp, Med Ctr, Div Cardiol, New York, NY 10032 USA.	ljm10@cumc.columbia.edu						Cholesterol Treatment Trialists&rsquo; (CTT) Collaboration, 2015, LANCET; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Institute of Medicine, 2010, WOM HLTH RES PROGR P; Kostis WJ, 2012, J AM COLL CARDIOL, V59, P572, DOI 10.1016/j.jacc.2011.09.067; Kotseva K, 2010, EUR J CARDIOV PREV R, V17, P530, DOI 10.1097/HJR.0b013e3283383f30; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5	12	10	10	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1368	+		10.1016/S0140-6736(14)62005-5	http://dx.doi.org/10.1016/S0140-6736(14)62005-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25595662				2022-12-28	WOS:000352719800005
J	Goodman, SN				Goodman, Steven N.			Clinical Trial Data Sharing: What Do We Do Now?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PUBLICATION		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Goodman, SN (corresponding author), Stanford Univ, 259 Campus Dr,HRP Redwood Bldg T265, Stanford, CA 94305 USA.	steve.goodman@stanford.edu		Goodman, Steven/0000-0002-3872-5723				Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Doshi P, 2013, TRENDS PHARMACOL SCI, V34, P645, DOI 10.1016/j.tips.2013.10.006; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Rosenblatt M, 2015, ANN INTERN MED, V162, P306, DOI 10.7326/M14-1299; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828	10	3	3	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					308	309		10.7326/M15-0021	http://dx.doi.org/10.7326/M15-0021			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25621467				2022-12-28	WOS:000350232500023
J	Sedgwick, P				Sedgwick, Philip			Bias in observational study designs: case-control studies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4488; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316	2	11	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2015	350								h560	10.1136/bmj.h560	http://dx.doi.org/10.1136/bmj.h560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AU	25636996				2022-12-28	WOS:000348778800004
J	Kostelecky, VA				Kostelecky, V. Alan			Relativity tested with a split electron	NATURE			English	Editorial Material							INERTIAL MASS; ANISOTROPY	Splitting and recombining an electron wave packet has been used to test relativity at a record sensitivity. The result heralds an era of precision measurements of relativity using quantum-information methods. SEE LETTER P.592	[Kostelecky, V. Alan] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Kostelecky, V. Alan] Indiana Univ, Ctr Spacelime Symmetries, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Kostelecky, VA (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	kostelec@indiana.edu						Colladay D, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.116002; DREVER RWP, 1961, PHILOS MAG, V6, P683, DOI 10.1080/14786436108244418; Eisele C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090401; Herrmann S, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.105011; Hohensee MA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.050401; HUGHES VW, 1960, PHYS REV LETT, V4, P342, DOI 10.1103/PhysRevLett.4.342; KOSTELECKY VA, 1995, PHYS REV D, V51, P3923, DOI 10.1103/PhysRevD.51.3923; Michelson AA, 1887, AM J SCI, V34, P333, DOI [DOI 10.2475/AJS.S3-34.203.333, 10.2475/ajs.s3-34.203.333]; Pruttivarasin T, 2015, NATURE, V517, P592, DOI 10.1038/nature14091	9	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					559	560		10.1038/517559a	http://dx.doi.org/10.1038/517559a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631440				2022-12-28	WOS:000348775000029
J	Dolzhnikov, DS; Zhang, H; Jang, J; Son, JS; Panthani, MG; Shibata, T; Chattopadhyay, S; Talapin, DV				Dolzhnikov, Dmitriy S.; Zhang, Hao; Jang, Jaeyoung; Son, Jae Sung; Panthani, Matthew G.; Shibata, Tomohiro; Chattopadhyay, Soma; Talapin, Dmitri V.			Composition-matched molecular "solders" for semiconductors	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; COLLOIDAL NANOCRYSTALS; SOLIDS; THERMOELECTRICS; REDUCTION; TRANSPORT; FILMS; PBS	We propose a general strategy to synthesize largely unexplored soluble chalcogenidometallates of cadmium, lead, and bismuth. These compounds can be used as "solders" for semiconductors widely used in photovoltaics and thermoelectrics. The addition of solder helped to bond crystal surfaces and link nano-or mesoscale particles together. For example, CdSe nanocrystals with Na2Cd2Se3 solder was used as a soluble precursor for CdSe films with electron mobilities exceeding 300 square centimeters per volt-second. CdTe, PbTe, and Bi2Te3 powders were molded into various shapes in the presence of a small additive of composition-matched chalcogenidometallate or chalcogel, thus opening new design spaces for semiconductor technologies.	[Dolzhnikov, Dmitriy S.; Zhang, Hao; Jang, Jaeyoung; Son, Jae Sung; Panthani, Matthew G.; Talapin, Dmitri V.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dolzhnikov, Dmitriy S.; Zhang, Hao; Jang, Jaeyoung; Son, Jae Sung; Panthani, Matthew G.; Talapin, Dmitri V.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Shibata, Tomohiro; Chattopadhyay, Soma] Argonne Natl Lab, MRCAT, Adv Photon Source, Sect 10, Argonne, IL 60439 USA; [Shibata, Tomohiro; Chattopadhyay, Soma] IIT, Dept Phys, Adv Mat Grp, Chicago, IL 60616 USA; [Talapin, Dmitri V.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory	Talapin, DV (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	dvtalapin@uchicago.edu	Son, Jae Sung/C-2903-2014; Panthani, Matthew/C-8829-2014	Panthani, Matthew/0000-0002-3795-2051; Dolzhnikov, Dmitriy/0000-0002-2588-0759	II-VI Foundation; U.S. Department of Energy (DOE) SunShot program [DE-EE0005312]; NSF [DMR-1310398]; Keck Foundation; NSF Materials Research Science and Engineering Center Program [DMR 08-20054, DMR 14-20709]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; DOE; MRCAT	II-VI Foundation; U.S. Department of Energy (DOE) SunShot program(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); NSF Materials Research Science and Engineering Center Program(National Science Foundation (NSF)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); MRCAT	We thank S. Kwon and V. Zyryanov for help with EXAFS measurements and N. James for reading the manuscript. The work was supported by the II-VI Foundation, U.S. Department of Energy (DOE) SunShot program under award DE-EE0005312 and by NSF under award DMR-1310398. D.V.T. also thanks the Keck Foundation. This work used facilities supported by the NSF Materials Research Science and Engineering Center Program under awards DMR 08-20054 and DMR 14-20709. Use of the Center for Nanoscale Materials and Advanced Photon Source was supported by the DOE, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. MRCAT operations are supported by the DOE and MRCAT host institutions.	Bag S, 2007, SCIENCE, V317, P490, DOI 10.1126/science.1142535; BASOL BM, 1985, J APPL PHYS, V58, P3803; Baumgardner WJ, 2013, NANO LETT, V13, P3225, DOI 10.1021/nl401298s; Biswas K, 2012, NATURE, V489, P414, DOI 10.1038/nature11439; BURNS RC, 1985, INORG CHEM, V24, P2615, DOI 10.1021/ic00211a008; Choi JH, 2012, NANO LETT, V12, P2631, DOI 10.1021/nl301104z; Chung DS, 2012, NANO LETT, V12, P1813, DOI 10.1021/nl203949n; Devlin S. S., 1967, PHYS CHEM 2 6 COMPOU; Girard SN, 2011, J AM CHEM SOC, V133, P16588, DOI 10.1021/ja206380h; insight, 2014, ENCY BRITANNICA ONLI; Kang LSJ., 2004, SINTERING DENSIFICAT; Klajn R, 2007, SCIENCE, V316, P261, DOI 10.1126/science.1139131; Kovalenko MV, 2009, SCIENCE, V324, P1417, DOI 10.1126/science.1170524; Lee JS, 2011, NAT NANOTECHNOL, V6, P348, DOI [10.1038/nnano.2011.46, 10.1038/NNANO.2011.46]; Liu Y, 2013, NANO LETT, V13, P1578, DOI 10.1021/nl304753n; Liu Y, 2010, NANO LETT, V10, P1960, DOI 10.1021/nl101284k; Mitzi DB, 2008, ADV MATER, V20, P3657, DOI 10.1002/adma.200800555; Mitzi DB, 2009, ADV MATER, V21, P3141, DOI 10.1002/adma.200802027; Mitzi DB, 2004, NATURE, V428, P299, DOI 10.1038/nature02389; Norman ZM, 2014, ACS NANO, V8, P7513, DOI 10.1021/nn502829s; Oh SJ, 2014, NANO LETT, V14, P1559, DOI 10.1021/nl404818z; PARK CW, 1995, CAN J CHEM, V73, P1148, DOI 10.1139/v95-141; Ridley BA, 1999, SCIENCE, V286, P746, DOI 10.1126/science.286.5440.746; Sze S., 2002, SEMICONDUCTOR DEVICE, V2nd; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Todorov TK, 2010, ADV MATER, V22, pE156, DOI 10.1002/adma.200904155; Wang RY, 2010, CHEM MATER, V22, P1943, DOI 10.1021/cm903769q; Webber DH, 2013, J AM CHEM SOC, V135, P15722, DOI 10.1021/ja4084336; Yu D, 2003, SCIENCE, V300, P1277, DOI 10.1126/science.1084424	29	154	156	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					425	428		10.1126/science.1260501	http://dx.doi.org/10.1126/science.1260501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25569110				2022-12-28	WOS:000348225800044
J	Fairchild, AL; Bayer, R				Fairchild, Amy L.; Bayer, Ronald			Smoke and fire over e-cigarettes	SCIENCE			English	Editorial Material									[Fairchild, Amy L.; Bayer, Ronald] Columbia Univ, Dept Sociomed Sci, New York, NY 10032 USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Dept Sociomed Sci, Rosenfield Bldg, New York, NY 10032 USA.	alf4@columbia.edu	Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				ASHFORD NA, 1999, PROTECTING PUBLIC HL, P198; Bhatnagar A., 2014, CIRCULATION, V2014, P1; Chapman S, 2013, TOB CONTROL, V22, P33, DOI 10.1136/tobaccocontrol-2012-050767; Commission of the European Communities, 2000, COMM COMM PREC PRINC; Fairchild A, 2004, AM J PUBLIC HEALTH, V94, P192, DOI 10.2105/AJPH.94.2.192; Jordan Andrew, 1999, PROTECTING PUBLIC HL, p[20, 25]; Pertschunk M., 2001, SMOKE THEIR EYES LES, P119; Richtel M., 2014, NY TIMES; Sunstein C. R., 1995, LAWS FEAR PRECAUTION; WHO, 2014, FCTCCOP6AR2 WHO, P8; Wiener JB, 2002, HUMAN AND ECOLOGICAL RISK ASSESSMENT: THEORY AND PRACTICE, P1509	11	31	31	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					375	376		10.1126/science.1260761	http://dx.doi.org/10.1126/science.1260761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4XZ	25613878				2022-12-28	WOS:000348225800018
J	Gibbs, HK; Rausch, L; Munger, J; Schelly, I; Morton, DC; Noojipady, P; Soares-Filho, B; Barreto, P; Micol, L; Walker, NF				Gibbs, H. K.; Rausch, L.; Munger, J.; Schelly, I.; Morton, D. C.; Noojipady, P.; Soares-Filho, B.; Barreto, P.; Micol, L.; Walker, N. F.			Brazil's Soy Moratorium	SCIENCE			English	Editorial Material							DEFORESTATION; AMAZON		[Gibbs, H. K.; Rausch, L.; Munger, J.; Schelly, I.] Univ Wisconsin, Madison, WI 53726 USA; [Morton, D. C.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Noojipady, P.] Univ Maryland, College Pk, MD 20742 USA; [Noojipady, P.; Walker, N. F.] Natl Wildlife Federat, Washington, DC 20006 USA; [Soares-Filho, B.] Univ Fed Minas Gerais, BR-31270901 Belo Horizonte, MG, Brazil; [Barreto, P.] IMAZON Amazon Inst People & Environm, BR-66060162 Belem, Para, Brazil; [Micol, L.] Inst Ctr Vida, BR-78045055 Cuiaba, Mato Grosso, Brazil	University of Wisconsin System; University of Wisconsin Madison; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Universidade Federal de Minas Gerais	Gibbs, HK (corresponding author), Univ Wisconsin, Madison, WI 53726 USA.	hkgibbs@wisc.edu	Morton, Douglas C/D-5044-2012; Noojipady, Praveen/B-2511-2010					Azevedo A. A., 2014, B AMAZONIA PAUTA, V3, P1; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Brazilian Vegetable Oil Industries Association, 2014, NEW AG SOYB AM BIOM; Lambin EF, 2013, GLOBAL ENVIRON CHANG, V23, P892, DOI 10.1016/j.gloenvcha.2013.05.005; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Rajao R, 2012, PUBLIC ADMIN DEVELOP, V32, P229, DOI 10.1002/pad.1620; Rocha G.F., 2012, REV BRAS CARTOGR, V63, P341; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Strassburg BBN, 2014, GLOBAL ENVIRON CHANG, V28, P84, DOI 10.1016/j.gloenvcha.2014.06.001; Rudorff BFT, 2011, REMOTE SENS-BASEL, V3, P185, DOI 10.3390/rs3010185	12	388	395	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					377	378		10.1126/science.aaa0181	http://dx.doi.org/10.1126/science.aaa0181			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613879				2022-12-28	WOS:000348225800019
J	Nagral, S				Nagral, Sanjay			We need to discuss India's reliance on private medical colleges	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Jaslok Hosp & Res Ctr, Dept Surg Gastroenterol, Mumbai 400026, Maharashtra, India		Nagral, S (corresponding author), Jaslok Hosp & Res Ctr, Dept Surg Gastroenterol, Mumbai 400026, Maharashtra, India.	sanjaynagral@gmail.com						Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Medical Council of India, LIST COLL TEACH MBBS; Shome S, 2011, SUPREME COURT JUDGEM; Vasudev S, 2004, INDIA TODAY	4	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2015	350								h237	10.1136/bmj.h237	http://dx.doi.org/10.1136/bmj.h237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZH	25608848				2022-12-28	WOS:000348433800001
J	Sandrian, MG				Sandrian, Michelle Gabriele			A European postdoc for the family	SCIENCE			English	Editorial Material											Sandrian, MG (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	SciCareerEditor@aaas.org							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					346	346		10.1126/science.347.6219.346	http://dx.doi.org/10.1126/science.347.6219.346			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0DA	25593190				2022-12-28	WOS:000347915300053
J	Xu, SY; Liu, C; Kushwaha, SK; Sankar, R; Krizan, JW; Belopolski, I; Neupane, M; Bian, G; Alidoust, N; Chang, TR; Jeng, HT; Huang, CY; Tsai, WF; Lin, H; Shibayev, PP; Chou, FC; Cava, RJ; Hasan, MZ				Xu, Su-Yang; Liu, Chang; Kushwaha, Satya K.; Sankar, Raman; Krizan, Jason W.; Belopolski, Ilya; Neupane, Madhab; Bian, Guang; Alidoust, Nasser; Chang, Tay-Rong; Jeng, Horng-Tay; Huang, Cheng-Yi; Tsai, Wei-Feng; Lin, Hsin; Shibayev, Pavel P.; Chou, Fang-Cheng; Cava, Robert J.; Hasan, M. Zahid			Observation of Fermi arc surface states in a topological metal	SCIENCE			English	Article							QUANTUM SPIN HALL; PHASE-TRANSITION; DIRAC SEMIMETALS; INSULATOR	The topology of the electronic structure of a crystal is manifested in its surface states. Recently, a distinct topological state has been proposed in metals or semimetals whose spin-orbit band structure features three-dimensional Dirac quasiparticles. We used angle-resolved photoemission spectroscopy to experimentally observe a pair of spin-polarized Fermi arc surface states on the surface of the Dirac semimetal Na3Bi at its native chemical potential. Our systematic results collectively identify a topological phase in a gapless material. The observed Fermi arc surface states open research frontiers in fundamental physics and possibly in spintronics.	[Xu, Su-Yang; Liu, Chang; Belopolski, Ilya; Neupane, Madhab; Bian, Guang; Alidoust, Nasser; Shibayev, Pavel P.; Hasan, M. Zahid] Princeton Univ, Dept Phys, Joseph Henry Lab, Princeton, NJ 08544 USA; [Xu, Su-Yang; Hasan, M. Zahid] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton Ctr Complex Mat, Princeton, NJ 08544 USA; [Kushwaha, Satya K.; Krizan, Jason W.; Cava, Robert J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Sankar, Raman; Chou, Fang-Cheng] Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 10617, Taiwan; [Chang, Tay-Rong; Jeng, Horng-Tay] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30013, Taiwan; [Jeng, Horng-Tay] Acad Sinica, Inst Phys, Taipei 11529, Taiwan; [Huang, Cheng-Yi; Tsai, Wei-Feng] Natl Sun Yat Sen Univ, Dept Phys, Kaohsiung 804, Taiwan; [Lin, Hsin] Natl Univ Singapore, Graphene Res Ctr, Singapore 117542, Singapore; [Lin, Hsin] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Chou, Fang-Cheng] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan	Princeton University; Princeton University; Princeton University; National Taiwan University; National Tsing Hua University; Academia Sinica - Taiwan; National Sun Yat Sen University; National University of Singapore; National University of Singapore; National Synchrotron Radiation Research Center	Hasan, MZ (corresponding author), Princeton Univ, Dept Phys, Joseph Henry Lab, Princeton, NJ 08544 USA.	mzhasan@princeton.edu	Lin, Hsin/F-9568-2012; HASAN, M. Zahid/D-8237-2012; Raman, Sankar/AAQ-1043-2021; Chang, Tay-Rong/K-3943-2015; Kushwaha, Satya K./B-8287-2017; Neupane, Madhab/ABE-8747-2020	Lin, Hsin/0000-0002-4688-2315; Raman, Sankar/0000-0003-2817-0952; Chang, Tay-Rong/0000-0003-1222-2527; Kushwaha, Satya K./0000-0002-3169-969X; Shibayev, Pavel/0000-0002-7214-5706; Liu, Chang/0000-0002-7738-743X	U.S. Department of Energy [DE-FG-02-05ER46200]; Singapore National Research Foundation (NRF) under NRF [NRF-NRFF2013-03]; Ministry of Science and Technology (MOST) in Taiwan [103-2112-M-110-008-MY3]; National Science Council, Taiwan; Army Research Office Multidisciplinary University Research Initiative on topological insulators [W911NF-12-1-0461]; MOST-Taiwan [103-2119-M-002-020-MY3];  [NSF-DMR-1006492]; Division Of Materials Research [1006492] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); Singapore National Research Foundation (NRF) under NRF(National Research Foundation, Singapore); Ministry of Science and Technology (MOST) in Taiwan(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Army Research Office Multidisciplinary University Research Initiative on topological insulators; MOST-Taiwan(Ministry of Science and Technology, Taiwan); ; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work at Princeton and Princeton-led synchrotron-based ARPES measurements are supported by U.S. Department of Energy grant DE-FG-02-05ER46200. H.L. acknowledges the Singapore National Research Foundation (NRF) for support under NRF award no. NRF-NRFF2013-03. C.-Y.H. and W.-F.T. are supported by the Ministry of Science and Technology (MOST) in Taiwan under grant no. 103-2112-M-110-008-MY3. T.-R.C. and H.-T.J. are supported by the National Science Council, Taiwan. H.-T.J. also thanks the National Center for High-Performance Computing, Taiwan; the Computer and Information Network Center-National Taiwan University, Taiwan; and the National Center for Theoretical Sciences, Taiwan, for technical support. Crystal growth was supported by the Army Research Office Multidisciplinary University Research Initiative on topological insulators, grant no. W911NF-12-1-0461. F.-C.C acknowledges the support provided by MOST-Taiwan under project number 103-2119-M-002-020-MY3. G.B. is supported by grant NSF-DMR-1006492. We gratefully acknowledge M. Leandersson, C. M. Polley, J. Adell, T. Balasubramanian, K. Miyamoto, T. Okuda, and M. Hashimoto for their beamline assistance at the Maxlab, the Hiroshima Synchrotron Radiation Center (Hisor), and the Stanford Synchrotron Radiation Lightsource (SSRL). We also thank C. Fang, B. A. Bernevig, and A. Vishwanath for discussions. ARPES data were collected at the beamline 5-4 at the SSRL at the Stanford Linear Accelerator Center in California, USA; the beamlines I3 and I4 at the MAX-lab in Lund, Sweden; and the beamline-9B of the Hisor in Hiroshima, Japan.	Borisenko S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.027603; Brahlek M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.186403; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hosur P, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195102; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Massalski T.B., 1996, BINARY ALLOY PHASE D, Vsecond; Moore J, 2009, NAT PHYS, V5, P378, DOI 10.1038/nphys1294; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; Neupane M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4786; Ojanen T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245112; Potter AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6161; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.125427; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Wen XG, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.035147; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274; Xu SY, 2011, SCIENCE, V332, P560, DOI 10.1126/science.1201607; Yang BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5898; Yang SYA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.046401; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405	22	525	532	15	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					294	298		10.1126/science.1256742	http://dx.doi.org/10.1126/science.1256742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593189				2022-12-28	WOS:000347915300042
J	Pemberton, M				Pemberton, Max			IF I RULED THE NHS Ban management consultants	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												max.pemberton@telegraph.co.uk							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2015	350								h28	10.1136/bmj.h28	http://dx.doi.org/10.1136/bmj.h28			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3ND	25592388				2022-12-28	WOS:000348133300005
J	Srivastava, R				Srivastava, Ranjana			On the Death of a Colleague	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia		Srivastava, R (corresponding author), Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					207	209		10.1056/NEJMp1410385	http://dx.doi.org/10.1056/NEJMp1410385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25587947				2022-12-28	WOS:000348119200004
J	Frost, P				Frost, Paul			COMPETENT NOVICE Intravenous fluid therapy in adult inpatients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYDROXYETHYL STARCH; SEVERE SEPSIS; RESUSCITATION; SALINE		[Frost, Paul] Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, S Glam, Wales; [Frost, Paul] Cardiff Univ, Inst Med Educ, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Frost, P (corresponding author), Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, S Glam, Wales.	Frostp2@cf.ac.uk						Arieff AI, 1999, CHEST, V115, P1371, DOI 10.1378/chest.115.5.1371; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Frost PJ, 2012, BMJ-BRIT MED J, V345, P43; Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148; Hartog CS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5981; Kaplan LJ, 2005, CRIT CARE, V9, P198, DOI 10.1188/cc2912; Medicines and Healthcare Products Regulatory Agency, 2013, HYDR STARCH INTR INF; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; National Confidential Enquiry into Perioperative Deaths, 1999, EXTR AGE 1999 REP NA; National Institute for Health and Care Excellence, 2013, CLIN GUID 174; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Powell-Tuck J, 2008, BRIT CONSENSUS GUIDE; Preau S, 2010, CRIT CARE MED, V38, P819, DOI 10.1097/CCM.0b013e3181c8fe7a; Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702; Spasovski G, 2014, INTENS CARE MED, V40, P320, DOI 10.1007/s00134-014-3210-2; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515	22	14	15	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2015	350								g7620	10.1136/bmj.g7620	http://dx.doi.org/10.1136/bmj.g7620			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LX	25569336				2022-12-28	WOS:000348130100001
J	Santavirta, T; Santavirta, N; Betancourt, TS; Gilman, SE				Santavirta, Torsten; Santavirta, Nina; Betancourt, Theresa S.; Gilman, Stephen E.			Long term mental health outcomes of Finnish children evacuated to Swedish families during the second world war and their non-evacuated siblings: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOSOCIAL SUPPORT; REFUGEE CHILDREN; RISK-FACTORS; CHILDHOOD; WAR; DEPRESSION; DISORDERS; CONFLICT; EXPERIENCES; PREVALENCE	Objectives To compare the risks of admission to hospital for any type of psychiatric disorder and for four specific psychiatric disorders among adults who as children were evacuated to Swedish foster families during the second world war and their non-evacuated siblings, and to evaluate whether these risks differ between the sexes. Design Cohort study. Setting National child evacuation scheme in Finland during the second world war. Participants Children born in Finland between 1933 and 1944 who were later included in a 10% sample of the 1950 Finnish census ascertained in 1997 (n=45 463; women: n=22 021; men: n=23 442). Evacuees in the sample were identified from war time government records. Main outcome measure Adults admitted to hospital for psychiatric disorders recorded between 1971 and 2011 in the Finnish hospital discharge register. Methods We used Cox proportional hazards models to estimate the association between evacuation to temporary foster care in Sweden during the second world war and admission to hospital for a psychiatric disorder between ages 38 and 78 years. Fixed effects methods were employed to control for all unobserved social and genetic characteristics shared among siblings. Results Among men and women combined, the risk of admission to hospital for a psychiatric disorder did not differ between Finnish adults evacuated to Swedish foster families and their non-evacuated siblings (hazard ratio 0.89, 95% confidence interval 0.64 to 1.26). Evidence suggested a lower risk of admission for any mental disorder (0.67, 0.44 to 1.03) among evacuated men, whereas for women there was no association between evacuation and the overall risk of admission for a psychiatric disorder (1.21, 0.80 to 1.83). When admissions for individual psychiatric disorders were analyzed, evacuated girls were significantly more likely than their non-evacuated sisters to be admitted to hospital for a mood disorder as an adult (2.19, 1.10 to 4.33). Conclusions The Finnish evacuation policy was not associated with an increased overall risk of admission to hospital for a psychiatric disorder in adulthood among former evacuees. In fact, evacuation was associated with a marginally reduced risk of admission for any psychiatric disorder among men. Among women who had been evacuated, however, the risk of being admitted to hospital for a mood disorder was increased.	[Santavirta, Torsten] Stockholm Univ, Swedish Inst Social Res, SE-10691 Stockholm, Sweden; [Santavirta, Nina] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Betancourt, Theresa S.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Gilman, Stephen E.] Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Dept Social & Behav Sci,Dept Psychiat, Boston, MA 02115 USA; [Gilman, Stephen E.] Harvard Univ, Sch Publ Hlth, Massachusetts Gen Hosp, Dept Epidemiol,Dept Psychiat, Boston, MA 02115 USA	Stockholm University; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital	Santavirta, T (corresponding author), Stockholm Univ, Swedish Inst Social Res, SE-10691 Stockholm, Sweden.	torsten.santavirta@sofi.su.se	Gilman, Stephen/E-7632-2010; Santavirta, Torsten/C-3918-2014; Santavirta, Torsten/AAE-1066-2021	Gilman, Stephen/0000-0002-8331-6419; Santavirta, Torsten/0000-0001-6613-3410; 	Academy of Finland; National Institutes of Health [MH087544]; Signe and Ane Gyllenberg Foundation; Tore Browaldh Foundation; Siamon Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087544] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Signe and Ane Gyllenberg Foundation; Tore Browaldh Foundation; Siamon Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Academy of Finland, National Institutes of Health (grant MH087544), and the Signe and Ane Gyllenberg Foundation. TS received additional support from the Tore Browaldh Foundation and the Siamon Foundation.	Almas AN, 2012, P NATL ACAD SCI USA, V109, P17228, DOI 10.1073/pnas.1121256109; Bean TM, 2007, SOC SCI MED, V64, P1204, DOI 10.1016/j.socscimed.2006.11.010; Betancourt TS, 2013, HARVARD REV PSYCHIAT, V21, P70, DOI 10.1097/HRP.0b013e318283bf8f; Betancourt TS, 2012, J ADOLESCENT HEALTH, V51, P544, DOI 10.1016/j.jadohealth.2012.02.010; Betancourt TS, 2012, DISASTERS, V36, P635, DOI 10.1111/j.1467-7717.2012.01280.x; Betancourt TS, 2011, J AM ACAD CHILD PSY, V50, P323, DOI 10.1016/j.jaac.2011.01.008; Betancourt TS, 2011, J ADOLESCENT HEALTH, V49, P21, DOI 10.1016/j.jadohealth.2010.09.021; Betancourt TS, 2008, INT REV PSYCHIATR, V20, P317, DOI 10.1080/09540260802090363; Bound J, 1999, ECON EDUC REV, V18, P169, DOI 10.1016/S0272-7757(98)00048-X; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Cameron CA, 2015, J HUM RESOU IN PRESS; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Donovan SJ, 2011, INT J EPIDEMIOL, V40, P345, DOI 10.1093/ije/dyr057; Eide K, 2013, ACTA PAEDIATR, V102, P666, DOI 10.1111/apa.12258; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Feldman R, 2011, J AM ACAD CHILD PSY, V50, P645, DOI 10.1016/j.jaac.2011.03.001; Freud A, 1943, WAR AND CHILDREN; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Gilman SE, 2015, MOL PSYCHIATR, V20, P329, DOI 10.1038/mp.2014.36; Gilman SE, 2003, AM J PSYCHIAT, V160, P939, DOI 10.1176/appi.ajp.160.5.939; Gilman SE, 2007, AM J EPIDEMIOL, V166, P1134, DOI 10.1093/aje/kwm251; Gilman SE, 2014, SOC SCI MED, V118, P191, DOI 10.1016/j.socscimed.2014.06.029; Gilman SE, 2012, AM J EPIDEMIOL, V176, P684, DOI 10.1093/aje/kws228; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; HOLT JD, 1974, BIOMETRIKA, V61, P17, DOI 10.1093/biomet/61.1.17; Huemer J, 2009, LANCET, V373, P612, DOI 10.1016/S0140-6736(09)60380-9; International Committee of the Red Cross. Central Tracing Agency and Protection Division, 2004, INT GUID PRINC UN SE; Isohanni M, 1997, SOC PSYCH PSYCH EPID, V32, P303, DOI 10.1007/BF00789044; Jaffee SR, 2002, ARCH GEN PSYCHIAT, V59, P215, DOI 10.1001/archpsyc.59.3.215; Kaven P, 2010, THESIS U HELSINKI; Kendler KS, 2002, PSYCHOL MED, V32, P1187, DOI 10.1017/S0033291702006219; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Lehtiranta L, 1996, MATKALLA KODISTA KOT; Lomu J, 1974, PUBLICATION SERIES N, p5a; Morgan C, 2007, PSYCHOL MED, V37, P495, DOI 10.1017/S0033291706009330; Ni Bhrolchain M, 2000, EUR SOCIOL REV, V16, P67; NUNNO MA, 1988, CHILD ABUSE NEGLECT, V12, P521, DOI 10.1016/0145-2134(88)90069-5; Panter-Brick C, 2014, J CHILD PSYCHOL PSYC, V55, P313, DOI 10.1111/jcpp.12167; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Pesonen AK, 2007, AM J EPIDEMIOL, V166, P1126, DOI 10.1093/aje/kwm254; Raikkonen K, 2011, J PSYCHIATR RES, V45, P332, DOI 10.1016/j.jpsychires.2010.07.003; Rasanen E, 1992, Acta Paedopsychiatr, V55, P19; ROSENZWEIG MR, 1995, ECONOMETRICA, V63, P303, DOI 10.2307/2951628; Santavirta N, 2014, HEALTH ECON, V23, P253, DOI 10.1002/hec.2913; Santavirta T, 2012, AM ECON J-APPL ECON, V4, P28, DOI 10.1257/app.4.3.28; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Skeer M, 2009, DRUG ALCOHOL DEPEN, V104, P65, DOI 10.1016/j.drugalcdep.2009.03.017; Statistics Finland, 2013, HDB STAT FINL, V38; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; TENNANT C, 1982, BRIT J PSYCHIAT, V141, P475, DOI 10.1192/bjp.141.5.475; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; Tyler KA, 2002, CHILD ABUSE NEGLECT, V26, P1261, DOI 10.1016/S0145-2134(02)00413-1; Vervliet M, 2014, EUR CHILD ADOLES PSY, V23, P337, DOI 10.1007/s00787-013-0463-1; Wilcox HC, 2010, J AM ACAD CHILD PSY, V49, P514, DOI 10.1016/j.jaac.2010.01.020; World Health Organization, 1992, INSTR MAN, V3; World Health Organization, 1965, INT STAT CLASS DIS I; World Health Organization, 1977, MAN INT STAT CLASS D; World Health Organization, 1992, TAB LIST, V2	62	24	25	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2015	350								g7753	10.1136/bmj.g7753	http://dx.doi.org/10.1136/bmj.g7753			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3LU	25569841	Green Published, hybrid			2022-12-28	WOS:000348129900003
J	Hering, D				Hering, Dagmara			Renal denervation superior to drug therapy in hypertension	LANCET			English	Editorial Material							REDUCTION; TRIAL		[Hering, Dagmara] Baker IDI Heart & Diabet Inst, Neurovasc Hypertens & Kidney Dis Lab, Melbourne, Vic 3004, Australia; [Hering, Dagmara] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland	Baker Heart and Diabetes Institute; Fahrenheit Universities; Medical University Gdansk	Hering, D (corresponding author), Baker IDI Heart & Diabet Inst, Neurovasc Hypertens & Kidney Dis Lab, Melbourne, Vic 3004, Australia.	dagmara.hering@bakeridi.edu.au	Hering, Dagmara/AAR-7692-2020	Hering, Dagmara/0000-0003-4649-9524				Azizi M, 2015, LANCET; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; DiBona GF, 2010, AM J PHYSIOL-REG I, V298, pR245, DOI 10.1152/ajpregu.00647.2009; Esler M, 2014, J AM SOC HYPERTENS, V8, P593, DOI 10.1016/j.jash.2014.06.001; Esler MD, 2014, EUR HEART J, V35, P1752, DOI 10.1093/eurheartj/ehu209; Hering D, 2014, HYPERTENSION, V64, P118, DOI 10.1161/HYPERTENSIONAHA.113.03098; Hering D, 2013, HYPERTENSION, V61, P457, DOI 10.1161/HYPERTENSIONAHA.111.00194; Kandzari D., 2014, LECT BEH SYMPL HTN 3; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc	11	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1922	1924		10.1016/S0140-6736(14)62050-X	http://dx.doi.org/10.1016/S0140-6736(14)62050-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI1YR	25631071				2022-12-28	WOS:000354541700006
J	Liu, SQ; Cai, X; Wu, JX; Cong, Q; Chen, X; Li, T; Du, FH; Ren, JY; Wu, YT; Grishin, NV; Chen, ZJJ				Liu, Siqi; Cai, Xin; Wu, Jiaxi; Cong, Qian; Chen, Xiang; Li, Tuo; Du, Fenghe; Ren, Junyao; Wu, You-Tong; Grishin, Nick V.; Chen, Zhijian J.			Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation	SCIENCE			English	Article							NF-KAPPA-B; CYCLIC GMP-AMP; CRYSTAL-STRUCTURE; RIG-I; NUCLEAR TRANSLOCATION; IKK-BETA; RECOGNITION; KINASE; SEQUENCE; COMPLEX	During virus infection, the adaptor proteins MAVS and STING transduce signals from the cytosolic nucleic acid sensors RIG-I and cGAS, respectively, to induce type I interferons (IFNs) and other antiviral molecules. Here we show that MAVS and STING harbor two conserved serine and threonine clusters that are phosphorylated by the kinases IKK and/or TBK1 in response to stimulation. Phosphorylated MAVS and STING then bind to a positively charged surface of interferon regulatory factor 3 (IRF3) and thereby recruit IRF3 for its phosphorylation and activation by TBK1. We further show that TRIF, an adaptor protein in Toll-like receptor signaling, activates IRF3 through a similar phosphorylation-dependent mechanism. These results reveal that phosphorylation of innate adaptor proteins is an essential and conserved mechanism that selectively recruits IRF3 to activate the type I IFN pathway.	[Liu, Siqi; Cai, Xin; Wu, Jiaxi; Chen, Xiang; Li, Tuo; Du, Fenghe; Ren, Junyao; Wu, You-Tong; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Cong, Qian; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Cong, Qian; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Xiang; Du, Fenghe; Grishin, Nick V.; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Wu, Jiaxi/K-3322-2016; Chen, Zhijian/C-6039-2012; Li, Tuo/L-6958-2015	Wu, Jiaxi/0000-0002-6976-4784; Chen, Zhijian/0000-0002-8475-8251; Cong, Qian/0000-0002-8909-0414	NIH [AI-93967, GM-63692, GM-094575]; Welch Foundation [I-1389, I-1505]; International Student Fellowships from HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575, R01GM063692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); International Student Fellowships from HHMI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Yu, H. Mirzae, and C. Long for advice on mass spectrometry; L. Jia for advice on generating phospho-specific antibodies; and L. Sun, N. Varnado, and M. Xu for critically reading our manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by grants from the NIH (AI-93967 and GM-63692 to Z.J.C. and GM-094575 to N.G.) and the Welch Foundation (I-1389 to Z.J.C. and I-1505 to N.G.). X. Cai, J.W., and Q.C. were supported by International Student Fellowships from HHMI. Z.J.C. is an HHMI Investigator.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Chen BY, 2014, CELL, V156, P195, DOI 10.1016/j.cell.2013.11.048; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Suhara W, 2000, J BIOCHEM-TOKYO, V128, P301, DOI 10.1093/oxfordjournals.jbchem.a022753; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	45	846	883	24	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 13	2015	347	6227					1217	U17	aaa2630	10.1126/science.aaa2630	http://dx.doi.org/10.1126/science.aaa2630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE9NH	25636800				2022-12-28	WOS:000370964100001
J	Rosenblatt, M; Jain, SH; Cahill, M				Rosenblatt, Michael; Jain, Sachin H.; Cahill, Matthew			Sharing of Clinical Trial Data: Benefits, Risks, and Uniform Principles	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rosenblatt, Michael; Jain, Sachin H.; Cahill, Matthew] Merck & Co Inc, Kenilworth, NJ 07033 USA	Merck & Company	Rosenblatt, M (corresponding author), Merck & Co Inc, K1-4118B,2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	michael.rosenblatt@merck.com						Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Bonini S, 2014, NEW ENGL J MED, V371, P2452, DOI 10.1056/NEJMp1409464; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Doshi P, 2013, TRENDS PHARMACOL SCI, V34, P645, DOI 10.1016/j.tips.2013.10.006; European Federation of Pharmaceutical Industries and Associations, 2013, PRINC RESP CLIN TRIA; Godlee F, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3306; Hiatt WR, 2013, NEW ENGL J MED, V369, P1285, DOI 10.1056/NEJMp1309610; Institute of Medicine, 2015, DISC FRAM CLIN TRIAL; NIH, 2007, NIH DAT SHAR POL; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373	10	11	11	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					306	307		10.7326/M14-1299	http://dx.doi.org/10.7326/M14-1299			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25622304				2022-12-28	WOS:000350232500022
J	Chinthapalli, K				Chinthapalli, Krishna			MEDICINE AND MEDIA Helping Eddie Redmayne to portray motor neurone disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London St Georges Hosp, London, England	St Georges University London	Chinthapalli, K (corresponding author), Univ London St Georges Hosp, London, England.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Hawking J., 2007, TRAVELLING INFINITY; Hawking S, 2009, ANN NEUROSCI, V16, P99, DOI 10.5214/ans.0972.7531.2009.160302	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2015	350								h483	10.1136/bmj.h483	http://dx.doi.org/10.1136/bmj.h483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AU	25637136				2022-12-28	WOS:000348778800002
J	Larrondo, LF; Olivares-Yanez, C; Baker, CL; Loros, JJ; Dunlap, JC				Larrondo, Luis F.; Olivares-Yanez, Consuelo; Baker, Christopher L.; Loros, Jennifer J.; Dunlap, Jay C.			Decoupling circadian clock protein turnover from circadian period determination	SCIENCE			English	Article							RNA HELICASE FRH; NEUROSPORA-CRASSA; TEMPERATURE COMPENSATION; FREQUENCY DETERMINES; NEGATIVE FEEDBACK; COP9 SIGNALOSOME; GENE-EXPRESSION; DEGRADATION; PHOSPHORYLATION; RHYTHMS	The mechanistic basis of eukaryotic circadian oscillators in model systems as diverse as Neurospora, Drosophila, and mammalian cells is thought to be a transcription-and-translation-based negative feedback loop, wherein progressive and controlled phosphorylation of one or more negative elements ultimately elicits their own proteasome-mediated degradation, thereby releasing negative feedback and determining circadian period length. The Neurospora crassa circadian negative element FREQUENCY (FRQ) exemplifies such proteins; it is progressively phosphorylated at more than 100 sites, and strains bearing alleles of frq with anomalous phosphorylation display abnormal stability of FRQ that is well correlated with altered periods or apparent arrhythmicity. Unexpectedly, we unveiled normal circadian oscillations that reflect the allelic state of frq but that persist in the absence of typical degradation of FRQ. This manifest uncoupling of negative element turnover from circadian period length determination is not consistent with the consensus eukaryotic circadian model.	[Larrondo, Luis F.; Olivares-Yanez, Consuelo] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Millennium Nucleus Fungal Integrat & Synthet Biol, Casilla 114-D, Santiago, Chile; [Larrondo, Luis F.; Baker, Christopher L.; Loros, Jennifer J.; Dunlap, Jay C.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH 03755 USA; [Loros, Jennifer J.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Pontificia Universidad Catolica de Chile; Dartmouth College; Dartmouth College	Larrondo, LF (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Millennium Nucleus Fungal Integrat & Synthet Biol, Casilla 114-D, Santiago, Chile.	llarrondo@bio.puc.cl; jay.c.dunlap@dartmouth.edu	Dunlap, Jay/L-6232-2013; Larrondo, Luis/J-1086-2016	Dunlap, Jay/0000-0003-1577-0457; Larrondo, Luis/0000-0002-8832-7109	National Institute of General Medical Sciences of the National Institutes of Health [R01 GM34985, P01 GM68087, R01 GM083336]; Millennium Nucleus for Fungal Integrative and Synthetic Biology [NC120043]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1090513, 1131030]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM034985, R01GM083336] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Millennium Nucleus for Fungal Integrative and Synthetic Biology; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences of the National Institutes of Health to J.C.D. (R01 GM34985 and P01 GM68087) and J.J.L. (R01 GM083336), Millennium Nucleus for Fungal Integrative and Synthetic Biology (NC120043), and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1090513 and 1131030) to L.F.L. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank I. Edery and A. Kramer for comments on the manuscript, V. Caballero for technical assistance, and the Fungal Genetics Stock Center at the University of Missouri for strains.	ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Blau J, 2008, GENE DEV, V22, P1737, DOI 10.1101/gad.1696408; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cha J, 2011, J BIOL CHEM, V286, P11469, DOI 10.1074/jbc.M111.219782; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Duffield G, 2005, METHOD ENZYMOL, V393, P315, DOI 10.1016/S0076-6879(05)93014-0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gao P, 2013, J BIOL CHEM, V288, P35277, DOI 10.1074/jbc.M113.509604; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Guo JH, 2010, J BIOL CHEM, V285, P11508, DOI 10.1074/jbc.M109.071688; He Q, 2005, BIOCHEM SOC T, V33, P953, DOI 10.1042/BST0330953; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hurley JM, 2013, MOL CELL, V52, P832, DOI 10.1016/j.molcel.2013.11.005; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Larrondo LF, 2012, FUNGAL GENET BIOL, V49, P681, DOI 10.1016/j.fgb.2012.06.001; Lauinger L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4598; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Maywood ES, 2011, J NEUROSCI, V31, P1539, DOI 10.1523/JNEUROSCI.4107-10.2011; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Montenegro-Montero A, 2013, NEUROSPORA: GENOMICS AND MOLECULAR BIOLOGY, P243; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Ohsaki K, 2008, J BIOCHEM, V144, P609, DOI 10.1093/jb/mvn112; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Ruoff P, 2005, J THEOR BIOL, V237, P41, DOI 10.1016/j.jtbi.2005.03.030; Shi GS, 2013, P NATL ACAD SCI USA, V110, P4750, DOI 10.1073/pnas.1302560110; Shi M, 2007, P NATL ACAD SCI USA, V104, P20102, DOI 10.1073/pnas.0706631104; Shi M, 2010, GENETICS, V184, P351, DOI 10.1534/genetics.109.111393; Syed S, 2011, J BIOL CHEM, V286, P27654, DOI 10.1074/jbc.M111.243618; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712	55	95	97	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221							1257277	10.1126/science.1257277	http://dx.doi.org/10.1126/science.1257277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE9MW	25635104	Green Accepted			2022-12-28	WOS:000370962800001
J	Mervis, J				Mervis, Jeffrey			An education that closed doors	SCIENCE			English	Editorial Material																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					578	578		10.1126/science.347.6221.578	http://dx.doi.org/10.1126/science.347.6221.578			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA0YK	25635102				2022-12-28	WOS:000348639300056
J	Page, L				Page, Leigh			Are soaring US malpractice rates just a memory now?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												leighpage@comcast.net						Allen M, 2014, PROPUBLICA; Hyman DA, 2013, CHEST, V143, P222, DOI 10.1378/chest.12-1916; Koca SJ, 2014, END ERA NONECONOMIC; Martin J, 2009, 0901 AM BAR ASS; Medical Liability Monitor, ANN SURV MED MALPR R; Mello MM, 2014, JAMA-J AM MED ASSOC, V312, P2146, DOI 10.1001/jama.2014.10705; Mello MM, 2011, MED MALPRACTICE UPDA; Sanders B, 2014, NEW HAMPSHIRE BUSINE; Seabury SA, 2014, HEALTH AFFAIR, V33, P2048, DOI 10.1377/hlthaff.2014.0492; Thorpe KE, 2004, HLTH AFF MILLWOOD S	10	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2015	350								h394	10.1136/bmj.h394	http://dx.doi.org/10.1136/bmj.h394			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZR	25626416				2022-12-28	WOS:000348775700007
J	Asano, S; Fukuda, Y; Beck, F; Aufderheide, A; Forster, F; Danev, R; Baumeister, W				Asano, Shoh; Fukuda, Yoshiyuki; Beck, Florian; Aufderheide, Antje; Foerster, Friedrich; Danev, Radostin; Baumeister, Wolfgang			A molecular census of 26S proteasomes in intact neurons	SCIENCE			English	Article							UBIQUITIN; ARCHITECTURE; CELL; CLASSIFICATION; SUBTOMOGRAMS; DEGRADATION; RESOLUTION; COMPLEX; SYSTEM	The 26S proteasome is a key player in eukaryotic protein quality control and in the regulation of numerous cellular processes. Here, we describe quantitative in situ structural studies of this highly dynamic molecular machine in intact hippocampal neurons. We used electron cryotomography with the Volta phase plate, which allowed high fidelity and nanometer precision localization of 26S proteasomes. We undertook a molecular census of single-and double-capped proteasomes and assessed the conformational states of individual complexes. Under the conditions of the experiment-that is, in the absence of proteotoxic stress-only 20% of the 26S proteasomes were engaged in substrate processing. The remainder was in the substrate-accepting ground state. These findings suggest that in the absence of stress, the capacity of the proteasome system is not fully used.	[Asano, Shoh; Fukuda, Yoshiyuki; Beck, Florian; Aufderheide, Antje; Foerster, Friedrich; Danev, Radostin; Baumeister, Wolfgang] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Max Planck Society	Baumeister, W (corresponding author), Max Planck Inst Biochem, Dept Mol Struct Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	baumeist@biochem.mpg.de	Foerster, Friedrich/D-3710-2009	Foerster, Friedrich/0000-0002-6044-2746	European Commission [ERC-2012-SyG_318987-ToPAG]; Deutsche Forschungsgemeinschaft Excellence Cluster CIPSM [SFB 1035, FO 716/3-1]	European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft Excellence Cluster CIPSM(German Research Foundation (DFG))	We thank Y. Chen for technical assistance and troubleshooting and P. Unverdorben for support in modeling and discussions. The research leading to these results has received funding from the European Commission under FP7 GA no. ERC-2012-SyG_318987-ToPAG. The work was additionally supported by the Deutsche Forschungsgemeinschaft Excellence Cluster CIPSM and SFB 1035 (both to W.B.) and FO 716/3-1 (to F.F.). Data availability: The cryo-EM maps for the GS and SPS were deposited into the EMDB with the accession codes EMD-2830 and EMD-2831, respectively. FEI Company has submitted a patent for the Volta phase plate, which is currently pending. Information on materials and methods is available on Science Online	Barthelme D, 2014, P NATL ACAD SCI USA, V111, pE1687, DOI 10.1073/pnas.1404823111; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Chen YX, 2014, STRUCTURE, V22, P1528, DOI 10.1016/j.str.2014.08.007; Chen YX, 2013, J STRUCT BIOL, V182, P235, DOI 10.1016/j.jsb.2013.03.002; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; PETERS JM, 1993, J MOL BIOL, V234, P932, DOI 10.1006/jmbi.1993.1646; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006; YOSHIMURA T, 1993, J STRUCT BIOL, V111, P200, DOI 10.1006/jsbi.1993.1050	26	209	216	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					439	442		10.1126/science.1261197	http://dx.doi.org/10.1126/science.1261197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613890				2022-12-28	WOS:000348225800048
J	Uchino, K				Uchino, Ken			Pooled RCTs: Alteplase within 4.5 hours of ischemic stroke improves the likelihood of a good outcome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cerebrovasc Ctr, Cleveland Clin, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Uchino, K (corresponding author), Cerebrovasc Ctr, Cleveland Clin, Cleveland, OH 44195 USA.		Uchino, Ken/ABC-1611-2021	Uchino, Ken/0000-0001-9468-4172				Ahmed N, 2013, JAMA NEUROL, V70, P837, DOI 10.1001/jamaneurol.2013.406; Cronin CA, 2014, STROKE, V45, P2745, DOI 10.1161/STROKEAHA.114.005443; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC3	10.7326/ACPJC-2015-162-2-003	http://dx.doi.org/10.7326/ACPJC-2015-162-2-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599363				2022-12-28	WOS:000350106600002
J	Lemieux, GA; Cunningham, KA; Lin, L; Mayer, F; Werb, Z; Ashrafi, K				Lemieux, George A.; Cunningham, Katherine A.; Lin, Lin; Mayer, Fahima; Werb, Zena; Ashrafi, Kaveh			Kynurenic Acid Is a Nutritional Cue that Enables Behavioral Plasticity	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; QUINOLINIC ACID; HUNTINGTONS-DISEASE; SIGNALING PATHWAY; GLUTAMATE RELEASE; FEEDING-BEHAVIOR; MAMMALIAN-CELLS; NERVOUS-SYSTEM; METABOLISM	The kynurenine pathway of tryptophan metabolism is involved in the pathogenesis of several brain diseases, but its physiological functions remain unclear. We report that kynurenic acid, a metabolite in this pathway, functions as a regulator of food-dependent behavioral plasticity in C. elegans. The experience of fasting in C. elegans alters a variety of behaviors, including feeding rate, when food is encountered postfast. Levels of neurally produced kynurenic acid are depleted by fasting, leading to activation of NMDA-receptor-expressing interneurons and initiation of a neuropeptide-y-like signaling axis that promotes elevated feeding through enhanced serotonin release when animals re-encounter food. Upon refeeding, kynurenic acid levels are eventually replenished, ending the elevated feeding period. Because tryptophan is an essential amino acid, these findings suggest that a physiological role of kynurenic acid is in directly linking metabolism to activity of NMDA and serotonergic circuits, which regulate a broad range of behaviors and physiologies.	[Lemieux, George A.; Cunningham, Katherine A.; Lin, Lin; Mayer, Fahima; Ashrafi, Kaveh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ashrafi, K (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	kaveh.ashrafi@ucsf.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; Program in Breakthrough Biomedical Research, UCSF Diabetes Family Fund for Innovative Patient Care [R21 ES021412, R01 AG046400, U01 ES019458]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458, R21ES021412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046400] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs; Program in Breakthrough Biomedical Research, UCSF Diabetes Family Fund for Innovative Patient Care; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Shao-Yi Huang, Paul Muchowski, Steve Finkbeiner, Mihir Vohra, and Erik Johnson for helpful discussions and shared equipment and the Nikon Imaging Center at UCSF for microscope access. Some C. elegans strains were provided by the Caenorhabditis Genetics Center, funded by NIH Office of Research Infrastructure Programs (P40 OD010440), and the Mitani Lab of the National Bioresource Project of Japan for the Experimental Animal C. elegans. This research was supported by funds from the Program in Breakthrough Biomedical Research, UCSF Diabetes Family Fund for Innovative Patient Care, R21 ES021412 (NIEHS), R01 AG046400 (NIA), and U01 ES019458 (NCI).	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Albuquerque EX, 2013, BIOCHEM PHARMACOL, V85, P1027, DOI 10.1016/j.bcp.2012.12.014; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery Leon, 2012, WormBook, P1, DOI 10.1895/wormbook.1.150.1; BEAL MF, 1992, J NEUROL SCI, V108, P80; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; Cohen M, 2009, CELL METAB, V9, P375, DOI 10.1016/j.cmet.2009.02.003; Cunningham KA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004394; Cunningham KA, 2012, CELL METAB, V16, P113, DOI 10.1016/j.cmet.2012.05.014; Douglas SJ, 2005, TRENDS NEUROSCI, V28, P644, DOI 10.1016/j.tins.2005.09.006; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Erhardt S, 2013, NEUROPSYCHOPHARMACOL, V38, P743, DOI 10.1038/npp.2012.248; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kubiak TM, 2008, BIOPOLYMERS, V90, P339, DOI 10.1002/bip.20850; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; LAPIN IP, 1969, LANCET, V1, P132; Lee BH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001219; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Liang B, 2006, CELL METAB, V4, P429, DOI 10.1016/j.cmet.2006.11.004; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; McElroy SL, 2014, J CLIN PSYCHIAT, V75, P46, DOI [10.4088/JCP.13r08634, 10.4088/JCP.13010tx4c]; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Sengupta L, 2013, CURR OPIN NEUROBIOL, V23, P68, DOI 10.1016/j.conb.2012.08.001; Song BM, 2013, ELIFE, V2, DOI 10.7554/eLife.00329; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Stipanuk M, 2013, BIOCH PHYSL MOL ASPE; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van der Goot AT, 2013, TRENDS MOL MED, V19, P336, DOI 10.1016/j.molmed.2013.02.007; Waggoner LF, 2000, GENETICS, V154, P1181; Whim MD, 2001, NEURON, V30, P37, DOI 10.1016/S0896-6273(01)00261-6; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	54	45	53	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					119	131		10.1016/j.cell.2014.12.028	http://dx.doi.org/10.1016/j.cell.2014.12.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594177	Green Accepted, Bronze			2022-12-28	WOS:000347923200013
J	Lin, JZ; Gagnon, MG; Bulkley, D; Steitz, TA				Lin, Jinzhong; Gagnon, Matthieu G.; Bulkley, David; Steitz, Thomas A.			Conformational Changes of Elongation Factor G on the Ribosome during tRNA Translocation	CELL			English	Article							EF-G; 70S RIBOSOME; STRUCTURAL BASIS; GTP HYDROLYSIS; PRETRANSLOCATION STATE; INTERSUBUNIT ROTATION; CRYSTAL-STRUCTURE; DYNAMICS; MOVEMENT; THIOSTREPTON	The universally conserved GTPase elongation factor G (EF-G) catalyzes the translocation of tRNA and mRNA on the ribosome after peptide bond formation. Despite numerous studies suggesting that EF-G undergoes extensive conformational rearrangements during translocation, high-resolution structures exist for essentially only one conformation of EF-G in complex with the ribosome. Here, we report four atomic-resolution crystal structures of EF-G bound to the ribosome programmed in the pre- and posttranslocational states and to the ribosome trapped by the antibiotic dityromycin. We observe a previously unseen conformation of EF-G in the pretranslocation complex, which is independently captured by dityromycin on the ribosome. Our structures provide insights into the conformational space that EF-G samples on the ribosome and reveal that tRNA translocation on the ribosome is facilitated by a structural transition of EF-G from a compact to an elongated conformation, which can be prevented by the antibiotic dityromycin.	[Lin, Jinzhong; Gagnon, Matthieu G.; Bulkley, David; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Bulkley, David; Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Gagnon, Matthieu G.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526; Gagnon, Matthieu/0000-0003-4516-604X; Bulkley, David/0000-0002-2535-904X	NIH [GM022778]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Moore, S. Seetharaman, Y. Polikanov, I. Lomakin, and A. Innis for their valuable discussions and critical reading of the manuscript. We thank R. Grodzicki and Y. Polikanov for preparing tRNAs. The antibiotic dityromycin was kindly provided by the Gualerzi laboratory at the University of Camerino, Italy. We also thank the staff of the Advanced Photon Source beamline 24-ID and the National Synchrotron Light Source beamline X25 for help during data collection and the Center for Structural Biology facility at Yale University for computational support. This work was supported by an NIH grant (GM022778).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bowen WS, 2005, J BIOL CHEM, V280, P2934, DOI 10.1074/jbc.M407008200; Brandi L, 2006, RNA, V12, P1262, DOI 10.1261/rna.61206; Brandi L, 2012, FEBS LETT, V586, P3373, DOI 10.1016/j.febslet.2012.07.040; Brilot AF, 2013, P NATL ACAD SCI USA, V110, P20994, DOI 10.1073/pnas.1311423110; Bulkley D, 2014, CELL REP, V6, P357, DOI 10.1016/j.celrep.2013.12.024; Chen CL, 2011, MOL CELL, V42, P367, DOI 10.1016/j.molcel.2011.03.024; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Czworkowski J, 1997, BIOCHEMISTRY-US, V36, P10327, DOI 10.1021/bi970610k; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gagnon MG, 2014, SCIENCE, V345, P684, DOI 10.1126/science.1253525; Gagnon MG, 2012, SCIENCE, V335, P1370, DOI 10.1126/science.1217443; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Guo ZJ, 2012, P NATL ACAD SCI USA, V109, P20391, DOI 10.1073/pnas.1218999109; Holtkamp W, 2014, EMBO J, V33, P1073, DOI 10.1002/embj.201387465; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Matassova NB, 2001, RNA, V7, P1879; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Salsi E, 2014, P NATL ACAD SCI USA, V111, P15060, DOI 10.1073/pnas.1410873111; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Ticu C, 2009, EMBO J, V28, P2053, DOI 10.1038/emboj.2009.169; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Walter JD, 2012, NUCLEIC ACIDS RES, V40, P360, DOI 10.1093/nar/gkr623; Wang Y, 2007, BIOCHEMISTRY-US, V46, P10767, DOI 10.1021/bi700657d; Wilson KS, 2004, J MOL BIOL, V337, P15, DOI 10.1016/j.jmb.2004.01.013; Zhou J, 2014, SCIENCE, V345, P1188, DOI 10.1126/science.1255030; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086	56	84	87	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					219	227		10.1016/j.cell.2014.11.049	http://dx.doi.org/10.1016/j.cell.2014.11.049			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594181	Bronze, Green Accepted			2022-12-28	WOS:000347923200020
J	Davies, I; Burman-Roy, S; Murphy, MS				Davies, Ieuan; Burman-Roy, Shona; Murphy, M. Stephen		Guideline Dev Grp	Gastro-oesophageal reflux disease in children: NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Davies, Ieuan] Univ Wales Hosp, Dept Paediat Gastroenterol, Cardiff CF14 4XW, S Glam, Wales; [Burman-Roy, Shona; Murphy, M. Stephen] Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England	Cardiff University	Davies, I (corresponding author), Univ Wales Hosp, Dept Paediat Gastroenterol, Cardiff CF14 4XW, S Glam, Wales.	ieuan.davies@wales.nhs.uk	Kunutsor, Setor K/H-9807-2019; Peek, Russell/ABC-5063-2021	Kunutsor, Setor K/0000-0002-2625-0273; Peek, Russell/0000-0003-3149-8414				National Institute for Health and Care Excellence, 2013, 160 NAT I HLTH CAR E; National Institute for Health and Care Excellence, 2014, 189 NAT I HLTH CAR E; National Institute for Health and Care Excellence, 2015, 193 NAT I HLTH CAR E; National Institute for Health and Clinical Excellence, 2007, 54 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2010, 102 NAT I HLTH CLIN; National Institute for Health and Clinical Excellence, 2006, 43 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2011, 116 NAT I HLTH CLIN; NHS Choices, SUDD INF DEATH SYNDR	8	60	60	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2015	350								g7703	10.1136/bmj.g7703	http://dx.doi.org/10.1136/bmj.g7703			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3NA	25591811	Green Published			2022-12-28	WOS:000348133000001
J	Dudney, NJ; Li, JC				Dudney, Nancy J.; Li, Juchuan			Using all energy in a battery	SCIENCE			English	Editorial Material							LI-ION BATTERIES; ELECTRODE MATERIALS; LITHIUM; CATHODES; DEGRADATION; TRANSPORT; FLUORIDE		[Dudney, Nancy J.; Li, Juchuan] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Dudney, NJ (corresponding author), Oak Ridge Natl Lab, Mat Sci & Technol Div, Post Off Box 2008,MS 6124, Oak Ridge, TN 37831 USA.	dudneynj@ornl.gov	Li, Juchuan/A-2992-2009; Dudney, Nancy J/I-6361-2016	Li, Juchuan/0000-0002-6587-5591; Dudney, Nancy J/0000-0001-7729-6178				Ban CM, 2010, ADV MATER, V22, pE145, DOI 10.1002/adma.200904285; Cabana J, 2010, ADV MATER, V22, pE170, DOI 10.1002/adma.201000717; Cai L, 2013, J POWER SOURCES, V236, P163, DOI 10.1016/j.jpowsour.2013.02.066; Cobb CL, 2014, J POWER SOURCES, V249, P357, DOI 10.1016/j.jpowsour.2013.10.084; Ebner M, 2013, SCIENCE, V342, P716, DOI 10.1126/science.1241882; Kirshenbaum K, 2015, SCIENCE, V347, P149, DOI 10.1126/science.1257289; Ko JK, 2014, ACS APPL MATER INTER, V6, P10858, DOI 10.1021/am500538b; Marschilok A, 2011, ENERG ENVIRON SCI, V4, P2943, DOI 10.1039/c1ee01507a; Martha SK, 2014, RSC ADV, V4, P6730, DOI 10.1039/c3ra47266c; Martha SK, 2011, J ELECTROCHEM SOC, V158, pA1060, DOI 10.1149/1.3611436; Nanda J, 2012, J PHYS CHEM C, V116, P8401, DOI 10.1021/jp3016003; Takeuchi ES, 2009, CHEM MATER, V21, P4934, DOI 10.1021/cm902102k; Wang F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2185; Woodford WH, 2014, J MECH PHYS SOLIDS, V70, P71, DOI 10.1016/j.jmps.2014.05.011; Yang FF, 2014, NANO LETT, V14, P4334, DOI 10.1021/nl502090z	15	88	89	4	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					131	132		10.1126/science.aaa2870	http://dx.doi.org/10.1126/science.aaa2870			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574010				2022-12-28	WOS:000347918900026
J	Ferrari, G				Ferrari, Gabriele			Dynamics of a cold quantum gas	SCIENCE			English	Editorial Material							SPONTANEOUS SYMMETRY-BREAKING; BOSE-EINSTEIN CONDENSATE		[Ferrari, Gabriele] Univ Trento, BEC Ctr, Ist Nazl Ott, CNR, I-38123 Povo, Italy; [Ferrari, Gabriele] Univ Trento, Dipartimento Fis, I-38123 Povo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Trento; University of Trento	Ferrari, G (corresponding author), Univ Trento, BEC Ctr, Ist Nazl Ott, CNR, I-38123 Povo, Italy.	ferrari@science.unitn.it	Ferrari, Gabriele/E-3755-2010; Ferrari, Gabriele/AAK-3657-2020	Ferrari, Gabriele/0000-0003-1827-5048; Ferrari, Gabriele/0000-0003-1827-5048				Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Corman L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.135302; Donner T, 2007, SCIENCE, V315, P1556, DOI 10.1126/science.1138807; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Lamporesi G, 2013, NAT PHYS, V9, P655, DOI 10.1038/NPHYS2734; Navon N, 2015, SCIENCE, V347, P167, DOI 10.1126/science.1258676; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; Weiler CN, 2008, NATURE, V455, P948, DOI 10.1038/nature07334; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	9	0	0	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					127	127		10.1126/science.aaa3016	http://dx.doi.org/10.1126/science.aaa3016			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574007				2022-12-28	WOS:000347918900023
J	Penzo, MA; Robert, V; Tucciarone, J; De Bundel, D; Wang, MH; Van Aelst, L; Darvas, M; Parada, LF; Palmiter, RD; He, M; Huang, ZJ; Li, B				Penzo, Mario A.; Robert, Vincent; Tucciarone, Jason; De Bundel, Dimitri; Wang, Minghui; Van Aelst, Linda; Darvas, Martin; Parada, Luis F.; Palmiter, Richard D.; He, Miao; Huang, Z. Josh; Li, Bo			The paraventricular thalamus controls a central amygdala fear circuit	NATURE			English	Article							CONDITIONAL DELETION; NEUROTROPHIC FACTOR; NUCLEUS; PROJECTIONS; EXPRESSION; PROTEIN; MIDLINE; STRESS; OREXIN	Appropriate responses to an imminent threat brace us for adversities. The ability to sense and predict threatening or stressful events is essential for such adaptive behaviour. In the mammalian brain, one putative stress sensor is the paraventricular nucleus of the thalamus (PVT), an area that is readily activated by both physical and psychological stressors(1-3). However, the role of the PVT in the establishment of adaptive behavioural responses remains unclear. Here we show in mice that the PVT regulates fear processing in the lateral division of the central amygdala (CeL), a structure that orchestrates fear learning and expression(4,5). Selective inactivation of CeL-projecting PVT neurons prevented fear conditioning, an effect that can be accounted for by an impairment in fear-conditioning-induced synaptic potentiation onto somatostatin-expressing (SOM+) CeL neurons, which has previously been shown to store fear memory(6). Consistently, we found that PVT neurons preferentially innervate SOM+ neurons in the CeL, and stimulation of PVT afferents facilitated SOM+ neuron activity and promoted intra-CeL inhibition, two processes that are critical for fear learning and expression(5,6). Notably, PVT modulation of SOM+ CeL neurons was mediated by activation of the brain-derived neurotrophic factor (BDNF) receptor tropomysin-related kinase B (TrkB). As a result, selective deletion of either Bdnf in the PVT or Trkb in SOM+ CeL neurons impaired fear conditioning, while infusion of BDNF into the CeL enhanced fear learning and elicited unconditioned fear responses. Our results demonstrate that the PVT-CeL pathway constitutes a novel circuit essential for both the establishment of fear memory and the expression of fear responses, and uncover mechanisms linking stress detection in PVT with the emergence of adaptive behaviour.	[Penzo, Mario A.; Robert, Vincent; Tucciarone, Jason; Wang, Minghui; Van Aelst, Linda; Huang, Z. Josh; Li, Bo] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Robert, Vincent] Ecole Normale Super, F-94230 Cachan, France; [Tucciarone, Jason] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11790 USA; [Tucciarone, Jason] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11790 USA; [De Bundel, Dimitri] INSERM, CNRS, Inst Genom Fonct, UMR 5203,U661, F-34090 Montpellier, France; [Darvas, Martin] Univ Washington, Dept Pathol, Seattle, WA 98104 USA; [Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA; [He, Miao] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [He, Miao] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Cold Spring Harbor Laboratory; UDICE-French Research Universities; Universite Paris Saclay; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fudan University; Fudan University	Penzo, MA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mpenzo@cshl.edu; bli@cshl.edu	Wang, Minghui/Y-3974-2019; De Bundel, Dimitri/C-5701-2015; De Bundel, Dimitri/AAG-9453-2020; Core, Vector/CAF-4832-2022; Darvas, Martin/E-2935-2015; Penzo, Mario/AAP-8789-2021; He, Miao/AAQ-1044-2020	Darvas, Martin/0000-0002-7942-2526; He, Miao/0000-0003-0731-6801; Tucciarone, Jason/0000-0002-6053-2952; Robert, Vincent/0000-0001-9919-0040; Li, Bo/0000-0002-0154-3088; De Bundel, Dimitri/0000-0002-6234-9908	National Institutes of Health (NIH); Dana Foundation; NARSAD; Louis Feil Trust; Stanley Family Foundation; Harvey L. Karp Discovery Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808, R01MH094705, R01MH101214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082266] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NARSAD(NARSAD); Louis Feil Trust; Stanley Family Foundation; Harvey L. Karp Discovery Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Nestler for providing us with the Trkb<SUP>lox/lox</SUP> mice generated by L.F.P., K. Deisseroth for the AAV-Ef1a-fDIO backbone, E. Valjent for supporting D.D.B.'s work, and members of the Li laboratory for discussions. This work was supported by grants from the National Institutes of Health (NIH) (B.L., L.V.A. and Z.J.H.), the Dana Foundation (B.L.), NARSAD (B.L. and Z.J.H.), Louis Feil Trust (B.L.), the Stanley Family Foundation (B.L. and Z.J.H.), and a Harvey L. Karp Discovery Award (M.A.P.).	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bhatnagar S, 2000, J NEUROSCI, V20, P5564, DOI 10.1523/JNEUROSCI.20-14-05564.2000; CHASTRETTE N, 1991, BRAIN RES, V563, P339, DOI 10.1016/0006-8993(91)91559-J; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Conner JM, 1997, J NEUROSCI, V17, P2295; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Darvas M, 2009, P NATL ACAD SCI USA, V106, P14664, DOI 10.1073/pnas.0907299106; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Johnson PL, 2012, PROG BRAIN RES, V198, P133, DOI 10.1016/B978-0-444-59489-1.00009-4; Krout KE, 2000, J COMP NEUROL, V428, P475, DOI 10.1002/1096-9861(20001218)428:3<475::AID-CNE6>3.0.CO;2-9; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Li S, 2008, J COMP NEUROL, V506, P263, DOI 10.1002/cne.21502; Li YH, 2010, PHARMACOL BIOCHEM BE, V95, P121, DOI 10.1016/j.pbb.2009.12.016; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Spencer SJ, 2004, BRAIN RES, V997, P234, DOI 10.1016/j.brainres.2003.10.054; Vertes RP, 2008, J COMP NEUROL, V508, P212, DOI 10.1002/cne.21679; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006; Zhang L, 2014, MOL PSYCHIATR, V19, P8, DOI 10.1038/mp.2012.180	26	271	275	7	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					455	+		10.1038/nature13978	http://dx.doi.org/10.1038/nature13978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25600269	Green Accepted			2022-12-28	WOS:000351602800053
J	Blumenthal, D; Davis, K; Guterman, S				Blumenthal, David; Davis, Karen; Guterman, Stuart			Medicare at 50-Moving Forward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE; PERFORMANCE; PAYMENT; GROWTH; COST		[Blumenthal, David] Commonwealth Fund, New York, NY USA; [Guterman, Stuart] Commonwealth Fund, Washington, DC USA; [Davis, Karen] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Commonwealth Fund; Commonwealth Fund; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY USA.							Aaron HJ, 2012, NEW ENGL J MED, V366, P877, DOI 10.1056/NEJMp1200448; Anderson G, 2010, CHRONIC CARE MAKING; [Anonymous], 2014, FACT SHEETS MED ACOS; [Anonymous], 2012, LONG TERM BUDG IMP P; [Anonymous], 2014, AHRQ PUBLICATION, V10(12)-EHC063-EF; [Anonymous], 2014, 2014 ANN REP BOARDS; [Anonymous], INN IS HAPP PION ACO; Antos J, 2013, PLAN COMPETITION CON; Antos JR, 2012, NEW ENGL J MED, V367, P954, DOI 10.1056/NEJMsb1207996; Baron RJ, 2014, NEW ENGL J MED, V370, P99, DOI 10.1056/NEJMp1314933; Blumenthal D, 2015, NEW ENGL J MED, V372, P479, DOI 10.1056/NEJMhpr1411701; Center for Medicare and Medicaid Innovation, INN MOD; Centers for Medicare and Medicaid Services, MED SHAR SAV PROGR A; Congressional Budget Office, 2014, 2014 LONG TERM BUDG; Cubanski J, 2014, HLTH CARE BUDGET FIN; Davis K, 2013, HEALTH AFFAIR, V32, P900, DOI 10.1377/hlthaff.2012.1203; Department of Health and Human Services, 2014, NEW HHS DAT SHOWS MA; Department of Health and Human Services Centers for Medicare and Medicaid Services, 2014, FED REGISTER, V79, P72759; Gold M., 2014, WHAT DO WE KNOW HLTH; Guterman S, 2009, HEALTH AFFAIR, V28, pW238, DOI 10.1377/hlthaff.28.2.w238; House Budget Committee, 2014, PATH PROSP FISC YEAR; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Kongstvedt P. R., 2007, ESSENTIALS MANAGED H; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mongan JJ, 2008, NEW ENGL J MED, V358, P1509, DOI 10.1056/NEJMsb0707912; Newhouse J.P., 2013, VARIATION HLTH CARE; Osborn R, 2014, HEALTH AFFAIR, V33, P2247, DOI 10.1377/hlthaff.2014.0947; Robinow A., 2010, POTENTIAL GLOBAL PAY; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Shih A., 2008, ORG US HLTH CARE DEL; Song ZR, 2014, NEW ENGL J MED, V371, P1704, DOI 10.1056/NEJMsa1404026; The Commonwealth Fund Commission on a High Performance Health System, 2013, CONFR COSTS STAB US; US Senate Commission on Long Term Care, 2013, REP C; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939; Zezza MA, 2012, BUNDLED PAYMENT CARE; Zezza MA, 2014, INCENTIVES 2 0 SYNER	37	23	23	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 12	2015	372	7					671	677		10.1056/NEJMhpr1414856	http://dx.doi.org/10.1056/NEJMhpr1414856			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA8CK	25629661				2022-12-28	WOS:000349143900016
J	Sullivan, WJ; Christofk, HR				Sullivan, William J.; Christofk, Heather R.			The Metabolic Milieu of Metastases	CELL			English	Editorial Material							CANCER; EXPRESSION		[Sullivan, William J.; Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Christofk, Heather R.] Univ Calif Los Angeles, David Geffen Sch Med, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Christofk, Heather R.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Christofk, HR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	hchristofk@mednet.ucla.edu		Christofk, Heather/0000-0002-8662-4425				Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Maffione AM, 2015, EUR J NUCL MED MOL I, V42, P152, DOI 10.1007/s00259-014-2930-4; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103	10	16	16	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					363	364		10.1016/j.cell.2015.01.023	http://dx.doi.org/10.1016/j.cell.2015.01.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635452	Bronze			2022-12-28	WOS:000349208000003
J	Ho, DK				Ho, David K.			Ineffective treatment of sex offenders fails victims	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									South Essex Partnership Univ NHS Fdn Trust, SEPT Secure Mental Hlth Serv, Wickford SS11 7FE, Essex, England		Ho, DK (corresponding author), South Essex Partnership Univ NHS Fdn Trust, SEPT Secure Mental Hlth Serv, Wickford SS11 7FE, Essex, England.	david.ho@nhs.net						Dennis JA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007507.pub2; Ho DK, 2012, CRIM BEHAV MENT HEAL, V22, P1, DOI 10.1002/cbm.1818; Losel F., 2005, J EXP CRIMINOL, V1, P117, DOI [10.1007/s11292-004-6466-7, DOI 10.1007/S11292-004-6466-7]	3	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2015	350								h199	10.1136/bmj.h199	http://dx.doi.org/10.1136/bmj.h199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZR	25627560				2022-12-28	WOS:000348775700003
J	Worthley, DL; Churchill, M; Compton, JT; Tailor, Y; Rao, M; Si, YL; Levin, D; Schwartz, MG; Uygur, A; Hayakawa, Y; Gross, S; Renz, BW; Setlik, W; Martinez, AN; Chen, XW; Nizami, S; Lee, HG; Kang, HP; Caldwell, JM; Asfaha, S; Westphalen, CB; Graham, T; Jin, GC; Nagar, K; Wang, HS; Kheirbek, MA; Kolhe, A; Carpenter, J; Glaire, M; Nair, A; Renders, S; Manieri, N; Muthupalani, S; Fox, JG; Reichert, M; Giraud, AS; Schwabe, RF; Pradere, JP; Walton, K; Prakash, A; Gumucio, D; Rustgi, AK; Stappenbeck, TS; Friedman, RA; Gershon, MD; Sims, P; Grikscheit, T; Lee, FY; Karsenty, G; Mukherjee, S; Wang, TC				Worthley, Daniel L.; Churchill, Michael; Compton, Jocelyn T.; Tailor, Yagnesh; Rao, Meenakshi; Si, Yiling; Levin, Daniel; Schwartz, Matthew G.; Uygur, Aysu; Hayakawa, Yoku; Gross, Stefanie; Renz, Bernhard W.; Setlik, Wanda; Martinez, Ashley N.; Chen, Xiaowei; Nizami, Saqib; Lee, Heon Goo; Kang, H. Paco; Caldwell, Jon-Michael; Asfaha, Samuel; Westphalen, C. Benedikt; Graham, Trevor; Jin, Guangchun; Nagar, Karan; Wang, Hongshan; Kheirbek, Mazen A.; Kolhe, Alka; Carpenter, Jared; Glaire, Mark; Nair, Abhinav; Renders, Simon; Manieri, Nicholas; Muthupalani, Sureshkumar; Fox, James G.; Reichert, Maximilian; Giraud, Andrew S.; Schwabe, Robert F.; Pradere, Jean-Phillipe; Walton, Katherine; Prakash, Ajay; Gumucio, Deborah; Rustgi, Anil K.; Stappenbeck, Thaddeus S.; Friedman, Richard A.; Gershon, Michael D.; Sims, Peter; Grikscheit, Tracy; Lee, Francis Y.; Karsenty, Gerard; Mukherjee, Siddhartha; Wang, Timothy C.			Gremlin 1 Identifies a Skeletal Stem Cell with Bone, Cartilage, and Reticular Stromal Potential	CELL			English	Article							PROGENITOR CELLS; MARROW; DIFFERENTIATION; OSTEOBLAST; LINEAGE; GROWTH; NESTIN; NICHE; MOUSE; FATE	The stem cells that maintain and repair the postnatal skeleton remain undefined. One model suggests that perisinusoidal mesenchymal stem cells (MSCs) give rise to osteoblasts, chondrocytes, marrow stromal cells, and adipocytes, although the existence of these cells has not been proven through fate-mapping experiments. We demonstrate here that expression of the bone morphogenetic protein (BMP) antagonist gremlin 1 defines a population of osteochondroreticular (OCR) stem cells in the bone marrow. OCR stem cells self-renew and generate osteoblasts, chondrocytes, and reticular marrow stromal cells, but not adipocytes. OCR stem cells are concentrated within the metaphysis of long bones not in the perisinusoidal space and are needed for bone development, bone remodeling, and fracture repair. Grem1 expression also identifies intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath. Grem1 expression identifies distinct connective tissue stem cells in both the bone (OCR stem cells) and the intestine (iRSCs).	[Worthley, Daniel L.; Churchill, Michael; Tailor, Yagnesh; Si, Yiling; Hayakawa, Yoku; Renz, Bernhard W.; Chen, Xiaowei; Asfaha, Samuel; Westphalen, C. Benedikt; Jin, Guangchun; Nagar, Karan; Wang, Hongshan; Kolhe, Alka; Carpenter, Jared; Glaire, Mark; Nair, Abhinav; Renders, Simon; Schwabe, Robert F.; Pradere, Jean-Phillipe; Mukherjee, Siddhartha; Wang, Timothy C.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Worthley, Daniel L.; Churchill, Michael; Tailor, Yagnesh; Si, Yiling; Hayakawa, Yoku; Renz, Bernhard W.; Chen, Xiaowei; Asfaha, Samuel; Westphalen, C. Benedikt; Jin, Guangchun; Nagar, Karan; Wang, Hongshan; Kolhe, Alka; Carpenter, Jared; Glaire, Mark; Nair, Abhinav; Renders, Simon; Schwabe, Robert F.; Pradere, Jean-Phillipe; Mukherjee, Siddhartha; Wang, Timothy C.] Columbia Univ, Irving Canc Res Ctr, New York, NY 10032 USA; [Worthley, Daniel L.] Univ Adelaide, Dept Med, Adelaide, SA 5005, Australia; [Worthley, Daniel L.] South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia; [Worthley, Daniel L.; Giraud, Andrew S.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Compton, Jocelyn T.; Martinez, Ashley N.; Nizami, Saqib; Lee, Heon Goo; Kang, H. Paco; Caldwell, Jon-Michael; Lee, Francis Y.] Columbia Univ, Med Ctr, Dept Orthoped Surg, New York, NY 10032 USA; [Rao, Meenakshi] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Levin, Daniel; Grikscheit, Tracy] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Schwartz, Matthew G.; Uygur, Aysu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Gross, Stefanie; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Setlik, Wanda; Gershon, Michael D.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Westphalen, C. Benedikt] Univ Munich, Univ Hosp Munich, Dept Internal Med 3, D-81377 Munich, Germany; [Graham, Trevor] Queen Mary Univ London, Barts & London Sch Med & Dent, Barts Canc Inst, London EC1M 6BQ, England; [Kheirbek, Mazen A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Manieri, Nicholas; Stappenbeck, Thaddeus S.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Muthupalani, Sureshkumar; Fox, James G.; Reichert, Maximilian] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Rustgi, Anil K.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Div Gastroenterol,Dept Med & Genet, Philadelphia, PA 19104 USA; [Pradere, Jean-Phillipe] Univ Toulouse 3, I2MC, INSERM, UMR1048, F-31432 Toulouse, France; [Walton, Katherine; Prakash, Ajay; Gumucio, Deborah] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Friedman, Richard A.] Columbia Univ, Herbert Irving Comprehens Canc Ctr Biomed Informa, New York, NY 10032 USA; [Friedman, Richard A.] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Sims, Peter] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA	Columbia University; Columbia University; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Columbia University; Columbia University; Children's Hospital Los Angeles; University of Southern California; Harvard University; Harvard Medical School; Columbia University; Columbia University; University of Munich; University of London; Queen Mary University London; Columbia University; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Michigan System; University of Michigan; Columbia University; Columbia University; Columbia University	Mukherjee, S (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	sm3252@columbia.edu; tcw21@columbia.edu	Asfaha, Samuel/I-8245-2015; Reichert, Maximilian/GOH-1246-2022; Schwabe, Robert/AAY-6506-2021; Caldwell, Jon-Michael/AAG-6503-2021; Muthupalani, Sureshkumar/C-7244-2015; Kheirbek, Mazen A/J-3656-2015; Hayakawa, Yoku/AAI-8581-2020	Asfaha, Samuel/0000-0001-6972-0338; Caldwell, Jon-Michael/0000-0003-3767-5813; Kheirbek, Mazen A/0000-0001-9157-7363; Hayakawa, Yoku/0000-0002-3988-2499; Wang, Timothy/0000-0001-5730-3019; Sims, Peter/0000-0002-3921-4837; Graham, Trevor/0000-0001-9582-1597; Pradere, Jean-Philippe/0000-0003-1734-1429; Walton, Katherine/0000-0001-9108-5617; Karsenty, Gerard/0000-0002-9253-7627; Churchill, Michael/0000-0001-7202-3891; Westphalen, Benedikt/0000-0002-5310-3754; Compton, Jocelyn/0000-0003-3306-7706; Manieri, Nicholas/0000-0002-5648-5989; Schwartz, Matthew/0000-0001-9549-9868	NIH [NIH 5U54 CA126513, R01 RHL115145A, NIH AR056246, EB006834]; American Cancer Society; NH&MRC and Menzies Foundation; Cancer Council SA's Beat Cancer; State Government of South Australia through the Department of Health, Gastroenterological Society of Australia; American Gastroenterological Association; American Association for Cancer Research; Royal Australasian College of Physicians; Ines Mandl Postdoctoral research fellowship Columbia University; NATIONAL CANCER INSTITUTE [U54CA126513] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NH&MRC and Menzies Foundation; Cancer Council SA's Beat Cancer(Cancer Council South Australia); State Government of South Australia through the Department of Health, Gastroenterological Society of Australia; American Gastroenterological Association; American Association for Cancer Research; Royal Australasian College of Physicians(General Electric); Ines Mandl Postdoctoral research fellowship Columbia University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Thank you to Dr. Liza Phillips. Thank you to all members of the Wang laboratory at Columbia University. Thank you to Professor David Callen, Dr. Miao Yang, and Dr. Laura Vrbanac at the University of Adelaide. Thank you to Dr. Lei Ding for his advice and assistance. Thank you to Dr. Grigori Enikolopov (Cold Spring Harbor Laboratory) and Dr. Rene Hen (Columbia University) for sharing their transgenic mice. Thank you to Dr. Victor Lin for his transgenic advice and to Dr. Brian Eyden for his advice regarding intestinal mesenchymal cells. We are grateful for the following funding: from the NIH to T.C.W. (NIH 5U54 CA126513), to S.M. (R01 RHL115145A), to F.Y.L. from the Robert Carroll and Jane Chace Carroll Laboratories and also the NIH (NIH AR056246 and EB006834), to A.K.R. from the American Cancer Society, and to D.L.W. from the NH&MRC and Menzies Foundation, Cancer Council SA's Beat Cancer Project on behalf of its donors and the State Government of South Australia through the Department of Health, Gastroenterological Society of Australia, the American Gastroenterological Association, the American Association for Cancer Research, the Royal Australasian College of Physicians, and the Ines Mandl Postdoctoral research fellowship Columbia University.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Belkind-Gerson J, 2013, NEUROGASTROENT MOTIL, V25, P61, DOI 10.1111/nmo.12015; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Delorme B, 2009, STEM CELLS, V27, P1142, DOI 10.1002/stem.34; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Jaeger E, 2012, NAT GENET, V44, P699, DOI 10.1038/ng.2263; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Levin Daniel E, 2013, Methods Mol Biol, V1001, P299, DOI 10.1007/978-1-62703-363-3_25; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Ono N, 2014, DEV CELL, V29, P330, DOI 10.1016/j.devcel.2014.03.014; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	40	411	427	4	108	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					269	284		10.1016/j.cell.2014.11.042	http://dx.doi.org/10.1016/j.cell.2014.11.042			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594183	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000347923200024
J	Paul, BC; Roland, JT				Paul, Benjamin C.; Roland, J. Thomas, Jr.			An Abnormal Audiogram	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEARING-LOSS		[Paul, Benjamin C.; Roland, J. Thomas, Jr.] NYU, Dept Otolaryngol Head & Neck Surg, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Roland, JT (corresponding author), NYU, Dept Otolaryngol, Langone Med Ctr, 550 First Ave,Ste 7Q, New York, NY 10016 USA.	john.roland@nyumc.org		Roland, Jr., J. Thomas/0000-0003-1181-4651				American Academy of Otolaryngology-Head and Neck Surgery, 1993, AAO HNS B, P16; Chau JK, 2012, OTOLARYNG CLIN N AM, V45, P941, DOI 10.1016/j.otc.2012.06.002; KOTLARZ JP, 1992, LARYNGOSCOPE, V102, P1108, DOI 10.1288/00005537-199210000-00004; Nash SD, 2011, ARCH OTOLARYNGOL, V137, P432, DOI 10.1001/archoto.2011.15; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; Stucken EZ, 2012, OTOLARYNG CLIN N AM, V45, P269, DOI 10.1016/j.otc.2011.12.001; Stucken EZ, 2012, OTOLARYNGOL CLIN N A, V45, pvii; Thomas J P, 2011, Otolaryngol Pol, V65, P162, DOI 10.1016/S0030-6657(11)70670-9	8	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					85	86		10.1001/jama.2014.12418	http://dx.doi.org/10.1001/jama.2014.12418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562271				2022-12-28	WOS:000347478000020
J	Lankisch, PG; Apte, M; Banks, PA				Lankisch, Paul Georg; Apte, Minoti; Banks, Peter A.			Acute pancreatitis	LANCET			English	Article							POST-ERCP PANCREATITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ABDOMINAL COMPUTED-TOMOGRAPHY; CLINICAL SCORING SYSTEMS; POPULATION-BASED-COHORT; MILD ACUTE-PANCREATITIS; BLOOD UREA NITROGEN; TERM-FOLLOW-UP; NECROTIZING PANCREATITIS	Acute pancreatitis, an inflammatory disorder of the pancreas, is the leading cause of admission to hospital for gastrointestinal disorders in the USA and many other countries. Gallstones and alcohol misuse are long-established risk factors, but several new causes have emerged that, together with new aspects of pathophysiology, improve understanding of the disorder. As incidence (and admission rates) of acute pancreatitis increase, so does the demand for effective management. We review how to manage patients with acute pancreatitis, paying attention to diagnosis, differential diagnosis, complications, prognostic factors, treatment, and prevention of second attacks, and the possible transition from acute to chronic pancreatitis.	[Lankisch, Paul Georg] Clin Ctr Luneburg, Dept Gen Internal Med & Gastroenterol, D-21337 Luneburg, Germany; [Apte, Minoti] Univ New S Wales, Fac Med, South Western Sydney Clin Sch, Pancreat Res Grp, Sydney, NSW, Australia; [Apte, Minoti] Liverpool Hosp, Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Banks, Peter A.] Harvard Univ, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA; [Banks, Peter A.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Liverpool Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Lankisch, PG (corresponding author), Clin Ctr Luneburg, Dept Gen Internal Med & Gastroenterol, Reiherstieg 23, D-21337 Luneburg, Germany.	paulgeorg.lankisch@t-online.de	Apte, Minoti/X-2864-2019	Apte, Minoti/0000-0003-0194-8939	National Health and Medical Research Council; Cancer Council of New South Wales, Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of New South Wales, Australia(Cancer Council New South Wales)	MA is supported by project grants from the National Health and Medical Research Council, and the Cancer Council of New South Wales, Australia.	Akbar A, 2013, CLIN GASTROENTEROL H, V11, P778, DOI 10.1016/j.cgh.2012.12.043; Aktas H, 2010, ENDOSCOPY, V42, P365, DOI 10.1055/s-0029-1243931; Aktas H, 2009, ENDOSCOPY, V41, P670, DOI 10.1055/s-0029-1214976; Alexandre M, 2012, AM J PHYSIOL-GASTR L, V303, pG696, DOI 10.1152/ajpgi.00138.2012; Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Apte MV, 2010, J GASTROEN HEPATOL, V25, P1816, DOI 10.1111/j.1440-1746.2010.06445.x; APTE MV, 1995, GUT, V36, P287, DOI 10.1136/gut.36.2.287; Apte MV, 2005, GUT, V54, P446, DOI 10.1136/gut.2004.048785; Ashburn MA, 2012, ANESTHESIOLOGY, V116, P248, DOI 10.1097/ALN.0b013e31823c1030; Asrani V, 2013, PANCREATOLOGY, V13, P468, DOI 10.1016/j.pan.2013.07.282; Bai Y, 2010, AM J GASTROENTEROL, V105, P705, DOI 10.1038/ajg.2009.676; Bakker OJ, 2011, BRIT J SURG, V98, P1446, DOI 10.1002/bjs.7587; Bakker OJ, 2012, JAMA-J AM MED ASSOC, V307, P1053, DOI 10.1001/jama.2012.276; Balachandra S, 2005, AM J SURG, V190, P489, DOI 10.1016/j.amjsurg.2005.03.009; BALTHAZAR EJ, 1985, RADIOLOGY, V156, P767, DOI 10.1148/radiology.156.3.4023241; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bansal D, 2011, SAUDI J GASTROENTERO, V17, P174, DOI 10.4103/1319-3767.80379; Bergert H, 2005, SURGERY, V137, P323, DOI 10.1016/j.surg.2004.10.009; Bertin C, 2012, AM J GASTROENTEROL, V107, P311, DOI 10.1038/ajg.2011.424; Berzin TM, 2007, PANCREATOLOGY, V7, P63, DOI 10.1159/000101879; Besselink MG, 2009, BRIT J SURG, V96, P267, DOI 10.1002/bjs.6447; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bollen TL, 2012, AM J GASTROENTEROL, V107, P612, DOI 10.1038/ajg.2011.438; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Butler JR, 2011, HPB, V13, P839, DOI 10.1111/j.1477-2574.2011.00375.x; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Capurso G, 2012, J CLIN GASTROENTEROL, V46, pS46, DOI 10.1097/MCG.0b013e3182652096; Cennamo V, 2010, ENDOSCOPY, V42, P381, DOI 10.1055/s-0029-1243992; Chiari H., 1896, ZEITSCHRIFTFURHEILKU, V17, P69; Chowdhury P, 2008, LANGENBECK ARCH SURG, V393, P547, DOI 10.1007/s00423-007-0267-1; Dai HF, 2009, HEPATOB PANCREAT DIS, V8, P11; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; De Waele JJ, 2007, PANCREAS, V34, P185, DOI 10.1097/mpa.0b013e31802d4136; de-Madaria E, 2011, AM J GASTROENTEROL, V106, P1843, DOI 10.1038/ajg.2011.236; Dellinger EP, 2012, ANN SURG, V256, P875, DOI 10.1097/SLA.0b013e318256f778; DiMagno MJ, 2012, AM J GASTROENTEROL, V107, P318, DOI 10.1038/ajg.2011.430; DOEPEL M, 1993, BRIT J SURG, V80, P1583, DOI 10.1002/bjs.1800801229; Dumonceau JM, 2010, ENDOSCOPY, V42, P503, DOI 10.1055/s-0029-1244208; Eatock FC, 2005, AM J GASTROENTEROL, V100, P432, DOI 10.1111/j.1572-0241.2005.40587.x; EBBEHOJ N, 1985, SCAND J GASTROENTERO, V20, P798, DOI 10.3109/00365528509088825; Eckerwall GE, 2006, ANN SURG, V244, P959, DOI 10.1097/01.sla.0000246866.01930.58; Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103; En-Qiang M, 2009, CHINESE MED J-PEKING, V122, P169, DOI 10.3760/cma.j.issn.0366-6999.2009.02.011; Freeman ML, 2012, PANCREAS, V41, P1176, DOI 10.1097/MPA.0b013e318269c660; Frick TW, 2012, SURGERY, V152, pS157, DOI 10.1016/j.surg.2012.05.013; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gaisano HY, 2001, J CLIN INVEST, V108, P1597; Gardner TB, 2011, GASTROINTEST ENDOSC, V73, P718, DOI 10.1016/j.gie.2010.10.053; Girman CJ, 2010, DIABETES OBES METAB, V12, P766, DOI 10.1111/j.1463-1326.2010.01231.x; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Haydock MD, 2013, ANN SURG, V257, P182, DOI 10.1097/SLA.0b013e31827773ff; Imrie C W, 1975, Bull Soc Int Chir, V34, P601; Jacobson BC, 2007, CLIN GASTROENTEROL H, V5, P946, DOI 10.1016/j.cgh.2007.04.012; Jiang K, 2012, WORLD J GASTROENTERO, V18, P279, DOI 10.3748/wjg.v18.i3.279; Kerner T, 1996, J SURG RES, V62, P165, DOI 10.1006/jsre.1996.0190; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; King NKK, 2003, SCAND J GASTROENTERO, V38, P433, DOI 10.1080/00365520310000915; Kumar A, 2006, J CLIN GASTROENTEROL, V40, P431, DOI 10.1097/00004836-200605000-00013; Lai SW, 2011, AM J GASTROENTEROL, V106, P1697, DOI 10.1038/ajg.2011.155; Lankisch PG, 2012, PANCREATOLOGY, V12, P85, DOI 10.1016/j.pan.2012.02.007; Lankisch PG, 2009, AM J GASTROENTEROL, V104, P2797, DOI 10.1038/ajg.2009.405; Lankisch PG, 2009, CLIN GASTROENTEROL H, V7, P702, DOI 10.1016/j.cgh.2009.02.020; Lankisch PG, 1999, GUT, V44, P542, DOI 10.1136/gut.44.4.542; LANKISCH PG, 1978, SCAND J GASTROENTERO, V13, P629, DOI 10.3109/00365527809181774; Lankisch PG, 2002, PANCREAS, V25, P411, DOI 10.1097/00006676-200211000-00015; Lawrence C, 2008, GASTROINTEST ENDOSC, V67, P673, DOI 10.1016/j.gie.2007.07.017; Li J, 2013, PANCREAS, V42, P88, DOI 10.1097/MPA.0b013e3182575fb5; Lindkvist B, 2008, PANCREATOLOGY, V8, P63, DOI 10.1159/000114868; LONDON NJM, 1989, BRIT J SURG, V76, P268, DOI 10.1002/bjs.1800760317; Lowenfels AB, 2000, GASTROENTEROLOGY, V119, P879, DOI 10.1053/gast.2000.17934; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Mazaki T, 2014, J GASTROENTEROL, V49, P343, DOI 10.1007/s00535-013-0806-1; Meier R, 2006, CLIN NUTR, V25, P275, DOI 10.1016/j.clnu.2006.01.019; Moraes JMM, 2010, J CLIN GASTROENTEROL, V44, P517, DOI 10.1097/MCG.0b013e3181c986b3; Meng WB, 2013, PANCREATOLOGY, V13, P201, DOI 10.1016/j.pan.2013.02.003; Mofidi R, 2007, WORLD J SURG, V31, P2002, DOI 10.1007/s00268-007-9164-6; Monfared SSMS, 2009, WORLD J GASTROENTERO, V15, P4481, DOI 10.3748/wjg.15.4481; Mortele KJ, 2004, AM J ROENTGENOL, V183, P1261, DOI 10.2214/ajr.183.5.1831261; Mounzer R, 2012, GASTROENTEROLOGY, V142, P1476, DOI 10.1053/j.gastro.2012.03.005; Mujica VR, 2000, PANCREAS, V21, P329, DOI 10.1097/00006676-200011000-00001; Nauck MA, 2013, DIABETES CARE, V36, P2126, DOI 10.2337/dc12-2504; Nitsche Claudia, 2012, Curr Gastroenterol Rep, V14, P131, DOI 10.1007/s11894-012-0245-9; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Nojgaard C, 2011, PANCREAS, V40, P1195, DOI 10.1097/MPA.0b013e318221f569; Nordback I, 2009, GASTROENTEROLOGY, V136, P848, DOI 10.1053/j.gastro.2008.11.044; Oskarsson V, 2011, PANCREATOLOGY, V11, P464, DOI 10.1159/000331502; Pandol SJ, 2011, ALCOHOL CLIN EXP RES, V35, P830, DOI 10.1111/j.1530-0277.2010.01408.x; Park CH, 2013, PANCREAS, V42, P655, DOI 10.1097/MPA.0b013e3182762928; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Perides G, 2010, GASTROENTEROLOGY, V138, P715, DOI 10.1053/j.gastro.2009.10.052; Petrov MS, 2008, ALIMENT PHARM THER, V28, P704, DOI 10.1111/j.1365-2036.2008.03786.x; Petrov MS, 2013, CLIN NUTR, V32, P697, DOI 10.1016/j.clnu.2012.12.011; Petrov MS, 2009, BRIT J NUTR, V101, P787, DOI 10.1017/S0007114508123443; Pezzilli R, 2009, HEPATOB PANCREAT DIS, V8, P316; Rebours V, 2012, PANCREAS, V41, P1219, DOI 10.1097/MPA.0b013e31825de97d; Runzi M, 2005, PANCREAS, V30, P195, DOI 10.1097/01.mpa.0000153613.17643.b3; Sadr-Azodi O, 2012, GUT, V61, P262, DOI 10.1136/gutjnl-2011-300566; SARLES H, 1974, GASTROENTEROLOGY, V66, P604, DOI 10.1016/s0016-5085(74)80050-8; Sathiaraj E, 2008, ALIMENT PHARM THER, V28, P777, DOI 10.1111/j.1365-2036.2008.03794.x; SCHRODER T, 1985, EUR J RADIOL, V5, P273; SEIDENSTICKER F, 1995, INT J PANCREATOL, V17, P225; Seifert H, 2000, LANCET, V356, P653, DOI 10.1016/S0140-6736(00)02611-8; Seifert H, 2009, GUT, V58, P1260, DOI 10.1136/gut.2008.163733; Singh N, 2012, PANCREAS, V41, P153, DOI 10.1097/MPA.0b013e318221c4a8; Singla A, 2009, GASTROENTEROLOGY, V137, P1995, DOI 10.1053/j.gastro.2009.08.056; Siriwardena AK, 2007, GUT, V56, P1439, DOI 10.1136/gut.2006.115873; Spanier BWM, 2010, PANCREATOLOGY, V10, P222, DOI 10.1159/000243731; Sutton R, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e3181675010; Symersky T, 2006, J PANCREAS, V7, P447; Talukdar R, 2013, INDIAN J GASTROENTER, V32, P143, DOI 10.1007/s12664-013-0306-5; Teich N, 2010, PANCREAS, V39, P1088, DOI 10.1097/MPA.0b013e3181d3ce05; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Tolstrup JS, 2009, ARCH INTERN MED, V169, P603, DOI 10.1001/archinternmed.2008.601; Tse F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009779.pub2; Urushihara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053224; van Santvoort HC, 2011, GASTROENTEROLOGY, V141, P1254, DOI 10.1053/j.gastro.2011.06.073; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Varadarajulu S, 2005, GASTROINTEST ENDOSC, V61, P568, DOI 10.1016/S0016-5107(04)02832-9; Varadarajulu S, 2008, GASTROINTEST ENDOSC, V68, P1102, DOI 10.1016/j.gie.2008.04.028; Villatoro E, 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002941.PUB3; Vonlaufen A, 2007, GASTROENTEROLOGY, V133, P1293, DOI 10.1053/j.gastro.2007.06.062; Warndorf MG, 2011, CLIN GASTROENTEROL H, V9, P705, DOI 10.1016/j.cgh.2011.03.032; Whitcomb DC, 2012, NAT GENET, V44, P1349, DOI 10.1038/ng.2466; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wittau M, 2010, HEPATO-GASTROENTEROL, V57, P1300; Wittau M, 2011, SCAND J GASTROENTERO, V46, P261, DOI 10.3109/00365521.2010.531486; Wu BU, 2008, GASTROENTEROLOGY, V135, P816, DOI 10.1053/j.gastro.2008.05.053; Wu BU, 2013, GASTROENTEROLOGY, V144, P1272, DOI 10.1053/j.gastro.2013.01.075; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Wu BU, 2011, ARCH INTERN MED, V171, P669, DOI 10.1001/archinternmed.2011.126; Wu BU, 2009, GASTROENTEROLOGY, V137, P129, DOI 10.1053/j.gastro.2009.03.056; Wu DQ, 2011, PANCREAS, V40, P1006, DOI 10.1097/MPA.0b013e31821fde3f; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126; Zheng MH, 2008, GUT, V57, P1632, DOI 10.1136/gut.2008.153866	137	599	681	24	185	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					85	96		10.1016/S0140-6736(14)60649-8	http://dx.doi.org/10.1016/S0140-6736(14)60649-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25616312				2022-12-28	WOS:000357519400031
J	Rouvinski, A; Guardado-Calvo, P; Barba-Spaeth, G; Duquerroy, S; Vaney, MC; Kikuti, CM; Sanchez, MEN; Dejnirattisai, W; Wongwiwat, W; Haouz, A; Girard-Blanc, C; Petres, S; Shepard, WE; Despres, P; Arenzana-Seisdedos, F; Dussart, P; Mongkolsapaya, J; Screaton, GR; Rey, FA				Rouvinski, Alexander; Guardado-Calvo, Pablo; Barba-Spaeth, Giovanna; Duquerroy, Stephane; Vaney, Marie-Christine; Kikuti, Carlos M.; Sanchez, M. Erika Navarro; Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Haouz, Ahmed; Girard-Blanc, Christine; Petres, Stephane; Shepard, William E.; Despres, Philippe; Arenzana-Seisdedos, Fernando; Dussart, Philippe; Mongkolsapaya, Juthathip; Screaton, Gavin R.; Rey, Felix A.			Recognition determinants of broadly neutralizing human antibodies against dengue viruses	NATURE			English	Article							IMMATURE FLAVIVIRUS PARTICLES; BORNE ENCEPHALITIS-VIRUS; DROSOPHILA S2 CELLS; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; FAB FRAGMENTS; MATURATION; REFINEMENT; MECHANISM; FUSION	Dengue disease is caused by four different flavivirus(1) serotypes, which infect 390 million people yearly with 25% symptomatic cases(2) and for which no licensed vaccine is available. Recent phase III vaccine trials showed partial protection, and in particular no protection for dengue virus serotype 2 (refs 3, 4). Structural studies so far have characterized only epitopes recognized by serotype-specific human antibodies(5,6). We recently isolated human antibodies potently neutralizing all four dengue virus serotypes(7). Here we describe the X-ray structures of four of these broadly neutralizing antibodies in complex with the envelope glycoprotein E from dengue virus serotype 2, revealing that the recognition determinants are at a serotype-invariant site at the E-dimer interface, including the exposed main chain of the E fusion loop(8) and the two conserved glycan chains. This 'E-dimer-dependent epitope' is also the binding site for the viral glycoprotein prM during virus maturation in the secretory pathway of the infected cell(9), explaining its conservation across serotypes and highlighting an Achilles' heel of the virus with respect to antibody neutralization. These findings will be instrumental for devising novel immunogens to protect simultaneously against all four serotypes of dengue virus.	[Rouvinski, Alexander; Guardado-Calvo, Pablo; Barba-Spaeth, Giovanna; Duquerroy, Stephane; Vaney, Marie-Christine; Kikuti, Carlos M.; Sanchez, M. Erika Navarro; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [Rouvinski, Alexander; Guardado-Calvo, Pablo; Barba-Spaeth, Giovanna; Duquerroy, Stephane; Vaney, Marie-Christine; Kikuti, Carlos M.; Sanchez, M. Erika Navarro; Rey, Felix A.] CNRS, UMR Virol 3569, F-75724 Paris 15, France; [Duquerroy, Stephane] Univ Paris Sud, Fac Sci, F-91405 Orsay, France; [Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Immunol & Inflammat, London W12 0NN, England; [Haouz, Ahmed; Girard-Blanc, Christine; Petres, Stephane; Rey, Felix A.] Inst Pasteur, Proteopole, CNRS, UMR 3528, F-75724 Paris 15, France; [Shepard, William E.] Orme Merisiers, Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Despres, Philippe] Inst Pasteur, Dept Virol, Unite Interact Mol Flavivirus Hotes, F-75724 Paris 15, France; [Arenzana-Seisdedos, Fernando] Inst Pasteur, Dept Virol, Unite Pathogenie Virale, INSERM,U1108, F-75724 Paris 15, France; [Dussart, Philippe] Inst Pasteur, Cayenne 97306, French Guiana; [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dengue Hemorrhag Fever Res Unit,Off Res & Dev, Bangkok 10700, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; SOLEIL Synchrotron; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University	Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.	j.mongkolsapaya@imperial.ac.uk; g.screaton@imperial.ac.uk; rey@pasteur.fr	Rey, Felix/B-6497-2012; Wongwiwat, Wiyada/AAJ-8936-2021; Dussart, Philippe/P-4152-2014; Guardado-Calvo, Pablo/O-5145-2019; Arenzana-Seisdedos, Fernando/E-5835-2016; de Villers, Thierry/AAF-3646-2021	Dussart, Philippe/0000-0002-1931-3037; Guardado-Calvo, Pablo/0000-0001-7292-5270; petres, stephane/0000-0002-4716-565X; Screaton, Gavin/0000-0002-3549-4309; Wongwiwat, Wiyada/0000-0002-5889-0929; Shepard, William/0000-0002-5724-1193; HAOUZ, Ahmed/0000-0003-1196-1635; Barba Spaeth, Giovanna/0000-0003-2069-9501; Rey, Felix/0000-0002-9953-7988; Duquerroy, Stephane/0000-0003-4386-8013	European Union; Insitut Pasteur, from the French Government's 'Investissements d'Avenir' program: Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; CNRS; Medical Research Council, UK; Wellcome Trust, UK; National Institute for Health Research Biomedical Research Centre; Pediatrics Dengue Vaccine Initiative; Medical Research Council [G0801508, G0400720] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10303] Funding Source: researchfish; MRC [G0400720, G0801508] Funding Source: UKRI	European Union(European Commission); Insitut Pasteur, from the French Government's 'Investissements d'Avenir' program: Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases'(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Pediatrics Dengue Vaccine Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was made possible by a Pediatrics Dengue Vaccine Initiative grant to F.A.R., allowing the set up of a production facility of recombinant DENV sE. The co-crystallization with the bnAbs was done with European Union funding (DenFree consortium) to F.A.R. and G.R.S./J.M. F.A.R. acknowledges support from Insitut Pasteur, from the French Government's 'Investissements d'Avenir' program: Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant number ANR-10-LABX-62-IBEID) and the CNRS. G.S.R. and J.M. were supported by the Medical Research Council, UK, the Wellcome Trust, UK, the National Institute for Health Research Biomedical Research Centre, Funding Scheme. G.R.S. is a Wellcome Trust Senior investigator. We thank staffs at beam lines PROXIMA-1 and PROXIMA-2 at the SOLEIL synchrotron (St Aubin, France) and ID23-2 and ID29 at the European Synchrotron Radiation Facility (Grenoble, France). We thank A. Sakuntabhai for coordination of the DenFree grant, G. Bricogne for advice on diffraction data collection strategies, J. Cockburn and P.-Y. Lozach for help with the initial sE constructs, and S. Halstead and S. Kliks for support through the Pediatrics Dengue Vaccine Initiative.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Backovic M, 2010, PROTEIN ENG DES SEL, V23, P169, DOI 10.1093/protein/gzp088; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W., 2014, NAT IMMUNOL, DOI DOI 10.1038/NI.3058; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Gilmartin AA, 2012, PROTEIN ENG DES SEL, V25, P59, DOI 10.1093/protein/gzr058; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Normile D, 2014, SCIENCE, V345, P367, DOI 10.1126/science.345.6195.367; Plevka P, 2014, J STRUCT BIOL, V185, P27, DOI 10.1016/j.jsb.2013.11.001; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	49	228	238	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					109	+		10.1038/nature14130	http://dx.doi.org/10.1038/nature14130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25581790	Green Submitted			2022-12-28	WOS:000352027700047
J	Kellogg, RA; Tay, S				Kellogg, Ryan A.; Tay, Savas			Noise Facilitates Transcriptional Control under Dynamic Inputs	CELL			English	Article							GENE REGULATORY CIRCUIT; SINGLE-CELL ANALYSIS; PHASE SYNCHRONIZATION; CALCIUM OSCILLATIONS; STOCHASTIC RESONANCE; SIGNALING DYNAMICS; FUNCTIONAL ROLES; LIVING CELLS; INFORMATION; EXPRESSION	Cells must respond sensitively to time-varying inputs in complex signaling environments. To understand how signaling networks process dynamic inputs into gene expression outputs and the role of noise in cellular information processing, we studied the immune pathway NF-kappa B under periodic cytokine inputs using microfluidic single-cell measurements and stochastic modeling. We find that NF-kappa B dynamics in fibroblasts synchronize with oscillating TNF signal and become entrained, leading to significantly increased NF-kappa B oscillation amplitude and mRNA output compared to non-entrained response. Simulations show that intrinsic biochemical noise in individual cells improves NF-kappa B oscillation and entrainment, whereas cell-to-cell variability in NF-kappa B natural frequency creates population robustness, together enabling entrainment over a wider range of dynamic inputs. This wide range is confirmed by experiments where entrained cells were measured under all input periods. These results indicate that synergy between oscillation and noise allows cells to achieve efficient gene expression in dynamically changing signaling environments.	[Kellogg, Ryan A.; Tay, Savas] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Tay, S (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.	savas.tay@bsse.ethz.ch		Kellogg, Ryan/0000-0002-5591-9466	European Union ERC Starting Grant (SingleCellDynamics); Swiss Nationalfonds; SNF SystemsX; NCCR Molecular Systems Engineering	European Union ERC Starting Grant (SingleCellDynamics); Swiss Nationalfonds(Swiss National Science Foundation (SNSF)); SNF SystemsX; NCCR Molecular Systems Engineering	We acknowledge Tomasz Lipniacki, Mustafa Khammash, Benjamin Hepp, and Ankit Gupta for discussions on NF-kappa B and transcription modeling, and Kobi Benenson and Alexander Hoffmann for commenting on the manuscript. S.T. acknowledges European Union ERC Starting Grant (SingleCellDynamics), Swiss Nationalfonds, SNF SystemsX, and NCCR Molecular Systems Engineering for funding support.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Erzberger A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0221; Falcke M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/396; Gerard C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002516; GOLDBETER A, 1990, BIOMED BIOCHIM ACTA, V49, P935; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Hoffmann A., 2002, IKAPPABNFKAPPAB SIGN, P1; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Jensen MH, 2012, FEBS LETT, V586, P1664, DOI 10.1016/j.febslet.2012.04.044; Junkin M, 2014, LAB CHIP, V14, P1246, DOI 10.1039/c3lc51182k; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kellogg RA, 2014, NAT PROTOC, V9, P1713, DOI 10.1038/nprot.2014.120; Kupzig S, 2005, P NATL ACAD SCI USA, V102, P7577, DOI 10.1073/pnas.0409611102; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Longo DM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003112; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Mori T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.218101; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Pekalski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078887; Perc M, 2003, PHYS LETT A, V316, P304, DOI 10.1016/j.physleta.2003.08.006; Phelps CB, 2000, J BIOL CHEM, V275, P24392, DOI 10.1074/jbc.M003784200; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schutze J, 2011, BIOPHYS J, V100, P809, DOI 10.1016/j.bpj.2010.12.3704; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Wee KB, 2012, BIOPHYS J, V102, P2413, DOI 10.1016/j.bpj.2012.04.023; Yde P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-115; Yissachar N, 2013, MOL CELL, V49, P322, DOI 10.1016/j.molcel.2012.11.003; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Zhou CS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.014101	59	147	147	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					381	392		10.1016/j.cell.2015.01.013	http://dx.doi.org/10.1016/j.cell.2015.01.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635454	Bronze			2022-12-28	WOS:000349208000006
J	Smith, JM				Smith, Jeanette M.			Man in Armour Holding a Pike Jan van Bijlert	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					336	337		10.1001/jama.2014.11541	http://dx.doi.org/10.1001/jama.2014.11541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626021				2022-12-28	WOS:000349072600001
J	Stiegler, MP				Stiegler, Marjorie Podraza			What I Learned About Adverse Events From Captain Sully It's Not What You Think	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Stiegler, MP (corresponding author), Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA.	mstiegler@aims.unc.edu		Stiegler, Marjorie/0000-0002-5369-1680				[Anonymous], 2009, CNN; Gazoni FM, 2012, ANESTH ANALG, V114, P596, DOI 10.1213/ANE.0b013e318227524e; Lindeman S, 1996, BRIT J PSYCHIAT, V168, P274, DOI 10.1192/bjp.168.3.274; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	4	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					361	362		10.1001/jama.2014.16025	http://dx.doi.org/10.1001/jama.2014.16025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626033				2022-12-28	WOS:000349072600015
J	Chok, S				Chok, Shera			IF I RULED THE NHS Release clinicians from the four walls of the hospital or practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												shera.chok@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2015	350								h298	10.1136/bmj.h298	http://dx.doi.org/10.1136/bmj.h298			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZH	25613213				2022-12-28	WOS:000348433800002
J	Ellman, T				Ellman, Tom			Demedicalizing AIDS Prevention and Treatment in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa		Ellman, T (corresponding author), Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa.							Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Kaiser Family Foundation and UNAIDS, 2014, FIN RESP HIV LOW MID; Piot P, 2014, LANCET, V384, pE62, DOI 10.1016/S0140-6736(14)62045-6; Shisana O, 2014, S AFRICAN NATL HIV P; South African National AIDS Council, 2014, PROGR REP NAT STRAT	5	21	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					303	305		10.1056/NEJMp1414730	http://dx.doi.org/10.1056/NEJMp1414730			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ4PJ	25607425				2022-12-28	WOS:000348204500003
J	Pullicino, P				Pullicino, Patrick			Incident perioperative AF increased risk for ischemic stroke at 1 year, with greater risk after noncardiac surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Kent, Canterbury, Kent, England	University of Kent	Pullicino, P (corresponding author), Univ Kent, Canterbury, Kent, England.		pullicino, Patrick/AAO-9018-2021					Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Seet RCS, 2011, CIRCULATION, V124, P477, DOI 10.1161/CIRCULATIONAHA.111.029801; Vanassche T, 2014, EUR HEART J	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC11	10.7326/ACPJC-2015-162-2-011	http://dx.doi.org/10.7326/ACPJC-2015-162-2-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599359				2022-12-28	WOS:000350106600010
J	Hankey, GJ; Blacker, DJ				Hankey, Graeme J.; Blacker, David J.			PRACTICE POINTER Is it a stroke?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; PATIENT; BEDSIDE; CARE		[Hankey, Graeme J.; Blacker, David J.] Univ Western Australia, Sch Med & Pharmacol, Harry Perkins Inst Med Res, QEII Med Ctr, Perth, WA 6009, Australia; [Hankey, Graeme J.; Blacker, David J.] Sir Charles Gairdner Hosp, Dept Neurol, Nedlands, WA 6009, Australia; [Blacker, David J.] Western Australian Neurosci Res Inst, Nedlands, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Harry Perkins Inst Med Res, QEII Med Ctr, Perth, WA 6009, Australia.	graeme.hankey@uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328; Blacker, David/0000-0003-0046-9776				BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Brazzelli M, 2014, ANN NEUROL, V75, P67, DOI 10.1002/ana.24026; Brazzelli M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007424.pub2; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Doubal FN, 2011, J NEUROL NEUROSUR PS, V82, P540, DOI 10.1136/jnnp.2009.190298; Edlow JA, 2011, LANCET NEUROL, V10, P550, DOI 10.1016/S1474-4422(11)70069-2; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fernandes Peter M, 2013, Pract Neurol, V13, P21, DOI 10.1136/practneurol-2012-000465; Gibson LM, 2013, J ROY COLL PHYS EDIN, V43, P114, DOI 10.4997/JRCPE.2013.205; Goldstein LB, 2005, JAMA-J AM MED ASSOC, V293, P2391, DOI 10.1001/jama.293.19.2391; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; Hankey GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2874; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Mair G, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140216; Merino JG, 2013, J STROKE CEREBROVASC, V22, pE397, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.018; National Institute of Neurological Disorders and Stroke, NIH STROK SCAL; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Nor AM, 2004, STROKE, V35, P1355, DOI 10.1161/01.STR.0000128529.63156.c5; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Tarnutzer AA, 2011, CAN MED ASSOC J, V183, P1025, DOI 10.1503/cmaj.100174; Warlow C, 2008, STROKE PRACTICAL MAN; Whiteley WN, 2011, J NEUROL NEUROSUR PS, V82, P1006, DOI 10.1136/jnnp.2010.235010; Yong AW, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-139	27	16	16	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2015	350								h56	10.1136/bmj.h56	http://dx.doi.org/10.1136/bmj.h56			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3ND	25591946	Green Published			2022-12-28	WOS:000348133300006
J	Rooney, MS; Shukla, SA; Wu, CJ; Getz, G; Hacohen, N				Rooney, Michael S.; Shukla, Sachet A.; Wu, Catherine J.; Getz, Gad; Hacohen, Nir			Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity	CELL			English	Article							CASEIN KINASE-II; T-CELLS; INDUCED APOPTOSIS; CANCER-CELLS; DOWN-REGULATION; EXPRESSION; SURVIVAL; RESISTANCE; LANDSCAPE; MELANOMA	How the genomic landscape of a tumor shapes and is shaped by anti-tumor immunity has not been systematically explored. Using large-scale genomic data sets of solid tissue tumor biopsies, we quantified the cytolytic activity of the local immune infiltrate and identified associated properties across 18 tumor types. The number of predicted MHC Class I-associated neoantigens was correlated with cytolytic activity and was lower than expected in colorectal and other tumors, suggesting immune-mediated elimination. We identified recurrently mutated genes that showed positive association with cytolytic activity, including beta-2-microglobulin (B2M), HLA-A, -B and -C and Caspase 8 (CASP8), highlighting loss of antigen presentation and blockade of extrinsic apoptosis as key strategies of resistance to cytolytic activity. Genetic amplifications were also associated with high cytolytic activity, including immunosuppressive factors such as PDL1/2 and ALOX12B/15B. Our genetic findings thus provide evidence for immunoediting in tumors and uncover mechanisms of tumor-intrinsic resistance to cytolytic activity.	[Rooney, Michael S.; Shukla, Sachet A.; Wu, Catherine J.; Getz, Gad; Hacohen, Nir] Broad Inst, Cambridge, MA 02142 USA; [Rooney, Michael S.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02141 USA; [Shukla, Sachet A.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Catherine J.; Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hacohen, N (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	nhacohen@mgh.harvard.edu			Blavatinik Family Foundation; MGH Research Scholars Program; NIH Training Programin Bioinformatics and Integrative Genomics training; NATIONAL CANCER INSTITUTE [R01CA155010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230] Funding Source: NIH RePORTER	Blavatinik Family Foundation; MGH Research Scholars Program; NIH Training Programin Bioinformatics and Integrative Genomics training; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the TCGA Research Network (http://cancergenome.nih.gov/), the Genotype-Tissue Expression (GTEx) Project (dbGaP phs000424.v3.p1), the FANTOM research consortium (http://fantom.gsc.riken.jp/), and the Broad-Novartis Cancer Cell Line Encyclopedia (http://www.broadinstitute.org/ccle/home) for providing the data analyzed in this manuscript. We thank Mara Rosenberg, Amaro Taylor-Weiner, Chloe Villani, Arnon Arazi, Pavan Bachireddy, and Dan-Avi Landau for their feedback and help accessing data and analysis tools and Leslie Gaffney for assistance with artwork. Funding was provided by the Blavatinik Family Foundation (N.H.), the MGH Research Scholars Program (N.H.), and the NIH Training Programin Bioinformatics and Integrative Genomics training grant (M.S.R.). G.G. is a consultant to the KEW Group.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Ayyoub M, 2004, J CLIN INVEST, V113, P1225, DOI 10.1172/JCI200420667; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Boller K, 1997, J VIROL, V71, P4581, DOI 10.1128/JVI.71.6.4581-4588.1997; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Chang CC, 2005, J IMMUNOL, V174, P1462, DOI 10.4049/jimmunol.174.3.1462; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fritsch EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29311; Garimella SV, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3645; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hinrichs CS, 2014, IMMUNOL REV, V257, P56, DOI 10.1111/imr.12132; Izeradjene K, 2005, ONCOGENE, V24, P2050, DOI 10.1038/sj.onc.1208397; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Kloor M, 2010, INT J CANCER, V127, P1001, DOI 10.1002/ijc.25283; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Liggins AP, 2007, BRIT J HAEMATOL, V138, P479, DOI 10.1111/j.1365-2141.2007.06680.x; Llobet D, 2008, ONCOGENE, V27, P2513, DOI 10.1038/sj.onc.1210924; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Manghera M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-16; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Ravi R, 2002, CANCER RES, V62, P4180; Rutledge WC, 2013, CLIN CANCER RES, V19, P4951, DOI 10.1158/1078-0432.CCR-13-0551; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Saturno Grazia, 2013, Oncotarget, V4, P1185; Schmitt K, 2013, GENOME BIOL EVOL, V5, P307, DOI 10.1093/gbe/evt010; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher K, 2001, CANCER RES, V61, P3932; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Textor S, 2011, CANCER RES, V71, P5998, DOI 10.1158/0008-5472.CAN-10-3211; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang GX, 2006, CANCER RES, V66, P2242, DOI 10.1158/0008-5472.CAN-05-2772; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018	62	1983	2026	11	166	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					48	61		10.1016/j.cell.2014.12.033	http://dx.doi.org/10.1016/j.cell.2014.12.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594174	Green Accepted, Bronze			2022-12-28	WOS:000347923200008
J	Schulz, E				Schulz, Emmanuelle			One catalyst, two reactions	NATURE			English	Editorial Material							HYDROAMINATION; ALKENES		Univ Paris 11, Inst Chim Mol & Mat Orsay, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	Schulz, E (corresponding author), Univ Paris 11, Inst Chim Mol & Mat Orsay, Bat 425, F-91405 Orsay, France.	emmanuelle.schulz@u-psud.fr		Schulz, Emmanuelle/0000-0002-0844-8825				Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b; Hannedouche J, 2013, CHEM-EUR J, V19, P4972, DOI 10.1002/chem.201203956; Miki Y, 2013, ANGEW CHEM INT EDIT, V52, P10830, DOI 10.1002/anie.201304365; Muller TE, 2008, CHEM REV, V108, P3795, DOI 10.1021/cr0306788; Shi SL, 2015, NAT CHEM, V7, P38, DOI [10.1038/nchem.2131, 10.1038/NCHEM.2131]; Zhu SL, 2013, J AM CHEM SOC, V135, P15746, DOI 10.1021/ja4092819	6	1	1	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					280	281		10.1038/517280a	http://dx.doi.org/10.1038/517280a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592531				2022-12-28	WOS:000347810300029
J	Collins, FS				Collins, Francis S.			Exceptional Opportunities in Medical Science A View From the National Institutes of Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Off Director, 1 Ctr Dr, Bethesda, MD 20892 USA.	collinsf@mail.nih.gov						[Anonymous], 2012, LEAD DECL ASS US INT; CDC, 2013, ANTIBIOTIC RESISTANC; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Naional Heart Lung and Blood Institute, NHLBI FACT BOOK FISC; National Institutes of Health, BRAIN RES ADV INN NE; Roth JA, 2014, ANN INTERN MED, V160, P594, DOI 10.7326/M13-2348; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208	8	51	53	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					131	132		10.1001/jama.2014.16736	http://dx.doi.org/10.1001/jama.2014.16736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585318	Bronze, Green Published			2022-12-28	WOS:000347679300006
J	Schlaich, M; Hering, D				Schlaich, Markus; Hering, Dagmara			Central arteriovenous anastomosis in resistant hypertension?	LANCET			English	Editorial Material							BLOOD-PRESSURE; DENERVATION; TRIAL		[Schlaich, Markus] Univ Western Australia, Royal Perth Hosp Unit, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Schlaich, Markus; Hering, Dagmara] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Royal Perth Hospital; University of Western Australia; Baker Heart and Diabetes Institute	Schlaich, M (corresponding author), Univ Western Australia, Royal Perth Hosp Unit, Sch Med & Pharmacol, Crawley, WA 6009, Australia.	markus.schlaich@uwa.edu.au	Hering, Dagmara/AAR-7692-2020	Hering, Dagmara/0000-0003-4649-9524; Schlaich, Markus/0000-0002-1765-0195				Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Jung O, 2013, J HYPERTENS, V31, P766, DOI 10.1097/HJH.0b013e32835e2286; Laurent S, 2012, LANCET, V380, P591, DOI 10.1016/S0140-6736(12)60825-3; Lobo MD, 2015, LANCET; Patel HC, 2015, HYPERTENSION, V65, P401, DOI 10.1161/HYPERTENSIONAHA.114.04640; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Pierdomenico SD, 2005, AM J HYPERTENS, V18, P1422, DOI 10.1016/j.amjhyper.2005.05.014	11	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1596	1597		10.1016/S0140-6736(14)62290-X	http://dx.doi.org/10.1016/S0140-6736(14)62290-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25620017				2022-12-28	WOS:000353418000009
J	Dunsmoor, JE; Murty, VP; Davachi, L; Phelps, EA				Dunsmoor, Joseph E.; Murty, Vishnu P.; Davachi, Lila; Phelps, Elizabeth A.			Emotional learning selectively and retroactively strengthens memories for related events	NATURE			English	Article							LONG-TERM-MEMORY; AROUSAL; RETENTION; FEAR	Neurobiological models of long-term memory propose a mechanism by which initially weak memories are strengthened through subsequent activation that engages common neural pathways minutes to hours later(1). This synaptic tag-and-capture model has been hypothesized to explain how inconsequential information is selectively consolidated following salient experiences. Behavioural evidence for tag-and-capture is provided by rodent studies in which weak early memories are strengthened by future behavioural training(2,3). Whether a process of behavioural tagging occurs in humans to transform weak episodic memories into stable long-term memories is unknown. Here we show, in humans, that information is selectively consolidated if conceptually related information, putatively represented in a common neural substrate, is made salient through an emotional learning experience. Memory for neutral objects was selectively enhanced if other objects from the same category were paired with shock. Retroactive enhancements as a result of emotional learning were observed following a period of consolidation, but were not observed in an immediate memory test or for items strongly encoded before fear conditioning. These findings provide new evidence for a generalized retroactive memory enhancement, whereby inconsequential information can be retroactively credited as relevant, and therefore selectively remembered, if conceptually related information acquires salience in the future.	[Dunsmoor, Joseph E.; Murty, Vishnu P.; Davachi, Lila; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Dunsmoor, Joseph E.; Murty, Vishnu P.; Davachi, Lila; Phelps, Elizabeth A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Phelps, Elizabeth A.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	New York University; New York University; Nathan Kline Institute for Psychiatric Research	Davachi, L (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lila.davachi@nyu.edu; liz.phelps@nyu.edu	Dunsmoor, Joseph/U-9183-2019	Davachi, Lila/0000-0003-4317-0889	NIH [RO1 MH097085, R01 MH047692, F31 DA036361]; NIMH Training Award in Systems and Integrative Neuroscience [T32 MH019524]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692, R01MH097085, T32MH019524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA036361] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Training Award in Systems and Integrative Neuroscience; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. L. Murphy for comments on the manuscript, and S. Lackovic and J. Reitzes for assistance with data collection. This study was supported by NIH RO1 MH097085, R01 MH047692, F31 DA036361, and NIMH Training Award in Systems and Integrative Neuroscience T32 MH019524.	Ballarini F, 2009, P NATL ACAD SCI USA, V106, P14599, DOI 10.1073/pnas.0907078106; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; da Silva BM, 2014, LEARN MEMORY, V21, P28, DOI 10.1101/lm.032169.113; Dunsmoor JE, 2014, CEREB CORTEX, V24, P2859, DOI 10.1093/cercor/bht138; Dunsmoor JE, 2012, BIOL PSYCHOL, V89, P300, DOI 10.1016/j.biopsycho.2011.11.002; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Green SR, 2014, INT J PSYCHOPHYSIOL, V91, P186, DOI 10.1016/j.ijpsycho.2013.10.015; KLEINSMITH LJ, 1963, J EXP PSYCHOL, V65, P190, DOI 10.1037/h0040288; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; Moncada D, 2011, P NATL ACAD SCI USA, V108, P12931, DOI 10.1073/pnas.1104495108; Myskiw JD, 2013, P NATL ACAD SCI USA, V110, P1071, DOI 10.1073/pnas.1220875110; Park J, 2005, PSYCHOL REP, V97, P339, DOI 10.2466/PR0.97.6.339-355; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; van Dongen EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043426; Wang SH, 2010, P NATL ACAD SCI USA, V107, P19537, DOI 10.1073/pnas.1008638107; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011	25	156	158	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					345	+		10.1038/nature14106	http://dx.doi.org/10.1038/nature14106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG0RI	25607357	Green Accepted			2022-12-28	WOS:000352974200038
J	Do-Monte, FH; Quinones-Laracuente, K; Quirk, GJ				Do-Monte, Fabricio H.; Quinones-Laracuente, Kelvin; Quirk, Gregory J.			A temporal shift in the circuits mediating retrieval of fear memory	NATURE			English	Article							PARAVENTRICULAR THALAMIC NUCLEUS; VENTROMEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; CONDITIONED FEAR; PROJECTIONS; RAT; EXTINCTION; CORTICES; CONSOLIDATION; HIPPOCAMPUS	Fear memories allow animals to avoid danger, thereby increasing their chances of survival. Fear memories can be retrieved long after learning(1,2), but little is known about how retrieval circuits change with time(3,4). Here we show that the dorsal midline thalamus of rats is required for the retrieval of auditory conditioned fear at late (24 hours, 7 days, 28 days), but not early (0.5 hours, 6 hours) time points after learning. Consistent with this, the paraventricular nucleus of the thalamus (PVT), a subregion of the dorsal midline thalamus, showed increased c-Fos expression only at late time points, indicating that the PVT is gradually recruited for fear retrieval. Accordingly, the conditioned tone responses of PVTneurons increased with time after training. The prelimbic (PL) prefrontal cortex, which is necessary for fear retrieval(5-7), sends dense projections to the PVT8. Retrieval at late time points activated PL neurons projecting to the PVT, and optogenetic silencing of these projections impaired retrieval at late, but not early, time points. In contrast, silencing of PL inputs to the basolateral amygdala impaired retrieval at early, but not late, time points, indicating a time-dependent shift in retrieval circuits. Retrieval at late time points also activated PVT neurons projecting to the central nucleus of the amygdala, and silencing these projections at late, but not early, time points induced a persistent attenuation of fear. Thus, the PVT may act as a crucial thalamic node recruited into cortico-amygdalar networks for retrieval and maintenance of long-term fear memories.	[Do-Monte, Fabricio H.; Quinones-Laracuente, Kelvin; Quirk, Gregory J.] Univ Puerto Rico, Dept Psychiat, Sch Med, San Juan, PR 00936 USA; [Do-Monte, Fabricio H.; Quinones-Laracuente, Kelvin; Quirk, Gregory J.] Univ Puerto Rico, Dept Anat & Neurobiol, Sch Med, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Do-Monte, FH (corresponding author), Univ Puerto Rico, Dept Psychiat, Sch Med, POB 365067, San Juan, PR 00936 USA.	fabriciodomonte@gmail.com	Core, Vector/CAF-4832-2022	Do Monte, Fabricio H./0000-0002-1079-0064	NIH [R01-MH058883, P50-MH086400]; University of Puerto Rico President's Office; MBRS-RISE Program [R25-GM061838]; NSF [DBI-0115825]; RCMI [8G12-MD007600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058883, K99MH105549, R37MH058883, P50MH086400] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico President's Office; MBRS-RISE Program; NSF(National Science Foundation (NSF)); RCMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank G. Manzano-Nieves for help with the optogenetic experiments, A. C. Felix-Ortiz for technical advice, and K. M. Tye for comments on the manuscript. We thank K. Deisseroth for viral constructs and the UNC Vector Core Facility for viral packaging. This study was supported by the NIH grants R01-MH058883, and P50-MH086400, and a grant from the University of Puerto Rico President's Office to G.J.Q.; the MBRS-RISE Program (R25-GM061838) to K.Q.L.; and NSF grant DBI-0115825 and RCMI grant 8G12-MD007600 for the Confocal Microscope Facility.	Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Heydendael W, 2011, ENDOCRINOLOGY, V152, P4738, DOI 10.1210/en.2011-1652; Jasnow AM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00175; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Li S, 2008, J COMP NEUROL, V506, P263, DOI 10.1002/cne.21502; Li S, 2012, BRAIN STRUCT FUNCT, V217, P257, DOI 10.1007/s00429-011-0360-7; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; MOGA MM, 1995, J COMP NEUROL, V359, P221, DOI 10.1002/cne.903590204; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Padilla-Coreano N, 2012, NEUROPHARMACOLOGY, V62, P457, DOI 10.1016/j.neuropharm.2011.08.037; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Schafe GE, 2000, J NEUROSCI, V20, P8177; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Tseng WT, 2011, J NEUROSCI METH, V201, P368, DOI 10.1016/j.jneumeth.2011.08.028; Van den Oever MC, 2013, J NEUROSCI, V33, P18225, DOI 10.1523/JNEUROSCI.2412-13.2013; Vertes RP, 2008, J COMP NEUROL, V508, P212, DOI 10.1002/cne.21679; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wiltgen BJ, 2013, NEUROBIOL LEARN MEM, V106, P365, DOI 10.1016/j.nlm.2013.06.001	30	272	276	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 26	2015	519	7544					460	+		10.1038/nature14030	http://dx.doi.org/10.1038/nature14030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE1WF	25600268	Green Accepted			2022-12-28	WOS:000351602800054
J	Powers, BW; Chaguturu, SK; Ferris, TG				Powers, Brian W.; Chaguturu, Sreekanth K.; Ferris, Timothy G.			Optimizing High-Risk Care Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Powers, Brian W.; Chaguturu, Sreekanth K.; Ferris, Timothy G.] Harvard Univ, Sch Med, Boston, MA USA; [Powers, Brian W.; Chaguturu, Sreekanth K.; Ferris, Timothy G.] Partners HealthCare, Boston, MA 02199 USA; [Chaguturu, Sreekanth K.; Ferris, Timothy G.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts General Hospital	Ferris, TG (corresponding author), Partners HealthCare, 800 Boylston St, Boston, MA 02199 USA.	tferris@partners.org						Bodenheimer T., 2009, CARE MANAGEMENT PATI; Hong C.S., 2014, CARING HIGH NEED HIG; Nelson L, 2012, 201201 CONGR BUDG OF; Schwenk TL, 2014, JAMA-J AM MED ASSOC, V311, P802, DOI 10.1001/jama.2014.352; Watson T., 2014, NEW HLTH CARE IMPERA	5	33	33	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					795	796		10.1001/jama.2014.18171	http://dx.doi.org/10.1001/jama.2014.18171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25611132				2022-12-28	WOS:000349826400009
J	Agaronyan, K; Morozov, YI; Anikin, M; Temiakov, D				Agaronyan, Karen; Morozov, Yaroslav I.; Anikin, Michael; Temiakov, Dmitry			Replication-transcription switch in human mitochondria	SCIENCE			English	Article							DNA COPY NUMBER; POLYMERASE ELONGATION COMPLEX; RNA-POLYMERASE; TERMINATION; MTDNA; EMBRYOGENESIS; INITIATION; NUSA	Coordinated replication and expression of the mitochondrial genome is critical for metabolically active cells during various stages of development. However, it is not known whether replication and transcription can occur simultaneously without interfering with each other and whether mitochondrial DNA copy number can be regulated by the transcription machinery. We found that interaction of human transcription elongation factor TEFM with mitochondrial RNA polymerase and nascent transcript prevents the generation of replication primers and increases transcription processivity and thereby serves as a molecular switch between replication and transcription, which appear to be mutually exclusive processes in mitochondria. TEFM may allow mitochondria to increase transcription rates and, as a consequence, respiration and adenosine triphosphate production without the need to replicate mitochondrial DNA, as has been observed during spermatogenesis and the early stages of embryogenesis.	[Agaronyan, Karen; Morozov, Yaroslav I.; Anikin, Michael; Temiakov, Dmitry] Rowan Univ, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Temiakov, D (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	temiakdm@rowan.edu			NIH [R01GM104231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Schwinghammer for help in cloning and isolation of TEFM and W. McAllister and M. Gottesman for the critical discussion and reading of the manuscript. This work was supported in part by NIH R01GM104231.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224; Monnot S, 2013, HUM MOL GENET, V22, P1867, DOI 10.1093/hmg/ddt040; Morozov YI, 2014, NUCLEIC ACIDS RES, V42, P3884, DOI 10.1093/nar/gkt1356; Pomerantz RT, 2010, CELL CYCLE, V9, P2537, DOI 10.4161/cc.9.13.12122; Rantanen A, 2000, Hum Reprod, V15 Suppl 2, P86; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; St John J, 2014, BBA-GEN SUBJECTS, V1840, P1345, DOI 10.1016/j.bbagen.2013.10.036; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802; Wanrooij PH, 2010, P NATL ACAD SCI USA, V107, P16072, DOI 10.1073/pnas.1006026107	26	108	113	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					548	551		10.1126/science.aaa0986	http://dx.doi.org/10.1126/science.aaa0986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635099	Green Accepted			2022-12-28	WOS:000348639300053
J	Jacobs, DB; Sommers, BD				Jacobs, Douglas B.; Sommers, Benjamin D.			Using Drugs to Discriminate - Adverse Selection in the Insurance Marketplace	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jacobs, Douglas B.; Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Jacobs, DB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Abaluck J, 2011, AM ECON REV, V101, P1180, DOI 10.1257/aer.101.4.1180; Pharmaceutical Research and Manufacturers of America, 2014, AN EXCH PLAN BEN CER; Sommers BD, 2014, NEW ENGL J MED, V371, P867, DOI 10.1056/NEJMsr1406753; The AIDS Institute and the National Health Law Program, ADM COMPL RE DISCR P; Zengerle Patricia, 2012, REUTERS         0624	5	41	41	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					399	402		10.1056/NEJMp1411376	http://dx.doi.org/10.1056/NEJMp1411376			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA1CD	25629737	Green Published			2022-12-28	WOS:000348649700003
J	Loo, JM; Scherl, A; Nguyen, A; Man, FY; Weinberg, E; Zeng, ZS; Saltz, L; Paty, PB; Tavazoie, SF				Loo, Jia Min; Scherl, Alexis; Alexander Nguyen; Man, Fung Ying; Weinberg, Ethan; Zeng, Zhaoshi; Saltz, Leonard; Paty, Philip B.; Tavazoie, Sohail F.			Extracellular Metabolic Energetics Can Promote Cancer Progression	CELL			English	Article							CREATINE-KINASE; GENE-TRANSFER; METASTASIS; HYPOXIA; INVASION; AMPK; PHOSPHOCREATINE; HOMEOSTASIS; ZONATION; DISEASE	Colorectal cancer primarily metastasizes to the liver and globally kills over 600,000 people annually. By functionally screening 661 microRNAs (miRNAs) in parallel during liver colonization, we have identified miR-551a and miR-483 as robust endogenous suppressors of liver colonization and metastasis. These miRNAs convergently target creatine kinase, brain-type (CKB), which phosphorylates the metabolite creatine, to generate phosphocreatine. CKB is released into the extracellular space by metastatic cells encountering hepatic hypoxia and catalyzes production of phosphocreatine, which is imported through the SLC6A8 transporter and used to generate ATP-fueling metastatic survival. Combinatorial therapeutic viral delivery of miR-551a and miR-483-5p through single-dose adeno-associated viral (AAV) delivery significantly suppressed colon cancer metastasis, as did CKB inhibition with a small-molecule inhibitor. Importantly, human liver metastases express higher CKB and SLC6A8 levels and reduced miR-551a/miR-483 levels relative to primary tumors. We identify the extracellular space as an important compartment for malignant energetic catalysis and therapeutic targeting.	[Loo, Jia Min; Scherl, Alexis; Alexander Nguyen; Man, Fung Ying; Weinberg, Ethan; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Zeng, Zhaoshi; Paty, Philip B.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Saltz, Leonard] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Weinberg, Ethan Michael/AAH-8009-2019	Weinberg, Ethan Michael/0000-0002-5605-8995; Loo, Jia Min/0000-0002-6605-4031; Saltz, Leonard/0000-0001-8353-4670; Nguyen, Alexander/0000-0001-6578-3454	Irma T. Hirschl/Monique Weill-Caulier Trust; Starr Cancer Consortium; Leona M. and Harry B. Helmsley Charitable Trust; NIH Director's New Innovator Award [1DP2OD006506-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006506] Funding Source: NIH RePORTER	Irma T. Hirschl/Monique Weill-Caulier Trust; Starr Cancer Consortium; Leona M. and Harry B. Helmsley Charitable Trust; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the S.F.T. laboratory and Dr. Siavash Kurdistani for helpful comments and discussion. We thank Dr. Victor Brodsky, Yifang Liu, and Liza Rivera of Weill Cornell Medical College for invaluable help with the tissue microarray and image acquisition. The work was supported by the Irma T. Hirschl/Monique Weill-Caulier Trust, the Starr Cancer Consortium, the Leona M. and Harry B. Helmsley Charitable Trust, and by the NIH Director's New Innovator Award under award number 1DP2OD006506-01. J.M.L is an A*STAR National Science Scholar. S.F.T. is a cofounder and shareholder of Rgenix and is a member of its scientific advisory board.	ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Brustovetsky N, 2001, J NEUROCHEM, V76, P425, DOI 10.1046/j.1471-4159.2001.00052.x; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davis MJ, 2012, J CELL BIOL, V199, P15, DOI 10.1083/jcb.201205167; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hickson J, 2010, CELL DEATH DIFFER, V17, P1003, DOI 10.1038/cdd.2009.205; Huddleston HG, 2005, GYNECOL ONCOL, V96, P77, DOI 10.1016/j.ygyno.2004.08.047; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li TG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/168756; Li ZR, 2012, CANCER LETT, V323, P41, DOI 10.1016/j.canlet.2012.03.029; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; RUBERY ED, 1982, EUR J CANCER CLIN ON, V18, P951, DOI 10.1016/0277-5379(82)90243-7; Salomons GS, 2001, AM J HUM GENET, V68, P1497, DOI 10.1086/320595; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; SHAROV VG, 1987, J THORAC CARDIOV SUR, V94, P749; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song QC, 2014, CANCER RES, V74, P3031, DOI 10.1158/0008-5472.CAN-13-2193; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	50	218	228	0	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					393	406		10.1016/j.cell.2014.12.018	http://dx.doi.org/10.1016/j.cell.2014.12.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25601461	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000349208000007
J	Marotzke, J; Forster, PM				Marotzke, Jochem; Forster, Piers M.			Forcing, feedback and internal variability in global temperature trends	NATURE			English	Article							CLIMATE SENSITIVITY; MODEL; PACIFIC	Most present-generation climate models simulate an increase in global-mean surface temperature (GMST) since 1998, whereas observations suggest a warming hiatus. It is unclear to what extent this mismatch is caused by incorrect model forcing, by incorrect model response to forcing or by random factors. Here we analyse simulations and observations of GMST from 1900 to 2012, and show that the distribution of simulated 15-year trends shows no systematic bias against the observations. Using a multiple regression approach that is physically motivated by surface energy balance, we isolate the impact of radiative forcing, climate feedback and ocean heat uptake on GMST-with the regression residual interpreted as internal variability-and assess all possible 15- and 62-year trends. The differences between simulated and observed trends are dominated by random internal variability over the shorter timescale and by variations in the radiative forcings used to drive models over the longer timescale. For either trend length, spread in simulated climate feedback leaves no traceable imprint on GMST trends or, consequently, on the difference between simulations and observations. The claim that climate models systematically overestimate the response to radiative forcing from increasing greenhouse gas concentrations therefore seems to be unfounded.	[Marotzke, Jochem] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Forster, Piers M.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	Max Planck Society; University of Leeds	Marotzke, J (corresponding author), Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany.	jochem.marotzke@mpimet.mpg.de	Forster, Piers M/F-9829-2010	Forster, Piers M/0000-0002-6078-0171	Max Planck Society for the Advancement of Science; Royal Society Wolfson Merit Award; EPSRC [EP/1014721/1]; Engineering and Physical Sciences Research Council [EP/I014721/1] Funding Source: researchfish; EPSRC [EP/I014721/1] Funding Source: UKRI	Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission); Royal Society Wolfson Merit Award(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are indebted to J. Fyfe for making his CMIP5 GMST data set available to us, and to D. Notz,J. Risbey and B. Santer for comments on the manuscript. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups (names of models listed in Extended Data Table 1) for producing and making available their model output For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. This work was supported by the Max Planck Society for the Advancement of Science (J.M.) and by a Royal Society Wolfson Merit Award and EPSRC grant EP/1014721/1 (P.M.F.).	Anderson JL, 1996, J CLIMATE, V9, P1518, DOI 10.1175/1520-0442(1996)009<1518:AMFPAE>2.0.CO;2; Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Block K, 2013, J ADV MODEL EARTH SY, V5, P676, DOI 10.1002/jame.20041; Cohen JL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050582; Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; Doblas-Reyes FJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2704; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Forster PM, 2013, J GEOPHYS RES-ATMOS, V118, P1139, DOI 10.1002/jgrd.50174; Foster G, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044022; Fyfe JC, 2013, GEOPHYS RES LETT, V40, P584, DOI 10.1002/grl.50156; Fyfe JC, 2013, NAT CLIM CHANGE, V3, P767, DOI 10.1038/nclimate1972; Gregory JM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010405; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018747; Guemas V, 2013, NAT CLIM CHANGE, V3, P649, DOI [10.1038/nclimate1863, 10.1038/NCLIMATE1863]; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Held IM, 2010, J CLIMATE, V23, P2418, DOI 10.1175/2009JCLI3466.1; Huber M, 2014, NAT GEOSCI, V7, P651, DOI [10.1038/NGEO2228, 10.1038/ngeo2228]; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Knight J. R., 2009, B AM METEOROL SOC, V90, pS22, DOI DOI 10.1175/BAMS-90-8-STATE0FTHECLIMATE; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Kuhlbrodt T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052952; Lean JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038932; Liebmann B, 2010, B AM METEOROL SOC, V91, P1485, DOI 10.1175/2010BAMS3030.1; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Meehl GA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053423; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Meraner K, 2013, GEOPHYS RES LETT, V40, P5944, DOI 10.1002/2013GL058118; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Notz D, 2013, J ADV MODEL EARTH SY, V5, P173, DOI 10.1002/jame.20016; Ridley DA, 2014, GEOPHYS RES LETT, V41, P7763, DOI 10.1002/2014GL061541; Risbey JS, 2014, NAT CLIM CHANGE, V4, P835, DOI [10.1038/nclimate2310, 10.1038/NCLIMATE2310]; Santer BD, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016263; Santer BD, 2014, NAT GEOSCI, V7, P185, DOI [10.1038/ngeo2098, 10.1038/NGEO2098]; Santer BD, 2013, P NATL ACAD SCI USA, V110, P26, DOI 10.1073/pnas.1210514109; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Simmons AJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012442; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Stott P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014024; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thompson DWJ, 2009, J CLIMATE, V22, P6120, DOI 10.1175/2009JCLI3089.1; Vial J, 2013, CLIM DYNAM, V41, P3339, DOI 10.1007/s00382-013-1725-9; Wang SW, 2010, ADV CLIM CHANG RES, V1, P49, DOI 10.3724/SP.J.1248.2010.00049	48	123	131	5	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					565	U291		10.1038/nature14117	http://dx.doi.org/10.1038/nature14117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631444	Green Accepted			2022-12-28	WOS:000348775000033
J	Wu, CY; Horibe, T; Jacobsen, CB; Toste, FD				Wu, Chung-Yeh; Horibe, Takahiro; Jacobsen, Christian Borch; Toste, F. Dean			Stable gold(III) catalysts by oxidative addition of a carbon-carbon bond	NATURE			English	Article							REDUCTIVE ELIMINATION; ARYL HALIDES; GOLD; REACTIVITY; COMPLEXES; FLUORINATION; ACTIVATION; CHEMISTRY; LIGANDS	Low-valent late transition-metal catalysis has become indispensable to chemical synthesis, but homogeneous high-valent transition-metal catalysis is underdeveloped, mainly owing to the reactivityofhigh-valent transition-metal complexes and the challenges associated with synthesizing them. Here we report a carbon-carbon bond cleavage at ambient conditions by a Au(I) complex that generates a stable Au(III) cationic complex. In contrast to the well-established soft and carbophilic Au(I) catalyst, this Au(III) complex exhibits hard, oxophilic Lewis acidity. For example, we observed catalytic activation of alpha,beta-unsaturated aldehydes towards selective conjugate additions as well as activation of an unsaturated aldehyde-allene for a [212] cycloaddition reaction. The origin of the regioselectivity and catalytic activity was elucidated by X-ray crystallographic analysis of an isolated Au(III)-activated cinnamaldehyde intermediate. The concepts revealed suggest a strategy for accessing high-valent transition-metal catalysis from readily available precursors.	[Wu, Chung-Yeh; Horibe, Takahiro; Jacobsen, Christian Borch; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Jacobsen, Christian Borch/B-8031-2014; Jacobsen, Christian Borch/D-1940-2016; Toste, F. Dean/Y-2556-2019	Jacobsen, Christian Borch/0000-0002-7502-9831; Toste, F. Dean/0000-0001-8018-2198; Horibe, Takahiro/0000-0002-4692-4642	NIHGMS [R01 GM073932]; Taiwan National Science Council; Uehara Memorial Foundation; Lundbeck Foundation; NIH Shared Instrumentation Grant [S10-RR027172]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073932] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Uehara Memorial Foundation(Uehara Memorial Foundation); Lundbeck Foundation(Lundbeckfonden); NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the NIHGMS (R01 GM073932) for financial support. C.-Y.W. thanks the Taiwan National Science Council for a postdoctoral fellowship (2011-2012). T.H. thanks the Uehara Memorial Foundation for a postdoctoral fellowship. C.B.J. is grateful to the Lundbeck Foundation for a postdoctoral fellowship. We thank A. DiPasquale (at the College of Chemistry X-ray Crystallography Facility of the University of California, Berkeley) for X-ray crystallographic data collection and we acknowledge support from the NIH Shared Instrumentation Grant S10-RR027172. We thank H.-J. Liu for his generous donation of the biphenylene.	Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; Akagawa K, 2014, ORG BIOMOL CHEM, V12, P3581, DOI 10.1039/c4ob00565a; Akagawa K, 2013, ANGEW CHEM INT EDIT, V52, P11585, DOI 10.1002/anie.201305004; Alcaide B, 2010, CHEM SOC REV, V39, P783, DOI 10.1039/b913749a; ALSTERS PL, 1993, ORGANOMETALLICS, V12, P1831, DOI 10.1021/om00029a045; Corma A, 2011, CHEM REV, V111, P1657, DOI 10.1021/cr100414u; Darmon JM, 2012, J AM CHEM SOC, V134, P17125, DOI 10.1021/ja306526d; de Fremont P, 2007, ORGANOMETALLICS, V26, P1376, DOI 10.1021/om060887t; Fackler JP, 1997, POLYHEDRON, V16, P1, DOI 10.1016/0277-5387(96)00190-8; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; Gaillard S, 2010, ORGANOMETALLICS, V29, P394, DOI 10.1021/om900814e; Gorin DJ, 2007, NATURE, V446, P395, DOI 10.1038/nature05592; Guenther J, 2014, J AM CHEM SOC, V136, P1778, DOI 10.1021/ja412432k; Hadfield MS, 2011, CHEM COMMUN, V47, P1333, DOI 10.1039/c0cc04217j; Hamilton GL, 2007, SCIENCE, V317, P496, DOI 10.1126/science.1145229; Hashmi ASK, 2012, ANGEW CHEM INT EDIT, V51, P12935, DOI 10.1002/anie.201208603; Hashmi ASK, 2012, ADV SYNTH CATAL, V354, P133, DOI 10.1002/adsc.201000044; Hashmi ASK, 2006, EUR J ORG CHEM, V2006, P1387, DOI 10.1002/ejoc.200600009; Hashmi ASK, 2000, J AM CHEM SOC, V122, P11553, DOI 10.1021/ja005570d; Hayashi Y, 2012, CHEMCATCHEM, V4, P959, DOI 10.1002/cctc.201200161; Hickman AJ, 2012, NATURE, V484, P177, DOI 10.1038/nature11008; Jones WD, 2014, TOP CURR CHEM, V346, P1, DOI [10.1109/NSSMIC.2014.7430842, 10.1007/128_2013_491]; Joost M, 2014, J AM CHEM SOC, V136, P14654, DOI 10.1021/ja506978c; Krause N, 2011, CHEM REV, V111, P1994, DOI 10.1021/cr1004088; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Levin MD, 2014, ANGEW CHEM INT EDIT, V53, P6211, DOI 10.1002/anie.201402924; Leyva-Perez A, 2012, ANGEW CHEM INT EDIT, V51, P614, DOI 10.1002/anie.201101726; Livendahl M, 2014, CHEM COMMUN, V50, P1533, DOI 10.1039/c3cc48914k; Mahrwald R, 1999, CHEM REV, V99, P1095, DOI 10.1021/cr980415r; MARUOKA K, 1994, J AM CHEM SOC, V116, P4131, DOI 10.1021/ja00088a080; North M, 2008, CHEM REV, V108, P5146, DOI 10.1021/cr800255k; Oliver-Meseguer J, 2012, SCIENCE, V338, P1452, DOI 10.1126/science.1227813; Perthuisot C, 2002, J MOL CATAL A-CHEM, V189, P157, DOI 10.1016/S1381-1169(02)00203-0; Pyykko P, 2006, CHEM-ASIAN J, V1, P623, DOI 10.1002/asia.200600181; Rosca DA, 2012, ANGEW CHEM INT EDIT, V51, P10643, DOI 10.1002/anie.201206468; Schmidbaur H, 2012, ARAB J SCI ENG, V37, P1187, DOI 10.1007/s13369-012-0313-3; USON R, 1980, J ORGANOMET CHEM, V198, P105, DOI 10.1016/S0022-328X(00)84669-0; Vicente J, 1996, CHEM BER, V129, P1395, DOI 10.1002/cber.19961291114; Wang YM, 2014, ACCOUNTS CHEM RES, V47, P889, DOI 10.1021/ar400188g; Weber SG, 2012, EUR J INORG CHEM, P2863, DOI 10.1002/ejic.201200327; Whitfield SR, 2007, J AM CHEM SOC, V129, P15142, DOI 10.1021/ja077866q; Wolf WJ, 2014, NAT CHEM, V6, P159, DOI [10.1038/NCHEM.1822, 10.1038/nchem.1822]; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, P1	44	207	207	5	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					449	454		10.1038/nature14104	http://dx.doi.org/10.1038/nature14104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25612049	Green Accepted, Green Submitted			2022-12-28	WOS:000348196500027
J	Herrigel, DJ; Willett, LR				Herrigel, Dana J.; Willett, Laura Rees			In hypertension with high CV risk, BP self-monitoring and medication self-titration reduced BP at 12 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Herrigel, Dana J.; Willett, Laura Rees] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Herrigel, DJ (corresponding author), Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA.							Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011	4	1	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC7	10.7326/ACPJC-2015-162-2-007	http://dx.doi.org/10.7326/ACPJC-2015-162-2-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599367				2022-12-28	WOS:000350106600006
J	Bishop, CM; Spivey, RJ; Hawkes, LA; Batbayar, N; Chua, B; Frappell, PB; Milsom, WK; Natsagdorj, T; Newman, SH; Scott, GR; Takekawa, JY; Wikelski, M; Butler, PJ				Bishop, C. M.; Spivey, R. J.; Hawkes, L. A.; Batbayar, N.; Chua, B.; Frappell, P. B.; Milsom, W. K.; Natsagdorj, T.; Newman, S. H.; Scott, G. R.; Takekawa, J. Y.; Wikelski, M.; Butler, P. J.			The roller coaster flight strategy of bar-headed geese conserves energy during Himalayan migrations	SCIENCE			English	Article							BRANTA-LEUCOPSIS; PACIFIC-OCEAN; HEART-RATE; BIRDS; BEHAVIOR; BLOOD	The physiological and biomechanical requirements of flight at high altitude have been the subject of much interest. Here, we uncover a steep relation between heart rate and wingbeat frequency (raised to the exponent 3.5) and estimated metabolic power and wingbeat frequency (exponent 7) of migratory bar-headed geese. Flight costs increase more rapidly than anticipated as air density declines, which overturns prevailing expectations that this species should maintain high-altitude flight when traversing the Himalayas. Instead, a "roller coaster" strategy, of tracking the underlying terrain and discarding large altitude gains only to recoup them later in the flight with occasional benefits from orographic lift, is shown to be energetically advantageous for flights over the Himalayas.	[Bishop, C. M.; Spivey, R. J.; Hawkes, L. A.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Batbayar, N.] Wildlife Sci & Conservat Ctr Mongolia, Ulaanbataar, Mongolia; [Chua, B.; Milsom, W. K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Frappell, P. B.] Univ Tasmania, Off Dean Grad Res, Hobart, Tas 7001, Australia; [Natsagdorj, T.] Mongolian Acad Sci, Ulaanbataar, Mongolia; [Newman, S. H.] Food & Agr Org United Nations FAO, Emergency Prevent Syst EMPRES Wildlife & Ecol Uni, Rome, Italy; [Scott, G. R.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4L8, Canada; [Takekawa, J. Y.] US Geol Survey, San Francisco Bay Estuary Field Stn, Western Ecol Res Ctr, Vallejo, CA 94592 USA; [Wikelski, M.] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Wikelski, M.] Univ Konstanz, Dept Biol, Constance, Germany; [Butler, P. J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Bangor University; University of British Columbia; University of Tasmania; Mongolian Academy of Sciences; Food & Agriculture Organization of the United Nations (FAO); McMaster University; United States Department of the Interior; United States Geological Survey; Max Planck Society; University of Konstanz; University of Birmingham	Bishop, CM (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	c.bishop@bangor.ac.uk; l.hawkes@exeter.ac.uk	Batbayar, Nyambayar/N-3761-2019; Batbayar, Nyambayar/N-7066-2015	Batbayar, Nyambayar/0000-0002-9138-9626; Batbayar, Nyambayar/0000-0002-9138-9626	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/FO15615/1]; Natural Sciences and Engineering Research Council of Canada; Max Planck Institute for Ornithology; U.S. Geological Survey; Western Ecological and Patuxent Wildlife Research Centers; Avian Influenza Programme; FAO through the Animal Health Service EMPRES surveillance program; Biotechnology and Biological Sciences Research Council [BB/F015615/1] Funding Source: researchfish; BBSRC [BB/F015615/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Max Planck Institute for Ornithology(Max Planck Society); U.S. Geological Survey(United States Geological Survey); Western Ecological and Patuxent Wildlife Research Centers; Avian Influenza Programme; FAO through the Animal Health Service EMPRES surveillance program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was conducted with permission from the Mongolian Academy of Sciences and the Wildlife Science and Conservation Centre. Primary funding was from a UK Biotechnology and Biological Sciences Research Council (BBSRC) award to C.M.B. and P.J.B. (grant no. BB/FO15615/1) and a Natural Sciences and Engineering Research Council of Canada award to W.K.M., with additional support from the Max Planck Institute for Ornithology, the U.S. Geological Survey, Western Ecological and Patuxent Wildlife Research Centers, Avian Influenza Programme, and the FAO through the Animal Health Service EMPRES surveillance program. We are grateful to the support of all the field team members in Mongolia, to A. Davies for developing the first generation of heart rate-data loggers, and to the work of Beaumaris Instruments Ltd. in the development of housings for the instruments. Thanks also to S. Ward for providing the wind tunnel heart rate-calibration data. The use of trade names in this document is for descriptive purposes only and does not imply endorsement by the U.S. government. Links to the data presented in the figures are provided in the supplementary materials. Author contributions. C.M.B. and P.J.B. led the study. C.M.B., P.J.B., L.A.H., N.B., W.K.M, G.R.S, J.Y.T., S.H.N., P.B.F., and M.W. conceived and/or designed the fieldwork. B.C. led and conducted the veterinary work, with assistance from the field team. N.B., L.A.H., T.N., C.M.B., G.R.S, and J.Y.T. conducted the fieldwork. C.M.B. and R.J.S. wrote the paper, which was then reviewed by all authors. R.J.S. designed the instruments, analyzed the data collected and generated the figures, in consultation with C.M.B.	Bishop CM, 2013, J THEOR BIOL, V323, P11, DOI 10.1016/j.jtbi.2013.01.002; Blum Arlene, 1998, ANNAPURNA WOMANS PLA; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Butler PJ, 2010, COMP BIOCHEM PHYS A, V156, P325, DOI 10.1016/j.cbpa.2010.01.016; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Butler PJ, 1998, J AVIAN BIOL, V29, P536, DOI 10.2307/3677173; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; FARACI FM, 1991, ANNU REV PHYSIOL, V53, P59, DOI 10.1146/annurev.ph.53.030191.000423; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Hawkes LA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2114; Hawkes LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094015; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Klaassen RHG, 2011, BIOL LETTERS, V7, P833, DOI 10.1098/rsbl.2011.0343; Liechti F, 1999, NATURWISSENSCHAFTEN, V86, P549, DOI 10.1007/s001140050673; Meir JU, 2013, J EXP BIOL, V216, P2172, DOI 10.1242/jeb.085282; Pennycuick CJ, 1996, J EXP BIOL, V199, P1613; PINSHOW B, 1985, AM J PHYSIOL, V249, pR758, DOI 10.1152/ajpregu.1985.249.6.R758; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; Schmaljohann H, 2007, P R SOC B, V274, P735, DOI 10.1098/rspb.2006.0011; Scott GR, 2006, RESP PHYSIOL NEUROBI, V154, P284, DOI 10.1016/j.resp.2006.02.012; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Spivey RJ, 2014, PROG OCEANOGR, V125, P62, DOI 10.1016/j.pocean.2014.04.005; Spivey RJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0404; Spivey RJ, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4854635; Ward S, 2002, J EXP BIOL, V205, P3347; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; [No title captured]	30	137	139	0	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					250	254		10.1126/science.1258732	http://dx.doi.org/10.1126/science.1258732			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593180	Green Submitted			2022-12-28	WOS:000347915300030
J	Eccleston, A; Gray, N; Shadan, S; Weiss, U				Eccleston, Alex; Gray, Noah; Shadan, Sadaf; Weiss, Ursula			Frontiers in biology	NATURE			English	Editorial Material														Gray, Noah/0000-0002-4672-7403					0	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					283	283		10.1038/517283a	http://dx.doi.org/10.1038/517283a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592532	Bronze			2022-12-28	WOS:000347810300031
J	McDonald, ME; Li, CD; Bian, HJ; Smith, BD; Layne, MD; Farmer, SR				McDonald, Meghan E.; Li, Chendi; Bian, Hejiao; Smith, Barbara D.; Layne, Matthew D.; Farmer, Stephen R.			Myocardin-Related Transcription Factor A Regulates Conversion of Progenitors to Beige Adipocytes	CELL			English	Article							WHITE ADIPOSE-TISSUE; BONE MORPHOGENETIC PROTEIN-7; ACTIN GENE-EXPRESSION; SMOOTH-MUSCLE-CELLS; GAMMA PPAR-GAMMA; BROWN ADIPOCYTES; STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; SKELETAL-MUSCLE; FAT	Adipose tissue is an essential regulator of metabolic homeostasis. In contrast with white adipose tissue, which stores excess energy in the form of triglycerides, brown adipose tissue is thermogenic, dissipating energy as heat via the unique expression of the mitochondrial uncoupling protein UCP1. A subset of UCP1+ adipocytes develops within white adipose tissue in response to physiological stimuli; however, the developmental origin of these "brite'' or "beige'' adipocytes is unclear. Here, we report the identification of a BMP7-ROCK signaling axis regulating beige adipocyte formation via control of the G-actin-regulated transcriptional coactivator myocardin-related transcription factor A, MRTFA. White adipose tissue from MRTFA(-/-) mice contains more multilocular adipocytes and expresses enhanced levels of brown-selective proteins, including UCP1. MRTFA(-/-) mice also show improved metabolic profiles and protection from diet-induced obesity and insulin resistance. Our study hence unravels a central pathway driving the development of physiologically functional beige adipocytes.	[McDonald, Meghan E.; Li, Chendi; Bian, Hejiao; Smith, Barbara D.; Layne, Matthew D.; Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Layne, MD (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	mlayne@bu.edu; sfarmer@bu.edu		Farmer, Stephen/0000-0003-2483-2795	NIH [DK051586, DK098830, HL078869]; BNORC pilot grant [P30 DK046200]; Scleroderma Foundation Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098830, P30DK046200, R01DK051586, R56DK051586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BNORC pilot grant; Scleroderma Foundation Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Eric Olson, UT Southwestern Medical Center, TX for the MRTFA<SUP>+/-</SUP> mice. We thank Tom Balon of the Mouse Phenotyping Core for his advice and assistance. This work was supported by NIH grants DK051586, DK098830 (S.R.F.), and HL078869, BNORC pilot grant P30 DK046200 (M.D.L.), and Scleroderma Foundation Research Grant (B.D.S).	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chang YF, 2003, AM J PHYSIOL-HEART C, V285, pH1675, DOI 10.1152/ajpheart.00165.2003; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; COUSIN B, 1992, J CELL SCI, V103, P931; Cousin B, 1996, J CELL PHYSIOL, V167, P285, DOI 10.1002/(SICI)1097-4652(199605)167:2<285::AID-JCP12>3.0.CO;2-7; Enerback S, 2009, NEW ENGL J MED, V360, P2021, DOI 10.1056/NEJMcibr0809610; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Farmer SR, 2009, NATURE, V458, P839, DOI 10.1038/458839a; FERNANDEZ JLR, 1989, DIFFERENTIATION, V42, P65, DOI 10.1111/j.1432-0436.1989.tb00608.x; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jakobsson L, 2013, EXP CELL RES, V319, P1264, DOI 10.1016/j.yexcr.2013.02.015; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Li J, 2012, DEVELOPMENT, V139, P3531, DOI 10.1242/dev.082222; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; LONCAR D, 1991, International Journal of Developmental Biology, V35, P321; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moustakas A, 2008, FEBS LETT, V582, P2051, DOI 10.1016/j.febslet.2008.03.027; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Nedergaard J, 2005, EMBO REP, V6, P917, DOI 10.1038/sj.embor.7400532; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pino E, 2012, J BIOL CHEM, V287, P18351, DOI 10.1074/jbc.M112.350918; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vernochet C, 2010, ENDOCRINOLOGY, V151, P586, DOI 10.1210/en.2009-1057; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang C, 2010, TISSUE ENG PT A, V16, P1201, DOI 10.1089/ten.TEA.2009.0303; Wang CJ, 2009, NITRIC OXIDE-BIOL CH, V20, P298, DOI 10.1016/j.niox.2009.02.006; Wang DH, 2012, J BIOL CHEM, V287, P28067, DOI 10.1074/jbc.M112.379487; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang SJ, 2012, J CELL MOL MED, V16, P2301, DOI 10.1111/j.1582-4934.2012.01538.x; Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	86	108	108	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					105	118		10.1016/j.cell.2014.12.005	http://dx.doi.org/10.1016/j.cell.2014.12.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25579684	Green Accepted, Bronze			2022-12-28	WOS:000347923200012
J	Abraham, RT				Abraham, Robert T.			Making sense of amino acid sensing	SCIENCE			English	Editorial Material							SIGNAL INTEGRATION; RAG GTPASES; MTORC1		Pfizer Worldwide Res & Dev, Oncol Res Unit, San Diego, CA 92121 USA	Pfizer	Abraham, RT (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res Unit, 10646-CB4 Sci Ctr Dr, San Diego, CA 92121 USA.	robert.abraham@pfizer.com						Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sanchez-Gurmaches J, 2014, CANCER CELL, V26, P601, DOI 10.1016/j.ccell.2014.10.011; Thomas JD, 2014, CANCER CELL, V26, P754, DOI 10.1016/j.ccell.2014.09.008; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	13	31	33	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					128	129		10.1126/science.aaa4570	http://dx.doi.org/10.1126/science.aaa4570			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574008				2022-12-28	WOS:000347918900024
J	Navon, N; Gaunt, AL; Smith, RP; Hadzibabic, Z				Navon, Nir; Gaunt, Alexander L.; Smith, Robert P.; Hadzibabic, Zoran			Critical dynamics of spontaneous symmetry breaking in a homogeneous Bose gas	SCIENCE			English	Article							EINSTEIN CONDENSATE; DEFECT FORMATION; SUPERFLUID HE-3; CRYSTALS; VORTICES; HELIUM; FLUX	Kibble-Zurek theory models the dynamics of spontaneous symmetry breaking, which plays an important role in a wide variety of physical contexts, ranging from cosmology to superconductors. We explored these dynamics in a homogeneous system by thermally quenching an atomic gas with short-range interactions through the Bose-Einstein phase transition. Using homodyne matter-wave interferometry to measure first-order correlation functions, we verified the central quantitative prediction of the Kibble-Zurek theory, namely the homogeneous-system power-law scaling of the coherence length with the quench rate. Moreover, we directly confirmed its underlying hypothesis, the freezing of the correlation length near the transition. Our measurements agree with a beyond-mean-field theory and support the expectation that the dynamical critical exponent for this universality class is z = 3/2.	[Navon, Nir; Gaunt, Alexander L.; Smith, Robert P.; Hadzibabic, Zoran] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge	Navon, N (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	nn270@cam.ac.uk	Smith, Robert P/A-1286-2014; Hadzibabic, Zoran/B-8102-2011	Smith, Robert P/0000-0002-6881-5690; Hadzibabic, Zoran/0000-0002-0118-9285; Navon, Nir/0000-0002-8917-3463	AFOSR; ARO; DARPA OLE; EPSRC [EP/K003615/1]; Trinity College, Cambridge; Royal Society; Engineering and Physical Sciences Research Council [1104880, EP/K003615/1] Funding Source: researchfish	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ARO; DARPA OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Trinity College, Cambridge; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Robert-de-Saint-Vincent for experimental assistance; R. Fletcher for comments on the manuscript; and N. Cooper, J. Dalibard, G. Ferrari, B. Phillips, and W. Zwerger tor insightful discussions. This work was supported by AFOSR, ARO, DARPA OLE, and EPSRC (grant no. EP/K003615/1). N.N. acknowledges support from Trinity College, Cambridge, and R.P.S. from the Royal Society.	Anglin JR, 1999, PHYS REV LETT, V83, P1707, DOI 10.1103/PhysRevLett.83.1707; Bauerle C, 1996, NATURE, V382, P332, DOI 10.1038/382332a0; Biroli G, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.050101; Carmi R, 1999, PHYS REV B, V60, P7595, DOI 10.1103/PhysRevB.60.7595; Carmi R, 2000, PHYS REV LETT, V84, P4966, DOI 10.1103/PhysRevLett.84.4966; Chae SC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.167603; Chen D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.235304; CHUANG I, 1991, SCIENCE, V251, P1336, DOI 10.1126/science.251.4999.1336; Corman L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.135302; del Campo A, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X1430018X; Dettmer S, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.160406; Donner T, 2007, SCIENCE, V315, P1556, DOI 10.1126/science.1138807; Ejtemaee S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.051401; Folk R, 2006, J PHYS A-MATH GEN, V39, pR207, DOI 10.1088/0305-4470/39/24/R01; Gaunt AL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.200406; Gotlibovych I, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.061604; Hagley EW, 1999, PHYS REV LETT, V83, P3112, DOI 10.1103/PhysRevLett.83.3112; HOHENBERG PC, 1977, REV MOD PHYS, V49, P435, DOI 10.1103/RevModPhys.49.435; Kardar M., 2007, STAT PHYS FIELDS; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Lamporesi G, 2013, NAT PHYS, V9, P655, DOI 10.1038/NPHYS2734; Monaco R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.080603; Pogorelov AA, 2007, JETP LETT+, V86, P39, DOI 10.1134/S0021364007130097; Pyka K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3291; Ruutu VMH, 1996, NATURE, V382, P334, DOI 10.1038/382334a0; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; Ulm S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3290; Weiler CN, 2008, NATURE, V455, P948, DOI 10.1038/nature07334; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	29	197	197	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					167	170		10.1126/science.1258676	http://dx.doi.org/10.1126/science.1258676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574021	Green Submitted			2022-12-28	WOS:000347918900041
J	Gitlin, AD; Nussenzweig, MC				Gitlin, Alexander D.; Nussenzweig, Michel C.			Fifty years of B lymphocytes	NATURE			English	Editorial Material							BURSA		[Gitlin, Alexander D.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY 10021 USA; [Nussenzweig, Michel C.] Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gitlin, AD (corresponding author), Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019	Gitlin, Alexander/0000-0002-9229-0919	NIGMS NIH HHS [T32 GM007739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Cooper MD, 2010, ANNU REV IMMUNOL, V28, P1, DOI 10.1146/annurev-immunol-030409-101248; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1965, NATURE, V205, P143, DOI 10.1038/205143a0; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Miller JFAP, 2002, IMMUNOL REV, V185, P7, DOI 10.1034/j.1600-065X.2002.18502.x; OWEN JJT, 1974, NATURE, V249, P361, DOI 10.1038/249361a0; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643	10	16	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					139	141		10.1038/517139a	http://dx.doi.org/10.1038/517139a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567266	Bronze			2022-12-28	WOS:000347477600011
J	Moy, B; Specht, MC; Lanuti, M; Rafferty, EA; Lerwill, MF				Moy, Beverly; Specht, Michelle C.; Lanuti, Michael; Rafferty, Elizabeth A.; Lerwill, Melinda F.			Case 1-2015: A 66-Year-Old Woman with Metastatic Breast Cancer after Endocrine Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; ADJUVANT TAMOXIFEN; AMERICAN SOCIETY; MRI; LETROZOLE; TRIAL; MUTATIONS; ARIMIDEX; EFFICACY		[Moy, Beverly] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Specht, Michelle C.; Lanuti, Michael] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Rafferty, Elizabeth A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lerwill, Melinda F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Moy, Beverly] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Specht, Michelle C.; Lanuti, Michael] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Rafferty, Elizabeth A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Lerwill, Melinda F.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moy, B (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Brennan S, 2010, AM J ROENTGENOL, V195, P510, DOI 10.2214/AJR.09.3573; Burstein HJ, 2010, J ONCOL PRACT, V6, P243, DOI 10.1200/JOP.000082; Carlson RW, 2012, J NATL COMPR CANC NE, V10, P821, DOI 10.6004/jnccn.2012.0086; Chia S, 2008, J CLIN ONCOL, V26, P1664, DOI 10.1200/JCO.2007.13.5822; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Friedel G, 2002, EUR J CARDIO-THORAC, V22, P335, DOI 10.1016/S1010-7940(02)00331-7; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goss PE, 2007, J CLIN ONCOL, V25, P2006, DOI 10.1200/JCO.2006.09.4482; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Hornbech K, 2011, EUR J CARDIO-THORAC, V39, P955, DOI 10.1016/j.ejcts.2010.10.001; Houssami N, 2013, ANN SURG, V257, P249, DOI 10.1097/SLA.0b013e31827a8d17; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Moy B, 2006, CLIN CANCER RES, V12, P4790, DOI 10.1158/1078-0432.CCR-06-1535; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Stewart HJ, 1996, BRIT J CANCER, V74, P297, DOI 10.1038/bjc.1996.356; Sung JS, 2014, AM J ROENTGENOL, V202, P1376, DOI 10.2214/AJR.13.11355; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Tormey DC, 1996, JNCI-J NATL CANCER I, V88, P1828, DOI 10.1093/jnci/88.24.1828	32	2	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					162	170		10.1056/NEJMcpc1408601	http://dx.doi.org/10.1056/NEJMcpc1408601			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25564900				2022-12-28	WOS:000347443300012
J	[Anonymous]				[Anonymous]			Science and Humanity (Reprinted from vol 114, pg 173-174, 1940)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1940, JAMA, V114, P173	1	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					99	99		10.1001/jama.2014.11520	http://dx.doi.org/10.1001/jama.2014.11520			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562283				2022-12-28	WOS:000347478000030
J	Gaudelli, NM; Long, DH; Townsend, CA				Gaudelli, Nicole M.; Long, Darcie H.; Townsend, Craig A.			beta-Lactam formation by a non-ribosomal peptide synthetase during antibiotic biosynthesis	NATURE			English	Article							CONDENSATION DOMAINS; NOCARDICIN; SPECIFICITY; ENZYMES	Non-ribosomal peptide synthetases are giant enzymes composed of modules that house repeated sets of functional domains, which select, activate and couple amino acids drawn from a pool of nearly 500 potential building blocks(1). The structurally and stereochemically diverse peptides generated in this manner underlie the biosynthesis of a large sector of natural products. Many of their derived metabolites are bioactive such as the antibiotics vancomycin, bacitracin, daptomycin and the beta-lactam-containing penicillins, cephalosporins andnocardicins. Penicillins and cephalosporins are synthesized from a classically derived non-ribosomal peptide synthetase tripeptide (from delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase)(2). Here we report an unprecedented non-ribosomal peptide synthetase activity that both assembles a serine-containing peptide and mediates its cyclization to the critical beta-lactamring of the nocardicin family of antibiotics. A histidine-rich condensation domain, which typically performs peptide bond formation during product assembly, also synthesizes the embedded four-membered ring. We propose a mechanism, and describe supporting experiments, that is distinct from the pathways that have evolved to the three other beta-lactam antibiotic families: penicillin/cephalosporins, clavams and carbapenems. These findings raise the possibility that beta-lactam rings can be regio- and stereospecifically integrated into engineered peptides for application as, for example, targeted protease inactivators(3,4).	[Gaudelli, Nicole M.; Long, Darcie H.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University	Townsend, CA (corresponding author), Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA.	ctownsend@jhu.edu		Long, Darcie/0000-0003-1367-8171; Gaudelli, Nicole/0000-0001-8608-4855	National Institutes of Health [AI014937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937, R56AI014937, R01AI014937, R01AI121072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI014937. We are indebted to D. W. Udwary (bioinformatics), K. A. Moshos, J. W. Labonte (chemistry) and R.-f. Li (molecular biology) for advice and discussion. We thank C. T. Walsh for the pET29-Sfp expression plasmid, I. P. Mortimer for high-resolution mass spectrometry (HRMS) data and C. Moore for help with NMR acquisitions.	Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bachmann BO, 1998, P NATL ACAD SCI USA, V95, P9082, DOI 10.1073/pnas.95.16.9082; BANKO G, 1987, J AM CHEM SOC, V109, P2858, DOI 10.1021/ja00243a068; Belshaw PJ, 1999, SCIENCE, V284, P486, DOI 10.1126/science.284.5413.486; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Burzlaff NI, 1999, NATURE, V401, P721, DOI 10.1038/44400; Clugston SL, 2003, BIOCHEMISTRY-US, V42, P12095, DOI 10.1021/bi035090+; Davidsen JM, 2013, J AM CHEM SOC, V135, P1749, DOI 10.1021/ja307710d; Davidsen JM, 2012, CHEM BIOL, V19, P297, DOI 10.1016/j.chembiol.2011.10.020; Demain AL, 2009, MED RES REV, V29, P821, DOI 10.1002/med.20154; Ehmann DE, 2000, CHEM BIOL, V7, P765, DOI 10.1016/S1074-5521(00)00022-3; Freeman MF, 2008, P NATL ACAD SCI USA, V105, P11128, DOI 10.1073/pnas.0804500105; Galletti P, 2011, CURR MED CHEM, V18, P4265, DOI 10.2174/092986711797200480; Gaudelli NM, 2014, NAT CHEM BIOL, V10, P251, DOI [10.1038/NCHEMBIO.1456, 10.1038/nchembio.1456]; Gunsior M, 2004, CHEM BIOL, V11, P927, DOI 10.1016/j.chembiol.2004.04.012; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Hubbard BK, 2000, CHEM BIOL, V7, P931, DOI 10.1016/S1074-5521(00)00043-0; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Reeve AM, 1998, J BIOL CHEM, V273, P30695, DOI 10.1074/jbc.273.46.30695; Roche ED, 2003, BIOCHEMISTRY-US, V42, P1334, DOI 10.1021/BI026867m; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; SALITURO GM, 1990, J AM CHEM SOC, V112, P760, DOI 10.1021/ja00158a040; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; Sattely ES, 2008, J AM CHEM SOC, V130, P12282, DOI 10.1021/ja804499r; Silverman R. B., 2002, ORGANIC CHEM ENZYME, P399; Tahlan K, 2013, J ANTIBIOT, V66, P401, DOI 10.1038/ja.2013.24; TOWNSEND CA, 1988, J AM CHEM SOC, V110, P3320, DOI 10.1021/ja00218a063; TOWNSEND CA, 1983, J AM CHEM SOC, V105, P913, DOI 10.1021/ja00342a046; TOWNSEND CA, 1983, J AM CHEM SOC, V105, P919, DOI 10.1021/ja00342a047; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0	35	77	84	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					383	+		10.1038/nature14100	http://dx.doi.org/10.1038/nature14100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25624104	Green Accepted			2022-12-28	WOS:000352974200046
J	Hibar, DP; Stein, JL; Renteria, ME; Arias-Vasquez, A; Desrivieres, S; Jahanshad, N; Toro, R; Wittfeld, K; Abramovic, L; Andersson, M; Aribisala, BS; Armstrong, NJ; Bernard, M; Bohlken, MM; Boks, MP; Bralten, J; Brown, AA; Chakravarty, MM; Chen, Q; Ching, CRK; Cuellar-Partida, G; den Braber, A; Giddaluru, S; Goldman, AL; Grimm, O; Guadalupe, T; Hass, J; Woldehawariat, G; Holmes, AJ; Hoogman, M; Janowitz, D; Jia, TY; Kim, S; Klein, M; Kraemer, B; Lee, PH; Loohuis, LMO; Luciano, M; Macare, C; Mather, KA; Mattheisen, M; Milaneschi, Y; Nho, K; Papmeyer, M; Ramasamy, A; Risacher, SL; Roiz-Santianez, R; Rose, EJ; Salami, A; Samann, PG; Schmaal, L; Schork, AJ; Shin, J; Strike, LT; Teumer, A; van Donkelaar, MMJ; van Eijk, KR; Walters, RK; Westlye, LT; Whelan, CD; Winkler, AM; Zwiers, MP; Alhusaini, S; Athanasiu, L; Ehrlich, S; Hakobjan, MMH; Hartberg, CB; Haukvik, UK; Heister, AJGAM; Hoehn, D; Kasperaviciute, D; Liewald, DCM; Lopez, LM; Makkinje, RRR; Matarin, M; Naber, MAM; Mckay, DR; Needham, M; Nugent, AC; Putz, B; Royle, NA; Shen, L; Sprooten, E; Trabzuni, D; van der Marel, SSL; van Hulzen, KJE; Walton, E; Wolf, C; Almasy, L; Ames, D; Arepalli, S; Assareh, AA; Bastin, ME; Brodaty, H; Bulayeva, KB; Carless, MA; Cichon, S; Corvin, A; Curran, JE; Czisch, M; de Zubicaray, GI; Dillman, A; Duggirala, R; Dyer, TD; Erk, S; Fedko, IO; Ferrucci, L; Foroud, TM; Fox, PT; Fukunaga, M; Gibbs, JR; Goring, HHH; Green, RC; Guelfi, S; Hansell, NK; Hartman, CA; Hegenscheid, K; Heinz, A; Hernandez, DG; Heslenfeld, DJ; Hoekstra, PJ; Holsboer, F; Homuth, G; Hottenga, JJ; Ikeda, M; Jack, CR; Jenkinson, M; Johnson, R; Kanai, R; Keil, M; Kent, JW; Kochunov, P; Kwok, JB; Lawrie, SM; Liu, XM; Longo, DL; McMahon, KL; Meisenzah, E; Melle, I; Mahnke, S; Montgomery, GW; Mostert, JC; Muhleisen, TW; Nalls, MA; Nichols, TE; Nilsson, LG; Nothen, MM; Ohi, K; Olvera, RL; Perez-Iglesias, R; Pike, GB; Potkin, SG; Reinvang, I; Reppermund, S; Rietschel, M; Romanczuk-Seiferth, N; Rosen, GD; Rujescu, D; Schnell, K; Schofield, PR; Smith, C; Steen, VM; Sussmann, JE; Thalamuthu, A; Toga, AW; Traynor, BJ; Troncoso, J; Turner, JA; Hernandez, MCV; van't Ent, D; van der Brug, M; van der Wee, NJA; van Tol, MJ; Veltman, DJ; Wassink, TH; Westman, E; Zielke, RH; Zonderman, AB; Ashbrook, DG; Hager, R; Lu, L; McMahon, FJ; Morris, DW; Williams, RW; Brunner, HG; Buckner, RL; Buitelaar, JK; Cahn, W; Calhoun, VD; Cavalleri, GL; Crespo-Facorro, B; Dale, AM; Davies, GE; Delanty, N; Depondt, C; Djurovic, S; Drevets, WC; Espeseth, T; Gollub, RL; Ho, BC; Hoffman, W; Hosten, N; Kahn, RS; Le Hellard, S; Meyer-Lindenberg, A; Muller-Myhsok, B; Nauck, M; Nyberg, L; Pandolfo, M; Penninx, BWJH; Roffman, JL; Sisodiya, SM; Smoller, JW; van Bokhoven, H; van Haren, NEM; Volzke, H; Walter, H; Weiner, MW; Wen, W; White, T; Agartz, I; Andreassen, OA; Blangero, J; Boomsma, DI; Brouwer, RM; Cannon, DM; Cookson, MR; de Geus, EJC; Deary, IJ; Donohoe, G; Fernandez, G; Fisher, SE; Francks, C; Glahn, DC; Grabe, HJ; Gruber, O; Hardy, J; Hashimoto, R; Pol, HEH; Jonsson, EG; Kloszewska, I; Lovestone, S; Mattay, VS; Mecocci, P; McDonald, C; McIntosh, AM; Ophoff, RA; Paus, T; Pausova, Z; Ryten, M; Sachdev, PS; Saykin, AJ; Simmons, A; Singleton, A; Soininen, H; Wardlaw, JM; Weale, ME; Weinberger, DR; Adams, HHH; Launer, LJ; Seiler, S; Schmidt, R; Chauhan, G; Satizabal, CL; Becker, JT; Yanek, L; van der Lee, SJ; Ebling, M; Fischl, B; Longstreth, WT; Greve, D; Schmidt, H; Nyquist, P; Vinke, LN; van Duijn, CM; Xue, LT; Mazoyer, B; Bis, JC; Gudnason, V; Seshadri, S; Ikram, MA; Martin, NG; Wright, MJ; Schumann, G; Franke, B; Thompson, PM; Medland, SE				Hibar, Derrek P.; Stein, Jason L.; Renteria, Miguel E.; Arias-Vasquez, Alejandro; Desrivieres, Sylvane; Jahanshad, Neda; Toro, Roberto; Wittfeld, Katharina; Abramovic, Lucija; Andersson, Micael; Aribisala, Benjamin S.; Armstrong, Nicola J.; Bernard, Manon; Bohlken, Marc M.; Boks, Marco P.; Bralten, Janita; Brown, Andrew A.; Chakravarty, M. Mallar; Chen, Qiang; Ching, Christopher R. K.; Cuellar-Partida, Gabriel; den Braber, Anouk; Giddaluru, Sudheer; Goldman, Aaron L.; Grimm, Oliver; Guadalupe, Tulio; Hass, Johanna; Woldehawariat, Girma; Holmes, Avram J.; Hoogman, Martine; Janowitz, Deborah; Jia, Tianye; Kim, Sungeun; Klein, Marieke; Kraemer, Bernd; Lee, Phil H.; Loohuis, Loes M. Olde; Luciano, Michelle; Macare, Christine; Mather, Karen A.; Mattheisen, Manuel; Milaneschi, Yuri; Nho, Kwangsik; Papmeyer, Martina; Ramasamy, Adaikalavan; Risacher, Shannon L.; Roiz-Santianez, Roberto; Rose, Emma J.; Salami, Alireza; Saemann, Philipp G.; Schmaal, Lianne; Schork, Andrew J.; Shin, Jean; Strike, Lachlan T.; Teumer, Alexander; van Donkelaar, Marjolein M. J.; van Eijk, Kristel R.; Walters, Raymond K.; Westlye, Lars T.; Whelan, Christopher D.; Winkler, Anderson M.; Zwiers, Marcel P.; Alhusaini, Saud; Athanasiu, Lavinia; Ehrlich, Stefan; Hakobjan, Marina M. H.; Hartberg, Cecilie B.; Haukvik, Unn K.; Heister, Angelien J. G. A. M.; Hoehn, David; Kasperaviciute, Dalia; Liewald, David C. M.; Lopez, Lorna M.; Makkinje, Remco R. R.; Matarin, Mar; Naber, Marlies A. M.; McKay, D. Reese; Needham, Margaret; Nugent, Allison C.; Puetz, Benno; Royle, Natalie A.; Shen, Li; Sprooten, Emma; Trabzuni, Daniah; van der Marel, Saskia S. L.; van Hulzen, Kimm J. E.; Walton, Esther; Wolf, Christiane; Almasy, Laura; Ames, David; Arepalli, Sampath; Assareh, Amelia A.; Bastin, Mark E.; Brodaty, Henry; Bulayeva, Kazima B.; Carless, Melanie A.; Cichon, Sven; Corvin, Aiden; Curran, Joanne E.; Czisch, Michael; de Zubicaray, Greig I.; Dillman, Allissa; Duggirala, Ravi; Dyer, Thomas D.; Erk, Susanne; Fedko, Iryna O.; Ferrucci, Luigi; Foroud, Tatiana M.; Fox, Peter T.; Fukunaga, Masaki; Gibbs, J. Raphael; Goering, Harald H. H.; Green, Robert C.; Guelfi, Sebastian; Hansell, Narelle K.; Hartman, Catharina A.; Hegenscheid, Katrin; Heinz, Andreas; Hernandez, Dena G.; Heslenfeld, Dirk J.; Hoekstra, Pieter J.; Holsboer, Florian; Homuth, Georg; Hottenga, Jouke-Jan; Ikeda, Masashi; Jack, Clifford R., Jr.; Jenkinson, Mark; Johnson, Robert; Kanai, Ryota; Keil, Maria; Kent, Jack W., Jr.; Kochunov, Peter; Kwok, John B.; Lawrie, Stephen M.; Liu, Xinmin; Longo, Dan L.; McMahon, Katie L.; Meisenzah, Eva; Melle, Ingrid; Mahnke, Sebastian; Montgomery, Grant W.; Mostert, Jeanette C.; Muehleisen, Thomas W.; Nalls, Michael A.; Nichols, Thomas E.; Nilsson, Lars G.; Noethen, Markus M.; Ohi, Kazutaka; Olvera, Rene L.; Perez-Iglesias, Rocio; Pike, G. Bruce; Potkin, Steven G.; Reinvang, Ivar; Reppermund, Simone; Rietschel, Marcella; Romanczuk-Seiferth, Nina; Rosen, Glenn D.; Rujescu, Dan; Schnell, Knut; Schofield, Peter R.; Smith, Colin; Steen, Vidar M.; Sussmann, Jessika E.; Thalamuthu, Anbupalam; Toga, Arthur W.; Traynor, Bryan J.; Troncoso, Juan; Turner, Jessica A.; Valdes Hernandez, Maria C.; van't Ent, Dennis; van der Brug, Marcel; van der Wee, Nic J. A.; van Tol, Marie-Jose; Veltman, Dick J.; Wassink, Thomas H.; Westman, Eric; Zielke, Ronald H.; Zonderman, Alan B.; Ashbrook, David G.; Hager, Reinmar; Lu, Lu; McMahon, Francis J.; Morris, Derek W.; Williams, Robert W.; Brunner, Han G.; Buckner, Randy L.; Buitelaar, Jan K.; Cahn, Wiepke; Calhoun, Vince D.; Cavalleri, Gianpiero L.; Crespo-Facorro, Benedicto; Dale, Anders M.; Davies, Gareth E.; Delanty, Norman; Depondt, Chantal; Djurovic, Srdjan; Drevets, Wayne C.; Espeseth, Thomas; Gollub, Randy L.; Ho, Beng-Choon; Hoffman, Wolfgang; Hosten, Norbert; Kahn, Rene S.; Le Hellard, Stephanie; Meyer-Lindenberg, Andreas; Mueller-Myhsok, Bertram; Nauck, Matthias; Nyberg, Lars; Pandolfo, Massimo; Penninx, Brenda W. J. H.; Roffman, Joshua L.; Sisodiya, Sanjay M.; Smoller, Jordan W.; van Bokhoven, Hans; van Haren, Neeltje E. M.; Voelzke, Henry; Walter, Henrik; Weiner, Michael W.; Wen, Wei; White, Tonya; Agartz, Ingrid; Andreassen, Ole A.; Blangero, John; Boomsma, Dorret I.; Brouwer, Rachel M.; Cannon, Dara M.; Cookson, Mark R.; de Geus, Eco J. C.; Deary, Ian J.; Donohoe, Gary; Fernandez, Guillen; Fisher, Simon E.; Francks, Clyde; Glahn, David C.; Grabe, Hans J.; Gruber, Oliver; Hardy, John; Hashimoto, Ryota; Pol, Hilleke E. Hulshoff; Joensson, Erik G.; Kloszewska, Iwona; Lovestone, Simon; Mattay, Venkata S.; Mecocci, Patrizia; McDonald, Colm; McIntosh, Andrew M.; Ophoff, Roel A.; Paus, Tomas; Pausova, Zdenka; Ryten, Mina; Sachdev, Perminder S.; Saykin, Andrew J.; Simmons, Andy; Singleton, Andrew; Soininen, Hilkka; Wardlaw, Joanna M.; Weale, Michael E.; Weinberger, Daniel R.; Adams, Hieab H. H.; Launer, Lenore J.; Seiler, Stephan; Schmidt, Reinhold; Chauhan, Ganesh; Satizabal, Claudia L.; Becker, James T.; Yanek, Lisa; van der Lee, Sven J.; Ebling, Maritza; Fischl, Bruce; Longstreth, W. T., Jr.; Greve, Douglas; Schmidt, Helena; Nyquist, Paul; Vinke, Louis N.; van Duijn, Cornelia M.; Xue, Luting; Mazoyer, Bernard; Bis, Joshua C.; Gudnason, Vilmundur; Seshadri, Sudha; Ikram, M. Arfan; Martin, Nicholas G.; Wright, Margaret J.; Schumann, Gunter; Franke, Barbara; Thompson, Paul M., Jr.; Medland, Sarah E.		Alzheimers Dis Neuroimaging; CHARGE Consortium; EPIGEN; IMAGEN; SYS	Common genetic variants influence human subcortical brain structures	NATURE			English	Article							GENOME-WIDE ASSOCIATION; BASAL GANGLIA; EXPRESSION; CHROMATIN; KINECTIN; IDENTIFICATION; HIPPOCAMPAL; EVOLUTION; STRIATUM; DYNAMICS	The highly complex structure of the human brain is strongly shaped by genetic influences(1). Subcortical brain regions form circuits with cortical areas to coordinate movement(2), learning, memory(3) and motivation(4), and altered circuits can lead to abnormal behaviour and disease(5). To investigate how common genetic variants affect the structure of these brain regions, here we conduct genome-wide association studies of the volumes of seven subcortical regions and the intracranial volume derived from magnetic resonance images of 30,717 individuals from 50 cohorts. We identify five novel genetic variants influencing the volumes of the putamen and caudate nucleus. We also find stronger evidence for three loci with previously established influences on hippocampal volume(5) and intracranial volume(6). These variants show specific volumetric effects on brain structures rather than global effects across structures. The strongest effects were found for the putamen, where a novel intergenic locus with replicable influence on volume (rs945270; P = 1.08 X 10(-33); 0.52% variance explained) showed evidence of altering the expression of the KTN1 gene in both brain and blood tissue. Variants influencing putamen volume clustered near developmental genes that regulate apoptosis, axon guidance and vesicle transport. Identification of these genetic variants provides insight into the causes of variability in human brain development, and may help to determine mechanisms of neuropsychiatric dysfunction.	[Hibar, Derrek P.; Stein, Jason L.; Jahanshad, Neda; Ching, Christopher R. K.; Whelan, Christopher D.; Thompson, Paul M., Jr.] Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Imaging Genet Ctr, Los Angeles, CA 90292 USA; [Stein, Jason L.; Ching, Christopher R. K.] Univ Calif Los Angeles, Sch Med, Dept Neurol, Neurogenet Program, Los Angeles, CA 90095 USA; [Renteria, Miguel E.; Cuellar-Partida, Gabriel; Strike, Lachlan T.; Hansell, Narelle K.; Montgomery, Grant W.; Martin, Nicholas G.; Wright, Margaret J.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Arias-Vasquez, Alejandro; Bralten, Janita; Hoogman, Martine; Klein, Marieke; van Donkelaar, Marjolein M. J.; Hakobjan, Marina M. H.; Heister, Angelien J. G. A. M.; Makkinje, Remco R. R.; Naber, Marlies A. M.; van der Marel, Saskia S. L.; van Hulzen, Kimm J. E.; Mostert, Jeanette C.; Brunner, Han G.; van Bokhoven, Hans; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6500 HB Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Bralten, Janita; Buitelaar, Jan K.; Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Arias-Vasquez, Alejandro; Bralten, Janita; Ching, Christopher R. K.; Hoogman, Martine; Klein, Marieke; van Donkelaar, Marjolein M. J.; Zwiers, Marcel P.; Hakobjan, Marina M. H.; Heister, Angelien J. G. A. M.; Makkinje, Remco R. R.; Naber, Marlies A. M.; van der Marel, Saskia S. L.; van Hulzen, Kimm J. E.; Mostert, Jeanette C.; Brunner, Han G.; Buitelaar, Jan K.; van Bokhoven, Hans; Fernandez, Guillen; Fisher, Simon E.; Francks, Clyde; Franke, Barbara] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 GL Nijmegen, Netherlands; [Desrivieres, Sylvane; Jia, Tianye; Macare, Christine; Schumann, Gunter] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC SGDP Ctr, London SE5 8AF, England; [Toro, Roberto] Inst Pasteur, Lab Human Genet & Cognit Funct, F-75015 Paris, France; [Toro, Roberto] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, F-75015 Paris, France; [Toro, Roberto] Univ Paris Diderot, Sorbonne Paris Cite, F-75015 Paris, France; [Wittfeld, Katharina; Hoffman, Wolfgang] German Ctr Neurodegenerat Dis DZNE, D-17487 Greifswald, Germany; [Wittfeld, Katharina; Janowitz, Deborah; Grabe, Hans J.] Univ Med Greifswald, Dept Psychiat, D-17489 Greifswald, Germany; [Abramovic, Lucija; Bohlken, Marc M.; Boks, Marco P.; van Eijk, Kristel R.; Cahn, Wiepke; Kahn, Rene S.; van Haren, Neeltje E. M.; Brouwer, Rachel M.; Pol, Hilleke E. Hulshoff; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, NL-3584 CX Utrecht, Netherlands; [Andersson, Micael; Salami, Alireza; Nilsson, Lars G.; Nyberg, Lars] Umea Univ, Ctr Funct Brain Imaging UFBI, S-90187 Umea, Sweden; [Aribisala, Benjamin S.; Royle, Natalie A.; Wardlaw, Joanna M.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Aribisala, Benjamin S.; Royle, Natalie A.; Wardlaw, Joanna M.] Lagos State Univ, Dept Comp Sci, Lagos, Nigeria; [Aribisala, Benjamin S.; Royle, Natalie A.; Bastin, Mark E.; Wardlaw, Joanna M.] Univ Edinburgh, Dept Neuroimaging Sci, Scottish Imaging Network, Edinburgh EH4 2XU, Midlothian, Scotland; [Armstrong, Nicola J.; Mather, Karen A.; Assareh, Amelia A.; Bastin, Mark E.; Brodaty, Henry; Reppermund, Simone; Thalamuthu, Anbupalam; Wen, Wei; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW 2052, Australia; [Armstrong, Nicola J.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Bernard, Manon; Shin, Jean; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Brown, Andrew A.; Athanasiu, Lavinia; Hartberg, Cecilie B.; Haukvik, Unn K.; Melle, Ingrid; Djurovic, Srdjan; Agartz, Ingrid; Andreassen, Ole A.; Joensson, Erik G.] Univ Oslo, Inst Clin Med, NORMENT KG Jebsen Ctr, N-0316 Oslo, Norway; [Brown, Andrew A.; Westlye, Lars T.; Athanasiu, Lavinia; Melle, Ingrid; Espeseth, Thomas; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT KG Jebsen Ctr, N-0424 Oslo, Norway; [Chakravarty, M. Mallar] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ H4H 1R3, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Psychiat & Biomed Engn, Montreal, PQ H3A 2B4, Canada; [Chen, Qiang; Goldman, Aaron L.; Mattay, Venkata S.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Ching, Christopher R. K.] Univ Calif Los Angeles, Sch Med, Interdept Neurosci Grad Program, Los Angeles, CA 90095 USA; [den Braber, Anouk; Fedko, Iryna O.; Hottenga, Jouke-Jan; van't Ent, Dennis; Boomsma, Dorret I.; de Geus, Eco J. C.] Vrije Univ Amsterdam, Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [den Braber, Anouk; Fedko, Iryna O.; Hottenga, Jouke-Jan; van't Ent, Dennis; Boomsma, Dorret I.; de Geus, Eco J. C.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands; [den Braber, Anouk; Fedko, Iryna O.; Hottenga, Jouke-Jan; van't Ent, Dennis; Boomsma, Dorret I.; de Geus, Eco J. C.] Vrije Univ Amsterdam Med Ctr, NL-1081 BT Amsterdam, Netherlands; [Giddaluru, Sudheer; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Sci, NORMENT KG Jebsen Ctr Psychosis Res, N-5021 Bergen, Norway; [Giddaluru, Sudheer; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr Einar Martens Res Grp Biol Psychiat, N-5021 Bergen, Norway; [Grimm, Oliver; Rietschel, Marcella; Meyer-Lindenberg, Andreas] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Guadalupe, Tulio; Fisher, Simon E.; Francks, Clyde] Max Planck Inst Psycholinguist, Language & Genet Dept, NL-6525 XD Nijmegen, Netherlands; [Guadalupe, Tulio] Int Max Planck Res Sch Language, NL-6525 XD Nijmegen, Netherlands; [Hass, Johanna; Ehrlich, Stefan; Walton, Esther] Tech Univ Dresden, Fac Med, Dept Child & Adolescent Psychiat, D-01307 Dresden, Germany; [Woldehawariat, Girma; Nugent, Allison C.; Liu, Xinmin; McMahon, Francis J.; Drevets, Wayne C.; Cannon, Dara M.] NIMH, Human Genet Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Woldehawariat, Girma; Nugent, Allison C.; Liu, Xinmin; McMahon, Francis J.; Drevets, Wayne C.; Cannon, Dara M.] NIMH, Expt Therapeut & Pathophysiol Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Holmes, Avram J.] Yale Univ, Dept Psychol, New Haven, CT 06511 USA; [Holmes, Avram J.; Lee, Phil H.; Ehrlich, Stefan; Buckner, Randy L.; Gollub, Randy L.; Roffman, Joshua L.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Kim, Sungeun; Nho, Kwangsik; Risacher, Shannon L.; Shen, Li; Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Neuroimaging Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Kim, Sungeun; Nho, Kwangsik; Shen, Li] Indiana Univ Sch Med, Ctr Computat Biol & Bloinformat, Indianapolis, IN 46202 USA; [Kim, Sungeun; Nho, Kwangsik; Risacher, Shannon L.; Shen, Li; Foroud, Tatiana M.; Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA; [Kraemer, Bernd; Keil, Maria; Gruber, Oliver] Univ Med Ctr, Dept Psychiat & Psychotherapy, Ctr Translat Res Syst Neurosci & Psychiat, D-37075 Gottingen, Germany; [Lee, Phil H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02115 USA; [Lee, Phil H.; Smoller, Jordan W.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Boston, MA 02141 USA; [Lee, Phil H.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Loohuis, Loes M. Olde; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Luciano, Michelle; Liewald, David C. M.; Lopez, Lorna M.; Royle, Natalie A.; Bastin, Mark E.; Deary, Ian J.; McIntosh, Andrew M.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Mattheisen, Manuel] Aarhus Univ Hosp, Dept Biomed, DK-8000 Aarhus, Denmark; [Mattheisen, Manuel] iPSYCH, Ludbeck Fdn Initiat Integrat Psychiat Res, DK-8000 Aarhus, Denmark; [Mattheisen, Manuel] iPSYCH, Ludbeck Fdn Initiat Integrat Psychiat Res, DK-8000 Copenhagen, Denmark; [Mattheisen, Manuel] Aarhus Univ, iSEQ, Ctr Integrated Sequencing, DK-8000 Aarhus, Denmark; [Milaneschi, Yuri; Schmaal, Lianne; Veltman, Dick J.; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr GGZ InGeest, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands; [Papmeyer, Martina; Sprooten, Emma; Lawrie, Stephen M.; Sussmann, Jessika E.; McIntosh, Andrew M.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Ramasamy, Adaikalavan; Ryten, Mina; Weale, Michael E.] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Ramasamy, Adaikalavan; Trabzuni, Daniah; Gibbs, J. Raphael; Guelfi, Sebastian; Hernandez, Dena G.; Hardy, John; Ryten, Mina] UCL, Inst Neurol, Reta Lila Weston Inst, London WC1N 3BG, England; [Ramasamy, Adaikalavan; Trabzuni, Daniah; Gibbs, J. Raphael; Guelfi, Sebastian; Hernandez, Dena G.; Hardy, John; Ryten, Mina] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Roiz-Santianez, Roberto; Crespo-Facorro, Benedicto] Univ Cantabria, IDIVAL, Sch Med, Dept Psychiat,Univ Hosp Marques de Valdecilla, Santander 39008, Spain; [Roiz-Santianez, Roberto; Perez-Iglesias, Rocio; Crespo-Facorro, Benedicto] Cibersam Ctr Invest Biomed Red Salud Mental, Madrid 28029, Spain; [Rose, Emma J.; Needham, Margaret; Corvin, Aiden; Morris, Derek W.; Donohoe, Gary] Univ Dublin Trinity Coll, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Rose, Emma J.; Needham, Margaret; Corvin, Aiden; Morris, Derek W.; Donohoe, Gary] Univ Dublin Trinity Coll, Dept Psychiat, Trinity Coll Inst Psychiat, Dublin 2, Ireland; [Rose, Emma J.] Univ Maryland, Sch Med, Dept Psychiat, Translat Res Advers Neurodev & Subst Abuse C TRAN, Columbia, MD 21045 USA; [Salami, Alireza] Karolinska Inst, Aging Res Ctr, S-11330 Stockholm, Sweden; [Salami, Alireza] Stockholm Univ, S-11330 Stockholm, Sweden; [Saemann, Philipp G.; Hoehn, David; Puetz, Benno; Wolf, Christiane; Czisch, Michael; Holsboer, Florian; Mueller-Myhsok, Bertram; Gruber, Oliver] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Schork, Andrew J.] Univ Calif San Diego, Dept Neurosci, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92161 USA; [Strike, Lachlan T.; de Zubicaray, Greig I.; Wright, Margaret J.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia; [Strike, Lachlan T.; McMahon, Katie L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Teumer, Alexander; Hoffman, Wolfgang; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Walters, Raymond K.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Walters, Raymond K.] Broad Inst Harvard & MIT, Med & Populat Genet Program, Boston, MA 02142 USA; [Westlye, Lars T.; Reinvang, Ivar; Espeseth, Thomas] Univ Oslo, Dept Psychol, N-0373 Oslo, Norway; [Winkler, Anderson M.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct MRI Brain, Oxford OX3 9DU, England; [Winkler, Anderson M.; McKay, D. Reese; Sprooten, Emma; Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA; [Alhusaini, Saud] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Alhusaini, Saud; Cavalleri, Gianpiero L.; Delanty, Norman] Royal Coll Surg, Mol & Cellular Therapeut, Dublin 2, Ireland; [Ehrlich, Stefan; Gollub, Randy L.; Ebling, Maritza; Fischl, Bruce; Greve, Douglas; Vinke, Louis N.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Hartberg, Cecilie B.; Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res & Dev, N-0319 Oslo, Norway; [Kasperaviciute, Dalia; Sisodiya, Sanjay M.] UCL, Inst Neurol, London, England; [Kasperaviciute, Dalia; Sisodiya, Sanjay M.] Epilepsy Soc, London WC1N 3BG, England; [Kasperaviciute, Dalia] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England; [Matarin, Mar] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; [McKay, D. Reese; Sprooten, Emma; Glahn, David C.] Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06106 USA; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Almasy, Laura; Carless, Melanie A.; Curran, Joanne E.; Duggirala, Ravi; Dyer, Thomas D.; Goering, Harald H. H.; Kent, Jack W., Jr.; Blangero, John] Texas Biomed Res Inst, San Antonio, TX 78245 USA; [Almasy, Laura; Dyer, Thomas D.; Fox, Peter T.; Blangero, John] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Ames, David] Royal Melbourne Hosp, Natl Ageing Res Inst, Melbourne, Vic 3052, Australia; [Ames, David; Gibbs, J. Raphael; Hernandez, Dena G.] Univ Melbourne, Acad Unit Psychiat Old Age, Melbourne, Vic 3101, Australia; [Arepalli, Sampath; Dillman, Allissa; Nalls, Michael A.; Traynor, Bryan J.; Cookson, Mark R.; Singleton, Andrew] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Bastin, Mark E.; Valdes Hernandez, Maria C.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland; [Bulayeva, Kazima B.] Russian Acad Sci, IN Vavilov Inst Gen Genet, Moscow 119333, Russia; [Cichon, Sven] Univ Basel, Dept Biomed, Div Med Genet, CH-4055 Basel, Switzerland; [Cichon, Sven; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Cichon, Sven; Muehleisen, Thomas W.] Forschungszentrum Julich, Inst Neurosci & Med INM 1, D-52425 Julich, Germany; [Cichon, Sven; Heinz, Andreas; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Dept Genom, D-53127 Bonn, Germany; [Cichon, Sven; Heinz, Andreas; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, D-53127 Bonn, Germany; [Erk, Susanne; Mahnke, Sebastian; Romanczuk-Seiferth, Nina; Walter, Henrik; Saykin, Andrew J.] Charite, CCM, Dept Psychiat & Psychotherapy, D-10117 Berlin, Germany; [Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 20892 USA; [Foroud, Tatiana M.; Olvera, Rene L.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Fox, Peter T.] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Fukunaga, Masaki] Osaka Univ, Immunol Frontier Res Ctr, Biofunct Imaging, Osaka 5650871, Japan; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Green, Robert C.; Gollub, Randy L.; Smoller, Jordan W.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hartman, Catharina A.; Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 GZ Groningen, Netherlands; [Hegenscheid, Katrin; Hosten, Norbert] Univ Med Greifswald, Inst Diagnost Radiolou & Neuroradiol, D-17475 Greifswald, Germany; [Heslenfeld, Dirk J.] Vrije Univ Amsterdam, Dept Cognit, NL-1081 BT Amsterdam, Netherlands; [Heslenfeld, Dirk J.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands; [Homuth, Georg] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17489 Greifswald, Germany; [Ikeda, Masashi] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan; [Jack, Clifford R., Jr.] Mayo Clin, Radiol, Rochester, MN 55905 USA; [Jenkinson, Mark; Nichols, Thomas E.] Univ Oxford, FMRIB Ctr, Oxford OX3 9DU, England; [Johnson, Robert; Zielke, Ronald H.] Univ Maryland, Sch Med, NICHD Brain & Tissue Bank Dev Disorders, Baltimore, MD 21201 USA; [Kanai, Ryota] Univ Sussex, Sch Psychol, Brighton BN1 9QH, E Sussex, England; [Kanai, Ryota] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Kochunov, Peter] Univ Maryland, Maryland Psychiat Res Ctr, Dept Psychiat, Baltimore, MD 21201 USA; [Kwok, John B.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Kwok, John B.; Schofield, Peter R.] UNSW, Sch Med Sci, Sydney, NSW 2052, Australia; [Liu, Xinmin] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Longo, Dan L.] NIA, Lymphocyte Cell Biol Unit, Genet Lab, NIH, Baltimore, MD 21224 USA; [Meisenzah, Eva; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Nichols, Thomas E.] Univ Warwick, WMG, Coventry CV4 7AL, W Midlands, England; [Ohi, Kazutaka] Osaka Univ, Dept Psychiat, Grad Sch Med, Osaka 5650871, Japan; [Perez-Iglesias, Rocio] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Pike, G. Bruce] Univ Calgary, Dept Neurol, Calgary, AB T2N 2T9, Canada; [Pike, G. Bruce] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada; [Potkin, Steven G.] Univ Calif Irvine, Psychiat & Human Behav, Irvine, CA 92617 USA; [Rosen, Glenn D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Rosen, Glenn D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Schnell, Knut] Heidelberg Univ Hosp, Dept Gen Psychiat, D-69115 Heidelberg, Germany; [Smith, Colin] Univ Edinburgh, MRC, Sudden Death Brain Bank Project, Dept Neuropathol, Edinburgh EH8 9AG, Midlothian, Scotland; [Toga, Arthur W.] Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Lab Neuro Imaging, Los Angeles, CA 90033 USA; [Troncoso, Juan] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21287 USA; [Turner, Jessica A.] Georgia State Univ, Dept Psychol, Atlanta, GA 30302 USA; [Turner, Jessica A.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30302 USA; [van der Brug, Marcel] Genentech Inc, San Francisco, CA 94080 USA; [van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Psychiat, NL-2333 ZA Leiden, Netherlands; [van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Leiden Inst Brain & Cogniton, NL-2333 ZA Leiden, Netherlands; [van Tol, Marie-Jose] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, NL-9713 AW Groningen, Netherlands; [Wassink, Thomas H.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, SE-14183 Stockholm, Sweden; [Zonderman, Alan B.] NIA, Behav Epidemiol Sect, Intramural Res Program, Bethesda, MD 20892 USA; [Ashbrook, David G.; Hager, Reinmar] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN 38163 USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Lu, Lu] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Peoples R China; [Morris, Derek W.; Donohoe, Gary] Natl Univ Ireland Galway, Sch Psychol, Cognit Genet & Therapy Grp, Galway, Ireland; [Morris, Derek W.; Donohoe, Gary] Natl Univ Ireland Galway, Discipline Biochem, Galway, Ireland; [Brunner, Han G.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6200 MD Maastricht, Netherlands; [Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Dept Psychol, Boston, MA 02138 USA; [Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Karakter Child & Adolescent Psychiat, NL-6500 HB Nijmegen, Netherlands; [Calhoun, Vince D.] Mind Res Network, Albuquerque, NM 87106 USA; [Calhoun, Vince D.] LBERI, Albuquerque, NM 87106 USA; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA; [Dale, Anders M.] Univ Calif San Diego, Ctr Translat Imaging & Personalized Med, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92093 USA; [Davies, Gareth E.] Avera Inst Human Genet, Sioux Falls, SD 57108 USA; [Delanty, Norman] Beaumont Hosp, Neurol Div, Dublin 9, Ireland; [Depondt, Chantal; Pandolfo, Massimo] Univ Libre Bruxelles, Hop Erasme, Dept Neurol, B-1070 Brussels, Belgium; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0450 Oslo, Norway; [Drevets, Wayne C.] Johnson & Johnson, Janssen Res & Dev, Titusville, NJ 08560 USA; [Ho, Beng-Choon] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Mueller-Myhsok, Bertram] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Weiner, Michael W.] Univ Calif San Francisco, San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94121 USA; [White, Tonya] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, NL-3000 CB Rotterdam, Netherlands; [White, Tonya; Adams, Hieab H. H.; Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Radiol, NL-3015 CN Rotterdam, Netherlands; [Agartz, Ingrid; Joensson, Erik G.] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Cannon, Dara M.; McDonald, Colm] Natl Univ Ireland Galway, Coll Med Nursing & Hlth Sci, Clin Neuroimaging Lab, Galway, Ireland; [Grabe, Hans J.] HELIOS Hosp, Dept Psychiat & Psychotherapy, D-18435 Stralsund, Germany; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka 5650871, Japan; [Kloszewska, Iwona] Med Univ Lodz, PL-90419 Lodz, Poland; [Lovestone, Simon] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Lovestone, Simon] Kings Coll London, NIHR Dementia Biomed Res Unit, London SE5 8AF, England; [Mattay, Venkata S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mecocci, Patrizia] Univ Perugia, Dept Med, Sect Gerontol & Geriat, I-06156 Perugia, Italy; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON M5T 1R8, Canada; [Paus, Tomas] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Pausova, Zdenka] Univ Toronto, Dept Physiol, Toronto, ON M5S 3E2, Canada; [Pausova, Zdenka] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW 2031, Australia; [Simmons, Andy] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London SE5 8AF, England; [Simmons, Andy] Kings Coll London, Biomed Res Ctr Mental Hlth, London SE5 8AF, England; [Simmons, Andy] Kings Coll London, Biomed Res Unit Dementia, London SE5 8AF, England; [Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med, Neurol, FI-70211 Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Neuroctr Neurol, FI-70211 Kuopio, Finland; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Adams, Hieab H. H.; van der Lee, Sven J.; van Duijn, Cornelia M.; Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3015 CN Rotterdam, Netherlands; [Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, Bethesda, MD 20892 USA; [Seiler, Stephan; Schmidt, Reinhold] Med Univ Graz, Clin Div Neurogeriatr, Dept Neurol, A-8010 Graz, Austria; [Chauhan, Ganesh] Univ Bordeaux, INSERM, U897, F-33076 Bordeaux, France; [Satizabal, Claudia L.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Satizabal, Claudia L.] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Becker, James T.; Seshadri, Sudha] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Becker, James T.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Becker, James T.] Univ Pittsburgh, Dept Psychol, Dietrich Sch Arts & Sci, Pittsburgh, PA 15260 USA; [Yanek, Lisa] Johns Hopkins Sch Med, Gen Internal Med, Baltimore, MD 21205 USA; [Ebling, Maritza; Fischl, Bruce; Greve, Douglas; Vinke, Louis N.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Fischl, Bruce] MIT, Comp Sci & Al Lab, Boston, MA 02141 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Schmidt, Helena] Med Univ, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Nyquist, Paul] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21205 USA; [Xue, Luting] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Mazoyer, Bernard] CEA, Grp Imagerie Neurofonct, UMR5296, CNRS, F-33076 Bordeaux, France; [Mazoyer, Bernard] Univ Bordeaux, F-33076 Bordeaux, France; [Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Iceland Heart Assoc, IS-101 Reykjavik, Iceland	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; QIMR Berghofer Medical Research Institute; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of London; King's College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Greifswald Medical School; Utrecht University; Utrecht University Medical Center; Umea University; University of Edinburgh; Lagos State University; University of Edinburgh; University of New South Wales Sydney; University of Sydney; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oslo; University of Oslo; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Bergen; University of Bergen; Haukeland University Hospital; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Max Planck Society; Technische Universitat Dresden; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Yale University; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Gottingen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of Edinburgh; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Vrije Universiteit Amsterdam; Royal Infirmary of Edinburgh; University of Edinburgh; University of London; King's College London; University of London; University College London; University of London; University College London; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Trinity College Dublin; Trinity College Dublin; Karolinska Institutet; Stockholm University; Max Planck Society; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Queensland; University of Queensland; Greifswald Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oslo; University of Oxford; Yale University; McGill University; Royal College of Surgeons - Ireland; Harvard University; Massachusetts General Hospital; Diakonhjemmet Hospital; University of London; University College London; Imperial College London; University of London; University College London; Hartford Hospital; King Faisal Specialist Hospital & Research Center; Texas Biomedical Research Institute; University of Texas System; University of Texas Health San Antonio; National Ageing Research Institute; Royal Melbourne Hospital; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; Russian Academy of Sciences; University of Basel; University of Bonn; Helmholtz Association; Research Center Julich; University of Bonn; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Osaka University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Groningen; Greifswald Medical School; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Greifswald Medical School; Fujita Health University; Mayo Clinic; University of Oxford; University System of Maryland; University of Maryland Baltimore; University of Sussex; University of London; University College London; University System of Maryland; University of Maryland Baltimore; Neuroscience Research Australia; University of New South Wales Sydney; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Munich; University of Warwick; University of Warwick; Osaka University; University of London; King's College London; University of Calgary; University of Calgary; University of California System; University of California Irvine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; University of Edinburgh; University of Southern California; Johns Hopkins University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Roche Holding; Genentech; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Iowa; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Manchester; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Nantong University; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Maastricht University; Harvard University; Radboud University Nijmegen; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; University of New Mexico; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Universite Libre de Bruxelles; University of Oslo; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson USA; University of Iowa; University of Munich; University of Liverpool; Greifswald Medical School; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; Ollscoil na Gaillimhe-University of Galway; Osaka University; Medical University Lodz; University of Oxford; University of London; King's College London; Johns Hopkins University; University of Perugia; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Graz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Boston University; Framingham Heart Study; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; Medical University of Graz; Johns Hopkins University; Boston University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Washington; University of Washington Seattle; Icelandic Heart Association; University of Iceland	Thompson, PM (corresponding author), Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Imaging Genet Ctr, Los Angeles, CA 90292 USA.	pthomp@usc.edu; Sarah.Medland@qimrberghofer.edu.au	Vaidya, Dhananjay/AAL-5684-2020; Gibbs, J. Raphael/A-3984-2010; Karen, Mather A/O-9795-2016; Martin, Nicholas/R-9235-2019; Medland, Sarah E/C-7630-2013; Poustka, Luise/D-9299-2017; Ramasamy, Adaikalavan/G-2632-2010; Kochunov, Peter/GQH-9532-2022; McIntosh, Andrew M/B-9379-2008; Walton, Esther/P-9832-2019; Luciano, Michelle/F-7277-2010; Walter, Henrik/O-2612-2013; Desrivières, Sylvane/ABC-4336-2021; Rentería, Miguel E./M-6671-2017; Longo, Dan L./F-6022-2011; Hoogman, Martine/G-8958-2015; Ehrlich, Stefan/ABB-4650-2020; Jia, Tianye/AAC-3925-2019; van Haren, Neeltje/AAC-7656-2020; Thalamuthu, Anbupalam/Z-5545-2019; Brunner, Han/C-9928-2013; White, Tonya/AAU-2226-2021; Blangero, John/ABA-7175-2021; Ohi, Kazutaka/J-7851-2019; mazoyer, bernard m/A-5369-2009; Artiges, Eric/C-2815-2019; Almasy, Laura/V-3156-2019; Hardy, John/C-2451-2009; chen, qiang/HGU-5418-2022; Hager, Reinmar/F-8659-2012; Zwiers, Marcel P/D-2968-2009; Bokhoven, J.H.L.M. van van/H-8015-2014; Fukunaga, Masaki/F-6441-2013; Thompson, Paul M/C-4194-2018; Hakobjan, Marina/A-5594-2016; Roiz-Santiañez, Roberto/H-6462-2015; Simmons, Andrew/B-8848-2008; Nyberg, Lars/M-5986-2019; Risacher, Shannon/AAI-2141-2019; lu, lu/HGA-0894-2022; Bralten, Janita/D-4647-2011; Bralten, Janita/AAB-9566-2019; Sachdev, Perminder/ABC-1137-2020; Cavalleri, Gianpiero/A-6632-2010; Trabzuni, Daniah M/C-4034-2012; McMahon, Katie L/C-6440-2009; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Jack, Clifford R/F-2508-2010; /ABD-6198-2020; Gudnason, Vilmundur/AAE-7126-2019; Pike, Bruce/K-5562-2014; Franke, Barbara/D-4836-2009; Melle, Ingrid S/B-4858-2011; Winkler, Anderson M/P-7773-2016; CHAUHAN, GANESH/AAI-5110-2021; Walton, Esther/GSN-8429-2022; Klein, Marieke/G-9870-2015; Schmidt, Reinhold/E-1137-2014; Partida, Gabriel Cuellar/C-6686-2017; Jenkinson, Mark/AAC-8861-2019; Zonderman, Alan B/A-5807-2013; lu, lu/HII-7530-2022; Shen, Li/AAB-6870-2021; Rujescu, Dan/GRS-3875-2022; Mecocci, Patrizia/W-2116-2019; Nichols, Thomas E./N-9902-2017; Makkinje, Remco/Q-2406-2015; Mattheisen, Manuel/S-3725-2019; Ho, Beng-Choon/D-6959-2011; Mattheisen, Manuel/B-4949-2012; Romanczuk-Seiferth, Nina/AFN-7029-2022; Trabzuni, Daniah/AAI-2037-2021; de Zubicaray, Greig I/B-1763-2008; Armstrong, Nicola J./AAF-3045-2021; Teumer, Alexander/S-7438-2019; de Geus, Eco J.C./M-9318-2015; Singleton, Andrew B/C-3010-2009; Gudnason, Vilmundur/K-6885-2015; Ikram, M. Arfan/AAM-5225-2021; Lopez, Lorna/AAR-4912-2020; Cookson, Mark/AAW-2516-2021; Artiges, Eric/AAT-7219-2021; Fernandez, Guillen/B-3771-2009; Matarin, Mar/F-1771-2016; Preda, Adrian/K-8889-2013; Buitelaar, J.K./AAY-7522-2020; Heister, Angelien/ABC-3651-2020; Heinz, Andreas/ABB-7736-2020; Strike, Lachlan T/R-3902-2018; Calhoun, Vince D./ACN-9399-2022; Wright, Margaret Jane/A-4560-2016; Penninx, Brenda WJH/S-7627-2017; Boomsma, Dorret I/AAX-4470-2020; Ryten, Mina/Q-8419-2016; Sprooten, Emma/N-3836-2017; Romanczuk-Seiferth, Nina/AFN-0829-2022; Morris, Derek/AAW-8343-2021; Ashbrook, David George/H-5702-2019; Jahanshad, Neda/ABD-5944-2021; Lawrie, Stephen MacGregor/AAD-1607-2021; Wardlaw, Joanna M/Y-3456-2019; Turner, Jessica A/H-7282-2015; Francks, Clyde/AGU-8875-2022; Cannon, Dara M/C-1323-2009; McMahon, Francis J/A-7290-2009; McDonald, Colm/C-1430-2009; Vasquez, A. Arias/L-4175-2015; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Montgomery, Grant W/B-7148-2008; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Westman, Eric/H-5771-2011; Williams, Steve C/D-6979-2011; Gruber, Oliver/AAY-5563-2020; Francks, Clyde/E-1384-2012; Hernandez, María/GYU-3543-2022; Lubbe, Steven/L-8261-2013; Vasquez, Alejandro Arias/E-4762-2012; Hansell, Narelle K/A-4553-2016; chen, qiang/GWZ-7308-2022; Deary, Ian J/C-6297-2009; Andreassen, Ole A./AAY-7531-2020; Donohoe, Gary/J-6481-2013; Medland, Sarah/AAT-7595-2020; Weale, Michael E/F-2587-2010; Roffman, Joshua/G-8228-2012; Fisher, Simon E./E-9130-2012; Wittfeld, Katharina/AFB-1549-2022; de Zubicaray, Greig/ABC-8955-2021; Meyer-Lindenberg, Andreas/H-1076-2011; Saykin, Andrew/A-1318-2007; Mostert, Jeanette/E-4745-2015; Williams, Robert W./H-8789-2016; Schofield, Peter/C-9669-2011; Cichon, Sven/B-9618-2014	Vaidya, Dhananjay/0000-0002-7164-1601; Gibbs, J. Raphael/0000-0002-6985-0658; Karen, Mather A/0000-0003-4143-8941; Martin, Nicholas/0000-0003-4069-8020; Medland, Sarah E/0000-0003-1382-380X; Ramasamy, Adaikalavan/0000-0002-7598-2892; McIntosh, Andrew M/0000-0002-0198-4588; Walton, Esther/0000-0002-0935-2200; Luciano, Michelle/0000-0003-0935-7682; Desrivières, Sylvane/0000-0002-9120-7060; Rentería, Miguel E./0000-0003-4626-7248; Hoogman, Martine/0000-0002-1261-7628; Ehrlich, Stefan/0000-0003-2132-4445; Jia, Tianye/0000-0001-5399-2953; van Haren, Neeltje/0000-0002-3090-7653; Thalamuthu, Anbupalam/0000-0002-7114-1260; White, Tonya/0000-0003-0271-1896; Ohi, Kazutaka/0000-0001-9577-9640; mazoyer, bernard m/0000-0003-0970-2837; Artiges, Eric/0000-0003-4461-7646; Hardy, John/0000-0002-3122-0423; Zwiers, Marcel P/0000-0001-5483-2935; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Fukunaga, Masaki/0000-0003-1010-2644; Thompson, Paul M/0000-0002-4720-8867; Roiz-Santiañez, Roberto/0000-0002-5176-2983; Simmons, Andrew/0000-0003-2306-5811; Nyberg, Lars/0000-0002-3367-1746; Bralten, Janita/0000-0003-1440-8675; Sachdev, Perminder/0000-0002-9595-3220; Trabzuni, Daniah M/0000-0003-4826-9570; McMahon, Katie L/0000-0002-6357-615X; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Jack, Clifford R/0000-0001-7916-622X; Gudnason, Vilmundur/0000-0001-5696-0084; Pike, Bruce/0000-0001-8924-683X; Franke, Barbara/0000-0003-4375-6572; Melle, Ingrid S/0000-0002-9783-548X; Winkler, Anderson M/0000-0002-4169-9781; Klein, Marieke/0000-0001-8784-5679; Partida, Gabriel Cuellar/0000-0001-7648-4097; Jenkinson, Mark/0000-0001-6043-0166; Zonderman, Alan B/0000-0003-3530-2319; Mecocci, Patrizia/0000-0003-0729-5246; Nichols, Thomas E./0000-0002-4516-5103; Mattheisen, Manuel/0000-0002-8442-493X; Ho, Beng-Choon/0000-0003-3976-1555; Mattheisen, Manuel/0000-0002-8442-493X; Trabzuni, Daniah/0000-0003-4826-9570; de Zubicaray, Greig I/0000-0003-4506-0579; Armstrong, Nicola J./0000-0002-4477-293X; Teumer, Alexander/0000-0002-8309-094X; de Geus, Eco J.C./0000-0001-6022-2666; Gudnason, Vilmundur/0000-0001-5696-0084; Lopez, Lorna/0000-0002-0241-9783; Cookson, Mark/0000-0002-1058-3831; Artiges, Eric/0000-0003-4461-7646; Fernandez, Guillen/0000-0002-5522-0604; Matarin, Mar/0000-0002-4717-5735; Preda, Adrian/0000-0003-3373-2438; Heinz, Andreas/0000-0001-5405-9065; Strike, Lachlan T/0000-0003-2885-5898; Calhoun, Vince D./0000-0001-9058-0747; Wright, Margaret Jane/0000-0001-7133-4970; Penninx, Brenda WJH/0000-0001-7779-9672; Sprooten, Emma/0000-0002-1691-9105; Romanczuk-Seiferth, Nina/0000-0002-6931-269X; Morris, Derek/0000-0002-3413-570X; Ashbrook, David George/0000-0002-7397-8910; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Wardlaw, Joanna M/0000-0002-9812-6642; Turner, Jessica A/0000-0003-0076-8434; Cannon, Dara M/0000-0001-7378-3411; McMahon, Francis J/0000-0002-9469-305X; McDonald, Colm/0000-0003-1661-5192; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Montgomery, Grant W/0000-0002-4140-8139; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Westman, Eric/0000-0002-3115-2977; Williams, Steve C/0000-0003-4299-1941; Francks, Clyde/0000-0002-9098-890X; Lubbe, Steven/0000-0002-7103-6671; Vasquez, Alejandro Arias/0000-0002-4786-0169; Hansell, Narelle K/0000-0002-8229-9741; Deary, Ian J/0000-0002-1733-263X; Donohoe, Gary/0000-0003-3037-7426; Medland, Sarah/0000-0003-1382-380X; Weale, Michael E/0000-0003-4593-1186; Roffman, Joshua/0000-0003-4073-532X; Fisher, Simon E./0000-0002-3132-1996; Wittfeld, Katharina/0000-0003-4383-5043; de Zubicaray, Greig/0000-0003-4506-0579; van der Lee, Sven/0000-0003-1606-8643; Whelan, Christopher/0000-0003-0308-5583; Shen, Li/0000-0002-5443-0503; Satizabal, Claudia L/0000-0002-1115-4430; Cavalleri, Gianpiero/0000-0002-9802-0506; Schmaal, Lianne/0000-0001-9822-048X; Wassink, Thomas/0000-0002-0952-8333; Beiser, Alexa/0000-0001-8551-7778; Wen, Wei/0000-0003-2753-3870; Van Duijn, Cornelia/0000-0002-2374-9204; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Seshadri, Sudha/0000-0001-6135-2622; Fedko, Iryna/0000-0003-1962-916X; Saykin, Andrew/0000-0002-1376-8532; Bokde, Arun/0000-0003-0114-4914; Mostert, Jeanette/0000-0002-0033-1622; Carless, Melanie/0000-0001-8350-2302; Gollub, Randy L./0000-0002-9434-4044; Boks, Marco/0000-0001-6163-7484; Nees, Frauke/0000-0002-7796-8234; Williams, Robert W./0000-0001-8924-4447; Corvin, Aiden/0000-0001-6717-4089; Westlye, Lars T./0000-0001-8644-956X; Nothen, Markus/0000-0002-8770-2464; Flor, Herta/0000-0003-4809-5398; Zonderman, Alan B/0000-0002-6523-4778; Curran, Joanne/0000-0002-6898-155X; Kanai, Ryota/0000-0002-0186-2687; Brown, Andrew/0000-0002-8087-3033; Nugent, Allison/0000-0003-2569-2480; Holmes, Avram/0000-0001-6583-803X; Blangero, John/0000-0001-6250-5723; boddaert, nathalie/0000-0003-0991-7774; Walter, Henrik/0000-0002-9403-6121; Erk, Susanne/0000-0003-0961-3543; Haukvik, Unn Kristin/0000-0002-0363-4127; Walters, James/0000-0002-6980-4053; Jonsson, Erik/0000-0001-8368-6332; Schofield, Peter/0000-0003-2967-9662; Toro, Roberto/0000-0002-6671-858X; Lovestone, Simon/0000-0003-0473-4565; Vernooij, Meike/0000-0003-4658-2176; Djurovic, Srdjan/0000-0002-8140-8061; van 't Ent, Dennis/0000-0003-2001-1375; Grimm, Oliver/0000-0002-0767-0301; Bastin, Mark/0000-0002-0490-0845; MIRANDA, RUBEN/0000-0002-9445-7348; Banaschewski, Tobias/0000-0003-4595-1144; Le Hellard, Stephanie/0000-0002-8085-051X; Rose, Emma/0000-0001-5365-4794; Cichon, Sven/0000-0002-9475-086X; den Braber, A./0000-0002-3377-2627; Stein, Jason/0000-0003-4829-0513; Risacher, Shannon/0000-0002-3304-7943; Delaney, Norman/0000-0002-3953-9842; Chauhan, Ganesh/0000-0002-8564-5021	Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: Medline; Medical Research Council [G0901858, G1001245, G0900908, MR/L016400/1, MR/N000390/1, G0701120, G0700704, G0802462, MR/K026992/1] Funding Source: Medline; NCATS NIH HHS [UL1 TR001120, UL1 TR001108] Funding Source: Medline; NIA NIH HHS [P50 AG005146, P50 AG005133, R01 AG040060, U24 AG021886, R01 AG008122, P30 AG013846, U01 AG049505, P30 AG062421, P50 AG005134, R01 AG033193, P30 AG010129, R01 AG019771, RF1 AG041915] Funding Source: Medline; NIBIB NIH HHS [R01 EB005846, R01 EB015611, R01 EB020407, P41 EB015922, U54 EB020403, R01 EB006841] Funding Source: Medline; NIMH NIH HHS [K99 MH101367, R01 MH090553, K01 MH099232] Funding Source: Medline; NINDS NIH HHS [R01 NS017950, T32 NS048004] Funding Source: Medline; NLM NIH HHS [R00 LM011384, K99 LM011384] Funding Source: Medline; Wellcome Trust [100309, 104036] Funding Source: Medline; Chief Scientist Office [ETM/84] Funding Source: Medline; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0901858, G0701120, G0700704, MR/L016400/1, G1001245, G0900908, G0802462, MR/N000390/1] Funding Source: UKRI; Alzheimers Research UK [ARUK-PhD2014-16] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [1088088] Funding Source: researchfish; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-017, NF-SI-0512-10053] Funding Source: researchfish; Wellcome Trust [100309/A/12/Z] Funding Source: researchfish; Epilepsy Research UK [F1206] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096, UL1TR001108, UL1TR002529, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005846, U54EB020403, R01EB015611, P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH101367, ZIAMH002810, R01MH090553, K01MH099232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950, T32NS048004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005133, ZIAAG000951, U01AG049505, P50AG005134, R01AG008122, U24AG021886, R01AG033193, R01AG019771, P50AG005146, R01AG040060, ZIAAG000947, RF1AG041915, P30AG013846, ZIAAG000950, ZIAAG007270] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM011384, R00LM011384] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Epilepsy Research UK; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Blokland GAM, 2012, TWIN RES HUM GENET, V15, P351, DOI 10.1017/thg.2012.11; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Deans MR, 2011, NEURON, V71, P820, DOI 10.1016/j.neuron.2011.06.026; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gutman BA, 2013, NEUROIMAGE, V70, P386, DOI 10.1016/j.neuroimage.2012.12.052; Gutman BA, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P716, DOI 10.1109/ISBI.2012.6235648; Hager R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2086; Hamasaki T, 2001, J NEUROSCI, V21, P4272, DOI 10.1523/JNEUROSCI.21-12-04272.2001; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Itoh K, 2001, ACTA NEUROPATHOL, V101, P92; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; KUMAR J, 1995, SCIENCE, V267, P1834, DOI 10.1126/science.7892610; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nithianantharajah J, 2013, NAT NEUROSCI, V16, P16, DOI 10.1038/nn.3276; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ramasamy A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt069; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Toyoshima I, 1996, NEUROSCI LETT, V211, P171, DOI 10.1016/0304-3940(96)12752-X; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Walters R, 2013, BEHAV GENET, V43, P548; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhang X, 2010, J CELL SCI, V123, P3901, DOI 10.1242/jcs.069153; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	57	516	524	42	413	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					224	U216		10.1038/nature14101	http://dx.doi.org/10.1038/nature14101			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25607358	Green Accepted, Green Published			2022-12-28	WOS:000352454600040
J	Foster, GR				Foster, Graham R.			Shorter treatments for hepatitis C: another step forward?	LANCET			English	Editorial Material							GENOTYPE 1 INFECTION; SOFOSBUVIR; HCV; LEDIPASVIR; INTERFERON; RIBAVIRIN; CIRRHOSIS; THERAPY; PLUS		Queen Marys Univ London, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London	Foster, GR (corresponding author), Queen Marys Univ London, Blizard Inst, London E1 2AT, England.	g.r.foster@qmul.ac.uk		Foster, Graham/0000-0002-3704-386X				Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; D'Souza R, 2004, J ROY SOC MED, V97, P223, DOI 10.1258/jrsm.97.5.223; Ferenci P, 2012, BEST PRACT RES CL GA, V26, P463, DOI 10.1016/j.bpg.2012.09.002; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Kohli A, 2014, LANCET; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037	11	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1054	1055		10.1016/S0140-6736(14)61600-7	http://dx.doi.org/10.1016/S0140-6736(14)61600-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25591504				2022-12-28	WOS:000351270400009
J	Enserink, M; Chin, G				Enserink, Martin; Chin, Gilbert			The End of PRIVACY	SCIENCE			English	Editorial Material																			0	25	26	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					490	491		10.1126/science.347.6221.490	http://dx.doi.org/10.1126/science.347.6221.490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635079				2022-12-28	WOS:000348639300032
J	Kane, CM; Hoskin, P; Bennett, MI				Kane, Christopher M.; Hoskin, Peter; Bennett, Michael I.			Cancer induced bone pain	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPINAL-CORD COMPRESSION; DOUBLE-BLIND; OPIOIDS; METASTASES; SINGLE; RADIOTHERAPY; PARACETAMOL; GUIDELINES; MECHANISMS; RADIATION		[Kane, Christopher M.; Bennett, Michael I.] Univ Leeds, Sch Med, Leeds Inst Hlth Sci, Acad Unit Palliat Care, Leeds LS2 9JT, W Yorkshire, England; [Hoskin, Peter] UCL, Mt Vernon Canc Ctr, London, England	University of Leeds; Mount Vernon Cancer Centre; University of London; University College London	Kane, CM (corresponding author), Univ Leeds, Sch Med, Leeds Inst Hlth Sci, Acad Unit Palliat Care, Leeds LS2 9JT, W Yorkshire, England.	Christopher.Kane@nhs.net	Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349; Hoskin, Peter/0000-0001-8323-9567	National Institute for Health Research [ACF-2013-02-011] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bennet MI., 2008, SYSTEMATIC REV PAIN; Bennett MI, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2806; Bennett MI, 2011, PALLIATIVE MED, V25, P553, DOI 10.1177/0269216310378546; Brown PD, 1999, J NEURO-ONCOL, V44, P175, DOI 10.1023/A:1006312306713; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Chaichana KL, 2008, NEUROSURGERY, V62, P683, DOI 10.1227/01.neu.0000317317.33365.15; Chow E, 2012, CLIN ONCOL-UK, V24, P112, DOI 10.1016/j.clon.2011.11.004; Chow E, 2014, LANCET ONCOL, V15, P164, DOI 10.1016/S1470-2045(13)70556-4; Chow EJ, 2014, J CLIN ONCOL; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Davies A, 2013, J PAIN SYMPTOM MANAG, V46, P619, DOI 10.1016/j.jpainsymman.2012.12.009; Davis MP, 2014, J PAIN SYMPTOM MANAG, V48, pE2, DOI 10.1016/j.jpainsymman.2014.03.003; Dennis K, 2013, RADIOTHER ONCOL, V106, P5, DOI 10.1016/j.radonc.2012.12.009; Falk S, 2014, J CLIN ONCOL, V32, P1647, DOI 10.1200/JCO.2013.51.7219; Gralow J, 2007, J PAIN SYMPTOM MANAG, V33, P462, DOI 10.1016/j.jpainsymman.2007.01.001; Grond S, 1996, PAIN, V64, P107, DOI 10.1016/0304-3959(95)00076-3; Hoskin P, 2011, EUR J CANCER, V47, P6, DOI 10.1016/S0959-8049(11)70106-X; Hurlow A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006276.pub3; Jandhyala R, 2013, J PAIN SYMPTOM MANAG, V46, P573, DOI 10.1016/j.jpainsymman.2012.09.009; Klepstad P, 2003, PAIN, V101, P193, DOI 10.1016/S0304-3959(02)00328-7; McNicol ED, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006332.pub2; Mhaskar R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003188.pub3; Middlemiss T, 2011, CLIN ONCOL-UK, V23, P387, DOI 10.1016/j.clon.2011.03.003; Nabal M, 2012, PALLIATIVE MED, V26, P305, DOI 10.1177/0269216311428528; National Institute for Health and Care Excellence, 2012, OP PALL CAR, V140; Paulsen O, 2014, J CLIN ONCOL, V32, P3221, DOI 10.1200/JCO.2013.54.3926; Riley J, 2015, J PAIN SYMPTOM MANAG, V49, P161, DOI 10.1016/j.jpainsymman.2014.05.021; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; White BD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2538; Wong R., 2002, COCHRANE DB SYST REV, V2002, pCD002068, DOI [DOI 10.1002/14651858.CD002068, 10.1002/14651858.CD002068]; World Health Organization, 1996, CANC PAIN REL; Yennurajalingam S, 2013, J CLIN ONCOL, V31, P3076, DOI 10.1200/JCO.2012.44.4661; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M	33	68	74	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2015	350								h315	10.1136/bmj.h315	http://dx.doi.org/10.1136/bmj.h315			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AT	25633978	Green Published			2022-12-28	WOS:000348778700002
J	Nieh, EH; Matthews, GA; Allsop, SA; Presbrey, KN; Leppla, CA; Wichmann, R; Neve, R; Wildes, CP; Tye, KM				Nieh, Edward H.; Matthews, Gillian A.; Allsop, Stephen A.; Presbrey, Kara N.; Leppla, Christopher A.; Wichmann, Romy; Neve, Rachael; Wildes, Craig P.; Tye, Kay M.			Decoding Neural Circuits that Control Compulsive Sucrose Seeking	CELL			English	Article							VENTRAL TEGMENTAL AREA; LATERAL HYPOTHALAMIC NEURONS; MEDIAL FOREBRAIN-BUNDLE; SELF-STIMULATION; SUBSTANTIA-NIGRA; POSITIVE REINFORCEMENT; HORSERADISH-PEROXIDASE; GLUTAMATERGIC NEURONS; DOPAMINE NEURONS; DRUG SEEKING	The lateral hypothalamic (LH) projection to the ventral tegmental area (VTA) has been linked to reward processing, but the computations within the LH-VTA loop that give rise to specific aspects of behavior have been difficult to isolate. We show that LH-VTA neurons encode the learned action of seeking a reward, independent of reward availability. In contrast, LH neurons downstream of VTA encode reward-predictive cues and unexpected reward omission. We show that inhibiting the LH-VTA pathway reduces "compulsive'' sucrose seeking but not food consumption in hungry mice. We reveal that the LH sends excitatory and inhibitory input onto VTA dopamine (DA) and GABA neurons, and that the GABAergic projection drives feeding-related behavior. Our study overlays information about the type, function, and connectivity of LH neurons and identifies a neural circuit that selectively controls compulsive sugar consumption, without preventing feeding necessary for survival, providing a potential target for therapeutic interventions for compulsive-overeating disorder.	[Nieh, Edward H.; Matthews, Gillian A.; Allsop, Stephen A.; Presbrey, Kara N.; Leppla, Christopher A.; Wichmann, Romy; Neve, Rachael; Wildes, Craig P.; Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Tye, KM (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	kaytye@mit.edu	Core, Vector/CAF-4832-2022	/0000-0003-2154-6224; /0000-0001-6754-0333	JPB Foundation; PIIF; Whitehall Foundation; Klingenstein Foundation; NARSAD Young Investigator Award; Alfred P. Sloan Foundation; Whitehead Career Development Chair; NIH (NIMH) [R01-MH102441-01]; NIH Director's New Investigator Award (NIDDK) [DP2-DK-102256-01]; NSF Graduate Research Fellowship; Integrative Neuronal Systems Fellowship; Training Program in the Neurobiology of Learning and Memory; Simons Center for the Social Brain Postdoctoral Fellowship; Jeffrey and Nancy Halis Fellowship; Henry E. Singleton Fund; James R. Killian Fellowship; Netherlands Organisation for Scientific Research (NWO) RUBICON fellowship program; PNDRF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102441, T32MH074249] Funding Source: NIH RePORTER	JPB Foundation; PIIF; Whitehall Foundation; Klingenstein Foundation(Klingenstein Philanthropies); NARSAD Young Investigator Award(NARSAD); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Whitehead Career Development Chair; NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH Director's New Investigator Award (NIDDK); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Integrative Neuronal Systems Fellowship; Training Program in the Neurobiology of Learning and Memory; Simons Center for the Social Brain Postdoctoral Fellowship; Jeffrey and Nancy Halis Fellowship; Henry E. Singleton Fund; James R. Killian Fellowship; Netherlands Organisation for Scientific Research (NWO) RUBICON fellowship program(Netherlands Organization for Scientific Research (NWO)); PNDRF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank N. Golan, R. Thomas, M. Anahtar, G. Glober, and A. Beyeler for their assistance with immunohistochemistry. We would also like to thank C. Seo, and S. Kim for their contributions throughout the project and M. Wilson and P. Shizgal for helpful discussion. K.M.T. is a New York Stem Cell Foundation - Robertson Investigator and acknowledges funding from the JPB Foundation, PIIF, PNDRF, Whitehall Foundation, Klingenstein Foundation, NARSAD Young Investigator Award, Alfred P. Sloan Foundation, Whitehead Career Development Chair, NIH R01-MH102441-01 (NIMH), and NIH Director's New Investigator Award DP2-DK-102256-01 (NIDDK). E.H.N. was supported by the NSF Graduate Research Fellowship, the Integrative Neuronal Systems Fellowship, and the Training Program in the Neurobiology of Learning and Memory. G.A.M. was supported by the Simons Center for the Social Brain Postdoctoral Fellowship. S.A.A. was supported by the Jeffrey and Nancy Halis Fellowship as well as the Henry E. Singleton Fund. C.A.L. was supported by the Integrative Neuronal Systems Fellowship and the James R. Killian Fellowship. R.W. was supported by the Netherlands Organisation for Scientific Research (NWO) RUBICON fellowship program.	Avena NM, 2007, EXP CLIN PSYCHOPHARM, V15, P481, DOI 10.1037/1064-1297.15.5.481; BARONE FC, 1981, BRAIN RES BULL, V7, P75, DOI 10.1016/0361-9230(81)90101-5; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; BENBASSAT J, 1959, ARCH INT PHARMACOD T, V122, P434; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; BIELAJEW C, 1986, J NEUROSCI, V6, P919; BURTON MJ, 1976, EXP NEUROL, V51, P668, DOI 10.1016/0014-4886(76)90189-8; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; GRATTON A, 1988, BRAIN RES, V438, P256, DOI 10.1016/0006-8993(88)91344-3; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; LACEY MG, 1989, J NEUROSCI, V9, P1233; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; Mietus-Snyder ML, 2008, ANNU REV MED, V59, P147, DOI 10.1146/annurev.med.59.103106.105628; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; NAKAMURA K, 1987, J NEUROPHYSIOL, V58, P1123, DOI 10.1152/jn.1987.58.5.1123; NORGREN R, 1970, BRAIN RES, V21, P63, DOI 10.1016/0006-8993(70)90021-1; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARTZBAUM JS, 1988, PHYSIOL BEHAV, V44, P507, DOI 10.1016/0031-9384(88)90313-7; SIMON H, 1979, BRAIN RES, V178, P17, DOI 10.1016/0006-8993(79)90085-4; Singh J, 1996, BRAIN RES BULL, V41, P399, DOI 10.1016/S0361-9230(96)00217-1; Tabuchi E, 2002, BRAIN RES, V951, P270, DOI 10.1016/S0006-8993(02)03173-6; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; YAMAMOTO T, 1989, BRAIN RES, V481, P286, DOI 10.1016/0006-8993(89)90805-6; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	46	228	230	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					528	541		10.1016/j.cell.2015.01.003	http://dx.doi.org/10.1016/j.cell.2015.01.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635460	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000349208000017
J	David, WS; Temin, ES; Kraeft, JJ; Hooper, DC				David, William S.; Temin, Elizabeth S.; Kraeft, Jessica J.; Hooper, David C.			Case 3-2015: A 60-Year-Old Woman with Abdominal Pain, Dyspnea, and Diplopia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUCCINYLCHOLINE-INDUCED HYPERKALEMIA; STATES		[David, William S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Temin, Elizabeth S.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Kraeft, Jessica J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hooper, David C.] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA; [David, William S.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Temin, Elizabeth S.] Harvard Univ, Sch Med, Dept Emergency Med, Boston, MA USA; [Kraeft, Jessica J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hooper, David C.] Harvard Univ, Sch Med, Dept Infect Dis, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	David, WS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.							[Anonymous], 2014, MMWR MORB MORTAL WKL, V63, P901; Gupta A, 2005, NEUROLOGY, V65, P1694, DOI 10.1212/01.wnl.0000187127.92446.4c; Huggins RM, 2003, AM J HEALTH-SYST PH, V60, P694, DOI 10.1093/ajhp/60.7.694; Lang M., 2014, EURO SURVEILL, V19; Martyn JAJ, 2006, ANESTHESIOLOGY, V104, P158, DOI 10.1097/00000542-200601000-00022; Wilcox SR, 2012, CRIT CARE MED, V40, P1808, DOI 10.1097/CCM.0b013e31824e0e67	6	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					364	372		10.1056/NEJMcpc1410936	http://dx.doi.org/10.1056/NEJMcpc1410936			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25607430				2022-12-28	WOS:000348204500012
J	Naviglio, S; Papanti, D; Moressa, V; Ventura, A				Naviglio, Samuele; Papanti, Duccio; Moressa, Valentina; Ventura, Alessandro			CASE REPORT An adolescent with an altered state of mind	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYNTHETIC CANNABINOIDS; CONSUMPTION		[Naviglio, Samuele; Papanti, Duccio; Moressa, Valentina; Ventura, Alessandro] Univ Trieste, Dept Med Surg & Hlth Sci, I-34149 Trieste, Italy; [Ventura, Alessandro] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy	University of Trieste; IRCCS Burlo Garofolo	Naviglio, S (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, I-34149 Trieste, Italy.	samuele.naviglio@gmail.com	Naviglio, Samuele/G-1297-2014	Naviglio, Samuele/0000-0002-1915-9965; Moressa, Valentina/0000-0001-7956-5431; Ventura, Alessandro/0000-0002-4657-1760				Ashton John C, 2012, Curr Drug Abuse Rev, V5, P158; Bhanushali GK, 2013, CLIN J AM SOC NEPHRO, V8, P523, DOI 10.2215/CJN.05690612; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Burlington County, 2010, BCHD10 115 PUBL HLTH; Durand Dante, 2015, Clin Schizophr Relat Psychoses, V8, P205, DOI 10.3371/CSRP.DUDE.031513; Freeman MJ, 2013, NEUROLOGY, V81, P2090, DOI 10.1212/01.wnl.0000437297.05570.a2; Gallup Organization, 2011, YOUTH ATT DRUGS AN R; Hermanns-Clausen M, 2013, ADDICTION, V108, P534, DOI 10.1111/j.1360-0443.2012.04078.x; Hoyte CO, 2012, ANN EMERG MED, V60, P435, DOI 10.1016/j.annemergmed.2012.03.007; Johnston L. D., 2014, MONITORING FUTURE NA, V1; Katz ER, 2010, TXB PEDIAT EMERGENCY; Kersten Brian P, 2015, J Pharm Pract, V28, P50, DOI 10.1177/0897190014544814; Lank PM, 2013, WEST J EMERG MED, V14, P467, DOI 10.5811/westjem.2013.1.14496; Louh IK, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0553-6; Mir A, 2011, PEDIATRICS, V128, pE1622, DOI 10.1542/peds.2010-3823; Nelson ME, 2014, EMERG MED CLIN N AM, V32, P1, DOI 10.1016/j.emc.2013.09.001; Ogata J, 2013, FORENSIC SCI INT, V227, P33, DOI 10.1016/j.forsciint.2012.09.006; Papanti D, 2014, ADV DUAL DIAGN, V7, P137, DOI 10.1108/ADD-02-2014-0006; Papanti D, 2013, HUM PSYCHOPHARM CLIN, V28, P379, DOI 10.1002/hup.2312; Park Y, 2013, FORENSIC TOXICOL, V31, P187, DOI 10.1007/s11419-012-0173-2; Sikich L, 2013, CHILD ADOL PSYCH CL, V22, P655, DOI 10.1016/j.chc.2013.06.005; Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality, 2014, UPD DRUG REL EM DEP; Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2011, DRUG AB WARN NETW 20; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P223, DOI 10.1007/s11419-013-0182-9; United Nations Office on Drug and Crime, 2014, WORLD DRUG REP 2014; United Nations Office on Drug and Crime, 2013, WORLD DRUG REP 2013; Wells DL, 2011, ANN PHARMACOTHER, V45, P414, DOI 10.1345/aph.1P580; Zimmermann US, 2009, DTSCH ARZTEBL INT, V106, P464, DOI 10.3238/arztebl.2009.0464	28	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2015	350								h299	10.1136/bmj.h299	http://dx.doi.org/10.1136/bmj.h299			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZG	25608972	Green Published			2022-12-28	WOS:000348433700008
J	da Silva Neto, EH; Comin, R; He, FZ; Sutarto, R; Jiang, YP; Greene, RL; Sawatzky, GA; Damascelli, A				da Silva Neto, Eduardo H.; Comin, Riccardo; He, Feizhou; Sutarto, Ronny; Jiang, Yeping; Greene, Richard L.; Sawatzky, George A.; Damascelli, Andrea			Charge ordering in the electron-doped superconductor Nd2-xCexCuO4	SCIENCE			English	Article							T-C SUPERCONDUCTOR; COPPER-OXIDE SUPERCONDUCTORS; QUASI-PARTICLE STATES; FERMI-SURFACE; BI2SR2CACU2O8+DELTA; OSCILLATIONS; EXCITATIONS; PSEUDOGAP; SPIN	In cuprate high-temperature superconductors, an antiferromagnetic Mott insulating state can be destabilized toward unconventional superconductivity by either hole or electron doping. In hole-doped (p-type) cuprates, a charge ordering (CO) instability competes with superconductivity inside the pseudogap state. We report resonant x-ray scattering measurements that demonstrate the presence of charge ordering in the n-type cuprate Nd2-xCexCuO4 near optimal doping. We find that the CO in Nd2-xCexCuO4 occurs with similar periodicity, and along the same direction, as in p-type cuprates. However, in contrast to the latter, the CO onset in Nd2-xCexCuO4 is higher than the pseudogap temperature, and is in the temperature range where antiferromagnetic fluctuations are first detected. Our discovery opens a parallel path to the study of CO and its relationship to antiferromagnetism and superconductivity.	[da Silva Neto, Eduardo H.; Comin, Riccardo; Sawatzky, George A.; Damascelli, Andrea] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [da Silva Neto, Eduardo H.; Comin, Riccardo; Sawatzky, George A.; Damascelli, Andrea] Univ British Columbia, Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada; [da Silva Neto, Eduardo H.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [da Silva Neto, Eduardo H.] Canadian Inst Adv Res, Quantum Mat Program, Toronto, ON M5G 1Z8, Canada; [He, Feizhou; Sutarto, Ronny] Canadian Light Source, Saskatoon, SK S7N 2V3, Canada; [Jiang, Yeping; Greene, Richard L.] Univ Maryland, Ctr Nanophys & Adv Mat, College Pk, MD 20742 USA; [Jiang, Yeping; Greene, Richard L.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	University of British Columbia; University of British Columbia; Max Planck Society; Canadian Institute for Advanced Research (CIFAR); University of Saskatchewan; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	da Silva Neto, EH (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	ehda@physics.ubc.ca; damascelli@physics.ubc.ca	damascelli, andrea/P-6329-2014; He, Feizhou/G-8493-2015; Comin, Riccardo/H-7731-2016	damascelli, andrea/0000-0001-9895-2226; He, Feizhou/0000-0002-3125-1406; Comin, Riccardo/0000-0002-1069-9973; da Silva Neto, Eduardo/0000-0001-6902-6100	Canadian Institute for Advanced Research (CIFAR) Global Academy; Government of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	Canadian Institute for Advanced Research (CIFAR) Global Academy; Government of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	We thank J. Shin for the wavelength dispersive x-ray (WDX) measurements, S. Saha for the susceptibility measurements, and N. P. Armitage, S. A. Kivelson, P. A. Lee, and A.-M. S. Tremblay for fruitful discussions. Supported by the Canadian Institute for Advanced Research (CIFAR) Global Academy (E.H.d.S.N.); the Government of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Achkar AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167001; Armitage NP, 2010, REV MOD PHYS, V82, P2421, DOI 10.1103/RevModPhys.82.2421; Armitage NP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.147003; Blanco-Canosa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054513; Blanco-Canosa S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.187001; CHEN CT, 1991, PHYS REV LETT, V66, P104, DOI 10.1103/PhysRevLett.66.104; Comin R, 2014, SCIENCE, V343, P390, DOI 10.1126/science.1242996; d'Astuto M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167002; Neto EHD, 2014, SCIENCE, V343, P393, DOI 10.1126/science.1243479; Davis JCS, 2013, P NATL ACAD SCI USA, V110, P17623, DOI 10.1073/pnas.1316512110; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Fink J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.092503; Fink J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100502; Fradkin E, 2012, NAT PHYS, V8, P864, DOI 10.1038/nphys2498; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hashimoto M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220511; Hawthorn DG, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3607438; Helm T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.247002; Helm T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.157002; Hinton JP, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217002; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Hucker M, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054514; Ishii K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4714; Kyung B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147004; Lee WS, 2014, NAT PHYS, V10, P883, DOI 10.1038/NPHYS3117; Motoyama EM, 2007, NATURE, V445, P186, DOI 10.1038/nature05437; Onose Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.024504; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; PELLEGRIN E, 1993, PHYS REV B, V47, P3354, DOI 10.1103/PhysRevB.47.3354; Sebastian SE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1468; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Wu T, 2011, NATURE, V477, P191, DOI 10.1038/nature10345; Yamada K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137004; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418	39	160	160	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					282	285		10.1126/science.1256441	http://dx.doi.org/10.1126/science.1256441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593186	Green Submitted			2022-12-28	WOS:000347915300038
J	Lopez-Carr, D; Marter-Kenyon, J				Lopez-Carr, David; Marter-Kenyon, Jessica			Manage climate-induced resettlement	NATURE			English	Editorial Material							CHANGE ADAPTATION; STRATEGIES		[Lopez-Carr, David; Marter-Kenyon, Jessica] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93117 USA	University of California System; University of California Santa Barbara	Lopez-Carr, D (corresponding author), Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93117 USA.	jsmarterkenyon@umail.ucsb.edu		Marter-Kenyon, Jessica/0000-0001-5145-8714				[Anonymous], 2013, PENINSULA PRINCIPLES; Barnett J., 2010, POLICY RES WORKING P; Black R, 2013, ENVIRON SCI POLICY, V27, pS32, DOI 10.1016/j.envsci.2012.09.001; Bronen R, 2013, P NATL ACAD SCI USA, V110, P9320, DOI 10.1073/pnas.1210508110; de Sherbinin A, 2011, SCIENCE, V334, P456, DOI 10.1126/science.1208821; McDowell C, 2013, DEV POLICY REV, V31, P677, DOI 10.1111/dpr.12030; Mortreux C, 2009, GLOBAL ENVIRON CHANG, V19, P105, DOI 10.1016/j.gloenvcha.2008.09.006; Patt AG, 2008, GLOBAL ENVIRON CHANG, V18, P458, DOI 10.1016/j.gloenvcha.2008.04.002; Zander KK, 2013, NAT HAZARDS, V67, P591, DOI 10.1007/s11069-013-0591-4	9	30	30	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					265	267		10.1038/517265a	http://dx.doi.org/10.1038/517265a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592519	Bronze			2022-12-28	WOS:000347810300015
J	Langer, R; Weissleder, R				Langer, Robert; Weissleder, Ralph			Nanotechnology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Langer, Robert] MIT, Cambridge, MA 02139 USA; [Weissleder, Ralph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Langer, R (corresponding author), MIT, Langer Res Lab, 500 Main St,Room 76-661, Cambridge, MA 02139 USA.	rlanger@mit.edu		/0000-0003-0828-4143				Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Langer R, 2013, J BIOMED MATER RES A, V101, P2449, DOI 10.1002/jbm.a.34811; Neely LA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005377; Weissleder R, 2014, NAT MATER, V13, P125, DOI [10.1038/nmat3780, 10.1038/NMAT3780]	6	51	51	1	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					135	136		10.1001/jama.2014.16315	http://dx.doi.org/10.1001/jama.2014.16315			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585320				2022-12-28	WOS:000347679300008
J	Fulcher, J; O'Connell, R; Voysey, M; Emberson, J; Blackwell, L; Mihaylova, B; Simes, J; Collins, R; Kirby, A; Colhoun, H; Braunwald, E; La Rosa, J; Pedersen, TR; Tonkin, A; Davis, B; Sleight, P; Franzosi, MG; Baigent, C; Keech, A; de Lemos, J; Blazing, M; Murphy, S; Downs, JR; Gotto, A; Clearfield, M; Holdaas, H; Gordon, D; Koren, M; Dahlof, B; Poulter, N; Sever, P; Knopp, RH; Fellstrom, B; Holdaas, H; Jardine, A; Schmieder, R; Zannad, F; Goldbourt, U; Kaplinsky, E; Colhoun, HM; Betteridge, DJ; Durrington, PN; Hitman, GA; Fuller, J; Neil, A; Wanner, C; Krane, V; Sacks, F; Moye, L; Pfeffer, M; Hawkins, CM; Kjekshus, J; Wedel, H; Wikstrand, J; Barter, P; Tavazzi, L; Maggioni, A; Marchioli, R; Tognoni, G; Bloomfield, H; Robins, S; Armitage, J; Parish, S; Peto, R; Pedersen, TR; Ridker, PM; Holman, R; Meade, T; MacMahon, S; Marschner, I; Shaw, J; Serruys, PW; Nakamura, H; Knatterud, G; Furberg, C; Byington, R; Macfarlane, P; Cobbe, S; Ford, I; Murphy, M; Blauw, GJ; Packard, C; Shepherd, J; Kjekshus, J; Pedersen, T; Wilhelmsen, L; Cannon, C; Murphy, S; Armitage, J; Bowman, L; Parish, S; Peto, R; Landray, M; Rossouw, J; Probstfield, J; Shepherd, J; Cobbe, S; Macfarlane, P; Ford, I; Flather, M; Kastelein, J; Newman, C; Shear, C; Tobert, J; Varigos, J; White, H; Yusuf, S; Barnes, EH; Keech, AC; Kirby, A; Marschner, IC; Blackwell, L; Emberson, J; Herrington, WG; Holland, LE; Mihaylova, B; Reith, C				Fulcher, Jordan; O'Connell, Rachel; Voysey, Merryn; Emberson, Jonathan; Blackwell, Lisa; Mihaylova, Borislava; Simes, John; Collins, Rory; Kirby, Adrienne; Colhoun, Helen; Braunwald, Eugene; La Rosa, John; Pedersen, T. R.; Tonkin, Andrew; Davis, Barry; Sleight, Peter; Franzosi, Maria Grazia; Baigent, Colin; Keech, Anthony; de Lemos, J.; Blazing, M.; Murphy, S.; Downs, J. R.; Gotto, A.; Clearfield, M.; Holdaas, H.; Gordon, D.; Koren, M.; Dahloef, B.; Poulter, N.; Sever, P.; Knopp, R. H.; Fellstroem, B.; Holdaas, H.; Jardine, A.; Schmieder, R.; Zannad, F.; Goldbourt, U.; Kaplinsky, E.; Colhoun, H. M.; Betteridge, D. J.; Durrington, P. N.; Hitman, G. A.; Fuller, J.; Neil, A.; Wanner, C.; Krane, V.; Sacks, F.; Moye, L.; Pfeffer, M.; Hawkins, C. M.; Kjekshus, J.; Wedel, H.; Wikstrand, J.; Barter, P.; Tavazzi, L.; Maggioni, A.; Marchioli, R.; Tognoni, G.; Bloomfield, H.; Robins, S.; Armitage, J.; Parish, S.; Peto, R.; Pedersen, T. R.; Ridker, P. M.; Holman, R.; Meade, T.; MacMahon, S.; Marschner, I.; Shaw, J.; Serruys, P. W.; Nakamura, H.; Knatterud, G.; Furberg, C.; Byington, R.; Macfarlane, P.; Cobbe, S.; Ford, I.; Murphy, M.; Blauw, G. J.; Packard, C.; Shepherd, J.; Kjekshus, J.; Pedersen, T.; Wilhelmsen, L.; Cannon, C.; Murphy, S.; Armitage, J.; Bowman, L.; Parish, S.; Peto, R.; Landray, M.; Rossouw, J.; Probstfield, J.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Ford, I.; Flather, M.; Kastelein, J.; Newman, C.; Shear, C.; Tobert, J.; Varigos, J.; White, H.; Yusuf, S.; Barnes, E. H.; Keech, A. C.; Kirby, A.; Marschner, I. C.; Blackwell, L.; Emberson, J.; Herrington, W. G.; Holland, L. E.; Mihaylova, B.; Reith, C.		Cholesterol Treatment Trialists' C	Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials	LANCET			English	Article							CORONARY-HEART-DISEASE; PRIMARY PREVENTION; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; STATIN THERAPY; SIMVASTATIN; ROSUVASTATIN; GUIDELINES; GENDER	Background Whether statin therapy is as effective in women as in men is debated, especially for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol Treatment Trialists' (CTT) Collaboration database to compare the effects of statin therapy between women and men. Methods We performed meta-analyses on data from 22 trials of statin therapy versus control (n=134 537) and five trials of more-intensive versus less-intensive statin therapy (n=39 612). Effects on major vascular events, major coronary events, stroke, coronary revascularisation and mortality were weighted per 1.0 mmol/L reduction in LDL cholesterol and effects in men and women compared with a Cox model that adjusted for non-sex differences. For subgroup analyses, we used 99% CIs to make allowance for the multiplicity of comparisons. Findings 46 675 (27%) of 174 149 randomly assigned participants were women. Allocation to a statin had similar absolute effects on 1 year lipid concentrations in both men and women (LDL cholesterol reduced by about 1.1 mmol/L in statin vs control trials and roughly 0.5 mmol/L for more-intensive vs less-intensive therapy). Women were generally at lower cardiovascular risk than were men in these trials. The proportional reductions per 1.0 mmol/L reduction in LDL cholesterol in major vascular events were similar overall for women (rate ratio [RR] 0.84, 99% CI 0.78-0.91) and men (RR 0.78, 99% CI 0.75-0.81, adjusted p value for heterogeneity by sex=0.33) and also for those women and men at less than 10% predicted 5 year absolute cardiovascular risk (adjusted heterogeneity p=0.11). Likewise, the proportional reductions in major coronary events, coronary revascularisation, and stroke did not differ significantly by sex. No adverse effect on rates of cancer incidence or non-cardiovascular mortality was noted for either sex. These net benefits translated into all-cause mortality reductions with statin therapy for both women (RR 0.91, 99% CI 0.84-0.99) and men (RR 0.90, 99% CI 0.86-0.95; adjusted heterogeneity p=0.43). Interpretation In men and women at an equivalent risk of cardiovascular disease, statin therapy is of similar effectiveness for the prevention of major vascular events.	[Braunwald, Eugene; de Lemos, J.; Blazing, M.; Murphy, S.] AFCAPS TEXCAPS AirForce Texas Coronary Atherosc, Bethesda, MD USA; [Downs, J. R.; Gotto, A.; Clearfield, M.] ALERT Assessment Lescol Renal Transplantat, Bethesda, MD USA; ALLHAT Antihypertens & Lipid Lowering Treatment P, Bethesda, MD USA; [Davis, Barry; Gordon, D.] ALLIANCE Aggress Lipid Lowering Initiat Abates Ne, Bethesda, MD USA; [Koren, M.] ASCOT Angloscandinavian Cardiac Outcomes Trial, Bethesda, MD USA; [Dahloef, B.; Poulter, N.; Sever, P.] ASPEN Atorvastatin Study Prevent Coronary Heart D, Bethesda, MD USA; [Knopp, R. H.] AURORA Study Evaluate Use Rosuvastatin Subjects R, Bethesda, MD USA; [Holdaas, H.; Fellstroem, B.; Jardine, A.; Schmieder, R.; Zannad, F.] BIP Bezafibrate Infarct Prevent Study, Tel Hashomer, Israel; [Goldbourt, U.; Kaplinsky, E.] CARDS Collaborat Atorvastatin Diabet Study, Dublin, Ireland; [Colhoun, H. M.; Betteridge, D. J.; Durrington, P. N.; Hitman, G. A.; Fuller, J.; Neil, A.] 4D Die Deutsch Diabet Dialyse Studie, Wurzburg, Germany; [Wanner, C.; Krane, V.] CARE Cholesterol & Recurrent Events Study, Bethesda, MD USA; [Braunwald, Eugene; Sacks, F.; Moye, L.; Pfeffer, M.; Hawkins, C. M.] CORONA Controlled Rosuvastatin Multinat Trial Hea, Bethesda, MD USA; [Barter, P.] GISSI Grp Italiano Studio Sopravvivenza Infarto M, Chieti, Italy; [Tavazzi, L.; Maggioni, A.] GISSI Prevent, Chieti, Italy; [Franzosi, Maria Grazia; Maggioni, A.; Marchioli, R.; Tognoni, G.] HIT Vet Affairs HDL Intervent Trial, Bethesda, MD USA; [Bloomfield, H.; Robins, S.] Heart Protect Study, Bethesda, MD USA; [Collins, Rory; Sleight, Peter; Keech, Anthony; Armitage, J.; Parish, S.; Peto, R.] IDEAL Incremental Decrease Endpoints Aggress Lipi, Oslo, Norway; [Pedersen, T. R.] JUPITER Justificat Use Statins Prevent Intervent, Bethesda, MD USA; [Ridker, P. M.] Lipids Diabet Study, Bethesda, MD USA; [Holman, R.] LEADER Lower Extrem Arterial Dis Event Reduct Tri, Bethesda, MD USA; [Meade, T.] LIPID Long Term Intervent Pravastatin Ischaem Dis, Bethesda, MD USA; [Simes, John; Tonkin, Andrew; Keech, Anthony; MacMahon, S.; Marschner, I.; Shaw, J.] Lescol Intervent Prevent Study, Iowa City, IA USA; [Serruys, P. W.] MEGA Management Elevated Cholesterol Primary Prev, Bethesda, MD USA; [Nakamura, H.] Post CABG Postcoronary Artery Bypass Graft Study, Bethesda, MD USA; Post CABG Postcoronary Artery Bypass Graft Study, Bethesda, MD USA; [Knatterud, G.] Pravastatin Pooling Project, Bethesda, MD USA; [Furberg, C.; Byington, R.] PROSPER Prospect Study Pravastatin Elderly Risk, Bethesda, MD USA; [Kjekshus, J.; Pedersen, T.; Wilhelmsen, L.] PROVE IT Pravastatin Atorvastatin Evaluat & Infec, Bethesda, MD USA; [Braunwald, Eugene; Murphy, S.; Cannon, C.] Study Effectiveness Addit Reduct Cholesterol & Ho, Bethesda, MD USA; [Collins, Rory; Sleight, Peter; Armitage, J.; Parish, S.; Peto, R.; Bowman, L.] SHARP Study Heart & Renal Protect, Bethesda, MD USA; [Collins, Rory; Baigent, Colin; Landray, M.] Treating New Targets, Bethesda, MD USA; [La Rosa, John] Womens Hlth Initiat, Bethesda, MD USA; [Rossouw, J.; Probstfield, J.] WOSCOPS West Scotland Coronary Prevent Study, Glasgow, Lanark, Scotland; [Simes, John; Barnes, E. H.; Keech, A. C.; Kirby, A.; Marschner, I. C.] Univ Sydney, CTC, Sydney, NSW 2006, Australia; [Collins, Rory; Baigent, Colin; Blackwell, L.; Emberson, J.; Herrington, W. G.; Holland, L. E.; Mihaylova, B.; Reith, C.] Univ Oxford, CTSU, Oxford OX1 2JD, England	University of Sydney; University of Oxford	Fulcher, J (corresponding author), Natl Hlth & Med Res Council NHMRC Clin Trials Ctr, Level 6 Med Fdn Bldg,92-94 Parramatta Rd, Camperdown, NSW 2050, Australia.	ctt@ctc.usyd.edu.au	Zannad, Faiez/K-4649-2019; Maggioni, Aldo Pietro/AAL-5334-2020; Tobert, Jonathan/AAD-2155-2020; Jardine, Alan/L-5770-2019; Collins, Rory/ABA-8487-2020; Kastelein, John/AAF-7950-2020; Tavazzi, Luigi/ABD-5119-2020; Ford, Ian/ABE-6145-2020; Blauw, Gerard/GWD-1079-2022; Blauw, Gerard/AAW-7904-2021	Maggioni, Aldo Pietro/0000-0003-2764-6779; Tobert, Jonathan/0000-0001-7105-299X; Tavazzi, Luigi/0000-0003-0336-8356; Colhoun, Helen/0000-0002-8345-3288; Venkatasubramanian, Siddharth/0000-0002-5860-0768; TAVAZZI, LUIGI/0000-0003-4448-5209; MacMahon, Stephen/0000-0003-2064-7699; Mihaylova, Borislava/0000-0002-0951-1304; Herrington, William/0000-0003-1172-8243; Jardine, Alan/0000-0001-5815-9370; Marschner, Ian/0000-0002-6225-1572; Emberson, Jonathan/0000-0001-7792-9422; Yusuf, Salim/0000-0003-4776-5601; Voysey, Merryn/0000-0001-6324-6559; bloomfield, hanna/0000-0002-0756-7064	UK Medical Research Council; British Heart Foundation; Australian National Health and Medical Research Council; European Community Biomed Program; Medical Research Council [MC_U137686849] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10059] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Community Biomed Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	UK Medical Research Council, British Heart Foundation, Australian National Health and Medical Research Council, European Community Biomed Program.	Abraha I, 2006, LANCET, V367, P469, DOI 10.1016/S0140-6736(06)68169-5; Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; Ajjan RA, 2012, DIABETES VASC DIS RE, V9, P243, DOI 10.1177/1479164112455534; [Anonymous], 2007, AM HEART J, V154, P815, DOI 10.1016/j.ahj.2007.06.034; [Anonymous], 2000, Ital Heart J, V1, P810; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blauwet LA, 2007, MAYO CLIN PROC, V82, P166; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Dale KM, 2007, CURR MED RES OPIN, V23, P565, DOI 10.1185/030079906X167516; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; DOWNS JR, 1995, AM J CARDIOL, V75, P1130; Eisenberg T, 2008, J EMPIR LEGAL STUD, V5, P507, DOI 10.1111/j.1740-1461.2008.00132.x; Fenton A, 2010, CLIMACTERIC, V13, P403, DOI 10.3109/13697137.2010.514704; Hague W, 2003, AM HEART J, V145, P643, DOI 10.1067/mhj.2003.1; Hocking RR, 1984, ANAL LINEAR MODELS; Kim ESH, 2009, ARTERIOSCL THROM VAS, V29, P279, DOI 10.1161/ATVBAHA.108.179796; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kostis WJ, 2012, J AM COLL CARDIOL, V59, P572, DOI 10.1016/j.jacc.2011.09.067; Mascitelli L, 2007, LANCET, V369, P1078, DOI 10.1016/S0140-6736(07)60518-2; Miettinen TA, 1997, CIRCULATION, V96, P4211; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Care Excellence, 2014, 181 NIH CAR EXC; National Research Council, 2010, WOM HLTH RES PROGR P; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Petretta M, 2010, INT J CARDIOL, V138, P25, DOI 10.1016/j.ijcard.2008.08.001; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Reidenberg MM, 2007, LANCET, V369, P1078, DOI 10.1016/S0140-6736(07)60517-0; Reiner Z, 2013, NAT REV CARDIOL, V10, P453, DOI 10.1038/nrcardio.2013.80; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140	36	814	841	3	96	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1397	1405		10.1016/S0140-6736(14)61368-4	http://dx.doi.org/10.1016/S0140-6736(14)61368-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25579834	Green Submitted			2022-12-28	WOS:000352719800028
J	Lenzer, J				Lenzer, Jeanne			PRESCRIBING California doctors under investigation for prescribing practices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jeanne.lenzer@gmail.com						De Sa K., 2014, SAN JOSE MERCUR 1123; De Sa K., 2015, SAN JOSE MERCUR 0112; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Kumar A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009582.pub2; Lord S., FOSTER CHILDREN HHS; Stanton T., 2012, DRUGGING OUR CHILDRE; Weber T, 2013, MEDICARE DRUG PROGRA	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2015	350								h74	10.1136/bmj.h74	http://dx.doi.org/10.1136/bmj.h74			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AT	25633865				2022-12-28	WOS:000348778700014
J	Wodarz, D; Zauber, AG				Wodarz, Dominik; Zauber, Ann G.			Risk factors and random chances	NATURE			English	Editorial Material							COLORECTAL-CANCER; SOMATIC EVOLUTION; INITIATION; DRIVEN; CELLS	The discovery that the estimated number of stem-cell divisions in a tissue correlates with cancer incidence suggests that the varying probability of developing cancer in different tissues is mostly down to random mutations.	[Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	University of California System; University of California Irvine; Memorial Sloan Kettering Cancer Center	Wodarz, D (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	dwodarz@uci.edu; zaubera@mskcc.org			NCI NIH HHS [P30 CA008748] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Doll R, 1981, J NATL CANCER I, V66, P1192; Frank SA, 2003, NATURE, V422, P494, DOI 10.1038/422494a; Goel A, 2003, CLIN CANCER RES, V9, P383; Komarova NL, 2004, CELL CYCLE, V3, P1558, DOI 10.4161/cc.3.12.1186; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Rodriguez-Brenes IA, 2011, P NATL ACAD SCI USA, V108, P18983, DOI 10.1073/pnas.1107621108; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rozhok AI, 2014, AGING-US, V6, P1033, DOI 10.18632/aging.100707; Ruschoff J, 1998, P NATL ACAD SCI USA, V95, P11301, DOI 10.1073/pnas.95.19.11301; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vogelstein B., 2002, GENETIC BASIS HUMAN; Wodarz D, 2014, DYNAMICS CANC MATH F	14	13	14	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					563	564		10.1038/517563a	http://dx.doi.org/10.1038/517563a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2ZL	25631443				2022-12-28	WOS:000348775000032
J	Castellucci, LA; Wells, PS; Duffett, L				Castellucci, Lana A.; Wells, Philip S.; Duffett, Lisa			Nonleg Venous Thrombosis in Critically Ill Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEEP-VEIN THROMBOSIS; DALTEPARIN; CATHETER; HEPARIN; CANCER	IMPORTANCE: Critically patients are at risk of venous thrombosis, and therefore guidelines recommend daily thromboprophylaxis. Deep vein thrombosis (DVT) commonly occurs in the lower extremities but can occur in other sites including the head and neck, trunk, and upper extremities. The risk of nonleg deep venous thromboses (NLDVTs), predisposing factors, and the association between NLDVTs and pulmonary embolism (PE) or death are unclear. OBJECTIVE: To describe the frequency, anatomical location, risk factors, management, and consequences of NLDVTs in a large cohort of medical-surgical critically ill adults. DESIGN, SETTING, AND PARTICIPATNS: A nested prospective cohort study in the setting of secondary and tertiary care intensive care units (ICUs). The study population comprised 3746 patients, who were expected to remain in the ICU for at least 3 days and were enrolled in a randomized clinical trial of dalteparion vs standard heparin for thromboprophyaxis. MAIN OUTCOMES AND MEASURES: The proportion of patients who had NLDVTs, the mean number per patient, and the anatomical location. We characterized NLDVTs as prevalent or incident (identified within 72 hours of ICU admission or thereafter) and whether they were catheter related or not. We used multi variable regression models to evaluate risk factors for NLDVT and to examine subsequent anticoagulant therapy, associated PE, and death. RESULTS Of 3746 trial patients, 84(2.2%) developed lor more non-leg vein thromboses (superficial or deep, proximal or distal). Thromboses were more commonly incident (n = 75 [2.0%]) than prevalent (n = 9 [0.2%]) (P <.001) and more often deep (n = 67 [1.8%]) than superficial (n = 31[0.8%]) (P <.001). Cancer was the only independent predictor of incident NLDVT (hazard ratio [HP], 2.22; 95% Cl, 1.06-4.65). After adjusting for Acute Physiology and Chronic Health Evaluation (APACHE) II scores, personal or family history of venous thromboembolism, body mass index, vasopressor use, type of thromboprophylaxis, and presence of leg DVT, NLDVTs were associated with an increased risk of PE (HR, 11.83; 95% Cl, 4.80-29.18). Nonleg DVTs were not associated with ICU mortality (HR. 1.09; 95% Cl, 0.62-1.92) in a model adjusting for age, APACHE II, vasopressor use, mechanical ventilation, renal replacement therapy, and platelet count below 50 x 109/L. CONCLUSIONS AND RELEVANCE Despite universal heparin thromboprophylaxis, nonleg thromboses are found in 2.2% of medical-surgical critically ill patients, primarily in deep veins and proximal veins. Patients who have a malignant condition may have a significantly higher risk of developing NLDVT, and patients with NLDVT, compared with those without, appeared to be at higher risk of PE but not higher risk of death.	[Castellucci, Lana A.; Duffett, Lisa] Univ Ottawa, Ottawa, ON K1H 8L6, Canada; [Wells, Philip S.] Univ Ottawa, Dept Med, Ottawa Hosp, Ottawa, ON K1H 8L6, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Wells, PS (corresponding author), Univ Ottawa, Dept Med, Ottawa Hosp, 501 Smyth Rd,Ste M1857, Ottawa, ON K1H 8L6, Canada.	pwells@toh.on.ca						Carrier M, 2007, J THROMB HAEMOST, V5, P2552, DOI 10.1111/j.1538-7836.2007.02751.x; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Donadini MP, 2011, SEMIN HEMATOL, V48, P264, DOI 10.1053/j.seminhematol.2011.08.005; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kovacs MJ, 2007, J THROMB HAEMOST, V5, P1650, DOI 10.1111/j.1538-7836.2007.02613.x; Kucher N, 2011, NEW ENGL J MED, V364, P861, DOI 10.1056/NEJMcp1008740; Lamontagne F, 2014, JAMA INTERN MED, V174, P689, DOI 10.1001/jamainternmed.2014.169	8	1	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					411	412		10.1001/jama.2014.12496	http://dx.doi.org/10.1001/jama.2014.12496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626038				2022-12-28	WOS:000349072600024
J	Hassig, M; Altwegg, K; Balsiger, H; Bar-Nun, A; Berthelier, JJ; Bieler, A; Bochsler, P; Briois, C; Calmonte, U; Combi, M; De Keyser, J; Eberhardt, P; Fiethe, B; Fuselier, SA; Galand, M; Gasc, S; Gombosi, TI; Hansen, KC; Jackel, A; Keller, HU; Kopp, E; Korth, A; Kuhrt, E; Le Roy, L; Mall, U; Marty, B; Mousis, O; Neefs, E; Owen, T; Reme, H; Rubin, M; Semon, T; Tornow, C; Tzou, CY; Waite, JH; Wurz, P				Hassig, M.; Altwegg, K.; Balsiger, H.; Bar-Nun, A.; Berthelier, J. J.; Bieler, A.; Bochsler, P.; Briois, C.; Calmonte, U.; Combi, M.; De Keyser, J.; Eberhardt, P.; Fiethe, B.; Fuselier, S. A.; Galand, M.; Gasc, S.; Gombosi, T. I.; Hansen, K. C.; Jackel, A.; Keller, H. U.; Kopp, E.; Korth, A.; Kuehrt, E.; Le Roy, L.; Mall, U.; Marty, B.; Mousis, O.; Neefs, E.; Owen, T.; Reme, H.; Rubin, M.; Semon, T.; Tornow, C.; Tzou, C. -Y.; Waite, J. H.; Wurz, P.			Time variability and heterogeneity in the coma of 67P/Churyumov-Gerasimenko	SCIENCE			English	Article							COMETS	Comets contain the best-preserved material from the beginning of our planetary system. Their nuclei and comae composition reveal clues about physical and chemical conditions during the early solar system when comets formed. ROSINA (Rosetta Orbiter Spectrometer for Ion and Neutral Analysis) onboard the Rosetta spacecraft has measured the coma composition of comet 67P/Churyumov-Gerasimenko with well-sampled time resolution per rotation. Measurements were made over many comet rotation periods and a wide range of latitudes. Thesemeasurements show large fluctuations in composition in a heterogeneous coma that has diurnal and possibly seasonal variations in the major outgassing species: water, carbon monoxide, and carbon dioxide. These results indicate a complex coma-nucleus relationship where seasonal variations may be driven by temperature differences just below the comet surface.	[Hassig, M.; Altwegg, K.; Balsiger, H.; Bieler, A.; Bochsler, P.; Calmonte, U.; Eberhardt, P.; Gasc, S.; Jackel, A.; Kopp, E.; Rubin, M.; Semon, T.; Tzou, C. -Y.; Wurz, P.] Univ Bern, Phys Inst, Sidlerstr 5, CH-3012 Bern, Switzerland; [Hassig, M.; Fuselier, S. A.; Waite, J. H.] SW Res Inst, San Antonio, TX 78238 USA; [Altwegg, K.; Le Roy, L.] Univ Bern, Ctr Space & Habitabil CSH, CH-3012 Bern, Switzerland; [Bar-Nun, A.] Tel Aviv Univ, Dept Geosci, IL-69978 Tel Aviv, Israel; [Berthelier, J. J.] UPMC, Univ Versailles St,Univ Pierre & Marie Curie,UVSQ, Inst Pierre Simon Laplace IPSL, Ctr Natl Rech Sci CNRS,Lab Atmospheres,Observ Spa, F-75252 Paris 05, France; [Bieler, A.; Combi, M.; Gombosi, T. I.; Hansen, K. C.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Briois, C.] Univ Orleans, Lab Phys & Chim Environm & Espace LPC2E, CNRS, UMR 7328, F-45067 Orleans, France; [De Keyser, J.] Belgian Inst Space Aeron BIRA IASB, B-1180 Brussels, Belgium; [De Keyser, J.] KULeuven, Ctr Plasma Astrophys, B-3001 Heverlee, Belgium; [Fiethe, B.] TU Braunschweig, Inst Comp & Network Engn IDA, D-38106 Braunschweig, Germany; [Galand, M.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Keller, H. U.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Korth, A.; Mall, U.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Keller, H. U.; Kuehrt, E.; Marty, B.; Tornow, C.] German Aerosp Ctr, Inst Planetary Res Asteroids & Comets, D-12489 Berlin, Germany; [Marty, B.] Ctr Rech Petrograph & Geochim CRPG, F-54501 Vandoeuvre Les Nancy, France; [Mousis, O.] Aix Marseille Univ, LAM Lab Astrophys Marseille, CNRS, UMR 7326, F-13388 Marseille, France; [Neefs, E.] BIRA IASB, Engn Div, B-1180 Brussels, Belgium; [Owen, T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Reme, H.] Univ Paul Sabathier UPS, Univ Toulouse, Inst Rech Astrophys & Planetol IRAP, Observ Midipyrenees OMP, Toulouse, France; [Reme, H.] CNRS, IRAP, F-31028 Toulouse 4, France	University of Bern; Southwest Research Institute; University of Bern; Tel Aviv University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Orleans; KU Leuven; Braunschweig University of Technology; Imperial College London; Braunschweig University of Technology; Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Hawaii System; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Hassig, M (corresponding author), Univ Bern, Phys Inst, Sidlerstr 5, CH-3012 Bern, Switzerland.	myrtha.haessig@swri.org	Gombosi, Tamas I/G-4238-2011; Rubin, Martin/I-7777-2013; Mousis, Olivier/X-2712-2019; Wurz, Peter/R-2273-2017; Combi, Michael/J-1697-2012; Hansen, Kenneth C/F-3693-2011; briois, christelle/B-2170-2015	Gombosi, Tamas I/0000-0001-9360-4951; Rubin, Martin/0000-0001-6549-3318; Wurz, Peter/0000-0002-2603-1169; Combi, Michael/0000-0002-9805-0078; Hansen, Kenneth C/0000-0002-8502-1980; BRIOIS, Christelle/0000-0002-5616-0180; Galand, Marina/0000-0001-5797-914X; Le Roy, Lena/0000-0002-5984-6153	State of Bern; Swiss National Science Foundation; European Space Agency (ESA) PRODEX Program; Max-Planck-Gesellschaft (MPG); Bundesministerium fur Wirtschaft und Energie (BMWI) [50QP1302]; Jet Propulsion Laboratory (JPL) [1496541]; NASA [NNX148F71G, JPL-1266313]; Belgian Science Policy Office via PRODEX/ROSINA PEA [90020]; Science and Technology Facilities Council (STFC); A*MIDEX project - Investissements d'Avenir French Government program [ANR-11-IDEX-0001-02]; CNES at IRAP; CNES at LATMOS; CNES at LPC2E; Laboratoire d'Astrophysique de Marseille (LAM); CRPG; European Research Council [267255]; Ministry of Science; Israel Space agency; NASA JPL [NAS703001TONMO710889]; STFC [ST/K001051/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K001051/1] Funding Source: researchfish	State of Bern; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Space Agency (ESA) PRODEX Program; Max-Planck-Gesellschaft (MPG)(Max Planck Society); Bundesministerium fur Wirtschaft und Energie (BMWI); Jet Propulsion Laboratory (JPL)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA)); Belgian Science Policy Office via PRODEX/ROSINA PEA; Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); A*MIDEX project - Investissements d'Avenir French Government program(French National Research Agency (ANR)); CNES at IRAP; CNES at LATMOS; CNES at LPC2E; Laboratoire d'Astrophysique de Marseille (LAM); CRPG; European Research Council(European Research Council (ERC)European Commission); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Israel Space agency; NASA JPL(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The authors thank the following institutions and agencies, which supported this work: Work at the University of Bern was funded by the State of Bern, the Swiss National Science Foundation, and the European Space Agency (ESA) PRODEX Program. Work at the Max-Planck Institut fur Sonnensystemforschung (MPS) was funded by the Max-Planck-Gesellschaft (MPG) and Bundesministerium fur Wirtschaft und Energie (BMWI) under contract 50QP1302. Work at Southwest Research institute (SwRI) was supported by subcontract 1496541 from the Jet Propulsion Laboratory (JPL) and under NASA prime contract NNX148F71G. Work at BIRA-IASB was supported by the Belgian Science Policy Office via PRODEX/ROSINA PEA 90020. Work at Imperial College London has been partially funded by the Science and Technology Facilities Council (STFC). This work has been carried out thanks to the support of the A*MIDEX project (ANR-11-IDEX-0001-02) funded by the Investissements d'Avenir French Government program, managed by the French National Research Agency (ANR). This work was supported by CNES grants at IRAP, LATMOS, LPC2E, Laboratoire d'Astrophysique de Marseille (LAM) and CRPG and by the European Research Council (grant 267255). A.B.-N. thanks the Ministry of Science and the Israel Space agency. Work at the University of Michigan was funded by NASA under contract JPL-1266313. Work by J.H.W. at SwRI was supported by NASA JPL subcontract NAS703001TONMO710889. ROSINA would not give such outstanding results without the work of the many engineers, technicians, and scientists involved in the mission, in the Rosetta spacecraft, and in the ROSINA instrument over the past 20 years whose contributions are gratefully acknowledged. Rosetta is an ESA mission with contributions from its member states and NASA. We thank the OSIRIS team for giving permission to use the shape model. We acknowledge herewith the work of the ESA Rosetta team. All ROSINA data are available on request until it is released to the PSA archive of ESA and to the PDS archive of NASA.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; A'Hearn MF, 2006, SCIENCE, V314, P1708, DOI 10.1126/science.1137083; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Balsiger H, 2007, SPACE SCI REV, V128, P745, DOI 10.1007/s11214-006-8335-3; Bonev BP, 2008, ASTROPHYS J LETT, V680, pL61, DOI 10.1086/589649; Dello Russo N, 2007, NATURE, V448, P172, DOI 10.1038/nature05908; Feaga LM, 2007, ICARUS, V190, P345, DOI [10.1016/j.icarus.2007.04.009, 10.1016/j.icarus.2007.04.038]; Glassmeier KH, 2007, SPACE SCI REV, V128, P1, DOI 10.1007/s11214-006-9140-8; KELLER HU, 1986, NATURE, V321, P320, DOI 10.1038/321320a0; Mottola S, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424590; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Schlappi B, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015734; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; WEAVER HA, 1986, NATURE, V324, P441, DOI 10.1038/324441a0	15	218	218	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							aaa0276	10.1126/science.aaa0276	http://dx.doi.org/10.1126/science.aaa0276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613892	Green Submitted			2022-12-28	WOS:000348225800032
J	Michel-Kerjan, E				Michel-Kerjan, Erwann			Effective risk response needs a prepared mindset	NATURE			English	Editorial Material									Univ Penn, Wharton Risk Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania	Michel-Kerjan, E (corresponding author), Univ Penn, Wharton Risk Ctr, Philadelphia, PA 19104 USA.	erwannmk@wharton.upenn.edu							0	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					413	413		10.1038/517413a	http://dx.doi.org/10.1038/517413a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25612017	Bronze			2022-12-28	WOS:000348196500005
J	Stoltz, DA; Meyerholz, DK; Welsh, MJ				Stoltz, David A.; Meyerholz, David K.; Welsh, Michael J.			Origins of Cystic Fibrosis Lung Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY SURFACE DEHYDRATION; CFTR-KNOCKOUT FERRETS; SUBMUCOSAL GLANDS; MUCOCILIARY TRANSPORT; BICARBONATE SECRETION; BRONCHIAL EPITHELIUM; PORCINE MODEL; NEWBORN PIGS; LIQUID PH		[Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Stoltz, David A.] Univ Iowa, Roy J & Lucille Carver Coll Med, Iowa City, IA 52242 USA; [Stoltz, David A.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa	Stoltz, DA (corresponding author), Univ Iowa, Carver Coll Med, 6322 PBDB,169 Newton Rd, Iowa City, IA 52242 USA.	david-stoltz@uiowa.edu; david-meyerholz@uiowa.edu; michael-welsh@uiowa.edu	Meyerholz, David/J-8131-2019	Meyerholz, David/0000-0003-1552-3253; Stoltz, David/0000-0003-0893-9015	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01 HL051670, DP2 HL117744] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL117744, P01HL051670] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abou Alaiwa MH, 2014, J CYST FIBROS, V13, P373, DOI 10.1016/j.jcf.2013.12.006; Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Adam RJ, 2013, AM J RESP CRIT CARE, V188, P1434, DOI 10.1164/rccm.201307-1268OC; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; Birket SE, 2014, AM J RESP CRIT CARE, V190, P421, DOI 10.1164/rccm.201404-0670OC; Bonvin E, 2008, J PHYSIOL-LONDON, V586, P3231, DOI 10.1113/jphysiol.2008.150763; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Chang EH, 2012, LARYNGOSCOPE, V122, P1898, DOI 10.1002/lary.23392; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Clancy JP, 2012, AM J RESP CRIT CARE, V186, P593, DOI 10.1164/rccm.201204-0785PP; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Cohen-Cymberknoh M, 2014, CHEST, V145, P738, DOI 10.1378/chest.13-1162; Cystic Fibrosis Foundation, CYST FIBR FDN PAT RE; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fischer AJ, 2014, PEDIATR PULM, V49, P960, DOI 10.1002/ppul.22922; Fisher JT, 2013, AM J RESP CELL MOL, V49, P837, DOI 10.1165/rcmb.2012-0433OC; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hall GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023932; Hobbs CA, 2013, J PHYSIOL-LONDON, V591, P4377, DOI 10.1113/jphysiol.2012.240861; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Hoegger MJ, 2014, P NATL ACAD SCI USA, V111, P2355, DOI 10.1073/pnas.1323633111; Hoo AF, 2012, THORAX, V67, P874, DOI 10.1136/thoraxjnl-2012-201747; Itani OA, 2011, P NATL ACAD SCI USA, V108, P10260, DOI 10.1073/pnas.1106695108; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; McShane D, 2004, EUR RESPIR J, V24, P95, DOI 10.1183/09031936.04.00097503; McShane D, 2003, EUR RESPIR J, V21, P37, DOI 10.1183/09031936.03.00027603; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Olivier AK, 2012, J CLIN INVEST, V122, P3755, DOI 10.1172/JCI60610; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pierucci-Alves F, 2011, BIOL REPROD, V85, P442, DOI 10.1095/biolreprod.111.090860; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robinson M, 2002, PEDIATR PULM, V33, P293, DOI 10.1002/ppul.10079; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Shamsuddin AKM, 2012, J PHYSIOL-LONDON, V590, P3561, DOI 10.1113/jphysiol.2012.230714; Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799, DOI 10.1152/ajplung.2000.279.5.L799; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Staudinger BJ, 2014, AM J RESP CRIT CARE, V189, P812, DOI 10.1164/rccm.201312-2142OC; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; STURGESS J, 1982, AM J PATHOL, V106, P303; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Sun XS, 2014, AM J PATHOL, V184, P1309, DOI 10.1016/j.ajpath.2014.01.035; Sun XS, 2014, AM J RESP CELL MOL, V50, P502, DOI 10.1165/rcmb.2013-0261OC; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Travis SM, 2001, CURR OPIN IMMUNOL, V13, P89, DOI 10.1016/S0952-7915(00)00187-4; TREZISE AEO, 1993, HUM MOL GENET, V2, P213, DOI 10.1093/hmg/2.3.213; Trout L, 1998, AM J PHYSIOL-LUNG C, V275, pL1095, DOI 10.1152/ajplung.1998.275.6.L1095; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; Uc A, 2015, CLIN SCI, V128, P131, DOI 10.1042/CS20140059; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Woodworth BA, 2007, AM J RHINOL, V21, P122, DOI 10.2500/ajr.2007.21.2905	75	349	355	6	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					351	362		10.1056/NEJMra1300109	http://dx.doi.org/10.1056/NEJMra1300109			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25607428	Green Accepted			2022-12-28	WOS:000348204500010
J	Barreto, PD				Barreto, Philipe de Souto			Global health agenda on non-communicable diseases: has WHO set a smart goal for physical activity?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR EVENTS; AMERICAN-COLLEGE; MORTALITY; LIFE; EXERCISE; RISK; PREVENTION; BEHAVIORS; BARRIERS; BURDEN		Univ Hosp Toulouse, INSERM, UMR1027, Gerontopole Toulouse, F-31000 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Barreto, PD (corresponding author), Univ Hosp Toulouse, INSERM, UMR1027, Gerontopole Toulouse, F-31000 Toulouse, France.	philipebarreto81@yahoo.com.br	de Souto Barreto, Philipe/A-8426-2018	de Souto Barreto, Philipe/0000-0002-8860-425X				Bethancourt HJ, 2014, CLIN MED RES, V12, P10, DOI 10.3121/cmr.2013.1171; Brown WJ, 2012, BRIT J SPORT MED, V46, P664, DOI 10.1136/bjsports-2011-090529; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Centers for Disease Control and Prevention, 2014, STAT IND REP PHYS AC; Costello E, 2011, J GERIATR PHYS THER, V34, P138, DOI 10.1519/JPT.0b013e31820e0e71; Department of Health and Children Health Service Executive, 2009, NAT GUID PHYS ACT IR; Ebrahim S, 2000, INT J EPIDEMIOL, V29, P478, DOI 10.1093/ije/29.3.478; Hamer M, 2014, BRIT J SPORT MED, V48, P239, DOI 10.1136/bjsports-2013-092993; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hawkes AL, 2008, SUPPORT CARE CANCER, V16, P1097, DOI 10.1007/s00520-008-0421-5; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Lan TY, 2006, PREV MED, V43, P36, DOI 10.1016/j.ypmed.2006.03.016; Lang IA, 2007, J AM GERIATR SOC, V55, P1836, DOI 10.1111/j.1532-5415.2007.01426.x; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; National Center for Chronic Disease Prevention and Health Promotion, 1999, PHYS ACT HLTH REP SU; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Schnohr P, 2006, EUR J CARDIOV PREV R, V13, P173, DOI 10.1097/01.hjr.0000198923.80555.b7; Sundquist K, 2004, AM J PREV MED, V27, P22, DOI 10.1016/j.amepre.2004.03.011; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wisloff U, 2006, EUR J CARDIOV PREV R, V13, P798, DOI 10.1097/01.hjr.0000216548.84560.ac; World Health Organization, 2010, Global recommendations on physical activity for health; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2008, GLOB HLTH OBS DAT RE; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P	31	40	41	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2015	350								h23	10.1136/bmj.h23	http://dx.doi.org/10.1136/bmj.h23			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZG	25608835				2022-12-28	WOS:000348433700007
J	Hautz, WE; Kammer, JE; Schauber, SK; Spies, CD; Gaissmaier, W				Hautz, Wolf E.; Kaemmer, Juliane E.; Schauber, Stefan K.; Spies, Claudia D.; Gaissmaier, Wolfgang			Diagnostic Performance by Medical Students Working Individually or in Teams	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ERROR		[Hautz, Wolf E.; Spies, Claudia D.] Charite Campus Mitte, Dept Anesthesiol & Intens Care Med, Berlin, Germany; [Hautz, Wolf E.; Spies, Claudia D.] Campus Virchow Klinikum, Berlin, Germany; [Kaemmer, Juliane E.] Max Planck Inst Human Dev, Ctr Adapt Rat, D-14195 Berlin, Germany; [Schauber, Stefan K.] Charite, Inst Med Sociol & Rehabil Sci, D-13353 Berlin, Germany; [Gaissmaier, Wolfgang] Univ Konstanz, Dept Psychol, Constance, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Konstanz	Kammer, JE (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rat, Lentzeallee 94, D-14195 Berlin, Germany.	kaemmer@mpib-berlin.mpg.de		Kammer, Juliane E./0000-0001-6042-8453; Schauber, Stefan K/0000-0002-1832-2732; Spies, Claudia/0000-0002-1062-0495; Hautz, Wolf/0000-0002-2445-984X; Gaissmaier, Wolfgang/0000-0001-6273-178X				Berner ES, 2008, AM J MED, V121, P2, DOI 10.1016/j.amjmed.2008.01.001; Blaum W, TEME A NEW COMPUTER; Christensen C, 2000, MED DECIS MAKING, V20, P45, DOI 10.1177/0272989X0002000106; LAUGHLIN PR, 1991, J PERS SOC PSYCHOL, V61, P50, DOI 10.1037/0022-3514.61.1.50; Norman GR, 2010, MED EDUC, V44, P94, DOI 10.1111/j.1365-2923.2009.03507.x	5	43	43	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					303	304		10.1001/jama.2014.15770	http://dx.doi.org/10.1001/jama.2014.15770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25603003	Green Submitted, Bronze			2022-12-28	WOS:000348145000024
J	Johnson, BC; Minton, DA; Melosh, HJ; Zuber, MT				Johnson, Brandon C.; Minton, David A.; Melosh, H. J.; Zuber, Maria T.			Impact jetting as the origin of chondrules	NATURE			English	Article							EARLY SOLAR-SYSTEM; RELATIVE VELOCITIES; PROTOPLANETARY DISK; CHONDRITES; PLANETESIMALS; ACCRETION; SIMULATIONS; CONSTRAINTS; PARTICLES; MODEL	Chondrules are the millimetre-scale, previously molten, spherules found in most meteorites(1). Before chondrules formed, large differentiating planetesimals had already accreted(2). Volatile-rich olivine reveals that chondrules formed inextremely solid-rich environments, more like impact plumes than the solar nebula(3-5). The unique chondrules in CB chondrites probably formed in a vapour-melt plume produced by a hypervelocity impact(6) with an impact velocity greater than 10 kilometres per second. An acceptable formation model for the overwhelming majority of chondrules, however, has not been established. Here we report that impacts can produce enough chondrules during the first five million years of planetary accretion to explain their observed abundance. Building on a previous study of impact jetting(7), we simulate protoplanetary impacts, finding that material is melted and ejected at high speed when the impact velocity exceeds 2.5 kilometres per second. Using a Monte Carlo accretion code, we estimate the location, timing, sizes, and velocities of chondrule-formingimpacts. Ejecta size estimates(8) indicate that jetted melt will form millimetre-scale droplets. Our radiative transfermodels show that these droplets experience the expected cooling rates of ten to a thousand kelvin per hour(9,10). An impact origin for chondrules implies that meteorites are a byproduct of planet formation rather than leftover building material.	[Johnson, Brandon C.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Minton, David A.; Melosh, H. J.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA	Massachusetts Institute of Technology (MIT); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Johnson, BC (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	brcjohns@mit.edu		Minton, David A/0000-0003-1656-9704; Johnson, Brandon/0000-0002-4267-093X	NASA [PGG NNX10AU88G]	NASA(National Aeronautics & Space Administration (NASA))	We thank I. Sanders for his review, which improved the manuscript. We gratefully acknowledge the developers of iSALE (www.isale-code.de/projects/iSALE), especially G. Collins, K. Wunnemann, D. Elbeshausen and B. Ivanov. This research was supported by NASA grant number PGG NNX10AU88G.	ABRAHAMSON J, 1975, CHEM ENG SCI, V30, P1371, DOI 10.1016/0009-2509(75)85067-6; Alexander CMO, 2008, SCIENCE, V320, P1617, DOI 10.1126/science.1156561; Alexander CMO, 2012, METEORIT PLANET SCI, V47, P1157, DOI 10.1111/j.1945-5100.2011.01308.x; Asphaug E, 2011, EARTH PLANET SC LETT, V308, P369, DOI 10.1016/j.epsl.2011.06.007; Bland PA, 2005, P NATL ACAD SCI USA, V102, P13755, DOI 10.1073/pnas.0501885102; Bowling T. J., 2013, J GEOPHYS RES PLANET; Ciesla FJ, 2006, METEORIT PLANET SCI, V41, P1347, DOI 10.1111/j.1945-5100.2006.tb00526.x; Collins GS, 2011, INT J IMPACT ENG, V38, P434, DOI 10.1016/j.ijimpeng.2010.10.013; Collins G. S., 2014, LUNAR PLANET SCI C, V2664; Collins GS, 2004, METEORIT PLANET SCI, V39, P217, DOI 10.1111/j.1945-5100.2004.tb00337.x; Cuzzi JN, 2006, NATURE, V441, P483, DOI 10.1038/nature04834; Davison TM, 2010, ICARUS, V208, P468, DOI 10.1016/j.icarus.2010.01.034; Desch SJ, 2012, METEORIT PLANET SCI, V47, P1139, DOI 10.1111/j.1945-5100.2012.01357.x; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Fedkin AV, 2013, GEOCHIM COSMOCHIM AC, V112, P226, DOI 10.1016/j.gca.2013.02.020; GRADY DE, 1982, J APPL PHYS, V53, P322, DOI 10.1063/1.329934; Hezel DC, 2007, GEOCHIM COSMOCHIM AC, V71, P4092, DOI 10.1016/j.gca.2007.06.035; Hood LL, 2012, METEORIT PLANET SCI, V47, P1715, DOI 10.1111/maps.12006; Johnson BC, 2014, ICARUS, V238, P13, DOI 10.1016/j.icarus.2014.05.003; Johnson BC, 2014, ICARUS, V228, P347, DOI 10.1016/j.icarus.2013.10.022; Keil K., 1982, LPI C CHONDR THEIR O, V493; Kraus RG, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004082; Krot AN, 2005, NATURE, V436, P989, DOI 10.1038/nature03830; Kurosawa K, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE004031; LOFGREN G, 1986, GEOCHIM COSMOCHIM AC, V50, P1715, DOI 10.1016/0016-7037(86)90133-X; Mastin LG, 2001, CONTRIB MINERAL PETR, V141, P307, DOI 10.1007/s004100000210; Melosh H. J., 2014, LUNAR PLANET SCI C, V1471; Melosh H. J., 1986, LPI C OR MOON, V1, P621; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Minton DA, 2014, ICARUS, V232, P118, DOI 10.1016/j.icarus.2014.01.001; O'Brien DP, 2007, ICARUS, V191, P434, DOI 10.1016/j.icarus.2007.05.005; Ormel CW, 2007, ASTRON ASTROPHYS, V466, P413, DOI 10.1051/0004-6361:20066899; Potter RWK, 2012, ICARUS, V220, P730, DOI 10.1016/j.icarus.2012.05.032; Sanders IS, 2012, METEORIT PLANET SCI, V47, P2170, DOI 10.1111/maps.12002; Scott ERD, 2007, ANNU REV EARTH PL SC, V35, P577, DOI 10.1146/annurev.earth.35.031306.140100; Su BJ, 1996, J QUANT SPECTROSC RA, V56, P337, DOI 10.1016/0022-4073(96)84524-9; Thompson S. L., 1984, SCRR710174; VICKERY AM, 1993, ICARUS, V105, P441, DOI 10.1006/icar.1993.1140; Weidenschilling SJ, 2011, ICARUS, V214, P671, DOI 10.1016/j.icarus.2011.05.024; Weidenschilling SJ, 2010, METEORIT PLANET SCI, V45, P276, DOI 10.1111/j.1945-5100.2010.01023.x; Weiss BP, 2013, ANNU REV EARTH PL SC, V41, P529, DOI 10.1146/annurev-earth-040610-133520; Wunnemann K, 2008, EARTH PLANET SC LETT, V269, P529, DOI 10.1016/j.epsl.2008.03.007; Wunnemann K, 2006, ICARUS, V180, P514, DOI 10.1016/j.icarus.2005.10.013	47	128	128	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					339	U421		10.1038/nature14105	http://dx.doi.org/10.1038/nature14105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592538				2022-12-28	WOS:000347810300039
J	Tan, XJ; Thapa, N; Sun, Y; Anderson, RA				Tan, Xiaojun; Thapa, Narendra; Sun, Yue; Anderson, Richard A.			A Kinase-Independent Role for EGF Receptor in Autophagy Initiation	CELL			English	Article							GROWTH-FACTOR RECEPTOR; CANCER-CELLS; LUNG-CANCER; BECLIN 1; INHIBITOR; LAPTM4B; ERLOTINIB; SURVIVAL; RESISTANCE; PROTEIN	The epidermal growth factor receptor (EGFR) is upregulated in numerous human cancers. Inhibition of EGFR signaling induces autophagy in tumor cells. Here, we report an unanticipated role for the inactive EGFR in autophagy initiation. Inactive EGFR interacts with the oncoprotein LAPTM4B that is required for the endosomal accumulation of EGFR upon serum starvation. Inactive EGFR and LAPTM4B stabilize each other at endosomes and recruit the exocyst subcomplex containing Sec5. We show that inactive EGFR, LAPTM4B, and the Sec5 subcomplex are required for basal and starvation- induced autophagy. LAPTM4B and Sec5 promote EGFR association with the autophagy inhibitor Rubicon, which in turn disassociates Beclin 1 from Rubicon to initiate autophagy. Thus, the oncoprotein LAPTM4B facilitates the role of inactive EGFR in autophagy initiation. This pathway is positioned to control tumor metabolism and promote tumor cell survival upon serum deprivation or metabolic stress.	[Tan, Xiaojun; Thapa, Narendra; Sun, Yue; Anderson, Richard A.] Univ Wisconsin, Madison Sch Med & Publ Hlth, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Madison Sch Med & Publ Hlth, Program Mol & Cellular Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu	Tan, Xiaojun/N-2142-2017	Tan, Xiaojun/0000-0003-3300-2240; Anderson, Richard/0000-0001-6265-8359	NIH [CA104708, GM057549]; Howard Hughes Medical Institute International Student Research Fellowship [59107631]; American Heart Association (AHA) [12SDG11950022]; NATIONAL CANCER INSTITUTE [R01CA104708] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); American Heart Association (AHA)(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M.A. White (University of Texas South Western) for sharing reagents, S.J. Parsons (University of Virginia) for the EGFR-K721A construct, R. Zhou (Peking University) for the LAPTM4B construct, R. Puertollano (NIH) for the LAPTM4A construct, Paul Bertics (University of Wisconsin-Madison) for the EGFR-GFP construct, J.E. Ladbury (University of Texas MD Anderson Cancer Center) for the FGFR2-GFP construct, H. Band (University of Nebraska Medical Center) for the PDGFRB-GFP construct, and D. Wheeler (University of Wisconsin-Madison) for the c-Met-GFP construct. We thank Drs. Randall Kimple, Alan Rapraeger, and Paul Lambert from University of Wisconsin-Madison and Drs. Andrew C. Hedman, Weimin Li, and Suyong Choi in the laboratory for extensive comments on the manuscript, research discussions, and reagents. This work is supported by NIH grants (CA104708 and GM057549) (to R.A.A.), a Howard Hughes Medical Institute International Student Research Fellowship (59107631) (to X.T.), and an American Heart Association (AHA) Scientist Development Grant (12SDG11950022) (to Y.S.).	Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Choi HS, 2013, TUBERC RESPIR DIS, V75, P9, DOI 10.4046/trd.2013.75.1.9; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Dragowska WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076503; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Eimer S, 2011, CANCER BIOL THER, V11, P1017, DOI 10.4161/cbt.11.12.15693; Ewald JA, 2003, EXP CELL RES, V282, P121, DOI 10.1016/S0014-4827(02)00014-9; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Foerster S, 2013, PROTEOMICS, V13, P3131, DOI 10.1002/pmic.201300154; Friedman JR, 2013, MOL BIOL CELL, V24, P1030, DOI 10.1091/mbc.E12-10-0733; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Gorzalczany Y, 2011, CANCER LETT, V310, P207, DOI 10.1016/j.canlet.2011.07.002; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Jutten B, 2014, CELL CYCLE, V13, P42, DOI 10.4161/cc.27518; Jutten B, 2013, RADIOTHER ONCOL, V108, P479, DOI 10.1016/j.radonc.2013.06.033; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li L, 2011, ANAT REC, V294, P1135, DOI 10.1002/ar.21421; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Li YY, 2013, LUNG CANCER, V81, P354, DOI 10.1016/j.lungcan.2013.05.012; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Sakuma Y, 2013, LAB INVEST, V93, P1137, DOI 10.1038/labinvest.2013.102; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Sobhakumari A, 2013, TOXICOL APPL PHARM, V272, P736, DOI 10.1016/j.taap.2013.07.013; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Sun QM, 2009, AUTOPHAGY, V5, P713, DOI 10.4161/auto.5.5.8524; Vergarajauregui S, 2011, J CELL SCI, V124, P459, DOI 10.1242/jcs.076240; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	48	160	167	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					145	160		10.1016/j.cell.2014.12.006	http://dx.doi.org/10.1016/j.cell.2014.12.006			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594178	Green Accepted, Bronze			2022-12-28	WOS:000347923200015
J	Marchio, EA				Marchio, Elizabeth A.			My metamorphosis	SCIENCE			English	Editorial Material									Texas A&M Univ, Dept Recreat Pk & Tourism Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Marchio, EA (corresponding author), Texas A&M Univ, Dept Recreat Pk & Tourism Sci, College Stn, TX 77843 USA.								0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					206	206		10.1126/science.347.6218.206	http://dx.doi.org/10.1126/science.347.6218.206			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0EK	25574026				2022-12-28	WOS:000347918900049
J	Teirstein, PS				Teirstein, Paul S.			Boarded to Death - Why Maintenance of Certification Is Bad for Doctors and Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Teirstein, Paul S.] Scripps Clin, La Jolla, CA 92037 USA; [Teirstein, Paul S.] Scripps Prebys Cardiovasc Inst, La Jolla, CA USA	Scripps Research Institute	Teirstein, PS (corresponding author), Scripps Clin, La Jolla, CA 92037 USA.							Fiorilli PN, 2014, J AM COLL CARDIOL, V63, pA1701, DOI 10.1016/S0735-1097(14)61704-6; Holmboe ES, 2008, JAMA-J AM MED ASSOC, V299, P338, DOI 10.1001/jama.299.3.338; Kritek Patricia A, 2010, N Engl J Med, V362, pe54, DOI 10.1056/NEJMclde1003227; Lee TH, 2014, JAMA-J AM MED ASSOC, V312, P2340, DOI 10.1001/jama.2014.13566; Sharp LK, 2002, ACAD MED, V77, P534, DOI 10.1097/00001888-200206000-00011	5	72	72	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					106	108		10.1056/NEJMp1407422	http://dx.doi.org/10.1056/NEJMp1407422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY2UA	25564895				2022-12-28	WOS:000347443300004
J	Suzuki, S; Ikegami, A; Hirota, Y; Ikusaka, M				Suzuki, Shingo; Ikegami, Akiko; Hirota, Yusuke; Ikusaka, Masatomi			Fever and cough without pulmonary abnormalities on CT: relapsing polychondritis restricted to the airways	LANCET			English	Editorial Material									[Suzuki, Shingo; Ikegami, Akiko; Hirota, Yusuke; Ikusaka, Masatomi] Chiba Univ Hosp, Dept Gen Med, Chiba 2608677, Japan	Chiba University	Suzuki, S (corresponding author), Chiba Univ Hosp, Dept Gen Med, Chiba 2608677, Japan.	shngszkthk@yahoo.co.jp						Manganelli P, 2006, CLIN EXP RHEUMATOL, V24, pS48; Niida Tomiharu, 2011, J Med Case Rep, V5, P295, DOI 10.1186/1752-1947-5-295; Sharma A, 2013, CLIN RHEUMATOL, V32, P1575, DOI 10.1007/s10067-013-2328-x; Yamashita H, 2014, RHEUMATOLOGY, V53, P1482, DOI 10.1093/rheumatology/keu147	4	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					88	88		10.1016/S0140-6736(14)61946-2	http://dx.doi.org/10.1016/S0140-6736(14)61946-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25592904				2022-12-28	WOS:000347154200030
J	Knott, G				Knott, Graham			Cold shock protects the brain	NATURE			English	Editorial Material							HYPOTHERMIA		Ecole Polytech Fed Lausanne, Fac Life Sci, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Knott, G (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, CH-1015 Lausanne, Switzerland.	graham.knott@epfl.ch		Knott, Graham W/0000-0002-2956-9052				BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; Wang H, 2006, ACTA NEUROCHIR, V148, P565, DOI 10.1007/s00701-006-0747-z; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174	7	6	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					177	178		10.1038/nature14195	http://dx.doi.org/10.1038/nature14195			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25607369				2022-12-28	WOS:000349190300028
J	Dodt, HU				Dodt, Hans-Ulrich			The superresolved brain	SCIENCE			English	Editorial Material							MOUSE-BRAIN; RECONSTRUCTION		[Dodt, Hans-Ulrich] Vienna Univ Technol, A-1040 Vienna, Austria; [Dodt, Hans-Ulrich] Med Univ Vienna, A-1090 Vienna, Austria	Technische Universitat Wien; Medical University of Vienna	Dodt, HU (corresponding author), Vienna Univ Technol, A-1040 Vienna, Austria.	dodt@tuwien.ac.at			Austrian Science Fund FWF [P 23102] Funding Source: Medline; Austrian Science Fund (FWF) [P 23102] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844	9	5	5	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					474	475		10.1126/science.aaa5084	http://dx.doi.org/10.1126/science.aaa5084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635071				2022-12-28	WOS:000348639300019
J	Moran, AE; Odden, MC; Thanataveerat, A; Tzong, KY; Rasmussen, PW; Guzman, D; Williams, L; Bibbins-Domingo, K; Coxson, PG; Goldman, L				Moran, Andrew E.; Odden, Michelle C.; Thanataveerat, Anusorn; Tzong, Keane Y.; Rasmussen, Petra W.; Guzman, David; Williams, Lawrence; Bibbins-Domingo, Kirsten; Coxson, Pamela G.; Goldman, Lee			Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; LOWERING TREATMENT; MORTALITY; RISK; METAANALYSIS; ADULTHOOD; DRUGS; TRIAL; OLDER	BACKGROUND On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines. METHODS We used the Cardiovascular Disease Policy Model to simulate drug-treatment and monitoring costs, costs averted for the treatment of cardiovascular disease, and quality-adjusted life-years (QALYs) gained by treating previously untreated adults between the ages of 35 and 74 years from 2014 through 2024. We assessed cost-effectiveness according to age, hypertension level, and the presence or absence of chronic kidney disease or diabetes. RESULTS The full implementation of the new hypertension guidelines would result in approximately 56,000 fewer cardiovascular events and 13,000 fewer deaths from cardiovascular causes annually, which would result in overall cost savings. The projections showed that the treatment of patients with existing cardiovascular disease or stage 2 hypertension would save lives and costs for men between the ages of 35 and 74 years and for women between the ages of 45 and 74 years. The treatment of men or women with existing cardiovascular disease or men with stage 2 hypertension but without cardiovascular disease would remain cost-saving even if strategies to increase medication adherence doubled treatment costs. The treatment of stage 1 hypertension was cost-effective (defined as <$50,000 per QALY) for all men and for women between the ages of 45 and 74 years, whereas treating women between the ages of 35 and 44 years with stage 1 hypertension but without cardiovascular disease had intermediate or low cost-effectiveness. CONCLUSIONS The implementation of the 2014 hypertension guidelines for U.S. adults between the ages of 35 and 74 years could potentially prevent about 56,000 cardiovascular events and 13,000 deaths annually, while saving costs. Controlling hypertension in all patients with cardiovascular disease or stage 2 hypertension could be effective and cost-saving.	[Moran, Andrew E.; Goldman, Lee] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Moran, Andrew E.; Thanataveerat, Anusorn; Tzong, Keane Y.; Rasmussen, Petra W.] Columbia Univ, Med Ctr, Div Gen Med, New York, NY 10032 USA; [Odden, Michelle C.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Guzman, David; Bibbins-Domingo, Kirsten; Coxson, Pamela G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Williams, Lawrence] Partners Hlth Care, Boston, MA USA	Columbia University; Columbia University; Oregon State University; University of California System; University of California San Francisco; Partners Healthcare System	Moran, AE (corresponding author), Columbia Univ, Presbyterian Hosp, Div Gen Med, 9th Fl East,Rm 105,622 West 168th St, New York, NY 10032 USA.	aem35@cumc.columbia.edu			National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK103992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS081760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG039387] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Heart, Lung, and Blood Institute and others.	Anderson JL, 2014, CIRCULATION, V129, P2329, DOI 10.1161/CIR.0000000000000042; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 2014, AV WHOL PRIC AWP POL; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cutler DM, 2007, HEALTH AFFAIR, V26, P97, DOI 10.1377/hlthaff.26.1.97; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Eddy DM, 2011, ANN INTERN MED, V154, P627, DOI 10.7326/0003-4819-154-9-201105030-00008; Fahey T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Gray L, 2011, J AM COLL CARDIOL, V58, P2396, DOI 10.1016/j.jacc.2011.07.045; HARRIS T, 1988, J AM GERIATR SOC, V36, P1023, DOI 10.1111/j.1532-5415.1988.tb04370.x; Heidenreich PA, 2008, J GEN INTERN MED, V23, P509, DOI 10.1007/s11606-008-0515-2; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; McCarron P, 2002, ARCH INTERN MED, V162, P610, DOI 10.1001/archinte.162.5.610; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Navar-Boggan AM, 2014, JAMA-J AM MED ASSOC, V311, P1424, DOI 10.1001/jama.2014.2531; Ofman Joshua J, 2003, J Manag Care Pharm, V9, P53; Ramsey S D, 1999, J Am Board Fam Pract, V12, P105; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Sussman J, 2013, CIRCULATION, V128, P2309, DOI 10.1161/CIRCULATIONAHA.113.002290; Timbie JW, 2010, HEALTH SERV RES, V45, P437, DOI 10.1111/j.1475-6773.2009.01075.x; Turnbull F, 2003, LANCET, V362, P1527; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981	32	152	158	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					447	455		10.1056/NEJMsa1406751	http://dx.doi.org/10.1056/NEJMsa1406751			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629742	Green Accepted			2022-12-28	WOS:000348649700009
J	Bagdasarian, N; Rao, K; Malani, PN				Bagdasarian, Natasha; Rao, Krishna; Malani, Preeti N.			Diagnosis and Treatment of Clostridium difficile in Adults A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FECAL MICROBIOTA TRANSPLANTATION; ANTIBIOTIC-ASSOCIATED DIARRHEA; INFECTION FOLLOWING TREATMENT; RISK-FACTORS; PSEUDOMEMBRANOUS COLITIS; LABORATORY DIAGNOSIS; INTESTINAL MICROBIOTA; TREATMENT STRATEGIES; SCORING SYSTEM; TOXIN-A	IMPORTANCE Since 2000, the incidence and severity of Clostridium difficile infection (CDI) have increased. OBJECTIVE To review current evidence regarding best practices for the diagnosis and treatment of CDI in adults (age >= 18 years). EVIDENCE REVIEW Ovid MEDLINE and Cochrane databases were searched using keywords relevant to the diagnosis and treatment of CDI in adults. Articles published between January 1978 and October 31, 2014, were selected for inclusion based on targeted keyword searches, manual review of bibliographies, and whether the article was a guideline, systematic review, or meta-analysis published within the past 10 years. Of 4682 articles initially identified, 196 were selected for full review. Of these, the most pertinent 116 articles were included. Clinical trials, large observational studies, and more recently published articles were prioritized in the selection process. FINDINGS Laboratory testing cannot distinguish between asymptomatic colonization and symptomatic infection with C difficile. Diagnostic approaches are complex due to the availability of multiple testing strategies. Multistep algorithms using polymerase chain reaction (PCR) for the toxin gene(s) or single-step PCR on liquid stool samples have the best test performance characteristics (for multistep: sensitivity was 0.68-1.00 and specificity was 0.92-1.00; and for single step: sensitivity was 0.86-0.92 and specificity was 0.94-0.97). Vancomycin and metronidazole are first-line therapies for most patients, although treatment failures have been associated with metronidazole in severe or complicated cases of CDI. Recent data demonstrate clinical success rates of 66.3% for metronidazole vs 78.5% for vancomycin for severe CDI. Newer therapies show promising results, including fidaxomicin (similar clinical cure rates to vancomycin, with lower recurrence rates for fidaxomicin, 15.4% vs vancomycin, 25.3%; P = .005) and fecal microbiota transplantation (response rates of 83%-94% for recurrent CDI). CONCLUSIONS AND RELEVANCE Diagnostic testing for CDI should be performed only in symptomatic patients. Treatment strategies should be based on disease severity, history of prior CDI, and the individual patient's risk of recurrence. Vancomycin is the treatment of choice for severe or complicated CDI, with or without adjunctive therapies. Metronidazole is appropriate for mild disease. Fidaxomicin is a therapeutic option for patients with recurrent CDI or a high risk of recurrence. Fecal microbiota transplantation is associated with symptom resolution of recurrent CDI but its role in primary and severe CDI is not established.	[Bagdasarian, Natasha] St John Hosp & Med Ctr, Div Infect Dis, Dept Infect Control, Detroit, MI USA; [Bagdasarian, Natasha] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA; [Rao, Krishna; Malani, Preeti N.] Univ Michigan, Sch Med, Div Infect Dis, Dept Internal Med,Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Rao, Krishna; Malani, Preeti N.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	St. John Hospital & Medical Center; Wayne State University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Malani, PN (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Infect Dis,Univ Michigan Hlth Syst,Taubman Ct, Ann Arbor, MI 48109 USA.	pmalani@umich.edu	Bagdasarian, Natasha/GNW-6317-2022; Rao, Krishna/R-3726-2019	Bagdasarian, Natasha/0000-0003-1133-8309; Rao, Krishna/0000-0002-9213-7850	National Institutes of Health [1U19AI090871-01]; Claude D. Pepper Older Americans Independence Center [AG-024824]; Michigan Institute for Clinical and Health Research [2UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claude D. Pepper Older Americans Independence Center; Michigan Institute for Clinical and Health Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health grant 1U19AI090871-01 (Drs Rao and Malani), the Claude D. Pepper Older Americans Independence Center grant AG-024824 (Dr Rao), and the Michigan Institute for Clinical and Health Research grant 2UL1TR000433 (Dr Rao).	Abou Chakra CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030258; Al-Nassir WN, 2008, CLIN INFECT DIS, V47, P56, DOI 10.1086/588293; Apisarnthanarak A, 2002, CLIN INFECT DIS, V35, P690, DOI 10.1086/342334; Asha NJ, 2006, J CLIN MICROBIOL, V44, P2785, DOI 10.1128/JCM.00165-06; Bakken JS, 2014, CLIN INFECT DIS, V59, P858, DOI 10.1093/cid/ciu429; Barbut F, 2014, CLIN MICROBIOL INFEC, V20, P136, DOI 10.1111/1469-0691.12221; BARTLETT JG, 1984, REV INFECT DIS, V6, pS235; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bartsch SM, 2013, CLIN INFECT DIS, V57, P555, DOI 10.1093/cid/cit346; Belmares J, 2007, J INFECTION, V55, P495, DOI 10.1016/j.jinf.2007.09.015; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; Brandt LJ, 2013, AM J GASTROENTEROL, V108, P177, DOI 10.1038/ajg.2012.450; Brazier J S, 2008, Euro Surveill, V13; Brecher SM, 2013, CLIN INFECT DIS, V57, P1175, DOI 10.1093/cid/cit424; Brown NA, 2011, INFECT DIS REP, V3, P15, DOI 10.4081/idr.2011.e5; BUBLIN JG, 1994, ANN PHARMACOTHER, V28, P1357; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Delmee M, 2001, CLIN MICROBIOL INFEC, V7, P411, DOI 10.1046/j.1198-743x.2001.00294.x; Deshpande A, 2011, CLIN INFECT DIS, V53, pE81, DOI 10.1093/cid/cir505; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; FEKETY R, 1989, AM J MED, V86, P15, DOI 10.1016/0002-9343(89)90223-4; Fernandez A, 2004, J CLIN GASTROENTEROL, V38, P414, DOI 10.1097/00004836-200405000-00005; Figueroa I, 2012, CLIN INFECT DIS, V55, pS104, DOI 10.1093/cid/cis357; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Garey KW, 2011, J ANTIMICROB CHEMOTH, V66, P2850, DOI 10.1093/jac/dkr377; Garimella PS, 2012, J POSTGRAD MED, V58, P194, DOI 10.4103/0022-3859.101392; Gerding DN, 2012, DISCOV MED, V13, P75; Goldenberg JZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub3; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Greenstein AJ, 2008, SURGERY, V143, P623, DOI 10.1016/j.surg.2007.12.008; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Henrich TJ, 2009, EMERG INFECT DIS, V15, P415, DOI 10.3201/eid1503.080312; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Horlen CK, 2000, ANN PHARMACOTHER, V34, P1273; Hu MY, 2008, CLIN GASTROENTEROL H, V6, P1354, DOI 10.1016/j.cgh.2008.06.024; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Johnson S, 2013, CLIN INFECT DIS, V56, P309, DOI 10.1093/cid/cis833; Johnson S, 2009, ANAEROBE, V15, P290, DOI 10.1016/j.anaerobe.2009.08.004; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; KEIGHLEY MRB, 1978, LANCET, V2, P1165; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Larson KC, 2011, ANN PHARMACOTHER, V45, P1005, DOI 10.1345/aph.1Q080; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Miller MA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-148; Modena S, 2006, J CLIN GASTROENTEROL, V40, P49, DOI 10.1097/01.mcg.0000190761.80615.0f; Mullane KM, 2013, AM J NEPHROL, V38, P1, DOI 10.1159/000351757; Mullane KM, 2011, CLIN INFECT DIS, V53, P440, DOI 10.1093/cid/cir404; Musgrave CR, 2011, INT J INFECT DIS, V15, pE438, DOI 10.1016/j.ijid.2011.03.017; Neal MD, 2011, ANN SURG, V254, P423, DOI 10.1097/SLA.0b013e31822ade48; Noren T, 2011, J CLIN MICROBIOL, V49, P710, DOI 10.1128/JCM.01824-10; O'Horo JC, 2014, INFECTION, V42, P43, DOI 10.1007/s15010-013-0496-x; O'Horo J, 2009, INT J INFECT DIS, V13, P663, DOI 10.1016/j.ijid.2008.11.012; O'Horo JC, 2012, MAYO CLIN PROC, V87, P643, DOI 10.1016/j.mayocp.2012.02.024; OLSON MM, 1994, INFECT CONT HOSP EP, V15, P371; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Parmar SR, 2014, J ONCOL PHARM PRACT, V20, P172, DOI 10.1177/1078155213490004; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Piche T, 2007, CAN J GASTROENTEROL, V21, P727, DOI 10.1155/2007/262478; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Pothoulakis C, 2000, ANN NY ACAD SCI, V915, P347; PRIVITERA G, 1991, ANTIMICROB AGENTS CH, V35, P208, DOI 10.1128/AAC.35.1.208; Rao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092578; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Safdar N, 2008, J CLIN PHARM THER, V33, P663, DOI 10.1111/j.1365-2710.2008.00980.x; Sailhamer EA, 2009, ARCH SURG-CHICAGO, V144, P433, DOI 10.1001/archsurg.2009.51; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Segarra-Newnham M, 2007, ANN PHARMACOTHER, V41, P1212, DOI 10.1345/aph.1K110; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Shetty N, 2011, J HOSP INFECT, V77, P1, DOI 10.1016/j.jhin.2010.07.024; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; SPITZER PG, 1984, ANN INTERN MED, V100, P533, DOI 10.7326/0003-4819-100-4-533; Stevens V, 2011, CLIN INFECT DIS, V53, P42, DOI 10.1093/cid/cir301; Stewart DB, 2013, COLORECTAL DIS, V15, P798, DOI 10.1111/codi.12134; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; TEDESCO FJ, 1985, AM J GASTROENTEROL, V80, P867; Tenover FC, 2011, J MOL DIAGN, V13, P573, DOI 10.1016/j.jmoldx.2011.06.001; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; TVEDE M, 1989, LANCET, V1, P1156; van der Wilden GM, 2014, J TRAUMA ACUTE CARE, V76, P424, DOI 10.1097/TA.0000000000000105; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vardakas KZ, 2012, INT J INFECT DIS, V16, pE768, DOI 10.1016/j.ijid.2012.07.010; Vardakas KZ, 2012, INT J ANTIMICROB AG, V40, P1, DOI 10.1016/j.ijantimicag.2012.01.004; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057; WILCOX MH, 1995, J ANTIMICROB CHEMOTH, V36, P673, DOI 10.1093/jac/36.4.673; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	112	281	306	3	88	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					398	408		10.1001/jama.2014.17103	http://dx.doi.org/10.1001/jama.2014.17103			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626036	Green Accepted			2022-12-28	WOS:000349072600022
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Quantifying treatment effects in randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h267; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1905; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7036; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5613	6	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2015	350								h420	10.1136/bmj.h420	http://dx.doi.org/10.1136/bmj.h420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZJ	25616422				2022-12-28	WOS:000348434100006
J	Goroll, AH; Hunt, DP				Goroll, Allan H.; Hunt, Daniel P.			Bridging the Hospitalist-Primary Care Divide through Collaborative Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goroll, Allan H.; Hunt, Daniel P.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Goroll, AH (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.		Hunt, Dan/AAL-3807-2021					Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Turner J, 2014, J GEN INTERN MED, V29, P1004, DOI 10.1007/s11606-013-2754-0; Wachter RM, 2002, DM-DIS MON, V48, P267, DOI 10.1016/S0011-5029(02)90034-9; West CP, 2012, JAMA-J AM MED ASSOC, V308, P2241, DOI 10.1001/jama.2012.47535; White HL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-58	5	17	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					308	309		10.1056/NEJMp1411416	http://dx.doi.org/10.1056/NEJMp1411416			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ4PJ	25607426				2022-12-28	WOS:000348204500005
J	Kachalia, A; Berg, A; Fagerlin, A; Fowler, KE; Hofer, TP; Flanders, SA; Saint, S				Kachalia, Allen; Berg, Aaron; Fagerlin, Angela; Fowler, Karen E.; Hofer, Timothy P.; Flanders, Scott A.; Saint, Sanjay			Overuse of Testing in Preoperative Evaluation and Syncope A Survey of Hospitalists	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE REFORM; REGIONAL-VARIATIONS; DEFENSIVE MEDICINE; NATIONAL-SURVEY; RESPONSE RATES; UNITED-STATES; PHYSICIANS; MEDICARE; OUTCOMES; GROWTH	Background: Health care reform efforts and initiatives seek to improve quality and reduce costs by eliminating unnecessary care. However, little is known about overuse and its drivers, especially in hospitals. Objective: To assess the extent of and factors associated with overuse of testing in U.S. hospitals. Design: National survey of practice patterns for 2 common clinical vignettes: preoperative evaluation and syncope. Respondents were randomly selected and randomly provided 1 of 4 versions of each vignette. Each version contained identical clinical information but varied in factors that could change physician behavior. Respondents were asked to identify what they believed most hospitalists at their institution would recommend in each vignette. Setting: Mailed survey conducted from June through October 2011. Participants: Physicians practicing adult hospital medicine in the United States. Measurements: Responses indicating overuse (more testing than recommended by American College of Cardiology/American Heart Association guidelines). Results: 68% (1020 of 1500) of hospitalists responded. They reported overuse in 52% to 65% of the preoperative evaluation vignettes and 82% to 85% of the syncope vignettes. Overuse more frequently resulted from a physician's desire to reassure patients or themselves than an incorrect belief that it was clinically indicated (preoperative evaluation, 63% vs. 37%; syncope, 69% vs. 31%; P < 0.001 for each). Limitation: Survey responses may not represent actual clinical choices. Conclusion: Physicians reported substantial overuse in 2 common clinical situations in the hospital. Improving provider knowledge of guidelines may help reduce overuse, but despite awareness of the guidelines, physicians often deviate from them to reassure patients or themselves.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Michigan, Sch Med, VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Ann Arbor, MI 48109 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Saint, S (corresponding author), Univ Michigan, Dept Internal Med, 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.		Hofer, Timothy Philip/AAC-9238-2022; Fowler, Karen/B-5383-2015; Saint, Sanjay/AAF-5126-2019	Fowler, Karen/0000-0001-8274-8407; Hofer, Timothy/0000-0003-0434-8787	Blue Cross Blue Shield of Michigan Foundation; Department of Veterans Affairs Center for Clinical Management Research; University of Michigan Specialist-Hospitalist Allied Research Program; Ann Arbor Veterans Affairs/University of Michigan Patient Safety Enhancement Program	Blue Cross Blue Shield of Michigan Foundation; Department of Veterans Affairs Center for Clinical Management Research; University of Michigan Specialist-Hospitalist Allied Research Program; Ann Arbor Veterans Affairs/University of Michigan Patient Safety Enhancement Program	By the Blue Cross Blue Shield of Michigan Foundation, Department of Veterans Affairs Center for Clinical Management Research, University of Michigan Specialist-Hospitalist Allied Research Program, and Ann Arbor Veterans Affairs/University of Michigan Patient Safety Enhancement Program.	Ackerman S, 2012, ANN INTERN MED, V157, P211, DOI 10.7326/0003-4819-157-3-201208070-00013; American Academy of Family Physicians, 2013, 15 THINGS PHYS PAT S; American Hospital Association, 2010, AHA ANN SURV HOSP; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Berwick DM, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1103602; Bishop TF, 2010, ARCH INTERN MED, V170, P1081, DOI 10.1001/archinternmed.2010.155; Bowers J, 2014, DIFFERENT WAYS HOSP; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Brody H, 2012, NEW ENGL J MED, V366, P1949, DOI 10.1056/NEJMp1203365; Brownlee S, 2008, OVERTREATED WHY TOO; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Cummings SM, 2001, HEALTH SERV RES, V35, P1347; Dillman D.A., 2007, MAIL INTERNET SURVEY, V2nd; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Emery DJ, 2013, JAMA INTERN MED, V173, P823, DOI 10.1001/jamainternmed.2013.3804; Fendrick AM, 2012, HEALTH SERV RES, V47, P404, DOI 10.1111/j.1475-6773.2011.01358.x; Fisher ES, 2009, NEW ENGL J MED, V360, P2495, DOI 10.1056/NEJMp0903923; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Gonzales R, 2012, ARCH INTERN MED, V172, P1471, DOI 10.1001/2013.jamainternmed.532; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; HART BG, 1990, FORDHAM LAW REV, V58, P1107; Hillman BJ, 2010, NEW ENGL J MED, V363, P4, DOI 10.1056/NEJMp1003173; Hussey PS, 2009, NEW ENGL J MED, V361, P2109, DOI 10.1056/NEJMp0910315; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Kale MS, 2013, JAMA INTERN MED, V173, P142, DOI 10.1001/2013.jamainternmed.1022; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Office of Technology Assessment; Congress of the United States, 1994, OTAH602 US GOV PRINT; Paterniti DA, 2010, ARCH INTERN MED, V170, P381, DOI 10.1001/archinternmed.2009.533; Pham HH, 2005, J GEN INTERN MED, V20, P101, DOI 10.1111/j.1525-1497.2005.40184.x; Rao VM, 2012, ANN INTERN MED, V157, P574, DOI 10.7326/0003-4819-157-8-201210160-00535; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; Smith KL, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-176; Society of Hospital Medicine, 2014, MIL HOSP MED MOV; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Stecker EC, 2013, NEW ENGL J MED, V368, P982, DOI 10.1056/NEJMp1214141; Strickberger SA, 2006, CIRCULATION, V113, P316, DOI 10.1161/CIRCULATIONAHA.105.170274; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Tilburt JC, 2010, MED CARE, V48, P341, DOI 10.1097/MLR.0b013e3181ca3ee2; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wachter RM, 2009, NEW ENGL J MED, V360, P2789, DOI 10.1056/NEJMc090754; Williamson R, 2011, GAO126R	52	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					100	+		10.7326/M14-0694	http://dx.doi.org/10.7326/M14-0694			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC1NB	25599349				2022-12-28	WOS:000350106600016
J	Graham, S; Hegde, D				Graham, Stuart; Hegde, Deepak			Disclosing patents' secrets	SCIENCE			English	Editorial Material									[Graham, Stuart] Georgia Inst Technol, Scheller Coll Business, Atlanta, GA 30308 USA; [Hegde, Deepak] NYU, Stern Sch Business, York, NY 10012 USA	University System of Georgia; Georgia Institute of Technology; New York University	Hegde, D (corresponding author), NYU, Stern Sch Business, York, NY 10012 USA.	dhegde@stern.nyu.edu						[Anonymous], 2000, U.S. patent, Patent No. [514,397, 514397]; Chen R., 2013, JAPANESE IP PRACTICE; Ergenzinger Jr E., 2002, WAKE FOREST INTELL P, V7, P146; Federal Trade Commission, 2011, EV IP MARK AL PAT NO; Hall Bronwyn H., 2001, 8498 NBER; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Hegde Deepak, 2013, 14019 HARV BUS SCH; Lanjouw JO, 2001, RAND J ECON, V32, P129, DOI 10.2307/2696401; Merrill S. A., 2004, PATENT SYSTEM 21 CEN; Modigliani F., 1999, COMMUNICATION; SCHANKERMAN M, 1986, ECON J, V96, P1052, DOI 10.2307/2233173; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502	12	41	43	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					236	237		10.1126/science.1262080	http://dx.doi.org/10.1126/science.1262080			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0DA	25593175				2022-12-28	WOS:000347915300021
J	Brodin, P; Jojic, V; Gao, TX; Bhattacharya, S; Angel, CJL; Furman, D; Shen-Orr, S; Dekker, CL; Swan, GE; Butte, AJ; Maecker, HT; Davis, MM				Brodin, Petter; Jojic, Vladimir; Gao, Tianxiang; Bhattacharya, Sanchita; Angel, Cesar J. Lopez; Furman, David; Shen-Orr, Shai; Dekker, Cornelia L.; Swan, Gary E.; Butte, Atul J.; Maecker, Holden T.; Davis, Mark M.			Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences	CELL			English	Article							BACTERIAL-INFECTIONS; T-CELLS; RESPONSES; VACCINE; TWINS; CYTOMEGALOVIRUS; IMMUNOGENICITY; VIRUS; ASSOCIATION; CHILDREN	There is considerable heterogeneity in immunological parameters between individuals, but its sources are largely unknown. To assess the relative contribution of heritable versus non-heritable factors, we have performed a systems-level analysis of 210 healthy twins between 8 and 82 years of age. We measured 204 different parameters, including cell population frequencies, cytokine responses, and serum proteins, and found that 77% of these are dominated (>50% of variance) and 58% almost completely determined (>80% of variance) by non-heritable influences. In addition, some of these parameters become more variable with age, suggesting the cumulative influence of environmental exposure. Similarly, the serological responses to seasonal influenza vaccination are also determined largely by non-heritable factors, likely due to repeated exposure to different strains. Lastly, in MZ twins discordant for cytomegalovirus infection, more than half of all parameters are affected. These results highlight the largely reactive and adaptive nature of the immune system in healthy individuals.	[Brodin, Petter] Karolinska Inst, Sci Life Lab, Dept Med, S-17121 Solna, Sweden; [Brodin, Petter; Angel, Cesar J. Lopez; Furman, David; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA; [Brodin, Petter; Bhattacharya, Sanchita; Angel, Cesar J. Lopez; Furman, David; Maecker, Holden T.; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94304 USA; [Jojic, Vladimir; Gao, Tianxiang] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Shen-Orr, Shai] Technion Israel Inst Technol, Fac Med, Dept Immunol, IL-31096 Haifa, Israel; [Dekker, Cornelia L.; Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94304 USA; [Swan, Gary E.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94304 USA; [Butte, Atul J.] Stanford Univ, Ctr Pediat Bioinformat, Lucille Packard Childrens Hosp, Stanford, CA 94304 USA; [Maecker, Holden T.] Stanford Univ, Sch Med, Human Immune Monitoring Ctr, Stanford, CA 94304 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94304 USA	Karolinska Institutet; Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Stanford University; Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Palo Alto, CA 94304 USA.	mmdavis@stanford.edu	Brodin, Petter/C-3317-2011	Brodin, Petter/0000-0002-8103-0046; Davis, Mark/0000-0001-6868-657X; Lopez Angel, Cesar/0000-0001-8564-8209; Shen-Orr, Shai/0000-0002-6991-7736	NIH [U19 AI090019, U19 AI057229, DA011170, DA023063, AI090019, ES022153]; Howard Hughes Medical Institute; Wenner-Gren Foundation and Sweden-America Foundation - Twin Registry were provided through SRI's Center for Health Sciences; NIH/NCRR [UL1 RR025744]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, U19AI090019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES022153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023063, R01DA011170] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wenner-Gren Foundation and Sweden-America Foundation - Twin Registry were provided through SRI's Center for Health Sciences; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank all members of the Davis and Y. Chien labs for inspiring discussions and the staff at the Human Immune Monitoring Center and the Stanford-LPCH Vaccine Program for sample collection and data generation. Thanks also to Rob Tibshirani and Chiara Sabatti for input on statistical analyses. Twins were recruited from Twin Research Registry at SRI International, Menlo Park, CA and the authors wish to thank the following individuals: Mary McElroy, Lisa Jack, Ruth Krasnow, Jill Rubin, Dina Basin, Lucia Panini, and Marty Ritchey. The Stanford-LPCH program thanks Project Manager Sally Mackey; Research Nurses Susan Swope, Tony Trela, and Cynthia Walsh; phlebotomist Michele Ugur; and CRAs Ashima Goel, Thu Quan, Kyrsten Spann, Sushil Batra, Isaac Chang, and Raquel Fleischmann. The authors also wish to thank the contributions and commitment to science provided by the twins through their ongoing participation in the Registry and various research studies. This work was supported by NIH grants U19 AI090019, U19 AI057229 and the Howard Hughes Medical Institute to M. M. D. Additional support was provided by the Wenner-Gren Foundation and Sweden-America Foundation to P. B, funds to the Twin Registry were provided through SRI's Center for Health Sciences and through grants from the NIH including DA011170, DA023063, AI090019 and ES022153. The Clinical and Translational Research Unit at Stanford University Hospital was supported by an NIH/NCRR CTSA award number UL1 RR025744.	Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Clementi M, 1999, HUM GENET, V105, P337, DOI 10.1007/s004390051111; Cooper GS, 1999, ENVIRON HEALTH PERSP, V107, P693, DOI 10.2307/3434329; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Duffy D, 2014, IMMUNITY, V40, P436, DOI 10.1016/j.immuni.2014.03.002; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Evans DM, 2004, GENES IMMUN, V5, P548, DOI 10.1038/sj.gene.6364126; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hohler T, 2002, LANCET, V360, P991, DOI 10.1016/S0140-6736(02)11083-X; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Jablonski W, 1922, ARCH AUGENHEILKD, V91, P308; Jacobson RM, 2007, VACCINE, V25, P3160, DOI 10.1016/j.vaccine.2007.01.048; Krasnow RE, 2013, TWIN RES HUM GENET, V16, P463, DOI 10.1017/thg.2012.81; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Lee YC, 2006, VACCINE, V24, P5335, DOI 10.1016/j.vaccine.2006.04.021; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Liu H, 2012, ANN STAT, V40, P2293, DOI 10.1214/12-AOS1037; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; O'Connor D, 2013, CLIN INFECT DIS, V57, P860, DOI 10.1093/cid/cit373; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Villeda SA, 2013, AUTOIMMUN REV, V12, P674, DOI 10.1016/j.autrev.2012.10.014; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wills M, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-10; Yan K, 2013, J HUM GENET, V58, P293, DOI 10.1038/jhg.2013.18	49	588	597	2	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					37	47		10.1016/j.cell.2014.12.020	http://dx.doi.org/10.1016/j.cell.2014.12.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594173	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000347923200007
J	Feng, LH; Rutherford, ST; Papenfort, K; Bagert, JD; van Kessel, JC; Tirrell, DA; Wingreen, NS; Bassler, BL				Feng, Lihui; Rutherford, Steven T.; Papenfort, Kai; Bagert, John D.; van Kessel, Julia C.; Tirrell, David A.; Wingreen, Ned S.; Bassler, Bonnie L.			A Qrr Noncoding RNA Deploys Four Different Regulatory Mechanisms to Optimize Quorum-Sensing Dynamics	CELL			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; VIBRIO-HARVEYI; HFQ; TRANSLATION; EXPRESSION; COMPETITION; ACTIVATION; ROLES; LOOP	Quorum sensing is a cell-cell communication process that bacteria use to transition between individual and social lifestyles. In vibrios, homologous small RNAs called the Qrr sRNAs function at the center of quorum-sensing pathways. The Qrr sRNAs regulate multiple mRNA targets including those encoding the quorum-sensing regulatory components luxR, luxO, luxM, and aphA. We show that a representative Qrr, Qrr3, uses four distinct mechanisms to control its particular targets: the Qrr3 sRNA represses luxR through catalytic degradation, represses luxM through coupled degradation, represses luxO through sequestration, and activates aphA by revealing the ribosome binding site while the sRNA itself is degraded. Qrr3 forms different base-pairing interactions with each mRNA target, and the particular pairing strategy determines which regulatory mechanism occurs. Combined mathematicalmodeling and experiments show that the specific Qrr regulatory mechanism employed governs the potency, dynamics, and competition of target mRNA regulation, which in turn, defines the overall quorum-sensing response.	[Feng, Lihui; Rutherford, Steven T.; Papenfort, Kai; van Kessel, Julia C.; Wingreen, Ned S.; Bassler, Bonnie L.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Bagert, John D.; Tirrell, David A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Princeton University; Howard Hughes Medical Institute; California Institute of Technology	Wingreen, NS (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	wingreen@princeton.edu; bbassler@princeton.edu	Papenfort, Kai/L-3187-2017	Papenfort, Kai/0000-0002-5560-9804; van Kessel, Julia/0000-0002-1612-2403; Bassler, Bonnie/0000-0002-0043-746X	Howard Hughes Medical Institute, NIH [5R01GM065859]; National Science Foundation (NSF) [MCB-0343821]; NIH [R01GM082938, R01GM062523, F32AI085922]; Institute for Collaborative Biotechnologies through from the U.S. Army Research Office [W911NF-09-0001]; Human Frontiers in Science Program (HFSP); Indiana University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI085922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938, R01GM062523, R01GM065859] Funding Source: NIH RePORTER; Direct For Biological Sciences [0948112] Funding Source: National Science Foundation	Howard Hughes Medical Institute, NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Collaborative Biotechnologies through from the U.S. Army Research Office; Human Frontiers in Science Program (HFSP)(Human Frontier Science Program); Indiana University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Terence Hwa for generously providing the BW-RI strain and the pZA31-lucNB and pZE12G plasmids. We are indebted to members of the B.L.B. and N.S.W. laboratories for insightful discussions and suggestions. This work was supported by the Howard Hughes Medical Institute, NIH grant 5R01GM065859 and National Science Foundation (NSF) grant MCB-0343821 to B.L.B., NIH grant R01GM082938 to N.S.W., and NIH grant R01GM062523 and the Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office to D.A.T. K.P. is supported by a postdoctoral fellowship from the Human Frontiers in Science Program (HFSP). S.T.R. was supported by NIH fellowship F32AI085922. J.C.V.K. is supported by funds from Indiana University.	Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Beisel CL, 2011, MOL CELL, V41, P286, DOI 10.1016/j.molcel.2010.12.027; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Hussein R, 2011, P NATL ACAD SCI USA, V108, P1110, DOI 10.1073/pnas.1010082108; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McCullen CA, 2010, J BACTERIOL, V192, P5559, DOI 10.1128/JB.00464-10; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Moon K, 2011, MOL MICROBIOL, V82, P1545, DOI 10.1111/j.1365-2958.2011.07907.x; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; Plumbridge J, 2014, MOL MICROBIOL, V92, P648, DOI 10.1111/mmi.12573; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011; Shao Y, 2013, EMBO J, V32, P2158, DOI 10.1038/emboj.2013.155; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; van Kessel JC, 2013, MBIO, V4, DOI 10.1128/mBio.00378-13; van Kessel JC, 2013, J BACTERIOL, V195, P436, DOI 10.1128/JB.01998-12; Vanderpool CK, 2004, MOL MICROBIOL, V54, P1076, DOI 10.1111/j.1365-2958.2004.04348.x; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wagner EGH, 2013, RNA BIOL, V10, P619, DOI 10.4161/rna.24044; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	39	94	96	2	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					228	240		10.1016/j.cell.2014.11.051	http://dx.doi.org/10.1016/j.cell.2014.11.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25579683	Bronze, Green Accepted			2022-12-28	WOS:000347923200021
J	Wang, AT; Smogorzewska, A				Wang, Anderson T.; Smogorzewska, Agata			SnapShot: Fanconi Anemia and Associated Proteins	CELL			English	Editorial Material							CROSS-LINK REPAIR; PATHWAY		[Wang, Anderson T.; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA	Rockefeller University	Wang, AT (corresponding author), Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA.			Wang, Anderson/0000-0002-3571-5095; Smogorzewska, Agata/0000-0001-6285-1562	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120922] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL120922] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Clauson C., 2013, PERSPECT MED, V3; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; McHugh PJ, 2012, CELL CYCLE, V11, P3739, DOI 10.4161/cc.21727; Sawyer S. L., 2014, CANCER DISCOV; Zhang JQ, 2014, DNA REPAIR, V19, P135, DOI 10.1016/j.dnarep.2014.03.018	10	98	100	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2								10.1016/j.cell.2014.12.031	http://dx.doi.org/10.1016/j.cell.2014.12.031			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594185	Bronze			2022-12-28	WOS:000347923200032
J	Crowcroft, NS; Thampi, N				Crowcroft, Natasha S.; Thampi, Nisha			The prevention and management of rabies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POSTEXPOSURE PROPHYLAXIS; ORGAN TRANSPLANTATIONS; COST-EFFECTIVENESS; UNITED-STATES; VACCINATION; DISEASE; AFRICA; BURDEN; DOG		[Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON M5G 1V2, Canada; [Thampi, Nisha] Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario	Crowcroft, NS (corresponding author), Publ Hlth Ontario, 480 Univ Ave,Suite 300, Toronto, ON M5G 1V2, Canada.	natasha.crowcroft@oahpp.ca						[Anonymous], 1977, Morbidity and Mortality Weekly Report, V26, P183; BERNARD KW, 1982, JAMA-J AM MED ASSOC, V248, P3136, DOI 10.1001/jama.248.23.3136; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Bourhy H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000839; Bronnert J, 2007, J TRAVEL MED, V14, P177, DOI 10.1111/j.1708-8305.2006.00095.x; Carrara P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002209; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P197; De Serres G, 2009, CLIN INFECT DIS, V48, P1493, DOI 10.1086/598998; Fitzpatrick MC, 2014, ANN INTERN MED, V160, P91, DOI 10.7326/M13-0542; HELMICK CG, 1987, REV INFECT DIS, V9, P511; HEMACHUDHA T, 1987, LANCET, V1, P1210; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Jackson AC, 2013, ANTIVIR RES, V99, P61, DOI 10.1016/j.antiviral.2013.01.003; Jentes ES, 2014, J TRAVEL MED, V21, P62, DOI 10.1111/jtm.12085; Kaul DR, 2013, JAMA-J AM MED ASSOC, V310, P378, DOI 10.1001/jama.2013.7989; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Madhusudana SN, 2014, EXPERT REV VACCINES, V13, P641, DOI 10.1586/14760584.2014.901893; Maier T, 2010, CLIN INFECT DIS, V50, P1112, DOI 10.1086/651267; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nel LH, 2013, EMERG INFECT DIS, V19, P529, DOI 10.3201/eid1904.120185; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; Public Health England, 2013, RABIES; Public Health Laboratory Service, 2002, COMMUN DIS REP CDR W, V12; Rumana R, 2013, SE ASIAN J TROP MED, V44, P244; Rupprecht Charles E., 2010, Morbidity and Mortality Weekly Report, V59, P1; Shim E, 2009, VACCINE, V27, P7167, DOI 10.1016/j.vaccine.2009.09.027; SMITH JS, 1991, NEW ENGL J MED, V324, P205, DOI 10.1056/NEJM199101243240401; Sudarshan M K, 2006, J Commun Dis, V38, P32; Tsiodras S, 2013, Euro Surveill, V18, P20474; Udow SJ, 2013, CLIN INFECT DIS, V57, P689, DOI 10.1093/cid/cit372; Vigilato MAN, 2013, EMERG INFECT DIS, V19, P678, DOI 10.3201/eid1904.121482; Vora NM, 2013, JAMA-J AM MED ASSOC, V310, P398, DOI 10.1001/jama.2013.7986; Wilde H, 1996, CLIN INFECT DIS, V22, P228, DOI 10.1093/clinids/22.2.228; Wilde H, 2007, VACCINE, V25, P7605, DOI 10.1016/j.vaccine.2007.08.054; Willoughby RE, 2005, NEW ENGL J MED, V352, P2508, DOI 10.1056/NEJMoa050382; WINKLER WG, 1973, JAMA-J AM MED ASSOC, V226, P1219, DOI 10.1001/jama.226.10.1219; World Health Organization, 2013, WHO EXP CONS RAB 2 R; Wunner WH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000591; Zinsstag J, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-22	41	25	25	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2015	350								g7827	10.1136/bmj.g7827	http://dx.doi.org/10.1136/bmj.g7827			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3NA	25589091	Bronze			2022-12-28	WOS:000348133000002
J	Torjesen, I				Torjesen, Ingrid			How much is too much breast screening?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com						[Anonymous], 2009, EVALUATION NET EFFEC; Bewley D, 2014, BMJ-BRIT MED J, V349, pg5601; Department of Health, 2011, IMPR OUTC STRAT CANC; Department of Health, 2007, CANC REF STRAT; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; House of Commons Science and Technology Committee, 2014, NAT HLTH SCREEN 3 RE; Independent UK Panel on Breast Cancer Screening, 2012, BEN HARMS BREAST CAN; ISRCTN Trial Registry, EV AG EXT NHS BREAST; Kremer ME, 2012, AM J ROENTGENOL, V198, P1218, DOI 10.2214/AJR.11.7200; Moser K, 2011, J MED SCREEN, V18, P96, DOI 10.1258/jms.2011.011065	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2015	350								h139	10.1136/bmj.h139	http://dx.doi.org/10.1136/bmj.h139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3NA	25588758				2022-12-28	WOS:000348133000008
J	Kawwass, JF; Kissin, DM; Kulkarni, AD; Creanga, AA; Session, DR; Callaghan, WM; Jamieson, DJ				Kawwass, Jennifer F.; Kissin, Dmitry M.; Kulkarni, Aniket D.; Creanga, Andreea A.; Session, Donna R.; Callaghan, William M.; Jamieson, Denise J.		Natl ART Surveillance Syst NASS Gr	Safety of Assisted Reproductive Technology in the United States, 2000-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kawwass, Jennifer F.; Session, Donna R.] Emory Univ, Sch Med, Div Reprod Endocrinol & Infertil, Atlanta, GA USA; [Kissin, Dmitry M.; Kulkarni, Aniket D.; Creanga, Andreea A.; Callaghan, William M.; Jamieson, Denise J.] US Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Kawwass, JF (corresponding author), 550 Peachtree St, Atlanta, GA 30308 USA.	jennifer.kawwass@gmail.com		Kawwass, Jennifer/0000-0001-7345-735X				Adashi EY, 2011, JAMA-J AM MED ASSOC, V306, P1135, DOI 10.1001/jama.2011.1249; Braat DDM, 2010, HUM REPROD, V25, P1782, DOI 10.1093/humrep/deq080; Centers for Disease Control and Prevention ASfRM, 2012, 2010 ASS REPR TECHN; de Ziegler D, 2013, FERTIL STERIL, V100, P1509, DOI 10.1016/j.fertnstert.2013.10.020; Schoendorf KC, 2006, AM J OBSTET GYNECOL, V194, P911, DOI 10.1016/j.ajog.2005.11.020; Wang Jeff, 2006, Ther Clin Risk Manag, V2, P355, DOI 10.2147/tcrm.2006.2.4.355	6	29	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					88	90		10.1001/jama.2014.14488	http://dx.doi.org/10.1001/jama.2014.14488			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25562272	Bronze			2022-12-28	WOS:000347478000021
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Jeremy Hunt should follow his own advice on emergency care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2013, CHANNEL 4 NEWS  1115; Department of Health media centre, 2014, 111 REAS CALL NHS111; General Practitioners Committee NHS England NHS Employers, 2014, GEN MED SERV CONTR 2; Huntley A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004746; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4300; National Audit Office, 2013, MEM PROV OUT OF HOUR; NHS Choices, NHS SERV EXPL; NHS Choices, NHS ENGL COR PRINC; NHS Support Federation, NHS UNL WHO RUNS OUR	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2015	350								h1	10.1136/bmj.h1	http://dx.doi.org/10.1136/bmj.h1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LU	25569208	Bronze			2022-12-28	WOS:000348129900006
J	Qin, L; Kufareva, I; Holden, LG; Wang, C; Zheng, Y; Zhao, CX; Fenalti, G; Wu, HX; Han, GW; Cherezov, V; Abagyan, R; Stevens, RC; Handel, TM				Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Wang, Chong; Zheng, Yi; Zhao, Chunxia; Fenalti, Gustavo; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Abagyan, Ruben; Stevens, Raymond C.; Handel, Tracy M.			Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-DERIVED FACTOR-1-ALPHA; VMIP-II; SULFOTYROSINE RECOGNITION; SMALL-MOLECULE; CC-CHEMOKINE; BINDING; HIV-1; LYMPHOPOIESIS; MYELOPOIESIS	Chemokines and their receptors control cell migration during development, immune system responses, and in numerous diseases, including inflammation and cancer. The structural basis of receptor: chemokine recognition has been a long-standing unanswered question due to the challenges of structure determination for membrane protein complexes. Here, we report the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at 3.1 angstrom resolution. The structure revealed a 1: 1 stoichiometry and a more extensive binding interface than anticipated from the paradigmatic two-site model. The structure helped rationalize a large body of mutagenesis data and together with modeling provided insights into CXCR4 interactions with its endogenous ligand CXCL12, its ability to recognize diverse ligands, and the specificity of CC and CXC receptors for their respective chemokines.	[Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Zheng, Yi; Zhao, Chunxia; Abagyan, Ruben; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Wang, Chong; Fenalti, Gustavo; Wu, Huixian] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Han, Gye Won; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA	University of California System; University of California San Diego; Scripps Research Institute; University of Southern California; University of Southern California	Kufareva, I (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	ikufareva@ucsd.edu; stevens@usc.edu; thandel@ucsd.edu	zheng, yi/G-1917-2016; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8673-2022; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8724-2022; Han, Gye Won/GLT-1531-2022; Wu, Huixian/N-6353-2014	zheng, yi/0000-0002-4871-0779; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Holden, Lauren/0000-0001-8014-4503; Kufareva, Irina/0000-0001-9083-7039; Wu, Huixian/0000-0003-1357-9747	National Institutes of Health [R01 GM071872, U01 GM094612, R01 GM081763, R21 AI101687, U54 GM094618]; Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, U01GM094612, R01GM071872, R01GM081763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank H. Zhang and W. Liu for help with data collection; A. Walker for assistance with manuscript preparation; M. Gustavsson and V. Katritch for valuable discussions and critical reading of the manuscript; M. Chu for assistance with insect cell expression; E. Lolis art J. Murphy for suggesting the use of vMIP-II; and T. Kawamura, D. Hamel, and K. Wang for assistance with chemokine production. The data in this manuscript are tabulated in the main paper and in the supplementary materials. Atomic coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with identification code 4RWS. This work was funded by National Institutes of Health grants R01 GM071872 (R.A.); U01 GM094612, R01 GM081763, and R21 AI101687 (T.M.H.): and U54 GM094618 (R.C.S.). L.G.H. is supported by a 2012 Postdoctoral Fellowship in Pharmacology/Toxicology from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. The General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source (GM/CA@APS) is supported by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006).	Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Choi WT, 2005, J VIROL, V79, P15398, DOI 10.1128/JVI.79.24.15398-15404.2005; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Koelink PJ, 2012, PHARMACOL THERAPEUT, V133, P1, DOI 10.1016/j.pharmthera.2011.06.008; Kufareva I., 2014, CHEMOKINES; Kufareva I, 2014, P NATL ACAD SCI USA, V111, pE5363, DOI 10.1073/pnas.1417037111; Lefrancois M, 2011, ACS MED CHEM LETT, V2, P597, DOI 10.1021/ml200084n; Luo ZW, 2000, BIOCHEMISTRY-US, V39, P13545, DOI 10.1021/bi000633q; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Millard CJ, 2014, STRUCTURE, V22, P1571, DOI 10.1016/j.str.2014.08.023; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Navenot JM, 2001, J MOL BIOL, V313, P1181, DOI 10.1006/jmbi.2001.5086; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Roumen L, 2012, Drug Discov Today Technol, V9, pe281, DOI 10.1016/j.ddtec.2012.05.002; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Smith EW, 2014, J MED CHEM, V57, P9693, DOI 10.1021/jm501194p; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; Tian SM, 2005, J VIROL, V79, P12667, DOI 10.1128/JVI.79.20.12667-12673.2005; Vabeno J, 2006, CHEM BIOL DRUG DES, V67, P346, DOI 10.1111/j.1747-0285.2006.00387.x; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yamin R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003568; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200; Zhou NM, 2000, BIOCHEMISTRY-US, V39, P3782, DOI 10.1021/bi992750v; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	37	265	268	0	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1117	1122		10.1126/science.1261064	http://dx.doi.org/10.1126/science.1261064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25612609	Green Submitted, Green Accepted			2022-12-28	WOS:000350354200047
J	Brugger, P				Brugger, Peter			Chicks with a number sense	SCIENCE			English	Editorial Material							SPACE; TIME		Univ Zurich Hosp, Dept Neurol, Neuropsychol Unit, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Brugger, P (corresponding author), Univ Zurich Hosp, Dept Neurol, Neuropsychol Unit, CH-8091 Zurich, Switzerland.	peter.brugger@usz.ch		Brugger, Peter/0000-0002-5137-0314				Cassia VM, 2012, COGNITION, V124, P183, DOI 10.1016/j.cognition.2012.05.004; de Hevia MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096412; de Hevia MD, 2014, P NATL ACAD SCI USA, V111, P4809, DOI 10.1073/pnas.1323628111; Dehaene S., 2011, NUMBER SENSE MIND CR; Fischer MH, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00260; Gobel SM, 2011, J CROSS CULT PSYCHOL, V42, P543, DOI 10.1177/0022022111406251; Kazandjian S, 2008, NAT REV NEUROSCI, V9, P965, DOI 10.1038/nrn2456-c1; Knops A, 2014, NEUROIMAGE, V84, P786, DOI 10.1016/j.neuroimage.2013.09.037; Low J, 2009, IBIS, V151, P775, DOI 10.1111/j.1474-919X.2009.00951.x; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rugani R, 2015, SCIENCE, V347, P534, DOI 10.1126/science.aaa1379; Rugani R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00150; Vuilleumier P, 2004, CORTEX, V40, P399, DOI 10.1016/S0010-9452(08)70134-5; White DJ, 2009, PSYCHOL SCI, V20, P1140, DOI 10.1111/j.1467-9280.2009.02418.x	14	10	10	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					477	478		10.1126/science.aaa4854	http://dx.doi.org/10.1126/science.aaa4854			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635074	Green Accepted			2022-12-28	WOS:000348639300022
J	Chen, F; Tillberg, PW; Boyden, ES				Chen, Fei; Tillberg, Paul W.; Boyden, Edward S.			Expansion microscopy	SCIENCE			English	Article							CELLULAR STRUCTURES	In optical microscopy, fine structural details are resolved by using refraction to magnify images of a specimen. We discovered that by synthesizing a swellable polymer network within a specimen, it can be physically expanded, resulting in physical magnification. By covalently anchoring specific labels located within the specimen directly to the polymer network, labels spaced closer than the optical diffraction limit can be isotropically separated and optically resolved, a process we call expansion microscopy (ExM). Thus, this process can be used to perform scalable superresolution microscopy with diffraction-limited microscopes. We demonstrate ExM with apparent similar to 70-nanometer lateral resolution in both cultured cells and brain tissue, performing three-color superresolution imaging of similar to 10(7) cubic micrometers of the mouse hippocampus with a conventional confocal microscope.	[Chen, Fei; Boyden, Edward S.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tillberg, Paul W.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, McGovern Inst, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, Ctr Neurobiol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Boyden, ES (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	esb@media.mit.edu	Hansen, Niels/B-2218-2018; Chen, Fei/HGE-5690-2022	Chen, Fei/0000-0003-2308-3649	NIH Director's Pioneer Award [1DP1NS087724]; NIH Director's Transformative Research Award [1R01MH103910-01]; New York Stem Cell Foundation-Robertson Investigator Award; MIT Center for Brains, Minds, and Machines NSF [CCF-1231216]; Google; NSF CAREER Award [CBET 1053233]; MIT Synthetic Intelligence Project; MIT Media Lab; MIT McGovern Institute; MIT Neurotechnology Fund; NSF Graduate Fellowship; Fannie and John Hertz Graduate Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS087724] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Transformative Research Award; New York Stem Cell Foundation-Robertson Investigator Award; MIT Center for Brains, Minds, and Machines NSF; Google(Google Incorporated); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); MIT Synthetic Intelligence Project; MIT Media Lab; MIT McGovern Institute; MIT Neurotechnology Fund; NSF Graduate Fellowship(National Science Foundation (NSF)); Fannie and John Hertz Graduate Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	E.S.B. was funded by NIH Director's Pioneer Award 1DP1NS087724 and NIH Director's Transformative Research Award 1R01MH103910-01, the New York Stem Cell Foundation-Robertson Investigator Award, the MIT Center for Brains, Minds, and Machines NSF CCF-1231216, Jeremy and Joyce Wertheimer, Google, NSF CAREER Award CBET 1053233, the MIT Synthetic Intelligence Project, the MIT Media Lab, the MIT McGovern Institute, and the MIT Neurotechnology Fund. F.C. was funded by an NSF Graduate Fellowship. P.W.T. was funded by a Fannie and John Hertz Graduate Fellowship. Confocal imaging was performed in the W. M. Keck Facility for Biological Imaging at the Whitehead Institute for Biomedical Research. Deltavision OMX SR-SIM imaging was performed at the Koch Institute Swanson Biotechnology Center imaging core. We acknowledge W. Salmon and E. Vasile for assistance with confocal and SR-SIM imaging. We acknowledge N. Pak for assistance with perfusions. We also acknowledge, for helpful discussions, B. Chow, A. Marblestone, G. Church, P. So, S. Manalis, J.-B. Chang, J. Enriquez, I. Gupta, M. Kardar, and A. Wissner-Gross. The authors have applied for a patent on the technology, assigned to MIT (U.S. Provisional Application 61943035). The order of co-first author names was determined by a coin toss. The imaging and other data reported in the paper are hosted by MIT (http://expansionmicroscopy.org/rawdataScience2014).	Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; BUCHHOLZ FL, 1994, ACS SYM SER, V573, P27; Calvet D, 2004, MACROMOLECULES, V37, P7762, DOI 10.1021/ma049072r; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; HECHT AM, 1985, MACROMOLECULES, V18, P2167, DOI 10.1021/ma00153a018; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; NEWMAN GR, 1983, HISTOCHEM J, V15, P543, DOI 10.1007/BF01954145; OHMINE I, 1982, J CHEM PHYS, V77, P5725, DOI 10.1063/1.443780; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Rollenhagen Astrid, 2010, Front Synaptic Neurosci, V2, P2, DOI 10.3389/fnsyn.2010.00002; TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636	18	597	626	48	409	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					543	548		10.1126/science.1260088	http://dx.doi.org/10.1126/science.1260088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25592419	Green Accepted, Green Submitted			2022-12-28	WOS:000348639300052
J	Kramer, A				Kramer, Achim			When the circadian clock becomes blind	SCIENCE			English	Editorial Material							SLEEP PHASE SYNDROME; PHOSPHORYLATION; PERIOD; SITE		Charite, Lab Chronobiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kramer, A (corresponding author), Charite, Lab Chronobiol, D-13353 Berlin, Germany.	achim.kramer@charite.de		Kramer, Achim/0000-0001-9671-6078				Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Cha J, 2011, J BIOL CHEM, V286, P11469, DOI 10.1074/jbc.M111.219782; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Larrondo LF, 2015, SCIENCE, V347, DOI 10.1126/science.1257277; Lauinger L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4598; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Shi GS, 2013, P NATL ACAD SCI USA, V110, P4750, DOI 10.1073/pnas.1302560110; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006	12	9	9	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					476	477		10.1126/science.aaa5085	http://dx.doi.org/10.1126/science.aaa5085			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635073				2022-12-28	WOS:000348639300021
J	Landau, S				Landau, Susan			Control use of data to protect privacy	SCIENCE			English	Editorial Material								Massive data collection by businesses and governments calls into question traditional methods for protecting privacy, underpinned by two core principles: (i) notice, that there should be no data collection system whose existence is secret, and (ii) consent, that data collected for one purpose not be used for another without user permission. But notice, designated as a fundamental privacy principle in a different era, makes little sense in situations where collection consists of lots and lots of small amounts of information, whereas consent is no longer realistic, given the complexity and number of decisions that must be made. Thus, efforts to protect privacy by controlling use of data are gaining more attention. I discuss relevant technology, policy, and law, as well as some examples that can illuminate the way.	Worcester Polytech Inst, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Landau, S (corresponding author), Worcester Polytech Inst, Worcester, MA 01609 USA.	susan.landau@privacyink.org						Alter Alexandra, 2012, WALL STREET J; [Anonymous], 2014, REP TEL REC PROGR CO; [Anonymous], 2014, BIG DAT PRIV TECHN P; Barocas S, 2014, COMMUN ACM, V57, P31, DOI 10.1145/2668897; Cate FH, 2013, INT DATA PRIV LAW, V3, P67, DOI 10.1093/idpl/ipt005; Cate Fred H., 2006, CONSUMER PROTECTION, P341; Duhigg Charles, 2012, NY TIMES, pMM30; Federal Trade Commission, 1998, PRIV ONL REP C; Federal Trade Commission, 2012, BUSINESSES POLICYMAK; Google, REV APP PERM; International data corporation, 2014, SMARTPH OS MARK SHAR; Kanter James, 2014, NY TIMES; Landau S., 2011, SURVEILLANCE SECURIT; Mayer Jonathan, 2014, METAPHONE SENSITIVIT; McDonald Aleecia M., 2009, IS J LAW POLICY INFO, V4, P540; Nissenbaum H, 2004, WASH LAW REV, V79, P119; OECD, 2013, GUIDELINES PROTECTIO; President's Review Committee on Intelligence and Communications Technologies, 2013, LIB SEC CHANG WORLD; Secretary's Advisory Committee on Automated Personal Data Systems, 1973, RECORDS COMPUTERS RI; Seneviratne O., 2011, IEEE INT S POL DISTR, P141; The White House, 2012, HOMELAND SECURITY DI; Voytek B., 2012, RIDES GLORY; Warren Samuel D., 1890, HARVARD LAW REV, V4, P193, DOI DOI 10.2307/1321160	23	33	34	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					504	506		10.1126/science.aaa4961	http://dx.doi.org/10.1126/science.aaa4961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635089				2022-12-28	WOS:000348639300042
J	Savage, N				Savage, Neil			CAREER COUNSELLING Pick a path Where to go to get advice on finding a job	NATURE			English	Editorial Material																		2014, NATURE, V511, P255	1	1	1	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					645	647		10.1038/nj7536-645a	http://dx.doi.org/10.1038/nj7536-645a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2ZL	25635281	Bronze			2022-12-28	WOS:000348775000050
J	Fitzgerald, M; Saville, BR; Lewis, RJ				Fitzgerald, Mark; Saville, Benjamin R.; Lewis, Roger J.			Decision Curve Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fitzgerald, Mark; Saville, Benjamin R.; Lewis, Roger J.] Berry Consultants, Austin, TX USA; [Saville, Benjamin R.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Lewis, Roger J.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90509 USA.	roger@emedharbor.edu		Fitzgerald, Mark/0000-0002-8912-1663				FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P345, DOI 10.1016/0895-4356(89)90039-5; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Siddiqui MM, JAMA-J AM MED ASSOC, DOI [10.1001/jama.201417942, DOI 10.1001/JAMA.201417942]; Sox HC, 2013, MED DECISION MAKING; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361	5	297	307	3	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					409	410		10.1001/jama.2015.37	http://dx.doi.org/10.1001/jama.2015.37			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626037				2022-12-28	WOS:000349072600023
J	Gulkis, S; Allen, M; von Allmen, P; Beaudin, G; Biver, N; Bockelee-Morvan, D; Choukroun, M; Crovisier, J; Davidsson, BJR; Encrenaz, P; Encrenaz, T; Frerking, M; Hartogh, P; Hofstadter, M; Ip, WH; Janssen, M; Jarchow, C; Keihm, S; Lee, S; Lellouch, E; Leyrat, C; Rezac, L; Schloerb, FP; Spilker, T				Gulkis, Samuel; Allen, Mark; von Allmen, Paul; Beaudin, Gerard; Biver, Nicolas; Bockelee-Morvan, Dominique; Choukroun, Mathieu; Crovisier, Jacques; Davidsson, Bjoern J. R.; Encrenaz, Pierre; Encrenaz, Therese; Frerking, Margaret; Hartogh, Paul; Hofstadter, Mark; Ip, Wing-Huen; Janssen, Michael; Jarchow, Christopher; Keihm, Stephen; Lee, Seungwon; Lellouch, Emmanuel; Leyrat, Cedric; Rezac, Ladislav; Schloerb, F. Peter; Spilker, Thomas			Subsurface properties and early activity of comet 67P/Churyumov-Gerasimenko	SCIENCE			English	Article							RADIATIVE-TRANSFER	Heat transport and ice sublimation in comets are interrelated processes reflecting properties acquired at the time of formation and during subsequent evolution. The Microwave Instrument on the Rosetta Orbiter (MIRO) acquired maps of the subsurface temperature of comet 67P/Churyumov-Gerasimenko, at 1.6 mm and 0.5 mm wavelengths, and spectra of water vapor. The total H2O production rate varied from 0.3 kg s(-1) in early June 2014 to 1.2 kg s(-1) in late August and showed periodic variations related to nucleus rotation and shape. Water outgassing was localized to the "neck" region of the comet. Subsurface temperatures showed seasonal and diurnal variations, which indicated that the submillimeter radiation originated at depths comparable to the diurnal thermal skin depth. A low thermal inertia (similar to 10 to 50 J K-1 m(-2) s(-0.5)), consistent with a thermally insulating powdered surface, is inferred.	[Gulkis, Samuel; Allen, Mark; von Allmen, Paul; Choukroun, Mathieu; Frerking, Margaret; Hofstadter, Mark; Janssen, Michael; Keihm, Stephen; Lee, Seungwon; Schloerb, F. Peter; Spilker, Thomas] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Beaudin, Gerard; Encrenaz, Pierre] Univ Paris 06, Observ Paris, PSL Res Univ, LERMA,CNRS,UMR8112, F-75014 Paris, France; [Biver, Nicolas; Bockelee-Morvan, Dominique; Crovisier, Jacques; Encrenaz, Therese; Lellouch, Emmanuel; Leyrat, Cedric] Univ Paris Diderot, UPMC, CNRS, LESIA Observ Paris, F-92195 Meudon, France; [Davidsson, Bjoern J. R.] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Hartogh, Paul; Jarchow, Christopher; Rezac, Ladislav] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Ip, Wing-Huen] Natl Cent Univ, Taoyuan 32001, Taiwan; [Schloerb, F. Peter] Univ Massachusetts, Amherst, MA 01003 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Uppsala University; Max Planck Society; National Central University; University of Massachusetts System; University of Massachusetts Amherst	Gulkis, S (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	samuel.gulkis@jpl.nasa.gov	Hofstadter, Mark/AAO-8401-2021; Choukroun, Mathieu/F-3146-2017	Hofstadter, Mark/0000-0002-3208-3918; 	entire MIRO project teams at the Jet Propulsion Laboratory; Max-Planck-Institut fur Sonnensystemforschung; LESIA-Observatoire de Paris; LERMA-Observatoire de Paris-Meudon; MIRO; National Aeronautics and Space Administration; Deutsches Zentrum fur Luft- und Raumfahrt; Max-Planck-Gesellschaft; Centre National d'Etudes Spatiales (CNES); CNRS/Institut National des Sciences de l'Univers (INSU); National Central University; Taiwanese National Science Counsel [101-2111-M-008-016]; University of Massachusetts, Amherst, USA; Uppsala University; Swedish National Space Board; ESOC in Germany; European Space Astronomy Center (ESAC) in Spain	entire MIRO project teams at the Jet Propulsion Laboratory; Max-Planck-Institut fur Sonnensystemforschung; LESIA-Observatoire de Paris; LERMA-Observatoire de Paris-Meudon; MIRO; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)); Max-Planck-Gesellschaft(Max Planck Society); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); CNRS/Institut National des Sciences de l'Univers (INSU); National Central University; Taiwanese National Science Counsel; University of Massachusetts, Amherst, USA; Uppsala University; Swedish National Space Board; ESOC in Germany; European Space Astronomy Center (ESAC) in Spain	The authors gratefully acknowledge the assistance and support of the entire MIRO project teams at the Jet Propulsion Laboratory, the Max-Planck-Institut fur Sonnensystemforschung, LESIA-Observatoire de Paris, and LERMA-Observatoire de Paris-Meudon. We thank Y. Anderson, T. Koch, R. Nowicki, and L. Pan for their efforts in scheduling, operations, and support of the MIRO instrument. The authors recognize here the enormous contributions that our friend and colleague, Lucas Kamp, made to the MIRO science and engineering efforts before his recent death. The authors acknowledge support from their institutions and funding sources. A part of the research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. A part of the research was carried out at the Max-Planck-Institut fur Sonnensystemforschung with financial support from Deutsches Zentrum fur Luft- und Raumfahrt and Max-Planck-Gesellschaft. Parts of the research were carried out by LESIA and LERMA, Observatoire de Paris, with financial support from Centre National d'Etudes Spatiales (CNES) and CNRS/Institut National des Sciences de l'Univers (INSU); at the National Central University with funding from the Taiwanese National Science Counsel grant 101-2111-M-008-016; at the University of Massachusetts, Amherst, USA; and at Uppsala University with financial support from the Swedish National Space Board. We acknowledge personnel at ESA's European Space Operations Center (ESOC) in Darmstadt, Germany, and at ESA and NASA/JPL tracking stations for their professional work in communication with and directing the Rosetta spacecraft, thereby making this mission possible. We acknowledge the excellent support provided by the Rosetta teams at the ESOC in Germany and the European Space Astronomy Center (ESAC) in Spain. Special mention is made of C. Vallat, whose superb efforts have made many difficult MIRO observing sequences possible; B. Grieger, whose calculations and visualizations have enabled and optimized our science return; and N. Altobelli and M. Kuppers, whose early liaison support and later oversight responsibilities have greatly benefited the mission as a whole. The authors thank Holger Sierks and the OSIRIS team for permission to use the SHAP2 shape model for analysis purposes and for permission to publish several images here. All MIRO data are released through the PSA archive of ESA and the PDS archive of NASA. The data reported here are scheduled for delivery to the archive on 19 May 2015 and are available on request until then.	Capaccioni F, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0628; Carusi A., 1985, LONG TERM EVOLUTION; Groussin O, 2007, MON NOT R ASTRON SOC, V376, P1399, DOI 10.1111/j.1365-2966.2007.11553.x; Gulkis S, 2007, SPACE SCI REV, V128, P561, DOI 10.1007/s11214-006-9032-y; HOUPIS HLF, 1985, ASTROPHYS J, V295, P654, DOI 10.1086/163409; Lee S, 2011, ICARUS, V215, P721, DOI 10.1016/j.icarus.2011.07.007; Mangum JG, 2007, ASTRON ASTROPHYS, V474, P679, DOI 10.1051/0004-6361:20077811; Meech KJ, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L1; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Zakharov V, 2007, ASTRON ASTROPHYS, V473, P303, DOI 10.1051/0004-6361:20066715	10	199	199	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							aaa0709	10.1126/science.aaa0709	http://dx.doi.org/10.1126/science.aaa0709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613896				2022-12-28	WOS:000348225800034
J	Jobst, BC; Cascino, GD				Jobst, Barbara C.; Cascino, Gregory D.			Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TEMPORAL-LOBE EPILEPSY; QUALITY-OF-LIFE; SEIZURE FREEDOM; CAVERNOUS MALFORMATIONS; SURGICAL RESECTION; PEDIATRIC-PATIENTS; FOLLOW-UP; OUTCOMES; LOBECTOMY; MEMORY	IMPORTANCE Epilepsy surgery is indicated for patients with focal seizures who do not respond to appropriate antiepileptic drug therapy consisting of 2 or more medications. OBJECTIVES To review resective surgery outcomes for focal epilepsy, to identify which patients benefit the most, and to discuss why epilepsy surgery may not be universally accepted. EVIDENCE REVIEW Medline and Cochrane databases were searched between January 1993 and June 2014 for randomized clinical trials, meta-analyses, systematic reviews, and large retrospective case series (>300 patients) using Medical Subject Headings and indexed text terms. Fifty-five articles were included. Subpopulations and prognostic factors were identified. Systematic reviews for cognitive, psychiatric, quality-of-life, and psychosocial outcomes were included. FINDINGS Two randomized clinical trials enrolling 118 patients with temporal lobe epilepsy found greater freedom from seizures with surgery when compared with continued medical treatment (58% vs 8% [n = 80] and 73% vs 0% [n = 38], P < .001). Nine systematic reviews and 2 large case series of medically refractory patients treated with surgery reported seizure-free outcomes in 34% to 74% of patients (median, 62.4%). The remainder of systematic reviews and meta-analyses examined subpopulations. Epilepsy surgery was less effective when there were extratemporal lesions, the epilepsy was not associated with a structural lesion, or both. Seizure-free outcomes were similar between children and adults. Hippocampal sclerosis and benign tumors were associated with better outcomes relative to other pathologies. Similar procedures such as selective amygdalohippocampectomy and temporal lobectomy for temporal lobe epilepsy were associated with subtle differences in seizure and neuropsychological outcome. There is low perioperative mortality (0.1%-0.5%) from epilepsy surgery. The most frequent neurologic complication is visual field defect occurring from temporal lobe resection. Quality of life improved after surgery but improved the most in patients who were seizure-free after surgery. CONCLUSIONS AND RELEVANCE Epilepsy surgery reduced seizure activity in randomized clinical trials when compared with continued medical therapy. Long-term cognitive, psychiatric, psychosocial, and quality-of-life outcomes were less well defined. Despite good outcomes from high-quality clinical trials, referrals of patients with seizures refractory to medical treatment remain infrequent.	[Jobst, Barbara C.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Neurol, Lebanon, NH 03756 USA; [Cascino, Gregory D.] Mayo Clin, Dept Neurol, Rochester, MN USA	Dartmouth College; Mayo Clinic	Jobst, BC (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, One Med Ctr Dr, Lebanon, NH 03756 USA.	barbara.c.jobst@hitchcock.org	Jobst, Barbara C./ABB-1969-2020		National Institutes of Health; Centers for Disease Control and Prevention; American Epilepsy Society; Pfizer Inc; Neuropace Inc; UCB Inc; Upsher-Smith; Lunbeck	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Epilepsy Society; Pfizer Inc(Pfizer); Neuropace Inc; UCB Inc(UCB Pharma SA); Upsher-Smith; Lunbeck	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Jobst reported receiving research support from the National Institutes of Health, Centers for Disease Control and Prevention, the American Epilepsy Society, Pfizer Inc, Neuropace Inc, UCB Inc, Upsher-Smith, and Lunbeck; serving on the scientific advisory committee of Neuropace Inc; and receiving royalties for medical writing from Medlink Inc. None of these activities represent a significant conflict of interest regarding the content of this review. Dr Cascino reported receiving research support from the National Institutes of Health; serving as an associate editor for the journal Neurology (American Academy of Neurology); receiving honoraria from the American Epilepsy Society and American Academy of Neurology for educational activities; and receiving royalty from the Mayo Foundation (Mayo Medical Ventures).	Ansari SF, 2010, CHILD NERV SYST, V26, P945, DOI 10.1007/s00381-009-1056-7; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Arya R, 2013, EPILEPSIA, V54, P828, DOI 10.1111/epi.12073; Baxendale S, 2006, EPILEPSIA, V47, P1887, DOI 10.1111/j.1528-1167.2006.00810.x; Bien CG, 2013, J NEUROL NEUROSUR PS, V84, P54, DOI 10.1136/jnnp-2011-301763; Boshuisen K, 2012, LANCET NEUROL, V11, P784, DOI 10.1016/S1474-4422(12)70165-5; Cleary RA, 2013, EPILEPSY BEHAV, V26, P322, DOI 10.1016/j.yebeh.2012.09.038; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Del Felice A, 2010, EPILEPSIA, V51, P37, DOI 10.1111/j.1528-1167.2009.02141.x; Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Englot DJ, 2013, J NEUROSURG-PEDIATR, V12, P134, DOI 10.3171/2013.5.PEDS12526; Englot DJ, 2013, J NEUROSURG-PEDIATR, V12, P126, DOI 10.3171/2013.5.PEDS1336; Englot DJ, 2012, J NEUROSURG, V116, P1042, DOI 10.3171/2012.1.JNS111620; Englot DJ, 2012, NEUROSURGERY, V70, P921, DOI 10.1227/NEU.0b013e31823c3a30; Englot DJ, 2012, EPILEPSIA, V53, P51, DOI 10.1111/j.1528-1167.2011.03269.x; Englot DJ, 2011, J NEUROSURG, V115, P1169, DOI 10.3171/2011.7.JNS11536; Englot DJ, 2011, J NEUROSURG, V115, P240, DOI 10.3171/2011.3.JNS1153; Fallah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053565; Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161; Hamid H, 2011, NEUROLOGY, V77, P1972, DOI 10.1212/WNL.0b013e31823a0c90; Hamid H, 2014, NEUROLOGY, V82, P887, DOI 10.1212/WNL.0000000000000183; Hamiwka L, 2011, EPILEPSIA, V52, P870, DOI 10.1111/j.1528-1167.2011.03074.x; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Health Quality Ontario, 2012, Ont Health Technol Assess Ser, V12, P1; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Helmstaedter C, 2013, EPILEPTIC DISORD, V15, P221, DOI 10.1684/epd.2013.0587; Helmstaedter C, 2011, J NEUROL NEUROSUR PS, V82, P1375, DOI 10.1136/jnnp.2010.240176; Hemb M, 2013, J NEUROL NEUROSUR PS, V84, P800, DOI 10.1136/jnnp-2012-304038; Hermann B, 1999, EPILEPSIA, V40, P1070, DOI 10.1111/j.1528-1157.1999.tb00821.x; Ibrahim GM, 2012, EPILEPSY RES TREAT, V2012; Ives-Deliperi VL, 2012, EPILEPSY BEHAV, V24, P194, DOI 10.1016/j.yebeh.2012.04.115; Jansen FE, 2007, EPILEPSIA, V48, P1477, DOI 10.1111/j.1528-1167.2007.01117.x; Janszky J, 2006, SEIZURE-EUR J EPILEP, V15, P125, DOI 10.1016/j.seizure.2005.12.002; Kobau Rosemarie, 2012, Morbidity and Mortality Weekly Report, V61, P909; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Langfitt JT, 2007, NEUROLOGY, V68, P1290, DOI 10.1212/01.wnl.0000259550.87773.3d; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Lutz MT, 2004, EPILEPSIA, V45, P809, DOI 10.1111/j.0013-9580.2004.54003.x; Macrodimitris S, 2011, EPILEPSIA, V52, P880, DOI 10.1111/j.1528-1167.2011.03014.x; McClelland S, 2011, ARCH NEUROL-CHICAGO, V68, P725, DOI 10.1001/archneurol.2011.7; McIntosh AM, 2001, EPILEPSIA, V42, P1288, DOI 10.1046/j.1528-1157.2001.02001.x; Mikati MA, 2010, EPILEPSY RES, V90, P207, DOI 10.1016/j.eplepsyres.2010.05.002; Mohammed HS, 2012, EPILEPSIA, V53, P712, DOI 10.1111/j.1528-1167.2011.03398.x; Moran NF, 1999, J NEUROL NEUROSUR PS, V66, P561, DOI 10.1136/jnnp.66.5.561; Perry MS, 2013, EPILEPSIA, V54, P2060, DOI 10.1111/epi.12427; Rayner G, 2010, EPILEPSY BEHAV, V19, P359, DOI 10.1016/j.yebeh.2010.07.019; Rowland NC, 2012, J NEUROSURG, V116, P1035, DOI 10.3171/2012.1.JNS111105; Schmidt D, 2004, EPILEPSY RES, V60, P187, DOI 10.1016/j.eplepsyres.2004.07.004; Schmidt D, 2009, EPILEPSIA, V50, P1301, DOI 10.1111/j.1528-1167.2008.01997.x; Schomer DL, 2012, JAMA-J AM MED ASSOC, V307, P966, DOI 10.1001/jama.2012.251; Schramm J, 2011, ACTA NEUROCHIR, V153, P209, DOI 10.1007/s00701-010-0900-6; Seiam AHR, 2011, EPILEPSY BEHAV, V21, P441, DOI 10.1016/j.yebeh.2011.05.005; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sherman EMS, 2011, EPILEPSIA, V52, P857, DOI 10.1111/j.1528-1167.2011.03022.x; Singh JA, 2012, J ARTHROPLASTY, V27, P1417, DOI 10.1016/j.arth.2012.03.008; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Tellez-Zenteno JF, 2007, BRAIN, V130, P334, DOI 10.1093/brain/awl316; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Tonini C, 2004, EPILEPSY RES, V62, P75, DOI 10.1016/j.eplepsyres.2004.08.006; Vaz SAM, 2004, SEIZURE-EUR J EPILEP, V13, P446, DOI 10.1016/j.seizure.2003.12.004; von der Brelie C, 2011, ACTA NEUROCHIR, V153, P249, DOI 10.1007/s00701-010-0915-z; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; WYLER AR, 1995, NEUROSURGERY, V37, P982, DOI 10.1227/00006123-199511000-00019; Zhang J, 2013, NEUROPSYCH DIS TREAT, V9, P1673, DOI 10.2147/NDT.S53802	67	332	340	7	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					285	293		10.1001/jama.2014.17426	http://dx.doi.org/10.1001/jama.2014.17426			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602999				2022-12-28	WOS:000348145000020
J	Rosenfeld, DN				Rosenfeld, David N.			Flamed on the Net	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												davidnr6@mac.com						Bellamy A, 1999, ELECT J SOCIOL; Mckay KM, 2006, J AFFECT DISORDERS, V92, P287, DOI 10.1016/j.jad.2006.01.020; Nathanson DL., 1992, SHAME PRIDE AFFECT S	3	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					249	250		10.1001/jama.2014.15847	http://dx.doi.org/10.1001/jama.2014.15847			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602993				2022-12-28	WOS:000348145000014
J	Zobel, M; Neder, RB; Kimber, SAJ				Zobel, Mirijam; Neder, Reinhard B.; Kimber, Simon A. J.			Universal solvent restructuring induced by colloidal nanoparticles	SCIENCE			English	Article							FORCE MEASUREMENTS; SOLVATION FORCES; LIQUID STRUCTURE; PROTON-TRANSFER; SOLID-SURFACES; ETHANOL; INTERFACE; METHANOL; ALKANES	Colloidal nanoparticles, used for applications from catalysis and energy applications to cosmetics, are typically embedded in matrixes or dispersed in solutions. The entire particle surface, which is where reactions are expected to occur, is thus exposed. Here, we show with x-ray pair distribution function analysis that polar and nonpolar solvents universally restructure around nanoparticles. Layers of enhanced order exist with a thickness influenced by the molecule size and up to 2 nanometers beyond the nanoparticle surface. These results show that the enhanced reactivity of solvated nanoparticles includes a contribution from a solvation shell of the size of the particle itself.	[Zobel, Mirijam; Neder, Reinhard B.] Univ Erlangen Nurnberg, Dept Phys, Lehrstuhl Kristallog & Strukturphys, D-91058 Erlangen, Germany; [Kimber, Simon A. J.] European Synchrotron Radiat Facil, F-38000 Grenoble, France	University of Erlangen Nuremberg; European Synchrotron Radiation Facility (ESRF)	Zobel, M (corresponding author), Univ Erlangen Nurnberg, Dept Phys, Lehrstuhl Kristallog & Strukturphys, Staudtstr 3, D-91058 Erlangen, Germany.	mirijam.zobel@fau.de; kimber@esrf.fr	Neder, Reinhard B/D-9877-2013; Zobel, Mirijam/AAI-2128-2020; Zobel, Mirijam/C-5658-2016; Kimber, Simon/E-8256-2011	Neder, Reinhard B/0000-0003-2592-2207; Zobel, Mirijam/0000-0002-8207-8316; Zobel, Mirijam/0000-0002-8207-8316; Kimber, Simon/0000-0002-3969-5095; Kimber, Simon/0000-0003-0489-1851	Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie [05K10WEB]; Friedrich-Alexander-University Erlangen-Nurnberg	Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); Friedrich-Alexander-University Erlangen-Nurnberg	We acknowledge the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie under grant 05K10WEB and a scholarship of the Friedrich-Alexander-University Erlangen-Nurnberg for financial support. Beam time at the European Synchrotron Radiation Facility and Argonne National Laboratory is gratefully acknowledged. We thank J. Hudspeth from beamline ID-15-B, European Synchrotron Radiation Facility, as well as K. Chapman and K. Beyer from beamline 11-ID-B, and Advanced Proton Source for support during our beamtime. We acknowledge A. Magerl and H. Reichert for discussions. All experimental raw data are stored at the European Synchrotron Radiation Facility. For access, please contact S.A.J.K. (kimber@esrf.fr).	Benmore CJ, 2000, J CHEM PHYS, V112, P5877, DOI 10.1063/1.481160; Bowron DT, 2009, J PHYS CHEM B, V113, P11858, DOI 10.1021/jp904382n; Cataliotti RS, 2009, PHYS CHEM CHEM PHYS, V11, P11258, DOI 10.1039/b915317a; CHRISTENSON HK, 1987, J CHEM PHYS, V87, P1834, DOI 10.1063/1.453196; Doerr AK, 1998, PHYSICA B, V248, P263, DOI 10.1016/S0921-4526(98)00245-2; Gotzelmann B, 1996, PHYS REV E, V53, P3456, DOI 10.1103/PhysRevE.53.3456; Hertz B. H. G., 1970, ANGEW CHEM INT EDIT, V9, P124; ISRAELACHVILI J, 1987, ACCOUNTS CHEM RES, V20, P415, DOI 10.1021/ar00143a005; Kawska A, 2008, NANO LETT, V8, P2336, DOI 10.1021/nl801169x; LONGMAN GW, 1979, POLYMER, V20, P1063, DOI 10.1016/0032-3861(79)90296-9; MAGNUSSEN OM, 1995, PHYS REV LETT, V74, P4444, DOI 10.1103/PhysRevLett.74.4444; Mancinelli R, 2007, PHYS CHEM CHEM PHYS, V9, P2959, DOI 10.1039/b701855j; Mezger M, 2008, SCIENCE, V322, P424, DOI 10.1126/science.1164502; Page K, 2011, J APPL CRYSTALLOGR, V44, P327, DOI 10.1107/S0021889811001968; Raymand D, 2011, J PHYS CHEM C, V115, P8573, DOI 10.1021/jp106144p; REICHERT H, 1995, PHYS REV LETT, V74, P2006, DOI 10.1103/PhysRevLett.74.2006; SNOOK IK, 1980, J CHEM PHYS, V72, P2907, DOI 10.1063/1.439489; Spagnoli D, 2011, LANGMUIR, V27, P1821, DOI 10.1021/la104190d; Valdez CN, 2014, ACS NANO, V8, P9463, DOI 10.1021/nn503603e; Vrhovsek A, 2011, J PHYS CHEM B, V115, P13473, DOI 10.1021/jp206665w; WERTZ DL, 1967, J CHEM PHYS, V47, P388, DOI 10.1063/1.1711905; Zachariasen WH, 1935, J CHEM PHYS, V3, P158, DOI 10.1063/1.1749623; Zhang XY, 2003, J PHYS CHEM B, V107, P3183, DOI 10.1021/jp021071i	23	142	143	1	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					292	294		10.1126/science.1261412	http://dx.doi.org/10.1126/science.1261412			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593188	Green Submitted			2022-12-28	WOS:000347915300041
J	Koh, MJ; Khan, RKM; Torker, S; Yu, M; Mikus, MS; Hoveyda, AH				Koh, Ming Joo; Khan, R. Kashif M.; Torker, Sebastian; Yu, Miao; Mikus, Malte S.; Hoveyda, Amir H.			High-value alcohols and higher-oxidation-state compounds by catalytic Z-selective cross-metathesis	NATURE			English	Article							RING-OPENING/CROSS-METATHESIS; NATURAL-PRODUCT SYNTHESIS; OLEFIN METATHESIS; COMPLEXES; MACROLIDE; CARBENE	Olefin metathesis catalysts provide access to molecules that are indispensable to physicians and researchers in the life sciences(1,2). A persisting problem, however, is the dearth of chemical transformations that directly generate acyclic Z allylic alcohols, including products that contain a hindered neighbouring substituent or reactive functional units such as a phenol, an aldehyde, or a carboxylic acid. Here we present an electronically modified ruthenium-disulfide catalyst that is effective in generating such high-value compounds by cross-metathesis. The ruthenium complex is prepared from a commercially available precursor and an easily generated air-stable zinc catechothiolate. Transformations typically proceed with 5.0 mole per cent of the complex and an inexpensive reaction partner in 4-8 hours under ambient conditions; products are obtained in up to 80 per cent yield and 98:2 Z:E diastereoselectivity. The use of this catalyst is demonstrated in the synthesis of the naturally occurring anti-tumour agent neopeltolide and in a single-step stereoselective gram-scale conversion of a renewable feedstock (oleic acid) to an anti-fungal agent. In this conversion, the new catalyst promotes cross-metathesis more efficiently than the commonly used dichloro-ruthenium complexes, indicating that its utility may extend beyond Z-selective processes.	[Koh, Ming Joo; Khan, R. Kashif M.; Torker, Sebastian; Yu, Miao; Mikus, Malte S.; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Koh, Ming Joo/M-6641-2018; Koh, Ming Joo/O-8549-2019; Khan, Rana Kashif/AAE-9271-2019; Koh, Ming Joo/GOV-7124-2022	Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921; Khan, Rana Kashif/0000-0002-7558-9206	National Science Foundation [CHE-1362763]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from the National Science Foundation (CHE-1362763). R.K.M.K. and M.Y. were partially supported as AstraZeneca Graduate Fellows. We thank Boston College for access to computational facilities.	Behr A, 2011, BEILSTEIN J ORG CHEM, V7, P1, DOI 10.3762/bjoc.7.1; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Buchmeiser MR, 2014, ANGEW CHEM INT EDIT, V53, P9384, DOI 10.1002/anie.201404655; Cannon JS, 2013, ANGEW CHEM INT EDIT, V52, P9001, DOI 10.1002/anie.201302724; DAmbrosio M, 1996, HELV CHIM ACTA, V79, P51, DOI 10.1002/hlca.19960790107; Furstner A, 2013, SCIENCE, V341, P1357, DOI 10.1126/science.1229713; Gunstone F. D., 2001, OLEOCHEMICAL MANUFAC, V1; Hartung J, 2014, ANGEW CHEM INT EDIT, V53, P3885, DOI 10.1002/anie.201310767; Hoveyda A. H., 2014, ANGEW CHEM INT ED; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Hoveyda AH, 2014, J ORG CHEM, V79, P4763, DOI 10.1021/jo500467z; Hoveyda AH, 2009, J AM CHEM SOC, V131, P8378, DOI 10.1021/ja9030903; Ibrahem I, 2009, J AM CHEM SOC, V131, P3844, DOI 10.1021/ja900097n; Kajetanowicz A, 2014, GREEN CHEM, V16, P1579, DOI 10.1039/c3gc42194e; Keitz BK, 2012, J AM CHEM SOC, V134, P693, DOI 10.1021/ja210225e; Keitz BK, 2011, J AM CHEM SOC, V133, P9686, DOI 10.1021/ja203488e; Khan RKM, 2013, J AM CHEM SOC, V135, P10258, DOI 10.1021/ja404208a; Kiesewetter ET, 2013, J AM CHEM SOC, V135, P6026, DOI 10.1021/ja403188t; Koh MJ, 2014, ANGEW CHEM INT EDIT, V53, P1968, DOI 10.1002/anie.201309430; Lin YA, 2010, BEILSTEIN J ORG CHEM, V6, P1219, DOI 10.3762/bjoc.6.140; Mann TJ, 2013, ANGEW CHEM INT EDIT, V52, P8395, DOI 10.1002/anie.201302538; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; Occhipinti G, 2013, J AM CHEM SOC, V135, P3331, DOI 10.1021/ja311505v; Rosebrugh LE, 2013, J AM CHEM SOC, V135, P1276, DOI 10.1021/ja311916m; ROSSITER BE, 1981, J AM CHEM SOC, V103, P464, DOI 10.1021/ja00392a038; SUZUKI Y, 1995, BIOSCI BIOTECH BIOCH, V59, P2049, DOI 10.1271/bbb.59.2049; Torker S, 2014, J AM CHEM SOC, V136, P3439, DOI 10.1021/ja410606b; Werner H, 2003, ORGANOMETALLICS, V22, P1558, DOI 10.1021/om0210006; Wright AE, 2007, J NAT PROD, V70, P412, DOI 10.1021/np060597h; Yu M, 2011, NATURE, V479, P88, DOI 10.1038/nature10563	30	132	136	3	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					181	186		10.1038/nature14061	http://dx.doi.org/10.1038/nature14061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567284				2022-12-28	WOS:000347477600032
J	McGlade, C; Ekins, P				McGlade, Christophe; Ekins, Paul			The geographical distribution of fossil fuels unused when limiting global warming to 2 degrees C	NATURE			English	Article							OIL; GAS; EMISSIONS	Policy makers have generally agreed that the average global temperature rise caused by greenhouse gas emissions should not exceed 2 degrees C above the average global temperature of pre-industrial times(1). It has been estimated that to have at least a 50 per cent chance of keeping warming below 2 degrees C throughout the twenty-first century, the cumulative carbon emissions between 2011 and 2050 need to be limited to around 1,100 gigatonnes of carbon dioxide (Gt CO2)(2,3). However, the greenhouse gas emissions contained in present estimates of global fossil fuel reserves are around three times higher than this(2,4), and so the unabated use of all current fossil fuel reserves is incompatible with a warming limit of 2 degrees C. Here we use a single integrated assessment model that contains estimates of the quantities, locations and nature of the world's oil, gas and coal reserves and resources, and which is shown to be consistent with a wide variety of modelling approaches with different assumptions(5), to explore the implications of this emissions limit for fossil fuel production in different regions. Our results suggest that, globally, a third of oil reserves, half of gas reserves and over 80 per cent of current coal reserves should remain unused from 2010 to 2050 in order to meet the target of 2 degrees C. We show that development of resources in the Arctic and any increase in unconventional oil production are incommensurate with efforts to limit average global warming to 2 degrees C. Our results show that policy makers' instincts to exploit rapidly and completely their territorial fossil fuels are, in aggregate, inconsistent with their commitments to this temperature limit. Implementation of this policy commitment would also render unnecessary continued substantial expenditure on fossil fuel exploration, because any new discoveries could not lead to increased aggregate production.	[McGlade, Christophe; Ekins, Paul] UCL, Inst Sustainable Resources, London WC1H 0NN, England	University of London; University College London	McGlade, C (corresponding author), UCL, Inst Sustainable Resources, Cent House,14 Upper Woburn Pl, London WC1H 0NN, England.	christophe.mcglade@ucl.ac.uk			UK Research Councils under Natural Environment Research Council [NE/G007748/1]; EPSRC [EP/L024756/1] Funding Source: UKRI; NERC [NE/G007748/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L024756/1] Funding Source: researchfish; Natural Environment Research Council [NE/G007748/1] Funding Source: researchfish	UK Research Councils under Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank I. Keppoat the UCL Energy Institute, E. Trutnevyte at ETH Zurich, and A.-M. Lyne at the UCL Department of Statistical Science. This research formed part of the programme of the UK Energy Research Centre and was supported by the UK Research Councils under Natural Environment Research Council award NE/G007748/1.	Ahlbrandt T., 2000, USGS WORLD PETROLEUM; Alberta Energy Regulator (AER), 2014, ALB EN RES 2013 SUPP; Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Anandarajah G, 2011, TIAM UCL GLOBAL MODE; Attanasi E. D., 2010, 2010 SURVEY ENERGY R, P123; Attanasi E. D., 2011, SPE EC MANAGE, V3, P149; Bauer N., 2013, CLIM CHANGE; Bentley R. W., 2009, UKERC REV EVIDENCE G; Brownfield M., 2011, ASSESSMENT PLACE OIL; Brownfield M., 2012, ESTIMATE UNDISCOVERE; Campbell C. J., 2013, ATLAS OIL GAS DEPLET; Carolus M., 2009, POTENTIAL OIL SHALE; CEDIGAZ, 2009, NAT GAS WORLD END JU; Clarke B, 2007, NPC GLOBAL OIL GAS S; Clarke L, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P413; Dyni J.R., 2006, GEOLOGY RESOURCES SO; Federal Institute for Geosciences and Natural Resources (BGR), 2012, EN STUD 2012 RES RES; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/NGEO2248, 10.1038/ngeo2248]; Gautier DL, 2009, SCIENCE, V324, P1175, DOI 10.1126/science.1169467; Herrmann L., 2013, OIL GAS BEGINNERS, P270; IEA, 2013, WORLD EN OUTL; IEA, 2008, INT EN AG WORLD EN O; IEA, 2011, WORLD EN OUTL; IEA, 2020, EUR UN 2020 EN POL R; IEA, 2013, RES RES; IPCC Working Group III, 2014, INT ASS MOD CONS IAM; Klett T., 2003, GIANT OIL GAS FIELDS, P107; Klett T. R., 2012, POTENTIAL ADDITIONS; Klett T. R., 2012, ASSESSMENT POTENTIAL; Leatherdale A, 2011, BIOENERGY REV TECHNI; Leaton J., 2011, UNBURNABLE CARBON AR; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; McGlade CE, 2012, ENERGY, V47, P262, DOI 10.1016/j.energy.2012.07.048; Mcglade CE, 2013, UNCERTAINTIES OUTLOO; McGlade C, 2014, ENERG POLICY, V64, P102, DOI 10.1016/j.enpol.2013.09.042; McGlade C, 2013, ENERGY, V55, P571, DOI 10.1016/j.energy.2013.01.048; MCKELVEY VE, 1972, AM SCI, V60, P32; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Owen NA, 2010, ENERG POLICY, V38, P4743, DOI 10.1016/j.enpol.2010.02.026; Raupach MR, 2014, NAT CLIM CHANGE, V4, P873, DOI 10.1038/NCLIMATE2384; Rogner H. H., 2012, GLOBAL ENERGY ASSESS, P423, DOI DOI 10.13140/RG.2.1.3049.8724; Schenk C., 2009, ESTIMATE RECOVERABLE; Shah A, 2010, ENERG ENVIRON SCI, V3, P700, DOI 10.1039/b918960b; Smith T., 2007, GEOEXPRO, V4, P16; SPE, 2008, PETR RES MAN SYST; Trinnaman J., 2010, SURV EN RES; United Nations Framework Convention on Climate Change (UNFCC), 2009, C PART ITS 15 SESS C; Usher W, 2012, ENERG POLICY, V41, P433, DOI 10.1016/j.enpol.2011.11.004; Yergin D., 2009, PRIZE EPIC QUEST OIL	51	943	962	38	451	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					187	U143		10.1038/nature14016	http://dx.doi.org/10.1038/nature14016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567285	Green Submitted			2022-12-28	WOS:000347477600033
J	Neumann, B; Coakley, S; Giordano-Santini, R; Linton, C; Lee, ES; Nakagawa, A; Xue, D; Hilliard, MA				Neumann, Brent; Coakley, Sean; Giordano-Santini, Rosina; Linton, Casey; Lee, Eui Seung; Nakagawa, Akihisa; Xue, Ding; Hilliard, Massimo A.			EFF-1-mediated regenerative axonal fusion requires components of the apoptotic pathway	NATURE			English	Article							CELL CORPSE ENGULFMENT; CAENORHABDITIS-ELEGANS; C-ELEGANS; SENSORY NEURONS; FUSOGEN EFF-1; RECEPTOR; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; MIGRATION; JMJD6	Functional regeneration after nervous system injury requires transected axons to reconnect with their original target tissue. Axonal fusion, a spontaneous regenerative mechanism identified in several species, provides an efficient means of achieving target reconnection as a regrowing axon is able to contact and fuse with its own separated axon fragment, thereby re-establishing the original axonal tract(1-7). Here we report a molecular characterization of this process in Caenorhabditis elegans, revealing dynamic changes in the subcellular localization of the EFF-1 fusogen after axotomy, and establishing phosphatidylserine (PS) and the PS receptor (PSR-1) as critical components for axonal fusion. PSR-1 functions cell-autonomously in the regrowing neuron and, instead of acting in its canonical signalling pathway(8), acts in a parallel phagocytic pathway that includes the transthyretin protein TTR-52, as well as CED-7, NRF-5 and CED-6 (refs 9-12). We show that TTR-52 binds to PS exposed on the injured axon, and can restore fusion several hours after injury. We propose that PS functions as a 'save-me' signal for the distal fragment, allowing conserved apoptotic cell clearance molecules to function in reestablishing axonal integrity during regeneration of the nervous system.	[Neumann, Brent; Coakley, Sean; Giordano-Santini, Rosina; Linton, Casey; Hilliard, Massimo A.] Univ Queensland, Queensland Brain Inst, CJCADR, Brisbane, Qld 4072, Australia; [Lee, Eui Seung; Nakagawa, Akihisa; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Queensland; University of Colorado System; University of Colorado Boulder	Hilliard, MA (corresponding author), Univ Queensland, Queensland Brain Inst, CJCADR, Brisbane, Qld 4072, Australia.	m.hilliard@uq.edu.au	; Neumann, Brent/C-8181-2009	Coakley, Sean/0000-0002-2750-5426; Linton, Casey/0000-0002-8899-6513; Neumann, Brent/0000-0002-7317-9385; Hilliard, Massimo A/0000-0001-7458-5812	NIH Office of Research Infrastructure Programs [P40 OD010440]; International C. elegans Gene Knockout Consortium; NHMRC [631634, 1068871]; NIH [R01 NS060129, GM059083, GM079097, GM088241]; ARC Future Fellowship [FT110100097]; HFSPO Fellowship [LT000762/2012]; Australian Postgraduate Award; University of Queensland Research Scholarship; ARC LIEF [LE130100078]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088241, R01GM059083, R01GM079097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International C. elegans Gene Knockout Consortium; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC Future Fellowship(Australian Research Council); HFSPO Fellowship; Australian Postgraduate Award(Australian Government); University of Queensland Research Scholarship(University of Queensland); ARC LIEF(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Hammond and S. Roy for support with microscopy; R. Tweedale for comments on the manuscript; P. Bazzicalupo, D. Hall, K. Nguyen, and members of the Hilliard laboratory for discussions and comments; and E. Jorgensen, S. Shaham and X. Wang for sharing reagents. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), and the International C. elegans Gene Knockout Consortium. This work was supported by NHMRC Project Grants 631634 and 1068871, NIH R01 NS060129, and ARC Future Fellowship FT110100097 to M.A.H.; NIH grants GM059083, GM079097 and GM088241 to D. X.; HFSPO Fellowship LT000762/2012 to R.G.S.; Australian Postgraduate Award to S. C.; The University of Queensland Research Scholarship to C. L.; and ARC LIEF grant LE130100078 for microscopy.	Bedi SS, 2001, J NEUROSCI, V21, P9667, DOI 10.1523/JNEUROSCI.21-24-09667.2001; BIRSE SC, 1976, BRAIN RES, V113, P575, DOI 10.1016/0006-8993(76)90058-5; BRENNER S, 1974, GENETICS, V77, P71; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; DERIEMER SA, 1983, BRAIN RES, V272, P157, DOI 10.1016/0006-8993(83)90373-6; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; HOY RR, 1967, SCIENCE, V156, P251, DOI 10.1126/science.156.3772.251; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; MACAGNO ER, 1985, J NEUROSCI, V5, P2510; Mapes J, 2012, CURR BIOL, V22, P1267, DOI 10.1016/j.cub.2012.05.052; MITANI S, 1993, DEVELOPMENT, V119, P773; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Neumann B, 2014, CELL REP, V6, P93, DOI 10.1016/j.celrep.2013.12.004; Neumann B, 2011, DEV DYNAM, V240, P1365, DOI 10.1002/dvdy.22606; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Perez-Vargas J, 2014, CELL, V157, P407, DOI 10.1016/j.cell.2014.02.020; Podbilewicz B., 2006, WORMBOOK; Procko C, 2011, DEVELOPMENT, V138, P1371, DOI 10.1242/dev.058305; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Yang H., NAT COMMUN IN PRESS; Zeev-Ben-Mordehai T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4912; Zhang Y, 2012, CURR BIOL, V22, P1276, DOI 10.1016/j.cub.2012.06.004; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zou W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000679	35	84	92	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					219	U259		10.1038/nature14102	http://dx.doi.org/10.1038/nature14102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567286				2022-12-28	WOS:000347477600040
J	Carter, JL; Coletti, RJ; Harris, RP				Carter, Jamie L.; Coletti, Russell J.; Harris, Russell P.			Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INVASIVE BREAST-CANCER; WOMEN AGED 40; PROSTATE-CANCER; LUNG-CANCER; LEAD TIME; FOLLOW-UP; MAMMOGRAPHY; PROGRAM; MODEL; OVERDETECTION	Objective To determine the optimal method for quantifying and monitoring overdiagnosis in cancer screening over time. Design Systematic review of primary research studies of any design that quantified overdiagnosis from screening for nine types of cancer. We used explicit criteria to critically appraise individual studies and assess strength of the body of evidence for each study design (double blinded review), and assessed the potential for each study design to accurately quantify and monitor overdiagnosis over time. Data sources PubMed and Embase up to 28 February 2014; hand searching of systematic reviews. Eligibility criteria for selecting studies English language studies of any design that quantified overdiagnosis for any of nine common cancers (prostate, breast, lung, colorectal, melanoma, bladder, renal, thyroid, and uterine); excluded case series, case reports, and reviews that only reported results of other studies. Results 52 studies met the inclusion criteria. We grouped studies into four methodological categories: (1) follow-up of a well designed randomized controlled trial (n=3), which has low risk of bias but may not be generalizable and is not suitable for monitoring; (2) pathological or imaging studies (n=8), drawing conclusions about overdiagnosis by examining biological characteristics of cancers, a simple design limited by the uncertain assumption that the measured characteristics are highly correlated with disease progression; (3) modeling studies (n=21), which can be done in a shorter time frame but require complex mathematical equations simulating the natural course of screen detected cancer, the fundamental unknown question; and (4) ecological and cohort studies (n=20), which are suitable for monitoring over time but are limited by a lack of agreed standards, by variable data quality, by inadequate follow-up time, and by the potential for population level confounders. Some ecological and cohort studies, however, have addressed these potential weaknesses in reasonable ways. Conclusions Well conducted ecological and cohort studies in multiple settings are the most appropriate approach for quantifying and monitoring overdiagnosis in cancer screening programs. To support this work, we need internationally agreed standards for ecological and cohort studies and a multinational team of unbiased researchers to perform ongoing analysis.	[Carter, Jamie L.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Coletti, Russell J.] Univ N Carolina, Div Gen Med, Chapel Hill, NC 27599 USA; [Harris, Russell P.] Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Harris, RP (corresponding author), Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA.	russell_harris@med.unc.edu			Agency for Healthcare Research and Quality (AHRQ) Research Centers for Excellence in Clinical Preventive Services [P01 HS021133]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS021133] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ) Research Centers for Excellence in Clinical Preventive Services; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by the Agency for Healthcare Research and Quality (AHRQ) Research Centers for Excellence in Clinical Preventive Services (grant No P01 HS021133). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The funders had no role in study design; in the collection, analysis, or interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Black WC, 2000, J NATL CANCER I, V92, P1280, DOI 10.1093/jnci/92.16.1280; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Ciatto S, 2005, EUR J CANCER, V41, P411, DOI 10.1016/j.ejca.2004.09.030; Coldman A, 2013, CAN MED ASSOC J, V185, pE492, DOI 10.1503/cmaj.121791; Davidov O, 2004, BIOSTATISTICS, V5, P603, DOI 10.1093/biostatistics/kxh012; de Bekker-Grob EW, 2013, BRIT J CANCER, V108, P533, DOI 10.1038/bjc.2013.5; de Gelder R, 2011, PREV MED, V53, P134, DOI 10.1016/j.ypmed.2011.06.009; de Gelder R, 2011, EPIDEMIOL REV, V33, P111, DOI 10.1093/epirev/mxr009; Dominioni L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-18; Donella P, 2009, EUR J CANCER, V45, P3166, DOI 10.1016/j.ejca.2009.06.014; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Duffy SW, 2014, BRIT J CANCER, V110, P1834, DOI 10.1038/bjc.2014.63; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Etzioni R, 2013, ANN INTERN MED, V158, P831, DOI 10.7326/0003-4819-158-11-201306040-00008; Falk RS, 2013, INT J CANCER, V133, P705, DOI 10.1002/ijc.28052; Graif T, 2007, J UROLOGY, V178, P88, DOI 10.1016/j.juro.2007.03.017; Gulati R, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt367; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Gunsoy NB, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3365; Harris R, 2011, PREV MED, V53, P108, DOI 10.1016/j.ypmed.2011.07.004; Hazelton WD, 2012, MATH BIOSCI, V240, P20, DOI 10.1016/j.mbs.2012.05.008; Heijnsdijk EAM, 2009, BRIT J CANCER, V101, P1833, DOI 10.1038/sj.bjc.6605422; Hellquist BN, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.011104; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Junod B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-401; Kalager M, 2012, ANN INTERN MED, V157, P221, DOI 10.7326/0003-4819-157-3-201208070-00025; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindell RM, 2007, RADIOLOGY, V242, P555, DOI 10.1148/radiol.2422052090; Luo DH, 2012, CANCER EPIDEMIOL, V36, pE54, DOI 10.1016/j.canep.2011.09.011; Martinez-Alonso M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2620; McGregor M, 1998, CAN MED ASSOC J, V159, P1368; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Njor SH, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1064; Olsen AH, 2003, BRIT J CANCER, V88, P362, DOI 10.1038/sj.bjc.6600712; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; Pashayan N, 2009, BRIT J CANCER, V100, P1198, DOI 10.1038/sj.bjc.6604973; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; PEETERS PHM, 1989, INT J EPIDEMIOL, V18, P295, DOI 10.1093/ije/18.2.295; Pelzer AE, 2008, BJU INT, V102, P24, DOI 10.1111/j.1464-410X.2008.07566.x; Pinsky PF, 2004, BIOMETRICS, V60, P191, DOI 10.1111/j.0006-341X.2004.00023.x; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Puliti D, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3090; Schwartz LM, 2000, WESTERN J MED, V173, P307, DOI 10.1136/ewjm.173.5.307; Seigneurin A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7017; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SOBUE T, 1992, CANCER, V69, P685, DOI 10.1002/1097-0142(19920201)69:3<685::AID-CNCR2820690315>3.0.CO;2-W; Sone S, 2007, LUNG CANCER, V58, P329, DOI 10.1016/j.lungcan.2007.06.022; Svendsen AL, 2006, CANCER-AM CANCER SOC, V106, P1883, DOI 10.1002/cncr.21823; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; Tsodikov A, 2006, STAT MED, V25, P2846, DOI 10.1002/sim.2257; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Wu GHM, 2012, INT J CANCER, V131, P1367, DOI 10.1002/ijc.27340; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2013, BRIT J CANCER, V109, P2014, DOI 10.1038/bjc.2013.427; Zahl Per-Henrik, 2012, Tidsskr Nor Laegeforen, V132, P414, DOI 10.4045/tidsskr.11.0195; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63; Zappa M, 1998, ANN ONCOL, V9, P1297, DOI 10.1023/A:1008492013196	67	124	128	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2015	350								g7773	10.1136/bmj.g7773	http://dx.doi.org/10.1136/bmj.g7773			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LZ	25569206	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000348130300003
J	Oka, Y; Ye, MY; Zuker, CS				Oka, Yuki; Ye, Mingyu; Zuker, Charles S.			Thirst driving and suppressing signals encoded by distinct neural populations in the brain	NATURE			English	Article							SENSORY CIRCUMVENTRICULAR ORGANS; SUBFORNICAL ORGAN; GABAERGIC NEURONS; STIMULATION; TASTE	Thirst is the basic instinct to drink water. Previously, it was shown that neurons in several circumventricular organs of the hypothalamus are activated by thirst-inducing conditions(1). Here we identify two distinct, genetically separable neural populations in the subfornical organ that trigger or suppress thirst. We show that optogenetic activation of subfornical organ excitatory neurons, marked by the expression of the transcription factor ETV-1, evokes intense drinking behaviour, and does so even in fully water-satiated animals. The light-induced response is highly specific for water, immediate and strictly locked to the laser stimulus. In contrast, activation of a second population of subfornical organ neurons, marked by expression of the vesicular GABA transporter VGAT, drastically suppresses drinking, even in water-craving thirsty animals. These results reveal an innate brain circuit that can turn an animal's water-drinking behaviour on and off, and probably functions as a centre for thirst control in the mammalian brain.	[Oka, Yuki; Ye, Mingyu; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, Columbia Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Oka, Yuki; Ye, Mingyu; Zuker, Charles S.] Columbia Univ, Howard Hughes Med Inst, Columbia Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Oka, Y (corresponding author), CALTECH, Div Biol & Biol Engn 216 76, Pasadena, CA 91125 USA.	yoka@caltech.edu	Ye, Mingyu/R-6778-2017	Ye, Mingyu/0000-0001-8560-4345; Oka, Yuki/0000-0003-2686-0677	National Institute on Drug Abuse; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035025] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Propp for help with mouse husbandry. We also thank H. Fishman for suggestions, Z. Turan, N. Ryba and T. Usdin for technical support, and N. Ryba and members of the Zuker laboratory for comments. We acknowledge B. Lowell and M. Krashes for advice. Y.O. and M.Y. were supported by grants from the National Institute on Drug Abuse and National Institute of Neurological Disorders and Stroke to C.S.Z. C.S.Z. is an investigator of the Howard Hughes Medical Institute.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; BOURQUE CW, 1994, FRONT NEUROENDOCRIN, V15, P231, DOI 10.1006/frne.1994.1010; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Daniels D, 2004, PHYSIOL BEHAV, V81, P319, DOI 10.1016/j.physbeh.2004.02.013; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; EPSTEIN AN, 1969, J PHYSIOL-LONDON, V200, pP98; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Geerling JC, 2008, EXP PHYSIOL, V93, P177, DOI 10.1113/expphysiol.2007.039891; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Johnson AK., 1992, PROG BRAIN RES, V91, P381; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Noda M, 2013, TRENDS NEUROSCI, V36, P661, DOI 10.1016/j.tins.2013.08.004; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; ROBERTSON A, 1983, BRAIN RES, V274, P197, DOI 10.1016/0006-8993(83)90541-3; SMITH PM, 1995, BRAIN RES BULL, V38, P209, DOI 10.1016/0361-9230(95)00088-V; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Stricker EM, 2000, NUTRITION, V16, P821, DOI 10.1016/S0899-9007(00)00412-3; STURGEON R D, 1973, Pharmacology Biochemistry and Behavior, V1, P353, DOI 10.1016/0091-3057(73)90128-7; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Verbalis JG, 2007, J AM SOC NEPHROL, V18, P3056, DOI 10.1681/ASN.2007070825; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Young J.K., 2012, HUNGER THIRST SEX SL	32	139	139	0	50	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					349	+		10.1038/nature14108	http://dx.doi.org/10.1038/nature14108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25624099	Green Accepted			2022-12-28	WOS:000352974200039
J	Joseph, AM; Adashi, EY				Joseph, Allan M.; Adashi, Eli Y.			Health CO-OPs of the Affordable Care Act Promise and Peril at the 5-Year Mark	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Joseph, Allan M.; Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu		Joseph, Allan/0000-0003-2768-0889				Edney A, OBAMACARE AIDED INSU; Gardiner T, REALIZING HLTH REFOR; Giaimo S, 2013, J HEALTH POLIT POLIC, V38, P599, DOI 10.1215/03616878-2079532; James J, HLTH POLICY BRIEF CO; Larson EB, 2009, NEW ENGL J MED, V361, P1620, DOI 10.1056/NEJMp0909021; Radnofsky L, 2014, WALL STREET J E 0612, pA3	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2015	313	14					1419	1420		10.1001/jama.2015.501	http://dx.doi.org/10.1001/jama.2015.501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF8OK	25633925				2022-12-28	WOS:000352821200013
J	Giles, S; Friedman, M; Brazeau, MD				Giles, Sam; Friedman, Matt; Brazeau, Martin D.			Osteichthyan-like cranial conditions in an Early Devonian stem gnathostome	NATURE			English	Article							INCOMPLETE TAXA; MISSING DATA; BRAINCASE; JAWS; CHARACTERS; RADIATION; PLACODERM; ORIGIN	The phylogeny of Silurian and Devonian (443-358 million years(Myr) ago) fishes remains the foremost problem in the study of the origin of modern gnathostomes (jawed vertebrates). A central question concerns themorphology of the last common ancestor of living jawed vertebrates, with competing hypotheses advancing either a chondrichthyan-(1-3) or osteichthyan-like(4,5) model. Here we present Janu-siscus schultzei gen. et sp. nov., an Early Devonian (approximately 415 Myr ago) gnathostome from Siberia previously interpreted as a ray-finned fish(6), which provides important new information about cranial anatomy near the last common ancestor of chondrichthyans and osteichthyans. The skull roof of Janusiscus resembles that of early osteichthyans, with large plates bearing vermiform ridges and partially enclosed sensory canals. High-resolution computed tomography (CT) reveals a braincase bearing characters typically associated with either chondrichthyans (large hypophyseal opening accommodating the internal carotid arteries) or osteichthyans (facial nerve exiting through jugular canal, endolymphatic ducts exiting posterior to the skull roof) but lacking a ventral cranial fissure, the presence of which is considered a derived feature of crown gnathostomes(7,8). A conjunction of well-developed cranial processes in Janusiscus helps unify the comparative anatomy of early jawed vertebrate neurocrania, clarifying primary homologies in 'placoderms', osteichthyans and chondrichthyans. Phylogenetic analysis further supports the chondrichthyan affinities of 'acanthodians', and places Janusiscus and the enigmatic Ramirosuarezia(9) in a polytomy with crown gnathostomes. The close correspondence between the skull roof of Janusiscus and that of osteichthyans suggests that an extensive dermal skeleton was present in the last common ancestor of jawed vertebrates(4), but ambiguities arise from uncertainties in the anatomy of Ramirosuarezia. The unexpected contrast between endoskeletal structure in Janusiscus and its superficially osteichthyan-like dermal skeleton highlights the potential importance of other incompletely known Siluro-Devonian 'bony fishes' for reconstructing patterns of trait evolution near the origin of modern gnathostomes.	[Giles, Sam; Friedman, Matt] Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England; [Brazeau, Martin D.] Nat Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Brazeau, Martin D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	University of Oxford; Naturalis Biodiversity Center; Imperial College London	Brazeau, MD (corresponding author), Nat Biodivers Ctr, POB 9517, NL-2300 RA Leiden, Netherlands.	m.brazeau@imperial.ac.uk	Brazeau, Martin D/AAU-5390-2020	Giles, Sam/0000-0001-9267-4392	Natural Environment Research Council Cohort [NE/J500045/1]; Philip Leverhulme Prize; John Fell Fund; European Research Council (ERC) under the European Union's Seventh Framework Programme [311092]; Natural Environment Research Council [1093317] Funding Source: researchfish	Natural Environment Research Council Cohort; Philip Leverhulme Prize; John Fell Fund; European Research Council (ERC) under the European Union's Seventh Framework Programme(European Research Council (ERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank U. Toom for access to material, E. Mark-Kurik for discussions on stratigraphy and specimen provenance, W. Renema and R. Garwood for assistance with scanning. This work was supported by a Natural Environment Research Council Cohort NE/J500045/1 grant to S.G., the Philip Leverhulme Prize and John Fell Fund, both to M.F., and the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement number 311092 to M.D.B.	Anderson PSL, 2011, NATURE, V476, P206, DOI 10.1038/nature10207; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Blieck A., 1993, P87; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2014, ZOOL J LINN SOC-LOND, V170, P779, DOI 10.1111/zoj.12111; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Broughton R.E., 2013, PLOS CURR; Cunningham JA, 2012, BIOL LETTERS, V8, P833, DOI 10.1098/rsbl.2012.0357; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Goujet D, 1984, POISSONS PLACODERMES; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Jarvik E., 1980, BASIC STRUCTURE EVOL; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; Pradel A, 2009, ACTA ZOOL-STOCKHOLM, V90, P123, DOI 10.1111/j.1463-6395.2008.00350.x; SCHAEFFER B, 1981, Bulletin of the American Museum of Natural History, V169, P1; SCHULTZE H-P, 1977, Palaeontologische Zeitschrift, V51, P152; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; SCHULTZE HP, 1992, FOSSIL FISHES LIVING, P233; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; Swofford D.L., 2003, PAUP VERSION 40 B10; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; Wikinson M., 2001, TAXEQ3 SOFTWARE DOCU; Wilkinson M, 1995, SYST BIOL, V44, P501, DOI 10.1093/sysbio/44.4.501; YOUNG GC, 1979, ZOOL J LINN SOC-LOND, V66, P309, DOI 10.1111/j.1096-3642.1979.tb01912.x; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617	35	79	81	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					82	U175		10.1038/nature14065	http://dx.doi.org/10.1038/nature14065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25581798	Green Submitted, Green Accepted			2022-12-28	WOS:000352027700041
J	Bourane, S; Grossmann, KS; Britz, O; Dalet, A; Del Barrio, MG; Stam, FJ; Garcia-Campmany, L; Koch, S; Goulding, M				Bourane, Steeve; Grossmann, Katja S.; Britz, Olivier; Dalet, Antoine; Del Barrio, Marta Garcia; Stam, Floor J.; Garcia-Campmany, Lidia; Koch, Stephanie; Goulding, Martyn			Identification of a Spinal Circuit for Light Touch and Fine Motor Control	CELL			English	Article							STUMBLING CORRECTIVE REACTION; DORSAL-ROOT GANGLION; SENSORY NEURONS; FUNCTIONAL-ORGANIZATION; MOLECULAR-MECHANISMS; HAIRY SKIN; IN-VIVO; LOCOMOTION; CORD; INTERNEURONS	Sensory circuits in the dorsal spinal cord integrate and transmit multiple cutaneous sensory modalities including the sense of light touch. Here, we identify a population of excitatory interneurons (INs) in the dorsal horn that are important for transmitting innocuous light touch sensation. These neurons express the ROR alpha (ROR alpha) nuclear orphan receptor and are selectively innervated by cutaneous low threshold mechanoreceptors (LTMs). Targeted removal of ROR alpha INs in the dorsal spinal cord leads to a marked reduction in behavioral responsiveness to light touch without affecting responses to noxious and itch stimuli. ROR alpha IN-deficient mice also display a selective deficit in corrective foot movements. This phenotype, together with our demonstration that the ROR alpha INs are innervated by corticospinal and vestibulospinal projection neurons, argues that the ROR alpha INs direct corrective reflex movements by integrating touch information with descending motor commands from the cortex and cerebellum.	[Bourane, Steeve; Grossmann, Katja S.; Britz, Olivier; Dalet, Antoine; Del Barrio, Marta Garcia; Stam, Floor J.; Garcia-Campmany, Lidia; Koch, Stephanie; Goulding, Martyn] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu	Bourane, Steeve/AAI-6143-2020	Bourane, Steeve/0000-0002-9805-2196; Stam, Floor/0000-0003-2017-6911; Koch, Stephanie/0000-0002-7131-4141	NIH [NS080586, NS086372, NS072031]; Catharina Foundation; Humboldt Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086372, P30NS072031, R01NS080586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catharina Foundation; Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Chris Kintner, Qiufu Ma, and John Thomas for discussions and helpful comments on this study. We acknowledge Bo Duan for advice on behavioral tests and Catherine Farrokhi for help with the rotarod and open field analysis. This work was supported by the NIH (NS080586, NS086372, NS072031) to M.G., the Catharina Foundation to S.B., and the Humboldt Foundation to K.S.G.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bourane S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-97; Bretzner F, 2005, J NEUROPHYSIOL, V94, P673, DOI 10.1152/jn.01247.2004; Brown, 1981, ORG SPINAL CORD ANAT; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Del Barrio MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077928; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; FORSSBERG H, 1979, J NEUROPHYSIOL, V42, P936, DOI 10.1152/jn.1979.42.4.936; Fyffe RE, 1992, SENSORY NEURONS DIVE, P131; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GRILLNER S, 1971, EXP BRAIN RES, V12, P457; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Hu J, 2012, J NEUROSCI, V32, P5362, DOI 10.1523/JNEUROSCI.6239-11.2012; HULTBORN H, 1976, ACTA PHYSIOL SCAND, V96, P368, DOI 10.1111/j.1748-1716.1976.tb10206.x; Ito M., 2012, CEREBELLUM BRAIN IMP; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Koch SC, 2012, P NATL ACAD SCI USA, V109, P12201, DOI 10.1073/pnas.1118960109; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li Y, 2013, P NATL ACAD SCI USA, V110, P9106, DOI 10.1073/pnas.1306912110; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; LUNDBERG A, 1962, ACTA PHYSIOL SCAND, V56, P201, DOI 10.1111/j.1748-1716.1962.tb02497.x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Patel M, 2009, EUR J APPL PHYSIOL, V105, P167, DOI 10.1007/s00421-008-0886-4; Perry SD, 2000, BRAIN RES, V877, P401, DOI 10.1016/S0006-8993(00)02712-8; Pratorius B, 2003, NEUROSCI LETT, V346, P173, DOI 10.1016/S0304-3940(03)00582-2; Quevedo J, 2005, J NEUROPHYSIOL, V94, P2045, DOI 10.1152/jn.00175.2005; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Sakurai K, 2013, CELL REP, V5, P87, DOI 10.1016/j.celrep.2013.08.051; Schouenborg J, 2008, BRAIN RES REV, V57, P111, DOI 10.1016/j.brainresrev.2007.08.007; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; SEMBA K, 1984, BRAIN RES, V302, P135, DOI 10.1016/0006-8993(84)91293-9; SHORTLAND P, 1993, J COMP NEUROL, V329, P491, DOI 10.1002/cne.903290406; Stal F, 2003, J VESTIBUL RES-EQUIL, V13, P39; Stam FJ, 2012, DEVELOPMENT, V139, P179, DOI 10.1242/dev.071134; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; WOOLF CJ, 1987, J COMP NEUROL, V261, P105, DOI 10.1002/cne.902610109; Xu Y, 2013, J NEUROSCI, V33, P14738, DOI 10.1523/JNEUROSCI.5512-12.2013; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Zhang JM, 2014, NEURON, V82, P138, DOI 10.1016/j.neuron.2014.02.013; Zia S, 2003, CLIN ANAT, V16, P241, DOI 10.1002/ca.10100	64	98	98	1	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					503	515		10.1016/j.cell.2015.01.011	http://dx.doi.org/10.1016/j.cell.2015.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635458	Green Accepted, Bronze			2022-12-28	WOS:000349208000015
J	Sharma, A; Hartwig, JF				Sharma, Ankit; Hartwig, John F.			Metal-catalysed azidation of tertiary C-H bonds suitable for late-stage functionalization	NATURE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; AMINATION; COMPLEX; CHEMISTRY; OXIDATION; NITROGEN; ALKANE; AZITHROMYCIN; ACTIVATION; MOLECULES	Many enzymes oxidize unactivated aliphatic C-H bonds selectively to form alcohols; however, biological systems do not possess enzymes that catalyse the analogous aminations of C-H bonds(1,2). The absence of such enzymes limits the discovery of potential medicinal candidates because nitrogen-containing groups are crucial to the biological activity of therapeutic agents and clinically useful natural products. In one prominent example illustrating the importance of incorporating nitrogen-based functionality, the conversion of the ketone of erythromycin to the -N(Me)CH2- group in azithromycin leads to a compound that can be dosed once daily with a shorter treatment time(3,4). For such reasons, synthetic chemists have sought catalysts that directly convert C-H bonds to C-N bonds. Most currently used catalysts for C-H bond amination are ill suited to the intermolecular functionalization of complex molecules because they require excess substrate or directing groups, harsh reaction conditions, weak or acidic C-H bonds, or reagents containing specialized groups on the nitrogen atom(5-14). Among C-H bond amination reactions, those forming a C-N bond at a tertiary alkyl group would be particularly valuable, because this linkage is difficult to form from ketones or alcohols that might be created in a biosynthetic pathway by oxidation(15). Here we report a mild, selective, iron-catalysed azidation of tertiary C-H bonds that occurs without excess of the valuable substrate. The reaction tolerates aqueous environments and is suitable for the functionalization of complex structures in the late stages of a multistep synthesis. Moreover, this azidation makes it possible to install a range of nitrogen-based functional groups, including those from Huisgen 'click' cycloadditions and the Staudinger ligation(16-19). We anticipate that these reactions will create opportunities to modify natural products, their precursors and their derivatives to produce analogues that contain different polarity and charge as a result of nitrogen-containing groups. It could also be used to help identify targets of biologically active molecules by creating a point of attachment for example, to fluorescent tags or 'handles' for affinity chromatography-directly on complex molecular structures.	[Sharma, Ankit; Hartwig, John F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jhartwig@berkeley.edu			US NIH [4R37GM055382, S10-RR027172]; Swiss National Science Foundation (SNSF [PBGEP2_145544]; US NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055382, R01GM055382] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF(Swiss National Science Foundation (SNSF)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the US NIH (4R37GM055382 to J.F.H.) and the Swiss National Science Foundation (SNSF; PBGEP2_145544 to AS) for financial support. We thank A. DiPasquale for assistance with crystallographic data and acknowledge US NIH shared instrumentation grant S10-RR027172.	Bollinger JM, 2009, CURR OPIN CHEM BIOL, V13, P51, DOI 10.1016/j.cbpa.2009.03.018; Brase S, 2005, ANGEW CHEM INT EDIT, V44, P5188, DOI 10.1002/anie.200400657; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Costas M, 2011, COORDIN CHEM REV, V255, P2912, DOI 10.1016/j.ccr.2011.06.026; Davies HML, 2011, CHEM SOC REV, V40, P1857, DOI 10.1039/c0cs00217h; Demko ZP, 2002, ANGEW CHEM INT EDIT, V41, P2113, DOI 10.1002/1521-3773(20020617)41:12<2113::AID-ANIE2113>3.0.CO;2-Q; Dequirez G, 2012, ANGEW CHEM INT EDIT, V51, P7384, DOI 10.1002/anie.201201945; Hennessy ET, 2013, SCIENCE, V340, P591, DOI 10.1126/science.1233701; HILL CL, 1983, J ORG CHEM, V48, P3277, DOI 10.1021/jo00167a023; Jeffrey JL, 2013, CHEM SCI, V4, P4092, DOI 10.1039/c3sc51420j; Kim C, 1997, J AM CHEM SOC, V119, P5964, DOI 10.1021/ja9642572; KOJIMA T, 1993, J AM CHEM SOC, V115, P11328, DOI 10.1021/ja00077a035; Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019; Lescot C, 2012, J ORG CHEM, V77, P7232, DOI 10.1021/jo301563j; Lewis JC, 2011, CHEM SOC REV, V40, P2003, DOI 10.1039/c0cs00067a; Li J, 2013, NAT CHEM, V5, P510, DOI [10.1038/NCHEM.1653, 10.1038/nchem.1653]; Louillat ML, 2014, CHEM SOC REV, V43, P901, DOI 10.1039/c3cs60318k; McNally A, 2014, NATURE, V510, P129, DOI 10.1038/nature13389; Michaudel Q, 2012, J AM CHEM SOC, V134, P2547, DOI 10.1021/ja212020b; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; O'Doherty B, 1998, EUR J CLIN MICROBIOL, V17, P828, DOI 10.1007/s100960050201; Ochiai M, 2011, SCIENCE, V332, P448, DOI 10.1126/science.1201686; Plouffe J, 2000, ANTIMICROB AGENTS CH, V44, P1796, DOI 10.1128/AAC.44.7.1796-1802.2000; Pronin SV, 2013, NATURE, V501, P195, DOI 10.1038/nature12472; Roizen JL, 2013, ANGEW CHEM INT EDIT, V52, P11343, DOI 10.1002/anie.201304238; Roizen JL, 2012, ACCOUNTS CHEM RES, V45, P911, DOI 10.1021/ar200318q; Schilling CI, 2011, CHEM SOC REV, V40, P4840, DOI 10.1039/c0cs00123f; Trippier PC, 2013, CHEMMEDCHEM, V8, P190, DOI 10.1002/cmdc.201200498; Zhdankin V. V., 2013, HYPERVALENT IODINE C; Zhdankin VV, 1996, J AM CHEM SOC, V118, P5192, DOI 10.1021/ja954119x	30	291	290	11	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					600	604		10.1038/nature14127	http://dx.doi.org/10.1038/nature14127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631448	Green Accepted, Green Submitted			2022-12-28	WOS:000348775000040
J	Gornall, J				Gornall, Jonathan			The truth about cash for referrals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						[Anonymous], 2014, PRIV HEALTHC MARK IN; [Anonymous], 2013, ROBOTIC RADIOSURGERY; [Anonymous], 2009, ROBOTIC RADIOSURGERY; [Anonymous], 2013, REPORT AND ACCOUNTS; [Anonymous], 2012, REPORT AND ACCOUNTS; [Anonymous], 2014, PRIVATE HEALTHCARE M; [Anonymous], 2008, ROBOTIC RADIOSURGERY; Competition and Markets Authority, 2014, PRIV HEALTHC MARK IN; Competition and Markets Authority, 2014, PRIV HEALTHC MARK IN; GMC, 2013, GOOD MED PRACT; HCA, 2012, PRIV HEALTHC MARK IN; HCA International Limited v Competition and Markets Authority, 2015, SUMM APPL MAIN HEAR; Office of Fair Trading, 2012, PRIV HEALTHC MARK ST; Roland D., 2014, DAILY TELEGRAPH	14	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2015	350								h396	10.1136/bmj.h396	http://dx.doi.org/10.1136/bmj.h396			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AS	25630584				2022-12-28	WOS:000348778600005
J	Topol, EJ; Steinhubl, SR; Torkamani, A				Topol, Eric J.; Steinhubl, Steven R.; Torkamani, Ali			Digital Medical Tools and Sensors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Topol, Eric J.; Steinhubl, Steven R.; Torkamani, Ali] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Topol, Eric J.; Steinhubl, Steven R.; Torkamani, Ali] Scripps Hlth, La Jolla, CA USA; [Topol, Eric J.; Torkamani, Ali] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct,Ste 300, La Jolla, CA 92037 USA.	etopol@scripps.edu		Torkamani, Ali/0000-0003-0232-8053	NCATS NIH HHS [UL1 TR001114, KL2 TR000110, UL1TR001114] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000110, UL1TR001114] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Halpern S., 2014, NEW YORK REV    1120; Lovejoy B., 2014, 9TO5MAC WEBSITE IPHO; Topol E., 2015, PATIENT WILL SEE YOU; Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012; Witze A, 2014, NATURE, V511, P278, DOI 10.1038/511278a; Woods B., NEXT WEB 2020 90 WOR	6	90	92	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					353	354		10.1001/jama.2014.17125	http://dx.doi.org/10.1001/jama.2014.17125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626031	Green Accepted			2022-12-28	WOS:000349072600011
J	Davis, MM				Davis, Mark M.			Flexibility for specificity	SCIENCE			English	Editorial Material							CD4(+) T-CELLS; EFFECTOR		Stanford Univ, Howard Hughes Med Inst, Inst Immun Transplantat & Infect, Dept Microbiol & Immunol,Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Inst Immun Transplantat & Infect, Dept Microbiol & Immunol,Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [U19 AI057229] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007	9	4	4	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					371	372		10.1126/science.aaa5082	http://dx.doi.org/10.1126/science.aaa5082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613876				2022-12-28	WOS:000348225800016
J	Millot, M; Dubrovinskaia, N; Cernok, A; Blaha, S; Dubrovinsky, L; Braun, DG; Celliers, PM; Collins, GW; Eggert, JH; Jeanloz, R				Millot, M.; Dubrovinskaia, N.; Cernok, A.; Blaha, S.; Dubrovinsky, L.; Braun, D. G.; Celliers, P. M.; Collins, G. W.; Eggert, J. H.; Jeanloz, R.			Shock compression of stishovite and melting of silica at planetary interior conditions	SCIENCE			English	Article							TEMPERATURES; SIO2; DYNAMICS; MGSIO3	Deep inside planets, extreme density, pressure, and temperature strongly modify the properties of the constituent materials. In particular, how much heat solids can sustain before melting under pressure is key to determining a planet's internal structure and evolution. We report laser-driven shock experiments on fused silica, alpha-quartz, and stishovite yielding equation-of-state and electronic conductivity data at unprecedented conditions and showing that the melting temperature of SiO2 rises to 8300 K at a pressure of 500 gigapascals, comparable to the core-mantle boundary conditions for a 5-Earth mass super-Earth. We show that mantle silicates and core metal have comparable melting temperatures above 500 to 700 gigapascals, which could favor long-lived magma oceans for large terrestrial planets with implications for planetary magnetic-field generation in silicate magma layers deep inside such planets.	[Millot, M.; Braun, D. G.; Celliers, P. M.; Collins, G. W.; Eggert, J. H.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Millot, M.; Jeanloz, R.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Dubrovinskaia, N.] Univ Bayreuth, Crystallog Lab, D-95440 Bayreuth, Germany; [Cernok, A.; Blaha, S.; Dubrovinsky, L.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of Bayreuth; University of Bayreuth	Millot, M (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	millot1@llnl.gov	Collins, Gilbert/ABH-2158-2020; MILLOT, Marius/GOE-5797-2022; Dubrovinskaia, Natalia/A-8013-2015	Dubrovinskaia, Natalia/0000-0002-8256-5675; Eggert, Jon/0000-0001-5730-7108; Celliers, Peter/0000-0001-7600-1227; Cernok, Ana/0000-0002-9884-6535; Dubrovinsky, Leonid/0000-0002-3717-7585; Millot, Marius/0000-0003-4414-3532	LLNL [DE-AC52-07NA27344]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG); Federal Ministry of Education and Research (BMBF, Germany) through DFG Heisenberg Program [DU 954-8/1]; BMBF [5K13WC3, O5K2013]; U.S. Department of Energy; University of California including UC Berkeley's Miller Institute for Basic Research in Science	LLNL; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF, Germany) through DFG Heisenberg Program(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); U.S. Department of Energy(United States Department of Energy (DOE)); University of California including UC Berkeley's Miller Institute for Basic Research in Science	Data are available in the supplementary materials and upon request to millot1@llnl.gov. Authors gratefully acknowledge assistance of A. Correa Barrios, W. Unites, R. Wallace, C. Davis, and J. Emig, Lawrence Livermore National Laboratory (LLNL); R. Paguio, M. Farrell, and A. Nikroo, General Atomics; M. Bonino, D. Harding, and the entire Omega Laser staff at the Laboratory for Laser Energetics (LLE); H. Schulze, T. Boffa Ballaran, A. Audetat, and H. Fischer (Bayreuth University); and discussions with D. K. Spaulding, T. R. Boehly, and J. R. Rygg. Prepared by LLNL under contract DE-AC52-07NA27344. Omega shots were allocated by LLE Laboratory Basic Science program. N.D. thanks the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) and the Federal Ministry of Education and Research (BMBF, Germany) for financial support through the DFG Heisenberg Program and project no. DU 954-8/1 and the BMBF grant no. 5K13WC3 (Verbundprojekt O5K2013, Teilprojekt 2, PT-DESY). Partial support was provided by the U.S. Department of Energy and the University of California, including UC Berkeley's Miller Institute for Basic Research in Science.	BELONOSHKO AB, 1995, GEOCHIM COSMOCHIM AC, V59, P1883, DOI 10.1016/0016-7037(95)00071-7; BOSLOUGH MB, 1988, J GEOPHYS RES-SOLID, V93, P6477, DOI 10.1029/JB093iB06p06477; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; DAVIES GF, 1982, GEOPHYS RES LETT, V9, P1267, DOI 10.1029/GL009i011p01267; Eggert JH, 2010, NAT PHYS, V6, P40, DOI 10.1038/NPHYS1438; Gonzalez-Cataldo F, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/79; Harada Y, 2014, NAT GEOSCI, V7, P569, DOI 10.1038/NGEO2211; Hicks DG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.025502; Hicks DG, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.2009528; Kerley G., 1999, KPS994, P4; Knudson MD, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.184107; Luo SN, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002860; Luo SN, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002317; LYZENGA GA, 1983, J GEOPHYS RES, V88, P2431, DOI 10.1029/JB088iB03p02431; McQueen R., 1992, SHOCK COMPRESSION CO; McWilliams RS, 2012, SCIENCE, V338, P1330, DOI 10.1126/science.1229450; Melosh HJ, 2007, METEORIT PLANET SCI, V42, P2079, DOI 10.1111/j.1945-5100.2007.tb01009.x; Nettelmann N, 2013, PLANET SPACE SCI, V77, P143, DOI 10.1016/j.pss.2012.06.019; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; SHEN GY, 1995, J GEOPHYS RES-SOL EA, V100, P17699, DOI 10.1029/95JB01864; Stevenson DJ, 2010, SPACE SCI REV, V152, P651, DOI 10.1007/s11214-009-9572-z; Stixrude L, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0076; Trunin R.F., 1994, PHYS-USP, V37, P1123, DOI DOI 10.1070/PU1994V037N11ABEH000055; Tsuchiya T, 2011, P NATL ACAD SCI USA, V108, P1252, DOI 10.1073/pnas.1013594108; Umemoto K, 2006, SCIENCE, V311, P983, DOI 10.1126/science.1120865; Wagner FW, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118441; Wang FL, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009100; ZHANG JZ, 1993, J GEOPHYS RES-SOL EA, V98, P19785, DOI 10.1029/93JB02218	29	108	110	3	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					418	420		10.1126/science.1261507	http://dx.doi.org/10.1126/science.1261507			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613887	Green Submitted, Green Published			2022-12-28	WOS:000348225800042
J	Skinner, MM; Stephens, NB; Tsegai, ZJ; Foote, AC; Nguyen, NH; Gross, T; Pahr, DH; Hublin, JJ; Kivell, TL				Skinner, Matthew M.; Stephens, Nicholas B.; Tsegai, Zewdi J.; Foote, Alexandra C.; Nguyen, N. Huynh; Gross, Thomas; Pahr, Dieter H.; Hublin, Jean-Jacques; Kivell, Tracy L.			Human-like hand use in Australopithecus africanus	SCIENCE			English	Article							THUMB CARPOMETACARPAL JOINT; MANUAL PROPORTIONS; AFARENSIS HAND; METACARPAL; MORPHOLOGY; HANDEDNESS; EVOLUTION; BONES; GRIPS; ATTRIBUTION	The distinctly human ability for forceful precision and power "squeeze" gripping is linked to two key evolutionary transitions in hand use: a reduction in arboreal climbing and the manufacture and use of tools. However, it is unclear when these locomotory and manipulative transitions occurred. Here we show that Australopithecus africanus (similar to 3 to 2 million years ago) and several Pleistocene hominins, traditionally considered not to have engaged in habitual tool manufacture, have a human-like trabecular bone pattern in the metacarpals consistent with forceful opposition of the thumb and fingers typically adopted during tool use. These results support archaeological evidence for stone tool use in australopiths and provide morphological evidence that Pliocene hominins achieved human-like hand postures much earlier and more frequently than previously considered.	[Skinner, Matthew M.; Kivell, Tracy L.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Skinner, Matthew M.; Foote, Alexandra C.] UCL, Dept Anthropol, London WC1H 0BW, England; [Skinner, Matthew M.; Stephens, Nicholas B.; Tsegai, Zewdi J.; Nguyen, N. Huynh; Hublin, Jean-Jacques; Kivell, Tracy L.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Skinner, Matthew M.; Kivell, Tracy L.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Skinner, Matthew M.; Kivell, Tracy L.] Univ Witwatersrand, Ctr Excellence PalaeoSci, ZA-2050 Johannesburg, South Africa; [Gross, Thomas; Pahr, Dieter H.] Vienna Univ Technol, Inst Lightweight Design & Struct Biomech, A-1040 Vienna, Austria	University of Kent; University of London; University College London; Max Planck Society; University of Witwatersrand; University of Witwatersrand; Technische Universitat Wien	Skinner, MM (corresponding author), Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England.	m.skinner@kent.ac.uk; t.l.kivell@kent.ac.uk	Tsegai, Zewdi/AAB-9996-2019; Skinner, Matthew/D-1104-2010; Stephens, Nicholas/J-5162-2017	Tsegai, Zewdi/0000-0001-9041-4829; Pahr, Dieter/0000-0002-5822-2082; Nguyen, Nhu Huynh/0000-0001-5493-3752; Skinner, Matthew/0000-0001-8321-3543; Stephens, Nicholas/0000-0002-2838-5606	Max Planck Society; European Research Council [336301]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission)	Tomographic scans of material from Sterkfontein were produced through a collaborative project between the University of the Witwatersrand and the Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology. We thank R. Lazenby for fruitful discussions and S. McPherron for helpful feedback on previous versions of this manuscript. We thank the following institutions and researchers for access to fossils and comparative specimens in their care: University of Witwatersrand (B. Zipfel), Berlin Museum fur Naturkunde (F. Mayer, S. Jancke), Max Planck Institute for Evolutionary Anthropology (C. Boesch), Musee Royal de l'Afrique Centrale (E. Gilissen, W. Wendelen), Museo Nazionale Preistorico Etnografico "Luigi Pigorini" (R. Macchiarelli), Naturhistorisches Museum Wien (M. Teschler-Nicola, R. Muehl), Senckenberg Museum of Frankfurt (V. Volpato), Tel Aviv University (Y. Rak, I. Herskovitz), and University of Florence (J. Moggi Cecchi, S. Bortoluzzi). We thank C. Moore, D. Reinhardt, P. Schoenfeld, and H. Temming for scanning and technical assistance. This research is supported by the Max Planck Society (M. M. S., T.L.K., Z.J.T., N.B.S., J.-J.H.) and the European Research Council Starting Grant 336301 (T.L.K. and M. M. S.). Author contributions: M. M. S., T.L.K., N.B.S., Z.J.T., A. C. F., and J.-J.H. collected data; D. H. P. developed MedTool software; D. H. P., T.G., and N.H.N. provided analytical support; N.B.S., Z.J.T. and A. C. F. ran analyses; M. M. S., T.L.K., N.B.S., Z.J.T., and A. C. F. interpreted results; M. M. S., T.L.K., N.B.S., Z.J.T., T.G., D. H. P., and J.-J.H. wrote the paper. We confirm no competing financial interests. The data reported in this paper are tabulated in the supplementary materials.	Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; Almecija S, 2014, J HUM EVOL, V73, P88, DOI 10.1016/j.jhevol.2014.02.006; Almecija S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011727; Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Boesch C., 1993, P31; Brooks A. S., 2005, TRANSITIONS TRANSITI, P233; BUSH ME, 1982, AM J PHYS ANTHROPOL, V57, P651, DOI 10.1002/ajpa.1330570410; de Heinzelin J, 1999, SCIENCE, V284, P625; Dominguez-Rodrigo M, 2010, P NATL ACAD SCI USA, V107, P20929, DOI 10.1073/pnas.1013711107; Green DJ, 2008, J HUM EVOL, V54, P705, DOI 10.1016/j.jhevol.2007.10.007; Gross T, 2014, PALAEONTOL ELECTRON, V17; Haara MM, 2004, J BONE JOINT SURG AM, V86A, P1452, DOI 10.2106/00004623-200407000-00013; Halilaj E, 2014, CLIN ORTHOP RELAT R, V472, P1114, DOI 10.1007/s11999-013-3063-y; Jenkins F.A. Jr., 1975, P213; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Koff MF, 2003, J HAND SURG-AM, V28A, P597, DOI 10.1016/S0363-5023(03)00145-X; Latimer B., 1991, P169; Lazenby RA, 2008, J HUM EVOL, V54, P875, DOI 10.1016/j.jhevol.2007.12.001; Lee AT, 2013, J HAND SURG-AM, V38A, P309, DOI 10.1016/j.jhsa.2012.10.038; Lorenzo C, 1999, J HUM EVOL, V37, P501, DOI 10.1006/jhev.1999.0341; Marzke MW, 2015, AM J PHYS ANTHROPOL, V156, P317, DOI 10.1002/ajpa.22651; Marzke MW, 1999, AM J PHYS ANTHROPOL, V110, P163; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; MARZKE MW, 1983, J HUM EVOL, V12, P197, DOI 10.1016/S0047-2484(83)80025-6; Marzke MW, 1996, INT J PRIMATOL, V17, P117, DOI 10.1007/BF02696162; MARZKE MW, 1992, AM J PHYS ANTHROPOL, V89, P283, DOI 10.1002/ajpa.1330890303; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Moya-Sola S, 2008, FOLIA PRIMATOL, V79, P215, DOI 10.1159/000113458; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Niewoehner WA, 1997, AM J PHYS ANTHROPOL, V103, P219, DOI 10.1002/(SICI)1096-8644(199706)103:2<219::AID-AJPA7>3.0.CO;2-O; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; Ricklan D.E., 1990, P171; Rolian C, 2013, AM J PHYS ANTHROPOL, V152, P393, DOI 10.1002/ajpa.22365; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Steele J, 2000, LATERALITY, V5, P193, DOI 10.1080/135765000406067; Stock JT, 2013, ANN NY ACAD SCI, V1288, P86, DOI 10.1111/nyas.12067; SUSMAN RL, 1994, SCIENCE, V265, P1570, DOI 10.1126/science.8079169; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; TRINKAUS E, 1990, AM J PHYS ANTHROPOL, V83, P419, DOI 10.1002/ajpa.1330830403; TRINKAUS E, 1991, AM J PHYS ANTHROPOL, V84, P249, DOI 10.1002/ajpa.1330840303; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; Ward CV, 2014, P NATL ACAD SCI USA, V111, P121, DOI 10.1073/pnas.1316014110; Ward CV, 2012, J HUM EVOL, V63, P1, DOI 10.1016/j.jhevol.2011.11.012; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Williams EM, 2012, J HUM EVOL, V62, P520, DOI 10.1016/j.jhevol.2012.02.005; Zeininger A, 2011, J HUM EVOL, V60, P703, DOI 10.1016/j.jhevol.2011.01.002	49	119	120	4	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					395	399		10.1126/science.1261735	http://dx.doi.org/10.1126/science.1261735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613885				2022-12-28	WOS:000348225800037
J	Fanciulli, A; Wenning, GK				Fanciulli, Alessandra; Wenning, Gregor K.			Multiple-System Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NEUROGENIC ORTHOSTATIC HYPOTENSION; PROGRESSIVE SUPRANUCLEAR PALSY; IDIOPATHIC PARKINSONS-DISEASE; DOUBLE-BLIND; OLIVOPONTOCEREBELLAR ATROPHY; CLINICAL-FEATURES; AUTONOMIC FAILURE; NATURAL-HISTORY; CYTOPLASMIC INCLUSIONS; NOCTURNAL HYPERTENSION		[Fanciulli, Alessandra; Wenning, Gregor K.] Med Univ Innsbruck, Dept Neurol, Div Neurobiol, Anichstr 35, A-6020 Innsbruck, Austria; [Fanciulli, Alessandra] Univ Roma La Sapienza, Dept Neurosci Mental Hlth & Sensory Organs, I-00185 Rome, Italy	Medical University of Innsbruck; Sapienza University Rome	Wenning, GK (corresponding author), Med Univ Innsbruck, Dept Neurol, Div Neurobiol, Anichstr 35, A-6020 Innsbruck, Austria.	gregor.wenning@i-med.ac.at		Wenning, Gregor/0000-0001-9077-1666	AstraZeneca; Lundbeck	AstraZeneca(AstraZeneca); Lundbeck(Lundbeck Corporation)	Dr. Wenning reports receiving consulting fees from AstraZeneca and lecture fees from Lundbeck. No other potential conflict of interest relevant to this article was reported.	Ahmed Z, 2012, NEUROPATH APPL NEURO, V38, P4, DOI 10.1111/j.1365-2990.2011.01234.x; Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Alam M, 1995, J HYPERTENS, V13, P1664; Apartis E, 2012, NEUROLOGY, V79, P1898, DOI 10.1212/WNL.0b013e318271f7ff; Asi YT, 2014, GLIA, V62, P964, DOI 10.1002/glia.22653; BECK RO, 1994, J UROLOGY, V151, P1336, DOI 10.1016/S0022-5347(17)35246-1; Behnke S, 2005, J NEUROL NEUROSUR PS, V76, P423, DOI 10.1136/jnnp.2004.049221; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; BenShlomo Y, 1997, NEUROLOGY, V48, P384, DOI 10.1212/WNL.48.2.384; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Boesch SM, 2002, J NEUROL NEUROSUR PS, V72, P300, DOI 10.1136/jnnp.72.3.300; Boeve BF, 2003, SLEEP MED, V4, P281, DOI 10.1016/S1389-9457(03)00072-8; Bordet R, 1996, MOVEMENT DISORD, V11, P268, DOI 10.1002/mds.870110309; Bower JH, 1997, NEUROLOGY, V49, P1284, DOI 10.1212/WNL.49.5.1284; Brooks DJ, 2009, MOVEMENT DISORD, V24, P949, DOI 10.1002/mds.22413; CHOBANIAN AV, 1979, NEW ENGL J MED, V301, P68, DOI 10.1056/NEJM197907123010202; Dodel R, 2010, MOVEMENT DISORD, V25, P97, DOI 10.1002/mds.22732; Eichhorn TE, 2001, MOVEMENT DISORD, V16, P1176, DOI 10.1002/mds.1211; Fanciulli A, 2013, EUR J NEUROL, V20, P231, DOI 10.1111/j.1468-1331.2012.03819.x; Fanciulli A., 2014, MULTIPLE SYSTEM ATRO, P169; Fanciulli A, 2014, J NEUROL, V261, P1291, DOI 10.1007/s00415-014-7339-2; Ferguson MC, 2014, CLIN AUTON RES, V24, P25, DOI 10.1007/s10286-013-0216-8; Figueroa JJ, 2014, MOVEMENT DISORD, V29, P1151, DOI 10.1002/mds.25927; FOUADTARAZI FM, 1995, AM J MED, V99, P604, DOI 10.1016/S0002-9343(99)80246-0; Freeman R, 1999, NEUROLOGY, V53, P2151, DOI 10.1212/WNL.53.9.2151; Freeman R, 2008, NEW ENGL J MED, V358, P615, DOI 10.1056/NEJMcp074189; Fukushima T, 2013, J NEUROL, V260, P475, DOI 10.1007/s00415-012-6660-x; Gazulla J, 2005, REV NEUROLOGIA, V40, P285, DOI 10.33588/rn.4005.2004448; Ghorayeb I, 2004, J NEUROL NEUROSUR PS, V75, P512; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gilman S, 2005, J NEURAL TRANSM, V112, P1687, DOI 10.1007/s00702-005-0381-6; Goldstein David S, 2013, Handb Clin Neurol, V117, P365, DOI 10.1016/B978-0-444-53491-0.00029-8; Goldstein DS, 2003, HYPERTENSION, V42, P136, DOI 10.1161/01.HYP.0000081216.11623.C3; Goldstein DS, 2003, NEUROLOGY, V60, P1327, DOI 10.1212/01.WNL.0000058766.46428.F3; Gwinn K, 2011, MOVEMENT DISORD, V26, P2134, DOI 10.1002/mds.23776; Heo JH, 2008, J NEUROL SCI, V271, P87, DOI 10.1016/j.jns.2008.03.016; Hussain IF, 2001, J NEUROL NEUROSUR PS, V71, P371, DOI 10.1136/jnnp.71.3.371; Iranzo A, 2005, SLEEP MED, V6, P297, DOI 10.1016/j.sleep.2005.01.006; Itoh K, 2014, NEUROPATHOLOGY, V34, P309, DOI 10.1111/neup.12092; Jain S, 2004, MOVEMENT DISORD, V19, P1360, DOI 10.1002/mds.20211; JANKOVIC J, 1993, AM J MED, V95, P38, DOI 10.1016/0002-9343(93)90230-M; Jecmenica-Lukic M, 2012, LANCET NEUROL, V11, P361, DOI 10.1016/S1474-4422(12)70022-4; Jordan J, 1998, AM J MED, V105, P116, DOI 10.1016/S0002-9343(98)00193-4; KAUFMANN H, 1992, NEUROLOGY, V42, P590, DOI 10.1212/WNL.42.3.590; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kikuchi A, 2010, BRAIN, V133, P1772, DOI 10.1093/brain/awq091; Kim HJ, 2011, MOVEMENT DISORD, V26, P909, DOI 10.1002/mds.23580; Kimber J, 2000, BRAIN, V123, P1422, DOI 10.1093/brain/123.7.1422; Kimber JR, 1997, LANCET, V349, P1877, DOI 10.1016/S0140-6736(96)10168-9; Klein C, 1997, MOVEMENT DISORD, V12, P514, DOI 10.1002/mds.870120407; Klockgether T, 1998, BRAIN, V121, P589, DOI 10.1093/brain/121.4.589; Kollensperger M, 2008, MOVEMENT DISORD, V23, P1093, DOI 10.1002/mds.21992; Kollensperger M, 2010, MOVEMENT DISORD, V25, P2604, DOI 10.1002/mds.23192; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Lin DJ, 2014, MOVEMENT DISORD, V29, P294, DOI 10.1002/mds.25847; Lipp A, 2009, ARCH NEUROL-CHICAGO, V66, P742, DOI 10.1001/archneurol.2009.71; Low PA, 1997, JAMA-J AM MED ASSOC, V277, P1046, DOI 10.1001/jama.277.13.1046; Low PA, 2014, LANCET NEUROL, V13, P268, DOI 10.1016/S1474-4422(13)70301-6; Low PA, 2013, J CLIN NEUROL, V9, P1, DOI 10.3988/jcn.2013.9.1.1; Mancini F, 2003, MOVEMENT DISORD, V18, P685, DOI 10.1002/mds.10420; Merlo IM, 2002, NEUROLOGY, V58, P649, DOI 10.1212/WNL.58.4.649; Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; ONROT J, 1985, NEW ENGL J MED, V313, P549, DOI 10.1056/NEJM198508293130905; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pellecchia MT, 2006, ANN NEUROL, V60, P611, DOI 10.1002/ana.20956; PERERA R, 1995, CLIN AUTON RES, V5, P211, DOI 10.1007/BF01824009; Petrovic IN, 2012, MOVEMENT DISORD, V27, P1184, DOI 10.1002/mds.25115; Poewe W, 2012, MOVEMENT DISORD, V27, pS390; QUINN N, 1989, J NEUROL NEUROSUR PS, P78; Rey MV, 2014, CNS DRUGS, V28, P483, DOI 10.1007/s40263-014-0159-1; Reyes JF, 2014, GLIA, V62, P387, DOI 10.1002/glia.22611; Roncevic D, 2014, J NEURAL TRANSM, V121, P507, DOI 10.1007/s00702-013-1133-7; Sailer A, 2012, MOVEMENT DISORD, V27, pS467; Sakakibara R, 2004, MOVEMENT DISORD, V19, P924, DOI 10.1002/mds.20165; Sakakibara R, 2003, CLIN AUTON RES, V13, P106, DOI 10.1007/s10286-003-0052-3; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; Sasaki H, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-24; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Singer W, 2003, J NEUROL NEUROSUR PS, V74, P1294, DOI 10.1136/jnnp.74.9.1294; Song YJC, 2007, AM J PATHOL, V171, P1291, DOI 10.2353/ajpath.2007.070201; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stankovic I, 2014, MOVEMENT DISORD, V29, P857, DOI 10.1002/mds.25880; Stemberger S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.04.001; Stemberger S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019808; Tison F, 1996, J NEUROL, V243, P153, DOI 10.1007/BF02444007; Vodusek DB, 2005, J NEURAL TRANSM, V112, P1657, DOI 10.1007/s00702-005-0377-2; Wakabayashi K, 2005, ACTA NEUROPATHOL, V110, P185, DOI 10.1007/s00401-005-1029-1; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Wenning GK, 2005, CLIN NEUROPHARMACOL, V28, P225, DOI 10.1097/01.wnf.0000183240.47960.f0; WENNING GK, 1994, BRAIN, V117, P835, DOI 10.1093/brain/117.4.835; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Wenning GK, 2013, LANCET NEUROL, V12, P264, DOI 10.1016/S1474-4422(12)70327-7; Winge K, 2006, MOVEMENT DISORD, V21, P737, DOI 10.1002/mds.20867; Wright RA, 1998, NEUROLOGY, V51, P120, DOI 10.1212/WNL.51.1.120; Zhang F, 2014, REV NEUROSCIENCE, V25, P653, DOI 10.1515/revneuro-2014-0023	101	393	403	3	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					249	263		10.1056/NEJMra1311488	http://dx.doi.org/10.1056/NEJMra1311488			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25587949				2022-12-28	WOS:000348119200009
J	Leslie, Q				Leslie, Quinn			Take a Look at Me Now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Mt Sinai St Lukes Mt Sinai Roosevelt, Dept Emergency Med, New York, NY 10025 USA	Mount Sinai St. Luke's; Mount Sinai West	Leslie, Q (corresponding author), Mt Sinai St Lukes Mt Sinai Roosevelt, Dept Emergency Med, New York, NY 10025 USA.	quinn.t.c.leslie@gmail.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					137	138		10.1001/jama.2014.15774	http://dx.doi.org/10.1001/jama.2014.15774			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585321				2022-12-28	WOS:000347679300009
J	Guigo, R; Valcarcel, J				Guigo, Roderic; Valcarcel, Juan			Prescribing splicing	SCIENCE			English	Editorial Material							GENE-EXPRESSION; CODE		[Guigo, Roderic; Valcarcel, Juan] Ctr Genom Regulat, Barcelona 08003, Spain; [Guigo, Roderic; Valcarcel, Juan] Univ Pompeu Fabra, Barcelona 08003, Spain; [Valcarcel, Juan] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Guigo, R (corresponding author), Ctr Genom Regulat, Barcelona 08003, Spain.	roderic.guigo@crg.cat	Valcarcel, Juan/O-9814-2014; Guigo, Roderic/D-1303-2010	Valcarcel, Juan/0000-0001-5398-3571; Guigo, Roderic/0000-0002-5738-4477	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG007234] Funding Source: NIH RePORTER; ICREA Funding Source: Custom; NHGRI NIH HHS [U41 HG007234] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ICREA(ICREA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kornblihtt A. R., 2013, MOL CELL BIOL, V14, P153; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150	12	6	6	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					124	125		10.1126/science.aaa4864	http://dx.doi.org/10.1126/science.aaa4864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574005	Green Accepted			2022-12-28	WOS:000347918900021
J	Huch, M				Huch, Meritxell			REGENERATIVE BIOLOGY The versatile and plastic liver	NATURE			English	Editorial Material							HEPATOCYTES; CELLS; DIFFERENTIATION; PROGENITORS; INJURY		[Huch, Meritxell] Wellcome Trust Res Labs, MRC Stem Cell Inst, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England; [Huch, Meritxell] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	Wellcome Trust Sanger Institute; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute	Huch, M (corresponding author), Wellcome Trust Res Labs, MRC Stem Cell Inst, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England.	m.huch@gurdon.cam.ac.uk			Wellcome Trust [104151] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; EVARTS RP, 1989, CANCER RES, V49, P1541; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Hattoum A, 2013, HUM PATHOL, V44, P743, DOI 10.1016/j.humpath.2012.07.018; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Vilarinho S, 2012, CELL, V150, P1096, DOI 10.1016/j.cell.2012.08.030; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003	13	8	8	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					155	156		10.1038/517155a	http://dx.doi.org/10.1038/517155a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567279				2022-12-28	WOS:000347477600025
J	Brent, DA; Brown, CH				Brent, David A.; Brown, C. Hendricks			Effectiveness of school-based suicide prevention programmes	LANCET			English	Editorial Material							INTERVENTIONS; REPLICATION; COMMUNITIES; BEHAVIOR; OUTCOMES		[Brent, David A.] Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; [Brown, C. Hendricks] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Northwestern University; Feinberg School of Medicine	Brent, DA (corresponding author), Western Psychiat Inst & Clin, 3811 OHara St, Pittsburgh, PA 15213 USA.	brentda@upmc.edu		Brown, C Hendricks/0000-0002-0294-2419				Apter A, 2009, OXFORD TXB SUICIDOLO, P653; Aseltine RH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-161; Brown CH, 2007, INT REV PSYCHIATR, V19, P617, DOI 10.1080/09540260701797779; Hawkins JD, 2014, JAMA PEDIATR, V168, P122, DOI 10.1001/jamapediatrics.2013.4009; Kellam SG, 2008, DRUG ALCOHOL DEPEN, V95, pS5, DOI 10.1016/j.drugalcdep.2008.01.004; Kuklinski MR, 2012, PREV SCI, V13, P150, DOI 10.1007/s11121-011-0259-9; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; Sandler I, 2014, ANNU REV CLIN PSYCHO, V10, P243, DOI 10.1146/annurev-clinpsy-050212-185524; SHAFFER D, 1990, JAMA-J AM MED ASSOC, V264, P3151, DOI 10.1001/jama.264.24.3151; Wasserman D., 2015, LANCET; Wilcox HC, 2008, DRUG ALCOHOL DEPEN, V95, pS60, DOI 10.1016/j.drugalcdep.2008.01.005; Wyman PA, 2010, AM J PUBLIC HEALTH, V100, P1653, DOI 10.2105/AJPH.2009.190025	12	8	8	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1489	1491		10.1016/S0140-6736(14)61586-5	http://dx.doi.org/10.1016/S0140-6736(14)61586-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25579835				2022-12-28	WOS:000353220000010
J	Tsai, HY; Chen, CCG; Conte, D; Moresco, JJ; Chaves, DA; Mitani, S; Yates, JR; Tsai, MD; Mello, CC				Tsai, Hsin-Yue; Chen, Chun-Chieh G.; Conte, Darryl, Jr.; Moresco, James J.; Chaves, Daniel A.; Mitani, Shohei; Yates, John R., III; Tsai, Ming-Daw; Mello, Craig C.			A Ribonuclease Coordinates siRNA Amplification and mRNA Cleavage during RNAi	CELL			English	Article							GERMLINE GENE-EXPRESSION; SMALL SILENCING RNAS; C. ELEGANS GERMLINE; CAENORHABDITIS-ELEGANS; EPIGENETIC MEMORY; POLYMERASE; DEGRADATION; PIRNAS; INTERFERENCE; REVEALS	Effective silencing by RNA-interference (RNAi) depends on mechanisms that amplify and propagate the silencing signal. In some organisms, small-interfering RNAs (siRNAs) are amplified from target mRNAs by RNA-dependent RNA polymerase (RdRP). Both RdRP recruitment and mRNA silencing require Argonaute proteins, which are generally thought to degrade RNAi targets by directly cleaving them. However, in C. elegans, the enzymatic activity of the primary Argonaute, RDE-1, is not required for silencing activity. We show that RDE-1 can instead recruit an endoribonuclease, RDE-8, to target RNA. RDE-8 can cleave RNA in vitro and is needed for the production of 30 uridylated fragments of target mRNA in vivo. We also find that RDE-8 promotes RdRP activity, thereby ensuring amplification of siRNAs. Together, our findings suggest a model in which RDE-8 cleaves target mRNAs to mediate silencing, while generating 30 uridylated mRNA fragments to serve as templates for the RdRP-directed amplification of the silencing signal.	[Tsai, Hsin-Yue; Chen, Chun-Chieh G.; Conte, Darryl, Jr.; Chaves, Daniel A.; Mello, Craig C.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Tsai, Hsin-Yue; Tsai, Ming-Daw] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Chaves, Daniel A.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Mitani, Shohei] Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan; [Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Academia Sinica - Taiwan; Scripps Research Institute; Universidade de Lisboa; Japan Science & Technology Agency (JST); Tokyo Women's Medical University	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Tsai, Ming-Daw/G-4689-2019	Tsai, Ming-Daw/0000-0003-1374-0414; TSAI, HSIN-YUE/0000-0002-7395-1603; Moresco, James/0000-0003-1178-1642	NIH Office of Research Infrastructure Programs [P40 OD010440]; Leukemia and Lymphoma Society [5247-09]; National Center for Research Resources [5P41RR011823]; National Institute on Aging [R01AG027463]; National Institute of General Medical Sciences [8P41GM103533]; Fundacao para Ciencia e a Tecnologia, Portugal [SFRH/BD/17629/2004/H6BM]; Academia Sinica; NIH [GM058800, 1S10RR027052]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823, S10RR027052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R37GM058800, R01GM058800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fundacao para Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Academia Sinica(Academia Sinica - Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Mello lab for great discussion; E. Kittler and the UMass Deep Sequencing Core for Illumina sequencing; P. Furcinitti and the UMass Light Microscopy Core and the Academia Sinica, Institute of Biological Chemistry Imaging & Cell Biology Core facilities for help with confocal microscopy. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). H.-Y.T was supported by a fellowship from the Leukemia and Lymphoma Society (5247-09). J.J.M. and J.R.Y. were supported by the National Center for Research Resources (5P41RR011823), National Institute on Aging (R01AG027463), and National Institute of General Medical Sciences (8P41GM103533). D.A.C. is supported by Fundacao para Ciencia e a Tecnologia, Portugal (SFRH/BD/17629/2004/H6BM). M.-D.T. is supported by Academia Sinica. C.C.M. is a Howard Hughes Medical Institute Investigator and is supported by NIH grants GM058800 and 1S10RR027052.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Anantharaman Vivek, 2006, RNA Biol, V3, P18; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BRENNER S, 1974, GENETICS, V77, P71; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2013, CELL, V155, P1532, DOI 10.1016/j.cell.2013.11.032; Correa RL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000903; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gu WF, 2012, CELL, V151, P1488, DOI 10.1016/j.cell.2012.11.023; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ibrahim F, 2010, P NATL ACAD SCI USA, V107, P3906, DOI 10.1073/pnas.0912632107; Jain C, 2012, J BACTERIOL, V194, P3883, DOI 10.1128/JB.06554-11; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Lee SR, 2009, RNA, V15, P1363, DOI 10.1261/rna.1630309; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Phillips CM, 2012, GENE DEV, V26, P1433, DOI 10.1101/gad.193904.112; Phillips CM, 2009, METHODS MOL BIOL, V558, P171, DOI 10.1007/978-1-60761-103-5_11; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Shirayama M, 2014, CURR BIOL, V24, P845, DOI 10.1016/j.cub.2014.03.008; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Talsky KB, 2010, J BIOL CHEM, V285, P27614, DOI 10.1074/jbc.M110.142273; Thivierge C, 2012, NAT STRUCT MOL BIOL, V19, P90, DOI 10.1038/nsmb.2186; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952; Xu JW, 2012, NUCLEIC ACIDS RES, V40, P6957, DOI 10.1093/nar/gks359; Yang H, 2012, GENE DEV, V26, P846, DOI 10.1101/gad.180679.111; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang C, 2011, P NATL ACAD SCI USA, V108, P1201, DOI 10.1073/pnas.1018695108	60	44	50	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					407	419		10.1016/j.cell.2015.01.010	http://dx.doi.org/10.1016/j.cell.2015.01.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635455	Green Accepted, Bronze			2022-12-28	WOS:000349208000008
J	Konecky, B				Konecky, Bronwen			Monsoon matters	NATURE			English	Editorial Material							ISOTOPES; PRECIPITATION		[Konecky, Bronwen] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Konecky, Bronwen] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Colorado System; University of Colorado Boulder; Oregon State University	Konecky, B (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	bronwen.konecky@colorado.edu		Konecky, Bronwen/0000-0003-1647-2865				Aggarwal PK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019911; Caley T., 2014, NATURE COMMUN, V5, P5731; Christensen J.H., 2013, CLIM CHANG 2013 PHYS, P1217; Clemens SC, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001926; DANSGAARD W, 1964, TELLUS, V16, P436; Dayem KE, 2010, EARTH PLANET SC LETT, V295, P219, DOI 10.1016/j.epsl.2010.04.003; Evans MN, 2013, QUATERNARY SCI REV, V76, P16, DOI 10.1016/j.quascirev.2013.05.024; Lee JE, 2008, HYDROL PROCESS, V22, P1, DOI 10.1002/hyp.6637; Moerman JW, 2014, GEOPHYS RES LETT, V41, P7907, DOI 10.1002/2014GL061696; Noone D, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P195, DOI 10.1007/978-90-481-3354-3_10	10	1	1	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					445	446		10.1038/517445a	http://dx.doi.org/10.1038/517445a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25612048				2022-12-28	WOS:000348196500025
J	Boulet, SL; Mehta, A; Kissin, DM; Warner, L; Kawwass, JF; Jamieson, DJ				Boulet, Sheree L.; Mehta, Akanksha; Kissin, Dmitry M.; Warner, Lee; Kawwass, Jennifer F.; Jamieson, Denise J.			Trends in Use of and Reproductive Outcomes Associated With Intracytoplasmic Sperm Injection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANCIES; INFERTILITY; ICSI	IMPORTANCE Intracytoplasmic sperm injection (ICSI) is increasingly used in patients without severe male factor infertility without clear evidence of a benefit over conventional in vitro fertilization (IVF). OBJECTIVE To assess national trends and reproductive outcomes for fresh IVF cycles (embryos transferred without being frozen) following the use of ICSI compared with conventional IVF with respect to clinical indications for ICSI use. DESIGN, SETTING, AND POPULATION Retrospective cohort study using data on fresh IVF and ICSI cycles reported to the US National Assisted Reproductive Technology Surveillance System during 1996-2012. MAIN OUTCOMES AND MEASURES Trends in ICSI use during 1996-2012 with respect to male factor infertility, unexplained infertility, maternal age 38 years or older, low oocyte yield, and 2 or more prior assisted reproductive technology cycles; reproductive outcomes for conventional IVF and ICSI cycles during 2008-2012, stratified by the presence or absence of male factor infertility. RESULTS Of the 1 395 634 fresh IVF cycles from 1996 through 2012, 908 767 (65.1%) used ICSI and 499 135 (35.8%) reported male factor infertility. Among cycles with male factor infertility, ICSI use increased from 76.3%(10 876/14 259) to 93.3%(32 191/34 506) (P < .001) during 1996-2012; for those without male factor infertility, ICSI use increased from 15.4%(4197/27 191) to 66.9%(42 321/63 250) (P < .001). During 2008-2012, male factor infertility was reported for 35.7%(176 911/494 907) of fresh cycles. Among those cycles, ICSI use was associated with a lower multiple birth rate compared with conventional IVF (30.9% vs 34.2%; adjusted relative risk [RR], 0.87; 95% CI, 0.83-0.91). Among cycles without male factor infertility (n = 317 996), ICSI use was associated with lower rates of implantation (23.0% vs 25.2%; adjusted RR, 0.93; 95% CI, 0.91-0.95), live birth (36.5% vs 39.2%; adjusted RR, 0.95; 95% CI, 0.93-0.97), and multiple live birth (30.1% vs 31.0%; adjusted RR, 0.93; 95% CI, 0.91-0.95) vs conventional IVF. CONCLUSIONS AND RELEVANCE Among fresh IVF cycles in the United States, ICSI use increased from 36.4% in 1996 to 76.2% in 2012, with the largest relative increase among cycles without male factor infertility. Compared with conventional IVF, ICSI use was not associated with improved postfertilization reproductive outcomes, irrespective of male factor infertility diagnosis.	[Boulet, Sheree L.; Mehta, Akanksha; Kissin, Dmitry M.; Warner, Lee; Kawwass, Jennifer F.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA 30341 USA; [Mehta, Akanksha] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA; [Kissin, Dmitry M.; Kawwass, Jennifer F.; Jamieson, Denise J.] Emory Univ, Sch Med, Dept Obstet & Gynecol, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Emory University; Emory University	Boulet, SL (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,MS K34, Atlanta, GA 30341 USA.	sbu1@cdc.gov		Boulet, Sheree/0000-0002-7638-7374; Kawwass, Jennifer/0000-0001-7345-735X; Jamieson, Denise/0000-0003-2597-1201	National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award UL1TR000454 (Dr Mehta).	Amor DJ, 2008, HUM REPROD, V23, P2826, DOI 10.1093/humrep/den310; Andersen AN, 2008, HUM REPROD UPDATE, V14, P593, DOI 10.1093/humupd/dmn032; Austin PC, 2008, J CLIN EPIDEMIOL, V61, P537, DOI 10.1016/j.jclinepi.2007.07.011; Beck-Fruchter R, 2014, FERTIL STERIL, V101, P690, DOI 10.1016/j.fertnstert.2013.12.004; Bhattacharya S, 2001, LANCET, V357, P2075, DOI 10.1016/S0140-6736(00)05179-5; Bonduelle M, 2002, HUM REPROD, V17, P2600, DOI 10.1093/humrep/17.10.2600; *CDCP, 2013, 2011 ASS REPR TECHN; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Gjerris AC, 2008, HUM REPROD, V23, P1545, DOI 10.1093/humrep/den103; Grimes DA, 2012, OBSTET GYNECOL, V120, P920, DOI 10.1097/AOG.0b013e31826af61a; Jain T, 2007, NEW ENGL J MED, V357, P251, DOI 10.1056/NEJMsa070707; Kim HH, 2007, FERTIL STERIL, V88, P622, DOI 10.1016/j.fertnstert.2006.12.013; Luna M, 2011, J ASSIST REPROD GEN, V28, P911, DOI 10.1007/s10815-011-9614-9; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1395, DOI 10.1016/j.fertnstert.2012.08.026; Sandin S, 2013, JAMA-J AM MED ASSOC, V310, P75, DOI 10.1001/jama.2013.7222; Schlegel PN, 1997, UROLOGY, V49, P435, DOI 10.1016/S0090-4295(97)00032-0; Wu AK, 2014, J UROLOGY, V191, P427, DOI 10.1016/j.juro.2013.08.083; Wu AK, 2013, FERTIL STERIL, V99, P2025, DOI 10.1016/j.fertnstert.2013.01.145; Zhu JL, 2006, BMJ-BRIT MED J, V333, P679, DOI 10.1136/bmj.38919.495718.AE	20	190	193	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					255	263		10.1001/jama.2014.17985	http://dx.doi.org/10.1001/jama.2014.17985			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602996	Green Accepted, Bronze			2022-12-28	WOS:000348145000017
J	Friedman, AM; Ananth, CV; Prendergast, E; D'Alton, ME; Wright, JD				Friedman, Alexander M.; Ananth, Cande V.; Prendergast, Eri; D'Alton, Mary E.; Wright, Jason D.			Variation in and Factors Associated With Use of Episiotomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Friedman, Alexander M.; Ananth, Cande V.; Prendergast, Eri; D'Alton, Mary E.; Wright, Jason D.] Columbia Univ Coll Phys & Surg, Div Maternal Fetal Med, Dept Obstet & Gynecol, New York, NY 10032 USA	Columbia University	Friedman, AM (corresponding author), Columbia Univ Coll Phys & Surg, Div Maternal Fetal Med, Dept Obstet & Gynecol, 622 E 168th St, New York, NY 10032 USA.	amf2104@columbia.edu						American College of Obstetricians-Gynecologists, 2006, Obstet Gynecol, V107, P957; Bansal RK, 1996, AM J OBSTET GYNECOL, V175, P897, DOI 10.1016/S0002-9378(96)80021-4; Frankman EA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.022; KASS RE, 1989, J AM STAT ASSOC, V84, P717, DOI 10.2307/2289653; Main EK, 2009, CURR OPIN OBSTET GYN, V21, P532, DOI 10.1097/GCO.0b013e328332d1b0	5	46	46	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					197	199		10.1001/jama.2014.14774	http://dx.doi.org/10.1001/jama.2014.14774			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585333				2022-12-28	WOS:000347679300021
J	Kain, K				Kain, Kirti			PERSONAL VIEW The NHS lacks cardiovascular screening tools suitable for patients of South Asian descent	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-FACTORS; DISEASE		Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Kain, K (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England.	k.kain@leeds.ac.uk		Kain, Kevin/0000-0001-6068-1272				Alshamsan R, 2011, DIABETES CARE, V34, P655, DOI 10.2337/dc10-1606; Chaturvedi N, 2007, ATHEROSCLEROSIS, V193, P204, DOI 10.1016/j.atherosclerosis.2006.06.017; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Kain K, 2008, J THROMB HAEMOST, V6, P737, DOI 10.1111/j.1538-7836.2008.02935.x; Kain K, 2014, DIABETES; Kain K, 2014, ANN INTERN MED, V160, P140, DOI 10.7326/L14-5001-3; Kain K, 2013, HEART, V99, P614, DOI 10.1136/heartjnl-2012-303217; NHS England, 2013, NHSE121313; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010	11	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2015	350								h52	10.1136/bmj.h52	http://dx.doi.org/10.1136/bmj.h52			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3ME	25575862	Green Accepted			2022-12-28	WOS:000348130800013
J	Jit, M; Brisson, M; Laprise, JF; Choi, YH				Jit, Mark; Brisson, Marc; Laprise, Jean-Francois; Choi, Yoon Hong			Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ECONOMIC-EVALUATION; HPV VACCINE; EFFICACY; BIVALENT; IMMUNOGENICITY; QUADRIVALENT; COUNTRIES	Objective To investigate the incremental cost effectiveness of two dose human papillomavirus vaccination and of additionally giving a third dose. Design Cost effectiveness study based on a transmission dynamic model of human papillomavirus vaccination. Two dose schedules for bivalent or quadrivalent human papillomavirus vaccines were assumed to provide 10, 20, or 30 years' vaccine type protection and cross protection or lifelong vaccine type protection without cross protection. Three dose schedules were assumed to give lifelong vaccine type and cross protection. Setting United Kingdom. Population Males and females aged 12-74 years. Interventions No, two, or three doses of human papillomavirus vaccine given routinely to 12 year old girls, with an initial catch-up campaign to 18 years. Main outcome measure Costs (from the healthcare provider's perspective), health related utilities, and incremental cost effectiveness ratios. Results Giving at least two doses of vaccine seems to be highly cost effective across the entire range of scenarios considered at the quadrivalent vaccine list price of 86.50 pound ((sic)109.23; $136.00) per dose. If two doses give only 10 years' protection but adding a third dose extends this to lifetime protection, then the third dose also seems to be cost effective at 86.50 pound per dose (median incremental cost effectiveness ratio 17 pound 000, interquartile range 11 pound 700-25 pound 800). If two doses protect for more than 20 years, then the third dose will have to be priced substantially lower (median threshold price 31 pound, interquartile range 28- pound 35) pound to be cost effective. Results are similar for a bivalent vaccine priced at 80.50 pound per dose and when the same scenarios are explored by parameterising a Canadian model (HPV-ADVISE) with economic data from the United Kingdom. Conclusions Two dose human papillomavirus vaccine schedules are likely to be the most cost effective option provided protection lasts for at least 20 years. As the precise duration of two dose schedules may not be known for decades, cohorts given two doses should be closely monitored.	[Jit, Mark; Choi, Yoon Hong] Publ Hlth England, Modelling & Econ Unit, London NW9 5EQ, England; [Jit, Mark] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Brisson, Marc; Laprise, Jean-Francois] CHU Quebec, Ctr Rech, SP POS, Quebec City, PQ, Canada; [Brisson, Marc] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London SW7 2AZ, England; [Brisson, Marc] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Choi, Yoon Hong] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London NW9 5EQ, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine; Laval University; Imperial College London; Laval University; Public Health England	Jit, M (corresponding author), Publ Hlth England, Modelling & Econ Unit, London NW9 5EQ, England.	mark.jit@phe.gov.uk	Datta, Samik/S-3822-2016; Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Jit, Mark/0000-0001-6658-8255	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England; Canada Research Chairs programme	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England; Canada Research Chairs programme(Canada Research Chairs)	This research was part funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England. MB is supported by the Canada Research Chairs programme. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; [Anonymous], 2013, BRIT NATL FORMULARY; Brisson M, 2013, VACCINE, V31, P3863, DOI 10.1016/j.vaccine.2013.06.064; Brisson M, 2009, PUBLIC HEALTH GENOM, V12, P343, DOI 10.1159/000214924; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Comite sur l'immunisation du Quebec, 2013, VACC PREAD VIR PAP H; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Fesenfeld M, 2013, VACCINE, V31, P3786, DOI 10.1016/j.vaccine.2013.06.060; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Jit M, 2014, VACCINE, V32, P3237, DOI 10.1016/j.vaccine.2014.03.098; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5775; Joint Committee on Vaccination and Immunisation, 11 12 FEBR 2014 M MI; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Luesley D, 2010, NHSCSP PUBLICATION, V20; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Naud PS, 2014, HUM VACC IMMUNOTHER, V10, P2147, DOI 10.4161/hv.29532; Romanowski B, 2014, HUM VACC IMMUNOTHER, V10, P1155, DOI 10.4161/hv.28022; Rossi PG, 2013, EMJ ONCOL, V1, P80; Stanley MA, 2014, EXPERT REV VACCINES, V13, P1027, DOI 10.1586/14760584.2014.935767; Steben M, 2010, EUROGIN 2010 MONT CA; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Wise J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3744; World Health Organization, 2014, SUMM SAG APR 2014 M	24	51	52	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2015	350								g7584	10.1136/bmj.g7584	http://dx.doi.org/10.1136/bmj.g7584			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LZ	25567037	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000348130300001
J	Riesel, JN				Riesel, Johanna N.			On seeing Roses	LANCET			English	Editorial Material									[Riesel, Johanna N.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Riesel, JN (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.	jriesel@mgh.harvard.edu							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2264	2265		10.1016/S0140-6736(14)62299-6	http://dx.doi.org/10.1016/S0140-6736(14)62299-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25625400				2022-12-28	WOS:000346655700032
J	Ezzedine, K; Eleftheriadou, V; Whitton, M; van Geel, N				Ezzedine, Khaled; Eleftheriadou, Viktoria; Whitton, Maxine; van Geel, Nanja			Vitiligo	LANCET			English	Article							QUALITY-OF-LIFE; DEPIGMENTATION THERAPY; KOEBNERS PHENOMENON; T-CELLS; INCREASED SENSITIVITY; GENERALIZED VITILIGO; SUSCEPTIBILITY LOCI; CHILDHOOD VITILIGO; HUMAN MELANOCYTES; IMMUNE-RESPONSE	Vitiligo, an acquired pigmentary disorder of unknown origin, is the most frequent cause of depigmentation worldwide, with an estimated prevalence of 1%. The disorder can be psychologically devastating and stigmatising, especially in dark skinned individuals. Vitiligo is clinically characterised by the development of white macules due to the loss of functioning melanocytes in the skin or hair, or both. Two forms of the disease are well recognised: segmental and non-segmental vitiligo (the commonest form). To distinguish between these two forms is of prime importance because therapeutic options and prognosis are quite different. The importance of early treatment and understanding of the profound psychosocial effect of vitiligo will be emphasised throughout this Seminar.	[Ezzedine, Khaled] Hop Pellegrin, Natl Ctr Rare Skin Disorders, Dept Dermatol & Paediat Dermatol, F-33076 Bordeaux, France; [Ezzedine, Khaled] Univ Bordeaux 2, INSERM, U1035, F-33076 Bordeaux, France; [Eleftheriadou, Viktoria; Whitton, Maxine] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England; [van Geel, Nanja] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium	CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Nottingham; Ghent University; Ghent University Hospital	Ezzedine, K (corresponding author), Hop St Andre, Natl Ctr Rare Skin Disorders, Dept Dermatol & Paediat Dermatol, Rue Jean Burguet, F-33075 Bordeaux, France.	khaled.ezzedine@chu-bordeaux.fr		Ezzedine, Khaled/0000-0002-5468-4589				Al-Refu K, 2012, PEDIATR DERMATOL, V29, P114, DOI 10.1111/j.1525-1470.2011.01478.x; AlGhamdi KM, 2011, J EUR ACAD DERMATOL, V25, P749, DOI 10.1111/j.1468-3083.2010.03876.x; Alikhan A, 2011, J AM ACAD DERMATOL, V65, P473, DOI 10.1016/j.jaad.2010.11.061; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; BEHL P N, 1972, Indian Journal of Dermatology, V17, P51; Bertolotti A, 2014, PIGM CELL MELANOMA R, V27, P398, DOI 10.1111/pcmr.12219; Birlea SA, 2008, ARCH DERMATOL, V144, P310, DOI 10.1001/archderm.144.3.310; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Boisseau-Garsaud AM, 2000, INT J DERMATOL, V39, P18, DOI 10.1046/j.1365-4362.2000.00880.x; Borimnejad Leili, 2006, Gend Med, V3, P124, DOI 10.1016/S1550-8579(06)80201-9; Brazzelli V, 2007, J EUR ACAD DERMATOL, V21, P1369, DOI 10.1111/j.1468-3083.2007.02278.x; Centre of Evidence Based Dermatology, PIL HIL TRAIL TREATM; Centre of Evidence Based Dermatology, TRAIN US HAND HELD L; Cowan K., 2010, J LIND ALLIANCE GUID; CUI J, 1993, J INVEST DERMATOL, V100, P812, DOI 10.1111/1523-1747.ep12476636; DAS S K, 1985, Genetic Epidemiology, V2, P71; Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x; Diallo A, 2013, PIGM CELL MELANOMA R, V26, P402, DOI 10.1111/pcmr.12065; Dogra S, 2005, INT J DERMATOL, V44, P193, DOI 10.1111/j.1365-4632.2004.01948.x; Dwivedi M, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12105; Eleftheriadou V, 2013, BRIT J DERMATOL, V169, P67, DOI 10.1111/bjd.12530; Eleftheriadou V, 2012, BRIT J DERMATOL, V167, P804, DOI 10.1111/j.1365-2133.2012.11056.x; Eleftheriadou V, 2011, BRIT J DERMATOL, V164, P530, DOI 10.1111/j.1365-2133.2010.10160.x; Eleftheriadou V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-51; Ezzedine K, 2012, BRIT J DERMATOL, V167, P490, DOI 10.1111/j.1365-2133.2012.11002.x; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, pE1, DOI 10.1111/j.1755-148X.2012.00997.x; Ezzedine K, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12186; Ezzedine K, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00999.x; Ezzedine K, 2012, ARCH DERMATOL, V148, P497, DOI 10.1001/archdermatol.2011.351; Ezzedine K, 2011, J AM ACAD DERMATOL, V65, P965, DOI 10.1016/j.jaad.2010.08.031; Falabella R, 2003, J EUR ACAD DERMATOL, V17, P518, DOI 10.1046/j.1468-3083.2003.00718.x; Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x; Gauthier Y, 1995, EUR J DERMATOL, V5, P704; Gauthier Y, 2003, BRIT J DERMATOL, V148, P95, DOI 10.1046/j.1365-2133.2003.05024.x; Gauthier Y, 2010, VITILIGO, P3, DOI 10.1007/978-3-540-69361-1_1; Gawkrodger DJ, 2008, BRIT J DERMATOL, V159, P1051, DOI 10.1111/j.1365-2133.2008.08881.x; Gawkrodger DJ, 2010, POSTGRAD MED J, V86, P466, DOI 10.1136/pgmj.2009.093278; Gey A, 2013, BRIT J DERMATOL, V168, P756, DOI 10.1111/bjd.12166; Gonzalez U, 2011, ARCH DERMATOL, V147, P1428, DOI 10.1001/archdermatol.2011.235; Gupta D, 2012, INDIAN J DERMATOL VE, V78, P49, DOI 10.4103/0378-6323.90946; Halder RM, 1997, CLIN DERMATOL, V15, P899, DOI 10.1016/S0738-081X(97)00131-4; HALDER RM, 1987, J AM ACAD DERMATOL, V16, P948, DOI 10.1016/S0190-9622(87)70119-4; Hann SK, 1996, J AM ACAD DERMATOL, V35, P671, DOI 10.1016/S0190-9622(96)90718-5; HARNING R, 1991, J INVEST DERMATOL, V97, P1078, DOI 10.1111/1523-1747.ep12492607; Harris JE, 2012, J INVEST DERMATOL, V132, P1869, DOI 10.1038/jid.2011.463; Hoffmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031298; Homan MWL, 2008, BRIT J DERMATOL, V159, P915, DOI 10.1111/j.1365-2133.2008.08788.x; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Hu Z, 2006, PEDIATR DERMATOL, V23, P114, DOI 10.1111/j.1525-1470.2006.00192.x; Jimbow K, 2001, BRIT J DERMATOL, V144, P55, DOI 10.1046/j.1365-2133.2001.03952.x; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kemp EH, 2007, AUTOIMMUN REV, V6, P138, DOI 10.1016/j.autrev.2006.09.010; Kim YJ, 2001, DERMATOL SURG, V27, P969, DOI 10.1046/j.1524-4725.2001.01101.x; KORANNE RV, 1988, INT J DERMATOL, V27, P676, DOI 10.1111/j.1365-4362.1988.tb01260.x; Kostopoulou P, 2009, BRIT J DERMATOL, V161, P128, DOI 10.1111/j.1365-2133.2009.09077.x; Kroll TM, 2005, J INVEST DERMATOL, V124, P798, DOI 10.1111/j.0022-202X.2005.23653.x; Kruger C, 2012, INT J DERMATOL, V51, P1206, DOI 10.1111/j.1365-4632.2011.05377.x; Le Poole I C, 1993, Exp Dermatol, V2, P145; Lilly E, 2013, J AM ACAD DERMATOL, V69, pE11, DOI 10.1016/j.jaad.2012.01.038; Liu JB, 2005, CLIN EXP DERMATOL, V30, P327, DOI 10.1111/j.1365-2230.2005.01813.x; Maresca V, 1997, J INVEST DERMATOL, V109, P310, DOI 10.1111/1523-1747.ep12335801; Mosenson JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005127; Mosenson JA, 2012, PIGM CELL MELANOMA R, V25, P88, DOI 10.1111/j.1755-148X.2011.00916.x; NAIR BKH, 1978, INT J DERMATOL, V17, P755, DOI 10.1111/ijd.1978.17.9.755; NAUGHTON GK, 1983, J INVEST DERMATOL, V81, P540, DOI 10.1111/1523-1747.ep12522891; NAUGHTON GK, 1983, J EXP MED, V158, P246, DOI 10.1084/jem.158.1.246; NAUGHTON GK, 1986, J AM ACAD DERMATOL, V15, P978, DOI 10.1016/S0190-9622(86)70260-0; Nicolaidou E, 2012, J AM ACAD DERMATOL, V66, P954, DOI 10.1016/j.jaad.2011.07.010; Njoo MD, 2000, J AM ACAD DERMATOL, V42, P760, DOI 10.1067/mjd.2000.103813; Njoo MD, 1998, ARCH DERMATOL, V134, P1543, DOI 10.1001/archderm.134.12.1543; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; Nogueira LSC, 2009, AN BRAS DERMATOL, V84, P41, DOI 10.1590/S0365-05962009000100006; Panda Ashok Kumar, 2005, Bull Indian Inst Hist Med Hyderabad, V35, P41; Papadopoulos L, 1999, BRIT J MED PSYCHOL, V72, P385, DOI 10.1348/000711299160077; Papadopoulos L, 1998, CLIN EXP DERMATOL, V23, P243; Parsad Davinder, 2003, Health Qual Life Outcomes, V1, P58, DOI 10.1186/1477-7525-1-58; PORTER J, 1978, ARCH DERMATOL, V114, P1384, DOI 10.1001/archderm.114.9.1384; PORTER J, 1979, GEN HOSP PSYCHIAT, V1, P73, DOI 10.1016/0163-8343(79)90081-1; PURI N, 1987, J INVEST DERMATOL, V88, P434, DOI 10.1111/1523-1747.ep12469795; Rao J, 2004, DERMATOL SURG, V30, P1043, DOI 10.1111/j.1524-4725.2004.30313.x; Rashighi M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007811; Rezaei N, 2007, J EUR ACAD DERMATOL, V21, P865, DOI 10.1111/j.1468-3083.2007.02228.x; Richmond JM, 2013, CURR OPIN IMMUNOL, V25, P676, DOI 10.1016/j.coi.2013.10.010; Sandoval-Cruz M, 2011, AUTOIMMUN REV, V10, P762, DOI 10.1016/j.autrev.2011.02.004; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; SCHALLREUTER KU, 1994, DERMATOLOGY, V188, P269, DOI 10.1159/000247164; SCHALLREUTER KU, 1994, BBA-MOL BASIS DIS, V1226, P181, DOI 10.1016/0925-4439(94)90027-2; Schmid-Ott G, 2007, J EUR ACAD DERMATOL, V21, P456, DOI 10.1111/j.1468-3083.2006.01897.x; Sehgal VN, 2007, INDIAN J DERMATOL VE, V73, P149, DOI 10.4103/0378-6323.32708; Silverberg NB, 2010, CURR OPIN PEDIATR, V22, P445, DOI 10.1097/MOP.0b013e32833b6ac3; Singh A, 2014, INDIAN J DERMATOL VE, V80, P29, DOI 10.4103/0378-6323.125479; SINGH M, 1985, INT J DERMATOL, V24, P233, DOI 10.1111/j.1365-4362.1985.tb05445.x; SPRITZ RA, 1994, ADV HUM GENET, V22, P1; SPRITZ RA, 1994, HUM MOL GENET, V3, P1469, DOI 10.1093/hmg/3.suppl_1.1469; Spritz RA, 2012, J INVEST DERMATOL, V132, P268, DOI 10.1038/jid.2011.321; Spritz RA, 2010, GENOME MED, V2, DOI 10.1186/gm199; Spritz RA, 2010, THYROID, V20, P745, DOI 10.1089/thy.2010.1643; Sukan M, 2007, J SEX MARITAL THER, V33, P55, DOI 10.1080/00926230600998482; Taieb A, 2013, BRIT J DERMATOL, V168, P5, DOI 10.1111/j.1365-2133.2012.11197.x; Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; Talsania N, 2010, CLIN EXP DERMATOL, V35, P736, DOI 10.1111/j.1365-2230.2009.03765.x; Tour SK, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-10; UK Dermatology Clinical Trials Network, TRAILS IN DEV; van den Boorn JG, 2011, J INVEST DERMATOL, V131, P1240, DOI 10.1038/jid.2011.16; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; van Geel N, 2012, BRIT J DERMATOL, V166, P240, DOI 10.1111/j.1365-2133.2011.10650.x; van Geel N, 2010, BRIT J DERMATOL, V163, P1186, DOI 10.1111/j.1365-2133.2010.10014.x; van Geel Nanja, 2011, J Cutan Aesthet Surg, V4, P17, DOI 10.4103/0974-2077.79181; van Geel N, 2011, PIGM CELL MELANOMA R, V24, P564, DOI 10.1111/j.1755-148X.2011.00838.x; Weiss G, 2002, J EUR ACAD DERMATOL, V16, P241, DOI 10.1046/j.1473-2165.2002.00406.x; Westerhof W, 1997, ARCH DERMATOL, V133, P1525; Whitton ME, 2010, COCHRANE DB SYST REV, V1; WHITTON ME, 2006, COCHRANE DB SYST REV, V1; Zhou L, 2012, PIGM CELL MELANOMA R, V25, P602, DOI 10.1111/j.1755-148X.2012.01019.x	118	427	449	10	169	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 4	2015	386	9988					74	84		10.1016/S0140-6736(14)60763-7	http://dx.doi.org/10.1016/S0140-6736(14)60763-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2OA	25596811				2022-12-28	WOS:000357519400030
J	Azizi, M; Sapoval, M; Gosse, P; Monge, M; Bobrie, G; Delsart, P; Midulla, M; Mounier-Vehier, C; Courand, PY; Lantelme, P; Denolle, T; Dourmap-Collas, C; Trillaud, H; Pereira, H; Plouin, PF; Chatellier, G				Azizi, Michel; Sapoval, Marc; Gosse, Philippe; Monge, Matthieu; Bobrie, Guillaume; Delsart, Pascal; Midulla, Marco; Mounier-Vehier, Claire; Courand, Pierre-Yves; Lantelme, Pierre; Denolle, Thierry; Dourmap-Collas, Caroline; Trillaud, Herve; Pereira, Helena; Plouin, Pierre-Francois; Chatellier, Gilles		Renal Denervation Hypertension DEN	Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial	LANCET			English	Article							BLOOD-PRESSURE; SYMPATHETIC DENERVATION; EUROPEAN-SOCIETY; SYMPLICITY; ELIGIBILITY; PROTECTION; GUIDELINES; ADHERENCE; THERAPY	Background Conflicting blood pressure-lowering effects of catheter-based renal artery denervation have been reported in patients with resistant hypertension. We compared the ambulatory blood pressure-lowering efficacy and safety of radiofrequency-based renal denervation added to a standardised stepped-care antihypertensive treatment (SSAHT) with the same SSAHT alone in patients with resistant hypertension. Methods The Renal Denervation for Hypertension (DENERHTN) trial was a prospective, open-label randomised controlled trial with blinded endpoint evaluation in patients with resistant hypertension, done in 15 French tertiary care centres specialised in hypertension management. Eligible patients aged 18-75 years received indapamide 1.5 mg, ramipril 10 mg (or irbesartan 300 mg), and amlodipine 10 mg daily for 4 weeks to confirm treatment resistance by ambulatory blood pressure monitoring before randomisation. Patients were then randomly assigned (1:1) to receive either renal denervation plus an SSAHT regimen (renal denervation group) or the same SSAHT alone (control group). The randomisation sequence was generated by computer, and stratified by centres. For SSAHT, after randomisation, spironolactone 25 mg per day, bisoprolol 10 mg per day, prazosin 5 mg per day, and rilmenidine 1 mg per day were sequentially added from months two to five in both groups if home blood pressure was more than or equal to 135/85 mm Hg. The primary endpoint was the mean change in daytime systolic blood pressure from baseline to 6 months as assessed by ambulatory blood pressure monitoring. The primary endpoint was analysed blindly. The safety outcomes were the incidence of acute adverse events of the renal denervation procedure and the change in estimated glomerular filtration rate from baseline to 6 months. This trial is registered with ClinicalTrials.gov, number NCT01570777. Findings Between May 22, 2012, and Oct 14, 2013, 1416 patients were screened for eligibility, 106 of those were randomly assigned to treatment (53 patients in each group, intention-to-treat population) and 101 analysed because of patients with missing endpoints (48 in the renal denervation group, 53 in the control group, modified intention-to-treat population). The mean change in daytime ambulatory systolic blood pressure at 6 months was -15.8 mm Hg (95% CI -19.7 to -11.9) in the renal denervation group and -9.9 mm Hg (-13.6 to -6.2) in the group receiving SSAHT alone, a baseline-adjusted difference of -5.9 mm Hg (-11.3 to -0.5; p=0.0329). The number of antihypertensive drugs and drug-adherence at 6 months were similar between the two groups. Three minor renal denervation-related adverse events were noted (lumbar pain in two patients and mild groin haematoma in one patient). A mild and similar decrease in estimated glomerular filtration rate from baseline to 6 months was observed in both groups. Interpretation In patients with well defined resistant hypertension, renal denervation plus an SSAHT decreases ambulatory blood pressure more than the same SSAHT alone at 6 months. This additional blood pressure lowering effect may contribute to a reduction in cardiovascular morbidity if maintained in the long term after renal denervation.	[Azizi, Michel; Sapoval, Marc; Plouin, Pierre-Francois; Chatellier, Gilles] Paris Descartes Univ, Paris, France; [Azizi, Michel; Monge, Matthieu; Bobrie, Guillaume; Plouin, Pierre-Francois] Hop Europeen Georges Pompidou, AP HP, Hypertens Unit, Paris, France; [Sapoval, Marc] Hop Europeen Georges Pompidou, AP HP, Vasc & Oncol Intervent Radiol Dept, Paris, France; [Azizi, Michel; Pereira, Helena; Chatellier, Gilles] INSERM, Ctr Invest Clin 1418, Paris, France; [Delsart, Pascal; Mounier-Vehier, Claire] CHRU Lille, Hop Cardiol Med Vasc & HTA Lille, Lille, France; [Midulla, Marco] CHRU Lille, Hop Cardiol Radiol & Imagerie Cardiaque & Vasc, F-59037 Lille, France; [Courand, Pierre-Yves; Lantelme, Pierre] Hop Croix Rousse, Dept Cardiol, European Soc Hypertens Excellence Ctr, Hosp Civils Lyon, F-69317 Lyon, France; [Lantelme, Pierre] Univ Lyon 1, Genom Fonct Hypertens Arterielle, F-69622 Villeurbanne, France; [Gosse, Philippe] Ctr Hosp Univ Bordeaux, Hop St Andre, Cardiol Hypertens Dept, Bordeaux, France; [Trillaud, Herve] Ctr Hosp Univ Bordeaux, Hop St Andre, Serv Imagerie Diagnost & Intervent, Bordeaux, France; [Trillaud, Herve] Hop Arthur Gardiner, Ctr Excellence HTA Rennes Dinard, Dinard, France; [Dourmap-Collas, Caroline] Ctr Hosp Univ Rennes, Serv Cardiol & Malad Vasc, Rennes, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Bordeaux; CHU Bordeaux; CHU Rennes; Universite de Rennes	Azizi, M (corresponding author), Hop Europeen Georges Pompidou, INSERM CIC1418, F-75015 Paris, France.	michel.azizi@egp.aphp.fr	Sosner, Philippe/I-6119-2019; Azizi, Michel/Y-9580-2019; Ferrari, Emile/R-2917-2016; Lantelme, Pierre/G-2708-2019; Amar, Laurence/P-5278-2017; Courand, Pierre-Yves/O-1054-2016; , Gosse/I-3950-2019; Lantelme, Pierre/B-4567-2013; Rouviere, Olivier/O-8150-2017	Sosner, Philippe/0000-0002-5771-8174; Amar, Laurence/0000-0003-3942-4276; Courand, Pierre-Yves/0000-0003-3199-7977; Le Jeune, Sylvain/0000-0002-2897-8102; Pereira, Helena/0000-0001-7620-2467; gosse, philippe/0000-0002-5840-7749; Persu, Alexandre/0000-0002-4007-9695; Rouviere, Olivier/0000-0002-0030-478X; Sapoval, marc/0000-0003-4226-6192; Mourad, Jean-Jacques/0000-0003-0877-8311	French Ministry of Health (Soutien aux Technologies Innovantes et Couteuses) [IC110175]; Assistance Publique-Hopitaux de Paris	French Ministry of Health (Soutien aux Technologies Innovantes et Couteuses); Assistance Publique-Hopitaux de Paris	French Ministry of Health.; The trial was sponsored by the Assistance Publique-Hopitaux de Paris and funded by a grant from the French Ministry of Health (Soutien aux Technologies Innovantes et Couteuses 2011, IC110175). We thank Pascaline Aucouturier, Nicolas Hollebecq, Nathalie Gomes, Laroussi Ben Zrig, and Abderraouf Bensaber the Clinical Trial Unit of the Georges Pompidou European Hospital for trial organisation, and data monitoring, collection, and management. We thank all the nursing teams and the DENERHTN investigators for their involvement in patient care. We thank Richard White at Oxford PharmaGenesis for editing the manuscript to journal style.	Al Raisi SI, 2014, EUROINTERVENTION, V10, P277, DOI 10.4244/EIJV10I2A46; Azizi M, 2012, EUR J VASC ENDOVASC, V43, P293, DOI 10.1016/j.ejvs.2011.11.022; Bakris GL, 2014, J AM COLL CARDIOL, V64, P1071, DOI 10.1016/j.jacc.2014.05.012; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bobrie G, 2012, J HYPERTENS, V30, P1656, DOI 10.1097/HJH.0b013e3283551e98; Burnier M, 2013, HYPERTENSION, V62, P218, DOI 10.1161/HYPERTENSIONAHA.113.00687; Davis MI, 2013, J AM COLL CARDIOL, V62, P231, DOI 10.1016/j.jacc.2013.04.010; Esler M, 2014, EUR HEART J, V35, P1178, DOI 10.1093/eurheartj/ehu091; Esler MD, 2014, EUR HEART J, V35, P1752, DOI 10.1093/eurheartj/ehu209; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Korb-Savoldelli V, 2012, J CLIN HYPERTENS, V14, P429, DOI 10.1111/j.1751-7176.2012.00634.x; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Macklin R, 1999, NEW ENGL J MED, V341, P992, DOI 10.1056/NEJM199909233411312; Mahfoud F, 2013, EUR HEART J, V34, P2149, DOI 10.1093/eurheartj/eht154; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Okada T, 2015, CARDIOVASC INTER RAD, V38, P79, DOI 10.1007/s00270-014-0865-6; Pancholy SB, 2014, AM J CARDIOL, V114, P856, DOI 10.1016/j.amjcard.2014.06.018; Persu A, 2014, J HUM HYPERTENS, V28, P150, DOI 10.1038/jhh.2013.88; Persu A, 2014, HYPERTENSION, V63, P1319, DOI 10.1161/HYPERTENSIONAHA.114.03194; Persu A, 2012, HYPERTENSION, V60, P596, DOI 10.1161/HYPERTENSIONAHA.112.195263; Schmieder RE, 2012, J HYPERTENS, V30, P837, DOI 10.1097/HJH.0b013e328352ce78; Smith DHG, 2003, J HYPERTENS, V21, P1291, DOI 10.1097/00004872-200307000-00016; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Stergiou GS, 2010, J HYPERTENS, V28, P1780, DOI 10.1097/HJH.0b013e32833d1e01; Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197; Zuern CS, 2013, J AM COLL CARDIOL, V62, P2124, DOI 10.1016/j.jacc.2013.07.046	30	344	359	1	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 16	2015	385	9981					1957	1965		10.1016/S0140-6736(14)61942-5	http://dx.doi.org/10.1016/S0140-6736(14)61942-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1YR	25631070				2022-12-28	WOS:000354541700029
J	Baubec, T; Colombo, DF; Wirbelauer, C; Schmidt, J; Burger, L; Krebs, AR; Akalin, A; Schubeler, D				Baubec, Tuncay; Colombo, Daniele F.; Wirbelauer, Christiane; Schmidt, Juliane; Burger, Lukas; Krebs, Arnaud R.; Akalin, Altuna; Schuebeler, Dirk			Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation	NATURE			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; PWWP DOMAIN; MAMMALIAN DEVELOPMENT; HISTONE H3; WIDE; MUTATIONS; HETEROCHROMATIN; TRANSCRIPTION; MAINTENANCE	DNA methylation is an epigenetic modification associated with transcriptional repression of promoters and is essential for mammalian development. Establishment of DNA methylation is mediated by the de novo DNA methyltransferases DNMT3A and DNMT3B, whereas DNMT1 ensures maintenance of methylation through replication(1). Absence of these enzymes is lethal(2), and somatic mutations in these genes have been associated with several human diseases(3,4). How genomic DNA methylation patterns are regulated remains poorly understood, as the mechanisms that guide recruitment and activity of DNMTs in vivo are largely unknown. To gain insights into this matter we determined genomic binding and site-specific activity of the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B. We show that both enzymes localize to methylated, CpG-dense regions in mouse stem cells, yet are excluded from active promoters and enhancers. By specifically measuring sites of de novo methylation, we observe that enzymatic activity reflects binding. De novo methylation increases with CpG density, yet is excluded from nudeosomes. Notably, we observed selective binding of DNMT3B to the bodies of transcribed genes, which leads to their preferential methylation. This targeting to transcribed sequences requires SETD2-mediated methylation of lysine 36 on histone H3 and a functional PWWP domain of DNMT3B. Together these findings reveal how sequence and chromatin cues guide de novo methyltransferase activity to ensure methylome integrity.	[Baubec, Tuncay; Colombo, Daniele F.; Wirbelauer, Christiane; Schmidt, Juliane; Burger, Lukas; Krebs, Arnaud R.; Akalin, Altuna; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Burger, Lukas] Swiss Inst Bioinformat, CH-4058 Basel, Switzerland; [Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4001 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; University of Basel	Baubec, T (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	tuncay.baubec@fmi.ch; dirk@fmi.ch	Baubec, Tuncay/J-3719-2014; Baubec, Tuncay/AAQ-8714-2021; AKALIN, ALTUNA/A-4424-2012	Baubec, Tuncay/0000-0001-8474-6587; Baubec, Tuncay/0000-0001-8474-6587; Krebs, Arnaud/0000-0001-7999-6127; Colombo, Daniele/0000-0003-1985-4551; AKALIN, ALTUNA/0000-0002-0468-0117	Novartis Research Foundation; European Union (NoE "EpiGeneSys") [FP7- HEALTH-2010-257082]; European Union ("Blueprint" consortium) [FP7-282510]; European Research Council (EpiGePlas); SNF Sinergia program; Swiss initiative in Systems Biology (RTD Cell Plasticity); Boehringer Ingelheim Fonds; EMBO postdoctoral long-term fellowships	Novartis Research Foundation; European Union (NoE "EpiGeneSys"); European Union ("Blueprint" consortium); European Research Council (EpiGePlas); SNF Sinergia program; Swiss initiative in Systems Biology (RTD Cell Plasticity); Boehringer Ingelheim Fonds(Boehringer Ingelheim); EMBO postdoctoral long-term fellowships	We are grateful to S. Dessus-Babus, K. Jacobeit, T. Roloff (FM I), I. Nissen, and C. Beisel (ETH BSSE) for processing deep-sequencing samples. We thank R. Sack for processing histone H3K27/36 methylation measurements and analysis. We further thank L. Hoerner for technical assistance and M. Stadler and D. Gaidatzis for bioinformatic advice and providing tools to process and analyse deep-sequencing data. FMI imaging and FACS facilities for technical support. P. Ginno (FMI), N. Thomae (FMI), and M. Lorincz (UBC Vancouver) for advice and critical comments on the manuscript. Research in the laboratory of D.S. is supported by the Novartis Research Foundation, the European Union (NoE "EpiGeneSys" FP7- HEALTH-2010-257082 and the "Blueprint" consortium FP7-282510), the European Research Council (EpiGePlas), the SNF Sinergia program, and the Swiss initiative in Systems Biology (RTD Cell Plasticity). J.S. acknowledges support from the Boehringer Ingelheim Fonds. T.B. and A.R.K. acknowledge support from EMBO postdoctoral long-term fellowships.	Akalin A., 2014, BIOINFORMATICS; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Felle M, 2011, NUCLEIC ACIDS RES, V39, P6956, DOI 10.1093/nar/gkr263; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jin BL, 2012, CELL REP, V2, P1411, DOI 10.1016/j.celrep.2012.10.017; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jung HR, 2010, MOL CELL PROTEOMICS, V9, P838, DOI 10.1074/mcp.M900489-MCP200; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kungulovski G, 2014, GENOME RES, V24, P1842, DOI 10.1101/gr.170985.113; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Nanty L, 2011, GENOME RES, V21, P1841, DOI 10.1101/gr.121640.111; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Qin S, 2014, TRENDS BIOCHEM SCI, V39, P536, DOI 10.1016/j.tibs.2014.09.001; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Shirohzu H, 2002, AM J MED GENET, V112, P31, DOI 10.1002/ajmg.10658; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang YL, 2014, CELL REP, V8, P1989, DOI 10.1016/j.celrep.2014.08.031	51	400	409	7	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					243	U278		10.1038/nature14176	http://dx.doi.org/10.1038/nature14176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25607372				2022-12-28	WOS:000352454600044
J	Hanks, TD; Kopec, CD; Brunton, BW; Duan, CA; Erlich, JC; Brody, CD				Hanks, Timothy D.; Kopec, Charles D.; Brunton, Bingni W.; Duan, Chunyu A.; Erlich, Jeffrey C.; Brody, Carlos D.			Distinct relationships of parietal and prefrontal cortices to evidence accumulation	NATURE			English	Article							PERCEPTUAL DECISION-MAKING; NEURAL BASIS; EYE FIELD; CORTEX; RAT; NEURONS; MACAQUE; MOTION; MONKEY; AREA	Gradual accumulation of evidence is thought to be fundamental for decision-making, and its neural correlates have been found in several brain regions'. Here we develop a generalizable method to measure tuning curves that specify the relationship between neural responses and mentally accumulated evidence, and apply it to distinguish the encoding of decision variables in posterior parietal cortex and prefrontal cortex (frontal orienting fields, FOF). We recorded the firing rates of neurons in posterior parietal cortex and FOF from rats performing a perceptual decision-making task. Classical analyses uncovered correlates of accumulating evidence, similar to previous observations in primates and also similar across the two regions. However, tuning curve assays revealed that while the posterior parietal cortex encodes a graded value of the accumulating evidence, the FOF has a more categorical encoding that indicates, throughout the trial, the decision provisionally favoured by the evidence accumulated so far. Contrary to current views(3,5,7,9), this suggests that premotor activity in the frontal cortex does not have a role in the accumulation process, but instead has a more categorical function, such as transforming accumulated evidence into a discrete choice. To probe causally the role of FOF activity, we optogenetically silenced it during different time points of the trial. Consistent with a role in committing to a categorical choice at the end of the evidence accumulation process, but not consistent with a role during the accumulation itself, a behavioural effect was observed only when FOF silencing occurred at the end of the perceptual stimulus. Our results place important constraints on the circuit logic of brain regions involved in decision-making.	[Hanks, Timothy D.; Kopec, Charles D.; Brunton, Bingni W.; Duan, Chunyu A.; Erlich, Jeffrey C.; Brody, Carlos D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Hanks, Timothy D.; Kopec, Charles D.; Brunton, Bingni W.; Duan, Chunyu A.; Erlich, Jeffrey C.; Brody, Carlos D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Brunton, Bingni W.] Univ Washington, Dept Biol, Seattle, WA 98105 USA; [Brunton, Bingni W.] Univ Washington, Dept Appl Math, Seattle, WA 98105 USA; [Erlich, Jeffrey C.] NYU Shanghai, NYU ECNU Inst Brain & Cognit Sci, Shanghai 200122, Peoples R China; [Brody, Carlos D.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; NYU Shanghai; Howard Hughes Medical Institute; Princeton University	Brody, CD (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	brody@princeton.edu	Erlich, Jeffrey C./G-3717-2011	Erlich, Jeffrey C./0000-0001-9073-7986	National Institutes of Health (NIH) [F32MH098572]; Howard Hughes Medical Institute; NIH [T32MH065214]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065214, F32MH098572] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K. Deisseroth for support with optogenetics. We thank A. Akrami, T. Buschman, J. Gold, B. Pesaran, B. Scott, D. Tank and M. Yartsev for comments on the manuscript. We thank A. Begelfer, K. Osorio and J. Teran for animal and laboratory support. T.D.H. was supported by National Institutes of Health (NIH) Award Number F32MH098572. C.A.D. was supported by a Howard Hughes Medical Institute predoctoral fellowship. C.D.K. was supported in part by the NIH Award Number T32MH065214.	Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Ding L, 2012, CEREB CORTEX, V22, P1052, DOI 10.1093/cercor/bhr178; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Guandalini P, 1998, BRAIN RES BULL, V47, P377, DOI 10.1016/S0361-9230(98)00122-1; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lambelet P, 1998, APPL OPTICS, V37, P7289, DOI 10.1364/AO.37.007289; LEONARD CM, 1969, BRAIN RES, V12, P321, DOI 10.1016/0006-8993(69)90003-1; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; Neafsey E. J., 1986, BRAIN RES, V11, P77; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Raposo D, 2014, NAT NEUROSCI, V17, P1784, DOI 10.1038/nn.3865; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	26	241	242	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					220	U195		10.1038/nature14066	http://dx.doi.org/10.1038/nature14066			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25600270	Green Accepted, Green Submitted			2022-12-28	WOS:000352454600039
J	Reuben, DB; Alvanzo, AAH; Ashikaga, T; Bogat, GA; Callahan, CM; Ruffing, V; Steffens, DC				Reuben, David B.; Alvanzo, Anika A. H.; Ashikaga, Takamaru; Bogat, G. Anne; Callahan, Christopher M.; Ruffing, Victoria; Steffens, David C.			National Institutes of Health Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain	ANNALS OF INTERNAL MEDICINE			English	Review								This National Institutes of Health (NIH) Pathways to Prevention Workshop was cosponsored by the NIH Office of Disease Prevention (ODP), the NIH Pain Consortium, the National Institute on Drug Abuse, and the National Institute of Neurological Disorders and Stroke. A multidisciplinary working group developed the workshop agenda, and an evidence-based practice center prepared an evidence report through a contract with the Agency for Healthcare Research and Quality to facilitate the workshop discussion. During the 1.5-day workshop, invited experts discussed the body of evidence, and attendees had opportunities to provide comments during open discussion periods. After weighing evidence from the evidence report, expert presentations, and public comments, an unbiased, independent panel prepared a draft report that identified research gaps and future research priorities. The report was posted on the ODP Web site for 2 weeks for public comment. This article is an abridged version of the panel's full report, which is available at https: //prevention.nih.gov/programs-events/pathways-to-prevention/workshops/opioids-chronic-pain/workshop-resources#final report.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; Johns Hopkins Univ, Baltimore, MD 21287 USA; Univ Vermont, Burlington, VT 05405 USA; Michigan State Univ, E Lansing, MI 48824 USA; Indiana Univ, Ctr Aging Res, Indianapolis, IN 46202 USA; Indiana Univ, Regenstrief Inst, Indianapolis, IN 46202 USA; Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; University of Vermont; Michigan State University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of Connecticut	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, 10945 Le Conte Ave, Los Angeles, CA 90095 USA.							Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Gomes T, 2014, ADDICTION, V109, P1482, DOI 10.1111/add.12598; Substance Abuse Mental Health Services Administration, 2014, NSDUH SER H, V(SMA) 14-4863; Warner M., 2014, NCHS HLTH E STAT TRE	4	113	113	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					295	300		10.7326/M14-2775	http://dx.doi.org/10.7326/M14-2775			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25581341	Green Published			2022-12-28	WOS:000350232500019
J	Zhao, QF; Wang, M; Xu, DX; Zhang, QL; Liu, W				Zhao, Qunfei; Wang, Min; Xu, Dongxiao; Zhang, Qinglin; Liu, Wen			Metabolic coupling of two small-molecule thiols programs the biosynthesis of lincomycin A	NATURE			English	Article							GENE-CLUSTER; MYCOTHIOL; INTERMEDIATE; BACILLITHIOL; MECHANISMS; PROTEINS; ENZYMES; SULFUR; OCTOSE	Low-molecular-mass thiols in organisms are well known for their redox-relevant role in protection against various endogenous and exogenous stresses(1-3). In eukaryotes and Gram-negative bacteria, the primary thiol is glutathione (GSH), a cysteinyl-containing tripeptide. In contrast, mycothiol(MSH), a cysteinyl pseudo-disaccharide, is dominant in Gram-positive actinobacteria, including antibiotic-producing actinomycetes and pathogenic mycobacteria. MSH is equivalent to GSH, either as a cofactor or as a substrate, in numerous biochemical processes(4), most of which have not been characterized, largely due to the dearth of information concerning MSH-dependent proteins. Actinomycetes are able to produce another thiol, ergothioneine (EGT), a histidine betaine derivative that is widely assimilated by plants and animals for variable physiological activities(5). The involvement of EGT in enzymatic reactions, however, lacks any precedent. Here we report that the unprecedented coupling of two bacterial thiols, MSH and EGT, has a constructive role in the biosynthesis of lincomycin A, a sulfur-containing lincosamide (C8 sugar) antibiotic that has been widely used for half a century to treat Gram-positive bacterial infections(6-9). EGT acts as a carrier to template the molecular assembly, and MSH is the sulfur donor for lincomycin maturation after thiol exchange. These thiols function through two unusual S-glycosylations that program lincosamide transfer, activation and modification, providing the first paradigm for EGT-associated biochemical processes and for the poorly understood MSH-dependent biotransformations, a newly described model that is potentially common in the incorporation of sulfur, an element essential for life and ubiquitous in living systems.	[Zhao, Qunfei; Wang, Min; Xu, Dongxiao; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Zhang, Qinglin; Liu, Wen] Huzhou Ctr Biosynthet Innovat, Huzhou 313000, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Liu, W (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	wliu@mail.sioc.ac.cn	Wang, Min/I-1273-2019	Wang, Min/0000-0002-4060-1375; Zhao, Qunfei/0000-0003-3115-7337	NSFC [81302674, 31430005, 91213303, 21472231, 91413101]; STCSM [14JC1407700, 13XD1404500]; MST of China [2012AA02A706]	NSFC(National Natural Science Foundation of China (NSFC)); STCSM(Science & Technology Commission of Shanghai Municipality (STCSM)); MST of China(Ministry of Science and Technology, China)	This work was supported in part by grants from NSFC (81302674, 31430005, 91213303, 21472231 and 91413101), STCSM (14JC1407700 and 13XD1404500) and MST (2012AA02A706) of China.	Ajayi K, 2010, ORG LETT, V12, P2630, DOI 10.1021/ol1008334; BRAHME NM, 1984, J AM CHEM SOC, V106, P7878, DOI 10.1021/ja00337a039; Cermak L, 2007, FOLIA MICROBIOL, V52, P457, DOI 10.1007/BF02932104; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Cooper AJL, 2011, AMINO ACIDS, V41, P7, DOI 10.1007/s00726-010-0552-0; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; FAHEY RC, 1987, METHOD ENZYMOL, V143, P85; Fahey RC, 2013, BBA-GEN SUBJECTS, V1830, P3182, DOI 10.1016/j.bbagen.2012.10.006; Fan F, 2009, CURR OPIN CHEM BIOL, V13, P451, DOI 10.1016/j.cbpa.2009.07.018; Feng J, 2006, J BIOL CHEM, V281, P10778, DOI 10.1074/jbc.M513192200; Gantt RW, 2011, NAT PROD REP, V28, P1811, DOI 10.1039/c1np00045d; Green MR, 2012, MOL CLONING LAB MANU, V1; Herr R. R., 1962, ANTIMICROB AGENTS CH, P560; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Kadlcik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084902; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koberska M, 2008, FOLIA MICROBIOL, V53, P395, DOI 10.1007/s12223-008-0060-8; Lee S, 2004, ORG LETT, V6, P365, DOI 10.1021/ol0362008; Lewis C, 1963, ANTIMICROB AGENTS CH, P570; Lin CI, 2014, J AM CHEM SOC, V136, P906, DOI 10.1021/ja412194w; Mason DJ., 1962, ANTIMICROB AGENTS CH, P554; Mason DJ, 1964, ANTIMICROB AGENTS CH, P7; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2011, BIOCHEMISTRY-US, V50, P10751, DOI 10.1021/bi201460j; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; PESCHKE U, 1995, MOL MICROBIOL, V16, P1137, DOI 10.1111/j.1365-2958.1995.tb02338.x; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; REUSSER F, 1975, ANTIMICROB AGENTS CH, V7, P32, DOI 10.1128/AAC.7.1.32; Sasaki E, 2014, NATURE, V510, P427, DOI 10.1038/nature13256; Sasaki E, 2012, J AM CHEM SOC, V134, P17432, DOI 10.1021/ja308221z; Scharf D.H., 2012, ANGEW CHEM, V124, P10211, DOI DOI 10.1002/ange.201205041; Seebeck FP, 2010, J AM CHEM SOC, V132, P6632, DOI 10.1021/ja101721e; Wang R, 2007, J BIOL CHEM, V282, P16288, DOI 10.1074/jbc.M610347200; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	35	87	98	5	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					115	+		10.1038/nature14137	http://dx.doi.org/10.1038/nature14137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25607359				2022-12-28	WOS:000349098000043
J	Carroll, PA; Eisenman, RN				Carroll, Patrick A.; Eisenman, Robert N.			Growing Old with Myc	CELL			English	Editorial Material							LONGEVITY		[Carroll, Patrick A.; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	eisenman@fhcrc.org		Carroll, Patrick/0000-0001-8147-5750	NATIONAL CANCER INSTITUTE [R01CA057138] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057138] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dang CV, 2014, MYC PATHWAY CANC; Freije A, 2014, CELL REP, V9, P1349, DOI 10.1016/j.celrep.2014.10.012; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Greer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074641; Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Loo LWM, 2005, MOL CELL BIOL, V25, P7078, DOI 10.1128/MCB.25.16.7078-7091.2005; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013	9	4	4	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					365	366		10.1016/j.cell.2015.01.018	http://dx.doi.org/10.1016/j.cell.2015.01.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635453	Green Accepted, Bronze			2022-12-28	WOS:000349208000004
J	Jacobs, RC; Meredyth, NA; Michelson, JD				Jacobs, Robert C.; Meredyth, Nicole A.; Michelson, James D.			Posterior shoulder dislocations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTURE		[Jacobs, Robert C.; Meredyth, Nicole A.; Michelson, James D.] Univ Vermont, Coll Med, Dept Orthopaed & Rehabil, Burlington, VT 05401 USA	University of Vermont	Michelson, JD (corresponding author), Univ Vermont, Coll Med, Dept Orthopaed & Rehabil, Burlington, VT 05401 USA.	james.michelson@uvm.edu	Michelson, James/C-6653-2013	Michelson, James/0000-0001-6997-2666				DETENBECK LC, 1972, J TRAUM, V12, P183, DOI 10.1097/00005373-197203000-00001; Espag MP, 2002, ANN ROY COLL SURG, V84, P334, DOI 10.1308/003588402760452466; Mackenzie DC, 2013, J EMERG MED, V44, P976, DOI 10.1016/j.jemermed.2012.11.080; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; Ogawa K, 1999, J TRAUMA, V46, P318, DOI 10.1097/00005373-199902000-00020; Robinson CM, 2011, J BONE JOINT SURG AM, V93A, P1605, DOI 10.2106/JBJS.J.00973; Robinson CM, 2005, J BONE JOINT SURG AM, V87A, P639, DOI 10.2106/JBJS.D.02371; Rouleau DM, 2014, J AM ACAD ORTHOP SUR, V22, P145, DOI 10.5435/JAAOS-22-03-145; Rouleau DM, 2012, J ORTHOP TRAUMA, V26, P246, DOI 10.1097/BOT.0b013e3182243909; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; ROWE CR, 1956, J BONE JOINT SURG AM, V38, P957, DOI 10.2106/00004623-195638050-00001; Schliemann B, 2011, ARCH ORTHOP TRAUM SU, V131, P1127, DOI 10.1007/s00402-011-1310-9	12	7	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2015	350								h75	10.1136/bmj.h75	http://dx.doi.org/10.1136/bmj.h75			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AS	25630372				2022-12-28	WOS:000348778600021
J	Thomas, N; Sierks, H; Barbieri, C; Lamy, PL; Rodrigo, R; Rickman, H; Koschny, D; Keller, HU; Agarwal, J; A'Hearn, MF; Angrilli, F; Auger, AT; Barucci, MA; Bertaux, JL; Bertini, I; Besse, S; Bodewits, D; Cremonese, G; Da Deppo, V; Davidsson, B; De Cecco, M; Debei, S; El-Maarry, MR; Ferri, F; Fornasier, S; Fulle, M; Giacomini, L; Groussin, O; Gutierrez, PJ; Guttler, C; Hviid, SF; Ip, WH; Jorda, L; Knollenberg, J; Kramm, JR; Kuhrt, E; Kuppers, M; La Forgia, F; Lara, LM; Lazzarin, M; Moreno, JJL; Magrin, S; Marchi, S; Marzari, F; Massironi, M; Michalik, H; Moissl, R; Mottola, S; Naletto, G; Oklay, N; Pajola, M; Pommerol, A; Preusker, F; Sabau, L; Scholten, F; Snodgrass, C; Tubiana, C; Vincent, JB; Wenzel, KP				Thomas, Nicolas; Sierks, Holger; Barbieri, Cesare; Lamy, Philippe L.; Rodrigo, Rafael; Rickman, Hans; Koschny, Detlef; Keller, Horst Uwe; Agarwal, Jessica; A'Hearn, Michael F.; Angrilli, Francesco; Auger, Anne-Therese; Barucci, M. Antonella; Bertaux, Jean-Loup; Bertini, Ivano; Besse, Sebastien; Bodewits, Dennis; Cremonese, Gabriele; Da Deppo, Vania; Davidsson, Bjoern; De Cecco, Mariolino; Debei, Stefano; El-Maarry, Mohamed Ramy; Ferri, Francesca; Fornasier, Sonia; Fulle, Marco; Giacomini, Lorenza; Groussin, Olivier; Gutierrez, Pedro J.; Guettler, Carsten; Hviid, Stubbe F.; Ip, Wing-Huen; Jorda, Laurent; Knollenberg, Joerg; Kramm, J. -Rainer; Kuehrt, Ekkehard; Kueppers, Michael; La Forgia, Fiorangela; Lara, Luisa M.; Lazzarin, Monica; Moreno, Jose J. Lopez; Magrin, Sara; Marchi, Simone; Marzari, Francesco; Massironi, Matteo; Michalik, Harald; Moissl, Richard; Mottola, Stefano; Naletto, Giampiero; Oklay, Nilda; Pajola, Maurizio; Pommerol, Antoine; Preusker, Frank; Sabau, Lola; Scholten, Frank; Snodgrass, Colin; Tubiana, Cecilia; Vincent, Jean-Baptiste; Wenzel, Klaus-Peter			The morphological diversity of comet 67P/Churyumov-Gerasimenko	SCIENCE			English	Article							THERMAL INERTIA; SURFACE; NUCLEUS; GEOLOGY; SHAPE; TOPOGRAPHY; ROUGHNESS	Images of comet 67P/Churyumov-Gerasimenko acquired by the OSIRIS (Optical, Spectroscopic and Infrared Remote Imaging System) imaging system onboard the European Space Agency's Rosetta spacecraft at scales of better than 0.8 meter per pixel show a wide variety of different structures and textures. The data show the importance of airfall, surface dust transport, mass wasting, and insolation weathering for cometary surface evolution, and they offer some support for subsurface fluidization models and mass loss through the ejection of large chunks of material.	[Thomas, Nicolas; El-Maarry, Mohamed Ramy; Pommerol, Antoine] Univ Bern, Phys Inst, Sidlerstr 5, CH-3012 Bern, Switzerland; [Sierks, Holger; Agarwal, Jessica; Guettler, Carsten; Hviid, Stubbe F.; Kramm, J. -Rainer; Oklay, Nilda; Snodgrass, Colin; Tubiana, Cecilia; Vincent, Jean-Baptiste] Univ Gottingen, Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Barbieri, Cesare; La Forgia, Fiorangela; Lazzarin, Monica; Magrin, Sara; Marzari, Francesco] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Lamy, Philippe L.] CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille 13, France; [Lamy, Philippe L.] Aix Marseille Univ, F-13388 Marseille 13, France; [Rodrigo, Rafael] Int Space Sci Inst, CH-3012 Bern, Switzerland; [Rodrigo, Rafael] CSIC, Inst Nacl Tecn Aeroesp, Ctr Astrobiol, Madrid 28850, Spain; [Rickman, Hans] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Rickman, Hans] Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland; [Koschny, Detlef; Besse, Sebastien; Wenzel, Klaus-Peter] European Space Agcy, Sci Support Off, NL-2201 Noordwijk, Netherlands; [Keller, Horst Uwe] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [A'Hearn, Michael F.; Bodewits, Dennis] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Angrilli, Francesco; Debei, Stefano] Univ Padua, Dept Ind Engn, I-35131 Padua, Italy; [Auger, Anne-Therese; Groussin, Olivier] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille, France; [Barucci, M. Antonella; Fornasier, Sonia] Univ Paris Diderot, Univ Paris 06, CNRS, Lab Etud Spatiales & Instrumentat Astrophys,Obser, F-92195 Meudon, France; [Bertaux, Jean-Loup] UVSQ, CNRS, IPSL, Lab Atmospheres,Observ Spatiales, F-78280 Guyancourt, France; [Bertini, Ivano; Ferri, Francesca; Massironi, Matteo; Naletto, Giampiero; Pajola, Maurizio] Univ Padua, Ctr Ateneo Studi Attivita Spaziali Giuseppe Colom, I-35131 Padua, Italy; [Cremonese, Gabriele] Osserv Astron Padova, Ist Nazl Astrofis, I-35122 Padua, Italy; [Da Deppo, Vania; Naletto, Giampiero] CNR IFN UOS Padova LUXOR, I-35131 Padua, Italy; [Davidsson, Bjoern] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [De Cecco, Mariolino] Univ Trent, UNITN, I-38100 Trento, Italy; [Fulle, Marco] Osserv Astron Trieste, INAF, I-34014 Trieste, Italy; [Giacomini, Lorenza; Massironi, Matteo] Univ Padua, Dipartimento Geosci, I-35131 Padua, Italy; [Gutierrez, Pedro J.; Lara, Luisa M.; Moreno, Jose J. Lopez] Inst Astrofis Andalucia CSIC, Granada 18008, Spain; [Keller, Horst Uwe; Hviid, Stubbe F.; Knollenberg, Joerg; Kuehrt, Ekkehard; Mottola, Stefano; Preusker, Frank; Scholten, Frank] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetenforsch, D-12489 Berlin, Germany; [Ip, Wing-Huen] Natl Cent Univ, Grad Inst Astron, Chungli 32054, Taiwan; [Jorda, Laurent] LabAstrophys Marseille, F-13388 Marseille 13, France; [Kueppers, Michael; Moissl, Richard] European Space Agcy, European Space Astron Ctr, Sci Operat Dept, Madrid 28691, Spain; [Marchi, Simone] SW Res Inst, Solar Syst Explorat Res Virtual Inst, Boulder, CO 80302 USA; [Michalik, Harald] Tech Univ Carolo Wilhelmina Braunschweig, Inst Datentech & Kommunikat Netze, D-38106 Braunschweig, Germany; [Naletto, Giampiero] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Sabau, Lola] Inst Nacl Tecn Aeroesp, Torrejon De Ardoz 28850, Madrid, Spain; [Snodgrass, Colin] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England	University of Bern; Max Planck Society; University of Gottingen; University of Padua; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Uppsala University; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; European Space Agency; Braunschweig University of Technology; University System of Maryland; University of Maryland College Park; University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of Padua; Istituto Nazionale Astrofisica (INAF); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Uppsala University; University of Trento; Istituto Nazionale Astrofisica (INAF); University of Padua; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Helmholtz Association; German Aerospace Centre (DLR); National Central University; European Space Agency; Braunschweig University of Technology; University of Padua; Open University - UK	Thomas, N (corresponding author), Univ Bern, Phys Inst, Sidlerstr 5, CH-3012 Bern, Switzerland.	nicolas.thomas@space.unibe.ch	Marzari, Francesco/X-2440-2019; Tubiana, Cecilia/AAG-8209-2019; Moreno, Jose Juan Lopez/M-5537-2019; Rickman, Hans/X-7631-2018; Naletto, Giampiero/S-6329-2016; Da Deppo, Vania/D-2897-2012; Gutiérrez, Pedro J/AAJ-6177-2020; La Forgia, Fiorangela/AAD-7477-2019; La Forgia, Fiorangela/F-3107-2015; Jorda, Laurent/AAA-1718-2021; El-Maarry, M. Ramy/K-1360-2018; Pajola, Maurizio/N-5574-2018; Lara, Luisa M/F-5614-2012; Thomas, Nicolas/G-4693-2015	Tubiana, Cecilia/0000-0001-8475-9898; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Rickman, Hans/0000-0002-9603-6619; Naletto, Giampiero/0000-0003-2007-3138; Da Deppo, Vania/0000-0001-6273-8738; Gutiérrez, Pedro J/0000-0002-7332-6269; La Forgia, Fiorangela/0000-0003-3924-1867; La Forgia, Fiorangela/0000-0003-3924-1867; El-Maarry, M. Ramy/0000-0002-8262-0320; Pajola, Maurizio/0000-0002-3144-1277; Lara, Luisa M/0000-0002-7184-920X; JORDA, Laurent/0000-0001-8735-3308; Snodgrass, Colin/0000-0001-9328-2905; fulle, marco/0000-0001-8435-5287; Debei, Stefano/0000-0002-6757-6616; Ferri, Francesca/0000-0003-2395-5275; Besse, Sebastien/0000-0002-1052-5439; Cremonese, Gabriele/0000-0001-9021-1140; De Cecco, Mariolino/0000-0003-1562-0328; Massironi, Matteo/0000-0002-7757-8818; Thomas, Nicolas/0000-0002-0146-0071; Bertini, Ivano/0000-0002-0616-2444	Department of the European Space Agency (ESA), Noordwijk, Netherlands; Instituto Nacional de Tecnica Aeroespacial, Madrid, Spain; Universidad Politechnica de Madrid, Spain; Department of Physics and Astronomy of Uppsala University, Sweden; Institut fur Datentechnik und Kommunikationsnetze der Technischen Universitat Braunschweig, Germany; Germany (Deutschen Zentrums fur Luft- und Raumfahrt); France (Centre National d'Etudes Spatiales); Italy (Agenzia Spaziale Italiana); Spain (Ministerio de Educacion, Cultura y Deporte); Sweden (Swedish National Space Board) [74/10:2]; ESA Technical Directorate; Polish National Science Center [2011/01/B/ST9/05442]; Ministry of Science and Technology, Taiwan [NSC 101-2111-M-008-016]; NASA through Jet Propulsion Laboratory [1267923]; European Space Astronomy Centre; European Space Operations Centre; European Space Research and Technology Centre; STFC [ST/L004569/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L004569/1] Funding Source: researchfish	Department of the European Space Agency (ESA), Noordwijk, Netherlands; Instituto Nacional de Tecnica Aeroespacial, Madrid, Spain; Universidad Politechnica de Madrid, Spain; Department of Physics and Astronomy of Uppsala University, Sweden; Institut fur Datentechnik und Kommunikationsnetze der Technischen Universitat Braunschweig, Germany; Germany (Deutschen Zentrums fur Luft- und Raumfahrt); France (Centre National d'Etudes Spatiales)(Centre National D'etudes Spatiales); Italy (Agenzia Spaziale Italiana); Spain (Ministerio de Educacion, Cultura y Deporte); Sweden (Swedish National Space Board); ESA Technical Directorate; Polish National Science Center; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); NASA through Jet Propulsion Laboratory; European Space Astronomy Centre(European Space Agency); European Space Operations Centre(European Space Agency); European Space Research and Technology Centre(European Space Agency); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	OSIRIS was built by a consortium of the Max-Planck-Institut fur Sonnensystemforschung, in Gottingen, Germany; Centro Interdipartimentale di Studi e Attivita Spaziali-University of Padova, Italy; the Laboratoire d'Astrophysique de Marseille, France; the Instituto de Astrofisica de Andalucia, Consejo Superior de Investigaciones Cientificas, Granada, Spain; the Research and Scientific Support Department of the European Space Agency (ESA), Noordwijk, Netherlands; the Instituto Nacional de Tecnica Aeroespacial, Madrid, Spain; the Universidad Politechnica de Madrid, Spain; the Department of Physics and Astronomy of Uppsala University, Sweden; and the Institut fur Datentechnik und Kommunikationsnetze der Technischen Universitat Braunschweig, Germany. The support of the national funding agencies of Germany (Deutschen Zentrums fur Luft- und Raumfahrt), France (Centre National d'Etudes Spatiales), Italy (Agenzia Spaziale Italiana), Spain (Ministerio de Educacion, Cultura y Deporte), Sweden (Swedish National Space Board; grant no. 74/10:2), and the ESA Technical Directorate is gratefully acknowledged. H.R. was also supported bygrant no. 2011/01/B/ST9/05442 of the Polish National Science Center. W.-H. I acknowledges the Ministry of Science and Technology, Taiwan (grant no. NSC 101-2111-M-008-016). M.F.A. acknowledges NASA funding through Jet Propulsion Laboratory contract no. 1267923. We thank the ESA teams at European Space Astronomy Centre, European Space Operations Centre, and European Space Research and Technology Centre for their work in support of the Rosetta mission. The data will be placed in ESA's Planetary Sciences Archive after the proprietary period and are available on request until that time.	[Anonymous], 1985, CAMBRIDGE PLANETARY; Basilevsky AT, 2006, PLANET SPACE SCI, V54, P808, DOI 10.1016/j.pss.2006.05.001; Belton MJS, 2009, ICARUS, V200, P280, DOI 10.1016/j.icarus.2008.11.012; Betterton MD, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.056129; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Cheng AF, 2013, ICARUS, V222, P808, DOI 10.1016/j.icarus.2012.10.004; Davidsson BJR, 2013, ICARUS, V224, P154, DOI 10.1016/j.icarus.2013.02.008; Gaskell RW, 2008, METEORIT PLANET SCI, V43, P1049, DOI 10.1111/j.1945-5100.2008.tb00692.x; Groussin O, 2013, ICARUS, V222, P580, DOI 10.1016/j.icarus.2012.10.003; Hall K, 2014, GEOMORPHOLOGY, V206, P1, DOI 10.1016/j.geomorph.2013.09.022; Huebner W. F., 2006, SR004 ISSI; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; KELLER HU, 1987, ASTRON ASTROPHYS, V187, P807; Korycansky DG, 2009, ICARUS, V204, P316, DOI 10.1016/j.icarus.2009.06.006; Lamy PL, 2008, ASTRON ASTROPHYS, V489, P777, DOI 10.1051/0004-6361:200809514; Maloof AC, 2002, EARTH PLANET SC LETT, V204, P1, DOI 10.1016/S0012-821X(02)00960-3; Poppe AR, 2012, ICARUS, V221, P135, DOI 10.1016/j.icarus.2012.07.018; Preusker F, 2012, PLANET SPACE SCI, V66, P54, DOI 10.1016/j.pss.2012.01.008; Roberts J. H., 2013, AM GEOPH UN AGU FALL; Robinson MS, 2001, NATURE, V413, P396, DOI 10.1038/35096518; Samarasinha NH, 2001, ICARUS, V154, P540, DOI 10.1006/icar.2001.6685; Shao YP, 2000, J GEOPHYS RES-ATMOS, V105, P22437, DOI 10.1029/2000JD900304; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Thomas P, 2013, ICARUS, V222, P453, DOI 10.1016/j.icarus.2012.02.037; Thomas PC, 2013, ICARUS, V222, P550, DOI 10.1016/j.icarus.2012.05.034; Thomas PC, 2007, ICARUS, V187, P4, DOI 10.1016/j.icarus.2006.12.013	26	244	245	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							aaa0440	10.1126/science.aaa0440	http://dx.doi.org/10.1126/science.aaa0440			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613893				2022-12-28	WOS:000348225800028
J	Marr, KA; Schlamm, HT; Herbrecht, R; Rottinghaus, ST; Bow, EJ; Cornely, OA; Heinz, WJ; Jagannatha, S; Koh, LP; Kontoyiannis, DP; Lee, DG; Nucci, M; Pappas, PG; Slavin, MA; Queiroz-Telles, F; Selleslag, D; Walsh, TJ; Wingard, JR; Maertens, JA				Marr, Kieren A.; Schlamm, Haran T.; Herbrecht, Raoul; Rottinghaus, Scott T.; Bow, Eric J.; Cornely, Oliver A.; Heinz, Werner J.; Jagannatha, Shyla; Koh, Liang Piu; Kontoyiannis, Dimitrios P.; Lee, Dong-Gun; Nucci, Marcio; Pappas, Peter G.; Slavin, Monica A.; Queiroz-Telles, Flavio; Selleslag, Dominik; Walsh, Thomas J.; Wingard, John R.; Maertens, Johan A.			Combination Antifungal Therapy for Invasive Aspergillosis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CELL TRANSPLANT RECIPIENTS; PULMONARY ASPERGILLOSIS; AMPHOTERICIN-B; GALACTOMANNAN INDEX; IN-VITRO; VORICONAZOLE; ANIDULAFUNGIN; PHARMACOKINETICS; MULTICENTER; MORTALITY	Background: Invasive aspergillosis (IA) is associated with poor outcomes in patients with hematologic malignancies (HMs) and hematopoietic cell transplantation (HCT). Small studies suggest a role for combination antifungal therapy. Objective: To assess the safety and efficacy of voriconazole and anidulafungin compared with voriconazole monotherapy for treatment of IA. Design: Randomized, double-blind, placebo-controlled multi-center trial. (ClinicalTrials.gov: NCT00531479) Setting: 93 international sites. Patients: 454 patients with HM or HCT and suspected or documented IA were randomly assigned to treatment with voriconazole and anidulafungin or placebo. Primary analysis was done in the modified intention-to-treat population of 277 patients in whom IA was confirmed. Measurements: The primary outcome was 6-week mortality; secondary outcomes included 12-week mortality, mortality in major subgroups, and safety measures. Results: Mortality rates at 6 weeks were 19.3% (26 of 135) for combination therapy and 27.5% (39 of 142) for monotherapy (difference, -8.2 percentage points [95% CI, -19.0 to 1.5]; P = 0.087). Secondary mortality outcomes favored combination therapy. Multivariable regression analysis suggested that maximum galactomannan value, Karnofsky score, and baseline platelet count had prognostic significance. Most patients (218 of 277 [78.7%]) had IA diagnosis established by radiographic findings and maximum galactomannan positivity. In a post hoc analysis of this dominant subgroup, 6-week mortality was lower in combination therapy than monotherapy (15.7% [17 of 108] vs. 27.3% [30 of 110]; difference, -11.5 percentage points [CI, -22.7 to -0.4]; P = 0.037). Safety measures, including hepatotoxicity, were not different. Limitations: Mortality at 6 weeks was higher than expected, and the difference in mortality was lower than expected, which reduced power to detect a treatment effect. Enrollment was restricted to patients with HM or HCT, which limited generalizability. Conclusion: Compared with voriconazole monotherapy, combination therapy with anidulafungin led to higher survival in subgroups of patients with IA. Limitations in power preclude definitive conclusions about superiority.	[Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Rottinghaus, Scott T.] Pfizer, New York, NY 10017 USA; [Schlamm, Haran T.] Cidara Therapeut, San Diego, CA 92121 USA; [Herbrecht, Raoul] CHU Strasbourg, Hop Hautepierre, F-67098 Strasbourg, France; [Jagannatha, Shyla] Johnson & Johnson, Titusville, NJ 08560 USA; [Bow, Eric J.] Univ Manitoba, Cancer Care Manitoba, Fac Hlth Sci, Coll Med,Infect Control Serv, Winnipeg, MB R3E 0V9, Canada; [Cornely, Oliver A.] Univ Hosp Cologne, D-50937 Cologne, Germany; [Heinz, Werner J.] Univ Wurzburg, Med Ctr, D-97080 Wurzburg, Germany; [Koh, Liang Piu] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore 119074, Singapore; [Kontoyiannis, Dimitrios P.] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Lee, Dong-Gun] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul 137701, South Korea; [Nucci, Marcio] Univ Fed Rio de Janeiro, Univ Hosp, BR-21941913 Rio De Janeiro, Brazil; [Pappas, Peter G.] Univ Alabama Birmingham, Med Ctr, Birmingham, AL 35233 USA; Peter MacCallum Canc Ctr, East Melbourne, Vic 3002, Australia; [Queiroz-Telles, Flavio] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil; [Selleslag, Dominik] Algemeen Ziekenhuis St Jan, B-8000 Brugge, Belgium; [Walsh, Thomas J.] Cornell Univ, Weill Cornell Med Ctr, New York, NY 10065 USA; [Wingard, John R.] Univ Florida, Gainesville, FL 32610 USA; [Maertens, Johan A.] Univ Ziekenhuizen Leuven, B-3000 Louvain, Belgium	Johns Hopkins University; Pfizer; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johnson & Johnson; Johnson & Johnson USA; University of Manitoba; University of Cologne; University of Wurzburg; National University of Singapore; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Catholic University of Korea; Seoul St. Mary's Hospital; Universidade Federal do Rio de Janeiro; University of Alabama System; University of Alabama Birmingham; Peter Maccallum Cancer Center; Universidade Federal do Parana; Cornell University; State University System of Florida; University of Florida; KU Leuven; University Hospital Leuven	Marr, KA (corresponding author), Johns Hopkins Univ, Sch Med, 720 Rutland Ave,Ross 1064, Baltimore, MD 21205 USA.	kmarr4@jhmi.edu	Cornely, Oliver A./J-5095-2013; Herbrecht, Raoul/AAT-1763-2021; Herbrecht, Raoul/GVU-1333-2022; Lee, Dong-Gun/AGF-9891-2022; Heinz, Werner/X-4470-2019	Cornely, Oliver A./0000-0001-9599-3137; Herbrecht, Raoul/0000-0002-9381-4876; Lee, Dong-Gun/0000-0003-4655-0641; Heinz, Werner/0000-0002-7833-9202; Slavin, Monica/0000-0002-8443-314X; Wingard, John/0000-0001-7478-5398	Pfizer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI085118] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Pfizer.	Alebic-Kolbah T, 2012, ANAL BIOANAL CHEM, V404, P2043, DOI 10.1007/s00216-012-6272-4; Andrews E, 2008, BRIT J CLIN PHARMACO, V65, P531, DOI 10.1111/j.1365-2125.2007.03084.x; Caillot D, 2010, EUR J RADIOL, V74, pE173, DOI 10.1016/j.ejrad.2009.05.058; Chai LYA, 2012, J CLIN MICROBIOL, V50, P2330, DOI 10.1128/JCM.06513-11; Cornely OA, 2007, CLIN INFECT DIS, V44, P1289, DOI 10.1086/514341; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dowell JA, 2005, J CLIN PHARMACOL, V45, P1373, DOI 10.1177/0091270005281234; Espinel-Ingroff A, 2001, MYCOPATHOLOGIA, V150, P101, DOI 10.1023/A:1010954803886; Fisher CE, 2013, CLIN INFECT DIS, V57, P1001, DOI 10.1093/cid/cit393; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; HWANG IK, 1990, STAT MED, V9, P1439, DOI 10.1002/sim.4780091207; Maertens JA, 2012, HAEMATOL-HEMATOL J, V97, P325, DOI 10.3324/haematol.2012.061952; Marr KA, 2004, CLIN INFECT DIS, V39, P797, DOI 10.1086/423380; Miceli MH, 2008, CLIN INFECT DIS, V46, P1412, DOI 10.1086/528714; Miceli MH, 2007, CANCER-AM CANCER SOC, V110, P112, DOI 10.1002/cncr.22738; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Neofytos D, 2013, TRANSPL INFECT DIS, V15, P233, DOI 10.1111/tid.12060; Nouer SA, 2012, CLIN INFECT DIS, V54, pE173, DOI 10.1093/cid/cis298; Perkhofer S, 2013, ANTIMICROB AGENTS CH, V57, P626, DOI 10.1128/AAC.01534-12; Petraitis V, 2009, ANTIMICROB AGENTS CH, V53, P2382, DOI 10.1128/AAC.00329-09; Purkins L, 2002, ANTIMICROB AGENTS CH, V46, P2546, DOI 10.1128/AAC.46.8.2546-2553.2002; Reichenberger F, 2002, EUR RESPIR J, V19, P743, DOI 10.1183/09031936.02.00256102; Rex JH, 2003, CLIN INFECT DIS, V36, P1221, DOI 10.1086/374850; Singh N, 2006, TRANSPLANTATION, V81, P320, DOI 10.1097/01.tp.0000202421.94822.f7; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wingard JR, 2008, CANCER, V112, P2309, DOI 10.1002/cncr.23441	27	282	294	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					81	89		10.7326/M13-2508	http://dx.doi.org/10.7326/M13-2508			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599346				2022-12-28	WOS:000350106600013
J	Lenzer, J				Lenzer, Jeanne			Chief architect of Obamacare sparks furore over wish to "die at 75"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jeanne.lenzer@gmail.com						Emanuel EJ., 2014, ATLANTIC	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2015	350								h292	10.1136/bmj.h292	http://dx.doi.org/10.1136/bmj.h292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7YY	25600164				2022-12-28	WOS:000348432800003
J	Casey, A				Casey, Amanda			PERSONAL VIEW Without mandatory regulation, clinical physiologists put patients at risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Registrat Council Clin Physiologists, Lichfield WS14 9DZ, Staffs, England		Casey, A (corresponding author), Registrat Council Clin Physiologists, Lichfield WS14 9DZ, Staffs, England.	a.e.a.casey@aston.ac.uk							0	1	1	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2015	350								g7860	10.1136/bmj.g7860	http://dx.doi.org/10.1136/bmj.g7860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3MX	25587049				2022-12-28	WOS:000348132700004
J	Ye, CH; Tsukruk, VV				Ye, Chunhong; Tsukruk, Vladimir V.			Designing two-dimensional materials that spring rapidly into three-dimensional shapes	SCIENCE			English	Editorial Material							THIN-FILMS; POLYMER; ARRAYS		[Ye, Chunhong; Tsukruk, Vladimir V.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Ye, CH (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	vladimir@mse.gatech.edu						Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Genzer J, 2006, SOFT MATTER, V2, P310, DOI 10.1039/b516741h; Grinthal A, 2013, CHEM SOC REV, V42, P7072, DOI 10.1039/c3cs60045a; Jiang C, 2006, NANO LETT, V6, P2254, DOI 10.1021/nl061630n; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Schweikart A, 2011, SOFT MATTER, V7, P4093, DOI 10.1039/c0sm01359e; Shim J, 2013, SOFT MATTER, V9, P8198, DOI 10.1039/c3sm51148k; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175; Stoychev G, 2013, ADV FUNCT MATER, V23, P2295, DOI 10.1002/adfm.201203245; Wu ZL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2549; Xu S, 2015, SCIENCE, V347, P154, DOI 10.1126/science.1260960; Ye CH, 2014, ADV FUNCT MATER, V24, P4364, DOI 10.1002/adfm.201400254	12	13	13	4	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					130	131		10.1126/science.aaa2643	http://dx.doi.org/10.1126/science.aaa2643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574009				2022-12-28	WOS:000347918900025
J	Zhong, MJ; Hedges, MP; Ahlefeldt, RL; Bartholomew, JG; Beavan, SE; Wittig, SM; Longdell, JJ; Sellars, MJ				Zhong, Manjin; Hedges, Morgan P.; Ahlefeldt, Rose L.; Bartholomew, John G.; Beavan, Sarah E.; Wittig, Sven M.; Longdell, Jevon J.; Sellars, Matthew J.			Optically addressable nuclear spins in a solid with a six-hour coherence time	NATURE			English	Article							ENTANGLEMENT DISTRIBUTION; QUANTUM REPEATERS; ATOMIC ENSEMBLES; TEMPERATURE; STORAGE; MEMORY	Space-like separation of entangled quantum states is a central concept in fundamental investigations of quantum mechanics and in quantum communication applications. Optical approaches are ubiquitous in the distribution of entanglement because entangled photons are easy to generate and transmit. However, extending this direct distribution beyond a range of a few hundred kilometres(1,2) to a worldwide network is prohibited by losses associated with scattering, diffraction and absorption during transmission. A proposal to overcome this range limitation is the quantum repeater protocol(3,4), which involves the distribution of entangled pairs of optical modes among many quantum memories stationed along the transmission channel. To be effective, the memories must store the quantum information encoded on the optical modes for times that are long compared to the direct optical transmission time of the channel(5). Here we measure a decoherence rate of 8 x 10(-5) per second over 100 milliseconds, which is the time required for light transmission on a global scale. The measurements were performed on a ground-state hyperfine transition of europium ion dopants in yttrium orthosilicate (Eu-151(3+):Y2SiO5) using optically detected nuclear magnetic resonance techniques. The observed decoherence rate is at least an order of magnitude lower than that of any other system suitable for an optical quantum memory. Furthermore, by employing dynamic decoupling, a coherence time of 370 +/- 60 minutes was achieved at 2 kelvin. It has been almost universally assumed that light is the best long-distance carrier for quantum information. However, the coherence time observed here is long enough that nuclear spins travelling at 9 kilometres per hour in a crystal would have a lower decoherence with distance than light in an optical fibre. This enables some very early approaches(6,7) to entanglement distribution to be revisited, in particular those in which the spins are transported rather than the light.	[Zhong, Manjin; Hedges, Morgan P.; Ahlefeldt, Rose L.; Bartholomew, John G.; Beavan, Sarah E.; Wittig, Sven M.; Sellars, Matthew J.] Australian Natl Univ, Laser Phys Ctr, Ctr Quantum Computat & Commun Technol, GPO Box 4, Canberra, ACT 0200, Australia; [Hedges, Morgan P.] Princeton Univ, Dept Phys, Princeton, NJ 08554 USA; [Ahlefeldt, Rose L.] Univ Paris Sud, Lab Aime Cotton, CNRS UPR 3321, F-91405 Orsay, France; [Ahlefeldt, Rose L.] ENS Cachan, F-91405 Orsay, France; [Beavan, Sarah E.] Univ Munich, Fak Phys, D-80539 Munich, Germany; [Beavan, Sarah E.] Univ Munich, Ctr Nanosci CeNS, D-80539 Munich, Germany; [Wittig, Sven M.] Kayser Threde GmbH, D-81379 Munich, Germany; [Longdell, Jevon J.] Univ Otago, Dodd Walls Ctr Photon & Quantum Technol, Dunedin 9016, New Zealand; [Longdell, Jevon J.] Univ Otago, Dept Phys, Dunedin 9016, New Zealand	Australian National University; Princeton University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Munich; University of Munich; Kayser-Threde GmbH; University of Otago; University of Otago	Zhong, MJ (corresponding author), Australian Natl Univ, Laser Phys Ctr, Ctr Quantum Computat & Commun Technol, GPO Box 4, Canberra, ACT 0200, Australia.	grace.zhong@anu.edu.au	Sellars, Matthew/J-3130-2014; Ahlefeldt, Rose L/C-5466-2017	Sellars, Matthew/0000-0002-0502-0444; Ahlefeldt, Rose L/0000-0002-2006-2941	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology [CE110001027]; Australian Research Council Future Fellowship [FT110100919]; Marsden Fund of the Royal Society of New Zealand [UOO1221]	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council); Marsden Fund of the Royal Society of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	We thank N. Manson and S. Rogge for comments on the manuscript. This work was supported by the Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology (CE110001027), and M.J.S. was supported by an Australian Research Council Future Fellowship (FT110100919). J.J.L. was supported by the Marsden Fund of the Royal Society of New Zealand (contract UOO1221).	Arcangeli A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184305; Bennett C.H., 1982, ADV CRYPTOLOGY P CRY, V82, P267, DOI DOI 10.1007/978-1-4757-0602-4_26; BOHM D, 1957, PHYS REV, V108, P1070, DOI 10.1103/PhysRev.108.1070; Bonarota M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013013; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Clausen C, 2011, NATURE, V469, P508, DOI 10.1038/nature09662; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Dynes JF, 2009, OPT EXPRESS, V17, P11440, DOI 10.1364/OE.17.011440; Fraval E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030506; Fraval E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077601; Fraval E., 2005, THESIS; Hedges MP, 2010, NATURE, V465, P1052, DOI 10.1038/nature09081; Heinze G, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.033601; Jobez P, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/8/083005; Konz F, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.085109; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Longdell JJ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195101; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; MIMS WB, 1968, PHYS REV, V168, P370, DOI 10.1103/PhysRev.168.370; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Saglamyurek E, 2011, NATURE, V469, P512, DOI 10.1038/nature09719; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; SHELBY RM, 1978, PHYS REV LETT, V41, P1739, DOI 10.1103/PhysRevLett.41.1739; Souza AM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.240501; Thiel CW, 2011, J LUMIN, V131, P353, DOI 10.1016/j.jlumin.2010.12.015; Thorpe MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/3/033006; Timoney N, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022324; Timoney N, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/12/124001; YANO R, 1991, OPT LETT, V16, P1884, DOI 10.1364/OL.16.001884; Yin J, 2012, NATURE, V488, P185, DOI 10.1038/nature11332	30	391	398	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					177	+		10.1038/nature14025	http://dx.doi.org/10.1038/nature14025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567283				2022-12-28	WOS:000347477600031
J	Lobo, MD; Sobotka, PA; Stanton, A; Cockcroft, JR; Sulke, N; Dolan, E; van der Giet, M; Hoyer, J; Furniss, SS; Foran, JP; Witkowski, A; Januszewicz, A; Schoors, D; Tsioufis, K; Rensing, BJ; Scott, B; Ng, GA; Ott, C; Schmieder, RE				Lobo, Melvin D.; Sobotka, Paul A.; Stanton, Alice; Cockcroft, John R.; Sulke, Neil; Dolan, Eamon; van der Giet, Markus; Hoyer, Joachim; Furniss, Stephen S.; Foran, John P.; Witkowski, Adam; Januszewicz, Andrzej; Schoors, Danny; Tsioufis, Konstantinos; Rensing, Benno J.; Scott, Benjamin; Ng, G. Andre; Ott, Christian; Schmieder, Roland E.		ROX CONTROL HTN Investigators	Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial	LANCET			English	Article							LOWERS BLOOD-PRESSURE; PULSE-WAVE VELOCITY; RESISTANT HYPERTENSION; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; HEART-DISEASE; FISTULA; METAANALYSIS; PREVALENCE; PREDICTION	Background Hypertension contributes to cardiovascular morbidity and mortality. We assessed the safety and efficacy of a central iliac arteriovenous anastomosis to alter the mechanical arterial properties and reduce blood pressure in patients with uncontrolled hypertension. Methods We enrolled patients in this open-label, multicentre, prospective, randomised, controlled trial between October, 2012, and April, 2014. Eligible patients had baseline office systolic blood pressure of 140 mm Hg or higher and average daytime ambulatory blood pressure of 135 mm Hg or higher systolic and 85 mm Hg or higher diastolic despite antihypertensive treatment. Patients were randomly allocated in a 1: 1 ratio to undergo implantation of an arteriovenous coupler device plus current pharmaceutical treatment or to maintain current treatment alone (control). The primary endpoint was mean change from baseline in office and 24 h ambulatory systolic blood pressure at 6 months. Analysis was by modified intention to treat (all patients remaining in follow-up at 6 months). This trial is registered with ClinicalTrials.gov, number NCT01642498. Findings 83 (43%) of 195 patients screened were assigned arteriovenous coupler therapy (n= 44) or normal care (n= 39). Mean office systolic blood pressure reduced by 26.9 (SD 23.9) mm Hg in the arteriovenous coupler group (p<0.0001) and by 3.7 (21.2) mm Hg in the control group (p=0.31). Mean systolic 24 h ambulatory blood pressure reduced by 13.5 (18.8) mm Hg (p<0.0001) in arteriovenous coupler recipients and by 0>5 (15>8) mm Hg (p=0.86) in controls. Implantation of the arteriovenous coupler was associated with late ipsilateral venous stenosis in 12 (29%) of 42 patients and was treatable with venoplasty or stenting. Interpretation Arteriovenous anastomosis was associated with significantly reduced blood pressure and hypertensive complications. This approach might be a useful adjunctive therapy for patients with uncontrolled hypertension.	[Lobo, Melvin D.] Queen Mary Univ London, Barts NIHR Cardiovasc Biomed Res Unit, William Harvey Res Inst, London EC1M 6BQ, England; [Sobotka, Paul A.] ROX Med, San Clemente, CA USA; [Sobotka, Paul A.] Ohio State Univ, Cardiovasc Med, Columbus, OH 43210 USA; [Stanton, Alice] Royal Coll Surgeons Ireland, Sch Med, Mol & Cellular Therapeut, Dublin 2, Ireland; [Cockcroft, John R.] Wales Heart Res Inst, Dept Cardiol, Cardiff, S Glam, Wales; [Sulke, Neil] Eastbourne Dist Gen Hosp, Dept Cardiol, Eastbourne, E Sussex, England; [Dolan, Eamon] Connolly Hosp, Dept Med Elderly, Dublin, Ireland; [van der Giet, Markus] Univ Med Berlin, Dept Endocinrol & Nephrol, Berlin, Germany; [Hoyer, Joachim] Univ Klinikum Giessen & Marburg GmbH, Dept Internal Med & Nephrol, Marburg, Germany; [Furniss, Stephen S.] East Sussex Healthcare NHS Trust, Dept Cardiol, Eastbourne, E Sussex, England; [Foran, John P.] Royal Brompton Hosp, Dept Cardiac, London SW3 6LY, England; [Foran, John P.] St Helier Hosp, Dept Cardiol, Surrey, England; [Witkowski, Adam] Inst Cardiol, Dept Intervent Cardiol & Angiol, Warsaw, Poland; [Januszewicz, Andrzej] Inst Cardiol, Dept Hypertens, Warsaw, Poland; [Schoors, Danny] Univ Ziekenhuis Brussel, Dept Cardiol, Brussels, Belgium; [Tsioufis, Konstantinos] Hippokrat Gen Hosp Athens, Dept Cardiol, Athens, Greece; [Rensing, Benno J.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Scott, Benjamin] ZNA Cardio Middelheim, Dept Cardiol, Antwerp, Belgium; [Ng, G. Andre] Univ Leicester, Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res, Dept Cardiovasc Sci, Leicester, Leics, England; [Ott, Christian; Schmieder, Roland E.] Univ Klinikum Erlangen, Dept Hypertens & Nephrol, Erlangen, Germany	University of London; Queen Mary University London; University System of Ohio; Ohio State University; Royal College of Surgeons - Ireland; Cardiff University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University Hospital of Giessen & Marburg; Royal Brompton Hospital; St Helier Hospital; Institute of Cardiology - Poland; Institute of Cardiology - Poland; University Hospital Brussels; Vrije Universiteit Brussel; St. Antonius Hospital Utrecht; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Erlangen Nuremberg	Lobo, MD (corresponding author), Queen Mary Univ London, Barts NIHR Cardiovasc Biomed Res Unit, William Harvey Heart Ctr, Charterhouse Sq, London EC1M 6BQ, England.	m.d.lobo@qmul.ac.uk	Hoyer, Joachim/GQB-1090-2022; Stanton, Alice V/F-4697-2012	Ng, G. Andre/0000-0001-5965-0671; MAthur, Anthony/0000-0001-7941-9653; Stanton, Alice/0000-0002-4961-165X; van der Giet, Markus/0000-0003-3590-5451; Witkowski, Adam/0000-0002-3514-2047	ROX Medical	ROX Medical	ROX Medical.	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Basile C, 2008, NEPHROL DIAL TRANSPL, V23, P282, DOI 10.1093/ndt/gfm549; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Burchell AE, 2014, HYPERTENSION, V64, P6, DOI 10.1161/HYPERTENSIONAHA.114.02925; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper CB, 2008, COPD, V5, P376, DOI 10.1080/15412550802522783; Coutinho T, 2011, JACC-CARDIOVASC IMAG, V4, P754, DOI 10.1016/j.jcmg.2011.04.011; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Faul J, 2014, J VASC SURG, V59, P1078, DOI 10.1016/j.jvs.2013.10.069; Foran JP, 2015, CATHETER CARDIO INTE, V85, P880, DOI 10.1002/ccd.25707; Gore JM, 2010, AM HEART J, V160, P521, DOI 10.1016/j.ahj.2010.06.032; Irvin MR, 2012, J CLIN HYPERTENS, V14, P694, DOI 10.1111/j.1751-7176.2012.00690.x; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1969, DIS CHEST, V56, P43, DOI 10.1378/chest.56.1.43; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Korsheed S, 2011, NEPHROL DIAL TRANSPL, V26, P3296, DOI 10.1093/ndt/gfq851; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MacRae Jennifer M, 2004, Am J Kidney Dis, V43, pe17, DOI 10.1053/j.ajkd.2004.01.016; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Ori Y, 1996, NEPHROL DIAL TRANSPL, V11, P94; Pimenta E, 2012, CIRCULATION, V125, P1594, DOI 10.1161/CIRCULATIONAHA.112.097345; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Saratzis N, 2008, J VASC ACCESS, V9, P285, DOI 10.1177/112972980800900410; Sobotka PA, 2014, N AM ART 4 ANN M CHI; Van Wijk BLG, 2005, J HYPERTENS, V23, P2101, DOI 10.1097/01.hjh.0000187261.40190.2e; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; Yiannakopoulou EC, 2005, EUR J CARDIOV PREV R, V12, P243, DOI 10.1097/01.hjr.0000160601.41762.44	33	113	116	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1634	1641		10.1016/S0140-6736(14)62053-5	http://dx.doi.org/10.1016/S0140-6736(14)62053-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6NG	25620016	Green Submitted			2022-12-28	WOS:000353418000036
J	Meisel, A				Meisel, Andreas			Preventive antibiotic therapy in stroke: PASSed away?	LANCET			English	Editorial Material							ACUTE ISCHEMIC-STROKE; MEDICAL COMPLICATIONS; PNEUMONIA; INFECTION; MORTALITY		Charite, Dept Neurol, Ctr Stroke Res Berlin, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meisel, A (corresponding author), Charite, Dept Neurol, Ctr Stroke Res Berlin, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany.	andreas.meisel@charite.de		Meisel, Andreas/0000-0001-7233-5342				Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Hetze S, 2013, J CEREBR BLOOD F MET, V33, P846, DOI 10.1038/jcbfm.2013.6; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Khaja AM, 2007, LANCET, V369, P319, DOI 10.1016/S0140-6736(07)60154-8; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Tong X, 2010, STROKE, V41, P980, DOI 10.1161/STROKEAHA.110.578674; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Westendorp W, 2015, LANCET	13	10	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1486	1487		10.1016/S0140-6736(15)60076-9	http://dx.doi.org/10.1016/S0140-6736(15)60076-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25612859				2022-12-28	WOS:000353220000008
J	Acquisti, A; Brandimarte, L; Loewenstein, G				Acquisti, Alessandro; Brandimarte, Laura; Loewenstein, George			Privacy and human behavior in the age of information	SCIENCE			English	Review							SELF-DISCLOSURE; SOCIAL ISSUE; BIG DATA; MANAGEMENT; DEFAULTS; DISTANCE	This Review summarizes and draws connections between diverse streams of empirical research on privacy behavior. We use three themes to connect insights from social and behavioral sciences: people's uncertainty about the consequences of privacy-related behaviors and their own preferences over those consequences; the context-dependence of people's concern, or lack thereof, about privacy; and the degree to which privacy concerns are malleable-manipulable by commercial and governmental interests. Organizing our discussion by these themes, we offer observations concerning the role of public policy in the protection of privacy in the information age.	[Acquisti, Alessandro; Brandimarte, Laura] Carnegie Mellon Univ, H John Heinz Coll 3, Pittsburgh, PA 15213 USA; [Loewenstein, George] Carnegie Mellon Univ, Dietrich Coll, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Acquisti, A (corresponding author), Carnegie Mellon Univ, H John Heinz Coll 3, Pittsburgh, PA 15213 USA.	acquisti@andrew.cmu.edu	Acquisti, Alessandro/AAW-3231-2020; Loewenstein, George/G-7616-2014	Acquisti, Alessandro/0000-0001-6582-6178; Loewenstein, George/0000-0003-2790-0474	Div Of Information & Intelligent Systems [1413864] Funding Source: National Science Foundation	Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Acquisti A., 2004, P 5 ACM C EL COMM NE, P21, DOI DOI 10.1145/988772.988777; Acquisti A, 2006, LECT NOTES COMPUT SC, V4258, P36; Acquisti A, 2013, J LEGAL STUD, V42, P249, DOI 10.1086/671754; Acquisti A, 2012, J MARKETING RES, V49, P160, DOI 10.1509/jmr.09.0215; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; ALTMAN I, 1977, J SOC ISSUES, V33, P66, DOI 10.1111/j.1540-4560.1977.tb01883.x; Altman I., 1973, SOCIAL PENETRATION D; Altman I., 1975, ENV SOCIAL BEHAVIOUR; [Anonymous], 1973, REC COMP RIGHTS CIT; [Anonymous], 2014, WAKE FOREST LAW REV; Bargh JA, 2002, J SOC ISSUES, V58, P33, DOI 10.1111/1540-4560.00247; Benn SI, 1984, PHILOS DIMENSIONS PR; boyd d, 2014, ITS COMPLICATED SOCI; Brandimarte L, 2013, SOC PSYCHOL PERS SCI, V4, P340, DOI 10.1177/1948550612455931; Calo R, 2014, GEORGE WASH LAW REV, V82, P995; CHAIKIN AL, 1976, J COUNS PSYCHOL, V23, P479; Cohen JE, 2000, STANFORD LAW REV, V52, P1373, DOI 10.2307/1229517; Conti G., 2010, 19 INT C WORLD WIDE, DOI [10.1145/1772690.1772719, DOI 10.1145/1772690.1772719]; Crawford K, 2014, INT J COMMUN-US, V8, P1663; Culnan MJ, 1999, ORGAN SCI, V10, P104, DOI 10.1287/orsc.10.1.104; DePaulo BM, 2003, J SOC ISSUES, V59, P391, DOI 10.1111/1540-4560.00070; DERLEGA VJ, 1977, J SOC ISSUES, V33, P102, DOI 10.1111/j.1540-4560.1977.tb01885.x; Duby Georges, 1992, HIST PRIVATE LIFE PA, V1; Enkin A., 2014, PRIVACY; Frattaroli J, 2006, PSYCHOL BULL, V132, P823, DOI 10.1037/0033-2909.132.6.823; Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322; Goffman E., 1971, RELATIONS PUBLIC MIC; Goldfarb A, 2011, MARKET SCI, V30, P389, DOI 10.1287/mksc.1100.0583; Gross R., 2005, P WPES 2005, P71, DOI DOI 10.1145/1102199.1102214; Hann IH, 2007, J MANAGE INFORM SYST, V24, P13, DOI 10.2753/MIS0742-1222240202; Hargittai Eszter., 2008, SOCIAL STRATIFICATIO, P936; Hartzog W., 2010, AM U L REV, V60, P1635; Hayat MA, 2007, INF COMMUN TECHNOL L, V16, P137, DOI 10.1080/13600830701532043; Honess T., 1992, CLOSED CIRCUIT TELEV; Jensen C, 2005, INT J HUM-COMPUT ST, V63, P203, DOI 10.1016/j.ijhcs.2005.04.019; Jensen C., 2004, PRIVACY POLICIES DEC, P179, DOI [DOI 10.1145/985692.985752, 10.1145/985692.985752]; John LK, 2011, J CONSUM RES, V37, P858, DOI 10.1086/656423; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Johnson EJ, 2002, MARKET LETT, V13, P5, DOI 10.1023/A:1015044207315; Joinson AN, 2001, EUR J SOC PSYCHOL, V31, P177, DOI 10.1002/ejsp.36; KIESLER S, 1984, AM PSYCHOL, V39, P1123, DOI 10.1037/0003-066X.39.10.1123; KLOPFER PH, 1977, J SOC ISSUES, V33, P52, DOI 10.1111/j.1540-4560.1977.tb01882.x; LAUFER RS, 1977, J SOC ISSUES, V33, P22, DOI 10.1111/j.1540-4560.1977.tb01880.x; LUBIN B, 1964, PSYCHOL REP, V15, P77, DOI 10.2466/pr0.1964.15.1.77; Margulis ST, 2003, J SOC ISSUES, V59, P243, DOI 10.1111/1540-4560.00063; Marx GT, 2001, ETHICS INF TECHNOL, V3, P157, DOI 10.1023/A:1012456832336; Mayer-Schonberger V., 2011, DELETE VIRTUE FORGET; McAfee A, 2012, HARVARD BUS REV, V90, P60; McDonald Aleecia M., 2009, IS J LAW POLICY INFO, V4, P540; McKenzie CRM, 2006, PSYCHOL SCI, V17, P414, DOI 10.1111/j.1467-9280.2006.01721.x; Moon Y, 2000, J CONSUM RES, V26, P323, DOI 10.1086/209566; Moore B., 1984, PRIVACY STUDIES SOCI; MURPHY RF, 1964, AM ANTHROPOL, V66, P1257, DOI 10.1525/aa.1964.66.6.02a00020; Nissenbaum Helen, 2009, PRIVACY CONTEXT; Norberg PA, 2007, J CONSUM AFF, V41, P100, DOI 10.1111/j.1745-6606.2006.00070.x; Oulasvirta A, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P41; Palen Leysia, 2003, P SIGCHI C HUMAN FAC, P129, DOI DOI 10.1145/642611.642635; PENNEBAKER JW, 1993, BEHAV RES THER, V31, P539, DOI 10.1016/0005-7967(93)90105-4; Petronio S., 2002, BOUNDARIES PRIVACY D; POSNER RA, 1981, AM ECON REV, V71, P405; Postmes T, 1998, PSYCHOL BULL, V123, P238; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Rykwert J, 2001, SOC RES, V68, P29; SCHWARTZ B, 1968, AM J SOCIOL, V73, P741, DOI 10.1086/224567; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; SINGER E, 1992, INT J PUBLIC OPIN R, V4, P256, DOI 10.1093/ijpor/4.3.256; SKOTKO VP, 1977, SOCIOMETRY, V40, P178, DOI 10.2307/3033520; SLOVIC P, 1995, AM PSYCHOL, V50, P364, DOI 10.1037/0003-066X.50.5.364; Smith HJ, 2011, MIS QUART, V35, P989; Smith HJ, 1996, MIS QUART, V20, P167, DOI 10.2307/249477; Solove DJ, 2013, HARVARD LAW REV, V126, P1880; Solove DJ, 2006, U PENN LAW REV, V154, P477, DOI 10.2307/40041279; Spiekermann S., 2001, EC'01. Proceedings of the 3rd ACM Conference on Electronic Commerce, P38, DOI 10.1145/501158.501163; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; Stutzman F. D., 2012, J PRIVACY CONFIDENTI, V4, P7; Stutzman F, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1553; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; SUNDSTROM E, 1976, HUM ECOL, V4, P47, DOI 10.1007/BF01531456; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Tamir DI, 2012, P NATL ACAD SCI USA, V109, P8038, DOI 10.1073/pnas.1202129109; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; Toma CL, 2013, PERS SOC PSYCHOL B, V39, P321, DOI 10.1177/0146167212474694; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Tsai JY, 2011, INFORM SYST RES, V22, P254, DOI 10.1287/isre.1090.0260; Tufekci Z., 2008, B SCI TECHNOL SOC, V28, p20?36, DOI [10.1177/0270467607311484, DOI 10.1177/0270467607311484]; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Weisband S., 1996, Human Factors in Computing Systems. Common Ground. CHI 96 Conference Proceedings, P3, DOI 10.1145/238386.238387; Westin A, 1984, PHILOS DIMENSIONS PR, P56, DOI [10.1017/CBO9780511625138. 004, DOI 10.1017/CBO9780511625138.004]; Westin A.F., 1967, PRIVACY FREEDOM; White TB, 2008, MARKET LETT, V19, P39, DOI 10.1007/s11002-007-9027-9; Whitman Christina B., 1985, INDIVIDUALISM HOLISM, P85; Xu H, 2009, J MANAGE INFORM SYST, V26, P135, DOI 10.2753/MIS0742-1222260305; Zhong CB, 2010, PSYCHOL SCI, V21, P311, DOI 10.1177/0956797609360754	94	669	678	54	617	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					509	514		10.1126/science.aaa1465	http://dx.doi.org/10.1126/science.aaa1465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA0YK	25635091				2022-12-28	WOS:000348639300044
J	Antal, CE; Hudson, AM; Kang, E; Zanca, C; Wirth, C; Stephenson, NL; Trotter, EW; Gallegos, LL; Miller, CJ; Fumari, FB; Hunter, T; Brognard, J; Newton, AC				Antal, Corina E.; Hudson, Andrew M.; Kang, Emily; Zanca, Ciro; Wirth, Christopher; Stephenson, Natalie L.; Trotter, Eleanor W.; Gallegos, Lisa L.; Miller, Crispin J.; Fumari, Frank B.; Hunter, Tony; Brognard, John; Newton, Alexandra C.			Cancer-Associated Protein Kinase C Mutations Reveal Kinase's Role as Tumor Suppressor	CELL			English	Article							DOWN-REGULATION; PKC-ZETA; CELL-PROLIFERATION; ALPHA; DELTA; ACTIVATION; EXPRESSION; PHOSPHORYLATION; CARCINOMA; ONCOGENE	Protein kinase C (PKC) isozymes have remained elusive cancer targets despite the unambiguous tumor promoting function of their potent ligands, phorbol esters, and the prevalence of their mutations. We analyzed 8% of PKC mutations identified in human cancers and found that, surprisingly, most were loss of function and none were activating. Loss-of-function mutations occurred in all PKC subgroups and impeded second-messenger binding, phosphorylation, or catalysis. Correction of a loss-of-function PKC beta mutation by CRISPR-mediated genome editing in a patient-derived colon cancer cell line suppressed anchorage-independent growth and reduced tumor growth in a xenograft model. Hemizygous deletion promoted anchorage-independent growth, revealing that PKCb is haploinsufficient for tumor suppression. Several mutations were dominant negative, suppressing global PKC signaling output, and bioinformatic analysis suggested that PKC mutations cooperate with co-occurring mutations in cancer drivers. These data establish that PKC isozymes generally function as tumor suppressors, indicating that therapies should focus on restoring, not inhibiting, PKC activity.	[Antal, Corina E.; Kang, Emily; Gallegos, Lisa L.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Antal, Corina E.; Gallegos, Lisa L.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Hudson, Andrew M.; Stephenson, Natalie L.; Trotter, Eleanor W.; Brognard, John] Univ Manchester, Canc Res UK Manchester Inst, Signalling Networks Canc Grp, Manchester M20 4BX, Lancs, England; [Zanca, Ciro; Fumari, Frank B.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Wirth, Christopher; Miller, Crispin J.] Univ Manchester, Canc Res UK Manchester Inst, Appl Computat Biol & Bioinformat Grp, Manchester M20 4BX, Lancs, England; [Hunter, Tony] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cancer Research UK; University of Manchester; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Cancer Research UK; University of Manchester; Salk Institute	Brognard, J (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Signalling Networks Canc Grp, Manchester M20 4BX, Lancs, England.	john.brognard@cruk.manchester.ac.uk; anewton@ucsd.edu	Kang, Emily/HDL-6550-2022; Brognard, John/T-5099-2019	Brognard, John/0000-0002-9243-6615; Wirth, Christopher/0000-0002-1800-0899; Stephenson, Natalie Louise/0000-0001-6341-1008; Miller, Crispin/0000-0003-4341-1283; Furnari, Frank/0000-0003-1909-4361	NIH [GM43154, NS080939, CA82683]; James S. McDonnell Foundation; UCSD Graduate Training Program in Cellular; Molecular Pharmacology [T32 GM007752]; NSF Graduate Research Fellowship [DGE1144086]; Cancer Research UK; Cancer Research UK [12936, 15675] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA082683, ZIABC011691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043154, T32GM007752, R01GM043154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James S. McDonnell Foundation; UCSD Graduate Training Program in Cellular; Molecular Pharmacology; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the lab for helpful comments, the Moores Cancer Center Histology Core for the TUNEL staining, Meghdad Rahdar for cell sorting, and Jack Dixon for equipment use. This work was supported by NIH GM43154 to A.C.N., NIH NS080939 and the James S. McDonnell Foundation to F.B.F., and NIH CA82683 to T.H. C.E.A. was supported by the UCSD Graduate Training Program in Cellular and Molecular Pharmacology (T32 GM007752) and the NSF Graduate Research Fellowship (DGE1144086). A.M.H., C.W., N.L.S., E.W.T., C.J.M., and J.B. were supported by Cancer Research UK. T.H. is a Frank and Else Schilling American Cancer Society Professor and holds the Renato Dulbecco Chair in Cancer Research.	Abbas T, 2004, J BIOL CHEM, V279, P9970, DOI 10.1074/jbc.M306979200; ALVARO V, 1993, J CLIN ENDOCR METAB, V77, P1125, DOI 10.1210/jc.77.5.1125; Antal CE, 2014, CHEM BIOL, V21, P459, DOI 10.1016/j.chembiol.2014.02.008; Barcelo C, 2014, CANCER RES, V74, P1190, DOI 10.1158/0008-5472.CAN-13-1750; Belot A, 2013, ARTHRITIS RHEUM-US, V65, P2161, DOI 10.1002/art.38008; Luna-Ulloa LB, 2011, CARCINOGENESIS, V32, P1615, DOI 10.1093/carcin/bgr190; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BLUMBERG PM, 1980, CRC CR REV TOXICOL, V8, P153, DOI 10.3109/10408448009037493; CACACE AM, 1993, ONCOGENE, V8, P2095; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHOI PM, 1990, MOL CELL BIOL, V10, P4650, DOI 10.1128/MCB.10.9.4650; CRAVEN PA, 1994, DIGEST DIS SCI, V39, P481, DOI 10.1007/BF02088331; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; DAVIDSON LA, 1994, ARCH BIOCHEM BIOPHYS, V312, P547, DOI 10.1006/abbi.1994.1344; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Don ASA, 2011, REV RECENT CLIN TRIA, V6, P24, DOI 10.2174/157488711793980147; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Paramio P, 1998, BIOCHEM J, V333, P631, DOI 10.1042/bj3330631; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gwak J, 2009, J CELL MOL MED, V13, P2171, DOI 10.1111/j.1582-4934.2009.00683.x; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hernandez-Maqueda JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058540; Hill KS, 2014, ONCOGENE, V33, P2134, DOI 10.1038/onc.2013.147; HIRAI S, 1994, EMBO J, V13, P2331, DOI 10.1002/j.1460-2075.1994.tb06517.x; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kang JH, 2014, NEW J SCI, V2014, P36, DOI [DOI 10.1155/2014/231418, 10.1155/2014/231418]; Kim JY, 2013, P NATL ACAD SCI USA, V110, P6418, DOI 10.1073/pnas.1221799110; Koren R, 2000, APPL IMMUNOHISTO M M, V8, P166, DOI 10.1097/00022744-200006000-00013; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kuehn HS, 2013, BLOOD, V121, P3117, DOI 10.1182/blood-2012-12-469544; Langzam L, 2001, AM J CLIN PATHOL, V116, P377, DOI 10.1309/1VKK-HWH7-YVJN-7UF7; Linch M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004068; Lu HC, 2009, PATHOLOGY, V41, P626, DOI 10.3109/00313020903273076; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Ma L, 2013, CELL, V152, P599, DOI 10.1016/j.cell.2012.12.028; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Mandil R, 2001, CANCER RES, V61, P4612; Mauro LV, 2010, PANCREAS, V39, pE31, DOI 10.1097/MPA.0b013e3181bce796; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mellemkjaer L, 1997, ARTHRITIS RHEUM-US, V40, P761, DOI 10.1002/art.1780400424; Mosior M, 1998, BIOCHEMISTRY-US, V37, P17271, DOI 10.1021/bi981344t; Myhre S, 2013, MOL ONCOL, V7, P704, DOI 10.1016/j.molonc.2013.02.018; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nezhat F, 2004, GYNECOL ONCOL, V93, P144, DOI 10.1016/j.ygyno.2003.12.021; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Perry AS, 2014, PROSTATE CANCER, V2014, DOI 10.1155/2014/481697; PONGRACZ J, 1995, INT J CANCER, V61, P35, DOI 10.1002/ijc.2910610107; Prevostel C, 1997, HORM RES, V47, P140, DOI 10.1159/000185457; Pu YS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-39; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Salzer E, 2013, BLOOD, V121, P3112, DOI 10.1182/blood-2012-10-460741; Suga K, 1998, BIOCHEM MOL BIOL INT, V44, P523; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Varga A, 2004, EUR UROL, V46, P462, DOI 10.1016/j.eururo.2004.04.014; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Walsh MF, 2004, CELL PROLIFERAT, V37, P427, DOI 10.1111/j.1365-2184.2004.00324.x; Wu B, 2013, TUMOR BIOL, V34, P837, DOI 10.1007/s13277-012-0614-x; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775; Zhang L.L., 2014, CLIN T ONCOL; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhu YM, 2005, CANCER RES, V65, P4520, DOI 10.1158/0008-5472.CAN-04-4506	78	215	230	2	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					489	502		10.1016/j.cell.2015.01.001	http://dx.doi.org/10.1016/j.cell.2015.01.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25619690	Green Accepted, Bronze			2022-12-28	WOS:000349208000014
J	Cho, SW; Chang, HY				Cho, Seung Woo; Chang, Howard Y.			CRISPR engineering turns on genes	NATURE			English	Editorial Material							RNA; ENDONUCLEASE; CAS9	The repurposing of a bacterial defence system known as CRISPR into a potent activator of gene expression in human cells enables powerful studies of gene function, as exemplified in cancer cells. SEE ARTICLE P. 583	[Cho, Seung Woo; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Cho, Seung Woo; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Cho, SW (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu	Cho, Seung Woo/B-2441-2019	Cho, Seung Woo/0000-0001-9091-0937				Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	10	0	0	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					560	562		10.1038/517560a	http://dx.doi.org/10.1038/517560a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631441				2022-12-28	WOS:000348775000030
J	Risbey, J				Risbey, James			Free and forced climate variations	NATURE			English	Editorial Material							CMIP5	A combination of simulations and data shows that short-term climate trends are dominated by natural internal variations, providing a basis for climate forecasting, but not for assessing sensitivity to forced changes. SEE ARTICLE P.565	Commonwealth Sci & Ind Res Org, Oceans & Atmosphere Flagship, Hobart, Tas 7001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Risbey, J (corresponding author), Commonwealth Sci & Ind Res Org, Oceans & Atmosphere Flagship, Hobart, Tas 7001, Australia.	james.risbey@csiro.au	Risbey, James/M-8419-2013	Risbey, James/0000-0003-3202-9142				Arguez A, 2011, B AM METEOROL SOC, V92, P699, DOI 10.1175/2010BAMS2955.1; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Forster PM, 2013, J GEOPHYS RES-ATMOS, V118, P1139, DOI 10.1002/jgrd.50174; Fyfe JC, 2013, NAT CLIM CHANGE, V3, P767, DOI 10.1038/nclimate1972; Marotzke J, 2015, NATURE, V517, P565, DOI 10.1038/nature14117; Meehl GA, 2014, NAT CLIM CHANGE, V4, P898, DOI [10.1038/NCLIMATE2357, 10.1038/nclimate2357]; Meehl GA, 2014, B AM METEOROL SOC, V95, P243, DOI 10.1175/BAMS-D-12-00241.1; O'Kane TJ, 2013, OCEAN MODEL, V69, P1, DOI 10.1016/j.ocemod.2013.04.009; Otto A, 2013, NAT GEOSCI, V6, P415, DOI 10.1038/ngeo1836; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Risbey JS, 2014, NAT CLIM CHANGE, V4, P835, DOI [10.1038/nclimate2310, 10.1038/NCLIMATE2310]; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1	14	8	8	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					562	563		10.1038/517562a	http://dx.doi.org/10.1038/517562a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631442				2022-12-28	WOS:000348775000031
J	Tomlinson, T; De Vries, R; Ryan, K; Kim, HM; Lehpamer, N; Kim, SYH				Tomlinson, Tom; De Vries, Raymond; Ryan, Kerry; Kim, Hyungjin Myra; Lehpamer, Nicole; Kim, Scott Y. H.			Moral Concerns and the Willingness to Donate to a Research Biobank	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Tomlinson, Tom] Michigan State Univ, Ctr Eth & Humanities Life Sci, E Lansing, MI 48824 USA; [De Vries, Raymond; Ryan, Kerry] Univ Michigan, Sch Med, Ctr Bioeth & Social Sci Med, Ann Arbor, MI USA; [Kim, Hyungjin Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Lehpamer, Nicole] Michigan State Univ, Dept Sociol, E Lansing, MI 48824 USA; [Kim, Scott Y. H.] NIH, Dept Bioeth, Bethesda, MD 20892 USA	Michigan State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Michigan State University; National Institutes of Health (NIH) - USA	Tomlinson, T (corresponding author), Michigan State Univ, Ctr Eth & Humanities Life Sci, 965 Fee Rd, E Lansing, MI 48824 USA.	tom.tomlinson@ht.msu.edu		Ryan, Kerry/0000-0002-0582-3693; De Vries, Raymond/0000-0003-3087-3040	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007172] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010540] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG007172] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CLINICAL CENTER; NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Gornick MC, 2014, J EMPIR RES HUM RES, V9, P22, DOI 10.1177/1556264614544277; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Tomlinson Tom, 2014, IRB, V36, P8; US Department of Health and Human Services, ANPRM REV COMM RUL; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544	5	44	44	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					417	419		10.1001/jama.2014.16363	http://dx.doi.org/10.1001/jama.2014.16363			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626040	Green Accepted			2022-12-28	WOS:000349072600026
J	Uhlen, M; Fagerberg, L; Hallstrom, BM; Lindskog, C; Oksvold, P; Mardinoglu, A; Sivertsson, A; Kampf, C; Sjostedt, E; Asplund, A; Olsson, I; Edlund, K; Lundberg, E; Navani, S; Szigyarto, CA; Odeberg, J; Djureinovic, D; Takanen, JO; Hober, S; Alm, T; Edqvist, PH; Berling, H; Tegel, H; Mulder, J; Rockberg, J; Nilsson, P; Schwenk, JM; Hamsten, M; von Feilitzen, K; Forsberg, M; Persson, L; Johansson, F; Zwahlen, M; von Heijne, G; Nielsen, J; Ponten, F				Uhlen, Mathias; Fagerberg, Linn; Hallstroem, Bjoern M.; Lindskog, Cecilia; Oksvold, Per; Mardinoglu, Adil; Sivertsson, Asa; Kampf, Caroline; Sjoestedt, Evelina; Asplund, Anna; Olsson, IngMarie; Edlund, Karolina; Lundberg, Emma; Navani, Sanjay; Szigyarto, Cristina Al-Khalili; Odeberg, Jacob; Djureinovic, Dijana; Takanen, Jenny Ottosson; Hober, Sophia; Alm, Tove; Edqvist, Per-Henrik; Berling, Holger; Tegel, Hanna; Mulder, Jan; Rockberg, Johan; Nilsson, Peter; Schwenk, Jochen M.; Hamsten, Marica; von Feilitzen, Kalle; Forsberg, Mattias; Persson, Lukas; Johansson, Fredric; Zwahlen, Martin; von Heijne, Gunnar; Nielsen, Jens; Ponten, Fredrik			Tissue-based map of the human proteome	SCIENCE			English	Article							QUANTITATIVE PROTEOMICS; GENE-EXPRESSION; SIGNAL PEPTIDES; CELL-LINES; GENOME; TRANSCRIPTOMICS; IDENTIFICATION; KNOWLEDGE; ELEMENTS; DRAFT	Resolving the molecular details of proteome variation in the different tissues and organs of the human body will greatly increase our knowledge of human biology and disease. Here, we present a map of the human tissue proteome based on an integrated omics approach that involves quantitative transcriptomics at the tissue and organ level, combined with tissue microarray-based immunohistochemistry, to achieve spatial localization of proteins down to the single-cell level. Our tissue-based analysis detected more than 90% of the putative protein-coding genes. We used this approach to explore the human secretome, the membrane proteome, the druggable proteome, the cancer proteome, and the metabolic functions in 32 different tissues and organs. All the data are integrated in an interactive Web-based database that allows exploration of individual proteins, as well as navigation of global expression patterns, in all major tissues and organs in the human body.	[Uhlen, Mathias; Fagerberg, Linn; Hallstroem, Bjoern M.; Oksvold, Per; Sivertsson, Asa; Sjoestedt, Evelina; Lundberg, Emma; Odeberg, Jacob; Alm, Tove; Nilsson, Peter; Schwenk, Jochen M.; von Feilitzen, Kalle; Forsberg, Mattias; Persson, Lukas; Johansson, Fredric; Zwahlen, Martin] KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Uhlen, Mathias; Hallstroem, Bjoern M.; Szigyarto, Cristina Al-Khalili; Takanen, Jenny Ottosson; Hober, Sophia; Berling, Holger; Tegel, Hanna; Rockberg, Johan; Hamsten, Marica] KTH Royal Inst Technol, Dept Prote, SE-10691 Stockholm, Sweden; [Uhlen, Mathias; Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2970 Horsholm, Denmark; [Lindskog, Cecilia; Kampf, Caroline; Sjoestedt, Evelina; Asplund, Anna; Olsson, IngMarie; Djureinovic, Dijana; Edqvist, Per-Henrik; Ponten, Fredrik] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Mardinoglu, Adil; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden; [Edlund, Karolina] Dortmund TU, Leibniz Res Ctr Working Environm & Human Factors, D-44139 Dortmund, Germany; [Navani, Sanjay] Lab Surgpath, Bombay, Maharashtra, India; [Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, SE-17177 Stockholm, Sweden; [von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology; Novo Nordisk Foundation; Technical University of Denmark; Uppsala University; Chalmers University of Technology; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Karolinska Institutet; Stockholm University	Uhlen, M (corresponding author), KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Schwenk, Jochen/AAS-4164-2021; von Heijne, Gunnar/F-5576-2011; Lindskog, Cecilia/AAO-2441-2021; Lindskog, Cecilia/AAE-5462-2019; Mulder, Jan/G-3909-2011; von Heijne, Gunnar/AAH-9389-2019; Schwenk, Jochen M/F-1730-2010; Odeberg, Jacob/I-8314-2016; Nilsson, Peter/E-4547-2010; Mulder, Jan/AAG-9761-2021; Mardinoglu, Adil/AAS-6360-2021; Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021; Lundberg, Emma S K/F-3891-2010; Nielsen, Jens/Q-1347-2017	Schwenk, Jochen/0000-0001-8141-8449; von Heijne, Gunnar/0000-0002-4490-8569; Mulder, Jan/0000-0003-3717-5018; Schwenk, Jochen M/0000-0001-8141-8449; Odeberg, Jacob/0000-0003-0996-1644; Nilsson, Peter/0000-0002-4657-8532; Uhlen, Mathias/0000-0002-4858-8056; Nielsen, Jens/0000-0002-9955-6003; Kaller Lundberg, Emma/0000-0001-7034-0850; Al-Khalili Szigyarto, Cristina/0000-0001-6990-1905; Oksvold, Per/0000-0003-3014-5502; Fagerberg, Linn/0000-0003-0198-7137; Lindskog, Cecilia/0000-0001-5611-1015	Science for Life Laboratory; National Genomics Infrastructure (NGI); Knut and Alice Wallenberg Foundation; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [High Throughput Molecular Bioscienc] Funding Source: researchfish	Science for Life Laboratory; National Genomics Infrastructure (NGI); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	We acknowledge the entire staff of the Human Protein Atlas program; the Science for Life Laboratory; and the pathology team in Mumbai, India, for valuable contributions. We thank the Department of Pathology at the Uppsala Akademiska Hospital, Uppsala, Sweden, and Uppsala Biobank for kindly providing clinical diagnostics and specimens used in this study. We also acknowledge support from Science for Life Laboratory, the National Genomics Infrastructure (NGI), and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure. Funding was provided by the Knut and Alice Wallenberg Foundation. The authors declare that they have no conflict of interest. Correspondence and requests for materials should be addressed to M.U. The mRNA levels of all genes in each tissue sample (n = 122) are available in table S18. The supplementary Excel tables are available in the supplementary material and at www.proteinatlas.org/about/publicationdata. The raw sequencing data are available at ArrayExpress (www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-2836/) and BioProject (NIH) (www.ncbi.nlm.nih.gov/bioproject/PRJNA183192). All Protein Atlas (protein) data are available in structured XML format and can be downloaded from www.proteinatlas.org/about/download.	Agren R, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.145122; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Crosswell LC, 2012, TRENDS BIOTECHNOL, V30, P241, DOI 10.1016/j.tibtech.2012.02.002; Danielsson F, 2013, J PROTEOME RES, V12, P299, DOI 10.1021/pr3009308; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gaudet P, 2013, J PROTEOME RES, V12, P293, DOI 10.1021/pr300830v; Gonzalez-Porta M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r70; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gremel G, 2015, J GASTROENTEROL, V50, P46, DOI 10.1007/s00535-014-0958-7; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kampf C, 2014, FASEB J, V28, P2901, DOI 10.1096/fj.14-250555; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mardinoglu A, 2012, J INTERN MED, V271, P142, DOI 10.1111/j.1365-2796.2011.02493.x; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123	38	7047	7162	73	1041	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							1260419	10.1126/science.1260419	http://dx.doi.org/10.1126/science.1260419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613900				2022-12-28	WOS:000348225800036
J	Brown, J; Farquhar, C				Brown, Julie; Farquhar, Cynthia			An Overview of Treatments for Endometriosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brown, Julie] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Farquhar, Cynthia] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand	University of Auckland; University of Auckland	Brown, J (corresponding author), Auckland Mail Ctr, Private Bag 92019, Auckland 1142, New Zealand.	j.brown@auckland.ac.nz		Farquhar, Cynthia/0000-0002-3685-3553; Brown, Julie/0000-0001-8155-677X				Brown J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009590.pub2; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Falcone T, 2010, OBSTET GYNECOL, V116, P440, DOI [10.1097/AOG.0b013e3181ea4fb6, 10.1097/AOG.0b013e3181e8b073]; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hickey M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1752; Ozkan S, 2008, ANN NY ACAD SCI, V1127, P92, DOI 10.1196/annals.1434.007	7	43	53	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					296	297		10.1001/jama.2014.17119	http://dx.doi.org/10.1001/jama.2014.17119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25603001				2022-12-28	WOS:000348145000022
J	Corrales-Medina, VF; Alvarez, KN; Weissfeld, LA; Angus, DC; Chirinos, JA; Chang, CCH; Newman, A; Loehr, L; Folsom, AR; Elkind, MS; Lyles, MF; Kronmal, RA; Yende, S				Corrales-Medina, Vicente F.; Alvarez, Karina N.; Weissfeld, Lisa A.; Angus, Derek C.; Chirinos, Julio A.; Chang, Chung-Chou H.; Newman, Anne; Loehr, Laura; Folsom, Aaron R.; Elkind, Mitchell S.; Lyles, Mary F.; Kronmal, Richard A.; Yende, Sachin			Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; INFLAMMATORY MARKERS; ATHEROSCLEROSIS RISK; ACUTE INFECTION; STROKE; MORTALITY; SEPSIS; POPULATION; SURVIVAL; HEALTH	IMPORTANCE The risk of cardiovascular disease (CVD) after infection is poorly understood. OBJECTIVE To determine whether hospitalization for pneumonia is associated with an increased short-term and long-term risk of CVD. DESIGN, SETTINGS, AND PARTICIPANTS We examined 2 community-based cohorts: the Cardiovascular Health Study (CHS, n = 5888; enrollment age, >= 65 years; enrollment period, 1989-1994) and the Atherosclerosis Risk in Communities study (ARIC, n = 15 792; enrollment age, 45-64 years; enrollment period, 1987-1989). Participants were followed up through December 31, 2010. We matched each participant hospitalized with pneumonia to 2 controls. Pneumonia cases and controls were followed for occurrence of CVD over 10 years after matching. We estimated hazard ratios (HRs) for CVD at different time intervals, adjusting for demographics, CVD risk factors, subclinical CVD, comorbidities, and functional status. EXPOSURES Hospitalization for pneumonia. MAIN OUTCOMES AND MEASURES Incident CVD (myocardial infarction, stroke, and fatal coronary heart disease). RESULTS Of 591 pneumonia cases in CHS, 206 had CVD events over 10 years after pneumonia hospitalization. Compared with controls, CVD risk among pneumonia cases was highest during the first year after hospitalization and remained significantly higher than among controls through 10 years. In ARIC, of 680 pneumonia cases, 112 had CVD events over 10 years after hospitalization. After the second year, CVD risk among pneumonia cases was not significantly higher than among controls. [GRAPHICS] CONCLUSIONS AND RELEVANCE Hospitalization for pneumonia was associated with increased short-term and long-term risk of CVD, suggesting that pneumonia may be a risk factor for CVD.	[Corrales-Medina, Vicente F.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Corrales-Medina, Vicente F.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Alvarez, Karina N.; Weissfeld, Lisa A.; Angus, Derek C.; Yende, Sachin] Univ Pittsburgh, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa A.; Chang, Chung-Chou H.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Chirinos, Julio A.] Univ Penn, Philadelphia, PA 19104 USA; [Chirinos, Julio A.] Philadelphia Vet Affairs Med Ctr, Div Cardiol, Philadelphia, PA USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Newman, Anne] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Loehr, Laura] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Elkind, Mitchell S.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Elkind, Mitchell S.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Lyles, Mary F.] Wake Forest Univ, Dept Med, Winston Salem, NC 27109 USA; [Kronmal, Richard A.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Yende, Sachin] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; Columbia University; Columbia University; Wake Forest University; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Yende, S (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, 606D Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu; yendes@upmc.edu	Newman, Anne B./C-6408-2013; Angus, Derek C/E-9671-2012	Newman, Anne B./0000-0002-0106-1150; Loehr, Laura/0000-0002-9054-1825; Corrales-Medina, Vicente/0000-0002-9691-491X	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, HL080295]; National Institute on Aging (NIA) [AG023629]; NHLBI [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; Department of Medicine of The Ottawa Hospital; Ottawa Hospital Research Institute in Ottawa, Ontario, Canada; National Institute of General Medical Sciences [K23GM083215, R01GM097471]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055019, N01HC085079, N01HC055222, N01HC085082, N01HC085083, N01HC085086, N01HC085081, N01HC085080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000145, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085083, R01HL080295, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM083215, R01GM097471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG023629, R01AG023629] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Medicine of The Ottawa Hospital; Ottawa Hospital Research Institute in Ottawa, Ontario, Canada; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Cardiovascular Health Study (CHS) was supported by contracts HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and grant HL080295 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by grant AG023629 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at CHS- NHLBI. org. The Atherosclerosis Risk in Communities study was supported by contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C from the NHLBI. This article is also supported by a Junior Investigator Award from the Department of Medicine of The Ottawa Hospital and the Ottawa Hospital Research Institute in Ottawa, Ontario, Canada (Dr Corrales- Medina) and by K23GM083215 and R01GM097471 from the National Institute of General Medical Sciences (Dr Yende).	Corrales-Medina VF, 2013, LANCET, V381, P496, DOI 10.1016/S0140-6736(12)61266-5; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; Elkind MSV, 2011, STROKE, V42, P1851, DOI 10.1161/STROKEAHA.110.608588; Foley RN, 2004, J AM SOC NEPHROL, V15, P1038, DOI 10.1097/01.ASN.0000119144.95922.C4; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Hall MJ, 2010, NATL HLTH STAT REPOR, p[1, 24], DOI DOI 10.3886/ICPSR28162.V1; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kasal J, 2004, CRIT CARE MED, V32, P700, DOI 10.1097/01.CCM.0000114819.37569.4B; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; KULLER L, 1994, AM J EPIDEMIOL, V139, P1164, DOI 10.1093/oxfordjournals.aje.a116963; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; Loeb Mark, 2010, BMJ Clin Evid, V2010; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Madjid M, 2007, TEX HEART I J, V34, P11; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Naghavi M, 2003, CIRCULATION, V107, P762, DOI 10.1161/01.CIR.0000048190.68071.2B; NHLBI, MORBIDITY AND MORTAL; O'Meara ES, 2005, J AM GERIATR SOC, V53, P1108, DOI 10.1111/j.1532-5415.2005.53352.x; Price T R, 1993, Ann Epidemiol, V3, P504; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Shah FA, 2013, AM J RESP CRIT CARE, V188, P586, DOI 10.1164/rccm.201212-2154OC; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Town Machell, 2006, Prev Chronic Dis, V3, pA53; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Wang MH, 2009, CANCER EPIDEM BIOMAR, V18, P706, DOI 10.1158/1055-9965.EPI-08-0839; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Yende S, 2013, CHEST, V144, P1008, DOI 10.1378/chest.12-2818; Yende S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022847	40	327	334	3	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					264	274		10.1001/jama.2014.18229	http://dx.doi.org/10.1001/jama.2014.18229			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602997	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000348145000018
J	Kassem, M; Bianco, P				Kassem, Moustapha; Bianco, Paolo			Skeletal Stem Cells in Space and Time	CELL			English	Editorial Material							BONE	The nature, biological characteristics, and contribution to organ physiology of skeletal stem cells are not completely determined. Chan et al. and Worthley et al. demonstrate that a stem cell for skeletal tissues, and a system of more restricted, downstream progenitors, can be identified in mice and demonstrate its role in skeletal tissue maintenance and regeneration.	[Kassem, Moustapha] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense C, Denmark; [Kassem, Moustapha] Univ Copenhagen, Panum Inst, Danish Stem Cell Ctr DanStem, DK-2200 Copenhagen, Denmark; [Bianco, Paolo] Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy	University of Southern Denmark; Odense University Hospital; University of Copenhagen; Sapienza University Rome	Kassem, M (corresponding author), Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense C, Denmark.	mkassem@health.sdu.dk; paolo.bianco@uniroma1.it	Kassem, Moustapha/O-3819-2019; Kassem, Moustapha/J-7688-2013	Kassem, Moustapha/0000-0003-1557-0869; Kassem, Moustapha/0000-0003-1557-0869	Novo Nordisk Fonden [NNF15CC0018344] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)		Abdallah BM, 2012, BONE, V50, P540, DOI 10.1016/j.bone.2011.06.030; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	10	47	48	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					17	19		10.1016/j.cell.2014.12.034	http://dx.doi.org/10.1016/j.cell.2014.12.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594172	Bronze			2022-12-28	WOS:000347923200005
J	Yang, J; Wu, ZH; Renier, N; Simon, DJ; Uryu, K; Park, DS; Greer, PA; Tournier, C; Davis, RJ; Tessier-Lavigne, M				Yang, Jing; Wu, Zhuhao; Renier, Nicolas; Simon, David J.; Uryu, Kunihiro; Park, David S.; Greer, Peter A.; Tournier, Cathy; Davis, Roger J.; Tessier-Lavigne, Marc			Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit	CELL			English	Article							PROMOTES WALLERIAN DEGENERATION; LEUCINE-ZIPPER KINASE; CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; REPEAT PROTEIN; CELL-DEATH; PATHWAY; INJURY; JNK3; PHOSPHORYLATION	Axonal death disrupts functional connectivity of neural circuits and is a critical feature of many neurodegenerative disorders. Pathological axon degeneration often occurs independently of known programmed death pathways, but the underlying molecular mechanisms remain largely unknown. Using traumatic injury as a model, we systematically investigate mitogen-activated protein kinase (MAPK) families and delineate a MAPK cascade that represents the early degenerative response to axonal injury. The adaptor protein Sarm1 is required for activation of this MAPK cascade, and this Sarm1-MAPK pathway disrupts axonal energy homeostasis, leading to ATP depletion before physical breakdown of damaged axons. The protective cytoNmnat1/Wld(s) protein inhibits activation of this MAPK cascade. Further, MKK4, a key component in the Sarm1-MAPK pathway, is antagonized by AKT signaling, which modulates the degenerative response by limiting activation of downstream JNK signaling. Our results reveal a regulatory mechanism that integrates distinct signals to instruct pathological axon degeneration.	[Yang, Jing; Wu, Zhuhao; Renier, Nicolas; Simon, David J.; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Uryu, Kunihiro] Rockefeller Univ, Electron Microscopy Resource Ctr, New York, NY 10065 USA; [Park, David S.] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON K1N 6N5, Canada; [Greer, Peter A.] Queens Univ, Canc Res Inst, Kingston, ON, Canada; [Tournier, Cathy] Univ Manchester, Manchester M13 9PT, Lancs, England; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	Rockefeller University; Rockefeller University; University of Ottawa; Queens University - Canada; University of Manchester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA.	marctl@rockefeller.edu	Renier, Nicolas/E-1855-2018; Wu, Zhuhao/I-5852-2018; Yang, Jing/M-2831-2017	Renier, Nicolas/0000-0003-2642-4402; Yang, Jing/0000-0002-2048-735X; Tournier, Cathy/0000-0002-4618-2570; Wu, Zhuhao/0000-0002-2471-0555; Davis, Roger/0000-0002-0130-1652; Simon, David/0000-0002-2683-5757; Park, David/0000-0002-4490-3784	NIH [1R01NS083813-01A1]; Alzheimers Research UK [ART-PG2011-10] Funding Source: researchfish; Medical Research Council [G0001285] Funding Source: researchfish; MRC [G0001285] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of Tessier-Lavigne lab for discussion and suggestions. This work was supported by NIH grant 1R01NS083813-01A1 to M.T.-L.	Blum ES, 2012, SCIENCE, V335, P970, DOI 10.1126/science.1215156; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Chen M, 2012, J NEUROSCI, V32, P13439, DOI 10.1523/JNEUROSCI.2039-12.2012; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kurz CL, 2007, BIOCHEM BIOPH RES CO, V363, P438, DOI 10.1016/j.bbrc.2007.08.190; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Pozniak CD, 2013, J EXP MED, V210, P2553, DOI 10.1084/jem.20122832; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Xiong X, 2012, J NEUROSCI, V32, P610, DOI 10.1523/JNEUROSCI.3586-11.2012; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034; Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024	30	192	196	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					161	176		10.1016/j.cell.2014.11.053	http://dx.doi.org/10.1016/j.cell.2014.11.053			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594179	Green Accepted, Bronze			2022-12-28	WOS:000347923200016
J	Ezenwa, VO; Jolles, AE				Ezenwa, Vanessa O.; Jolles, Anna E.			Opposite effects of anthelmintic treatment on microbial infection at individual versus population scales	SCIENCE			English	Article							HELMINTH INFECTIONS; INNATE IMMUNITY; HEALTH-POLICY; TUBERCULOSIS; COINFECTION; ELIMINATION; HIV/AIDS; PROGRAMS; IMPACT	Parasitic worms modulate host immune responses in ways that affect microbial co-infections. For this reason, anthelmintic therapy may be a potent tool for indirectly controlling microbial pathogens. However, the population-level consequences of this type of intervention on co-infecting microbes are unknown. We evaluated the effects of anthelmintic treatment on bovine tuberculosis (BTB) acquisition, mortality after infection, and pathogen fitness in free-ranging African buffalo. We found that treatment had no effect on the probability of BTB infection, but buffalo survival after infection was ninefold higher among treated individuals. These contrasting effects translated into an approximately eightfold increase in the reproductive number of BTB for anthelmintic-treated compared with untreated buffalo. Our results indicate that anthelmintic treatment can enhance the spread of microbial pathogens in some real-world situations.	[Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA; [Ezenwa, Vanessa O.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Jolles, Anna E.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Jolles, Anna E.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Oregon State University; Oregon State University	Ezenwa, VO (corresponding author), Univ Georgia, Coll Vet Med, Odum Sch Ecol, Athens, GA 30602 USA.	vezenwa@uga.edu		Jolles, Anna/0000-0003-3074-9912	National Science Foundation Ecology of Infectious Diseases [EF-0723918/DEB-1102493, EF-0723928]	National Science Foundation Ecology of Infectious Diseases(National Science Foundation (NSF))	We thank South African National Parks (SANParks) for permission to conduct this study in Kruger and M. Hofmeyr, P. Buss, and the entire SANParks Veterinary Wildlife Services Department for invaluable assistance with animal captures and project logistics. We thank R. Spam, J. Spaan, K. Thompson, B. Beechler, P. Snyder, and B. Henrichs for work on animal captures and sample processing; A. Park for illuminating discussion about R<INF>0</INF> estimation; and S. Altizer and the Ezenwa and Altizer lab groups for valuable comments on earlier drafts of the manuscript. Animal protocols for this study were approved by the University of Georgia. (UGA) and Oregon State University (OSU) Institutional Animal Care am Use Committees (UGA AUP A2010 10-190-Y3-A5; OSU AUP 3822 and 4325). This study was supported by a National Science Foundation Ecology of Infectious Diseases Grant (EF-0723918/DEB-1102493, EF-0723928). The authors report no conflicts of interest related to this research. Data presented in this paper me available from the Dryad Digital Repository (DOI: 10.5061/dryad.q2m38).	ANDERSON R M, 1991; Apiwattanakul N, 2014, MED MICROBIOL IMMUN, V203, P357, DOI 10.1007/s00430-014-0344-3; Bengis R. G., 1999, TUBERCULOSIS; Borkow G, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000160; Bundy DAP, 2013, TRENDS PARASITOL, V29, P142, DOI 10.1016/j.pt.2012.12.003; Charlier J, 2014, TRENDS PARASITOL, V30, P361, DOI 10.1016/j.pt.2014.04.009; Chenine AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000265; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; George PJ, 2013, J IMMUNOL, V190, P5161, DOI 10.4049/jimmunol.1203311; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002570; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Lankowski AJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003036; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Mulu A, 2013, INT J INFECT DIS, V17, pE897, DOI 10.1016/j.ijid.2013.03.022; Noblick J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001022; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Rafi W, 2012, CURR OPIN HIV AIDS, V7, P239, DOI 10.1097/COH.0b013e3283524dc5; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Su LB, 2014, INFECT IMMUN, V82, P3855, DOI 10.1128/IAI.02023-14; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Walson JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub3; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x	27	107	113	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					175	177		10.1126/science.1261714	http://dx.doi.org/10.1126/science.1261714			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574023				2022-12-28	WOS:000347918900043
J	Shear, MK				Shear, M. Katherine			Complicated Grief	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; ACUTE MYOCARDIAL-INFARCTION; PROLONGED GRIEF; SIGNIFICANT PERSON; SUICIDAL IDEATION; BEREAVEMENT; DEATH; RISK; LIFE; INTERVENTION	A 68-year-old woman seeks care from her primary physician because of trouble sleeping 4 years after the death of her husband. On questioning, she reveals that she is sleeping on a couch in her living room because she cannot bear to sleep in the bed she shared with him. She has stopped eating regular meals because preparing them makes her miss him too much; she still has meals that she cooked for him in her freezer. The patient often ruminates about how unfair it was for her husband to die, and she is alternately angry with the medical staff who cared for him and angry at herself for not recognizing his illness earlier. She finds it too painful to do things that she and her husband used to do together, and she thinks about him constantly and often wishes she could die to be with him. How should this patient be evaluated and treated?	[Shear, M. Katherine] Columbia Univ Coll Phys & Surg, Columbia Univ Sch Social Work, Ctr Complicated Grief, New York, NY 10032 USA	Columbia University	Shear, MK (corresponding author), 1255 Amsterdam Ave, New York, NY 10027 USA.	ks2394@columbia.edu						Acierno R, 2012, AM J HOSP PALLIAT ME, V29, P13, DOI 10.1177/1049909111411471; Allen JY, 2013, J PALLIAT MED, V16, P745, DOI 10.1089/jpm.2012.0450; Boelen PA, 2013, DEPRESS RES TREAT, V2013; Boelen PA, 2007, J CONSULT CLIN PSYCH, V75, P277, DOI 10.1037/0022-006X.75.2.277; Boelen PA, 2010, J NERV MENT DIS, V198, P252, DOI 10.1097/NMD.0b013e3181d619e4; Bowlby J., 1980, LOSS SADNESS DEPRESS, V3; Bryant RA, 2014, JAMA PSYCHIAT; Buckley Thomas, 2012, Dialogues Clin Neurosci, V14, P129; Bui Eric, 2012, Dialogues Clin Neurosci, V14, P149; Denderen MV, 2013, TRAUMA VIOLENCE ABUS; GRIMBY A, 1993, ACTA PSYCHIAT SCAND, V87, P72, DOI 10.1111/j.1600-0447.1993.tb03332.x; Guldin MB, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-9; Gupta S, 2011, J ABNORM PSYCHOL, V120, P635, DOI 10.1037/a0023541; Hall CA, 2014, J PSYCHIATR RES, V58, P20, DOI 10.1016/j.jpsychires.2014.07.002; He L, 2014, PSYCHIAT RES, V219, P347, DOI 10.1016/j.psychres.2014.05.022; Holland JM, 2009, J PSYCHOPATHOL BEHAV, V31, P190, DOI 10.1007/s10862-008-9113-1; Kersting A, 2013, PSYCHOTHER PSYCHOSOM, V82, P372, DOI 10.1159/000348713; Kersting A, 2011, J AFFECT DISORDERS, V131, P339, DOI 10.1016/j.jad.2010.11.032; Keyes KM, 2014, AM J PSYCHIAT, V171, P864, DOI 10.1176/appi.ajp.2014.13081132; Litz BT, 2014, BEHAV RES THER, V61, P23, DOI 10.1016/j.brat.2014.07.005; Martinez-Selles M, 2012, CIRCULATION, V126, pE36, DOI 10.1161/CIRCULATIONAHA.112.094581; Meert KL, 2011, J PALLIAT MED, V14, P207, DOI 10.1089/jpm.2010.0291; Mitchell AM, 2005, SUICIDE LIFE-THREAT, V35, P498, DOI 10.1521/suli.2005.35.5.498; Mostofsky E, 2012, CIRCULATION, V125, P491, DOI 10.1161/CIRCULATIONAHA.111.061770; Nakajima Satomi, 2012, Dialogues Clin Neurosci, V14, P210; O'Connor MF, 2008, NEUROIMAGE, V42, P969, DOI 10.1016/j.neuroimage.2008.04.256; O'Connor MF, 2014, J GERONTOL B-PSYCHOL, V69, P12, DOI 10.1093/geronb/gbt025; O'Connor MF, 2012, PSYCHONEUROENDOCRINO, V37, P725, DOI 10.1016/j.psyneuen.2011.08.009; Papa A, 2013, BEHAV THER, V44, P639, DOI 10.1016/j.beth.2013.04.009; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Robinaugh DJ, 2013, CLIN PSYCHOL SCI, V1, P290, DOI 10.1177/2167702613476027; Rosner R, 2014, J AFFECT DISORDERS, V167, P56, DOI 10.1016/j.jad.2014.05.035; Rosner R, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.7995; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Shear MK, 2014, JAMA PSYCHIAT, V71, P1287, DOI 10.1001/jamapsychiatry.2014.1242; Shear MK, 2012, CURR PSYCHIAT REP, V14, P169, DOI 10.1007/s11920-012-0270-2; Shear MK, 2011, DEPRESS ANXIETY, V28, P103, DOI 10.1002/da.20780; Shear MK, 2001, AM J PSYCHIAT, V158, P1506, DOI 10.1176/appi.ajp.158.9.1506; Simon NM, 2008, PSYCHIAT RES, V159, P31, DOI 10.1016/j.psychres.2007.05.011; Simon NM, 2007, COMPR PSYCHIAT, V48, P395, DOI 10.1016/j.comppsych.2007.05.002; Simon NM, 2013, JAMA-J AM MED ASSOC, V310, P416, DOI 10.1001/jama.2013.8614; Szanto K, 1997, SUICIDE LIFE-THREAT, V27, P194; Szanto K, 2006, J CLIN PSYCHIAT, V67, P233, DOI 10.4088/JCP.v67n0209; Tal Young Ilanit, 2012, Dialogues Clin Neurosci, V14, P177; Wagner B, 2006, DEATH STUD, V30, P429, DOI 10.1080/07481180600614385; WEISSMAN MM, 2000, COMPREHENSIVE GUIDE; Zisook S, 2007, PSYCHOL MED, V37, P779, DOI 10.1017/S0033291707009865	47	249	253	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					153	160		10.1056/NEJMcp1315618	http://dx.doi.org/10.1056/NEJMcp1315618			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY2UA	25564898				2022-12-28	WOS:000347443300010
J	Tolaney, SM; Barry, WT; Dang, CT; Yardley, DA; Moy, B; Marcom, PK; Albain, KS; Rugo, HS; Ellis, M; Shapira, I; Wolff, AC; Carey, LA; Overmoyer, BA; Partridge, AH; Guo, H; Hudis, CA; Krop, IE; Burstein, HJ; Winer, EP				Tolaney, Sara M.; Barry, William T.; Dang, Chau T.; Yardley, Denise A.; Moy, Beverly; Marcom, P. Kelly; Albain, Kathy S.; Rugo, Hope S.; Ellis, Matthew; Shapira, Iuliana; Wolff, Antonio C.; Carey, Lisa A.; Overmoyer, Beth A.; Partridge, Ann H.; Guo, Hao; Hudis, Clifford A.; Krop, Ian E.; Burstein, Harold J.; Winer, Eric P.			Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY; CHEMOTHERAPY; EFFICACY; OVEREXPRESSION; ONCOGENE; SAFETY; WOMEN; RISK	BACKGROUND No single standard treatment exists for patients with small, node-negative, human epidermal growth factor receptor type 2 (HER2)-positive breast cancers, because most of these patients have been ineligible for the pivotal trials of adjuvant trastuzumab. METHODS We performed an uncontrolled, single-group, multicenter, investigator-initiated study of adjuvant paclitaxel and trastuzumab in 406 patients with tumors measuring up to 3 cm in greatest dimension. Patients received weekly treatment with paclitaxel and trastuzumab for 12 weeks, followed by 9 months of trastuzumab monotherapy. The primary end point was survival free from invasive disease. RESULTS The median follow-up period was 4.0 years. The 3-year rate of survival free from invasive disease was 98.7% (95% confidence interval [CI], 97.6 to 99.8). Among the 12 relapses seen, 2 were due to distant metastatic breast cancer. Excluding contralateral HER2-negative breast cancers and nonbreast cancers, 7 disease-specific events were noted. A total of 13 patients (3.2%; 95% CI, 1.7 to 5.4) reported at least one episode of grade 3 neuropathy, and 2 had symptomatic congestive heart failure (0.5%; 95% CI, 0.1 to 1.8), both of whom had normalization of the left ventricular ejection fraction after discontinuation of trastuzumab. A total of 13 patients had significant asymptomatic declines in ejection fraction (3.2%; 95% CI, 1.7 to 5.4), as defined by the study, but 11 of these patients were able to resume trastuzumab therapy after a brief interruption. CONCLUSIONS Among women with predominantly stage I HER2-positive breast cancer, treatment with adjuvant paclitaxel plus trastuzumab was associated with a risk of early recurrence of about 2%; 6% of patients withdrew from the study because of protocol-specified adverse events. (Funded by Genentech; ClinicalTrials.gov number, NCT00542451.)	[Tolaney, Sara M.; Overmoyer, Beth A.; Partridge, Ann H.; Krop, Ian E.; Burstein, Harold J.; Winer, Eric P.] Massachusetts Gen Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02114 USA; [Barry, William T.; Guo, Hao] Massachusetts Gen Hosp, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02114 USA; [Moy, Beverly] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; [Dang, Chau T.; Hudis, Clifford A.] Mem Sloan Kettering Canc Ctr, Solid Tumor Div, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA; [Dang, Chau T.; Hudis, Clifford A.] Weill Cornell Med Ctr, Dept Med, New York, NY USA; [Shapira, Iuliana] Hofstra North Shore LIJ Sch Med, Dept Med Oncol, New Hyde Pk, NY USA; [Yardley, Denise A.] Sarah Cannon Canc Ctr, Dept Med Oncol, Nashville, TN USA; [Marcom, P. Kelly] Duke Canc Inst, Dept Med, Div Med Oncol, Durham, NC USA; [Carey, Lisa A.] Univ N Carolina, Dept Med Oncol, Chapel Hill, NC USA; [Albain, Kathy S.] Loyola Univ Chicago Stritch Sch Med, Div Hematol Oncol, Dept Med, Cardinal Bernardin Canc Ctr, Maywood, IL USA; [Rugo, Hope S.] Univ Calif San Francisco, Div Oncol, Dept Med, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Ellis, Matthew] Washington Univ, Dept Med Oncol, St Louis, MO 63130 USA; [Wolff, Antonio C.] Johns Hopkins Kimmel Canc Ctr, Dept Oncol, Baltimore, MD USA	Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; Hofstra University; Northwell Health; Sarah Cannon Research Institute; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Loyola University Chicago; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine	Winer, EP (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	ewiner@-partners.org	Wolff, Antonio C./T-8796-2019; Marcom, Paul/M-4516-2019; Guo, Hao/E-8921-2015; Hudis, Clifford/AAW-9482-2021; Marcom, Paul/AAE-4761-2020	Wolff, Antonio C./0000-0003-3734-1063; Guo, Hao/0000-0003-1658-0989; Hudis, Clifford/0000-0001-7144-8791; Marcom, Paul/0000-0001-5302-6368	Genentech; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Genentech; ClinicalTrials.gov number, NCT00542451.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Chia S, 2008, J CLIN ONCOL, V26, P5697, DOI 10.1200/JCO.2007.15.8659; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Curigliano G, 2009, J CLIN ONCOL, V27, P5693, DOI 10.1200/JCO.2009.22.0962; Fehrenbacher L, 2014, J CLIN ONCOL, V32, P2151, DOI 10.1200/JCO.2013.52.0858; Goldhirsch A, 2013, LANCET, V382, P1021, DOI 10.1016/S0140-6736(13)61094-6; Gonzalez-Angulo AM, 2009, J CLIN ONCOL, V27, P5700, DOI 10.1200/JCO.2009.23.2025; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; McArthur HL, 2011, CANCER-AM CANCER SOC, V117, P5461, DOI 10.1002/cncr.26171; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; PRESS MF, 1993, CANCER RES, V53, P4960; Romond E, 2012, SAN ANT BREAST CANC; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Vaz-Luis I, 2014, J CLIN ONCOL, V32, P2142, DOI 10.1200/JCO.2013.53.1608; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719	19	447	473	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					134	141		10.1056/NEJMoa1406281	http://dx.doi.org/10.1056/NEJMoa1406281			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25564897	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000347443300008
J	Ewer, K; Rampling, T; Venkatraman, N; Bowyer, G; Wright, D; Lambe, T; Imoukhuede, EB; Payne, R; Fehling, SK; Strecker, T; Biedenkopf, N; Krahling, V; Tully, CM; Edwards, NJ; Bentley, EM; Samuel, D; Labbe, G; Jin, J; Gibani, M; Minhinnick, A; Wilkie, M; Poulton, I; Lella, N; Roberts, R; Hartnell, F; Bliss, C; Sierra-Davidson, K; Powlson, J; Berrie, E; Tedder, R; Roman, F; De Ryck, I; Nicosia, A; Sullivan, NJ; Stanley, DA; Mbaya, OT; Ledgerwood, JE; Schwartz, RM; Siani, L; Colloca, S; Folgori, A; Di Marco, S; Cortese, R; Wright, E; Becker, S; Graham, BS; Koup, RA; Levine, MM; Volkmann, A; Chaplin, P; Pollard, AJ; Draper, SJ; Ballou, WR; Lawrie, A; Gilbert, SC; Hill, AVS				Ewer, K.; Rampling, T.; Venkatraman, N.; Bowyer, G.; Wright, D.; Lambe, T.; Imoukhuede, E. B.; Payne, R.; Fehling, S. K.; Strecker, T.; Biedenkopf, N.; Kraehling, V.; Tully, C. M.; Edwards, N. J.; Bentley, E. M.; Samuel, D.; Labbe, G.; Jin, J.; Gibani, M.; Minhinnick, A.; Wilkie, M.; Poulton, I.; Lella, N.; Roberts, R.; Hartnell, F.; Bliss, C.; Sierra-Davidson, K.; Powlson, J.; Berrie, E.; Tedder, R.; Roman, F.; De Ryck, I.; Nicosia, A.; Sullivan, N. J.; Stanley, D. A.; Mbaya, O. T.; Ledgerwood, J. E.; Schwartz, R. M.; Siani, L.; Colloca, S.; Folgori, A.; Di Marco, S.; Cortese, R.; Wright, E.; Becker, S.; Graham, B. S.; Koup, R. A.; Levine, M. M.; Volkmann, A.; Chaplin, P.; Pollard, A. J.; Draper, S. J.; Ballou, W. R.; Lawrie, A.; Gilbert, S. C.; Hill, A. V. S.			A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTECTS NONHUMAN-PRIMATES; IMMUNITY; VIRUS; CHALLENGE; INFECTION; HUMANS	BACKGROUND The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak. METHODS In this phase 1 study, we administered a single dose of the chimpanzee adenovirus 3 (ChAd3) vaccine encoding the surface glycoprotein of Zaire ebolavirus (ZEBOV) to 60 healthy adult volunteers in Oxford, United Kingdom. The vaccine was administered in three dose levels - 1x10(10) viral particles, 2.5x10(10) viral particles, and 5x10(10) viral particles - with 20 participants in each group. We then assessed the effect of adding a booster dose of a modified vaccinia Ankara (MVA) strain, encoding the same Ebola virus glycoprotein, in 30 of the 60 participants and evaluated a reduced prime-boost interval in another 16 participants. We also compared antibody responses to inactivated whole Ebola virus virions and neutralizing antibody activity with those observed in phase 1 studies of a recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) to determine relative potency and assess durability. RESULTS No safety concerns were identified at any of the dose levels studied. Four weeks after immunization with the ChAd3 vaccine, ZEBOV-specific antibody responses were similar to those induced by rVSV-ZEBOV vaccination, with a geometric mean titer of 752 and 921, respectively. ZEBOV neutralization activity was also similar with the two vaccines (geometric mean titer, 14.9 and 22.2, respectively). Boosting with the MVA vector increased virus-specific antibodies by a factor of 12 (geometric mean titer, 9007) and increased glycoprotein-specific CD8+ T cells by a factor of 5. Significant increases in neutralizing antibodies were seen after boosting in all 30 participants (geometric mean titer, 139; P<0.001). Virus-specific antibody responses in participants primed with ChAd3 remained positive 6 months after vaccination (geometric mean titer, 758) but were significantly higher in those who had received the MVA booster (geometric mean titer, 1750; P<0.001). CONCLUSIONS The ChAd3 vaccine boosted with MVA elicited B-cell and T-cell immune responses to ZEBOV that were superior to those induced by the ChAd3 vaccine alone.	[Ewer, K.; Rampling, T.; Venkatraman, N.; Bowyer, G.; Wright, D.; Lambe, T.; Imoukhuede, E. B.; Payne, R.; Tully, C. M.; Edwards, N. J.; Labbe, G.; Jin, J.; Gibani, M.; Minhinnick, A.; Wilkie, M.; Poulton, I.; Lella, N.; Roberts, R.; Hartnell, F.; Bliss, C.; Sierra-Davidson, K.; Powlson, J.; Berrie, E.; Pollard, A. J.; Draper, S. J.; Lawrie, A.; Gilbert, S. C.; Hill, A. V. S.] Univ Oxford, Jenner Inst, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England; [Ewer, K.; Rampling, T.; Venkatraman, N.; Bowyer, G.; Wright, D.; Lambe, T.; Imoukhuede, E. B.; Payne, R.; Tully, C. M.; Edwards, N. J.; Labbe, G.; Jin, J.; Gibani, M.; Minhinnick, A.; Wilkie, M.; Poulton, I.; Lella, N.; Roberts, R.; Hartnell, F.; Bliss, C.; Sierra-Davidson, K.; Powlson, J.; Berrie, E.; Pollard, A. J.; Draper, S. J.; Lawrie, A.; Gilbert, S. C.; Hill, A. V. S.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7DQ, England; [Ewer, K.; Rampling, T.; Venkatraman, N.; Bowyer, G.; Wright, D.; Lambe, T.; Imoukhuede, E. B.; Payne, R.; Tully, C. M.; Edwards, N. J.; Labbe, G.; Jin, J.; Gibani, M.; Minhinnick, A.; Wilkie, M.; Poulton, I.; Lella, N.; Roberts, R.; Hartnell, F.; Bliss, C.; Sierra-Davidson, K.; Powlson, J.; Berrie, E.; Pollard, A. J.; Draper, S. J.; Lawrie, A.; Gilbert, S. C.; Hill, A. V. S.] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England; [Bentley, E. M.; Wright, E.] Univ Westminster, Fac Sci & Technol, Viral Pseudotype Unit, London W1R 8AL, England; [Samuel, D.; Tedder, R.] Publ Hlth Agcy, Virus Reference Dept, London, England; [Fehling, S. K.; Strecker, T.; Biedenkopf, N.; Kraehling, V.; Becker, S.] Univ Marburg, Inst Virol, D-35032 Marburg, Germany; [Becker, S.] German Ctr Infect Res, Partner Site Giessen Marburg Langen, Marburg, Germany; [Volkmann, A.; Chaplin, P.] Bavarian Nord, Martinsried, Germany; [Roman, F.; De Ryck, I.; Ballou, W. R.] GlaxoSmithKline Biol, Rixensart, Belgium; [Nicosia, A.; Siani, L.; Colloca, S.; Folgori, A.; Di Marco, S.] ReiThera, Rome, Italy; [Nicosia, A.] Univ Naples Federico II, CEINGE, Naples, Italy; [Nicosia, A.] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Sullivan, N. J.; Stanley, D. A.; Mbaya, O. T.; Ledgerwood, J. E.; Schwartz, R. M.; Graham, B. S.; Koup, R. A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Levine, M. M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Cortese, R.] Keires, Basel, Switzerland	University of Oxford; Jenner Institute; University of Oxford; University of Oxford; University of Westminster; Public Health England; Philipps University Marburg; German Center for Infection Research; Bavarian Nordic; GlaxoSmithKline; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore	Hill, AVS (corresponding author), Univ Oxford, Jenner Inst, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England.	adrian.hill@ndm.ox.ac.uk	Strecker, Thomas/AAR-8442-2020; Poedts, Stefaan/C-9775-2012; Gilbert, Sarah C./H-2857-2019; Lambe, Teresa/E-5733-2016; Ewer, Katie J/B-4328-2011; bowyer, georgina/T-3890-2019; Graham, Barney S./AAC-5898-2019; Draper, Simon J/F-1758-2011	Poedts, Stefaan/0000-0002-1743-0651; Gilbert, Sarah C./0000-0002-6823-9750; Lambe, Teresa/0000-0001-7711-897X; Ewer, Katie J/0000-0001-9827-9836; Graham, Barney S./0000-0001-8112-0853; Draper, Simon J/0000-0002-9415-1357; Tedder, Richard/0000-0002-9672-5721; Rampling, Tommy/0000-0001-9111-2486; Wright, Edward/0000-0001-7041-5138; De Ryck, Iris/0000-0003-3044-1117; Wright, Daniel/0000-0002-8114-1838; Labbe, Genevieve/0000-0002-1015-8579; Gibani, Malick/0000-0003-1781-0053; Strecker, Thomas/0000-0002-7857-937X; Bliss, Carly/0000-0002-5117-1016; Edwards, Nick/0000-0002-7030-7839; Bentley, Emma M./0000-0001-6109-2840; Bowyer, Georgina/0000-0002-2058-4045; Payne, Ruth/0000-0002-8490-671X	Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005123, ZIAAI005047, ZIAAI005073] Funding Source: NIH RePORTER; MRC [G1000527] Funding Source: UKRI; Medical Research Council [G1000527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10158] Funding Source: researchfish; Wellcome Trust [106917/Z/15/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by the Wellcome Trust and others; ClinicalTrials.gov number, NCT02240875.	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Antrobus RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048322; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Borthwick NJ, 2015, IMMUN INFLAMM DIS, V3, P82, DOI 10.1002/iid3.52; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; Enama ME, 2011, 14 ANN C VACC RES BA; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Fausther-Bovendo H, 2012, CURR OPIN VIROL, V2, P324, DOI 10.1016/j.coviro.2012.04.003; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kibuuka H, 2015, LANCET, V385, P1545, DOI 10.1016/S0140-6736(14)62385-0; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Malaeb BS, 2005, UROLOGY, V66, P830, DOI 10.1016/j.urology.2005.04.041; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Qiu XG, 2011, CLIN IMMUNOL, V141, P218, DOI 10.1016/j.clim.2011.08.008; Rampling T, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1411627, DOI 10.1056/NEJMOA1411627, 10.1056/NEJMoa1411627.]; Regules JA, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1414216, DOI 10.1056/NEJMOA1414216]; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Tapia MD, 2016, LANCET INFECT DIS, V16, P16; Zhou Y, 2015, CURR OPIN IMMUNOL, V35, P131, DOI 10.1016/j.coi.2015.06.006; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0	30	200	203	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1635	1646		10.1056/NEJMoa1411627	http://dx.doi.org/10.1056/NEJMoa1411627			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK3UR	25629663	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000374843400007
J	Kolkowitz, S; Safira, A; High, AA; Devlin, RC; Choi, S; Unterreithmeier, QP; Patterson, D; Zibrov, AS; Manucharyan, VE; Park, H; Lukin, MD				Kolkowitz, S.; Safira, A.; High, A. A.; Devlin, R. C.; Choi, S.; Unterreithmeier, Q. P.; Patterson, D.; Zibrov, A. S.; Manucharyan, V. E.; Park, H.; Lukin, M. D.			Probing Johnson noise and ballistic transport in normal metals with a single-spin qubit	SCIENCE			English	Article							SILVER	Thermally induced electrical currents, known as Johnson noise, cause fluctuating electric and magnetic fields in proximity to a conductor. These fluctuations are intrinsically related to the conductivity of the metal. We use single-spin qubits associated with nitrogen-vacancy centers in diamond to probe Johnson noise in the vicinity of conductive silver films. Measurements of polycrystalline silver films over a range of distances (20 to 200 nanometers) and temperatures (10 to 300 kelvin) are consistent with the classically expected behavior of the magnetic fluctuations. However, we find that Johnson noise is markedly suppressed next to single-crystal films, indicative of a substantial deviation from Ohm's law at length scales below the electron mean free path. Our results are consistent with a generalized model that accounts for the ballistic motion of electrons in the metal, indicating that under the appropriate conditions, nearby electrodes may be used for controlling nanoscale optoelectronic, atomic, and solid-state quantum systems.	[Kolkowitz, S.; Safira, A.; High, A. A.; Choi, S.; Unterreithmeier, Q. P.; Patterson, D.; Zibrov, A. S.; Park, H.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [High, A. A.; Devlin, R. C.; Park, H.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Manucharyan, V. E.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	Harvard University; Harvard University; University System of Maryland; University of Maryland College Park	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	hongkun_park@harvard.edu; lukin@physics.harvard.edu	Zibrov, Alexander S/G-7419-2014; High, Alexander A/E-2541-2012; High, Alexander A/U-1307-2018; Park, Hongkun/R-9842-2019; Kolkowitz, Shimon/AAD-5921-2019	High, Alexander A/0000-0003-0428-5448; Park, Hongkun/0000-0001-9576-8829; Kolkowitz, Shimon/0000-0001-7095-1547	Center for Ultracold Atoms; National Science Foundation (NSF); Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout program; Air Force Office of Scientific Research Multidisciplinary University Research Initiative; Gordon and Betty Moore Foundation; National Defense Science and Engineering Graduate fellowship; Society of Fellows of Harvard University; NSF Graduate Research Fellowship; NSF [ECS-0335765]; Direct For Mathematical & Physical Scien [1125846] Funding Source: National Science Foundation	Center for Ultracold Atoms; National Science Foundation (NSF)(National Science Foundation (NSF)); Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Defense Science and Engineering Graduate fellowship; Society of Fellows of Harvard University; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank E. Demler, A. Bleszynski Jayich, B. Myers, A. Yacoby, M. Vavilov, R. Joynt, A. Poudel, and L. Langsjoen for helpful discussions and insightful comments. Financial support was provided by the Center for Ultracold Atoms, the National Science Foundation (NSF), the Defense Advanced Research Projects Agency Quantum-Assisted Sensing and Readout program, the Air Force Office of Scientific Research Multidisciplinary University Research Initiative, and the Gordon and Betty Moore Foundation. S.K. and A.S. acknowledge financial support from the National Defense Science and Engineering Graduate fellowship, V.E.M. from the Society of Fellows of Harvard University, and S.K. from the NSF Graduate Research Fellowship. All fabrication and metrology were performed at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF under award no. ECS-0335765. The CNS is part of Harvard University.	Anton SM, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.147002; Ashcroft N.W., 1976, SOLID STATE PHYS; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; BASKI AA, 1994, SURF SCI, V313, P275, DOI 10.1016/0039-6028(94)90048-5; BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; Bleszynski-Jayich AC, 2009, SCIENCE, V326, P272, DOI 10.1126/science.1178139; Bluhm H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136802; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Datta S., 1997, CAMBRIDGE STUDIES SE; Falk AL, 2009, NAT PHYS, V5, P475, DOI 10.1038/NPHYS1284; Faoro L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.227005; FORD GW, 1984, PHYS REP, V113, P195, DOI 10.1016/0370-1573(84)90098-X; Harber DM, 2003, J LOW TEMP PHYS, V133, P229, DOI 10.1023/A:1026084606385; Jones MPA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080401; Langsjoen LS, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.010301; Lin YJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.050404; Lundstrom M, 2003, SCIENCE, V299, P210, DOI 10.1126/science.1079567; Maher P, 2014, SCIENCE, V345, P61, DOI 10.1126/science.1252875; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Novotny L., 2012, PRINCIPLES NANOOPTIC; Park JH, 2012, ADV MATER, V24, P3988, DOI 10.1002/adma.201200812; Rothfuss D, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816760; Taminiau TH, 2014, NAT NANOTECHNOL, V9, P171, DOI [10.1038/NNANO.2014.2, 10.1038/nnano.2014.2]; Tetienne JP, 2014, SCIENCE, V344, P1366, DOI 10.1126/science.1250113; Weber B, 2012, SCIENCE, V335, P64, DOI 10.1126/science.1214319; Xu QF, 2005, NATURE, V435, P325, DOI 10.1038/nature03569	27	103	104	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 6	2015	347	6226					1129	1132		10.1126/science.aaa4298	http://dx.doi.org/10.1126/science.aaa4298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4WB	25636797				2022-12-28	WOS:000350354200050
J	Haffajee, RL; Jena, AB; Weiner, SG				Haffajee, Rebecca L.; Jena, Anupam B.; Weiner, Scott G.			Mandatory Use of Prescription Drug Monitoring Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Haffajee, Rebecca L.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02215 USA; [Haffajee, Rebecca L.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Weiner, Scott G.] Brigham & Womens Hosp, Div Hlth Policy Res Translat, Dept Emergency Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research; Harvard University; Brigham & Women's Hospital	Haffajee, RL (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,Sixth Floor, Boston, MA 02215 USA.	haffajee@fas.harvard.edu		Weiner, Scott/0000-0002-4672-5184	NIH HHS [DP5 OD017897, 1DP5OD017897-01] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Commonwealth of Massachusetts Department of Public Health, PRESCR MON PROGR; Haegerich TM, 2014, DRUG ALCOHOL DEPEN, V145, P34, DOI 10.1016/j.drugalcdep.2014.10.001; Kreiner P, BUREAU JUSTICE ASSIS; National Alliance for Model State Drug Laws, STAT REQ PRESCR DISP; National Alliance for Model State Drug Laws, STAT REQ ALL LIC PRE; Perrone J, 2012, NEW ENGL J MED, V366, P2341, DOI 10.1056/NEJMp1204493; Prescription Drug Monitoring Program Center of Excellence at Brandeis, COE BRIEF; Substance Abuse and Mental Health Services Administration, DAWN REP; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, RES 2013 NAT SURV DR; Warner M, 2014, TRENDS DRUG POISONIN	10	149	150	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					891	892		10.1001/jama.2014.18514	http://dx.doi.org/10.1001/jama.2014.18514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25622279	Green Accepted			2022-12-28	WOS:000350231800007
J	Monier, B; Gettings, M; Gay, G; Mangeat, T; Schott, S; Guarner, A; Suzanne, M				Monier, Bruno; Gettings, Melanie; Gay, Guillaume; Mangeat, Thomas; Schott, Sonia; Guarner, Ana; Suzanne, Magali			Apico-basal forces exerted by apoptotic cells drive epithelium folding	NATURE			English	Article							NEURAL-TUBE CLOSURE; DROSOPHILA EMBRYOGENESIS; MESODERM INVAGINATION; ADHERENS JUNCTIONS; MYOSIN-II; CONSTRICTION; SHAPE; MORPHOGENESIS; CONTRACTIONS; MECHANISM	Epithelium folding is a basic morphogenetic event that is essential in transforming simple two-dimensional epithelial sheets into three-dimensional structures in both vertebrates and invertebrates(1). Folding has been shown to rely on apical constriction(2-7). The resulting cell-shape changes depend either on adherens junction basal shift(2) or on a redistribution of myosin II3-5,7, which could be driven by mechanical signals(8). Yet the initial cellular mechanisms that trigger and coordinate cell remodelling remain largely unknown. Here we unravel the active role of apoptotic cells in initiating morphogenesis, thus revealing a novel mechanism of epithelium folding. We show that, in a live developing tissue, apoptotic cells exert a transient pulling force upon the apical surface of the epithelium through a highly dynamic apico-basal myosin II cable. The apoptotic cells then induce a non-autonomous increase in tissue tension together with cortical myosin II apical stabilization in the surrounding tissue, eventually resulting in epithelium folding. Together our results, supported by a theoretical biophysical three-dimensional model, identify an apoptotic myosin-II-dependent signal as the initial signal leading to cell reorganization and tissue folding. This work further reveals that, far from being passively eliminated as generally assumed ( for example, during digit individualization(9)), apoptotic cells actively influence their surroundings and trigger tissue remodelling through regulation of tissue tension.	[Monier, Bruno; Gettings, Melanie; Mangeat, Thomas; Schott, Sonia; Suzanne, Magali] Univ Toulouse, UPS, LBCMCP, F-31062 Toulouse, France; [Monier, Bruno; Gettings, Melanie; Mangeat, Thomas; Schott, Sonia; Suzanne, Magali] CNRS, LBCMCP, F-31062 Toulouse, France; [Gay, Guillaume] DamCB, Data Anal & Modelling Cell Biol, F-13005 Marseille, France; [Guarner, Ana] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, E-28049 Madrid, Spain	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Suzanne, M (corresponding author), Univ Toulouse, UPS, LBCMCP, F-31062 Toulouse, France.	guillaume@damcb.com; magali.suzanne@univ-tlse3.fr		Monier, Bruno/0000-0002-3553-6396; Gay, Guillaume/0000-0002-5444-5246; Suzanne, Magali/0000-0003-0801-3706	Agence Nationale de la Recherche (ANR); Fondation de la Recherche et de l'Innovation Therapeutique en Cancerologie (RITC); University of Toulouse	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation de la Recherche et de l'Innovation Therapeutique en Cancerologie (RITC); University of Toulouse	We thank C. Benassayag, E. Farge, Y. Gachet, T. Lecuit, P.-F. Lenne, F. Payre, E. Sanchez-Herrero, B. Sanson and S. Tournier for comments on the manuscript, T. de Paula Peixoto for providing the graph-tool library, D. Kiehart, H. Steller, X. Wang, R. Ward, BDSC and DSHB for stocks and reagents, the TRI platform for imaging facilities and M. Aguirrebengoa for helping us with statistics. The Suzanne laboratory is supported by grants from the Agence Nationale de la Recherche (ANR), Fondation de la Recherche et de l'Innovation Therapeutique en Cancerologie (RITC) and the University of Toulouse.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Davidson LA, 2012, TRENDS CELL BIOL, V22, P82, DOI 10.1016/j.tcb.2011.10.005; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Guarner A, 2014, DEV BIOL, V385, P350, DOI 10.1016/j.ydbio.2013.10.011; He B, 2014, NATURE, V508, P392, DOI 10.1038/nature13070; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Lubkov V, 2014, CURR BIOL, V24, P868, DOI 10.1016/j.cub.2014.02.057; Manjon C, 2007, NAT CELL BIOL, V9, P57, DOI 10.1038/ncb1518; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Montero JA, 2010, APOPTOSIS, V15, P365, DOI 10.1007/s10495-009-0444-5; Oda H, 2001, J CELL SCI, V114, P493; Peixoto P. T., 2014, GRAPH TOOL PYTHON LI; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938; Yamaguchi Y, 2013, CELL MOL LIFE SCI, V70, P3171, DOI 10.1007/s00018-012-1227-7; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057	29	148	150	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					245	U252		10.1038/nature14152	http://dx.doi.org/10.1038/nature14152			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25607361	Green Published			2022-12-28	WOS:000349190300041
J	Blumenthal, D; Davis, K; Guterman, S				Blumenthal, David; Davis, Karen; Guterman, Stuart			Medicare at 50-Origins and Evolution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Blumenthal, David] Commonwealth Fund, New York, NY 10021 USA; [Guterman, Stuart] Commonwealth Fund, Washington, DC USA; [Davis, Karen] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Commonwealth Fund; Commonwealth Fund; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Blumenthal, D (corresponding author), Commonwealth Fund, New York, NY 10021 USA.							American Medical Association Practice Management Center, 2009, FEE SCHED BAS MED RE; ANDERSEN R, 1976, 2 DECADES HLTH SERVI; [Anonymous], 2014, BOARDS TRUST FED HOS; [Anonymous], 2014, HLTH CAR SPEND MED P; Biles Brian, 2009, CONTINUING COST PRIV; BLUMENTHAL D, 1988, RENEWING PROMISE MED; Blumenthal D, 2008, NEW ENGL J MED, V359, P2384, DOI 10.1056/NEJMhpr0806879; Busse R, 2011, DIAGNOSIS RELATED GR; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Congressional Budget Office, 2014, 2014 LONG TERM BUDG; Cooper BS, 1973, SOC SECUR B, V36, P1; DeNavas-Walt C, 2011, INCOME POVERTY HLTH; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Guterman S, 2014, NEW ENGL J MED, V370, P2261, DOI 10.1056/NEJMp1401460; Marmor Theodore R., 2000, POLITICS MEDICARE; Mayes R, 2006, MEDICARE PROSPECTIVE; McGuire TG, 2013, MILBANK Q, V91, P210, DOI 10.1111/milq.12011; MOON M, 1993, MEDICARE NOW FUTURE; Muennig PA, 2010, HEALTH AFFAIR, V29, P2105, DOI 10.1377/hlthaff.2010.0073; Newhouse JP, 2014, MILBANK Q, V92, P351, DOI 10.1111/1468-0009.12061; Oberlander J., 2003, POLITICAL LIFE MEDIC; RICE DP, 1964, SOC SECUR BULL, V27, P9; S. Data in text from Trends in Hospital Utilization: United States, 1989, DATA NATL HLTH SURVE, V101, P1; Smith DB, 2005, HEALTH AFFAIR, V24, P317, DOI 10.1377/hlthaff.24.2.317; Williams J.P., 2014, US NEWS WORLD REPORT; Zarabozo C, 2000, HEALTH CARE FINANC R, V22, P61	26	30	30	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					479	486		10.1056/NEJMhpr1411701	http://dx.doi.org/10.1056/NEJMhpr1411701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA1CD	25587859				2022-12-28	WOS:000348649700015
J	Galimidi, RP; Klein, JS; Politzer, MS; Bai, SY; Seaman, MS; Nussenzweig, MC; West, AP; Bjorkman, PJ				Galimidi, Rachel P.; Klein, Joshua S.; Politzer, Maria S.; Bai, Shiyu; Seaman, Michael S.; Nussenzweig, Michel C.; West, Anthony P., Jr.; Bjorkman, Pamela J.			Intra-Spike Crosslinking Overcomes Antibody Evasion by HIV-1	CELL			English	Article							PROTEIN	Antibodies developed during HIV-1 infection lose efficacy as the viral spike mutates. We postulated that anti-HIV-1 antibodies primarily bind monovalently because HIV's low spike density impedes bivalent binding through inter-spike crosslinking, and the spike structure prohibits bivalent binding through intra-spike crosslinking. Monovalent binding reduces avidity and potency, thus expanding the range of mutations permitting antibody evasion. To test this idea, we engineered antibody-based molecules capable of bivalent binding through intra-spike crosslinking. We used DNA as a "molecular ruler'' to measure intra-epitope distances on virion-bound spikes and construct intra-spike crosslinking molecules. Optimal bivalent reagents exhibited up to 2.5 orders of magnitude increased potency (>100-fold average increases across virus panels) and identified conformational states of virion-bound spikes. The demonstration that intra-spike crosslinking lowers the concentration of antibodies required for neutralization supports the hypothesis that low spike densities facilitate antibody evasion and the use of molecules capable of intra-spike crosslinking for therapy or passive protection.	[Galimidi, Rachel P.; Klein, Joshua S.; Politzer, Maria S.; Bai, Shiyu; West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.; Bjorkman, Pamela J.] Howard Hughes Med Inst, Chevy Chase, MD USA	California Institute of Technology; Harvard University; Beth Israel Deaconess Medical Center; Rockefeller University; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	Nussenzweig, Michel/AAE-7292-2019		Director's Pioneer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006961] Funding Source: NIH RePORTER	Director's Pioneer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Martin Witte, Jessica Ingram, Chris Theile, and Hidde Ploegh for advice and help with sortase/ click chemistry experiments; Sriram Subramaniam for helpful discussions, coordinates, and files to make schematic figures; David Baltimore, Bil Clemons, Ron Diskin, Jennifer Keeffe, Sarkis Mazmanian, Stuart Sievers, Louise Scharf, and Kai Zinn for suggestions; Jost Vielmetter and the Caltech Protein Expression Center for assistance with protein production and neutralization assay development; Priyanthi Gnanapragasam for doing in- house neutralization assays; the NIH AIDS Reagent Program, the Fraunhofer Institut IBMT, and Rene Mares for pseudoviruses; Erin Isaza, Siduo Jiang, and Jennifer Keeffe for reagents; and Sonal N. Patel and Marta Murphy for help with figures. This work was supported by the Director's Pioneer Award ( 1DP1OD006961- 01 to P. J. B.), National Institutes of Health HIVRAD ( P01 Al100148 to P. J. B.), and Collaboration for AIDS Vaccine Discovery ( CAVD) grants with support from the Bill and Melinda Gates Foundation ( grant 38660 [ P. J. B.] and grant 1032144 [ M. S. S.]). P. J. B. and M. C. N. are HHMI Investigators.	YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhou HX, 2004, BIOCHEMISTRY-US, V43, P2141, DOI 10.1021/bi036269n; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; ZINGLER K, 1993, J VIROL, V67, P2824, DOI 10.1128/JVI.67.5.2824-2831.1993	5	83	84	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					433	446		10.1016/j.cell.2015.01.016	http://dx.doi.org/10.1016/j.cell.2015.01.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635457	Green Accepted, Bronze			2022-12-28	WOS:000349208000010
J	Long, M; Lichtenstein, D				Long, Michelle; Lichtenstein, David			Review: In high-risk ulcers, intermittent and continuous PPI therapy do not differ for recurrent bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; PEPTIC-ULCER		[Long, Michelle; Lichtenstein, David] Boston Med Ctr, Boston, MA 02118 USA	Boston Medical Center	Long, M (corresponding author), Boston Med Ctr, Boston, MA 02118 USA.		Long, Michelle T/H-3801-2019	Long, Michelle/0000-0001-6131-3981				Gralnek IM, 2008, NEW ENGL J MED, V359, P928, DOI 10.1056/NEJMra0706113; Laine L, 2009, CLIN GASTROENTEROL H, V7, P33, DOI 10.1016/j.cgh.2008.08.016; Leontiadis GI, 2007, MAYO CLIN PROC, V82, P286; PATCHETT SE, 1989, GUT, V30, P1704, DOI 10.1136/gut.30.12.1704	4	0	1	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC8	10.7326/ACPJC-2015-162-2-008	http://dx.doi.org/10.7326/ACPJC-2015-162-2-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599368				2022-12-28	WOS:000350106600007
J	Wharam, JF; Graves, AJ; Kozhimannil, KB				Wharam, J. Frank; Graves, Amy J.; Kozhimannil, Katy B.			Navigating the Rise of High-Deductible Health Insurance Childbirth in the Bronze Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wharam, J. Frank] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02114 USA; [Wharam, J. Frank] Harvard Pilgrim Hlth Care Inst, Boston, MA 02114 USA; [Graves, Amy J.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Kozhimannil, Katy B.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, 133 Brookline Ave,Sixth Floor, Boston, MA 02114 USA.	jwharam@post.harvard.edu		Wharam, James/0000-0003-2053-0757	NCI NIH HHS [1R01CA172639, R01 CA172639] Funding Source: Medline; NICHD NIH HHS [K12HD055887] Funding Source: Medline; NIDDK NIH HHS [R01 DK100304, 1R01DK100304] Funding Source: Medline; NCCDPHP CDC HHS [1U58DP02719] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055887] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA172639] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100304] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCCDPHP CDC HHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Childbirth Connection; Catalyst for Payment Reform; Center for Healthcare Quality and Payment Reform, 2013, COST HAV BAB US; Kaiser Family Foundation and Health Research & Educational Trust, EMPL HLTH BEN 2014 A; Kozhimannil KB, 2011, AM J MANAG CARE, V17, P17; LearnVest; Chase Blueprint, FAC PERS FIN; Livingston Gretchen, 2012, US BIRTH RATE FALLS; Patient Protection and Affordable Care Act, 2013, FED REG, V78; Reinhardt UE, 2013, JAMA-J AM MED ASSOC, V310, P1927, DOI 10.1001/jama.2013.281854; Wharam JF, 2013, NEW ENGL J MED, V369, P1481, DOI 10.1056/NEJMp1309490	8	7	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					245	246		10.1001/jama.2014.16085	http://dx.doi.org/10.1001/jama.2014.16085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602991				2022-12-28	WOS:000348145000012
J	Penner, AM				Penner, Andrew M.			Gender inequality in science	SCIENCE			English	Editorial Material									Univ Calif Irvine, Dept Sociol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Penner, AM (corresponding author), Univ Calif Irvine, Dept Sociol, Irvine, CA 92697 USA.	andrew.penner@uci.edu						Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Correll SJ, 2004, AM SOCIOL REV, V69, P93, DOI 10.1177/000312240406900106; Dillow S.A., 2013, DIGEST ED STAT 2012; England P, 1992, COMP WORTH; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Li D., 2012, THESIS MIT CAMBRIDGE; Valian, 1998, WHY SO SLOW; Wang MT, 2013, PSYCHOL SCI, V24, P770, DOI 10.1177/0956797612458937; Xie Y., 2012, IS AM SCI DECLINE	9	24	25	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					234	235		10.1126/science.aaa3781	http://dx.doi.org/10.1126/science.aaa3781			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0DA	25593174				2022-12-28	WOS:000347915300020
J	Kleinert, S; Benham, L; Collingridge, D; Summerskill, W; Horton, R				Kleinert, Sabine; Benham, Laura; Collingridge, David; Summerskill, William; Horton, Richard			Further emphasis on research in context	LANCET			English	Editorial Material							REDUCING WASTE; INCREASING VALUE; BIOMEDICAL-RESEARCH; CLINICAL-TRIALS		[Kleinert, Sabine; Benham, Laura; Summerskill, William; Horton, Richard] The Lancet, London EC2Y 5AS, England; [Collingridge, David] Lancet Oncol, London EC2Y 5AS, England		Kleinert, S (corresponding author), The Lancet, 125 London Wall, London EC2Y 5AS, England.							Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Clark S, 2010, LANCET, V376, P10, DOI 10.1016/S0140-6736(10)61001-X; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	10	17	18	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2176	2177		10.1016/S0140-6736(14)62047-X	http://dx.doi.org/10.1016/S0140-6736(14)62047-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX0QC	25625383				2022-12-28	WOS:000346655700007
J	Pruttivarasin, T; Ramm, M; Porsev, SG; Tupitsyn, II; Safronova, MS; Hohensee, MA; Haffner, H				Pruttivarasin, T.; Ramm, M.; Porsev, S. G.; Tupitsyn, I. I.; Safronova, M. S.; Hohensee, M. A.; Haeffner, H.			Michelson-Morley analogue for electrons using trapped ions to test Lorentz symmetry	NATURE			English	Article							INERTIAL MASS; INVARIANCE; VIOLATION; ANISOTROPY; CPT	All evidence so far suggests that the absolute spatial orientation of an experiment never affects its outcome. This is reflected in the standard model of particle physics by requiring all particles and fields to be invariant under Lorentz transformations. The best-known tests of this important cornerstone of physics are Michelson-Morley-type experiments verifying the isotropy of the speed of light(1-3). For matter, Hughes-Drever-type experiments(4-11) test whether the kinetic energy of particles is independent of the direction of their velocity, that is, whether their dispersion relations are isotropic. To provide more guidance for physics beyond the standard model, refined experimental verifications of Lorentz symmetry are desirable. Here we search for violation of Lorentz symmetry for electrons by performing an electronic analogue of a Michelson-Morley experiment. We split an electron wave packet bound inside a calcium ion into two parts with different orientations and recombine them after a time evolution of 95 milliseconds. As the Earth rotates, the absolute spatial orientation of the two parts of the wave packet changes, and anisotropies in the electron dispersion will modify the phase of the interference signal. To remove noise, we prepare a pair of calcium ions in a superposition of two decoherence-free states, thereby rejecting magnetic field fluctuations common to both ions(12). After a 23-hour measurement, we find a limit of h x 11 millihertz (h is Planck's constant) on the energy variations, verifying the isotropy of the electron's dispersion relation at the level of one part in 10(18), a 100-fold improvement on previous work(9). Alternatively, we can interpret our result as testing the rotational invariance of the Coulomb potential. Assuming that Lorentz symmetry holds for electrons and that the photon dispersion relation governs the Coulomb force, we obtain a fivefold-improved limit on anisotropies in the speed of light(2,3). Our result probes Lorentz symmetry violation at levels comparable to the ratio between the electroweak and Planck energy scales(13). Our experiment demonstrates the potential of quantum information techniques in the search for physics beyond the standard model.	[Pruttivarasin, T.; Ramm, M.; Hohensee, M. A.; Haeffner, H.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Pruttivarasin, T.] RIKEN, Quantum Metrol Lab, Wako, Saitama 3510198, Japan; [Porsev, S. G.; Safronova, M. S.] Univ Delaware, Dept Phys & Astron, Newark, DC 19716 USA; [Porsev, S. G.] Petersburg Nucl Phys Inst, Gatchina 188300, Leningrad Distr, Russia; [Tupitsyn, I. I.] St Petersburg State Univ, Dept Phys, St Petersburg 198504, Russia; [Safronova, M. S.] NIST, Joint Quantum Inst, College Pk, MD 20742 USA; [Safronova, M. S.] Univ Maryland, College Pk, MD 20742 USA; [Hohensee, M. A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Berkeley; RIKEN; University of Delaware; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Saint Petersburg State University; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Pruttivarasin, T (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	thaned.pruttivarasin@riken.jp; hhaeffner@berkeley.edu	Tupitsyn, Ilya Igorevich/J-6611-2013; Haeffner, Hartmut/D-8046-2012	Tupitsyn, Ilya Igorevich/0000-0001-9237-5667; Haeffner, Hartmut/0000-0002-5113-9622	NSF CAREER programme grant [PHY 0955650]; NSF [PHY 1212442, PHY 1404156]; US Department of Energy, Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	NSF CAREER programme grant; NSF(National Science Foundation (NSF)); US Department of Energy, Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	This work was supported by the NSF CAREER programme grant no. PHY 0955650 and NSF grants no. PHY 1212442 and no. PHY 1404156, and was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. We thank H. Muller for critical reading of the manuscript.	Allmendinger F, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.110801; Altschul B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.201101; Altschul B, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.041701; Bailey QG, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.076006; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Chwalla M, 2007, APPL PHYS B-LASERS O, V89, P483, DOI 10.1007/s00340-007-2867-4; Colladay D, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.116002; Colladay D, 1997, PHYS REV D, V55, P6760, DOI 10.1103/PhysRevD.55.6760; DREVER RWP, 1961, PHILOS MAG, V6, P683, DOI 10.1080/14786436108244418; Eisele C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090401; Haffner H, 2005, APPL PHYS B-LASERS O, V81, P151, DOI 10.1007/s00340-005-1917-z; Herrmann S, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.105011; Hohensee MA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.050401; Horava P, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.084008; HUGHES VW, 1960, PHYS REV LETT, V4, P342, DOI 10.1103/PhysRevLett.4.342; Iskrenova-Tchoukova E, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012508; Jiang DS, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.022514; Kostelecky VA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.11; Kostelecky VA, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.056005; KOSTELECKY VA, 1989, PHYS REV D, V39, P683, DOI 10.1103/PhysRevD.39.683; Kostelecky VA, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.116010; KOSTELECKY VA, 1995, PHYS REV D, V51, P3923, DOI 10.1103/PhysRevD.51.3923; Kramida A., 2013, NIST ATOMIC SPECTRA; Kreuter A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032504; Liberati S., 2012, PREPRINT; Madej AA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203002; Matveev A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.230801; Michelson AA, 1887, AM J SCI, V34, P333, DOI [DOI 10.2475/AJS.S3-34.203.333, 10.2475/ajs.s3-34.203.333]; Muller H, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.045004; Muller H, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.116006; Nibbelink SG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.081601; Peck SK, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.012109; Pospelov M, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.105001; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Safronova MS, 2008, ADV ATOM MOL OPT PHY, V55, P191, DOI 10.1016/S1049-250X(07)55004-4; Safronova MS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.030801; Smiciklas M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.171604; Tupitsyn II, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.042701; Tupitsyn II, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.062503; Wolf P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.060801; YU N, 1994, PHYS REV A, V50, P2738, DOI 10.1103/PhysRevA.50.2738	41	76	77	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					592	U357		10.1038/nature14091	http://dx.doi.org/10.1038/nature14091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631446	Green Submitted			2022-12-28	WOS:000348775000038
J	Tappin, D; Bauld, L; Purves, D; Boyd, K; Sinclair, L; MacAskill, S; McKell, J; Friel, B; McConnachie, A; de Caestecker, L; Tannahill, C; Radley, A; Coleman, T				Tappin, David; Bauld, Linda; Purves, David; Boyd, Kathleen; Sinclair, Lesley; MacAskill, Susan; McKell, Jennifer; Friel, Brenda; McConnachie, Alex; de Caestecker, Linda; Tannahill, Carol; Radley, Andrew; Coleman, Tim		Cessation Pregnancy Incentives	Financial incentives for smoking cessation in pregnancy: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STILLBIRTH	Objective To assess the efficacy of a financial incentive added to routine specialist pregnancy stop smoking services versus routine care to help pregnant smokers quit. Design Phase II therapeutic exploratory single centre, individually randomised controlled parallel group superiority trial. Setting One large health board area with a materially deprived, inner city population in the west of Scotland, United Kingdom. Participants 612 self reported pregnant smokers in NHS Greater Glasgow and Clyde who were English speaking, at least 16 years of age, less than 24 weeks pregnant, and had an exhaled carbon monoxide breath test result of 7 ppm or more. 306 women were randomised to incentives and 306 to control. Interventions The control group received routine care, which was the offer of a face to face appointment to discuss smoking and cessation and, for those who attended and set a quit date, the offer of free nicotine replacement therapy for 10 weeks provided by pharmacy services, and four, weekly support phone calls. The intervention group received routine care plus the offer of up to (sic)400 of shopping vouchers: (sic)50 for attending a face to face appointment and setting a quit date; then another (sic)50 if at four weeks' post-quit date exhaled carbon monoxide confirmed quitting; a further (sic)100 was provided for continued validated abstinence of exhaled carbon monoxide after 12 weeks; a final (sic)200 voucher was provided for validated abstinence of exhaled carbon monoxide at 34-38 weeks' gestation. Main outcome measure The primary outcome was cotinine verified cessation at 34-38 weeks' gestation through saliva (<14.2 ng/mL) or urine (<44.7 ng/mL). Secondary outcomes included birth weight, engagement, and self reported quit at four weeks. Results Recruitment was extended from 12 to 15 months to achieve the target sample size. Follow-up continued until September 2013. Of the 306 women randomised, three controls opted out soon after enrolment; these women did not want their data to be used, leaving 306 intervention and 303 control group participants in the intention to treat analysis. No harms of financial incentives were documented. Significantly more smokers in the incentives group than control group stopped smoking: 69 (22.5%) versus 26 (8.6%). The relative risk of not smoking at the end of pregnancy was 2.63 (95% confidence interval 1.73 to 4.01) P<0.001. The absolute risk difference was 14.0% (95% confidence interval 8.2% to 19.7%). The number needed to treat (where financial incentives need to be offered to achieve one extra quitter in late pregnancy) was 7.2 (95% confidence interval 5.1 to 12.2). The mean birth weight was 3140 g (SD 600 g) in the incentives group and 3120 (SD 590) g in the control group (P=0.67). Conclusion This phase II randomised controlled trial provides substantial evidence for the efficacy of incentives for smoking cessation in pregnancy; as this was only a single centre trial, incentives should now be tested in different types of pregnancy cessation services and in different parts of the United Kingdom.	[Tappin, David] Univ Glasgow, PEACH Unit, Glasgow G3 8SJ, Lanark, Scotland; [Bauld, Linda; Sinclair, Lesley; MacAskill, Susan; McKell, Jennifer] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland; [Bauld, Linda; Sinclair, Lesley; MacAskill, Susan; McKell, Jennifer] Univ Stirling, UK Ctr Tobacco & Alcohol Studies, Stirling FK9 4LA, Scotland; [Purves, David] Univ Strathclyde, Glasgow, Lanark, Scotland; [Boyd, Kathleen] Univ Glasgow, Hlth Econ & Hlth Technol Assessment Unit, Inst Hlth & Wellbeing, Glasgow G3 8SJ, Lanark, Scotland; [Friel, Brenda; de Caestecker, Linda] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow G3 8SJ, Lanark, Scotland; [McConnachie, Alex] Univ Glasgow, Glasgow Clin Trials Unit, Glasgow G3 8SJ, Lanark, Scotland; [Tannahill, Carol] Glasgow Ctr Populat Hlth, Glasgow, Lanark, Scotland; [Radley, Andrew] NHS Tayside, Directorate Publ Hlth, Dundee, Scotland; [Coleman, Tim] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Coleman, Tim] Univ Nottingham, UK Ctr Tobacco & Alcohol Studies, Nottingham NG7 2RD, England	University of Glasgow; University of Stirling; University of Stirling; University of Strathclyde; University of Glasgow; University of Glasgow; University of Glasgow; University of Dundee; University of Nottingham; University of Nottingham	Tappin, D (corresponding author), Univ Glasgow, PEACH Unit, Yorkhill, Glasgow G3 8SJ, Lanark, Scotland.	david.tappin@glasgow.ac.uk	Radley, Andrew/AAO-7068-2021	Coleman, Tim/0000-0002-7303-4805; Radley, Andrew/0000-0003-4772-2388; McKell, Jennifer/0000-0002-2912-0837; Sinclair, Lesley/0000-0002-2210-8181; Boyd, Kathleen/0000-0002-9764-0113	Chief Scientist Office, Scottish Government; Glasgow Centre for Population Health and the Education; Research Endowment Fund of the Director of Public Health Greater Glasgow and Clyde health board; Yorkhill Children's Charity; Royal Samaritan Endowment Fund; East Midlands Collaboration for Leadership in Applied Health Research and Care; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish; National Institute for Health Research [11/93/01] Funding Source: researchfish; Chief Scientist Office [CZH/4/594] Funding Source: researchfish	Chief Scientist Office, Scottish Government; Glasgow Centre for Population Health and the Education; Research Endowment Fund of the Director of Public Health Greater Glasgow and Clyde health board; Yorkhill Children's Charity; Royal Samaritan Endowment Fund; East Midlands Collaboration for Leadership in Applied Health Research and Care; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	The primary funder was the Chief Scientist Office, Scottish Government. Two additional main funders were the Glasgow Centre for Population Health and the Education and Research Endowment Fund of the Director of Public Health Greater Glasgow and Clyde health board. Additional funders were the Yorkhill Children's Charity and the Royal Samaritan Endowment Fund. The funders had no role in writing the manuscript or the decision to submit it for publication. No payment from a pharmaceutical or any other company has been paid to write this article. The corresponding author had full access to all the study data and had the final responsibility for the decision to submit for publication. TC acknowledges the support of East Midlands Collaboration for Leadership in Applied Health Research and Care for his work in general, but no payment was received by him specifically for this study.	[Anonymous], 1997, GEN CONS CLIN TRIALS; Chamberlain Catherine, 2013, Cochrane Database Syst Rev, pCD001055, DOI 10.1002/14651858.CD001055.pub4; Coleman T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078; Dietz PM, 2010, AM J PREV MED, V39, P45, DOI 10.1016/j.amepre.2010.03.009; Director of Public Health Greater Glasgow and Clyde NHS Board, 2014, 1252 DIR PUBL HLTH G; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Gray R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3754; Health and Social Care Information Centre, 2012, INF FEED SURV 2010; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hoddinott P, 2012, LANCET S30, V380, pS48; Information Services Division NHS National Services Scotland, 2009, BIRTHS BAB SMOK PREG; Jochelson K., 2007, PAYING PATIENT IMPRO; Jurkovic D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3676; McGowan A, 2010, MIDWIFERY, V26, pE1, DOI 10.1016/j.midw.2008.05.005; National Institute for Health and Care Excellence, 2010, QUITT SMOK PREGN FOL; National Institute for Health and Care Excellence, GUID METH TECHN APPR; NHS, 2005, SCOTT PROGR CLIN EFF, P35; Office for National Statistics, 2011, STAT B; Radley A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-343; Tappin D, LANCET ABST IN PRESS; Tappin DM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-113; Tappin DM, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-1; Tappin DM, 2005, BMJ-BRIT MED J, V331, P373, DOI 10.1136/bmj.331.7513.373; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Usmani ZC, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-4; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x	26	120	120	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2015	350								h134	10.1136/bmj.h134	http://dx.doi.org/10.1136/bmj.h134			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZR	25627664	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000348775700001
J	Balsells, M; Garcia-Patterson, A; Sola, I; Roque, M; Gich, I; Corcoy, R				Balsells, Montserrat; Garcia-Patterson, Apolonia; Sola, Ivan; Roque, Marta; Gich, Ignasi; Corcoy, Rosa			Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYBURIDE; MELLITUS; MANAGEMENT; PREGNANCY; RECOMMENDATIONS; WOMEN	Objective To summarize short term outcomes in randomized controlled trials comparing glibenclamide or metformin versus insulin or versus each other in women with gestational diabetes requiring drug treatment. Design Systematic review and meta-analysis. Eligibility criteria for selecting studies Randomized controlled trials that fulfilled all the following: (1) published as full text; (2) addressed women with gestational diabetes requiring drug treatment; (3) compared glibenclamide v insulin, metformin v insulin, or metformin v glibenclamide; and (4) provided information on maternal or fetal outcomes. Data sources Medline, CENTRAL, and Embase were searched up to 20 May 2014. Outcomes measures We considered 14 primary outcomes (6 maternal, 8 fetal) and 16 secondary (5 maternal, 11 fetal) outcomes. Results We analyzed 15 articles, including 2509 subjects. Significant differences for primary outcomes in glibenclamide v insulin were obtained in birth weight (mean difference 109 g (95% confidence interval 35.9 to 181)), macrosomia (risk ratio 2.62 (1.35 to 5.08)), and neonatal hypoglycaemia (risk ratio 2.04 (1.30 to 3.20)). In metformin v insulin, significance was reached for maternal weight gain (mean difference -1.14 kg (-2.22 to -0.06)), gestational age at delivery (mean difference -0.16 weeks (-0.30 to -0.02)), and preterm birth (risk ratio 1.50 (1.04 to 2.16)), with a trend for neonatal hypoglycaemia (risk ratio 0.78 (0.60 to 1.01)). In metformin v glibenclamide, significance was reached for maternal weight gain (mean difference -2.06 kg (-3.98 to -0.14)), birth weight (mean difference -209 g (-314 to -104)), macrosomia (risk ratio 0.33 (0.13 to 0.81)), and large for gestational age newborn (risk ratio 0.44 (0.21 to 0.92)). Four secondary outcomes were better for metformin in metformin v insulin, and one was worse for metformin in metformin v glibenclamide. Treatment failure was higher with metformin than with glibenclamide. Conclusions At short term, in women with gestational diabetes requiring drug treatment, glibenclamide is clearly inferior to both insulin and metformin, while metformin (plus insulin when required) performs slightly better than insulin. According to these results, glibenclamide should not be used for the treatment of women with gestational diabetes if insulin or metformin is available. Systematic review registration NCT01998113	[Balsells, Montserrat] Hosp Univ Mutua Terrassa, Dept Endocrinol & Nutr, Terrassa 8821, Spain; [Garcia-Patterson, Apolonia; Corcoy, Rosa] Hosp Santa Creu & Sant Pau, Dept Endocrinol & Nutr, Barcelona 08025, Spain; [Sola, Ivan; Roque, Marta] Hosp Santa Creu & Sant Pau, Iberoamer Cochrane Ctr, Barcelona 08025, Spain; [Sola, Ivan; Roque, Marta] Hosp Santa Creu & Sant Pau, Inst Biomed Res IIB St Pau, Barcelona 08025, Spain; [Sola, Ivan; Roque, Marta; Gich, Ignasi] Inst Salud Carlos III, CIBERESP, Madrid 28029, Spain; [Gich, Ignasi] Hosp Santa Creu & Sant Pau, Dept Epidemiol, Barcelona 08025, Spain; [Gich, Ignasi] Univ Autonoma Barcelona, Dept Clin Pharmacol & Therapeut, Bellaterra 08193, Cerdanyola Del, Spain; [Corcoy, Rosa] Inst Salud Carlos III, CIBER BBN, Madrid 28029, Spain; [Corcoy, Rosa] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain	Hospital Universitario Mutua Terrassa; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III; Autonomous University of Barcelona	Corcoy, R (corresponding author), Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Avinguda St Antoni Maria Claret 167, Barcelona 08025, Spain.	rcorcoy@santpau.cat	Corcoy, Rosa/A-2140-2009	Corcoy, Rosa/0000-0001-5055-6814; Roque i Figuls, Marta/0000-0003-0043-1364; Sola, Ivan/0000-0003-0078-3706; Gich, Ignasi/0000-0003-3975-6588	Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	The study sponsor is Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; the sponsor was not involved in the design or execution of the systematic review or in the writing of the manuscript.	Anjalakshi C, 2007, DIABETES RES CLIN PR, V76, P474, DOI 10.1016/j.diabres.2006.09.031; [Anonymous], 2013, Obstet Gynecol, V122, P406, DOI 10.1097/01.AOG.0000433006.09219.f1; Bennett WL, 2012, J WOMENS HEALTH, V21, P925, DOI 10.1089/jwh.2011.3270; Castillo WC, 2014, OBSTET GYNECOL, V123, P1177, DOI 10.1097/AOG.0000000000000285; Coetzee EJ, 2009, INT J GYNECOL OBSTET, V104, pS39, DOI 10.1016/j.ijgo.2008.11.027; Dhulkotia JS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.044; ELLIOTT BD, 1991, AM J OBSTET GYNECOL, V165, P807, DOI 10.1016/0002-9378(91)90421-M; Garcia-Patterson A, 2012, J CLIN ENDOCR METAB, V97, P1623, DOI 10.1210/jc.2011-3425; Goh JEL, 2011, DIABETIC MED, V28, P1082, DOI 10.1111/j.1464-5491.2011.03361.x; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Hebert MF, 2009, CLIN PHARMACOL THER, V85, P607, DOI 10.1038/clpt.2009.5; Heilmaier C, 2014, J OBSTET GYNAECOL RE, V40, P1592, DOI 10.1111/jog.12384; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Ijas H, 2011, BJOG-INT J OBSTET GY, V118, P880, DOI 10.1111/j.1471-0528.2010.02763.x; Jacobson GF, 2005, AM J OBSTET GYNECOL, V193, P118, DOI 10.1016/j.ajog.2005.03.018; Lain KY, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.038; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moore LE, 2007, J REPROD MED, V52, P1011; Moore LE, 2010, OBSTET GYNECOL, V115, P55, DOI 10.1097/AOG.0b013e3181c52132; Moretti ME, 2008, ANN PHARMACOTHER, V42, P483, DOI 10.1345/aph.1K577; Mukhopadhyay P, 2012, J SAFOG, V4, P28, DOI DOI 10.5005/jp-journals-10006-1167; National Institute for Health and Care Excellence, 2008, DIAB PREGN MAN DIAB, P63; Niromanesh S, 2012, DIABETES RES CLIN PR, V98, P422, DOI 10.1016/j.diabres.2012.09.031; Ogunyemi Dotun, 2007, Endocr Pract, V13, P427; Rowan JA, 2008, NEW ENGL J MED, V359, P106; Siega-Riz AM, 2006, MATERN CHILD HLTH J, V10, pS153, DOI 10.1007/s10995-006-0115-x; Silva JC, 2007, ARQ BRAS ENDOCRINOL, V51, P541, DOI 10.1590/S0004-27302007000400007; Silva JC, 2012, J PERINAT MED, V40, P225, DOI 10.1515/jpm-2011-0175; Spaulonci CP, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.022; Su DF, 2014, DIABETES RES CLIN PR, V104, P353, DOI 10.1016/j.diabres.2013.12.056; Tempe A, 2013, J OBSTET GYNAECOL RE, V39, P1147, DOI 10.1111/jog.12042; Tertti K, 2013, DIABETES OBES METAB, V15, P246, DOI 10.1111/dom.12017; Vanky E, 2012, ACTA OBSTET GYN SCAN, V91, P1460, DOI 10.1111/aogs.12015; Waugh N, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14360; Zeng YC, 2014, ADV MED SCI-POLAND, V59, P95, DOI 10.1016/j.advms.2014.03.001	38	235	248	5	55	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2015	350								h102	10.1136/bmj.h102	http://dx.doi.org/10.1136/bmj.h102			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZG	25609400	Green Published, hybrid			2022-12-28	WOS:000348433700003
J	Burt, RK; Balabanov, R; Han, XQ; Sharrack, B; Morgan, A; Quigley, K; Yaung, K; Helenowski, IB; Jovanovic, B; Spahovic, D; Arnautovic, I; Lee, DC; Benefield, BC; Futterer, S; Oliveira, MC; Burman, J				Burt, Richard K.; Balabanov, Roumen; Han, Xiaoqiang; Sharrack, Basil; Morgan, Amy; Quigley, Kathleeen; Yaung, Kim; Helenowski, Irene B.; Jovanovic, Borko; Spahovic, Dzemila; Arnautovic, Indira; Lee, Daniel C.; Benefield, Brandon C.; Futterer, Stephen; Oliveira, Maria Carolina; Burman, Joachim			Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; CONTROLLED PHASE-3 TRIAL; STATUS SCALE EDSS; IMMUNE THROMBOCYTOPENIA; INTERFERON-BETA; RATING-SCALE; NATALIZUMAB; ALEMTUZUMAB; FINGOLIMOD	IMPORTANCE No current therapy for relapsing-remitting multiple sclerosis (MS) results in significant reversal of disability. OBJECTIVE To determine the association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability and other clinical outcomes in patients with MS. DESIGN, SETTING, AND PARTICIPANTS Case series of patients with relapsing-remitting MS (n = 123) or secondary-progressive MS (n = 28) (mean age, 36 years; range, 18-60 years; 85 women) treated at a single US institution between 2003 and 2014 and followed up for 5 years. Final follow-up was completed in June 2014. INTERVENTIONS Treatment with cyclophosphamide and alemtuzumab (22 patients) or cyclophosphamide and thymoglobulin (129 patients) followed by infusion of unmanipulated peripheral blood stem cells. MAIN OUTCOMES AND MEASURES Primary end point was reversal or progression of disability measured by change in the Expanded Disability Status Scale (EDSS) score of 1.0 or greater (score range, 0-10). Secondary outcomes included changes in the Neurologic Rating Scale (NRS) score of 10 or greater (score range, 0-100), Multiple Sclerosis Functional Composite (MSFC) score, quality-of-life Short Form 36 questionnaire scores, and T2 lesion volume on brain magnetic resonance imaging scan. RESULTS Outcome analysis was available for 145 patients with a median follow-up of 2 years and a mean of 2.5 years. Scores from the EDSS improved significantly from a pretransplant median of 4.0 to 3.0 (interquartile range [IQR], 1.5 to 4.0; n = 82) at 2 years and to 2.5 (IQR, 1.9 to 4.5; n = 36) at 4 years (P < .001 at each assessment). There was significant improvement in disability (decrease in EDSS score of >= 1.0) in 41 patients (50%; 95% CI, 39% to 61%) at 2 years and in 23 patients (64%; 95% CI, 46% to 79%) at 4 years. Four-year relapse-free survival was 80% and progression-free survival was 87%. The NRS scores improved significantly from a pretransplant median of 74 to 88.0 (IQR, 77.3 to 93.0; n = 78) at 2 years and to 87.5 (IQR, 75.0 to 93.8; n = 34) at 4 years (P < .001 at each assessment). The median MSFC scores were 0.38 (IQR, -0.01 to 0.64) at 2 years (P < .001) and 0.45 (0.04 to 0.60) at 4 years (P =.02). Total quality-of-life scores improved from a mean of 46 (95% CI, 43 to 49) pretransplant to 64 (95% CI, 61 to 68) at a median follow-up of 2 years posttransplant (n = 132) (P < .001). There was a decrease in T2 lesion volume from a pretransplant median of 8.57 cm(3) (IQR, 2.78 to 22.08 cm(3)) to 5.74 cm(3) (IQR, 1.88 to 14.45 cm(3)) (P < .001) at the last posttransplant assessment (mean follow-up, 27 months; n = 128). CONCLUSIONS AND RELEVANCE Among patients with relapsing-remitting MS, nonmyeloablative hematopoietic stem cell transplantation was associated with improvement in neurological disability and other clinical outcomes. These preliminary findings from this uncontrolled study require confirmation in randomized trials.	[Burt, Richard K.; Han, Xiaoqiang; Morgan, Amy; Quigley, Kathleeen; Yaung, Kim; Spahovic, Dzemila; Arnautovic, Indira] Northwestern Univ, Dept Med, Div Immunotherapy, Feinberg Sch Med, Chicago, IL 60611 USA; [Balabanov, Roumen] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA; [Sharrack, Basil] Sheffield Teaching Hosp NHS Fdn Trust, Acad Dept Neurosci, Sheffield, S Yorkshire, England; [Helenowski, Irene B.; Jovanovic, Borko] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Lee, Daniel C.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA; [Benefield, Brandon C.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Futterer, Stephen] Northwestern Univ, Feinberg Sch Med, Dept Neuroradiol, Chicago, IL 60611 USA; [Oliveira, Maria Carolina] Univ Sao Paulo, Ribeirao Preto Med Sch, Div Clin Immunol, BR-14049 Ribeirao Preto, Brazil; [Burman, Joachim] Uppsala Univ, Dept Neurosci & Neurol, Uppsala, Sweden	Northwestern University; Feinberg School of Medicine; Rush University; University of Sheffield; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Universidade de Sao Paulo; Uppsala University	Burt, RK (corresponding author), Northwestern Univ, Dept Med, Div Immunotherapy, Feinberg Sch Med, 446 E Ontario, Chicago, IL 60611 USA.	rburt@northwestern.edu	Rodrigues, Maria Carolina Oliveira/A-2302-2012; Burman, Joachim/H-7230-2019; CTC USP, CEPID 13 18/J-8951-2014	Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; Burman, Joachim/0000-0002-7045-1806; Burt, Richard K/0000-0002-0922-4145; CTC USP, CEPID 13 18/0000-0002-7123-9524; Arnautovic, Indira/0000-0001-6272-2648; Quigley, Kathleen/0000-0002-6344-3904; Lee, Daniel/0000-0001-9447-4175	Danhakl family; Cumming Foundation; Zakat Foundation; McNamara Purcell Foundation; Morgan Stanley and Company	Danhakl family; Cumming Foundation; Zakat Foundation; McNamara Purcell Foundation; Morgan Stanley and Company	This study was made possible by financial support from the Danhakl family, the Cumming Foundation, the Zakat Foundation, the McNamara Purcell Foundation, and Morgan Stanley and Company.	Abrahamsson SV, 2013, BRAIN, V136, P2888, DOI 10.1093/brain/awt182; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Bol Y, 2012, ACTA NEUROL SCAND, V126, P384, DOI 10.1111/j.1600-0404.2012.01660.x; Burt RK, 2009, LANCET NEUROL, V8, P309, DOI 10.1016/S1474-4422(09)70017-1; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Burt RK, 2009, LANCET NEUROL, V8, P244, DOI 10.1016/S1474-4422(09)70017-1; Butzkueven H, 2014, J NEUROL NEUROSUR PS, V85, P1190, DOI 10.1136/jnnp-2013-306936; Cohen JA, 2007, MULTIPLE SCLEROSIS T, P3; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Cuker A, 2011, BLOOD, V118, P6299, DOI 10.1182/blood-2011-08-371138; Daniels GH, 2014, J CLIN ENDOCR METAB, V99, P80, DOI 10.1210/jc.2013-2201; Devonshire V, 2012, LANCET NEUROL, V11, P420, DOI 10.1016/S1474-4422(12)70056-X; Fischer J., MULTIPLE SCLEROSIS F; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Kobelt G, 2006, NEUROLOGY, V66, P1696, DOI 10.1212/01.wnl.0000218309.01322.5c; Koziol JA, 1999, CAN J NEUROL SCI, V26, P283, DOI 10.1017/S0317167100000391; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Loh Y, 2007, BLOOD, V109, P2643, DOI 10.1182/blood-2006-07-035766; Meyer-Moock S, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-58; Morris ES, 2007, BONE MARROW TRANSPL, V40, P1003, DOI 10.1038/sj.bmt.1705854; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Nash RA, 2015, JAMA NEUROL, V72, P159, DOI 10.1001/jamaneurol.2014.3780; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Phillips JT, 2011, MULT SCLER J, V17, P970, DOI 10.1177/1352458511399611; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Rudick RA, 2007, ANN NEUROL, V62, P335, DOI 10.1002/ana.21163; Segal JB, 2006, J THROMB HAEMOST, V4, P2377, DOI 10.1111/j.1538-7836.2006.02147.x; Sharrack B, 1996, J NEUROL SCI, V135, P1, DOI 10.1016/0022-510X(95)00261-Y; Shirani A, 2012, JAMA-J AM MED ASSOC, V308, P247, DOI 10.1001/jama.2012.7625; SIPE JC, 1984, NEUROLOGY, V34, P1368, DOI 10.1212/WNL.34.10.1368; Yandall BS, 1997, PRACTICAL DATA ANAL; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	40	132	134	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					275	284		10.1001/jama.2014.17986	http://dx.doi.org/10.1001/jama.2014.17986			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602998	Green Published			2022-12-28	WOS:000348145000019
J	Ospina, NS; Montori, VM				Ospina, Naykky Singh; Montori, Victor M.			Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA(1c) without increasing hypoglycemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ospina, Naykky Singh; Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Ospina, NS (corresponding author), Mayo Clin, Rochester, MN 55905 USA.			Singh Ospina, Naykky/0000-0003-4240-6239				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2	3	5	5	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC6	10.7326/ACPJC-2015-162-2-006	http://dx.doi.org/10.7326/ACPJC-2015-162-2-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599366				2022-12-28	WOS:000350106600005
J	Pichichero, ME				Pichichero, Michael E.			Antibiotics for Acute Otitis Media Yes or No	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; MIDDLE-EAR EFFUSION; ANTIMICROBIAL TREATMENT; CHILDREN	IMPORTANCE Antimicrobial treatment reduces the symptoms of acute otitis media (AOM). The effect of antimicrobial treatment on the duration of middle ear effusion (MEE) and concomitant hearing impairment is not known. OBJECTIVE To determine whether the antimicrobial treatment of AOM reduces the duration of MEE. DESIGN, SETTING, AND PARTICIPANTS This randomized, double-blind, placebo-controlled trial involved a total of 84 children with AOM between 6 months and 15 years of age. Participants were recruited from September 14, 1999, to January 4, 2000; October 10, 2005, to December 16, 2005; and September 22, 2009, to June 4, 2012, from among children attending an AOM prevention trial and children visiting local outpatient clinics in Oulu, Finland. INTERVENTIONS Children were randomly allocated to receive either 40mg/kg of amoxicillin-clavulanate or a placebo mixture per day for 7 days. MAIN OUTCOMES AND MEASURES The primary outcome measure was the time to the disappearance of MEE as defined by a normal tympanogram finding (A curve) from both ears on 2 consecutive measurement days. Parents performed daily tympanometry at home. The study physician performed tympanometry and otoscopy at study entry, after 3 and 7 days, and then weekly until both ears were healthy. The main secondary outcome measures were the time to normal otoscopy findings and the proportion of children without persistent MEE at 14 days and 2 months. RESULTS Middle ear effusion disappeared 2.0 weeks (13.7 days) earlier (P = .02) in the antimicrobial group (mean time, 2.7 weeks; 95% CI, 1.7-3.7) than in the placebo group (4.7 weeks; 95% CI, 3.6-5.7). Normal otoscopy findings were observed 1.4 weeks sooner in the antimicrobial group than in the placebo group (P = .02). Onday 14, 69% of children in the antimicrobial group and 38% in the placebo group had normal tympanometry findings (number needed to treat, 3.2; 95% CI, 2.0-10.5). Onday 60, 2 children (5%) in the antimicrobial group and 10 children (24%) in the placebo group had persistent MEE (P = .01). CONCLUSIONS AND RELEVANCE Antimicrobial treatment effectively reduced the duration of MEE and possible concomitant hearing impairment in children with AOM. Antimicrobial treatment also reduced the risk for persistent MEE.	Rochester Gen Hosp, Res Inst, 1425 Portland Ave, Rochester, NY 14621 USA	Rochester General Hospital	Pichichero, ME (corresponding author), Rochester Gen Hosp, Res Inst, 1425 Portland Ave, Rochester, NY 14621 USA.	michael.pichichero@rochestergeneral.org	Pichichero, Michael E/AID-7886-2022					[Anonymous], 2011, WORKSHOP SPONSORED B; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Lieberthal AS, 2014, PEDIATRICS, V133, P346, DOI 10.1542/peds.2013-3791; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Pichichero ME, 1998, JAMA-J AM MED ASSOC, V279, P1748, DOI 10.1001/jama.279.21.1748; Pichichero ME, 2008, INT J PEDIATR OTORHI, V72, P737, DOI 10.1016/j.ijporl.2008.02.020; Puhakka T, 2014, PEDIATR INFECT DIS J, V33, pE183, DOI 10.1097/INF.0000000000000273; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; Tapiainen T, 2014, JAMA PEDIATR, V168, P635, DOI 10.1001/jamapediatrics.2013.5311	9	3	3	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					294	+		10.1001/jama.2014.14990	http://dx.doi.org/10.1001/jama.2014.14990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25603000				2022-12-28	WOS:000348145000021
J	Yang, YT; Silverman, RD				Yang, Y. Tony; Silverman, Ross D.			Legislative Prescriptions for Controlling Nonmedical Vaccine Exemptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCHOOL IMMUNIZATION REQUIREMENTS; PERTUSSIS; MEASLES		[Yang, Y. Tony] George Mason Univ, Dept Hlth Adm & Policy, Fairfax, VA 22030 USA; [Silverman, Ross D.] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Hlth Policy & Management, Indianapolis, IN 46204 USA; [Silverman, Ross D.] Indiana Univ, McKinney Sch Law, Indianapolis, IN 46204 USA	George Mason University; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Yang, YT (corresponding author), George Mason Univ, Dept Hlth Adm & Policy, MS 1J3,4400 Univ Dr, Fairfax, VA 22030 USA.	ytyang@gmu.edu		Silverman, Ross D./0000-0003-4492-3096				Centers for Disease Control and Prevention (CDC), CDC CURR OUTBR LIST; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Gastanaduy PA, 2014, MMWR-MORBID MORTAL W, V63, P496; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Omer SB, 2014, JAMA-J AM MED ASSOC, V311, P620, DOI 10.1001/jama.2013.282869; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Silverman Ross D, 2003, Ann Health Law, V12, P277; Yang YT, 2013, ICPSR34486	9	35	35	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					247	248		10.1001/jama.2014.16286	http://dx.doi.org/10.1001/jama.2014.16286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602992	Green Submitted			2022-12-28	WOS:000348145000013
J	Dunn, RE; Stromberg, CAE; Madden, RH; Kohn, MJ; Carlini, AA				Dunn, Regan E.; Stroemberg, Caroline A. E.; Madden, Richard H.; Kohn, Matthew J.; Carlini, Alfredo A.			Linked canopy, climate, and faunal change in the Cenozoic of Patagonia	SCIENCE			English	Article							LEAF-AREA INDEX; EOCENE; ORIGIN; FOREST; ECOSYSTEMS; DIVERSITY; SAVANNA; AMERICA; REVEAL; SPREAD	Vegetation structure is a key determinant of ecosystems and ecosystem function, but paleoecological techniques to quantify it are lacking. We present a method for reconstructing leaf area index (LAI) based on light-dependent morphology of leaf epidermal cells and phytoliths derived from them. Using this proxy, we reconstruct LAI for the Cenozoic (49 million to 11 million years ago) of middle-latitude Patagonia. Our record shows that dense forests opened up by the late Eocene; open forests and shrubland habitats then fluctuated, with a brief middle-Miocene regreening period. Furthermore, endemic herbivorous mammals show accelerated tooth crown height evolution during open, yet relatively grass-free, shrubland habitat intervals. Our Patagonian LAI record provides a high-resolution, sensitive tool with which to dissect terrestrial ecosystem response to changing Southern Ocean conditions during the Cenozoic.	[Dunn, Regan E.; Stroemberg, Caroline A. E.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Dunn, Regan E.; Stroemberg, Caroline A. E.] Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Madden, Richard H.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Kohn, Matthew J.] Boise State Univ, Dept Geosci, Boise, ID 83725 USA; [Carlini, Alfredo A.] Univ Nacl La Plata, Consejo Nacl Invest Cient & Tecn CONICET, La Plata, Buenos Aires, Argentina	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; Idaho; Boise State University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Dunn, RE (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	dunnr@u.washington.edu	Kohn, Matthew/A-2562-2012	Kohn, Matthew/0000-0002-7202-4525; Stromberg, Caroline A. E./0000-0003-0612-0305	National Science Foundation [DEB-1110354, EAR-0819910, EAR-0819842, EAR-0819837, EAR-1349749]; Proyecto de Investigacion en Ciencias y Tecnicas 1860 of the Fondo Nacional de Ciencia y Tecnologia (FONCyT); Geological Society of America; University of Washington Department of Biology and Burke Museum of Natural History and Culture	National Science Foundation(National Science Foundation (NSF)); Proyecto de Investigacion en Ciencias y Tecnicas 1860 of the Fondo Nacional de Ciencia y Tecnologia (FONCyT); Geological Society of America; University of Washington Department of Biology and Burke Museum of Natural History and Culture	Supplementary data are included in the data file. This research was funded in part by National Science Foundation grants DEB-1110354 to R.E.D. and C.A.E.S. (Doctoral Dissertation Improvement Grant) and EAR-0819910 to C.A.E.S., EAR-0819842 to R.H.M., and EAR-0819837 and EAR-1349749 to M.J.K.; Proyecto de Investigacion en Ciencias y Tecnicas 1860 of the Fondo Nacional de Ciencia y Tecnologia (FONCyT) To A.A.C.; the Geological Society of America; and the University of Washington Department of Biology and Burke Museum of Natural History and Culture. We thank G. Vucetich, M. Ciancio, M. Conner, A. Loeser, Pan American Energy, Organization for Tropical Studies, Area Conservacion de Guanacaste, and three reviewers.	Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; Asner GP, 2003, ECOL APPL, V13, P629, DOI 10.1890/1051-0761(2003)013[0629:DICACI]2.0.CO;2; BARRADAS MCD, 1987, FOLIA GEOBOT PHYTOTX, V22, P415, DOI 10.1007/BF02853240; Barraza V., 2013, IEEE J-STARS, V7, P421; Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Bellosi E.S., 2010, PALEONTOLOGY GRAN BA, P293; Bellosi E.S., 2010, PALEONTOLOGY GRAN BA, P278; Betts RA, 1997, NATURE, V387, P796, DOI 10.1038/42924; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Bremond L, 2005, GLOBAL PLANET CHANGE, V45, P277, DOI 10.1016/j.gloplacha.2004.09.002; Breshears DD, 2003, EARTH SURF PROC LAND, V28, P1189, DOI 10.1002/esp.1034; Dermody O, 2007, PLANT SOIL, V301, P255, DOI 10.1007/s11104-007-9443-x; Dunn RE, 2013, GEOL SOC AM BULL, V125, P539, DOI 10.1130/B30660.1; Ganguly S, 2008, REMOTE SENS ENVIRON, V112, P4318, DOI 10.1016/j.rse.2008.07.013; Gutiurrez E., 1991, OECOLOGIA AQUATICA, V10, P351; Hinojosa LF, 2005, PALAEOGEOGR PALAEOCL, V217, P1, DOI 10.1016/j.palaeo.2004.11.013; Hinojosa LF, 2005, REV GEOL CHILE, V32, P95; Ibrahim MH, 2010, ACTA PHYSIOL PLANT, V32, P305, DOI 10.1007/s11738-009-0408-y; Iio A., 2013, GLOBAL ECOL BIOGEOGR, V23, P274; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; Kohn MJ, 2004, GEOLOGY, V32, P621, DOI 10.1130/G20442.1; Kurschner WM, 1997, REV PALAEOBOT PALYNO, V96, P1, DOI 10.1016/S0034-6667(96)00051-6; Livermore R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2005GC001224; Madden R.H., 2014, HYPSODONTY MAMMALS E; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Palazzesi L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2299; Punyasena SW, 2008, PALAEOGEOGR PALAEOCL, V265, P226, DOI 10.1016/j.palaeo.2008.04.025; ROMERO EJ, 1986, ANN MO BOT GARD, V73, P449, DOI 10.2307/2399123; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Stromberg CAE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2508; Stromberg CAE, 2004, PALAEOGEOGR PALAEOCL, V207, P239, DOI 10.1016/j.palaeo.2003.09.028; Warny S, 2009, GEOLOGY, V37, P955, DOI 10.1130/G30139A.1; Watson R. W., 1942, NEW PHYTOL, V41, P223, DOI 10.1111/j.1469-8137.1942.tb07075.x; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Woodgate WL, 2012, INT ARCH PHOTOGRAMM, V39-B8, P457; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	39	118	125	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					258	261		10.1126/science.1260947	http://dx.doi.org/10.1126/science.1260947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593182	Green Published			2022-12-28	WOS:000347915300032
J	Werner, R				Werner, Reinhard			The focus on bibliometrics makes papers less useful	NATURE			English	Editorial Material									Leibniz Univ Hannover, Hanover, NH 03755 USA		Werner, R (corresponding author), Leibniz Univ Hannover, Hanover, NH 03755 USA.	reinhard.werner@itp.uni-hannover.de	Werner, Reinhard F/C-1123-2009	Werner, Reinhard F/0000-0003-2288-468X					0	36	36	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					245	245		10.1038/517245a	http://dx.doi.org/10.1038/517245a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY8NK	25592498	Bronze			2022-12-28	WOS:000347810300004
J	Minev, IR; Musienko, P; Hirsch, A; Barraud, Q; Wenger, N; Moraud, EM; Gandar, J; Capogrosso, M; Milekovic, T; Asboth, L; Torres, RF; Vachicouras, N; Liu, QH; Pavlova, N; Duis, S; Larmagnac, A; Voros, J; Micera, S; Suo, ZG; Courtine, G; Lacour, SP				Minev, Ivan R.; Musienko, Pavel; Hirsch, Arthur; Barraud, Quentin; Wenger, Nikolaus; Moraud, Eduardo Martin; Gandar, Jerome; Capogrosso, Marco; Milekovic, Tomislav; Asboth, Leonie; Torres, Rafael Fajardo; Vachicouras, Nicolas; Liu, Qihan; Pavlova, Natalia; Duis, Simone; Larmagnac, Alexandre; Voeroes, Janos; Micera, Silvestro; Suo, Zhigang; Courtine, Gregoire; Lacour, Stephanie P.			Electronic dura mater for long-term multimodal neural interfaces	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; STIMULATION; ARRAY	The mechanical mismatch between soft neural tissues and stiff neural implants hinders the long-term performance of implantable neuroprostheses. Here, we designed and fabricated soft neural implants with the shape and elasticity of dura mater, the protective membrane of the brain and spinal cord. The electronic dura mater, which we call e-dura, embeds interconnects, electrodes, and chemotrodes that sustain millions of mechanical stretch cycles, electrical stimulation pulses, and chemical injections. These integrated modalities enable multiple neuroprosthetic applications. The soft implants extracted cortical states in freely behaving animals for brain-machine interface and delivered electrochemical spinal neuromodulation that restored locomotion after paralyzing spinal cord injury.	[Minev, Ivan R.; Hirsch, Arthur; Vachicouras, Nicolas; Lacour, Stephanie P.] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Bertarelli Fdn Chair Neuroprosthet Technol, Lab Soft Bioelect Interfaces,Inst Microengn, CH-1015 Lausanne, Switzerland; [Minev, Ivan R.; Hirsch, Arthur; Moraud, Eduardo Martin; Capogrosso, Marco; Vachicouras, Nicolas; Micera, Silvestro; Lacour, Stephanie P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Musienko, Pavel; Barraud, Quentin; Wenger, Nikolaus; Gandar, Jerome; Milekovic, Tomislav; Asboth, Leonie; Torres, Rafael Fajardo; Vachicouras, Nicolas; Pavlova, Natalia; Duis, Simone; Courtine, Gregoire] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Int Parapleg Fdn Chair Spinal Cord Repair, CH-1015 Lausanne, Switzerland; [Musienko, Pavel; Barraud, Quentin; Wenger, Nikolaus; Gandar, Jerome; Milekovic, Tomislav; Asboth, Leonie; Torres, Rafael Fajardo; Vachicouras, Nicolas; Pavlova, Natalia; Duis, Simone; Courtine, Gregoire] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Musienko, Pavel; Pavlova, Natalia] IP Pavlov Physiol Inst, St Petersburg 199034, Russia; [Moraud, Eduardo Martin; Capogrosso, Marco; Micera, Silvestro] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Translat Neural Engn Lab, CH-1015 Lausanne, Switzerland; [Liu, Qihan; Suo, Zhigang] Harvard Univ, Kavli Inst Bionano Sci & Technol, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Larmagnac, Alexandre; Voeroes, Janos] Inst Biomed Engn Univ, Lab Biosensors & Bioelect, Zurich, Switzerland; [Larmagnac, Alexandre; Voeroes, Janos] Swiss Fed Inst Technol, Zurich, Switzerland; [Micera, Silvestro] Scuola Super Sant Anna, BioRobot Inst, I-55025 Pisa, Italy	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Scuola Superiore Sant'Anna	Courtine, G (corresponding author), Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Int Parapleg Fdn Chair Spinal Cord Repair, CH-1015 Lausanne, Switzerland.	gregoire.courtine@epfl.ch; stephanie.lacour@epfl.ch	Micera, Silvestro/AAD-6630-2021; Suo, Zhigang/B-1067-2008; Lacour, Stephanie P./E-6375-2010; courtine, gregoire/AAJ-1694-2020; Lacour, Stephanie/AAR-2213-2020; Milekovic, Tomislav/R-7972-2017; Liu, Qihan/F-9044-2010; Minev, Ivan/AAI-6072-2021; Minev, Ivan/C-8896-2015; Liu, Qihan/AAY-5040-2020; Hirsch, Arthur/Q-2793-2018; Musienko, Pavel/L-6677-2015	Suo, Zhigang/0000-0002-4068-4844; courtine, gregoire/0000-0002-5744-4142; Lacour, Stephanie/0000-0001-9075-4022; Milekovic, Tomislav/0000-0001-6769-6506; Minev, Ivan/0000-0003-2055-7386; Minev, Ivan/0000-0003-2055-7386; Musienko, Pavel/0000-0002-7324-9021; Martin Moraud, Eduardo/0000-0002-6148-7065; Barraud, Quentin/0000-0003-0894-1959; Capogrosso, Marco/0000-0002-0975-316X; Voros, Janos/0000-0001-6054-6230; Asboth, Leonie/0000-0003-2414-9574; Liu, Qihan/0000-0002-0907-4773	Fondation Bertarelli; International Paraplegic Foundation; European Research Council [ERG 259419 ESKIN, ERG 261247 Walk-Again]; Nano-tera.ch [20NA_145923 SpineRepair]; Swiss National Science Foundation through the National Centre of Competence in Research (NCCR) in Robotics; European Commission's Seven Framework Program [CP-IP 258654 NeuWalk]; National Science Foundation, Materials Research Science and Engineering Center [DMR-0820484]	Fondation Bertarelli; International Paraplegic Foundation; European Research Council(European Research Council (ERC)European Commission); Nano-tera.ch; Swiss National Science Foundation through the National Centre of Competence in Research (NCCR) in Robotics; European Commission's Seven Framework Program; National Science Foundation, Materials Research Science and Engineering Center(National Science Foundation (NSF))	We thank D. Pioletti for Providing access to the micro-computed tomography (CT) scanner. Financial support was provided by the Fondation Bertarelli, the International Paraplegic Foundation, Starting Grants from the European Research Council (ERG 259419 ESKIN and ERG 261247 Walk-Again), Nano-tera.ch (20NA_145923 SpineRepair), the Swiss National Science Foundation through the National Centre of Competence in Research (NCCR) in Robotics, European Commission's Seven Framework Program (CP-IP 258654 NeuWalk), and the National Science Foundation, Materials Research Science and Engineering Center (DMR-0820484). A patent application (PCT/EP2014/059779) describing aspects of the implant fabrication was filed on 13 May 2014.	Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Aregueta-Robles Ulises A, 2014, Front Neuroeng, V7, P15, DOI 10.3389/fneng.2014.00015; Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014; Borton D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005968; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; ENZMANN DR, 1992, RADIOLOGY, V185, P653, DOI 10.1148/radiology.185.3.1438741; Fan JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4266; Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496; Ferraro MC, 2022, LANCET NEUROL, V21, P405, DOI 10.1016/S1474-4422(22)00096-5; Gad P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-2; Guo CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4121; Harrison DE, 1999, J MANIP PHYSIOL THER, V22, P227, DOI 10.1016/S0161-4754(99)70049-7; Kim DH, 2012, P NATL ACAD SCI USA, V109, P19910, DOI 10.1073/pnas.1205923109; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Konrad P, 2010, NEUROBIOL DIS, V38, P369, DOI 10.1016/j.nbd.2009.12.007; Lacour SP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201874; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Musienko P, 2009, IEEE T BIO-MED ENG, V56, P2707, DOI 10.1109/TBME.2009.2027226; NeuroNexus, 2014, SURF PROB; Park DW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6258; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Potter KA, 2014, ACTA BIOMATER, V10, P2209, DOI 10.1016/j.actbio.2014.01.018; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vanfleteren J, 2014, PROC TECH, V15, P208, DOI 10.1016/j.protcy.2014.09.073	30	614	637	30	539	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					159	163		10.1126/science.1260318	http://dx.doi.org/10.1126/science.1260318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574019	Green Published, Green Submitted			2022-12-28	WOS:000347918900039
J	Kassler, WJ; Tomoyasu, N; Conway, PH				Kassler, William J.; Tomoyasu, Naomi; Conway, Patrick H.			Beyond a Traditional Payer - CMS's Role in Improving Population Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Kassler, William J.] Ctr Medicare Serv, Boston, MA 02203 USA; [Kassler, William J.] Ctr Medicaid Serv, Boston, MA USA; [Tomoyasu, Naomi; Conway, Patrick H.] Ctr Medicare Serv, Baltimore, MD USA; [Tomoyasu, Naomi; Conway, Patrick H.] Ctr Medicaid Serv, Baltimore, MD USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Cincinnati Children's Hospital Medical Center	Kassler, WJ (corresponding author), Ctr Medicare Serv, Boston, MA 02203 USA.							Hacker K, 2013, AM J PUBLIC HEALTH, V103, P1163, DOI 10.2105/AJPH.2013.301254; Jacobson DM, 2012, ENV SCAN INTEGRATED; Kindig D, 2003, AM J PUBLIC HEALTH, V93, P380, DOI 10.2105/AJPH.93.3.380; Shortell SM, 2013, JAMA-J AM MED ASSOC, V309, P1121, DOI 10.1001/jama.2013.887	4	43	43	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					109	111		10.1056/NEJMp1406838	http://dx.doi.org/10.1056/NEJMp1406838			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY2UA	25564896				2022-12-28	WOS:000347443300005
J	McQuaid, F; Long, AM; Warne, SA				McQuaid, Fiona; Long, Anna-May; Warne, Stephanie A.			CASE REPORT A vomiting baby	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROTAVIRUS VACCINATION; INTUSSUSCEPTION RISK; UK; ENGLAND; INFANTS		[McQuaid, Fiona] John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Long, Anna-May; Warne, Stephanie A.] John Radcliffe Hosp, Dept Paediat Surg, Oxford OX3 9DU, England	University of Oxford; University of Oxford	McQuaid, F (corresponding author), 35-3 Barony St, Edinburgh EH3 6NX, Midlothian, Scotland.	fionamcquaid@hotmail.com						Bines JE, 2005, CURR OPIN GASTROEN, V21, P20; Boudville IC, 2006, ANN ACAD MED SINGAP, V35, P674; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Department of Health, 2013, IMM INF DIS GREEN BO; Eshel G, 1997, J PEDIATR GASTR NUTR, V24, P253, DOI 10.1097/00005176-199703000-00004; Hannon E, 2014, CLIN RADIOL, V69, P344, DOI 10.1016/j.crad.2013.10.024; Harrington L, 1998, J PEDIATR-US, V132, P836, DOI 10.1016/S0022-3476(98)70314-2; Harris JP, 2007, VACCINE, V25, P3962, DOI 10.1016/j.vaccine.2007.02.072; Hernandez J Alberto, 2004, Emerg Radiol, V10, P323; Hryhorczuk AL, 2009, PEDIATR RADIOL, V39, P1075, DOI 10.1007/s00247-009-1353-z; Jiang JQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055729, 10.1371/journal.pone.0068482]; Jit M, 2007, HUM VACCINES, V3, P23, DOI 10.4161/hv.3.1.3748; NEWMAN J, 1987, CAN MED ASSOC J, V136, P266; O'Ryan M, 2011, EXPERT REV VACCINES, V10, P1645, DOI [10.1586/ERV.11.152, 10.1586/erv.11.152]; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Patel MM, 2009, EXPERT REV VACCINES, V8, P1555, DOI 10.1586/ERV.09.106; Samad L, 2012, BRIT J SURG, V99, P411, DOI 10.1002/bjs.7821; Samad L, 2013, VACCINE, V31, P4098, DOI 10.1016/j.vaccine.2013.06.084; Shalaby MS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6949; Soares-Weiser K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008521.pub3; Vesikari T, 2012, CLIN MICROBIOL INFEC, V18, P57, DOI 10.1111/j.1469-0691.2012.03981.x; Waseem M, 2008, PEDIATR EMERG CARE, V24, P793, DOI 10.1097/PEC.0b013e31818c2a3e; Weintraub ES, 2014, NEW ENGL J MED, V370, P513, DOI 10.1056/NEJMoa1311738; Yih WK, 2014, NEW ENGL J MED, V370, P503, DOI 10.1056/NEJMoa1303164	24	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2015	350								h14	10.1136/bmj.h14	http://dx.doi.org/10.1136/bmj.h14			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LX	25568960				2022-12-28	WOS:000348130100007
J	Lo, B				Lo, Bernard			Sharing Clinical Trial Data Maximizing Benefits, Minimizing Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Greenwall Fdn, New York, NY 10119 USA		Lo, B (corresponding author), Greenwall Fdn, One Penn Plaza,Ste 4726, New York, NY 10119 USA.	bernardlo@greenwall.org	de Leeuw, Peter W./J-4552-2016	de Leeuw, Peter W./0000-0002-4949-5812	Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Christakis DA, 2013, JAMA-J AM MED ASSOC, V310, P2499, DOI 10.1001/jama.2013.281337; European Medicines Agency (EMA), PUBL CLIN DAT; Institute of Medicine (IOM), I MED IOM COMM STRAT; Krumholz HM, 2014, JAMA-J AM MED ASSOC, V312, P1002, DOI 10.1001/jama.2014.9647; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794	6	84	87	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2015	313	8					793	794		10.1001/jama.2015.292	http://dx.doi.org/10.1001/jama.2015.292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7RY	25594500	Bronze			2022-12-28	WOS:000349826400008
J	Polsky, D; Richards, M; Basseyn, S; Wissoker, D; Kenney, GM; Zuckerman, S; Rhodes, KV				Polsky, Daniel; Richards, Michael; Basseyn, Simon; Wissoker, Douglas; Kenney, Genevieve M.; Zuckerman, Stephen; Rhodes, Karin V.			Appointment Availability after Increases in Medicaid Payments for Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICIAN PARTICIPATION; ACCEPT	Background Providing increases in Medicaid reimbursements for primary care, a key provision of the Affordable Care Act (ACA), raised Medicaid payments to Medicare levels in 2013 and 2014 for selected services and providers. The federally funded increase in reimbursements was aimed at expanding access to primary care for the growing number of Medicaid enrollees. The reimbursement increase expired at the end of 2014 in most states before policymakers had much empirical evidence about its effects. Methods We measured the availability of and waiting times for appointments in 10 states during two periods: from November 2012 through March 2013 and from May 2014 through July 2014. Trained field staff posed as either Medicaid enrollees or privately insured enrollees seeking new-patient primary care appointments. We estimated state-level changes over time in a stable cohort of primary care practices that participated in Medicaid to assess whether willingness to provide appointments for new Medicaid enrollees was related to the size of increases in Medicaid reimbursements in each state. Results The availability of primary care appointments in the Medicaid group increased by 7.7 percentage points, from 58.7% to 66.4%, between the two time periods. The states with the largest increases in availability tended to be those with the largest increases in reimbursements, with an estimated increase of 1.25 percentage points in availability per 10% increase in Medicaid reimbursements (P = 0.03). No such association was observed in the private-insurance group. During the same periods, waiting times to a scheduled new-patient appointment remained stable over time in the two study groups. Conclusions Our study provides early evidence that increased Medicaid reimbursement to primary care providers, as mandated in the ACA, was associated with improved appointment availability for Medicaid enrollees among participating providers without generating longer waiting times.	[Polsky, Daniel; Basseyn, Simon; Rhodes, Karin V.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Polsky, Daniel; Richards, Michael; Rhodes, Karin V.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Wissoker, Douglas; Kenney, Genevieve M.; Zuckerman, Stephen] Urban Inst, Washington, DC 20037 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Urban Institute	Polsky, D (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, 3641 Locust Walk,Suite 210, Philadelphia, PA 19104 USA.	polsky@wharton.upenn.edu			Robert Wood Johnson Foundation [70160]	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Supported by a grant (70160) from the Robert Wood Johnson Foundation.	[Anonymous], 2013, PCPS AR STILL WAIT A; Arvantes J, 2013, STATE MED PROGRAMS S; Baltic S, 2014, MED EC; Berman S, 2002, PEDIATRICS, V110, P239, DOI 10.1542/peds.110.2.239; Centers for Medicare and Medicaid Services, QS AS INCR MED PAYM; Centers for Medicare and Medicaid Services, MED STAT PLAN AM; Crawford Maia, 2014, MED PRIMARY CARE RAT; Cunningham Peter J, 2011, Res Brief, P1; DAVIDSON SM, 1982, J HEALTH POLIT POLIC, V6, P703, DOI 10.1215/03616878-6-4-703; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; Kaiser Commission on Medicaid and the Uninsured, 2014, INCR MED PRIM CAR FE; Medicare Cf Medicaid Services H, 2012, FINAL RULE FED REG, V77, P66669; Rhodes KV, 2014, JAMA INTERN MED, V174, P861, DOI 10.1001/jamainternmed.2014.20; SK&A, FACT SHEET HEALTHC P; SLOAN F, 1978, J HUM RESOUR, V13, P211, DOI 10.2307/145253; Snyder L, 2014, ACA PRIMARY CARE INC; Wilk AS, 2014, J HEALTH POLIT POLIC, V39, P1263, DOI 10.1215/03616878-2829495; YUDKOWSKY BK, 1990, PEDIATRICS, V85, P567; Zuckerman S, 2014, REVERSING MED FEE BU; Zuckerman S, 2012, MUCH WILL MED PHYS F; Zuckerman S., 2004, HLTH AFF MILLWOOD S	21	163	163	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 5	2015	372	6					537	545		10.1056/NEJMsa1413299	http://dx.doi.org/10.1056/NEJMsa1413299			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA8CH	25607243				2022-12-28	WOS:000349143600008
J	Meyer, HE; Holvik, K; Lips, P				Meyer, Haakon E.; Holvik, Kristin; Lips, Paul			UNCERTAINTIES PAGE Should vitamin D supplements be recommended to prevent chronic diseases?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SERUM 25-HYDROXYVITAMIN D; FRACTURE RISK; D DEFICIENCY; EUROPE; COHORT; HEALTH; WOMEN		[Meyer, Haakon E.; Holvik, Kristin] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway; [Meyer, Haakon E.] Univ Oslo, Dept Community Med, Oslo, Norway; [Lips, Paul] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Endocrine Sect, Amsterdam, Netherlands	Norwegian Institute of Public Health (NIPH); University of Oslo; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Meyer, HE (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Box 4404, N-0403 Oslo, Norway.	haakon.meyer@fhi.no	Holvik, Kristin/X-8678-2019; Meyer, Haakon E./AAH-9333-2019	Holvik, Kristin/0000-0003-3132-2822; Meyer, Haakon E/0000-0002-3262-8260				Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Avenell A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub4; BJELAKOVIC G, 2014, COCHRANE DB SYST REV, P7469, DOI [10.1002/14651858.cd007470.pub3, DOI 10.1002/14651858.CD007470.PUB3]; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Cauley JA, 2011, J BONE MINER RES, V26, P2378, DOI 10.1002/jbmr.449; Health Council of the Netherlands, 2012, EC DIET REF VAL VIT; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Lamberg-Allardt C, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.22671; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Robinson-Cohen C, 2013, JAMA-J AM MED ASSOC, V310, P179, DOI 10.1001/jama.2013.7228; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; van der Meer IM, 2011, OSTEOPOROSIS INT, V22, P1009, DOI 10.1007/s00198-010-1279-1	17	43	43	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2015	350								h321	10.1136/bmj.h321	http://dx.doi.org/10.1136/bmj.h321			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AT	25633148				2022-12-28	WOS:000348778700003
J	Villar, D; Berthelot, C; Aldridge, S; Rayner, TF; Lukk, M; Pignatelli, M; Park, TJ; Deaville, R; Erichsen, JT; Jasinska, AJ; Turner, JMA; Bertelsen, MF; Murchison, EP; Flicek, P; Odom, DT				Villar, Diego; Berthelot, Camille; Aldridge, Sarah; Rayner, Tim F.; Lukk, Margus; Pignatelli, Miguel; Park, Thomas J.; Deaville, Robert; Erichsen, Jonathan T.; Jasinska, Anna J.; Turner, James M. A.; Bertelsen, Mads F.; Murchison, Elizabeth P.; Flicek, Paul; Odom, Duncan T.			Enhancer Evolution across 20 Mammalian Species	CELL			English	Article							TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; CHIP-SEQ; TRANSPOSABLE ELEMENTS; COMPARATIVE GENOMICS; REGULATORY DNA; STEM-CELLS; CONSERVATION; CHROMATIN; TISSUES	The mammalian radiation has corresponded with rapid changes in noncoding regions of the genome, but we lack a comprehensive understanding of regulatory evolution in mammals. Here, we track the evolution of promoters and enhancers active in liver across 20 mammalian species from six diverse orders by profiling genomic enrichment of H3K27 acetylation and H3K4 trimethylation. We report that rapid evolution of enhancers is a universal feature of mammalian genomes. Most of the recently evolved enhancers arise from ancestral DNA exaptation, rather than lineage-specific expansions of repeat elements. In contrast, almost all liver promoters are partially or fully conserved across these species. Our data further reveal that recently evolved enhancers can be associated with genes under positive selection, demonstrating the power of this approach for annotating regulatory adaptations in genomic sequences. These results provide important insight into the functional genetics underpinning mammalian regulatory evolution.	[Villar, Diego; Aldridge, Sarah; Rayner, Tim F.; Lukk, Margus; Odom, Duncan T.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Berthelot, Camille; Pignatelli, Miguel; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; UIC, Dept Biol Sci, Chicago, IL 60607 USA; [Deaville, Robert] Zool Soc London, UK Cetacean Strandings Invest Programme CSIP, London NW1 4RY, England; [Deaville, Robert] Zool Soc London, Inst Zool, London NW1 4RY, England; [Erichsen, Jonathan T.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF24 4HQ, S Glam, Wales; [Jasinska, Anna J.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Turner, James M. A.] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Bertelsen, Mads F.] Ctr Zoo & Wild Anim Hlth, DK-2000 Copenhagen, Denmark; [Murchison, Elizabeth P.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Flicek, Paul; Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge CB10 1SD, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of Illinois System; University of Illinois Chicago; Zoological Society of London; Zoological Society of London; Cardiff University; University of California System; University of California Los Angeles; MRC National Institute for Medical Research; University of Cambridge; Wellcome Trust Sanger Institute	Flicek, P (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	flicek@ebi.ac.uk; duncan.odom@cruk.cam.ac.uk	Bertelsen, Mads/AAA-5746-2022; Berthelot, Camille/K-5570-2017; Villar, Diego/K-8595-2017; Erichsen, Jonathan/A-1779-2011	Bertelsen, Mads/0000-0001-9201-7499; Berthelot, Camille/0000-0001-5054-2690; Villar, Diego/0000-0002-8614-6232; Erichsen, Jonathan/0000-0003-1545-9853; Lukk, Margus/0000-0002-0701-5358; Jasinska, Anna/0000-0002-1897-4570; Murchison, Elizabeth Proby/0000-0001-7462-8907; Odom, Duncan/0000-0001-6201-5599; Flicek, Paul/0000-0002-3897-7955; Rayner, Tim/0000-0002-6992-5592	Cancer Research UK; European Molecular Biology Laboratory; Wellcome Trust [WT095908, WT098051]; European Research Council; EMBO Young Investigator Programme; National Science Foundation [0744979]; NIH [P40 OD010965, R01 OD010980, R37 MH060233]; MRC [U117588498]; Defra; Governments of Scotland; Wales; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010980, P40OD010965] Funding Source: NIH RePORTER; Cancer Research UK [15603, 20412] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Molecular Biology Laboratory; Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Governments of Scotland; Wales; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK)	We thank Stephen Watt, Frances Connor, the CRUK-CI Genomics and Bioinformatics cores, Biological Resources Unit (Matthew Clayton), Margaret Brown (West Yorkshire bat hospital), Julie E. Horvath (North Carolina Central University), and Chris Dillingham (University of Cardiff) for technical assistance; Matthieu Muffato for assistance with whole-genome alignments; Claudia Kutter, Gordon Brown, Christine Feig, and Christina Ernst for useful comments and discussions, and the EBI systems team for management of computational resources. This research was supported by Cancer Research UK (D.V., D.T.O.), the European Molecular Biology Laboratory (C.B., P.F.), the Wellcome Trust (WT095908) (P.F.) and (WT098051) (P.F., D.T.O.), the European Research Council, EMBO Young Investigator Programme (D.T.O.), the National Science Foundation (0744979) (T.J.P.), NIH (P40 OD010965, R01 OD010980, R37 MH060233) (A.J.J.) and MRC (U117588498) (J.M.A.T.). Cetacean samples were collected by the UK Cetacean Strandings Investigation Programme, funded by Defra and the Governments of Scotland and Wales.	Aldridge S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r124; Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arnold CD, 2014, NAT GENET, V46, P685, DOI 10.1038/ng.3009; Ballester B, 2014, ELIFE, V3, DOI 10.7554/eLife.02626; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cain CE, 2011, GENETICS, V187, P1225, DOI 10.1534/genetics.110.126177; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Frith MC, 2006, GENOME RES, V16, P713, DOI 10.1101/gr.5031006; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jacques PE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003504; Kheradpour P, 2013, GENOME RES, V23, P800, DOI 10.1101/gr.144899.112; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000330; Krebs AR, 2011, MOL CELL, V44, P410, DOI 10.1016/j.molcel.2011.08.037; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Lynch M, 2011, ANNU REV GENOM HUM G, V12, P347, DOI 10.1146/annurev-genom-082410-101412; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Paris M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003748; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rands CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004525; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schwaiger M, 2014, GENOME RES, V24, P639, DOI 10.1101/gr.162529.113; Shibata Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002789; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	55	364	371	7	110	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					554	566		10.1016/j.cell.2015.01.006	http://dx.doi.org/10.1016/j.cell.2015.01.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635462	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000349208000019
J	Campion, EW				Campion, Edward W.			Treating Millions for HIV - The Adherence Clubs of Khayelitsha	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SOUTH-AFRICA; HEALTH-CARE											Farmer PE, 2013, NEW ENGL J MED, V369, P2424, DOI 10.1056/NEJMsa1310472; Katz IT, 2013, NEW ENGL J MED, V369, P1385, DOI 10.1056/NEJMp1310982; Mayosi BM, 2014, NEW ENGL J MED, V371, P1344, DOI 10.1056/NEJMsr1405012; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5	4	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					301	303		10.1056/NEJMp1414213	http://dx.doi.org/10.1056/NEJMp1414213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ4PJ	25607424	Bronze			2022-12-28	WOS:000348204500002
J	Hay, CC; Morrow, E; Kopp, RE; Mitrovica, JX				Hay, Carling C.; Morrow, Eric; Kopp, Robert E.; Mitrovica, Jerry X.			Probabilistic reanalysis of twentieth-century sea-level rise	NATURE			English	Article							ATMOSPHERIC-PRESSURE; MASS-BALANCE; ICE SHEETS; GLACIERS; TRENDS	Estimating and accounting for twentieth-century global mean sea-level (GMSL) rise is critical to characterizing current and future human-induced sea-level change. Several previous analyses of tide gauge records(1-6)-employing different methods to accommodate the spatial sparsity and temporal incompleteness of the data and to constrain the geometry of long-term sea-level change-have concluded that GMSL rose over the twentieth century at a mean rate of 1.6 to 1.9 millimetres per year. Efforts to account for this rate by summing estimates of individual contributions from glacier and ice-sheet mass loss, ocean thermal expansion, and changes in land water storage fall significantly short in the period before 1990(7). The failure to close the budget of GMSL during this period has led to suggestions that several contributions may have been systematically underestimated(8). However, the extent to which the limitations of tide gauge analyses have affected estimates of the GMSL rate of change is unclear. Here we revisit estimates of twentieth-century GMSL rise using probabilistic techniques(9,10) and find a rate of GMSL rise from 1901 to 1990 of 1.2 +/- 0.2 millimetres per year (90% confidence interval). Based on individual contributions tabulated in the Fifth Assessment Report(7) of the Intergovernmental Panel on Climate Change, this estimate closes the twentieth-century sea-level budget. Our analysis, which combines tide gauge records with physics-based and model-derived geometries of the various contributing signals, also indicates that GMSL rose at a rate of 3.0 +/- 0.7 millimetres per year between 1993 and 2010, consistent with prior estimates from tide gauge records(4). The increase in rate relative to the 1901-90 trend is accordingly larger than previously thought; this revision may affect some projections(11) of future sea-level rise.	[Hay, Carling C.; Morrow, Eric; Mitrovica, Jerry X.] Harvard Univ, Cambridge, MA 02138 USA; [Hay, Carling C.; Morrow, Eric; Kopp, Robert E.] Rutgers State Univ, Piscataway, NJ 08854 USA; [Kopp, Robert E.] Rutgers State Univ, Rutgers Energy Inst, New Brunswick, NJ 08901 USA	Harvard University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Hay, CC (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	carlinghay@fas.harvard.edu		Hay, Carling/0000-0002-9240-2036; Kopp, Robert/0000-0003-4016-9428	US National Science Foundation [ARC-1203414, ARC-1203415]; New Jersey Sea Grant Consortium; National Oceanic and Atmospheric Administration (NJSGC) [6410-0012]; Rutgers University; Harvard University; Office of Polar Programs (OPP) [1203415] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); New Jersey Sea Grant Consortium; National Oceanic and Atmospheric Administration (NJSGC); Rutgers University; Harvard University; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Tide gauge data were provided by PMSL (www.psmsl.org). This work was supported by US National Science Foundation grants ARC-1203414 and ARC-1203415, the New Jersey Sea Grant Consortium and the National Oceanic and Atmospheric Administration (NJSGC project 6410-0012), Rutgers University (R.E.K., C.C.H.), and Harvard University (J.X.M., C.C.H. and E.M.). We thank P. Woodworth for comments on earlier versions of this manuscript.	Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Calafat FM, 2014, J GEOPHYS RES-OCEANS, V119, P1572, DOI 10.1002/2013JC009298; Christiansen B, 2010, J CLIMATE, V23, P4306, DOI 10.1175/2010JCLI3014.1; Church J. A, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Church JA, 2004, J CLIMATE, V17, P2609, DOI 10.1175/1520-0442(2004)017<2609:EOTRDO>2.0.CO;2; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; CLARK JA, 1977, NATURE, V269, P206, DOI 10.1038/269206a0; Conrad CP, 1997, GEOPHYS RES LETT, V24, P1503, DOI 10.1029/97GL01338; Davis JL, 1996, NATURE, V379, P331, DOI 10.1038/379331a0; Douglas BC, 1997, SURV GEOPHYS, V18, P279, DOI 10.1023/A:1006544227856; EKMAN M, 1988, PURE APPL GEOPHYS, V127, P73, DOI 10.1007/BF00878691; Gelb A., 1974, APPL OPTIMAL ESTIMAT, P42; Gomis D, 2008, GLOBAL PLANET CHANGE, V63, P215, DOI 10.1016/j.gloplacha.2008.06.005; Gregory JM, 2013, J CLIMATE, V26, P4476, DOI 10.1175/JCLI-D-12-00319.1; Hay CC, 2013, P NATL ACAD SCI USA, V110, P3692, DOI 10.1073/pnas.1117683109; Holgate SJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028492; Holgate SJ, 2013, J COASTAL RES, V29, P493, DOI 10.2112/JCOASTRES-D-12-00175.1; Jevrejeva S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033611; Kaser G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027511; Kendall RA, 2005, GEOPHYS J INT, V161, P679, DOI 10.1111/j.1365-246X.2005.02553.x; Kopp RE, 2013, GEOPHYS RES LETT, V40, P3981, DOI 10.1002/grl.50781; Kopp RE, 2010, CLIMATIC CHANGE, V103, P619, DOI 10.1007/s10584-010-9935-1; MEHRA RK, 1970, IEEE T AUTOMAT CONTR, VAC15, P175, DOI 10.1109/TAC.1970.1099422; Milne GA, 1998, GEOPHYS J INT, V133, P1, DOI 10.1046/j.1365-246X.1998.1331455.x; Mitrovica JX, 2011, GEOPHYS J INT, V187, P729, DOI 10.1111/j.1365-246X.2011.05090.x; MITROVICA JX, 1995, GEOPHYS RES LETT, V22, P2529, DOI 10.1029/95GL02240; Mitrovica JX, 2002, QUATERNARY SCI REV, V21, P2179, DOI 10.1016/S0277-3791(02)00080-X; Mitrovica JX, 2001, NATURE, V409, P1026, DOI 10.1038/35059054; Munk W, 2002, P NATL ACAD SCI USA, V99, P6550, DOI 10.1073/pnas.092704599; Nerem RS, 2010, MAR GEOD, V33, P435, DOI 10.1080/01490419.2010.491031; PELTIER WR, 1989, SCIENCE, V244, P806, DOI 10.1126/science.244.4906.806; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Permanent Service for Mean Sea Level (PSMSL), 2014, TID GAUG DAT; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; RAUCH HE, 1965, AIAA J, V3, P1445, DOI 10.2514/3.3166; Ray RD, 2011, PROG OCEANOGR, V91, P496, DOI 10.1016/j.pocean.2011.07.021; Rhein M., 2013, CLIMATE CHANGE 2013; Talbot A, 2006, WATER AVAILABILITY I; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tsimplis MN, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023867; Wenzel M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005630; Woppelmann G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035783; Woodward R S, 1888, US GEOL SURV B, V48, P87; Woodworth PL, 2009, INT J CLIMATOL, V29, P777, DOI 10.1002/joc.1771; Woodworth PL, 1999, GEOPHYS RES LETT, V26, P1589, DOI 10.1029/1999GL900323	46	340	352	11	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					481	+		10.1038/nature14093	http://dx.doi.org/10.1038/nature14093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25629092				2022-12-28	WOS:000348196500033
J	Tolar, J; Wagner, JE				Tolar, Jakub; Wagner, John E.			A Biologic Velcro Patch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DYSTROPHIC EPIDERMOLYSIS-BULLOSA		[Tolar, Jakub] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tolar, J (corresponding author), Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA.			Tolar, Jakub/0000-0002-0957-4380	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063070] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR063070] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bruckner-Tuderman L, 2010, DERMATOL CLIN, V28, P107, DOI 10.1016/j.det.2009.10.020; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Sebastiano V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009540; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501	5	11	12	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					382	384		10.1056/NEJMcibr1414709	http://dx.doi.org/10.1056/NEJMcibr1414709			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25607432				2022-12-28	WOS:000348204500015
J	Lamacraft, A				Lamacraft, Austen			New SQUID on the Bloch	SCIENCE			English	Editorial Material							PHASE		Univ Cambridge, Dept Phys, Cambridge CB3 0HE, England	University of Cambridge	Lamacraft, A (corresponding author), Univ Cambridge, Dept Phys, Cambridge CB3 0HE, England.	al200@cam.ac.uk		Lamacraft, Austen/0000-0002-0707-0488				BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Duca L, 2015, SCIENCE, V347, P288, DOI 10.1126/science.1259052; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	5	0	0	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					232	233		10.1126/science.aaa4201	http://dx.doi.org/10.1126/science.aaa4201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593172				2022-12-28	WOS:000347915300018
J	Casanova, JL; Abel, L				Casanova, Jean-Laurent; Abel, Laurent			Disentangling Inborn and Acquired Immunity in Human Twins	CELL			English	Editorial Material							DISEASE	The human geneticist Archibald Garrod noted in 1931 that, "It is, of necessity, no easy matter to distinguish between immunity which is inborn and that which has been acquired'' (The Inborn Factors in Disease). In this issue of Cell, Brodin et al. show that the heritability of blood counts rapidly decreases with age for the lymphoid subsets responsible for adaptive immunity, unlike cells from other hematopoietic lineages.	[Casanova, Jean-Laurent; Abel, Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA; [Casanova, Jean-Laurent; Abel, Laurent] Necker Hosp Sick Children, Inserm U1163, Lab Human Genet Infect Dis, Necker Branch, Paris, France; [Casanova, Jean-Laurent; Abel, Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol & Immunol Unit, Paris, France	Rockefeller University; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, 1230 York Ave, New York, NY 10021 USA.	casanova@rockefeller.edu	Abel, Laurent/H-8888-2017; Casanova, Jean-Laurent/I-3418-2017	Abel, Laurent/0000-0001-7016-6493; Casanova, Jean-Laurent/0000-0002-7782-4169				Bogdanos DP, 2012, J AUTOIMMUN, V38, pJ156, DOI 10.1016/j.jaut.2011.11.003; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Garner C, 2000, BLOOD, V95, P342; Hirano M, 2013, NATURE, V501, P435, DOI 10.1038/nature12467; Marchant A, 2006, J INFECT DIS, V193, P1598, DOI 10.1086/503775; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; WHITFIELD J B, 1985, Genetic Epidemiology, V2, P133, DOI 10.1002/gepi.1370020204	10	13	13	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					13	15		10.1016/j.cell.2014.12.029	http://dx.doi.org/10.1016/j.cell.2014.12.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594170	Bronze			2022-12-28	WOS:000347923200003
J	Dodd, GT; Decherf, S; Loh, K; Simonds, SE; Wiede, F; Balland, E; Merry, TL; Munzberg, H; Zhang, ZY; Kahn, BB; Neel, BG; Bence, KK; Andrews, ZB; Cowley, MA; Tiganis, T				Dodd, Garron T.; Decherf, Stephanie; Loh, Kim; Simonds, Stephanie E.; Wiede, Florian; Balland, Eglantine; Merry, Troy L.; Muenzberg, Heike; Zhang, Zhong-Yin; Kahn, Barbara B.; Neel, Benjamin G.; Bence, Kendra K.; Andrews, Zane B.; Cowley, Michael A.; Tiganis, Tony			Leptin and Insulin Act on POMC Neurons to Promote the Browning of White Fat	CELL			English	Article							DIET-INDUCED OBESITY; ARCUATE PROOPIOMELANOCORTIN NEURONS; ADIPOSE-TISSUE; GLUCOSE-HOMEOSTASIS; ENERGY-BALANCE; TRPC CHANNELS; AGRP NEURONS; BODY-WEIGHT; ACTIVATION; RESISTANCE	The primary task of white adipose tissue (WAT) is the storage of lipids. However, "beige'' adipocytes also exist in WAT. Beige adipocytes burn fat and dissipate the energy as heat, but their abundance is diminished in obesity. Stimulating beige adipocyte development, or WAT browning, increases energy expenditure and holds potential for combating metabolic disease and obesity. Here, we report that insulin and leptin act together on hypothalamic neurons to promote WAT browning and weight loss. Deletion of the phosphatases PTP1B and TCPTP enhanced insulin and leptin signaling in proopiomelanocortin neurons and prevented diet-induced obesity by increasing WAT browning and energy expenditure. The coinfusion of insulin plus leptin into the CNS or the activation of proopiomelanocortin neurons also increased WAT browning and decreased adiposity. Our findings identify a homeostatic mechanism for coordinating the status of energy stores, as relayed by insulin and leptin, with the central control of WAT browning.	[Dodd, Garron T.; Decherf, Stephanie; Loh, Kim; Wiede, Florian; Merry, Troy L.; Tiganis, Tony] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Simonds, Stephanie E.; Balland, Eglantine; Andrews, Zane B.; Cowley, Michael A.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Muenzberg, Heike] LSU Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Zhang, Zhong-Yin] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02215 USA; [Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Neel, Benjamin G.] Univ Toronto, Campbell Family Canc Res Inst, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Neel, Benjamin G.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Bence, Kendra K.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	Monash University; Monash University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Indiana University System; Indiana University Bloomington; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Pennsylvania	Tiganis, T (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	tony.tiganis@monash.edu	Dodd, Garron Thomas/AAC-9171-2019; Muenzberg-Gruening, Heike/N-1978-2017; Tiganis, Tony/AAV-3495-2020; Cowley, Michael A/B-9428-2008; Decherf, Stephanie/GYU-1222-2022	Dodd, Garron Thomas/0000-0002-7554-4876; Tiganis, Tony/0000-0002-8065-9942; Cowley, Michael A/0000-0001-7811-134X; Bence, Kendra/0000-0002-5879-4726; Balland, Eglantine/0000-0003-3225-100X; Andrews, Zane B./0000-0002-9097-7944; Loh, Kim/0000-0003-3781-1926; Wiede, Florian/0000-0001-5145-7180; SIMONDS, STEPHANIE/0000-0003-1590-6190; Merry, Troy/0000-0001-8699-500X	NHMRC of Australia; NIH [R37-CA49152, RO1-CA69202, RO1-DK082417, RO1-DK98002]; Ontario Ministry of Health and Long Term Care; Princess Margaret Cancer Foundation; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA069202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098002, R01DK082417] Funding Source: NIH RePORTER	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Cancer Foundation(University of Toronto); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NHMRC of Australia (to T.T., Z.B.A., and M.A.C.); the NIH to B.G.N. (R37-CA49152), Z.-Y.Z. (RO1-CA69202), K.K.B. (RO1-DK082417), and B.B.K. (RO1-DK98002); and funds from the Ontario Ministry of Health and Long Term Care and the Princess Margaret Cancer Foundation (B.G.N.).	Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Benoit SC, 2002, J NEUROSCI, V22, P9048; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Chiappini F, 2014, J CLIN INVEST, V124, P3781, DOI 10.1172/JCI68585; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Coll AP, 2004, J CLIN ENDOCR METAB, V89, P2557, DOI 10.1210/jc.2004-0428; Commins SP, 2000, J BIOL CHEM, V275, P33059, DOI 10.1074/jbc.M006328200; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Qiu J, 2014, CELL METAB, V19, P682, DOI 10.1016/j.cmet.2014.03.004; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Rahmouni K, 2004, J CLIN INVEST, V114, P652, DOI 10.1172/JCI200421737; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zhang S, 2009, J AM CHEM SOC, V131, P13072, DOI 10.1021/ja903733z	52	252	266	3	119	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					88	104		10.1016/j.cell.2014.12.022	http://dx.doi.org/10.1016/j.cell.2014.12.022			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594176	Bronze, Green Accepted			2022-12-28	WOS:000347923200011
J	Koretz, RL; Lin, KW; Ioannidis, JPA; Lenzer, J				Koretz, Ronald L.; Lin, Kenneth W.; Ioannidis, John P. A.; Lenzer, Jeanne			Is widespread screening for hepatitis C justified?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUSTAINED VIROLOGICAL RESPONSE; ALL-CAUSE MORTALITY; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; FOLLOW-UP; INTERFERON-ALPHA; NATURAL-HISTORY; PEGINTERFERON ALPHA-2A; DISEASE PROGRESSION; CHRONIC HCV		[Koretz, Ronald L.] David Geffen UCLA Sch Med, Davis, CA USA; [Lin, Kenneth W.] Georgetown Univ, Sch Med, Washington, DC USA; [Ioannidis, John P. A.] Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Georgetown University; Stanford University		jeanne.lenzer@gmail.com	Ioannidis, John P. A./G-9836-2011					Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2014, 3 YEARS FOLL UP SUBJ; [Anonymous], 2013, GOV CUOM SIGNS BILL; [Anonymous], 2014, TRANSPLANT YEAR DONO; [Anonymous], 1997, NIH CONS STAT, V15, P1; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Barrett S, 2001, GUT, V49, P423, DOI 10.1136/gut.49.3.423; Brok J, 2010, COCHRANE DB SYST REV, V1; Bruno S, 2001, J HEPATOL, V34, P748, DOI 10.1016/S0168-8278(01)00062-9; Casey LC, 2013, CURR OPIN GASTROEN, V29, P243, DOI 10.1097/MOG.0b013e32835ff972; Casiraghi MA, 2004, HEPATOLOGY, V39, P90, DOI 10.1002/hep.20030; CDC, 2011, VIR HEP STAT SURV; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Chavalitdhamrong D, 2006, WORLD J GASTROENTERO, V12, P5532, DOI 10.3748/wjg.v12.i34.5532; Chou R, 2013, ANN INTERN MED, V158, P101, DOI 10.7326/0003-4819-158-2-201301150-00574; Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986; Ciancio A, 2006, AM J GASTROENTEROL, V101, P1811, DOI 10.1111/j.1572-0241.2006.00669.x; DeMitri MS, 1997, ITAL J GASTROENTEROL, V29, P255; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Di Bisceglie AM, 2011, HEPATOLOGY, V53, P1100, DOI 10.1002/hep.24169; Everson GT, 2005, J HEPATOL, V42, pS65, DOI 10.1016/j.jhep.2005.01.009; Fattovich G, 1997, J HEPATOL, V27, P201, DOI 10.1016/S0168-8278(97)80302-9; Feld J, 2013, 64 ANN M AM ASS STUD; Fiore LD, 2011, CLIN TRIALS, V8, P183, DOI [10.1177/1740774510395635, 10.1177/1740774511398368]; Fontaine H, 2000, LANCET, V356, P41, DOI 10.1016/S0140-6736(00)02434-X; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hara K, 2014, J INFECT DIS, V209, P38, DOI 10.1093/infdis/jit541; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Institute for Safe Medication Practices, 2014, QUARTERWATCH; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Koretz R, 2013, COCHRANE DB SYST REV, V1; Koretz R., 1995, CURRENT HEPATOLOGY, V15, P49; Koretz R L, 2000, Gastroenterology, V118, P1268, DOI 10.1016/S0016-5085(00)70381-7; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lai ME, 2013, EUR J HAEMATOL, V90, P501, DOI 10.1111/ejh.12086; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Liang TJ, 2014, NEW ENGL J MED, V370, P2043, DOI 10.1056/NEJMe1403619; Locasciulli A, 1997, BLOOD, V90, P4628; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; Martinot-Peignoux M, 2010, HEPATOLOGY, V51, P1122, DOI 10.1002/hep.23444; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; McCombs J, 2014, JAMA INTERN MED, V174, P204, DOI 10.1001/jamainternmed.2013.12505; Missiha SB, 2008, GASTROENTEROLOGY, V134, P1699, DOI 10.1053/j.gastro.2008.02.069; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Ollendorf DA, 2014, JAMA INTERN MED, V174, P1170, DOI 10.1001/jamainternmed.2014.2151; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; REICHARD O, 1995, HEPATOLOGY, V21, P918, DOI 10.1016/0270-9139(95)90234-1; ROMEO R, 1994, ANN INTERN MED, V121, P276, DOI 10.7326/0003-4819-121-4-199408150-00008; Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P1059, DOI 10.1111/apt.12717; Tong MJ, 1996, WESTERN J MED, V164, P399; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Voelker R, 2012, JAMA-J AM MED ASSOC, V307, P1242, DOI 10.1001/jama.2012.337; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; [WHO W. H. Organization], 2014, GUID SCREEN CAR TREA; Wiese M, 2014, HEPATOLOGY, V59, P49, DOI 10.1002/hep.26644; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P1899, DOI 10.1001/jama.2013.3448; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	67	38	38	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2015	350								g7809	10.1136/bmj.g7809	http://dx.doi.org/10.1136/bmj.g7809			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3MX	25587052				2022-12-28	WOS:000348132700003
J	Cullen, TW; Schofield, WB; Barry, NA; Putnam, EE; Rundell, EA; Trent, MS; Degnan, PH; Booth, CJ; Yu, H; Goodman, AL				Cullen, T. W.; Schofield, W. B.; Barry, N. A.; Putnam, E. E.; Rundell, E. A.; Trent, M. S.; Degnan, P. H.; Booth, C. J.; Yu, H.; Goodman, A. L.			Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation	SCIENCE			English	Article							IMMUNE-SYSTEM; LIPID-A; MICROBIOTA; BACTERIAL; MEMBRANE; HOST; COLONIZATION; RESPONSES; DISEASE	Resilience to host inflammation and other perturbations is a fundamental property of gut microbial communities, yet the underlying mechanisms are not well understood. We have found that human gut microbes from all dominant phyla are resistant to high levels of inflammation-associated antimicrobial peptides (AMPs) and have identified a mechanism for lipopolysaccharide (LPS) modification in the phylum Bacteroidetes that increases AMP resistance by four orders of magnitude. Bacteroides thetaiotaomicron mutants that fail to remove a single phosphate group from their LPS were displaced from the microbiota during inflammation triggered by pathogen infection. These findings establish a mechanism that determines the stability of prominent members of a healthy microbiota during perturbation.	[Cullen, T. W.; Schofield, W. B.; Barry, N. A.; Putnam, E. E.; Rundell, E. A.; Goodman, A. L.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA; [Cullen, T. W.; Schofield, W. B.; Barry, N. A.; Putnam, E. E.; Goodman, A. L.] Yale Univ, Sch Med, Microbial Sci Inst, New Haven, CT 06520 USA; [Trent, M. S.] Yale Univ, Comparat Med Sect, Sch Med, New Haven, CT 06520 USA; [Trent, M. S.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Trent, M. S.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Degnan, P. H.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Yu, H.] Univ Hawaii, Canc Epidemiol Program, Ctr Canc, Honolulu, HI 96813 USA	Yale University; Yale University; Yale University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign; Cancer Research Center of Hawaii; University of Hawaii System	Goodman, AL (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06520 USA.	andrew.goodman@yale.edu		Putnam, Emily/0000-0002-3428-094X	NIH [DK089121, GM103574, GM105456, AI064184, AI76322]; Global Probiotics Council; Crohn's and Colitis Foundation of America; Army Research Office grant [W911NF-12-1-0390]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007640, R56AI076322, R01AI064184, R01AI076322, R21AI119879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105456, R01GM103574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Probiotics Council; Crohn's and Colitis Foundation of America; Army Research Office grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Groisman, J. Galan, and the Goodman lab for helpful suggestions; C. Jacobs-Wagner for microscopy assistance; J. Leong for a rodentium strains; and I. Ivanov for SFB. This work was supported by NIH grants DK089121, GM103574, GM105456, the Global Probiotics Council, and the Crohn's and Colitis Foundation of America to A.L.G. NIH grants AI064184 and AI76322 to M.S.T.; and Army Research Office grant W911NF-12-1-0390 to M.S.T. All human studies were conducted with approval from the Yale University Human Investigation Committee, and the sequences reported in this paper have been deposited with the European Bioinformatics Institute under accession number PRJEB7697.	Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; Coats SR, 2009, INT J ORAL SCI, V1, P126, DOI 10.4248/IJOS.09062; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Langhorst J, 2009, AM J GASTROENTEROL, V104, P404, DOI 10.1038/ajg.2008.86; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Mallick EM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00011; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang XY, 2006, J BIOL CHEM, V281, P9321, DOI 10.1074/jbc.M600435200	23	234	244	6	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					170	175		10.1126/science.1260580	http://dx.doi.org/10.1126/science.1260580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574022	Green Accepted			2022-12-28	WOS:000347918900042
J	Brown, C				Brown, Craig			PERSONAL VIEW A compassionate complaint about hospital care made a difference	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												cbrown9811@aol.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2015	350								g7823	10.1136/bmj.g7823	http://dx.doi.org/10.1136/bmj.g7823			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LU	25569431				2022-12-28	WOS:000348129900004
J	Lambert, N; Strebel, P; Orenstein, W; Icenogle, J; Poland, GA				Lambert, Nathaniel; Strebel, Peter; Orenstein, Walter; Icenogle, Joseph; Poland, Gregory A.			Rubella	LANCET			English	Article							IMMUNE-RESPONSE; T-CELL; CYTOKINE RESPONSES; FUCHS UVEITIS; SYNDROME CRS; ORAL FLUID; PCR ASSAY; VIRUS; MEASLES; VACCINE	Rubella remains an important pathogen worldwide, with roughly 100 000 cases of congenital rubella syndrome estimated to occur every year. Rubella-containing vaccine is highly effective and safe and, as a result, endemic rubella transmission has been interrupted in the Americas since 2009. Incomplete rubella vaccination programmes result in continued disease transmission, as evidenced by recent large outbreaks in Japan and elsewhere. In this Seminar, we provide present results regarding rubella control, elimination, and eradication policies, and a brief review of new laboratory diagnostics. Additionally, we provide novel information about rubella-containing vaccine immunogenetics and review the emerging evidence of interindividual variability in humoral and cell-mediated innate and adaptive immune responses to rubella-containing vaccine and their association with haplotypes and single-nucleotide polymorphisms across the human genome.	[Lambert, Nathaniel; Poland, Gregory A.] Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN 55902 USA; [Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA; [Strebel, Peter] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland; [Orenstein, Walter] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Icenogle, Joseph] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Mayo Clinic; Mayo Clinic; World Health Organization; Emory University; Centers for Disease Control & Prevention - USA	Poland, GA (corresponding author), Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN 55902 USA.	poland.gregory@mayo.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R37AI48793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048793, R01AI048793] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this Seminar was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R37AI48793 (which recently received a MERIT Award). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The findings and conclusions in this Seminar are those of the authors and do not necessarily represent the views of the US Department of Health and Human Services. PS is a staff member of the World Health Organization. PS is responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy, or views of the World Health Organization. We thank Caroline L Vitse for her editorial assistance.	Abernathy E, 2009, J CLIN MICROBIOL, V47, P182, DOI 10.1128/JCM.01231-08; Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; ALFORD CA, 1964, NEW ENGL J MED, V271, P1275, DOI 10.1056/NEJM196412172712501; Alonso PL, 2013, VACCINE, V31, pB3, DOI 10.1016/j.vaccine.2013.02.035; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079; Andrus JK, 2011, VACCINE, V29, pD91, DOI 10.1016/j.vaccine.2011.04.059; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P1; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P337; [Anonymous], 2012, VACCINES-BASEL; [Anonymous], 2019, RUBELLA; Babigumira JB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-406; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; Battisti AJ, 2012, J VIROL, V86, P11078, DOI 10.1128/JVI.01390-12; Bellini WJ, 2011, MANUAL CLIN MICROBIO, V2, P1372; Berger BE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-340; BEST JM, 1992, INTERVIROLOGY, V34, P164; Best JM, 2002, BRIT MED J, V325, P147, DOI 10.1136/bmj.325.7356.147; BEST JM, 1967, LANCET, V2, P237; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P657; Chen MH, 2007, J VIROL METHODS, V146, P414, DOI 10.1016/j.jviromet.2007.08.021; Cimino L, 2013, GRAEF ARCH CLIN EXP, V251, P1607, DOI 10.1007/s00417-013-2287-6; Cohen BJ, 2007, VACCINE, V26, P59, DOI 10.1016/j.vaccine.2007.10.046; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Cordoba P, 2000, CLIN DIAGN LAB IMMUN, V7, P964, DOI 10.1128/CDLI.7.6.964-966.2000; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; Cutts FT, 2000, EPIDEMIOL INFECT, V124, P467, DOI 10.1017/S0950268899003532; Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55; Dabbagh AJ, 2013, MMWR-MORBID MORTAL W, V62, P983; Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993; Demicheli V, 2013, EVID BASED CHILD HLT, V8, P2239; Dhiman N, 2010, CYTOKINE, V50, P24, DOI 10.1016/j.cyto.2009.12.002; Dhiman N, 2010, IMMUNOGENETICS, V62, P197, DOI 10.1007/s00251-010-0423-6; Duvanel CB, 2001, J NEUROSCI RES, V65, P446, DOI 10.1002/jnr.1173; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; ForleoNeto E, 1997, VACCINE, V15, P1898, DOI 10.1016/S0264-410X(97)00135-7; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; GINSBERGFELLNER F, 1984, DIABETOLOGIA, V27, P87, DOI 10.1007/BF00275655; Goodson JL, 2011, J INFECT DIS, V204, pS215, DOI 10.1093/infdis/jir108; GREGG NM, 1991, EPIDEMIOL INFECT, V107, pR3, DOI 10.1017/S0950268800048627; GRILLNER L, 1983, SCAND J INFECT DIS, V15, P321, DOI 10.3109/inf.1983.15.issue-4.01; Haralambieva IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062149; Haralambieva IH, 2010, HUM IMMUNOL, V71, P383, DOI 10.1016/j.humimm.2010.01.004; Helfand RF, 2007, CLIN VACCINE IMMUNOL, V14, P1522, DOI 10.1128/CVI.00144-07; Hinman AR, 2002, B WORLD HEALTH ORGAN, V80, P264; Hubschen JM, 2008, J VIROL METHODS, V149, P246, DOI 10.1016/j.jviromet.2008.01.032; Infectious Diseases Society of America, 2013, PRES FY 2014 BUDG SU; Jacobson Robert M, 2009, Paediatr Child Health, V19, pS156; Janta D, 2012, EURO SURVEILL, V17; Jin L, 2002, B WORLD HEALTH ORGAN, V80, P76; Kakoulidou M, 2013, VACCINE, V31, P711, DOI 10.1016/j.vaccine.2012.11.031; KATOW S, 1985, J CLIN MICROBIOL, V21, P449, DOI 10.1128/JCM.21.3.449-451.1985; Kennedy RB, 2014, IMMUNOGENETICS, V66, P493, DOI 10.1007/s00251-014-0776-3; Kennedy RB, 2010, HUM IMMUNOL, V71, P128, DOI 10.1016/j.humimm.2009.11.002; KISTLER GS, 1967, SCHWEIZ MED WSCHR, V97, P1377; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13; Maldonado, 2010, INFECT DIS FETUS NEW; Manikkavasagan G, 2010, EMERG INFECT DIS, V16, P1532, DOI 10.3201/eid1610.100560; MILLER E, 1982, LANCET, V2, P781; Minakami H, 2014, J INFECTION, V68, P99, DOI 10.1016/j.jinf.2013.09.002; MITCHELL LA, 1994, VACCINE, V12, P639, DOI 10.1016/0264-410X(94)90270-4; MITCHELL LA, 1992, J CLIN MICROBIOL, V30, P1841, DOI 10.1128/JCM.30.7.1841-1847.1992; Mitchell LA, 1996, J CLIN MICROBIOL, V34, P2210, DOI 10.1128/JCM.34.9.2210-2218.1996; Mitchell LA, 1998, J INFECT DIS, V177, P5, DOI 10.1086/513807; Mubareka S, 2007, J CLIN MICROBIOL, V45, P231, DOI 10.1128/JCM.01243-06; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; OSHEA S, 1988, LANCET, V2, P909; OSHIRO LS, 1969, J GEN VIROL, V5, P205, DOI 10.1099/0022-1317-5-2-205; OU DW, 1994, HUM IMMUNOL, V39, P177, DOI 10.1016/0198-8859(94)90258-5; Ou DW, 1998, HUM IMMUNOL, V59, P149, DOI 10.1016/S0198-8859(98)00006-8; Ovsyannikova IG, 2010, HUM GENET, V127, P207, DOI 10.1007/s00439-009-0763-1; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Ovsyannikova IG, 2009, VACCINE, V27, P6926, DOI 10.1016/j.vaccine.2009.08.109; Ovsyannikova IG, 2009, VACCINE, V27, P3359, DOI 10.1016/j.vaccine.2009.01.079; Paradowska-Stankiewicz I, 2013, EUROSURVEILLANCE, V18, P2; Petruzziello R, 1996, J GEN VIROL, V77, P303, DOI 10.1099/0022-1317-77-2-303; Plotkin S, 2008, VACCINES, P471; PLOTKIN SA, 1965, AM J DIS CHILD, V110, P381, DOI 10.1001/archpedi.1965.02090030401007; PLOTKIN SA, 1973, JAMA-J AM MED ASSOC, V225, P585, DOI 10.1001/jama.225.6.585; Plotkin SA, 1999, VACCINES-BASEL, V3rd, P409; Poethko-Muller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042867; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007; Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344; PRECHTL HFR, 1992, SEMIN PERINATOL, V16, P258; Pugachev KV, 1997, J VIROL, V71, P562, DOI 10.1128/JVI.71.1.562-568.1997; Pukhalsky AL, 2003, MEDIAT INFLAMM, V12, P203, DOI 10.1080/09629350310001599639; Seetoo K, 2013, MMWR-MORBID MORTAL W, V62, P226; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Strebel P, 2013, VACCINES, P352; Suzuki J, 2010, GRAEF ARCH CLIN EXP, V248, P1487, DOI 10.1007/s00417-010-1434-6; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; VAANANEN P, 1986, VACCINE, V4, P5, DOI 10.1016/0264-410X(86)90090-3; Pham VH, 2013, J CLIN VIROL, V57, P152, DOI 10.1016/j.jcv.2013.02.008; Wandinger KP, 2011, J VIROL METHODS, V174, P85, DOI 10.1016/j.jviromet.2011.04.001; Warrener L, 2011, B WORLD HEALTH ORGAN, V89, P675, DOI 10.2471/BLT.11.088427; Watson J C, 1998, MMWR Recomm Rep, V47, P1; WEIL ML, 1975, NEW ENGL J MED, V292, P994, DOI 10.1056/NEJM197505082921903; Weller TH, 1963, JAMA-J AM MED ASSOC, V183, P243; Who Publication, 2011, Vaccine, V29, P8767, DOI 10.1016/j.vaccine.2011.08.061; Wilson KM, 2006, CLIN VACCINE IMMUNOL, V13, P380, DOI 10.1128/CVI.13.3.380-386.2006; Winchester SA, 2013, J CLIN MICROBIOL, V51, P1622, DOI 10.1128/JCM.03239-12; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2545; World Health Organization, 2012, M DEV GLOB CONS PREC; World Health Organization, 2013, WHO UNICEF EST MCV C; Zhou YM, 2007, J GEN VIROL, V88, P932, DOI 10.1099/vir.0.82495-0; Zhu Z, 2007, J CLIN MICROBIOL, V45, P2847, DOI 10.1128/JCM.00289-07; ZREIN M, 1993, J CLIN MICROBIOL, V31, P1521, DOI 10.1128/JCM.31.6.1521-1524.1993	110	159	173	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2297	2307		10.1016/S0140-6736(14)60539-0	http://dx.doi.org/10.1016/S0140-6736(14)60539-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1CR	25576992	Green Accepted			2022-12-28	WOS:000355943500033
J	Hershkovitz, I; Marder, O; Ayalon, A; Bar-Matthews, M; Yasur, G; Boaretto, E; Caracuta, V; Alex, B; Frumkin, A; Goder-Goldberger, M; Gunz, P; Holloway, RL; Latimer, B; Lavi, R; Matthews, A; Slon, V; Mayer, DBY; Berna, F; Bar-Oz, G; Yeshurun, R; May, H; Hans, MG; Weber, GW; Barzilai, O				Hershkovitz, Israel; Marder, Ofer; Ayalon, Avner; Bar-Matthews, Miryam; Yasur, Gal; Boaretto, Elisabetta; Caracuta, Valentina; Alex, Bridget; Frumkin, Amos; Goder-Goldberger, Mae; Gunz, Philipp; Holloway, Ralph L.; Latimer, Bruce; Lavi, Ron; Matthews, Alan; Slon, Viviane; Mayer, Daniella Bar-Yosef; Berna, Francesco; Bar-Oz, Guy; Yeshurun, Reuven; May, Hila; Hans, Mark G.; Weber, Gerhard W.; Barzilai, Omry			Levantine cranium from Manot Cave (Israel) foreshadows the first European modern humans	NATURE			English	Article							MODERN HUMAN COLONIZATION; BURIAL SITE; AFRICA; PLEISTOCENE; DIVERSITY; SEQUENCE; SKELETON; REMAINS; SEA	A key event in human evolution is the expansion of modern humans of African origin across Eurasia between 60 and 40 thousand years (kyr) before present (BP), replacing all other forms of hominins(1). Owing to the scarcity of human fossils from this period, these ancestors of all present-day non-African modern populations remain largely enigmatic. Here we describe a partial calvaria, recently discovered at Manot Cave (Western Galilee, Israel) and dated to 54.7 +/- 5.5 kyr BP (arithmetic mean 2 standard deviations) by uranium-thorium dating, that sheds light on this crucial event. The overall shape and discrete morphological features of the Manot I calvaria demonstrate that this partial skull is unequivocally modern. It is similar in shape to recent African skulls as well as to European skulls from the Upper Palaeolithic period, but different from most other early anatomically modern humans in the Levant. This suggests that the Manot people could be closely related to the first modern humans who later successfully colonized Europe. Thus, the anatomical features used to support the 'assimilation model' in Europe might not have been inherited from European Neanderthals, but rather from earlier Levantine populations. Moreover, at present, Manot I is the only modern human specimen to provide evidence that during the Middle to Upper Palaeolithic interface, both modern humans and Neanderthals contemporaneously inhabited the southern Levant, close in time to the likely interbreeding event with Neanderthals(2,3).	[Hershkovitz, Israel; Slon, Viviane] Tel Aviv Univ, Sackler Fac Med, Dan David Lab Search & Study Modern Humans, IL-6997801 Tel Aviv, Israel; [Hershkovitz, Israel; Mayer, Daniella Bar-Yosef; May, Hila] Tel Aviv Univ, Steinhardt Museum Nat Hist & Natl Res Ctr, IL-6997801 Tel Aviv, Israel; [Marder, Ofer] Ben Gurion Univ Negev, Archaeol Div, IL-8410501 Beer Sheva, Israel; [Ayalon, Avner; Bar-Matthews, Miryam; Yasur, Gal] Geol Survey Israel, IL-95501 Jerusalem, Israel; [Boaretto, Elisabetta; Caracuta, Valentina; Alex, Bridget] Weizmann Inst Sci, D REAMS Radiocarbon Lab, Max Planck Soc Weizmann Inst Ctr Integrat Archaeo, IL-76100 Rehovot, Israel; [Alex, Bridget] Harvard Univ, Dept Anthropol & Human Evolutionary Biol, Cambridge, MA 02138 USA; [Frumkin, Amos] Hebrew Univ Jerusalem, Dept Geog, IL-91905 Jerusalem, Israel; [Goder-Goldberger, Mae] Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel; [Gunz, Philipp] Max Planck Inst Evolutionare Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Holloway, Ralph L.] Columbia Univ, Dept Anthropol, New York, NY 10027 USA; [Latimer, Bruce] Case Western Reserve Univ, Dept Anat, Cleveland, OH 44106 USA; [Latimer, Bruce; Hans, Mark G.] Case Western Reserve Univ, Sch Dent Med, Dept Orthodont, Cleveland, OH 44106 USA; [Matthews, Alan; Bar-Oz, Guy; Yeshurun, Reuven] Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; [Berna, Francesco] Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; [Bar-Oz, Guy; Yeshurun, Reuven] Univ Haifa, Zinman Inst Archaeol, IL-3498838 Haifa, Israel; [May, Hila] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel; [Weber, Gerhard W.] Univ Vienna, Dept Anthropol, A-1090 Vienna, Austria; [Weber, Gerhard W.] Univ Vienna, Core Facil Microcomp Tomog, A-1090 Vienna, Austria; [Barzilai, Omry] Israel Antiqu Author, IL-91004 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Ben Gurion University; Geological Survey Israel; Weizmann Institute of Science; Harvard University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Max Planck Society; Columbia University; Case Western Reserve University; Case Western Reserve University; Hebrew University of Jerusalem; Simon Fraser University; University of Haifa; Tel Aviv University; Sackler Faculty of Medicine; University of Vienna; University of Vienna	Hershkovitz, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dan David Lab Search & Study Modern Humans, POB 39040, IL-6997801 Tel Aviv, Israel.	anatom2@post.tau.ac.il	Yeshurun, Reuven/A-3182-2013; BarOz, Guy/ABF-6518-2020; Gunz, Philipp/C-7748-2009; Weber, Gerhard W/F-2583-2010; Hershkovitz, Israel/ABH-4511-2020; CARACUTA, Valentina/AAN-4127-2020	BarOz, Guy/0000-0002-1009-5619; Gunz, Philipp/0000-0002-2350-4450; Weber, Gerhard W/0000-0002-8542-6259; Hershkovitz, Israel/0000-0001-5841-6090; Berna, Francesco/0000-0002-3839-4012; Yeshurun, Reuven/0000-0002-1734-0138; Goder-Goldberger, Mae/0000-0001-9758-509X	Dan David Foundation; Israel Antiquities Authority; Case Western Reserve University; Leakey Foundation; Irene Levi Sala CARE Archaeological Foundation; Keren Kayemet L'Israel; Israel Science Foundation; National Science Foundation; Exilarch's Foundation; Max Planck Society-Weizman Institute Joint Center for Integrative Archaeology and Anthropology; Bertha and Louis Weinstein Research Fund	Dan David Foundation; Israel Antiquities Authority; Case Western Reserve University; Leakey Foundation; Irene Levi Sala CARE Archaeological Foundation; Keren Kayemet L'Israel; Israel Science Foundation(Israel Science Foundation); National Science Foundation(National Science Foundation (NSF)); Exilarch's Foundation; Max Planck Society-Weizman Institute Joint Center for Integrative Archaeology and Anthropology; Bertha and Louis Weinstein Research Fund	The excavation at Manot Cave was initiated and supported throughout the years by the late D. David, founder of the 'Dan David Prize', and his son A. David. The ongoing research is financially supported by the Dan David Foundation, the Israel Antiquities Authority, Case Western Reserve University, the Leakey Foundation, the Irene Levi Sala CARE Archaeological Foundation, the Keren Kayemet L'Israel and the Israel Science Foundation. Radiocarbon dating research has been supported by the National Science Foundation, the Exilarch's Foundation and the Max Planck Society-Weizman Institute Joint Center for Integrative Archaeology and Anthropology. Geological research was supported by The Bertha and Louis Weinstein Research Fund. We thank other research members of the Manot team: J.-M. Tejero and S. Weiner. We thank A. Behar and L. Barda for their drawings, C. Amit for the photography of the skull, and V. Essman and Y. Shmidov for surveying and drafting the cave. We thank I. Mureinik for editorial assistance. Special thanks are due to the following students and scholars: L. Weissbrod, D. Stein, H. Cohen, B. Medlej, M. Feldman, O. Hay, T. Abulafia, L. Davis, N. Schneller-Pels, D. Yegorov, M. Ullman and G. Hertzelinger. Thanks are also due to the Maale Yossef Regional Council, the residents of modern Manot and N. Reuven. We are also grateful to the late S. Dorfman, U. Dahari, D. Barshad, E. Stern and J. Goldberg. We thank I. Gilead and O. Bar-Yosef for reading and commenting on a previous version of this paper. We are grateful to C. Stringer for comments and suggestions.	ARENSBURG B, 1973, THESIS TEL AVIV U; Balzeau A, 2011, J HUM EVOL, V61, P488, DOI 10.1016/j.jhevol.2011.07.002; Balzeau A, 2010, J HUM EVOL, V58, P1, DOI 10.1016/j.jhevol.2009.05.016; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Crevecoeur I, 2009, AM J PHYS ANTHROPOL, V140, P347, DOI 10.1002/ajpa.21080; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grun R, 2000, J HUM EVOL, V39, P601, DOI 10.1006/jhev.2000.0443; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Haile-Selassie Y, 2004, AM J PHYS ANTHROPOL, V123, P1, DOI 10.1002/ajpa.10330; Harvati K, 2007, J HUM EVOL, V53, P732, DOI 10.1016/j.jhevol.2007.09.009; Harvati K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024024; HERSHKOVITZ I, 1995, AM J PHYS ANTHROPOL, V96, P215, DOI 10.1002/ajpa.1330960302; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; HUBLIN JJ, 1980, ANTHROPOLOGIE, V84, P81; HUBLIN JJ, 1988, HOMME NEANDERTAL, V3, P67; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Lieberman DE, 1996, AM J PHYS ANTHROPOL, V101, P217, DOI 10.1002/(SICI)1096-8644(199610)101:2<217::AID-AJPA7>3.3.CO;2-7; Marder O, 2013, ANTIQUITY, V87; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Schwartz JH, 2010, AM J PHYS ANTHROPOL, P94, DOI 10.1002/ajpa.21443; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Takai H., 1970, AMUD MAN HIS CAVE SI, P123; VALLADAS H, 1987, NATURE, V330, P159, DOI 10.1038/330159a0; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Wolpoff MH, 2001, SCIENCE, V291, P293, DOI 10.1126/science.291.5502.293	35	136	141	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					216	U178		10.1038/nature14134	http://dx.doi.org/10.1038/nature14134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CF3NA	25629628				2022-12-28	WOS:000352454600038
J	Kohli, A; Osinusi, A; Sims, Z; Nelson, A; Meissner, EG; Barrett, LL; Bon, D; Marti, MM; Silk, R; Kotb, C; Gross, C; Jolley, TA; Sidharthan, S; Petersen, T; Townsend, K; Egerson, D; Kapoor, R; Spurlin, E; Sneller, M; Proschan, M; Herrmann, E; Kwan, R; Teferi, G; Talwani, R; Diaz, G; Kleiner, DE; Wood, BJ; Chavez, J; Abbott, S; Symonds, WT; Subramanian, GM; Pang, PS; McHutchison, J; Polis, MA; Fauci, AS; Masur, H; Kottilil, S				Kohli, Anita; Osinusi, Anuoluwapo; Sims, Zayani; Nelson, Amy; Meissner, Eric G.; Barrett, Lisa L.; Bon, Dimitra; Marti, Miriam M.; Silk, Rachel; Kotb, Colleen; Gross, Chloe; Jolley, Tim A.; Sidharthan, Sreetha; Petersen, Tess; Townsend, Kerry; Egerson, D'Andrea; Kapoor, Rama; Spurlin, Emily; Sneller, Michael; Proschan, Michael; Herrmann, Eva; Kwan, Richard; Teferi, Gebeyehu; Talwani, Rohit; Diaz, Gabbie; Kleiner, David E.; Wood, Brad J.; Chavez, Jose; Abbott, Stephen; Symonds, William T.; Subramanian, G. Mani; Pang, Phillip S.; McHutchison, John; Polis, Michael A.; Fauci, Anthony S.; Masur, Henry; Kottilil, Shyam			Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study	LANCET			English	Article							GENOTYPE 1 INFECTION; INHIBITOR SOFOSBUVIR PLUS; DIRECT-ACTING ANTIVIRALS; TREATMENT-NAIVE PATIENTS; INTERFERON-FREE THERAPY; PEGYLATED INTERFERON; PROTEASE INHIBITOR; VIRUS-INFECTION; CHRONIC HCV; OPEN-LABEL	Background Direct-acting antiviral drugs have a high cure rate and favourable tolerability for patients with hepatitis C virus (HCV). Shorter courses could improve affordability and adherence. Sofosbuvir and ledipasvir with ribavirin have high efficacy when taken for 8 weeks but not for 6 weeks. We assessed whether the addition of a third direct-acting antiviral drug to sofosbuvir and ledipasvir would allow a shorter treatment duration. Methods In this single-centre, open-label, phase 2A trial, we sequentially enrolled treatment-naive patients with HCV genotype 1 infection into three treatment groups: 12 weeks of sofosbuvir and ledipasvir; 6 weeks of sofosbuvir, ledipasvir, and GS-9669; or 6 weeks of sofosbuvir, ledipasvir, and GS-9451. Patients and investigators were not masked to treatment assignment. The primary endpoint was the propotion of patients with sustained viral response at 12 weeks after treatment completion (SVR12), assessed by serum HCV RNA concentrations lower than 43 IU/mL (the lower limit of quantification). We did an intention-to-treat analysis for the primary endpoint and adverse events. This study is registered with ClinicalTrials. gov, number NCT01805882. Findings Between Jan 11, 2013, and Dec 17, 2013, we enrolled 60 patients, and sequentially assigned them into three groups of 20. We noted an SVR12 in all 20 patients (100%, 95% CI 83-100) allocated to sofosbuvir and ledipasvir for 12 weeks; in 19 (95%, 75-100) of the 20 patients allocated to sofosbuvir, ledipasvir, and GS-9669 for 6 weeks (one patient relapsed 2 weeks after completion of treatment); and in 19 (95%, 75-100%) of the 20 patients allocated to sofosbuvir, ledipasvir, and GS-9451 for 6 weeks (one patient was lost to follow-up after reaching sustained viral response at 4 weeks). Most adverse events were mild and no patients discontinued treatment. Two serious adverse events occurred (pain after a post-treatment liver biopsy and vertigo), both unrelated to study drugs. Interpretation In this small proof-of-concept study, two different three-drug regimens that were given for 6 weeks resulted in high cure rates for HCV infection with excellent tolerability. Addition of a third potent direct-acting antiviral drug can reduce the duration of treatment required to achieve sustained viral response in patients with chronic HCV genotype 1 infection without cirrhosis.	[Kohli, Anita; Sims, Zayani; Sidharthan, Sreetha; Petersen, Tess; Masur, Henry] NIH, NIH Clin Ctr, Dept Crit Care Med, Bethesda, MD 20892 USA; [Kohli, Anita; Osinusi, Anuoluwapo; Silk, Rachel; Kotb, Colleen; Gross, Chloe; Egerson, D'Andrea; Kapoor, Rama; Diaz, Gabbie] Frederick Natl Lab Canc Res, Clin Monitoring Res Program, Clin Res Directorate, Leidos Biomed Res, Frederick, MD USA; [Nelson, Amy; Meissner, Eric G.; Barrett, Lisa L.; Marti, Miriam M.; Jolley, Tim A.; Townsend, Kerry; Spurlin, Emily; Sneller, Michael; Kwan, Richard; Polis, Michael A.; Fauci, Anthony S.; Kottilil, Shyam] Immunoregulat Lab, New York, NY USA; [Proschan, Michael] Biostat Res Branch, Baltimore, MD USA; [Talwani, Rohit] NIH, NIAID, Bethesda, MD USA; [Talwani, Rohit] Univ Maryland, Inst Human Virol, Div Infect Dis, Bethesda, MD USA; [Osinusi, Anuoluwapo; Barrett, Lisa L.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Bon, Dimitra; Herrmann, Eva] Goethe Univ Frankfurt, Inst Biostat & Math Modeling, D-60054 Frankfurt, Germany; [Teferi, Gebeyehu; Chavez, Jose; Abbott, Stephen] Unity Hlth Care, Washington, DC USA; [Diaz, Gabbie] NCI, NIH, Bethesda, MD 20892 USA; [Kleiner, David E.] NCI, Pathol Lab, Bethesda, MD 20892 USA; [Wood, Brad J.] NIH, Ctr Clin, Ctr Intervent Oncol Radiol & Imaging Sci, Bethesda, MD USA; [Wood, Brad J.] NCI, Bethesda, MD 20892 USA; [Symonds, William T.; Subramanian, G. Mani; Pang, Phillip S.; McHutchison, John] Gilead Sci, Foster City, CA USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Dalhousie University; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gilead Sciences	Kottilil, S (corresponding author), NIH, NIAID, Immunoregulat Lab, Immunopathogenesis Sect, Bethesda, MD 20892 USA.	skottilil@niaid.nih.gov	Talwani, Rohit/B-8234-2019; Wood, Bradford J/M-7995-2017; Kleiner, David E/N-2770-2013; Kottilil, Shyam/ABF-7605-2021	Wood, Bradford J/0000-0002-4297-0051; Kleiner, David E/0000-0003-3442-4453; Nelson, Amy/0000-0001-9028-1894	National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute and Clinical Center Intramural Program; German Research Foundation; National Institutes of Health; Gilead Sciences; NATIONAL CANCER INSTITUTE [ZIDBC011242] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL040015, ZIACL009010] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute and Clinical Center Intramural Program; German Research Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute and Clinical Center Intramural Program, German Research Foundation, National Institutes of Health, Gilead Sciences.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Conover W.J., 1999, PRACTICAL NONPARAMET, V350; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Guedj J, 2010, J THEOR BIOL, V267, P330, DOI 10.1016/j.jtbi.2010.08.036; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lawitz E, 2012, J HEPATOL, V56, pS471, DOI 10.1016/S0168-8278(12)61201-X; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, J HEPATOL, V59, P18, DOI 10.1016/j.jhep.2013.02.009; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz EJ, 2013, ANTIVIR THER, V18, P311, DOI 10.3851/IMP2415; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; *SUN, 2010, LAT LUR PACK INS; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744	32	120	122	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1107	1113		10.1016/S0140-6736(14)61228-9	http://dx.doi.org/10.1016/S0140-6736(14)61228-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25591505	Green Accepted			2022-12-28	WOS:000351270400028
J	Bauer, T; Banzer, P; Karimi, E; Orlov, S; Rubano, A; Marrucci, L; Santamato, E; Boyd, RW; Leuchs, G				Bauer, Thomas; Banzer, Peter; Karimi, Ebrahim; Orlov, Sergej; Rubano, Andrea; Marrucci, Lorenzo; Santamato, Enrico; Boyd, Robert W.; Leuchs, Gerd			Observation of optical polarization Mobius strips	SCIENCE			English	Article							VORTEX; DISLOCATIONS; BEAMS	Mobius strips are three-dimensional geometrical structures, fascinating for their peculiar property of being surfaces with only one "side"-or, more technically, being "nonorientable" surfaces. Despite being easily realized artificially, the spontaneous emergence of these structures in nature is exceedingly rare. Here, we generate Mobius strips of optical polarization by tightly focusing the light beam emerging from a q-plate, a liquid crystal device that modifies the polarization of light in a space-variantmanner. Using a recently developed-method for the three-dimensional nanotomography of optical vector fields, we fully reconstruct the light polarization structure in the focal region, confirming the appearance of Mobius polarization structures. The preparation of such structured light modes may be important for complex light beam engineering and optical micro-and nanofabrication.	[Bauer, Thomas; Banzer, Peter; Orlov, Sergej; Leuchs, Gerd] Max Planck Inst Sci Light, D-91058 Erlangen, Germany; [Bauer, Thomas; Banzer, Peter; Orlov, Sergej; Leuchs, Gerd] Univ Erlangen Nurnberg, Inst Opt Informat & Photon, D-91058 Erlangen, Germany; [Banzer, Peter; Karimi, Ebrahim; Boyd, Robert W.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Rubano, Andrea; Marrucci, Lorenzo; Santamato, Enrico] Univ Naples Federico II, Dipartimento Fis, I-80126 Naples, Italy; [Rubano, Andrea; Marrucci, Lorenzo] Consiglio Nazl Ric CNR SPIN, I-80126 Naples, Italy; [Boyd, Robert W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA	Max Planck Society; University of Erlangen Nuremberg; University of Ottawa; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); University of Rochester	Karimi, E (corresponding author), Univ Ottawa, Dept Phys, 25 Templeton St, Ottawa, ON K1N 6N5, Canada.	ekarimi@uottawa.ca	Leuchs, Gerd/G-6178-2012; Marrucci, Lorenzo/A-4331-2012; Orlovas, Sergejus/ABD-3923-2020; Orlovas, Sergejus/J-8775-2015; Karimi, Ebrahim/V-1253-2019; Rubano, Andrea/J-9967-2016; Banzer, Peter/P-3094-2014	Leuchs, Gerd/0000-0003-1967-2766; Marrucci, Lorenzo/0000-0002-1154-8966; Orlovas, Sergejus/0000-0003-1692-0189; Orlovas, Sergejus/0000-0003-1692-0189; Banzer, Peter/0000-0002-6336-6953; Bauer, Thomas/0000-0003-0887-4717; Karimi, Ebrahim/0000-0002-8168-7304	Canada Excellence Research Chairs (CERC) Program	Canada Excellence Research Chairs (CERC) Program	The authors thank C. Marquardt for fruitful discussions. E.K. and R.W.B. acknowledge the support of the Canada Excellence Research Chairs (CERC) Program.	Ambrosio A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1996; BASISTIY IV, 1995, OPT COMMUN, V119, P604, DOI 10.1016/0030-4018(95)00267-C; Bauer T, 2014, NAT PHOTONICS, V8, P24, DOI [10.1038/nphoton.2013.289, 10.1038/NPHOTON.2013.289]; Beckley AM, 2010, OPT EXPRESS, V18, P10777, DOI 10.1364/OE.18.010777; Berry MV, 2004, J OPT A-PURE APPL OP, V6, P675, DOI 10.1088/1464-4258/6/7/003; BERRY MV, 1977, J PHYS A-MATH GEN, V10, P1809, DOI 10.1088/0305-4470/10/11/009; Cardano F, 2013, OPT EXPRESS, V21, P8815, DOI 10.1364/OE.21.008815; Chang CW, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.259903; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Dennis MR, 2010, NAT PHYS, V6, P118, DOI 10.1038/NPHYS1504; Dennis MR, 2009, PROG OPTICS, V53, P293, DOI 10.1016/S0079-6638(08)00205-9; Flossmann F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.203902; Freund I, 2005, OPT COMMUN, V249, P7, DOI 10.1016/j.optcom.2004.12.052; Freund I, 2010, OPT LETT, V35, P148, DOI 10.1364/OL.35.000148; Freund I, 2010, OPT COMMUN, V283, P1, DOI 10.1016/j.optcom.2009.09.042; Galvez EJ, 2012, APPL OPTICS, V51, P2925, DOI 10.1364/AO.51.002925; Leach J, 2004, NATURE, V432, P165, DOI 10.1038/432165a; Machon T, 2013, P NATL ACAD SCI USA, V110, P14174, DOI 10.1073/pnas.1308225110; Marrucci L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.163905; NYE JF, 1974, P ROY SOC LOND A MAT, V336, P165, DOI 10.1098/rspa.1974.0012; Nye JF, 1999, NATURAL FOCUSING FIN; Pickover C. A., 2005, MOBIUS STRIP A MOBIU; RICHARDS B, 1959, PROC R SOC LON SER-A, V253, P358, DOI 10.1098/rspa.1959.0200; Siegman A. E., 1986, LASER; Slussarenko S, 2011, OPT EXPRESS, V19, P4085, DOI 10.1364/OE.19.004085; Starostin EL, 2007, NAT MATER, V6, P563, DOI 10.1038/nmat1929; Sugioka K, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.30; Tanda S, 2002, NATURE, V417, P397, DOI 10.1038/417397a; Toyoda K, 2012, NANO LETT, V12, P3645, DOI 10.1021/nl301347j; Ynnerman A, 2002, IEEE T PLASMA SCI, V30, P18, DOI 10.1109/TPS.2002.1003902; Zhao YQ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.073901	31	240	241	20	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					964	966		10.1126/science.1260635	http://dx.doi.org/10.1126/science.1260635			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25636796				2022-12-28	WOS:000349958900030
J	Leconte, J; Wu, HB; Menou, K; Murray, N				Leconte, Jeremy; Wu, Hanbo; Menou, Kristen; Murray, Norman			Asynchronous rotation of Earth-mass planets in the habitable zone of lower-mass stars	SCIENCE			English	Article							ATMOSPHERIC TIDES; SPIN; CLIMATE; VENUS; EVOLUTION	Planets in the habitable zone of lower-mass stars are often assumed to be in a state of tidally synchronized rotation, which would considerably affect their putative habitability. Although thermal tides cause Venus to rotate retrogradely, simple scaling arguments tend to attribute this peculiarity to the massive Venusian atmosphere. Using a global climate model, we show that even a relatively thin atmosphere can drive terrestrial planets' rotation away from synchronicity. We derive a more realistic atmospheric tide model that predicts four asynchronous equilibrium spin states, two being stable, when the amplitude of the thermal tide exceeds a threshold that is met for habitable Earth-like planets with a 1-bar atmosphere around stars more massive than similar to 0.5 to 0.7 solar mass. Thus, many recently discovered terrestrial planets could exhibit asynchronous spin-orbit rotation, even with a thin atmosphere.	[Leconte, Jeremy; Wu, Hanbo; Murray, Norman] Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada; [Leconte, Jeremy; Menou, Kristen] Univ Toronto Scarborough, Dept Phys & Environm Sci, Ctr Planetary Sci, Toronto, ON M1C 1A4, Canada; [Leconte, Jeremy] Inst Pierre Simon Laplace, Lab Meteorol Dynam, F-75252 Paris, France; [Wu, Hanbo; Murray, Norman] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Menou, Kristen] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H8, Canada	University of Toronto; University of Toronto; University Toronto Scarborough; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Toronto; University of Toronto	Leconte, J (corresponding author), Univ Toronto, Canadian Inst Theoret Astrophys, 60 St George St, Toronto, ON M5S 3H8, Canada.	jleconte@cita.utoronto.ca		Murray, Norman/0000-0002-8659-3729	Canada Research Chair program; Natural Sciences and Engineering Research Council of Canada	Canada Research Chair program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	J.L. thanks S. Lebonnois for providing the numerical outputs of the Venus model. The authors thank three anonymous referees for their insightful comments that substantially enhanced the manuscript. N.M. is supported in part by the Canada Research Chair program. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada to K.M. and N.M. J.L. is a Banting Fellow.	Chapman S., 1970, ATMOSPHERIC TIDES TH; Correia ACM, 2008, ASTRON ASTROPHYS, V488, pL63, DOI 10.1051/0004-6361:200810388; Correia ACM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002059; Correia ACM, 2003, ICARUS, V163, P1, DOI 10.1016/S0019-1035(03)00042-3; Correia ACM, 2001, NATURE, V411, P767, DOI 10.1038/35081000; Cunha D, 2015, INT J ASTROBIOL, V14, P233, DOI 10.1017/S1473550414000226; DOBROVOLSKIS AR, 1980, ICARUS, V41, P1, DOI 10.1016/0019-1035(80)90156-6; Edson AR, 2012, ASTROBIOLOGY, V12, P562, DOI 10.1089/ast.2011.0762; Efroimsky M, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/150; Forget F, 2013, ICARUS, V222, P81, DOI 10.1016/j.icarus.2012.10.019; GOLD T, 1969, ICARUS, V11, P356, DOI 10.1016/0019-1035(69)90068-2; Heller R, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015809; Heng K, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/60; INGERSOLL AP, 1978, NATURE, V275, P37, DOI 10.1038/275037a0; Joshi M. M., 1993, ICARUS, V101, P108; Kite ES, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/41; Leconte J, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321042; Leconte J, 2013, NATURE, V504, P268, DOI 10.1038/nature12827; Makarov VV, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/83; Menou K, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/51; Selsis F, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321661; Snellen IAG, 2014, NATURE, V509, P63, DOI 10.1038/nature13253; Yang J, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/2/L45	25	104	104	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					632	635		10.1126/science.1258686	http://dx.doi.org/10.1126/science.1258686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25592420	Green Submitted			2022-12-28	WOS:000349145200037
J	Laliberte, F; Zika, J; Mudryk, L; Kushner, PJ; Kjellsson, J; Doos, K				Laliberte, F.; Zika, J.; Mudryk, L.; Kushner, P. J.; Kjellsson, J.; Doos, K.			Constrained work output of the moist atmospheric heat engine in a warming climate	SCIENCE			English	Article							RADIATIVE-CONVECTIVE EQUILIBRIUM; ENTROPY BUDGET; THERMODYNAMIC PROPERTIES; GENERAL-CIRCULATION; TRANSPORT; DISSIPATION; ENERGY	Incoming and outgoing solar radiation couple with heat exchange at Earth's surface to drive weather patterns that redistribute heat and moisture around the globe, creating an atmospheric heat engine. Here, we investigate the engine's work output using thermodynamic diagrams computed from reanalyzed observations and from a climate model simulation with anthropogenic forcing. We show that the work output is always less than that of an equivalent Carnot cycle and that it is constrained by the power necessary to maintain the hydrological cycle. In the climate simulation, the hydrological cycle increases more rapidly than the equivalent Carnot cycle. We conclude that the intensification of the hydrological cycle in warmer climates might limit the heat engine's ability to generate work.	[Laliberte, F.; Kushner, P. J.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A1, Canada; [Zika, J.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Mudryk, L.; Kjellsson, J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Doos, K.] Stockholm Univ, Dept Meteorol, S-10691 Stockholm, Sweden	University of Toronto; NERC National Oceanography Centre; University of Southampton; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Stockholm University	Laliberte, F (corresponding author), Univ Toronto, Dept Phys, Toronto, ON M5S 1A1, Canada.	frederic.laliberte@utoronto.ca	Kushner, Paul J/H-6716-2016	Kushner, Paul J/0000-0002-6404-4518; Laliberte, Frederic/0000-0001-9668-1418; Zika, Jan/0000-0003-3462-3559	G8 Research Initiative grant "ExArch: Climate analytics on distributed exascale data archives" through the Natural Sciences and Engineering Research Council (NSERC); Natural Environment Research Council [NE/K012932/1, bas0100028, bas0100033] Funding Source: researchfish; NERC [bas0100033, NE/K012932/1, bas0100028] Funding Source: UKRI	G8 Research Initiative grant "ExArch: Climate analytics on distributed exascale data archives" through the Natural Sciences and Engineering Research Council (NSERC); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge the Global Modeling and Assimilation Office (GMAO) and the Goddard Earth Sciences Data and Information Services Center (GES DISC) for the dissemination of MERRA data. This work was supported by the G8 Research Initiative grant "ExArch: Climate analytics on distributed exascale data archives" made available through the Natural Sciences and Engineering Research Council (NSERC).	Ambaum M. H. P., 2010, THERMAL PHYS ATMOSPH, P203; Barry L, 2002, NATURE, V415, P774, DOI 10.1038/415774a; Caballero R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021581; Doos K, 2012, J PHYS OCEANOGR, V42, P1445, DOI 10.1175/JPO-D-11-0163.1; Feistel R, 2010, OCEAN SCI, V6, P91, DOI 10.5194/os-6-91-2010; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Goody R, 2000, Q J ROY METEOR SOC, V126, P1953, DOI 10.1256/smsqj.56619; Groeskamp S, 2014, J PHYS OCEANOGR, V44, P1735, DOI 10.1175/JPO-D-13-0213.1; Hartmann D., 2013, CLIMATE CHANGE 2013; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Johnson D. R., 2001, INT GEOPHYS, P659; Kjellsson J, 2014, J ATMOS SCI, V71, P916, DOI 10.1175/JAS-D-13-0173.1; Lucarini V, 2011, J ATMOS SCI, V68, P2438, DOI 10.1175/2011JAS3713.1; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; O'Gorman PA, 2008, J CLIMATE, V21, P5797, DOI 10.1175/2008JCLI2099.1; Pascale S, 2011, CLIM DYNAM, V36, P1189, DOI 10.1007/s00382-009-0718-1; Pauluis O, 2002, J ATMOS SCI, V59, P125, DOI 10.1175/1520-0469(2002)059<0125:EBOAAI>2.0.CO;2; Pauluis O, 2000, J ATMOS SCI, V57, P989, DOI 10.1175/1520-0469(2000)057<0989:FDIAPA>2.0.CO;2; Pauluis O, 2002, J ATMOS SCI, V59, P140, DOI 10.1175/1520-0469(2002)059<0140:EBOAAI>2.0.CO;2; Pauluis O, 2012, SCIENCE, V335, P953, DOI 10.1126/science.1215869; Pauluis O, 2011, J ATMOS SCI, V68, P91, DOI 10.1175/2010JAS3530.1; Pauluis OM, 2013, J ATMOS SCI, V70, P3673, DOI 10.1175/JAS-D-12-0205.1; PEIXOTO JP, 1991, J GEOPHYS RES-ATMOS, V96, P10981, DOI 10.1029/91JD00721; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Romps DM, 2008, J ATMOS SCI, V65, P3779, DOI 10.1175/2008JAS2679.1; Schneider T, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000302; Sherwood SC, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000301; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; WULF OR, 1952, J METEOROL, V9, P79; Zika JD, 2012, J PHYS OCEANOGR, V42, P708, DOI 10.1175/JPO-D-11-0139.1	31	45	47	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					540	543		10.1126/science.1257103	http://dx.doi.org/10.1126/science.1257103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635098				2022-12-28	WOS:000348639300051
J	Norman, JM; Handley, SA; Baldridge, MT; Droit, L; Liu, CY; Keller, BC; Kambal, A; Monaco, CL; Zhao, G; Fleshner, P; Stappenbeck, TS; McGovern, DPB; Keshavarzian, A; Mutlu, EA; Sauk, J; Gevers, D; Xavier, RJ; Wang, D; Parkes, M; Virgin, HW				Norman, Jason M.; Handley, Scott A.; Baldridge, Megan T.; Droit, Lindsay; Liu, Catherine Y.; Keller, Brian C.; Kambal, Amal; Monaco, Cynthia L.; Zhao, Guoyan; Fleshner, Phillip; Stappenbeck, Thaddeus S.; McGovern, Dermot P. B.; Keshavarzian, Ali; Mutlu, Ece A.; Sauk, Jenny; Gevers, Dirk; Xavier, Ramnik J.; Wang, David; Parkes, Miles; Virgin, Herbert W.			Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease	CELL			English	Article							CROHNS-DISEASE; FECAL MICROBIOTA; GUT MICROBIOTA; METAGENOMIC ANALYSIS; ANTIBIOTICS INDUCE; CYSTIC-FIBROSIS; COMMUNITY; BACTERIOPHAGES; SEQUENCES; EVOLUTION	Decreases in the diversity of enteric bacterial populations are observed in patients with Crohn's disease (CD) and ulcerative colitis (UC). Less is known about the virome in these diseases. We show that the enteric virome is abnormal in CD and UC patients. In-depth analysis of preparations enriched for free virions in the intestine revealed that CD and UC were associated with a significant expansion of Caudovirales bacteriophages. The viromes of CD and UC patients were disease and cohort specific. Importantly, it did not appear that expansion and diversification of the enteric virome was secondary to changes in bacterial populations. These data support a model in which changes in the virome may contribute to intestinal inflammation and bacterial dysbiosis. We conclude that the virome is a candidate for contributing to, or being a biomarker for, human inflammatory bowel disease and speculate that the enteric virome may play a role in other diseases.	[Norman, Jason M.; Handley, Scott A.; Baldridge, Megan T.; Droit, Lindsay; Liu, Catherine Y.; Keller, Brian C.; Kambal, Amal; Monaco, Cynthia L.; Zhao, Guoyan; Stappenbeck, Thaddeus S.; Wang, David; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Keller, Brian C.; Monaco, Cynthia L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Zhao, Guoyan; Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Fleshner, Phillip] Cedars Sinai Med Ctr, Div Colorectal Surg, Los Angeles, CA 90048 USA; [McGovern, Dermot P. B.] F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Keshavarzian, Ali; Mutlu, Ece A.] Rush Univ, Med Ctr, Div Digest Dis & Nutr, Dept Med, Chicago, IL 60612 USA; [Sauk, Jenny; Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Sauk, Jenny; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Sauk, Jenny; Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Gevers, Dirk; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Div Gastroenterol, Cambridge CB2 0QQ, England; [Parkes, Miles] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Rush University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Keller, Brian C/E-2996-2016; Gevers, Dirk/C-1451-2009; Baldridge, Megan/T-7274-2019	Keller, Brian C/0000-0003-2997-6712; Baldridge, Megan/0000-0002-7030-6131; Virgin, Herbert/0000-0001-8580-7628; Zhao, Guoyan/0000-0001-5615-6774; Monaco, Cynthia/0000-0003-3093-5563; Parkes, Miles/0000-0002-6467-0631; Norman, Jason/0000-0001-5049-8415	Crohn's and Colitis Foundation [R01 AI084887, R01 OD011170, 3132, 274415]; Broad Medical Foundation [IBD-0357]; NIH grant [5T32AI007163-35, 5T32CA009547, T32 HL007317-36, 5T32AI007172-34]; European Union [305479]; Leona M. and Harry B. Helmsley Charitable Trust; NIHR Biomedical Research Centre awards; University of Cambridge School of Clinical Medicine; NIH Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research grant [U54 AI057160]; NCI Cancer Center Support grant [P30 CA91842]; National Center for Research Resources (NCRR) [UL1TR000448]; NIHR Biomedical Research Centre award; Agency for Healthcare Research and Quality [HS021747];  [R01 AT007143];  [DK071838];  [AT001628];  [DK062413];  [DK046763-19];  [AI067068];  [U54DE023789-01];  [U54 DE023798];  [R01 DK092405]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021747] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA091842, T32CA009547] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT001628] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT007143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, T32AI007172, U01AI067068, U54AI057160, R01AI084887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023789, U54DE023798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, R21DK071838, R01DK092405, U01DK062413, P30DK043351] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation; Broad Medical Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Leona M. and Harry B. Helmsley Charitable Trust; NIHR Biomedical Research Centre awards; University of Cambridge School of Clinical Medicine; NIH Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research grant; NCI Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIHR Biomedical Research Centre award; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); ; ; ; ; ; ; ; ; ; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H.W.V., S.A.H., and J.M.N. were supported by R01 AI084887, R01 OD011170, grants 3132 and 274415 from the Crohn's and Colitis Foundation, and grant IBD-0357 from the Broad Medical Foundation. T.S.S. was supported by grant 3132 from the Crohn's and Colitis Foundation. J.M.N. was supported by NIH grant 5T32AI007163-35. M.T.B. was supported by NIH grant 5T32CA009547. B.C.K. was supported by NIH grant T32 HL007317-36. C.L.M. was supported by NIH grant 5T32AI007172-34. A. Keshavarzian and E.A.M. were supported by R01 AT007143, DK071838, and AT001628. D.P.B.M. was supported by DK062413, DK046763-19, AI067068, and U54DE023789-01, grant HS021747 from the Agency for Healthcare Research and Quality, grant 305479 from the European Union, and The Leona M. and Harry B. Helmsley Charitable Trust. M.P. was supported by the NIHR Biomedical Research Centre awards to Addenbrooke's Hospital and University of Cambridge School of Clinical Medicine. D.W. was supported by the NIH Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research grant U54 AI057160. D.G. and R.J.X. were supported by U54 DE023798 and R01 DK092405. We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is partially supported by NCI Cancer Center Support grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA grant UL1TR000448 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. We would like to thank the patients and relatives who contributed samples to this collection and the team of research nurses and coordinators who supported this activity, including Claire Dawson, Elizabeth Andersen, and Martina Lofthouse (Cambridge, UK) and Gildardo Barron (Los Angeles, USA). We also acknowledge the NIHR Biomedical Research Centre award to support research infrastructure at Addenbrooke's Hospital/University of Cambridge School of Clinical Medicine. We would also like to thank Jessica Hoisington-Lopez from the Center for Genome Sciences and Systems Biology at Washington University School of Medicine for her sequencing expertise.	Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Butterworth AD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006634.pub2; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Duerkop BA, 2012, P NATL ACAD SCI USA, V109, P17621, DOI 10.1073/pnas.1206136109; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Eriksson F, 2009, J IMMUNOL, V182, P3105, DOI 10.4049/jimmunol.0800224; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gorski A, 2006, FEMS IMMUNOL MED MIC, V46, P313, DOI 10.1111/j.1574-695X.2006.00044.x; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Irving PM, 2008, NAT CLIN PRACT GASTR, V5, P18, DOI 10.1038/ncpgasthep1004; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lepage P, 2008, GUT, V57, DOI 10.1136/gut.2007.134668; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Naidoo K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007443.pub2; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; PARENT K, 1971, GUT, V12, P1019, DOI 10.1136/gut.12.12.1019; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Perez-Brocal V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.9; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reyes A, 2013, P NATL ACAD SCI USA, V110, P20236, DOI 10.1073/pnas.1319470110; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Shanahan F, 2014, GASTROENTEROLOGY, V146, P1554, DOI 10.1053/j.gastro.2014.01.050; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Stappenbeck TS, 2011, AUTOPHAGY, V7, P355, DOI 10.4161/auto.7.2.13074; Sun LL, 2011, CURR OPIN GASTROEN, V27, P321, DOI 10.1097/MOG.0b013e32834661b4; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; UHR JW, 1962, J CLIN INVEST, V41, P1509, DOI 10.1172/JCI104606; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wagner J, 2013, INFLAMM BOWEL DIS, V19, P1598, DOI 10.1097/MIB.0b013e318292477c; Waller AS, 2014, ISME J, V8, P1391, DOI 10.1038/ismej.2014.30; Weitz J.S., 2012, BIOL REP, V4, P17, DOI DOI 10.3410/B4-17; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zhang YF, 2008, VET MICROBIOL, V129, P418, DOI 10.1016/j.vetmic.2007.11.032	65	684	708	6	149	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					447	460		10.1016/j.cell.2015.01.002	http://dx.doi.org/10.1016/j.cell.2015.01.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25619688	Bronze, Green Accepted			2022-12-28	WOS:000349208000011
J	Puc, J; Kozbial, P; Li, WB; Tan, YL; Liu, ZJ; Suter, T; Ohgi, KA; Zhang, J; Aggarwal, AK; Rosenfeld, MG				Puc, Janusz; Kozbial, Piotr; Li, Wenbo; Tan, Yuliang; Liu, Zhijie; Suter, Tom; Ohgi, Kenneth A.; Zhang, Jie; Aggarwal, Aneel K.; Rosenfeld, Michael G.			Ligand-Dependent Enhancer Activation Regulated by Topoisomerase-I Activity	CELL			English	Article							ANDROGEN RECEPTOR; DNA-REPAIR; GENOME INSTABILITY; TRANSCRIPTION; GENE; CANCER; RNAS; COACTIVATOR; EXPRESSION; PROTEIN	The discovery that enhancers are regulated transcription units, encoding eRNAs, has raised new questions about the mechanisms of their activation. Here, we report an unexpected molecular mechanism that underlies ligand-dependent enhancer activation, based on DNA nicking to relieve torsional stress from eRNA synthesis. Using dihydrotestosterone (DHT)-induced binding of androgen receptor (AR) to prostate cancer cell enhancers as a model, we show rapid recruitment, within minutes, of DNA topoisomerase I (TOP1) to a large cohort of AR-regulated enhancers. Furthermore, we show that the DNA nicking activity of TOP1 is a prerequisite for robust eRNA synthesis and enhancer activation and is kinetically accompanied by the recruitment of ATR and the MRN complex, followed by additional components of DNA damage repair machinery to the AR-regulated enhancers. Together, our studies reveal a linkage between eRNA synthesis and ligand-dependent TOP1-mediated nicking-a strategy exerting quantitative effects on eRNA expression in regulating AR-bound enhancer-dependent transcriptional programs.	[Puc, Janusz; Kozbial, Piotr; Li, Wenbo; Tan, Yuliang; Liu, Zhijie; Suter, Tom; Ohgi, Kenneth A.; Zhang, Jie; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Suter, Tom] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	li, wenbo/GZM-8930-2022		NIH; NCI [DK018477, HL065445, NS034934, GM104459, DK039949, DK074868, DK097748, CA173903]; NIDDK Mentored Research Scientist Development Award [K01DK080180]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA097134, R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080180, R01DK039949, P01DK074868, R37DK039949, U24DK097748, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK Mentored Research Scientist Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Bogdan Tanasa and Daria Merkurjev for help with statistical analyses, Charles Nelson for cell-culture assistance, Tara Rambaldo for help with cell-cycle analysis, and Janet Hightower for assistance with figure preparation. We are particularly grateful to Dr. E. Peter Geiduschek for a critical reading of the manuscript and Drs. Kalotina Machini and Patricia Cortes for discussions and helpful suggestions and thank the members of the M.G.R. laboratory for their comments on the work. This work was supported by grants from NIH and NCI to M.G.R. (DK018477, HL065445, NS034934, GM104459, DK039949, DK074868, DK097748, and CA173903). J.P. was supported, in part, by a NIDDK Mentored Research Scientist Development Award (K01DK080180). M.G.R. is an Investigator with the HHMI.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Choi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086358; Clinckemalie L, 2013, MOL ENDOCRINOL, V27, P2028, DOI 10.1210/me.2013-1098; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Gurel B, 2010, AM J SURG PATHOL, V34, P1097, DOI 10.1097/PAS.0b013e3181e6cbf3; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; HERENDEEN DR, 1992, SCIENCE, V256, P1298, DOI 10.1126/science.1598572; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; KRETZSCHMAR M, 1993, P NATL ACAD SCI USA, V90, P11508, DOI 10.1073/pnas.90.24.11508; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Laine JP, 2003, CANCER RES, V63, P7136; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Li H, 2013, MUTAT RES-FUND MOL M, V745, P16, DOI 10.1016/j.mrfmmm.2013.03.010; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ma J, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.28636; MADDEN KR, 1992, CANCER RES, V52, P525; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; Mo XM, 2002, MOL CELL BIOL, V22, P8088, DOI 10.1128/MCB.22.22.8088-8099.2002; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pedersen JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003128; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Potenski CJ, 2014, NATURE, V511, P251, DOI 10.1038/nature13292; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Sacho EJ, 2011, J BIOL CHEM, V286, P44945, DOI 10.1074/jbc.M111.299347; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Simmons DT, 1998, J BIOL CHEM, V273, P20390, DOI 10.1074/jbc.273.32.20390; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; TSAO YP, 1993, CANCER RES, V53, P5908; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115	72	97	97	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					367	380		10.1016/j.cell.2014.12.023	http://dx.doi.org/10.1016/j.cell.2014.12.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25619691	Green Accepted, Bronze			2022-12-28	WOS:000349208000005
J	Grover, S				Grover, Sanjiv			PERSONAL VIEW Don't dismiss the little notes that patients bring	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sanjivgrover@rediffmail.com		GROVER, SANJIV/0000-0002-0626-4117				Beard GM., 1869, BOSTON MED SURG J, V3, P217, DOI [10.1056/nejm186904290801301, 10.1056/NEJM186904290801301, DOI 10.1056/NEJM186904290801301]; Benbadis SR, 2006, NEUROLOGY, V67, P904, DOI 10.1212/01.wnl.0000221738.82505.bf; BURNUM JF, 1985, NEW ENGL J MED, V313, P690, DOI 10.1056/NEJM198509123131110; Christmas WA, 1999, J AM COLL HEALTH, V47, P289, DOI 10.1080/07448489909595661; Ellis C., 1989, BMJ-BRIT MED J, V299, P123; Elpern DJ, 2007, J AM ACAD DERMATOL, V57, P170, DOI 10.1016/j.jaad.2007.02.014; Gray JAM, 1999, BRIT MED J, V319, P1476, DOI 10.1136/bmj.319.7223.1476; Holly JL., QUALITY 101 TRANSFOR; Iandolo C, 1967, Policlinico Prat, V74, P321; JADAD AR, 1995, BRIT MED J, V311, P746, DOI 10.1136/bmj.311.7007.746a; Partin Jr C., HIST OSLERS APHORISM; SCULLY C, 1993, BRIT DENT J, V175, P289, DOI 10.1038/sj.bdj.4808304	12	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2015	350								h20	10.1136/bmj.h20	http://dx.doi.org/10.1136/bmj.h20			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZM	25623025				2022-12-28	WOS:000348775100001
J	Pitcher, MJ; Mandal, P; Dyer, MS; Alaria, J; Borisov, P; Niu, H; Claridge, JB; Rosseinsky, MJ				Pitcher, Michael J.; Mandal, Pranab; Dyer, Matthew S.; Alaria, Jonathan; Borisov, Pavel; Niu, Hongjun; Claridge, John B.; Rosseinsky, Matthew J.			Tilt engineering of spontaneous polarization and magnetization above 300 K in a bulk layered perovskite	SCIENCE			English	Article							WEAK FERROMAGNETISM; ROOM-TEMPERATURE; FERROELECTRICITY; BALA2FE2O7; SRTB2FE2O7; CRYSTALS; ROTATION; PHASES	Crystalline materials that combine electrical polarization and magnetization could be advantageous in applications such as information storage, but these properties are usually considered to have incompatible chemical bonding and electronic requirements. Recent theoretical work on perovskite materials suggested a route for combining both properties. We used crystal chemistry to engineer specific atomic displacements in a layered perovskite, (CaySr1-y)(1.15)Tb1.85Fe2O7, that change its symmetry and simultaneously generate electrical polarization and magnetization above room temperature. The two resulting properties are magnetoelectrically coupled as they arise from the same displacements.	[Pitcher, Michael J.; Mandal, Pranab; Dyer, Matthew S.; Borisov, Pavel; Niu, Hongjun; Claridge, John B.; Rosseinsky, Matthew J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Alaria, Jonathan] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England	University of Liverpool; University of Liverpool	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Crown St, Liverpool L69 7ZD, Merseyside, England.	j.b.claridge@liv.ac.uk; m.j.rosseinsky@liv.ac.uk	Claridge, John B/I-7395-2012; Dyer, Matthew S/Q-2762-2019; Borisov, Pavel/A-6218-2015; Dyer, Matthew S/E-8633-2017; Pitcher, Michael J/B-7157-2019	Claridge, John B/0000-0003-4849-6714; Dyer, Matthew S/0000-0002-4923-3003; Borisov, Pavel/0000-0003-1464-6999; Dyer, Matthew S/0000-0002-4923-3003; Pitcher, Michael J/0000-0003-2044-6774; Alaria, Jonathan/0000-0001-5868-0318	European Research Council (ERC) [227987]; N8 consortium; Engineering and Physical Sciences Research Council (EPSRC) [EP/K000225/1]; UK's national high-performance computing service HECToR through UK's High-Performance Computing Materials Chemistry Consortium by EPSRC [EP/L000202]; Engineering and Physical Sciences Research Council [EP/H000925/1, EP/K000209/1, EP/L000202/1, EP/K000225/1] Funding Source: researchfish; EPSRC [EP/K000225/1, EP/H000925/1, EP/L000202/1, EP/K000209/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)European Commission); N8 consortium; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK's national high-performance computing service HECToR through UK's High-Performance Computing Materials Chemistry Consortium by EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is funded by the European Research Council (ERC grant agreement 227987 RLUCIM). Synchrotron x-ray diffraction work was carried out with the support of Diamond Light Source (UK). Time-of-flight neutron diffraction work was carried out with the support of ISIS Spallation Source (UK). We thank C. Tang, S. Thompson, J. Parker, and P. Adamson for assistance on beamline I11 (Diamond Light Source); W. Kockelmann and D. Keen for assistance on GEM (ISIS); A. Daoud-Aladine and K. Knight for assistance on the high-resolution powder diffractometer (ISIS); and R. Smith for assistance on POLARIS (ISIS). Computational resources were provided and funded by the N8 consortium and Engineering and Physical Sciences Research Council (EPSRC) (EP/K000225/1) and the UK's national high-performance computing service HECToR through the UK's High-Performance Computing Materials Chemistry Consortium funded by EPSRC (EP/L000202). M.J.R. is a Royal Society Research Professor.	Alaria J, 2014, CHEM SCI, V5, P1599, DOI 10.1039/c3sc53248h; ALEKSANDROV KS, 1994, J PHYS-CONDENS MAT, V6, P8219, DOI 10.1088/0953-8984/6/40/013; Benedek NA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.107204; Bibes M, 2008, NAT MATER, V7, P425, DOI 10.1038/nmat2189; DZIALOSHINSKII IE, 1957, SOV PHYS JETP-USSR, V5, P1259; ELCOMBE MM, 1991, ACTA CRYSTALLOGR B, V47, P305, DOI 10.1107/S0108768190013416; Evans DM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2548; Ghita M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.054114; GLAZER AM, 1972, ACTA CRYSTALLOGR B, VB 28, P3384, DOI 10.1107/S0567740872007976; Gurusinghe NNM, 2013, MATER RES BULL, V48, P3537, DOI 10.1016/j.materresbull.2013.05.058; HANZEL D, 1977, J MAGN MAGN MATER, V5, P243, DOI 10.1016/0304-8853(77)90164-0; Hill NA, 2000, J PHYS CHEM B, V104, P6694, DOI [10.1021/jp000114x, 10.1021/jpc00114x]; Lobanov MV, 2004, J PHYS-CONDENS MAT, V16, P5339, DOI 10.1088/0953-8984/16/29/023; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Perks NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2294; Reaney IM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4705431; Rondinelli JM, 2012, ADV MATER, V24, P1961, DOI 10.1002/adma.201104674; Sakai H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.137601; SAMARAS D, 1973, J SOLID STATE CHEM, V7, P337, DOI 10.1016/0022-4596(73)90142-4; SAMARAS D, 1975, SOLID STATE COMMUN, V16, P1279, DOI 10.1016/0038-1098(75)90828-5; Schmid H, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434201; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; VANSUCHTELEN J, 1972, PHILIPS RES REP, V27, P28; Vaz CAF, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/33/333201; Yoshida Y, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.054412; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184	26	159	162	2	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					420	424		10.1126/science.1262118	http://dx.doi.org/10.1126/science.1262118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613888				2022-12-28	WOS:000348225800043
J	Mathew, A; Brufsky, A				Mathew, Aju; Brufsky, Adam			Bisphosphonates do not reduce breast cancer in postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mathew, Aju; Brufsky, Adam] Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Mathew, A (corresponding author), Univ Pittsburgh, Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA.		Brufsky, Adam/AAE-7470-2020	Brufsky, Adam/0000-0001-8080-7960				Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Coleman R, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S4-07	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC5	10.7326/ACPJC-2015-162-2-005	http://dx.doi.org/10.7326/ACPJC-2015-162-2-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599365				2022-12-28	WOS:000350106600004
J	Penaloza-MacMaster, P; Barber, DL; Wherry, EJ; Provine, NM; Teigler, JE; Parenteau, L; Blackmore, S; Borducchi, EN; Larocca, RA; Yates, KB; Shen, H; Haining, WN; Sommerstein, R; Pinschewer, DD; Ahmed, R; Barouch, DH				Penaloza-MacMaster, Pablo; Barber, Daniel L.; Wherry, E. John; Provine, Nicholas M.; Teigler, Jeffrey E.; Parenteau, Lily; Blackmore, Stephen; Borducchi, Erica N.; Larocca, Rafael A.; Yates, Kathleen B.; Shen, Hao; Haining, W. Nicholas; Sommerstein, Rami; Pinschewer, Daniel D.; Ahmed, Rafi; Barouch, Dan H.			Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8(+); PERSISTENCE; MEMORY; HELP; RESPONSES; EPITOPE; IDENTIFICATION; ACTIVATION; PEPTIDE	CD4 T cells promote innate and adaptive immune responses, but how vaccine-elicited CD4 T cells contribute to immune protection remains unclear. We evaluated whether induction of virus-specific CD4 T cells by vaccination would protect mice against infection with chronic lymphocytic choriomeningitis virus (LCMV). Immunization with vaccines that selectively induced CD4 T cell responses resulted in catastrophic inflammation and mortality after challenge with a persistent strain of LCMV. Immunopathology required antigen-specific CD4 T cells and was associated with a cytokine storm, generalized inflammation, and multi-organ system failure. Virus-specific CD8 T cells or antibodies abrogated the pathology. These data demonstrate that vaccine-elicited CD4 T cells in the absence of effective antiviral immune responses can trigger lethal immunopathology.	[Penaloza-MacMaster, Pablo; Provine, Nicholas M.; Teigler, Jeffrey E.; Parenteau, Lily; Blackmore, Stephen; Borducchi, Erica N.; Larocca, Rafael A.; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barber, Daniel L.] NIAID, Lab Parasit Dis, Bethesda, MD 20892 USA; [Wherry, E. John; Shen, Hao] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Wherry, E. John; Shen, Hao] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yates, Kathleen B.; Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Sommerstein, Rami; Pinschewer, Daniel D.] Univ Geneva, WHO Collaborating Ctr Vaccine Immunol, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland; [Pinschewer, Daniel D.] Univ Basel, Div Expt Virol, Dept Biomed Haus Peterspl, CH-4009 Basel, Switzerland; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Geneva; University of Basel; Emory University; Emory University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Sommerstein, Rami/AAS-8075-2020; Wherry, John/ABI-1280-2020; Barouch, Dan/Y-3918-2019; shen, hao/HGF-0551-2022; Barber, Daniel L./V-1190-2019	Pinschewer, Daniel/0000-0002-1594-3189; Sommerstein, Rami/0000-0003-1011-6878	NIH [AI007245, AI07387, AI078526, AI096040, AI030048]; Bill and Melinda Gates Foundation [OPP1033091]; Swiss National Science Foundation [310030_149340/1]; European Research Council; Ragon Institute; NIAID Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Ragon Institute; NIAID Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Wieland, M. Rasheed, A. Kamphorst, K. Araki, S. Crotty, B. Walker, C. Bricault, P. Abbink, and F. Ball for generous advice, assistance, and reagents. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. Supported by NIH grants AI007245 and AI07387 (P.P.M.), AI078526 and AI096040 (D.H.B.), and AI030048 (R.A.); Bill and Melinda Gates Foundation grant OPP1033091 (D.H.B.); Swiss National Science Foundation grant 310030_149340/1 (D.D.P.); the European Research Council (D.D.P.) the Ragon Institute (D.H.B.); and the NIAID Intramural Research Program (D.L.B.). Gene expression data have been uploaded to GEO (accession no. GSE63825). The authors declare no financial conflicts of interest.	Abrams SI, 1996, EUR J IMMUNOL, V26, P435, DOI 10.1002/eji.1830260225; Amara RR, 2004, J VIROL, V78, P3811, DOI 10.1128/JVI.78.8.3811-3816.2004; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; BATTEGAY M, 1994, J VIROL, V68, P4700, DOI 10.1128/JVI.68.7.4700-4704.1994; BRUNS M, 1983, VIROLOGY, V130, P247, DOI 10.1016/0042-6822(83)90135-6; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Dao T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006730; Dow C, 2008, J VIROL, V82, P11734, DOI 10.1128/JVI.00435-08; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fauci AS, 2014, SCIENCE, V344, P49, DOI 10.1126/science.1250672; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Homann D, 2007, VIROLOGY, V363, P113, DOI 10.1016/j.virol.2006.12.025; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lichterfeld M, 2012, JAIDS-J ACQ IMM DEF, V59, P1, DOI 10.1097/QAI.0b013e3182373b77; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; May RJ, 2007, CLIN CANCER RES, V13, P4547, DOI 10.1158/1078-0432.CCR-07-0708; Ou DW, 1997, VIROLOGY, V235, P286, DOI 10.1006/viro.1997.8704; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Rodriguez F, 2001, J VIROL, V75, P10421, DOI 10.1128/JVI.75.21.10421-10430.2001; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014	29	55	58	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					278	283		10.1126/science.aaa2148	http://dx.doi.org/10.1126/science.aaa2148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593185	Green Accepted			2022-12-28	WOS:000347915300037
J	Yan, YQ; Jiang, W; Liu, L; Wang, XQ; Ding, C; Tian, ZG; Zhou, RB				Yan, Yiqing; Jiang, Wei; Liu, Lei; Wang, Xiaqiong; Ding, Chen; Tian, Zhigang; Zhou, Rongbin			Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome	CELL			English	Article							LYMPHOCYTES; CELLS; NEURODEGENERATION; NEUROTRANSMITTER; DEUBIQUITINATION; CATECHOLAMINES; MODULATION; ACTIVATION; EXPRESSION; RECEPTORS	Inflammasomes are involved in diverse inflammatory diseases, so the activation of inflammasomes needs to be tightly controlled to prevent excessive inflammation. However, the endogenous regulatory mechanisms of inflammasome activation are still unclear. Here, we report that the neurotransmitter dopamine (DA) inhibits NLRP3 inflammasome activation via dopamine D1 receptor (DRD1). DRD1 signaling negatively regulates NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP), which binds to NLRP3 and promotes its ubiquitination and degradation via the E3 ubiquitin ligase MARCH7. Importantly, in vivo data show that DA and DRD1 signaling prevent NLRP3 inflamma-some-dependent inflammation, including neurotoxin induced neuroinflammation, LPS-induced systemic inflammation, and monosodium urate crystal (MSU)-induced peritoneal inflammation. Taken together, our results reveal an endogenous mechanism of inflammasome regulation and suggest DRD1 as a potential target for the treatment of NLRP3 inflamma-some-driven diseases.	[Yan, Yiqing; Jiang, Wei; Liu, Lei; Wang, Xiaqiong; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, Inst Immunol, Hefei 230027, Peoples R China; [Yan, Yiqing; Jiang, Wei; Liu, Lei; Wang, Xiaqiong; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, Sch Life Sci, Hefei 230027, Peoples R China; [Yan, Yiqing; Jiang, Wei; Liu, Lei; Wang, Xiaqiong; Tian, Zhigang; Zhou, Rongbin] Univ Sci & Technol China, Med Ctr, Hefei 230027, Peoples R China; [Tian, Zhigang; Zhou, Rongbin] Innovat Ctr Cell Biol, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Peoples R China; [Ding, Chen] Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, Beijing 102206, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei 230027, Peoples R China.	tzg@ustc.edu.cn; zrb1980@ustc.edu.cn	Zhou, Rongbin/B-1430-2013; Jiang, Wei/C-7986-2018; Tian, Zhigang/J-3512-2013	Jiang, Wei/0000-0001-8327-3079; 	National Basic Research Program of China [2014CB910800, 2013CB944904]; Natural Science Foundation of China (NSFC) [81330078, 81222040]; Doctoral Fund of Ministry of Education of China [20123402120001, 20123402110010]; One Hundred Person Project; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); One Hundred Person Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Dr. Jurg Tschopp (University of Lausanne) for providing Nlrp3<SUP>-/-</SUP> mice, Dr. Jiawei Zhou (Shanghai Institutes for Biological Sciences) and Dr. Yuqiang Ding (Tongji University School of Medicine) for providing Drd1<SUP>-/-</SUP> and Drd2<SUP>-/-</SUP> mice. This work was supported by National Basic Research Program of China (2014CB910800, 2013CB944904), Natural Science Foundation of China (NSFC) (81330078, 81222040), Doctoral Fund of Ministry of Education of China (20123402120001, 20123402110010), One Hundred Person Project (R.Z.), and the Fundamental Research Funds for the Central Universities (R.Z. and W.J.).	Alfonso-Loeches S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00216; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meredith EJ, 2005, IMMUNOLOGY, V115, P289, DOI 10.1111/j.1365-2567.2005.02166.x; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nishi A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00043; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Ricci A, 1999, J NEUROIMMUNOL, V96, P234, DOI 10.1016/S0165-5728(99)00042-9; Rodrigues MCO, 2014, J NEUROIMMUNOL, V269, P1, DOI [10.1016/j.jneuroim.2013.09.020, 10.1016/iineuroim.2013.09.020]; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Wullner U, 2003, J NEUROL, V250, P35, DOI 10.1007/s00415-003-1107-x; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	48	586	631	9	161	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					62	73		10.1016/j.cell.2014.11.047	http://dx.doi.org/10.1016/j.cell.2014.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594175	Bronze			2022-12-28	WOS:000347923200009
J	Cuskin, F; Lowe, EC; Temple, MJ; Zhu, YP; Cameron, EA; Pudlo, NA; Porter, NT; Urs, K; Thompson, AJ; Cartmell, A; Rogowski, A; Hamilton, BS; Chen, R; Tolbert, TJ; Piens, K; Bracke, D; Vervecken, W; Hakki, Z; Speciale, G; Munoz-Munoz, JL; Day, A; Pena, MJ; McLean, R; Suits, MD; Boraston, AB; Atherly, T; Ziemer, CJ; Williams, SJ; Davies, GJ; Abbott, DW; Martens, EC; Gilbert, HJ				Cuskin, Fiona; Lowe, Elisabeth C.; Temple, Max J.; Zhu, Yanping; Cameron, Elizabeth A.; Pudlo, Nicholas A.; Porter, Nathan T.; Urs, Karthik; Thompson, Andrew J.; Cartmell, Alan; Rogowski, Artur; Hamilton, Brian S.; Chen, Rui; Tolbert, Thomas J.; Piens, Kathleen; Bracke, Debby; Vervecken, Wouter; Hakki, Zalihe; Speciale, Gaetano; Munoz-Munoz, Jose L.; Day, Andrew; Pena, Maria J.; McLean, Richard; Suits, Michael D.; Boraston, Alisdair B.; Atherly, Todd; Ziemer, Cherie J.; Williams, Spencer J.; Davies, Gideon J.; Abbott, D. Wade; Martens, Eric C.; Gilbert, Harry J.			Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism	NATURE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; POLYSACCHARIDE UTILIZATION; BACTERIA; CATABOLISM; MICROBIOTA; INSIGHTS; COMPLEX; FAMILY; STARCH	Yeasts, which have been a component of the human diet for at least 7,000 years, possess an elaborate cell wall alpha-mannan. The influence of yeast mannan on the ecology of the human microbiota is unknown. Here we show that yeast alpha-mannan is a viable food source for the Gram-negative bacterium Bacteroides thetaiotaomicron, a dominant member of the microbiota. Detailed biochemical analysis and targeted gene disruption studies support a model whereby limited cleavage of alpha-mannan on the surface generates large oligosaccharides that are subsequently depolymerized to mannose by the action of periplasmic enzymes. Co-culturing studies showed that metabolism of yeast mannan by B. thetaiotaomicron presents a 'selfish' model for the catabolism of this difficult to breakdown polysaccharide. Genomic comparison with B. thetaiotaomicron in conjunction with cell culture studies show that a cohort of highly successful members of the microbiota has evolved to consume sterically-restricted yeast glycans, an adaptation that may reflect the incorporation of eukaryotic microorganisms into the human diet.	[Cuskin, Fiona; Lowe, Elisabeth C.; Temple, Max J.; Zhu, Yanping; Rogowski, Artur; Munoz-Munoz, Jose L.; Day, Andrew; Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Cuskin, Fiona; Zhu, Yanping; Pena, Maria J.; Abbott, D. Wade; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Cameron, Elizabeth A.; Pudlo, Nicholas A.; Porter, Nathan T.; Urs, Karthik; Martens, Eric C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Thompson, Andrew J.; Davies, Gideon J.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Cartmell, Alan; Hakki, Zalihe; Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Cartmell, Alan; Hakki, Zalihe; Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Hamilton, Brian S.] Indiana Univ, Interdisciplinary Biochem Grad Program, Bloomington, IN 47405 USA; [Chen, Rui] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Tolbert, Thomas J.] Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66047 USA; [Piens, Kathleen; Bracke, Debby; Vervecken, Wouter] Oxyrane, B-9052 Ghent, Belgium; [McLean, Richard; Abbott, D. Wade] Agr & Agrifood Canada, Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada; [Suits, Michael D.; Boraston, Alisdair B.] Univ Victoria, Victoria, BC V8P 5C2, Canada; [Atherly, Todd; Ziemer, Cherie J.] ARS, USDA, Natl Lab Agr & Environm, Ames, IA 50011 USA	Newcastle University - UK; University System of Georgia; University of Georgia; University of Michigan System; University of Michigan; University of York - UK; University of Melbourne; University of Melbourne; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Kansas; Agriculture & Agri Food Canada; University of Victoria; United States Department of Agriculture (USDA)	Abbott, DW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	wade.abbott@agr.gc.ca; emartens@umich.edu	Thompson, Andrew James/ABH-4904-2020; Munoz-Munoz, Jose/G-3506-2016; Davies, Gideon J/A-9042-2011; Porter, Nathan/AAV-9098-2020; Williams, Spencer/C-3545-2009	Thompson, Andrew James/0000-0001-7865-1856; Munoz-Munoz, Jose/0000-0003-0010-948X; Davies, Gideon J/0000-0002-7343-776X; Porter, Nathan/0000-0001-8523-6909; Williams, Spencer/0000-0001-6341-4364; Hakki, Zalihe/0000-0001-9415-7890; Day, Andrew/0000-0002-2722-1597; Abbott, Wade/0000-0003-4893-5799; Temple, Max/0000-0003-4678-9396; McLean, Richard/0000-0002-3237-3288; Cuskin, Fiona/0000-0003-4287-4921; Lowe, Elisabeth/0000-0001-9812-0614; Speciale, Gaetano/0000-0001-6354-605X; Cartmell, Alan/0000-0002-5512-249X; Boraston, Alisdair/0000-0001-6417-0592	European Research Council [322820]; Wellcome Trust [WT097907AIA]; BBSRC [BB/G016127/1]; US Department of Energy (DOE) Bioenergy Research Center (BESC) - Office of Biological and Environmental Research in the DOE Office of Science; National Institutes of Health [GM090080]; University of Michigan Medical School Host Microbiome Initiative; Agriculture and Agri-Food Canada; AgriFlex [2510]; Canadian Institute of Health Research operating grant [MOP-68913]; Australian Research Council; Mizutani Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099513, R01GM090080, T32GM007544] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G016127/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US Department of Energy (DOE) Bioenergy Research Center (BESC) - Office of Biological and Environmental Research in the DOE Office of Science(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical School Host Microbiome Initiative; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); AgriFlex; Canadian Institute of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); Australian Research Council(Australian Research Council); Mizutani Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the European Research Council (G.J.D., Glycopoise; H.J.G., No. 322820), The Wellcome Trust (H.J.G., WT097907AIA), BBSRC (M.J.T., G.J.D.; BB/G016127/1), US Department of Energy (DOE) Bioenergy Research Center (BESC) supported by the Office of Biological and Environmental Research in the DOE Office of Science (M.J.P.) and the National Institutes of Health (E.C.M. and T.J.T., GM090080). Gnotobiotic mouse experiments were supported by a subsidy from the University of Michigan Medical School Host Microbiome Initiative, Agriculture and Agri-Food Canada, AgriFlex (D.W.A., #2510), Canadian Institute of Health Research operating grant (A.B.B., MOP-68913), Australian Research Council; Mizutani Foundation (S.J.W.). We thank the staff of the Diamond Light Source for the provision of beamline facilities. We would also like to thank various members of ICaMB for providing the yeast strains used in this work. We were greatly saddened by the passing of C.Z. during the course of this work.	ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BALLOU CE, 1994, P NATL ACAD SCI USA, V91, P9327, DOI 10.1073/pnas.91.20.9327; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ciucanu I, 2006, ANAL CHIM ACTA, V576, P147, DOI 10.1016/j.aca.2006.06.009; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Everard A, 2014, MBIO, V5, DOI 10.1128/mBio.01011-14; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Konrad A, 2004, INFLAMM BOWEL DIS, V10, P97, DOI 10.1097/00054725-200403000-00006; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2014, J MOL BIOL, V426, P3851, DOI 10.1016/j.jmb.2014.06.022; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mpofu CM, 2007, GASTROENTEROLOGY, V133, P1487, DOI 10.1053/j.gastro.2007.08.004; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; RASCHKE WC, 1973, J BIOL CHEM, V248, P4660; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; STEWART TS, 1968, BIOCHEMISTRY-US, V7, P1843, DOI 10.1021/bi00845a032; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	42	305	318	15	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					165	U86		10.1038/nature13995	http://dx.doi.org/10.1038/nature13995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567280	Green Accepted, Green Submitted			2022-12-28	WOS:000347477600028
J	Epstein, RJ				Epstein, Richard J.			PERSONAL VIEW "By the way doctor, I've booked an African safari after my next chemo"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; TRAVEL; BOOMERS; CANCER		UNSW Clin Sch, St Vincents Hosp, Kinghorn Canc Ctr, Dept Oncol, Sydney, NSW 2010, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney	Epstein, RJ (corresponding author), UNSW Clin Sch, St Vincents Hosp, Kinghorn Canc Ctr, Dept Oncol, 384 Victoria St, Sydney, NSW 2010, Australia.	richard.epstein@svha.org.au						Barr P, 2014, TRUSTEE, V67, P1; Barr Paul, 2014, Trustee, V67, P13; Evans Maggie, 2007, BMC Complement Altern Med, V7, P25, DOI 10.1186/1472-6882-7-25; Ho TF, 2014, J AM BOARD FAM MED, V27, P465, DOI 10.3122/jabfm.2014.04.130238; Hochberg NS, 2013, MAYO CLIN PROC, V88, P1231, DOI 10.1016/j.mayocp.2013.07.018; Hunter-Jones P, 2003, J TRAVEL MED, V10, P170, DOI 10.2310/7060.2003.35762; Kahana Eva, 2014, Virtual Mentor, V16, P380, DOI 10.1001/virtualmentor.2014.16.05.msoc2-1405; Kreatsoulas C, 2014, J INTERN MED, V275, P494, DOI 10.1111/joim.12165; LaRocque RC, 2012, CLIN INFECT DIS, V54, P455, DOI 10.1093/cid/cir839; Naraindas Harish, 2011, Anthropol Med, V18, P1, DOI 10.1080/13648470.2010.525871; Perdue C, 2007, POSTGRAD MED J, V83, P437, DOI 10.1136/pgmj.2006.054593; Ricketts TC, 2011, ANNU REV PUBL HEALTH, V32, P417, DOI 10.1146/annurev-publhealth-031210-101227	12	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2015	350								g7822	10.1136/bmj.g7822	http://dx.doi.org/10.1136/bmj.g7822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LX	25569245				2022-12-28	WOS:000348130100003
J	Verde, F; Riboldi, G; Zappa, C; Ferretti, M; Silani, V; Mari, D; Priori, A				Verde, Federico; Riboldi, Giulietta; Zappa, Carlo; Ferretti, Marco; Silani, Vincenzo; Mari, Daniela; Priori, Alberto			An old woman with pressure ulcer, rigidity, and opisthotonus: never forget tetanus!	LANCET			English	Editorial Material							THREAT		[Verde, Federico; Riboldi, Giulietta; Zappa, Carlo; Silani, Vincenzo; Mari, Daniela; Priori, Alberto] Univ Milan, Milan, Italy; [Silani, Vincenzo] IRCCS Ist Auxol Italiano, Milan, Italy; [Ferretti, Marco; Mari, Daniela; Priori, Alberto] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy	University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico	Priori, A (corresponding author), Osped Maggiore Policlin, Via Francesco Sforza 35, I-20122 Milan, Italy.	alberto.priori@unimi.it	Priori, Alberto/K-9603-2016; Silani, Vincenzo/P-4421-2017; Mari, Daniela/K-5663-2016	Priori, Alberto/0000-0002-1549-3851; Silani, Vincenzo/0000-0002-7698-3854; Mari, Daniela/0000-0002-6950-0789; Verde, Federico/0000-0002-3977-6995; Riboldi, Giulietta/0000-0003-0322-5718				Afshar M, 2011, ANN INTERN MED, V154, P329, DOI 10.7326/0003-4819-154-5-201103010-00007; Farrar JJ, 2000, J NEUROL NEUROSUR PS, V69, P292, DOI 10.1136/jnnp.69.3.292; Filia A, 2014, VACCINE, V32, P639, DOI 10.1016/j.vaccine.2013.12.012; Thwaites CL, 2003, BMJ-BRIT MED J, V326, P117, DOI 10.1136/bmj.326.7381.117; Tiwari T., 2011, Morbidity and Mortality Weekly Report, V60, P365	5	6	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2266	2266		10.1016/S0140-6736(14)61832-8	http://dx.doi.org/10.1016/S0140-6736(14)61832-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25625401				2022-12-28	WOS:000346655700033
J	Annane, D				Annane, Djillali			Corticosteroids and pneumonia: time to change practice	LANCET			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA; EFFICACY		[Annane, Djillali] Univ Versailles SQY, Raymond Poincare Hosp, AP HP, F-92380 Garches, France; [Annane, Djillali] INSERM, Lab Cell Death Inflammat & Infect U1173, F-92380 Garches, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Annane, D (corresponding author), Univ Versailles SQY, Raymond Poincare Hosp, AP HP, F-92380 Garches, France.	djillali.annane@rpc.aphp.fr	Annane, Djillali/R-7947-2019					Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2; Blum C. A., 2015, LANCET; Broulette J, 2013, AM HEALTH DRUG BENEF, V6, P494; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ostermann H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-36; Polverino E, 2014, AM THOR SOC INT C SA, pC105; Sabry NA, 2011, PHARM PHARM, V2, P73, DOI DOI 10.4236/PP.2011.22009; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Walsh F, 2014, BBC NEWS; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; Wortham JM, 2014, JAMA INTERN MED, V174, P1520, DOI 10.1001/jamainternmed.2014.3456	14	8	8	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1484	1485		10.1016/S0140-6736(14)62391-6	http://dx.doi.org/10.1016/S0140-6736(14)62391-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25608755				2022-12-28	WOS:000353220000007
J	Reijns, MAM; Kemp, H; Ding, J; de Proce, SM; Jackson, AP; Taylor, MS				Reijns, Martin A. M.; Kemp, Harriet; Ding, James; de Proce, Sophie Marion; Jackson, Andrew P.; Taylor, Martin S.			Lagging-strand replication shapes the mutational landscape of the genome	NATURE			English	Article							OKAZAKI FRAGMENT MATURATION; DNA-POLYMERASE-ALPHA; MISMATCH REPAIR; RIBONUCLEOTIDE INCORPORATION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN GENOME; YEAST; FIDELITY; ERRORS; DELTA	The origin of mutations is central to understanding evolution and of key relevance to health. Variation occurs non-randomly across the genome, and mechanisms for this remain to be defined. Here we report that the 5' ends of Okazaki fragments have significantly increased levels of nucleotide substitution, indicating a replicative origin for such mutations. Using a novel method, emRiboSeq, we map the genome-wide contribution of polymerases, and show that despite Okazaki fragment processing, DNA synthesized by error-prone polymerase-alpha (Pol-alpha) is retained in vivo, comprising approximately 1.5% of the mature genome. We propose that DNA-binding proteins that rapidly re-associate post-replication act as partial barriers to Pol-delta-mediated displacement of Pol-alpha-synthesized DNA, resulting in incorporation of such Pol-a tracts and increased mutation rates at specific sites. We observe a mutational cost to chromatin and regulatory protein binding, resulting in mutation hotspots at regulatory elements, with signatures of this process detectable in both yeast and humans.	[Reijns, Martin A. M.; Kemp, Harriet; Ding, James; de Proce, Sophie Marion; Jackson, Andrew P.; Taylor, Martin S.] Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Jackson, AP (corresponding author), Univ Edinburgh, MRC Human Genet Unit, MRC Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	andrew.jackson@igmm.ed.ac.uk; martin.taylor@igmm.ed.ac.uk	Reijns, Martin/L-4355-2013; Ding, James/AAC-6887-2019; Taylor, Martin S/C-3825-2009; Jackson, Andrew P/D-3442-2009	Reijns, Martin/0000-0002-5048-2752; Ding, James/0000-0001-7273-9646; Taylor, Martin S/0000-0001-7656-330X; Jackson, Andrew P/0000-0002-8739-2646; Marion de Proce, Sophie/0000-0001-5324-7312	MRC Centenary Award; MRC; Lister Institute of Preventive Medicine; Medical Research Foundation; Medical Research Council [MC_PC_U127580972, MC_PC_U127597124] Funding Source: researchfish; MRC [MC_PC_U127597124, MC_PC_U127580972] Funding Source: UKRI	MRC Centenary Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute of Preventive Medicine; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Hastie and P. Burgers for discussions, I. Adams, J. Caceres, T. Aitman and P. Heyn for comments on the manuscript, and A. Gallacher for technical assistance. We are indebted to J. Williams, A. Clausen and T. Kunkel for sharing yeast strains and unpublished data, and to S. Cerritelli and R. Crouch for RNH201 vectors. Funding: MRC Centenary Award to M.A.M.R.; MRC and Lister Institute of Preventive Medicine to A.P.J.; MRC and Medical Research Foundation to M.S.T.	Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Balakrishnan L, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010173; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clausen A. R., 2015, NATURE STRUCT MOL BI; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Daigaku Y, 2015, NAT STRUCT MOL BIOL, V22, P192, DOI 10.1038/nsmb.2962; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; JOHNSTON LH, 1978, NATURE, V274, P891, DOI 10.1038/274891a0; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Koh K. D., 2015, NATURE METHODS; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; KUNKEL TA, 1989, MOL CELL BIOL, V9, P4447, DOI 10.1128/MCB.9.10.4447; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Liberti SE, 2013, DNA REPAIR, V12, P92, DOI 10.1016/j.dnarep.2012.11.001; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lujan SA, 2014, GENOME RES, V24, P1751, DOI 10.1101/gr.178335.114; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; Lujan SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003016; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Niimi A, 2004, MOL CELL BIOL, V24, P2734, DOI 10.1128/MCB.24.7.2734-2746.2004; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Perera RL, 2013, ELIFE, V2, DOI 10.7554/eLife.00482; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Prendergast JGD, 2011, GENOME RES, V21, P1777, DOI 10.1101/gr.122275.111; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schmidt S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000281; Semple CAM, 2009, SCIENCE, V323, P347, DOI 10.1126/science.1169408; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; Walsh E, 2014, NUCLEIC ACIDS MOL BI, V30, P17, DOI 10.1007/978-3-642-39796-7_2; Warnecke T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000250; Washietl S, 2008, TRENDS GENET, V24, P583, DOI 10.1016/j.tig.2008.09.003; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Ying H, 2010, MOL BIOL EVOL, V27, P637, DOI 10.1093/molbev/msp253; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	50	149	150	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					502	506		10.1038/nature14183	http://dx.doi.org/10.1038/nature14183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25624100	Green Accepted			2022-12-28	WOS:000350097300039
J	Taylor, JJ; Pape, KA; Steach, HR; Jenkins, MK				Taylor, Justin J.; Pape, Kathryn A.; Steach, Holly R.; Jenkins, Marc K.			Apoptosis and antigen affinity limit effector cell differentiation of a single naive B cell	SCIENCE			English	Article							GERMINAL CENTER B; CD8(+) T-CELLS; PLASMA-CELL; FATE; MEMORY; INFECTION; RECEPTOR	When exposed to antigens, naive B cells differentiate into different types of effector cells: antibody-producing plasma cells, germinal center cells, or memory cells. Whether an individual naive B cell can produce all of these different cell fates remains unclear. Using a limiting dilution approach, we found that many individual naive B cells produced only one type of effector cell subset, whereas others produced all subsets. The capacity to differentiate into multiple subsets was a characteristic of clonal populations that divided many times and resisted apoptosis, but was independent of isotype switching. Antigen receptor affinity also influenced effector cell differentiation. These findings suggest that diverse effector cell types arise in the primary immune response as a result of heterogeneity in responses by individual naive B cells.	[Taylor, Justin J.; Pape, Kathryn A.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA; [Taylor, Justin J.; Steach, Holly R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98019 USA	University of Minnesota System; University of Minnesota Twin Cities	Taylor, JJ (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Ctr Immunol, Minneapolis, MN 55455 USA.	jtaylor3@fhcrc.org	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Steach, Holly/0000-0003-0018-3129	Cancer Research Institute; National Institutes of Health [P01AI035296, R01AI036914, R37AI027998]; NATIONAL CANCER INSTITUTE [P30CA077598, T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027998, P01AI035296, R01AI027998, R01AI039614] Funding Source: NIH RePORTER	Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Walter, A. Quade, K. Anderson, S. Voght, B. Debuysscher, the Jenkins Lab, and the University of Minnesota Flow Cytometry Resource for technical assistance and helpful discussions; M. Jankovic, M. Nussenzweig, D. Liao, and G. Kelsoe for providing AID-deficient cells; and L. Manlove, M. Farrar, S. Roepke, and M. Prlic for providing Bim-deficient cells. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the Irvington Fellowship Program of the Cancer Research Institute (J.J.T), and the National Institutes of Health [P01AI035296, R01AI036914, and R37AI027998 (M.K.J.)]. The authors have no conflicting financial interests.	Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; LAVOIE TB, 1992, J IMMUNOL, V148, P503; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; O'Connor BP, 2006, J IMMUNOL, V177, P7723, DOI 10.4049/jimmunol.177.11.7723; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; TASWELL C, 1981, J IMMUNOL, V126, P1614; Taylor JJ, 2012, TRENDS IMMUNOL, V33, P590, DOI 10.1016/j.it.2012.07.005; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Zotos D, 2012, TRENDS IMMUNOL, V33, P281, DOI 10.1016/j.it.2012.04.003	20	91	92	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					784	787		10.1126/science.aaa1342	http://dx.doi.org/10.1126/science.aaa1342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25636798	Green Accepted			2022-12-28	WOS:000349221300051
J	Cao, XT				Cao, Xuetao			A call for global research on non-communicable diseases	LANCET			English	Editorial Material									Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Chinese Acad Med Sci, Beijing 100730, Peoples R China.	caoxt@immunol.org						Bloom DE, 2011, GEN WORLD EC FOR 201; GACD, 2014, WORLD DIAB DAY GACD; NCD Alliance, THE GLOB EP; The NCD Alliance, 2014, UN NCD REV; WHO, 2014, WHO HIGHL NEED COUNT; World Health Organisation, 2011, PREV CONTR NCDS PRIO; World Health Organization, 2008, NONC DIS NOW BIGG KI	7	10	10	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					E5	E6		10.1016/S0140-6736(14)62383-7	http://dx.doi.org/10.1016/S0140-6736(14)62383-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25631069				2022-12-28	WOS:000349213600001
J	Melancon, CE				Melancon, Charles E., III			Elusive source of sulfur unravelled	NATURE			English	Editorial Material							GENE-CLUSTER; BIOSYNTHESIS; LINCOMYCIN		Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA	University of New Mexico	Melancon, CE (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	cemelanc@unm.edu						Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Cermak L, 2007, FOLIA MICROBIOL, V52, P457, DOI 10.1007/BF02932104; Chatterjee A, 2011, NATURE, V478, P542, DOI 10.1038/nature10503; Kadlcik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084902; Sasaki E, 2014, NATURE, V510, P427, DOI 10.1038/nature13256; Sasaki E, 2012, J AM CHEM SOC, V134, P17432, DOI 10.1021/ja308221z; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Zeng Y, 2012, ACS CHEM BIOL, V7, P1565, DOI 10.1021/cb300173x; Zhao QF, 2015, NATURE, V518, P115, DOI 10.1038/nature14137	9	1	1	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					45	46		10.1038/nature14197	http://dx.doi.org/10.1038/nature14197			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25607363				2022-12-28	WOS:000349098000027
J	Jennings, JH; Ung, RL; Resendez, SL; Stamatakis, AM; Taylor, JG; Huang, J; Veleta, K; Kantak, PA; Aita, M; Shilling-Scrivo, K; Ramakrishnan, C; Deisseroth, K; Otte, S; Stuber, GD				Jennings, Joshua H.; Ung, Randall L.; Resendez, Shanna L.; Stamatakis, Alice M.; Taylor, Johnathon G.; Huang, Jonathan; Veleta, Katie; Kantak, Pranish A.; Aita, Megumi; Shilling-Scrivo, Kelson; Ramakrishnan, Charu; Deisseroth, Karl; Otte, Stephani; Stuber, Garret D.			Visualizing Hypothalamic Network Dynamics for Appetitive and Consummatory Behaviors	CELL			English	Article							VESICULAR GABA TRANSPORTER; PROTEIN-COUPLED RECEPTORS; LATERAL HYPOTHALAMUS; FEEDING-BEHAVIOR; SELF-STIMULATION; LEPTIN ACTION; ELECTRICAL-STIMULATION; NEUROTENSIN NEURONS; AREA; OREXIN	Optimally orchestrating complex behavioral states, such as the pursuit and consumption of food, is critical for an organism's survival. The lateral hypothalamus (LH) is a neuroanatomical region essential for appetitive and consummatory behaviors, but whether individual neurons within the LH differentially contribute to these interconnected processes is unknown. Here, we show that selective optogenetic stimulation of a molecularly defined subset of LH GABAergic (Vgat-expressing) neurons enhances both appetitive and consummatory behaviors, whereas genetic ablation of these neurons reduced these phenotypes. Furthermore, this targeted LH subpopulation is distinct from cells containing the feeding-related neuropeptides, melaninconcentrating hormone (MCH), and orexin (Orx). Employing in vivo calcium imaging in freely behaving mice to record activity dynamics from hundreds of cells, we identified individual LH GABAergic neurons that preferentially encode aspects of either appetitive or consummatory behaviors, but rarely both. These tightly regulated, yet highly intertwined, behavioral processes are thus dissociable at the cellular level.	[Jennings, Joshua H.; Ung, Randall L.; Resendez, Shanna L.; Stamatakis, Alice M.; Taylor, Johnathon G.; Huang, Jonathan; Kantak, Pranish A.; Aita, Megumi; Shilling-Scrivo, Kelson; Stuber, Garret D.] Univ N Carolina, Dept Psychiat & Cell Biol, Chapel Hill, NC 27599 USA; [Jennings, Joshua H.; Ung, Randall L.; Resendez, Shanna L.; Stamatakis, Alice M.; Taylor, Johnathon G.; Huang, Jonathan; Kantak, Pranish A.; Aita, Megumi; Shilling-Scrivo, Kelson; Stuber, Garret D.] Univ N Carolina, Dept Physiol, Chapel Hill, NC 27599 USA; [Jennings, Joshua H.; Ung, Randall L.; Stamatakis, Alice M.; Veleta, Katie; Stuber, Garret D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; [Jennings, Joshua H.; Ung, Randall L.; Resendez, Shanna L.; Stamatakis, Alice M.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Otte, Stephani] Inscopix Inc, Palo Alto, CA 94303 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Stanford University	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat & Cell Biol, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	Stuber, Garret/E-1160-2011; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Core, Vector/CAF-4832-2022	Stuber, Garret/0000-0003-1730-4855; Ung, Randall/0000-0002-5303-3741	UNC Neuroscience Center Microscopy Core [P30 NS045892]; Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation for Prader-Willi Research; Foundation of Hope; National Institute on Drug Abuse [DA032750, DA038168, DA034472]; National Institute on Alcohol Abuse and Alcoholism [P60 AA011605]; National Institute of Mental Health [MH104013];  [T32HD040127]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127, U54HD079124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, F31MH104013, R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007431, P30NS045892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA011605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA034472, R01DA032750, R37DA035377, R01DA038168] Funding Source: NIH RePORTER	UNC Neuroscience Center Microscopy Core; Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation for Prader-Willi Research; Foundation of Hope; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Spencer Smith, Ilana Witten, Mark Schnitzer, and the members of the Stuber lab for helpful discussion. We thank the UNC vector core for viral packaging, Bradford Lowell and Linh Vong for the Vgat-IRES-Cre mice, and the UNC Neuroscience Center Microscopy Core (P30 NS045892). This work is dedicated to Johnathon Gregory Taylor (1996-2014), whose contributions were greatly appreciated and valued for this project. This study was supported by The Klarman Family Foundation, The Brain and Behavior Research Foundation, the Foundation for Prader-Willi Research, the Foundation of Hope, the National Institute on Drug Abuse (DA032750 and DA038168), and the National Institute on Alcohol Abuse and Alcoholism (P60 AA011605). J.H.J. was supported by a grant from the National Institute of Mental Health (MH104013), and A.M.S. was supported by grants from the National Institute on Drug Abuse (DA034472). S.L.R. was supported by T32HD040127. S.O. is an employee of Inscopix, Inc.	Adamantidis A, 2009, J PHYSIOL-LONDON, V587, P33, DOI 10.1113/jphysiol.2008.164400; Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; ALLEN GV, 1995, NEUROSCIENCE, V69, P533, DOI 10.1016/0306-4522(95)00261-G; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Ball GF, 2008, HORM BEHAV, V53, P307, DOI 10.1016/j.yhbeh.2007.09.023; Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Craig W, 1917, P NATL ACAD SCI USA, V3, P685, DOI 10.1073/pnas.3.12.685; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goforth PB, 2014, J NEUROSCI, V34, P11405, DOI 10.1523/JNEUROSCI.5167-13.2014; Gutierrez R, 2011, IUBMB LIFE, V63, P824, DOI 10.1002/iub.539; Hahn JD, 2012, J COMP NEUROL, V520, P1831, DOI 10.1002/cne.23064; HARRELL LE, 1975, PHYSIOL BEHAV, V15, P133, DOI 10.1016/0031-9384(75)90292-9; HOEBEL BG, 1965, SCIENCE, V149, P452, DOI 10.1126/science.149.3682.452; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Jarvie BC, 2012, J COMP NEUROL, V520, P3863, DOI 10.1002/cne.23127; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jennings JH, 2014, CURR BIOL, V24, pR41, DOI 10.1016/j.cub.2013.11.042; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; KIMURA H, 1975, J NEUROCHEM, V24, P903, DOI 10.1111/j.1471-4159.1975.tb03654.x; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lamas M, 2001, MOL BRAIN RES, V93, P209, DOI 10.1016/S0169-328X(01)00202-9; Laque A, 2013, AM J PHYSIOL-ENDOC M, V304, pE999, DOI 10.1152/ajpendo.00643.2012; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Lorenz K. Z., 1950, PHYSL MECH ANIMAL BE, P221; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MOLINABORJA M, 1989, BEHAV BRAIN RES, V32, P197, DOI 10.1016/S0166-4328(89)80085-3; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; ONO T, 1981, NEUROSCI LETT, V26, P79, DOI 10.1016/0304-3940(81)90429-8; ONO T, 1986, BRAIN RES, V373, P92, DOI 10.1016/0006-8993(86)90319-7; QUAADE F, 1974, ACTA NEUROCHIR, V30, P111, DOI 10.1007/BF01405759; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SCHALLERT T, 1978, J COMP PHYSIOL PSYCH, V92, P720, DOI 10.1037/h0077504; Sherrington C, 1906, INTEGRATIVE ACTION N; Sperk G, 2003, HIPPOCAMPUS, V13, P806, DOI 10.1002/hipo.10133; Tinbergen N, 1951, STUDY INSTINCT; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Whiddon BB, 2013, J NEUROSCI, V33, P2009, DOI 10.1523/JNEUROSCI.3921-12.2013; WISE RA, 1971, PHYSIOL BEHAV, V6, P569, DOI 10.1016/0031-9384(71)90207-1; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	57	321	326	2	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					516	527		10.1016/j.cell.2014.12.026	http://dx.doi.org/10.1016/j.cell.2014.12.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635459	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000349208000016
J	Vannucchi, AM; Kiladjian, JJ; Griesshammer, M; Masszi, T; Durrant, S; Passamonti, F; Harrison, CN; Pane, F; Zachee, P; Mesa, R; He, S; Jones, MM; Garrett, W; Li, JJ; Pirron, U; Habr, D; Verstovsek, S				Vannucchi, Alessandro M.; Kiladjian, Jean Jacques; Griesshammer, Martin; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Harrison, Claire N.; Pane, Fabrizio; Zachee, Pierre; Mesa, Ruben; He, Shui; Jones, Mark M.; Garrett, William; Li, Jingjin; Pirron, Ulrich; Habr, Dany; Verstovsek, Srdan			Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; MOLECULAR RESPONSES; INTERFERON-ALPHA; HYDROXYUREA; INTOLERANCE; RESISTANCE; MECHANISMS; SURVIVAL; LEUKEMIA	BACKGROUND Ruxolitinib, a Janus kinase (JAK) 1 and 2 inhibitor, was shown to have a clinical benefit in patients with polycythemia vera in a phase 2 study. We conducted a phase 3 open-label study to evaluate the efficacy and safety of ruxolitinib versus standard therapy in patients with polycythemia vera who had an inadequate response to or had unacceptable side effects from hydroxyurea. METHODS We randomly assigned phlebotomy-dependent patients with splenomegaly, in a 1: 1 ratio, to receive ruxolitinib (110 patients) or standard therapy (112 patients). The primary end point was both hematocrit control through week 32 and at least a 35% reduction in spleen volume at week 32, as assessed by means of imaging. RESULTS The primary end point was achieved in 21% of the patients in the ruxolitinib group versus 1% of those in the standard-therapy group (P<0.001). Hematocrit control was achieved in 60% of patients receiving ruxolitinib and 20% of those receiving standard therapy; 38% and 1% of patients in the two groups, respectively, had at least a 35% reduction in spleen volume. A complete hematologic remission was achieved in 24% of patients in the ruxolitinib group and 9% of those in the standard-therapy group (P = 0.003); 49% versus 5% had at least a 50% reduction in the total symptom score at week 32. In the ruxolitinib group, grade 3 or 4 anemia occurred in 2% of patients, and grade 3 or 4 thrombocytopenia occurred in 5%; the corresponding percentages in the standard-therapy group were 0% and 4%. Herpes zoster infection was reported in 6% of patients in the ruxolitinib group and 0% of those in the standard-therapy group (grade 1 or 2 in all cases). Thromboembolic events occurred in one patient receiving ruxolitinib and in six patients receiving standard therapy. CONCLUSIONS In patients who had an inadequate response to or had unacceptable side effects from hydroxyurea, ruxolitinib was superior to standard therapy in controlling the hematocrit, reducing the spleen volume, and improving symptoms associated with polycythemia vera.	[Vannucchi, Alessandro M.] Univ Florence, Azienda Osped Univ Careggi, I-50134 Florence, Italy; [Passamonti, Francesco] Osped Circolo & Fdn Macchi, Varese, Italy; [Pane, Fabrizio] Univ Naples Federico II, Naples, Italy; [Kiladjian, Jean Jacques] Hop St Louis, Paris, France; [Kiladjian, Jean Jacques] Univ Paris Diderot, Paris, France; [Griesshammer, Martin] Johannes Wesling Clin, Minden, Germany; [Masszi, Tamas] St Istvan & St Laszlo Hosp, Budapest, Hungary; [Masszi, Tamas] Semmelweis Univ, H-1085 Budapest, Hungary; [Durrant, Simon] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Harrison, Claire N.] Guys & St Thomas NHS Fdn Trust, London, England; [Zachee, Pierre] Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium; [Mesa, Ruben] Mayo Clin, Ctr Canc, Scottsdale, AZ USA; [He, Shui; Jones, Mark M.; Garrett, William] Incyte, Wilmington, DE USA; [Li, Jingjin; Habr, Dany] Novartis Pharmaceut, E Hanover, NJ USA; [Pirron, Ulrich] Novartis Pharmaceut, Basel, Switzerland; [Verstovsek, Srdan] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Florence; Azienda Ospedaliero Universitaria Careggi; Ospedale Circolo & Fondazione Macchi; University of Naples Federico II; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Ruhr University Bochum; Semmelweis University; Royal Brisbane & Women's Hospital; Guy's & St Thomas' NHS Foundation Trust; ZNA Stuivenberg; Mayo Clinic; Mayo Clinic Phoenix; Incyte; Novartis; Novartis; University of Texas System; UTMD Anderson Cancer Center	Vannucchi, AM (corresponding author), Univ Florence, Azienda Osped Univ Careggi, Largo Brambilla 3, I-50134 Florence, Italy.	amvannucchi@unifi.it	Vannucchi, Alessandro M./K-7499-2016; Kiladjian, Jean-Jacques/K-5345-2019; Passamonti, Francesco/AAB-2262-2022; Zachee, Pierre/B-5391-2018	Vannucchi, Alessandro M./0000-0001-5755-0730; Passamonti, Francesco/0000-0001-8068-5289; Zachee, Pierre/0000-0002-2275-5143; Verstovsek, MD, PhD, Professor of Medicine, Srdan/0000-0002-6912-8569; Kiladjian, Jean-Jacques/0000-0002-8121-438X; Masszi, Tamas/0000-0003-2322-9863	Incyte; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Incyte; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Incyte and others; RESPONSE ClinicalTrials.gov number, NCT01243944.	Abelsson J, 2013, LEUKEMIA LYMPHOMA, V54, P2226, DOI 10.3109/10428194.2013.766732; Alvarez-Larran A, 2012, BLOOD, V119, P1363, DOI 10.1182/blood-2011-10-387787; Barbui T, 2011, HAEMATOL-HEMATOL J, V96, P315, DOI 10.3324/haematol.2010.031070; Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436; Barbui T, 2009, BLOOD, V114, P759, DOI 10.1182/blood-2009-02-206797; Barosi G, 2010, BRIT J HAEMATOL, V148, P961, DOI 10.1111/j.1365-2141.2009.08019.x; Bjorkholm M, 2011, J CLIN ONCOL, V29, P2410, DOI 10.1200/JCO.2011.34.7542; Cervantes F, 2013, BLOOD, V122, P4047, DOI 10.1182/blood-2013-02-485888; Finazzi G, 2005, BLOOD, V105, P2664, DOI 10.1182/blood-2004-09-3426; Kiladjian JJ, 2008, LEUKEMIA, V22, P1990, DOI 10.1038/leu.2008.280; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kiladjian JJ, 2011, J CLIN ONCOL, V29, P3907, DOI 10.1200/JCO.2011.36.0792; Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Landolfi R, 2007, BLOOD, V109, P2446, DOI 10.1182/blood-2006-08-042515; Larsen TS, 2013, LEUKEMIA RES, V37, P1041, DOI 10.1016/j.leukres.2013.06.012; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; Nordic MPN Study Group, 2013, NORD GUID DIAGN TREA; Passamonti F, 2004, AM J MED, V117, P755, DOI 10.1016/j.amjmed.2004.06.032; Quintas-Cardama A, 2009, J CLIN ONCOL, V27, P5418, DOI 10.1200/JCO.2009.23.6075; Sever M, 2014, LEUK LYMPHOMA; Spivak JL, 2013, NEW ENGL J MED, V368, P1556, DOI 10.1056/NEJMc1301262; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Tefferi A, 2013, LEUKEMIA, V27, P1874, DOI 10.1038/leu.2013.163; Tefferi Ayalew, 2013, Am J Hematol, V88, P507, DOI 10.1002/ajh.23417; Tibes R, 2013, EXPERT OPIN EMERG DR, V18, P393, DOI 10.1517/14728214.2013.832754; Verstovsek S, 2014, CANCER-AM CANCER SOC, V120, P513, DOI 10.1002/cncr.28441	28	518	541	5	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					426	435		10.1056/NEJMoa1409002	http://dx.doi.org/10.1056/NEJMoa1409002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629741	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000348649700007
J	Vela, P; Pascual, E				Vela, Paloma; Pascual, Eliseo			An Unusual Tophus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vela, Paloma; Pascual, Eliseo] Hosp Gen Univ Alicante, Alicante, Spain	General University Hospital of Alicante	Vela, P (corresponding author), Hosp Gen Univ Alicante, Alicante, Spain.	palomavela62@gmail.com	Vela Casasempere, Paloma/HCH-3831-2022	Vela Casasempere, Paloma/0000-0001-8566-5172; Pascual, Eliseo/0000-0002-3056-4478					0	1	1	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					E6	E6		10.1056/NEJMicm1309677	http://dx.doi.org/10.1056/NEJMicm1309677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629758				2022-12-28	WOS:000348649700001
J	Zhang, P; Cohen, RE; Haule, K				Zhang, Peng; Cohen, R. E.; Haule, K.			RETRACTED: Effects of electron correlations on transport properties of iron at Earth's core conditions(Retracted article.See vol.536,pg.112,2016)	NATURE			English	Article; Retracted Publication							MEAN-FIELD THEORY; HIGH-PRESSURE; CONDUCTIVITY; TRANSITION; RESISTIVITY; MAGNETISM; TEMPERATURE; RESISTANCE; SYSTEMS; METALS	Earth's magnetic field has been thought to arise from thermal convection of molten iron alloy in the outer core, but recent density functional theory calculations have suggested that the conductivity of iron is too high to support thermal convection(1-4), resulting in the investigation of chemically driven convection(5,6). These calculations for resistivity were based on electron-phonon scattering. Here we apply self-consistent density functional theory plus dynamical meanfield theory (DFT+DMFT)(7) to iron and find that at high temperatures electron-electron scattering iscomparable to the electron-phonon scattering, bringing theory into agreement with experiments and solving the transport problem in Earth's core. The conventional thermal dynamo picture is safe. We find that electron-electron scattering of d electrons is important at high temperatures in transition metals, in contrast to textbook analyses since Mott(8,9), and that 4s electron contributions to transport are negligible, in contrast to numerous models used for over fifty years. The DFT+DMFT method should be applicable to other high-temperature systems where electron correlations are important.	[Zhang, Peng; Cohen, R. E.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Cohen, R. E.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Haule, K.] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA	Carnegie Institution for Science; University of London; University College London; Rutgers State University New Brunswick	Cohen, RE (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	rcohen@carnegiescience.edu	Zhang, Peng/C-2845-2015; Cohen, Ronald/AAY-2570-2020	Haule, Kristjan/0000-0002-2284-1551	National Science Foundation (NSF) [EAR-1214807, DMS-1025392, DMR-1405303]; Carnegie Institution; European Research Council Advanced Grant ToMCaT; NSF [DMR-1405303]; Office of Science of the US Department of Energy [DE-AC05-000R22725]; Division Of Earth Sciences [1214807] Funding Source: National Science Foundation; Division Of Materials Research [1405303] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Carnegie Institution; European Research Council Advanced Grant ToMCaT; NSF(National Science Foundation (NSF)); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by National Science Foundation (NSF) grants EAR-1214807, DMS-1025392, and DMR-1405303. R.E.C. is supported by the Carnegie Institution and the European Research Council Advanced Grant ToMCaT. K.H. is supported by NSF grant DMR-1405303. This research used the NSF Extreme Science and Engineering Discovery Environment (XSEDE) supercomputer 'Stampede', and also used the resources of the Oak Ridge Leadership Computing Facility at the Oak Ridge National Laboratory, which is supported by the Office of Science of the US Department of Energy under contract number DE-AC05-000R22725. R.E.C. and P.Z. thank I. Mazin,S. Labrosse and R. Caracas for discussions. We also acknowledge J. Robb for assistance with the manuscript preparation.	Allen PB, 2006, CONT CONCEPT CONDENS, P165, DOI 10.1016/S1572-0934(06)02006-3; Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P767, DOI 10.1088/0953-8984/9/4/002; BALCHAN AS, 1961, REV SCI INSTRUM, V32, P308, DOI 10.1063/1.1717350; Basov DN, 2011, REV MOD PHYS, V83, P471, DOI 10.1103/RevModPhys.83.471; Bi Y, 2002, J PHYS-CONDENS MAT, V14, P10849, DOI 10.1088/0953-8984/14/44/389; Blaha P., 2001, WIEN2K; BLOCHL PE, 1994, PHYS REV B, V49, P16223, DOI 10.1103/PhysRevB.49.16223; BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; Buffett B, 2012, NATURE, V485, P319, DOI 10.1038/485319a; Cohen RE, 1998, MATER RES SOC SYMP P, V499, P27; CZYZYK MT, 1994, PHYS REV B, V49, P14211, DOI 10.1103/PhysRevB.49.14211; de Koker N, 2012, P NATL ACAD SCI USA, V109, P4070, DOI 10.1073/pnas.1111841109; Deng LW, 2013, GEOPHYS RES LETT, V40, P33, DOI 10.1029/2012GL054347; Deng XY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.086401; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; ELSASSER WM, 1946, PHYS REV, V70, P202, DOI 10.1103/PhysRev.70.202; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Gomi H, 2013, PHYS EARTH PLANET IN, V224, P88, DOI 10.1016/j.pepi.2013.07.010; GURVITCH M, 1987, PHYS REV LETT, V59, P1337, DOI 10.1103/PhysRevLett.59.1337; Haule K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195107; Jarrell M, 1996, PHYS REP, V269, P133, DOI 10.1016/0370-1573(95)00074-7; Keeler R. N., 1971, PHYS HIGH ENERGY DEN, V48, P106; KEELER RN, 1969, SOLID STATE COMMUN, V7, P271, DOI 10.1016/0038-1098(69)90397-4; KHURANA A, 1990, PHYS REV LETT, V64, P1990, DOI 10.1103/PhysRevLett.64.1990; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Liu MS, 2012, NAT PHYS, V8, P376, DOI [10.1038/nphys2268, 10.1038/NPHYS2268]; Mandal S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220502; MOTT NF, 1964, ADV PHYS, V13, P325, DOI 10.1080/00018736400101041; Nguyen JH, 2004, NATURE, V427, P339, DOI 10.1038/nature02248; Ohta K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.026403; Olson P, 2013, SCIENCE, V342, P431, DOI 10.1126/science.1243477; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pourovskii LV, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115130; Pozzo M, 2014, EARTH PLANET SC LETT, V393, P159, DOI 10.1016/j.epsl.2014.02.047; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; REICHLIN RL, 1983, REV SCI INSTRUM, V54, P1674, DOI 10.1063/1.1137308; Seagle CT, 2013, GEOPHYS RES LETT, V40, P5377, DOI 10.1002/2013GL057930; Sha XW, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.064103; Sha XW, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/7/075401; Sha XW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042224; Sha XW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.094105; Shim JH, 2007, SCIENCE, V318, P1615, DOI 10.1126/science.1149064; Shim JH, 2007, NATURE, V446, P513, DOI 10.1038/nature05647; Stacey FD, 2001, PHYS EARTH PLANET IN, V124, P153, DOI 10.1016/S0031-9201(01)00186-8; Steinle-Neumann G, 2004, P NATL ACAD SCI USA, V101, P33, DOI 10.1073/pnas.2237239100; Steinle-Neumann G, 2004, J PHYS-CONDENS MAT, V16, pS1109, DOI 10.1088/0953-8984/16/14/020; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P24729, DOI 10.1029/97JB02125; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; Werner P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.076405; Wu BJ, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008511; Wu ZG, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235116; Yin ZP, 2011, NAT MATER, V10, P932, DOI [10.1038/NMAT3120, 10.1038/nmat3120]; YOO CS, 1995, SCIENCE, V270, P1473, DOI 10.1126/science.270.5241.1473	56	49	50	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					605	U376		10.1038/nature14090	http://dx.doi.org/10.1038/nature14090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631449				2022-12-28	WOS:000348775000041
J	Ioannidis, JPA; Horbar, JD; Ovelman, CM; Brosseau, Y; Thorlund, K; Buus-Frank, ME; Mills, EJ; Soll, RF				Ioannidis, John P. A.; Horbar, Jeffrey D.; Ovelman, Colleen M.; Brosseau, Yolanda; Thorlund, Kristian; Buus-Frank, Madge E.; Mills, Edward J.; Soll, Roger F.			Completeness of main outcomes across randomized trials in entire discipline: survey of chronic lung disease outcomes in preterm infants	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEMATIC REVIEWS; CLINICAL-TRIALS; REPORTING BIAS; PUBLICATION; DATABASE; SET	OBJECTIVE To map the availability of information on a major clinical outcome-chronic lung disease-across the randomized controlled trials in systematic reviews of an entire specialty, specifically interventions in preterm infants. DESIGN Survey of systematic reviews. DATA SOURCES Cochrane Database of Systematic Reviews. STUDY SELECTION AND METHODS All Cochrane systematic reviews (as of November 2013) that had evaluated interventions in preterm infants. We identified how many of those systematic reviews had looked for information on chronic lung disease, how many reported on chronic lung disease, and how many of the randomized controlled trials included in the systematic reviews reported on chronic lung disease. We also randomly selected 10 systematic reviews that did not report on chronic lung disease and 10 that reported on any such outcomes and identified whether any information on chronic lung disease appeared in the primary reports of the randomized controlled trials but not in the systematic reviews. MAIN OUTCOME MEASURES Whether availability of chronic lung disease outcomes differed by type of population and intervention and whether additional non-extracted data might have been available in trial reports. RESULTS 174 systematic reviews with 1041 trials exclusively concerned preterm infants. Of those, 105 reviews looked for chronic lung disease outcomes, and 79 reported on these outcomes. Of the 1041 included trials, 202 reported on chronic lung disease at 28 days and 200 at 36 weeks postmenstrual; 320 reported on chronic lung disease with any definition. The proportion of systematic reviews that looked for or reported on chronic lung disease and the proportion of trials that reported on chronic lung disease was larger in preterm infants with respiratory distress or support than others (P < 0.001) and differed across interventions (P < 0.001). Even for trials on children with ventilation interventions, only 56% (48/86) reported on chronic lung disease. In the random sample, 45 of 84 trials (54%) had no outcomes on chronic lung disease in the systematic reviews, and only 9/45 (20%) had such information in the primary trial reports. CONCLUSIONS Most trials included in systematic reviews of interventions on preterm infants are missing information on one of the most common serious outcomes in this population. Use of standardized clinical outcomes that would have to be collected and reported by default in all trials in a given specialty should be considered.	[Ioannidis, John P. A.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Palo Alto, CA 94304 USA; [Horbar, Jeffrey D.; Soll, Roger F.] Univ Vermont, Coll Med, Dept Pediat, Burlington, VT 05405 USA; [Horbar, Jeffrey D.] Vermont Oxford Network, Burlington, VT USA; [Horbar, Jeffrey D.; Ovelman, Colleen M.; Brosseau, Yolanda; Soll, Roger F.] Cochrane Neonatal Review Grp, Burlington, VT USA; [Thorlund, Kristian] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Buus-Frank, Madge E.] Univ Vermont, Vermont Oxford Network, Burlington, VT 05405 USA; [Buus-Frank, Madge E.] Geisel Sch Med Dartmouth, Burlington, VT USA; [Mills, Edward J.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Vermont; McMaster University; University of Vermont; Stanford University	Ioannidis, JPA (corresponding author), 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Ovelman, Colleen/GQB-0672-2022	Ovelman, Colleen/0000-0001-5038-6747	Laura and John Arnold Foundation	Laura and John Arnold Foundation	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. METRICS is funded by a grant from the Laura and John Arnold Foundation.	Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Dwan Kerry, 2011, Cochrane Database Syst Rev, pMR000031, DOI 10.1002/14651858.MR000031.pub2; Dwan K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002709; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gallini F, 2014, Acta Biomed, V85, P30; Gargon E, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-279; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-21; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Rosenthal R, 2013, ANN SURG, V257, P1007, DOI 10.1097/SLA.0b013e318283cf7f; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Sinclair JC, 2003, CLIN PERINATOL, V30, P285, DOI 10.1016/S0095-5108(03)00025-3; Sinha IP, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-103; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	25	22	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2015	350								h72	10.1136/bmj.h72	http://dx.doi.org/10.1136/bmj.h72			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZM	25623087	hybrid			2022-12-28	WOS:000348775100017
J	Kourra, CMBK; Cramer, N				Kourra, Christopher M. B. K.; Cramer, Nicolai			Gold unleashes the power of three	NATURE			English	Editorial Material							CARBON-CARBON BOND		[Kourra, Christopher M. B. K.; Cramer, Nicolai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, SB ISIC LCSA, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kourra, CMBK (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, SB ISIC LCSA, BCH 4305, CH-1015 Lausanne, Switzerland.	nicolai.cramer@epfl.ch		Cramer, Nicolai/0000-0001-5740-8494				Akagawa K, 2013, ANGEW CHEM INT EDIT, V52, P11585, DOI 10.1002/anie.201305004; Corma A, 2011, CHEM REV, V111, P1657, DOI 10.1021/cr100414u; Gaillard S, 2010, ORGANOMETALLICS, V29, P394, DOI 10.1021/om900814e; Hickman AJ, 2012, NATURE, V484, P177, DOI 10.1038/nature11008; Pennell MN, 2011, J ORG CHEM, V76, P1479, DOI 10.1021/jo102263t; Perthuisot C, 2002, J MOL CATAL A-CHEM, V189, P157, DOI 10.1016/S1381-1169(02)00203-0; Wolf WJ, 2014, NAT CHEM, V6, P159, DOI [10.1038/NCHEM.1822, 10.1038/nchem.1822]; Wu CY, 2015, NATURE, V517, P449, DOI 10.1038/nature14104; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V1	9	2	2	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					440	441		10.1038/517440a	http://dx.doi.org/10.1038/517440a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25612046				2022-12-28	WOS:000348196500021
J	Wu, N; Ming, X; Xiao, J; Wu, Z; Chen, X; Shinawi, M; Shen, Y; Yu, G; Liu, J; Xie, H; Gucev, ZS; Liu, S; Yang, N; Al-Kateb, H; Chen, J; Zhang, J; Hauser, N; Zhang, T; Tasic, V; Liu, P; Su, X; Pan, X; Liu, C; Wang, L; Shen, J; Shen, JX; Chen, Y; Zhang, T; Zhang, JG; Choy, KW; Wang, J; Wang, Q; Li, S; Zhou, W; Guo, J; Wang, Y; Zhang, C; Zhao, H; An, Y; Zhao, Y; Wang, JC; Liu, Z; Zuo, Y; Tian, Y; Weng, X; Sutton, VR; Wang, H; Ming, Y; Kulkarni, S; Zhong, TP; Giampietro, PF; Dunwoodie, SL; Cheung, SW; Zhang, X; Jin, L; Lupski, JR; Qiu, G; Zhang, F				Wu, N.; Ming, X.; Xiao, J.; Wu, Z.; Chen, X.; Shinawi, M.; Shen, Y.; Yu, G.; Liu, J.; Xie, H.; Gucev, Z. S.; Liu, S.; Yang, N.; Al-Kateb, H.; Chen, J.; Zhang, Jian; Hauser, N.; Zhang, T.; Tasic, V.; Liu, P.; Su, X.; Pan, X.; Liu, C.; Wang, L.; Shen, Joseph; Shen, Jianxiong; Chen, Y.; Zhang, T.; Zhang, Jianguo; Choy, K. W.; Wang, Jun; Wang, Q.; Li, S.; Zhou, W.; Guo, J.; Wang, Y.; Zhang, C.; Zhao, H.; An, Y.; Zhao, Y.; Wang, Jiucun; Liu, Z.; Zuo, Y.; Tian, Y.; Weng, X.; Sutton, V. R.; Wang, H.; Ming, Y.; Kulkarni, S.; Zhong, T. P.; Giampietro, P. F.; Dunwoodie, S. L.; Cheung, S. W.; Zhang, X.; Jin, L.; Lupski, J. R.; Qiu, G.; Zhang, F.			TBX6 Null Variants and a Common Hypomorphic Allele in Congenital Scoliosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOMINANT SPONDYLOCOSTAL DYSOSTOSIS; GENE-ENVIRONMENT INTERACTION; CHROMOSOME 16P11.2; VERTEBRAL MALFORMATIONS; MOUSE EMBRYOS; P19CL6 CELLS; MUTATION; ETIOLOGY; GENOME; MICRODELETION	BACKGROUND Congenital scoliosis is a common type of vertebral malformation. Genetic susceptibility has been implicated in congenital scoliosis. METHODS We evaluated 161 Han Chinese persons with sporadic congenital scoliosis, 166 Han Chinese controls, and 2 pedigrees, family members of which had a 16p11.2 deletion, using comparative genomic hybridization, quantitative polymerase-chainreaction analysis, and DNA sequencing. We carried out tests of replication using an additional series of 76 Han Chinese persons with congenital scoliosis and a multicenter series of 42 persons with 16p11.2 deletions. RESULTS We identified a total of 17 heterozygous TBX6 null mutations in the 161 persons with sporadic congenital scoliosis (11%); we did not observe any null mutations in TBX6 in 166 controls (P<3.8x10(-6)). These null alleles include copy-number variants (12 instances of a 16p11.2 deletion affecting TBX6) and single-nucleotide variants (1 nonsense and 4 frame-shift mutations). However, the discordant intrafamilial phenotypes of 16p11.2 deletion carriers suggest that heterozygous TBX6 null mutation is insufficient to cause congenital scoliosis. We went on to identify a common TBX6 haplotype as the second risk allele in all 17 carriers of TBX6 null mutations (P<1.1x10(-6)). Replication studies involving additional persons with congenital scoliosis who carried a deletion affecting TBX6 confirmed this compound inheritance model. In vitro functional assays suggested that the risk haplotype is a hypomorphic allele. Hemivertebrae are characteristic of TBX6-associated congenital scoliosis. CONCLUSIONS Compound inheritance of a rare null mutation and a hypomorphic allele of TBX6 accounted for up to 11% of congenital scoliosis cases in the series that we analyzed.	[Wu, N.; Wu, Z.; Liu, J.; Liu, S.; Chen, J.; Su, X.; Shen, Jianxiong; Zhang, Jianguo; Li, S.; Wang, Y.; Zhao, H.; Zhao, Y.; Liu, Z.; Zuo, Y.; Tian, Y.; Weng, X.; Qiu, G.] Beijing Union Med Coll Hosp, Dept Orthoped Surg, Beijing, Peoples R China; [Ming, Y.] Canc Hosp, PET CT Ctr, Beijing, Peoples R China; [Zhang, X.] Peking Union Med Coll, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, Beijing 100021, Peoples R China; [Zhang, X.] Peking Union Med Coll, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China; Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, X.; Xie, H.; Zhang, T.; Guo, J.] Capital Inst Pediat, Affiliated Childrens Hosp, Beijing Municipal Key Lab Child Dev & Nutri, Beijing, Peoples R China; Capital Inst Pediat, Affiliated Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Ming, X.; Xiao, J.; Yu, G.; Yang, N.; Zhang, Jian; Pan, X.; Chen, Y.; Wang, Q.; Zhou, W.; Zhang, C.; An, Y.; Wang, Jiucun; Wang, H.; Zhong, T. P.; Jin, L.; Zhang, F.] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200438, Peoples R China; [Ming, X.; Xiao, J.; Yu, G.; Yang, N.; Zhang, Jian; Pan, X.; Chen, Y.; Wang, Q.; Zhou, W.; Zhang, C.; An, Y.; Wang, Jiucun; Wang, H.; Zhong, T. P.; Jin, L.; Zhang, F.] Fudan Univ, Minist Educ, Sch Life Sci, Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China; [Xiao, J.; Wang, H.; Zhong, T. P.; Jin, L.; Zhang, F.] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, Shanghai 200438, Peoples R China; [Shen, Y.] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhang, T.] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Gastroenterol Hepatol & Nutr, Shanghai 200030, Peoples R China; [Liu, C.] Nanjing Med Univ, Sch Basic Med Sci, Dept Biotechnol, Nanjing, Jiangsu, Peoples R China; [Choy, K. W.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wang, Jiucun; Jin, L.; Zhang, F.] Fudan Taizhou Inst Hlth Sci, Taizhou, Peoples R China; [Shinawi, M.] Washington Univ, Sch Med, Div Genet & Genom Med, Dept Pediat, St Louis, MO 63130 USA; [Al-Kateb, H.; Kulkarni, S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Shen, Y.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Shen, Y.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Gucev, Z. S.; Tasic, V.] Univ Childrens Hosp, Med Fac Skopje, Dept Endocrinol & Genet, Skopje, Macedonia; [Hauser, N.; Shen, Joseph] Childrens Hosp Cent Calif, Dept Med Genet & Metab, Madera, CA USA; [Liu, P.; Sutton, V. R.; Cheung, S. W.; Lupski, J. R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, J. R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Sutton, V. R.; Lupski, J. R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Giampietro, P. F.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Dunwoodie, S. L.] Univ New S Wales, Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Sydney, NSW, Australia; [Dunwoodie, S. L.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Dunwoodie, S. L.] Univ New S Wales, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Institute of Pediatrics (CIP); Capital Institute of Pediatrics (CIP); Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing Medical University; Chinese University of Hong Kong; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney	Zhang, F (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, 2005 Song Hu Rd, Shanghai 200438, Peoples R China.	qiuguixingpumch@gmail.com; zhangfeng@fudan.edu.cn	Ye, Yiyi/J-7849-2019; liu, chunyu/GWQ-9357-2022; Tasic, Velibor/H-8714-2019; Xiao, Jianqiu/AAB-7860-2021; Shen, Jianxiong/AAH-6200-2019; Zhou, Weichen/AAA-3207-2020; Liu, Pengfei/U-9743-2019; Choy, Richard/AAW-8230-2020; Jin, Li/C-1468-2009; Shen, Joseph/AAY-5083-2020; Jin, Li/M-5063-2019; Yang, Nan/AAQ-4510-2021; Wu, Nan/R-2186-2017; Zhang, Feng/C-7735-2009; Dunwoodie, Sally L/M-4019-2018; ZHAO, YU/GZL-3154-2022	liu, chunyu/0000-0002-6732-3758; Tasic, Velibor/0000-0002-3377-1245; Zhou, Weichen/0000-0003-4755-1072; Liu, Pengfei/0000-0002-4177-709X; Choy, Richard/0000-0002-3616-6200; Jin, Li/0000-0002-4546-2415; Shen, Joseph/0000-0002-5604-7639; Yang, Nan/0000-0002-6052-5728; Wu, Nan/0000-0002-9429-2889; Zhang, Feng/0000-0003-4556-8276; Dunwoodie, Sally L/0000-0002-2069-7349; Chen, Xiaoli/0000-0003-0536-1553; ZHAO, YU/0000-0001-9025-2014; Qiu, Guixing/0000-0002-4597-9350; shinawi, Marwan/0000-0003-1329-4100; Weng, Xisheng/0000-0002-6021-1462; Ming, Xuan/0000-0003-0867-1549; Xiao, Jianqiu/0000-0002-8896-9187; Wang, Yipeng/0000-0001-9769-9839; Liu, Jiaqi/0000-0002-9775-2342	National Basic Research Program of China [2012CB944600, 2011CBA00401]; National Natural Science Foundation of China [81222014, 81130034, 81100841, 31171210, 81271942, 81370708, 81171673, 81371903]; 111 Project [B13016]; Beijing Natural Science Foundation [7144235]; Shu Guang Project [12SG08]; Shanghai Pujiang Program [10PJ1400300]; Recruitment Program of Global Experts, U.S. National Institute of Neurological Disorders and Stroke [R01NS058529]; U.S. National Human Genome Research Institute [U54HG006542]; Australian National Health and Medical Research Council Senior Research Fellowship [ID1042002]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Shu Guang Project(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Recruitment Program of Global Experts, U.S. National Institute of Neurological Disorders and Stroke; U.S. National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Australian National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by grants from the National Basic Research Program of China (2012CB944600 and 2011CBA00401), the National Natural Science Foundation of China (81222014, 81130034, 81100841, 31171210, 81271942, 81370708, 81171673, and 81371903), the 111 Project (B13016), the Beijing Natural Science Foundation (7144235), the Shu Guang Project (12SG08), the Shanghai Pujiang Program (10PJ1400300), the Recruitment Program of Global Experts, U.S. National Institute of Neurological Disorders and Stroke (R01NS058529), and the U.S. National Human Genome Research Institute (U54HG006542) and by an Australian National Health and Medical Research Council Senior Research Fellowship (ID1042002).	Al-Kateb H, 2014, AM J MED GENET A, V164, P1118, DOI 10.1002/ajmg.a.36401; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Cheng YM, 2006, BIOINFORMATICS, V22, P2320, DOI 10.1093/bioinformatics/btl394; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fei Q, 2010, SPINE, V35, P983, DOI 10.1097/BRS.0b013e3181bc963c; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Fujimi TJ, 2008, GENE EXPR PATTERNS, V8, P376, DOI 10.1016/j.gep.2008.05.003; Gavrilov S, 2012, DIFFERENTIATION, V84, P176, DOI 10.1016/j.diff.2012.04.007; Ghebranious N, 2008, J BONE MINER RES, V23, P1576, DOI 10.1359/JBMR.080503; Giampietro PF, 2005, CLIN GENET, V68, P448, DOI 10.1111/j.1399-0004.2005.00520.x; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Gucev ZS, 2010, AM J MED GENET A, V152A, P1378, DOI 10.1002/ajmg.a.33471; Hitachi K, 2008, BIOCHEM BIOPH RES CO, V372, P607, DOI 10.1016/j.bbrc.2008.05.083; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kawamura A, 2008, MOL CELL BIOL, V28, P3236, DOI 10.1128/MCB.01754-07; Kurotaki N, 2005, GENET MED, V7, P479, DOI 10.1097/01.GIM.0000177419.43309.37; Li L, 2012, J CELL BIOCHEM, V113, P3788, DOI 10.1002/jcb.24254; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; O'Reilly VC, 2014, DEV BIOL, V391, P99, DOI 10.1016/j.ydbio.2014.03.005; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Rosenfeld JA, 2013, GENET MED, V15, P478, DOI 10.1038/gim.2012.164; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Shen YP, 2007, CLIN CHEM, V53, P2051, DOI 10.1373/clinchem.2007.090290; Shen YP, 2011, AM J MED GENET B, V156B, P225, DOI 10.1002/ajmg.b.31147; Shimojima K, 2009, EUR J MED GENET, V52, P433, DOI 10.1016/j.ejmg.2009.09.007; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Sparrow DB, 2013, HUM MOL GENET, V22, P1625, DOI 10.1093/hmg/ddt012; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Watabe-Rudolph M, 2002, MECH DEVELOP, V119, P251, DOI 10.1016/S0925-4773(02)00394-5; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; White PH, 2003, DEVELOPMENT, V130, P1681, DOI 10.1242/dev.00367; WYNNEDAVIES R, 1975, J MED GENET, V12, P280, DOI 10.1136/jmg.12.3.280	44	182	200	4	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					341	350		10.1056/NEJMoa1406829	http://dx.doi.org/10.1056/NEJMoa1406829			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25564734	Green Accepted			2022-12-28	WOS:000348204500009
J	Sharpe, T				Sharpe, Tom			The birth of the geological map	SCIENCE			English	Editorial Material									[Sharpe, Tom] Lyme Regis Museum, Lyme Regis DT7 3QA, Dorset, England; [Sharpe, Tom] Cardiff Univ, Dept Lifelong Learning, Cardiff CF24 4AG, S Glam, Wales	Cardiff University	Sharpe, T (corresponding author), Lyme Regis Museum, Bridge St, Lyme Regis DT7 3QA, Dorset, England.	sharpet@cardiff.ac.uk						COX L. R, 1942, P YORKS GEOL SOC, V25, P1; EYLES J M, 1969, Journal of the Society for the Bibliography of Natural History, V5, P87; Eyles V. A, 1938, ANN SCI, V3, P190; Fuller J. G. C. M., 1995, S SMITH HIS STRATIGR; Knell Simon J., 2000, CULTURE ENGLISH GEOL; Rudwick M. J. S., 2005, BURSTING LIMITS TIME; Smith W., 1817, STRATIGRAPHICAL SYST; Smith W., 2015, MEMOIR MAP DELINEATI; Smith W., 1816, STRATA IDENTIFIED OR; Tanaka K. L., 2014, GEOLOGIC MAP MARS; Torrens HS, 2001, GEOL SOC SPEC PUBL, V190, P61, DOI 10.1144/GSL.SP.2001.190.01.06; TORRENS HS, 2004, OXFORD DICT NATL BIO, V51, P372; Wigley P., 2007, S SMITH HIST 200 YEA	13	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					230	232		10.1126/science.aaa2330	http://dx.doi.org/10.1126/science.aaa2330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593171				2022-12-28	WOS:000347915300017
J	Smith, JM				Smith, Jeanette M.			Fogbound Shores, Antarctica Leland Curtis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					118	119		10.1001/jama.2014.11513	http://dx.doi.org/10.1001/jama.2014.11513			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585309				2022-12-28	WOS:000347679300001
J	Jewell, JL; Kim, YC; Russell, RC; Yu, FX; Park, HW; Plouffe, SW; Tagliabracci, VS; Guan, KL				Jewell, Jenna L.; Kim, Young Chul; Russell, Ryan C.; Yu, Fa-Xing; Park, Hyun Woo; Plouffe, Steven W.; Tagliabracci, Vincent S.; Guan, Kun-Liang			Differential regulation of mTORC1 by leucine and glutamine	SCIENCE			English	Article							AMINO-ACID SUFFICIENCY; P70 S6 KINASE; RAG GTPASES; COMPLEX; PROTEINS; ARF; ACTIVATION; RAGULATOR; MECHANISM; REVEALS	The mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates environmental and intracellular signals to regulate cell growth. Amino acids stimulatem TORC1 activation at the lysosome in a manner thought to be dependent on the Rag small guanosine triphosphatases (GTPases), the Ragulator complex, and the vacuolar H+-adenosine triphosphatase (v-ATPase). We report that leucine and glutamine stimulate mTORC1 by Rag GTPase-dependent and -independent mechanisms, respectively. Glutamine promoted mTORC1 translocation to the lysosome in RagA and RagB knockout cells and required the v-ATPase but not the Ragulator. Furthermore, we identified the adenosine diphosphate ribosylation factor-1 GTPase to be required for mTORC1 activation and lysosomal localization by glutamine. Our results uncover a signaling cascade to mTORC1 activation independent of the Rag GTPases and suggest that mTORC1 is differentially regulated by specific amino acids.	[Jewell, Jenna L.; Kim, Young Chul; Russell, Ryan C.; Park, Hyun Woo; Plouffe, Steven W.; Tagliabracci, Vincent S.; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Jewell, Jenna L.; Kim, Young Chul; Russell, Ryan C.; Park, Hyun Woo; Plouffe, Steven W.; Tagliabracci, Vincent S.; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Yu, Fa-Xing] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Yu, Fa-Xing] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; Fudan University; Fudan University	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Park, Hyun Woo/0000-0001-7736-2286; Kim, Young Chul/0000-0002-6782-2186; Yu, Fa-Xing/0000-0003-4834-9335	NIH [R01GM051586, R01CA108941, T32CA121938, T32GM007752, K99DK099254]; Department of Defense [W81XWH-13-1-055]; Hartwell Foundation; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA108941, T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK099254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM051586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Hartwell Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Guan laboratory for critical comments; L. Huber for p14 null cells; and F. Flores, J. Zhou, and C. Worby for technical help. Supported by grants from NIH (R01GM051586 and R01CA108941 to K.-L.G.; T32CA121938 to J.L.J.; T32GM007752 to S.W.P.; and K99DK099254 to V.S.T), Department of Defense (W81XWH-13-1-055) to K.-L.G., The Hartwell Foundation to J.L.J., and a Canadian Institutes of Health Research grant to R.C.R.	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	25	456	477	9	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					194	198		10.1126/science.1259472	http://dx.doi.org/10.1126/science.1259472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25567907	Green Accepted			2022-12-28	WOS:000347918900048
J	Ochi, T; Blackford, AN; Coates, J; Jhujh, S; Mehmood, S; Tamura, N; Travers, J; Wu, Q; Draviam, VM; Robinson, CV; Blundell, TL; Jackson, SP				Ochi, Takashi; Blackford, Andrew N.; Coates, Julia; Jhujh, Satpal; Mehmood, Shahid; Tamura, Naoka; Travers, Jon; Wu, Qian; Draviam, Viji M.; Robinson, Carol V.; Blundell, Tom L.; Jackson, Stephen P.			PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ORGANIZATION; PROTEIN; COMPLEX	XRCC4 and XLF are two structurally related proteins that function in DNA double-strand break (DSB) repair. Here, we identify human PAXX (PAralog of XRCC4 and XLF, also called C9orf142) as a new XRCC4 superfamily member and show that its crystal structure resembles that of XRCC4. PAXX interacts directly with the DSB-repair protein Ku and is recruited to DNA-damage sites in cells. Using RNA interference and CRISPR-Cas9 to generate PAXX(-/-) cells, we demonstrate that PAXX functions with XRCC4 and XLF to mediate DSB repair and cell survival in response to DSB-inducing agents. Finally, we reveal that PAXX promotes Ku-dependent DNA ligation in vitro and assembly of core nonhomologous end-joining (NHEJ) factors on damaged chromatin in cells. These findings identify PAXX as a new component of the NHEJ machinery.	[Ochi, Takashi; Wu, Qian; Blundell, Tom L.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Blackford, Andrew N.; Coates, Julia; Jhujh, Satpal; Travers, Jon; Jackson, Stephen P.] Univ Cambridge, Canc Res UK Garden Inst, Wellcome Trust, Cambridge CB2 1QN, England; [Mehmood, Shahid; Robinson, Carol V.] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Tamura, Naoka; Draviam, Viji M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Oxford; University of Cambridge; Wellcome Trust Sanger Institute	Jackson, SP (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	tlb20@cam.ac.uk; s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Blackford, Andrew N/H-6575-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Blackford, Andrew N/0000-0003-1979-021X; Wu, Qian/0000-0002-6948-7043; Draviam, Viji/0000-0001-8295-3689; Jhujh, Satpal Singh/0000-0001-5766-659X; robinson, carol/0000-0001-7829-5505; Ochi, Takashi/0000-0001-8546-6341	Wellcome Trust [WT 093165, WT092096]; Cancer Research UK (CRUK) program [C6/A11224]; European Research Council; European Community Seventh Framework Programme [HEALTH-F2-2010-259893]; CRUK [06946/A1442]; CRUK Career Development Fellowship [C28598/A9787]; Cancer Research UK [11224, 9787, 18796] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK (CRUK) program; European Research Council(European Research Council (ERC)European Commission); European Community Seventh Framework Programme(European Commission); CRUK(Cancer Research UK); CRUK Career Development Fellowship; Cancer Research UK(Cancer Research UK)	T.O., Q.W. and T.L.B. are supported by the Wellcome Trust (WT 093165. The Jackson laboratory is funded by Cancer Research UK (CRUK) program grant C6/A11224, the European Research Council, and the European Community Seventh Framework Programme grant agreement HEALTH-F2-2010-259893 (DDResponse). Core infrastructure funding to the Jackson lab is provided by CRUK (06946/A1442) and the Wellcome Trust (WT092096). S.P.J. receives his salary from the University of Cambridge, supplemented by CRUK. V.M.D. is a CRUK Career Development Fellow. The Draviam lab is funded by a CRUK Career Development Fellowship (C28598/A9787). We thank M. Hyvonen, V. Bolanos-Garcia, and L. Hanakahi for reagents; K. Scott for assistance with SPR; beamline scientists allot and. 122 for their help at the Diamond Light Source; and J. Brown, K. Inoue, Y. Kimata, M. Lamers, B. Luisi, N. Lukashchuk, R. Nishi, C. le Sage, C. Schmidt, and P. Wijnhoven for useful discussions and technical assistance. Crystallization and. initial x-ray diffraction experiments :were performed in the x-ray crystallographic facility at the Department of Biochemistry, University of Cambridge, with help from the Facility Manager, D. Chirgadze. Protein Data Bank accession numbers of PAXX<SUP>1-66</SUP> and PAXX<SUP>1-204</SUP> are 3WTD and 3WTF respectively.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Ochi T, 2014, DNA REPAIR, V17, P98, DOI 10.1016/j.dnarep.2014.02.010; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011	13	207	219	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					185	188		10.1126/science.1261971	http://dx.doi.org/10.1126/science.1261971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574025	Green Accepted			2022-12-28	WOS:000347918900046
J	Wang, SY; Tsun, ZY; Wolfson, RL; Shen, K; Wyant, GA; Plovanich, ME; Yuan, ED; Jones, TD; Chantranupong, L; Comb, W; Wang, T; Bar-Peled, L; Zoncu, R; Straub, C; Kim, C; Park, J; Sabatini, BL; Sabatini, DM				Wang, Shuyu; Tsun, Zhi-Yang; Wolfson, Rachel L.; Shen, Kuang; Wyant, Gregory A.; Plovanich, Molly E.; Yuan, Elizabeth D.; Jones, Tony D.; Chantranupong, Lynne; Comb, William; Wang, Tim; Bar-Peled, Liron; Zoncu, Roberto; Straub, Christoph; Kim, Choah; Park, Jiwon; Sabatini, Bernardo L.; Sabatini, David M.			Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1	SCIENCE			English	Article							P70 S6 KINASE; RAG GTPASES; TUMOR-SUPPRESSOR; COMPLEX; ACTIVATION; PATHWAY; RAPAMYCIN; MEMBRANE; VACUOLAR; FOLLICULIN	The mechanistic target of rapamycin complex 1 (mTORC1) protein kinase is a master growth regulator that responds to multiple environmental cues. Amino acids stimulate, in a Rag-, Ragulator-, and vacuolar adenosine triphosphatase-dependent fashion, the translocation of mTORC1 to the lysosomal surface, where it interacts with its activator Rheb. Here, we identify SLC38A9, an uncharacterized protein with sequence similarity to amino acid transporters, as a lysosomal transmembrane protein that interacts with the Rag guanosine triphosphatases (GTPases) and Ragulator in an amino acid-sensitive fashion. SLC38A9 transports arginine with a high Michaelis constant, and loss of SLC38A9 represses mTORC1 activation by amino acids, particularly arginine. Overexpression of SLC38A9 or just its Ragulator-binding domain makes mTORC1 signaling insensitive to amino acid starvation but not to Rag activity. Thus, SLC38A9 functions upstream of the Rag GTPases and is an excellent candidate for being an arginine sensor for the mTORC1 pathway.	[Wang, Shuyu; Tsun, Zhi-Yang; Wolfson, Rachel L.; Shen, Kuang; Wyant, Gregory A.; Yuan, Elizabeth D.; Jones, Tony D.; Chantranupong, Lynne; Comb, William; Wang, Tim; Bar-Peled, Liron; Zoncu, Roberto; Kim, Choah; Park, Jiwon; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wang, Shuyu; Tsun, Zhi-Yang; Wolfson, Rachel L.; Shen, Kuang; Wyant, Gregory A.; Yuan, Elizabeth D.; Jones, Tony D.; Chantranupong, Lynne; Comb, William; Wang, Tim; Bar-Peled, Liron; Zoncu, Roberto; Kim, Choah; Park, Jiwon; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Wang, Shuyu; Tsun, Zhi-Yang; Wolfson, Rachel L.; Shen, Kuang; Wyant, Gregory A.; Yuan, Elizabeth D.; Jones, Tony D.; Chantranupong, Lynne; Comb, William; Wang, Tim; Bar-Peled, Liron; Zoncu, Roberto; Kim, Choah; Park, Jiwon; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Wang, Shuyu; Tsun, Zhi-Yang; Wolfson, Rachel L.; Shen, Kuang; Wyant, Gregory A.; Yuan, Elizabeth D.; Jones, Tony D.; Chantranupong, Lynne; Comb, William; Wang, Tim; Bar-Peled, Liron; Zoncu, Roberto; Kim, Choah; Park, Jiwon; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wang, Shuyu; Tsun, Zhi-Yang; Wolfson, Rachel L.; Shen, Kuang; Wyant, Gregory A.; Yuan, Elizabeth D.; Jones, Tony D.; Chantranupong, Lynne; Comb, William; Wang, Tim; Bar-Peled, Liron; Zoncu, Roberto; Kim, Choah; Park, Jiwon; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Plovanich, Molly E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Straub, Christoph; Sabatini, Bernardo L.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Dept Neurobiol, Boston, MA 02110 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Wang, shuyu/GZM-3462-2022; Shen, Kuang/H-9441-2016	/0000-0002-1446-7256; Park, Jiwon/0000-0003-4446-4707; Wang, Timothy/0000-0001-5730-3019	NIH [R01 CA103866, AI47389, F30 CA180754, T32 GM007753, F31 AG044064, F31 CA180271]; Department of Defense [W81XWH-07-0448]; National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship; American Cancer Society-Ellison Foundation Postdoctoral Fellowship [PF-13-356-01-TBE]; German Academic Exchange Service (DAAD) Fellowship; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [F31CA189437, F31CA180271, F30CA180754, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG044064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Defense Science and Engineering Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); American Cancer Society-Ellison Foundation Postdoctoral Fellowship; German Academic Exchange Service (DAAD) Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all members of the Sabatini Lab for helpful insights, E. Spooner for the mass spectrometric analyses, and G. Superti-Furga and M. Rebsamen for suggesting the use of the Sigma antibody to detect SLC38A9. This work was supported by grants from the NIH (R01 CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D.M.S. and fellowship support from the NIH to Z.-Y.T. (F30 CA180754), to S.W. (T32 GM007753 and F31 AG044064), to L.C. (F31 CA180271), and to R.L.W. (T32 GM007753); a National Defense Science and Engineering Graduate Fellowship to G.A.W.; an NSF Graduate Research Fellowship to T.W.; an American Cancer Society-Ellison Foundation Postdoctoral Fellowship to W.C. (PF-13-356-01-TBE); a German Academic Exchange Service (DAAD) Fellowship to C.S.; and support from the Howard Hughes Medical Institute to T.D.J., C.K., and J.P. D.M.S. and B.L.S. are investigators of the Howard Hughes Medical Institute.	Ban H, 2004, INT J MOL MED, V13, P537; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HARMS E, 1981, BIOCHEM BIOPH RES CO, V99, P830, DOI 10.1016/0006-291X(81)91239-0; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kahan BD, 2001, TRANSPLANTATION, V72, P1181, DOI 10.1097/00007890-200110150-00001; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Lamming DW, 2013, J CLIN INVEST, V123, P980, DOI 10.1172/JCI64099; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	37	520	553	8	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					188	194		10.1126/science.1257132	http://dx.doi.org/10.1126/science.1257132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25567906	Green Accepted, Green Submitted			2022-12-28	WOS:000347918900047
J	Linkins, LA				Linkins, Lori-Ann			Heparin induced thrombocytopenia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MOLECULAR-WEIGHT HEPARIN; PLATELET-DERIVED MICROPARTICLES; LINKED-IMMUNOSORBENT-ASSAY; PROCOAGULANT ACTIVITY; ANTIBODIES; DIAGNOSIS; RISK; PATHOGENESIS; FONDAPARINUX; BINDS		[Linkins, Lori-Ann] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Linkins, Lori-Ann] Juravinski Hosp & Canc Ctr, Hamilton, ON, Canada	McMaster University; McMaster University	Linkins, LA (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	linkinla@univmail.cis.mcmaster.ca						Alatri A, 2012, THROMB RES, V129, P426, DOI 10.1016/j.thromres.2011.11.041; AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95; Bakchoul T, 2012, THER ADV HEMATOL, V3, P237, DOI 10.1177/2040620712443537; CHONG BH, 1989, BRIT J HAEMATOL, V73, P235, DOI 10.1111/j.1365-2141.1989.tb00258.x; CINES DB, 1987, NEW ENGL J MED, V316, P581, DOI 10.1056/NEJM198703053161004; Cuker A, 2010, J THROMB HAEMOST, V8, P2642, DOI 10.1111/j.1538-7836.2010.04059.x; Cuker A, 2012, BLOOD, V120, P4160, DOI 10.1182/blood-2012-07-443051; Greinacher A, 2008, THROMB RES, V122, P211, DOI 10.1016/j.thromres.2007.11.007; Greinacher A, 2005, THROMB HAEMOSTASIS, V94, P132, DOI 10.1160/TH04-12-0825; Greinacher A, 2011, BLOOD, V118, P1395, DOI 10.1182/blood-2011-03-342857; Greinacher A, 2009, BLOOD, V113, P4970, DOI 10.1182/blood-2008-08-173062; KELTON JG, 1994, BLOOD, V83, P3232; Koster A, 2013, HEPARIN INDUCED THRO, P550; Krauel K, 2011, BLOOD, V117, P1370, DOI 10.1182/blood-2010-08-301424; Lindhoff-Last E, 2002, BRIT J HAEMATOL, V118, P1137, DOI 10.1046/j.1365-2141.2002.03687.x; Linkins LA, 2012, CHEST S, V141, pe495S; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Lo GK, 2007, AM J HEMATOL, V82, P1037, DOI 10.1002/ajh.21032; Lubenow N, 2010, BLOOD, V115, P1797, DOI 10.1182/blood-2009-07-231506; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; Pouplard C, 1999, AM J CLIN PATHOL, V111, P700; Prandoni P, 2005, BLOOD, V106, P3049, DOI 10.1182/blood-2005-03-0912; Raschke RA, 2013, CHEST, V144, P1269, DOI 10.1378/chest.12-2712; Rauova L, 2010, BLOOD, V116, P5021, DOI 10.1182/blood-2010-03-276964; VISENTIN GP, 1994, J CLIN INVEST, V93, P81, DOI 10.1172/JCI116987; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; Warkentin TE, 2001, NEW ENGL J MED, V344, P1286, DOI 10.1056/NEJM200104263441704; Warkentin TE, 2005, J LAB CLIN MED, V146, P341, DOI 10.1016/j.lab.2005.08.003; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; Warkentin TE, 2003, BRIT J HAEMATOL, V121, P535, DOI 10.1046/j.1365-2141.2003.04334.x; Warkentin TE, 1997, ANN INTERN MED, V127, P804, DOI 10.7326/0003-4819-127-9-199711010-00005; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; Warkentin TE, 1998, THROMB HAEMOSTASIS, V79, P1; Warkentin TE, 1999, PLATELETS, V10, P319; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Warkentin TE, 2006, BLOOD, V108, P2937, DOI 10.1182/blood-2005-11-012450; Warkentin TE, 2014, EXPERT OPIN DRUG SAF, V13, P25, DOI 10.1517/14740338.2013.823946; Warkentin Theodore E, 2003, Curr Hematol Rep, V2, P148; Warkentin TE, 2010, EXPERT REV HEMATOL, V3, P567, DOI [10.1586/ehm.10.54, 10.1586/EHM.10.54]; Warkentin TE, 2009, BLOOD, V113, P4963, DOI 10.1182/blood-2008-10-186064	40	23	24	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2015	350								g7566	10.1136/bmj.g7566	http://dx.doi.org/10.1136/bmj.g7566			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3MB	25569604				2022-12-28	WOS:000348130500001
J	Crawford, BCW; Sewell, J; Golembeski, G; Roshan, C; Long, JA; Yanofsky, MF				Crawford, Brian C. W.; Sewell, Jared; Golembeski, Greg; Roshan, Carmel; Long, Jeff A.; Yanofsky, Martin F.			Genetic control of distal stem cell fate within root and embryonic meristems	SCIENCE			English	Article							AUXIN GRADIENTS; ARABIDOPSIS; TRACT; AXIS	The root meristem consists of populations of distal and proximal stem cells and an organizing center known as the quiescent center. During embryogenesis, initiation of the root meristem occurs when an asymmetric cell division of the hypophysis forms the distal stem cells and quiescent center. We have identified NO TRANSMITTING TRACT (NTT) and two closely related paralogs as being required for the initiation of the root meristem. All three genes are expressed in the hypophysis, and their expression is dependent on the auxin-signaling pathway. Expression of these genes is necessary for distal stem cell fate within the root meristem, whereas misexpression is sufficient to transform other stem cell populations to a distal stem cell fate in both the embryo and mature roots.	[Crawford, Brian C. W.; Golembeski, Greg; Roshan, Carmel; Yanofsky, Martin F.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Sewell, Jared; Long, Jeff A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles	Long, JA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jeffalong@ucla.edu; marty@ucsd.edu		Sewell, Jared/0000-0003-3229-2645	NSF [IOS-0817544, IOS-1121055, IOS-0822411]; NIH (NIH/NIGMS) [5 R01 GM072764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH (NIH/NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Gallavotti and B. Bargmann for their critical comments and M. Estelle and Y. Zhang for use and help with the confocal microscope. This work was funded by the NSF (grants IOS-0817544 and IOS-1121055 to M.F.Y. and IOS-0822411 to J.A.L.) and the NIH (NIH/NIGMS grant 5 R01 GM072764 to J.A.L.). The supplementary materials contain additional data.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bennett T, 2010, CURR TOP DEV BIOL, V91, P67, DOI 10.1016/S0070-2153(10)91003-X; BERLETH T, 1993, DEVELOPMENT, V118, P575; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Crawford BCW, 2008, CURR BIOL, V18, pR972, DOI 10.1016/j.cub.2008.08.010; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; SCHERES B, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0101; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, PLANT CELL, V17, P2517, DOI 10.1105/tpc.105.034637	18	58	60	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 6	2015	347	6222					655	659		10.1126/science.aaa0196	http://dx.doi.org/10.1126/science.aaa0196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CX	25612610				2022-12-28	WOS:000349145200043
J	Milisavljevic, D; Fesen, RA				Milisavljevic, Dan; Fesen, Robert A.			The bubble-like interior of the core-collapse supernova remnant Cassiopeia A	SCIENCE			English	Article							3-DIMENSIONAL STRUCTURE; A SUPERNOVA; EJECTA; EXPLOSIONS; INSTABILITIES; ASYMMETRY; TURBULENT; SHELL; IRON; AGE	The death of massive stars is believed to involve aspheric explosions initiated by the collapse of an iron core. The specifics of these catastrophic explosions remain uncertain, due partly to limited observational constraints on asymmetries deep inside the star. Here we present near-infrared observations of the young supernova remnant Cassiopeia A, descendant of a type IIb core-collapse explosion, and a three-dimensional map of its interior unshocked ejecta. The remnant's interior has a bubble-like morphology that smoothly connects to and helps explain the multiringed structures seen in the remnant's bright reverse-shocked main shell of expanding debris. This internal structure may originate from turbulent mixing processes that encouraged outwardly expanding plumes of radioactive Ni-56-rich ejecta. If this is true, substantial amounts of its decay product, Fe-56, may still reside in these interior cavities.	[Milisavljevic, Dan] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fesen, Robert A.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Dartmouth College	Milisavljevic, D (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	dmilisav@cfa.harvard.edu			National Science Foundation [AST-0908237]; Guest Observer program [10286]; NASA [NAS 5-26555]	National Science Foundation(National Science Foundation (NSF)); Guest Observer program; NASA(National Aeronautics & Space Administration (NASA))	This material is based on work supported by the National Science Foundation under grant no. AST-0908237, as well as observations made with the NASA/European Space Agency HST associated with Guest Observer program 10286 (Principal Investigator, R. Fesen) and obtained from the data archive at the Space Telescope Science Institute (STScI). STScI is operated by the Association of Universities for Research in Astronomy under NASA contract NAS 5-26555. Visual modeling of our observations was aided with the use of MeshLab (http://meshlab.sourceforge.net), a tool developed with the support of the 3D-CoForm project. We thank anonymous reviewers for providing suggestions that improved the content and presentation of the manuscript and D. Patnaude for helpful discussions.	Arnett WD, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/1/33; BETHE HA, 1985, ASTROPHYS J, V295, P14, DOI 10.1086/163343; Blondin JM, 2001, ASTROPHYS J, V557, P782, DOI 10.1086/321674; Burrows A., 2005, ASP C SERIES, V342; Burrows A, 2013, REV MOD PHYS, V85, P245, DOI 10.1103/RevModPhys.85.245; COLGATE SA, 1966, ASTROPHYS J, V143, P626, DOI 10.1086/148549; DeLaney T, 2010, ASTROPHYS J, V725, P2038, DOI 10.1088/0004-637X/725/2/2038; Eriksen KA, 2001, AIP CONF PROC, V565, P193; Fesen RA, 2001, ASTROPHYS J SUPPL S, V133, P161, DOI 10.1086/319181; Fesen RA, 2006, ASTROPHYS J, V645, P283, DOI 10.1086/504254; Grefenstette BW, 2014, NATURE, V506, P339, DOI 10.1038/nature12997; Hammer NJ, 2010, ASTROPHYS J, V714, P1371, DOI 10.1088/0004-637X/714/2/1371; Hwang U, 2003, ASTROPHYS J, V597, P362, DOI 10.1086/378269; Hwang U, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/130; Isensee K, 2010, ASTROPHYS J, V725, P2059, DOI 10.1088/0004-637X/725/2/2059; ITOH M, 1987, NATURE, V330, P233, DOI 10.1038/330233a0; Janka HT, 2012, ANNU REV NUCL PART S, V62, P407, DOI 10.1146/annurev-nucl-102711-094901; Kifonidis K, 2003, ASTRON ASTROPHYS, V408, P621, DOI 10.1051/0004-6361:20030863; Krause O, 2008, SCIENCE, V320, P1195, DOI 10.1126/science.1155788; LI HW, 1993, ASTROPHYS J, V419, P824, DOI 10.1086/173534; Maeda K, 2008, SCIENCE, V319, P1220, DOI 10.1126/science.1149437; Milisavljevic D, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/134; Milisavljevic D, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/25; Nagataki S, 1998, ASTROPHYS J, V492, pL45, DOI 10.1086/311089; REED JE, 1995, ASTROPHYS J, V440, P706, DOI 10.1086/175308; Rest A, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/3; Smith JDT, 2009, ASTROPHYS J, V693, P713, DOI 10.1088/0004-637X/693/1/713; Thorstensen JR, 2001, ASTRON J, V122, P297, DOI 10.1086/321138; Wang LF, 2008, ANNU REV ASTRON ASTR, V46, P433, DOI 10.1146/annurev.astro.46.060407.145139; Wheeler JC, 2002, ASTROPHYS J, V568, P807, DOI 10.1086/338953; WILSON JR, 1982, NUMERICAL ASTROPHYSI, P422	33	59	59	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					526	530		10.1126/science.1261949	http://dx.doi.org/10.1126/science.1261949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635094	Green Submitted			2022-12-28	WOS:000348639300047
J	Cooper, CM; Baron, JM				Cooper, Cynthia M.; Baron, Jason M.			Case 4-2015: A 49-Year-Old Man with Obtundation Followed by Agitation and Acidosis Ethylene glycol ingestion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUICIDAL IDEATION; ANION-GAP; META-CHLOROPHENYLPIPERAZINE; METABOLIC-ACIDOSIS; OSMOLAL GAP; SERUM; RISK; DERIVATION; OVERDOSE; LACTATE		[Cooper, Cynthia M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02163 USA; [Baron, Jason M.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Cooper, Cynthia M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Baron, Jason M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cooper, CM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02163 USA.							ALBERT MS, 1967, ANN INTERN MED, V66, P312, DOI 10.7326/0003-4819-66-2-312; ARRIGHI HM, 1991, UROLOGY, V38, P4, DOI 10.1016/0090-4295(91)80191-9; Baron JM, 2011, J ANAL TOXICOL, V35, P364, DOI 10.1093/anatox/35.6.364; Barthel P, 2013, EUR HEART J, V34, P1644, DOI 10.1093/eurheartj/ehs420; Batista M, 2013, CLIN TOXICOL, V51, P92, DOI 10.3109/15563650.2012.763133; Bianchi W, 2013, ANN EMERG MED, V61, P37, DOI 10.1016/j.annemergmed.2012.05.030; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bosse GM, 2008, J MED TOXICOL, V4, P18, DOI 10.1007/BF03160945; Christodoulou C, 2012, ACTA PSYCHIAT SCAND, V125, P127, DOI 10.1111/j.1600-0447.2011.01750.x; Chung KJ, 2008, J EMERG MED, V35, P171, DOI 10.1016/j.jemermed.2007.02.036; Churpek MM, 2013, CHEST, V143, P1758, DOI 10.1378/chest.12-1605; Churpek MM, 2012, CRIT CARE MED, V40, P2102, DOI 10.1097/CCM.0b013e318250aa5a; CHUTE CG, 1993, J UROLOGY, V150, P85, DOI 10.1016/S0022-5347(17)35405-8; Cottler LB, 2005, J NERV MENT DIS, V193, P431, DOI 10.1097/01.nmd.0000168245.56563.90; Dattilo PB, 2007, J CLIN PSYCHIAT, V68, P1309, DOI 10.4088/JCP.v68n0821e; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Desai RA, 2003, J NERV MENT DIS, V191, P365, DOI 10.1097/01.NMD.0000071584.88965.E1; Dommasch M, 2014, J AM COLL CARDIOL, V63, P2432, DOI 10.1016/j.jacc.2014.02.525; Feuchtl A, 2004, PHARMACOPSYCHIATRY, V37, P180, DOI 10.1055/s-2004-827175; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Francino MC, 2012, CLIN TOXICOL, V50, P215, DOI 10.3109/15563650.2012.660696; Fulop M, 1997, AM J NEPHROL, V17, P421, DOI 10.1159/000169134; Gijsman HJ, 1998, J CLIN PSYCHOPHARM, V18, P289, DOI 10.1097/00004714-199808000-00007; HALL RCW, 1981, BRIT J CLIN PHARMACO, V11, pS99; HAMIK A, 1989, BIOL PSYCHIAT, V25, P569, DOI 10.1016/0006-3223(89)90217-5; Horinek EL, 2009, ANN PHARMACOTHER, V43, P1964, DOI 10.1345/aph.1M313; Howell C, 2007, BRIT J CLIN PHARMACO, V64, P192, DOI 10.1111/j.1365-2125.2007.02849.x; Humphreys BD, 2005, AM J KIDNEY DIS, V46, P143, DOI 10.1053/j.ajkd.2005.04.010; Kalantar-Zadeh K, 2013, NEW ENGL J MED, V369, P374, DOI 10.1056/NEJMcpc1208154; Kovaleva J, 2008, THER DRUG MONIT, V30, P394, DOI 10.1097/FTD.0b013e318170a879; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Kraut JA, 2011, AM J KIDNEY DIS, V58, P480, DOI 10.1053/j.ajkd.2011.05.018; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Manini AF, 2009, J ANAL TOXICOL, V33, P174, DOI 10.1093/jat/33.3.174; Martinez MA, 2005, J ANAL TOXICOL, V29, P262, DOI 10.1093/jat/29.4.262; Marwick J, 2012, ANAESTHESIA, V67, P299, DOI 10.1111/j.1365-2044.2012.07067.x; McQuade DJ, 2014, ANN CLIN BIOCHEM, V51, P167, DOI 10.1177/0004563213506697; Morris CG, 2008, ANAESTHESIA, V63, P294, DOI 10.1111/j.1365-2044.2007.05370.x; Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906; Naghshineh S, 2008, J GEN INTERN MED, V23, P991, DOI 10.1007/s11606-008-0667-0; Oostvogels R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6904; Petrie MS, 2012, CLIN CHEM, V58, P1631, DOI 10.1373/clinchem.2011.174649; Porter WH, 2012, CLIN CHIM ACTA, V413, P365, DOI 10.1016/j.cca.2011.10.034; Postolache TT, 2010, J AFFECT DISORDERS, V121, P88, DOI 10.1016/j.jad.2009.05.015; Prigerson HG, 2003, SOC PSYCH PSYCH EPID, V38, P213, DOI 10.1007/s00127-003-0621-8; PUOPOLO PR, 1991, CLIN CHEM, V37, P701; Robin Christian, 2002, Anesth Prog, V49, P128; SCHELLING JR, 1990, ANN INTERN MED, V113, P580, DOI 10.7326/0003-4819-113-8-580; Semler MW, 2013, CHEST, V143, P1740, DOI 10.1378/chest.12-1837; Service JA, 2008, CLIN TOXICOL, V46, P71, DOI 10.1080/15563650701275322; Weinbroum AA, 2001, EUR J ANAESTH, V18, P789, DOI 10.1046/j.1365-2346.2001.00922.x; Wilson A. D., 2007, Journal of Toxicological Sciences, V32, P97, DOI 10.2131/jts.32.97	52	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					465	473		10.1056/NEJMcpc1410940	http://dx.doi.org/10.1056/NEJMcpc1410940			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629745				2022-12-28	WOS:000348649700012
J	Green, RC; Lautenbach, D; McGuire, AL				Green, Robert C.; Lautenbach, Denise; McGuire, Amy L.			GINA, Genetic Discrimination, and Genomic Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Green, Robert C.; Lautenbach, Denise] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Green, Robert C.] Partners Personalized Med, Boston, MA USA; [Green, Robert C.] Broad Inst, Boston, MA USA; [Green, Robert C.] Harvard Univ, Sch Med, Boston, MA USA; [McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Baylor College of Medicine	Green, RC (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.							Bard JS, 2011, J LAW MED ETHICS, V39, P469, DOI 10.1111/j.1748-720X.2011.00615.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Parkman AA, 2014, J GENET COUNS; Taylor DH, 2010, HEALTH AFFAIR, V29, P102, DOI 10.1377/hlthaff.2009.0525; Vassy JL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-85	5	115	116	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					397	399		10.1056/NEJMp1404776	http://dx.doi.org/10.1056/NEJMp1404776			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629736				2022-12-28	WOS:000348649700002
J	Slomski, A				Slomski, Anita			Hyperkalemia Controlled With 2 Novel Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Packham DK, 2015, NEW ENGL J MED, V372, P222, DOI 10.1056/NEJMoa1411487; Weir MR, 2015, NEW ENGL J MED, V372, P211, DOI 10.1056/NEJMoa1410853	2	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					347	347		10.1001/jama.2014.18441	http://dx.doi.org/10.1001/jama.2014.18441			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626028				2022-12-28	WOS:000349072600008
J	Zahnle, K				Zahnle, Kevin			Play it again, SAM	SCIENCE			English	Editorial Material							MARS; VOLATILES; METHANE; ORIGIN; LIFE		NASA, Space Sci & Astrobiol Div, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Zahnle, K (corresponding author), NASA, Space Sci & Astrobiol Div, Ames Res Ctr, Moffett Field, CA 94035 USA.	kevin.j.zahnle@nasa.gov						Amerstorfer U. V., 2003, INT J ASTROBIOL, V2, P195, DOI [10.1017/S1473550403001605, DOI 10.1017/S1473550403001605]; ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; Bogard DD, 2001, SPACE SCI REV, V96, P425, DOI 10.1023/A:1011974028370; Christensen PR, 2006, ELEMENTS, V2, P151, DOI 10.2113/gselements.2.3.151; CHYBA CF, 1990, NATURE, V348, P113, DOI 10.1038/348113a0; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Mahaffy PR, 2015, SCIENCE, V347, P412, DOI 10.1126/science.1260291; Montmessin F, 2007, J GEOPHYS RES-PLANET, V112, DOI [10.1029/2006JE002772, 10.1029/2007JE002944]; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Sullivan W, 1969, NEW YORK TIMES 0808 NEW YORK TIMES 0808, P1; Webster CR, 2015, SCIENCE, V347, P415, DOI 10.1126/science.1261713; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027	12	21	21	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					370	371		10.1126/science.aaa3687	http://dx.doi.org/10.1126/science.aaa3687			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613875				2022-12-28	WOS:000348225800015
J	Zhang, B; Cao, C				Zhang, Bo; Cao, Cong			Four gaps in China's new environmental law	NATURE			English	Editorial Material									[Zhang, Bo] Minist Environm Protect, Informat Ctr, Beijing, Peoples R China; [Cao, Cong] Univ Nottingham, Sch Contemporary Chinese Studies, Nottingham NG7 2RD, England	University of Nottingham	Zhang, B (corresponding author), Minist Environm Protect, Informat Ctr, Beijing, Peoples R China.	zhangbo@mep.gov.cn; cong.cao@nottingham.ac.uk	Cao, Cong/U-1847-2019					Boyd D. R., 2014, STATUS CONSTITUTIONA; Economy E. C., 2010, RIVERS RUNS BLACK EN; HAHN RW, 1994, NAT RESOUR J, V34, P305; McElwee Charles R., 2011, ENV LAW CHINA MITIGA; Ren Y, 2000, INT REV ENV STRATEGI, V1, P79; Wang AL, 2013, HARVARD ENVIRON LAW, V37, P365	6	53	54	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					433	434		10.1038/517433a	http://dx.doi.org/10.1038/517433a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ4MU	25612037	Bronze			2022-12-28	WOS:000348196500014
J	Katz, IT; Leister, E; Kacanek, D; Hughes, MD; Bardeguez, A; Livingston, E; Stek, A; Shapiro, DE; Tuomala, R				Katz, Ingrid T.; Leister, Erin; Kacanek, Deborah; Hughes, Michael D.; Bardeguez, Arlene; Livingston, Elizabeth; Stek, Alice; Shapiro, David E.; Tuomala, Ruth			Factors Associated With Lack of Viral Suppression at Delivery Among Highly Active Antiretroviral Therapy-Naive Women With HIV A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1-INFECTED WOMEN; RISK-FACTORS; HEALTH LITERACY; TRANSMISSION; ADHERENCE; LOAD; RNA; PREVENTION; INFANTS	Background: A high delivery maternal plasma HIV-1 RNA level (viral load [VL]) is a risk factor for mother-to-child transmission and poor maternal health. Objective: To identify factors associated with detectable VL at delivery despite initiation of highly active antiretroviral therapy (HAART) during pregnancy. Design: Multicenter observational study. (ClinicalTrial.gov: NCT00028145) Setting: 67 U.S. AIDS clinical research sites. Patients: Pregnant women with HIV who initiated HAART during pregnancy. Measurements: Descriptive summaries and associations among sociodemographic, HIV disease, and treatment characteristics; pregnancy-related risk factors; and detectable VL (>400 copies/mL) at delivery. Results: Between 2002 and 2011, 671 women met inclusion criteria and 13.1% had detectable VL at delivery. Factors associated with detectable VL included multiparity (16.4% vs. 8.0% nulliparity; P = 0.002), black ethnicity (17.6% vs. 6.6% Hispanic and 6.6% white; P < 0.001), 11th grade education or less (17.6% vs. 12.1% had a high school diploma; P = 0.013), initiation of HAART in the third trimester (23.9% vs. 12.3% and 8.6% in the second and trimesters, respectively; P = 0.003), having an HIV diagnosis before the current pregnancy (16.1% vs. 11.0% during the current pregnancy; P = 0.051), and having the first prenatal visit in the third trimester (33.3% vs. 14.3% and 10.5% in the second and third trimesters, respectively; P = 0.002). Women who had treatment interruptions or reported poor medication adherence were more likely to have detectable VL at delivery. Limitation: Data on many covariates were incomplete because women entered the study at varying times during pregnancy. Conclusion: A total of 13.1% of women who initiated HAART during pregnancy had detectable VL at delivery. The timing of HAART initiation and prenatal care, along with medication adherence during pregnancy, were associated with detectable VL at delivery. Social factors, including ethnicity and education, may help identify women who could benefit from focused efforts to promote early HAART initiation and adherence.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Brigham & Womens Hosp,Ctr Global Hlth, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Duke Univ, Sch Med, Durham, NC USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; Duke University; University of Southern California	Katz, IT (corresponding author), Brigham & Womens Hosp, Div Womens Hlth, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.	ikatz2@partners.org	Livingston, Elizabeth/AAQ-8879-2021	Livingston, Elizabeth/0000-0003-1642-5516; Katz, Ingrid/0000-0002-3014-238X	U.S. Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068634, U01AI068632, U01AI041110, U01AI068616, P30AI060354, UM1AI068616, UM1AI068632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097667] Funding Source: NIH RePORTER	U.S. Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	U.S. Department of Health and Human Services.	Abramczuk BM, 2011, CLIN VACCINE IMMUNOL, V18, P1406, DOI 10.1128/CVI.05065-11; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2012, REC US ANT DRUGS PRE, P1; Bailey A, 1999, AIDS, V13, P1377, DOI 10.1097/00002030-199907300-00016; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bardeguez AD, 2008, JAIDS-J ACQ IMM DEF, V48, P408, DOI 10.1097/QAI.0b013e31817bbe80; Bogart LM, 2005, JAIDS-J ACQ IMM DEF, V38, P213, DOI 10.1097/00126334-200502010-00014; Borges-Almeida E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-38; CHOO V, 1994, LANCET, V343, P533, DOI 10.1016/S0140-6736(94)91477-X; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Cunningham CK, 2004, JAIDS-J ACQ IMM DEF, V36, P800, DOI 10.1097/00126334-200407010-00006; Cunningham WE, 2005, J HEALTH CARE POOR U, V16, P655; Frater AJ, 2002, AIDS, V16, P1139, DOI 10.1097/00002030-200205240-00007; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; Heresi GP, 1997, CLIN INFECT DIS, V25, P739, DOI 10.1086/516938; Izzo I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-124; Joao EC, 2012, INT J STD AIDS, V23, P44, DOI 10.1258/ijsa.2011.010545; Kalichman SC, 2010, PSYCHOSOM MED, V72, P810, DOI 10.1097/PSY.0b013e3181f01be3; Katz IT, 2011, AIDS, V25, P2177, DOI 10.1097/QAD.0b013e32834b6464; Katz IT, 2010, JAIDS-J ACQ IMM DEF, V54, P27, DOI 10.1097/QAI.0b013e3181caea89; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Leisegang R, 2011, P 18 C RETR OPP INF; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Melekhin VV, 2010, AIDS PATIENT CARE ST, V24, P279, DOI 10.1089/apc.2009.0283; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Okonji JA, 2012, JAIDS-J ACQ IMM DEF, V61, P249, DOI 10.1097/QAI.0b013e318262514f; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P835, DOI 10.1111/j.1525-1497.2006.00527.x; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Peters V, 2003, PEDIATRICS, V111, P1186; Read PJ, 2012, AIDS, V26, P1095, DOI 10.1097/QAD.0b013e3283536a6c; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sha BE, 2011, HIV CLIN TRIALS, V12, P9, DOI 10.1310/hct1201-9; Shacham E, 2010, AIDS PATIENT CARE ST, V24, P229, DOI 10.1089/apc.2009.0275; Shaffer N, 1999, J INFECT DIS, V179, P590, DOI 10.1086/314641; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Slogrove A, 2012, J TROP PEDIATRICS, V58, P505, DOI 10.1093/tropej/fms019; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thorburn S, 2005, WOMEN HEALTH, V42, P23, DOI 10.1300/J013v42n01_02; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2	48	30	32	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					90	+		10.7326/M13-2005	http://dx.doi.org/10.7326/M13-2005			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC1NB	25599347	Green Accepted			2022-12-28	WOS:000350106600015
J	Sisti, DA; Segal, AG; Emanuel, EJ				Sisti, Dominic A.; Segal, Andrea G.; Emanuel, Ezekiel J.			Improving Long-term Psychiatric Care Bring Back the Asylum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STATES		[Sisti, Dominic A.; Segal, Andrea G.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Sisti, DA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 3401 Market St,Ste 320, Philadelphia, PA 19104 USA.	sistid@upenn.edu		Sisti, Dominic/0000-0002-2282-9253				Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Dlugacz H. A., 2013, ETHICAL ISSUES PRISO, P49; James DJ, 2006, MENTAL HLTH PROBLEMS; Kisely SR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004408.pub3; MORRISSEY JP, 1986, ANN AM ACAD POLIT SS, V484, P12, DOI 10.1177/0002716286484001002; Scull Andrew, 2011, SAGE HDB MENTAL HLTH, P430; Swanson JW, 2013, AM J PSYCHIAT, V170, P1423, DOI 10.1176/appi.ajp.2013.12091152; Torrey Deberniere J., 2012, JUGYO YOJI; Torrey E. F., 2010, MORE MENTALLY ILL PE	9	83	84	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					243	244		10.1001/jama.2014.16088	http://dx.doi.org/10.1001/jama.2014.16088			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3RS	25602990				2022-12-28	WOS:000348145000011
J	Gomez, H; Kellum, JA				Gomez, Hernando; Kellum, John A.			Lactate in Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EMERGENCY-DEPARTMENT PATIENTS; VENOUS OXYGEN-SATURATION; SERUM LACTATE; PREDICTOR; MORTALITY; THERAPY		[Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Crit Care Med, CRISMA Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kellum, JA (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kellumja@ccm.upmc.edu	Kellum, John A/HCH-2944-2022; Kellum, John/AAP-3072-2020; Gomez, Hernando/ABB-4589-2020	Kellum, John A/0000-0003-1995-2653; Kellum, John/0000-0003-1995-2653; 				[Anonymous], 2014, NEW ENGL J MED, DOI DOI 10.1056/NEJMoa1401602; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Kellum JA, 1997, CHEST, V111, P1301, DOI 10.1378/chest.111.5.1301; Levy B, 2000, CRIT CARE MED, V28, P114, DOI 10.1097/00003246-200001000-00019; Monnet X, 2013, CRIT CARE MED, V41, P1412, DOI 10.1097/CCM.0b013e318275cece; Puskarich MA, 2014, J CRIT CARE, V29, P334, DOI 10.1016/j.jcrc.2013.12.017; Shapiro NI, 2005, ANN EMERG MED, V45, P524, DOI 10.1016/j.annemergmed.2004.12.006; Trzeciak S, 2007, INTENS CARE MED, V33, P970, DOI 10.1007/s00134-007-0563-9	10	18	23	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					194	195		10.1001/jama.2014.13811	http://dx.doi.org/10.1001/jama.2014.13811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585332				2022-12-28	WOS:000347679300020
J	Moses, H; Matheson, DHM; Cairns-Smith, S; George, BP; Palisch, C; Dorsey, ER				Moses, Hamilton, III; Matheson, David H. M.; Cairns-Smith, Sarah; George, Benjamin P.; Palisch, Chase; Dorsey, E. Ray			The Anatomy of Medical Research US and International Comparisons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIOMEDICAL-RESEARCH; HEALTH-CARE; SAFETY; COSTS	IMPORTANCE Medical research is a prerequisite of clinical advances, while health service research supports improved delivery, access, and cost. Few previous analyses have compared the United States with other developed countries. OBJECTIVES To quantify total public and private investment and personnel (economic inputs) and to evaluate resulting patents, publications, drug and device approvals, and value created (economic outputs). EVIDENCE REVIEW Publicly available data from 1994 to 2012 were compiled showing trends in US and international research funding, productivity, and disease burden by source and industry type. Patents and publications (1981-2011) were evaluated using citation rates and impact factors. FINDINGS (1) Reduced science investment: Total US funding increased 6% per year (1994-2004), but rate of growth declined to 0.8% per year (2004-2012), reaching $117 billion (4.5%) of total health care expenditures. Private sources increased from 46%(1994) to 58% (2012). Industry reduced early-stage research, favoring medical devices, bioengineered drugs, and late-stage clinical trials, particularly for cancer and rare diseases. National Insitutes of Health allocations correlate imperfectly with disease burden, with cancer and HIV/AIDS receiving disproportionate support. (2) Underfunding of service innovation: Health services research receives $5.0 billion (0.3% of total health care expenditures) or only 1/20th of science funding. Private insurers ranked last (0.04% of revenue) and health systems 19th (0.1% of revenue) among 22 industries in their investment in innovation. An increment of $8 billion to $15 billion yearly would occur if service firms were to reach median research and development funding. (3) Globalization: US government research funding declined from 57%(2004) to 50% (2012) of the global total, as did that of US companies (50% to 41%), with the total US (public plus private) share of global research funding declining from 57% to 44%. Asia, particularly China, tripled investment from $2.6 billion (2004) to $9.7 billion (2012) preferentially for education and personnel. The US share of life science patents declined from 57%(1981) to 51%(2011), as did those considered most valuable, from 73% (1981) to 59%(2011). CONCLUSIONS AND RELEVANCE New investment is required if the clinical value of past scientific discoveries and opportunities to improve care are to be fully realized. Sources could include repatriation of foreign capital, new innovation bonds, administrative savings, patent pools, and public-private risk sharing collaborations. Given international trends, the United States will relinquish its historical international lead in the next decade unless such measures are undertaken.	[Moses, Hamilton, III] Aler Inst, North Garden, VA USA; [Moses, Hamilton, III] Aler Advisors LLC, North Garden, VA USA; [Moses, Hamilton, III] Johns Hopkins Sch Med, Baltimore, MD USA; [Matheson, David H. M.; Cairns-Smith, Sarah; Palisch, Chase] Boston Consulting Grp Inc, Boston, MA USA; [George, Benjamin P.; Dorsey, E. Ray] Univ Rochester, Sch Med, Rochester, NY USA; [Palisch, Chase] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Johns Hopkins University; Johns Hopkins Medicine; Boston Consulting Group (BCG); University of Rochester; Stanford University	Moses, H (corresponding author), Alerion, POB 150, North Garden, VA 22959 USA.	hm@alerion.us						[Anonymous], 2014, ECONOMIST; Arriaga AF, 2014, ANN SURG, V259, P403, DOI 10.1097/SLA.0000000000000342; Azoulay P., 2013, HDB ORG EC, P575, DOI [10.1515/9781400845354-016, DOI 10.1515/9781400845354-016]; Battelle, 2011, 2012 GLOB R D FUND F; Callahan D, 2009, TAMING THE BELOVED BEAST: HOW MEDICAL TECHNOLOGY COSTS ARE DESTROYING OUR HEALTH CARE SYSTEM, P1; Chakma J, 2014, NEW ENGL J MED, V370, P3, DOI 10.1056/NEJMp1311068; Chatterjee SK, 2014, NAT BIOTECHNOL, V32, P52, DOI 10.1038/nbt.2785; Citeline, 2014, CIT PHARM R D ANN RE; Cortese DA, 2013, JAMA-J AM MED ASSOC, V310, P1937, DOI 10.1001/jama.2013.281856; Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; Cryer L, 2012, HEALTH AFFAIR, V31, P1237, DOI 10.1377/hlthaff.2011.1132; Daniels RJ, 2014, REVERSE GRAYING SCI; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Eappen S, 2013, JAMA-J AM MED ASSOC, V309, P1599, DOI 10.1001/jama.2013.2773; Emanuel EJ, 2013, JAMA-J AM MED ASSOC, V309, P1589, DOI 10.1001/jama.2013.2096; Fingar T, 2013, WASH QUART, V36, P125, DOI 10.1080/0163660X.2013.861718; Fortunato S, 2014, NATURE, V508, P186, DOI 10.1038/508186a; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Goodwin I, 2000, PHYS TODAY, V53, P53, DOI 10.1063/1.883037; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Hoffman A, 2013, JAMA-J AM MED ASSOC, V309, P661, DOI 10.1001/jama.2012.214571; Johnson JA, 2013, BRIEF HIST NIH FUNDI; Lerner J, 2014, SCIENCE, V343, P972, DOI 10.1126/science.1246439; Mathews AW, 2014, WELLPOINT ADVISES HL; McGraw Hill Financial, S P DOW JON IND DAT; Mokyr Joel, 1990, LEVER RICHES TECHNOL; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Moses H, 2013, JAMA-J AM MED ASSOC, V310, P1947, DOI 10.1001/jama.2013.281425; Moses H, 2011, NEW ENGL J MED, V364, P567, DOI 10.1056/NEJMsb1007634; Mullard A, 2014, NAT REV DRUG DISCOV, V13, P241, DOI 10.1038/nrd4293; Murphy K, 2003, PERSPECT BIOL MED, V46, pS108, DOI 10.1353/pbm.2003.0048; National Institutes of Health Office of Budget, 2013, PRINC IND; National Science Foundation, SCI ENG IND 2012 OUT; National Science Foundation, BUS R D INN SURV; New York Stock Exchange, IND SERV; Organisation for Economic Co-operation and Development, OECD SCI TECHN R D S; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571; Pearl R, 2014, HEALTH AFFAIR, V33, P251, DOI 10.1377/hlthaff.2013.1005; Pew Research Center, 2009, PUBL PRAIS SCI SCI F; Pharmaceutical Research and Manufacturers of America, RAR DIS REP ORPH DRU; Pharmaceutical Research and Manufacturers of America, 2013, 2013 BIOPH RES IND P; Pronovost PJ, 2014, AM J MED QUAL, V29, P165, DOI 10.1177/1062860613495554; Rai Arti K., 2003, LAW CONTEMP PROBL, V66, P289; Reardon S, 2014, NATURE, V508, P16, DOI 10.1038/508016a; Semel ME, 2010, HEALTH AFFAIR, V29, P1593, DOI 10.1377/hlthaff.2009.0709; Stevens H., 2013, LIFE OUT SEQUENCE DA; Stewart T.A, 2007, WEALTH KNOWLEDGE INT; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261; US Census Bureau, ANN Q SERV	49	263	269	2	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					174	189		10.1001/jama.2014.15939	http://dx.doi.org/10.1001/jama.2014.15939			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY6MC	25585329				2022-12-28	WOS:000347679300017
J	Iacobucci, G				Iacobucci, Gareth			PROFILE Terence Stephenson: ready to navigate stormy waters once again?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLAN					giacobucci@bmj.com						Iacobucci G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h12; Iacobucci G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6430; Limb M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1146	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2015	350								h143	10.1136/bmj.h143	http://dx.doi.org/10.1136/bmj.h143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3ME	25575498				2022-12-28	WOS:000348130800005
J	Elwyn, G; Buckman, L				Elwyn, Glyn; Buckman, Laurence			Should doctors encourage patients to record consultations?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Elwyn, Glyn] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA; [Buckman, Laurence] Temple Fortune Hlth Ctr, London, England	Dartmouth College	Elwyn, G (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, 37 Dewey Field Rd, Hanover, NH 03755 USA.	GElwynglynelwyn@gmail.com; LBuckmanl.buckman@ntlworld.com	Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286; Li, Yu-Chuan (Jack)/0000-0001-6497-4232				Clements N, 2012, DILEMMA RECORDING CO; Coleman T, 2000, FAM PRACT, V17, P422, DOI 10.1093/fampra/17.5.422; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Elwyn G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2078; General Medical Council, 2013, MAK US VIS AUD REC P; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; Medical Defence Union, 2013, WHAT SHOULD YOU DO P; PRINGLE M, 1990, BRIT J GEN PRACT, V40, P455; Stacey D., 2014, COCHRANE DB SYST REV, V4, pCD001431, DOI [10.1002/14651858.CD001431.pub5, DOI 10.1002/14651858.CD001431.PUB5, 10.1002/14651858.CD001431.pub4, DOI 10.1002/14651858.CD001431.PUB4]; Tsulukidze M, 2014, PATIENT EDUC COUNS, V95, P297, DOI 10.1016/j.pec.2014.02.007; Vox F., 2010, REUTERS; Walker J, 2014, NEW ENGL J MED, V370, P6, DOI 10.1056/NEJMp1310132; Welch H, 2011, OVERDIAGNOSED MAKING	13	14	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2015	350								g7645	10.1136/bmj.g7645	http://dx.doi.org/10.1136/bmj.g7645			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3MB	25569249				2022-12-28	WOS:000348130500002
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Working miracles for the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2015	350								g7842	10.1136/bmj.g7842	http://dx.doi.org/10.1136/bmj.g7842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LX	25569632				2022-12-28	WOS:000348130100005
J	Robins, AH; Holland, M				Robins, Ashley H.; Holland, Merlin			The art of medicine The enigmatic illness and death of Constance, wife of Oscar Wilde	LANCET			English	Editorial Material									[Robins, Ashley H.] Univ Cape Town, Sch Med, Dept Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Robins, AH (corresponding author), Univ Cape Town, Sch Med, Dept Med, ZA-7925 Cape Town, South Africa.	ashley.robins@uct.ac.za							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					21	22		10.1016/S0140-6736(14)62468-5	http://dx.doi.org/10.1016/S0140-6736(14)62468-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AX8IW	25592892				2022-12-28	WOS:000347154200015
J	Green, A				Green, Andrew			Remembering health workers who died from Ebola in 2014 Obituary	LANCET			English	Biographical-Item																			0	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2201	2206		10.1016/S0140-6736(14)62417-X	http://dx.doi.org/10.1016/S0140-6736(14)62417-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25625389	Bronze			2022-12-28	WOS:000346655700015
J	Westendorp, WF; Vermeij, JD; Zock, E; Hooijenga, IJ; Kruyt, ND; Bosboom, HJLW; Kwa, VIH; Weisfelt, M; Remmers, MJM; ten Houten, R; Schreuder, AHCM; Vermeer, SE; van Dijk, EJ; Dippel, DWJ; Dijkgraaf, MGW; Spanjaard, L; Vermeulen, M; van der Poll, T; Prins, JM; Vermeij, FH; Roos, YBWEM; Kleyweg, RP; Kerkhoff, H; Brouwer, MC; Zwinderman, AH; van de Beek, D; Nederkoorn, PJ				Westendorp, Willeke F.; Vermeij, Jan-Dirk; Zock, Elles; Hooijenga, Imke J.; Kruyt, Nyika D.; Bosboom, Hans J. L. W.; Kwa, Vincent I. H.; Weisfelt, Martijn; Remmers, Michel J. M.; ten Houten, Robert; Schreuder, A. H. C. M. (Tobien); Vermeer, Sarah E.; van Dijk, Ewout J.; Dippel, Diederik W. J.; Dijkgraaf, Marcel G. W.; Spanjaard, Lodewijk; Vermeulen, Marinus; van der Poll, Tom; Prins, Jan M.; Vermeij, Frederique H.; Roos, Yvo B. W. E. M.; Kleyweg, Ruud P.; Kerkhoff, Henk; Brouwer, Matthijs C.; Zwinderman, Aeilko H.; van de Beek, Diederik; Nederkoorn, Paul J.		PASS Investigators	The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial	LANCET			English	Article							ACUTE ISCHEMIC-STROKE; INFECTION; THERAPY; CARE; MINOCYCLINE; OUTCOMES; UPDATE	Background In adults with acute stroke, infections occur commonly and are associated with an unfavourable functional outcome. In the Preventive Antibiotics in Stroke Study (PASS) we aimed to establish whether or not preventive antimicrobial therapy with a third-generation cephalosporin, ceftriaxone, improves functional outcome in patients with acute stroke. Methods In this multicentre, randomised, open-label trial with masked endpoint assessment, patients with acute stroke were randomly assigned to intravenous ceftriaxone at a dose of 2 g, given every 24 h intravenously for 4 days, in addition to stroke unit care, or standard stroke unit care without preventive antimicrobial therapy; assignments were made within 24 h after symptom onset. The primary endpoint was functional outcome at 3 months, defined according to the modified Rankin Scale and analysed by intention to treat. The primary analysis was by ordinal regression of the primary outcome. Secondary outcomes included death, infection rates, antimicrobial use, and length of hospital stay. Participants and caregivers were aware of treatment allocation but assessors of outcome were masked to group assignment. This trial is registered with controlled-trials.com, number ISRCTN66140176. Findings Between July 6, 2010, and March 23, 2014, a total of 2550 patients from 30 sites in the Netherlands, including academic and non-academic medical centres, were randomly assigned to the two treatment groups: 1275 patients to ceftriaxone and 1275 patients to standard treatment (control group). 12 patients (seven in the ceftriaxone group and five in the control group) withdrew consent immediately after randomisation, leaving 2538 patients available for the intention-to-treat-analysis (1268 in the ceftriaxone group and 1270 in the control group). 2514 (99%) of 2538 patients (1257 in each group) completed 3-month follow-up. Preventive ceftriaxone did not affect the distribution of functional outcome scores on the modified Rankin Scale at 3 months (adjusted common odds ratio 0.95 [95% CI 0.82-1.09], p=0.46). Preventive ceftriaxone did not result in an increased occurrence of adverse events. Overgrowth infection with Clostridium difficile occurred in two patients (<1%) in the ceftriaxone group and none in the control group. Interpretation Preventive ceftriaxone does not improve functional outcome at 3 months in adults with acute stroke. The results of our trial do not support the use of preventive antibiotics in adults with acute stroke.	[Westendorp, Willeke F.; Vermeij, Jan-Dirk; Hooijenga, Imke J.; Vermeulen, Marinus; Roos, Yvo B. W. E. M.; Brouwer, Matthijs C.; van de Beek, Diederik; Nederkoorn, Paul J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; [Spanjaard, Lodewijk] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Med Microbiol, NL-1100 DD Amsterdam, Netherlands; [van der Poll, Tom; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Infect Dis, NL-1100 DD Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Clin Epidemiol & Biostat, NL-1100 DD Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Clin Res Unit, NL-1100 DD Amsterdam, Netherlands; [Zock, Elles; Kleyweg, Ruud P.; Kerkhoff, Henk] Albert Schweitzer Hosp, Dept Neurol, Dordrecht, Netherlands; [Kruyt, Nyika D.] Slotervaart Hosp, Dept Neurol, Amsterdam, Netherlands; [Bosboom, Hans J. L. W.] Onze Lieve Vrouw Hosp, Dept Neurol, Amsterdam, Netherlands; [Weisfelt, Martijn] Kennemer Gasthuis, Dept Neurol, Haarlem, Netherlands; [Remmers, Michel J. M.] Amphia Ziekenhuis, Dept Neurol, Breda, Netherlands; [ten Houten, Robert] Med Centrum Alkmaar, Dept Neurol, Alkmaar, Netherlands; [Schreuder, A. H. C. M. (Tobien)] Atrium Med Ctr, Dept Neurol, Heerlen, Netherlands; [Vermeer, Sarah E.] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands; [van Dijk, Ewout J.] Donders Inst Brain Cognit & Behav, Radboudumc, Dept Neurol, Nijmegen, Netherlands; [Dippel, Diederik W. J.] Erasmus MC Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Vermeij, Frederique H.] St Franciscus Gasthuis, Dept Neurol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Albert Schweitzer Ziekenhuis; Slotervaart Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Spaarne Hospital; Amphia Hospital; Medical Center Of Alkmaar; Atrium Medical Center; Rijnstate Hospital; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Franciscus Gasthuis	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Neurol, POB 22660, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	Prins, Jan M./AAF-4945-2020; Dippel, Diederik/AAJ-2192-2020; van de Beek, Diederik/Y-2713-2019; Westendorp, Willeke/GWQ-7878-2022; van Dijk, Ewoud J/J-7951-2012; Roos, Yvo BWEM/B-9843-2013	Dippel, Diederik/0000-0002-9234-3515; van de Beek, Diederik/0000-0002-4571-044X; Brouwer, Matthijs/0000-0001-7775-7843; Prins, Jan/0000-0002-5415-8933	Netherlands Organization for Health Research and Development; Netherlands Heart Foundation; European Research Council	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); European Research Council(European Research Council (ERC)European Commission)	Netherlands Organization for Health Research and Development, Netherlands Heart Foundation, and the European Research Council.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; De Falco FA, 1998, RIV NEUROBIOLOGIA, V44, P63; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Harms H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002158; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Machado LS, 2009, STROKE, V40, P3028, DOI 10.1161/STROKEAHA.109.556852; Nederkoorn PJ, 2011, INT J STROKE, V6, P159, DOI 10.1111/j.1747-4949.2010.00555.x; Popovic N, 2013, J STROKE CEREBROVASC, V22, P424, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.003; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schwarz S, 2008, STROKE, V39, P1220, DOI 10.1161/STROKEAHA.107.499533; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Wechsler LR, 2011, NEW ENGL J MED, V364, P2138, DOI 10.1056/NEJMct1007370; Westendorp WF, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-382; Westendorp WF, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-133; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; WHITEHEAD J, 1993, STAT MED, V12, P2257, DOI 10.1002/sim.4780122404; World Health Organization (WHO), ATC DDD IND 2015	25	191	201	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1519	1526		10.1016/S0140-6736(14)62456-9	http://dx.doi.org/10.1016/S0140-6736(14)62456-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25612858				2022-12-28	WOS:000353220000033
J	Geula, S; Moshitch-Moshkovitz, S; Dominissini, D; Mansour, AA; Kol, N; Salmon-Divon, M; Hershkovitz, V; Peer, E; Mor, N; Manor, YS; Ben-Haim, MS; Eyal, E; Yunger, S; Pinto, Y; Jaitin, DA; Viukov, S; Rais, Y; Krupalnik, V; Chomsky, E; Zerbib, M; Maza, I; Rechavi, Y; Massarwa, R; Hanna, S; Amit, I; Levanon, EY; Amariglio, N; Stern-Ginossar, N; Novershtern, N; Rechavi, G; Hanna, JH				Geula, Shay; Moshitch-Moshkovitz, Sharon; Dominissini, Dan; Mansour, Abed AlFatah; Kol, Nitzan; Salmon-Divon, Mali; Hershkovitz, Vera; Peer, Eyal; Mor, Nofar; Manor, Yair S.; Ben-Haim, Moshe Shay; Eyal, Eran; Yunger, Sharon; Pinto, Yishay; Jaitin, Diego Adhemar; Viukov, Sergey; Rais, Yoach; Krupalnik, Vladislav; Chomsky, Elad; Zerbib, Mirie; Maza, Itay; Rechavi, Yoav; Massarwa, Rada; Hanna, Suhair; Amit, Ido; Levanon, Erez Y.; Amariglio, Ninette; Stern-Ginossar, Noam; Novershtern, Noa; Rechavi, Gideon; Hanna, Jacob H.			m(6)A mRNA methylation facilitates resolution of naive pluripotency toward differentiation	SCIENCE			English	Article							STATE	Naive and primed pluripotent states retain distinct molecular properties, yet limited knowledge exists on how their state transitions are regulated. Here, we identify Mettl3, an N-6-methyladenosine (m(6)A) transferase, as a regulator for terminating murine naive pluripotency. Mettl3 knockout preimplantation epiblasts and naive embryonic stem cells are depleted for m(6)A in mRNAs, yet are viable. However, they fail to adequately terminate their naive state and, subsequently, undergo aberrant and restricted lineage priming at the postimplantation stage, which leads to early embryonic lethality. m(6)A predominantly and directly reduces mRNA stability, including that of key naive pluripotency-promoting transcripts. This study highlights a critical role for an mRNA epigenetic modification in vivo and identifies regulatory modules that functionally influence naive and primed pluripotency in an opposing manner.	[Geula, Shay; Mansour, Abed AlFatah; Mor, Nofar; Manor, Yair S.; Viukov, Sergey; Rais, Yoach; Krupalnik, Vladislav; Chomsky, Elad; Zerbib, Mirie; Maza, Itay; Rechavi, Yoav; Massarwa, Rada; Hanna, Suhair; Stern-Ginossar, Noam; Novershtern, Noa; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Moshitch-Moshkovitz, Sharon; Kol, Nitzan; Salmon-Divon, Mali; Hershkovitz, Vera; Peer, Eyal; Ben-Haim, Moshe Shay; Eyal, Eran; Yunger, Sharon; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Moshitch-Moshkovitz, Sharon; Kol, Nitzan; Salmon-Divon, Mali; Hershkovitz, Vera; Peer, Eyal; Ben-Haim, Moshe Shay; Eyal, Eran; Yunger, Sharon; Amariglio, Ninette; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Dominissini, Dan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dominissini, Dan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Pinto, Yishay; Levanon, Erez Y.; Amariglio, Ninette] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Jaitin, Diego Adhemar; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Hanna, Suhair] Technion Israel Inst Technol, Rambam Med Ctr, Dept Pediat, Haifa, Israel; [Hanna, Suhair] Technion Israel Inst Technol, Rambam Med Ctr, Pediat Immunol Unit, Haifa, Israel; [Hanna, Suhair] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel	Weizmann Institute of Science; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Chicago; University of Chicago; Bar Ilan University; Weizmann Institute of Science; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	noa.novershtern@weizmann.ac.il; gidi.rechavi@sheba.health.gov.il; jacob.hanna@weizmann.ac.il	Salmon-Divon, Mali/AAG-4479-2019; Pinto, Yishay/ABF-2877-2020; Geula, Shay Yosef/Z-3789-2019; mansour, abed/GWC-2134-2022; Hanna, Jacob/K-1339-2012; Levanon, Erez Y/A-8128-2012	Salmon-Divon, Mali/0000-0002-7272-0846; Geula, Shay Yosef/0000-0001-8111-4410; Hanna, Jacob/0000-0003-2042-9974; Levanon, Erez Y/0000-0002-3641-4198; , Noam/0000-0003-3583-5932; Dominissini, Dan/0000-0003-1121-5130; Ben-Haim, Moshe Shay/0000-0003-4737-9102; Mansour, Abed AlFatah/0000-0001-9025-6998; Mor, Nofar/0000-0001-5826-4533; Novershtern, Noa/0000-0002-2244-6877	Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation [1667/12, 41/11, 1796/12]; Israeli Centers of Excellence (I-CORE) Program; Ernest and Bonnie Beutler Research Program; Human Frontier Science Program long-term fellowship; Ilana and Pascal Mantoux; New York Stem Cell Foundation; FAMRI; Kimmel Innovator Research Award; European Research Council [StG-2011-281906]; Leona M. and Harry B. Helmsley Charitable Trust; Britain Israel Research and Academic Exchange Partnership Regenerative Medicine Initiative; Sir Charles Clore Research Prize; Israel Science Foundation; Israel Cancer Research Fund; Benoziyo endowment fund; Helen and Martin Kimmel Institute for Stem Cell Research; Fritz Thyssen Stiftung; Erica A. and Robert Drake; Weizmann Institute	Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation(Israel Science Foundation); Israeli Centers of Excellence (I-CORE) Program; Ernest and Bonnie Beutler Research Program; Human Frontier Science Program long-term fellowship(Human Frontier Science Program); Ilana and Pascal Mantoux; New York Stem Cell Foundation; FAMRI; Kimmel Innovator Research Award; European Research Council(European Research Council (ERC)European Commission); Leona M. and Harry B. Helmsley Charitable Trust; Britain Israel Research and Academic Exchange Partnership Regenerative Medicine Initiative; Sir Charles Clore Research Prize; Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; Benoziyo endowment fund; Helen and Martin Kimmel Institute for Stem Cell Research; Fritz Thyssen Stiftung; Erica A. and Robert Drake; Weizmann Institute	G.R. is supported by grants from the Flight Attendant Medical Research Institute (FAMRI), the Israel Science Foundation (grant no. 1667/12), the Israeli Centers of Excellence (I-CORE) Program and The Israel Science Foundation (grants no. 41/11 and no. 1796/12), and the Ernest and Bonnie Beutler Research Program. G.R. is a member of the Sagol Neuroscience Network and holds the Djerassi Chair for Oncology (Sackler Faculty of Medicine, Tel-Aviv University, Israel). D.D. is supported by a Human Frontier Science Program long-term fellowship. J.H.H. is supported by a generous gift from Ilana and Pascal Mantoux; the New York Stem Cell Foundation; FAMRI; the Kimmel Innovator Research Award; the European Research Council starting grant (StG-2011-281906); the Leona M. and Harry B. Helmsley Charitable Trust; Britain Israel Research and Academic Exchange Partnership Regenerative Medicine Initiative; The Sir Charles Clore Research Prize; the Israel Science Foundation (Bikura, Morasha, ICORE, and Regular research programs); the Israel Cancer Research Fund; the Benoziyo endowment fund; the Helen and Martin Kimmel Institute for Stem Cell Research; Fritz Thyssen Stiftung; and Erica A. and Robert Drake. J.H.H. is a New York Stem Cell Foundation-Robertson Investigator. We thank Weizmann Institute management for providing critical financial and infrastructural support. DNA sequencing data have been deposited under National Center for Biotechnology Information, Gene Expression Omnibus submission GSE61998. All authors declare lack of conflict of interest.	Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Saletore Y, 2013, RNA BIOL, V10, P342, DOI 10.4161/rna.23812; Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902	13	955	1000	17	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					1002	1006		10.1126/science.1261417	http://dx.doi.org/10.1126/science.1261417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25569111				2022-12-28	WOS:000349958900041
J	Peretti, D; Bastide, A; Radford, H; Verity, N; Molloy, C; Martin, MG; Moreno, JA; Steinert, JR; Smith, T; Dinsdale, D; Willis, AE; Mallucci, GR				Peretti, Diego; Bastide, Amandine; Radford, Helois; Verity, Nicholas; Molloy, Colin; Martin, Maria Guerra; Moreno, Julie A.; Steinert, Joern R.; Smith, Tim; Dinsdale, David; Willis, Anne E.; Mallucci, Giovanna R.			RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration	NATURE			English	Article							BINDING PROTEIN RBM3; ALZHEIMERS-DISEASE; HYPOTHERMIA; HIBERNATION; DYSFUNCTION; SECTIONS; DYNAMICS; MICE; RAT; CA1	In the healthy adult brain synapses are continuously remodelled through a process of elimination and formation known as structural plasticity(1). Reduction in synapse number is a consistent early feature of neurodegenerative diseases(2,3), suggesting deficient compensatory mechanisms. Although much is known about toxic processes leading to synaptic dysfunction and loss in these disorders(2,3), how synaptic regeneration is affected is unknown. In hibernating mammals, cooling induces loss of synaptic contacts, which are reformed on rewarming, a form of structural plasticity(4,5). We have found that similar changes occur in artificially cooled laboratory rodents. Cooling and hibernation also induce a number of cold-shock proteins in the brain, including the RNA binding protein, RBM3 (ref. 6). The relationship of such proteins to structural plasticity is unknown. Here we show that synapse regeneration is impaired in mouse models of neurodegenerative disease, in association with the failure to induce RBM3. In both prion-infected and 5XFAD (Alzheimer-type) mice(7), the capacity to regenerate synapses after cooling declined in parallel with the loss of induction of RBM3. Enhanced expression of RBM3 in the hippocampus prevented this deficit and restored the capacity for synapse reassembly after cooling. RBM3 overexpression, achieved either by boosting endogenous levels through hypothermia before the loss of the RBM3 response or by lentiviral delivery, resulted in sustained synaptic protection in 5XFAD mice and throughout the course of prion disease, preventing behavioural deficits and neuronal loss and significantly prolonging survival. In contrast, knockdown of RBM3 exacerbated synapse loss in both models and accelerated disease and prevented the neuroprotective effects of cooling. Thus, deficient synapse regeneration, mediated at least in part by failure of the RBM3 stress response, contributes to synapse loss throughout the course of neurodegenerative disease. The data support enhancing cold-shock pathways as potential protective therapies in neurodegenerative disorders.	[Peretti, Diego; Bastide, Amandine; Radford, Helois; Verity, Nicholas; Molloy, Colin; Martin, Maria Guerra; Moreno, Julie A.; Steinert, Joern R.; Smith, Tim; Dinsdale, David; Willis, Anne E.; Mallucci, Giovanna R.] Univ Leicester, Toxicol Unit, MRC, Leicester LE1 9HN, Leics, England; [Mallucci, Giovanna R.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0AH, England	University of Leicester; University of Cambridge	Mallucci, GR (corresponding author), Univ Leicester, Toxicol Unit, MRC, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	gm522@cam.ac.uk	Steinert, Joern/ABB-4561-2020; Steinert, Joern R/AAI-2742-2020; Moreno, Julie/L-1832-2018; Steinert, Joern/A-6678-2008; Martín, María/HDL-9512-2022	Steinert, Joern R/0000-0003-1640-0845; Moreno, Julie/0000-0002-9618-2712; Steinert, Joern/0000-0003-1640-0845; Molloy, Colin/0000-0001-7179-7721; Mallucci, Giovanna/0000-0001-8504-1191; Bastide, Amandine/0000-0001-7896-8490; Willis, Anne/0000-0002-1470-8531	Medical Research Council, UK; BBSRC [BB/F018738/1, BB/F02326X/2, BB/I019790/1] Funding Source: UKRI; MRC [MC_U132681855, MC_U132692719, MC_UP_A600_1023] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F018738/1, BB/F02326X/2, BB/I019790/1] Funding Source: researchfish; Medical Research Council [MC_U132681855, MC_U132692719, MC_UP_A600_1023] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Edwards, J. McWilliam and D. Read of the MRC Toxicology Unit; members of University of Leicester Department of Biological Services staff; and D. Morrison, University of Cambridge, for technical assistance. We thank J. Skepper, University of Cambridge, for advice about stereological procedures. This work was funded by the Medical Research Council, UK.	Chip S, 2011, NEUROBIOL DIS, V43, P388, DOI 10.1016/j.nbd.2011.04.010; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138, DOI [10.1017/S1431927610055170, DOI 10.1017/S1431927610055170]; Dresios J, 2005, P NATL ACAD SCI USA, V102, P1865, DOI 10.1073/pnas.0409764102; Haustein MD, 2010, J PHYSIOL-LONDON, V588, P4683, DOI 10.1113/jphysiol.2010.199778; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Lee CC, 2008, ANNU REV MED, V59, P177, DOI 10.1146/annurev.med.59.061506.110403; Magarinos AM, 2006, P NATL ACAD SCI USA, V103, P18775, DOI 10.1073/pnas.0608785103; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nguyen KB, 1996, J NEUROSCI METH, V65, P51, DOI 10.1016/0165-0270(95)00145-X; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Popov VI, 2007, NEUROSCIENCE, V149, P549, DOI 10.1016/j.neuroscience.2007.07.059; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; Ruediger J, 2007, SYNAPSE, V61, P343, DOI 10.1002/syn.20380; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; West M. J., 2013, COLD SPRING HARB PRO; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; YANG GCH, 1975, J MICROSC-OXFORD, V103, P385, DOI 10.1111/j.1365-2818.1975.tb03994.x; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	31	134	141	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					236	U215		10.1038/nature14142	http://dx.doi.org/10.1038/nature14142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25607368	Green Accepted, Green Submitted			2022-12-28	WOS:000349190300039
J	Graham, NAJ; Jennings, S; MacNeil, MA; Mouillot, D; Wilson, SK				Graham, Nicholas A. J.; Jennings, Simon; MacNeil, M. Aaron; Mouillot, David; Wilson, Shaun K.			Predicting climate-driven regime shifts versus rebound potential in coral reefs	NATURE			English	Article							GREAT-BARRIER-REEF; MARINE PROTECTED AREAS; FISH COMMUNITIES; PHASE-SHIFTS; INDIAN-OCEAN; STRUCTURAL COMPLEXITY; RECOVERY; RESILIENCE; ECOSYSTEMS; MANAGEMENT	Climate-induced coral bleaching is among the greatest current threats to coral reefs, causing widespread loss of live coral cover(1). Conditions under which reefs bounce back from bleaching events or shift from coral to algal dominance are unknown, making it difficult to predict and plan for differing reef responses under climate change(2). Herewe document and predict long-term reef responses to a major climate-induced coral bleaching event that caused unprecedented region-wide mortality of Indo-Pacific corals. Following loss of >90% live coral cover, 12 of 21 reefs recovered towards pre-disturbance live coral states, while nine reefs underwent regime shifts to fleshy macroalgae. Functional diversity of associated reef fish communities shifted substantially following bleaching, returning towards pre-disturbance structure on recovering reefs, while becoming progressively altered on regime shifting reefs. We identified threshold values for a range of factors that accurately predicted ecosystem response to the bleaching event. Recovery was favoured when reefs were structurally complex and in deeper water, when density of juvenile corals and herbivorous fishes was relatively high and when nutrient loads were low. Whether reefs were inside no-take marine reserves had no bearing on ecosystem trajectory. Although conditions governing regime shift or recovery dynamics were diverse, pre-disturbance quantification of simple factors such as structural complexity and water depth accurately predicted ecosystem trajectories. These findings foreshadow the likely divergent but predictable outcomes for reef ecosystems in response to climate change, thus guiding improved management and adaptation.	[Graham, Nicholas A. J.; MacNeil, M. Aaron; Mouillot, David] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Jennings, Simon] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 OHT, Suffolk, England; [Jennings, Simon] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [MacNeil, M. Aaron] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Mouillot, David] Univ Montpellier 2, ECOSYM, UMR CNRS UM2 5119, F-34095 Montpellier, France; [Wilson, Shaun K.] Dept Pk & Wildlife, Perth, WA 6151, Australia; [Wilson, Shaun K.] Univ Western Australia, Oceans Inst, Sch Plant Biol, Crawley, WA 6009, Australia	James Cook University; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; Australian Institute of Marine Science; Universite de Montpellier; University of Western Australia	Graham, NAJ (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	nick.graham@jcu.edu.au	Graham, Nicholas AJ/C-8360-2014; Jennings, Simon/F-5085-2012; Wilson, Shaun/K-8597-2019; MacNeil, M. Aaron/ABD-6444-2021; MacNeil, Aaron/E-8196-2017	Graham, Nicholas AJ/0000-0002-0304-7467; Jennings, Simon/0000-0002-2390-7225; Wilson, Shaun/0000-0002-4590-0948; MacNeil, M. Aaron/0000-0001-8406-325X; MacNeil, Aaron/0000-0001-8406-325X	Australian Research Council [DP1094932, DE130101705]; Leverhulme Trust [F/00 125/M]; Western Indian Ocean Marine Science Association; Natural Environment Research Council [GR3/1154]	Australian Research Council(Australian Research Council); Leverhulme Trust(Leverhulme Trust); Western Indian Ocean Marine Science Association; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was principally supported by the Australian Research Council (DP1094932, DE130101705), the Leverhulme Trust (F/00 125/M), and the Western Indian Ocean Marine Science Association. The Natural Environment Research Council (GR3/1154) funded work in Fiji. We thank the Seychelles Fishing Authority, Seychelles Marine Parks Authority, Nature Seychelles, and Seychelles National Meteorological Services for technical and logistical assistance. Many thanks to N. Polunin for support early in the project, to N. Cariglia for collecting the sea urchin data, to K. Chong-Seng for collecting the juvenile coral data, to C. Huchery for helping develop the wave exposure model, to J. Turner for photos a and b in Extended Data Fig. 1, and T. McClanahan and N. Dulvy for sharing data used in Extended Data Table 3 and Extended Data Fig. 5. J. Cinner, C. Hicks, K. Nash, and three anonymous referees provided useful comments on the manuscript.	Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Ateweberhan M, 2005, MAR ECOL PROG SER, V292, P159, DOI 10.3354/meps292159; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Atkinson M. J., 1983, LIMNOL OCEANOGR, V26, P1074; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burkepile DE, 2006, ECOLOGY, V87, P2821, DOI 10.1890/0012-9658(2006)87[2821:CMCBMA]2.0.CO;2; Burkepile DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01493; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Cheal AJ, 2013, ECOL APPL, V23, P174, DOI 10.1890/11-2253.1; Chollett I, 2012, CORAL REEFS, V31, P493, DOI 10.1007/s00338-011-0867-7; Chong-Seng KM, 2014, CORAL REEFS, V33, P449, DOI 10.1007/s00338-014-1137-2; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; Done T., 1983, PERSPECTIVES CORAL R, P107; Ekebom J, 2003, ESTUAR COAST SHELF S, V57, P887, DOI 10.1016/S0272-7714(02)00419-5; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Froese R., 2012, FISHBASE; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101204; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jennings S, 1995, CORAL REEFS, V14, P225, DOI 10.1007/BF00334346; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Larned ST, 1997, MAR ECOL PROG SER, V157, P295, DOI 10.3354/meps157295; Legendre P., 2012, NUMERICAL ECOLOGY; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Letourneur Y, 1998, NAGA, V21, P39; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Madin JS, 2006, NATURE, V444, P477, DOI 10.1038/nature05328; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093385; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nash KL, 2013, ECOL APPL, V23, P1632, DOI 10.1890/12-2031.1; Patil A, 2010, J STAT SOFTW, V35, P1; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Rohweder J., 2012, APPL WIND FETCH WAVE; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Umezawa Y, 2002, LIMNOL OCEANOGR, V47, P1405, DOI 10.4319/lo.2002.47.5.1405; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Wessel P., 2014, GSHHG GLOBAL SELF CO; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009	73	469	478	29	625	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					94	+		10.1038/nature14140	http://dx.doi.org/10.1038/nature14140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25607371				2022-12-28	WOS:000349098000038
J	de Montjoye, YA; Radaelli, L; Singh, VK; Pentland, A				de Montjoye, Yves-Alexandre; Radaelli, Laura; Singh, Vivek Kumar; Pentland, Alex Sandy			Unique in the shopping mall: On the reidentifiability of credit card metadata	SCIENCE			English	Article								Large-scale data sets of human behavior have the potential to fundamentally transform the way we fight diseases, design cities, or perform research. Metadata, however, contain sensitive information. Understanding the privacy of these data sets is key to their broad use and, ultimately, their impact. We study 3 months of credit card records for 1.1 million people and show that four spatiotemporal points are enough to uniquely reidentify 90% of individuals. We show that knowing the price of a transaction increases the risk of reidentification by 22%, on average. Finally, we show that even data sets that provide coarse information at any or all of the dimensions provide little anonymity and that women are more reidentifiable than men in credit card metadata.	[de Montjoye, Yves-Alexandre; Singh, Vivek Kumar; Pentland, Alex Sandy] MIT, Media Lab, Cambridge, MA 02139 USA; [Radaelli, Laura] Aarhus Univ, Dept Comp Sci, DK-8200 Aarhus, Denmark; [Singh, Vivek Kumar] Rutgers State Univ, Sch Commun & Informat, New Brunswick, NJ 08901 USA	Massachusetts Institute of Technology (MIT); Aarhus University; Rutgers State University New Brunswick	de Montjoye, YA (corresponding author), MIT, Media Lab, 20 Amherst St, Cambridge, MA 02139 USA.	yvesalexandre@demontjoye.com	Singh, Vivek/AAD-2381-2019	Radaelli, Laura/0000-0002-7277-801X	Geocrowd Initial Training Network - European Commission [264994]; Army Research Laboratory [W911NF-09-2-0053]; Belgian American Educational Foundation; Wallonie-Bruxelles International	Geocrowd Initial Training Network - European Commission; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Belgian American Educational Foundation; Wallonie-Bruxelles International	For contractual and privacy reasons, we unfortunately cannot make the raw data available. Upon request we can, however, make individual-level data of gender, income level, resolution (h, v, a), and unicity (true, false), along with the appropriate documentation, available for replication. This allows the re-creation of Figs. 2 to 4, as well as the GLM model and all of the unicity statistics. A randomly subsampled data set for the four points case can be found at http://web.media.mit.edu/similar to yva/uniqueintheshoppingmall/ and in the supplementary materials. This work was supported in part by the Geocrowd Initial Training Network funded by the European Commission as an FP7-People Marie Curie Action under grant agreement number 264994, and in part by the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053. Y.-A.d.M. was partially supported by the Belgian American Educational Foundation and Wallonie-Bruxelles International. L. R. did part of this work while visiting the MIT Media Lab. We gratefully acknowledge B. Bozkaya and a bank that wishes to remain anonymous for access to the data. Views and conclusions in this document are those of the authors and should not be interpreted as representing the policies, either expressed or implied, of the sponsors.	[Anonymous], 2013, 2013 FEDERAL RESERVE; [Anonymous], 2013, TRUST ADVANTAGE WIN; Bhattacharyya S, 2011, DECIS SUPPORT SYST, V50, P602, DOI 10.1016/j.dss.2010.08.008; Blondel V. D., 2012, DATA DEV D4D CHALL M; Bloom T, 2013, DATA ACCESS OPEN ACC; Boulton G, 2012, NATURE, V486, P441, DOI 10.1038/486441a; Burns K., 2013, GUARDIAN; Charaudeau S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083002; de Montjoye Yves-Alexandre, 2013, Social Computing, Behavioral-Cultural Modeling and Prediction. 6th International Conference, SBP 2013. Proceedings, P48, DOI 10.1007/978-3-642-37210-0_6; de Montjoye YA, 2012, IEEE DATA ENG B, V35, P5; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Deutsche Telekom, 2014, GUID PRINC BIG DAT; Dwork C, 2006, LECT NOTES COMPUT SC, V4052, P1; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; eMarketer, 2013, US MOB PAYM TOP 1 BI; European Commission, 2012, GEN DAT PROT REG; Giles J, 2012, NATURE, V488, P448, DOI 10.1038/488448a; Higginbotham, 2011, SCI BIG DAT MICR 21; Huang CL, 2007, EXPERT SYST APPL, V33, P847, DOI 10.1016/j.eswa.2006.07.007; Kendall J., 2014, BROOKINGS ISSUES TEC, V26; Krumme C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01645; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Massachusetts Bay Transportation Authority, 2010, REAL TIM COMM RAIL D; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; Mutchler P., 2014, METAPHONE SENSITIVIT; Narayanan A, 2008, P IEEE S SECUR PRIV, P111, DOI 10.1109/SP.2008.33; Padmanabhan V., 2013, U.S. Patent, Patent No. [8,423,255, 8423255]; Schwartz PM, 2014, CALIF LAW REV, V102, P877; Smoreda Z., 2014, D4D SEN 2 MOB PHON D; Solomon A, 2012, P 2 ACM SIGHIT INT H, P523, DOI DOI 10.1145/2110363.2110422; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Watts D. J., 2013, WINTER ISSUE BRIDGE, V43, P5; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467	33	235	237	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					536	539		10.1126/science.1256297	http://dx.doi.org/10.1126/science.1256297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635097	Green Submitted			2022-12-28	WOS:000348639300050
J	Dunning, GT; Glowacki, DR; Preston, TJ; Greaves, SJ; Greetham, GM; Clark, IP; Towrie, M; Harvey, JN; Orr-Ewing, AJ				Dunning, G. T.; Glowacki, D. R.; Preston, T. J.; Greaves, S. J.; Greetham, G. M.; Clark, I. P.; Towrie, M.; Harvey, J. N.; Orr-Ewing, A. J.			Vibrational relaxation and microsolvation of DF after F-atom reactions in polar solvents	SCIENCE			English	Article							REACTION DYNAMICS; TRANSITION-STATE; RESONANCES; PLUS; HF; SPECTROSCOPY; FLUORIDE	Solvent-solute interactions influence the mechanisms of chemical reactions in solution, but the response of the solvent is often slower than the reactive event. Here, we report that exothermic reactions of fluorine (F) atoms in d(3)-acetonitrile and d(2)-dichloromethane involve efficient energy flow to vibrational motion of the deuterium fluoride (DF) product that competes with dissipation of the energy to the solvent bath, despite strong solvent coupling. Transient infrared absorption spectroscopy and molecular dynamics simulations show that after DF forms its first hydrogen bond on a subpicosecond time scale, DF vibrational relaxation and further solvent restructuring occur over more than 10 picoseconds. Characteristic dynamics of gas-phase F-atom reactions with hydrogen-containing molecules persist in polar organic solvents, and the spectral evolution of the DF products serves as a probe of solvent reorganization induced by a chemical reaction.	[Dunning, G. T.; Glowacki, D. R.; Preston, T. J.; Harvey, J. N.; Orr-Ewing, A. J.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Glowacki, D. R.] Dept Comp Sci, Bristol BS8 1UB, Avon, England; [Glowacki, D. R.] Stanford Univ, Photon Ultrafast Laser Sci & Engn PULSE Inst, Stanford, CA 94305 USA; [Glowacki, D. R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Glowacki, D. R.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Greaves, S. J.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Greetham, G. M.; Clark, I. P.; Towrie, M.] Rutherford Appleton Lab, Sci & Technol Facil Council, Cent Laser Facil, Didcot OX11 0QX, Oxon, England	University of Bristol; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Heriot Watt University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Orr-Ewing, AJ (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	a.orr-ewing@bristol.ac.uk	Greaves, Stuart/D-9213-2011; Harvey, Jeremy/AAC-6433-2019; Harvey, Jeremy N/E-8848-2010	Greaves, Stuart/0000-0002-5238-7150; Harvey, Jeremy/0000-0002-1728-1596; Harvey, Jeremy N/0000-0002-1728-1596; Preston, Thomas/0000-0002-4221-3931; Clark, Ian/0000-0002-0105-4743; Towrie, Mike/0000-0002-1305-701X; Orr-Ewing, Andrew/0000-0001-5551-9609	Engineering and Physical Sciences Research Council (EPSRC) [EP/G00224X, EPSRC EP/J002534/2]; European Research Council (ERC) [290966 CAPRI]; Royal Society University Research fellowship; Science and Technology Facilities Council (STFC) [ST/501784]; Engineering and Physical Sciences Research Council [EP/J002534/2, EP/G00224X/1] Funding Source: researchfish; EPSRC [EP/J002534/2, EP/G00224X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Royal Society University Research fellowship(Royal Society of London); Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Bristol group thanks the Engineering and Physical Sciences Research Council (EPSRC, Programme Grant EP/G00224X and a studentship for G.T.D.) and the European Research Council (ERC, Advanced Grant 290966 CAPRI) for financial support. D.R.G. acknowledges award of a Royal Society University Research fellowship, J.N.H. acknowledges a Royal Society Wolfson Merit Award, and S.J.G. thanks EPSRC for award of a Career Acceleration Fellowship (EPSRC EP/J002534/2). Experimental measurements were conducted at the ULTRA Laser Facility, which is supported by the Science and Technology Facilities Council (STFC, Facility Grant ST/501784). We are grateful to F. Abou-Chahine for assistance with collection of some of the experimental data and to M.P. Grubb and M.N.R. Ashfold for valuable discussions. All experimental data and analysis files are archived in the University of Bristol's Research Data Storage Facility. The supplementary materials contain summaries of the data analysis procedures and outcomes. Individual contributions to the work: A.J.O.-E. and G.T.D. devised and carried out the experiments, with assistance from S.J.G., and analyzed the experimental data with T.J.P. and S.J.G. G.M.G., I.P.C., and M.T. constructed and operated the ultrafast laser system at the Central Laser Facility, with which all experimental data were collected. D.R.G. and J.N.H. devised and performed the MD simulations and analyzed the computational results. A.J.O.-E., G.T.D., T.J.P., D.R.G., and J.N.H. wrote the paper.	ADAMS RM, 1957, J MOL SPECTROSC, V1, P306, DOI 10.1016/0022-2852(57)90032-2; Bagchi B, 2010, CHEM SOC REV, V39, P1936, DOI 10.1039/b902048a; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; Dehe K, 1996, CHEM PHYS LETT, V262, P683, DOI 10.1016/S0009-2614(96)01148-7; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Dunning GT, 2014, PHYS CHEM CHEM PHYS, V16, P16095, DOI 10.1039/c4cp01854k; Glowacki DR, 2011, NAT CHEM, V3, P850, DOI [10.1038/NCHEM.1154, 10.1038/nchem.1154]; Glowacki DR, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3595259; Greaves SJ, 2011, SCIENCE, V331, P1423, DOI 10.1126/science.1197796; JOHNSON GL, 1983, J PHYS CHEM-US, V87, P1852, DOI 10.1021/j100234a006; JORGENSEN WL, 1988, MOL PHYS, V63, P547, DOI 10.1080/00268978800100371; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; NEUMARK DM, 1985, J CHEM PHYS, V82, P3045, DOI 10.1063/1.448254; Nicoleti CR, 2012, J BRAZIL CHEM SOC, V23, P1488, DOI 10.1590/S0103-50532012005000007; Orr-Ewing AJ, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4866761; Otto R, 2014, SCIENCE, V343, P396, DOI 10.1126/science.1247424; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Rey R, 2002, J PHYS CHEM A, V106, P11993, DOI 10.1021/jp026419o; Rose RA, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603966; Tizniti M, 2014, NAT CHEM, V6, P141, DOI [10.1038/NCHEM.1835, 10.1038/nchem.1835]; Wang T, 2013, SCIENCE, V342, P1499, DOI 10.1126/science.1246546; WICKRAMAARATCHI MA, 1985, CHEM PHYS, V94, P109, DOI 10.1016/0301-0104(85)85070-9; Zolot AM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2973630	26	44	44	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					530	533		10.1126/science.aaa0103	http://dx.doi.org/10.1126/science.aaa0103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635095	Green Submitted			2022-12-28	WOS:000348639300048
J	Newman, AL				Newman, Abraham L.			What the "right to be forgotten" means for privacy in a digital age	SCIENCE			English	Editorial Material								Despite the attention the right has received, we should not forget that it is just one innovative piece of a comprehensive privacy framework that must be implemented locally and enforced globally.	Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Washington, DC 20057 USA	Georgetown University	Newman, AL (corresponding author), Georgetown Univ, Edmund A Walsh Sch Foreign Serv, Washington, DC 20057 USA.	aln24@georgetown.edu						[Anonymous], 2014, NY TIMES, pA1; [Anonymous], WASHINGTON POST; Bennett CJ, 2008, PRIVACY ADVOCATES: RESISTING THE SPREAD OF SURVEILLANCE, P1; Bignami F, 2011, AM J COMP LAW, V59, P411, DOI 10.5131/AJCL.2010.0017; Dixon Pam, 2014, WORLD PRIVACY FORUM; European Commission, 2014, FACTSH RIGHT FORG RU; Experian, 2015, DAT BREACH IND FOR; Google, 2014, TRANSP REP EUR PRIV; Horwitz J., 2014, COLUMBUS DISPAT 0617; Jentzsch N., 2007, FINANCIAL PRIVACY IN; Mayer-Schonberger V., 2011, DELETE VIRTUES FORGE; Newman A.L., 2008, PROTECTORS PRIVACY R; Regan Priscilla M., 1995, LEGISLATING PRIVACY; Schechner S., 2014, WALL STREET J; SOLOVE DANIEL J., 2014, INFORM PRIVACY LAW; The New York Times Company, 2014, NY TIMES, pA26	16	26	26	7	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					507	508		10.1126/science.aaa4603	http://dx.doi.org/10.1126/science.aaa4603			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635090				2022-12-28	WOS:000348639300043
J	Shi, D; Adinolfi, V; Comin, R; Yuan, MJ; Alarousu, E; Buin, A; Chen, Y; Hoogland, S; Rothenberger, A; Katsiev, K; Losovyj, Y; Zhang, X; Dowben, PA; Mohammed, OF; Sargent, EH; Bakr, OM				Shi, Dong; Adinolfi, Valerio; Comin, Riccardo; Yuan, Mingjian; Alarousu, Erkki; Buin, Andrei; Chen, Yin; Hoogland, Sjoerd; Rothenberger, Alexander; Katsiev, Khabiboulakh; Losovyj, Yaroslav; Zhang, Xin; Dowben, Peter A.; Mohammed, Omar F.; Sargent, Edward H.; Bakr, Osman M.			Low trap-state density and long carrier diffusion in organolead trihalide perovskite single crystals	SCIENCE			English	Article							HALIDE PEROVSKITES; MINORITY-CARRIERS; SOLAR-CELLS; SILICON; TRANSISTORS	The fundamental properties and ultimate performance limits of organolead trihalide MAPbX(3) (MA = CH3NH3+; X = Br- or I-) perovskites remain obscured by extensive disorder in polycrystalline MAPbX(3) films. We report an antisolvent vapor-assisted crystallization approach that enables us to create sizable crack-free MAPbX(3) single crystals with volumes exceeding 100 cubic millimeters. These large single crystals enabled a detailed characterization of their optical and charge transport characteristics. We observed exceptionally low trap-state densities on the order of 109 to 1010 per cubic centimeter in MAPbX(3) single crystals (comparable to the best photovoltaic-quality silicon) and charge carrier diffusion lengths exceeding 10 micrometers. These results were validated with density functional theory calculations.	[Shi, Dong; Alarousu, Erkki; Chen, Yin; Rothenberger, Alexander; Katsiev, Khabiboulakh; Mohammed, Omar F.; Bakr, Osman M.] KAUST, SPERC, Thuwal 239556900, Saudi Arabia; [Adinolfi, Valerio; Comin, Riccardo; Yuan, Mingjian; Buin, Andrei; Hoogland, Sjoerd; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Losovyj, Yaroslav] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Zhang, Xin; Dowben, Peter A.] Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA	King Abdullah University of Science & Technology; University of Toronto; Indiana University System; Indiana University Bloomington; University of Nebraska System; University of Nebraska Lincoln	Bakr, OM (corresponding author), KAUST, SPERC, Thuwal 239556900, Saudi Arabia.	osman.bakr@kaust.edu.sa	Sargent, Edward H./O-9520-2014; Zhang, Xin/J-5478-2015; Dowben, Peter/ABH-5036-2020; chen, yin/G-8081-2015; Bakr, Osman M./R-4963-2019; Comin, Riccardo/H-7731-2016; Rothenberger, Alexander/B-9119-2015; Mohammed, Omar F./Q-5092-2016	Sargent, Edward H./0000-0003-0396-6495; Zhang, Xin/0000-0001-9232-427X; Bakr, Osman M./0000-0002-3428-1002; Comin, Riccardo/0000-0002-1069-9973; Mohammed, Omar F./0000-0001-8500-1130; Alarousu, Erkki/0000-0002-9492-7725; Shi, Dong/0000-0003-2916-6357; chen, yin/0000-0002-5968-4713	KAUST [KUS-11-009-21]; Ontario Research Fund Research Excellence Program; Natural Sciences and Engineering Research Council of Canada	KAUST(King Abdullah University of Science & Technology); Ontario Research Fund Research Excellence Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank N. Kherani, B. Ramautarsingh, A. Flood, and P. O'Brien for the use of the Hall setup. Supported by KAUST (O.M.B.) and by KAUST award KUS-11-009-21, the Ontario Research Fund Research Excellence Program, and the Natural Sciences and Engineering Research Council of Canada (E.H.S.).	AYRES JR, 1993, J APPL PHYS, V74, P1787, DOI 10.1063/1.354782; Balcioglu A, 2000, J APPL PHYS, V88, P7175, DOI 10.1063/1.1326465; Capan I, 2007, SOL ENERG MAT SOL C, V91, P931, DOI 10.1016/j.solmat.2007.02.011; Choi JJ, 2014, NANO LETT, V14, P127, DOI 10.1021/nl403514x; Edri E, 2013, J PHYS CHEM LETT, V4, P897, DOI 10.1021/jz400348q; Giorgi G, 2015, J MATER CHEM A, V3, P8981, DOI 10.1039/c4ta05046k; Goldmann C, 2006, J APPL PHYS, V99, DOI 10.1063/1.2170421; HAYNES JR, 1955, PHYS REV, V100, P606, DOI 10.1103/PhysRev.100.606; HAYNES JR, 1951, PHYS REV, V81, P835, DOI 10.1103/PhysRev.81.835; HORNBECK JA, 1955, PHYS REV, V97, P311, DOI 10.1103/PhysRev.97.311; Kerr LL, 2004, SOLID STATE ELECTRON, V48, P1579, DOI 10.1016/j.sse.2004.03.005; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lampert M. A., 1970, CURRENT INJECTION SO; Mitzi DB, 1999, PROG INORG CHEM, V48, P1, DOI 10.1002/9780470166499.ch1; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Sum TC, 2014, ENERG ENVIRON SCI, V7, P2518, DOI 10.1039/c4ee00673a; Tidhar Y, 2014, J AM CHEM SOC, V136, P13249, DOI 10.1021/ja505556s; Wehrenfennig C, 2014, ENERG ENVIRON SCI, V7, P2269, DOI 10.1039/c4ee01358a; Xiao MD, 2014, ANGEW CHEM INT EDIT, V53, P9898, DOI 10.1002/anie.201405334; Yang YS, 2002, APPL PHYS LETT, V80, P1595, DOI 10.1063/1.1459117	20	3456	3517	115	1487	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					519	522		10.1126/science.aaa2725	http://dx.doi.org/10.1126/science.aaa2725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635092	Green Published			2022-12-28	WOS:000348639300045
J	Bahng, JH; Yeom, B; Wang, YC; Tung, SO; Hoff, JD; Kotov, N				Bahng, Joong Hwan; Yeom, Bongjun; Wang, Yichun; Tung, Siu On; Hoff, J. Damon; Kotov, Nicholas			Anomalous dispersions of 'hedgehog' particles	NATURE			English	Article							SURFACE; WATER; AIR; NANOPARTICLES; INTERFACE	Hydrophobic particles in water and hydrophilic particles in oil aggregate, but can form colloidal dispersions if their surfaces are chemically camouflaged with surfactants, organic tethers, adsorbed polymers or other particles that impart affinity for the solvent and increase interparticle repulsion(1,2). A different strategy for modulating the interaction between a solid and a liquid uses surface corrugation, which gives rise to unique wetting behaviour(3-5). Here we show that this topographical effect can also be used to disperse particles in a wide range of solvents without recourse to chemicals to camouflage the particles' surfaces: we produce micrometre-sized particles that are coated with stiff, nanoscale spikes and exhibit long-term colloidal stability in both hydrophilic and hydrophobic media. We find that these 'hedgehog' particles do not interpenetrate each other with their spikes, which markedly decreases the contact area between the particles and, therefore, the attractive forces between them. The trapping of air in aqueous dispersions, solvent autoionization at highly developed interfaces, and long-range electrostatic repulsion in organic media also contribute to the colloidal stability of our particles. The unusual dispersion behaviour of our hedgehog particles, overturning the notion that like dissolves like, might help to mitigate adverse environmental effects of the use of surfactants and volatile organic solvents, and deepens our understanding of interparticle interactions and nanoscale colloidal chemistry.	[Bahng, Joong Hwan; Wang, Yichun; Kotov, Nicholas] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Yeom, Bongjun; Kotov, Nicholas] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Tung, Siu On; Kotov, Nicholas] Univ Michigan, Macromol Sci & Engn Program, Ann Arbor, MI 48109 USA; [Hoff, J. Damon] Single Mol Anal Real Time SMART Ctr, Ann Arbor, MI 48109 USA; [Kotov, Nicholas] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Kotov, Nicholas] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kotov, N (corresponding author), Univ Michigan, Dept Biomed Engn, 1107 Carl A Gerstacker Bldg,2200 Bonisteel Blvd, Ann Arbor, MI 48109 USA.	kotov@umich.edu	Hoff, Jeremy D/B-5906-2008; Kotov, Nicholas/AAZ-4204-2021	Kotov, Nicholas/0000-0002-6864-5804; Yeom, Bongjun/0000-0001-8914-0947; Hoff, Jeremy/0000-0002-4054-848X	Center for Solar and Thermal Energy Conversion, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000957]; US NSF [ECS-0601345, CBET 0933384, CBET 0932823, CBET 1036672]; US Department of Defense [W911NF-10-1-0518, MURI W911NF-12-1-0407]	Center for Solar and Thermal Energy Conversion, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US NSF(National Science Foundation (NSF)); US Department of Defense(United States Department of Defense)	This material is based on work partially supported by the Center for Solar and Thermal Energy Conversion, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under award number DE-SC0000957. We acknowledge support from the US NSF under grant ECS-0601345, CBET 0933384, CBET 0932823 and CBET 1036672. The work is also partly supported by the US Department of Defense under grant awards nos W911NF-10-1-0518, MURI W911NF-12-1-0407 and MURI W911NF-12-1-0407. We want express our appreciation to N. Walter for his leadership in organizing the SMART Center at the University of Michigan; J. Young Kim, Q. Che and X. Lu for help with the synthesis of CdTe nanoparticles; D. Bukharina for help with synthesis of hedgehog particles and SEM imaging of samples for dispersions in hydrophobic solvents; and D. Sorenson for assistance with TEM imaging of nanoparticle assemblies on OTMS-HPs. We also want to express our appreciation of H. Yu and G. Khan, who calculated van der Waals interactions of ZnO nanorods using the coupled dipole method. The guidance of C. Silvera Batista in this process is also much appreciated.	Beattie JK, 2009, FARADAY DISCUSS, V141, P31, DOI 10.1039/b805266b; Beattie JK, 2004, ANGEW CHEM INT EDIT, V43, P3568, DOI 10.1002/anie.200453916; Dong AG, 2010, NATURE, V466, P474, DOI 10.1038/nature09188; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; GRACIAA A, 1995, J COLLOID INTERF SCI, V172, P131, DOI 10.1006/jcis.1995.1234; Hollingsworth A., 2008, B AM PHYS SOC, V53; Huang RX, 2013, LANGMUIR, V29, P11560, DOI 10.1021/la4020674; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P253, DOI 10.1016/B978-0-12-375182-9.10013-2; Kim SH, 2011, J AM CHEM SOC, V133, P5516, DOI 10.1021/ja200139w; Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924; Mao M, 2004, LANGMUIR, V20, P1843, DOI 10.1021/la0361722; Martines E, 2006, LANGMUIR, V22, P11230, DOI 10.1021/la061611t; Papadopoulos P, 2013, P NATL ACAD SCI USA, V110, P3254, DOI 10.1073/pnas.1218673110; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Poetes R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166104; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Saltzman W. M., 2008, DRUG DELIVERY SYSTEM; Sperling RA, 2010, PHILOS T R SOC A, V368, P1333, DOI 10.1098/rsta.2009.0273; Takahashi M, 2005, J PHYS CHEM B, V109, P21858, DOI 10.1021/jp0445270; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Tyrrell JWG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.176104; Verho T, 2011, ADV MATER, V23, P673, DOI 10.1002/adma.201003129; Walther A, 2013, CHEM REV, V113, P5194, DOI 10.1021/cr300089t; Wang S, 2007, ADV MATER, V19, P3423, DOI 10.1002/adma.200700934; Whyman G, 2011, LANGMUIR, V27, P8171, DOI 10.1021/la2011869; Yan J, 2012, NATURE, V491, P578, DOI 10.1038/nature11619; Yang PD, 2002, ADV FUNCT MATER, V12, P323, DOI 10.1002/1616-3028(20020517)12:5<323::AID-ADFM323>3.0.CO;2-G; Zhou H, 2014, ADV FUNCT MATER, V24, P1439, DOI 10.1002/adfm.201302405	29	100	101	7	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					596	599		10.1038/nature14092	http://dx.doi.org/10.1038/nature14092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631447				2022-12-28	WOS:000348775000039
J	Cohn, LB; Silva, IT; Oliveira, TY; Rosales, RA; Parrish, EH; Learn, GH; Hahn, BH; Czartoski, JL; McElrath, MJ; Lehmann, C; Klein, F; Caskey, M; Walker, BD; Siliciano, JD; Siliciano, RF; Jankovic, M; Nussenzweig, MC				Cohn, Lillian B.; Silva, Israel T.; Oliveira, Thiago Y.; Rosales, Rafael A.; Parrish, Erica H.; Learn, Gerald H.; Hahn, Beatrice H.; Czartoski, Julie L.; McElrath, M. Juliana; Lehmann, Clara; Klein, Florian; Caskey, Marina; Walker, Bruce D.; Siliciano, Janet D.; Siliciano, Robert F.; Jankovic, Mila; Nussenzweig, Michel C.			HIV-1 Integration Landscape during Latent and Active Infection	CELL			English	Article							CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; SEQUENCING REVEALS; SITES; PERSISTENCE; RESERVOIR; GENES; PROLIFERATION; VIRUS; IDENTIFICATION	The barrier to curing HIV-1 is thought to reside primarily in CD4(+) T cells containing silent proviruses. To characterize these latently infected cells, we studied the integration profile of HIV-1 in viremic progressors, individuals receiving antiretroviral therapy, and viremic controllers. Clonally expanded T cells represented the majority of all integrations and increased during therapy. However, none of the 75 expanded T cell clones assayed contained intact virus. In contrast, the cells bearing single integration events decreased in frequency over time on therapy, and the surviving cells were enriched for HIV-1 integration in silent regions of the genome. Finally, there was a strong preference for integration into, or in close proximity to, Alu repeats, which were also enriched in local hotspots for integration. The data indicate that dividing clonally expanded T cells contain defective proviruses and that the replication-competent reservoir is primarily found in CD4(+) T cells that remain relatively quiescent.	[Cohn, Lillian B.; Silva, Israel T.; Oliveira, Thiago Y.; Klein, Florian; Caskey, Marina; Jankovic, Mila; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Silva, Israel T.] Natl Inst Sci & Technol Stem Cell & Cell Therapy, BR-14051140 Ribeirao Preto, Brazil; [Silva, Israel T.] Ctr Cell Based Therapy, BR-14051140 Ribeirao Preto, Brazil; [Rosales, Rafael A.] Univ Sao Paulo, Dept Comp & Matemat, BR-14049901 Ribeirao Preto, Brazil; [Parrish, Erica H.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Parrish, Erica H.; Learn, Gerald H.; Hahn, Beatrice H.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Czartoski, Julie L.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Lehmann, Clara] Univ Hosp Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; [Lehmann, Clara] German Ctr Infect Res, D-50924 Cologne, Germany; [Walker, Bruce D.] Ragon Inst MGH, Cambridge, MA 02139 USA; [Walker, Bruce D.; Siliciano, Robert F.; Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Rockefeller University; Universidade de Sao Paulo; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Fred Hutchinson Cancer Center; University of Cologne; German Center for Infection Research; University of Cologne; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; Johns Hopkins University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Silva, Israel T/N-3858-2014; Nussenzweig, Michel/AAE-7292-2019; Lehmann, Clara/F-9671-2016; Rosales, Rafael/ABG-2951-2021; Learn, Jerry/E-3356-2012; Oliveira, Thiago Y/ABF-5186-2020; Oliveira, Thiago Y/HGA-3848-2022; Rosales, Rafael/F-6819-2013	Silva, Israel T/0000-0002-4687-1499; Lehmann, Clara/0000-0002-7042-1578; Rosales, Rafael/0000-0002-7518-2975; Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Rosales, Rafael/0000-0002-7518-2975; Caskey, Marina/0000-0003-1727-8693; Hahn, Beatrice/0000-0002-9400-9887	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery Grant [OPP 1033115]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, U01AI069481, T32AI070084, R37AI066998, UM1AI069481, P30AI045008, UM1AI100645] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to acknowledge all patients who contributed to this study. We thank Qiao Wang for invaluable discussions; Johannes Scheid for the coordination and preparation of viremic controller samples; Joshua Horwitz for samples during the initial development of integration sequencing; Klara Velinzon and Gaelle Breton for FACSorting; Zoran Jankovic for laboratory support; Rockefeller Genomics Resource Center and New York Genome Center for sequencing; David Chambliss for assistance in obtaining human samples; Arlene Hurley and Gisela Kremer for assistance in patient coordination; and all members of Nussenzweig and Mucida labs for valuable discussion and advice. This work was supported in part by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery Grant OPP 1033115 (to M. C. N.) and CHAVI-ID Award UM1AI100663. This work was also supported in part by grant # 8 UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. E. H. P., G. H. L., and B. H. H. are supported by UM1 AI100645 and R37 AI 066998. M. C. N., R. F. S., and B. D. W. are Howard Hughes Medical Institute Investigators. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	BAILEY TL, 1994, ISMB, V2, P28; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Ikeda T, 2007, J INFECT DIS, V195, P716, DOI 10.1086/510915; Imamichi H, 2014, AIDS, V28, P1091, DOI 10.1097/QAD.0000000000000223; Janovitz T, 2013, J VIROL, V87, P8559, DOI 10.1128/JVI.01135-13; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Serrao E, 2014, NUCLEIC ACIDS RES, V42, P5164, DOI 10.1093/nar/gku136; Sherrill-Mix S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-90; Silva IT, 2014, BIOINFORMATICS, V30, P2551, DOI 10.1093/bioinformatics/btu351; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wagner TA, 2013, J VIROL, V87, P1770, DOI 10.1128/JVI.01985-12; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937	39	285	290	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					420	432		10.1016/j.cell.2015.01.020	http://dx.doi.org/10.1016/j.cell.2015.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635456	Green Accepted, Bronze			2022-12-28	WOS:000349208000009
J	Magee, LA; von Dadelszen, P; Rey, E; Ross, S; Asztalos, E; Murphy, KE; Menzies, J; Sanchez, J; Singer, J; Gafni, A; Gruslin, A; Helewa, M; Hutton, E; Lee, SK; Lee, T; Logan, AG; Ganzevoort, W; Welch, R; Thornton, JG; Moutquin, JM				Magee, Laura A.; von Dadelszen, Peter; Rey, Evelyne; Ross, Susan; Asztalos, Elizabeth; Murphy, Kellie E.; Menzies, Jennifer; Sanchez, Johanna; Singer, Joel; Gafni, Amiram; Gruslin, Andree; Helewa, Michael; Hutton, Eileen; Lee, Shoo K.; Lee, Terry; Logan, Alexander G.; Ganzevoort, Wessel; Welch, Ross; Thornton, Jim G.; Moutquin, Jean-Marie			Less-Tight versus Tight Control of Hypertension in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREECLAMPSIA; MANAGEMENT; DISORDERS; DIAGNOSIS; ECLAMPSIA	BACKGROUND The effects of less-tight versus tight control of hypertension on pregnancy complications are unclear. METHODS We performed an open, international, multicenter trial involving women at 14 weeks 0 days to 33 weeks 6 days of gestation who had nonproteinuric preexisting or gestational hypertension, office diastolic blood pressure of 90 to 105 mm Hg (or 85 to 105 mm Hg if the woman was taking antihypertensive medications), and a live fetus. Women were randomly assigned to less-tight control (target diastolic blood pressure, 100 mm Hg) or tight control (target diastolic blood pressure, 85 mm Hg). The composite primary outcome was pregnancy loss or high-level neonatal care for more than 48 hours during the first 28 postnatal days. The secondary outcome was serious maternal complications occurring up to 6 weeks post partum or until hospital discharge, whichever was later. RESULTS Included in the analysis were 987 women; 74.6% had preexisting hypertension. The primary-outcome rates were similar among 493 women assigned to less-tight control and 488 women assigned to tight control (31.4% and 30.7%, respectively; adjusted odds ratio, 1.02; 95% confidence interval [CI], 0.77 to 1.35), as were the rates of serious maternal complications (3.7% and 2.0%, respectively; adjusted odds ratio, 1.74; 95% CI, 0.79 to 3.84), despite a mean diastolic blood pressure that was higher in the less-tight-control group by 4.6 mm Hg (95% CI, 3.7 to 5.4). Severe hypertension (>= 160/110 mm Hg) developed in 40.6% of the women in the less-tight-control group and 27.5% of the women in the tight-control group (P<0.001). CONCLUSIONS We found no significant between-group differences in the risk of pregnancy loss, high-level neonatal care, or overall maternal complications, although less- tight control was associated with a significantly higher frequency of severe maternal hypertension.	[Magee, Laura A.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Magee, Laura A.; von Dadelszen, Peter; Menzies, Jennifer] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Magee, Laura A.; von Dadelszen, Peter; Singer, Joel] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Singer, Joel; Lee, Terry] Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, Providence Hlth Care Res Inst, Vancouver, BC V5Z 1M9, Canada; [Rey, Evelyne] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Rey, Evelyne] Univ Montreal, Dept Obstet & Gynaecol, Montreal, PQ, Canada; [Ross, Susan] Univ Alberta, Dept Obstet & Gynaecol, Edmonton, AB, Canada; [Asztalos, Elizabeth; Murphy, Kellie E.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Asztalos, Elizabeth; Lee, Shoo K.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Logan, Alexander G.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Asztalos, Elizabeth; Murphy, Kellie E.; Sanchez, Johanna] Univ Toronto, Sunnybrook Res Inst, Ctr Mother Infant & Child Res, Toronto, ON, Canada; [Gafni, Amiram] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Hutton, Eileen] McMaster Univ, Dept Obstet & Gynaecol, Hamilton, ON, Canada; [Gruslin, Andree] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; [Helewa, Michael] Univ Manitoba, Dept Obstet & Gynaecol, Winnipeg, MB, Canada; [Moutquin, Jean-Marie] Univ Sherbrooke, Dept Obstet & Gynaecol, Sherbrooke, PQ J1K 2R1, Canada; [Ganzevoort, Wessel] Univ Amsterdam, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Welch, Ross] Derriford Hosp, Dept Obstet & Gynaecol, Plymouth, Devon, England; [Thornton, Jim G.] Univ Nottingham, Dept Obstet & Gynaecol, Nottingham NG7 2RD, England	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Universite de Montreal; Universite de Montreal; University of Alberta; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; McMaster University; University of Ottawa; University of Manitoba; University of Sherbrooke; University of Amsterdam; Derriford Hospital; University of Nottingham	Magee, LA (corresponding author), BC Womens Hosp, 4500 Oak St, Vancouver, BC V6H 3N1, Canada.	LMagee@cw.bc.ca	Logan, Alexander G/E-4626-2013; Asztalos, Elizabeth/L-8834-2019; Thornton, Jim/B-8336-2008; Murphy, Kellie E/B-7616-2016; Ganzevoort, Wessel/AAH-4468-2020; von Dadelszen, Peter/AAP-7480-2021; Lee, Shoo K/P-3016-2015	Asztalos, Elizabeth/0000-0002-9468-2860; Thornton, Jim/0000-0001-9764-6876; Ganzevoort, Wessel/0000-0002-7243-2115; Sanchez, Johanna/0000-0003-2295-3251; Hutton, Eileen/0000-0003-0895-7395; Murphy, Kellie/0000-0002-7327-2600; von Dadelszen, Peter/0000-0003-4136-3070; Helewa, Michael/0000-0001-6792-4951	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research; CHIPS Current Controlled Trials number, ISRCTN71416914; ClinicalTrials.gov number, NCT01192412.	Abalos E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002863; Arguedas JA, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004349.PUB2; BROWN MA, 1995, HYPERTENS PREGNANCY, V14, P57, DOI 10.3109/10641959509058051; El Guindy AA, 2008, J PERINAT MED, V36, P413, DOI 10.1515/JPM.2008.060; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lewis G, 2007, 7 CEMACH; Magee L A, 2007, BJOG, V114, pe13, DOI 10.1111/j.1471-0528.2007.01315.x; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; Magee LA, 2014, PREGNANCY HYPERTENS, V4, P105, DOI 10.1016/j.preghy.2014.01.003; Magee LA, 2009, CURR HYPERTENS REP, V11, P429, DOI 10.1007/s11906-009-0073-y; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56; National Institute for Health and Care Excellence, 2010, HYP PREN MAN HYP DIS; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Thompson SG, 2004, STAT MED, V23, P389, DOI 10.1002/sim.1567; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; von Dadelszen Peter, 2002, J Obstet Gynaecol Can, V24, P941; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7	21	309	341	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					407	417		10.1056/NEJMoa1404595	http://dx.doi.org/10.1056/NEJMoa1404595			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629739	Green Accepted, Green Published			2022-12-28	WOS:000348649700005
J	Slomski, A				Slomski, Anita			Short Therapy Reduces Depression in Family Caregivers of Patients With Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Geulayov Galit, LANCET PSYCHIAT, V6, P1021, DOI [10.1016/S2215-0366(19)30402-X, DOI 10.1016/S2215-0366(19)30402-X]	1	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					347	347		10.1001/jama.2014.17991	http://dx.doi.org/10.1001/jama.2014.17991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626027				2022-12-28	WOS:000349072600007
J	Artis, D; Spits, H				Artis, David; Spits, Hergen			The biology of innate lymphoid cells	NATURE			English	Review							NATURAL-KILLER-CELLS; TRANSCRIPTION FACTOR GATA3; ROR-GAMMA-T; TISSUE-INDUCER CELLS; TYPE-2 IMMUNE-RESPONSE; HOST-DEFENSE; IFN-GAMMA; INFLAMMATION; BET; DRIVES	The innate immune system is composed of a diverse array of evolutionarily ancient haematopoietic cell types, including dendritic cells, monocytes, macrophages and granulocytes. These cell populations collaborate with each other, with the adaptive immune system and with non-haematopoietic cells to promote immunity, inflammation and tissue repair. Innate lymphoid cells are the most recently identified constituents of the innate immune system and have been the focus of intense investigation over the past five years. We summarize the studies that formally identified innate lymphoid cells and highlight their emerging roles in controlling tissue homeostasis in the context of infection, chronic inflammation, metabolic disease and cancer.	[Artis, David] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Cornell University; University of Amsterdam; Academic Medical Center Amsterdam	Artis, D (corresponding author), Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA.	dartis@med.cornell.edu; hergen.spits@amc.uva.nl	Spits, Hergen/N-2581-2019	Spits, Hergen/0000-0003-3269-8338; Artis, David/0000-0002-1753-4100	US National Institutes of Health [AI061570, AI095603, AI074878, AI095466, AI106697, AI102942, AI097333]; Crohns and Colitis Foundation of America; Burroughs Wellcome Fund; European Research Council [341038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097333, R01AI102942, P01AI106697, R01AI061570, R01AI095466, U01AI095608, R01AI074878] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Osborne, R German M. R. Hepworth, E Tait Wojno and G. F Sonnenberg for discussions and critical reading of the manuscript. We apologize to colleagues whose work could not be directly quoted due to space constraints. Research in the Artis laboratory is supported by the US National Institutes of Health (AI061570, AI095603, AI074878, AI095466, AI106697. AI102942, AI097333), the Crohns and Colitis Foundation of America and the Burroughs Wellcome Fund. Research in the Spits lab is supported by an advanced grant (341038) of the European Research Council.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bartemes KR, 2014, J ALLERGY CLIN IMMUN, V134, P671, DOI 10.1016/j.jaci.2014.06.024; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chan IH, 2014, MUCOSAL IMMUNOL, V7, P842, DOI 10.1038/mi.2013.101; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Drake LY, 2014, ALLERGY, V69, P1300, DOI 10.1111/all.12446; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hambly N, 2014, CURR OPIN PULM MED, V20, P87, DOI 10.1097/MCP.0000000000000007; Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ichii M, 2010, IMMUNOL REV, V237, P10, DOI 10.1111/j.1600-065X.2010.00933.x; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kang ZZ, 2012, IMMUNITY, V36, P821, DOI 10.1016/j.immuni.2012.03.021; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Korn LL, 2014, MUCOSAL IMMUNOL, V7, P1045, DOI 10.1038/mi.2013.121; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mair F, 2014, EUR J IMMUNOL, V44, P37, DOI 10.1002/eji.201343653; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Pitt JM, 2012, J IMMUNOL, V189, P4079, DOI 10.4049/jimmunol.1201061; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Saenz SA, 2013, J EXP MED, V210, P1823, DOI 10.1084/jem.20122332; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taube C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021799; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Van Maele L, 2014, J INFECT DIS, V210, P493, DOI 10.1093/infdis/jiu106; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu X, 2014, MUCOSAL IMMUNOL, V7, P730, DOI 10.1038/mi.2013.92; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	125	984	1025	12	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					293	301		10.1038/nature14189	http://dx.doi.org/10.1038/nature14189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592534				2022-12-28	WOS:000347810300033
J	Ma, CD; Wang, CX; Acevedo-Velez, C; Gellman, SH; Abbott, NL				Ma, C. Derek; Wang, Chenxuan; Acevedo-Velez, Claribel; Gellman, Samuel H.; Abbott, Nicholas L.			Modulation of hydrophobic interactions by proximally immobilized ions	NATURE			English	Article							CHEMICAL FORCE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; BETA-PEPTIDES; INTERMOLECULAR INTERACTIONS; SURFACES; WATER; SPECTROSCOPY; INTERFACES; SIGNATURE; HYDRATION	The structure of water near non-polar molecular fragments or surfaces mediates the hydrophobic interactions that underlie a broad range of interfacial, colloidal and biophysical phenomena(1-4),. Substantial progress over the past decade has improved our understanding of hydrophobic interactions in simple model systems(1,5-10), but most biologically and technologically relevant structures contain non-polar domains in close proximity to polar and charged functional groups. Theories and simulations exploring such nanometre-scale chemical heterogeneity find it can have an important effect(8,10-12), but the influence of this heterogeneity on hydrophobic interactions has not been tested experimentally. Here we report chemical force microscopy measurements on alkyl-functionalized surfaces that reveal a dramatic change in the surfaces' hydrophobic interaction strengths on coimmobilization of amine or guanidine groups. Protonation of amine groups doubles the strength of hydrophobic interactions, and guanidinium groups eliminate measurable hydrophobic interactions in all pH ranges investigated. We see these divergent effects of proximally immobilized cations also in single-molecule measurements on conformationally stable beta-peptides with non-polar subunits located one nanometre from either amine- or guanidine-bearing subunits. Our results demonstrate the importance of nanometre-scale chemical heterogeneity, with hydrophobicity not an intrinsic property of any given non-polar domain but strongly modulated by functional groups located as far away as one nanometre. The judicious placing of charged groups near hydrophobic domains thus provides a strategy for tuning hydrophobic driving forces to optimize molecular recognition or self-assembly processes.	[Ma, C. Derek; Wang, Chenxuan; Acevedo-Velez, Claribel; Abbott, Nicholas L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Wang, Chenxuan; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gellman, SH (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	gellman@chem.wisc.edu; abbott@engr.wisc.edu		Acevedo-Velez, Claribel/0000-0001-6297-7747	Wisconsin Nanoscale Science and Engineering Center (NSF grant) [DMR-0832760]; Wisconsin Materials Research Science and Engineering Center (NSF grant) [DMR-1121288]	Wisconsin Nanoscale Science and Engineering Center (NSF grant); Wisconsin Materials Research Science and Engineering Center (NSF grant)	This research was supported by the Wisconsin Nanoscale Science and Engineering Center (NSF grant DMR-0832760). Use of facilities supported by the Wisconsin Materials Research Science and Engineering Center is also acknowledged (NSF grant DMR-1121288).	Acevedo-Velez C, 2011, J AM CHEM SOC, V133, P3981, DOI 10.1021/ja1089183; Acharya H, 2010, FARADAY DISCUSS, V146, P353, DOI 10.1039/b927019a; Alsteens D, 2007, LANGMUIR, V23, P11977, DOI 10.1021/la702765c; Ashby PD, 2000, J AM CHEM SOC, V122, P9467, DOI 10.1021/ja0020613; Awada H, 2005, SURF INTERFACE ANAL, V37, P755, DOI 10.1002/sia.2076; Burns AR, 1999, LANGMUIR, V15, P2922, DOI 10.1021/la981521r; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Cheng RP, 2001, CHEM REV, V101, P3219, DOI 10.1021/cr000045i; Davis JG, 2012, NATURE, V491, P582, DOI 10.1038/nature11570; Drelich J, 2004, J COLLOID INTERF SCI, V280, P484, DOI 10.1016/j.jcis.2004.08.002; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Giovambattista N, 2007, J PHYS CHEM C, V111, P1323, DOI 10.1021/jp065419b; Godawat R, 2010, J PHYS CHEM B, V114, P2246, DOI 10.1021/jp906976q; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Hiemenz P. C., 1997, PRINCIPLES COLLOID S, V3rd; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; Hwang S, 2011, J PHYS CHEM B, V115, P6653, DOI 10.1021/jp111448a; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Li ITS, 2011, P NATL ACAD SCI USA, V108, P16527, DOI 10.1073/pnas.1105450108; Li LB, 2014, J PHYS CHEM B, V118, P6431, DOI 10.1021/jp4115139; Lo Nostro P, 2012, CHEM REV, V112, P2286, DOI 10.1021/cr200271j; Meyer EE, 2006, P NATL ACAD SCI USA, V103, P15739, DOI 10.1073/pnas.0606422103; Patel AJ, 2012, J PHYS CHEM B, V116, P2498, DOI 10.1021/jp2107523; Patel AJ, 2010, J PHYS CHEM B, V114, P1632, DOI 10.1021/jp909048f; Pomerantz WC, 2008, ORG LETT, V10, P1799, DOI 10.1021/ol800622e; Pomerantz WC, 2007, CHEM MATER, V19, P4436, DOI 10.1021/cm070265d; Pomerantz WC, 2011, J AM CHEM SOC, V133, P13604, DOI 10.1021/ja204874h; Raguse TL, 2003, J AM CHEM SOC, V125, P5592, DOI 10.1021/ja0341485; Seog J, 2002, MACROMOLECULES, V35, P5601, DOI 10.1021/ma0121621; Skulason H, 2000, LANGMUIR, V16, P6294, DOI 10.1021/la000208y; Tian CS, 2009, P NATL ACAD SCI USA, V106, P15148, DOI 10.1073/pnas.0901480106; Vacha R, 2011, J AM CHEM SOC, V133, P10204, DOI 10.1021/ja202081x; Vezenov DV, 2005, J ADHES SCI TECHNOL, V19, P313, DOI 10.1163/1568561054352702; Vezenov DV, 2003, J ADHES SCI TECHNOL, V17, P1385, DOI 10.1163/156856103769172805; Vezenov DV, 2002, J AM CHEM SOC, V124, P10578, DOI 10.1021/ja025951m; Wang JL, 2012, J COLLOID INTERF SCI, V379, P114, DOI 10.1016/j.jcis.2012.04.032; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]; Zangi R, 2005, J AM CHEM SOC, V127, P2272, DOI 10.1021/ja044426f	43	130	134	9	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					347	U443		10.1038/nature14018	http://dx.doi.org/10.1038/nature14018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592540				2022-12-28	WOS:000347810300041
J	Tamplin, OJ; Durand, EM; Carr, LA; Childs, SJ; Hagedorn, EJ; Li, PL; Yzaguirre, AD; Speck, NA; Zon, LI				Tamplin, Owen J.; Durand, Ellen M.; Carr, Logan A.; Childs, Sarah J.; Hagedorn, Elliott J.; Li, Pulin; Yzaguirre, Amanda D.; Speck, Nancy A.; Zon, Leonard I.			Hematopoietic Stem Cell Arrival Triggers Dynamic Remodeling of the Perivascular Niche	CELL			English	Article							GROWTH-FACTOR-BETA; BONE-MARROW NICHE; AORTIC ENDOTHELIUM; PROGENITOR CELLS; SELF-RENEWAL; MOUSE EMBRYO; ZEBRAFISH; MAINTENANCE; TRANSPLANTATION; ENGRAFTMENT	Hematopoietic stem and progenitor cells (HSPCs) can reconstitute and sustain the entire blood system. We generated a highly specific transgenic reporter of HSPCs in zebrafish. This allowed us to perform high-resolution live imaging on endogenous HSPCs not currently possible in mammalian bone marrow. Using this system, we have uncovered distinct interactions between single HSPCs and their niche. When an HSPC arrives in the perivascular niche, a group of endothelial cells remodel to form a surrounding pocket. This structure appears conserved in mouse fetal liver. Correlative light and electron microscopy revealed that endothelial cells surround a single HSPC attached to a single mesenchymal stromal cell. Live imaging showed that mesenchymal stromal cells anchor HSPCs and orient their divisions. A chemical genetic screen found that the compound lycorine promotes HSPC-niche interactions during development and ultimately expands the stem cell pool into adulthood. Our studies provide evidence for dynamic niche interactions upon stem cell colonization.	[Tamplin, Owen J.; Durand, Ellen M.; Carr, Logan A.; Hagedorn, Elliott J.; Li, Pulin; Zon, Leonard I.] Harvard Univ, Sch Med, Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Tamplin, Owen J.; Durand, Ellen M.; Carr, Logan A.; Hagedorn, Elliott J.; Li, Pulin; Zon, Leonard I.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Tamplin, Owen J.; Durand, Ellen M.; Carr, Logan A.; Hagedorn, Elliott J.; Li, Pulin; Zon, Leonard I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Durand, Ellen M.; Zon, Leonard I.] Harvard Univ, Cambridge, MA 02138 USA; [Childs, Sarah J.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 4N1, Canada; [Li, Pulin; Zon, Leonard I.] Harvard Univ, Chem Biol Program, Cambridge, MA 02138 USA; [Yzaguirre, Amanda D.; Speck, Nancy A.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yzaguirre, Amanda D.; Speck, Nancy A.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; University of Calgary; Harvard University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Zon, LI (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Childs, Sarah/AAG-5111-2021; Tamplin, Owen/C-1617-2014	Tamplin, Owen/0000-0001-9146-4860; Childs, Sarah/0000-0003-2261-580X; Li, Pulin/0000-0002-8525-4936	HHMI; NIH [R01 HL04880, 5P30 DK49216, 5R01 DK53298, 5U01 HL10001-05, R24 DK092760, R01 HL091724, U01HL100405, 1F31HL120615]; American Society of Hematology; Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research (CIHR) [MOP-97787]; Alberta Innovates Health Solutions; Helen Hay Whitney Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091724, R01HL048801, P01HL032262, F31HL120615, U01HL100405, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053298, R24DK092760, P30DK049216] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Helen Hay Whitney Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following for their support and contributions: L. Cameron for confocal imaging (Dana Farber Cancer Institute); T. Schlaeger, S. Datta, and P.D. Manos for chemical screening (Boston Children's Hospital [BCH]); R. Mathieu for flow cytometry (BCH); L. Bu and A. Hill for confocal imaging (BCH); H.A. Feldman and W. London for statistical analysis (BCH); T.P. Ward and Y. Zhou for computer support (BCH); J. Hutchinson, O.M. Hofmann, and W.A. Hide for microarray analysis (Harvard School of Public Health); M. Ericsson and E.J. Benecchi for conventional electron microscopy (Harvard Medical School); A. Roholt for serial block face scanning EM (Renovo Neural, Cleveland, USA); T. Fuerstenhaupt for guidance in EM tomographic reconstructions (University of Calgary); and T. Bowman for immunohistochemistry (Brigham and Women's Hospital). We thank T.V. Bowman, J.R. Perlin, and C.K. Kaufman for critical reading of this manuscript. This work was supported by HHMI and NIH grants R01 HL04880, 5P30 DK49216, 5R01 DK53298, 5U01 HL10001-05, and R24 DK092760 (to L.I.Z.); R01 HL091724 and U01HL100405 (to N.A.S.); and 1F31HL120615 (to A.D.Y.). O.J.T. was supported by the American Society of Hematology, Canadian Institutes of Health Research (CIHR), and Heart and Stroke Foundation of Canada. S.J.C. was supported by CIHR (MOP-97787) and Alberta Innovates Health Solutions. E.J.H. was supported by a Helen Hay Whitney Foundation Fellowship. L.I.Z. is a founder and stockholder of Fate Therapeutics, Inc. and Scholar Rock and is a scientific advisor for Stemgent.	Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; Glass TJ, 2011, BLOOD, V118, P766, DOI 10.1182/blood-2011-01-328476; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Kang JJ, 2012, INT IMMUNOPHARMACOL, V12, P249, DOI 10.1016/j.intimp.2011.11.018; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Lamoral-Theys D, 2009, J MED CHEM, V52, P6244, DOI 10.1021/jm901031h; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osawa M, 1996, J IMMUNOL, V156, P3207; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Soma T, 1996, BLOOD, V87, P4561, DOI 10.1182/blood.V87.11.4561.bloodjournal87114561; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639	38	217	220	0	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					241	252		10.1016/j.cell.2014.12.032	http://dx.doi.org/10.1016/j.cell.2014.12.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594182	Bronze, Green Accepted			2022-12-28	WOS:000347923200022
J	Viguier, M; Lafaurie, M				Viguier, Manuelle; Lafaurie, Matthieu			Actinomycetoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Viguier, Manuelle; Lafaurie, Matthieu] Hop St Louis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Viguier, M (corresponding author), Hop St Louis, Paris, France.	matthieu.lafaurie@sls.aphp.fr							0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					264	264		10.1056/NEJMicm1316013	http://dx.doi.org/10.1056/NEJMicm1316013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25587950				2022-12-28	WOS:000348119200010
J	Irons, MB; Nora, LM				Irons, Mira B.; Nora, Lois M.			Maintenance of Certification 2.0-Strong Start, Continued Evolution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPROVEMENT		[Irons, Mira B.; Nora, Lois M.] Amer Board Med Specialties, Chicago, IL 60654 USA		Irons, MB (corresponding author), Amer Board Med Specialties, Chicago, IL 60654 USA.							Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; Gorzkowski JA, 2014, PEDIATRICS, V134, P747, DOI 10.1542/peds.2014-0316; Peterson LE, 2014, ANN FAM MED, V12, P17, DOI 10.1370/afm.1592; Vernacchio L, 2014, PEDIATRICS, V134, pE242, DOI 10.1542/peds.2013-2643; Wittich CM, 2014, ACAD MED, V89, P1392, DOI 10.1097/ACM.0000000000000323	5	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					104	106		10.1056/NEJMp1409923	http://dx.doi.org/10.1056/NEJMp1409923			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY2UA	25564894				2022-12-28	WOS:000347443300003
J	Palmer, J; Boyce, N				Palmer, Joanna; Boyce, Niall			2014 Wakley Prize Essay winner: a good year for the Roses	LANCET			English	Editorial Material									[Palmer, Joanna] The Lancet, London EC2Y 5AS, England; [Boyce, Niall] Lancet Psychiat, London EC2Y 5AS, England		Palmer, J (corresponding author), The Lancet, London EC2Y 5AS, England.								0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2185	2185		10.1016/S0140-6736(14)62381-3	http://dx.doi.org/10.1016/S0140-6736(14)62381-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25625385				2022-12-28	WOS:000346655700012
J	Weinberger, SE				Weinberger, Steven E.			Challenges for Internal Medicine as the American College of Physicians Celebrates Its 100th Anniversary	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Weinberger, SE (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.							[Anonymous], 2015, WHAT IS INT MED; [Anonymous], 2015, HIGH VAL CAR; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Doherty RB, 2013, ANN INTERN MED, V159, P620, DOI 10.7326/0003-4819-159-9-201311050-00710; Institute of Medicine, 2010, HEALTHC IMP LOW COST; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; STEVENS R, 1986, ANN INTERN MED, V105, P592, DOI 10.7326/0003-4819-105-4-592; Zuger A, 2004, NEW ENGL J MED, V350, P69, DOI 10.1056/NEJMsr031703	8	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2015	162	8					585	+		10.7326/M14-2905	http://dx.doi.org/10.7326/M14-2905			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG4GT	25621813				2022-12-28	WOS:000353244300020
J	Marsolier, J; Perichon, M; DeBarry, JD; Villoutreix, BO; Chluba, J; Lopez, T; Garrido, C; Zhou, XZ; Lu, KP; Fritsch, L; Ait-Si-Ali, S; Mhadhbi, M; Medjkane, S; Weitzman, JB				Marsolier, J.; Perichon, M.; DeBarry, J. D.; Villoutreix, B. O.; Chluba, J.; Lopez, T.; Garrido, C.; Zhou, X. Z.; Lu, K. P.; Fritsch, L.; Ait-Si-Ali, S.; Mhadhbi, M.; Medjkane, S.; Weitzman, J. B.			Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation	NATURE			English	Article							IN-VIVO; C-JUN; PIN1; ANNULATA; GENE; ISOMERIZATION; BUPARVAQUONE; CONFORMATION; RECOGNITION; CANCER	Infectious agents develop intricate mechanisms to interact with host cell pathways and hijack their genetic and epigenetic machinery to change host cell phenotypic states. Among the Apicomplexa phylum of obligate intracellular parasites, which cause veterinary and human diseases, Theileria is the only genus that transforms its mammalian host cells(1). Theileria infection of bovine leukocytes induces proliferative and invasive phenotypes associated with activated signalling pathways, notably JNK and AP-1 (ref. 2). The transformed phenotypes are reversed by treatment with the theilericidal drug buparvaquone(3). We used comparative genomics to identify a homologue of the peptidyl-prolyl isomerase PIN1 in T. annulata (TaPIN1) that is secreted into the host cell and modulates oncogenic signalling pathways. Here we show that TaPIN1 is a bona fide prolyl isomerase and that it interacts with the host ubiquitin ligase FBW7, leading to its degradation and subsequent stabilization of c-JUN, which promotes transformation. We performed in vitro and in silico analysis and in vivo zebrafish xenograft experiments to demonstrate that TaPIN1 is directly inhibited by the anti-parasite drug buparvaquone (and other known PIN1 inhibitors) and is mutated in a drug-resistant strain. Prolyl isomerization is thus a conserved mechanism that is important in cancer and is used by Theileria parasites to manipulate host oncogenic signalling.	[Marsolier, J.; Perichon, M.; Fritsch, L.; Ait-Si-Ali, S.; Medjkane, S.; Weitzman, J. B.] Univ Paris Diderot, Sorbonne Paris Cite, Epigenet & Cell Fate, UMR CNRS 7216, F-75013 Paris, France; [DeBarry, J. D.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Villoutreix, B. O.] Univ Paris Diderot, Sorbonne Paris Cite, Mol Therapeut Silico, INSERM UMR S 973, F-75013 Paris, France; [Chluba, J.; Lopez, T.; Garrido, C.] INSERM, UMR866, Equipe Labellisee Ligue Canc, F-21000 Dijon, France; [Chluba, J.; Lopez, T.; Garrido, C.] Lab Excellence LipSTIC, F-21000 Dijon, France; [Chluba, J.; Lopez, T.; Garrido, C.] Univ Burgundy, Fac Med & Pharm, F-21000 Dijon, France; [Garrido, C.] CGFL, Ctr Anticanc George Francois Leclerc, F-21000 Dijon, France; [Zhou, X. Z.; Lu, K. P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Mhadhbi, M.] Univ Manouba, Ecole Natl Med Vet, Lab Parasitol, Sidi Thabet 2020, Tunisia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; University of Georgia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universite de la Manouba	Weitzman, JB (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Epigenet & Cell Fate, UMR CNRS 7216, F-75013 Paris, France.	jonathan.weitzman@univ-paris-diderot.fr	Garrido, Carolina/GWM-5557-2022; Villoutreix, Bruno/I-4565-2015; Mhadhbi, Moez/S-3742-2018; Garrido, carmen/G-1633-2018; Lopez, Tessy/R-3678-2019; Chluba, Johanna/D-1224-2012	Villoutreix, Bruno/0000-0002-6456-7730; Mhadhbi, Moez/0000-0002-4857-1780; Garrido, carmen/0000-0003-1368-1493; Chluba, Johanna/0000-0001-8779-8016; Medjkane, Souhila/0000-0001-7973-7707; Marsolier, Justine/0000-0001-8464-9306; Lopez, Tatiana/0000-0002-3658-682X; DeBarry, Jeremy/0000-0001-5718-2675	National Institutes of Health [R01CA167677]; Association for International Cancer Research [08-0111]; French National Research Agency (ANR) [Blanc 11-BSV3-016-01]; "Who Am I?" Laboratory of Excellence - French Government through its "Investments for the Future" program [ANR-11-LABX-0071]; ANR [ANR-11-IDEX-0005-01]; NATIONAL CANCER INSTITUTE [R01CA167677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association for International Cancer Research; French National Research Agency (ANR)(French National Research Agency (ANR)); "Who Am I?" Laboratory of Excellence - French Government through its "Investments for the Future" program; ANR(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Langsley, M. A. Darghouth and M. Weitzman for critical reading of the manuscript and advice on this study. We thank members of the UMR7216 for discussions. J.B.W. thanks C. Gawer for advice and support. We thank the following for providing reagents: G. Langsley for TBL3-, BL3- and TpMD409-infected cells and for a Theileria complementary DNA library; C. Francastel for NIH/3T3 cells; G. Del Sal for Pin1<SUP>-/-</SUP> murine immortalized fibroblasts; B. E. Clurman for FBW7 plasmids; J. Baum for the rabbit anti-Apicomplexa actin antibody; and T. Uchida for DTM. Measurements of the PPIase activities were performed at the Flexstation III facility of the Biologie Fonctionnelle et Adaptative laboratory. Confocal analysis was performed at the microscopy facility of the ImagoSeine platform (Jacques Monod Institute). This work was supported by National Institutes of Health grant R01CA167677 to K.P.L., the Association for International Cancer Research (#08-0111), the French National Research Agency (ANR) (Blanc 11-BSV3-016-01), and the "Who Am I?" Laboratory of Excellence #ANR-11-LABX-0071 funded by the French Government through its "Investments for the Future" program operated by the ANR under grant #ANR-11-IDEX-0005-01.	Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Chen CH, 2013, CANCER RES, V73, P3951, DOI 10.1158/0008-5472.CAN-12-4360; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; Goh JY, 2010, FEBS LETT, V584, P2901, DOI 10.1016/j.febslet.2010.04.077; Grove LE, 2013, BIOINFORMATICS, V29, P1218, DOI 10.1093/bioinformatics/btt102; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Ji QJ, 2013, P NATL ACAD SCI USA, V110, P5010, DOI 10.1073/pnas.1219446110; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Lagorce David, 2009, BMC Chemical Biology, V9, P6, DOI 10.1186/1472-6769-9-6; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Landrieu I, 2002, J MOL BIOL, V320, P321, DOI 10.1016/S0022-2836(02)00429-1; Landrieu I, 2000, J BIOL CHEM, V275, P10577, DOI 10.1074/jbc.275.14.10577; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Marsolier J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003222; MCHARDY N, 1985, RES VET SCI, V39, P29, DOI 10.1016/S0034-5288(18)31765-X; Mhadhbi M, 2010, VET PARASITOL, V169, P241, DOI 10.1016/j.vetpar.2010.01.013; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Miteva MA, 2005, NUCLEIC ACIDS RES, V33, pW372, DOI 10.1093/nar/gki365; Moore JD, 2013, BIOORG MED CHEM LETT, V23, P4283, DOI 10.1016/j.bmcl.2013.05.088; Moreau MF, 1999, INFECT IMMUN, V67, P6678; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Sauton N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-184; Sharifiyazdi H, 2012, VET PARASITOL, V187, P431, DOI 10.1016/j.vetpar.2012.01.016; Shiels BR, 2004, EUKARYOT CELL, V3, P495, DOI 10.1128/EC.3.2.495-505.2004; Spitzer R, 2012, J COMPUT AID MOL DES, V26, P687, DOI 10.1007/s10822-011-9533-y; Sun LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043017; Tatara Y, 2009, BIOCHEM BIOPH RES CO, V384, P394, DOI 10.1016/j.bbrc.2009.04.144; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Winkler KE, 2000, SCIENCE, V287, P1644, DOI 10.1126/science.287.5458.1644; Witschi M, 2013, INT J PARASITOL, V43, P173, DOI 10.1016/j.ijpara.2012.10.017; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yao JL, 2001, J BIOL CHEM, V276, P13517, DOI 10.1074/jbc.M007006200	41	76	80	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 16	2015	520	7547					378	+		10.1038/nature14044	http://dx.doi.org/10.1038/nature14044			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG0RI	25624101	Green Accepted, Green Submitted			2022-12-28	WOS:000352974200045
J	Fillmore, CM; Xu, CX; Desai, PT; Berry, JM; Rowbotham, SP; Lin, YJ; Zhang, HK; Marquez, VE; Hammerman, PS; Wong, KK; Kim, CF				Fillmore, Christine M.; Xu, Chunxiao; Desai, Pooja T.; Berry, Joanne M.; Rowbotham, Samuel P.; Lin, Yi-Jang; Zhang, Haikuo; Marquez, Victor E.; Hammerman, Peter S.; Wong, Kwok-Kin; Kim, Carla F.			EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors	NATURE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; CANCER; ADENOCARCINOMA; MUTATIONS; COMPLEXES; POLYCOMB; SWI/SNF; GROWTH; ANTAGONISM	Non-small-cell lung cancer is the leading cause of cancer-related death worldwide(1). Chemotherapies such as the topoisomerase II (TopoII) inhibitor etoposide effectively reduce disease in a minority of patients with this cancer(2,3); therefore, alternative drug targets, including epigenetic enzymes, are under consideration for therapeutic intervention(4). A promising potential epigenetic target is the methyltransferase EZH2, which in the context of the polycomb repressive complex 2 (PRC2) is well known to tri-methylate histone H3 at lysine 27 (H3K27me3) and elicit gene silencing(5). Here we demonstrate that EZH2 inhibition has differential effects on the TopoII inhibitor response of non-small-cell lung cancers in vitro and in vivo. EGFR and BRG1 mutations are genetic biomarkers that predict enhanced sensitivity to TopoII inhibitor in response to EZH2 inhibition. BRG1 loss-of-function mutant tumours respond to EZH2 inhibition with increased S phase, anaphase bridging, apoptosis and TopoII inhibitor sensitivity. Conversely, EGFR and BRG1 wild-type tumours upregulate BRG1 in response to EZH2 inhibition and ultimately become more resistant to TopoII inhibitor. EGFR gain-of-function mutant tumours are also sensitive to dual EZH2 inhibition and TopoII inhibitor, because of genetic antagonism between EGFR and BRG1. These findings suggest an opportunity for precision medicine in the genetically complex disease of non-small-cell lung cancer.	[Fillmore, Christine M.; Desai, Pooja T.; Berry, Joanne M.; Rowbotham, Samuel P.; Kim, Carla F.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Fillmore, Christine M.; Rowbotham, Samuel P.; Lin, Yi-Jang; Kim, Carla F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Fillmore, Christine M.; Rowbotham, Samuel P.; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Xu, Chunxiao; Zhang, Haikuo; Hammerman, Peter S.; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xu, Chunxiao; Zhang, Haikuo; Wong, Kwok-Kin] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Marquez, Victor E.] NCI, Biol Chem Lab, NIH, Frederick, MD 21702 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kim, CF (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	carla.kim@childrens.harvard.edu	Marquez, Victor/AAP-3549-2021	Brainson, Christine/0000-0002-0854-5043; wong, kwok kin/0000-0001-6323-235X	Ladies Auxiliary to the Veterans of Foreign Wars; American Cancer Society [PF-12-151-01-DMC]; Uniting Against Lung Cancer Young Investigator Award; Boston University Undergraduate Research Opportunities Program; American Cancer Society Research Scholar Grant [RSG-08-082-01-MGO]; V Foundation for Cancer Research; Basil O'Conner March of Dimes Starter Award; Harvard Stem Cell Institute; Lung Cancer Research Foundation; National Institutes of Health (NIH) [CA122794, CA140594, CA163896, CA166480, CA154303, CA120964]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NIH [K08 CA163677];  [RO1 HL090136];  [U01 HL100402 RFA-HL-09-004]; NATIONAL CANCER INSTITUTE [R01CA166480, R01CA163896, R01CA140594, R01CA122794, P01CA154303, K08CA163677, P01CA120964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL090136] Funding Source: NIH RePORTER	Ladies Auxiliary to the Veterans of Foreign Wars; American Cancer Society(American Cancer Society); Uniting Against Lung Cancer Young Investigator Award; Boston University Undergraduate Research Opportunities Program; American Cancer Society Research Scholar Grant(American Cancer Society); V Foundation for Cancer Research; Basil O'Conner March of Dimes Starter Award; Harvard Stem Cell Institute; Lung Cancer Research Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Kim laboratory, F. Luo, P. Louis, K. Harrington, X. Wang and J. Brainson for technical assistance and discussions, and J. Crabtree, D. Hargreaves, C. Kadoch, L. Zon, K. Cichowski, M. Enos, S. Orkin, A. Gutierrez and C. Roberts for discussions. This work was supported in part by the Ladies Auxiliary to the Veterans of Foreign Wars, PF-12-151-01-DMC from the American Cancer Society, and the Uniting Against Lung Cancer Young Investigator Award supported by Meryl Bralower (C. M. F.), Boston University Undergraduate Research Opportunities Program (P.T.D.), RO1 HL090136, U01 HL100402 RFA-HL-09-004, American Cancer Society Research Scholar Grant RSG-08-082-01-MGO, the V Foundation for Cancer Research, a Basil O'Conner March of Dimes Starter Award, the Harvard Stem Cell Institute, and the Lung Cancer Research Foundation (C. F. K.), the National Institutes of Health (NIH) grants CA122794, CA140594, CA163896, CA166480, CA154303 and CA120964 (K.K.W.), the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (V.E.M.), and the NIH grant K08 CA163677 (P.S.H.).	Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Choudhury SR, 2011, CARCINOGENESIS, V32, P1525, DOI 10.1093/carcin/bgr171; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dykhuizen EC, 2013, NATURE, V497, P624, DOI 10.1038/nature12146; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gordon GJ, 2002, CANCER RES, V62, P4963; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Matsubara D, 2013, CANCER SCI, V104, P266, DOI 10.1111/cas.12065; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Miyanaga A, 2008, MOL CANCER THER, V7, P1923, DOI 10.1158/1535-7163.MCT-07-2140; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rohrbeck A, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-69; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Su AI, 2001, CANCER RES, V61, P7388; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Wang LH, 2012, LUNG CANCER, V77, P89, DOI 10.1016/j.lungcan.2012.02.011; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Xi QR, 2008, J BIOL CHEM, V283, P1146, DOI 10.1074/jbc.M707479200; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zornosa C, 2012, J NATL COMPR CANC NE, V10, P847, DOI 10.6004/jnccn.2012.0088	51	176	187	0	110	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 9	2015	520	7546					239	U261		10.1038/nature14122	http://dx.doi.org/10.1038/nature14122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3NA	25629630	Green Accepted, Green Submitted			2022-12-28	WOS:000352454600043
J	Kuhn, T; Basch, P; Barr, M; Yackel, T				Kuhn, Thomson; Basch, Peter; Barr, Michael; Yackel, Thomas		Med Informatics Comm Amer Coll Phy	Clinical Documentation in the 21st Century: Executive Summary of a Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							ELECTRONIC HEALTH RECORDS; MEDICAL-RECORDS; DECISION-SUPPORT; CHALLENGE; DOCTORS; FUTURE; SYSTEM; TEACH; GUIDE; PASTE	Clinical documentation was developed to track a patient's condition and communicate the author's actions and thoughts to other members of the care team. Over time, other stakeholders have placed additional requirements on the clinical documentation process for purposes other than direct care of the patient. More recently, new information technologies, such as electronic health record (EHR) systems, have led to further changes in the clinical documentation process. Although computers and EHRs can facilitate and even improve clinical documentation, their use can also add complexities; new challenges; and, in the eyes of some, an increase in inappropriate or even fraudulent documentation. At the same time, many physicians and other health care professionals have argued that the quality of the systems being used for clinical documentation is inadequate. The Medical Informatics Committee of the American College of Physicians has undertaken this review of clinical documentation in an effort to clarify the broad range of complex and interrelated issues surrounding clinical documentation and to suggest a path forward such that care and clinical documentation in the 21st century best serve the needs of patients and families.	[Kuhn, Thomson] Amer Coll Physicians, Washington, DC 20001 USA; MedStar Hlth, Washington, DC 20003 USA; Natl Comm Qual Assurance, Washington, DC 20005 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	American College of Physicians; Oregon Health & Science University	Kuhn, T (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	tkuhn@acponline.org		Cimino, James/0000-0003-4101-1622				Abelson Reed, 2012, NY TIMES, p[A1, A3]; Ahern DK, 2011, AM J PREV MED, V40, pS162, DOI 10.1016/j.amepre.2011.01.005; Bachman JW, 2003, MAYO CLIN PROC, V78, P67, DOI 10.4065/78.1.67; Barr MS, 2010, ANN INTERN MED, V153, P682, DOI 10.7326/0003-4819-153-10-201011160-00015; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Berenson RA, 2011, NEW ENGL J MED, V364, P1892, DOI 10.1056/NEJMp1102099; Blumenthal D, 2011, NEW ENGL J MED, V365, P2323, DOI 10.1056/NEJMsr1110507; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Chen ES, 2004, STUD HEALTH TECHNOL, V107, P18; Cimino JJ, 2013, JAMA-J AM MED ASSOC, V309, P991, DOI 10.1001/jama.2013.890; Cusack CM, 2013, J AM MED INFORM ASSN, V20, P134, DOI 10.1136/amiajnl-2012-001093; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; Delbanco T, 2010, ANN INTERN MED, V153, P121, DOI 10.7326/0003-4819-153-2-201007200-00008; Ejnes Y, 2013, ENGLISH IS 2 LANGUAG; Embi PJ, 2004, J AM MED INFORM ASSN, V11, P300, DOI 10.1197/jamia.M1525; Foote RS, 2013, JAMA INTERN MED, V173, P1171, DOI 10.1001/jamainternmed.2013.976; Hirschtick RE, 2006, JAMA-J AM MED ASSOC, V295, P2335, DOI 10.1001/jama.295.20.2335; Lowes R, 2012, MEDSCAPE MED NEWS; Mamykina L, 2012, J AM MED INFORM ASSN, V19, P1025, DOI 10.1136/amiajnl-2012-000901; Mechanic D, 2009, ANN INTERN MED, V151, P66, DOI 10.7326/0003-4819-151-1-200907070-00012; Rattner S, 2012, MEDSCAPE; Rosenbloom ST, 2011, J AM MED INFORM ASSN, V18, P181, DOI 10.1136/jamia.2010.007237; Siegler EL, 2010, ANN INTERN MED, V153, P671, DOI 10.7326/0003-4819-153-10-201011160-00012; Siegler EL, 2009, AM J MED, V122, P495, DOI 10.1016/j.amjmed.2009.02.010; Sinsky CA, 2012, COMP USER EXPERIENCE; Sinsky CA, 2014, ANN INTERN MED, V160, P727, DOI 10.7326/M13-2589; Slack WV, 2012, J AM MED INFORM ASSN, V19, P545, DOI 10.1136/amiajnl-2011-000580; U.S. Department of Health and Human Services Office of Inspector General, 2012, COD TRENDS MED EV MA; Walker J, 2014, NEW ENGL J MED, V370, P6, DOI 10.1056/NEJMp1310132; WEED LL, 1968, NEW ENGL J MED, V278, P652, DOI 10.1056/NEJM196803212781204; WEED LL, 1968, NEW ENGL J MED, V278, P593, DOI 10.1056/NEJM196803142781105	31	133	133	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					301	303		10.7326/M14-2128	http://dx.doi.org/10.7326/M14-2128			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC3FU	25581028				2022-12-28	WOS:000350232500020
J	Mandell, DJ; Lajoie, MJ; Mee, MT; Takeuchi, R; Kuznetsov, G; Norville, JE; Gregg, CJ; Stoddard, BL; Church, GM				Mandell, Daniel J.; Lajoie, Marc J.; Mee, Michael T.; Takeuchi, Ryo; Kuznetsov, Gleb; Norville, Julie E.; Gregg, Christopher J.; Stoddard, Barry L.; Church, George M.			Biocontainment of genetically modified organisms by synthetic protein design	NATURE			English	Article							ESCHERICHIA-COLI; BIOLOGICAL CONTAINMENT; SYSTEM; RECOMBINATION; ALGORITHMS	Genetically modified organisms (GMOs) are increasingly deployed at large scales and in open environments. Genetic biocontainment strategies are needed to prevent unintended proliferation of GMOs in natural ecosystems. Existing biocontainment methods are insufficient because they impose evolutionary pressure on the organism to eject the safeguard by spontaneous mutagenesis or horizontal gene transfer, or because they can be circumvented by environmentally available compounds. Here we computationally redesign essential enzymes in the first organism possessing an altered genetic code (Escherichia coli strain C321.Delta A) to confer metabolic dependence on non-standard amino acids for survival. The resulting GMOs cannot metabolically bypass their biocontainment mechanisms using known environmental compounds, and they exhibit unprecedented resistance to evolutionary escape through mutagenesis and horizontal gene transfer. This work provides a foundation for safer GMOs that are isolated from natural ecosystems by a reliance on synthetic metabolites.	[Mandell, Daniel J.; Lajoie, Marc J.; Mee, Michael T.; Kuznetsov, Gleb; Norville, Julie E.; Gregg, Christopher J.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lajoie, Marc J.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Mee, Michael T.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Takeuchi, Ryo; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston University; Fred Hutchinson Cancer Center; Harvard University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969; Norville, Julie/0000-0001-9205-8936	US Department of Defense National Defense Science and Engineering Graduate Fellowship; Canadian Institutes of Health Research; Department of Energy [DE-FG02-02ER63445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER	US Department of Defense National Defense Science and Engineering Graduate Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Renfrew for help with NSAA modelling in Rosetta, D. Goodman and R. Chari for sequence analysis assistance, M. Napolitano for advice on Lon-mediated escape assays, J. Teramoto and B. Wanner for the pJTE2 jumpstart plasmid, and F. Isaacs for manuscript comments. D. J. M. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. M.J.L. was supported by a US Department of Defense National Defense Science and Engineering Graduate Fellowship. M.T.M. was supported by a Doctoral Study Award from the Canadian Institutes of Health Research. The research was supported by Department of Energy Grant DE-FG02-02ER63445.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; CURTISS R, 1978, J INFECT DIS, V137, P668, DOI 10.1093/infdis/137.5.668; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gregg CJ, 2014, NUCLEIC ACIDS RES, V42, P4779, DOI 10.1093/nar/gkt1374; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; KNUDSEN S, 1995, APPL ENVIRON MICROB, V61, P985, DOI 10.1128/AEM.61.3.985-991.1995; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Li Q, 2009, APPL MICROBIOL BIOT, V82, P749, DOI 10.1007/s00253-009-1857-3; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; MOLIN S, 1987, BIO-TECHNOL, V5, P1315, DOI 10.1038/nbt1287-1315; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasotti L, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-8; Renfrew PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032637; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Ronchel MC, 2001, APPL ENVIRON MICROB, V67, P2649, DOI 10.1128/AEM.67.6.2649-2656.2001; SaiSree L, 2001, J BACTERIOL, V183, P6943, DOI 10.1128/JB.183.23.6943-6946.2001; Schmidt M, 2012, FEBS LETT, V586, P2199, DOI 10.1016/j.febslet.2012.02.022; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Tolonen AC, 2009, MOL MICROBIOL, V74, P1300, DOI 10.1111/j.1365-2958.2009.06890.x; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WOLLMAN EL, 1956, COLD SPRING HARB SYM, V21, P141, DOI 10.1101/SQB.1956.021.01.012; Wright O., 2014, ACS SYNTH BIOL; WU HC, 1971, J BACTERIOL, V105, P455, DOI 10.1128/JB.105.2.455-466.1971; Xie JM, 2007, ANGEW CHEM INT EDIT, V46, P9239, DOI 10.1002/anie.200703397; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu H., 2012, SOLVENT ACCESSIBLE S	47	234	250	12	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					55	+		10.1038/nature14121	http://dx.doi.org/10.1038/nature14121			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25607366	Green Accepted, Green Submitted			2022-12-28	WOS:000349098000030
J	Zhao, ML; Wu, SP; Zhou, QJ; Vivona, S; Cipriano, DJ; Cheng, YF; Brunger, AT				Zhao, Minglei; Wu, Shenping; Zhou, Qiangjun; Vivona, Sandro; Cipriano, Daniel J.; Cheng, Yifan; Brunger, Axel T.			Mechanistic insights into the recycling machine of the SNARE complex	NATURE			English	Article							SENSITIVE FACTOR NSF; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; CONFORMATIONAL-CHANGES; TERMINAL DOMAIN; ALPHA-SNAP; AAA ATPASE; FUSION; PROTEINS; RESOLUTION	Evolutionarily conserved SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptors) proteins form a complex that drives membrane fusion in eukaryotes. The ATPase NSF (N-ethylmaleimide sensitive factor), together with SNAPs (soluble NSF attachment protein), disassembles the SNARE complex into its protein components, making individual SNAREs available for subsequent rounds of fusion. Here we report structures of ATP- and ADP-bound NSF, and the NSF/SNAP/SNARE (20S) supercomplex determined by single-particle electron cryomicroscopy at nearatomic to sub-nanometre resolution without imposing symmetry. Large, potentially force-generating, conformational differences exist between ATP- and ADP-bound NSF. The 20S supercomplex exhibits broken symmetry, transitioning fromsix-fold symmetry of the NSF ATPase domains to pseudo four-fold symmetry of the SNARE complex. SNAPs interact with the SNARE complex with an opposite structural twist, suggesting an unwinding mechanism. The interfaces between NSF, SNAPs, and SNAREs exhibit characteristic electrostatic patterns, suggesting how one NSF/SNAP species can act on many different SNARE complexes.	[Zhao, Minglei; Zhou, Qiangjun; Vivona, Sandro; Cipriano, Daniel J.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Wu, Shenping; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Adv Microscopy Lab, San Francisco, CA 94158 USA; [Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Dept Biol Struct, Dept Photon Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	ycheng@ucsf.edu; brunger@stanford.edu	Zhao, Minglei/J-4446-2015	Zhao, Minglei/0000-0001-5832-6060; Zhou, Qiangjun/0000-0003-1789-9588; Brunger, Axel/0000-0001-5121-2036; Zhou, Qiangjun/0000-0002-7768-0249; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R37MH63105, 5-U01AI082051-05, R01GM082893, R01GM098672, P50GM082250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, R01GM098672, R01GM082893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank W.I. Weis for discussions and reading of the manuscript; S. Kenrick from Wyatt Technology Corporation for technical help with CG-MALS analysis. This research was supported in part by the National Institutes of Health (R37MH63105 to A.T.B., and a subcontract from Grant #5-U01AI082051-05 to A.T.B.; R01GM082893, R01GM098672 and P50GM082250 to Y.C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bitto E, 2008, PROTEINS, V70, P93, DOI 10.1002/prot.21468; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cipriano DJ, 2013, J BIOL CHEM, V288, P23436, DOI 10.1074/jbc.M113.476705; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; Penczek P, 1999, J STRUCT BIOL, V128, P44, DOI 10.1006/jsbi.1999.4157; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Saad A, 2001, J STRUCT BIOL, V133, P32, DOI 10.1006/jsbi.2001.4330; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Strop P, 2008, J BIOL CHEM, V283, P1113, DOI 10.1074/jbc.M707912200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739; Zorman S, 2014, ELIFE, V3, DOI 10.7554/eLife.03348; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	66	170	172	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					61	+		10.1038/nature14148	http://dx.doi.org/10.1038/nature14148			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25581794	Green Accepted, Green Submitted			2022-12-28	WOS:000349098000031
J	Bras, J; Guerreiro, R; Hardy, J				Bras, Jose; Guerreiro, Rita; Hardy, John			SnapShot: Genetics of Parkinson's Disease	CELL			English	Editorial Material							RISK LOCI; PATHWAY		[Bras, Jose; Guerreiro, Rita; Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 1PJ, England	University of London; University College London	Bras, J (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 1PJ, England.		Hardy, John/C-2451-2009; Guerreiro, Rita J L/A-1327-2011; Bras, Jose MT/A-1428-2011	Hardy, John/0000-0002-3122-0423; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333	Parkinson&quot;s UK [G-0907] Funding Source: researchfish; Medical Research Council Funding Source: Medline; Parkinson&apos;s UK [G-0907] Funding Source: Medline; Wellcome Trust [WT089698] Funding Source: Medline	Parkinson&quot;s UK(Parkinson&apos;s UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&apos;s UK(Parkinson&apos;s UK); Wellcome Trust(Wellcome Trust)		Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Bras J, 2012, NAT REV NEUROSCI, V13, P453, DOI 10.1038/nrn3271; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Holmans P, 2013, HUM MOL GENET, V22, P1039, DOI 10.1093/hmg/dds492; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Singleton A, 2011, HUM MOL GENET, V20, pR158, DOI 10.1093/hmg/ddr358	7	60	62	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					570	U239	570.e1	10.1016/j.cell.2015.01.019	http://dx.doi.org/10.1016/j.cell.2015.01.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635463	Bronze			2022-12-28	WOS:000349208000021
J	di Lernia, S				di Lernia, Savino			Save Libyan archaeology	NATURE			English	Editorial Material							AFRICA; SAHARA		Univ Roma La Sapienza, Archaeol Mission Sahara, Rome, Italy	Sapienza University Rome	di Lernia, S (corresponding author), Univ Roma La Sapienza, Archaeol Mission Sahara, Rome, Italy.	savino.dilernia@uniroma1.it	di Lernia, Savino/AAI-4535-2020					Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; deMenocal PB, 2012, NATURE ED KNOWLEDGE, V3, P12; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Lawler A, 2014, SCIENCE, V346, P1162, DOI 10.1126/science.346.6214.1162; Mattingly DJ, 2013, ANTIQUITY, V87, P503, DOI 10.1017/S0003598X00049097	7	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					547	549		10.1038/517547a	http://dx.doi.org/10.1038/517547a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CA2ZL	25631429	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000348775000016
J	Pielke, R				Pielke, Roger, Jr.			Gather data to reveal true extent of doping in sport	NATURE			English	Editorial Material									Univ Colorado, Ctr Sci & Technol Policy Res, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Pielke, R (corresponding author), Univ Colorado, Ctr Sci & Technol Policy Res, Boulder, CO 80309 USA.	rpielkejr@gmail.com							0	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					529	529		10.1038/517529a	http://dx.doi.org/10.1038/517529a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2ZL	25631409	Bronze			2022-12-28	WOS:000348775000004
J	Rawlins, EL				Rawlins, Emma L.			Emergency back-up for lung repair	NATURE			English	Editorial Material							AIRWAY STEM-CELLS; ALVEOLAR; REGENERATION	Influenza virus severely damages the epithelial tissue that lines the lung. Findings suggest that, in mice, activation of a back-up population of stem cells mediates effective repair of the injured lung. SEE LETTERS P.616&P.621	[Rawlins, Emma L.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Wellcome Trust MRC Stern Cell Inst, Cambridge CB2 1QN, England; [Rawlins, Emma L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Rawlins, EL (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Wellcome Trust MRC Stern Cell Inst, Cambridge CB2 1QN, England.	e.rawlins@gurdon.cam.ac.uk		Rawlins, Emma Louise/0000-0001-7426-3792	MRC [G0900424] Funding Source: UKRI; Medical Research Council [G0900424] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	12	10	11	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					556	557		10.1038/517556a	http://dx.doi.org/10.1038/517556a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631438				2022-12-28	WOS:000348775000026
J	Siddiqui, MM; Rais-Bahrami, S; Turkbey, B; George, AK; Rothwax, J; Shakir, N; Okoro, C; Raskolnikov, D; Parnes, HL; Linehan, WM; Merino, MJ; Simon, RM; Choyke, PL; Wood, BJ; Pinto, PA				Siddiqui, M. Minhaj; Rais-Bahrami, Soroush; Turkbey, Baris; George, Arvin K.; Rothwax, Jason; Shakir, Nabeel; Okoro, Chinonyerem; Raskolnikov, Dima; Parnes, Howard L.; Linehan, W. Marston; Merino, Maria J.; Simon, Richard M.; Choyke, Peter L.; Wood, Bradford J.; Pinto, Peter A.			Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TARGETED BIOPSY; RESONANCE; MRI; RISK; LOCALIZATION; RECURRENCE; OUTCOMES; SCORE	IMPORTANCE Targeted magnetic resonance (MR)/ultrasound fusion prostate biopsy has been shown to detect prostate cancer. The implications of targeted biopsy alone vs standard extended-sextant biopsy or the 2 modalities combined are not well understood. OBJECTIVE To assess targeted vs standard biopsy and the 2 approaches combined for the diagnosis of intermediate-to high-risk prostate cancer. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 1003 men undergoing both targeted and standard biopsy concurrently from 2007 through 2014 at the National Cancer Institute in the United States. Patients were referred for elevated level of prostate-specific antigen (PSA) or abnormal digital rectal examination results, often with prior negative biopsy results. Risk categorization was compared among targeted and standard biopsy and, when available, whole-gland pathology after prostatectomy as the "gold standard." INTERVENTIONS Patients underwent multiparametric prostate magnetic resonance imaging to identify regions of prostate cancer suspicion followed by targeted MR/ultrasound fusion biopsy and concurrent standard biopsy. MAIN OUTCOMES AND MEASURES The primary objective was to compare targeted and standard biopsy approaches for detection of high-risk prostate cancer (Gleason score >= 4 + 3); secondary end points focused on detection of low-risk prostate cancer (Gleason score 3 + 3 or low-volume 3 + 4) and the biopsy ability to predict whole-gland pathology at prostatectomy. RESULTS Targeted MR/ultrasound fusion biopsy diagnosed 461 prostate cancer cases, and standard biopsy diagnosed 469 cases. There was exact agreement between targeted and standard biopsy in 690 men (69%) undergoing biopsy. Targeted biopsy diagnosed 30% more high-risk cancers vs standard biopsy (173 vs 122 cases, P < .001) and 17% fewer low-risk cancers (213 vs 258 cases, P < .001). When standard biopsy cores were combined with the targeted approach, an additional 103 cases (22%) of mostly low-risk prostate cancer were diagnosed (83% low risk, 12% intermediate risk, and 5% high risk). The predictive ability of targeted biopsy for differentiating low-risk from intermediate-and high-risk disease in 170 men with whole-gland pathology after prostatectomy was greater than that of standard biopsy or the 2 approaches combined (area under the curve, 0.73, 0.59, and 0.67, respectively; P < .05 for all comparisons). CONCLUSIONS AND RELEVANCE Among men undergoing biopsy for suspected prostate cancer, targeted MR/ultrasound fusion biopsy, compared with standard extended-sextant ultrasound-guided biopsy, was associated with increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer. Future studies will be needed to assess the ultimate clinical implications of targeted biopsy.	[Siddiqui, M. Minhaj; Rais-Bahrami, Soroush; George, Arvin K.; Rothwax, Jason; Shakir, Nabeel; Okoro, Chinonyerem; Raskolnikov, Dima; Linehan, W. Marston; Wood, Bradford J.; Pinto, Peter A.] NCI, Urol Oncol Branch, NIH, Bethesda, MD 20892 USA; [Turkbey, Baris; Choyke, Peter L.] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Parnes, Howard L.] NCI, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Merino, Maria J.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Simon, Richard M.] NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Wood, Bradford J.; Pinto, Peter A.] NIH, Ctr Intervent Oncol, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Wood, Bradford J.; Pinto, Peter A.] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pinto, PA (corresponding author), NCI, Urol Oncol Branch, NIH, 10 Ctr Dr,MSC 1210,Bldg 10 CRC,Room 2W-5940, Bethesda, MD 20892 USA.	pintop@mail.nih.gov	Shakir, Nabeel/ABI-6623-2020; Siddiqui, Mohummad/V-1196-2019; Wood, Bradford J/M-7995-2017	Shakir, Nabeel/0000-0002-9066-3670; Wood, Bradford J/0000-0002-4297-0051; Siddiqui, Mohummad/0000-0002-4484-6820; Rais-Bahrami, Soroush/0000-0001-9466-9925	Intramural Research Program of the National Institutes of Health (NIH); National Cancer Institute; Center for Cancer Research; Center for Interventional Oncology; NIH; Foundation for the NIH from Pfizer; Leona M. and Harry B. Helmsley Charitable Trust; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [ZIABC011406, ZIDBC011242, ZIABC010655] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL040011, ZIACL040015] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Interventional Oncology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH from Pfizer; Leona M. and Harry B. Helmsley Charitable Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research, and Center for Interventional Oncology. The NIH, Philips Healthcare, and Invivo have a cooperative research and development agreement. The NIH, Philips Healthcare, and Invivo share intellectual property in the field. This research was also made possible through the NIH Medical Research Scholars Program, a public-private partnership supported jointly by the NIH and generous contributions to the Foundation for the NIH from Pfizer, the Leona M. and Harry B. Helmsley Charitable Trust, and the Howard Hughes Medical Institute, as well as other private donors. For a complete list, visit the foundation website at http://www.fnih.org.	[Anonymous], EP BIOST DEC CURV AN; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bul M, 2012, BJU INT, V110, P1672, DOI 10.1111/j.1464-410X.2012.11434.x; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; de Rooij M, 2014, EUR UROL, V66, P430, DOI 10.1016/j.eururo.2013.12.012; Emberton M, 2013, EUR UROL, V64, P720, DOI 10.1016/j.eururo.2013.06.050; Emberton Mark, 2014, EUR UROL, V65, pe106; Futterer JJ, 2006, RADIOLOGY, V241, P449, DOI 10.1148/radiol.2412051866; Haider MA, 2007, AM J ROENTGENOL, V189, P323, DOI 10.2214/AJR.07.2211; Kaplan I, 2002, MAGN RESON IMAGING, V20, P295, DOI 10.1016/S0730-725X(02)00490-3; Kasivisvanathan V, 2013, J UROLOGY, V189, P860, DOI 10.1016/j.juro.2012.10.009; Kitajima K, 2010, J MAGN RESON IMAGING, V31, P625, DOI 10.1002/jmri.22075; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Moore CM, 2013, EUR UROL, V64, P544, DOI 10.1016/j.eururo.2013.03.030; Pinto PA, 2011, J UROLOGY, V186, P1281, DOI 10.1016/j.juro.2011.05.078; Rais-Bahrami S, 2013, J UROLOGY, V190, P1721, DOI 10.1016/j.juro.2013.05.052; Ramos CG, 2004, J UROLOGY, V172, P137, DOI 10.1097/01.ju.0000132139.40964.75; Selvadurai ED, 2013, EUR UROL, V64, P981, DOI 10.1016/j.eururo.2013.02.020; Siddiqui MM, 2013, EUR UROL, V64, P713, DOI 10.1016/j.eururo.2013.05.059; Sonn GA, 2014, EUR UROL, V65, P809, DOI 10.1016/j.eururo.2013.03.025; Sonn GA, 2013, J UROLOGY, V189, P86, DOI 10.1016/j.juro.2012.08.095; Stark JR, 2009, J CLIN ONCOL, V27, P3459, DOI 10.1200/JCO.2008.20.4669; Turkbey B, 2013, RADIOLOGY, V268, P144, DOI 10.1148/radiol.13121325; Turkbey B, 2011, J UROLOGY, V186, P1818, DOI 10.1016/j.juro.2011.07.013; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Villeirs GM, 2010, EUR J RADIOL, V73, P352, DOI 10.1016/j.ejrad.2008.10.034; Wysock JS, 2014, EUR UROL, V66, P343, DOI 10.1016/j.eururo.2013.10.048; Wysock JS, 2014, AM UR ASS ANN M MAY; Xu S, 2007, LECT NOTES COMPUT SC, V4791, P128; Yerram NK, 2012, BJU INT, V110, pE783, DOI 10.1111/j.1464-410X.2012.11646.x	30	1100	1138	4	99	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					390	397		10.1001/jama.2014.17942	http://dx.doi.org/10.1001/jama.2014.17942			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626035	Bronze, Green Accepted			2022-12-28	WOS:000349072600021
J	Brendel, K; Payne, D				Brendel, Kelly; Payne, David			MEDICINE AND THE MEDIA Going gently into that good night: what is the best death?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kbrendel@bmj.com						[Anonymous], 2007, GUARDIAN; BBC, 2015, TODAY           0102; Hope J., 2015, DAILY MAIL; Smith R., 2014, DYING CANC IS BEST D; Smith R., 2015, DEATH DEBATE RESPONS	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2015	350								h393	10.1136/bmj.h393	http://dx.doi.org/10.1136/bmj.h393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZJ	25616275				2022-12-28	WOS:000348434100004
J	Rotundi, A; Sierks, H; Della Corte, V; Fulle, M; Gutierrez, PJ; Lara, L; Barbieri, C; Lamy, PL; Rodrigo, R; Koschny, D; Rickman, H; Keller, HU; Lopez-Moreno, JJ; Accolla, M; Agarwal, J; A'Hearn, MF; Altobelli, N; Angrilli, F; Barucci, MA; Bertaux, JL; Bertini, I; Bodewits, D; Bussoletti, E; Colangeli, L; Cosi, M; Cremonese, G; Crifo, JF; Da Deppo, V; Davidsson, B; Debei, S; De Cecco, M; Esposito, F; Ferrari, M; Fornasier, S; Giovane, F; Gustafson, B; Green, SF; Groussin, O; Grun, E; Guttler, C; Herranz, ML; Hviid, SF; Ip, W; Ivanovski, S; Jernimo, JM; Jorda, L; Knollenberg, J; Kramm, R; Kuhrt, E; Kuppers, M; Lazzarin, M; Leese, MR; Lopez-Jimenez, AC; Lucarelli, F; Lowry, SC; Marzari, F; Epifani, EM; McDonnell, JAM; Mennella, V; Michalik, H; Molina, A; Morales, R; Moreno, F; Mottola, S; Naletto, G; Oklay, N; Ortiz, JL; Palomba, E; Palumbo, P; Perrin, JM; Rodriguez, J; Sabau, L; Snodgrass, C; Sordini, R; Thomas, N; Tubiana, C; Vincent, JB; Weissman, P; Wenzel, KP; Zakharov, V; Zarnecki, JC				Rotundi, Alessandra; Sierks, Holger; Della Corte, Vincenzo; Fulle, Marco; Gutierrez, Pedro J.; Lara, Luisa; Barbieri, Cesare; Lamy, Philippe L.; Rodrigo, Rafael; Koschny, Detlef; Rickman, Hans; Keller, Horst Uwe; Lopez-Moreno, Jose J.; Accolla, Mario; Agarwal, Jessica; A'Hearn, Michael F.; Altobelli, Nicolas; Angrilli, Francesco; Barucci, M. Antonietta; Bertaux, Jean-Loup; Bertini, Ivano; Bodewits, Dennis; Bussoletti, Ezio; Colangeli, Luigi; Cosi, Massimo; Cremonese, Gabriele; Crifo, Jean-Francois; Da Deppo, Vania; Davidsson, Bjoern; Debei, Stefano; De Cecco, Mariolino; Esposito, Francesca; Ferrari, Marco; Fornasier, Sonia; Giovane, Frank; Gustafson, Bo; Green, Simon F.; Groussin, Olivier; Grun, Eberhard; Guttler, Carsten; Herranz, Miguel L.; Hviid, Stubbe F.; Ip, Wing; Ivanovski, Stavro; Jernimo, Jose M.; Jorda, Laurent; Knollenberg, Joerg; Kramm, Rainer; Kuhrt, Ekkehard; Kuppers, Michael; Lazzarin, Monica; Leese, Mark R.; Lopez-Jimenez, Antonio C.; Lucarelli, Francesca; Lowry, Stephen C.; Marzari, Francesco; Epifani, Elena Mazzotta; McDonnell, J. Anthony M.; Mennella, Vito; Michalik, Harald; Molina, Antonio; Morales, Rafael; Moreno, Fernando; Mottola, Stefano; Naletto, Giampiero; Oklay, Nilda; Ortiz, Jose L.; Palomba, Ernesto; Palumbo, Pasquale; Perrin, Jean-Marie; Rodriguez, Julio; Sabau, Lola; Snodgrass, Colin; Sordini, Roberto; Thomas, Nicolas; Tubiana, Cecilia; Vincent, Jean-Baptiste; Weissman, Paul; Wenzel, Klaus-Peter; Zakharov, Vladimir; Zarnecki, John C.			Dust measurements in the coma of comet 67P/Churyumov-Gerasimenko inbound to the Sun	SCIENCE			English	Article							ROSETTA MISSION; 81P/WILD 2; PARTICLES; ORBITS; GIOTTO; WILD-2; MODEL; SIZE	Critical measurements for understanding accretion and the dust/gas ratio in the solar nebula, where planets were forming 4.5 billion years ago, are being obtained by the GIADA (Grain Impact Analyser and Dust Accumulator) experiment on the European Space Agency's Rosetta spacecraft orbiting comet 67P/Churyumov-Gerasimenko. Between 3.6 and 3.4 astronomical units inbound, GIADA and OSIRIS (Optical, Spectroscopic, and Infrared Remote Imaging System) detected 35 outflowing grains of mass 10(-10) to 10(-7) kilograms, and 48 grains of mass 10(-5) to 10(-2) kilograms, respectively. Combined with gas data from the MIRO (Microwave Instrument for the Rosetta Orbiter) and ROSINA (Rosetta Orbiter Spectrometer for Ion and Neutral Analysis) instruments, we find a dust/gas mass ratio of 4 +/- 2 averaged over the sunlit nucleus surface. A cloud of larger grains also encircles the nucleus in bound orbits from the previous perihelion. The largest orbiting clumps are meter-sized, confirming the dust/gas ratio of 3 inferred at perihelion from models of dust comae and trails.	[Rotundi, Alessandra; Della Corte, Vincenzo; Accolla, Mario; Ferrari, Marco; Ivanovski, Stavro; Palomba, Ernesto; Palumbo, Pasquale; Sordini, Roberto] Ist Nazl Astrofis INAF, Ist Astrofis & Planetol Spaziali, Via Fosso Cavaliere 100, I-0133 Rome, Italy; [Rotundi, Alessandra; Accolla, Mario; Bussoletti, Ezio; Ferrari, Marco; Lucarelli, Francesca; Palumbo, Pasquale] Uni Napoli Parthenope, Dipartimento Sci & Tecnol, CDN IC4, I-80143 Naples, Italy; [Sierks, Holger; Agarwal, Jessica; Guttler, Carsten; Kramm, Rainer; Oklay, Nilda; Snodgrass, Colin; Tubiana, Cecilia; Vincent, Jean-Baptiste] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Fulle, Marco] Osserv Astron Trieste, INAF, I-34143 Trieste, Italy; [Gutierrez, Pedro J.; Lara, Luisa; Lopez-Moreno, Jose J.; Herranz, Miguel L.; Jernimo, Jose M.; Lopez-Jimenez, Antonio C.; Morales, Rafael; Moreno, Fernando; Ortiz, Jose L.; Rodriguez, Julio] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Barbieri, Cesare; Lazzarin, Monica] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Lamy, Philippe L.; Groussin, Olivier; Jorda, Laurent] CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille, France; [Lamy, Philippe L.; Groussin, Olivier; Jorda, Laurent] Aix Marseille Univ, F-13388 Marseille, France; [Rodrigo, Rafael] CSIC, Inst Nacl Tecn Aerosp, Ctr Astrobiol, Madrid 28691, Spain; [Rodrigo, Rafael; Zarnecki, John C.] Int Space Sci Inst, CH-3012 Bern, Switzerland; [Koschny, Detlef; Wenzel, Klaus-Peter] European Space Agcy, Sci Support Off, NL-2201 Noordwijk, Netherlands; [Rickman, Hans; Davidsson, Bjoern] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Rickman, Hans] Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland; [Keller, Horst Uwe] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [A'Hearn, Michael F.; Bodewits, Dennis] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Altobelli, Nicolas; Kuppers, Michael] European Space Agcy, European Space Astron Ctr, Madrid 28692, Spain; [Angrilli, Francesco; Debei, Stefano] Univ Padua, Dept Mech Engn, I-35131 Padua, Italy; [Barucci, M. Antonietta; Fornasier, Sonia; Zakharov, Vladimir] Univ Paris Diderot, Univ Paris 06, Lab Etud Spatiales & Instrumentat Astron, Observ Paris,CNRS, F-92195 Meudon, France; [Bertaux, Jean-Loup; Crifo, Jean-Francois; Perrin, Jean-Marie] Univ Versailles St Quentin En Yvelines, Inst Pierre Simon Laplace, Lab Atmospheres, Observ Spatiales,CNRS, F-78280 Guyancourt, France; [Bertini, Ivano] Univ Padua, Ctr Interdipartimentale Studi & Attivita Spaziali, I-35100 Padua, Italy; [Colangeli, Luigi] ESA, European Space Res & Technol Ctr ESTEC, Noordwijk 2201 AZ, Netherlands; [Cosi, Massimo] Selex ES, Florence, Italy; [Cremonese, Gabriele] Osserv Astron Padova, INAF, I-35122 Padua, Italy; [Da Deppo, Vania] CNR, Ist Foton & Nanotecnol, Unita Operat Supporto Padova LUXOR, I-35131 Padua, Italy; [De Cecco, Mariolino] Univ Trent, I-38100 Trento, Italy; [Esposito, Francesca; Epifani, Elena Mazzotta; Mennella, Vito] Osserv Astron Capodimonte, INAF, I-80133 Naples, Italy; [Giovane, Frank] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Gustafson, Bo] Univ Florida, Gainesville, FL 32611 USA; [Green, Simon F.; Leese, Mark R.; McDonnell, J. Anthony M.; Snodgrass, Colin; Zarnecki, John C.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Grun, Eberhard] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hviid, Stubbe F.; Knollenberg, Joerg; Kuhrt, Ekkehard; Mottola, Stefano] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetary Res, D-12489 Berlin, Germany; [Ip, Wing] Natl Cent Univ, Inst Space Sci, Chungli 32054, Taiwan; [Lowry, Stephen C.; McDonnell, J. Anthony M.] Univ Kent, Sch Phys Sci, Canterbury CT2 7NZ, Kent, England; [Marzari, Francesco] Univ Padua, Dept Phys, I-35131 Padua, Italy; [McDonnell, J. Anthony M.] Unispacekent, Canterbury CT2 8EF, Kent, England; [Michalik, Harald] Inst Datentech & Kommunikat Netze, D-38106 Braunschweig, Germany; [Molina, Antonio] Univ Granada, Fac Ciencias, Dept Fis Aplicada, E-18071 Granada, Spain; [Naletto, Giampiero] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Perrin, Jean-Marie] Observ Haute Provence, OSU Pytheas, AMU, CNRS,UMS 2244, F-04870 St Michel lObservatoire, France; [Sabau, Lola] Inst Nacl Tecn Aeroesp, Madrid 28850, Spain; [Thomas, Nicolas] Univ Bern, Phys Inst, CH-3012 Bern, Switzerland; [Weissman, Paul] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Istituto Nazionale Astrofisica (INAF); Parthenope University Naples; Max Planck Society; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); European Space Agency; Uppsala University; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Braunschweig University of Technology; University System of Maryland; University of Maryland College Park; European Space Agency; University of Padua; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Padua; European Space Agency; Leonardo; Istituto Nazionale Astrofisica (INAF); University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Trento; Istituto Nazionale Astrofisica (INAF); Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida; Open University - UK; Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR); National Central University; University of Kent; University of Padua; University of Granada; University of Padua; Centre National de la Recherche Scientifique (CNRS); University of Bern; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Rotundi, A (corresponding author), Ist Nazl Astrofis INAF, Ist Astrofis & Planetol Spaziali, Via Fosso Cavaliere 100, I-0133 Rome, Italy.	rotundi@uniparthenope.it	Ivanovski, Stavro/AAN-3309-2020; Accolla, Mario/AAH-1675-2019; Da Deppo, Vania/D-2897-2012; De La Revilla, Miguel Luis Herranz/L-5991-2014; Gutiérrez, Pedro J/AAJ-6177-2020; Lara, Luisa M/F-5614-2012; Lopez-Moreno, Jose Juan/C-7976-2011; Palomba, Ernesto/E-8287-2017; Naletto, Giampiero/S-6329-2016; Lopez Jimenez, Antonio C./L-4738-2014; Esposito, Francesca/ABA-1467-2020; Green, Simon F/C-7408-2009; Jorda, Laurent/AAA-1718-2021; Tubiana, Cecilia/AAG-8209-2019; Ortiz, Jose L./L-3192-2014; Moreno, Fernando/AAT-4609-2021; Marzari, Francesco/X-2440-2019; Rickman, Hans/X-7631-2018; Moreno, Jose Juan Lopez/M-5537-2019; Thomas, Nicolas/G-4693-2015	Da Deppo, Vania/0000-0001-6273-8738; De La Revilla, Miguel Luis Herranz/0000-0003-4343-6632; Gutiérrez, Pedro J/0000-0002-7332-6269; Lara, Luisa M/0000-0002-7184-920X; Lopez-Moreno, Jose Juan/0000-0002-7946-2624; Palomba, Ernesto/0000-0002-9101-6774; Naletto, Giampiero/0000-0003-2007-3138; Lopez Jimenez, Antonio C./0000-0002-6297-0681; Esposito, Francesca/0000-0001-9962-1648; Green, Simon F/0000-0002-9153-9786; Tubiana, Cecilia/0000-0001-8475-9898; Ortiz, Jose L./0000-0002-8690-2413; Moreno, Fernando/0000-0003-0670-356X; Rickman, Hans/0000-0002-9603-6619; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Palumbo, Pasquale/0000-0003-2323-9228; Cremonese, Gabriele/0000-0001-9021-1140; Colangeli, Luigi/0000-0001-6801-9152; Jeronimo, Jose M./0000-0002-4944-5823; Accolla, Mario/0000-0002-9509-5967; De Cecco, Mariolino/0000-0003-1562-0328; Thomas, Nicolas/0000-0002-0146-0071; fulle, marco/0000-0001-8435-5287; Della Corte, Vincenzo/0000-0001-6461-5803; Ferrari, Marco/0000-0002-7447-6146; Bertini, Ivano/0000-0002-0616-2444; Mazzotta Epifani, Elena/0000-0003-1412-0946; Morales Munoz, Rafael/0000-0003-1661-0594; Debei, Stefano/0000-0002-6757-6616; JORDA, Laurent/0000-0001-8735-3308; Lowry, Stephen/0000-0002-5605-4329; Snodgrass, Colin/0000-0001-9328-2905; Mennella, Vito/0000-0001-9525-895X; /0000-0002-2242-6147; Rotundi, Alessandra/0000-0001-5467-157X	GIADA; Spanish Ministry of Education and Science Ministerio de Educacion y Ciencias (MEC); NASA through the U.S. Rosetta Project; Germany (DLR); France (Centre National d'Etudes Spatiales); Italy (Italian Space Agency); Spain (MEC); Sweden (Sweden National Science Board); ESA Technical Directorate; Science and Technology Facilities Council [ST/L000776/1, ST/L004569/1, ST/I001964/1] Funding Source: researchfish; STFC [ST/L000776/1, ST/I001964/1, ST/L004569/1] Funding Source: UKRI	GIADA; Spanish Ministry of Education and Science Ministerio de Educacion y Ciencias (MEC)(German Research Foundation (DFG)); NASA through the U.S. Rosetta Project; Germany (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); France (Centre National d'Etudes Spatiales)(Centre National D'etudes Spatiales); Italy (Italian Space Agency); Spain (MEC)(Spanish Government); Sweden (Sweden National Science Board); ESA Technical Directorate; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	GIADA was built by a consortium led by the Universita degli Studi di Napoli "Parthenope" and INAF-Osservatorio Astronomico di Capodimonte, in collaboration with the Instituto de Astrofisica de Andalucia, Selex-ES, FI, and SENER. GIADA is presently managed and operated by Istituto di Astrofisica e Planetologia Spaziali-INAF, Italy. GIADA was funded and managed by the Agenzia Spaziale Italiana, with the support of the Spanish Ministry of Education and Science Ministerio de Educacion y Ciencias (MEC). GIADA was developed from a Principal Investigator proposal from the University of Kent; science and technology contributions were provided by CISAS, Italy; Laboratoire d'Astrophysique Spatiale, France, and institutions from the UK, Italy, France, Germany, and the USA. Science support was provided by NASA through the U.S. Rosetta Project managed by the Jet Propulsion Laboratory/California Institute of Technology. We would like to thank A. Coradini for her contribution as a GIADA Co-Investigator. GIADA calibrated data will be available through ESA's Planetary Science Archive (PSA) Web site (www.rssd.esa.int/index.php?project=PSA&page=index). All data presented here are available on request before archival in the PSA. OSIRIS was built by a consortium led by the Max-Planck-Institut fur Sonnensystemforschung, Katlenburg-Lindau, Germany, in collaboration with CISAS, University of Padova, Italy; the Laboratoire d'Astrophysique de Marseille, France; the Instituto de Astrofisica de Andalucia, CSIC, Granada, Spain; the Scientific Support Office of the European Space Agency, Noordwijk, The Netherlands; the Instituto Nacional de Tecnica Aeroespacial, Madrid, Spain; the Universidad Politechnica de Madrid, Spain; the Department of Physics and Astronomy of Uppsala University, Sweden; and the Institut fur Datentechnik und Kommunikationsnetze der Technischen Universitat Braunschweig, Germany. The support of the national funding agencies of Germany (DLR), France (Centre National d'Etudes Spatiales), Italy (Italian Space Agency), Spain (MEC), Sweden (Sweden National Science Board), and the ESA Technical Directorate is gratefully acknowledged. We thank the MIRO and ROSINA teams for sharing their early results with us. We thank the Rosetta Science Ground Segment at ESAC, the Rosetta Mission Operations Centre at ESOC (European Space Operations Center), and the Rosetta Project at ESTEC (European Space Technology Center) for their outstanding work enabling the science return of the Rosetta Mission. We gratefully acknowledge the referees for very constructive comments.	Agarwal J, 2010, ICARUS, V207, P992, DOI 10.1016/j.icarus.2010.01.003; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Colangeli L, 2007, SPACE SCI REV, V128, P803, DOI 10.1007/s11214-006-9038-5; Crifo JF, 2004, ASTROPHYS SPACE SC L, V311, P119; Della Corte V, 2014, J ASTRON INSTRUM, V3, DOI 10.1142/S2251171713500116; Economou TE, 2013, ICARUS, V222, P526, DOI 10.1016/j.icarus.2012.09.019; Fulle M, 2000, ASTRON J, V119, P1968, DOI 10.1086/301285; FULLE M, 1995, ASTRON ASTROPHYS, V304, P622; Fulle M, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201014928; Fulle M, 1997, ASTRON ASTROPHYS, V325, P1237; Green SF, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002318; Gulkis S, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0709; Hassig M, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0276; Kearsley AT, 2008, METEORIT PLANET SCI, V43, P41, DOI 10.1111/j.1945-5100.2008.tb00609.x; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; MCDONNELL JAM, 1990, P LUNAR PLANET SCI, P373; MCDONNELL JAM, 1993, NATURE, V362, P732, DOI 10.1038/362732a0; RICHTER K, 1995, ICARUS, V114, P355, DOI 10.1006/icar.1995.1068; RIETMEIJER FJM, 1998, PLANETARY MAT, V36; Rotundi A, 2014, METEORIT PLANET SCI, V49, P550, DOI 10.1111/maps.12274; Scheeres DJ, 2000, ASTRON ASTROPHYS, V356, P747; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Snodgrass C, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201322020; Tubiana C, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424735; Zolensky M, 2008, METEORIT PLANET SCI, V43, P261, DOI 10.1111/j.1945-5100.2008.tb00621.x	25	304	304	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							aaa3905	10.1126/science.aaa3905	http://dx.doi.org/10.1126/science.aaa3905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613898	Green Published			2022-12-28	WOS:000348225800029
J	Worster, A				Worster, Andrew			In suspected nephrolithiasis, US did not differ from CT for high-risk diagnoses but reduced radiation exposure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Worster, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Heidenreich A, 2002, EUR UROL, V41, P351, DOI 10.1016/S0302-2838(02)00064-7; Miller OF, 1999, J UROLOGY, V162, P688, DOI 10.1097/00005392-199909010-00014	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC4	10.7326/ACPJC-2015-162-2-004	http://dx.doi.org/10.7326/ACPJC-2015-162-2-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599364				2022-12-28	WOS:000350106600003
J	Liu, YY; Stehlik, J; Eichler, C; Gullans, MJ; Taylor, JM; Petta, JR				Liu, Y. -Y.; Stehlik, J.; Eichler, C.; Gullans, M. J.; Taylor, J. M.; Petta, J. R.			Semiconductor double quantum dot micromaser	SCIENCE			English	Article							LASER; QUBIT; ELECTRODYNAMICS; NANOCAVITY; JUNCTIONS; EMISSION; SYSTEM	The coherent generation of light, from masers to lasers, relies upon the specific structure of the individual emitters that lead to gain. Devices operating as lasers in the few-emitter limit provide opportunities for understanding quantum coherent phenomena, from terahertz sources to quantum communication. Here we demonstrate a maser that is driven by single-electron tunneling events. Semiconductor double quantum dots (DQDs) serve as a gain medium and are placed inside a high-quality factor microwave cavity. We verify maser action by comparing the statistics of the emitted microwave field above and below the maser threshold.	[Liu, Y. -Y.; Stehlik, J.; Eichler, C.; Petta, J. R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Gullans, M. J.; Taylor, J. M.] Univ Maryland, Joint Quantum Inst, NIST, College Pk, MD 20742 USA; [Taylor, J. M.] Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA; [Taylor, J. M.] NIST, College Pk, MD 20742 USA; [Petta, J. R.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Princeton University; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; University of California System; University of California Santa Barbara	Petta, JR (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	petta@princeton.edu	Taylor, Jacob M/B-7826-2011; Taylor, Jacob/O-1670-2019; Liu, Yinyu/AAX-1621-2020	Taylor, Jacob M/0000-0003-0493-5594; Taylor, Jacob/0000-0003-0493-5594; 	Packard Foundation; National Science Foundation [DMR-1409556, DMR-1420541]; Defense Advanced Research Projects Agency QuEST [HR0011-09-1-0007]; Army Research Office [W911NF-08-1-0189]	Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency QuEST; Army Research Office	We thank K. Petersson for assistance with sample fabrication. Research was supported by the Packard Foundation, National Science Foundation (DMR-1409556 and DMR-1420541), Defense Advanced Research Projects Agency QuEST (HR0011-09-1-0007), and Army Research Office (W911NF-08-1-0189). Identification of certain commercial equipment, instruments, or materials (or suppliers or software) in this paper does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose. All data described in the paper are presented in this report and supplementary materials. Y.-Y.L., J.R.P., and Princeton University have filed a provisional patent application that relates to the quantum dot micromaser.	Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Delbecq MR, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.256804; DINGLE R, 1974, PHYS REV LETT, V33, P827, DOI 10.1103/PhysRevLett.33.827; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; Fasth C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.266801; Frey T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046807; Haken H., 1983, LASER THEORY; HALL RN, 1962, PHYS REV LETT, V9, P366, DOI 10.1103/PhysRevLett.9.366; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Jin PQ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035322; Liu YY, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.036801; McKeever J, 2003, NATURE, V425, P268, DOI 10.1038/nature01974; Megrant A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3693409; MESCHEDE D, 1985, PHYS REV LETT, V54, P551, DOI 10.1103/PhysRevLett.54.551; Milonni P. W., 2010, LASER PHYS; Nadj-Perge S, 2010, NATURE, V468, P1084, DOI 10.1038/nature09682; NATHAN MI, 1962, APPL PHYS LETT, V1, P62, DOI 10.1063/1.1777371; Nomura M, 2010, NAT PHYS, V6, P279, DOI 10.1038/NPHYS1518; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; Protsenko I, 1999, PHYS REV A, V59, P1667, DOI 10.1103/PhysRevA.59.1667; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; SCHAWLOW AL, 1958, PHYS REV, V112, P1940, DOI 10.1103/PhysRev.112.1940; Siegman A. E., 1986, LASER; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Xie ZG, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117401; Yao Y, 2012, NAT PHOTONICS, V6, P432, DOI [10.1038/nphoton.2012.143, 10.1038/NPHOTON.2012.143]; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119	28	99	101	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					285	287		10.1126/science.aaa2501	http://dx.doi.org/10.1126/science.aaa2501			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593187	Green Submitted			2022-12-28	WOS:000347915300039
J	Drazen, JM				Drazen, Jeffrey M.			Sharing Individual Patient Data from Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Institute of Medicine, 2014, DISC FRAM CLIN TRIAL, DOI 10.17226/18610	1	46	47	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					201	202		10.1056/NEJMp1415160	http://dx.doi.org/10.1056/NEJMp1415160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3HX	25587944				2022-12-28	WOS:000348119200001
J	Farina, SC; Summers, AP				Farina, Stacy C. .; Summers, Adam P.			Boxed up and ready to go	NATURE			English	Editorial Material							BOXFISHES TELEOSTEI; OSTRACIIDAE; FISHES		[Farina, Stacy C. .] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Summers, Adam P.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	Cornell University; University of Washington	Farina, SC (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	stacy.farina@gmail.com; fishguy@uw.edu	Farina, Stacy C/L-6281-2014	Farina, Stacy/0000-0003-2479-1268; Summers, Adam/0000-0003-1930-9748	Division Of Environmental Biology [1310812] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1256602] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bartol IK, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/014001; Bartol IK, 2003, J EXP BIOL, V206, P725, DOI 10.1242/jeb.00137; Bartol IK, 2005, J EXP BIOL, V208, P327, DOI 10.1242/jeb.01356; Bartol IK, 2002, INTEGR COMP BIOL, V42, P971, DOI 10.1093/icb/42.5.971; Crickmore P., 2003, NIGHTHAWK F 117 STEA; Hove JR, 2001, J EXP BIOL, V204, P1459; Van Wassenbergh S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1146; Walker JA, 2000, J EXP BIOL, V203, P3391	8	7	7	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					274	275		10.1038/517274a	http://dx.doi.org/10.1038/517274a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592528				2022-12-28	WOS:000347810300024
J	Liu, L; Zhang, K; Sandoval, H; Yamamoto, S; Jaiswal, M; Sanz, E; Li, ZH; Hui, J; Graham, BH; Quintana, A; Bellen, HJ				Liu, Lucy; Zhang, Ke; Sandoval, Hector; Yamamoto, Shinya; Jaiswal, Manish; Sanz, Elisenda; Li, Zhihong; Hui, Jessica; Graham, Brett H.; Quintana, Albert; Bellen, Hugo J.			Glial Lipid Droplets and ROS Induced by Mitochondrial Defects Promote Neurodegeneration	CELL			English	Article							COMPLEX-I DEFICIENCY; OXIDATIVE STRESS; RETINAL DEGENERATION; LIFE-SPAN; DROSOPHILA; BRAIN; PEROXIDATION; SREBP; ACTIVATION; MODEL	Reactive oxygen species (ROS) and mitochondrial defects in neurons are implicated in neurodegenerative disease. Here, we find that a key consequence of ROS and neuronal mitochondrial dysfunction is the accumulation of lipid droplets (LD) in glia. In Drosophila, ROS triggers c-Jun-N-terminal Kinase (JNK) and Sterol Regulatory Element Binding Protein (SREBP) activity in neurons leading to LD accumulation in glia prior to or at the onset of neurodegeneration. The accumulated lipids are peroxidated in the presence of ROS. Reducing LD accumulation in glia and lipid peroxidation via targeted lipase overexpression and/or lowering ROS significantly delays the onset of neurodegeneration. Furthermore, a similar pathway leads to glial LD accumulation in Ndufs4 mutant mice with neuronal mitochondrial defects, suggesting that LD accumulation following mitochondrial dysfunction is an evolutionarily conserved phenomenon, and represents an early, transient indicator and promoter of neurodegenerative disease.	[Liu, Lucy; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zhang, Ke; Bellen, Hugo J.] Baylor Coll Med, Houston, TX 77030 USA; [Zhang, Ke; Bellen, Hugo J.] Baylor Coll Med, Mol Biophys Grad Program, Houston, TX 77030 USA; [Sandoval, Hector; Yamamoto, Shinya; Jaiswal, Manish; Li, Zhihong; Graham, Brett H.; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Yamamoto, Shinya; Bellen, Hugo J.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Jaiswal, Manish; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Sanz, Elisenda; Quintana, Albert] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Hui, Jessica; Quintana, Albert] Univ Washington, Ctr Dev Therapeut, Seattle, WA 98195 USA; [Quintana, Albert] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hbellen@bcm.edu	Quintana, Albert/N-5544-2015; Graham, Brett/R-8685-2018; Yamamoto, Shinya/ABB-2837-2021; Sanz, Elisenda/I-2765-2015; Zhang, Ke/B-8598-2018	Quintana, Albert/0000-0003-1674-7160; Graham, Brett/0000-0001-8451-8154; Yamamoto, Shinya/0000-0003-2172-8036; Sanz, Elisenda/0000-0002-7932-8556; Zhang, Ke/0000-0002-4794-8355; Sandoval, Hector/0000-0002-9186-7384; Jaiswal, Manish/0000-0001-8360-8289; Liu, Lucy/0000-0003-1176-0753; Bellen, Hugo/0000-0001-5992-5989	BCM Intellectual and Developmental Disabilities Research Center [NIH/NICHHD P30 HD024064]; NIH [5R01GM067858, T32 NS043124-11, 1RC4GM096355]; Research Education and Career Horizon Institutional Research and Academic Career Development Award [5K12GM084897]; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital;  [5T32GM008507-18]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092, P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008507, R01GM067858, R01GM098387, R01GM084947, K12GM084897, RC4GM096355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124] Funding Source: NIH RePORTER	BCM Intellectual and Developmental Disabilities Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Education and Career Horizon Institutional Research and Academic Career Development Award; Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Karen Schulze, Richard Palmiter, Bertrand Mollereau, and Kartik Venkatachalam for comments; Robert Rawson (SREBP antibody), Ronald Kuhnlein (UAS-bmm), the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi center, and the TRiP at Harvard Medical School (NIH/NIGMS R01- GM084947) for providing stocks and reagents; Ching-On Wong for help with westerns; and Lita Duraine for TEM. Confocal microscopy was supported by the BCM Intellectual and Developmental Disabilities Research Center (NIH/NICHHD P30 HD024064). H.S. was supported by NIH 5R01GM067858, NIH T32 NS043124-11 and the Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship 5K12GM084897. L.L. was supported by the Neuroscience graduate program training grant (5T32GM008507-18) from 2011 to 2012. S.Y. is supported by the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital. We acknowledge support of the NW Mitochondrial Research Guild to A.Q. We acknowledge support of the NIH (1RC4GM096355), the Robert A. and Renee E. Belfer Family Foundation, the Huffington Foundation and Target ALS to H.J.B. S.Y. is supported by the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital. H.J.B. is an Investigator of the Howard Hughes Medical Institute.	Amer J, 2008, BBA-GEN SUBJECTS, V1780, P249, DOI 10.1016/j.bbagen.2007.11.009; Assouline Z, 2012, BBA-MOL BASIS DIS, V1822, P1062, DOI 10.1016/j.bbadis.2012.01.013; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Beal M Flint, 2007, Novartis Found Symp, V287, P183; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Boaretto F, 2010, NEUROLOGY, V74, P1919, DOI 10.1212/WNL.0b013e3181e240f9; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Cabodevilla AG, 2013, J BIOL CHEM, V288, P27777, DOI 10.1074/jbc.M113.466656; Camargo N, 2009, FEBS J, V276, P628, DOI 10.1111/j.1742-4658.2008.06808.x; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Debattisti V, 2013, MOL CELL NEUROSCI, V55, P77, DOI 10.1016/j.mcn.2012.08.007; Del Bo R, 2008, NEUROLOGY, V71, P1959, DOI 10.1212/01.wnl.0000327095.32005.a4; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; Edwards TN, 2010, PROG NEUROBIOL, V90, P471, DOI 10.1016/j.pneurobio.2010.01.001; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Galasko DR, 2012, ARCH NEUROL-CHICAGO, V69, P836, DOI 10.1001/archneurol.2012.85; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hulshagen L, 2008, J NEUROSCI, V28, P4015, DOI 10.1523/JNEUROSCI.4968-07.2008; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Mato M, 1999, ANAT REC, V256, P165; McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; PAVLOPOULOS TG, 1990, APPL OPTICS, V29, P3885, DOI 10.1364/AO.29.003885; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Quintana A, 2012, J CLIN INVEST, V122, P2359, DOI 10.1172/JCI62923; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; Sandoval H, 2014, ELIFE, V3, DOI 10.7554/eLife.03558; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schimel AM, 2011, AM J PATHOL, V178, P2032, DOI 10.1016/j.ajpath.2011.01.036; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Stowers RS, 1999, GENETICS, V152, P1631; Sun XP, 2012, AGING CELL, V11, P783, DOI 10.1111/j.1474-9726.2012.00842.x; Thiffault I, 2006, BRAIN, V129, P2332, DOI 10.1093/brain/awl110; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Xie H, 2013, P NATL ACAD SCI USA, V110, P7904, DOI 10.1073/pnas.1217938110; Xiong B, 2013, TRENDS NEUROSCI, V36, P652, DOI 10.1016/j.tins.2013.08.003; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	64	404	413	21	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					177	190		10.1016/j.cell.2014.12.019	http://dx.doi.org/10.1016/j.cell.2014.12.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594180	Bronze, Green Accepted			2022-12-28	WOS:000347923200017
J	Mumford, D; Tate, J				Mumford, David; Tate, John			Alexander Gfotl tendieck, (1928-2014) OBITUARY	NATURE			English	Biographical-Item									[Mumford, David; Tate, John] Harvard Univ, Cambridge, MA 02138 USA; [Mumford, David] Brown Univ, Providence, RI 02912 USA; [Tate, John] Univ Texas Austin, Austin, TX 78712 USA	Harvard University; Brown University; University of Texas System; University of Texas Austin	Mumford, D (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	dbmumford@gmail.com; tate@math.utexas.edu							0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					272	272		10.1038/517272a	http://dx.doi.org/10.1038/517272a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592527	Bronze			2022-12-28	WOS:000347810300023
J	Bowling, M; Burch, N; Johanson, M; Tammelin, O				Bowling, Michael; Burch, Neil; Johanson, Michael; Tammelin, Oskari			Heads-up limit hold'em poker is solved	SCIENCE			English	Article							GAMES	Poker is a family of games that exhibit imperfect information, where players do not have full knowledge of past events. Whereas many perfect-information games have been solved (e. g., Connect Four and checkers), no nontrivial imperfect-information game played competitively by humans has previously been solved. Here, we announce that heads-up limit Texas hold'em is now essentially weakly solved. Furthermore, this computation formally proves the common wisdom that the dealer in the game holds a substantial advantage. This result was enabled by a new algorithm, CFR+, which is capable of solving extensive-form games orders of magnitude larger than previously possible.	[Bowling, Michael; Burch, Neil; Johanson, Michael] Univ Alberta, Dept Comp Sci, Edmonton, AB T6G 2E8, Canada	University of Alberta	Bowling, M (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB T6G 2E8, Canada.	bowling@cs.ualberta.ca			Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures through the Alberta Innovates Centre for Machine Learning	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures through the Alberta Innovates Centre for Machine Learning	The author order is alphabetical reflecting equal contribution by Me authors. The Mea of CFR<SUP>+</SUP> and compressing the regrets and Strategy originated with O.T. (39). This research was supported by Natural Sciences and Engineering Research Council of Canada and Alberta Innovates Technology Futures through the Alberta Innovates Centre for Machine Learning and was made possible by the computing resources of Compute Canada and Calcul Quebec. We thank all of the current and past members of the University of Alberta Computer Poker Research Group, where the idea to solve heads-up let it Texas hold'em was is discussed; J. Schaeffer, R. Holte. D. Szafron, and A. Brown for comments on early drafts of this article; and B. Paradis for insight into the conventional wisdom of top human poker players.	Allis V., 1988, THESIS VRIJE U BRUSS; Allis V. L., 1994, THESIS U LUMBURG; [Anonymous], 2008, WIRED; [Anonymous], 2007, ECONOMIST, P31; [Anonymous], 2011, IJCAI, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-054; Babbage C., 1864, PASSAGES LIFE PHILOS; Billings D, 2002, ARTIF INTELL, V134, P201, DOI 10.1016/S0004-3702(01)00130-8; Billings D., 2003, IJCAI, P661; Borel E., 1938, APPL THEORIE PROBABI; Bowling M., 2008, P 25 INT C MACH LEAR, P72; Bronowski J., 1973, ASCENT MAN; Buro M, 2004, INT FED INFO PROC, V135, P361; Campbell M, 2002, ARTIF INTELL, V134, P57, DOI 10.1016/S0004-3702(01)00129-1; Chen Katherine, 2012, ADV NEURAL INF PROCE, P2078; Craig M., 2006, PROFESSOR BANKER SUI; Gilpin A, 2007, LECT NOTES COMPUT SC, V4858, P57; Gilpin A, 2007, J ACM, V54, DOI 10.1145/1284320.1284324; Jackson E., 2012, P 2012 COMP POK S; Johanson M, 2012, P 11 INT C AUT AG MU, V2, P837; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; Koller D, 1997, ARTIF INTELL, V94, P167, DOI 10.1016/S0004-3702(97)00023-4; Koller D, 1996, GAME ECON BEHAV, V14, P247, DOI 10.1006/game.1996.0051; Kuhn H.W., 1950, CONTRIBUTIONS THEORY, V1, P97; MIROWSKI P, 1992, HIST POLIT ECON, V24, P113, DOI 10.1215/00182702-24-Supplement-113; Morgenstern O., 1961, NY TIMES MAGAZINE, P21; Nash J. F., 1950, CONTRIBUTIONS THEORY, P105; Nesterov Y, 2005, SIAM J OPTIMIZ, V16, P235, DOI 10.1137/S1052623403422285; Romanovskii I, 1962, SOVIET MATH, V3, P678; Rubin J, 2011, ARTIF INTELL, V175, P958, DOI 10.1016/j.artint.2010.12.005; Sandholm T, 2010, AI MAG, V31, P13, DOI 10.1609/aimag.v31i4.2311; Schaeffer J, 1995, AI MAG, V17, P21; Schaeffer J, 2007, SCIENCE, V317, P1518, DOI 10.1126/science.1144079; Shannon C. E., 1950, PHILOS MAG SERIES, V41, P256; Shi J., 2000, 2 INT C COMP GAM, P333; Southey F., 2005, P 21 ANN C UNC ART I, P550; Tambe M., 2011, SECURITY GAME THEORY; Turing A., 1976, FASTER THOUGHT; von Neumann J, 1928, MATH ANN, V100, P295; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Waugh K., 2015, AAAI WORKSH COMP POK; Zermelo E, 1913, PROC 5 C MATHEMATICI, P501; Zinkevich M., 2006, J INT COMPUT GAMES A, V29, P166; Zinkevich M., 2008, ADV NEURAL INFORM PR, V20, P905	45	155	164	5	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					145	149		10.1126/science.1259433	http://dx.doi.org/10.1126/science.1259433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574016	Green Submitted			2022-12-28	WOS:000347918900036
J	Xu, S; Yan, Z; Jang, KI; Huang, W; Fu, HR; Kim, J; Wei, Z; Flavin, M; McCracken, J; Wang, R; Badea, A; Liu, Y; Xiao, DQ; Zhou, GY; Lee, J; Chung, HU; Cheng, HY; Ren, W; Banks, A; Li, XL; Paik, U; Nuzzo, RG; Huang, YG; Zhang, YH; Rogers, JA				Xu, Sheng; Yan, Zheng; Jang, Kyung-In; Huang, Wen; Fu, Haoran; Kim, Jeonghyun; Wei, Zijun; Flavin, Matthew; McCracken, Joselle; Wang, Renhan; Badea, Adina; Liu, Yuhao; Xiao, Dongqing; Zhou, Guoyan; Lee, Jungwoo; Chung, Ha Uk; Cheng, Huanyu; Ren, Wen; Banks, Anthony; Li, Xiuling; Paik, Ungyu; Nuzzo, Ralph G.; Huang, Yonggang; Zhang, Yihui; Rogers, John A.			Assembly of micro/nanomaterials into complex, three-dimensional architectures by compressive buckling	SCIENCE			English	Article							STRETCHABLE ELECTRONICS; OPTICAL-DEVICES; METAMATERIALS; NANOHELICES; FABRICATION; ULTRALIGHT; NANOTUBES; INDUCTORS; ORIGAMI; SILICON	Complex three-dimensional (3D) structures in biology (e. g., cytoskeletal webs, neural circuits, and vasculature networks) form naturally to provide essential functions in even the most basic forms of life. Compelling opportunities exist for analogous 3D architectures in human-made devices, but design options are constrained by existing capabilities in materials growth and assembly. We report routes to previously inaccessible classes of 3D constructs in advanced materials, including device-grade silicon. The schemes involve geometric transformation of 2D micro/nanostructures into extended 3D layouts by compressive buckling. Demonstrations include experimental and theoretical studies of more than 40 representative geometries, from single and multiple helices, toroids, and conical spirals to structures that resemble spherical baskets, cuboid cages, starbursts, flowers, scaffolds, fences, and frameworks, each with single- and/or multiple-level configurations.	[Xu, Sheng; Yan, Zheng; Jang, Kyung-In; Kim, Jeonghyun; Wei, Zijun; Flavin, Matthew; Wang, Renhan; Liu, Yuhao; Lee, Jungwoo; Chung, Ha Uk; Cheng, Huanyu; Banks, Anthony; Nuzzo, Ralph G.; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Xu, Sheng; Yan, Zheng; Jang, Kyung-In; Kim, Jeonghyun; Wei, Zijun; Flavin, Matthew; Wang, Renhan; Liu, Yuhao; Lee, Jungwoo; Chung, Ha Uk; Cheng, Huanyu; Banks, Anthony; Nuzzo, Ralph G.; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Huang, Wen; Li, Xiuling; Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Fu, Haoran; Zhou, Guoyan; Cheng, Huanyu; Huang, Yonggang; Zhang, Yihui] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Fu, Haoran; Zhou, Guoyan; Cheng, Huanyu; Huang, Yonggang; Zhang, Yihui] Northwestern Univ, Ctr Engn & Hlth, Dept Mech Engn, Evanston, IL 60208 USA; [Fu, Haoran; Zhou, Guoyan; Cheng, Huanyu; Huang, Yonggang; Zhang, Yihui] Northwestern Univ, Skin Dis Res Ctr, Evanston, IL 60208 USA; [Fu, Haoran] Zhejiang Univ, Dept Civil Engn & Architecture, Hangzhou 310058, Zhejiang, Peoples R China; [Kim, Jeonghyun; Lee, Jungwoo; Paik, Ungyu] Hanyang Univ, Dept Energy Engn, Dept Mat Sci & Engn, Seoul 133791, South Korea; [McCracken, Joselle; Badea, Adina; Xiao, Dongqing; Ren, Wen; Nuzzo, Ralph G.; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Zhou, Guoyan] E China Univ Sci & Technol, Sch Mech & Power Engn, Key Lab Pressure Syst & Safety MOE, Shanghai 200237, Peoples R China; [Zhang, Yihui] Tsinghua Univ, Ctr Mech & Mat, Beijing 100084, Peoples R China; [Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Northwestern University; Zhejiang University; Hanyang University; University of Illinois System; University of Illinois Urbana-Champaign; East China University of Science & Technology; Tsinghua University; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.	yihui.zhang2011@gmail.com; y-huang@northwestern.edu; jrogers@illinois.edu	Fu, Haoran/ABA-6690-2021; Rogers, John/L-2798-2016; Cheng, Huanyu/J-7379-2015; Xu, Sheng/D-7717-2011; yang, zheng/HGC-7753-2022; Huang, Yonggang/B-6998-2009; huang, yonggang/O-6236-2019; Zhang, Yihui/G-9876-2011; Flavin, Matthew/B-7196-2015	Fu, Haoran/0000-0002-5400-3042; Cheng, Huanyu/0000-0001-6075-4208; Xu, Sheng/0000-0002-3120-4992; Zhang, Yihui/0000-0003-0885-2067; Flavin, Matthew/0000-0001-6636-0445; Badea, Adina/0000-0002-7077-2810; Yan, Zheng/0000-0001-5968-0934; McCracken, Joselle/0000-0002-0411-3542				Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Arpin KA, 2010, ADV MATER, V22, P1084, DOI 10.1002/adma.200904096; Bishop D, 2012, J LOW TEMP PHYS, V169, P386, DOI 10.1007/s10909-012-0654-z; Cho JH, 2011, SMALL, V7, P1943, DOI 10.1002/smll.201100568; Crane NB, 2013, MICROFLUID NANOFLUID, V14, P383, DOI 10.1007/s10404-012-1060-1; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Fischer J, 2013, LASER PHOTONICS REV, V7, P22, DOI 10.1002/lpor.201100046; Gao PX, 2005, SCIENCE, V309, P1700, DOI 10.1126/science.1116495; Gao W, 2014, NANO LETT, V14, P305, DOI 10.1021/nl404044d; Guo XY, 2009, P NATL ACAD SCI USA, V106, P20149, DOI 10.1073/pnas.0907390106; Huang MH, 2011, NANOSCALE, V3, P96, DOI 10.1039/c0nr00648c; Huang W, 2012, NANO LETT, V12, P6283, DOI 10.1021/nl303395d; Hwang G, 2009, NANO LETT, V9, P554, DOI 10.1021/nl8026718; Jang JH, 2007, ADV FUNCT MATER, V17, P3027, DOI 10.1002/adfm.200700140; Kim DH, 2012, MRS BULL, V37, P226, DOI 10.1557/mrs.2012.36; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Lee JH, 2014, ADV MATER, V26, P532, DOI 10.1002/adma.201303456; Leong TG, 2009, P NATL ACAD SCI USA, V106, P703, DOI 10.1073/pnas.0807698106; Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451; Noorduin WL, 2013, SCIENCE, V340, P832, DOI 10.1126/science.1234621; Prinz VY, 2000, PHYSICA E, V6, P828, DOI 10.1016/S1386-9477(99)00249-0; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Schmidt OG, 2001, NATURE, V410, P168, DOI 10.1038/35065525; Schumann M, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.56; Shenoy VB, 2012, MRS BULL, V37, P847, DOI 10.1557/mrs.2012.184; Singamaneni S, 2010, SOFT MATTER, V6, P5681, DOI 10.1039/c0sm00374c; Songmuang R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2472546; Soukoulis CM, 2011, NAT PHOTONICS, V5, P523, DOI [10.1038/NPHOTON.2011.154, 10.1038/nphoton.2011.154]; Sun K, 2013, ADV MATER, V25, P4539, DOI 10.1002/adma.201301036; Sun YG, 2006, NAT NANOTECHNOL, V1, P201, DOI 10.1038/nnano.2006.131; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]; Wood RJ, 2014, AM SCI, V102, P124, DOI 10.1511/2014.107.124; Yang S, 2010, ADV FUNCT MATER, V20, P2550, DOI 10.1002/adfm.201000034; Yu MR, 2011, ACS NANO, V5, P2447, DOI 10.1021/nn103618d; Yue CP, 2000, IEEE T ELECTRON DEV, V47, P560, DOI 10.1109/16.824729; Zhang HG, 2011, NAT NANOTECHNOL, V6, P277, DOI [10.1038/NNANO.2011.38, 10.1038/nnano.2011.38]; Zhang L, 2006, MICROELECTRON ENG, V83, P1237, DOI 10.1016/j.mee.2006.01.154; Zheng W, 2005, ADV FUNCT MATER, V15, P732, DOI 10.1002/adfm.200400595; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291	39	617	632	52	1004	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					154	159		10.1126/science.1260960	http://dx.doi.org/10.1126/science.1260960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574018				2022-12-28	WOS:000347918900038
J	Webster, MWI; Ormiston, JA				Webster, Mark W. I.; Ormiston, John A.			Drug-eluting stents-SORTed	LANCET			English	Editorial Material							BARE-METAL STENTS; COMPREHENSIVE NETWORK METAANALYSIS; CLINICAL-OUTCOMES; FOLLOW-UP; TRIAL		[Webster, Mark W. I.; Ormiston, John A.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1031, New Zealand	Auckland City Hospital	Webster, MWI (corresponding author), Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland 1031, New Zealand.	mwebster@adhb.govt.nz						Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pilgrim T, 2014, LANCET; Raungaard B, 2014, LANCET; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Yonetsu T, 2012, AM J CARDIOL, V110, P933, DOI 10.1016/j.amjcard.2012.05.027	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1487	1489		10.1016/S0140-6736(14)62009-2	http://dx.doi.org/10.1016/S0140-6736(14)62009-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25601787				2022-12-28	WOS:000353220000009
J	Banerjee, R; Proshlyakov, Y; Lipscomb, JD; Proshlyakov, DA				Banerjee, Rahul; Proshlyakov, Yegor; Lipscomb, John D.; Proshlyakov, Denis A.			Structure of the key species in the enzymatic oxidation of methane to methanol	NATURE			English	Article							MONOOXYGENASE CATALYTIC CYCLE; O-O BOND; METHYLOSINUS-TRICHOSPORIUM OB3B; DENSITY-FUNCTIONAL CALCULATIONS; DIAMOND CORE; INTERMEDIATE-Q; SPECTROSCOPIC CHARACTERIZATION; PEROXODIFERRIC INTERMEDIATE; RIBONUCLEOTIDE REDUCTASE; DELTA(9) DESATURASE	Methane monooxygenase (MMO) catalyses the O-2-dependent conversion of methane to methanol in methanotrophic bacteria, thereby preventing the atmospheric egress of approximately one billion tons of this potent greenhouse gas annually. The key reaction cycle intermediate of the soluble form of MMO(sMMO) is termed compoundQ (Q). Q contains a unique dinuclear Fe-IV cluster that reacts with methane to break an exceptionally strong 105 kcal mol(-1) C-H bond and insert one oxygen atom(1,2). No other biological oxidant, except that found in the particulate form of MMO, is capable of such catalysis. The structure of Q remains controversial despite numerous spectroscopic, computational and synthetic model studies(2-7). A definitive structural assignment can be made from resonance Raman vibrational spectroscopy but, despite efforts over the past two decades, no vibrational spectrum of Q has yet been obtained. Here we report the core structures of Q and the following product complex, compound T, using time-resolved resonance Raman spectroscopy (TR3). TR3 permits fingerprinting of intermediates by their unique vibrational signatures through extended signal averaging for short-lived species. We report unambiguous evidence that Q possesses a bis-mu-oxo diamond core structure and show that both bridging oxygens originate from O-2. This observation strongly supports a homolytic mechanism for O-Obond cleavage. We also show that T retains a single oxygen atom from O-2 as a bridging ligand, while the other oxygen atom is incorporated into the product(8). Capture of the extreme oxidizing potential of Q is of great contemporary interest for bioremediation and the development of synthetic approaches to methane-based alternative fuels and chemical industry feedstocks. Insight into the formation and reactivity of Q from the structure reported here is an important step towards harnessing this potential.	[Banerjee, Rahul; Lipscomb, John D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Banerjee, Rahul; Lipscomb, John D.] Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA; [Proshlyakov, Yegor; Proshlyakov, Denis A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University	Proshlyakov, DA (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	lipsc001@umn.edu; dapro@chemistry.msu.edu	BANERJEE, RAHUL/Q-7260-2019; Banerjee, Rahul/M-2316-2016	BANERJEE, RAHUL/0000-0002-3547-4746; Banerjee, Rahul/0000-0002-8193-7369; Lipscomb, John/0000-0002-8158-5594	NIH [GM40466, GM100943, GM096132]; STFC [ST/I005765/1, ST/L001314/1, ST/K00106X/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100943, R01GM040466, R01GM096132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. T. Babcock (deceased), S.-K. Lee and J.C. Nesheim (deceased) for initial studies that led to this project and E. Bergeron for technical assistance. This work was supported by the NIH grants GM40466 and GM100943 (to J.D.L.) and grant GM096132 (to D.A.P.).	Banerjee R, 2013, BIOCHEMISTRY-US, V52, P4331, DOI 10.1021/bi400182y; Brazeau BJ, 2000, BIOCHEMISTRY-US, V39, P13503, DOI 10.1021/bi001473l; Broadwater JA, 1998, BIOCHEMISTRY-US, V37, P14664, DOI 10.1021/bi981839i; Carter EL, 2012, J INORG BIOCHEM, V111, P195, DOI 10.1016/j.jinorgbio.2011.10.016; Collman JP, 2009, P NATL ACAD SCI USA, V106, P10528, DOI 10.1073/pnas.0904634106; Dunietz BD, 2000, J AM CHEM SOC, V122, P2828, DOI 10.1021/ja9920967; England J, 2009, ANGEW CHEM INT EDIT, V48, P3622, DOI 10.1002/anie.200900863; FOX BG, 1994, BIOCHEMISTRY-US, V33, P12776, DOI 10.1021/bi00209a008; FOX BG, 1989, J BIOL CHEM, V264, P10023; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Han WG, 2008, INORG CHEM, V47, P2975, DOI 10.1021/ic701194b; Han WG, 2008, INORG CHIM ACTA, V361, P973, DOI 10.1016/j.ica.2007.06.007; Hohenberger J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1718; Jensen KP, 2009, J AM CHEM SOC, V131, P12155, DOI 10.1021/ja809983g; LEE SK, 1993, J BIOL CHEM, V268, P21569; LEE SK, 1993, J AM CHEM SOC, V115, P6450, DOI 10.1021/ja00067a086; Lee SY, 1999, BIOCHEMISTRY-US, V38, P4423, DOI 10.1021/bi982712w; LIU KE, 1994, J AM CHEM SOC, V116, P7465, DOI 10.1021/ja00095a083; Moenne-Loccoz P, 1999, BIOCHEMISTRY-US, V38, P5290, DOI 10.1021/bi990095l; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; Nesheim JC, 1996, BIOCHEMISTRY-US, V35, P10240, DOI 10.1021/bi960596w; Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; SHIEMKE AK, 1986, J AM CHEM SOC, V108, P2437, DOI 10.1021/ja00269a050; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Siegbahn PEM, 2001, J BIOL INORG CHEM, V6, P27, DOI 10.1007/s007750000184; SITTER AJ, 1988, J BIOL CHEM, V263, P13032; SJOBERG BM, 1982, BIOCHEMISTRY-US, V21, P96; Srnec M, 2012, INORG CHEM, V51, P2806, DOI 10.1021/ic2018067; Stone KL, 2006, P NATL ACAD SCI USA, V103, P12307, DOI 10.1073/pnas.0603159103; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473; Tinberg CE, 2009, BIOCHEMISTRY-US, V48, P12145, DOI 10.1021/bi901672n; Tolman WB, 1997, ACCOUNTS CHEM RES, V30, P227, DOI 10.1021/ar960052m; Vu VV, 2009, P NATL ACAD SCI USA, V106, P14814, DOI 10.1073/pnas.0904553106; Wilkinson EC, 1998, J AM CHEM SOC, V120, P955, DOI 10.1021/ja973220u; Xue GQ, 2007, P NATL ACAD SCI USA, V104, P20713, DOI 10.1073/pnas.0708516105; Xue GQ, 2010, NAT CHEM, V2, P400, DOI [10.1038/NCHEM.586, 10.1038/nchem.586]; Zhang JY, 2006, BIOCHEMISTRY-US, V45, P1459, DOI 10.1021/bi051721j; Zheng H, 2006, BIOCHEMISTRY-US, V45, P1685, DOI 10.1021/bi051605g; Zheng H, 1999, J AM CHEM SOC, V121, P2226, DOI 10.1021/ja983615t	41	176	179	8	493	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					431	434		10.1038/nature14160	http://dx.doi.org/10.1038/nature14160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25607364	Green Accepted			2022-12-28	WOS:000349547400049
J	Willis, MJ; Herried, BG; Bevis, MG; Bell, RE				Willis, Michael J.; Herried, Bradley G.; Bevis, Michael G.; Bell, Robin E.			Recharge of a subglacial lake by surface meltwater in northeast Greenland	NATURE			English	Article							ICE-SHEET; GLACIER; WATER; ACCELERATION; SYSTEM; CAP	In a warming climate, surface meltwater production on large ice sheets is expected to increase. If this water is delivered to the ice sheet base it may have important consequences for ice dynamics. For example, basal water distributed in a diffuse network can decrease basal friction(1,2) and accelerate ice flow(3-8), whereas channelized basal water can move quickly to the ice margin, where it can alter fjord circulation and submarine melt rates(9,10). Less certain is whether surface meltwater can be trapped and stored in subglacial lakes beneath large ice sheets. Here we show that a subglacial lake in Greenland drained quickly, as seen in the collapse of the ice surface, and then refilled from surface meltwater input. We use digital elevation models from stereo satellite imagery and airborne measurements to resolve elevation changes during the evolution of the surface and basal hydrologic systems at the Flade Isblink ice cap in northeast Greenland. During the autumn of 2011, a collapse basin about 70 metres deep and about 0.4 cubic kilometres in volume formed near the southern summit of the ice cap as a subglacial lake drained into a nearby fjord. Over the next two years, rapid uplift of the floor of the basin (which is approximately 8.4 square kilometres in area) occurred as surface meltwater flowed into crevasses around the basin margin and refilled the subglacial lake. Our observations show that surface meltwater can be trapped and stored at the bed of an ice sheet. Sensible and latent heat released by this trapped meltwater could soften nearby colder basal ice(11) and alter downstream ice dynamics(12,13). Heat transport associated with meltwater trapped in subglacial lakes should be considered when predicting how ice sheet behaviour will change in a warming climate.	[Willis, Michael J.] Cornell Univ, Ithaca, NY 14853 USA; [Willis, Michael J.] Univ N Carolina, Dept Geol Sci, Chapel Hill, NC 27599 USA; [Herried, Bradley G.] Univ Minnesota, Polar Geospatial Ctr, St Paul, MN 55108 USA; [Bevis, Michael G.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Bell, Robin E.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University; Columbia University	Willis, MJ (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	mike.willis@cornell.edu			US National Science Foundation [ARC-1111882, ANT-1043681]; Office of Polar Programs (OPP) [1043681] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The copyright for the satellite imagery is held by DigitalGlobe, Inc. We thank M. Studinger, T. Wagner, the NASA Operation IceBridge project team and the National Snow and Ice Data Center for the airborne radar and laser altimetry. We thank S. Palmer for providing the European Remote Sensing satellite InSAR DEM. We thank the University of North Carolina at Chapel Hill Research Computing group for providing computational resources that have contributed to these research results. We thank M. Tedesco and X. Fettweis for help with MAR (Modele Atmospherique Regional) output. We thank T. Pavelsky, B. Mirus and J. Rich for comments and suggestions that improved the paper. This work was supported by US National Science Foundation grant number ARC-1111882. WorldView imagery was provided by the Polar Geospatial Center at the University of Minnesota, which is supported by grant ANT-1043681 from the US National Science Foundation.	Adalgeirsdottir G, 2000, ANN GLACIOL, V31, P104, DOI 10.3189/172756400781819914; Andrews LC, 2014, NATURE, V514, P80, DOI 10.1038/nature13796; Bamber JL, 2013, CRYOSPHERE, V7, P499, DOI 10.5194/tc-7-499-2013; Bartholomew I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002220; Bell RE, 2008, NAT GEOSCI, V1, P297, DOI 10.1038/ngeo186; Bell RE, 2014, NAT GEOSCI, V7, P497, DOI [10.1038/NGEO2179, 10.1038/ngeo2179]; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Fricker HA, 2007, SCIENCE, V315, P1544, DOI 10.1126/science.1136897; Glasser NF, 2002, EARTH SURF PROC LAND, V27, P673, DOI 10.1002/esp.344; Gogineni P., 2012, CRESIS RADAR DEPTH S; Gulley JD, 2012, J GLACIOL, V58, P926, DOI 10.3189/2012JoG11J189; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; IKEN A, 1986, J GLACIOL, V32, P101, DOI 10.3189/S0022143000006936; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Krabill W. B., 2014, ICEBRIDGE ATM L2 LCE; Krabill WB, 2002, J GEODYN, V34, P357, DOI 10.1016/S0264-3707(02)00040-6; Livingstone SJ, 2013, CRYOSPHERE, V7, P1721, DOI 10.5194/tc-7-1721-2013; Moratto Z. M., 2010, LUNAR PLANET SCI C, VXLI; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Palmer SJ, 2013, GEOPHYS RES LETT, V40, P6154, DOI 10.1002/2013GL058383; Palmer SJ, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2010JF001686; Phillips T, 2013, J GEOPHYS RES-EARTH, V118, P1241, DOI 10.1002/jgrf.20079; Rennermalm AK, 2013, CRYOSPHERE, V7, P1433, DOI 10.5194/tc-7-1433-2013; Rinne EJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF001972; Rogozhina I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002098; Rolstad C, 2009, J GLACIOL, V55, P666, DOI 10.3189/002214309789470950; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Shreve R.L., 1972, J GLACIOL, V11, P205, DOI [DOI 10.3189/S002214300002219X, 10.3189/S002214300002219X]; Smith BE, 2009, J GLACIOL, V55, P573, DOI 10.3189/002214309789470879; Stearns LA, 2008, NAT GEOSCI, V1, P827, DOI 10.1038/ngeo356; Tedesco M, 2014, MAR GREENLAND OUTPUT; Thoma M, 2012, ANN GLACIOL, V53, P173, DOI 10.3189/2012AoG60A009; Wolovick MJ, 2013, J GEOPHYS RES-EARTH, V118, P140, DOI 10.1029/2012JF002555; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	35	61	61	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					223	U165		10.1038/nature14116	http://dx.doi.org/10.1038/nature14116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25607355				2022-12-28	WOS:000349190300036
J	Guo, YZ; Kalathur, RC; Liu, Q; Kloss, B; Bruni, R; Ginter, C; Kloppmann, E; Rost, B; Hendrickson, WA				Guo, Youzhong; Kalathur, Ravi C.; Liu, Qun; Kloss, Brian; Bruni, Renato; Ginter, Christopher; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.			Structure and activity of tryptophan-rich TSPO proteins	SCIENCE			English	Article							MITOCHONDRIAL TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; 18 KDA; PROTOPORPHYRIN-IX; IN-VIVO; BINDING-AFFINITY; PORPHYRINS; TRANSPORT; COMPLEX; OXYGEN	Translocator proteins (TSPOs) bind steroids and porphyrins, and they are implicated in many human diseases, for which they serve as biomarkers and therapeutic targets. TSPOs have tryptophan-rich sequences that are highly conserved from bacteria to mammals. Here we report crystal structures for Bacillus cereus TSPO (BcTSPO) down to 1.7 angstrom resolution, including a complex with the benzodiazepine-like inhibitor PK11195. We also describe BcTSPO-mediated protoporphyrin IX (PpIX) reactions, including catalytic degradation to a previously undescribed heme derivative. We used structure-inspired mutations to investigate reaction mechanisms, and we showed that TSPOs from Xenopus and man have similar PpIX-directed activities. Although TSPOs have been regarded as transporters, the catalytic activity in PpIX degradation suggests physiological importance for TSPOs in protection against oxidative stress.	[Guo, Youzhong; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kalathur, Ravi C.; Liu, Qun; Kloss, Brian; Bruni, Renato; Ginter, Christopher; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.] New York Consortium Membrane Prot Struct NYCOMPS, New York Struct Biol Ctr, New York, NY 10027 USA; [Liu, Qun; Hendrickson, Wayne A.] Brookhaven Natl Lab, New York Struct Biol Ctr, Upton, NY 11973 USA; [Kloppmann, Edda; Rost, Burkhard] Tech Univ Munich, Dept Informat Bioinformat & Computat Biol, D-85748 Garching, Germany; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; United States Department of Energy (DOE); Brookhaven National Laboratory; Technical University of Munich; Columbia University	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@xtl.cumc.columbia.edu	Guo, Youzhong/AAW-3010-2021; Liu, Qun/A-8757-2011; Rost, Burkhard/A-1908-2016; Kalathur, Ravi/L-7696-2016	Liu, Qun/0000-0002-1179-290X; Rost, Burkhard/0000-0003-0179-8424; Kalathur, Ravi/0000-0003-1669-9277; kalathur, ravi/0000-0002-4889-8003; Kloss, Brian/0000-0003-0130-8739	NIH [GM095315, GM107462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, R01GM107462, U54GM075026] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Hendrickson laboratory, especially J. Lidestri for LCP instrumentation, O. Clarke for thought-provoking discussion, K. Hu from Stuyvesant High School for help in collecting fluorescence data, and O. Clarke and J. Qin for help in crystallographic computing. We also thank J. Schwanof and R. Abramowitz at National Synchrotron Light Source (NSLS) beamlines X4A and X4C for help in measuring diffraction data, M. L. Hackert of the University of Texas at Austin for insightful suggestions related to phycocyanobilin, A. Palmer of Columbia University for advice on spectroscopic interpretation, and S. Ferguson-Miller of Michigan State University for sharing coordinates ahead of publication. This work was supported in part by NIH grant GM095315 and GM107462 to W.A.H. X4 beamlines were supported by the New York Structural Biology Center at the NSLS of Brookhaven National Laboratory, a U.S. Department of Energy facility. The crystallographic data reported here are deposited in the Protein Data Bank with identification codes listed in table S2. Y.G. and W.A.H. designed research, analyzed data, and wrote the paper; Y.G. performed experiments; E.K. and B.R. performed bioinformatics analyses; B.K. and R.B. performed expression tests; R.C.K. and R.B. overexpressed eukaryotic proteins; Q.L. participated in diffraction analysis; and C.G. participated in the design of activity assays.	BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; COX GS, 1982, J AM CHEM SOC, V104, P516, DOI 10.1021/ja00366a023; DALTON J, 1972, NATURE, V235, P388, DOI 10.1038/235388a0; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Farrera J A, 1994, Bioorg Med Chem, V2, P181, DOI 10.1016/S0968-0896(00)82013-1; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Ginter C, 2013, BIOCHEMISTRY-US, V52, P3609, DOI 10.1021/bi400364z; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Jockusch S, 2014, PHOTOCH PHOTOBIO SCI, V13, P1180, DOI 10.1039/c4pp00090k; KONINGSBERGER JC, 1993, EUR J CLIN INVEST, V23, P716, DOI 10.1111/j.1365-2362.1993.tb01291.x; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; Lartey FM, 2014, MOL IMAGING BIOL, V16, P109, DOI 10.1007/s11307-013-0664-5; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Marcelli A, 2013, PHOTOCH PHOTOBIO SCI, V12, P348, DOI 10.1039/c2pp25247c; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; MUKHIN AG, 1989, P NATL ACAD SCI USA, V86, P9813, DOI 10.1073/pnas.86.24.9813; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Qi XL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/162934; Rosenberg N, 2013, J BIOENERG BIOMEMBR, V45, P333, DOI 10.1007/s10863-013-9501-4; Ruksha T, 2012, ARCH DERMATOL RES, V304, P839, DOI 10.1007/s00403-012-1294-5; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Veenman L, 2014, ANTI-CANCER AGENT ME, V14, P559, DOI 10.2174/1871520614666140309230338; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Zhou T, 2014, J VIROL, V88, P3474, DOI 10.1128/JVI.03286-13	33	119	120	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					551	555		10.1126/science.aaa1534	http://dx.doi.org/10.1126/science.aaa1534			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635100	Green Accepted			2022-12-28	WOS:000348639300054
J	Nie, WY; Tsai, HH; Asadpour, R; Blancon, JC; Neukirch, AJ; Gupta, G; Crochet, JJ; Chhowalla, M; Tretiak, S; Alam, MA; Wang, HL; Mohite, AD				Nie, Wanyi; Tsai, Hsinhan; Asadpour, Reza; Blancon, Jean-Christophe; Neukirch, Amanda J.; Gupta, Gautam; Crochet, Jared J.; Chhowalla, Manish; Tretiak, Sergei; Alam, Muhammad A.; Wang, Hsing-Lin; Mohite, Aditya D.			High-efficiency solution-processed perovskite solar cells with millimeter-scale grains	SCIENCE			English	Article							RECOMBINATION; TEMPERATURE; MORPHOLOGY; LENGTHS	State-of-the-art photovoltaics use high-purity, large-area, wafer-scale single-crystalline semiconductors grown by sophisticated, high-temperature crystal growth processes. We demonstrate a solution-based hot-casting technique to grow continuous, pinhole-free thin films of organometallic perovskites with millimeter-scale crystalline grains. We fabricated planar solar cells with efficiencies approaching 18%, with little cell-to-cell variability. The devices show hysteresis-free photovoltaic response, which had been a fundamental bottleneck for the stable operation of perovskite devices. Characterization and modeling attribute the improved performance to reduced bulk defects and improved charge carrier mobility in large-grain devices. We anticipate that this technique will lead the field toward synthesis of wafer-scale crystalline perovskites, necessary for the fabrication of high-efficiency solar cells, and will be applicable to several other material systems plagued by polydispersity, defects, and grain boundary recombination in solution-processed thin films.	[Nie, Wanyi; Gupta, Gautam; Mohite, Aditya D.] Los Alamos Natl Lab, Mat Phys & Applicat Div, Los Alamos, NM 87545 USA; [Tsai, Hsinhan; Blancon, Jean-Christophe; Crochet, Jared J.; Wang, Hsing-Lin] Los Alamos Natl Lab, Phys Chem & Appl Spect Div, Los Alamos, NM 87545 USA; [Asadpour, Reza; Alam, Muhammad A.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Neukirch, Amanda J.; Tretiak, Sergei] Los Alamos Natl Lab, Theoret Chem & Mol Phys Div, Los Alamos, NM 87545 USA; [Neukirch, Amanda J.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Chhowalla, Manish] Rutgers State Univ, Piscataway, NJ 08854 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Rutgers State University New Brunswick	Mohite, AD (corresponding author), Los Alamos Natl Lab, Mat Phys & Applicat Div, POB 1663, Los Alamos, NM 87545 USA.	hwang@lanl.gov; amohite@lanl.gov	Wang, Hsing-Lin/L-3438-2018; Tsai, Hsinhan/AAN-7850-2020; Nie, Wanyi/AAC-5354-2019; Tretiak, Sergei/B-5556-2009; Mohite, Aditya D./AAF-2908-2019; Blancon, Jean-Christophe/Q-7950-2017	Tretiak, Sergei/0000-0001-5547-3647; Blancon, Jean-Christophe/0000-0002-3833-5792; MOHITE, ADITYA/0000-0001-8865-409X; Crochet, Jared/0000-0002-9570-2173	U.S. Department of Energy, Office of Basic Energy Sciences [08SPCE973]; LANL LORD program [XW11]; U.S. Department of Energy under DOE [DE-EE0004946]	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); LANL LORD program; U.S. Department of Energy under DOE(United States Department of Energy (DOE))	Work at Los Alamos National Laboratuy (LANL) was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Work Proposal 08SPCE973 (W.N., G.G., and. A.D.M.) and by We LANL LORD program XW11 (A.D.M., H.-L.W., and S.T.). This work was done in part at the Center for Integrated Nanotechnologies, an Office of Science User Facility. Work at Purdue University was supported by the U.S. Department of Energy under DOE Cooperative Agreement no. DE-EE0004946 ("PVMI Bay Area PV Consortium"). We thank C. Sheehan for the high-resolution cross-sectional SEM images. A.J.N. and S.T. thank C. Katan, J. Even, L. Pedesseatl, and M. Kepenekian for useful discussions as well as starting coordinates for bulk peeovskites. Author contributions: A.D.M. conceived the idea, designed and supervised experiments, analyzed data, and wrote the manuscript. H.-L.W. and H.T. designed the synthesis chemistry for perovskite thin-film growth and analyzed data. W.N. developed the hot-casting, slow-quenching method for large-area crystal growth along with H. I. and also performed device fabrication and solar cell testing, x-ray diffraction and analyzed the data. J.-C.B. performed optical spectroscopy measurements, analyzed the data under the supervision of J.J.C. R.A. performed device modeling simulations. conceived the device modeling, superyised the device modeling, analyzed crystal growth mechanisms, and co-wrote the paper. A.J.N. performed OFT calculations under the guida.nce of SI., who designed the OFT calculations, analyzed the data, and provided guidance to the project. G.G. and M.C. conceived the XRD measurements and analyzed the data, co-designed the experiments, and contributed to the organization of the manuscript. All authors have read the manuscript and agree to its contents.	[Anonymous], 2014, NAT PHOTONICS, V8, P665, DOI DOI 10.1038/NPHOTON.2014.212; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chen Q, 2014, J AM CHEM SOC, V136, P622, DOI 10.1021/ja411509g; Conings B, 2014, ADV MATER, V26, P2041, DOI 10.1002/adma.201304803; Cowan SR, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.245207; Docampo P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3761; Dualeh A, 2014, ADV FUNCT MATER, V24, P3250, DOI 10.1002/adfm.201304022; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Gratzel M, 2014, NAT MATER, V13, P838, DOI 10.1038/nmat4065; Grancini G, 2014, J PHYS CHEM LETT, V5, P3836, DOI 10.1021/jz501877h; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Kim HB, 2014, NANOSCALE, V6, P6679, DOI 10.1039/c4nr00130c; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Malinkiewicz O, 2014, NAT PHOTONICS, V8, P128, DOI [10.1038/NPHOTON.2013.141, 10.1038/nphoton.2013.341]; Manser JS, 2014, NAT PHOTONICS, V8, P737, DOI [10.1038/nphoton.2014.171, 10.1038/NPHOTON.2014.171]; McGehee MD, 2014, NAT MATER, V13, P845, DOI 10.1038/nmat4050; Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763; Proctor CM, 2013, PROG POLYM SCI, V38, P1941, DOI 10.1016/j.progpolymsci.2013.08.008; Proctor CM, 2013, ADV FUNCT MATER, V23, P3584, DOI 10.1002/adfm.201202643; Sanchez RS, 2014, J PHYS CHEM LETT, V5, P2357, DOI 10.1021/jz5011187; Seo J, 2014, ENERG ENVIRON SCI, V7, P2642, DOI 10.1039/c4ee01216j; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Wang Q, 2014, ENERG ENVIRON SCI, V7, P2359, DOI 10.1039/c4ee00233d; Wehrenfennig C, 2014, ADV MATER, V26, P1584, DOI 10.1002/adma.201305172; Xiao MD, 2014, ANGEW CHEM INT EDIT, V53, P9898, DOI 10.1002/anie.201405334; Xiao ZG, 2014, ADV MATER, V26, P6503, DOI 10.1002/adma.201401685; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050	31	2650	2698	72	1134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					522	525		10.1126/science.aaa0472	http://dx.doi.org/10.1126/science.aaa0472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635093	Green Submitted			2022-12-28	WOS:000348639300046
J	Emdin, CA; Odutayo, A; Hsiao, AJ; Shakir, M; Hopewell, S; Rahimi, K; Altman, DG				Emdin, Connor A.; Odutayo, Ayodele; Hsiao, Allan J.; Shakir, Mubeen; Hopewell, Sally; Rahimi, Kazem; Altman, Douglas G.			Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials-ESORT)	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVES To determine whether an association exists between the number of published randomised controlled trials and the global burden of disease, whether certain diseases are under-investigated relative to their burden, and whether the relation between the output of randomised trials and global burden of disease can be explained by the relative disease burden in high and low income regions. DESIGN Cross sectional investigation. STUDY SAMPLE All primary reports of randomised trials published in December 2012 and indexed in PubMed by 17 November 2013. MAIN OUTCOME MEASURES Number of trials conducted and number of participants randomised for each of 239 different diseases or injuries; variation in each outcome explainable by total disability adjusted life years (a measure of the overall burden of each disease) and the ratio of disability adjusted life years in low income to high income regions (a measure of whether a disease is more likely to affect people living in high income regions) quantified using multivariable regression. RESULTS 4190 abstracts were reviewed and 1351 primary randomised trials identified, of which 1097 could be classified using the global burden of disease taxonomy. Total disability adjusted life years was poorly associated with number of randomised trials and number of participants randomised in univariable analysis (Spearman's r = 0.35 and 0.33, respectively), although it was a significant predictor in the univariable and multivariable models (P < 0.001). Diseases for which the burden was predominantly located in low income regions had sevenfold fewer trials per million disability adjusted life years than diseases predominantly located in high income regions. However, only 26% of the variation in number of trials among diseases could be explained by total disability adjusted life years and the ratio of disability adjusted life years in low income regions to high income regions. Many high income type diseases (for example, neck pain, glomerulonephritis) have proportionally fewer randomised trials compared with low income type diseases (for example, vitamin A deficiency). CONCLUSIONS Overall, a weak association existed between global burden of disease and number of published randomised trials. A global observatory for research is needed to monitor and reduce the discordance between the output of randomised trials and global burden of disease.	[Emdin, Connor A.; Rahimi, Kazem] Univ Oxford, George Inst Global Hlth, Oxford OX1 3DB, England; [Odutayo, Ayodele; Hopewell, Sally; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX1 3DB, England; [Odutayo, Ayodele] Univ Toronto, Fac Med, Toronto, ON, Canada; [Hsiao, Allan J.; Shakir, Mubeen] Univ Oxford, Oxford OX1 3DB, England; [Hopewell, Sally] Univ Paris 05, INSERM, U1153, Ctr Epidemiol Clin, Paris, France	University of Oxford; University of Oxford; University of Toronto; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Emdin, CA (corresponding author), Univ Oxford, George Inst Global Hlth, Oxford OX1 3DB, England.	cemdin@georgeinstitute.org.uk	Rahimi, Kazem/AAA-4250-2022; Rahimi, Kazem/Q-1279-2015; Emdin, Connor/B-6746-2015	Rahimi, Kazem/0000-0002-4807-4610; Emdin, Connor/0000-0002-2385-8259; Hopewell, Sally/0000-0002-6881-6984	Rhodes scholarship; National Institute for Health Research [CDF-2013-06-012]; NIHR Oxford BRC; Cancer Research UK [16895] Funding Source: researchfish	Rhodes scholarship; National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Oxford BRC; Cancer Research UK(Cancer Research UK)	This study received no external funding. AO, CAE, AJH, and MS are funded by the Rhodes scholarship. KR is funded by the National Institute for Health Research (CDF-2013-06-012) and the NIHR Oxford BRC.	Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Dolgin E, 2009, NATURE, V460, P939, DOI 10.1038/460939a; Institute of Medicine (US) Committee on the NIH Research Priority-Setting Process, 1998, SCIENTIFIC OPPORTUNI; Institute of Medicine (US) Committee on the US Commitment to Global Health, 2009, THE US COMMITMENT TO; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Swingler GH, 2003, BRIT MED J, V327, P1083, DOI 10.1136/bmj.327.7423.1083; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599; World Bank Group, 2013, WORLD DEVELOPMENT IN	14	29	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2015	350								h117	10.1136/BMJ.h117	http://dx.doi.org/10.1136/BMJ.h117			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AS	25630558	Green Published, hybrid			2022-12-28	WOS:000348778600001
J	Lalya, I; Mansouri, H				Lalya, Issam; Mansouri, Hamid			Bilateral Lower Palpebral MALT Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lalya, Issam; Mansouri, Hamid] Mil Teaching Hosp Mohammed V, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Lalya, I (corresponding author), Mil Teaching Hosp Mohammed V, Rabat, Morocco.	issamlalya@yahoo.fr	lalya, issam/AAM-2145-2020						0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					363	363		10.1056/NEJMicm1400091	http://dx.doi.org/10.1056/NEJMicm1400091			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25607429				2022-12-28	WOS:000348204500011
J	DeCamp, M; Lehmann, LS				DeCamp, Matthew; Lehmann, Lisa Soleymani			Guiding Choice - Ethically Influencing Referrals in ACOs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[DeCamp, Matthew] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [DeCamp, Matthew] Johns Hopkins Univ, Div Gen Internal Med, Baltimore, MD USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Boston, MA USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	DeCamp, M (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA.		DeCamp, Matthew/N-6028-2014	DeCamp, Matthew/0000-0002-9371-8729	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023684] Funding Source: NIH RePORTER; AHRQ HHS [K08 HS023684] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Biller-Andorno N, 2013, NEW ENGL J MED, V368, P980, DOI 10.1056/NEJMp1300373; Levinson W, 1999, JAMA-J AM MED ASSOC, V282, P1477, DOI 10.1001/jama.282.15.1477; McClellan MB, 2014, HLTH POLICY ISSUE BR; McWilliams JM, 2014, JAMA INTERN MED, V174, P938, DOI 10.1001/jamainternmed.2014.1073; Song ZR, 2014, JAMA-J AM MED ASSOC, V312, P597, DOI 10.1001/jama.2014.7878	5	12	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					205	207		10.1056/NEJMp1412083	http://dx.doi.org/10.1056/NEJMp1412083			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3HX	25587946	Green Accepted			2022-12-28	WOS:000348119200003
J	Makris, GC				Makris, Gregory C.			Crowdfunding: from startup businesses to startup science	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Cambridge Univ Hosp, Acad Radiol Dept, Cambridge, England	University of Cambridge	Makris, GC (corresponding author), Cambridge Univ Hosp, Acad Radiol Dept, Cambridge, England.	gm482@cam.ac.uk	Makris, Gregory/AAR-4430-2021	MAKRIS, GREGORY/0000-0003-3437-621X				Baek P, 2014, UNDERSTANDING ALTERN; Byrnes JEK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110329; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; eMarketer, 2013, SOC NETW REACH NEARL; Gamble C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005234; Kickstarter, STATS; National Institute for Health Research, 2014, ANN STAT REP; Paul J, 2013, TIMES HIGHER ED; Sciencewise, VAL BEN DIAL ROUT BE; Verhoeven D, 2014, RES MY WORLD CROWDFU	10	6	6	0	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2015	350								h18	10.1136/bmj.h18	http://dx.doi.org/10.1136/bmj.h18			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3NA	25588667				2022-12-28	WOS:000348133000015
J	Record, NB; Onion, DK; Prior, RE; Dixon, DC; Record, SS; Fowler, FL; Cayer, GR; Amos, CI; Pearson, TA				Record, N. Burgess; Onion, Daniel K.; Prior, Roderick E.; Dixon, David C.; Record, Sandra S.; Fowler, Fenwick L.; Cayer, Gerald R.; Amos, Christopher I.; Pearson, Thomas A.			Community-Wide Cardiovascular Disease Prevention Programs and Health Outcomes in a Rural County, 1970-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NORTH-KARELIA PROJECT; SCIENTIFIC STATEMENT; RISK-FACTORS; MORTALITY; EDUCATION; CARE; DECLINE; POLICY	IMPORTANCE Few comprehensive cardiovascular risk reduction programs, particularly those in rural, low-income communities, have sustained community-wide interventions for more than 10 years and demonstrated the effect of risk factor improvements on reductions in morbidity and mortality. OBJECTIVE To document health outcomes associated with an integrated, comprehensive cardiovascular risk reduction program in Franklin County, Maine, a low-income rural community. DESIGN, SETTING, AND PARTICIPANTS Forty-year observational study involving residents of Franklin County, Maine, a rural, low-income population of 22 444 in 1970, that used the preceding decade as a baseline and compared Franklin County with other Maine counties and state averages. INTERVENTIONS Community-wide programs targeting hypertension, cholesterol, and smoking, as well as diet and physical activity, sponsored by multiple community organizations, including the local hospital and clinicians. MAIN OUTCOMES AND MEASURES Resident participation; hypertension and hyperlipidemia detection, treatment, and control; smoking quit rates; hospitalization rates from 1994 through 2006, adjusted for median household income; and mortality rates from 1970 through 2010, adjusted for household income and age. RESULTS More than 150 000 individual county resident contacts occurred over 40 years. Over time, as cardiovascular risk factor programs were added, relevant health indicators improved. Hypertension control had an absolute increase of 24.7%(95% CI, 21.6%-27.7%) from 18.3% to 43.0%, from 1975 to 1978; later, elevated cholesterol control had an absolute increase of 28.5%(95% CI, 25.3%-31.6%) from 0.4% to 28.9%, from 1986 to 2010. Smoking quit rates improved from 48.5% to 69.5%, better than state averages (observed - expected [O - E], 11.3%; 95% CI, 5.5%-17.7%; P < .001), 1996-2000; these differences later disappeared when Maine's overall quit rate increased. Franklin County hospitalizations per capita were less than expected for the measured period, 1994-2006 (O - E, -17 discharges/1000 residents; 95% CI -20.1 to -13.9; P <. 001). Franklin was the only Maine county with consistently lower adjusted mortality than predicted over the time periods 1970-1989 and 1990-2010 (O - E, -60.4 deaths/100 000; 95% CI, -97.9 to -22.8; P <. 001, and -41.6/100 000; 95% CI, -77.3 to -5.8; P = .005, respectively). CONCLUSIONS AND RELEVANCE Sustained, community-wide programs targeting cardiovascular risk factors and behavior changes to improve a Maine county's population health were associated with reductions in hospitalization and mortality rates over 40 years, compared with the rest of the state. Further studies are needed to assess the generalizability of such programs to other US county populations, especially rural ones, and to other parts of the world.	[Record, N. Burgess; Prior, Roderick E.; Dixon, David C.; Record, Sandra S.; Cayer, Gerald R.] Franklin Mem Hosp, Farmington, ME USA; [Onion, Daniel K.] Maine Dartmouth Family Med Residency, Augusta, GA USA; [Onion, Daniel K.; Amos, Christopher I.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA; [Fowler, Fenwick L.] Western Maine Community Act, Wilton, CT USA; [Pearson, Thomas A.] Univ Florida, Hlth Sci Ctr, Gainesville, FL USA	Dartmouth College; State University System of Florida; University of Florida	Prior, RE (corresponding author), 243 High St, Farmington, ME 04938 USA.	rprior04938@myfairpoint.net			Franklin Memorial Hospital; Federal Health Underserved Rural Area grant program; Bingham Program; Regional Medical Program; Maine Bureau of Health; Maine Department of Human Services [314]; Western Maine Community Partnership; Healthy Communities Coalition; United Way; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	Franklin Memorial Hospital; Federal Health Underserved Rural Area grant program; Bingham Program; Regional Medical Program; Maine Bureau of Health; Maine Department of Human Services; Western Maine Community Partnership; Healthy Communities Coalition; United Way; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Logistical and financial support was provided by Franklin Memorial Hospital. Federal support beginning in 1972 until the mid-1980s came from the Office of Economic Opportunity and the Rural Health Care Service Outreach grant program; multiple small grants of $10 000 to $80 000 over the past 40 years, mostly during the initial 2 decades came from the Federal Health Underserved Rural Area grant program, the Bingham Program, the Regional Medical Program, Maine Bureau of Health, Maine Department of Human Services 314(d) grants, Western Maine Community Partnership, the Healthy Communities Coalition, Franklin Memorial Hospital, the United Way, and others, the details for which are no longer available.	Ades PA, 2002, J AM COLL CARDIOL, V40, P615, DOI 10.1016/S0735-1097(02)02084-3; [Anonymous], US COUNT DAT FIL DOW; [Anonymous], BRFSS BEH RISK FACT; [Anonymous], HOSP ENC RESTR HOSP; [Anonymous], 1997, WORLDW EFF IMPR HEAR; CARLETON RA, 1995, AM J PUBLIC HEALTH, V85, P777, DOI 10.2105/AJPH.85.6.777; Centers for Disease Control and Prevention, COMPR MORT FIL; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cossman JS, 2010, AM J PUBLIC HEALTH, V100, P1417, DOI 10.2105/AJPH.2009.174185; Dixon D C, 1971, J Maine Med Assoc, V62, P278; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; FARQUHAR JW, 1977, LANCET, V1, P1192; FARQUHAR JW, 1985, AM J EPIDEMIOL, V122, P323, DOI 10.1093/oxfordjournals.aje.a114104; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; Ghorob Amireh, 2013, Fam Pract Manag, V20, P40; Goff DC, 2007, CIRCULATION, V115, P127, DOI 10.1161/CIRCULATIONAHA.106.179904; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Institute for Healthcare Improvement, COUNT INT ACH BETT O; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; LENFANT C, 1984, CHEST, V86, P459, DOI 10.1378/chest.86.3.459; LUEPKER RV, 1994, AM J PUBLIC HEALTH, V84, P1383, DOI 10.2105/AJPH.84.9.1383; MARMOT MG, 1986, LANCET, V2, P274; Mauksch Larry, 2013, Fam Pract Manag, V20, P35; Miller F S 3rd, 1976, J Maine Med Assoc, V67, P280; Mittelmark M B, 1993, J Public Health Policy, V14, P437, DOI 10.2307/3342877; MITTELMARK MB, 1986, PREV MED, V15, P1, DOI 10.1016/0091-7435(86)90031-9; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nafziger AN, 2001, SCAND J PUBLIC HEALT, P21; Onion D K, 1980, Med Group Manage, V27, P17; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Pearson TA, 2001, SCAND J PUBLIC HEALT, P5; Pearson TA, 2007, HEALTH AFFAIR, V26, P49, DOI 10.1377/hlthaff.26.1.49; Pearson TA, 2013, CIRCULATION, V127, P1730, DOI 10.1161/CIR.0b013e31828f8a94; PUSKA P, 1973, WHO CHRON, V27, P55; Puska P, 1995, N KERELIA PROJECT 20; RECORD NB, 1979, J MAINE MED ASSOC, V70, P141; Record NB, 2000, AM J PREV MED, V19, P30, DOI 10.1016/S0749-3797(00)00164-1; Robert Wood Johnson Foundation and University of Wisconsin Population Health Institute, MAIN RANK DAT COUNT; Rogers EM, 1971, COMMUNICATION INNOVA; Rosenbaum S, 2011, PUBLIC HEALTH REP, V126, P283, DOI 10.1177/003335491112600220; SALONEN JT, 1987, LANCET, V2, P269; Schneider J, 2004, BUILDING HLTH COMMUN; Schooler C, 1997, ANN EPIDEMIOL, V7, pS54, DOI 10.1016/S1047-2797(97)80008-7; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sox HC, 2013, JAMA-J AM MED ASSOC, V310, P1933, DOI 10.1001/jama.2013.281998; TUOMILEHTO J, 1986, BRIT MED J, V293, P1068, DOI 10.1136/bmj.293.6554.1068; Weinehall L, 2001, SCAND J PUBLIC HEALT, P13; Winkleby MA, 1997, J CLIN EPIDEMIOL, V50, P645, DOI 10.1016/S0895-4356(97)00020-6; Winkleby MA, 1996, AM J PUBLIC HEALTH, V86, P1773, DOI 10.2105/AJPH.86.12.1773; Yach D, 2014, JAMA-J AM MED ASSOC, V312, P791, DOI 10.1001/jama.2014.8900; Young GJ, 2013, NEW ENGL J MED, V368, P1519, DOI 10.1056/NEJMsa1210239	52	63	64	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					147	155		10.1001/jama.2014.16969	http://dx.doi.org/10.1001/jama.2014.16969			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY6MC	25585326	Green Accepted, Bronze			2022-12-28	WOS:000347679300014
J	Reiling, J				Reiling, Jennifer			The Medicine of the Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1890, JAMA-J AM MED ASSOC, V15, P921	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					205	205		10.1001/jama.2014.11506	http://dx.doi.org/10.1001/jama.2014.11506			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585342				2022-12-28	WOS:000347679300031
J	Lamb, EJ; Stevens, PE; Deeks, JJ				Lamb, E. J.; Stevens, P. E.; Deeks, J. J.			UNCERTAINTIES PAGE What is the best glomerular filtration marker to identify people with chronic kidney disease most likely to have poor outcomes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CKD-EPI EQUATION; CYSTATIN C; COMBINED ASSOCIATION; RENAL-DISEASE; ESTIMATED GFR; ALL-CAUSE; CREATININE; RISK; ALBUMINURIA; PROGRESSION		[Lamb, E. J.] East Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England; [Stevens, P. E.] East Kent Hosp Univ NHS Fdn Trust, Kent Kidney Care Ctr, Canterbury CT1 3NG, Kent, England; [Deeks, J. J.] Univ Birmingham, Sch Hlth & Populat Sci, Test Evaluat Res Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Lamb, EJ (corresponding author), East Kent Hosp Univ NHS Fdn Trust, Canterbury CT1 3NG, Kent, England.	elamb@nhs.net	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971				Carville S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4507; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Foote C, 2014, AM J KIDNEY DIS, V64, P359, DOI 10.1053/j.ajkd.2014.02.023; Foster MC, 2013, AM J KIDNEY DIS, V62, P42, DOI 10.1053/j.ajkd.2013.01.016; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Johnson David W, 2012, Med J Aust, V197, P224; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT, V3, P1, DOI [10.1038/kisup.2012.73, DOI 10.1038/KISUP.2012.73]; Kwong YT, 2010, AM J KIDNEY DIS, V56, P39, DOI 10.1053/j.ajkd.2010.02.347; Lamb EJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-13; Levin A, 2011, NAT REV NEPHROL, V7, P446, DOI 10.1038/nrneph.2011.86; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Matsushita K, 2012, AM J KIDNEY DIS, V60, P241, DOI 10.1053/j.ajkd.2012.03.016; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; National Institute for Health and Care Excellence, 2014, CHRON KIDN DIS EARL; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Padala S, 2012, AM J KIDNEY DIS, V60, P217, DOI 10.1053/j.ajkd.2012.01.024; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Rule AD, 2013, CLIN J AM SOC NEPHRO, V8, P1414, DOI 10.2215/CJN.01240213; Shastri S, 2011, AM J KIDNEY DIS, V57, P832, DOI 10.1053/j.ajkd.2010.11.021; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Tangri N, 2012, J AM SOC NEPHROL, V23, P351, DOI 10.1681/ASN.2011070663; Waheed S, 2013, CLIN J AM SOC NEPHRO, V8, P434, DOI 10.2215/CJN.04960512; Waheed S, 2012, AM J KIDNEY DIS, V60, P207, DOI 10.1053/j.ajkd.2012.03.011; Xie DW, 2008, CLIN J AM SOC NEPHRO, V3, P1332, DOI 10.2215/CJN.05631207	28	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2015	350								g7667	10.1136/bmj.g7667	http://dx.doi.org/10.1136/bmj.g7667			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3MT	25583704				2022-12-28	WOS:000348132400001
J	Leung, JH; Schurig-Briccio, LA; Yamaguchi, M; Moeller, A; Speir, JA; Gennis, RB; Stout, CD				Leung, Josephine H.; Schurig-Briccio, Lici A.; Yamaguchi, Mutsuo; Moeller, Arne; Speir, Jeffrey A.; Gennis, Robert B.; Stout, Charles D.			Division of labor in transhydrogenase by alternating proton translocation and hydride transfer	SCIENCE			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; ESCHERICHIA-COLI TRANSHYDROGENASE; BINDING-CHANGE MECHANISM; NADP(H) BINDING; DOMAIN-III; CONFORMATIONAL-CHANGE; ENERGY TRANSDUCTION; CRYSTAL-STRUCTURE; C57BL/6J MICE; BETA-SUBUNIT	NADPH/NADP(+) (the reduced form of NADP(+)/nicotinamide adenine dinucleotide phosphate) homeostasis is critical for countering oxidative stress in cells. Nicotinamide nucleotide transhydrogenase (TH), a membrane enzyme present in both bacteria and mitochondria, couples the proton motive force to the generation of NADPH. We present the 2.8 angstrom crystal structure of the transmembrane proton channel domain of TH from Thermus thermophilus and the 6.9 angstrom crystal structure of the entire enzyme (holo-TH). The membrane domain crystallized as a symmetric dimer, with each protomer containing a putative proton channel. The holo-TH is a highly asymmetric dimer with the NADP(H)-binding domain (dIII) in two different orientations. This unusual arrangement suggests a catalytic mechanism in which the two copies of dIII alternatively function in proton translocation and hydride transfer.	[Leung, Josephine H.; Yamaguchi, Mutsuo; Stout, Charles D.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Schurig-Briccio, Lici A.; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Moeller, Arne; Speir, Jeffrey A.] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA	Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	dave@scripps.edu		Moeller, Arne/0000-0003-1101-5366	National Institutes of Health (NIH) [5R01GM061545 2004 - 2008]; National Institute of General Medical Sciences (NIGMS) [1R01GM103838 - 01A1, GM095600]; NIH NIGMS [P41GM103310]; NIH [GM073197]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R01GM103838, R01GM095600, R01GM061545, P50GM073197] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Hatefi for commitment and inspiration on TH; M. Yeager, H. Heaslet, J. Chartron, and R. Akhouri for their work on E. coli holo-TH; M. Saier and Z. Zhang for providing the bacterial strain; M. Soltis and D. Terrell for the Gryphon robot: V. Cherezov and M. Caffrey for helpful comments and suggestions; and W. Liu for help with using the RockImager. We thank the staff of the Stanford Synchrotron Radiation Lightsource and the staff of the Northeastern Collaborative Access Team at the Advanced Photon Source for assistance with data collection. This research was funded by National Institutes of Health (NIH) grant 5R01GM061545 2004 - 2008 and by National Institute of General Medical Sciences (NIGMS) grant 1R01GM103838 - 01A1, GM095600 (to R.B.G) PA is the Program Announcement number of NIH Research Project Grant. "Structural Biology of Membrane Proteins" is the title of the program. It was mistake to include it in acknowledgements. The work was performed at the National Resource for Automated Molecular Microscopy, which is supported by a grant from the NIH NIGMS (P41GM103310). A. Moeller is supported by NIH grant GM073197. Atomic coordinates and diffraction data for Me structures reported here are deposited in the RCSB Protein Data. Bank under accession codes 4093 and 409U. The authors declare no competing financial interests. For the crystallography research, J.H.L. and C.D.S. designed experiments; J.H.L., MY, and C.D.S. performed experiments; and J.H.L. and C.D.S. analyzed the data. For the cryo-EM research, A.M. and. J.A.S. designed and performed experiments and analyzed data. L.A.S. and R.B.G. contributed the Tt TN operon for expression and initial purification. L.A.S., J.H.L., and R.B.G. created holo-TH constructs and expressed and assayed mutants. J.H.L., R.B.G., and C.D.S. wrote the manuscript.	Althage M, 2001, BIOCHEMISTRY-US, V40, P9968, DOI 10.1021/bi0103157; Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; Bizouarn T, 1996, BBA-BIOENERGETICS, V1273, P4, DOI 10.1016/0005-2728(95)00125-5; Bizouarn T, 2000, BBA-BIOENERGETICS, V1457, P211, DOI 10.1016/S0005-2728(00)00103-1; Bizouarn T, 2000, BBA-BIOENERGETICS, V1459, P284, DOI 10.1016/S0005-2728(00)00163-8; Bragg PD, 2001, ARCH BIOCHEM BIOPHYS, V388, P299, DOI 10.1006/abbi.2001.2298; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Hatefi Y, 1996, FASEB J, V10, P444, DOI 10.1096/fasebj.10.4.8647343; HUTTON M, 1994, EUR J BIOCHEM, V219, P1041, DOI 10.1111/j.1432-1033.1994.tb18587.x; Jackson JB, 2012, BBA-BIOENERGETICS, V1817, P1839, DOI 10.1016/j.bbabio.2012.04.006; Jackson JB, 2002, BIOCHEMISTRY-US, V41, P4173, DOI 10.1021/bi012078d; Johansson C, 2002, EUR J BIOCHEM, V269, P4505, DOI 10.1046/j.1432-1033.2002.03144.x; Johansson T, 2005, J MOL BIOL, V352, P299, DOI 10.1016/j.jmb.2005.07.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Meuller J, 1996, BBA-BIOENERGETICS, V1273, P191, DOI 10.1016/0005-2728(95)00154-9; Pedersen A, 2005, BBA-BIOENERGETICS, V1707, P254, DOI 10.1016/j.bbabio.2004.12.004; Pedersen A, 2008, J BIOENERG BIOMEMBR, V40, P463, DOI 10.1007/s10863-008-9170-x; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; Prasad GS, 2002, BIOCHEMISTRY-US, V41, P12745, DOI 10.1021/bi020251f; Sundaresan V, 2005, J MOL BIOL, V346, P617, DOI 10.1016/j.jmb.2004.11.070; Sundaresan V, 2003, BIOCHEMISTRY-US, V42, P12143, DOI 10.1021/bi035006q; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Venning JD, 2001, J BIOL CHEM, V276, P30678, DOI 10.1074/jbc.M104429200; White SA, 2000, STRUCT FOLD DES, V8, P1, DOI 10.1016/S0969-2126(00)00075-7; YAMAGUCHI M, 1995, J BIOL CHEM, V270, P16653, DOI 10.1074/jbc.270.28.16653; Yamaguchi M, 2002, J BIOL CHEM, V277, P33670, DOI 10.1074/jbc.M204170200	28	29	30	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					178	181		10.1126/science.1260451	http://dx.doi.org/10.1126/science.1260451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574024	Green Accepted, Green Submitted			2022-12-28	WOS:000347918900044
J	Jakob, M; Hilaire, J				Jakob, Michael; Hilaire, Jerome			CLIMATE SCIENCE Unburnable fossil-fuel reserves	NATURE			English	Editorial Material									[Jakob, Michael; Hilaire, Jerome] Head Res Domain III, Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Jakob, Michael] Mercator Res Inst Global Commons & Climate Change, D-10829 Berlin, Germany	Potsdam Institut fur Klimafolgenforschung	Jakob, M (corresponding author), Head Res Domain III, Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany.	jakob@mcc-berlin.net; hilaire@pik-potsdam.de		Hilaire, Jerome/0000-0002-9879-6339	STFC [ST/H002456/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		[Anonymous], 2014, BP STAT REV WORLD EN; Bauer N., 2013, CLIM CHANGE; Clarke L.E, 2014, CLIMATE CHANGE 2014; Edenhofer O, 2013, ATMOSPHERE GLOBAL CO; Fenton A, 2014, NAT CLIM CHANGE, V4, P650, DOI 10.1038/nclimate2303; Jakob M., OXFORD REV IN PRESS; Jakob M, 2014, NAT CLIM CHANGE, V4, P961, DOI 10.1038/NCLIMATE2370; Jewell J, 2013, CLIM CHANG ECON, V4, DOI 10.1142/S2010007813400113; McCollum D, 2014, CLIMATIC CHANGE, V123, P413, DOI 10.1007/s10584-013-0939-5; McGlade C, 2015, NATURE, V517, P187, DOI 10.1038/nature14016; McJeon H, 2014, NATURE, V514, P482, DOI 10.1038/nature13837; Steckel JC, 2011, ENERG POLICY, V39, P3443, DOI 10.1016/j.enpol.2011.03.042; Unburnable carbon, 2013, UNB CARB 2013 WAST C	13	93	95	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					150	152		10.1038/517150a	http://dx.doi.org/10.1038/517150a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567276				2022-12-28	WOS:000347477600022
J	Blum, CA; Nigro, N; Briel, M; Schuetz, P; Ullmer, E; Suter-Widmer, I; Winzeler, B; Bingisser, R; Elsaesser, H; Drozdov, D; Arici, B; Urwyler, SA; Refardt, J; Tarr, P; Wirz, S; Thomann, R; Baumgartner, C; Duplain, H; Burki, D; Zimmerli, W; Rodondi, N; Mueller, B; Christ-Crain, M				Blum, Claudine Angela; Nigro, Nicole; Briel, Matthias; Schuetz, Philipp; Ullmer, Elke; Suter-Widmer, Isabelle; Winzeler, Bettina; Bingisser, Roland; Elsaesser, Hanno; Drozdov, Daniel; Arici, Birsen; Urwyler, Sandrine Andrea; Refardt, Julie; Tarr, Philip; Wirz, Sebastian; Thomann, Robert; Baumgartner, Christine; Duplain, Herve; Burki, Dieter; Zimmerli, Werner; Rodondi, Nicolas; Mueller, Beat; Christ-Crain, Mirjam			Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial	LANCET			English	Article							RESPIRATORY-TRACT INFECTIONS; SEVERE SEPSIS; GUIDELINES; CORTICOSTEROIDS; MANAGEMENT; HYDROCORTISONE; EFFICACY	Background Clinical trials yielded conflicting data about the benefit of adding systemic corticosteroids for treatment of community-acquired pneumonia. We assessed whether short-term corticosteroid treatment reduces time to clinical stability in patients admitted to hospital for community-acquired pneumonia. Methods In this double-blind, multicentre, randomised, placebo-controlled trial, we recruited patients aged 18 years or older with community-acquired pneumonia from seven tertiary care hospitals in Switzerland within 24 h of presentation. Patients were randomly assigned (1:1 ratio) to receive either prednisone 50 mg daily for 7 days or placebo. The computer-generated randomisation was done with variable block sizes of four to six and stratified by study centre. The primary endpoint was time to clinical stability defined as time (days) until stable vital signs for at least 24 h, and analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00973154. Findings From Dec 1, 2009, to May 21, 2014, of 2911 patients assessed for eligibility, 785 patients were randomly assigned to either the prednisone group (n=392) or the placebo group (n=393). Median time to clinical stability was shorter in the prednisone group (3.0 days, IQR 2.5-3.4) than in the placebo group (4.4 days, 4.0-5.0; hazard ratio [HR] 1.33, 95% CI 1.15-1.50, p<0.0001). Pneumonia-associated complications until day 30 did not differ between groups (11 [3%] in the prednisone group and 22 [6%] in the placebo group; odds ratio [OR] 0.49 [95% CI 0.23-1.02]; p=0.056). The prednisone group had a higher incidence of in-hospital hyperglycaemia needing insulin treatment (76 [19%] vs 43 [11%]; OR 1.96, 95% CI 1.31-2.93, p=0.0010). Other adverse events compatible with corticosteroid use were rare and similar in both groups. Interpretation Prednisone treatment for 7 days in patients with community-acquired pneumonia admitted to hospital shortens time to clinical stability without an increase in complications. This finding is relevant from a patient perspective and an important determinant of hospital costs and efficiency.	[Blum, Claudine Angela; Nigro, Nicole; Suter-Widmer, Isabelle; Winzeler, Bettina; Arici, Birsen; Urwyler, Sandrine Andrea; Refardt, Julie; Christ-Crain, Mirjam] Univ Basel Hosp, Dept Internal Med, Endocrinol Diabetol & Metab, CH-4031 Basel, Switzerland; [Blum, Claudine Angela; Nigro, Nicole; Suter-Widmer, Isabelle; Winzeler, Bettina; Arici, Birsen; Urwyler, Sandrine Andrea; Refardt, Julie; Christ-Crain, Mirjam] Univ Basel Hosp, Dept Clin Res, CH-4031 Basel, Switzerland; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Briel, Matthias] Univ Basel Hosp, Dept Clin Res, CH-4031 Basel, Switzerland; [Bingisser, Roland] Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland; [Blum, Claudine Angela; Schuetz, Philipp; Drozdov, Daniel; Arici, Birsen; Mueller, Beat] Kantonsspital Aarau, Med Univ Clin, Dept Internal, Aarau, Switzerland; [Blum, Claudine Angela; Schuetz, Philipp; Drozdov, Daniel; Arici, Birsen; Mueller, Beat] Kantonsspital Aarau, Dept Emergency Med, Aarau, Switzerland; [Blum, Claudine Angela; Schuetz, Philipp; Drozdov, Daniel; Arici, Birsen; Mueller, Beat] Kantonsspital Aarau, Dept Endocrinol Diabetol & Clin Nutr, Aarau, Switzerland; [Briel, Matthias] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ullmer, Elke; Elsaesser, Hanno; Zimmerli, Werner] Kantonsspital Baselland Liestal, Med Univ Clin, Liestal, Switzerland; [Tarr, Philip; Wirz, Sebastian] Kantonsspital Baselland Bruderholz, Med Univ Clin, Bruderholz, Switzerland; [Thomann, Robert] Burgerspital, Dept Internal Med, Solothurn, Switzerland; [Baumgartner, Christine; Rodondi, Nicolas] Univ Hosp Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Duplain, Herve] Hop Jura, Clin Internal Med, Delemont, Switzerland; [Burki, Dieter] Viollier AG, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); McMaster University; Kantonsspital Baselland; Kantonsspital Baselland; University of Bern; University Hospital of Bern	Christ-Crain, M (corresponding author), Univ Basel Hosp, Dept Internal Med, Clin Endocrinol Diabetol & Metab, Petersgraben 4, CH-4031 Basel, Switzerland.	mirjam.christ@usb.ch	Briel, Matthias/AAT-9284-2021; Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013; Blum, Claudine Angela A/G-8467-2016; Refardt, Julie/AAH-1889-2019	schuetz, philipp/0000-0001-6400-4949; Blum, Claudine Angela A/0000-0003-0487-5587; Refardt, Julie/0000-0002-3040-4685; Rodondi, Nicolas/0000-0001-9083-6896; Baumgartner, Christine/0000-0003-2296-9632; Winzeler, Bettina/0000-0001-8305-2700; Christ-Crain, Mirjam/0000-0002-6336-0965; Drozdov, Daniel/0000-0002-3010-7525; TARR, Philip/0000-0002-1488-5407; Briel, Matthias/0000-0002-2070-5230	Swiss National Science Foundation; Viollier AG; Nora van Meeuwen Haefliger Stiftung; Julia und Gottfried Bangerter-Rhyner Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Viollier AG; Nora van Meeuwen Haefliger Stiftung; Julia und Gottfried Bangerter-Rhyner Stiftung	Swiss National Science Foundation, Viollier AG, Nora van Meeuwen Haefliger Stiftung, Julia und Gottfried Bangerter-Rhyner Stiftung.	Blum CA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-257; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Chamberlain G, 1994, ADV EC 6 WORLD C, V2, P171, DOI DOI 10.1017/CCOL0521444594.005; Chen Y, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007720.PUB2; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; El Moussaoui R, 2004, THORAX, V59, P591, DOI 10.1136/thx.2003.015107; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garcia-Vidal C, 2007, EUR RESPIR J, V30, P951, DOI 10.1183/09031936.00027607; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Laifer G, MANAGEMENT COMMUNITY; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARIK P, 1993, CHEST, V104, P389, DOI 10.1378/chest.104.2.389; MCHARDY VU, 1972, BRIT MED J, V4, P569, DOI 10.1136/bmj.4.5840.569; Meduri GU, 2010, AM J RESP CRIT CARE, V181, P880, DOI 10.1164/rccm.201001-0034ED; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3; Nafae RM, 2013, EGYPT J CHEST DIS TU, V62, P439, DOI 10.1016/j.ejcdt.2013.03.009; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Sabry NA, 2011, PHARM PHARM, V2, P73, DOI DOI 10.4236/PP.2011.22009; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Shafiq M, 2013, J HOSP MED, V8, P68, DOI 10.1002/jhm.1992; Siempos II, 2008, J ANTIMICROB CHEMOTH, V62, P661, DOI 10.1093/jac/dkn283; Snijders D, 2012, EUR RESP J S56, V40, pP1734; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; World Health Organization, 2014, TOP 10 CAUS DEATH	33	234	246	1	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1511	1518		10.1016/S0140-6736(14)62447-8	http://dx.doi.org/10.1016/S0140-6736(14)62447-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25608756				2022-12-28	WOS:000353220000032
J	Chao, W; Hsieh, JT; Chang, CH; Lin, JJM				Chao, Wen; Hsieh, Jun-Ting; Chang, Chun-Hung; Lin, Jim Jr-Min			Direct kinetic measurement of the reaction of the simplest Criegee intermediate with water vapor	SCIENCE			English	Article							GAS-PHASE OZONOLYSIS; ABSORPTION-SPECTRUM; CARBONYL OXIDES; CH2OO; ACID; SO2; ALKENES; YIELD; ETHENE; OZONE	Carbonyl oxides, or Criegee intermediates, are important transient species formed in the reactions of unsaturated hydrocarbons with ozone. Although direct detection of Criegee intermediates has recently been realized, the main atmospheric sink of Criegee intermediates remains unclear. We report ultraviolet absorption spectroscopic measurements of the lifetime of the simplest Criegee intermediate, CH2OO, at various relative humidity levels up to 85% at 298 kelvin. An extremely fast decay rate of CH2OO was observed at high humidity. The observed quadratic dependence of the decay rate on water concentration implied a predominant reaction with water dimer. On the basis of the water dimer equilibrium constant, the effective rate coefficient of the CH2OO + (H2O)(2) reaction was determined to be 6.5 (+/-0.8) x 10(-12) cubic centimeters per second. This work would help modelers to better constrain the atmospheric concentrations of CH2OO.	[Chao, Wen; Hsieh, Jun-Ting; Chang, Chun-Hung; Lin, Jim Jr-Min] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan; [Chao, Wen; Lin, Jim Jr-Min] Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan; [Hsieh, Jun-Ting] Stanford Univ, Stanford, CA 94305 USA; [Lin, Jim Jr-Min] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30010, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Stanford University; National Yang Ming Chiao Tung University	Lin, JJM (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan.	jimlin@gate.sinica.edu.tw	Lin, Jim/F-7916-2012	Lin, Jim/0000-0002-8308-2552	Academia Sinica; Ministry of Science and Technology, Taiwan [MOST103-2113-M-001-019-MY3, MOST103-2815-C-001-001-M]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Materials and methods and more kinetic data are presented in the supplementary materials. Supported by Academia Sinica and Ministry of Science and Technology, Taiwan, grants MOST103-2113-M-001-019-MY3 and MOST103-2815-C-001-001-M. We thank Y. T. Lee for discussion.	Anglada JM, 2011, PHYS CHEM CHEM PHYS, V13, P13034, DOI 10.1039/c1cp20872a; Beames JM, 2012, J AM CHEM SOC, V134, P20045, DOI 10.1021/ja310603j; BECKER KH, 1993, ATMOS ENVIRON A-GEN, V27, P57, DOI 10.1016/0960-1686(93)90070-F; Berndt T, 2014, PHYS CHEM CHEM PHYS, V16, P19130, DOI 10.1039/c4cp02345e; Berndt T, 2014, ATMOS ENVIRON, V89, P603, DOI 10.1016/j.atmosenv.2014.02.062; Berndt T, 2012, J PHYS CHEM LETT, V3, P2892, DOI 10.1021/jz301158u; Hasson AS, 2001, J GEOPHYS RES-ATMOS, V106, P34131, DOI 10.1029/2001JD000597; Johnson D, 2001, J PHYS CHEM A, V105, P2933, DOI 10.1021/jp003975e; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Leather KE, 2012, ATMOS CHEM PHYS, V12, P469, DOI 10.5194/acp-12-469-2012; Lehman JH, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4824655; Nakajima M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4821165; Neeb P, 1997, ATMOS ENVIRON, V31, P1417, DOI 10.1016/S1352-2310(96)00322-6; Ouyang B, 2013, PHYS CHEM CHEM PHYS, V15, P17070, DOI 10.1039/c3cp53024h; Ruscic B, 2013, J PHYS CHEM A, V117, P11940, DOI 10.1021/jp403197t; Ryzhkov AB, 2004, PHYS CHEM CHEM PHYS, V6, P5042, DOI 10.1039/b408414d; Sander S. P., 2011, JPL PUBL, V10-6, P17; Smith MC, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4892582; Stone D, 2014, PHYS CHEM CHEM PHYS, V16, P1139, DOI 10.1039/c3cp54391a; Su YT, 2013, SCIENCE, V340, P174, DOI 10.1126/science.1234369; SUTO M, 1985, ENVIRON SCI TECHNOL, V19, P815, DOI 10.1021/es00139a008; Taatjes CA, 2014, PHYS CHEM CHEM PHYS, V16, P1704, DOI 10.1039/c3cp52842a; Taatjes CA, 2013, SCIENCE, V340, P177, DOI 10.1126/science.1234689; Ting WL, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4894405; Ting WL, 2014, PHYS CHEM CHEM PHYS, V16, P10438, DOI 10.1039/c4cp00877d; Vereecken L, 2014, PHYS CHEM CHEM PHYS, V16, P4039, DOI 10.1039/c3cp54514h; Vereecken L, 2013, SCIENCE, V340, P154, DOI 10.1126/science.1236475; Welz O, 2014, ANGEW CHEM INT EDIT, V53, P4547, DOI 10.1002/anie.201400964; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229	29	194	193	19	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223					751	754		10.1126/science.1261549	http://dx.doi.org/10.1126/science.1261549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25569112				2022-12-28	WOS:000349221300043
J	Goroff, DL				Goroff, Daniel L.			Balancing privacy versus accuracy in research protocols	SCIENCE			English	Editorial Material									Alfred P Sloan Fdn, New York, NY 10111 USA		Goroff, DL (corresponding author), Alfred P Sloan Fdn, New York, NY 10111 USA.	gorof@sloan.org						Dwork C, 2006, LECT NOTES COMPUT SC, V4052, P1; Dwork C, 2006, LECT NOTES COMPUT SC, V3876, P265, DOI 10.1007/11681878_14; Dwork C, 2014, PRIVACY, BIG DATA, AND THE PUBLIC GOOD: FRAMEWORKS FOR ENGAGEMENT, P296; Einav L, 2014, SCIENCE, V346, P715, DOI 10.1126/science.1243089; Gentry C, 2009, ACM S THEORY COMPUT, P169, DOI 10.1145/1536414.1536440; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; Lopez-Alt A, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P1219; Machanavajjhala A, 2008, PROC INT CONF DATA, P277, DOI 10.1109/ICDE.2008.4497436; Narayanan A, 2008, P IEEE S SECUR PRIV, P111, DOI 10.1109/SP.2008.33; Prabhakaran M., 2013, SECURE MULTIPARTY CO; Sweeney L, 1997, J LAW MED ETHICS, V25, P98, DOI 10.1111/j.1748-720X.1997.tb01885.x	11	13	13	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					479	480		10.1126/science.aaa3483	http://dx.doi.org/10.1126/science.aaa3483			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA0YK	25635075				2022-12-28	WOS:000348639300023
J	Mahony, C				Mahony, Chris			MEDICINE AND THE MEDIA Public health marketing campaigns: who profits?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chris.mahony@cjmedia.biz						Bala MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub3; Public Health England, 2014, ROL SMOK PROGR DECL; Public Health England, 2014, PUBL HLTH ENGL MARK; Smokefree Resource Centre, SMOK HOM CARS 2013	4	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2015	350								h514	10.1136/bmj.h514	http://dx.doi.org/10.1136/bmj.h514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AT	25633267				2022-12-28	WOS:000348778700008
J	Merino, MM; Rhiner, C; Lopez-Gay, JM; Buechel, D; Hauert, B; Moreno, E				Merino, Marisa M.; Rhiner, Christa; Lopez-Gay, Jesus M.; Buechel, David; Hauert, Barbara; Moreno, Eduardo			Elimination of Unfit Cells Maintains Tissue Health and Prolongs Lifespan	CELL			English	Article							DETECTABLE CLONAL MOSAICISM; FITNESS FINGERPRINTS; DROSOPHILA; COMPETITION; CANCER; DEATH; APOPTOSIS; MYC; NEURODEGENERATION; ACTIVATION	Viable yet damaged cells can accumulate during development and aging. Although eliminating those cells may benefit organ function, identification of this less fit cell population remains challenging. Previously, we identified a molecular mechanism, based on "fitness fingerprints'' displayed on cell membranes, which allows direct fitness comparison among cells in Drosophila. Here, we study the physiological consequences of efficient cell selection for the whole organism. We find that fitness-based cell culling is naturally used to maintain tissue health, delay aging, and extend lifespan in Drosophila. We identify a gene, azot, which ensures the elimination of less fit cells. Lack of azot increases morphological malformations and susceptibility to random mutations and accelerates tissue degeneration. On the contrary, improving the efficiency of cell selection is beneficial for tissue health and extends lifespan.	[Merino, Marisa M.; Rhiner, Christa; Lopez-Gay, Jesus M.; Buechel, David; Hauert, Barbara; Moreno, Eduardo] Univ Bern, Inst Cell Biol, IZB, CH-3012 Bern, Switzerland; [Lopez-Gay, Jesus M.] Inst Curie, CNRS, INSERM, UMR 3215,U934,Polarity Div, F-75231 Paris, France; [Lopez-Gay, Jesus M.] Inst Curie, CNRS, INSERM, UMR 3215,U934, F-75231 Paris, France	University of Bern; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Moreno, E (corresponding author), Univ Bern, Inst Cell Biol, IZB, CH-3012 Bern, Switzerland.	emoreno@izb.unibe.ch	LOPEZ-GAY, Jesus/AAB-9759-2021	Lopez-Gay, Jesus/0000-0002-9388-4065; Rhiner, Christa/0000-0001-7577-8042; moreno, eduardo/0000-0001-5040-452X; M. Merino, Marisa/0000-0002-7003-3890	European Research Council; Swiss National Science Foundation; Josef Steiner Cancer Research Foundation; bilateral Japanese-Swiss ST; Swiss Cancer League	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Josef Steiner Cancer Research Foundation; bilateral Japanese-Swiss ST; Swiss Cancer League	We thank H. Bellen, H. Stocker, M. Vidal, H. Ryoo, A. Bergmann, B. Mignotte, M. Portela, VDRC, and Hybridoma bank and Bloomington for flies and antibodies; CONSOLIDER consortium for injecting flies; and members of our laboratory for comments on the manuscript. Work in our laboratory is funded by the European Research Council, Swiss National Science Foundation, Josef Steiner Cancer Research Foundation, the bilateral Japanese-Swiss ST, and Swiss Cancer League.	Baillon L, 2014, SEMIN CELL DEV BIOL, V32, P137, DOI 10.1016/j.semcdb.2014.04.034; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; de Beco S, 2012, DEV DYNAM, V241, P831, DOI 10.1002/dvdy.23783; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gaumer S, 2000, CELL DEATH DIFFER, V7, P804, DOI 10.1038/sj.cdd.4400714; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; He Y, 2014, METHODS, V68, P129, DOI 10.1016/j.ymeth.2014.04.008; Hogan C, 2011, INT J BIOCHEM CELL B, V43, P496, DOI 10.1016/j.biocel.2010.12.019; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Lolo FN, 2012, CELL REP, V2, P526, DOI 10.1016/j.celrep.2012.08.012; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Merino MM, 2013, CURR BIOL, V23, P1300, DOI 10.1016/j.cub.2013.05.053; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Moreno E, 2014, CURR OPIN CELL BIOL, V31, P16, DOI 10.1016/j.ceb.2014.06.011; Moreno E, 2014, NATURE, V509, P435, DOI 10.1038/nature13337; Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001; Parisi F, 2014, CELL REP, V6, P855, DOI 10.1016/j.celrep.2014.01.039; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Petrova E, 2012, DIS MODEL MECH, V5, P553, DOI 10.1242/dmm.008623; Portela M, 2010, DEV CELL, V19, P562, DOI 10.1016/j.devcel.2010.09.004; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Reeves Henry M., 2006, Archives of Natural History, V33, P302, DOI 10.3366/anh.2006.33.2.302; Rhiner C, 2010, DEV CELL, V18, P985, DOI 10.1016/j.devcel.2010.05.010; Rodrigues AB, 2012, DEVELOPMENT, V139, P4051, DOI 10.1242/dev.076760; Simi A, 2010, DEV NEUROBIOL, V70, P323, DOI 10.1002/dneu.20773; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Suzanne M, 2010, CURR BIOL, V20, P1773, DOI 10.1016/j.cub.2010.08.056; SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30; Tamori Y, 2011, J GENET GENOMICS, V38, P483, DOI 10.1016/j.jgg.2011.09.006; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Vincent JP, 2011, DEV CELL, V21, P366, DOI 10.1016/j.devcel.2011.06.021; Willert K, 1999, DEVELOPMENT, V126, P4165; WOLFF T, 1991, DEVELOPMENT, V113, P825	48	97	98	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					461	476		10.1016/j.cell.2014.12.017	http://dx.doi.org/10.1016/j.cell.2014.12.017			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25601460	hybrid, Green Published			2022-12-28	WOS:000349208000012
J	Wheatley, LM; Togias, A				Wheatley, Lisa M.; Togias, Alkis			Allergic Rhinitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; RANDOMIZED CONTROLLED-TRIAL; SUBLINGUAL IMMUNOTHERAPY; NONALLERGIC RHINITIS; HAY-FEVER; SUBCUTANEOUS IMMUNOTHERAPY; GENERAL-PRACTICE; NATIONAL-HEALTH; UNITED-STATES; ASTHMA	A 35-year-old woman has a history of nasal congestion on most days of the year, dating back to her late teens. She has chronic nasal drainage, which is clear and thick. Her congestion is worst in the late summer and early fall and again in the early spring; at these times, she also has sneezing, nasal itching, and cough. Five years ago, she had an episode of shortness of breath with wheezing on a day when her nasal symptoms were severe, but this episode resolved spontaneously and has not recurred. Her eyes do not bother her. Over-the-counter oral antihistamines help her symptoms a little, as do nasal decongestants, which she uses occasionally. Her 6-year-old son has similar symptoms. How should this case be managed?	[Wheatley, Lisa M.; Togias, Alkis] NIAID, Allergy Asthma & Airway Biol Branch, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wheatley, LM (corresponding author), NIH, 5601 Fishers Ln,Rm 6B56, Bethesda, MD 20892 USA.	lisa.wheatley@nih.gov			Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Bende M, 2002, ANN ALLERG ASTHMA IM, V88, P617, DOI 10.1016/S1081-1206(10)61894-7; Benninger M, 2010, ANN ALLERG ASTHMA IM, V104, P13, DOI 10.1016/j.anai.2009.11.020; Bielory L, 2010, CURR ALLERGY ASTHM R, V10, P122, DOI 10.1007/s11882-010-0087-1; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet PJ, 2010, ANN EPIDEMIOL, V20, P797, DOI 10.1016/j.annepidem.2010.05.012; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Carr W, 2012, J ALLERGY CLIN IMMUN, V129, P1282, DOI 10.1016/j.jaci.2012.01.077; Corren J, 1997, J ALLERGY CLIN IMMUN, V100, P781, DOI 10.1016/S0091-6749(97)70274-4; CORREN J, 1998, J ALLERGY CLIN IMMUN, V101, P792; Creticos PS, 2013, J ALLERGY CLIN IMMUN, V131, P1342, DOI 10.1016/j.jaci.2013.03.019; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; Di Bona D, 2012, J ALLERGY CLIN IMMUN, V130, P1097, DOI 10.1016/j.jaci.2012.08.012; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Epstein TG, 2014, J ALLER CL IMM-PRACT, V2, P161, DOI 10.1016/j.jaip.2014.01.004; Genuneit J, 2013, PEDIAT ALLERG IMM-UK, V24, P293, DOI 10.1111/pai.12053; GRAF P, 1994, ORL J OTO-RHINO-LARY, V56, P334, DOI 10.1159/000276687; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Hopper JL, 2012, J ALLERGY CLIN IMMUN, V130, P1117, DOI 10.1016/j.jaci.2012.08.003; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Kiel MA, 2013, J ALLERGY CLIN IMMUN, V132, P353, DOI 10.1016/j.jaci.2013.03.013; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Lee TA, 2007, PHARMACOTHERAPY, V27, P852, DOI 10.1592/phco.27.6.852; Maloney J, 2014, ANN ALLERG ASTHMA IM, V112, P146, DOI 10.1016/j.anai.2013.11.018; McKeever TM, 2001, THORAX, V56, P758, DOI 10.1136/thorax.56.10.758; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Monto AS, 2002, CLIN THER, V24, P1987, DOI 10.1016/S0149-2918(02)80093-5; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Nathan RA, 2006, ANN ALLERG ASTHMA IM, V97, P389, DOI 10.1016/S1081-1206(10)60806-X; Nelson HS, 2014, J ALLER CL IMM-PRACT, V2, P144, DOI 10.1016/j.jaip.2013.11.018; Rodrigo GJ, 2006, ANN ALLERG ASTHMA IM, V96, P779, DOI 10.1016/S1081-1206(10)61339-7; Rondon C, 2012, J ALLERGY CLIN IMMUN, V129, P1460, DOI 10.1016/j.jaci.2012.02.032; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Sarin S, 2006, J ALLERGY CLIN IMMUN, V118, P999, DOI 10.1016/j.jaci.2006.09.013; Settipane RA, 2001, ALLERGY ASTHMA PROC, V22, P185; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Sin Betul, 2011, Proc Am Thorac Soc, V8, P106, DOI 10.1513/pats.201008-057RN; Slater JW, 1999, DRUGS, V57, P31, DOI 10.2165/00003495-199957010-00004; Vaidyanathan S, 2010, AM J RESP CRIT CARE, V182, P19, DOI 10.1164/rccm.200911-1701OC; WACHS M, 1989, J ALLERGY CLIN IMMUN, V84, P492, DOI 10.1016/0091-6749(89)90362-X; WALDEN SM, 1991, AM REV RESPIR DIS, V144, P642, DOI 10.1164/ajrccm/144.3_Pt_1.642; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Weiner JM, 1998, BMJ-BRIT MED J, V317, P1624, DOI 10.1136/bmj.317.7173.1624; Westman M, 2013, ALLERGY, V68, P1571, DOI 10.1111/all.12267; White P, 1998, CLIN EXP ALLERGY, V28, P266; Yonekura S, 2012, INT ARCH ALLERGY IMM, V157, P73, DOI 10.1159/000324475	49	256	288	17	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					456	463		10.1056/NEJMcp1412282	http://dx.doi.org/10.1056/NEJMcp1412282			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629743	Green Accepted			2022-12-28	WOS:000348649700010
J	Schubeler, D				Schuebeler, Dirk			Function and information content of DNA methylation	NATURE			English	Review							ACUTE MYELOID-LEUKEMIA; DE-NOVO METHYLATION; GENOME-WIDE; TET PROTEINS; CPG ISLAND; ENDOGENOUS RETROVIRUSES; EPIGENETIC INHERITANCE; TRANSPOSABLE ELEMENTS; CHROMATIN-STRUCTURE; ENHANCER ACTIVITY	Cytosine methylation is a DNA modification generally associated with transcriptional silencing. Factors that regulate methylation have been linked to human disease, yet how they contribute to malignances remains largely unknown. Genomic maps of DNA methylation have revealed unexpected dynamics at gene regulatory regions, including active demethylation by TET proteins at binding sites for transcription factors. These observations indicate that the underlying DNA sequence largely accounts for local patterns of methylation. As a result, this mark is highly informative when studying gene regulation in normal and diseased cells, and it can potentially function as a biomarker. Although these findings challenge the view that methylation is generally instructive for gene silencing, several open questions remain, including how methylation is targeted and recognized and in what context it affects genome readout.	[Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch			Novartis research foundation; European Union (NoE EpiGeneSys) [FP7- HEALTH-2010-257082]; European Union (Blueprint consortium) [FP7-282510]; European Research Council (EpiGePlas); SNF Sinergia programme; Swiss Initiative in Systems Biology (RTD Cell Plasticity)	Novartis research foundation; European Union (NoE EpiGeneSys); European Union (Blueprint consortium); European Research Council (EpiGePlas); SNF Sinergia programme; Swiss Initiative in Systems Biology (RTD Cell Plasticity)	I apologize to colleagues, whose work I could not cite or only discuss in a limited context owing to space limitations. I thank in particular P. Ginno and further T Baubec., M. Lorincz and N. Thomae for critical input on the manuscript. Work in my laboratory is supported by the Novartis research foundation, the European Union (NoE EpiGeneSys FP7- HEALTH-2010-257082 and the Blueprint consortium FP7-282510), the European Research Council (EpiGePlas), the SNF Sinergia programme and the Swiss Initiative in Systems Biology (RTD Cell Plasticity).	ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Bell JT, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-172; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Feldmann A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003994; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hahn MA, 2014, GENOMICS, V104, P314, DOI 10.1016/j.ygeno.2014.08.015; Han L, 2001, MOL CELL BIOL, V21, P3416, DOI 10.1128/MCB.21.10.3416-3424.2001; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hon GC, 2014, MOL CELL, V56, P286, DOI 10.1016/j.molcel.2014.08.026; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Krebs AR, 2014, ELIFE, V3, DOI 10.7554/eLife.04094; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu S, 2014, GENE DEV, V28, P2041, DOI 10.1101/gad.244848.114; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Lu FL, 2014, GENE DEV, V28, P2103, DOI 10.1101/gad.248005.114; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Schillebeeckx M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt230; Selker EU, 1997, TRENDS GENET, V13, P296, DOI 10.1016/S0168-9525(97)01201-8; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P3418, DOI 10.1073/pnas.79.11.3418; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; VARDIMON L, 1982, P NATL ACAD SCI-BIOL, V79, P1073, DOI 10.1073/pnas.79.4.1073; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	123	1198	1235	29	646	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					321	326		10.1038/nature14192	http://dx.doi.org/10.1038/nature14192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592537				2022-12-28	WOS:000347810300036
J	Cummings, JR				Cummings, Janet R.			Rates of Psychiatrists' Participation in Health Insurance Networks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE	IMPORTANCE There have been recent calls for increased access to mental health services, but access may be limited owing to psychiatrist refusal to accept insurance. OBJECTIVE To describe recent trends in acceptance of insurance by psychiatrists compared with physicians in other specialties. DESIGN, SETTING, AND PARTICIPANTS We used data from a national survey of office-based physicians in the United States to calculate rates of acceptance of private noncapitated insurance, Medicare, and Medicaid by psychiatrists vs physicians in other specialties and to compare characteristics of psychiatrists who accepted insurance and those who did not. MAIN OUTCOMES AND MEASURES Our main outcome variables were physician acceptance of new patients with private noncapitated insurance, Medicare, or Medicaid. Our main independent variables were physician specialty and year groupings (2005-2006, 2007-2008, and 2009-2010). RESULTS The percentage of psychiatrists who accepted private noncapitated insurance in 2009-2010 was significantly lower than the percentage of physicians in other specialties (55.3% [95% CI, 46.7%-63.8%] vs 88.7%[86.4%-90.7%]; P < .001) and had declined by 17.0% since 2005-2006. Similarly, the percentage of psychiatrists who accepted Medicare in 2009-2010 was significantly lower than that for other physicians (54.8%[95% CI, 46.6%-62.7%] vs 86.1%[84.4%-87.7%]; P < .001) and had declined by 19.5% since 2005-2006. Psychiatrists' Medicaid acceptance rates in 2009-2010 were also lower than those for other physicians (43.1%[95% CI, 34.9%-51.7%] vs 73.0% [70.3%-75.5%]; P < .001) but had not declined significantly from 2005-2006. Psychiatrists in the Midwest were more likely to accept private noncapitated insurance (85.1%) than those in the Northeast (48.5%), South (43.0%), or West (57.8%) (P = .02). CONCLUSIONS AND RELEVANCE Acceptance rates for all types of insurance were significantly lower for psychiatrists than for physicians in other specialties. These low rates of acceptance may pose a barrier to access to mental health services.	Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd NE,Room 650, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Cummings, JR (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd NE,Room 650, Atlanta, GA 30322 USA.	jrcummi@emory.edu			National Institute of Mental Health [K01MH095823]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH095823] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (K01MH095823).	[Anonymous], 2012, HHS PUBL SMA, V13-4797; Bishop TF, 2014, JAMA PSYCHIAT, V71, P176, DOI 10.1001/jamapsychiatry.2013.2862; Faulkner LR, 2011, ACAD PSYCHIATR, V35, P35, DOI 10.1176/appi.ap.35.1.35; Garfield RL, 2011, AM J PSYCHIAT, V168, P486, DOI 10.1176/appi.ajp.2010.10060792; Harris Gardiner, 2011, NY TIMES, pA1; Kyanko KA, 2012, INQUIRY, V49, P352; Thomas KC, 2009, PSYCHIAT SERV, V60, P1323, DOI 10.1176/ps.2009.60.10.1323; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616	8	22	22	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					190	+		10.1001/jama.2014.12472	http://dx.doi.org/10.1001/jama.2014.12472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AY6MC	25585330	Green Accepted			2022-12-28	WOS:000347679300018
J	Ogata, H; Nishikawa, K; Lubitz, W				Ogata, Hideaki; Nishikawa, Koji; Lubitz, Wolfgang			Hydrogens detected by subatomic resolution protein crystallography in a [NiFe] hydrogenase	NATURE			English	Article							CATALYTIC CYCLE; ACTIVE-SITE; ELECTRON-DENSITY; ACTIVATION; LIGAND; BONDS; REACTIVITY; SPECTROSCOPY; COMPLEXES; PATHWAYS	The enzyme hydrogenase reversibly converts dihydrogen to protons and electrons at a metal catalyst(1). The location of the abundant hydrogens is of key importance for understanding structure and function of the protein(2-6). However, in protein X-ray crystallography the detection of hydrogen atoms is one of the major problems, since they display only weak contributions to diffraction and the quality of the single crystals is often insufficient to obtain sub-angstrom resolution'. Here we report the crystal structure of a standard [NiFe] hydrogenase (similar to 91.3 ltDa molecular mass) at 0.89 angstrom resolution. The strictly anoxically isolated hydrogenase has been obtained in a specific spectroscopic state, the active reduced Ni-R (subform Ni-R1) state. The high resolution, proper refinement strategy and careful modelling allow the positioning of a large part of the hydrogen atoms in the structure. This has led to the direct detection of the products of the heterolytic splitting of dihydrogen into a hydride (H-) bridging the Ni and Fe and a proton (H+) attached to the sulphur of a cysteine ligand. The Ni-H- and Fe-H- bond lengths are 1.58 angstrom and 1.78 angstrom, respectively. Furthermore, we can assign the Fe-CO and Fe-CN- ligands at the active site, and can obtain the hydrogen-bond networks and the preferred proton transfer pathway in the hydrogenase. Our results demonstrate the precise comprehensive information available from ultra-high-resolution structures of proteins as an alternative to neutron diffraction and other methods such as NMR structural analysis.	[Ogata, Hideaki; Nishikawa, Koji; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany	Max Planck Society	Ogata, H (corresponding author), Max Planck Inst Chem Energy Convers, Stiftstr 34-36, D-45470 Mulheim, Germany.	hideaki.ogata@cec.mpg.de; wolfgang.lubitz@cec.mpg.de	Ogata, Hideaki/J-4975-2013	Ogata, Hideaki/0000-0002-2894-2417	Max Planck Society; Bundesministerium far Bildung und Forschung (BMBF) [03SF0355C]; EU/Energy Network project SOLAR-H2 [212508]; Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft [EXC1069]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium far Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EU/Energy Network project SOLAR-H2(European Commission); Cluster of Excellence RESOLV - Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank P. Malkowski for her help with the sample preparation and K. Krause for critically reading the manuscript. We are grateful to the staff of BESSYII MX-beamline (Helmholtz-Zentrum Berlin, Germany) for their help during the data collection. The work was supported by the Max Planck Society, the Bundesministerium far Bildung und Forschung (BMBF) (03SF0355C), EU/Energy Network project SOLAR-H2 (FP7 contract 212508), and in part by the Cluster of Excellence RESOLV (EXC1069) funded by the Deutsche Forschungsgemeinschaft.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2004, ACTA CRYSTALLOGR D, V60, P260, DOI 10.1107/S0907444903026209; Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Barton BE, 2010, J AM CHEM SOC, V132, P14877, DOI 10.1021/ja105312p; Bau R, 1997, INORG CHIM ACTA, V259, P27, DOI 10.1016/S0020-1693(97)89125-6; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Breitenfeld J, 2012, ORGANOMETALLICS, V31, P2128, DOI 10.1021/om201279j; Chotard JN, 2006, ANGEW CHEM INT EDIT, V45, P7770, DOI 10.1002/anie.200603651; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAN CL, 1991, J AM CHEM SOC, V113, P20, DOI 10.1021/ja00001a003; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Galvan IF, 2008, PROTEINS, V73, P195, DOI 10.1002/prot.22045; Gehring H, 2013, CHEM-EUR J, V19, P1629, DOI 10.1002/chem.201203201; Gruene T, 2014, J APPL CRYSTALLOGR, V47, P462, DOI 10.1107/S1600576713027659; Higuchi Y, 1999, STRUCT FOLD DES, V7, P549, DOI 10.1016/S0969-2126(99)80071-9; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Huang DG, 2010, J AM CHEM SOC, V132, P4693, DOI 10.1021/ja1003125; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kramer T, 2013, CHEMBIOCHEM, V14, P1898, DOI 10.1002/cbic.201300104; Lee CH, 2013, DALTON T, V42, P2355, DOI 10.1039/c2dt32885b; Lindahl PA, 2012, J INORG BIOCHEM, V106, P172, DOI 10.1016/j.jinorgbio.2011.08.012; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; Ogo S, 2013, SCIENCE, V339, P682, DOI 10.1126/science.1231345; Pandelia ME, 2012, CHEM COMMUN, V48, P823, DOI 10.1039/c1cc16109a; Pandelia ME, 2010, CHEMPHYSCHEM, V11, P1127, DOI 10.1002/cphc.200900950; Rippers Y, 2012, CHEMPHYSCHEM, V13, P3852, DOI 10.1002/cphc.201200562; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Stein M, 2001, PHYS CHEM CHEM PHYS, V3, P5115, DOI 10.1039/b105723p; Teixeira VH, 2008, PROTEINS, V70, P1010, DOI 10.1002/prot.21588; Vicic DA, 2004, J AM CHEM SOC, V126, P8132, DOI 10.1021/ja047956k; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Weber K, 2012, J AM CHEM SOC, V134, P20745, DOI 10.1021/ja309563p; WHITEHEAD JP, 1993, J AM CHEM SOC, V115, P5629, DOI 10.1021/ja00066a032; Zhang XF, 2012, INORG CHEM, V51, P11017, DOI 10.1021/ic301506x	43	203	203	3	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 23	2015	520	7548					571	+		10.1038/nature14110	http://dx.doi.org/10.1038/nature14110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG5LX	25624102				2022-12-28	WOS:000353334500050
J	Dong, QF; Fang, YJ; Shao, YC; Mulligan, P; Qiu, J; Cao, L; Huang, JS				Dong, Qingfeng; Fang, Yanjun; Shao, Yuchuan; Mulligan, Padhraic; Qiu, Jie; Cao, Lei; Huang, Jinsong			Electron-hole diffusion lengths > 175 mu m in solution-grown CH3NH3PbI3 single crystals	SCIENCE			English	Article							HALIDE PEROVSKITES; SOLAR-CELL; MOBILITIES	Long, balanced electron and hole diffusion lengths greater than 100 nanometers in the polycrystalline organolead trihalide compound CH3NH3PbI3 are critical for highly efficient perovskite solar cells. We found that the diffusion lengths in CH3NH3PbI3 single crystals grown by a solution-growth method can exceed 175 micrometers under 1 sun (100 mW cm(-2)) illumination and exceed 3 millimeters under weak light for both electrons and holes. The internal quantum efficiencies approach 100% in 3-millimeter-thick single-crystal perovskite solar cells under weak light. These long diffusion lengths result from greater carrier mobility, longer lifetime, and much smaller trap densities in the single crystals than in polycrystalline thin films. The long carrier diffusion lengths enabled the use of CH3NH3PbI3 in radiation sensing and energy harvesting through the gammavoltaic effect, with an efficiency of 3.9% measured with an intense cesium-137 source.	[Dong, Qingfeng; Fang, Yanjun; Shao, Yuchuan; Huang, Jinsong] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Mulligan, Padhraic; Qiu, Jie; Cao, Lei] Ohio State Univ, Dept Mech & Aerosp Engn, Nucl Engn Program, Columbus, OH 43210 USA	University of Nebraska System; University of Nebraska Lincoln; University System of Ohio; Ohio State University	Huang, JS (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	jhuang2@unl.edu	Mulligan, Padhraic/AAS-3121-2021; Shao, Yuchuan/Y-2831-2019; Cao, Lei/B-3254-2012; Fang, Yanjun/AAM-3413-2020	Cao, Lei/0000-0003-4018-9496; Huang, Jinsong/0000-0002-0509-8778; Dong, Qingfeng/0000-0002-7618-6249; Mulligan, Padhraic/0000-0002-5826-5402	U.S. Department of Energy [DE-EE0006709]; Defense Threat Reduction Agency [HDTRA1-14-1-0030]	U.S. Department of Energy(United States Department of Energy (DOE)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Supported by U.S. Department of Energy award DE-EE0006709 (solar cell) and Defense Threat Reduction Agency award HDTRA1-14-1-0030 (radiation detector). J.H. conceived the idea and supervised the project; Q.D. grew the single crystals and fabricated the devices; Q.D., Y.F., and Y.S. conducted the electric and optical characterization of the devices; P.M., J.Q., and L.C. measured the devices under gamma ray irradiation and did the simulation; and J.H. wrote the paper.	Baikie T, 2013, J MATER CHEM A, V1, P5628, DOI 10.1039/c3ta10518k; BUBE RH, 1962, J APPL PHYS, V33, P1733, DOI 10.1063/1.1728818; Dong R, 2015, ADV MATER, V27, P1912, DOI 10.1002/adma.201405116; Kim J, 2014, J PHYS CHEM LETT, V5, P1312, DOI 10.1021/jz500370k; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Manser JS, 2014, NAT PHOTONICS, V8, P737, DOI [10.1038/nphoton.2014.171, 10.1038/NPHOTON.2014.171]; Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763; Noel NK, 2014, ACS NANO, V8, P9815, DOI 10.1021/nn5036476; Shkrob IA, 2014, J PHYS CHEM LETT, V5, P1066, DOI 10.1021/jz5004022; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Stranks SD, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.034007; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Tan ZK, 2014, NAT NANOTECHNOL, V9, P687, DOI [10.1038/nnano.2014.149, 10.1038/NNANO.2014.149]; Wehrenfennig C, 2014, ADV MATER, V26, P1584, DOI 10.1002/adma.201305172; Xiao ZG, 2014, ADV MATER, V26, P6503, DOI 10.1002/adma.201401685; Xing GC, 2014, NAT MATER, V13, P476, DOI [10.1038/NMAT3911, 10.1038/nmat3911]	16	3797	3843	121	2137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 27	2015	347	6225					967	970		10.1126/science.aaa5760	http://dx.doi.org/10.1126/science.aaa5760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB9NQ	25636799				2022-12-28	WOS:000349958900031
J	Rosenzweig, AC				Rosenzweig, Amy C.			BIOCHEMISTRY Breaking methane	NATURE			English	Editorial Material							DIAMOND CORE; INTERMEDIATE-Q; MONOOXYGENASE; ACTIVATION		[Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	amyr@northwestern.edu			NCI NIH HHS [P30 CA060553] Funding Source: Medline; NIGMS NIH HHS [R01 GM070473] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070473] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee R, 2015, NATURE, V518, P431, DOI 10.1038/nature14160; Culpepper MA, 2012, CRIT REV BIOCHEM MOL, V47, P483, DOI 10.3109/10409238.2012.697865; Haynes CA, 2014, NAT CHEM BIOL, V10, P331, DOI 10.1038/nchembio.1509; LEE SK, 1993, J BIOL CHEM, V268, P21569; Salmon R., 2013, FLARING N DAKOTA NAT; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473; Xue GQ, 2007, P NATL ACAD SCI USA, V104, P20713, DOI 10.1073/pnas.0708516105; Xue GQ, 2010, NAT CHEM, V2, P400, DOI [10.1038/NCHEM.586, 10.1038/nchem.586]	10	13	13	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					309	310		10.1038/nature14199	http://dx.doi.org/10.1038/nature14199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25607367	Green Accepted			2022-12-28	WOS:000349547400023
J	Crandall, CJ; Yildiz, V; Wactawski-Wende, J; Johnson, KC; Chen, Z; Going, SB; Wright, NC; Cauley, JA				Crandall, Carolyn J.; Yildiz, Vedat; Wactawski-Wende, Jean; Johnson, Karen C.; Chen, Zhao; Going, Scott B.; Wright, Nicole C.; Cauley, Jane A.			Postmenopausal weight change and incidence of fracture: post hoc findings from Women's Health Initiative Observational Study and Clinical Trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIP FRACTURE; WHITE WOMEN; RISK; OBESITY; INCREASE	OBJECTIVES To determine associations between postmenopausal change in body weight and incidence of fracture and associations between voluntary and involuntary weight loss and risk of fracture. DESIGN Post hoc analysis of data from the Women's Health Initiative Observational Study and Clinical Trials. SETTING 40 clinical centers in the United States. PARTICIPANTS 120 566 postmenopausal women, aged 50-79 at baseline (1993-98), followed through 2013 (mean fracture follow-up duration 11 years from baseline). EXPOSURES Annualized percentage change in measured body weight from baseline to year 3, classified as stable (<5% change), weight loss (>= 5%), or weight gain (>= 5%). Self assessment of whether weight loss was intentional or unintentional. Cox proportional hazards regression models were adjusted for age, race/ethnicity, baseline body mass index (BMI), smoking, alcohol intake, level of physical activity, energy expenditure, calcium and vitamin D intake, physical function score, oophorectomy, hysterectomy, previous fracture, comorbidity score, and drug use. MAIN OUTCOMES Incident self reported fractures of the upper limbs, lower limbs, and central body; hip fractures confirmed by medical records. RESULTS Mean participant age was 63.3. Mean annualized percent weight change was 0.30% (95% confidence interval 0.28 to 0.32). Overall, 79 279 (65.6%) had stable weight; 18 266 (15.2%) lost weight; and 23 021 (19.0%) gained weight. Compared with stable weight, weight loss was associated with a 65% higher incidence rates of fracture in hip (adjusted hazard ratio 1.65, 95% confidence interval 1.49 to 1.82), upper limb (1.09, 1.03 to 1.16), and central body (1.30, 1.20 to 1.39); weight gain was associated with higher incidence rates of fracture in upper limb (1.10, 1.05 to 1.18) and lower limb (1.18, 1.12 to 1.25). Compared with stable weight, unintentional weight loss was associated with a 33% higher incidence rates of hip fracture (1.33, 1.19 to 1.47) and increased incidence rates of vertebral fracture (1.16, 1.06 to 1.26); intentional weight loss was associated with increased incidence rates of lower limb fracture (1.11, 1.05 to 1.17) and decreased incidence of hip fracture (0.85, 0.76 to 0.95). CONCLUSIONS Weight gain, weight loss, and intentional weight loss are associated with increased incidence of fracture, but associations differ by fracture location. Clinicians should be aware of fracture patterns after weight gain and weight loss.	[Crandall, Carolyn J.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, UCLA Med GIM, Los Angeles, CA 90024 USA; [Yildiz, Vedat] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14214 USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN 38163 USA; [Chen, Zhao] Univ Arizona, Div Epidemiol & Biostat, Tucson, AZ USA; [Going, Scott B.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA; [Wright, Nicole C.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Cauley, Jane A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Tennessee System; University of Tennessee Health Science Center; University of Arizona; University of Arizona; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Crandall, CJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, UCLA Med GIM, 911 Broxton Ave,1st Floor, Los Angeles, CA 90024 USA.	ccrandall@mednet.ucla.edu	Cauley, Jane A/N-4836-2015; Wactawski-Wende, Jean/AGH-5457-2022	Cauley, Jane A/0000-0003-0752-4408; Wactawski-Wende, Jean/0000-0003-3096-9595; Wright, Nicole/0000-0001-8414-4842	National Heart, Lung, and Blood Institute, National Institutes or Health, US Department of Hearth and Human Services [HHSN268201100046C, HHSN268101100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032115] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes or Health, US Department of Hearth and Human Services; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes or Health, US Department of Hearth and Human Services through contracts HHSN268201100046C, HHSN268101100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. The builders had no role in the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Beck TJ, 2009, J BONE MINER RES, V24, P1369, DOI [10.1359/JBMR.090307, 10.1359/jbmr.090307]; Cauley JA, 2008, OSTEOPOROSIS INT, V19, P1717, DOI 10.1007/s00198-008-0634-y; Chen Z, 2004, MENOPAUSE, V11, P264, DOI 10.1097/01.GME.0000094210.15096.FD; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Ensrud KE, 2003, J AM GERIATR SOC, V51, P1740, DOI 10.1046/j.1532-5415.2003.51558.x; Ensrud KE, 1997, ARCH INTERN MED, V157, P857, DOI 10.1001/archinte.157.8.857; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Langlois JA, 1996, ARCH INTERN MED, V156, P989, DOI 10.1001/archinte.156.9.989; Langlois JA, 2001, OSTEOPOROSIS INT, V12, P763, DOI 10.1007/s001980170053; Omsland TK, 2009, OSTEOPOROSIS INT, V20, P2009, DOI 10.1007/s00198-009-0894-1; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Premaor MO, 2010, J BONE MINER RES, V25, P292, DOI 10.1359/jbmr.091004; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Seeley DG, 1996, J BONE MINER RES, V11, P1347; Sogaard AJ, 2012, OSTEOPOROSIS INT, V23, P2835, DOI 10.1007/s00198-012-1916-y; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Taveras EM, 2013, JAMA PEDIATR, V167, P731, DOI 10.1001/jamapediatrics.2013.85; US Department of Health and Human Services, 2004, BON HLTH OST REP SUR; Wilsgaard T, 2011, OSTEOPOROSIS INT, V22, P1237, DOI 10.1007/s00198-010-1318-y	21	67	67	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2015	350								h25	10.1136/bmj.h25	http://dx.doi.org/10.1136/bmj.h25			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZR	25627698	Green Published, hybrid			2022-12-28	WOS:000348775700004
J	Wherley, S; Chatterjee, S				Wherley, Susan; Chatterjee, Subhankar			India's growing problem of injecting drug misuse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIV PREVENTION; USERS; SERVICES; MANIPUR; AVAILABILITY; NAGALAND; PEOPLE		[Wherley, Susan] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA; [Chatterjee, Subhankar] RG Kar Med Coll & Hosp, Kolkata, W Bengal, India	University System of Ohio; Wright State University Dayton; RG Kar Medical College & Hospital	Chatterjee, S (corresponding author), RG Kar Med Coll & Hosp, Kolkata, W Bengal, India.	chatterjeeaspiresubhankar.92@gmail.com						Aceijas C, 2006, SEX TRANSM INFECT, V82, pIII10, DOI 10.1136/sti.2005.019471; Armstrong G, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-29; Bergenstrom A, 2013, OVERVIEW EPIDEMIOLOG; Corrigan Patrick W, 2009, World Psychiatry, V8, P75; Datta S, 2006, EMERG INFECT DIS, V12, P1954; India HIV/AIDS Alliance, 2014, HARSH DRUG LAWS UND; Jones D, 2013, INT J BEHAV MED, V20, P344, DOI 10.1007/s12529-012-9235-4; Larance B, 2011, DRUG ALCOHOL REV, V30, P246, DOI 10.1111/j.1465-3362.2011.00304.x; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Medhi GK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-64; Modi N, 2014, TEXT PRIME MINISTERS; Nagarajan R., 2014, TIMES INDIA; Petersen Z, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-13; Solomon SS, 2008, INDIAN J MED RES, V127, P447; Suohu K, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-40; Tun W, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-16; United Nations Office on Drugs and Crime, WORLD DRUG REP 2014; United Nations Office on Drugs and Crime, 2006, DRUG US NE STAT IND; United Nations Office on Drugs and Crime, WORLD DRUG REP 2010; United Nations Office on Drugs and Crime Government of India Ministry of Social Justice and Empowerment, 2004, INJ DRUG US HIV IND; US Department of Health and Human Services (HHS) Office of Disease Prevention and Health Promotion, 2010, HLTH PEOPL 2010 MIDC	21	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2015	350								h397	10.1136/bmj.h397	http://dx.doi.org/10.1136/bmj.h397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZR	25627257				2022-12-28	WOS:000348775700008
J	Alahdab, F; Saligram, S				Alahdab, Fares; Saligram, Shreyas			Acute Colonic Pseudo-Obstruction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Alahdab, Fares] Mayo Clin, Rochester, MN 55902 USA; [Saligram, Shreyas] Univ Kansas, Kansas City, KS USA	Mayo Clinic; University of Kansas	Alahdab, F (corresponding author), Mayo Clin, Rochester, MN 55902 USA.	fares.alahdab@gmail.com	Alahdab, Fares/N-6680-2013	Alahdab, Fares/0000-0001-5481-696X					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					E5	E5		10.1056/NEJMicm1311399	http://dx.doi.org/10.1056/NEJMicm1311399			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25607448				2022-12-28	WOS:000348204500001
J	Biswas, A; Oh, PI; Faulkner, GE; Bajaj, RR; Silver, MA; Mitchell, MS; Alter, DA				Biswas, Aviroop; Oh, Paul I.; Faulkner, Guy E.; Bajaj, Ravi R.; Silver, Michael A.; Mitchell, Marc S.; Alter, David A.			Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RECREATIONAL PHYSICAL-ACTIVITY; TYPE-2 DIABETES-MELLITUS; TELEVISION VIEWING TIME; ALL-CAUSE MORTALITY; SITTING TIME; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; CANCER; BEHAVIORS; SPENT	Background: The magnitude, consistency, and manner of association between sedentary time and outcomes independent of physical activity remain unclear. Purpose: To quantify the association between sedentary time and hospitalizations, all-cause mortality, cardiovascular disease, diabetes, and cancer in adults independent of physical activity. Data Sources: English-language studies in MEDLINE, PubMed, EMBASE, CINAHL, Cochrane Library, Web of Knowledge, and Google Scholar databases were searched through August 2014 with hand-searching of in-text citations and no publication date limitations. Study Selection: Studies assessing sedentary behavior in adults, adjusted for physical activity and correlated to at least 1 outcome. Data Extraction: Two independent reviewers performed data abstraction and quality assessment, and a third reviewer resolved inconsistencies. Data Synthesis: Forty-seven articles met our eligibility criteria. Meta-analyses were performed on outcomes for cardiovascular disease and diabetes (14 studies), cancer (14 studies), and all-cause mortality (13 studies). Prospective cohort designs were used in all but 3 studies; sedentary times were quantified using self-report in all but 1 study. Significant hazard ratio (HR) associations were found with all-cause mortality (HR, 1.240 [95% CI, 1.090 to 1.410]), cardiovascular disease mortality (HR, 1.179 [CI, 1.106 to 1.257]), cardiovascular disease incidence (HR, 1.143 [CI, 1.002 to 1.729]), cancer mortality (HR, 1.173 [CI, 1.108 to 1.242]), cancer incidence (HR, 1.130 [CI, 1.053 to 1.213]), and type 2 diabetes incidence (HR, 1.910 [CI, 1.642 to 2.222]). Hazard ratios associated with sedentary time and outcomes were generally more pronounced at lower levels of physical activity than at higher levels. Limitation: There was marked heterogeneity in research designs and the assessment of sedentary time and physical activity. Conclusion: Prolonged sedentary time was independently associated with deleterious health outcomes regardless of physical activity.	[Biswas, Aviroop] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Oh, Paul I.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M4G 1R7, Canada; [Faulkner, Guy E.; Mitchell, Marc S.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5S 2W6, Canada; [Bajaj, Ravi R.] Sunnybrook Hlth Sci Ctr, Dept Cardiol, Toronto, ON M4N 3A5, Canada; [Silver, Michael A.] York Univ, Osgoode Hall Law Sch, N York, ON M3J 1P3, Canada; [Alter, David A.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; York University - Canada; University of Toronto	Alter, DA (corresponding author), Inst Clin Evaluat Sci, 2075 Bayview Ave,G1-06, Toronto, ON M4N 3M5, Canada.	dalter@ices.on.ca	Mitchell, Marc/ABC-3562-2021; Faulkner, Guy/ABE-6536-2020	Mitchell, Marc/0000-0002-2772-9614; Oh, Paul/0000-0002-0603-6958	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research-Public Health Agency of Canada (CIHR-PHAC) Chair in Applied Public Health; Goodlife Fitness Chair in Cardiovascular Rehabilitation and Prevention, University Health Network-Toronto Rehabilitation Institute, University of Toronto	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research-Public Health Agency of Canada (CIHR-PHAC) Chair in Applied Public Health(Canadian Institutes of Health Research (CIHR)); Goodlife Fitness Chair in Cardiovascular Rehabilitation and Prevention, University Health Network-Toronto Rehabilitation Institute, University of Toronto	Dr. Alter is supported with a career investigator award from the Heart and Stroke Foundation of Canada. Dr Faulkner is supported with a Canadian Institutes of Health Research-Public Health Agency of Canada (CIHR-PHAC) Chair in Applied Public Health. Dr. Oh is supported with a Goodlife Fitness Chair in Cardiovascular Rehabilitation and Prevention, University Health Network-Toronto Rehabilitation Institute, University of Toronto.	Ainsworth BE, 2012, PHYSICAL ACTIVITY AND PUBLIC HEALTH PRACTICE, pVII; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Tran B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093111; Campbell PT, 2013, J CLIN ONCOL, V31, P876, DOI 10.1200/JCO.2012.45.9735; Canadian Society for Exercise Physiology, 2013, CAN PHYS ACT GUID CA; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Colley R. C., 2011, HLTH REPORTS, V22, P15; Craft LL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-122; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford ES, 2010, J DIABETES, V2, P23, DOI 10.1111/j.1753-0407.2009.00047.x; Friberg E, 2006, CANCER EPIDEM BIOMAR, V15, P2136, DOI 10.1158/1055-9965.EPI-06-0465; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; George SM, 2010, AM J PUBLIC HEALTH, V100, P2288, DOI 10.2105/AJPH.2009.180828; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hildebrand JS, 2013, CANCER EPIDEM BIOMAR, V22, P1906, DOI 10.1158/1055-9965.EPI-13-0407; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Howard R, 2008, PEDIATR ANESTH, V18, P19, DOI 10.1111/j.1460-9592.2008.02430.x; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kim Y, 2013, INT J EPIDEMIOL, V42, P1040, DOI 10.1093/ije/dyt108; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Krishnan S, 2009, AM J EPIDEMIOL, V169, P428, DOI 10.1093/aje/kwn344; Lee IM, 2003, CIRCULATION, V107, P1110, DOI 10.1161/01.CIR.0000052626.63602.58; Leon-Munoz LM, 2013, MED SCI SPORT EXER, V45, P1501, DOI 10.1249/MSS.0b013e3182897e87; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Pavey TG, 2015, BRIT J SPORT MED, V49, P95, DOI 10.1136/bjsports-2012-091676; Peplonska B, 2008, EPIDEMIOLOGY, V19, P226, DOI 10.1097/EDE.0b013e3181633bfb; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Schmid D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju098; Scott JM, 2007, APPL PHYSIOL NUTR ME, V32, P332, DOI 10.1139/H06-087; Seguin R, 2014, AM J PREV MED, V46, P122, DOI 10.1016/j.amepre.2013.10.021; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sorensen JB, 2006, SCAND J PRIM HEALTH, V24, P69, DOI 10.1080/02813430600700027; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Teras LR, 2012, INT J CANCER, V131, P1912, DOI 10.1002/ijc.27445; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Whaley M., 2006, ACSMS GUIDELINES EXE; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Wisse Willeke, 2010, Diabetes Res Clin Pract, V88, pe10, DOI 10.1016/j.diabres.2010.01.015; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang M, 2004, CANCER CAUSE CONTROL, V15, P83, DOI 10.1023/B:CACO.0000016633.47025.2a	61	1519	1552	20	333	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					123	+		10.7326/M14-1651	http://dx.doi.org/10.7326/M14-1651			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599350				2022-12-28	WOS:000350106600018
J	Staud, R				Staud, Roland			Patients with polymyalgia rheumatica had a 2.6-fold increased risk for vascular events at a median 7.8 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ARTERITIS		Univ Florida, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Staud, R (corresponding author), Univ Florida, Gainesville, FL 32611 USA.		Staud, Roland/A-8442-2008					Dasgupta B, 2012, ARTHRITIS RHEUM-US, V64, P943, DOI 10.1002/art.34356; Gran JT, 2001, RHEUMATOLOGY, V40, P1238, DOI 10.1093/rheumatology/40.11.1238; Hancock AT, 2012, ARTHRIT CARE RES, V64, P1301, DOI 10.1002/acr.21712; WEYAND CM, 1994, ARTHRITIS RHEUM, V37, P514, DOI 10.1002/art.1780370411	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC12	10.7326/ACPJC-2015-162-2-012	http://dx.doi.org/10.7326/ACPJC-2015-162-2-012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599360				2022-12-28	WOS:000350106600011
J	Leslie, SJ; Cimpian, A; Meyer, M; Freeland, E				Leslie, Sarah-Jane; Cimpian, Andrei; Meyer, Meredith; Freeland, Edward			Expectations of brilliance underlie gender distributions across academic disciplines	SCIENCE			English	Article							PERFORMANCE; INTELLIGENCE; ACHIEVEMENT; PERSPECTIVE; SCIENCE	The gender imbalance in STEM subjects dominates current debates about women's underrepresentation in academia. However, women are well represented at the Ph.D. level in some sciences and poorly represented in some humanities (e.g., in 2011, 54% of U.S. Ph.D.'s in molecular biology were women versus only 31% in philosophy). We hypothesize that, across the academic spectrum, women are underrepresented in fields whose practitioners believe that raw, innate talent is the main requirement for success, because women are stereotyped as not possessing such talent. This hypothesis extends to African Americans' underrepresentation as well, as this group is subject to similar stereotypes. Results from a nationwide survey of academics support our hypothesis (termed the field-specific ability beliefs hypothesis) over three competing hypotheses.	[Leslie, Sarah-Jane] Princeton Univ, Dept Philosophy, Princeton, NJ 08544 USA; [Cimpian, Andrei] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Meyer, Meredith] Otterbein Univ, Dept Psychol, Westerville, OH 43081 USA; [Freeland, Edward] Princeton Univ, Survey Res Ctr, Princeton, NJ 08544 USA	Princeton University; University of Illinois System; University of Illinois Urbana-Champaign; Otterbein University; Princeton University	Leslie, SJ (corresponding author), Princeton Univ, Dept Philosophy, Princeton, NJ 08544 USA.	sjleslie@princeton.edu; acimpian@illinois.edu	Cimpian, Andrei/X-4605-2019	Cimpian, Andrei/0000-0002-3553-6097	NSF [BCS-1226942]; Spencer Foundation [201100111]	NSF(National Science Foundation (NSF)); Spencer Foundation	We thank E. Anastasia, R. Baillargeon, R. Bigler, C. Chaudhry, R. Fusello, E. Harman, M. Johnston, Y. Lee, S. Lubienski, A. Penner, H. Perhai, E. Pomerantz, J. Robinson-Cimpian, and the members of the Cognitive Development Lab, University of Illinois at Urbana-Champaign. We also thank five anonymous reviewers for their comments. This work was supported by NSF grant BCS-1226942 to S.-J.L. and by Spencer Foundation grant 201100111 to A. C. The data are available in the SM, with values for the primary variables given in table S4. The SM contains additional data.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Bennett M, 1996, J SOC PSYCHOL, V136, P411, DOI 10.1080/00224545.1996.9714021; Bethlehem J, 2010, INT STAT REV, V78, P161, DOI 10.1111/j.1751-5823.2010.00112.x; Billington J, 2007, LEARN INDIVID DIFFER, V17, P260, DOI 10.1016/j.lindif.2007.02.004; Ceci S.J., 2007, WHY ARENT MORE WOMEN, DOI 10.1037/11546-000; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Dar-Nimrod I, 2006, SCIENCE, V314, P435, DOI 10.1126/science.1131100; Dweck C.S., 2006, MINDSET NEW PSYCHOL; Educational Testing Service, 2012, GRE GUID US SCOR; Ferriman K, 2009, J PERS SOC PSYCHOL, V97, P517, DOI 10.1037/a0016030; Geary D.C., 2010, MALE FEMALE EVOLUTIO; Gould S. J., 1996, MISMEASURE MAN; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Kirkcaldy B, 2007, EUR PSYCHOL, V12, P173, DOI 10.1027/1016-9040.12.3.173; Lecklider Aaron., 2013, INVENTING EGGHEAD; Lippa R, 1998, J PERS SOC PSYCHOL, V74, P996, DOI 10.1037/0022-3514.74.4.996; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P1001, DOI 10.2307/2290792; National Science Foundation, 2011, SURV EARN DOCT; Penner AM, 2008, AM J SOCIOL, V114, pS138, DOI 10.1086/589252; Shih M, 1999, PSYCHOL SCI, V10, P80, DOI 10.1111/1467-9280.00111; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Tiedemann J., 2000, EDUC STUD MATH, V41, P191, DOI [DOI 10.1023/A:1003953801526, 10.1023/A:1003953801526]; Valian V, 1998, WHY SO SLOW ADVANCEM; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015	27	608	614	19	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					262	265		10.1126/science.1261375	http://dx.doi.org/10.1126/science.1261375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AZ0DA	25593183				2022-12-28	WOS:000347915300033
J	McCauley, DJ; Pinsky, ML; Palumbi, SR; Estes, JA; Joyce, FH; Warner, RR				McCauley, Douglas J.; Pinsky, Malin L.; Palumbi, Stephen R.; Estes, James A.; Joyce, Francis H.; Warner, Robert R.			Marine defaunation: Animal loss in the global ocean	SCIENCE			English	Review							CORAL-REEFS; PROTECTED AREAS; CLIMATE-CHANGE; FISH; IMPACTS; CONSERVATION; EVOLUTION; ECOLOGY; DECLINE; EXTINCTIONS	Marine defaunation, or human-caused animal loss in the oceans, emerged forcefully only hundreds of years ago, whereas terrestrial defaunation has been occurring far longer. Though humans have caused few global marine extinctions, we have profoundly affected marine wildlife, altering the functioning and provisioning of services in every ocean. Current ocean trends, coupled with terrestrial defaunation lessons, suggest that marine defaunation rates will rapidly intensify as human use of the oceans industrializes. Though protected areas are a powerful tool to harness ocean productivity, especially when designed with future climate in mind, additional management strategies will be required. Overall, habitat degradation is likely to intensify as a major driver of marine wildlife loss. Proactive intervention can avert a marine defaunation disaster of the magnitude observed on land.	[McCauley, Douglas J.; Joyce, Francis H.; Warner, Robert R.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Pinsky, Malin L.] Rutgers State Univ, Inst Marine & Coastal Sci, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Palumbi, Stephen R.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Estes, James A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA	University of California System; University of California Santa Barbara; Rutgers State University New Brunswick; Stanford University; University of California System; University of California Santa Cruz	McCauley, DJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	douglas.mccauley@lifesci.ucsb.edu	Pinsky, Malin L./K-2884-2015	Pinsky, Malin L./0000-0002-8523-8952; Joyce, Francis/0000-0002-6699-1842	National Science Foundation; Gordon and Betty Moore Foundation; Division Of Ocean Sciences [1426891, 1430218] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank A. Barnosky, N. Dulvy, M. Galetti, C. Golden, T. Rogier, E. Selig, T. White, the World Database on Protected Areas, B. Worm, and H. Young. Figure images were contributed by T. Llobet, A. Musser, and IAN/UMCES (112). Funding was provided by the National Science Foundation and the Gordon and Betty Moore Foundation.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2014, ANTHROPOCENE REV, V1, P225, DOI 10.1177/2053019614547433; Boyce DG, 2014, PROG OCEANOGR, V122, P163, DOI 10.1016/j.pocean.2014.01.004; Branch TA, 2013, TRENDS ECOL EVOL, V28, P178, DOI 10.1016/j.tree.2012.10.001; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2014, SCIENCE, V345, P376, DOI 10.1126/science.1256734; Britten GL, 2014, ECOL LETT, V17, P1518, DOI 10.1111/ele.12354; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Carr MH, 2003, ECOL APPL, V13, pS90; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davis JS, 2007, ENVIRON PLANN D, V25, P213, DOI 10.1068/d1405; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Dulvy Nicholas K., 2009, P129; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Estes J. A., 2006, WHALES WHALING AND O; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FAO, 2007, FAO FORESTRY PAPER 1; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Fisheries and Aquaculture Department FAO, 2012, THE STATE OF WORLD F; Fowler S. L., 2005, SHARKS RAYS AND CHIM, pS; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hutchings JA, 2010, CAN J FISH AQUAT SCI, V67, P1205, DOI 10.1139/F10-081; International Seabed Authority Contractors., CONTRACTORS; IUCN, 2014, THE IUCN RED LIST OF; IUCN (International Union for Conservation of Nature), 2013, THE IUCN RED LIST OF; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Jimenez JE, 1996, BIOL CONSERV, V77, P1, DOI 10.1016/0006-3207(95)00116-6; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; KAY EA, 1987, TRENDS ECOL EVOL, V2, P183, DOI 10.1016/0169-5347(87)90017-6; Kenyon KW, 1969, N AMER FAUNA, V68, P1, DOI DOI 10.3996/NAFA.68.0001; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; McCauley DJ, 2006, ECOLOGY, V87, P2657, DOI 10.1890/0012-9658(2006)87[2657:IEOLHO]2.0.CO;2; Mccauley DJ, 2014, CONSERV BIOL, V28, P1312, DOI 10.1111/cobi.12314; McCauley DJ, 2014, MAR BIOL, V161, P1987, DOI 10.1007/s00227-014-2478-7; McCauley DJ, 2013, BIOL CONSERV, V165, P139, DOI 10.1016/j.biocon.2013.05.026; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; McCauley DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00409; McCauley DJ, 2010, MAR BIOL, V157, P2739, DOI 10.1007/s00227-010-1533-2; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Mengerink KJ, 2014, SCIENCE, V344, P696, DOI 10.1126/science.1251458; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; Palumbi S. R., 2010, THE DEATH AND LIFE O; Palumbi S. R., 2014, THE EXTREME LIFE OF; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pillay R, 2011, BIOL CONSERV, V144, P1567, DOI 10.1016/j.biocon.2011.01.026; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Qiu WF, 2013, MAR POLICY, V39, P182, DOI 10.1016/j.marpol.2012.10.010; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reeves R. R., 2010, MAR FISH REV, V72, P1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roman J, 2014, FRONT ECOL ENVIRON, V12, P377, DOI 10.1890/130220; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Sale PF, 2011, AMBIO, V40, P4, DOI 10.1007/s13280-010-0092-6; Saxby T., IAN IMAGE AND VIDEO; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; TERBORGH J, 2013, TROPHIC CASCADES PRE; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; The World Bank, 2013, FISH TO 2030 PROSPEC, P1; The World Bank, CONTAINER PORT TRAFF; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Turvey ST, 2009, HOLOCENE EXTINCTIONS; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; White C, 2012, P NATL ACAD SCI USA, V109, P4696, DOI 10.1073/pnas.1114215109; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; WWF, 2012, LIVING PLANET REPORT; Young HS, 2014, P NATL ACAD SCI USA, V111, P7036, DOI 10.1073/pnas.1404958111	117	688	699	36	863	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219							1255641	10.1126/science.1255641	http://dx.doi.org/10.1126/science.1255641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593191	Green Published			2022-12-28	WOS:000347915300028
J	Neppl, S; Ernstorfer, R; Cavalieri, AL; Lemell, C; Wachter, G; Magerl, E; Bothschafter, EM; Jobst, M; Hofstetter, M; Kleineberg, U; Barth, JV; Menzel, D; Burgdorfer, J; Feulner, P; Krausz, F; Kienberger, R				Neppl, S.; Ernstorfer, R.; Cavalieri, A. L.; Lemell, C.; Wachter, G.; Magerl, E.; Bothschafter, E. M.; Jobst, M.; Hofstetter, M.; Kleineberg, U.; Barth, J. V.; Menzel, D.; Burgdoerfer, J.; Feulner, P.; Krausz, F.; Kienberger, R.			Direct observation of electron propagation and dielectric screening on the atomic length scale	NATURE			English	Article							METAL-SURFACES; PHOTOEMISSION; SPECTROSCOPY	The propagation and transport of electrons in crystals is a fundamental process pertaining to the functioning of most electronic devices. Microscopic theories describe this phenomenon as being based on the motion of Bloch wave packets(1). These wave packets are superpositions of individual Bloch states with the group velocity determined by the dispersion of the electronic band structure near the central wavevector in momentum space1. This concept has been verified experimentally in artificial superlattices by the observation of Bloch oscillations(2)-periodic oscillations of electrons in real and momentum space. Here we present a direct observation of electron wave packet motion in a real-space and real-time experiment, on length and time scales shorter than the Bloch oscillation amplitude and period. We show that attosecond metrology(3) (1 as=10(-18) seconds) now enables quantitative insight into weakly disturbed electron wave packet propagation on the atomic length scale without being hampered by scattering effects, which inevitably occur over macroscopic propagation length scales. Weuse sub-femtosecond(less than 10(-15) seconds) extreme-ultraviolet light pulses(3) to launch photoelectron wave packets inside a tungsten crystal that is covered by magnesium films of varied, well-defined thicknesses of a few angstroms(4). Probing the moment of arrival of the wave packets at the surface with attosecond precision reveals free-electron-like, ballistic propagation behaviour inside the magnesium adlayer-constituting the semi-classical limit of Bloch wave packet motion. Real-time access to electron transport through atomic layers and interfaces promises unprecedented insight into phenomena that may enable the scaling of electronic and photonic circuits to atomic dimensions. In addition, this experiment allows us to determine the penetration depth of electrical fields at optical frequencies at solid interfaces on the atomic scale.	[Neppl, S.; Jobst, M.; Barth, J. V.; Menzel, D.; Feulner, P.; Kienberger, R.] Tech Univ Munich, Dept Phys, D-85747 Garching, Germany; [Neppl, S.; Magerl, E.; Jobst, M.; Hofstetter, M.; Kleineberg, U.; Krausz, F.; Kienberger, R.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Ernstorfer, R.; Menzel, D.] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Cavalieri, A. L.] Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany; [Cavalieri, A. L.] Univ Hamburg, Fak Math Informat & Nat Wissensch, D-22761 Hamburg, Germany; [Cavalieri, A. L.] Ctr Free Electron Laser Sci CFEL, D-22761 Hamburg, Germany; [Lemell, C.; Wachter, G.; Burgdoerfer, J.] Vienna Univ Technol, Inst Theoret Phys, A-1040 Vienna, Austria; [Bothschafter, E. M.; Hofstetter, M.; Kleineberg, U.; Krausz, F.] Univ Munich, Fak Phys, D-85748 Garching, Germany; [Burgdoerfer, J.] Hungarian Acad Sci ATOMKI, Inst Nucl Res, H-4001 Debrecen, Hungary	Technical University of Munich; Max Planck Society; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Max Planck Society; University of Hamburg; Technische Universitat Wien; University of Munich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Hungarian Institute for Nuclear Research	Neppl, S (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA.	sneppl@lbl.gov; reinhard.kienberger@tum.de	Bothschafter, Elisabeth/D-4021-2016; BARTH, Johannes V/E-4060-2013; Ernstorfer, Ralph/D-1590-2009; Lemell, Christoph/B-5147-2009	BARTH, Johannes V/0000-0002-6270-2150; Ernstorfer, Ralph/0000-0001-6665-3520; Lemell, Christoph/0000-0003-2560-4495; Kienberger, Reinhard/0000-0001-8781-3685; Neppl, Stefan/0000-0003-0536-1932; Menzel, Dietrich/0000-0002-7188-8532	Munich-Centre for Advanced Photonics; FWF special research programs [SFB-041, SFB-049, P21141-N16]; International Max Planck Research School for Advanced Photon Science (IMPRS-APS); ERC; Helmholtz Zentrum Berlin; Austrian Science Fund (FWF) [P 23359] Funding Source: researchfish	Munich-Centre for Advanced Photonics; FWF special research programs; International Max Planck Research School for Advanced Photon Science (IMPRS-APS); ERC(European Research Council (ERC)European Commission); Helmholtz Zentrum Berlin; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Munich-Centre for Advanced Photonics. C.L., G.W. and J.B. acknowledge support by the FWF special research programs SFB-041 (ViCoM) and SFB-049 (NextLite) and project P21141-N16. G.W. is supported by the International Max Planck Research School for Advanced Photon Science (IMPRS-APS). R.K. acknowledges an ERC Starting Grant Calculations have been performed on the Vienna Scientific Cluster. S.N. and P.F. thank the Helmholtz Zentrum Berlin for support. We thank P. Echenique, E. E. Krasovskii, A. Kazansky and A. D. Sanchez-Portal for discussions.	Aballe L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115411; BARTYNSKI RA, 1986, PHYS REV B, V33, P3644, DOI 10.1103/PhysRevB.33.3644; BERGLUND CN, 1964, PHYS REV A-GEN PHYS, V136, P1030; Bloch F, 1929, Z PHYS, V52, P555, DOI 10.1007/BF01339455; Borisov G., 2013, PHYS REV B, V87; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; FEIBELMAN PJ, 1974, PHYS REV B, V10, P4932, DOI 10.1103/PhysRevB.10.4932; Gremillet L, 1999, PHYS REV LETT, V83, P5015, DOI 10.1103/PhysRevLett.83.5015; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Kazansky AK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.177401; Krasovskii EE, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195106; KROEMER H, 1975, P IEEE, V63, P988, DOI 10.1109/PROC.1975.9871; LANG ND, 1973, PHYS REV B, V7, P3541, DOI 10.1103/PhysRevB.7.3541; Lemell C, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062901; LEO K, 1992, SOLID STATE COMMUN, V84, P943, DOI 10.1016/0038-1098(92)90798-E; Liao Q, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.023602; LIEBSCH A, 1987, PHYS SCRIPTA, V35, P354, DOI 10.1088/0031-8949/35/3/022; Mahan GD, 1970, PHYS REV B-SOLID ST, V2, P4334, DOI 10.1103/PhysRevB.2.4334; Neppl S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.087401; Schiller F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125106; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; SHA W, 1991, PHYS REV LETT, V67, P2553, DOI 10.1103/PhysRevLett.67.2553; SHA WJ, 1992, IEEE J QUANTUM ELECT, V28, P2445, DOI 10.1109/3.159551; Shaner EA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.037402; Tanuma S, 2011, SURF INTERFACE ANAL, V43, P689, DOI 10.1002/sia.3522; Vinogradov NA, 2009, PHYS SOLID STATE+, V51, P179, DOI 10.1134/S1063783409010235; Wachter G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035402; Zhang CH, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.033401; Zhang CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.123601; Zhang C. H., 2011, PHYS REV A, V84, P1	30	127	129	3	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					342	346		10.1038/nature14094	http://dx.doi.org/10.1038/nature14094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592539	Green Submitted			2022-12-28	WOS:000347810300040
J	Woodhead, J				Woodhead, Jon			Mixing it up in the mantle	NATURE			English	Editorial Material							OCEANIC-CRUST; FRACTIONATION; EVOLUTION; ISOTOPES; LAVAS		Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia	University of Melbourne	Woodhead, J (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	jdwood@unimelb.edu.au		Woodhead, Jon/0000-0002-7614-0136				Andersen MB, 2015, NATURE, V517, P356, DOI 10.1038/nature14062; Cabral RA, 2013, NATURE, V496, P490, DOI 10.1038/nature12020; CHASE CG, 1981, EARTH PLANET SC LETT, V52, P277, DOI 10.1016/0012-821X(81)90182-5; Elliott T, 1999, EARTH PLANET SC LETT, V169, P129, DOI 10.1016/S0012-821X(99)00077-1; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Stirling CH, 2007, EARTH PLANET SC LETT, V264, P208, DOI 10.1016/j.epsl.2007.09.019; Stracke A, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000223; Weyer S, 2008, GEOCHIM COSMOCHIM AC, V72, P345, DOI 10.1016/j.gca.2007.11.012; Workman RK, 2008, GEOLOGY, V36, P551, DOI 10.1130/G24558A.1	9	1	1	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					275	276		10.1038/517275a	http://dx.doi.org/10.1038/517275a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592529				2022-12-28	WOS:000347810300025
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Combination of exercise and social interaction is why I love parkrun	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Mahtani KR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002058; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Stevinson C, 2014, J PUBLIC HEALTH-UK, V36, P268, DOI 10.1093/pubmed/fdt082	4	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2015	350								h230	10.1136/bmj.h230	http://dx.doi.org/10.1136/bmj.h230			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3NA	25591884	Bronze			2022-12-28	WOS:000348133000018
J	Fontanarosa, PB; Bauchner, H				Fontanarosa, Phil B.; Bauchner, Howard			Scientific Discovery and the Future of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Fontanarosa, PB (corresponding author), 330 N Wabash Ave, Chicago, IL 60611 USA.	phil.fontanarosa@jamanetwork.org						Collins FS, 2015, JAMA-J AM MED ASSOC, V313, P131, DOI 10.1001/jama.2014.16736; Dzau VJ, 2015, JAMA-J AM MED ASSOC, V313, P143, DOI 10.1001/jama.2014.17660; Langer R, 2015, JAMA-J AM MED ASSOC, V313, P135, DOI 10.1001/jama.2014.16315; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Tjian R, 2015, JAMA-J AM MED ASSOC, V313, P133, DOI 10.1001/jama.2014.16543; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	6	14	14	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					145	146		10.1001/jama.2014.17937	http://dx.doi.org/10.1001/jama.2014.17937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585325				2022-12-28	WOS:000347679300013
J	Bensdorp, AJ; Tjon-Kon-Fat, RI; Bossuyt, PMM; Koks, CAM; Oosterhuis, GJE; Hoek, A; Hompes, PGA; Broekmans, FJM; Verhoeve, HR; de Bruin, JP; van Golde, R; Repping, S; Cohlen, BJ; Lambers, MDA; van Bommel, PF; Slappendel, E; Perquin, D; Smeenk, JM; Pelinck, MJ; Gianotten, J; Hoozemans, DA; Maas, JWM; Eijkemans, MJC; van der Veen, F; Mol, BWJ; van Wely, M				Bensdorp, A. J.; Tjon-Kon-Fat, R. I.; Bossuyt, P. M. M.; Koks, C. A. M.; Oosterhuis, G. J. E.; Hoek, A.; Hompes, P. G. A.; Broekmans, F. J. M.; Verhoeve, H. R.; de Bruin, J. P.; van Golde, R.; Repping, S.; Cohlen, B. J.; Lambers, M. D. A.; van Bommel, P. F.; Slappendel, E.; Perquin, D.; Smeenk, J. M.; Pelinck, M. J.; Gianotten, J.; Hoozemans, D. A.; Maas, J. W. M.; Eijkemans, M. J. C.; van der Veen, F.; Mol, B. W. J.; van Wely, M.			Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL COMMITTEE; IVF; STIMULATION; INFERTILITY; RATES; PROGNOSIS; NUMBER	Objectives To compare the effectiveness of in vitro fertilisation with single embryo transfer or in vitro fertilisation in a modified natural cycle with that of intrauterine insemination with controlled ovarian hyperstimulation in terms of a healthy child. Design Multicentre, open label, three arm, parallel group, randomised controlled non-inferiority trial. Setting 17 centres in the Netherlands. Participants Couples seeking fertility treatment after at least 12 months of unprotected intercourse, with the female partner aged between 18 and 38 years, an unfavourable prognosis for natural conception, and a diagnosis of unexplained or mild male subfertility. Interventions Three cycles of in vitro fertilisation with single embryo transfer (plus subsequent cryocycles), six cycles of in vitro fertilisation in a modified natural cycle, or six cycles of intrauterine insemination with ovarian hyperstimulation within 12 months after randomisation. Main outcome measures The primary outcome was birth of a healthy child resulting from a singleton pregnancy conceived within 12 months after randomisation. Secondary outcomes were live birth, clinical pregnancy, ongoing pregnancy, multiple pregnancy, time to pregnancy, complications of pregnancy, and neonatal morbidity and mortality Results 602 couples were randomly assigned between January 2009 and February 2012; 201 were allocated to in vitro fertilisation with single embryo transfer, 194 to in vitro fertilisation in a modified natural cycle, and 207 to intrauterine insemination with controlled ovarian hyperstimulation. Birth of a healthy child occurred in 104 (52%) couples in the in vitro fertilisation with single embryo transfer group, 83 (43%) in the in vitro fertilisation in a modified natural cycle group, and 97 (47%) in the intrauterine insemination with controlled ovarian hyperstimulation group. This corresponds to a risk, relative to intrauterine insemination with ovarian hyperstimulation, of 1.10 (95% confidence interval 0.91 to 1.34) for in vitro fertilisation with single embryo transfer and 0.91 (0.73 to 1.14) for in vitro fertilisation in a modified natural cycle. These 95% confidence intervals do not extend below the predefined threshold of 0.69 for inferiority. Multiple pregnancy rates per ongoing pregnancy were 6% (7/121) after in vitro fertilisation with single embryo transfer, 5% (5/102) after in vitro fertilisation in a modified natural cycle, and 7% (8/119) after intrauterine insemination with ovarian hyperstimulation (one sided P=0.52 for in vitro fertilisation with single embryo transfer compared with intrauterine insemination with ovarian hyperstimulation; one sided P= 0.33 for in vitro fertilisation in a modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation). Conclusions In vitro fertilisation with single embryo transfer and in vitro fertilisation in a modified natural cycle were non-inferior to intrauterine insemination with controlled ovarian hyperstimulation in terms of the birth of a healthy child and showed comparable, low multiple pregnancy rates.	[Bensdorp, A. J.; Tjon-Kon-Fat, R. I.; Repping, S.; van der Veen, F.; van Wely, M.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1100 DD Amsterdam, Netherlands; [Bossuyt, P. M. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DD Amsterdam, Netherlands; [Koks, C. A. M.; Maas, J. W. M.] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Oosterhuis, G. J. E.] St Antonius Hosp, Nieuwegein, Netherlands; [Hoek, A.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands; [Hompes, P. G. A.] Vrije Univ Amsterdam, Med Ctr, Ctr Reprod Med, Amsterdam, Netherlands; [Broekmans, F. J. M.] Univ Med Ctr Utrecht, Dept Reprod Med, Utrecht, Netherlands; [Verhoeve, H. R.] Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [de Bruin, J. P.] Jeroen Bosch Hosp, Dept Obstet & Gynaecol, Shertogenbosch, Netherlands; [van Golde, R.] Univ Med Ctr Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands; [Cohlen, B. J.] Isala Clin, Dept Obstet & Gynaecol, Zwolle, Netherlands; [Lambers, M. D. A.] Albert Schweitzer Hosp, Dept Obstet & Gynaecol, Dordrecht, Netherlands; [van Bommel, P. F.] Amphia Hosp, Dept Obstet & Gynaecol, Breda, Netherlands; [Slappendel, E.] Catharina Hosp, Dept Obstet & Gynaecol, Eindhoven, Netherlands; [Perquin, D.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Smeenk, J. M.] Elisabeth Hosp, Dept Obstet & Gynaecol, Tilburg, Netherlands; [Pelinck, M. J.] Scheper Hosp, Dept Obstet & Gynaecol, Emmen, Netherlands; [Gianotten, J.] Kennemer Gasthuis, Dept Obstet & Gynaecol, Haarlem, Netherlands; [Hoozemans, D. A.] Med Spectrum Twente, Dept Obstet & Gynaecol, Enschede, Netherlands; [Eijkemans, M. J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Mol, B. W. J.] Univ Adelaide, Robinson Res Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maxima Medical Center; St. Antonius Hospital Utrecht; University of Groningen; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Onze Lieve Vrouwe Gasthuis Hospital; Jeroen Bosch Ziekenhuis; Maastricht University; Maastricht University Medical Centre (MUMC); Isala Clinics; Albert Schweitzer Ziekenhuis; Amphia Hospital; Catharina Hospital; Medical Center Leeuwarden; Elisabeth-TweeSteden Ziekenhuis (ETZ); Spaarne Hospital; Medical Spectrum Twente; Utrecht University; Utrecht University Medical Center; Robinson Research Institute; University of Adelaide	van Wely, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1100 DD Amsterdam, Netherlands.	m.vanwely@amc.nl	Bossuyt, Patrick M./B-4557-2016; van Wely, Madelon/GXV-1757-2022; Bossuyt, Patrick M/AAR-1183-2021	Bossuyt, Patrick M./0000-0003-4427-0128; Bossuyt, Patrick M/0000-0003-4427-0128; Repping, Sjoerd/0000-0002-6959-149X	ZonMW, the Dutch Organization for Health Research and Development [120620027]; Zorgverzekeraars Nederland, the Dutch association of healthcare insurers [09-003]	ZonMW, the Dutch Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Zorgverzekeraars Nederland, the Dutch association of healthcare insurers	The study was supported by a grant from ZonMW, the Dutch Organization for Health Research and Development (120620027) and a grant from Zorgverzekeraars Nederland, the Dutch association of healthcare insurers (09-003). The funders had no role in study design or in collection, analysis, or interpretation of the data.	Aanesen A, 2010, REPROD BIOMED ONLINE, V20, P156, DOI 10.1016/j.rbmo.2009.10.017; Bensdorp AJ, 2007, COCHRANE DB SYST REV, V4; Bensdorp Alexandra J, 2009, BMC Womens Health, V9, P35, DOI 10.1186/1472-6874-9-35; Boivin J, 2011, BMJ-BRIT MED J, V23, P1; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Brandes M, 2011, HUM REPROD, V26, P360, DOI 10.1093/humrep/deq349; Brandes M, 2010, HUM REPROD, V25, P118, DOI 10.1093/humrep/dep341; Custers IM, 2011, FERTIL STERIL, V96, P1107, DOI 10.1016/j.fertnstert.2011.08.005; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Gerris J, 2004, HUM REPROD, V19, P917, DOI 10.1093/humrep/deh188; Gleicher N, 2000, NEW ENGL J MED, V343, P2, DOI 10.1056/NEJM200007063430101; Goldman MB, 2014, FERTIL STERIL, V101, P1574, DOI 10.1016/j.fertnstert.2014.03.012; Gordon JD, 2013, FERTIL STERIL, V100, P392, DOI 10.1016/j.fertnstert.2013.03.037; Goverde AJ, 2000, LANCET, V355, P13, DOI 10.1016/S0140-6736(99)04002-7; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Land J. A., 2003, Human Reproduction (Oxford), V18, P455, DOI 10.1093/humrep/deg081; Lukassen HGM, 2005, HUM REPROD, V20, P702, DOI 10.1093/humrep/deh672; Mansour R, 2014, HUM REPROD, V29, P1536, DOI 10.1093/humrep/deu084; Matsuura T, 2008, J ASSIST REPROD GEN, V25, P163, DOI 10.1007/s10815-008-9204-7; National Institute for Health and Care Excellence, 2013, FERT ASS TREATM PEOP; Ombelet W, 2005, HUM REPROD UPDATE, V11, P3, DOI 10.1093/humupd/dmh048; Pandian Z, 2005, HUM REPROD, V20, P2681, DOI 10.1093/humrep/dei153; Pandian Z, 2012, COCHRANE DB SYST REV, V4; Pandian Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003416.pub4; Pelinck MJ, 2007, HUM REPROD, V22, P2463, DOI 10.1093/humrep/dem164; Pfeifer S, 2012, FERTIL STERIL, V97, P835, DOI 10.1016/j.fertnstert.2011.11.050; Pfeifer S, 2012, FERTIL STERIL, V97, P825, DOI 10.1016/j.fertnstert.2011.11.048; PUISSANT F, 1987, HUM REPROD, V2, P705, DOI 10.1093/oxfordjournals.humrep.a136618; Reindollar RH, 2010, FERTIL STERIL, V94, P888, DOI 10.1016/j.fertnstert.2009.04.022; Schimberni M, 2009, FERTIL STERIL, V92, P1297, DOI 10.1016/j.fertnstert.2008.07.1765; Steures P, 2007, REPROD BIOMED ONLINE, V14, P110, DOI 10.1016/S1472-6483(10)60772-9; Steures P, 2006, LANCET, V368, P216, DOI 10.1016/S0140-6736(06)69042-9; Sullivan EA, 2013, HUM REPROD, V28, P1375, DOI 10.1093/humrep/det036; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; van der Steeg JW, 2007, HUM REPROD, V22, P536, DOI 10.1093/humrep/del378; van Montfoort APA, 2005, HUM REPROD, V20, P433, DOI 10.1093/humrep/deh619; van Rumste MME, 2008, HUM REPROD UPDATE, V14, P563, DOI 10.1093/humupd/dmn034; Veltman-Verhulst SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001838.pub4; Verberg MFG, 2009, HUM REPROD UPDATE, V15, P13, DOI 10.1093/humupd/dmn056; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Wirtberg I, 2007, HUM REPROD, V22, P598, DOI 10.1093/humrep/del401	42	80	82	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2015	350								g7771	10.1136/bmj.g7771	http://dx.doi.org/10.1136/bmj.g7771			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3ME	25576320	Green Published, hybrid			2022-12-28	WOS:000348130800001
J	Krengel, U; Tornroth-Horsefield, S				Krengel, Ute; Tornroth-Horsefield, Susanna			Coping with oxidative stress	SCIENCE			English	Editorial Material							TRANSHYDROGENASE		[Krengel, Ute] Univ Oslo, Dept Chem, NO-0315 Oslo, Norway; [Tornroth-Horsefield, Susanna] Lund Univ, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden	University of Oslo; Lund University	Krengel, U (corresponding author), Univ Oslo, Dept Chem, NO-0315 Oslo, Norway.	ute.krengel@kjemi.uio.no; susanna.horsefeld@biochemistry.lu.se		Krengel, Ute/0000-0001-6688-8151; Tornroth-Horsefield, Susanna/0000-0002-9435-8243				Arkblad EL, 2005, FREE RADICAL BIO MED, V38, P1518, DOI 10.1016/j.freeradbiomed.2005.02.012; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; HACKNEY DD, 1979, P NATL ACAD SCI USA, V76, P3646, DOI 10.1073/pnas.76.8.3646; Henderson PJF, 2013, NAT STRUCT MOL BIOL, V20, P654, DOI 10.1038/nsmb.2604; Jackson JB, 2012, BBA-BIOENERGETICS, V1817, P1839, DOI 10.1016/j.bbabio.2012.04.006; KAPLAN NO, 1952, J BIOL CHEM, V195, P107; Leung JH, 2015, SCIENCE, V347, P178, DOI 10.1126/science.1260451; Rydstrom J, 2006, TRENDS BIOCHEM SCI, V31, P355, DOI 10.1016/j.tibs.2006.05.003; Stewart AG, 2014, CURR OPIN STRUC BIOL, V25, P40, DOI 10.1016/j.sbi.2013.11.013; Sundaresan V, 2005, J MOL BIOL, V346, P617, DOI 10.1016/j.jmb.2004.11.070; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z	12	18	21	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					125	126		10.1126/science.aaa3602	http://dx.doi.org/10.1126/science.aaa3602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574006				2022-12-28	WOS:000347918900022
J	Najafi, E; Scarborough, TD; Tang, J; Zewail, A				Najafi, Ebrahim; Scarborough, Timothy D.; Tang, Jau; Zewail, Ahmed			Four-dimensional imaging of carrier interface dynamics in p-n junctions	SCIENCE			English	Article							ELECTRON-MICROSCOPY; SILICON	The dynamics of charge transfer at interfaces are fundamental to the understanding of many processes, including light conversion to chemical energy. Here, we report imaging of charge carrier excitation, transport, and recombination in a silicon p-n junction, where the interface is well defined on the nanoscale. The recorded images elucidate the spatiotemporal behavior of carrier density after optical excitation. We show that carrier separation in the p-n junction extends far beyond the depletion layer, contrary to the expected results from the widely accepted drift-diffusion model, and that localization of carrier density across the junction takes place for up to tens of nanoseconds, depending on the laser fluence. The observations reveal a ballistic-type motion, and we provide a model that accounts for the spatiotemporal density localization across the junction.	[Najafi, Ebrahim; Scarborough, Timothy D.; Tang, Jau; Zewail, Ahmed] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA; [Tang, Jau] Natl Chiao Tung Univ, Inst Photon, Hsinchu 300, Taiwan	California Institute of Technology; National Yang Ming Chiao Tung University	Zewail, A (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu		Tang, Jau/0000-0003-2078-1513; gaber, sarah/0000-0002-5995-7291	NSF [DMR-0964886]; Air Force Office of Scientific Research in the Physical Biology Center for Ultrafast Science and Technology at California Institute of Technology - Gordon and Betty Moore Foundation [FA9550-11-1-0055]	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Physical Biology Center for Ultrafast Science and Technology at California Institute of Technology - Gordon and Betty Moore Foundation	This work was supported by NSF grant DMR-0964886 and Air Force Office of Scientific Research grant FA9550-11-1-0055 in the Physical Biology Center for Ultrafast Science and Technology at California Institute of Technology, which is supported by the Gordon and Betty Moore Foundation.	Auston D. H., 1993, TOP APPL PHYS, V60, P183; BRUNETTI R, 1981, J APPL PHYS, V52, P6713, DOI 10.1063/1.328622; Chee KWA, 2008, J PHYS CONF SER, V126, DOI 10.1088/1742-6596/126/1/012033; Chee K. W. A., 2008, MICROSCOPY SEMICONDU; Elliott SL, 2002, J APPL PHYS, V91, P9116, DOI 10.1063/1.1476968; Goldstein J., 2007, SCANNING ELECT MICRO; Hommelhoff P, 2013, ANN PHYS-BERLIN, V525, pA13, DOI 10.1002/andp.201300709; JELLISON GE, 1981, PHYS REV LETT, V46, P1414, DOI 10.1103/PhysRevLett.46.1414; Lin YH, 2005, SURF INTERFACE ANAL, V37, P895, DOI 10.1002/sia.2107; Mohammed OF, 2011, J AM CHEM SOC, V133, P7708, DOI 10.1021/ja2031322; Prasankumar RP, 2009, PHYS STATUS SOLIDI B, V246, P1973, DOI 10.1002/pssb.200945128; Rodgers P., 2010, NANOSCIENCE TECHNOLO; Sapoval B., 1995, PHYS SEMICONDUCTORS; Saraniti M., 2006, P 14 INT C JUL 25 29; Schafer S, 2010, CHEM PHYS LETT, V493, P11, DOI 10.1016/j.cplett.2010.04.049; Sealy CP, 2000, J ELECTRON MICROSC, V49, P311, DOI 10.1093/oxfordjournals.jmicro.a023811; Shah J., 1999, ULTRAFAST SPECTROSCO; Tsen K.-T., 2004, ULTRAFAST DYNAMICAL; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135	19	64	67	7	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					164	167		10.1126/science.aaa0217	http://dx.doi.org/10.1126/science.aaa0217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574020				2022-12-28	WOS:000347918900040
J	Neyskens, P; Van Eck, S; Jorissen, A; Goriely, S; Siess, L; Plez, B				Neyskens, P.; Van Eck, S.; Jorissen, A.; Goriely, S.; Siess, L.; Plez, B.			The temperature and chronology of heavy-element synthesis in low-mass stars	NATURE			English	Article							ASYMPTOTIC GIANT BRANCH; AGB STARS; S-PROCESS; CHEMICAL-COMPOSITION; NIOBIUM ABUNDANCES; DREDGE-UP; TECHNETIUM; NUCLEOSYNTHESIS; EVOLUTION; MODELS	Roughly half of the heavy elements (atomic mass greater than that of iron) are believed to be synthesized in the late evolutionary stages of stars with masses between 0.8 and 8 solar masses. Deep inside the star, nuclei (mainly iron) capture neutrons and progressively build up (through the slow-neutron-capture process(1,2), or s-process) heavier elements that are subsequently brought to the stellar surface by convection. Two neutron sources, activated at distinct temperatures, have been proposed: C-13 and Ne-22, each releasing one neutron per alpha-particle (He-4) captured(1-4). To explain the measured stellar abundances(1-7), stellar evolution models invoking the C-13 neutron source (which operates at temperatures of about one hundred million kelvin) are favoured. Isotopic ratios in primitive meteorites, however, reflecting nucleosynthesis in the previous generations of stars that contributed material to the Solar System, point to higher temperatures (more than three hundred million kelvin), requiring at least a late activation of Ne-22 (ref. 1). Here we report a determination of the s-process temperature directly in evolved low-mass giant stars, using zirconium and niobium abundances, independently of stellar evolution models. The derived temperature supports C-13 as the s-process neutron source. The radioactive pair Zr-93-Nb-93 used to estimate the s-process temperature also provides, together with the pair Tc-99-Ru-99, chronometric information on the time elapsed since the start of the s-process, which we determine to be one million to three million years.	[Neyskens, P.; Van Eck, S.; Jorissen, A.; Goriely, S.; Siess, L.] Univ Libre Bruxelles, Inst Astron & Astrophys, B-1050 Brussels, Belgium; [Plez, B.] Univ Montpellier 2, CNRS, Lab Univ & Particules Montpellier, F-34095 Montpellier, France	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Van Eck, S (corresponding author), Univ Libre Bruxelles, Inst Astron & Astrophys, CP 226, B-1050 Brussels, Belgium.	svaneck@astro.ulb.ac.be	Goriely, Stephane/AAE-1742-2021; Plez, Bertrand/G-6697-2011	Plez, Bertrand/0000-0002-0398-4434	FRIA (FNRS) fellowship; CNRS Programme National de Physique Stellaire; Action de recherche concertee (ARC) from the Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique, Communaute francaise de Belgique; Fund for Scientific Research of Flanders (FWO); Research Council of K.U. Leuven; Fonds National de la Recherche Scientifique (FRS-FNRS), Belgium; Royal Observatory of Belgium; Observatoire de Geneve, Switzerland; Thuringer Landessternwarte Tautenburg, Germany	FRIA (FNRS) fellowship(Fonds de la Recherche Scientifique - FNRS); CNRS Programme National de Physique Stellaire; Action de recherche concertee (ARC) from the Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique, Communaute francaise de Belgique; Fund for Scientific Research of Flanders (FWO)(FWO); Research Council of K.U. Leuven(KU Leuven); Fonds National de la Recherche Scientifique (FRS-FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); Royal Observatory of Belgium; Observatoire de Geneve, Switzerland; Thuringer Landessternwarte Tautenburg, Germany	P.N. acknowledges the support of a FRIA (FNRS) fellowship. S.G., L.S. and S.V.E. are FRS-FNRS Research Associates. B.P. is supported in part by the CNRS Programme National de Physique Stellaire. This work has been partly funded by an Action de recherche concertee (ARC) from the Direction generale de l'Enseignement non obligatoire et de la Recherche scientifique, Communaute francaise de Belgique. It was based on observations obtained using the HERMES spectrograph, which is supported by the Fund for Scientific Research of Flanders (FWO); the Research Council of K.U. Leuven; the Fonds National de la Recherche Scientifique (FRS-FNRS), Belgium; the Royal Observatory of Belgium; the Observatoire de Geneve, Switzerland; and the Thuringer Landessternwarte Tautenburg, Germany.	Alvarez R, 1998, ASTRON ASTROPHYS, V330, P1109; Asplund M, 2005, ASTR SOC P, V336, P25; Bao ZY, 2000, ATOM DATA NUCL DATA, V76, P70, DOI 10.1006/adnd.2000.0838; BIEMONT E, 1981, ASTROPHYS J, V248, P867, DOI 10.1086/159213; Cristallo S, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/17; de Laverny P, 2006, ASTRON ASTROPHYS, V446, P1107, DOI 10.1051/0004-6361:20053423; Garcia-Hernandez DA, 2006, SCIENCE, V314, P1751, DOI 10.1126/science.1133706; Goriely S, 2000, ASTRON ASTROPHYS, V362, P599; Goriely S, 2004, ASTRON ASTROPHYS, V421, pL25, DOI 10.1051/0004-6361:20040184; Gustafsson B, 2008, ASTRON ASTROPHYS, V486, P951, DOI 10.1051/0004-6361:200809724; Joint IRAS Science Working Group, 1986, IRAS CAT POINT SOURC; JORISSEN A, 1993, ASTRON ASTROPHYS, V271, P463; Kappeler F, 2011, REV MOD PHYS, V83, P157, DOI 10.1103/RevModPhys.83.157; Kappeler F, 1999, PROG PART NUCL PHYS, V43, P419, DOI 10.1016/S0146-6410(99)00098-8; Kashiv Y, 2010, ASTROPHYS J, V713, P212, DOI 10.1088/0004-637X/713/1/212; Kupka F, 1999, ASTRON ASTROPHYS SUP, V138, P119, DOI 10.1051/aas:1999267; LAMBERT DL, 1995, ASTROPHYS J, V450, P302, DOI 10.1086/176141; MATHEWS GJ, 1986, ASTROPHYS J, V302, P410, DOI 10.1086/163999; MERRILL PW, 1952, ASTROPHYS J, V116, P21; Neyskens P., 2014, THESIS U LIBRE BRUXE; Raskin G, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015435; Savina MR, 2004, SCIENCE, V303, P649, DOI 10.1126/science.3030649; Schroder KP, 2005, ASTROPHYS J, V630, pL73, DOI 10.1086/491579; Siess L, 2006, ASTRON ASTROPHYS, V448, P717, DOI 10.1051/0004-6361:20053043; SMITH VV, 1983, ASTROPHYS J, V273, P742, DOI 10.1086/161409; STEPHENSON CB, 1984, GEN CATALOGUE GALACT; STRANIERO O, 1995, ASTROPHYS J, V440, pL85, DOI 10.1086/187767; Tagliente G, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014622; TAKAHASHI K, 1987, ATOM DATA NUCL DATA, V36, P375, DOI 10.1016/0092-640X(87)90010-6; Trippella O, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/41; Van Eck S, 1998, ASTRON ASTROPHYS, V329, P971; Van Eck S, 1999, ASTRON ASTROPHYS, V345, P127; Van Eck S, 2001, NATURE, V412, P793, DOI 10.1038/35090514; Van Eck S, 2011, J PHYS CONF SER, V328, DOI 10.1088/1742-6596/328/1/012009; Wallerstein G, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201015280	36	39	39	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					174	U116		10.1038/nature14050	http://dx.doi.org/10.1038/nature14050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567282	Green Submitted			2022-12-28	WOS:000347477600030
J	Rosenbaum, L				Rosenbaum, Lisa			Beyond Belief - How People Feel about Taking Medications for Heart Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MYOCARDIAL-INFARCTION; ADHERENCE; ASSOCIATION; RISK								Robert Wood Johnson Clinical Scholars Program	Robert Wood Johnson Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF))	Supported by the Robert Wood Johnson Clinical Scholars Program.	Akincigil A, 2008, J GEN INTERN MED, V23, P115, DOI 10.1007/s11606-007-0351-9; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lown B, PERSONAL BLOG; McAfee T, 2013, LANCET, V382, P2003, DOI 10.1016/S0140-6736(13)61686-4; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Slovic P, 2007, DRUG INF J, V41, P81, DOI 10.1177/009286150704100110; Tilson HH, 2004, ANN PHARMACOTHER, V38, P161, DOI 10.1345/aph.1D207	12	27	28	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					183	187		10.1056/NEJMms1409015	http://dx.doi.org/10.1056/NEJMms1409015			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25564902				2022-12-28	WOS:000347443300016
J	Payne, D				Payne, David			ONLINE REPUTATIONS Google, doctors, and the "right to be forgotten"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dpayne@bmj.com						[Anonymous], 2014, TELEGRAPH; Boycott O., 2014, GUARDIAN; Dredge S, 2014, GUARDIAN; Drummond D., 2014, GUARDIAN; Dyer C, 2001, BRIT MED J, V323, P711, DOI 10.1136/bmj.323.7315.711; Electronic responses, 2005, BMJ; Electronic responses, 2006, BMJ; European Commission, 2014, FACT SHEET RIGHT FOR; Frizzell S., 2013, TIME; Google, TRANSP REP EUR PRIV; Google, EU PRIV REM WEB SEAR; Hughes G., 2014, ELSEVIER CONNECT; Scott M, 2014, NY TIMES; Shankland S., 2014, CNET 2014; Watson L, 2014, MAIL ONLINE     0702; Wilson Brett, SEARCH ENGINE RESULT	16	2	2	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2015	350								h27	10.1136/bmj.h27	http://dx.doi.org/10.1136/bmj.h27			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LX	25569207				2022-12-28	WOS:000348130100008
J	Dritsoula, AK; Greenstreet, D; Thevasagayam, MS				Dritsoula, Aikaterini K.; Greenstreet, David; Thevasagayam, Mahilravi S.			10-MINUTE CONSULTATION The drooling child	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CEREBRAL-PALSY		[Dritsoula, Aikaterini K.; Thevasagayam, Mahilravi S.] Sheffield Childrens Hosp, Paediat ENT Dept, Sheffield S10 2TH, S Yorkshire, England; [Greenstreet, David] Sloan Med Ctr, Sheffield, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Dritsoula, AK (corresponding author), Sheffield Childrens Hosp, Paediat ENT Dept, Sheffield S10 2TH, S Yorkshire, England.	mdritsoula@yahoo.gr						Garnock-Jones KP, 2012, PEDIATR DRUGS, V14, P263, DOI 10.2165/11208120-000000000-00000; Little SA, 2009, CLIN OTOLARYNGOL, V34, P236, DOI 10.1111/j.1749-4486.2009.01917.x; Scheffer ART, 2010, ARCH OTOLARYNGOL, V136, P873, DOI 10.1001/archoto.2010.147; Van der Burg JJW, 2006, DEV MED CHILD NEUROL, V48, P103, DOI 10.1017/S0012162206000235; van der Burg JJW, 2006, EUR J PEDIATR, V165, P37, DOI 10.1007/s00431-005-1759-z	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2015	350								h38	10.1136/bmj.h38	http://dx.doi.org/10.1136/bmj.h38			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AT	25632946				2022-12-28	WOS:000348778700004
J	Taylor, MGGT; Alexander, C; Altobelli, N; Fulle, M; Fulchignoni, M; Grun, E; Weissman, P				Taylor, M. G. G. T.; Alexander, C.; Altobelli, N.; Fulle, M.; Fulchignoni, M.; Grun, E.; Weissman, P.			Rosetta begins its COMET TALE	SCIENCE			English	Editorial Material									[Taylor, M. G. G. T.] European Space Agcy, European Space Res & Technol Ctr, Sci & Robot Explorat Directorate, NL-2200 AG Noordwijk, Netherlands; [Alexander, C.; Weissman, P.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Altobelli, N.] European Space Agcy, Sci & Robot Explorat Directorate, European Space Astron Ctr, Madrid, Spain; [Fulle, M.] INAF Osservatorio Astron, Trieste, Italy; [Fulchignoni, M.] Univ Paris Diderot, Observ Paris, Lab Etud Spatiales & Instrumentat Astrophys, Paris, France; [Grun, E.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany	European Space Agency; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); European Space Agency; Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Max Planck Society	Taylor, MGGT (corresponding author), European Space Agcy, European Space Res & Technol Ctr, Sci & Robot Explorat Directorate, NL-2200 AG Noordwijk, Netherlands.	mtaylor@cosmos.esa.int		fulle, marco/0000-0001-8435-5287					0	29	29	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					387	387		10.1126/science.aaa4542	http://dx.doi.org/10.1126/science.aaa4542			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613884	Green Submitted			2022-12-28	WOS:000348225800026
J	Iglehart, JK				Iglehart, John K.			Institute of Medicine Report on GME - A Call for Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EDUCATION											American College of Physicians, 2011, AL GME POL NAT HLTH; [Anonymous], 2014, 21 CENT HLTH CAR WOR; [Anonymous], 2011, ENS EFF PHYS WORKF U; [Anonymous], 2010, ENS EFF PHYS WORKF A; Bennet MF, 2011, COMMUNICATION; Buerhaus PI, 2013, HEALTH AFFAIR, V32, P2021, DOI 10.1377/hlthaff.2013.0385; Chandra A, 2014, NEW ENGL J MED, V370, P2357, DOI 10.1056/NEJMp1402468; Chen C, 2013, ACAD MED, V88, P1267, DOI 10.1097/ACM.0b013e31829a3ce9; Eden J., 2014, GRADUATE MED ED MEET; Enders T, 2014, ADV ACAD HLTH SYSTEM; Fishman L, 2014, AHA STATEMENT IOM GM; Goodman DC, 2013, HEALTH AFFAIR, V32, P1887, DOI 10.1377/hlthaff.2013.0451; Hackbarth G, 2011, NEW ENGL J MED, V364, P693, DOI 10.1056/NEJMp1012691; *I MED, 1997, IMPL NAT GRAD MED ED; Kerry J, 2012, COMMUNICATION   0620; Ludmerer KM., 2015, LET ME HEAL OPPORTUN; Medicare Payment Advisory Commission, 2010, REP C AL INC MED WAS; Mullan F, 2013, HEALTH AFFAIR, V32, P1914, DOI 10.1377/hlthaff.2013.0545; Nguyen XN, 2011, INDIRECT MED ED DISP; Shannon SC, 2013, HEALTH AFFAIR, V32, P1899, DOI 10.1377/hlthaff.2013.0533; Weisman J, 2014, NY TIMES, VA23; Wilensky GR, 2014, NEW ENGL J MED, V371, P792, DOI 10.1056/NEJMp1406174; Wynn BO, DOES IT COST MORE TR	23	21	21	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					376	381		10.1056/NEJMhpr1413236	http://dx.doi.org/10.1056/NEJMhpr1413236			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ4PJ	25607431				2022-12-28	WOS:000348204500014
J	Witze, A				Witze, Alexandra			California study targets rivers in the sky	NATURE			English	News Item																		Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Dettinger MD, 2013, J HYDROMETEOROL, V14, P1721, DOI 10.1175/JHM-D-13-02.1; Lavers D. A., 2014, J HYDROL	3	2	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					424	425		10.1038/517424a	http://dx.doi.org/10.1038/517424a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25612033	Bronze			2022-12-28	WOS:000348196500010
J	Chan, CKF; Seo, EY; Chen, JY; Lo, D; McArdle, A; Sinha, R; Tevlin, R; Seita, J; Vincent-Tompkins, J; Wearda, T; Lu, WJ; Senarath-Yapa, K; Chung, MT; Marecic, O; Tran, M; Yan, KS; Upton, R; Walmsley, GG; Lee, AS; Sahoo, D; Kuo, CJ; Weissman, IL; Longaker, MT				Chan, Charles K. F.; Seo, Eun Young; Chen, James Y.; Lo, David; McArdle, Adrian; Sinha, Rahul; Tevlin, Ruth; Seita, Jun; Vincent-Tompkins, Justin; Wearda, Taylor; Lu, Wan-Jin; Senarath-Yapa, Kshemendra; Chung, Michael T.; Marecic, Owen; Tran, Misha; Yan, Kelley S.; Upton, Rosalynd; Walmsley, Graham G.; Lee, Andrew S.; Sahoo, Debashis; Kuo, Calvin J.; Weissman, Irving L.; Longaker, Michael T.			Identification and Specification of the Mouse Skeletal Stem Cell	CELL			English	Article							HEMATOPOIETIC NICHE; BONE; CARTILAGE; GROWTH; ANGIOGENESIS; LINEAGE; VEGF; OSTEOARTHRITIS; REGENERATION; OSSIFICATION	How are skeletal tissues derived from skeletal stem cells? Here, we map bone, cartilage, and stromal development from a population of highly pure, postnatal skeletal stem cells (mouse skeletal stem cells, mSSCs) to their downstream progenitors of bone, cartilage, and stromal tissue. We then investigated the transcriptome of the stem/progenitor cells for unique gene-expression patterns that would indicate potential regulators of mSSC lineage commitment. We demonstrate that mSSC niche factors can be potent inducers of osteogenesis, and several specific combinations of recombinant mSSC niche factors can activate mSSC genetic programs in situ, even in nonskeletal tissues, resulting in de novo formation of cartilage or bone and bone marrow stroma. Inducing mSSC formation with soluble factors and subsequently regulating the mSSC niche to specify its differentiation toward bone, cartilage, or stromal cells could represent a paradigm shift in the therapeutic regeneration of skeletal tissues.	[Chan, Charles K. F.; Seo, Eun Young; Lo, David; McArdle, Adrian; Tevlin, Ruth; Wearda, Taylor; Senarath-Yapa, Kshemendra; Chung, Michael T.; Marecic, Owen; Tran, Misha; Walmsley, Graham G.; Longaker, Michael T.] Stanford Univ, Dept Surg, Palo Alto, CA 94305 USA; [Chen, James Y.; Sinha, Rahul; Seita, Jun; Vincent-Tompkins, Justin; Lu, Wan-Jin; Upton, Rosalynd; Lee, Andrew S.; Sahoo, Debashis; Weissman, Irving L.] Stanford Univ, Dept Pathol, Palo Alto, CA 94305 USA; [Chen, James Y.; Sinha, Rahul; Seita, Jun; Vincent-Tompkins, Justin; Lu, Wan-Jin; Upton, Rosalynd; Lee, Andrew S.; Sahoo, Debashis; Weissman, Irving L.] Stanford Univ, Dept Dev Biol, Palo Alto, CA 94305 USA; [Yan, Kelley S.; Kuo, Calvin J.] Stanford Univ, Stanford Canc Inst, Palo Alto, CA 94305 USA; [Chan, Charles K. F.; Seo, Eun Young; Lo, David; McArdle, Adrian; Sinha, Rahul; Tevlin, Ruth; Seita, Jun; Wearda, Taylor; Lu, Wan-Jin; Walmsley, Graham G.; Sahoo, Debashis; Weissman, Irving L.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA; [Sahoo, Debashis] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; University of California System; University of California San Diego	Chan, CKF (corresponding author), Stanford Univ, Dept Surg, 450 Serra Mall, Palo Alto, CA 94305 USA.	chazchan@stanford.edu; longaker@stanford.edu	Lee, Andrew/GVU-2817-2022; Seita, Jun/AAM-1478-2020	Seita, Jun/0000-0002-3008-3615; Lu, Wan-Jin/0000-0002-2186-9800; Kuo, Calvin/0000-0002-7427-5985; Tevlin, Ruth/0000-0002-7590-8123	National Institutes of Health (NIH) [U01HL099999, R01 CA86065, R01 HL058770, R01 DE021683, R21 DE024230, R01 DE019434, RC2 DE020771, U01 HL099776, R21 DE019274, 1R01CA158528, 1R01NS064517, 2U01DK085527-06]; Siebel Fellowship from Thomas and Stacey Siebel Foundation; Prostate Cancer Foundation Young Investigator Award; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Gunn/Olivier Research Fund, StinehartReed Fund; Stanford Medical Scientist Training Program [NIHT32GM007365]; Stanford University Transplant and Tissue Engineering Center of Excellence Fellowship; Plastic Surgery Foundation/Plastic Surgery Research Council; American Society of Maxillofacial Surgeons Research; Burroughs Wellcome Career Award for Medical Scientists [K08 DK096048 01]; Stanford Developmental Cancer Research Award; Stanford Medical Scientist Training Program, NIGMS [GM07365]; Anonymous Donor Skeletal Stem Cell Research Fund;  [CIRM TR1- 01249]; NATIONAL CANCER INSTITUTE [R01CA086065, R01CA158528, T32CA009302, R00CA151673] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, U01HL099999, U01HL099776, R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024230, R01DE021683, R01DE019434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019274, RC2DE020771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527, K08DK096048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064517] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siebel Fellowship from Thomas and Stacey Siebel Foundation; Prostate Cancer Foundation Young Investigator Award; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Gunn/Olivier Research Fund, StinehartReed Fund; Stanford Medical Scientist Training Program; Stanford University Transplant and Tissue Engineering Center of Excellence Fellowship; Plastic Surgery Foundation/Plastic Surgery Research Council; American Society of Maxillofacial Surgeons Research; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); Stanford Developmental Cancer Research Award; Stanford Medical Scientist Training Program, NIGMS; Anonymous Donor Skeletal Stem Cell Research Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge Seth Karten for his critical help in editing the manuscript; Christopher Duldulao and Tejaswitha Naik for technical assistance; Shirley Kantoff, Libuse Jerabek, and Terry Storm for laboratory management; Aaron McCarty, Joel Dollaga, and Felix Manuel for animal care; Patty Lovelace and Jennifer Ho in the Shared FACS Facility in the Lokey Stem Cell Institute; Steve Quake, Norma Neff, Sopheak Sim, and Gary Mantalas for critical help while performing single- cell RNA sequencing; and Natalia Kosovilka and Michael Eckart at Stanford PAN Facility for help with microarray analysis. The authors would like to acknowledge ongoing support for this work: Virginia and D. K. Ludwig Fund for Cancer Research, National Institutes of Health (NIH) Grants U01HL099999, R01 CA86065, and R01 HL058770 (to I.L.W.); R01 DE021683, R21 DE024230, R01 DE019434, RC2 DE020771, U01 HL099776, and R21 DE019274 (to M.T.L.); and 1R01CA158528, 1R01NS064517, and 2U01DK085527-06 (to C.J.K.); Siebel Fellowship from Thomas and Stacey Siebel Foundation and Prostate Cancer Foundation Young Investigator Award (to C.K.F.C.); CIRM TR1- 01249, the Oak Foundation, the Hagey Laboratory for Pediatric Regenerative Medicine, the Gunn/Olivier Research Fund, StinehartReed Fund (to M.T.L.); the Stanford Medical Scientist Training Program, NIHT32GM007365 (to J.Y.C.); Stanford University Transplant and Tissue Engineering Center of Excellence Fellowship (to A.M. and R.T.); the Plastic Surgery Foundation/Plastic Surgery Research Council Pilot Grant and the American Society of Maxillofacial Surgeons Research Grant (to R.T.); Burroughs Wellcome Career Award for Medical Scientists, K08 DK096048 01(to K.S.Y.); Stanford Developmental Cancer Research Award (to D. S.); the Stanford Medical Scientist Training Program, NIGMS training grant GM07365 (to G.G.W.); and the Anonymous Donor Skeletal Stem Cell Research Fund (to E.Y.S., C.K.F.C., and M.T.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Burr DB, 2004, J RHEUMATOL, V31, P77; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carlevaro MF, 2000, J CELL SCI, V113, P59; Chan CKF, 2013, P NATL ACAD SCI USA, V110, P12643, DOI 10.1073/pnas.1310212110; Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Galloway JL, 2009, NATURE, V460, P400, DOI 10.1038/nature08117; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634; Kilic G, 2014, AM J MED SCI, V347, P382, DOI 10.1097/MAJ.0b013e31829a348b; Makris E.A., 2014, NAT REV RHEUMATOLOGY; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mitchell MJ, 1998, RADIOGRAPHICS, V18, P1125, DOI 10.1148/radiographics.18.5.9747611; Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	31	377	392	9	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					285	298		10.1016/j.cell.2014.12.002	http://dx.doi.org/10.1016/j.cell.2014.12.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594184	Green Accepted, Bronze			2022-12-28	WOS:000347923200025
J	Virtanen, M; Jokela, M; Nyberg, ST; Madsen, IEH; Lallukka, T; Ahola, K; Alfredsson, L; Batty, GD; Bjorner, JB; Borritz, M; Burr, H; Casini, A; Clays, E; De Bacquer, D; Dragano, N; Erbel, R; Ferrie, JE; Fransson, EI; Hamer, M; Heikkila, K; Jockel, KH; Kittel, F; Knutsson, A; Koskenvuo, M; Ladwig, KH; Lunau, T; Nielsen, ML; Nordin, M; Oksanen, T; Pejtersen, JH; Pentti, J; Rugulies, R; Salo, P; Schupp, J; Siegrist, J; Singh-Manoux, A; Steptoe, A; Suominen, SB; Theorell, T; Vahtera, J; Wagner, GG; Westerholm, PJM; Westerlund, H; Kivimaki, M				Virtanen, Marianna; Jokela, Markus; Nyberg, Solja T.; Madsen, Ida E. H.; Lallukka, Tea; Ahola, Kirsi; Alfredsson, Lars; Batty, G. David; Bjorner, Jakob B.; Borritz, Marianne; Burr, Hermann; Casini, Annalisa; Clays, Els; De Bacquer, Dirk; Dragano, Nico; Erbel, Raimund; Ferrie, Jane E.; Fransson, Eleonor I.; Hamer, Mark; Heikkila, Katriina; Joeckel, Karl-Heinz; Kittel, France; Knutsson, Anders; Koskenvuo, Markku; Ladwig, Karl-Heinz; Lunau, Thorsten; Nielsen, Martin L.; Nordin, Maria; Oksanen, Tuula; Pejtersen, Jan H.; Pentti, Jaana; Rugulies, Reiner; Salo, Paula; Schupp, JRgen; Siegrist, Johannes; Singh-Manoux, Archana; Steptoe, Andrew; Suominen, Sakari B.; Theorell, Tores; Vahtera, Jussi; Wagner, Gert G.; Westerholm, Peter J. M.; Westerlund, Hugo; Kivimaki, Mika			Long working hours and alcohol use: systematic review and meta-analysis of published studies and unpublished individual participant data	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; 3-YEAR FOLLOW-UP; OVERTIME WORK; JOB STRAIN; COHORT PROFILE; RISK-FACTORS; LIFE-STYLE; BASE-LINE; MYOCARDIAL-INFARCTION; HEALTH BEHAVIORS	Objective To quantify the association between long working hours and alcohol use. Design Systematic review and meta-analysis of published studies and unpublished individual participant data. Data sources A systematic search of PubMed and Embase databases in April 2014 for published studies, supplemented with manual searches. Unpublished individual participant data were obtained from 27 additional studies. Review methods The search strategy was designed to retrieve cross sectional and prospective studies of the association between long working hours and alcohol use. Summary estimates were obtained with random effects meta-analysis. Sources of heterogeneity were examined with meta-regression. Results Cross sectional analysis was based on 61 studies representing 333 693 participants from 14 countries. Prospective analysis was based on 20 studies representing 100 602 participants from nine countries. The pooled maximum adjusted odds ratio for the association between long working hours and alcohol use was 1.11 (95% confidence interval 1.05 to 1.18) in the cross sectional analysis of published and unpublished data. Odds ratio of new onset risky alcohol use was 1.12 (1.04 to 1.20) in the analysis of prospective published and unpublished data. In the 18 studies with individual participant data it was possible to assess the European Union Working Time Directive, which recommends an upper limit of 48 hours a week. Odds ratios of new onset risky alcohol use for those working 49-54 hours and >= 55 hours a week were 1.13 (1.02 to 1.26; adjusted difference in incidence 0.8 percentage points) and 1.12 (1.01 to 1.25; adjusted difference in incidence 0.7 percentage points), respectively, compared with working standard 35-40 hours (incidence of new onset risky alcohol use 6.2%). There was no difference in these associations between men and women or by age or socioeconomic groups, geographical regions, sample type (population based v occupational cohort), prevalence of risky alcohol use in the cohort, or sample attrition rate. Conclusions Individuals whose working hours exceed standard recommendations are more likely to increase their alcohol use to levels that pose a health risk.	[Virtanen, Marianna; Nyberg, Solja T.; Lallukka, Tea; Ahola, Kirsi; Oksanen, Tuula; Pentti, Jaana; Salo, Paula; Vahtera, Jussi; Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki 00250, Finland; [Jokela, Markus] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Madsen, Ida E. H.; Bjorner, Jakob B.; Rugulies, Reiner] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Lallukka, Tea; Koskenvuo, Markku; Kivimaki, Mika] Univ Helsinki, Dept Publ Hlth, Fac Med, Helsinki, Finland; [Alfredsson, Lars; Fransson, Eleonor I.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Alfredsson, Lars] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Batty, G. David; Ferrie, Jane E.; Hamer, Mark; Singh-Manoux, Archana; Steptoe, Andrew; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Batty, G. David] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Borritz, Marianne] Koge Hosp, Dept Occupat Med, Koge, Denmark; [Burr, Hermann] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany; [Casini, Annalisa; Kittel, France] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Clays, Els; De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Dragano, Nico; Lunau, Thorsten; Siegrist, Johannes] Univ Dusseldorf, Fac Med, Inst Med Sociol, Dusseldorf, Germany; [Erbel, Raimund] Univ Duisburg Essen, West German Heart Ctr Essen, Dept Cardiol, Essen, Germany; [Ferrie, Jane E.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Fransson, Eleonor I.; Nordin, Maria; Theorell, Tores; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Fransson, Eleonor I.] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Heikkila, Katriina] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Joeckel, Karl-Heinz] Univ Duisburg Essen, Fac Med, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Knutsson, Anders] Mid Sweden Univ, Dept Hlth Sci, Sundsvall, Sweden; [Ladwig, Karl-Heinz] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, D-85764 Oberschleissheim, Germany; [Nielsen, Martin L.] Frederiksberg Univ Hosp, Unit Social Med, DK-2000 Copenhagen, Denmark; [Nordin, Maria] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Pejtersen, Jan H.] Danish Natl Ctr Social Res, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rugulies, Reiner] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Salo, Paula] Univ Turku, Dept Psychol, Turku, Finland; [Schupp, JRgen; Wagner, Gert G.] German Inst Econ Res, Berlin, Germany; [Schupp, JRgen] Free Univ Berlin, Berlin, Germany; [Singh-Manoux, Archana] Ctr Res Epidemiol & Populat Hlth, Inserm U1018, Villejuif, France; [Suominen, Sakari B.; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Suominen, Sakari B.] Nord Sch Publ Hlth, Gothenburg, Sweden; [Suominen, Sakari B.] Folkhalsan Res Ctr, Helsinki, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Wagner, Gert G.] Max Planck Inst Human Dev, Berlin, Germany; [Wagner, Gert G.] Berlin Univ Technol, Berlin, Germany; [Westerholm, Peter J. M.] Uppsala Univ, Uppsala, Sweden	Finnish Institute of Occupational Health; University of Helsinki; National Research Centre for the Working Environment; University of Helsinki; Karolinska Institutet; Stockholm County Council; University of London; University College London; University of Edinburgh; University of Edinburgh; Universite Libre de Bruxelles; Ghent University; Heinrich Heine University Dusseldorf; University of Duisburg Essen; University of Bristol; Stockholm University; Jonkoping University; Tampere University; University of Duisburg Essen; Mid-Sweden University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Umea University; University of Copenhagen; University of Copenhagen; University of Turku; DIW Berlin - Deutsches Institut fur Wirtschaftsforschung; Free University of Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Turku; Folkhalsan Research Center; University of Turku; Max Planck Society; Technical University of Berlin; Uppsala University	Virtanen, M (corresponding author), Finnish Inst Occupat Hlth, Helsinki 00250, Finland.	marianna.virtanen@ttl.fi	Pejtersen, Jan/AAP-2383-2020; Rugulies, Reiner/E-8140-2010; Hamer, Mark/AAJ-6814-2021; Salo, Paula/D-6649-2013; Batty, GD/Y-4401-2018; Hamer, Mark/C-1602-2008; Wagner, Gert G./AIC-8679-2022; Siegrist, Johannes/AAL-6814-2021; Casini, Annalisa/ABG-2250-2020; Westerlund, Hugo/A-3049-2012; Ferrie, Jane/AAZ-2009-2020; Kivimaki, Mika/B-3607-2012; Ladwig, Karl-Heinz/B-5351-2014; De Bacquer, Dirk/HGU-3191-2022; Nielsen, Martin Lindhardt/E-3071-2012; Singh-Manoux, Archana/F-6804-2013; Jokela, Markus/A-4669-2009; Alfredsson, Lars/AAC-9007-2019; Steptoe, Andrew/Y-2440-2019; Fransson, Eleonor I/J-7792-2013; zhong, feng/G-4623-2015; Schupp, Juergen/D-2721-2011; Oksanen, Tuula/AAK-5599-2021	Rugulies, Reiner/0000-0002-7752-131X; Hamer, Mark/0000-0002-8726-7992; Salo, Paula/0000-0002-0812-277X; Batty, GD/0000-0003-1822-5753; Hamer, Mark/0000-0002-8726-7992; Siegrist, Johannes/0000-0002-7530-4178; Casini, Annalisa/0000-0002-3539-4500; Westerlund, Hugo/0000-0002-8806-5698; Kivimaki, Mika/0000-0002-4699-5627; Ladwig, Karl-Heinz/0000-0003-0710-1720; Nielsen, Martin Lindhardt/0000-0002-1523-0453; Singh-Manoux, Archana/0000-0002-1244-5037; Jokela, Markus/0000-0003-0117-0012; Alfredsson, Lars/0000-0003-1688-6697; Fransson, Eleonor I/0000-0001-9042-4832; Schupp, Juergen/0000-0001-5273-643X; De Bacquer, Dirk/0000-0002-3202-7238; Theorell, Tores/0000-0003-1956-7931; Suominen, Sakari B./0000-0001-6648-603X; Burr, Hermann/0000-0002-3864-6347; Vahtera, Jussi/0000-0002-6036-061X; Lallukka, Tea/0000-0003-3841-3129; Heikkila, Katriina/0000-0001-6269-6881; Clays, Els/0000-0002-1092-945X	EU New OSH ERA Research Program; Finnish Work Environment Fund; Academy of Finland, Finland; Swedish Research Council for Health, Working Life and Welfare, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; BUPA Foundation [22094477]; Dutch Ministry of Social Affairs and Employment, Netherlands; Academy of Finland [258598, 265174]; Medical Research Council [K013351]; Economic and Social Research Council; US National Institutes of Health [R01HL036310, R01AG034454]; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020166, U19AG051426, R01AG034454] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, G0100222] Funding Source: researchfish	EU New OSH ERA Research Program; Finnish Work Environment Fund; Academy of Finland, Finland(Academy of Finland); Swedish Research Council for Health, Working Life and Welfare, Sweden; German Social Accident Insurance, Germany; Danish Work Environment Research Fund, Denmark; BUPA Foundation; Dutch Ministry of Social Affairs and Employment, Netherlands; Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The IPD-Work Consortium is supported by the EU New OSH ERA Research Program (funded by the Finnish Work Environment Fund and the Academy of Finland, Finland; the Swedish Research Council for Health, Working Life and Welfare, Sweden; the German Social Accident Insurance, Germany; and the Danish Work Environment Research Fund, Denmark); the BUPA Foundation (grant 22094477), and the Dutch Ministry of Social Affairs and Employment, Netherlands. MV is supported by the Academy of Finland (grants 258598, 265174), MK is supported by the Medical Research Council (grant K013351), the Economic and Social Research Council, and the US National Institutes of Health (grants R01HL036310 and R01AG034454), and SN is supported by the Finnish Work Environment Fund. AS is a BHF professor. Funding bodies for each participating cohort study are listed on their websites. The sponsors had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Alfredsson L, 2002, SCAND J WORK ENV HEA, V28, P238, DOI 10.5271/sjweh.671; [Anonymous], 2014, ALC WORKPL; Au N, 2013, INT J OBESITY, V37, P718, DOI 10.1038/ijo.2012.92; Baldwin DC, 2003, ACAD MED, V78, P1154, DOI 10.1097/00001888-200311000-00018; Baldwin PJ, 1997, SOC SCI MED, V45, P35, DOI 10.1016/S0277-9536(96)00306-1; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Bazargan M, 2009, ACAD PSYCHIATR, V33, P289, DOI 10.1176/appi.ap.33.4.289; Berkman LF, 1983, HLTH WAYS LIVING ALA; Bildt C, 2002, INT ARCH OCC ENV HEA, V75, P252, DOI 10.1007/s00420-001-0299-8; Borenstein M., 2009, INTRO METAANALYSIS; Borritz M, 2006, SCAND J PUBLIC HEALT, V34, P49, DOI 10.1080/14034940510032275; Brim O, 2010, 2760 ICPSR; Caruso CC, 2006, IND HEALTH, V44, P531, DOI 10.2486/indhealth.44.531; Cheng WJ, 2012, ALCOHOL ALCOHOLISM, V47, P372, DOI 10.1093/alcalc/ags034; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; de Oliveira GS, 2013, ANESTH ANALG, V117, P182, DOI 10.1213/ANE.0b013e3182917da9; Drago R, 2009, BRIT J IND RELAT, V47, P571, DOI 10.1111/j.1467-8543.2009.00717.x; Elliott J, 2006, INT J EPIDEMIOL, V35, P836, DOI 10.1093/ije/dyl174; European Commission, 2014, WORK COND WORK TIM D; EZOE S, 1994, PREV MED, V23, P98, DOI 10.1006/pmed.1994.1014; Feveile H, 2007, STAT TRANSIT, V8, P441; FRIEDMAN M, 1971, ANN CLIN RES, V3, P300; Friedmann PD, 2013, NEW ENGL J MED, V368, P365, DOI [10.1056/NEJMcp1204714, 10.1056/NEJMc1302445]; Frone MR, 2010, J STUD ALCOHOL DRUGS, V71, P526, DOI 10.15288/jsad.2010.71.526; Frone MR, 1999, ALCOHOL RES HEALTH, V23, P284; Gibb SJ, 2012, ADDICTION, V107, P81, DOI 10.1111/j.1360-0443.2011.03543.x; Gu JK, 2012, J OCCUP ENVIRON MED, V54, P1374, DOI 10.1097/JOM.0b013e31825f2bea; Harma M, 2003, SCAND J WORK ENV HEA, V29, P167; Hasegawa T, 2013, IND HEALTH, V51, P490, DOI 10.2486/indhealth.2013-0035; Heikkila K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040101; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Holtermann A, 2010, HEART, V96, P1638, DOI 10.1136/hrt.2010.197145; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; International Center for Alcohol Policies, 2010, INT DRINK GUID; Jones F, 2007, J APPL PSYCHOL, V92, P1731, DOI 10.1037/0021-9010.92.6.1731; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; KAWAKAMI N, 1993, ENVIRON RES, V62, P314, DOI 10.1006/enrs.1993.1116; Kawakami N, 1999, IND HEALTH, V37, P174, DOI 10.2486/indhealth.37.174; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kobayashi T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-395; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Krause N, 2009, PREV CHRONIC DIS, V6, DOI 10.1177/1479972308100538; Lahelma E, 2013, INT J EPIDEMIOL, V42, P722, DOI 10.1093/ije/dys039; Lallukka T, 2008, SOC SCI MED, V66, P1681, DOI 10.1016/j.socscimed.2007.12.027; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; MADANS JH, 1986, PUBLIC HEALTH REP, V101, P465; Marchand Alain, 2003, Work, V21, P153; Marchand A, 2011, INT J ENV RES PUB HE, V8, P2692, DOI 10.3390/ijerph8072692; Marchand A, 2011, SUBST USE MISUSE, V46, P1003, DOI 10.3109/10826084.2010.543249; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Maruyama S, 1995, Nihon Eiseigaku Zasshi, V50, P849; Midford R, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P191, DOI 10.1002/9780470713624.ch16; Mulder RT, 2002, AUST NZ J PSYCHIAT, V36, P44, DOI 10.1046/j.1440-1614.2002.00958.x; Nakanishi N, 1999, OCCUP MED-OXFORD, V49, P109, DOI 10.1093/occmed/49.2.109; Nakata A, 2012, SCAND J WORK ENV HEA, V38, P56, DOI 10.5271/sjweh.3183; Nash LM, 2010, MED J AUSTRALIA, V193, P161, DOI 10.5694/j.1326-5377.2010.tb03837.x; National Institute for Health and Clinical Excellence, 2010, AL US DIS PREV DEV H; Nicholson P, 2014, ALCOHOL DRUGS WORKPL; Nielsen ML, 2002, WORK STRESS, V16, P191, DOI 10.1080/02678370210164003; Nishikitani M, 2005, IND HEALTH, V43, P623, DOI 10.2486/indhealth.43.623; Otsuka Y, 2009, IND HEALTH, V47, P22, DOI 10.2486/indhealth.47.22; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Pimenta AM, 2009, J HYPERTENS, V27, P34, DOI 10.1097/HJH.0b013e3283163c3c; Poulsen OM, 2013, SCAND J PUBLIC HEALT, V41, P150, DOI 10.1177/1403494812471909; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Proctor SP, 1996, SCAND J WORK ENV HEA, V22, P124, DOI 10.5271/sjweh.120; RAGGATT PTF, 1991, J ORGAN BEHAV, V12, P565, DOI 10.1002/job.4030120702; Reis JP, 2005, MED SCI SPORT EXER, V37, P2075, DOI 10.1249/01.mss.0000179103.20821.00; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Schluter PJ, 2012, INT J NURS STUD, V49, P701, DOI 10.1016/j.ijnurstu.2012.01.005; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Schupp J, 2012, BUNDESGESUNDHEITSBLA, V55, P767, DOI 10.1007/s00103-012-1496-1; SEAMAN FJ, 1981, DRUG ALCOHOL DEPEN, V7, P285, DOI 10.1016/0376-8716(81)90100-9; Sewell W. H., 1975, ED OCCUPATION EARNIN; Shields M, 1999, Health Rep, V11, P33; Sparks K, 1997, J OCCUP ORGAN PSYCH, V70, P391, DOI 10.1111/j.2044-8325.1997.tb00656.x; Speicher C, 2010, EUR PSYCH C 18 EUR C; Spurgeon A, 1997, OCCUP ENVIRON MED, V54, P367, DOI 10.1136/oem.54.6.367; Statistics BoL, 2005, NLSY79 NLS HDB; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Stockwell T., 2005, PREVENTING HARMFUL S; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Summerfield M, 2013, HILDA USER MANUAL RE; Sweet James, 1988, 1 NSFH U WISC MAD CT; Tarumi K, 2003, IND HEALTH, V41, P101, DOI 10.2486/indhealth.41.101; Trinkoff AM, 1998, AM J IND MED, V34, P266, DOI 10.1002/(SICI)1097-0274(199809)34:3<266::AID-AJIM9>3.3.CO;2-#; Uchiyama S, 2005, J OCCUP HEALTH, V47, P102, DOI 10.1539/joh.47.102; United States Department of Agriculture and Department of Health and Human Services, 2010, DIET GUID AM 2010; Vahtera J, 2002, AM J EPIDEMIOL, V156, P969, DOI 10.1093/aje/kwf138; van der Hulst M, 2003, SCAND J WORK ENV HEA, V29, P171, DOI 10.5271/sjweh.720; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	98	114	120	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2015	350								g7772	10.1136/bmj.g7772	http://dx.doi.org/10.1136/bmj.g7772			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3MX	25587065	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000348132700001
J	Gabizon, A; Bradbury, M; Prabhakar, U; Zamboni, W; Libutti, S; Grodzinski, P				Gabizon, Alberto; Bradbury, Michelle; Prabhakar, Uma; Zamboni, William; Libutti, Steven; Grodzinski, Piotr			Cancer nanomedicines: closing the translational gap	LANCET			English	Editorial Material							PERSONALIZED MEDICINE; NANOPARTICLES		[Gabizon, Alberto] Shaare Zedek Med Ctr, Jerusalem, Israel; [Gabizon, Alberto] Hebrew Univ Jerusalem, Sch Med, IL-91010 Jerusalem, Israel; [Bradbury, Michelle] Cornell Univ, Sloan Kettering Inst Canc Res, New York, NY 10021 USA; [Bradbury, Michelle] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Prabhakar, Uma; Grodzinski, Piotr] NCI, Alliance Nanotechnol Canc, Bethesda, MD 20892 USA; [Zamboni, William] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, UNC Eshelman Sch Pharm, Chapel Hill, NC USA; [Libutti, Steven] Albert Einstein Coll Med, New York, NY USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; Yeshiva University	Grodzinski, P (corresponding author), NCI, Alliance Nanotechnol Canc, Bethesda, MD 20892 USA.	grodzinp@mail.nih.gov	Gabizon, Alberto/C-6171-2009		NCI NIH HHS [R01 CA161280] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2014, WORLD CANC REP 2014; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Duncan R, 2011, MOL PHARMACEUT, V8, P2101, DOI 10.1021/mp200394t; Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013; Jain KK, 2011, MED PRIN PRACT, V20, P1, DOI 10.1159/000319928; Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446; Petersen AL, 2012, ADV DRUG DELIVER REV, V64, P1417, DOI 10.1016/j.addr.2012.09.003; Phillips E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009524; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Xing Y, 2014, THERANOSTICS, V4, P290, DOI 10.7150/thno.7341	12	53	55	1	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2175	2176		10.1016/S0140-6736(14)61457-4	http://dx.doi.org/10.1016/S0140-6736(14)61457-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX0QC	25625382	Green Accepted			2022-12-28	WOS:000346655700006
J	Schnupf, P; Gaboriau-Routhiau, V; Gros, M; Friedman, R; Moya-Nilges, M; Nigro, G; Cerf-Bensussan, N; Sansonetti, PJ				Schnupf, Pamela; Gaboriau-Routhiau, Valerie; Gros, Marine; Friedman, Robin; Moya-Nilges, Maryse; Nigro, Giulia; Cerf-Bensussan, Nadine; Sansonetti, Philippe J.			Growth and host interaction of mouse segmented filamentous bacteria in vitro	NATURE			English	Article							GUT; GENOME; MICE; MATURATION; RESPONSES	The gut microbiota plays a crucial role in the maturation of the intestinal mucosal immune system of its host(1,2). Within the thousand bacterial species present in the intestine, the symbiont segmented filamentous bacterium(SFB) is unique in its ability to potently stimulate the post-natal maturation of the B-and T-cell compartments and induce a striking increase in the small-intestinal Th17 responses(3-5). Unlike other commensals, SFB intimately attaches to absorptive epithelial cells in the ileum and cells overlying Peyer's patches(6,7). This colonization does not result in pathology; rather, it protects the host from pathogens(4). Yet, little is known about the SFB-host interaction that underlies the important immunostimulatory properties of SFB, because SFB have resisted in vitro culturing for more than 50 years. Here we grow mouse SFB outside their host in an SFB-host cell co-culturing system. Single-celled SFB isolated from mono-colonized mice undergo filamentation, segmentation, and differentiation to release viable infectious particles, the intracellular offspring, which can colonize mice to induce signature immune responses. In vitro, intracellular offspring can attach to mouse and human host cells and recruit actin. In addition, SFB can potently stimulate the upregulation of host innate defence genes, inflammatory cytokines, and chemokines. In vitro culturing thereby mimics the in vivo niche, provides new insights into SFB growth requirements and their immunostimulatory potential, and makes possible the investigation of the complex developmental stages of SFB and the detailed dissection of the unique SFB-host interaction at the cellular and molecular levels.	[Schnupf, Pamela; Friedman, Robin; Nigro, Giulia; Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; [Schnupf, Pamela; Friedman, Robin; Nigro, Giulia; Sansonetti, Philippe J.] Inst Pasteur, INSERM, Unit U786, F-75724 Paris 15, France; [Schnupf, Pamela; Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] Inst Imagine, INSERM, UMR1163, Lab Intestinal Immun, F-75015 Paris, France; [Gaboriau-Routhiau, Valerie] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Gaboriau-Routhiau, Valerie; Gros, Marine; Cerf-Bensussan, Nadine] Univ Paris 05, Sorbonne Paris Cite, F-75015 Paris, France; [Gaboriau-Routhiau, Valerie; Gros, Marine; Cerf-Bensussan, Nadine] Inst Imagine, F-75015 Paris, France; [Gros, Marine] Ecole Normale Super Lyon, Dept Biol, F-69007 Lyon, France; [Moya-Nilges, Maryse] Inst Pasteur, Imagopole, Ultrastruct Microscopy Platform, F-75724 Paris 15, France; [Sansonetti, Philippe J.] Coll France, Microbiol & Malad Infect, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Ecole Normale Superieure de Lyon (ENS de LYON); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France	Sansonetti, PJ (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	nadine.cerf-bensussan@inserm.fr; psanson@pasteur.fr	Cerf-Bensussan, nadine/H-9505-2017; GABORIAU-ROUTHIAU, Valérie/H-9493-2017; Schnupf, Pamela/G-6040-2017	Cerf-Bensussan, nadine/0000-0003-0665-1245; GABORIAU-ROUTHIAU, Valérie/0000-0002-7662-4034; GROS, Marine/0000-0003-3914-7264; Nigro, Giulia/0000-0002-1014-7394; Schnupf, Pamela/0000-0003-4292-1257	INSERM, Institut Pasteur, College de France; INRA; Investissement d'Avenir [ANR-10-IAHU-01]; LabEX IBEID;  [TORNADO-FP7-KBBE-2007-2A-222720];  [ANR-2010-BLAN1317];  [ERC-2009-AG-232798-HOMEOPITH];  [ERC-2013-AdG-339579-DECRYPT];  [ERC-2013-AdG-339407-IMMUNOBIOTA]	INSERM, Institut Pasteur, College de France; INRA; Investissement d'Avenir(French National Research Agency (ANR)); LabEX IBEID; ; ; ; ; 	We are grateful to B. Marteyn, F.-X. Campbell-Valois, and C. Parsot for discussions, M. Picard and S. Rakotobe for help with in vivo experiments, and T. Angelique for animal care. This work was supported by INSERM, Institut Pasteur, College de France, and INRA, and grants TORNADO-FP7-KBBE-2007-2A-222720, ANR-2010-BLAN1317, ERC-2009-AG-232798-HOMEOPITH, ERC-2013-AdG-339579-DECRYPT, and ERC-2013-AdG-339407-IMMUNOBIOTA and the Investissement d'Avenir ANR-10-IAHU-01 and LabEX IBEID. P.J.S. is a Howard Hughes Medical Institute Foreign Scholar.	Bolotine A., 2014, GENOME ANNOUNC, V2, P1; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chappert P, 2013, IMMUNITY, V38, P1198, DOI 10.1016/j.immuni.2013.06.005; CHASE DG, 1976, J BACTERIOL, V127, P572, DOI 10.1128/JB.127.1.572-583.1976; FERGUSON DJP, 1979, ACTA PATH MICRO IM B, V87, P247; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; He GL, 1999, P NATL ACAD SCI USA, V96, P4586, DOI 10.1073/pnas.96.8.4586; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; JEPSON MA, 1993, INFECT IMMUN, V61, P4001, DOI 10.1128/IAI.61.9.4001-4004.1993; KLAASEN HLBM, 1992, FEMS MICROBIOL LETT, V88, P165, DOI 10.1111/j.1574-6968.1992.tb04986.x; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kuwahara T, 2011, DNA RES, V18, P291, DOI 10.1093/dnares/dsr022; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Pamp SJ, 2012, GENOME RES, V22, P1107, DOI 10.1101/gr.131482.111; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schnupf P, 2013, SEMIN IMMUNOL, V25, P342, DOI 10.1016/j.smim.2013.09.001; Schnupf P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036446; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shima T, 2008, FEMS IMMUNOL MED MIC, V52, P69, DOI 10.1111/j.1574-695X.2007.00344.x; TANNOCK GW, 1984, APPL ENVIRON MICROB, V47, P441, DOI 10.1128/AEM.47.2.441-442.1984; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yin YS, 2013, ISME J, V7, P615, DOI 10.1038/ismej.2012.128; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	27	97	102	4	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					99	U231		10.1038/nature14027	http://dx.doi.org/10.1038/nature14027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25600271	Green Accepted			2022-12-28	WOS:000352027700045
J	Kim, SYH; Miller, FG				Kim, Scott Y. H.; Miller, Franklin G.			Varieties of Standard-of-Care Treatment Randomized Trials Ethical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kim, Scott Y. H.; Miller, Franklin G.] NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kim, SYH (corresponding author), NIH, Ctr Clin, Dept Bioeth, 10 Ctr Dr,1C118, Bethesda, MD 20892 USA.	scott.kim@nih.gov			CLINICAL CENTER [ZIACL010538] Funding Source: NIH RePORTER	CLINICAL CENTER		Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Carter BL, 2014, J CLIN HYPERTENS, V16, P115, DOI 10.1111/jch.12238; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Ernst ME, 2006, HYPERTENSION, V47, P352, DOI 10.1161/01.HYP.0000203309.07140.d3; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Office for Human Research Protections, DRAFT GUID DISCL REA; Schreiner MS, 2014, PEDIATRICS, V134, P1006, DOI 10.1542/peds.2014-0207; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7	9	23	23	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					895	896		10.1001/jama.2014.18528	http://dx.doi.org/10.1001/jama.2014.18528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25591061				2022-12-28	WOS:000350231800009
J	Chou, R; Turner, JA; Devine, EB; Hansen, RN; Sullivan, SD; Blazina, I; Dana, T; Bougatsos, C; Deyo, RA				Chou, Roger; Turner, Judith A.; Devine, Emily B.; Hansen, Ryan N.; Sullivan, Sean D.; Blazina, Ian; Dana, Tracy; Bougatsos, Christina; Deyo, Richard A.			The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC NONCANCER PAIN; CONTROLLED-RELEASE OXYCODONE; TRANSDERMAL FENTANYL; BACK-PAIN; PRESCRIPTION OPIOIDS; PRESCRIBING PATTERNS; SCREENING METHODS; DRUG-DEPENDENCE; MENTAL-HEALTH; MORTALITY	Background: Increases in prescriptions of opioid medications for chronic pain have been accompanied by increases in opioid overdoses, abuse, and other harms and uncertainty about long-term effectiveness. Purpose: To evaluate evidence on the effectiveness and harms of long-term (> 3 months) opioid therapy for chronic pain in adults. Data Sources: MEDLINE, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, PsycINFO, and CINAHL (January 2008 through August 2014); relevant studies from a prior review; reference lists; and ClinicalTrials. gov. Study Selection: Randomized trials and observational studies that involved adults with chronic pain who were prescribed long-term opioid therapy and that evaluated opioid therapy versus placebo, no opioid, or nonopioid therapy; different opioid dosing strategies; or risk mitigation strategies. Data Extraction: Dual extraction and quality assessment. Data Synthesis: No study of opioid therapy versus no opioid therapy evaluated long-term (> 1 year) outcomes related to pain, function, quality of life, opioid abuse, or addiction. Good- and fair-quality observational studies suggest that opioid therapy for chronic pain is associated with increased risk for overdose, opioid abuse, fractures, myocardial infarction, and markers of sexual dysfunction, although there are few studies for each of these outcomes; for some harms, higher doses are associated with increased risk. Evidence on the effectiveness and harms of different opioid dosing and risk mitigation strategies is limited. Limitations: Non-English-language articles were excluded, meta-analysis could not be done, and publication bias could not be assessed. No placebo-controlled trials met inclusion criteria, evidence was lacking for many comparisons and outcomes, and observational studies were limited in their ability to address potential confounding. Conclusion: Evidence is insufficient to determine the effectiveness of long-term opioid therapy for improving chronic pain and function. Evidence supports a dose-dependent risk for serious harms.	[Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Univ Washington, Seattle, WA 98195 USA	Oregon Health & Science University; University of Washington; University of Washington Seattle	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Agency for Healthcare Research and Quality, 2010, METH GUID MED TEST R; Akbik H, 2006, J PAIN SYMPTOM MANAG, V32, P287, DOI 10.1016/j.jpainsymman.2006.03.010; Allan L, 2005, SPINE, V30, P2484, DOI 10.1097/01.brs.0000186860.23078.a8; American Pain Society American Academy of Pain Medicine, 2009, GUID US CHRON OP THE; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], AHRQ PUBLICATION; Banta-Green CJ, 2009, DRUG ALCOHOL DEPEN, V104, P34, DOI 10.1016/j.drugalcdep.2009.03.021; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Byas-Smith MG, 2005, CLIN J PAIN, V21, P345, DOI 10.1097/01.ajp.0000125244.29279.c1; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Carman WJ, 2011, PHARMACOEPIDEM DR S, V20, P754, DOI 10.1002/pds.2131; Center for Behavioral Health Statistics and Quality, 2012, DAWN REP HIGHL 2010; Centers for Disease Control and Prevention, 2014, PRESCR DRUG OV US FA; Chou R, 2014, PROSPERO INT PROSPEC; Chou Roger, 2014, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA218; Chou R, 2014, J PAIN, V15, P321, DOI 10.1016/j.jpain.2014.01.494; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Compton PA, 2008, J PAIN SYMPTOM MANAG, V36, P383, DOI 10.1016/j.jpainsymman.2007.11.006; Cowan DT, 2005, PAIN MED, V6, P113, DOI 10.1111/j.1526-4637.2005.05020.x; Cowan DT, 2003, PAIN MED, V4, P340, DOI 10.1111/j.1526-4637.2003.03038.x; Deyo RA, 2013, SPINE, V38, P909, DOI 10.1097/BRS.0b013e3182830482; Deyo RA, 2011, J AM BOARD FAM MED, V24, P717, DOI 10.3122/jabfm.2011.06.100232; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Fleming MF, 2007, J PAIN, V8, P573, DOI 10.1016/j.jpain.2007.02.432; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Furlan AD, 2011, PAIN RES MANAG, V16, P337, DOI 10.1155/2011/465281; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gaertner J, 2006, SCHMERZ, V20, P61, DOI 10.1007/s00482-005-0396-9; Galski T, 2000, J PAIN SYMPTOM MANAG, V19, P200, DOI 10.1016/S0885-3924(99)00158-X; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hartung DM, 2007, ANN PHARMACOTHER, V41, P921, DOI 10.1345/aph.1K066; Hojsted J, 2010, EUR J PAIN, V14, P1014, DOI 10.1016/j.ejpain.2010.04.006; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; International Association for the Study of Pain Subcommittee on Taxonomy, 1986, PAIN S3, V3, pS1; Jamison RN, 1998, SPINE, V23, P2591, DOI 10.1097/00007632-199812010-00014; Jones Ted, 2013, J Opioid Manag, V9, P19, DOI 10.5055/jom.2013.0143; Jones T, 2012, CLIN J PAIN, V28, P93, DOI 10.1097/AJP.0b013e318225da9e; Krebs EE, 2011, PAIN, V152, P1789, DOI [10.1016/ j. pain. 2011 .03.023, DOI 10.1016/J.PAIN.2011]; Krebs EE, 2011, PAIN, V152, P1789, DOI 10.1016/j.pain.2011.03.023; Li L, 2013, J INTERN MED, V273, P511, DOI 10.1111/joim.12035; Li L, 2013, AM J EPIDEMIOL, V178, P559, DOI 10.1093/aje/kwt013; Mailis-Gagnon A, 2011, CAN FAM PHYSICIAN, V57, pE97; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Menefee LA, 2004, PAIN MED, V5, P42, DOI 10.1111/j.1526-4637.2004.04005.x; Mitra F, 2013, PAIN MED, V14, P75, DOI 10.1111/pme.12011; Moore TM, 2009, PAIN MED, V10, P1426, DOI 10.1111/j.1526-4637.2009.00743.x; Naliboff BD, 2011, J PAIN, V12, P288, DOI 10.1016/j.jpain.2010.09.003; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; O'Connor AB, 2013, PAIN, V154, P2324, DOI 10.1016/j.pain.2013.06.035; Olsen Y, 2006, J PAIN, V7, P225, DOI 10.1016/j.jpain.2005.11.006; Owens D, 2011, METHODS GUIDE EFFECT; Paulozzi LJ, 2012, PAIN MED, V13, P87, DOI 10.1111/j.1526-4637.2011.01260.x; Portenoy RK, 2007, CLIN J PAIN, V23, P287, DOI 10.1097/AJP.0b013e31802b582f; RALPHS JA, 1994, PAIN, V56, P279, DOI 10.1016/0304-3959(94)90166-X; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; Rolita L, 2013, J AM GERIATR SOC, V61, P335, DOI 10.1111/jgs.12148; Sabatowski R, 2003, J PAIN SYMPTOM MANAG, V25, P38, DOI 10.1016/S0885-3924(02)00539-0; Saffier K, 2007, J SUBST ABUSE TREAT, V33, P303, DOI 10.1016/j.jsat.2006.12.011; Salzman RT, 1999, J PAIN SYMPTOM MANAG, V18, P271, DOI 10.1016/S0885-3924(99)00079-2; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Schneider Jennifer P, 2010, J Opioid Manag, V6, P385; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Starrels JL, 2011, J GEN INTERN MED, V26, P958, DOI 10.1007/s11606-011-1648-2; Starrels JL, 2010, ANN INTERN MED, V152, P712, DOI 10.7326/0003-4819-152-11-201006010-00004; Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS), 1999, DASIS SERIES S, V56; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; TENNANT FS, 1982, ARCH INTERN MED, V142, P1845, DOI 10.1001/archinte.142.10.1845; U.S. Food and Drug Administration, 2013, PUBL HLTH ADV IMP IN; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wild JE, 2010, PAIN PRACT, V10, P416, DOI 10.1111/j.1533-2500.2010.00397.x	77	977	991	1	183	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 17	2015	162	4					276	+		10.7326/M14-2559	http://dx.doi.org/10.7326/M14-2559			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FU	25581257				2022-12-28	WOS:000350232500017
J	Vasquez, CG; Martin, AC				Vasquez, Claudia G.; Martin, Adam C.			Death drags down the neighbourhood	NATURE			English	Editorial Material							EPITHELIAL MORPHOGENESIS; INVAGINATION; SIGNALS; CELLS		[Vasquez, Claudia G.; Martin, Adam C.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Vasquez, CG (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	acmartin@mit.edu		Vasquez, Claudia G/0000-0002-3030-4828	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Herrgen L, 2014, DEV CELL, V31, P599, DOI 10.1016/j.devcel.2014.10.012; Lubkov V, 2014, CURR BIOL, V24, P868, DOI 10.1016/j.cub.2014.02.057; Manjon C, 2007, NAT CELL BIOL, V9, P57, DOI 10.1038/ncb1518; Manning AJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004427; Monier B, 2015, NATURE, V518, P245, DOI 10.1038/nature14152; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Vasquez CG, 2014, J CELL BIOL, V206, P435, DOI 10.1083/jcb.201402004	15	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					171	173		10.1038/nature14198	http://dx.doi.org/10.1038/nature14198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8SD	25607370	Green Submitted			2022-12-28	WOS:000349190300024
J	Crowcroft, NS; Deeks, SL; Upshur, RE				Crowcroft, Natasha S.; Deeks, Shelley L.; Upshur, Ross E.			Do we need a new approach to making vaccine recommendations?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							B MENINGOCOCCUS VACCINE; IMMUNIZATION		[Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON M5S 1A8, Canada; [Deeks, Shelley L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Upshur, Ross E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto	Crowcroft, NS (corresponding author), Publ Hlth Ontario, 480 Univ Ave,Suite 300, Toronto, ON M5S 1A8, Canada.	natasha.crowcroft@oahpp.ca						Australian Department of Health, ARTG ID 190718 BEXS; Black S, 2013, LANCET, V382, P858, DOI 10.1016/S0140-6736(13)61863-2; Blewitt J, 2013, LANCET, V382, P857, DOI 10.1016/S0140-6736(13)61861-9; Christensen H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5725; Christensen H, 2013, VACCINE, V31, P2638, DOI 10.1016/j.vaccine.2013.03.034; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; EKOS Research Associates, 2011, SURV PAR KEY ISS REL; Erickson LJ, 2005, VACCINE, V23, P2470, DOI 10.1016/j.vaccine.2004.10.029; European Medicines Agency, 2012, EUR PUBL ASS REP BEX; Eurosurveillance editorial team, 2010, EUROSURVEILLANCE, V15, P19670; Finn A, 2013, LANCET, V382, P857, DOI 10.1016/S0140-6736(13)61860-7; Health Canada, REG INN DRUGS; Joint Committee on Vaccination and Immunisation, M TUESD 11 WEDN 12 F; Kelly A, 2013, APMIS, V121, P56, DOI 10.1111/j.1600-0463.2012.02934.x; Lambert PH, 2013, LANCET, V382, P1019, DOI [10.1016/S0140-6736(13)61969-8, 10.1016/S0140-6736(13)61968-6]; Madlon-Kay D J, 1994, Arch Fam Med, V3, P610, DOI 10.1001/archfami.3.7.610; Mandeville KL, 2014, J EPIDEMIOL COMMUN H, V68, P197, DOI 10.1136/jech-2013-203128; Martinon-Torres F, 2013, LANCET, V382, P1552, DOI 10.1016/S0140-6736(13)62323-5; Moxon ER, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2929; Moxon R, 2013, LANCET, V382, P369, DOI 10.1016/S0140-6736(13)61572-X; Neville S, 2014, FINANCIAL TIMES; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Peretti-Watel P, 2014, SOC SCI MED, V109, P10, DOI 10.1016/j.socscimed.2014.02.035; Plotkin SA, 2013, LANCET, V382, P858, DOI 10.1016/S0140-6736(13)61862-0; Pollard AJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2859; Public Health Agency of Canada, 2013, CAN IMM GUID BEN VAC; Public Health Agency of Canada. An advisory committee statement, 2014, LI REV SER B INV MEN; Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013; Thompson AK, 2006, BMC MED ETHICS, V7, P12, DOI [10.1186/1472-6939-7-12, DOI 10.1186/1472-6939-7-12]	29	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 30	2015	350								h308	10.1136/bmj.h308	http://dx.doi.org/10.1136/bmj.h308			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AU	25637290				2022-12-28	WOS:000348778800001
J	Li, F; Liu, J; Zheng, Y; Garavito, RM; Ferguson-Miller, S				Li, Fei; Liu, Jian; Zheng, Yi; Garavito, R. Michael; Ferguson-Miller, Shelagh			Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism	SCIENCE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA; RHODOBACTER-SPHAEROIDES; MEMBRANE-PROTEIN; IN-VITRO; BINDING; IDENTIFICATION; EXPRESSION; MECHANISM; TRANSPORT	The 18-kilodalton translocator protein (TSPO), proposed to be a key player in cholesterol transport into mitochondria, is highly expressed in steroidogenic tissues, metastatic cancer, and inflammatory and neurological diseases such as Alzheimer's and Parkinson's. TSPO ligands, including benzodiazepine drugs, are implicated in regulating apoptosis and are extensively used in diagnostic imaging. We report crystal structures (at 1.8, 2.4, and 2.5 angstrom resolution) of TSPO from Rhodobacter sphaeroides and a mutant that mimics the human Ala(147)-> Thr(147) polymorphism associated with psychiatric disorders and reduced pregnenolone production. Crystals obtained in the lipidic cubic phase reveal the binding site of an endogenous porphyrin ligand and conformational effects of the mutation. The three crystal structures show the same tightly interacting dimer and provide insights into the controversial physiological role of TSPO and how the mutation affects cholesterol binding.	[Li, Fei; Liu, Jian; Zheng, Yi; Garavito, R. Michael; Ferguson-Miller, Shelagh] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Ferguson-Miller, S (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	fergus20@msu.edu	zheng, yi/G-1917-2016; Liu, Jian/C-4018-2015	zheng, yi/0000-0002-4871-0779; Liu, Jian/0000-0002-5668-542X	NIH [GM094625, GM26916]; Michigan State University Strategic Partnership Grant, Mitochondrial Science and Medicine; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026916, R37GM026916, U54GM094625] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University Strategic Partnership Grant, Mitochondrial Science and Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The atomic coordinates and structure factors have been deposited in the Protein Data Bank under identification numbers 4UC3 (WT), 4UC1 (A139T_C2), and 4UC2 (A139T_P2<INF>1</INF>2<INF>1</INF>2<INF>1</INF>). We thank S. Kaplan, X. Zeng (University of Texas, Houston), and A. Yeliseev (NIH) for providing the expression plasmid; R. M. Stroud, J. Lee, and members of the University of California, San Francisco, Membrane Protein Expression Center (NIH grant GM094625 to R. M. Stroud) for initial collaboration on the project and training on the lipidic cubic phase crystallization method, as well as continued support and discussion; M. Caffrey and D.-F. Li for helpful discussion of selenomethionine phasing strategies and supplying some noncommercial lipids; and A. Kruse and C. Wang for suggestions on data collection and heavy-metal soaking strategies. We also thank B. Atshaves, C. Najt, and L. Valls for assistance in obtaining the fluorescence quenching data; C. Hiser and N. Bowlby for technical assistance in protein expression and purification and careful reading of the manuscript; K. Parent for discussion on analyzing the EM map; and C. Ogata, R. Sanishvili, N. Venugopalan, M. Becker, and S. Corcoran at beamline 23ID at GM/CA CAT Advanced Photon Source, as well as M. Soltis, C. Smith, and A. Cohen at BL12-2 at the Stanford Synchrotron Radiation Light Source, for assistance and consultation. Funding was provided by NIH grant GM26916 (to S. F.-M.) and Michigan State University Strategic Partnership Grant, Mitochondrial Science and Medicine (to S. F.-M.). GM/CA@APS has been funded in whole or in part with federal funds from the National Cancer Institute (grant ACB-12002) and the National Institute of General Medical Sciences (grant AGM-12006). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357.	Bird JLE, 2010, ATHEROSCLEROSIS, V210, P388, DOI 10.1016/j.atherosclerosis.2009.11.047; Colasanti A, 2013, PSYCHONEUROENDOCRINO, V38, P2826, DOI 10.1016/j.psyneuen.2013.07.007; Costa B, 2009, ENDOCRINOLOGY, V150, P5438, DOI 10.1210/en.2009-0752; Costa B, 2009, PSYCHIAT GENET, V19, P110, DOI 10.1097/YPG.0b013e32832080f6; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Dutzler R, 2002, STRUCTURE, V10, P1273, DOI 10.1016/S0969-2126(02)00811-0; Esser C, 2007, BIOL LETT-UK, V3, P180, DOI 10.1098/rsbl.2006.0582; Fan J, 2012, CURR MOL MED, V12, P369; Fan JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076701; FARGES R, 1994, MOL PHARMACOL, V46, P1160; Gatliff J, 2012, CURR MOL MED, V12, P356; Hardwick M, 1999, CANCER RES, V59, P831; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; Kreisl WC, 2013, J CEREBR BLOOD F MET, V33, P53, DOI 10.1038/jcbfm.2012.131; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Li F, 2013, BIOCHEMISTRY-US, V52, P5884, DOI 10.1021/bi400431t; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Nakamura K, 2006, AM J MED GENET B, V141B, P222, DOI 10.1002/ajmg.b.30211; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Scarf AM, 2012, CURR MOL MED, V12, P488; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101; Yeliseev AA, 1999, J BIOL CHEM, V274, P21234, DOI 10.1074/jbc.274.30.21234; Yeliseev AA, 2000, J BIOL CHEM, V275, P5657, DOI 10.1074/jbc.275.8.5657; Zeno S, 2012, CURR MOL MED, V12, P494	30	124	126	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					555	558		10.1126/science.1260590	http://dx.doi.org/10.1126/science.1260590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635101	Green Submitted, Green Accepted			2022-12-28	WOS:000348639300055
J	Rugani, R; Vallortigara, G; Priftis, K; Regolin, L				Rugani, Rosa; Vallortigara, Giorgio; Priftis, Konstantinos; Regolin, Lucia			Number-space mapping in the newborn chick resembles humans' mental number line	SCIENCE			English	Article							NUMERICAL COMPETENCE; REPRESENTATION; PSEUDONEGLECT; BISECTION; NEGLECT; MONKEYS; CORTEX	Humans represent numbers along a mental number line (MNL), where smaller values are located on the left and larger on the right. The origin of the MNL and its connections with cultural experience are unclear: Pre-verbal infants and nonhuman species master a variety of numerical abilities, supporting the existence of evolutionary ancient precursor systems. In our experiments, 3-day-old domestic chicks, once familiarized with a target number (5), spontaneously associated a smaller number (2) with the left space and a larger number (8) with the right space. The same number (8), though, was associated with the left space when the target number was 20. Similarly to humans, chicks associate smaller numbers with the left space and larger numbers with the right space.	[Rugani, Rosa; Priftis, Konstantinos; Regolin, Lucia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Rugani, Rosa; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy	University of Padua; University of Trento	Rugani, R (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	rosa.rugani@unipd.it	Regolin, Lucia/N-9564-2019; Rugani, Rosa/C-2219-2013; Priftis, Konstantinos/B-7862-2008	Regolin, Lucia/0000-0001-8960-0309; Rugani, Rosa/0000-0001-5294-6306; Priftis, Konstantinos/0000-0002-5215-4621	University of Padova [GRIC101142, CPDA127200]; European Research Council (ERC) [PREMESOR ERC-2011-ADG_20110406]	University of Padova; European Research Council (ERC)(European Research Council (ERC))	This study was supported by the University of Padova (Progetto Giovani 2010, to R.R., GRIC101142; and Progetto di Ateneo 2012 to R.L., CPDA127200) and by European Research Council (ERC) Advanced Grant PREMESOR ERC-2011-ADG_20110406 to G.V. Raw data are provided in the supplementary materials.	Adachi I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090373; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; de Hevia MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096412; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S., 2011, NUMBER SENSE MIND CR; Diekamp B, 2005, CURR BIOL, V15, pR372, DOI 10.1016/j.cub.2005.05.017; Drucker CB, 2014, COGNITION, V132, P57, DOI 10.1016/j.cognition.2014.03.011; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nieder A, 2013, J COMP PHYSIOL A, V199, P1, DOI 10.1007/s00359-012-0763-9; Regolin L, 2006, CORTEX, V42, P101, DOI 10.1016/S0010-9452(08)70330-7; Rogers L.J., 2013, DIVIDED BRAINS; Roitman JD, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00025; Rugani R, 2007, J EXP PSYCHOL ANIM B, V33, P21, DOI 10.1037/0097-7403.33.1.21; Rugani R, 2011, NEUROBIOL LEARN MEM, V95, P231, DOI 10.1016/j.nlm.2010.11.012; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Scarf D, 2011, SCIENCE, V334, P1664, DOI 10.1126/science.1213357; Shaki S, 2009, PSYCHON B REV, V16, P328, DOI 10.3758/PBR.16.2.328; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Umilta  C, 2009, EXP BRAIN RES, V192, P561, DOI 10.1007/s00221-008-1623-2; Zebian S, 2005, J COGN CULT, V5, P165, DOI 10.1163/1568537054068660; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	26	194	197	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					534	536		10.1126/science.aaa1379	http://dx.doi.org/10.1126/science.aaa1379			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA0YK	25635096	Green Submitted			2022-12-28	WOS:000348639300049
J	Crocker-Buque, T				Crocker-Buque, Tim			IF I RULED THE NHS Ban sale of cigarettes to people born after 2000	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Crocker-Buque, T (corresponding author), Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.	drtimcb@fastmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2015	350								h469	10.1136/bmj.h469	http://dx.doi.org/10.1136/bmj.h469			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AT	25633121	Green Accepted			2022-12-28	WOS:000348778700005
J	Klass, P				Klass, Perri			Death Takes a Weekend	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY 10012 USA	New York University	Klass, P (corresponding author), NYU, New York, NY 10012 USA.		Callahan, Charles D/L-1641-2013					Goldstein SD, 2014, J PEDIATR SURG, V49, P1087, DOI 10.1016/j.jpedsurg.2014.01.001; Klass SS, 2013, NY TIMES; Klass SS, 2013, HEKTOEN INT J ME WIN; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785	4	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					402	405		10.1056/NEJMp1413363	http://dx.doi.org/10.1056/NEJMp1413363			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629738				2022-12-28	WOS:000348649700004
J	Lawrence, MS; Sougnez, C; Lichtenstein, L; Cibulskisl, K; Lander, E; Gabriel, SB; Getz, G; Ally, A; Balasundaram, M; Birol, I; Bowlby, R; Brooks, D; Butterfield, YSN; Carlsen, R; Cheng, D; Chu, A; Dhalla, N; Guin, R; Holt, RA; Jones, SJM; Lee, D; Li, HYI; Marra, MA; Mayo, M; Moore, RA; Mungall, AJ; Robertson, AG; Schein, JE; Sipahimalan, P; Tam, A; Thiessen, N; Wong, T; Protopopov, A; Santoso, N; Lee, S; Parfenov, M; Zhang, JH; Mahadeshwar, HS; Tang, JB; Ren, XJ; Seth, S; Haseley, P; Zeng, D; Yang, LX; Xu, AW; Song, XZ; Pantazi, A; Bristow, CA; Hadjipanayis, A; Seidman, J; Chin, L; Park, PJ; Kucherlapati, R; Akbani, R; Casasent, T; Liu, WB; Le, Y; Mille, G; Motter, T; Weinstein, J; Diao, LX; Wang, J; Fan, YH; Lie, JZ; Wang, K; Auman, JT; Balu, S; Bodenheimer, T; Buda, E; Hayes, DN; Hoadley, KA; Hoyle, AP; Jefferys, SR; Jones, CD; Kimes, PK; Liu, YF; Marron, JS; Meng, SW; Mieczkowski, PA; Mose, LE; Parker, JS; Perou, CM; Prins, JF; Roach, J; Shi, Y; Simons, JV; Singh, D; Soloway, MG; Tan, DH; Veluvolu, U; Walter, V; Waring, S; Wilkerson, MD; Wu, JY; Zhao, N; Cherniack, AD; Hammerman, PS; Tward, AD; Pedamallu, CS; Saksena, G; Jung, J; Ojesina, AI; Carter, SL; Zack, TI; Schumacher, SE; Beroukhim, R; Freeman, SS; Meyerson, M; Cho, J; Chin, L; Getz, G; Noble, MS; DiCara, D; Zhang, H; Heiman, DI; Gehlenborg, N; Voet, D; Lin, P; Frazer, S; Stojanov, P; Liu, YC; Zou, LH; Kim, J; Sougnez, C; Gabriel, SB; Lawrence, MS; Muzny, D; Doddapaneni, H; Kovar, C; Reid, J; Morton, D; Han, Y; Hale, W; Chao, H; Chang, K; Drummond, JA; Gibbs, RA; Kakkar, N; Wheeler, D; Xi, L; Ciriello, G; Ladanyi, M; Lee, W; Ramirez, R; Sander, C; Shen, R; Sinhal, R; Weinhold, N; Taylor, BS; Aksoy, BA; Dresdner, G; Gao, JJ; Gross, B; Jacobsen, A; Reva, B; Schultz, N; Sumer, SO; Sun, YC; Chan, TA; Morris, LG; Stuart, J; Benz, S; Ng, S; Benz, C; Yau, C; Baylin, SB; Cope, L; Danilova, L; Herman, JG; Bootwalla, M; Maglinte, DT; Larid, PW; Triche, T; Weisenberger, DJ; Van den Berg, DJ; Agrawal, N; Bishop, J; Boutros, PC; Bruce, JP; Byers, LA; Califano, J; Carey, TE; Chen, Z; Cheng, H; Chiosea, SI; Cohen, E; Diergaarde, B; Egloff, AM; El-Naggar, AK; Ferris, RL; Frederick, MJ; Grandis, JR; Guo, Y; Haddad, RI; Hammerman, PS; Harris, T; Hayes, DN; Hui, ABY; Lee, JJ; Lippman, SM; Liu, FF; McHugh, JB; Myers, J; Ng, PKS; Perez-Ordonez, B; Pickering, CR; Prystowsky, M; Romkes, M; Saleh, AD; Sartor, MA; Seethala, R; Seiwert, TY; Si, H; Tward, AD; Van Waes, C; Waggott, DM; Wiznerowicz, M; Yarbrough, WG; Zhang, JX; Zuo, ZX; Burnett, K; Crain, D; Gardner, J; Lau, K; Mallery, D; Morris, S; Lauskis, JP; Penny, R; Shelton, C; Shelton, T; Sherman, M; Yena, P; Black, AD; Bowen, J; Frick, J; Gastier-Foster, JM; Harper, HA; Leraas, K; Lichtenberg, TM; Ramirez, NC; Wise, L; Zmuda, E; Baboud, J; Jensen, MA; Kahn, AB; Pihl, TD; Pot, DA; Srinivasan, D; Walton, JS; Wan, YH; Burton, RA; Davidsen, T; Demchok, JA; Eley, G; Ferguson, ML; Shaw, KRM; Ozenberger, BA; Sheth, M; Sofia, HJ; Tarnuzzer, R; Wang, ZN; Yang, LM; Zenklusen, JC; Saller, C; Tarvi, K; Chen, C; Bollag, R; Weinberger, P; Golusinski, W; Golusinski, P; Ibbs, M; Korski, K; Mackiewicz, A; Suchorska, W; Szybiak, B; Wiznerowicz, M; Burnett, K; Curley, E; Gardner, J; Mallery, D; Penny, R; Shelton, T; Yena, P; Beard, C; Mitchell, C; Sandusky, G; Agrawal, N; Ahn, J; Bishop, J; Califano, J; Khan, Z; Bruce, JP; Hui, ABY; Irish, J; Liu, FF; Perez-Ordonez, B; Waldron, J; Boutros, PC; Waggott, DM; Myers, J; William, WN; Lippman, SM; Egea, S; Gomez-Fernandez, C; Herbert, L; Bradford, CR; Carey, TE; Chepeha, DB; Haddad, AS; Jones, TR; Komarck, CM; Malakh, M; McHugh, JB; Moyer, JS; Nguyen, A; Peterson, LA; Prince, ME; Rozek, LS; Sartor, MA; Taylor, EG; Walline, HM; Wolf, GT; Boice, L; Chera, BS; Funkhouser, WK; Gulley, ML; Hackman, TG; Hayes, DN; Hayward, MC; Huang, M; Rathmell, WK; Salazar, AH; Shockley, WW; Shores, CG; Thorne, L; Weissler, MC; Wrenn, S; Zanation, AM; Chiosea, SI; Diergaarde, B; Egloff, AM; Ferris, RL; Romkes, M; Seethala, R; Brown, BT; Guo, Y; Pham, M; Yarbrough, WG				Lawrence, Michael S.; Sougnez, Carrie; Lichtenstein, Lee; Cibulskisl, Kristian; Lander, Eric; Gabriel, Stacey B.; Getz, Gad; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Bowlby, Reanne; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Cheng, Dean; Chu, Andy; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Robertson, A. Gordon; Schein, Jacqueline E.; Sipahimalan, Payal; Tam, Angela; Thiessen, Nina; Wong, Tina; Protopopov, Alexei; Santoso, Netty; Lee, Semin; Parfenov, Michael; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Ren, Xiaojia; Seth, Sahil; Haseley, Psalm; Zeng, Dong; Yang, Lixing; Xu, Andrew W.; Song, Xingzhi; Pantazi, Angeliki; Bristow, Christopher A.; Hadjipanayis, Angela; Seidman, Jonathan; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Akbani, Rehan; Casasent, Tod; Liu, Wenbin; Le, Yiling; Mille, Gordon; Motter, Thomas; Weinstein, John; Diao, Lixia; Wang, Jing; Fan, You Hong; Lie, Jinze; Wang, Kai; Auman, J. Todd; Balu, Saianand; Bodenheimer, Thomas; Buda, Elizabeth; Hayes, D. Neil; Hoadley, Katherine A.; Hoyle, Alan P.; Jefferys, Stuart R.; Jones, Corbin D.; Kimes, Patrick K.; Liu, Yufeng; Marron, J. S.; Meng, Shaowu; Mieczkowski, Piotr A.; Mose, Lisle E.; Parker, Joel S.; Perou, Charles M.; Prins, Jan F.; Roach, Jeffrey; Shi, Yan; Simons, Janae V.; Singh, Darshan; Soloway, Matthew G.; Tan, Donghui; Veluvolu, Umadevi; Walter, Vonn; Waring, Scot; Wilkerson, Matthew D.; Wu, Junyuan; Zhao, Ni; Cherniack, Andrew D.; Hammerman, Peter S.; Tward, Aaron D.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Jung, Joonil; Ojesina, Akinyemi I.; Carter, Scott L.; Zack, Travis I.; Schumacher, Steven E.; Beroukhim, Rameen; Freeman, Samuel S.; Meyerson, Matthew; Cho, Juok; Chin, Lynda; Getz, Gad; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Heiman, David I.; Gehlenborg, Nils; Voet, Doug; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zou, Lihua; Kim, Jaegil; Sougnez, Carrie; Gabriel, Stacey B.; Lawrence, Michael S.; Muzny, Donna; Doddapaneni, HarshaVardhan; Kovar, Christie; Reid, Jeff; Morton, Donna; Han, Yi; Hale, Walker; Chao, Hsu; Chang, Kyle; Drummond, Jennifer A.; Gibbs, Richard A.; Kakkar, Nipun; Wheeler, David; Xi, Liu; Ciriello, Giovanni; Ladanyi, Marc; Lee, William; Ramirez, Ricardo; Sander, Chris; Shen, Ronglai; Sinhal, Rileen; Weinhold, Nils; Taylor, Barry S.; Aksoy, B. Arman; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Reva, Boris; Schultz, Nikolaus; Sumer, S. Onur; Sun, Yichao; Chan, Timothy A.; Morris, Luc G.; Stuart, Joshua; Benz, Stephen; Ng, Sam; Benz, Christopher; Yau, Christina; Baylin, Stephen B.; Cope, Leslie; Danilova, Ludmila; Herman, James G.; Bootwalla, Moiz; Maglinte, Dennis T.; Larid, Peter W.; Triche, Timothy, Jr.; Weisenberger, Daniel J.; Van den Berg, David J.; Agrawal, Nishant; Bishop, Justin; Boutros, Paul C.; Bruce, Jeff P.; Byers, Lauren Averett; Califano, Joseph; Carey, Thomas E.; Chen, Zhong; Cheng, Hui; Chiosea, Simion I.; Cohen, Ezra; Diergaarde, Brenda; Egloff, Ann Marie; El-Naggar, Adel K.; Ferris, Robert L.; Frederick, Mitchell J.; Grandis, Jennifer R.; Guo, Yan; Haddad, Robert I.; Hammerman, Peter S.; Harris, Thomas; Hayes, D. Neil; Hui, Angela B. Y.; Lee, J. Jack; Lippman, Scott M.; Liu, Fei-Fei; McHugh, Jonathan B.; Myers, Jeff; Ng, Patrick Kwok Shing; Perez-Ordonez, Bayardo; Pickering, Curtis R.; Prystowsky, Michael; Romkes, Marjorie; Saleh, Anthony D.; Sartor, Maureen A.; Seethala, Raja; Seiwert, Tanguy Y.; Si, Han; Tward, Aaron D.; Van Waes, Carter; Waggott, Daryl M.; Wiznerowicz, Maciej; Yarbrough, Wendell G.; Zhang, Jiexin; Zuo, Zhixiang; Burnett, Ken; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Mallery, David; Morris, Scott; Lauskis, Joseph Pau; Penny, Robert; Shelton, Candace; Shelton, Troy; Sherman, Mark; Yena, Peggy; Black, Aaron D.; Bowen, Jay; Frick, Jessica; Gastier-Foster, Julie M.; Harper, Hollie A.; Leraas, Kristen; Lichtenberg, Tara M.; Ramirez, Nilsa C.; Wise, Lisa; Zmuda, Erik; Baboud, Julien; Jensen, Mark A.; Kahn, An B.; Pihl, Todd D.; Pot, David A.; Srinivasan, Deepak; Walton, Jessica S.; Wan, Yunhu; Burton, Robert A.; Davidsen, Tanja; Demchok, John A.; Eley, Greg; Ferguson, Martin L.; Shaw, Kenna R. Mills; Ozenberger, Bradley A.; Sheth, Margi; Sofia, Heidi J.; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude; Saller, Charles; Tarvi, Katherine; Chen, Chu; Bollag, Roni; Weinberger, Paul; Golusinski, Wojciech; Golusinski, Pawel; Ibbs, Matthew; Korski, Konstanty; Mackiewicz, Andrzej; Suchorska, Wiktoria; Szybiak, Bartosz; Wiznerowicz, Maciej; Burnett, Ken; Curley, Erin; Gardner, Johanna; Mallery, David; Penny, Robert; Shelton, Troy; Yena, Peggy; Beard, Christina; Mitchell, Colleen; Sandusky, George; Agrawal, Nishant; Ahn, Julie; Bishop, Justin; Califano, Joseph; Khan, Zubair; Bruce, Jeff P.; Hui, Angela B. Y.; Irish, Jonathan; Liu, Fei-Fei; Perez-Ordonez, Bayardo; Waldron, John; Boutros, Paul C.; Waggott, Daryl M.; Myers, Jeff; William, William N., Jr.; Lippman, Scott M.; Egea, Sophie; Gomez-Fernandez, Carmen; Herbert, Lynn; Bradford, Carol R.; Carey, Thomas E.; Chepeha, Douglas B.; Haddad, Andrea S.; Jones, Tamara R.; Komarck, Christine M.; Malakh, Mayya; McHugh, Jonathan B.; Moyer, Jeffrey S.; Nguyen, Ariane; Peterson, Lisa A.; Prince, Mark E.; Rozek, Laura S.; Sartor, Maureen A.; Taylor, Evan G.; Walline, Heather M.; Wolf, Gregory T.; Boice, Lori; Chera, Bhishamjit S.; Funkhouser, William K.; Gulley, Margaret L.; Hackman, Trevor G.; Hayes, D. Neil; Hayward, Michele C.; Huang, Mei; Rathmell, W. Kimryn; Salazar, Ashley H.; Shockley, William W.; Shores, Carol G.; Thorne, Leigh; Weissler, Mark C.; Wrenn, Sylvia; Zanation, Adam M.; Chiosea, Simion I.; Diergaarde, Brenda; Egloff, Ann Marie; Ferris, Robert L.; Romkes, Marjorie; Seethala, Raja; Brown, Brandee T.; Guo, Yan; Pham, Michelle; Yarbrough, Wendell G.		Canc Genome Atlas Network	Comprehensive genomic characterization of head and neck squamous cell carcinomas	NATURE			English	Article							NF-KAPPA-B; GROWTH-FACTOR-RECEPTOR; LIM PROTEIN AJUBA; CANCER GROWTH; ACTIVATION; EGFR; CLASSIFICATION; RESISTANCE; INHIBITORS; MUTATIONS	The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a comprehensive landscape of somatic genomic alterations. Here we show that human-papillomavirus-associated tumours are dominated by helical domain mutations of the oncogene PIK3CA, novel alterations involving loss of TRAF3, and amplification of the cell cycle gene E2F1. Smoking-related HNSCCs demonstrate near universal loss-of-function TP53 mutations and CDKN2A inactivation with frequent copy number alterations including amplification of 3q26/28 and 11q13/22. A subgroup of oral cavity tumours with favourable clinical outcomes displayed infrequent copy number alterations in conjunction with activating mutations of HRAS or PIK3CA, coupled with inactivating mutations of CASP8, NOTCH1 and TP53. Other distinct subgroups contained loss-of-function alterations of the chromatin modifier NSD1, WNT pathway genes AJUBA and FAT1, and activation of oxidative stress factor NFE2L2, mainly in laryngeal tumours. Therapeutic candidate alterations were identified in most HNSCCs.	[Lichtenstein, Lee; Cibulskisl, Kristian; Lander, Eric; Gabriel, Stacey B.; Cherniack, Andrew D.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Jung, Joonil; Ojesina, Akinyemi I.; Carter, Scott L.; Zack, Travis I.; Schumacher, Steven E.; Beroukhim, Rameen; Freeman, Samuel S.; Meyerson, Matthew; Cho, Juok; Noble, Michael S.; DiCara, Daniel; Zhang, Hailei; Heiman, David I.; Gehlenborg, Nils; Voet, Doug; Lin, Pei; Frazer, Scott; Stojanov, Petar; Liu, Yingchun; Zou, Lihua; Kim, Jaegil] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Bowlby, Reanne; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Cheng, Dean; Chu, Andy; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Robertson, A. Gordon; Schein, Jacqueline E.; Sipahimalan, Payal; Tam, Angela; Thiessen, Nina; Wong, Tina] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Protopopov, Alexei; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Seth, Sahil; Zeng, Dong; Song, Xingzhi; Bristow, Christopher A.; Akbani, Rehan; Casasent, Tod; Liu, Wenbin; Le, Yiling; Mille, Gordon; Motter, Thomas; Weinstein, John; Diao, Lixia; Wang, Jing; Fan, You Hong; Byers, Lauren Averett; El-Naggar, Adel K.; Frederick, Mitchell J.; Lee, J. Jack; Myers, Jeff; Ng, Patrick Kwok Shing; Pickering, Curtis R.; Zhang, Jiexin; William, William N., Jr.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Santoso, Netty; Lee, Semin; Parfenov, Michael; Ren, Xiaojia; Haseley, Psalm; Yang, Lixing; Xu, Andrew W.; Pantazi, Angeliki; Hadjipanayis, Angela; Seidman, Jonathan; Park, Peter J.; Kucherlapati, Raju; Beroukhim, Rameen; Meyerson, Matthew; Tward, Aaron D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hadjipanayis, Angela; Park, Peter J.; Kucherlapati, Raju] Brigham & Womens Hosp, Boston, MA 02115 USA; [Park, Peter J.] Boston Childrens Hosp, Boston, MA 02115 USA; [Lie, Jinze; Wang, Kai] Univ Kentucky, Lexington, KY 40506 USA; [Auman, J. Todd; Balu, Saianand; Bodenheimer, Thomas; Buda, Elizabeth; Hoadley, Katherine A.; Hoyle, Alan P.; Jefferys, Stuart R.; Jones, Corbin D.; Kimes, Patrick K.; Liu, Yufeng; Marron, J. S.; Meng, Shaowu; Mieczkowski, Piotr A.; Mose, Lisle E.; Parker, Joel S.; Perou, Charles M.; Prins, Jan F.; Roach, Jeffrey; Shi, Yan; Simons, Janae V.; Singh, Darshan; Soloway, Matthew G.; Tan, Donghui; Veluvolu, Umadevi; Walter, Vonn; Waring, Scot; Wilkerson, Matthew D.; Wu, Junyuan; Zhao, Ni; Boice, Lori; Chera, Bhishamjit S.; Funkhouser, William K.; Gulley, Margaret L.; Hackman, Trevor G.; Hayward, Michele C.; Huang, Mei; Rathmell, W. Kimryn; Salazar, Ashley H.; Shockley, William W.; Shores, Carol G.; Thorne, Leigh; Weissler, Mark C.; Wrenn, Sylvia; Zanation, Adam M.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Pedamallu, Chandra Sekhar; Ojesina, Akinyemi I.; Zack, Travis I.; Schumacher, Steven E.; Beroukhim, Rameen; Meyerson, Matthew; Stojanov, Petar; Haddad, Robert I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Zack, Travis I.] Harvard Univ, Boston, MA 02115 USA; [Muzny, Donna; Doddapaneni, HarshaVardhan; Kovar, Christie; Reid, Jeff; Morton, Donna; Han, Yi; Hale, Walker; Chao, Hsu; Chang, Kyle; Drummond, Jennifer A.; Gibbs, Richard A.; Kakkar, Nipun; Wheeler, David; Xi, Liu] Baylor Coll Med, Houston, TX 77030 USA; [Ciriello, Giovanni; Ladanyi, Marc; Lee, William; Ramirez, Ricardo; Sander, Chris; Shen, Ronglai; Sinhal, Rileen; Weinhold, Nils; Taylor, Barry S.; Aksoy, B. Arman; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Reva, Boris; Schultz, Nikolaus; Sumer, S. Onur; Sun, Yichao; Chan, Timothy A.; Morris, Luc G.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Stuart, Joshua; Benz, Stephen; Ng, Sam; Benz, Christopher; Yau, Christina] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Baylin, Stephen B.; Cope, Leslie; Danilova, Ludmila; Herman, James G.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Bootwalla, Moiz; Maglinte, Dennis T.; Larid, Peter W.; Triche, Timothy, Jr.; Weisenberger, Daniel J.; Van den Berg, David J.] Univ So Calif, Los Angeles, CA 90033 USA; [Agrawal, Nishant; Bishop, Justin; Califano, Joseph; Ahn, Julie; Khan, Zubair] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Boutros, Paul C.; Waggott, Daryl M.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Bruce, Jeff P.; Hui, Angela B. Y.] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Carey, Thomas E.; McHugh, Jonathan B.; Sartor, Maureen A.; Bradford, Carol R.; Chepeha, Douglas B.; Haddad, Andrea S.; Jones, Tamara R.; Komarck, Christine M.; Malakh, Mayya; Moyer, Jeffrey S.; Nguyen, Ariane; Peterson, Lisa A.; Prince, Mark E.; Rozek, Laura S.; Taylor, Evan G.; Walline, Heather M.; Wolf, Gregory T.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chen, Zhong; Cheng, Hui; Saleh, Anthony D.; Si, Han; Van Waes, Carter] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA; [Chiosea, Simion I.; Diergaarde, Brenda; Egloff, Ann Marie; Ferris, Robert L.; Grandis, Jennifer R.; Romkes, Marjorie; Seethala, Raja] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Cohen, Ezra; Seiwert, Tanguy Y.; Zuo, Zhixiang] Univ Chicago, Chicago, IL 60637 USA; [Guo, Yan; Brown, Brandee T.; Pham, Michelle] Vanderbilt Univ, Med Ctr, Med Ctr East 7209, Nashville, TN 37232 USA; [Harris, Thomas; Prystowsky, Michael] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Lippman, Scott M.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Liu, Fei-Fei; Irish, Jonathan; Waldron, John] Univ Toronto, Toronto, ON M5G 2M9, Canada; [Perez-Ordonez, Bayardo] Univ Hlth Network, Toronto, ON M5G 2C4, Canada; [Wiznerowicz, Maciej; Golusinski, Wojciech; Golusinski, Pawel; Ibbs, Matthew; Korski, Konstanty; Mackiewicz, Andrzej; Suchorska, Wiktoria; Szybiak, Bartosz] Greater Poland Canc Ctr, PL-61866 Poznan, Poland; [Yarbrough, Wendell G.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Burnett, Ken; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Mallery, David; Morris, Scott; Lauskis, Joseph Pau; Shelton, Candace; Shelton, Troy; Sherman, Mark; Yena, Peggy; Curley, Erin] Int Genom Consortium, Phoenix, AZ 85004 USA; [Black, Aaron D.; Bowen, Jay; Frick, Jessica; Gastier-Foster, Julie M.; Harper, Hollie A.; Leraas, Kristen; Lichtenberg, Tara M.; Ramirez, Nilsa C.; Wise, Lisa; Zmuda, Erik] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Baboud, Julien; Jensen, Mark A.; Kahn, An B.; Pihl, Todd D.; Pot, David A.; Srinivasan, Deepak; Walton, Jessica S.; Wan, Yunhu] SRA Int, Fairfax, VA 22033 USA; [Burton, Robert A.] Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Davidsen, Tanja; Demchok, John A.; Ferguson, Martin L.; Shaw, Kenna R. Mills; Sheth, Margi; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude] NCI, Bethesda, MD 20892 USA; [Eley, Greg] Scimentis LLC, Atlanta, GA 30666 USA; [Ozenberger, Bradley A.; Sofia, Heidi J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Saller, Charles; Tarvi, Katherine] Analyt Biol Serv Inc, St Petersburg 198013, Russia; [Chen, Chu] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bollag, Roni; Weinberger, Paul] Georgia Regents Univ, Augusta, GA 30912 USA; [Beard, Christina; Mitchell, Colleen; Sandusky, George] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Egea, Sophie; Gomez-Fernandez, Carmen; Herbert, Lynn] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; British Columbia Cancer Agency; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute; Harvard University; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; University of California System; University of California Santa Cruz; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Wielkopolskie Centrum Onkologii; Yale University; International Genomics Consortium; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fred Hutchinson Cancer Center; University System of Georgia; Augusta University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Miami	Hayes, DN (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	hayes@med.unc.edu; anaggar@mdanderson.org; grandisjr@upmc.edu	Lawrence, Michael/AAC-8202-2020; Jones, Steven J/C-3621-2009; Bruce, Jeff/AAF-1350-2019; Suchorska, Wiktoria/CAG-0479-2022; Schultz, Nikolaus/ABE-6347-2020; Marra, Marco A/B-5987-2008; Cherniack, Andrew/AAC-5310-2019; Kucherlapati, Raju/ABC-8807-2021; Skanderup, Anders Jacobsen/K-1081-2013; Sartor, Maureen/L-2902-2019; Zhao, Ni/P-9086-2014; Schein, Jacquie E/G-3674-2015; Ibbs, Matthew/AAU-1511-2021; Birol, Inanc/G-5440-2011; Chan, Timothy A/ABD-5850-2021; Ladanyi, Marc/AAG-8585-2019; Seth, Sahil/I-5809-2019; William, William/GRX-5352-2022; Van Den Berg, David J/G-8598-2017; Reva, Boris/AAB-8932-2022; Wheeler, David A/M-9740-2018; Laird, Peter W/G-8683-2012; Parker, Joel/AAG-1108-2019; Stojanov, Petar/GQI-4462-2022; Perou, Charles M/H-9934-2014; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Akbani, Rehan/AAG-1490-2019; Lee, Jack/P-7331-2019; Cherniack, Andrew D./AAY-8132-2020; Walter, Vonn/AAI-3450-2021; Drummond, Jennifer/AAG-1654-2020; Holt, Robert A/C-3303-2009; Pedamallu, Chandra Sekhar/AAV-6745-2020; Lee, Semin/S-2629-2016; Mungall, Andrew J./U-7067-2018; Pedamallu, Chandra Sekhar/AAV-6723-2020; Weinberger, Paul/B-7007-2008; Gao, JianJiong/B-5673-2016; Zuo, Zhixiang/M-4441-2016; Weisenberger, Daniel/AAA-8314-2020	Jones, Steven J/0000-0003-3394-2208; Bruce, Jeff/0000-0001-5509-9990; Marra, Marco A/0000-0001-7146-7175; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Zhao, Ni/0000-0002-7762-3949; Ibbs, Matthew/0000-0003-2510-3447; Birol, Inanc/0000-0003-0950-7839; Seth, Sahil/0000-0003-4579-3959; Van Den Berg, David J/0000-0002-5404-5218; Wheeler, David A/0000-0002-9056-6299; Laird, Peter W/0000-0001-9117-3641; Stojanov, Petar/0000-0001-7815-776X; Perou, Charles M/0000-0001-9827-2247; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Lee, Jack/0000-0002-4584-929X; Cherniack, Andrew D./0000-0003-0470-0111; Walter, Vonn/0000-0001-6114-6714; Drummond, Jennifer/0000-0002-2612-5958; Holt, Robert A/0000-0002-7259-1247; Lee, Semin/0000-0002-9015-6046; Mungall, Andrew J./0000-0002-0905-2742; Weinberger, Paul/0000-0002-5885-2631; Gao, JianJiong/0000-0002-5739-1781; Zuo, Zhixiang/0000-0002-2492-2689; Weisenberger, Daniel/0000-0001-8303-2603; Carey, Thomas/0000-0002-5202-7518; Freeman, Samuel/0000-0001-8285-0057; doddapaneni, harshavardhan/0000-0002-2433-633X; Diergaarde, Brenda/0000-0002-3578-6547; Auman, James/0000-0002-9328-8829; Spence, Tara/0000-0001-7098-4103; Heiman, David/0000-0001-7895-4259; Bowen, Jay/0000-0001-6861-9043; Jensen, Mark/0000-0001-5215-101X; Ciriello, Giovanni/0000-0003-2021-8683; Triche, Tim/0000-0001-5665-946X; Haddad, Robert/0000-0003-1413-0079; Liu, Fei-Fei/0000-0003-4344-6486; Stuart, Joshua/0000-0002-2171-565X; Chang, Kyle/0000-0001-5295-9676; Ojesina, Akinyemi/0000-0003-0755-3639; Nguyen, Ariane/0000-0001-5556-4258; Weinstein, John/0000-0001-9401-6908; Golusinski, Pawel/0000-0002-3937-5315; Meyerson, Matthew/0000-0002-9133-8108; Cibulskis, Kristian/0000-0003-1343-1582; Suchorska, Wiktoria/0000-0003-4742-2465; Schultz, Nikolaus/0000-0002-0131-4904; GOLUSINSKI, WOJCIECH/0000-0002-6075-3464; Park, Peter/0000-0001-9378-960X; Mieczkowski, Piotr/0000-0003-2418-0096; Perez-Ordonez, Bayardo/0000-0003-1222-8208; Tarnuzzer, Roy/0000-0002-3725-4173; Chepeha, Douglas/0000-0001-9062-3719; Pickering, Curtis/0000-0002-7942-728X; Gehlenborg, Nils/0000-0003-0327-8297; Sinha, Rileen/0000-0001-5497-5055; Chiosea, Simion/0000-0002-5766-8779; Waldron, John/0000-0002-1050-7329; Benz, Stephen/0000-0002-4067-0602; Hoadley, Katherine/0000-0002-1216-477X; Boutros, Paul/0000-0003-0553-7520; Pot, David/0000-0002-1480-9826	National Institutes of Health (NIH) [P50CA097190, P50CA16672, U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, RO1 CA 095419]; Bobby F. Garrett Fund for Head and Neck Cancer Research; NIDCD Intramural Projects [ZIA-DC-000016, 73, 74]; Direct For Computer & Info Scie & Enginr [1054631] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, U24CA143848, R01CA095419, U24CA143843, P50CA097190, U24CA143799, U24CA143858, U24CA144025, U24CA143883, P30CA177558, U24CA143835, U24CA143866, U24CA180951, U24CA143867, P30CA008748, U24CA143845, P30CA047904, U24CA143840, U24CA143882] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006272, U54HG003273, U54HG003079, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023685, K08DE024774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000074, ZIADC000073, ZIADC000016] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bobby F. Garrett Fund for Head and Neck Cancer Research; NIDCD Intramural Projects; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Health (NIH) grants: P50CA097190, P50CA16672, U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025 and RO1 CA 095419. Supported by The Bobby F. Garrett Fund for Head and Neck Cancer Research and NIDCD Intramural Projects ZIA-DC-000016, 73 and 74.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Eliopoulos AG, 1996, ONCOGENE, V13, P2243; ESTEBAN F, 1990, BRIT J CANCER, V62, P1047, DOI 10.1038/bjc.1990.437; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fickie MR, 2011, AM J MED GENET A, V155A, P2105, DOI 10.1002/ajmg.a.34156; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haraguchi K, 2008, ONCOGENE, V27, P274, DOI 10.1038/sj.onc.1210644; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Kalan Sampada, 2013, Frontiers in Genetics, V4, P95, DOI 10.3389/fgene.2013.00095; Karim R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003384; KEATING PJ, 1995, BRIT J CANCER, V72, P405, DOI 10.1038/bjc.1995.346; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Nagai Y, 2010, BIOCHEM BIOPH RES CO, V396, P887, DOI 10.1016/j.bbrc.2010.05.017; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Nola S, 2011, J CELL BIOL, V195, P855, DOI 10.1083/jcb.201107162; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Park SJ, 2001, BIOCHEM BIOPH RES CO, V287, P1140, DOI 10.1006/bbrc.2001.5713; POPESCU NC, 1987, CYTOGENET CELL GENET, V44, P58, DOI 10.1159/000132342; Quintana RM, 2013, J INVEST DERMATOL, V133, P239, DOI 10.1038/jid.2012.245; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Sanhaji M, 2013, CELL CYCLE, V12, P1340, DOI 10.4161/cc.24573; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smeets SJ, 2009, CELL ONCOL, V31, P291, DOI 10.3233/CLO-2009-0471; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wong JV, 2011, CELL CYCLE, V10; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445	45	2221	2249	16	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					576	582		10.1038/nature14129	http://dx.doi.org/10.1038/nature14129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631445	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000348775000035
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Focusing to Achieve a World Without AIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV		[Fauci, Anthony S.; Marston, Hilary D.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Bldg 31,Room 7A-03,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Rosenberg ES, 2014, LANCET HIV, V1, pE112, DOI 10.1016/S2352-3018(14)00011-3; UNAIDS, FAST TRACK END AIDS; UNAIDS, ISS BRIEF LOC EP; US Public Health Service, PREEXP PROPH PREV HI; World Health Organization, 2014, CONS GUID HIV PREV D	7	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					357	358		10.1001/jama.2014.17454	http://dx.doi.org/10.1001/jama.2014.17454			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626032				2022-12-28	WOS:000349072600013
J	Asghar, M; Hasselquist, D; Hansson, B; Zehtindjiev, P; Westerdahl, H; Bensch, S				Asghar, M.; Hasselquist, D.; Hansson, B.; Zehtindjiev, P.; Westerdahl, H.; Bensch, S.			Hidden costs of infection: Chronic malaria accelerates telomere degradation and senescence in wild birds	SCIENCE			English	Article							GREAT REED WARBLERS; ACROCEPHALUS-ARUNDINACEUS; AVIAN MALARIA; PARASITES; DYNAMICS; LENGTH; MORTALITY; POLYGYNY; ECOLOGY; COMPLEX	Recovery from infection is not always complete, and mild chronic infection may persist. Although the direct costs of such infections are apparently small, the potential for any long-term effects on Darwinian fitness is poorly understood. In a wild population of great reed warblers, we found that low-level chronic malaria infection reduced life span as well as the lifetime number and quality of offspring. These delayed fitness effects of malaria appear to be mediated by telomere degradation, a result supported by controlled infection experiments on birds in captivity. The results of this study imply that chronic infection may be causing a series of small adverse effects that accumulate and eventually impair phenotypic quality and Darwinian fitness.	[Asghar, M.; Hasselquist, D.; Hansson, B.; Westerdahl, H.; Bensch, S.] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Asghar, M.] Karolinska Inst, Dept Med Solna, Infect Dis Unit, S-17176 Stockholm, Sweden; [Zehtindjiev, P.] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, BU-1113 Sofia, Bulgaria	Lund University; Karolinska Institutet; Bulgarian Academy of Sciences	Hasselquist, D (corresponding author), Lund Univ, Dept Biol, Ecol Bldg, S-22362 Lund, Sweden.	dennis.hasselquist@biol.lu.se	Zehtidiev, Pavel/K-3236-2012; Hansson, Bengt/L-8874-2013; Asghar, Muhammad/C-6730-2013	Zehtidiev, Pavel/0000-0002-9786-3974; Hansson, Bengt/0000-0001-6694-8169; Asghar, Muhammad/0000-0002-9017-2206	Swedish Research Council; Higher Education Commission of Pakistan; CAnMove - Swedish Research Council; CAnMove - Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); CAnMove - Swedish Research Council; CAnMove - Lund University	This work was supported by the Swedish Research Council (grants to D.H., B.H., H.W., and S.B.), the Higher Education Commission of Pakistan (to M.A.), and CAnMove (a Linnaeus research excellence environment financed by the Swedish Research Council and Lund University). The field work was conducted in collaboration with Kvismare Bird Observatory (report 174), and the experiment was conducted at Kalimok Field Station (Bulgarian Academy of Sciences, report 56). We thank C. Cornwallis, J.-A. Nilsson, T. Alerstam, M. Strandh, and A. Marzal for manuscript comments and discussions. M. A., S.B., and D. H. designed the study. Field data and blood samples were collected by S.B., B.H., D. H., H.W., and many field assistants over 25 years. M. A. and S.B. developed the qPCR methods to quantify parasite intensity and telomere length. S.B. and P.Z. did the experimental infections. M. A. did the molecular analyses and analyzed the data together with S.B., D. H., and B.H. All authors interpreted the data. M. A., D. H., and S.B. wrote the manuscript, with extensive contributions from B.H., H.W., and P.Z. Data are available from the Dryad Digital Repository: http://doi.org/10.5061/dryad.d04h0. We declare no competing financial interests.	Asghar M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2263; Asghar M, 2012, PARASITOLOGY, V139, P1246, DOI 10.1017/S0031182012000510; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; Ashley N. T., 2012, ECOIMMUNOLOGY, P45; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bensch S, 1996, J ANIM ECOL, V65, P283, DOI 10.2307/5875; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Hasselquist D., 2012, ECOIMMUNOLOGY, P165; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Ilmonen P, 2008, J EVOLUTION BIOL, V21, P834, DOI 10.1111/j.1420-9101.2008.01510.x; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Westerdahl H, 2012, P ROY SOC B-BIOL SCI, V279, P577, DOI 10.1098/rspb.2011.0917; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	29	320	324	8	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					436	438		10.1126/science.1261121	http://dx.doi.org/10.1126/science.1261121			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613889				2022-12-28	WOS:000348225800047
J	Cloetingh, S; Haq, BU				Cloetingh, Sierd; Haq, Bilal U.			Inherited landscapes and sea level change	SCIENCE			English	Review							DYNAMIC TOPOGRAPHY; VERTICAL MOTION; ATLANTIC; SUBSIDENCE; CONTINENTS; EVOLUTION; RHEOLOGY; SUBDUCTION; CHRONOLOGY; HISTORY	Enabled by recently gained understanding of deep-seated and surficial Earth processes, a convergence of views between geophysics and sedimentary geology has been quietly taking place over the past several decades. Surface topography resulting from lithospheric memory, retained at various temporal and spatial scales, has become the connective link between these two methodologically diverse geoscience disciplines. Ideas leading to the hypothesis of plate tectonics originated largely with an oceanic focus, where dynamic and mostly horizontal movements of the crust could be envisioned. But when these notions were applied to the landscapes of the supposedly rigid plate interiors, there was less success in explaining the observed anomalies in terrestrial topography. Solid-Earth geophysics has now reached a developmental stage where vertical movements can be measured and modeled at meaningful scales and the deep-seated structures can be imaged with increasing resolution. Concurrently, there have been advances in quantifying mechanical properties of the lithosphere (the solid outer skin of Earth, usually defined to include both the crust and the solid but elastic upper mantle above the asthenosphere). The lithosphere acts as the intermediary that transfers the effects of mantle dynamics to the surface. These developments have allowed us to better understand the previously puzzling topographic features of plate interiors and continental margins. On the sedimentary geology side, new quantitative modeling techniques and holistic approaches to integrating source-to-sink sedimentary systems have led to clearer understanding of basin evolution and sediment budgets that allow the reconstruction of missing sedimentary records and past geological landscapes.	[Cloetingh, Sierd] Univ Utrecht, Utrecht, Netherlands; [Haq, Bilal U.] Natl Sci Fdn, Arlington, VA 22230 USA; [Haq, Bilal U.] Univ Paris 06, F-75005 Paris, France; [Haq, Bilal U.] CNRS, ISTeP, UMR 7193, F-75005 Paris, France	Utrecht University; National Science Foundation (NSF); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Haq, BU (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	bilhaq@gmail.com	Haq, Bilal/Q-8112-2019; Haq, Bilal U./B-2836-2017; Cloetingh, Sierd APL/E-5194-2012	Cloetingh, Sierd APL/0000-0001-9472-7881	Netherlands Research Center for Integrated Solid Earth Science; Utrecht University	Netherlands Research Center for Integrated Solid Earth Science; Utrecht University	We thank E. Burov, T. Francois, and H. Thybo for valuable discussions and comments on this paper, and our colleagues T. Watts and the late P. Ziegler with whom our discussions over the years have evolved our views about the interaction of solid Earth with eustasy. B.U.H. acknowledges National Science Foundation for many years of unfettered access to research time as a part of his functions at the Foundation. S.C. acknowledges the generous support provided by the Netherlands Research Center for Integrated Solid Earth Science and Utrecht University.	Artemieva I., 2011, THE LITHOSPHERE AN I; Becker TW, 2009, EARTH PLANET SC LETT, V278, P233, DOI 10.1016/j.epsl.2008.12.007; Bertotti G, 2012, INT J EARTH SCI, V101, P2151, DOI 10.1007/s00531-012-0773-4; Boschi L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045001; Burov EB, 2010, TECTONOPHYSICS, V484, P4, DOI 10.1016/j.tecto.2009.06.013; Burov EB, 2011, MAR PETROL GEOL, V28, P1402, DOI 10.1016/j.marpetgeo.2011.05.008; Burov E, 2014, NATURE, V513, P85, DOI 10.1038/nature13703; Burov E, 2009, GEOPHYS J INT, V178, P1691, DOI 10.1111/j.1365-246X.2009.04238.x; Cloetingh S, 2013, GONDWANA RES, V24, P815, DOI 10.1016/j.gr.2012.11.012; CLOETINGH S, 1985, EARTH PLANET SC LETT, V75, P157, DOI 10.1016/0012-821X(85)90098-6; Cloetingh S., 2007, TREATISE GEOPHYS, V6, P486; Cloetingh S, 2013, TECTONOPHYSICS, V602, P1, DOI 10.1016/j.tecto.2013.05.023; COFFIN MF, 1994, REV GEOPHYS, V32, P1, DOI 10.1029/93RG02508; Cogne JP, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001148; Conrad CP, 2013, GEOL SOC AM BULL, V125, P1027, DOI 10.1130/B30764.1; Conrad CP, 1997, GEOPHYS RES LETT, V24, P1503, DOI 10.1029/97GL01338; COURTILLOT V, 1986, EARTH PLANET SC LETT, V80, P361, DOI 10.1016/0012-821X(86)90118-4; Dewey J. F., 1997, SEPM SPEC PUB, V58, P95; Deynoux M., 1994, EARTHS GLACIAL RECOR; Dupre S, 2007, MAR PETROL GEOL, V24, P151, DOI 10.1016/j.marpetgeo.2006.11.003; Duretz T, 2013, TECTONOPHYSICS, V602, P124, DOI 10.1016/j.tecto.2012.12.024; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; Flament N, 2013, LITHOSPHERE-US, V5, P189, DOI 10.1130/L245.1; Francois T, 2013, TECTONOPHYSICS, V602, P106, DOI 10.1016/j.tecto.2012.10.009; GURNIS M, 1992, SCIENCE, V255, P1556, DOI 10.1126/science.255.5051.1556; GURNIS M, 1993, NATURE, V364, P589, DOI 10.1038/364589a0; GURNIS M, 1990, SCIENCE, V250, P970, DOI 10.1126/science.250.4983.970; Gurnis M, 1998, SCIENCE, V279, P1499, DOI 10.1126/science.279.5356.1499; Haq BU, 2008, SCIENCE, V322, P64, DOI 10.1126/science.1161648; Haq BU, 2014, GLOBAL PLANET CHANGE, V113, P44, DOI 10.1016/j.gloplacha.2013.12.007; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hay W.W., 1990, SEA LEVEL CHANGE, P161, DOI DOI 10.17226/1345; Hay WW, 2008, CRETACEOUS RES, V29, P725, DOI 10.1016/j.cretres.2008.05.025; Ito G, 1998, EARTH PLANET SC LETT, V161, P85, DOI 10.1016/S0012-821X(98)00139-3; JACOBS DK, 1993, NATURE, V361, P710, DOI 10.1038/361710a0; JANSSEN ME, 1995, GEOL SOC AM BULL, V107, P1317, DOI 10.1130/0016-7606(1995)107<1317:TASCBC>2.3.CO;2; Jaupart C., 2007, MANTLE DYNAMICS, V7, P253, DOI DOI 10.1016/B978-; Johnson H., 2008, GEOL SOC LONDON SPEC, V206; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; Kominz M. A., 1984, AM ASS PET GEOL, V36, P109; Lambeck K, 1998, GEOPHYS J INT, V135, P375, DOI 10.1046/j.1365-246X.1998.00643.x; LithgowBertelloni C, 1997, GEOLOGY, V25, P735; Liu LJ, 2008, SCIENCE, V322, P934, DOI 10.1126/science.1162921; Liu SF, 2014, EARTH PLANET SC LETT, V389, P221, DOI 10.1016/j.epsl.2014.01.006; Matenco L, 2013, GLOBAL PLANET CHANGE, V103, P1, DOI 10.1016/j.gloplacha.2013.01.003; MATTHEWS RK, 1980, GEOLOGY, V8, P501, DOI 10.1130/0091-7613(1980)8<501:TORAGS>2.0.CO;2; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; Miall AD, 1995, SEDIMENT GEOL, V100, P5, DOI 10.1016/0037-0738(95)00100-X; Miller KG, 2003, GEOLOGY, V31, P585, DOI 10.1130/0091-7613(2003)031<0585:LCCOLR>2.0.CO;2; Miller MS, 2014, GEOLOGY, V42, P35, DOI 10.1130/G34959.1; MITROVICA JX, 1989, TECTONICS, V8, P1079, DOI 10.1029/TC008i005p01079; MITROVICA JX, 1991, J GEOPHYS RES-SOL EA, V96, P20053, DOI 10.1029/91JB01284; Mitrovica JX, 2001, NATURE, V409, P1026, DOI 10.1038/35059054; Moucha R, 2008, EARTH PLANET SC LETT, V271, P101, DOI 10.1016/j.epsl.2008.03.056; Moucha R, 2011, NAT GEOSCI, V4, P707, DOI [10.1038/ngeo1235, 10.1038/NGEO1235]; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; National Research Council, 1990, SEA LEV CHANG STUD G, P3; Nittrrouer C. A., 2007, INTL ASSOC SEDIMENTO, V37; Pitman III W.C., 1983, SEPM SPEC PUBL, V33, P41, DOI DOI 10.2110/PEC.83.06.0041; Rickers F, 2013, EARTH PLANET SC LETT, V367, P39, DOI 10.1016/j.epsl.2013.02.022; Ritsema J, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002610; Ritsema J, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004566; RONOV AB, 1994, AM J SCI, V294, P777, DOI 10.2475/ajs.294.7.777; Rowley DB, 2013, SCIENCE, V340, P1560, DOI 10.1126/science.1229180; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; Schlanger S. O, 1986, GEODYN SER AM GEOPHY, V15, P61; Sigloch K, 2008, NAT GEOSCI, V1, P458, DOI 10.1038/ngeo231; Skogseid J, 2000, GEOL SOC SPEC PUBL, V167, P295, DOI 10.1144/GSL.SP.2000.167.01.12; Spasojevic S, 2012, AAPG BULL, V96, P2037, DOI 10.1306/03261211121; Spasojevic S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033511; STECKLER MS, 1978, EARTH PLANET SC LETT, V41, P1, DOI 10.1016/0012-821X(78)90036-5; Steinberger B, 2008, SCIENCE, V322, P866, DOI 10.1126/science.1166395; Stoll HM, 1996, SCIENCE, V272, P1771, DOI 10.1126/science.272.5269.1771; Stoll HM, 2000, GEOL SOC AM BULL, V112, P308, DOI 10.1130/0016-7606(2000)112<308:HSIRFT>2.0.CO;2; Tesauro M, 2012, GLOBAL PLANET CHANGE, V90-91, P51, DOI 10.1016/j.gloplacha.2011.12.003; Unternehr P, 2010, PETROL GEOSCI, V16, P207, DOI 10.1144/1354-079309-904; van der Meer DG, 2010, NAT GEOSCI, V3, P36, DOI 10.1038/NGEO708; van der Wal W, 2013, GEOPHYS J INT, V194, P61, DOI 10.1093/gji/ggt099; Wagreich M, 2014, AUSTRIAN J EARTH SCI, V107, P115; Watts A.B., 2007, TREATISE GEOPHYS, V6, P1; Wendler JE, 2014, NEWSL STRATIGR, V47, P1, DOI 10.1127/0078-0421/2014/0038; Ziegler PA, 2004, EARTH-SCI REV, V64, P1, DOI 10.1016/S0012-8252(03)00041-2; Zuhlke R, 2004, MAR PETROL GEOL, V21, P225, DOI 10.1016/j.marpetgeo.2003.11.014	83	50	50	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							1258375	10.1126/science.1258375	http://dx.doi.org/10.1126/science.1258375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613899				2022-12-28	WOS:000348225800035
J	Sierks, H; Barbieri, C; Lamy, PL; Rodrigo, R; Koschny, D; Rickman, H; Keller, HU; Agarwal, J; A'Hearn, MF; Angrilli, F; Auger, AT; Barucci, MA; Bertaux, JL; Bertini, I; Besse, S; Bodewits, D; Capanna, C; Cremonese, G; Da Deppo, V; Davidsson, B; Debei, S; De Cecco, M; Ferri, F; Fornasier, S; Fulle, M; Gaskell, R; Giacomini, L; Groussin, O; Gutierrez-Marques, P; Gutierrez, PJ; Guttler, C; Hoekzema, N; Hviid, SF; Ip, WH; Jorda, L; Knollenberg, J; Kovacs, G; Kramm, JR; Kuhrt, E; Kuppers, M; La Forgia, F; Lara, LM; Lazzarin, M; Leyrat, C; Moreno, JJL; Magrin, S; Marchi, S; Marzari, F; Massironi, M; Michalik, H; Moissl, R; Mottola, S; Naletto, G; Oklay, N; Pajola, M; Pertile, M; Preusker, F; Sabau, L; Scholten, F; Snodgrass, C; Thomas, N; Tubiana, C; Vincent, JB; Wenzel, KP; Zaccariotto, M; Patzold, M				Sierks, Holger; Barbieri, Cesare; Lamy, Philippe L.; Rodrigo, Rafael; Koschny, Detlef; Rickman, Hans; Keller, Horst Uwe; Agarwal, Jessica; A'Hearn, Michael F.; Angrilli, Francesco; Auger, Anne-Therese; Barucci, M. Antonella; Bertaux, Jean-Loup; Bertini, Ivano; Besse, Sebastien; Bodewits, Dennis; Capanna, Claire; Cremonese, Gabriele; Da Deppo, Vania; Davidsson, Bjoern; Debei, Stefano; De Cecco, Mariolino; Ferri, Francesca; Fornasier, Sonia; Fulle, Marco; Gaskell, Robert; Giacomini, Lorenza; Groussin, Olivier; Gutierrez-Marques, Pablo; Gutierrez, Pedro J.; Guettler, Carsten; Hoekzema, Nick; Hviid, Stubbe F.; Ip, Wing-Huen; Jorda, Laurent; Knollenberg, Joerg; Kovacs, Gabor; Kramm, J. Rainer; Kuehrt, Ekkehard; Kueppers, Michael; La Forgia, Fiorangela; Lara, Luisa M.; Lazzarin, Monica; Leyrat, Cedric; Moreno, Jose J. Lopez; Magrin, Sara; Marchi, Simone; Marzari, Francesco; Massironi, Matteo; Michalik, Harald; Moissl, Richard; Mottola, Stefano; Naletto, Giampiero; Oklay, Nilda; Pajola, Maurizio; Pertile, Marco; Preusker, Frank; Sabau, Lola; Scholten, Frank; Snodgrass, Colin; Thomas, Nicolas; Tubiana, Cecilia; Vincent, Jean-Baptiste; Wenzel, Klaus-Peter; Zaccariotto, Mirco; Paetzold, Martin			On the nucleus structure and activity of comet 67P/Churyumov-Gerasimenko	SCIENCE			English	Article							EVOLUTION; OSIRIS; STATE	Images from the OSIRIS scientific imaging system onboard Rosetta show that the nucleus of 67P/Churyumov-Gerasimenko consists of two lobes connected by a short neck. The nucleus has a bulk density less than half that of water. Activity at a distance from the Sun of >3 astronomical units is predominantly from the neck, where jets have been seen consistently. The nucleus rotates about the principal axis of momentum. The surface morphology suggests that the removal of larger volumes of material, possibly via explosive release of subsurface pressure or via creation of overhangs by sublimation, may be a major mass loss process. The shape raises the question of whether the two lobes represent a contact binary formed 4.5 billion years ago, or a single body where a gap has evolved via mass loss.	[Sierks, Holger; Agarwal, Jessica; A'Hearn, Michael F.; Gutierrez-Marques, Pablo; Gutierrez, Pedro J.; Guettler, Carsten; Hoekzema, Nick; Hviid, Stubbe F.; Kovacs, Gabor; Kramm, J. Rainer; Kuehrt, Ekkehard; Oklay, Nilda; Snodgrass, Colin; Tubiana, Cecilia; Vincent, Jean-Baptiste] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Barbieri, Cesare; La Forgia, Fiorangela; Lazzarin, Monica; Magrin, Sara; Marzari, Francesco] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Lamy, Philippe L.] CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille 13, France; [Lamy, Philippe L.] Aix Marseille Univ, F-13388 Marseille 13, France; [Rodrigo, Rafael] CSIC INTA, Ctr Astrobiol, Madrid 28850, Spain; [Rodrigo, Rafael] Int Space Sci Inst, CH-3012 Bern, Switzerland; [Koschny, Detlef; Besse, Sebastien; Wenzel, Klaus-Peter] European Space Res & Technol Ctr ESA, Sci Support Off, NL-2201 AZ Noordwijk, Netherlands; [Rickman, Hans] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Rickman, Hans] PAS Space Res Ctr, PL-00716 Warsaw, Poland; [Keller, Horst Uwe] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Keller, Horst Uwe; Guettler, Carsten; Knollenberg, Joerg; Kuehrt, Ekkehard; Mottola, Stefano; Preusker, Frank; Scholten, Frank] Deutsch Zentrum Luft & Raumfahrt, Inst Planetenforsch, D-12489 Berlin, Germany; [A'Hearn, Michael F.; Bodewits, Dennis] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [A'Hearn, Michael F.; Davidsson, Bjoern] Akad Wissensch Gottingen, D-37077 Gottingen, Germany; [Angrilli, Francesco; Pertile, Marco; Zaccariotto, Mirco] Univ Padua, Dept Ind Engn, I-35131 Padua, Italy; Univ Paris 06, Univ Paris Diderot, LESIA Observ Paris, CNRS, F-92195 Meudon, Italy; [Auger, Anne-Therese; Capanna, Claire; Giacomini, Lorenza; Hviid, Stubbe F.; Jorda, Laurent] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille, France; [Bertaux, Jean-Loup] UVSQ, LATMOS, CNRS, IPSL, F-78280 Guyancourt, France; [Bertini, Ivano; De Cecco, Mariolino; Gaskell, Robert; Massironi, Matteo; Naletto, Giampiero; Pajola, Maurizio; Pertile, Marco; Zaccariotto, Mirco] Univ Padua, Ctr Ateneo Studi Attivit Spaziali Giuseppe Colomb, I-35131 Padua, Italy; [Cremonese, Gabriele] Osserv Astron Padova, INAF, I-35122 Padua, Italy; [Da Deppo, Vania; Naletto, Giampiero] CNR IFN UOS Padova LUXOR, I-35131 Padua, Italy; [Debei, Stefano; Naletto, Giampiero] Univ Trent, I-38100 Trento, Italy; [Fornasier, Sonia] Osserv Astron Trieste, INAF, I-34014 Trieste, Italy; [Fulle, Marco] Planetary Sci Inst, Tucson, AZ 85719 USA; [Gutierrez-Marques, Pablo; Lara, Luisa M.; Moreno, Jose J. Lopez] Inst Astrofis Andalucia CSIC, Granada 18008, Spain; [Ip, Wing-Huen] Natl Cent Univ, Grad Inst Astron, Chungli 32054, Taiwan; [Ip, Wing-Huen] Macau Univ Sci & Technol, Space Sci Inst, Macau, Peoples R China; [Kueppers, Michael; Moissl, Richard] European Space Astron Ctr ESA, Operat Dept, Madrid 28691, Spain; [Marchi, Simone] SW Res Inst, Virtual Inst, Boulder, CO 80302 USA; [Massironi, Matteo] Univ Padua, Dipartimento Geosci, I-35131 Padua, Italy; [Michalik, Harald] TU Braunschweig, Inst Datentech & Kommunikat Netze, D-38106 Braunschweig, Germany; [Naletto, Giampiero] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Sabau, Lola] Inst Nacl Tecn Aeroespacial, Madrid 28850, Spain; [Thomas, Nicolas] Univ Bern, Phys Inst, CH-3012 Bern, Switzerland; [Thomas, Nicolas] Univ Bern, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [Paetzold, Martin] Univ Cologne, Rhein Inst Umweltforsch, Abt Planetenforsch, D-50931 Cologne, Germany	Max Planck Society; University of Padua; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Uppsala University; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Braunschweig University of Technology; Helmholtz Association; German Aerospace Centre (DLR); University System of Maryland; University of Maryland College Park; University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; University of Padua; Istituto Nazionale Astrofisica (INAF); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); University of Trento; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); National Central University; Macau University of Science & Technology; European Space Agency; University of Padua; Braunschweig University of Technology; University of Padua; University of Bern; University of Bern; University of Cologne	Sierks, H (corresponding author), Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany.	sierks@mps.mpg.de	Pajola, Maurizio/N-5574-2018; La Forgia, Fiorangela/F-3107-2015; Rickman, Hans/X-7631-2018; Kovacs, Gabor/E-4688-2010; Moreno, Jose Juan Lopez/M-5537-2019; Tubiana, Cecilia/AAG-8209-2019; Marzari, Francesco/X-2440-2019; Naletto, Giampiero/S-6329-2016; Gutiérrez, Pedro J/AAJ-6177-2020; Kovacs, Gabor/H-5819-2012; Lara, Luisa M/F-5614-2012; Jorda, Laurent/AAA-1718-2021; Da Deppo, Vania/D-2897-2012; La Forgia, Fiorangela/AAD-7477-2019; Thomas, Nicolas/G-4693-2015	Pajola, Maurizio/0000-0002-3144-1277; La Forgia, Fiorangela/0000-0003-3924-1867; Rickman, Hans/0000-0002-9603-6619; Kovacs, Gabor/0000-0002-6431-0556; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Tubiana, Cecilia/0000-0001-8475-9898; Naletto, Giampiero/0000-0003-2007-3138; Gutiérrez, Pedro J/0000-0002-7332-6269; Kovacs, Gabor/0000-0002-6431-0556; Lara, Luisa M/0000-0002-7184-920X; Da Deppo, Vania/0000-0001-6273-8738; La Forgia, Fiorangela/0000-0003-3924-1867; Debei, Stefano/0000-0002-6757-6616; Ferri, Francesca/0000-0003-2395-5275; Besse, Sebastien/0000-0002-1052-5439; fulle, marco/0000-0001-8435-5287; Thomas, Nicolas/0000-0002-0146-0071; De Cecco, Mariolino/0000-0003-1562-0328; Cremonese, Gabriele/0000-0001-9021-1140; JORDA, Laurent/0000-0001-8735-3308; Massironi, Matteo/0000-0002-7757-8818; zaccariotto, mirco/0000-0001-9750-0877; Snodgrass, Colin/0000-0001-9328-2905; Bertini, Ivano/0000-0002-0616-2444	Germany (DLR); France (CNES); Italy (ASI); Spain (MEC); Sweden (SNSB); ESA Technical Directorate; NASA JPL [1267923]; NSC from Ministry of Science and Technology, Taiwan [101-2111-M-008-016]; Polish National Science Center [2011/01/B/ST9/05442]; Swedish National Space Board [74/10:2]; Swiss National Science Foundation; STFC [ST/L004569/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L004569/1] Funding Source: researchfish	Germany (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); France (CNES)(Centre National D'etudes Spatiales); Italy (ASI)(Agenzia Spaziale Italiana (ASI)); Spain (MEC)(Spanish Government); Sweden (SNSB); ESA Technical Directorate; NASA JPL(National Aeronautics & Space Administration (NASA)); NSC from Ministry of Science and Technology, Taiwan; Polish National Science Center; Swedish National Space Board; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	In memory of our colleague and co-investigator, Michel Festou. We thank our retired co-investigators M. E. Bailey, P. Barthol, J. A. Burns, W. Curdt, F. Gliem, A. Llebaria, and J. P. Sivan for their contribution to the success of OSIRIS, as well as the team of optical, electrical, mechanical, thermal, and software engineers that turned the instrument into reality and supported it throughout in flight operations. OSIRIS was built by a consortium led by the Max-Planck-Institut fur Sonnensystemforschung, Gottingen, Germany, in collaboration with CISAS, University of Padova, Italy, the Laboratoire d'Astrophysique de Marseille, France, the Instituto de Astrofisica de Andalucia, CSIC, Granada, Spain, the Scientific Support Office of the European Space Agency, Noordwijk, Netherlands, the Instituto Nacional de Tecnica Aeroespacial, Madrid, Spain, the Universidad Politechnica de Madrid, Spain, the Department of Physics and Astronomy of Uppsala University, Sweden, and the Institut fur Datentechnik und Kommunikationsnetze der Technischen Universitat Braunschweig, Germany. The support of the national funding agencies of Germany (DLR), France (CNES), Italy (ASI), Spain (MEC), Sweden (SNSB), and the ESA Technical Directorate is gratefully acknowledged. We acknowledge the support of the local institutes that realized the instrument. Also supported by NASA JPL contract 1267923 to the University of Maryland (M.F.A'H.), grant NSC 101-2111-M-008-016 from the Ministry of Science and Technology, Taiwan (W.H.I.), grant 2011/01/B/ST9/05442 from the Polish National Science Center and grant 74/10:2 of the Swedish National Space Board (H.R.), and travel grants from the Swiss National Science Foundation (N.T.). All data presented in this paper will be delivered to ESA's Planetary Science Archive and NASA's Planetary Data System in accordance with the schedule established by the Rosetta project and will be available on request prior to that archiving. We thank the Rosetta Science Ground Segment at ESAC, the Rosetta Mission Operations Centre at ESOC, and the Rosetta Project at ESTEC for their outstanding work enabling the science return of the Rosetta Mission. The OSIRIS team thanks the MIRO team and its principal investigator, S. Gulkis, for providing prepublication data and helpful discussion regarding use of their limb scans to determine the shape.	A'Hearn MF, 2011, ANNU REV ASTRON ASTR, V49, P281, DOI 10.1146/annurev-astro-081710-102506; ASPHAUG E, 1994, NATURE, V370, P120, DOI 10.1038/370120a0; Belton MJS, 2008, ICARUS, V198, P189, DOI 10.1016/j.icarus.2008.07.009; Belyaev N. A., 1986, CATALOGUE OF SHORT P; Carusi A., 1985, LONG TERM EVOLUTION; Davidsson BJR, 2014, ICARUS, V243, P58, DOI 10.1016/j.icarus.2014.08.039; Davidsson BJR, 2005, ICARUS, V176, P453, DOI 10.1016/j.icarus.2005.02.006; Davis DR, 1997, ICARUS, V125, P50, DOI 10.1006/icar.1996.5595; Dombard AJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015181; Ernst CA, 2007, ICARUS, V190, P334, DOI 10.1016/j.icarus.2007.03.030; ESA, DETERMINING THE MASS; Gaskell RW, 2008, METEORIT PLANET SCI, V43, P1049, DOI 10.1111/j.1945-5100.2008.tb00692.x; Groussin O, 2007, MON NOT R ASTRON SOC, V376, P1399, DOI 10.1111/j.1365-2966.2007.11553.x; Gutierrez PJ, 2005, PLANET SPACE SCI, V53, P1135, DOI 10.1016/j.pss.2004.12.012; Harmon JK, 2010, ICARUS, V207, P499, DOI 10.1016/j.icarus.2009.12.026; Hassig M, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0276; Hermalyn B, 2013, ICARUS, V222, P625, DOI 10.1016/j.icarus.2012.09.030; Jansson KW, 2014, ASTRON ASTROPHYS, V570, DOI 10.1051/0004-6361/201424369; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; Lamy PL, 2007, SPACE SCI REV, V128, P23, DOI 10.1007/s11214-007-9146-x; Li JH, 2007, INT J FUZZY SYST, V9, P1; Mottola S, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424590; Preusker F, 2012, PLANET SPACE SCI, V66, P54, DOI 10.1016/j.pss.2012.01.008; Richardson JE, 2007, ICARUS, V190, P357, DOI 10.1016/j.icarus.2007.08.001; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Thomas PC, 2013, ICARUS, V222, P550, DOI 10.1016/j.icarus.2012.05.034; Tubiana C, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201424735; Vincent JB, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201219350; Weidenschilling SJ, 2004, SPACE SCI S, P97	29	321	326	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							aaa1044	10.1126/science.aaa1044	http://dx.doi.org/10.1126/science.aaa1044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613897				2022-12-28	WOS:000348225800027
J	Bryson, JFJ; Nichols, CIO; Herrero-Albillos, J; Kronast, F; Kasama, T; Alimadadi, H; van der Laan, G; Nimmo, F; Harrison, RJ				Bryson, James F. J.; Nichols, Claire I. O.; Herrero-Albillos, Julia; Kronast, Florian; Kasama, Takeshi; Alimadadi, Hossein; van der Laan, Gerrit; Nimmo, Francis; Harrison, Richard J.			Long-lived magnetism from solidification-driven convection on the pallasite parent body	NATURE			English	Article							FE-NI; DYNAMO; PLANETESIMALS; DIFFERENTIATION; CHONDRITES; RECORDS; ORIGIN; METAL; AL-26	Palaeomagnetic measurements of meteorites(1-5) suggest that, shortly after the birth of the Solar System, the molten metallic cores of many small planetary bodies convected vigorously and were capable of generating magnetic fields(6). Convection on these bodies is currently thought to have been thermally driven(7,8), implying that magnetic activity would have been short-lived(9). Here we report a time-series palaeomagnetic record derived from nanomagnetic imaging(10) of the Imilac and Esquel pallasite meteorites, a group of meteorites consisting of centimetre-sized metallic and silicate phases. We find a history of long-lived magnetic activity on the pallasite parent body, capturing the decay and eventual shutdown of the magnetic field as core solidification completed. We demonstrate that magnetic activity driven by progressive solidification of an inner core(11-13) is consistent with our measured magnetic field characteristics and cooling rates(14). Solidification-driven convection was probably common among small body cores(15), and, in contrast to thermally driven convection, will have led to a relatively late (hundreds of millions of years after accretion), long-lasting, intense and widespread epoch of magnetic activity among these bodies in the early Solar System.	[Bryson, James F. J.; Nichols, Claire I. O.; Harrison, Richard J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Herrero-Albillos, Julia] Ctr Univ Def, E-50090 Zaragoza, Spain; [Herrero-Albillos, Julia] Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, E-50009 Zaragoza, Spain; [Kronast, Florian] Helmholtz Zentrum Berlin Mat & Energie, D-12489 Berlin, Germany; [Kasama, Takeshi; Alimadadi, Hossein] Tech Univ Denmark, Ctr Electron Nanoscopy, DK-2800 Kongens Lyngby, Denmark; [van der Laan, Gerrit] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); University of Zaragoza; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Technical University of Denmark; Diamond Light Source; University of California System; University of California Santa Cruz	Bryson, JFJ (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	jfjb2@cam.ac.uk	Harrison, Richard/R-8802-2019; Herrero-Albillos, Julia/B-9837-2009; Harrison, Richard J/B-3609-2010; Herrero-Albillos, Julia/I-5462-2012; Herrero-Albillos, Julia/M-5489-2019; Alimadadi, Hossein/P-1710-2017; Kasama, Takeshi/K-5383-2012; van der Laan, Gerrit/Q-1662-2015	Harrison, Richard/0000-0003-3469-762X; Herrero-Albillos, Julia/0000-0002-0901-8341; Harrison, Richard J/0000-0003-3469-762X; Herrero-Albillos, Julia/0000-0002-0901-8341; Herrero-Albillos, Julia/0000-0002-0901-8341; Alimadadi, Hossein/0000-0003-3865-2226; Kasama, Takeshi/0000-0003-3312-781X; van der Laan, Gerrit/0000-0001-6852-2495; Nichols, Claire I.O./0000-0003-2947-5694; Bryson, James/0000-0002-5675-8545	European Research Council under the European Union [320750, 312284]; Natural Environment Research Council; Fundacion ARAID; Spanish MINECO [MAT2011-23791]; Natural Environment Research Council [1089641] Funding Source: researchfish	European Research Council under the European Union(European Research Council (ERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fundacion ARAID; Spanish MINECO(Spanish Government); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge the Helmholtz-Zentrum Berlin for the use of the synchrotron radiation beamtime at beamline UE49 of BESSY II. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement numbers 320750 and 312284, the Natural Environment Research Council, Fundacion ARAID and the Spanish MINECO MAT2011-23791. We thank the Natural History Museum, London, and the Sedgwick Museum of Earth Sciences, University of Cambridge, for samples. We also thank J. Tarduno for discussions concerning magnetic shielding.	ALBERTSEN JF, 1981, PHYS SCRIPTA, V23, P301, DOI 10.1088/0031-8949/23/3/015; ANDERS E, 1964, SPACE SCI REV, V3, P583; Bryson JFJ, 2014, EARTH PLANET SC LETT, V396, P125, DOI 10.1016/j.epsl.2014.04.016; Bryson JFJ, 2014, EARTH PLANET SC LETT, V388, P237, DOI 10.1016/j.epsl.2013.12.004; Carporzen L, 2011, P NATL ACAD SCI USA, V108, P6386, DOI 10.1073/pnas.1017165108; CLARKE RS, 1980, AM MINERAL, V65, P624; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V305, P1, DOI 10.1016/j.epsl.2011.03.010; FEARN DR, 1981, NATURE, V289, P393, DOI 10.1038/289393a0; Fu RR, 2012, SCIENCE, V338, P238, DOI 10.1126/science.1225648; Garrick-Bethell I, 2009, SCIENCE, V323, P356, DOI 10.1126/science.1166804; Goldstein JI, 2009, CHEM ERDE-GEOCHEM, V69, P293, DOI 10.1016/j.chemer.2009.01.002; HAACK H, 1990, J GEOPHYS RES-SOLID, V95, P5111, DOI 10.1029/JB095iB04p05111; Hevey PJ, 2006, METEORIT PLANET SCI, V41, P95, DOI 10.1111/j.1945-5100.2006.tb00195.x; Laneuville M, 2014, EARTH PLANET SC LETT, V401, P251, DOI 10.1016/j.epsl.2014.05.057; NEEL L, 1964, J APPL PHYS, V35, P873, DOI 10.1063/1.1713516; Nimmo F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037997; Nimmo F., 2015, TREATISE GEOPHYS, P27, DOI DOI 10.1016/B978-044452748-6.00128-0; Ohldag H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.247201; Olson P, 2006, EARTH PLANET SC LETT, V250, P561, DOI 10.1016/j.epsl.2006.08.008; Sahijpal S, 2007, METEORIT PLANET SCI, V42, P1529, DOI 10.1111/j.1945-5100.2007.tb00589.x; SCOTT ERD, 1973, GEOCHIM COSMOCHIM AC, V37, P2283, DOI 10.1016/0016-7037(73)90104-X; Sterenborg MG, 2013, PHYS EARTH PLANET IN, V214, P53, DOI 10.1016/j.pepi.2012.10.006; Stevenson DJ, 2010, SPACE SCI REV, V152, P651, DOI 10.1007/s11214-009-9572-z; Stohr J, 1999, J MAGN MAGN MATER, V200, P470, DOI 10.1016/S0304-8853(99)00407-2; Stohr J, 1998, SURF REV LETT, V5, P1297, DOI 10.1142/S0218625X98001638; Tarduno JA, 2012, SCIENCE, V338, P939, DOI 10.1126/science.1223932; Uehara M, 2011, EARTH PLANET SC LETT, V306, P241, DOI 10.1016/j.epsl.2011.04.008; van der Laan G, 2013, J PHYS CONF SER, V430, DOI 10.1088/1742-6596/430/1/012127; Warren PH, 2011, METEORIT PLANET SCI, V46, P53, DOI 10.1111/j.1945-5100.2010.01138.x; Weiss BP, 2008, SCIENCE, V322, P713, DOI 10.1126/science.1162459; Weiss BP, 2010, SPACE SCI REV, V152, P341, DOI 10.1007/s11214-009-9580-z; Weiss BP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035585; Williams Q, 2009, EARTH PLANET SC LETT, V284, P564, DOI 10.1016/j.epsl.2009.05.019; Yang J, 2005, METEORIT PLANET SCI, V40, P239, DOI 10.1111/j.1945-5100.2005.tb00378.x; Yang JJ, 2010, GEOCHIM COSMOCHIM AC, V74, P4471, DOI 10.1016/j.gca.2010.04.016	35	51	54	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					472	+		10.1038/nature14114	http://dx.doi.org/10.1038/nature14114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25612050	Green Accepted			2022-12-28	WOS:000348196500031
J	Aung, K				Aung, Koko			Compared with unilateral TKA, simultaneous bilateral TKA was linked to in-hospital mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TOTAL KNEE ARTHROPLASTY; OUTCOMES		Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Aung, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				Meehan JP, 2011, J BONE JOINT SURG AM, V93A, P2203, DOI 10.2106/JBJS.J.01350; Memtsoudis SG, 2009, ANESTHESIOLOGY, V111, P1206, DOI 10.1097/ALN.0b013e3181bfab7d	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC13	10.7326/ACPJC-2015-162-2-013	http://dx.doi.org/10.7326/ACPJC-2015-162-2-013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599361				2022-12-28	WOS:000350106600012
J	Fekete, T				Fekete, Thomas			In critical illness, high-protein enteral nutrition with immune-modulating nutrients did not reduce infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Temple Univ, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.		van Zanten, Arthur R.H./ABB-1169-2021; Fekete, Thomas/AFI-5367-2022	van Zanten, Arthur R.H./0000-0001-6276-7192; 				Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234	2	0	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC9	10.7326/ACPJC-2015-162-2-009	http://dx.doi.org/10.7326/ACPJC-2015-162-2-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599369				2022-12-28	WOS:000350106600008
J	Hirsch, C				Hirsch, Calvin			In older adults, high- vs standard-dose influenza vaccine reduced laboratory-confirmed influenza	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Ferguson M, 2012, J INFECT DIS, V205, P733, DOI 10.1093/infdis/jir641; Gorina Y., 2008, TRENDS INFLUENZA PNE	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC2	10.7326/ACPJC-2015-162-2-002	http://dx.doi.org/10.7326/ACPJC-2015-162-2-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599362				2022-12-28	WOS:000350106600001
J	Wilks, J; Golovkina, T				Wilks, Jessica; Golovkina, Tatyana			Interfering with interferons	SCIENCE			English	Editorial Material							ENTERIC VIRUS; INFECTION; MICROBIOTA; BACTERIA		[Wilks, Jessica; Golovkina, Tatyana] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Wilks, J (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	tgolovki@bsd.uchicago.edu						Angel J, 1999, J INTERF CYTOK RES, V19, P655, DOI 10.1089/107999099313802; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037	12	0	0	5	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					233	234		10.1126/science.aaa5056	http://dx.doi.org/10.1126/science.aaa5056			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593173				2022-12-28	WOS:000347915300019
J	Cao, L; Naylor, R; Henriksson, P; Leadbitter, D; Metian, M; Troell, M; Zhang, WB				Cao, Ling; Naylor, Rosamond; Henriksson, Patrik; Leadbitter, Duncan; Metian, Marc; Troell, Max; Zhang, Wenbo			China's aquaculture and the world's wild fisheries	SCIENCE			English	Editorial Material							FISH-MEAL		[Cao, Ling; Naylor, Rosamond] Stanford Univ, Stanford, CA 94035 USA; [Henriksson, Patrik] Leiden Univ, NL-2333 CC Leiden, Netherlands; [Leadbitter, Duncan] Univ Wollongong, Wollongong, NSW 2522, Australia; [Metian, Marc; Troell, Max] Stockholm Univ, S-10691 Stockholm, Sweden; [Troell, Max] Royal Swedish Acad Sci, S-10405 Stockholm, Sweden; [Zhang, Wenbo] Univ Stirling, Stirling FK9 4LA, Scotland; [Zhang, Wenbo] Shanghai Ocean Univ, Shanghai 201306, Peoples R China	Stanford University; Leiden University; Leiden University - Excl LUMC; University of Wollongong; Stockholm University; Royal Swedish Academy of Sciences; University of Stirling; Shanghai Ocean University	Cao, L (corresponding author), Stanford Univ, Stanford, CA 94035 USA.	roz@stanford.edu	Metian, Marc/F-8010-2018; Cao, Ling/I-9429-2012; Leadbitter, Duncan/GSD-2991-2022; Troell, Max/I-1724-2019	Metian, Marc/0000-0003-1485-5029; Troell, Max/0000-0002-7509-8140; Zhang, Wenbo/0000-0003-3765-3980; Henriksson, Patrik JG/0000-0002-3439-623X				Ai CX, 2013, FEED IND, V34, P1; Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204; Ayadi F.Y., 2012, J AQUACULT FEED SCI, V4, P1, DOI [10.3923/joafsnu.2012.1.26, DOI 10.3923/JOAFSNU.2012.1.26]; Blomeyer R., 2012, DIRECTORATE GEN INTE; Cao L, 2011, ENVIRON SCI TECHNOL, V45, P6531, DOI 10.1021/es104058z; Chiu A, 2013, AQUACULTURE, V414, P127, DOI 10.1016/j.aquaculture.2013.07.049; FAO, 2014, FISHSTATJ SOFTW FISH; Food and Agricultural Organization of the United Nations, 2014, STAT WORLD FISH AQ; Funge-Smith S., 2005, ASIAN FISHERIES TODA; Ghaly A. E., 2013, Journal of Microbial and Biochemical Technology, V5, P107; Grainger R., 2005, PRODUCTION UTILIZATI; Hasan MR., 2009, FISH FEED INPUTS AQU; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Mallory TG, 2013, MAR POLICY, V38, P99, DOI 10.1016/j.marpol.2012.05.024; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Newton R, 2014, CRIT REV FOOD SCI, V54, P495, DOI 10.1080/10408398.2011.588349; Olsen RL, 2014, TRENDS FOOD SCI TECH, V36, P144, DOI 10.1016/j.tifs.2014.01.007; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Villasante S, 2013, AMBIO, V42, P923, DOI 10.1007/s13280-013-0448-9; Xie B, 2013, AQUACULTURE, V414, P243, DOI 10.1016/j.aquaculture.2013.08.019; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	28	245	265	25	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					133	135		10.1126/science.1260149	http://dx.doi.org/10.1126/science.1260149			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574011				2022-12-28	WOS:000347918900027
J	Macilwain, C				Macilwain, Colin			Economic divide taking toll on European science	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					123	123		10.1038/517123a	http://dx.doi.org/10.1038/517123a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3IM	25567247	Bronze			2022-12-28	WOS:000347477600003
J	Reniere, ML; Whiteley, AT; Hamilton, KL; John, SM; Lauer, P; Brennan, RG; Portnoy, DA				Reniere, Michelle L.; Whiteley, Aaron T.; Hamilton, Keri L.; John, Sonya M.; Lauer, Peter; Brennan, Richard G.; Portnoy, Daniel A.			Glutathione activates virulence gene expression of an intracellular pathogen	NATURE			English	Article							LISTERIA-MONOCYTOGENES; REGULATOR PRFA; PROTEIN; ACTA; SURVIVAL; BACTERIA; REQUIRES; BINDING; GROWTH; THIOL	Intracellular pathogens are responsible for much of the world-wide morbidity and mortality due to infectious diseases. To colonize their hosts successfully, pathogens must sense their environment and regulate virulence gene expression appropriately. Accordingly, on entry into mammalian cells, the facultative intracellular bacterial pathogen Listeria monocytogenes remodels its transcriptional program by activating the master virulence regulator PrfA. Here we show that bacterial and host-derived glutathione are required to activate PrfA. In this study a genetic selection led to the identification of a bacterial mutant in glutathione synthase that exhibited reduced virulence gene expression and was attenuated 150-fold in mice. Genome sequencing of suppressor mutants that arose spontaneously in vivo revealed a single nucleotide change in prfA that locks the protein in the active conformation (PrfA*) and completely bypassed the requirement for glutathione during infection. Biochemical and genetic studies support a model in which glutathione-dependent PrfA activation is mediated by allosteric binding of glutathione to PrfA. Whereas glutathione and other low-molecular-weight thiols have important roles in redox homeostasis in all forms of life, here we demonstrate that glutathione represents a critical signalling molecule that activates the virulence of an intracellular pathogen.	[Reniere, Michelle L.; John, Sonya M.; Portnoy, Daniel A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Whiteley, Aaron T.] Univ Calif Berkeley, Sch Publ Hlth, Grad Grp Infect Dis & Immun, Berkeley, CA 94720 USA; [Hamilton, Keri L.; Brennan, Richard G.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Lauer, Peter] Aduro BioTech Inc, Berkeley, CA 94710 USA; [Portnoy, Daniel A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Duke University; University of California System; University of California Berkeley	Portnoy, DA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	portnoy@berkeley.edu		Whiteley, Aaron/0000-0002-0075-7519; Brennan, Richard/0000-0001-7647-485X; Reniere, Michelle/0000-0002-0770-7784	NIH [S10RR029668, S10RR027303]; UCSF; National Institutes of Health [1PO1 AI63302, 1R01 AI27655]; NSF GRFP [DGE 1106400];  [F32AI104247];  [F32GM008487]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027655, F32AI104247, P01AI063302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Freitag for providing strains and P. Hwang (UCSF Biosensor Core Facility) for technical support and advice regarding bio-layer interferometry. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation grants S10RR029668 and S10RR027303 and the UCSF Funding Shared Equipment Award. This work was supported by National Institutes of Health grants 1PO1 AI63302 and 1R01 AI27655 to D.A.P.; M.L.R. is supported by F32AI104247; A.T.W. is supported by the NSF GRFP DGE 1106400; K.L.H. is supported by F32GM008487.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Bockmann R, 1996, MOL MICROBIOL, V22, P643, DOI 10.1046/j.1365-2958.1996.d01-1722.x; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gopal S, 2005, J BACTERIOL, V187, P3839, DOI 10.1128/JB.187.11.3839-3847.2005; KOHLER S, 1991, J BACTERIOL, V173, P4668; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Melton-Witt JA, 2012, INFECT IMMUN, V80, P2221, DOI 10.1128/IAI.06196-11; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; ROUZER CA, 1981, P NATL ACAD SCI-BIOL, V78, P2532, DOI 10.1073/pnas.78.4.2532; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; Skoble J, 2000, J CELL BIOL, V150, P527, DOI 10.1083/jcb.150.3.527; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Valladares A, 2008, J BACTERIOL, V190, P6126, DOI 10.1128/JB.00787-08; Vazquez-Boland JA, 2011, CURROPINMICROBIOL, V14, P118, DOI DOI 10.1016/J.MIB.2011.01.005; Xayarath B, 2012, FUTURE MICROBIOL, V7, P839, DOI [10.2217/fmb.12.57, 10.2217/FMB.12.57]; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09	37	156	158	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					170	U100		10.1038/nature14029	http://dx.doi.org/10.1038/nature14029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567281	Green Accepted			2022-12-28	WOS:000347477600029
J	Hyttel-Sorensen, S; Pellicer, A; Alderliesten, T; Austin, T; van Bel, F; Benders, M; Claris, O; Dempsey, E; Franz, AR; Fumagalli, M; Gluud, C; Grevstad, B; Hagmann, C; Lemmers, P; van Oeveren, W; Pichler, G; Plomgaard, AM; Riera, J; Sanchez, L; Winkel, P; Wolf, M; Greisen, G				Hyttel-Sorensen, Simon; Pellicer, Adelina; Alderliesten, Thomas; Austin, Topun; van Bel, Frank; Benders, Manon; Claris, Olivier; Dempsey, Eugene; Franz, Axel R.; Fumagalli, Monica; Gluud, Christian; Grevstad, Berit; Hagmann, Cornelia; Lemmers, Petra; van Oeveren, Wim; Pichler, Gerhard; Plomgaard, Anne Mette; Riera, Joan; Sanchez, Laura; Winkel, Per; Wolf, Martin; Greisen, Gorm			Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VENA-CAVA FLOW; OXYGEN-SATURATION; TREATMENT GUIDELINE; EMPIRICAL-EVIDENCE; TISSUE OXIMETRY; CELL-DEATH; BRAIN; TIME; SAFEBOOSC; PRESSURE	Objective To determine if it is possible to stabilise the cerebral oxygenation of extremely preterm infants monitored by cerebral near infrared spectroscopy (NIRS) oximetry. Design Phase II randomised, single blinded, parallel clinical trial. Setting Eight tertiary neonatal intensive care units in eight European countries. Participants 166 extremely preterm infants born before 28 weeks of gestation:86 were randomised to cerebral NIRS monitoring and 80 to blinded NIRS monitoring. The only exclusion criterion was a decision not to provide life support. Interventions Monitoring of cerebral oxygenation using NIRS in combination with a dedicated treatment guideline during the first 72 hours of life (experimental) compared with blinded NIRS oxygenation monitoring with standard care (control). Main outcome measures The primary outcome measure was the time spent outside the target range of 55-85% for cerebral oxygenation multiplied by the mean absolute deviation, expressed in % hours (burden of hypoxia and hyperoxia). One hour with an oxygenation of 50% gives 5% hours of hypoxia. Secondary outcomes were all cause mortality at term equivalent age and a brain injury score assessed by cerebral ultrasonography. Randomisation Allocation sequence 1:1 with block sizes 4 and 6 in random order concealed for the investigators. The allocation was stratified for gestational age (<26 weeks or >= 26 weeks). Blinding Cerebral oxygenation measurements were blinded in the control group. All outcome assessors were blinded to group allocation. Results The 86 infants randomised to the NIRS group had a median burden of hypoxia and hyperoxia of 36.1% hours (interquartile range 9.2-79.5% hours) compared with 81.3 (38.5-181.3) % hours in the control group, a reduction of 58% (95% confidence interval 35% to 73%, P<0.001). In the experimental group the median burden of hypoxia was 16.6 (interquartile range 5.4-68.1) % hours, compared with 53.6 (17.4-171.3) % hours in the control group (P=0.0012). The median burden of hyperoxia was similar between the groups: 1.2 (interquartile range 0.3-9.6) % hours in the experimental group compared with 1.1 (0.1-23.4) % hours in the control group (P= 0.98). We found no statistically significant differences between the two groups at term corrected age. No severe adverse reactions were associated with the device. Conclusions Cerebral oxygenation was stabilised in extremely preterm infants using a dedicated treatment guideline in combination with cerebral NIRS monitoring.	[Hyttel-Sorensen, Simon; Plomgaard, Anne Mette; Greisen, Gorm] Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, DK-2100 Copenhagen, Denmark; [Pellicer, Adelina; Riera, Joan; Sanchez, Laura] La Paz Univ Hosp, Dept Neonatol, Madrid, Spain; [Alderliesten, Thomas; van Bel, Frank; Benders, Manon; Lemmers, Petra] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Austin, Topun] Cambridge Univ Hosp NHS Fdn Trust, Rosie Hosp, Cambridge, England; [Benders, Manon] Kings Coll London, Ctr Dev Brain, London WC2R 2LS, England; [Claris, Olivier] Hop Femme Mere Enfants, Dept Neonatol, Bron, France; [Dempsey, Eugene] Natl Univ Ireland Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Franz, Axel R.] Univ Childrens Hosp Tubingen, Dept Neonatol, Tubingen, Germany; [Fumagalli, Monica] Fdn IRCCS Ca Granda Osped Maggiore Policlin, NICU, Milan, Italy; [Gluud, Christian; Winkel, Per] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark; [Grevstad, Berit] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen, Denmark; [Hagmann, Cornelia] Univ Zurich, Div Neonatol, Zurich, Switzerland; [van Oeveren, Wim] Haemoscan, Groningen, Netherlands; [Pichler, Gerhard] Med Univ Graz, Dept Pediat, Graz, Austria; [Riera, Joan] Tech Univ Madrid, Ctr Biomed Technol, Madrid, Spain; [Wolf, Martin] Univ Zurich Hosp, Div Neonatol, Biomed Opt Res Lab, CH-8091 Zurich, Switzerland	Rigshospitalet; University of Copenhagen; Hospital Universitario La Paz; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Cambridge; University of London; King's College London; CHU Lyon; University College Cork; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; IRCCS Ca Granda Ospedale Maggiore Policlinico; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Zurich; Medical University of Graz; Universidad Politecnica de Madrid; University of Zurich; University Zurich Hospital	Hyttel-Sorensen, S (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neonatol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	simonhyttelsrensen@gmail.com	Dempsey, Eugene/AAG-3037-2021; Austin, Topun/ABG-1960-2021; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Franz, Axel/AAC-8067-2022; Fumagalli, Monica/K-6717-2016; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022; Greisen, Gorm/AAA-6463-2022; Dempsey, Eugene Michael/H-8051-2015	Austin, Topun/0000-0002-8428-8624; Fumagalli, Monica/0000-0002-0186-0710; Gluud, Christian/0000-0002-8861-0799; Greisen, Gorm/0000-0001-8042-3262; Pichler, Gerhard/0000-0003-2405-7143; Hagmann, Cornelia/0000-0003-2647-9809; Franz, Axel/0000-0001-5066-0857; Dempsey, Eugene Michael/0000-0002-6266-3462	Danish Council for Strategic Research [DKK 11,100,105]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by an unconditional and unrestricted grant from the Danish Council for Strategic Research (DKK 11,100,105). The funder had no role in the design, conduct, or analysis of the trial.	Alderliesten T, 2014, J PEDIATR-US, V164, P986, DOI 10.1016/j.jpeds.2013.12.042; [Anonymous], 2009, INT C HARM, P1; Benitz WE, 2010, J PERINATOL, V30, P241, DOI 10.1038/jp.2010.3; Dix LML, 2013, PEDIATR RES, V74, P557, DOI 10.1038/pr.2013.133; Dullenkopf A, 2003, PAEDIATR ANAESTH, V13, P384, DOI 10.1046/j.1460-9592.2003.01111.x; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gerstner B, 2008, J NEUROSCI, V28, P1236, DOI 10.1523/JNEUROSCI.3213-07.2008; Greisen G, 2011, PHILOS T R SOC A, V369, P4440, DOI 10.1098/rsta.2011.0261; Hansen BM, 2004, ACTA PAEDIATR, V93, P190, DOI 10.1080/08035250310008195; Hessel TW, 2014, ACTA PAEDIATR, V103, P488, DOI 10.1111/apa.12567; Hunt RW, 2004, J PEDIATR-US, V145, P588, DOI 10.1016/j.jpeds.2004.06.056; Hyttel-Sorensen S, 2014, J CLIN MONIT COMPUT, V28, P149, DOI 10.1007/s10877-013-9507-9; Hyttel-Sorensen S, 2013, BIOMED OPT EXPRESS, V4, P1662, DOI 10.1364/BOE.4.001662; Hyttel-Sorensen S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-120; Hyttel-Sorensen S, 2013, DAN MED J, V60; Hyttel-Sorensen S, 2011, BIOMED OPT EXPRESS, V2, P3047, DOI 10.1364/BOE.2.003047; International Committee for the Classification of Retinopathy of Prematurity, 2005, INT CLASS RET PREM R, P991; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kluckow M, 2000, ARCH DIS CHILD-FETAL, V82, pF182, DOI 10.1136/fn.82.3.F182; Kramer RS, 2009, ANN THORAC SURG, V87, P44; Kurth CD, 2009, ANESTH ANALG, V108, P1268, DOI 10.1213/ane.0b013e318196ac8e; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Noori S, 2014, J PEDIAT, V164, p[264, e1]; Noori S, 2009, CLIN PERINATOL, V36, P723, DOI 10.1016/j.clp.2009.07.015; Pellicer A, 2013, NEONATOLOGY, V104, P171, DOI 10.1159/000351346; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Serenius F, 2014, ACTA PAEDIATR, V103, P27, DOI 10.1111/apa.12421; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Sorensen LC, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357730; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wintermark P, 2014, NEUROIMAGE, V85, P287, DOI 10.1016/j.neuroimage.2013.04.072; Wolf M, 2009, CLIN PERINATOL, V36, P807, DOI 10.1016/j.clp.2009.07.007; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Yis U, 2008, BRAIN DEV-JPN, V30, P556, DOI 10.1016/j.braindev.2008.01.010	39	174	176	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2015	350								g7635	10.1136/bmj.g7635	http://dx.doi.org/10.1136/bmj.g7635			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LU	25569128	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000348129900002
J	Raungaard, B; Jensen, LO; Tilsted, HH; Christiansen, EH; Maeng, M; Terkelsen, CJ; Krusell, LR; Kaltoft, A; Kristensen, SD; Botker, HE; Thuesen, L; Aaroe, J; Jensen, SE; Villadsen, AB; Thayssen, P; Veien, KT; Hansen, KN; Junker, A; Madsen, M; Ravkilde, J; Lassen, JF				Raungaard, Bent; Jensen, Lisette Okkels; Tilsted, Hans-Henrik; Christiansen, Evald Hoj; Maeng, Michael; Terkelsen, Christian Juhl; Krusell, Lars Romer; Kaltoft, Anne; Kristensen, Steen Dalby; Botker, Hans Erik; Thuesen, Leif; Aaroe, Jens; Jensen, Svend Eggert; Villadsen, Anton Boel; Thayssen, Per; Veien, Karsten Tange; Hansen, Knud Norregaard; Junker, Anders; Madsen, Morten; Ravkilde, Jan; Lassen, Jens Flensted		Scandinavian Org Randomized Trials	Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial	LANCET			English	Article							BARE-METAL STENTS; ARTERY-DISEASE; CLINICAL-OUTCOMES; MYOCARDIAL-INFARCTION; ALL-COMERS; OPEN-LABEL; SIROLIMUS; THROMBOSIS; PACLITAXEL; SAFETY	Background New-generation drug-eluting coronary stents have reduced the risk of coronary events, especially in patients with complex disease or lesions. To what extent different stent platforms, polymers, and antiproliferative drugs affect outcomes, however, is unclear. We investigated the safety and efficacy of a third-generation stent by comparing a highly biocompatible durable-polymer-coated zotarolimus-eluting stent with a biodegradable-polymer-coated biolimus-eluting stent. Methods This open-label, randomised, multicentre, non-inferiority trial was done at three sites across western Denmark. All patients who presented with stable coronary artery disease or acute coronary syndromes and at least one coronary artery lesion (more than 50% stenosis) from March, 2011, to August, 2012, were assessed for eligibility. Patients were randomly assigned in a 1: 1 ratio to receive either the durable-polymer zotarolimus-eluting stent or the biodegradable-polymer biolimus-eluting stent. The primary endpoint was a composite of safety (cardiac death and myocardial infarction not clearly attributable to a non-target lesion) and efficacy (target-lesion revascularisation) at 12 months, analysed by intention to treat. The trial was powered to assess non-inferiority of durable-polymer zotarolimus-eluting stent compared with the biodegradable-polymer biolimus-eluting stent with a predetermined non-inferiority margin of 0.025. This trial is registered with ClinicalTrials.gov, number NCT01956448. Findings Of 7103 screened, 1502 patients with 1883 lesions were assigned to receive the durable-polymer zotarolimus-eluting stent and 1497 patients with 1791 lesions to receive the biodegradable-polymer biolimus-eluting stent. 79 (5.3%) and 75 (5.0%) patients, respectively, met the primary endpoint (absolute risk difference 0.0025, upper limit of one-sided 95% CI 0.016%; p=0.004). The individual components of the primary endpoint did not differ significantly between stent types at 12 months. Interpretation The durable-polymer-coated zotarolimus-eluting stent was non-inferior to the biodegradable-polymer-coated biolimus-eluting stent in unselected patients.	[Raungaard, Bent; Tilsted, Hans-Henrik; Aaroe, Jens; Jensen, Svend Eggert; Villadsen, Anton Boel; Ravkilde, Jan] Aalborg Univ Hosp, Dept Cardiol, DK-9000 Aalborg, Denmark; [Jensen, Lisette Okkels; Thayssen, Per; Veien, Karsten Tange; Hansen, Knud Norregaard; Junker, Anders] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Christiansen, Evald Hoj; Maeng, Michael; Terkelsen, Christian Juhl; Krusell, Lars Romer; Kaltoft, Anne; Kristensen, Steen Dalby; Botker, Hans Erik; Thuesen, Leif; Lassen, Jens Flensted] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Madsen, Morten] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; Aarhus University; Aarhus University	Raungaard, B (corresponding author), Aalborg Univ Hosp, Dept Cardiol, DK-9000 Aalborg, Denmark.	rau@dadlnet.dk	Lassen, Jens Flensted/AAY-2127-2021; Maeng, Michael/AAY-2135-2021; terkelsen, christian/ABD-6294-2021	Lassen, Jens Flensted/0000-0001-7972-9192; Maeng, Michael/0000-0002-4310-6433; terkelsen, christian juhl/0000-0003-0205-9551; Botker, Hans Erik/0000-0001-6358-8962; Madsen, Morten/0000-0002-6036-8240; Jensen, Lisette Okkels/0000-0002-4838-2429; Christiansen, Evald/0000-0002-8740-4862	Medtronic Cardiovascular and Biosensors Interventional Technologies; Novo Nordisk Fonden [NNF14OC0008817, NNF14OC0013337, NNF13OC0007447] Funding Source: researchfish	Medtronic Cardiovascular and Biosensors Interventional Technologies; Novo Nordisk Fonden(Novo Nordisk Foundation)	Medtronic Cardiovascular and Biosensors Interventional Technologies.	Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625; Byrne RA, 2011, J AM COLL CARDIOL, V58, P1325, DOI 10.1016/j.jacc.2011.06.027; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Caputo R, 2014, CATHETER CARDIO INTE, V84, P17, DOI 10.1002/ccd.25485; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Jensen LO, 2010, EUROINTERVENTION, V5, P898, DOI 10.4244/; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Lam MK, 2014, AM HEART J, V167, P445, DOI 10.1016/j.ahj.2013.11.014; Lee JY, 2014, CIRC-CARDIOVASC INTE, V7, P322, DOI 10.1161/CIRCINTERVENTIONS.113.000841; Lee JM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-398; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P1208, DOI 10.1016/j.jcin.2009.10.008; Li XT, 2014, CORONARY ARTERY DIS, V25, P405, DOI 10.1097/MCA.0000000000000098; Maeng M, 2014, LANCET, V383, P2047, DOI 10.1016/S0140-6736(14)60405-0; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Park KW, 2014, JACC-CARDIOVASC INTE, V7, P471, DOI 10.1016/j.jcin.2013.12.201; Pilgrim T, 2014, LANCET; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Talarico GP, 2013, CATHETER CARDIO INTE, V81, P268, DOI 10.1002/ccd.24498; Teeuwen K, 2014, EUROINTERVENTION; Thuesen Leif, 2013, Clin Epidemiol, V5, P357, DOI 10.2147/CLEP.S44651; Thygesen K, 2007, EUR HEART J, V28, P2525; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; von Birgelen C, 2014, LANCET, V383, P413, DOI 10.1016/S0140-6736(13)62037-1; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Zhang Q, 2014, J INTERV CARDIOL, V27, P131, DOI 10.1111/joic.12102	41	90	93	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1527	1535		10.1016/S0140-6736(14)61794-3	http://dx.doi.org/10.1016/S0140-6736(14)61794-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25601789				2022-12-28	WOS:000353220000034
J	Bas, M; Greve, J; Stelter, K; Havel, M; Strassen, U; Rotter, N; Veit, J; Schossow, B; Hapfelmeier, A; Kehl, V; Kojda, G; Hoffmann, TK				Bas, Murat; Greve, Jens; Stelter, Klaus; Havel, Miriam; Strassen, Ulrich; Rotter, Nicole; Veit, Johannes; Schossow, Beate; Hapfelmeier, Alexander; Kehl, Victoria; Kojda, Georg; Hoffmann, Thomas K.			A Randomized Trial of Icatibant in ACE-Inhibitor-Induced Angioedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITOR; BRADYKININ-RECEPTOR ANTAGONIST; MEDIATED ANGIOEDEMA; ANGIOTENSIN; EDEMA; MANAGEMENT; RISK	BACKGROUND Angioedema induced by treatment with angiotensin-converting-enzyme (ACE) inhibitors accounts for one third of angioedema cases in the emergency room; it is usually manifested in the upper airway and the head and neck region. There is no approved treatment for this potentially life-threatening condition. METHODS In this multicenter, double-blind, double-dummy, randomized phase 2 study, we assigned patients who had ACE-inhibitor-induced angioedema of the upper aerodigestive tract to treatment with 30 mg of subcutaneous icatibant, a selective bradykinin B2 receptor antagonist, or to the current off-label standard therapy consisting of intravenous prednisolone (500 mg) plus clemastine (2 mg). The primary efficacy end point was the median time to complete resolution of edema. RESULTS All 27 patients in the per-protocol population had complete resolution of edema. The median time to complete resolution was 8.0 hours (interquartile range, 3.0 to 16.0) with icatibant as compared with 27.1 hours (interquartile range, 20.3 to 48.0) with standard therapy (P = 0.002). Three patients receiving standard therapy required rescue intervention with icatibant and prednisolone; 1 patient required tracheotomy. Significantly more patients in the icatibant group than in the standard-therapy group had complete resolution of edema within 4 hours after treatment (5 of 13 vs. 0 of 14, P = 0.02). The median time to the onset of symptom relief (according to a composite investigator-assessed symptom score) was significantly shorter with icatibant than with standard therapy (2.0 hours vs. 11.7 hours, P = 0.03). The results were similar when patient-assessed symptom scores were used. CONCLUSIONS Among patients with ACE-inhibitor-induced angioedema, the time to complete resolution of edema was significantly shorter with icatibant than with combination therapy with a glucocorticoid and an antihistamine.	[Bas, Murat; Strassen, Ulrich] Tech Univ Munich, Klinikum Rechts Isar, Dept Otorhinolaryngol, D-81675 Munich, Germany; [Schossow, Beate] Tech Univ Munich, Klinikum Rechts Isar, Munchner Studien Zentrum, D-81675 Munich, Germany; [Hapfelmeier, Alexander; Kehl, Victoria] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, D-81675 Munich, Germany; [Stelter, Klaus; Havel, Miriam] Univ Munich, Dept Otorhinolaryngol, Grosshadern Med Ctr, Munich, Germany; [Greve, Jens; Rotter, Nicole; Veit, Johannes; Hoffmann, Thomas K.] Univ Ulm, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-89069 Ulm, Germany; [Kojda, Georg] Univ Hosp Dusseldorf, Inst Pharmacol & Clin Pharmacol, Dusseldorf, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Ulm University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Bas, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Otorhinolaryngol, Ismaninger Str 22, D-81675 Munich, Germany.	m.bas.hno@gmail.com	Greve, Jens/AAF-2688-2021; Hapfelmeier, Alexander/I-9966-2019	Hapfelmeier, Alexander/0000-0001-6765-6352; Rotter, Nicole/0000-0003-1537-8340	Shire; Federal Ministry of Education and Research of Germany	Shire; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF))	Funded by Shire and the Federal Ministry of Education and Research of Germany; ClinicalTrials.gov number, NCT01154361.	Banerji A, 2008, ANN ALLERG ASTHMA IM, V100, P327, DOI 10.1016/S1081-1206(10)60594-7; Bas M, 2004, HNO, V52, P886, DOI 10.1007/s00106-003-1017-5; Bas M, 2011, ANAESTHESIST, V60, P1141, DOI 10.1007/s00101-010-1798-3; Bas M, 2010, ANN EMERG MED, V56, P278, DOI 10.1016/j.annemergmed.2010.03.032; Cicardi M, 2010, NEW ENGL J MED, V363, P532, DOI 10.1056/NEJMoa0906393; DASARATHY Y, 1992, AM J PHYSIOL, V263, pL645, DOI 10.1152/ajplung.1992.263.6.L645; Dean DE, 2001, J FORENSIC SCI, V46, P1239; Gainer JV, 1998, NEW ENGL J MED, V339, P1285, DOI 10.1056/NEJM199810293391804; Gallitelli M, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2011.09.014; Holm JPY, 2012, DAN MED J, V59; Hoover T, 2010, CLIN EXP ALLERGY, V40, P50, DOI 10.1111/j.1365-2222.2009.03323.x; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Javaud N, 2011, ANN FR ANESTH, V30, P848, DOI 10.1016/j.annfar.2011.07.005; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Manders K, 2012, NETH J MED, V70, P386; Miller DR, 2008, HYPERTENSION, V51, P1624, DOI 10.1161/HYPERTENSIONAHA.108.110270; Nosbaum A, 2013, REV MED INTERNE, V34, P209, DOI 10.1016/j.revmed.2012.12.017; Schmidt PW, 2010, J AM ACAD DERMATOL, V63, P913, DOI 10.1016/j.jaad.2010.03.023; SLATER EE, 1988, JAMA-J AM MED ASSOC, V260, P967, DOI 10.1001/jama.260.7.967; Toh S, 2012, ARCH INTERN MED, V172, P1582, DOI 10.1001/2013.jamainternmed.34; Vleeming W, 1998, DRUG SAFETY, V18, P171, DOI 10.2165/00002018-199818030-00003	21	131	139	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					418	425		10.1056/NEJMoa1312524	http://dx.doi.org/10.1056/NEJMoa1312524			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629740				2022-12-28	WOS:000348649700006
J	Noto, MJ; Domenico, HJ; Byrne, DW; Talbot, T; Rice, TW; Bernard, GR; Wheeler, AP				Noto, Michael J.; Domenico, Henry J.; Byrne, Daniel W.; Talbot, Tom; Rice, Todd W.; Bernard, Gordon R.; Wheeler, Arthur P.			Chlorhexidine Bathing and Health Care-Associated Infections A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; TRANSMISSION; PREVENTION; ORGANISMS; GLUCONATE; IMPACT; COSTS	IMPORTANCE Daily bathing of critically ill patients with the broad-spectrum, topical antimicrobial agent chlorhexidine is widely performed and may reduce health care-associated infections. OBJECTIVE To determine if daily bathing of critically ill patients with chlorhexidine decreases the incidence of health care-associated infections. DESIGN, SETTING, AND PARTICIPANTS A pragmatic cluster randomized, crossover study of 9340 patients admitted to 5 adult intensive care units of a tertiary medical center in Nashville, Tennessee, from July 2012 through July 2013. INTERVENTIONS Units performed once-daily bathing of all patients with disposable cloths impregnated with 2% chlorhexidine or nonantimicrobial cloths as a control. Bathing treatments were performed for a 10-week period followed by a 2-week washout period during which patients were bathed with nonantimicrobial disposable cloths, before crossover to the alternate bathing treatment for 10 weeks. Each unit crossed over between bathing assignments 3 times during the study. MAIN OUTCOMES AND MEASURES The primary prespecified outcome was a composite of central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated pneumonia (VAP), and Clostridium difficile infections. Secondary outcomes included rates of clinical cultures that tested positive for multidrug-resistant organisms, blood culture contamination, health care-associated bloodstream infections, and rates of the primary outcome by ICU. RESULTS During the chlorhexidine bathing period, 55 infections occurred: 4 CLABSI, 21 CAUTI, 17 VAP, and 13 C difficile. During the control bathing period, 60 infections occurred: 4 CLABSI, 32 CAUTI, 8 VAP, and 16 C difficile. The primary outcome rate was 2.86 per 1000 patient-days during the chlorhexidine and 2.90 per 1000 patient-days during the control bathing periods (rate difference, -0.04; 95% CI, -1.10 to 1.01; P = .95). After adjusting for baseline variables, no difference between groups in the rate of the primary outcome was detected. Chlorhexidine bathing did not change rates of infection-related secondary outcomes including hospital-acquired bloodstream infections, blood culture contamination, or clinical cultures yielding multidrug-resistant organisms. In a prespecified subgroup analysis, no difference in the primary outcome was detected in any individual intensive care unit. CONCLUSION AND RELEVANCE In this pragmatic trial, daily bathing with chlorhexidine did not reduce the incidence of health care-associated infections including CLABSIs, CAUTIs, VAP, or C difficile. These findings do not support daily bathing of critically ill patients with chlorhexidine.	[Noto, Michael J.; Talbot, Tom; Rice, Todd W.; Bernard, Gordon R.; Wheeler, Arthur P.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Domenico, Henry J.; Byrne, Daniel W.] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Noto, MJ (corresponding author), Vanderbilt Univ, Med Ctr, MCN, 1161 21st Ave S,T-1223, Nashville, TN 37232 USA.	michael.j.noto@vanderbilt.edu	Byrne, Daniel/GRE-6302-2022; Rice, Todd/X-7853-2019; 卢, 悄佳/Z-5223-2019	Rice, Todd/0000-0002-7136-5408; Talbot, Thomas/0000-0002-6139-212X	National Institutes of Health and through the Vanderbilt Institute for Clinical and Translational Research [UL1 TR000445, 2T32HL087738-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087738] Funding Source: NIH RePORTER	National Institutes of Health and through the Vanderbilt Institute for Clinical and Translational Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by grants UL1 TR000445 and 2T32HL087738-06 from the National Institutes of Health and through the Vanderbilt Institute for Clinical and Translational Research. The chlorhexidine impregnated and nonantimicrobial cloths were purchased from Sage Products.	Calfee DP, 2014, INFECT CONT HOSP EP, V35, P772, DOI [10.1086/676534, 10.1017/S0899823X00193882]; Centers for Disease Control and Prevention, CDC NHSN SURV DEF SP; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Karki S, 2012, J HOSP INFECT, V82, P71, DOI 10.1016/j.jhin.2012.07.005; Kassakian SZ, 2011, INFECT CONT HOSP EP, V32, P238, DOI 10.1086/658334; Kaye KS, 2014, J AM GERIATR SOC, V62, P306, DOI 10.1111/jgs.12634; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Roberts RR, 2010, MED CARE, V48, P1026, DOI 10.1097/MLR.0b013e3181ef60a2; Rupp ME, 2012, INFECT CONT HOSP EP, V33, P1094, DOI 10.1086/668024; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Suwantarat N, 2014, INFECT CONT HOSP EP, V35, P1183, DOI 10.1086/677628; University HealthSystem Consortium, AB UHC; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Viray MA, 2014, INFECT CONT HOSP EP, V35, P243, DOI 10.1086/675292; Wang JT, 2008, J ANTIMICROB CHEMOTH, V62, P514, DOI 10.1093/jac/dkn208; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D	19	124	131	0	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					369	378		10.1001/jama.2014.18400	http://dx.doi.org/10.1001/jama.2014.18400			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25602496	Bronze, Green Accepted			2022-12-28	WOS:000349072600019
J	[Anonymous]				[Anonymous]			The Architecture of Viruses (Reprinted from JAMA, vol 114, pg 328, 1940)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Frampton VL, 1939, SCIENCE, V89, P84, DOI 10.1126/science.89.2300.84; Kogl F, 1939, Z PHYSL CHEM, V258, P57; Stanley W. M., 1937, COMPARE HARVEY LECT, V33, P1937; Stanley WM, 1939, PHYSIOL REV, V19, P524, DOI 10.1152/physrev.1939.19.4.524; 1940, JAMA, V114, P328	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					426	426		10.1001/jama.2014.11548	http://dx.doi.org/10.1001/jama.2014.11548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626051				2022-12-28	WOS:000349072600036
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Don't be bullied into prescribing Tamiflu	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cohen D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h258; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Steel N, 2014, J CLIN EPIDEMIOL, V67, P1251, DOI 10.1016/j.jclinepi.2014.05.020	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2015	350								h417	10.1136/bmj.h417	http://dx.doi.org/10.1136/bmj.h417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZH	25613746	Bronze			2022-12-28	WOS:000348433800007
J	Peeples, MS				Peeples, Molly S.			Cosmic fog and smog	NATURE			English	Editorial Material									Space Telescope Sci Inst, Baltimore, MD 21218 USA	Space Telescope Science Institute	Peeples, MS (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	molly@stsci.edu						Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Cooksey KL, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/37; Cooksey KL, 2010, ASTROPHYS J, V708, P868, DOI 10.1088/0004-637X/708/1/868; Corrales L., 2014, PREPRINT; Danforth C. W., 2014, PREPRINT; Shull JM, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/1/49	8	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2015	517	7535					444	445		10.1038/517444a	http://dx.doi.org/10.1038/517444a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4MU	25612047				2022-12-28	WOS:000348196500024
J	D'Silva, J				D'Silva, Jeetha			CORRUPTION IN INDIA India's private medical colleges and capitation fees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						[Anonymous], 2014, TIMES INDIA; [Anonymous], 2014, OP LETT INCR CORR PR; [Anonymous], 2014, M SHIKSH SHULK SAM D; Boulet J, 2007, MED TEACH, V29, P20, DOI 10.1080/01421590601131823; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; India College Finder, LIST MED COLL SEATS; Kalpana P, 2014, BUSINESS STANDA 0628; Nagarajan R., 2014, TIMES INDIA; Narayan P, 2014, TIMES INDIA; Pasha S, 2013, IBN LIVE        0404; PRS Legislative Research, 2010, PROH UNF PRACT TECHN; Sharma A, 2014, CAREERS360      0806; Vaidhyasubramaniam S, 2014, NEW INDIAN EXPR 0830; Venkatesan J., 2014, HINDU; Venkatesan V, 2003, FRONTLINE, V20	15	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2015	350								h106	10.1136/bmj.h106	http://dx.doi.org/10.1136/bmj.h106			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZG	25608519				2022-12-28	WOS:000348433700004
J	Sparling, PB; Howard, BJ; Dunstan, DW; Owen, N				Sparling, Phillip B.; Howard, Bethany J.; Dunstan, David W.; Owen, Neville			Recommendations for physical activity in older adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTPRANDIAL GLUCOSE; ACTIVITY GUIDELINES; SITTING TIME; EXERCISE; HEALTH; FITNESS; DISEASE		[Sparling, Phillip B.] Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA; [Howard, Bethany J.; Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Dunstan, David W.] Univ Western Australia, Nedlands, WA 6009, Australia; [Dunstan, David W.; Owen, Neville] Monash Univ, Clayton, Vic 3800, Australia; [Dunstan, David W.] Deakin Univ, Geelong, Vic 3217, Australia; [Owen, Neville] Univ Queensland, Brisbane, Qld 4072, Australia; [Owen, Neville] Univ Melbourne, Melbourne, Vic 3010, Australia	University System of Georgia; Georgia Institute of Technology; Baker Heart and Diabetes Institute; University of Western Australia; Monash University; Deakin University; University of Queensland; University of Melbourne	Sparling, PB (corresponding author), Georgia Inst Technol, Sch Appl Physiol, 555 14th St NW, Atlanta, GA 30332 USA.	phil.sparling@gatech.edu	Dunstan, David Wayne/E-8473-2010; Owen, Neville/K-5986-2012	Dunstan, David Wayne/0000-0003-2629-9568; Owen, Neville/0000-0003-2784-4820				Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Agency for Healthcare Research and Quality, 2012, GUID CLIN PREV SERV; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Boyington JI, 2014, MED SCI SPORTS EXERC; Broskey NT, 2014, J CLIN ENDOCR METAB, V99, P1852, DOI 10.1210/jc.2013-3983; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Department of Health, 2011, START ACT STAY ACT R; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Hamer M, 2014, AM J PREV MED, V47, P452, DOI 10.1016/j.amepre.2014.05.044; Jefferis BJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-382; Khan KM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4141; Lunt H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083256, 10.1371/journal.pone.0105360]; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; National Institute for Health and Care Excellence, 2013, NICE PUBL HLTH GUID, P44; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID AM; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Schrack JA, 2014, J GERONTOL A-BIOL, V69, P973, DOI 10.1093/gerona/glt199; Thorp AA, 2014, MED SCI SPORT EXER, V46, P2053, DOI 10.1249/MSS.0000000000000337; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Vuori IM, 2013, MAYO CLIN PROC, V88, P1446, DOI 10.1016/j.mayocp.2013.08.020; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; World Health Organization, 2010, Global recommendations on physical activity for health	31	227	228	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2015	350								h100	10.1136/bmj.h100	http://dx.doi.org/10.1136/bmj.h100			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZG	25608694				2022-12-28	WOS:000348433700002
J	Lewis, E				Lewis, Emma			WHAT YOUR PATIENT IS THINKING Why there's no point telling me to lose weight	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OBESITY											Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Kalantar-Zadeh Kamyar, 2006, Hemodial Int, V10, P315, DOI 10.1111/j.1542-4758.2006.00124.x; Kang XP, 2006, J AM COLL CARDIOL, V47, P1418, DOI 10.1016/j.jacc.2005.11.062; KRAMER FM, 1989, INT J OBESITY, V13, P123; Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220	7	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2015	350								g6845	10.1136/bmj.g6845	http://dx.doi.org/10.1136/bmj.g6845			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZB	25603805	Bronze			2022-12-28	WOS:000348433200002
J	Di Saverio, S; Lombardi, R; Bianchi, E; Tugnoli, G; Jovine, E				Di Saverio, Salomone; Lombardi, Raffaele; Bianchi, Elisa; Tugnoli, Gregorio; Jovine, Elio			An elderly woman with chest pain and constipation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PARAESOPHAGEAL HERNIA; LAPAROSCOPIC REPAIR; FUNDOPLICATION; OPERATION; SURGERY; REFLUX		[Di Saverio, Salomone; Lombardi, Raffaele; Bianchi, Elisa; Jovine, Elio] Local Hlth Dist, Bologna, Italy; [Tugnoli, Gregorio] Local Hlth Dist, Head Trauma Surg Unit, Bologna, Italy		Di Saverio, S (corresponding author), Local Hlth Dist, Bologna, Italy.	salo75@inwind.it	Di Saverio, Salomone/G-1437-2012; Lombardi, Raffaele/AAD-2517-2022	Di Saverio, Salomone/0000-0001-5685-5022; Lombardi, Raffaele/0000-0002-2219-4972				Antoniou SA, 2012, SURG LAPARO ENDO PER, V22, P498, DOI 10.1097/SLE.0b013e3182747ac2; Bhayani NH, 2013, SURG ENDOSC, V27, P267, DOI 10.1007/s00464-012-2436-8; Blencowe NS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3095; Camilleri M, 2010, GUT, V59, P1288, DOI 10.1136/gut.2009.199653; CASKEY CI, 1989, RADIOLOGY, V171, P385, DOI 10.1148/radiology.171.2.2704802; COHEN JR, 1978, RADIOLOGY, V127, P315, DOI 10.1148/127.2.315; Collet D, 2013, J VISC SURG, V150, P395, DOI 10.1016/j.jviscsurg.2013.07.002; Di Saverio S, 2014, NEW ENGL J MED, V371, pE29, DOI 10.1056/NEJMicm1400032; Di Saverio S, 2014, CAN MED ASSOC J, V186, pE400, DOI 10.1503/cmaj.131333; Di Saverio S, 2013, FRONT MED-PRC, V7, P386, DOI 10.1007/s11684-013-0278-y; Eren S, 2005, EUR J RADIOL, V54, P448, DOI 10.1016/j.ejrad.2004.09.008; Fasano NC, 2003, DYSPHAGIA, V18, P9, DOI 10.1007/s00455-002-0075-2; Garden OJ, 2012, PRINCIPLES PRACTICE; Groth Shawn S, 2009, Thorac Surg Clin, V19, P511, DOI 10.1016/j.thorsurg.2009.08.003; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Kavic SM, 2006, SURG INNOV, V13, P49, DOI 10.1177/155335060601300108; Kohn GP, 2013, GUIDELINES MANAGEMEN; Larusson HJ, 2009, WORLD J SURG, V33, P980, DOI 10.1007/s00268-009-9958-9; Lee YY, 2014, GUT, V63, P1053, DOI 10.1136/gutjnl-2013-305803; Luketich JD, 2000, ANN SURG, V232, P608, DOI 10.1097/00000658-200010000-00016; Maganty K, 2008, DIGESTION, V77, P214, DOI 10.1159/000144281; Maish MS, 2010, SURG CLIN N AM, V90, P955, DOI 10.1016/j.suc.2010.07.005; Menon S, 2011, EUR J GASTROEN HEPAT, V23, P133, DOI 10.1097/MEG.0b013e3283426f57; Mitiek MO, 2010, ANN THORAC SURG, V89, pS2168, DOI 10.1016/j.athoracsur.2010.03.022; Morris-Stiff G, 2008, HERNIA, V12, P299, DOI 10.1007/s10029-008-0332-x; Mungo B, 2014, J AM COLL SURG; Novelline RA, 2004, SQUIRES FUNDAMENTALS; Parker DM, 2013, SURG ENDOSC, V27, P4081, DOI 10.1007/s00464-013-3064-7; Rashid F, 2010, INT J SURG, V8, P18, DOI 10.1016/j.ijsu.2009.11.002; Revenig LM, 2013, J AM COLL SURGEONS, V217, P665, DOI 10.1016/j.jamcollsurg.2013.06.012; Reynolds JH, 2010, BRIT J RADIOL, V83, P998, DOI 10.1259/bjr/31200593; Roberts Heidi C, 2009, Thorac Surg Clin, V19, P431, DOI 10.1016/j.thorsurg.2009.08.008; Santivanez S, 2010, CURR OPIN PULM MED, V16, P257, DOI 10.1097/MCP.0b013e3283386282; Schieman Colin, 2009, Thorac Surg Clin, V19, P473, DOI 10.1016/j.thorsurg.2009.08.006; Sihvo EI, 2009, J THORAC CARDIOV SUR, V137, P419, DOI 10.1016/j.jtcvs.2008.05.042; Stylopoulos N, 2002, ANN SURG, V236, P492, DOI 10.1097/00000658-200210000-00012; van der Westhuizen L, 2013, AM SURGEON, V79, P572; Walker CM, 2014, AM J ROENTGENOL, V202, P479, DOI 10.2214/AJR.13.11463	38	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2015	350								h166	10.1136/bmj.h166	http://dx.doi.org/10.1136/bmj.h166			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7YY	25601597				2022-12-28	WOS:000348432800001
J	Garde, S				Garde, Shekhar			Hydrophobic interactions in context	NATURE			English	Editorial Material							GUANIDINIUM; BEHAVIOR		Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Garde, S (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA.	gardes@rpi.edu						Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Giovambattista N, 2007, J PHYS CHEM C, V111, P1323, DOI 10.1021/jp065419b; Jungwirth P, 2014, NAT CHEM, V6, P261, DOI 10.1038/nchem.1899; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; Mason PE, 2004, J AM CHEM SOC, V126, P11462, DOI 10.1021/ja040034x; Patel AJ, 2014, J PHYS CHEM B, V118, P1564, DOI 10.1021/jp4081977; Patel AJ, 2012, J PHYS CHEM B, V116, P2498, DOI 10.1021/jp2107523; Perchiacca JM, 2012, PROTEIN ENG DES SEL, V25, P591, DOI 10.1093/protein/gzs042; Shih O, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813281; Werner J, 2014, J PHYS CHEM B, V118, P7119, DOI 10.1021/jp500867w	10	27	27	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					277	279		10.1038/517277a	http://dx.doi.org/10.1038/517277a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592530				2022-12-28	WOS:000347810300027
J	Murali, MR; Uyeda, JW; Tingpej, B				Murali, Mandakolathur R.; Uyeda, Jennifer W.; Tingpej, Bhatraphol			Case 2-2015: A 25-Year-Old Man with Abdominal Pain, Syncope, and Hypotension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYSTIC ECHINOCOCCOSIS; ANAPHYLAXIS; SHOCK		[Murali, Mandakolathur R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Uyeda, Jennifer W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Tingpej, Bhatraphol] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Murali, Mandakolathur R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Uyeda, Jennifer W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Tingpej, Bhatraphol] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Murali, MR (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Brown SGA, 2007, IMMUNOL ALLERGY CLIN, V27, P165, DOI 10.1016/j.iac.2007.03.003; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; FILICE C, 1990, GASTROENTEROLOGY, V98, P1366, DOI 10.1016/0016-5085(90)90358-8; Frider B, 1999, J HEPATOL, V30, P228, DOI 10.1016/S0168-8278(99)80066-X; Izikson L, 2006, J AM ACAD DERMATOL, V55, P193, DOI 10.1016/j.jaad.2005.07.057; Jedidi M, 2014, AM J FOREN MED PATH, V35, P29, DOI 10.1097/PAF.0000000000000064; Junghanss T, 2008, AM J TROP MED HYG, V79, P301, DOI 10.4269/ajtmh.2008.79.301; Li YM, 2011, AM J TROP MED HYG, V85, P452, DOI 10.4269/ajtmh.2011.10-0448; Lieberman P, 2010, J ALLERGY CLIN IMMUN, V126, P477, DOI 10.1016/j.jaci.2010.06.022; PAN CV, 1992, ARCH INTERN MED, V152, P1089, DOI 10.1001/archinte.1992.00400170155028; Tinsley B, 2013, CASE REPORTS HEPATOL, V2013; Triggiani M, 2008, CLIN EXP IMMUNOL, V153, P7, DOI 10.1111/j.1365-2249.2008.03714.x; WILKIN JK, 1993, CLIN DERMATOL, V11, P211, DOI 10.1016/0738-081X(93)90057-J	14	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					265	273		10.1056/NEJMcpc1410939	http://dx.doi.org/10.1056/NEJMcpc1410939			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25587951				2022-12-28	WOS:000348119200012
J	Shim, HS; Longo, VD				Shim, Hong Seok; Longo, Valter D.			A Protein Restriction-Dependent Sulfur Code for Longevity	CELL			English	Editorial Material							LIFE-SPAN; IGF-1	The restriction of proteins has recently emerged as the most important factor for the beneficial effects of calorie restriction. Hine et al. now provide strong evidence for the role of the hydrogen sulfide (H2S) gas in the protective effects of calorie and protein restriction against ischemia/reperfusion injury (IRI) but also implicate H2S in longevity extension in model organisms.	[Shim, Hong Seok; Longo, Valter D.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Longo, Valter D.] Univ So Calif, Longev Inst, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Longo, Valter D.] FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy	University of Southern California; University of Southern California; IFOM - FIRC Institute of Molecular Oncology	Longo, VD (corresponding author), Univ So Calif, Dept Biol Sci, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	vlongo@usc.edu			Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Bruce KD, 2013, EXP GERONTOL, V48, P1129, DOI [10.1016/j.exger.2013.02.003, 10.1016/j.exge]; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Parrella E, 2013, AGING CELL, V12, P257, DOI 10.1111/acel.12049; Ruckenstuhl C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004347; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009	10	13	14	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 15	2015	160	1-2					15	17		10.1016/j.cell.2014.12.027	http://dx.doi.org/10.1016/j.cell.2014.12.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0GD	25594171	Bronze			2022-12-28	WOS:000347923200004
J	Teodorescu, M; Barnet, JH; Hagen, EW; Palta, M; Young, TB; Peppard, PE				Teodorescu, Mihaela; Barnet, Jodi H.; Hagen, Erika W.; Palta, Mari; Young, Terry B.; Peppard, Paul E.			Association Between Asthma and Risk of Developing Obstructive Sleep Apnea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UPPER AIRWAY; GASTROESOPHAGEAL-REFLUX; SYSTEMIC INFLAMMATION; INCREASED PREVALENCE; DAYTIME SLEEPINESS; SELF-REPORT; ADULTS; POPULATION; STEROIDS; DISEASE	IMPORTANCE Obstructive sleep apnea (OSA) is more common among patients with asthma; whether asthma is associated with the development of OSA is unknown. OBJECTIVE To examine the prospective relationship of asthma with incident OSA. DESIGN, SETTING, AND PARTICIPANTS Population-based prospective epidemiologic study (the Wisconsin Sleep Cohort Study) beginning in 1988. Adult participants were recruited from a random sample of Wisconsin state employees to attend overnight polysomnography studies at 4-year intervals. Asthma and covariate information were assessed during polysomnography studies through March 2013. Eligible participants were identified as free of OSA (apnea-hypopnea index [AHI] of <5 events/h and not treated) by 2 baseline polysomnography studies. There were 1105 4-year follow-up intervals provided by 547 participants (52% women; mean [SD] baseline age, 50 [8] years). EXPOSURES Questionnaire-assessed presence and duration of self-reported physician-diagnosed asthma. MAIN OUTCOMES AND MEASURES The associations of presence and duration of asthma with 4-year incidences of both OSA (AHI of >= 5 or positive airway pressure treatment) and OSA concomitant with habitual daytime sleepiness were estimated using repeated-measures Poisson regression, adjusting for confounders. RESULTS Twenty-two of 81 participants (27%[95% CI, 17%-37%]) with asthma experienced incident OSA over their first observed 4-year follow-up interval compared with 75 of 466 participants (16%[95% CI, 13%-19%]) without asthma. Using all 4-year intervals, participants with asthma experienced 45 cases of incident OSA during 167 4-year intervals (27%[95% CI, 20%-34%]) and participants without asthma experienced 160 cases of incident OSA during 938 4-year intervals (17%[95% CI, 15%-19%]); the corresponding adjusted relative risk (RR) was 1.39 (95% CI, 1.06-1.82), controlling for sex, age, baseline and change in body mass index, and other factors. Asthma was also associated with new-onset OSA with habitual sleepiness (RR, 2.72 [95% CI, 1.26-5.89], P = .045). Asthma duration was related to both incident OSA (RR, 1.07 per 5-year increment in asthma duration [95% CI, 1.02-1.13], P = .01) and incident OSA with habitual sleepiness (RR, 1.18 [95% CI, 1.07-1.31], P = .02). CONCLUSIONS AND RELEVANCE Asthma was associated with an increased risk of new-onset OSA. Studies investigating the mechanisms underlying this association and the value of periodic OSA evaluation in patients with asthma are warranted.	[Teodorescu, Mihaela] William S Middleton Mem Vet Adm Med Ctr, James B Skatrud Pulm Sleep Res Lab, Madison, WI USA; [Teodorescu, Mihaela] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53792 USA; [Teodorescu, Mihaela] Univ Wisconsin, Sch Med & Publ Hlth, Ctr Sleep Med & Sleep Res, Madison, WI 53792 USA; [Barnet, Jodi H.; Hagen, Erika W.; Palta, Mari; Young, Terry B.; Peppard, Paul E.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Teodorescu, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, K4-910 CSC 9988,600 Highland Ave, Madison, WI 53792 USA.	mt3@medicine.wisc.edu			National Heart, Lung, and Blood Institute [R01HL62252]; National Institute on Aging [R01AG036838]; National Center for Research Resources at the National Institutes of Health (NIH) [1UL1RR025011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036838] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Heart, Lung, and Blood Institute (R01HL62252), National Institute on Aging (R01AG036838), and the National Center for Research Resources (1UL1RR025011) at the National Institutes of Health (NIH); additional resources were from the William S. Middleton Memorial VA Hospital, Madison. This work was performed at the University of Wisconsin and William S. Middleton Memorial VA Hospital, Madison.	Alkhalil M, 2008, ANN ALLERG ASTHMA IM, V101, P350, DOI 10.1016/S1081-1206(10)60309-2; Alkhalil M, 2009, J CLIN SLEEP MED, V5, P71; Auckley D, 2008, SLEEP MED, V9, P494, DOI 10.1016/j.sleep.2007.06.010; BALLARD RD, 1990, J APPL PHYSIOL, V68, P2034, DOI 10.1152/jappl.1990.68.5.2034; Bjermer L, 2007, J ALLERGY CLIN IMMUN, V120, P1269, DOI 10.1016/j.jaci.2007.09.017; Demeter P, 2004, J GASTROENTEROL, V39, P815, DOI 10.1007/s00535-004-1416-8; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Emilsson OI, 2013, EUR RESPIR J, V41, P1347, DOI 10.1183/09031936.00052512; Huxtable AG, 2011, RESP PHYSIOL NEUROBI, V178, P482, DOI 10.1016/j.resp.2011.06.017; Janson C, 1996, EUR RESPIR J, V9, P2132, DOI 10.1183/09031936.96.09102132; Jensen OE, FLOWS DEFORMABLE AIR; Julien JY, 2009, J ALLERGY CLIN IMMUN, V124, P371, DOI 10.1016/j.jaci.2009.05.016; Kalra M, 2006, ANN ALLERG ASTHMA IM, V97, P231, DOI 10.1016/S1081-1206(10)60019-1; Knuiman M, 2006, CHEST, V130, P1779, DOI 10.1378/chest.130.6.1779; Lakser OJ, 2008, EUR RESPIR J, V32, P1224, DOI 10.1183/09031936.00092908; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDER N, 1995, J PEDIATR-US, V127, P651, DOI 10.1016/S0022-3476(95)70133-8; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; Orr WC, 2000, AM J GASTROENTEROL, V95, P37; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; SENTHILSELVAN A, 1993, J ASTHMA, V30, P185, DOI 10.3109/02770909309054516; SERIES F, 1994, AM J RESP CRIT CARE, V150, P481, DOI 10.1164/ajrccm.150.2.8049833; Teodorescu M, 2006, SLEEP MED, V7, P607, DOI 10.1016/j.sleep.2006.02.001; Teodorescu M, 2014, J CLIN SLEEP MED, V10, P183, DOI 10.5664/jcsm.3450; Teodorescu M, 2012, J ASTHMA, V49, P620, DOI 10.3109/02770903.2012.689408; Teodorescu M, 2010, CHEST, V138, P543, DOI 10.1378/chest.09-3066; Teodorescu M, 2009, CHEST, V135, P1125, DOI 10.1378/chest.08-1273; VANDEGRAAFF WB, 1988, J APPL PHYSIOL, V65, P2124, DOI 10.1152/jappl.1988.65.5.2124; White DP, 2005, AM J RESP CRIT CARE, V172, P1363, DOI 10.1164/rccm.200412-1631SO; WILLIAMS AJ, 1983, THORAX, V38, P813, DOI 10.1136/thx.38.11.813; Yigla M, 2003, J ASTHMA, V40, P865, DOI 10.1081/JAS-120023577; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	34	110	115	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					156	164		10.1001/jama.2014.17822	http://dx.doi.org/10.1001/jama.2014.17822			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585327	Green Accepted			2022-12-28	WOS:000347679300015
J	Cunningham, LL; Tucci, DL				Cunningham, Lisa L.; Tucci, Debara L.			Restoring Synaptic Connections in the Inner Ear after Noise Damage	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cunningham, Lisa L.] Natl Inst Deafness & Other Commun Disorders, Bethesda, MD 20892 USA; [Tucci, Debara L.] Duke Univ Med Ctr, Dept Otolaryngol Head & Neck Surg, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Duke University	Cunningham, LL (corresponding author), Natl Inst Deafness & Other Commun Disorders, Bethesda, MD 20892 USA.		Cunningham, Lisa/AAH-9051-2020	Cunningham, Lisa/0000-0001-5320-964X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000079] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Moser T, 2013, OTOL NEUROTOL, V34, P995, DOI 10.1097/MAO.0b013e3182814d4a; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564	4	20	21	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					181	182		10.1056/NEJMcibr1413201	http://dx.doi.org/10.1056/NEJMcibr1413201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25564901				2022-12-28	WOS:000347443300015
J	Mansoor, AM; Karlapudi, SP				Mansoor, Andre M.; Karlapudi, Sudhakar P.			Kussmaul's Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mansoor, Andre M.; Karlapudi, Sudhakar P.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Mansoor, AM (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	mansooan@ohsu.edu							0	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					E3	E3		10.1056/NEJMicm1310957	http://dx.doi.org/10.1056/NEJMicm1310957			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25564921				2022-12-28	WOS:000347443300001
J	Morton, JJL; Molmer, K				Morton, John J. L.; Molmer, Klaus			QUANTUM INFORMATION Spin memories in for the long haul	NATURE			English	Editorial Material									[Morton, John J. L.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Morton, John J. L.] UCL, Dept Elect & Elect Engn, London WC1H 0AH, England; [Molmer, Klaus] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus, Denmark	University of London; University College London; University of London; University College London; Aarhus University	Morton, JJL (corresponding author), UCL, London Ctr Nanotechnol, London WC1H 0AH, England.	jjl.morton@ucl.ac.uk	Morton, John/I-3515-2013		Engineering and Physical Sciences Research Council [EP/H025952/1, EP/I035536/2, EP/I035536/1, EP/H025952/2, EP/K025945/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Atature M, 2014, SCIENCE, V345, P510, DOI 10.1126/science.1256698; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Clausen C, 2011, NATURE, V469, P508, DOI 10.1038/nature09662; Fraval E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030506; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Sangouard N, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.062301; Simon C, 2010, EUR PHYS J D, V58, P1, DOI 10.1140/epjd/e2010-00103-y; Tang Y.-L., 2013, PHYS REV LETT, V113; Zhong MJ, 2015, NATURE, V517, P177, DOI 10.1038/nature14025	10	6	7	0	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					153	154		10.1038/517153a	http://dx.doi.org/10.1038/517153a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25567278				2022-12-28	WOS:000347477600024
J	Burwell, SM				Burwell, Sylvia M.			Setting Value-Based Payment Goals - HHS Efforts to Improve US Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CMS						Callahan, Charles D/L-1641-2013					Brennan N, 2014, HEALTH AFFAIR, V33, P1195, DOI 10.1377/hlthaff.2014.0130; Chappel A, 2014, ASPE ISSUE BRIEF MED; Newport F., 2014, GALLUP          1114; Office of the National Coordinator for Health Information Technology, 2014, REP TO C; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703	5	729	732	4	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 5	2015	372	10					897	899		10.1056/NEJMp1500445	http://dx.doi.org/10.1056/NEJMp1500445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC4EU	25622024				2022-12-28	WOS:000350304500003
J	Steffen, W; Richardson, K; Rockstrom, J; Cornell, SE; Fetzer, I; Bennett, EM; Biggs, R; Carpenter, SR; de Vries, W; de Wit, CA; Folke, C; Gerten, D; Heinke, J; Mace, GM; Persson, LM; Ramanathan, V; Reyers, B; Sorlin, S				Steffen, Will; Richardson, Katherine; Rockstrom, Johan; Cornell, Sarah E.; Fetzer, Ingo; Bennett, Elena M.; Biggs, Reinette; Carpenter, Stephen R.; de Vries, Wim; de Wit, Cynthia A.; Folke, Carl; Gerten, Dieter; Heinke, Jens; Mace, Georgina M.; Persson, Linn M.; Ramanathan, Veerabhadran; Reyers, Belinda; Sorlin, Sverker			Planetary boundaries: Guiding human development on a changing planet	SCIENCE			English	Article							EARLY-WARNING SIGNALS; SAFE OPERATING SPACE; FUNCTIONAL DIVERSITY; NITROGEN; CLIMATE; WATER; SUSTAINABILITY; RESILIENCE; ECOSYSTEMS; CHEMICALS	The planetary boundaries framework defines a safe operating space for humanity based on the intrinsic biophysical processes that regulate the stability of the Earth system. Here, we revise and update the planetary boundary framework, with a focus on the underpinning biophysical science, based on targeted input from expert research communities and on more general scientific advances over the past 5 years. Several of the boundaries now have a two-tier approach, reflecting the importance of cross-scale interactions and the regional-level heterogeneity of the processes that underpin the boundaries. Two core boundaries-climate change and biosphere integrity-have been identified, each of which has the potential on its own to drive the Earth system into a new state should they be substantially and persistently transgressed.	[Steffen, Will; Rockstrom, Johan; Cornell, Sarah E.; Fetzer, Ingo; Biggs, Reinette; Folke, Carl; Reyers, Belinda] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Steffen, Will] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 2601, Australia; [Richardson, Katherine] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Bennett, Elena M.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Bennett, Elena M.] McGill Univ, McGill Sch Environm, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Biggs, Reinette] Univ Stellenbosch, Ctr Studies Complex, ZA-7602 Stellenbosch, South Africa; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [de Vries, Wim] Alterra Wageningen Univ & Res Ctr, NL-6700 AA Wageningen, Netherlands; [de Vries, Wim] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AA Wageningen, Netherlands; [de Wit, Cynthia A.] Stockholm Univ, Dept Environm Sci & Analyt Chem, S-10691 Stockholm, Sweden; [Folke, Carl] Royal Swedish Acad Sci, Beijer Inst Ecol Econ, SE-10405 Stockholm, Sweden; [Gerten, Dieter; Heinke, Jens] Potsdam Inst Climate Impact Res PIK, Res Domain Earth Syst Anal, D-14473 Potsdam, Germany; [Heinke, Jens] Int Livestock Res Inst, Nairobi 00100, Kenya; [Heinke, Jens] CSIRO, St Lucia, Qld 4067, Australia; [Mace, Georgina M.] UCL, CBER, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Persson, Linn M.] Stockholm Environm Inst, SE-10451 Stockholm, Sweden; [Ramanathan, Veerabhadran] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Ramanathan, Veerabhadran] TERI Energy & Resources Inst Univ, Delhi 110070, India; [Reyers, Belinda] CSIR, ZA-7599 Stellenbosch, South Africa; [Sorlin, Sverker] KTH Royal Inst Technol, Div Hist Sci Technol & Environm, SE-10044 Stockholm, Sweden	Stockholm University; Australian National University; University of Copenhagen; McGill University; McGill University; Stellenbosch University; University of Wisconsin System; University of Wisconsin Madison; Wageningen University & Research; Wageningen University & Research; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Potsdam Institut fur Klimafolgenforschung; CGIAR; International Livestock Research Institute (ILRI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of London; University College London; Stockholm Environment Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography; TERI University; Council for Scientific & Industrial Research (CSIR) - South Africa; Royal Institute of Technology	Steffen, W (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.	will.steffen@anu.edu.au	Reyers, Belinda/AAF-6225-2019; Haygarth, Philip Matthew/F-6790-2014; Mace, Georgina M/I-3072-2016; Fetzer, Ingo/A-6748-2015; de Wit, Cynthia A/J-8063-2012; Richardson, Katherine/D-7592-2014; Bennett, Elena/A-9553-2008; Gerten, Dieter/B-2975-2013; Cornell, Sarah/F-7003-2014; Biggs, Reinette/A-5155-2010; Carpenter, Stephen/AAQ-6404-2020; Folke, Carl/Z-1545-2019	Reyers, Belinda/0000-0002-2194-8656; Mace, Georgina M/0000-0001-8965-5211; Fetzer, Ingo/0000-0001-7335-5679; de Wit, Cynthia A/0000-0001-8497-2699; Richardson, Katherine/0000-0003-3785-2787; Gerten, Dieter/0000-0002-6214-6991; Cornell, Sarah/0000-0003-4367-1296; Biggs, Reinette/0000-0003-0300-4149; Folke, Carl/0000-0002-4050-3281; Carpenter, Stephen/0000-0001-8097-8700; de Vries, Wim/0000-0001-9974-0612; Rockstrom, Johan/0000-0001-8988-2983; Bennett, Elena/0000-0003-3944-2925	MISTRA (Swedish Foundation for Strategic Environmental Research); Swedish Research Council; Natural Sciences and Engineering Research Council of Canada; Trottier Institute for Science and Public Policy; Branco Weiss Fellowship; Family Erling Persson Academy Programme on Global Economic Dynamics and the Biosphere; Stordalen Foundation (Norway); Riksbanken Jubileumsfond; Institute for Advanced Study, Princeton NJ; U.S. National Science Foundation; Direct For Biological Sciences [1440297] Funding Source: National Science Foundation	MISTRA (Swedish Foundation for Strategic Environmental Research)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Trottier Institute for Science and Public Policy; Branco Weiss Fellowship; Family Erling Persson Academy Programme on Global Economic Dynamics and the Biosphere; Stordalen Foundation (Norway); Riksbanken Jubileumsfond; Institute for Advanced Study, Princeton NJ; U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Foley and N. Ramunkutty for contributions to the land-system change boundary; A. Pastor for analytical work on the PB for freshwater; B. Armstrong, C. Butler, T. McMichael, and A. Woodward for contributions to the novel entities boundary; and B. Scholes for comments on an earlier version of the manuscript. Data associated with the paper are located at the Stockholm Resilience Centre, Sweden (http://www.stockholmresilience.org/21/research/research-programmes/planetary-boundaries.html). The planetary boundaries research at the Stockholm Resilience Centre is made possible through a core grant from MISTRA (Swedish Foundation for Strategic Environmental Research). S.E.C. is supported by the Swedish Research Council, E.M.B. is supported by the Natural Sciences and Engineering Research Council of Canada and by the Trottier Institute for Science and Public Policy, R.B. is supported by a Branco Weiss Fellowship, C.F. is supported by the Family Erling Persson Academy Programme on Global Economic Dynamics and the Biosphere, I.F. is supported by the Stordalen Foundation (Norway), S.S. is supported by the Riksbanken Jubileumsfond and the Institute for Advanced Study, Princeton NJ, and S.R.C. and V.R. are supported by the U.S. National Science Foundation.	Anderies JM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044048; Bakke J, 2009, NAT GEOSCI, V2, P202, DOI 10.1038/NGEO439; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BAS (British Antarctic Survey), 2013, ANT OZ; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; BISHOP RC, 1978, AM J AGR ECON, V60, P10, DOI 10.2307/1240156; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Cardinale B, 2012, SCIENCE, V336, P552, DOI 10.1126/science.1222102; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014009; Castree N, 2014, NAT CLIM CHANGE, V4, P763, DOI 10.1038/NCLIMATE2339; Chin M, 2014, ATMOS CHEM PHYS, V14, P3657, DOI 10.5194/acp-14-3657-2014; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; Cornell S. E., 2012, UNDERSTANDING THE EA; Costanza R, 1991, ECOLOGICAL EC SCI MA; Costanza R., 2006, INTEGRATED HIST FUTU; Crowards TM, 1998, ECOL ECON, V25, P303, DOI 10.1016/S0921-8009(97)00041-4; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; D'agata S, 2014, CURR BIOL, V24, P555, DOI 10.1016/j.cub.2014.01.049; de Vries W, 2013, CURR OPIN ENV SUST, V5, P392, DOI 10.1016/j.cosust.2013.07.004; Dearing JA, 2014, GLOBAL ENVIRON CHANG, V28, P227, DOI 10.1016/j.gloenvcha.2014.06.012; EEA, 2001, 222001 EEA; EEA (European Environment Agency), 2002, 28 EUR ENV AG; Egeghy PP, 2012, SCI TOTAL ENVIRON, V414, P159, DOI 10.1016/j.scitotenv.2011.10.046; EPI (Earth Policy Institute), 2014, FOR COV; Falkenmark M, 1997, PHILOS T ROY SOC B, V352, P929, DOI 10.1098/rstb.1997.0072; FOLKE C, 1991, LINKING NATURAL ENV, P77; Folke C, 2010, ECOL SOC, V15, DOI 10.5751/es-03610-150420; Galaz V, 2014, GLOBAL ENV GOVERNANC, DOI 10.4337/9781781955550; Gee D, 2006, ENVIRON HEALTH PERSP, V114, P152, DOI 10.1289/ehp.8134; Gerten D, 2013, CURR OPIN ENV SUST, V5, P551, DOI 10.1016/j.cosust.2013.11.001; Greenwood DJ, 2008, ANN BOT-LONDON, V102, P967, DOI 10.1093/aob/mcn188; Gress SE, 2007, ECOLOGY, V88, P119, DOI 10.1890/0012-9658(2007)88[119:NLISED]2.0.CO;2; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Heise Ursula K., 2008, SENSE PLACE SENSE PL; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hillebrand H, 2011, AM NAT, V178, P171, DOI 10.1086/660831; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P389, DOI 10.1016/j.tree.2013.05.019; IPCC, 2012, MANAGING RISKS EXTRE, DOI DOI 10.1017/CB09781139177245; do Sul JAI, 2014, ENVIRON POLLUT, V185, P352, DOI 10.1016/j.envpol.2013.10.036; Kessler Rebecca, 2011, Environ Health Perspect, V119, pa120, DOI 10.1289/ehp.119-a120; Lau KM, 2008, B AM METEOROL SOC, V89, P369, DOI 10.1175/BAMS-89-3-369; Lenton T., 2011, REVOLUTIONS MADE EAR; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2013, TRENDS ECOL EVOL, V28, P380, DOI 10.1016/j.tree.2013.06.001; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Mace GM, 2014, GLOBAL ENVIRON CHANG, V28, P289, DOI 10.1016/j.gloenvcha.2014.07.009; MacLeod M, 2014, ENVIRON SCI TECHNOL, V48, P11057, DOI 10.1021/es501893m; Masco J, 2010, SOC STUD SCI, V40, P7, DOI 10.1177/0306312709341598; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/NGEO1765, 10.1038/ngeo1765]; NOAA (National Oceanic and Atmospheric Administration), 2014, NOAA ESRL ANN CO2 DA; Palsson G, 2013, ENVIRON SCI POLICY, V28, P3, DOI 10.1016/j.envsci.2012.11.004; Pastor AV, 2014, HYDROL EARTH SYST SC, V18, P5041, DOI 10.5194/hess-18-5041-2014; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Persson LM, 2013, ENVIRON SCI TECHNOL, V47, P12619, DOI 10.1021/es402501c; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Rees M., 2003, OUR FINAL CENTURY WI; Richardson K., 2011, CLIMATE CHANGE GLOBA; Robin Libby, 2013, FUTURE NATURE DOCUME; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Sanderson K, 2011, NATURE, V469, P18, DOI 10.1038/469018a; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Scheringer M, 2012, ATMOS POLLUT RES, V3, P383, DOI 10.5094/APR.2012.044; Scholes RJ, 2005, NATURE, V434, P45, DOI 10.1038/nature03289; Schulte PA, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-31; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; Sorlin S, 2009, NATURES END: HISTORY AND THE ENVIRONMENT, P1; Steffen W., 2004, IGBP BOOK SRIES; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Steffen W, 2013, CURR OPIN ENV SUST, V5, P403, DOI 10.1016/j.cosust.2013.04.007; Stocker T., 2013, AR5 IPCC WGI, P571; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Strempel S, 2012, ENVIRON SCI TECHNOL, V46, P5680, DOI 10.1021/es3002713; The Royal Society, 2005, 1205 ROYAL SOC; UNEP (United Nations Environment Programme), 2013, GCO GLOB CHEM OUTL S; United Nations Secretary-General's High-level Panel on Global Sustainability (UN GSP), 2012, RES PEOPL RES PLAN F; Vandevenne F, 2012, FRONT ECOL ENVIRON, V10, P243, DOI 10.1890/110046; Wallace JS, 2003, PHILOS T R SOC B, V358, P2011, DOI 10.1098/rstb.2003.1383; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; WBCSD (World Business Council on Sustainable Development), ACT 2020 OV; West PC, 2011, FRONT ECOL ENVIRON, V9, P126, DOI 10.1890/090015; WHO, BURD DIS JOINT EFF H	95	4887	4972	241	2958	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 13	2015	347	6223							1259855	10.1126/science.1259855	http://dx.doi.org/10.1126/science.1259855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9DT	25592418	Green Submitted			2022-12-28	WOS:000349221300039
J	Schulz, R; Hilchenbach, M; Langevin, Y; Kissel, J; Silen, J; Briois, C; Engrand, C; Hornung, K; Baklouti, D; Bardyn, A; Cottin, H; Fischer, H; Fray, N; Godard, M; Lehto, H; Le Roy, L; Merouane, S; Orthous-Daunay, FR; Paquette, J; Ryno, J; Siljestrom, S; Stenzel, O; Thirkell, L; Varmuza, K; Zaprudin, B				Schulz, Rita; Hilchenbach, Martin; Langevin, Yves; Kissel, Jochen; Silen, Johan; Briois, Christelle; Engrand, Cecile; Hornung, Klaus; Baklouti, Donia; Bardyn, Anais; Cottin, Herve; Fischer, Henning; Fray, Nicolas; Godard, Marie; Lehto, Harry; Le Roy, Lena; Merouane, Sihane; Orthous-Daunay, Francois-Regis; Paquette, John; Ryno, Jouni; Siljestrom, Sandra; Stenzel, Oliver; Thirkell, Laurent; Varmuza, Kurt; Zaprudin, Boris			Comet 67P/Churyumov-Gerasimenko sheds dust coat accumulated over the past four years	NATURE			English	Article							SOLAR-SYSTEM; DEEP IMPACT; WATER ICE; PARTICLES; COSIMA	Comets are composed of dust and frozen gases. The ices are mixed with the refractory material either as an icy conglomerate(1), or as an aggregate of pre-solar grains (grains that existed prior to the formation of the Solar System), mantled by an ice layer(2,3). The presence of water-ice grains in periodic comets is now well established(4-6). Modelling of infrared spectra obtained about ten kilometres from the nucleus of comet Hartley 2 suggests that larger dust particles are being physically decoupled from fine-grained water-ice particles that may be aggregates(7), which supports the icy-conglomerate model. It is known that comets build up crusts of dust that are subsequently shed as they approach perihelion(8-10). Micrometre-sized interplanetary dust particles collected in the Earth's stratosphere and certain micrometeorites are assumed to be of cometary origin(11-13). Here we report that grains collected from the Jupiter-family comet 67P/Churyumov-Gerasimenko come from a dusty crust that quenches the material outflow activity at the comet surface(14). The larger grains (exceeding 50 micrometres across) are fluffy (with porosity over 50 per cent), and many shattered when collected on the target plate, suggesting that they are agglomerates of entities in the size range of interplanetary dust particles. Their surfaces are generally rich in sodium, which explains the high sodium abundance in cometary meteoroids(15). The particles collected to date therefore probably represent parent material of interplanetary dust particles. This argues against comet dust being composed of a silicate core mantled by organic refractory material and then by a mixture of water-dominated ices(2,3). At its previous recurrence (orbital period 6.5 years), the comet's dust production doubled when it was between 2.7 and 2.5 astronomical units from the Sun(14), indicating that this was when the nucleus shed its mantle. Once the mantle is shed, unprocessed material starts to supply the developing coma, radically changing its dust component, which then also contains icy grains, as detected during encounters with other comets closer to the Sun(4,5).	[Schulz, Rita] European Space Agcy, Sci Support Off, Keplerlaan 1,Postbus 299, NL-2200 AG Noordwijk, Netherlands; [Hilchenbach, Martin; Kissel, Jochen; Fischer, Henning; Merouane, Sihane; Paquette, John; Stenzel, Oliver] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Langevin, Yves; Baklouti, Donia] Univ Paris Sud, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France; [Silen, Johan; Ryno, Jouni] Finnish Meteorol Inst, Observat Serv, FI-00560 Helsinki, Finland; [Briois, Christelle; Bardyn, Anais; Thirkell, Laurent] Univ Orleans, CNRS, Lab Phys & Chim Environm & Espace LPC2E, F-45071 Orleans, France; [Engrand, Cecile; Godard, Marie] Univ Paris Sud, CNRS, IN2P3, Ctr Sci Nucl & Sci Mat,UMR8609, F-91405 Orsay, France; [Hornung, Klaus] Univ Bundeswehr, D-85577 Neubiberg, Germany; [Bardyn, Anais; Cottin, Herve; Fray, Nicolas] Univ Paris Est Creteil, LISA, CNRS, UMR 7583, F-94000 Creteil, France; [Lehto, Harry; Zaprudin, Boris] Univ Paris Diderot, Inst Pierre Simon Laplace, F-94000 Creteil, France; [Le Roy, Lena] Univ Turku, Dept Phys & Astron, Tuorla Observ Vaisantie, Piikkio 21500, Finland; [Orthous-Daunay, Francois-Regis] Univ Bern, CSH, CH-3012 Bern, Switzerland; [Siljestrom, Sandra] Univ Grenoble Alpes, CNRS, Inst Planetol & Astrophys Grenoble, F-38000 Grenoble, France; [Varmuza, Kurt] SP Tech Res Inst Sweden, Dept Chem Mat & Surfaces, S-50115 Boras, Sweden; Vienna Univ Technol, Inst Stat & Wahrscheinlichkeitstheorie, A-1040 Vienna, Austria	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Finnish Meteorological Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; Bundeswehr University Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; University of Turku; University of Bern; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); SP Technical Research Institute of Sweden; Technische Universitat Wien	Schulz, R (corresponding author), European Space Agcy, Sci Support Off, Keplerlaan 1,Postbus 299, NL-2200 AG Noordwijk, Netherlands.	rita.schulz@esa.int	Cottin, Hervé/H-5654-2013; Cottin, Hervé/M-6154-2019; Godard, Marie/H-6451-2011; briois, christelle/B-2170-2015	Cottin, Hervé/0000-0001-9170-5265; Cottin, Hervé/0000-0001-9170-5265; Godard, Marie/0000-0002-7276-4021; Orthous-Daunay, Francois-Regis/0000-0002-1170-0550; Fray, Nicolas/0000-0002-9140-5462; Baklouti, Donia/0000-0002-2754-7829; BRIOIS, Christelle/0000-0002-5616-0180; Siljestrom, Sandra/0000-0002-4975-6074; Stenzel, Oliver/0000-0001-7253-8588; Le Roy, Lena/0000-0002-5984-6153	national funding agencies of Germany (DLR) [50QP1302]; national funding agencies of France (CNES); national funding agencies of Austria; national funding agencies of Finland; ESA Technical Directorate; Swedish National Space Board [121/11]	national funding agencies of Germany (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); national funding agencies of France (CNES); national funding agencies of Austria; national funding agencies of Finland; ESA Technical Directorate; Swedish National Space Board	COSIMA was built by a consortium led by the Max-Planck-Institut fur Extraterrestrische Physik, Garching, Germany, in collaboration with the Laboratoire de Physique et Chimie de l'Environnement et de l'Espace, Orleans, France, the Institut d'Astrophysique Spatiale, CNRS/Universite Paris Sud, Orsay, France, the Finnish Meteorological Institute, Helsinki, Finland, the Universitat Wuppertal, Wuppertal, Germany, von Hoerner und Sulger GmbH, Schwetzingen, Germany, the Universitat der Bundeswehr, Neubiberg, Germany, the Institut fur Physik, Forschungszentrum Seibersdorf, Seibersdorf, Austria, the Institut fur Weltraumforschung, Osterreichische Akademie der Wissenschaften, Graz, Austria and is led by the Max-Planck-Institut fur Sonnensystemforschung, Gottingen, Germany. The support of the national funding agencies of Germany (DLR, grant 50QP1302), France (CNES), Austria, Finland and the ESA Technical Directorate is gratefully acknowledged. S.S. acknowledges the support by the Swedish National Space Board grant (contract number 121/11). We thank the Rosetta Science Ground Segment at the European Space Astronomy Centre, the Rosetta Mission Operations Centre at the European Space Operations Centre, and the Rosetta Project at the European Space Research and Technology Centre for their work, which enabled the science return of the Rosetta mission.	A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; BRIN GD, 1979, ASTROPHYS J, V229, P402, DOI 10.1086/156966; Brownlee D. E., 2007, TREATISE GEOCHEMISTR, P663; Brownlee D, 2014, ANNU REV EARTH PL SC, V42, P179, DOI 10.1146/annurev-earth-050212-124203; Dartois E, 2013, ICARUS, V224, P243, DOI 10.1016/j.icarus.2013.03.002; DiSanti MA, 2007, ICARUS, V187, P240, DOI 10.1016/j.icarus.2006.10.007; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Greenberg JM, 1999, SPACE SCI REV, V90, P149, DOI 10.1023/A:1005298014670; Guilbert-Lepoutre A, 2014, ASTRON ASTROPHYS, V567, DOI 10.1051/0004-6361/201424186; Hornung K, 2014, PLANET SPACE SCI, V103, P309, DOI 10.1016/j.pss.2014.08.011; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; Jewitt DC, 2002, ASTRON J, V123, P1039, DOI 10.1086/338692; JEWITT DC, 1987, ASTROPHYS J, V317, P992, DOI 10.1086/165347; Kearsley AT, 2012, METEORIT PLANET SCI, V47, P737, DOI 10.1111/j.1945-5100.2012.01363.x; Kissel J, 2007, SPACE SCI REV, V128, P823, DOI 10.1007/s11214-006-9083-0; Krueger H., 2015, PLANET SPACE SCI; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Protopapa S, 2014, ICARUS, V238, P191, DOI 10.1016/j.icarus.2014.04.008; RICKMAN H, 1990, ASTRON ASTROPHYS, V237, P524; Schulz R, 2006, ASTRON ASTROPHYS, V448, pL53, DOI 10.1051/0004-6361:200600003; Schulz R, 2009, SOLAR SYST RES+, V43, P343, DOI 10.1134/S0038094609040091; Schulz R., 2009, ROSETTA ESAS MISSION; Stephan T, 2008, SPACE SCI REV, V138, P247, DOI 10.1007/s11214-007-9291-2; Tozzi GP, 2004, ASTRON ASTROPHYS, V424, P325, DOI 10.1051/0004-6361:20035893; Trigo-Rodriguez JM, 2007, ADV SPACE RES, V39, P517, DOI 10.1016/j.asr.2006.05.007; Tsou P, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002317; Villanueva GL, 2011, ICARUS, V216, P227, DOI 10.1016/j.icarus.2011.08.024; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; Yang B, 2009, ASTRON J, V137, P4538, DOI 10.1088/0004-6256/137/5/4538	30	131	132	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					216	218		10.1038/nature14159	http://dx.doi.org/10.1038/nature14159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25624103				2022-12-28	WOS:000349190300034
J	Pauluis, OM				Pauluis, Olivier M.			The global engine that could	SCIENCE			English	Editorial Material							GENERAL-CIRCULATION; ATMOSPHERE; CLIMATE; WORK		NYU, Ctr Atmosphere Ocean Sci, New York, NY 10012 USA	New York University	Pauluis, OM (corresponding author), NYU, Ctr Atmosphere Ocean Sci, 550 1St Ave, New York, NY 10012 USA.	pauluis@cims.nyu.edu						CARNOT S, 1924, REFLEXIONS PUISSANCE; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Kjellsson J, 2014, J ATMOS SCI, V71, P916, DOI 10.1175/JAS-D-13-0173.1; Laliberte F, 2015, SCIENCE, V347, P540, DOI 10.1126/science.1257103; LORENZ EN, 1955, TELLUS, V7, P157; Lucarini V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021118; Pascale S, 2011, CLIM DYNAM, V36, P1189, DOI 10.1007/s00382-009-0718-1; Pauluis O, 2002, J ATMOS SCI, V59, P140, DOI 10.1175/1520-0469(2002)059<0140:EBOAAI>2.0.CO;2; Pauluis O, 2012, SCIENCE, V335, P953, DOI 10.1126/science.1215869; Pauluis O, 2011, J ATMOS SCI, V68, P91, DOI 10.1175/2010JAS3530.1; Renno NO, 2008, TELLUS A, V60, P688, DOI 10.1111/j.1600-0870.2008.00331.x; Zika JD, 2012, J PHYS OCEANOGR, V42, P708, DOI 10.1175/JPO-D-11-0139.1	12	1	1	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2015	347	6221					475	476		10.1126/science.aaa3681	http://dx.doi.org/10.1126/science.aaa3681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0YK	25635072				2022-12-28	WOS:000348639300020
J	Hilton, D				Hilton, Douglas			Donald Metcalf (1929-2014) OBITUARY	NATURE			English	Biographical-Item									[Hilton, Douglas] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Hilton, Douglas] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Hilton, D (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	hilton@wehi.edu.au	Hilton, Douglas J/C-7250-2013	Hilton, Douglas J/0000-0002-7698-2392				METCALF D, PUBLICATION LIST	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					554	554		10.1038/517554a	http://dx.doi.org/10.1038/517554a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631437	Bronze			2022-12-28	WOS:000348775000025
J	McLean, AS; Tang, B; Huang, SJ				McLean, Anthony S.; Tang, Benjamin; Huang, Stephen J.			Investigating sepsis with biomarkers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENOUS OXYGEN-SATURATION; MOLECULAR DIAGNOSTICS; LACTATE CLEARANCE; PROCALCITONIN; INFECTION		[McLean, Anthony S.; Tang, Benjamin; Huang, Stephen J.] Univ Sydney, Dept Intens Care Med, Sydney, NSW 2006, Australia; [Huang, Stephen J.] Nepean Hosp, Sydney, NSW, Australia	University of Sydney; Nepean Hospital	McLean, AS (corresponding author), Univ Sydney, Nepean Hosp, Dept Intens Care Med, Sydney, NSW 2006, Australia.	anthony.mclean@sydney.edu.au	Huang, Stephen/O-6195-2019	Huang, Stephen/0000-0003-2518-0506				Afshari A, 2012, CRIT CARE, V16, DOI 10.1186/cc11202; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Nguyen HB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-6; Paran Y, 2009, CRIT CARE, V13, DOI 10.1186/cc7775; Park JH, 2014, LUNG, V192, P435, DOI 10.1007/s00408-014-9564-y; Phypers B, 2006, BJA EDUC, V6, P128, DOI 10.1093/bjaceaccp/mkl018; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7	12	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2015	350								h254	10.1136/bmj.h254	http://dx.doi.org/10.1136/bmj.h254			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA3AS	25630835				2022-12-28	WOS:000348778600002
J	Abubakar, I; Thomas, HL; Morgan, M; Anderson, S; Zenner, D; Cosford, P				Abubakar, Ibrahim; Thomas, H. Lucy; Morgan, Mike; Anderson, Sarah; Zenner, Dominik; Cosford, Paul			A collaborative strategy to tackle tuberculosis in England	LANCET			English	Editorial Material							TIDE		[Abubakar, Ibrahim] UCL, Ctr Infect Dis Epidemiol, London WC1E 6JB, England; [Abubakar, Ibrahim] UCL, MRC, Clin Trials Unit, London WC1E 6JB, England; [Abubakar, Ibrahim; Thomas, H. Lucy; Anderson, Sarah; Zenner, Dominik; Cosford, Paul] Publ Hlth England, London, England; [Morgan, Mike] NHS England, London, England	University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London; Public Health England	Abubakar, I (corresponding author), UCL, Ctr Infect Dis Epidemiol, London WC1E 6JB, England.	i.abubakar@ucl.ac.uk	Zenner, Dominik/AAF-5134-2019	Zenner, Dominik/0000-0002-9200-6180; Abubakar, Ibrahim/0000-0002-0370-1430				Abubakar I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4281; De Vries G, 2014, EURO SURVEILL, V19; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; *PUBL HLTH ENGL, 2015, COLL TUB STRAT ENGL; The Stop TB Partnership, WHA APPR POST 2015 G; Zenner D, 2013, LANCET, V382, P1311, DOI 10.1016/S0140-6736(13)62113-3	6	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					312	313		10.1016/S0140-6736(14)61638-X	http://dx.doi.org/10.1016/S0140-6736(14)61638-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ9CN	25608753				2022-12-28	WOS:000348509000007
J	Capaccioni, F; Coradini, A; Filacchione, G; Erard, S; Arnold, G; Drossart, P; De Sanctis, MC; Bockelee-Morvan, D; Capria, MT; Tosi, F; Leyrat, C; Schmitt, B; Quirico, E; Cerroni, P; Mennella, V; Raponi, A; Ciarniello, M; McCord, T; Moroz, L; Palomba, E; Ammannito, E; Barucci, MA; Bellucci, G; Benkhoff, J; Bibring, JP; Blanco, A; Blecka, M; Carlson, R; Carsenty, U; Colangeli, L; Combes, M; Combi, M; Crovisier, J; Encrenaz, T; Federico, C; Fink, U; Fonti, S; Ip, WH; Irwin, P; Jaumann, R; Kuehrt, E; Langevin, Y; Magni, G; Mottola, S; Orofino, V; Palumbo, P; Piccioni, G; Schade, U; Taylor, F; Tiphene, D; Tozzi, GP; Beck, P; Biver, N; Bonal, L; Combe, JP; Despan, D; Flamini, E; Fornasier, S; Frigeri, A; Grassi, D; Gudipati, M; Longobardo, A; Markus, K; Merlin, F; Orosei, R; Rinaldi, G; Stephan, K; Cartacci, M; Cicchetti, A; Giuppi, S; Hello, Y; Henry, F; Jacquinod, S; Noschese, R; Peter, G; Politi, R; Reess, JM; Semery, A				Capaccioni, F.; Coradini, A.; Filacchione, G.; Erard, S.; Arnold, G.; Drossart, P.; De Sanctis, M. C.; Bockelee-Morvan, D.; Capria, M. T.; Tosi, F.; Leyrat, C.; Schmitt, B.; Quirico, E.; Cerroni, P.; Mennella, V.; Raponi, A.; Ciarniello, M.; McCord, T.; Moroz, L.; Palomba, E.; Ammannito, E.; Barucci, M. A.; Bellucci, G.; Benkhoff, J.; Bibring, J. P.; Blanco, A.; Blecka, M.; Carlson, R.; Carsenty, U.; Colangeli, L.; Combes, M.; Combi, M.; Crovisier, J.; Encrenaz, T.; Federico, C.; Fink, U.; Fonti, S.; Ip, W. H.; Irwin, P.; Jaumann, R.; Kuehrt, E.; Langevin, Y.; Magni, G.; Mottola, S.; Orofino, V.; Palumbo, P.; Piccioni, G.; Schade, U.; Taylor, F.; Tiphene, D.; Tozzi, G. P.; Beck, P.; Biver, N.; Bonal, L.; Combe, J. -Ph.; Despan, D.; Flamini, E.; Fornasier, S.; Frigeri, A.; Grassi, D.; Gudipati, M.; Longobardo, A.; Markus, K.; Merlin, F.; Orosei, R.; Rinaldi, G.; Stephan, K.; Cartacci, M.; Cicchetti, A.; Giuppi, S.; Hello, Y.; Henry, F.; Jacquinod, S.; Noschese, R.; Peter, G.; Politi, R.; Reess, J. M.; Semery, A.			The organic-rich surface of comet 67P/Churyumov-Gerasimenko as seen by VIRTIS/Rosetta	SCIENCE			English	Article							SPECTRAL REFLECTANCE PROPERTIES; CARBONACEOUS CHONDRITES; WATER ICE; MICROMETEORITES; SPECTROSCOPY; 81P/WILD-2; NUCLEUS; ANALOGS; MATTER; SNOW	The VIRTIS (Visible, Infrared and Thermal Imaging Spectrometer) instrument on board the Rosetta spacecraft has provided evidence of carbon-bearing compounds on the nucleus of the comet 67P/Churyumov-Gerasimenko. The very low reflectance of the nucleus (normal albedo of 0.060 +/- 0.003 at 0.55 micrometers), the spectral slopes in visible and infrared ranges (5 to 25 and 1.5 to 5% k angstrom(-1)), and the broad absorption feature in the 2.9-to-3.6-micrometer range present across the entire illuminated surface are compatible with opaque minerals associated with nonvolatile organic macromolecular materials: a complex mixture of various types of carbon-hydrogen and/or oxygen-hydrogen chemical groups, with little contribution of nitrogen-hydrogen groups. In active areas, the changes in spectral slope and absorption feature width may suggest small amounts of water-ice. However, no ice-rich patches are observed, indicating a generally dehydrated nature for the surface currently illuminated by the Sun.	[Capaccioni, F.; Coradini, A.; Filacchione, G.; De Sanctis, M. C.; Capria, M. T.; Tosi, F.; Cerroni, P.; Raponi, A.; Ciarniello, M.; Palomba, E.; Bellucci, G.; Magni, G.; Frigeri, A.; Grassi, D.; Longobardo, A.; Rinaldi, G.; Noschese, R.; Politi, R.] Ist Nazl Astrofis INAF, Ist Astrofis & Planetol Spaziali, Rome, Italy; [Erard, S.; Drossart, P.; Bockelee-Morvan, D.; Leyrat, C.; Barucci, M. A.; Combes, M.; Crovisier, J.; Encrenaz, T.; Tiphene, D.; Biver, N.; Despan, D.; Fornasier, S.; Merlin, F.; Hello, Y.; Henry, F.; Jacquinod, S.; Reess, J. M.; Semery, A.] Univ Paris Diderot, Univ Paris 06, Lab Etud Spatiales & Instrumentat Astrophys, Observ Paris,CNRS, Meudon, France; [Arnold, G.; Moroz, L.; Carsenty, U.; Jaumann, R.; Kuehrt, E.; Mottola, S.; Markus, K.; Stephan, K.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetary Res, Berlin, Germany; [Schmitt, B.; Quirico, E.; Beck, P.; Bonal, L.] Univ Grenoble Alpes, CNRS, Inst Planetol & Astrophys Grenoble, Grenoble, France; [Mennella, V.] Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; [McCord, T.; Combe, J. -Ph.] Bear Fight Inst, Winthrop, WA 98862 USA; [Ammannito, E.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Benkhoff, J.; Colangeli, L.] European Space Agcy ESA, European Space Res & Technol Ctr ESTEC, Noordwijk, Netherlands; [Bibring, J. P.; Langevin, Y.] CNRS, Inst Astrophys Spatial, F-91405 Orsay, France; [Blanco, A.; Fonti, S.; Orofino, V.] Univ Salento, Dipartimento Matemat & Fis Ennio De Giorgi, Lecce, Italy; [Blecka, M.] Polish Acad Sci, Ctr Space Res, Warsaw, Poland; [Carlson, R.; Gudipati, M.] NASA, Jet Prop Lab, Pasadena, CA 91109 USA; [Combi, M.] Univ Michigan, Space Phys Res Lab, Ann Arbor, MI 48109 USA; [Federico, C.] Univ Perugia, I-06100 Perugia, Italy; [Fink, U.] Univ Arizona, Lunar Planetary Lab, Tucson, AZ 85721 USA; [Ip, W. H.] Natl Cent Univ, Taipei, Taiwan; [Irwin, P.; Taylor, F.] Univ Oxford, Dept Phys, Oxford, England; [Jaumann, R.] Free Univ Berlin, Inst Geosci, D-12249 Berlin, Germany; [Palumbo, P.] Univ Parthenope, Naples, Italy; [Schade, U.] Helmholtz Zentrum Berlin Mat & Energie, Berlin, Germany; [Tozzi, G. P.] Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; [Flamini, E.] Agenzia Spaziale Italiana, Rome, Italy; [Gudipati, M.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Orosei, R.] CNR, Ist Radioastron, INAF, I-40126 Bologna, Italy; [Peter, G.] DLR, Inst Opt Sensorsyst, Berlin, Germany	Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles; European Space Agency; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Salento; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Michigan System; University of Michigan; University of Perugia; University of Arizona; National Central University; University of Oxford; Free University of Berlin; Parthenope University Naples; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); University System of Maryland; University of Maryland College Park; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); Helmholtz Association; German Aerospace Centre (DLR)	Capaccioni, F (corresponding author), Ist Nazl Astrofis INAF, Ist Astrofis & Planetol Spaziali, Rome, Italy.	fabrizio.capaccioni@iaps.inaf.it	Schmitt, Bernard/A-1064-2009; Bellucci, Giancarlo/ABA-9201-2020; Filacchione, Gianrico/S-2320-2017; Grassi, Davide/B-7916-2018; Frigeri, Alessandro/K-9679-2019; quirico, eric/K-9650-2013; Drossart, Pierre/H-8670-2013; Jaumann, Ralf/N-1001-2018; Combi, Michael/J-1697-2012; Gudipati, Murthy S/F-7575-2011; Palomba, Ernesto/E-8287-2017; Stephan, Katrin/U-2524-2018; Piccioni, Giuseppe/T-9272-2017; Beck, Pierre/F-3149-2011; Frigeri, Alessandro/F-2151-2010; Tosi, Federico/F-2321-2018; De Sanctis, Maria Cristina/G-5232-2013	Schmitt, Bernard/0000-0002-1230-6627; Bellucci, Giancarlo/0000-0003-0867-8679; Filacchione, Gianrico/0000-0001-9567-0055; Grassi, Davide/0000-0003-1653-3066; Frigeri, Alessandro/0000-0002-9140-3977; quirico, eric/0000-0003-2768-0694; Jaumann, Ralf/0000-0002-9759-6597; Combi, Michael/0000-0002-9805-0078; Gudipati, Murthy S/0000-0001-5992-373X; Palomba, Ernesto/0000-0002-9101-6774; Piccioni, Giuseppe/0000-0002-7893-6808; Frigeri, Alessandro/0000-0002-9140-3977; Tosi, Federico/0000-0003-4002-2434; Cerroni, Priscilla/0000-0003-0239-2741; Noschese, Raffaella/0000-0003-0502-0337; CICCHETTI, ANDREA/0000-0002-9588-6531; Blecka, Maria/0000-0002-6473-1211; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Politi, Romolo/0000-0002-9793-9780; Raponi, Andrea/0000-0003-4996-0099; Mennella, Vito/0000-0001-9525-895X; Capaccioni, Fabrizio/0000-0003-1631-4314; Palumbo, Pasquale/0000-0003-2323-9228; Giuppi, Stefano/0000-0001-6900-3427; Cartacci, Marco/0000-0001-9825-1817; Longobardo, Andrea/0000-0002-1797-2741; Colangeli, Luigi/0000-0001-6801-9152; De Sanctis, Maria Cristina/0000-0002-3463-4437; BONAL, Lydie/0000-0002-0655-4034; Tozzi, Gian Paolo/0000-0003-4775-5788; Schade, Ulrich/0000-0002-4194-2235; Erard, Stephane/0000-0002-9099-8366; capria, maria teresa/0000-0002-9814-9588; Ciarniello, Mauro/0000-0002-7498-5207; Rinaldi, Giovanna/0000-0002-2968-0455; Taylor, Fred/0000-0002-0675-9769	Italian Space Agency (ASI, Italy); Centre National d'Etudes Spatiales (CNES, France); DLR (Germany); NASA (USA) Rosetta Program; Science and Technology Facilities Council (UK); CNES; ASI; Rosetta Science Ground Segment; Rosetta Mission Operations Centre; STFC [ST/I001948/1, ST/K00106X/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K00106X/1, ST/I001948/1] Funding Source: researchfish	Italian Space Agency (ASI, Italy)(Agenzia Spaziale Italiana (ASI)); Centre National d'Etudes Spatiales (CNES, France)(Centre National D'etudes Spatiales); DLR (Germany)(Helmholtz AssociationGerman Aerospace Centre (DLR)); NASA (USA) Rosetta Program; Science and Technology Facilities Council (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); CNES(Centre National D'etudes Spatiales); ASI(Agenzia Spaziale Italiana (ASI)); Rosetta Science Ground Segment; Rosetta Mission Operations Centre; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the following institutions and agencies for support of this work: Italian Space Agency (ASI, Italy), Centre National d'Etudes Spatiales (CNES, France), DLR (Germany), NASA (USA) Rosetta Program, and Science and Technology Facilities Council (UK). VIRTIS was built by a consortium, which includes Italy, France, and Germany, under the scientific responsibility of the Istituto di Astrofisica e Planetologia Spaziali of INAF, Italy, which also guides the scientific operations. The VIRTIS instrument development has been funded and managed by ASI, with contributions from Observatoire de Meudon financed by CNES, and from DLR. We thank the Rosetta Science Ground Segment and the Rosetta Mission Operations Centre for their support throughout the early phases of the mission. The VIRTIS calibrated data will be available through the ESA's Planetary Science Archive Website (www.rssd.esa.int/index.php?project=PSA&page=index) and is available upon request until posted to the archive. The VIRTIS Team wishes to dedicate this paper to the memory of Angioletta Coradini, conceiver of the instrument, our leader, and friend.	Barucci MA, 2005, ASTRON J, V130, P1291, DOI 10.1086/431957; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Caro GMM, 2003, ASTRON ASTROPHYS, V412, P121, DOI 10.1051/0004-6361:20031408; Cloutis EA, 2012, ICARUS, V217, P389, DOI 10.1016/j.icarus.2011.11.004; Cloutis EA, 2011, ICARUS, V216, P309, DOI 10.1016/j.icarus.2011.09.009; Cloutis EA, 2011, ICARUS, V212, P180, DOI 10.1016/j.icarus.2010.12.009; COMBES M, 1986, NATURE, V321, P266, DOI 10.1038/321266a0; Coradini A, 2007, SPACE SCI REV, V128, P529, DOI 10.1007/s11214-006-9127-5; Dartois E, 2013, ICARUS, V224, P243, DOI 10.1016/j.icarus.2013.03.002; De Bergh C., 2008, SOLAR SYSTEM NEPTUNE, P483; Dobrica E, 2009, METEORIT PLANET SCI, V44, P1643, DOI 10.1111/j.1945-5100.2009.tb01196.x; Festou MC, 2004, SPACE SCI S, P3; Kebukawa Y, 2010, METEORIT PLANET SCI, V45, P99, DOI 10.1111/j.1945-5100.2009.01008.x; Kissel J, 2004, SCIENCE, V304, P1774, DOI 10.1126/science.1098836; Klima RL, 2007, METEORIT PLANET SCI, V42, P235, DOI 10.1111/j.1945-5100.2007.tb00230.x; McDonald GD, 1996, ICARUS, V122, P107, DOI 10.1006/icar.1996.0112; Moroz LV, 1998, ICARUS, V134, P253, DOI 10.1006/icar.1998.5955; Mumma MJ, 2011, ANNU REV ASTRON ASTR, V49, P471, DOI 10.1146/annurev-astro-081309-130811; Ore CMD, 2009, ASTRON ASTROPHYS, V501, P349, DOI 10.1051/0004-6361/200911752; Orthous-Daunay FR, 2013, ICARUS, V223, P534, DOI 10.1016/j.icarus.2013.01.003; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Rietmeijer F. J. M., 1998, PLANETARY MAT; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Soderblom LA, 2004, ICARUS, V167, P100, DOI 10.1016/j.icarus.2003.08.019; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Takir D, 2012, ICARUS, V219, P641, DOI 10.1016/j.icarus.2012.02.022; Tosi F, 2014, ICARUS, V240, P36, DOI 10.1016/j.icarus.2014.03.017; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	31	276	278	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							aaa0628	10.1126/science.aaa0628	http://dx.doi.org/10.1126/science.aaa0628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613895				2022-12-28	WOS:000348225800031
J	Nilsson, H; Wieser, GS; Behar, E; Wedlund, CS; Gunell, H; Yamauchi, M; Lundin, R; Barabash, S; Wieser, M; Carr, C; Cupido, E; Burch, JL; Fedorov, A; Sauvaud, JA; Koskinen, H; Kallio, E; Lebreton, JP; Eriksson, A; Edberg, N; Goldstein, R; Henri, P; Koenders, C; Mokashi, P; Nemeth, Z; Richter, I; Szego, K; Volwerk, M; Vallat, C; Rubin, M				Nilsson, Hans; Wieser, Gabriella Stenberg; Behar, Etienne; Wedlund, Cyril Simon; Gunell, Herbert; Yamauchi, Masatoshi; Lundin, Rickard; Barabash, Stas; Wieser, Martin; Carr, Chris; Cupido, Emanuele; Burch, James L.; Fedorov, Andrei; Sauvaud, Jean-Andre; Koskinen, Hannu; Kallio, Esa; Lebreton, Jean-Pierre; Eriksson, Anders; Edberg, Niklas; Goldstein, Raymond; Henri, Pierre; Koenders, Christoph; Mokashi, Prachet; Nemeth, Zoltan; Richter, Ingo; Szego, Karoly; Volwerk, Martin; Vallat, Claire; Rubin, Martin			Birth of a comet magnetosphere: A spring of water ions	SCIENCE			English	Article							ROSETTA PLASMA CONSORTIUM; SOLAR-WIND INTERACTION; HALLEY; RPC; 67P/CHURYUMOV-GERASIMENKO; ENVIRONMENT; PLANETS	The Rosetta mission shall accompany comet 67P/Churyumov-Gerasimenko from a heliocentric distance of >3.6 astronomical units through perihelion passage at 1.25 astronomical units, spanning low and maximum activity levels. Initially, the solar wind permeates the thin comet atmosphere formed from sublimation, until the size and plasma pressure of the ionized atmosphere define its boundaries: A magnetosphere is born. Using the Rosetta Plasma Consortium ion composition analyzer, we trace the evolution from the first detection of water ions to when the atmosphere begins repelling the solar wind (similar to 3.3 astronomical units), and we report the spatial structure of this early interaction. The near-comet water population comprises accelerated ions (<800 electron volts), produced upstream of Rosetta, and lower energy locally produced ions; we estimate the fluxes of both ion species and energetic neutral atoms.	[Nilsson, Hans; Wieser, Gabriella Stenberg; Behar, Etienne; Yamauchi, Masatoshi; Lundin, Rickard; Barabash, Stas; Wieser, Martin] Swedish Inst Space Phys, S-98128 Kiruna, Sweden; [Nilsson, Hans; Behar, Etienne] Lulea Univ Technol, Dept Comp Sci Elect & Space Engn, S-98128 Kiruna, Sweden; [Wedlund, Cyril Simon; Kallio, Esa] Aalto Univ, Sch Elect Engn, Dept Radio Sci & Engn, FI-00076 Aalto, Finland; [Gunell, Herbert; Goldstein, Raymond] Belgian Inst Space Aeron, B-1180 Brussels, Belgium; [Carr, Chris; Cupido, Emanuele] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Burch, James L.; Mokashi, Prachet] SW Res Inst, San Antonio, TX 78238 USA; [Fedorov, Andrei; Sauvaud, Jean-Andre] Inst Rech Astrophys & Planetol, Toulouse, France; [Koskinen, Hannu] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Koskinen, Hannu; Kallio, Esa] Finnish Meteorol Inst, FI-00101 Helsinki, Finland; [Lebreton, Jean-Pierre; Henri, Pierre] Univ Orleans, CNRS, Lab Phys & Chim Environm & Espace LPC2E, UMR 7328, F-45067 Orleans, France; [Eriksson, Anders; Edberg, Niklas] Swedish Inst Space Phys, Angstrom Lab, Uppsala, Sweden; [Koenders, Christoph; Richter, Ingo] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Nemeth, Zoltan; Szego, Karoly] Wigner Res Ctr Phys, Budapest, Hungary; [Volwerk, Martin] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Vallat, Claire] European Space Astron Ctr, Rosetta Sci Ground Segment Sci & Robot Explorat S, Off A006, Madrid 28691, Spain; [Rubin, Martin] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Lulea University of Technology; Aalto University; Imperial College London; Southwest Research Institute; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Helsinki; Finnish Meteorological Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Orleans; Braunschweig University of Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Austrian Academy of Sciences; European Space Agency; University of Bern	Nilsson, H (corresponding author), Swedish Inst Space Phys, POB 812, S-98128 Kiruna, Sweden.	hans.nilsson@irf.se	Gunell, Herbert/D-5611-2013; Kallio, Esa/F-9410-2014; kallio, esa/M-9541-2019; vallat, claire/ABB-7683-2021; Eriksson, Anders I/C-2887-2009; Koskinen, Hannu E. J./B-4971-2017; Rubin, Martin/I-7777-2013	Gunell, Herbert/0000-0001-5379-1158; Kallio, Esa/0000-0002-9791-804X; kallio, esa/0000-0002-9791-804X; Eriksson, Anders I/0000-0003-2926-6761; Koskinen, Hannu E. J./0000-0003-3839-6461; Rubin, Martin/0000-0001-6549-3318; Simon Wedlund, Cyril/0000-0003-2201-7615; Carr, Chris/0000-0002-6879-3970; Stenberg Wieser, Gabriella/0000-0002-4260-2937; Yamauchi, Masatoshi/0000-0001-7065-9087	Swedish National Space Board [108/12, 112/13, 149/12, 135/13]; Belgian Science Policy Office through Solar-Terrestrial Centre of Excellence; PRODEX/ROSETTA/ROSINA PEA [4000107705]; UK Space Agency, the Academy of Finland [251573]; Swedish Research Council [621-2013-4191]; NASA through Jet Propulsion Laboratory, California Institute of Technology; Bundesministerium fur Wirtschaft und Energie; DLR [50QP1001]; Hungarian ESA PECS [4200098080]; Science and Technology Facilities Council [ST/K001051/1, ST/H002383/1] Funding Source: researchfish; UK Space Agency [ST/K001698/1, ST/H004262/1] Funding Source: researchfish; STFC [ST/H002383/1, ST/K001051/1] Funding Source: UKRI	Swedish National Space Board; Belgian Science Policy Office through Solar-Terrestrial Centre of Excellence; PRODEX/ROSETTA/ROSINA PEA; UK Space Agency, the Academy of Finland; Swedish Research Council(Swedish Research CouncilEuropean Commission); NASA through Jet Propulsion Laboratory, California Institute of Technology; Bundesministerium fur Wirtschaft und Energie; DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Hungarian ESA PECS; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Rosetta is a European Space Agency (ESA) mission with contributions from its member states and the National Aeronautics and Space Administration (NASA). Rosetta's Philae lander is provided by a consortium led by Deutsches Zentrum fur Luft- und Raumfahrt, Max-Planck Society, Centre National d'Etudes Spatiales, and Agenzia Spaziale Italiana. The work on RPC-ICA was funded by the Swedish National Space Board under contracts 108/12, 112/13, 149/12, and 135/13. Work at BIRA-IASB was supported by the Belgian Science Policy Office through the Solar-Terrestrial Centre of Excellence and by PRODEX/ROSETTA/ROSINA PEA 4000107705. The work was also supported by the UK Space Agency, the Academy of Finland through contract 251573, the Swedish Research Council through contract 621-2013-4191, NASA through the Jet Propulsion Laboratory, California Institute of Technology, the Bundesministerium fur Wirtschaft und Energie and DLR under contract 50QP1001 for ROSETTA, and the Hungarian ESA PECS agreement 4200098080. We are indebted to the whole Rosetta mission team, Science Ground Segment, and Rosetta Mission Operation Control for their hard work making this mission possible. The RPC data will be made available through the Planetary Science Archive of ESA and the Planetary Data System archive of NASA and will be available upon request until that point.	Altwegg K, 1999, SPACE SCI REV, V90, P3, DOI 10.1023/A:1005256607402; Balsiger H, 2007, SPACE SCI REV, V128, P745, DOI 10.1007/s11214-006-8335-3; Carr C, 2007, SPACE SCI REV, V128, P629, DOI 10.1007/s11214-006-9136-4; Coates AJ, 1997, ADV SPACE RES-SERIES, V20, P255, DOI 10.1016/S0273-1177(97)00543-7; COATES AJ, 1993, GEOPHYS RES LETT, V20, P483, DOI 10.1029/93GL00174; Eriksson AI, 2007, SPACE SCI REV, V128, P729, DOI 10.1007/s11214-006-9003-3; GRINGAUZ KI, 1986, NATURE, V321, P282, DOI 10.1038/321282a0; Hansen KC, 2007, SPACE SCI REV, V128, P133, DOI 10.1007/s11214-006-9142-6; Hassig M., SCIENCE; JOHNSTONE A, 1986, NATURE, V321, P344, DOI 10.1038/321344a0; Kallio E, 2006, ICARUS, V182, P448, DOI 10.1016/j.icarus.2005.12.019; LUHMANN JG, 1990, GEOPH MONOG SERIES, V58, P401; MUKAI T, 1986, NATURE, V321, P299, DOI 10.1038/321299a0; NEUBAUER FM, 1987, ASTRON ASTROPHYS, V187, P73; Nilsson H, 2007, SPACE SCI REV, V128, P671, DOI 10.1007/s11214-006-9031-z; Rees M. H., 1989, PHYSICS AND CHEMISTR; REINHARD R, 1986, NATURE, V321, P313, DOI 10.1038/321313a0; Ribas I, 2005, ASTROPHYS J, V622, P680, DOI 10.1086/427977; Rubin M, 2014, ICARUS, V242, P38, DOI 10.1016/j.icarus.2014.07.021; Szego K, 2000, SPACE SCI REV, V94, P429, DOI 10.1023/A:1026568530975	20	103	103	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220							aaa0571	10.1126/science.aaa0571	http://dx.doi.org/10.1126/science.aaa0571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613894	Green Submitted			2022-12-28	WOS:000348225800033
J	Baumrin, E; Piette, E; Micheletti, R				Baumrin, Emily; Piette, Evan; Micheletti, Robert			A Crusted Rash in a Patient With AIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCABIES		[Baumrin, Emily] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Piette, Evan; Micheletti, Robert] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Micheletti, Robert] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Micheletti, R (corresponding author), Univ Penn, Hosp Univ Penn, Dept Med, 3400 Spruce St,2 Maloney Bldg, Philadelphia, PA 19104 USA.	robert.micheletti@uphs.upenn.edu		Micheletti, Robert/0000-0003-2517-7008				Bouvresse S, 2010, CURR OPIN INFECT DIS, V23, P111, DOI 10.1097/QCO.0b013e328336821b; Davis JS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002387; Karthikeyan K, 2009, INDIAN J DERMATOL VE, V75, P340, DOI 10.4103/0378-6323.53128; Portu JJ, 1996, J AM ACAD DERMATOL, V34, P915, DOI 10.1016/S0190-9622(96)90079-1; Workowski Kimberly A., 2011, Morbidity and Mortality Weekly Report, V60, P18; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	6	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					298	299		10.1001/jama.2014.16051	http://dx.doi.org/10.1001/jama.2014.16051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25603002				2022-12-28	WOS:000348145000023
J	Pannill, FC				Pannill, Fitzhugh C., III			Review: Assessment of lower urinary tract symptoms did not detect bladder outlet obstruction in men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INCONTINENCE		Univ Connecticut, Sch Med, Southbury Med Associates, Southbury, CT 06488 USA	University of Connecticut	Pannill, FC (corresponding author), Univ Connecticut, Sch Med, Southbury Med Associates, Southbury, CT 06488 USA.							Holroyd-Leduc JM, 2008, JAMA-J AM MED ASSOC, V299, P1446, DOI 10.1001/jama.299.12.1446; Nygaard I, 2010, NEW ENGL J MED, V363, P1156, DOI 10.1056/NEJMcp1003849; Schatzl G, 2001, EUR UROL, V40, P213, DOI 10.1159/000049775	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2							JC10	10.7326/ACPJC-2015-162-2-010	http://dx.doi.org/10.7326/ACPJC-2015-162-2-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25599358				2022-12-28	WOS:000350106600009
J	Sedgwick, P				Sedgwick, Philip			Treatment effects and placebo effects	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3434; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5819; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5584; Sedgwick P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8262; Verdon F, 2003, BRIT MED J, V326, P1124, DOI 10.1136/bmj.326.7399.1124	5	17	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2015	350								h267	10.1136/bmj.h267	http://dx.doi.org/10.1136/bmj.h267			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3NF	25596585				2022-12-28	WOS:000348133500003
J	Weyer, GW; Davis, AM				Weyer, George W.; Davis, Andrew M.			Screening for Asymptomatic Carotid Artery Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weyer, George W.; Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA	University of Chicago	Weyer, GW (corresponding author), Univ Chicago, Gen Internal Med Sect, Dept Med, 5841 S Maryland Ave,B210 MC 2007, Chicago, IL 60637 USA.	gweyer@medicine.bsd.uchicago.edu		Weyer, George/0000-0002-2175-1159				Brott TG, 2011, CIRCULATION, V124, pE54, DOI [10.1161/CIR.0b013e31820d8c98, 10.1161/CIR.0b0113e31820d8c98]; Curtis LH, 2010, CIRC-CARDIOVASC QUAL, V3, P599, DOI 10.1161/CIRCOUTCOMES.110.950279; de Weerd M, 2014, STROKE, V45, P2366, DOI 10.1161/STROKEAHA.114.005145; de Weerd M, 2009, STROKE, V40, P1105, DOI 10.1161/STROKEAHA.108.532218; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Jonas DE, 2014, ANN INTERN MED, V161, P336, DOI 10.7326/M14-0530; Raman G, 2013, ANN INTERN MED, V158, P676, DOI 10.7326/0003-4819-158-9-201305070-00007	8	10	12	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					192	193		10.1001/jama.2014.16804	http://dx.doi.org/10.1001/jama.2014.16804			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585331				2022-12-28	WOS:000347679300019
J	Ghamari-Langroudi, M; Digby, GJ; Sebag, JA; Millhauser, GL; Palomino, R; Matthews, R; Gillyard, T; Panaro, BL; Tough, IR; Cox, HM; Denton, JS; Cone, RD				Ghamari-Langroudi, Masoud; Digby, Gregory J.; Sebag, Julien A.; Millhauser, Glenn L.; Palomino, Rafael; Matthews, Robert; Gillyard, Taneisha; Panaro, Brandon L.; Tough, Iain R.; Cox, Helen M.; Denton, Jerod S.; Cone, Roger D.			G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons	NATURE			English	Article							MELANOCORTIN-4 RECEPTOR; POTASSIUM CHANNELS; PEPTIDE YY; K+ CHANNEL; IN-VITRO; ACTIVATION; VIVO	The regulated release of anorexigenic alpha-melanocyte stimulating hormone (alpha-MSH) and orexigenic Agouti-related protein (AgRP) from discrete hypothalamic arcuate neurons onto common target sites in the central nervous system has a fundamental role in the regulation of energy homeostasis. Both peptides bind with high affinity to the melanocortin-4 receptor (MC4R); existing data show that alpha-MSH is an agonist that couples the receptor to the Gas signalling pathway(1), while AgRP binds competitively to block alpha-MSH binding(2) and blocks the constitutive activity mediated by the ligand-mimetic amino-terminal domain of the receptor(3). Here we show that, in mice, regulation of firing activity of neurons from the paraventricular nucleus of the hypothalamus (PVN) by alpha-MSH and AgRP can be mediated independently of G alpha(s) signalling by ligand-induced coupling of MC4R to closure of inwardly rectifying potassium channel, Kir7.1. Furthermore, AgRP is a biased agonist that hyperpolarizes neurons by binding to MC4R and opening Kir7.1, independently of its inhibition of alpha-MSH binding. Consequently, Kir7.1 signalling appears to be central to melanocortin-mediated regulation of energy homeostasis within the PVN. Coupling of MC4R to Kir7.1 may explain unusual aspects of the control of energy homeostasis by melanocortin signalling, including the gene dosage effect of MC4R4 and the sustained effects of AgRP on food intake(5).	[Ghamari-Langroudi, Masoud; Digby, Gregory J.; Sebag, Julien A.; Matthews, Robert; Gillyard, Taneisha; Panaro, Brandon L.; Cone, Roger D.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA; [Millhauser, Glenn L.; Palomino, Rafael] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Gillyard, Taneisha] Meharry Med Coll, Dept Pharmacol, Nashville, TN 37208 USA; [Tough, Iain R.; Cox, Helen M.] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; [Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; University of California System; University of California Santa Cruz; Meharry Medical College; University of London; King's College London; Vanderbilt University; Vanderbilt University	Ghamari-Langroudi, M (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA.	masoud.ghamari-langroudi@vanderbilt.edu; roger.cone@vanderbilt.edu	Cox, Helen M/F-2783-2015; sebag, julien/AAU-2142-2020; Tough, Iain R/H-9127-2018	Cox, Helen/0000-0001-9024-1497; sebag, julien/0000-0002-8366-312X; Gillyard, Taneisha/0000-0002-4536-3724; Tough, Iain Robertson/0000-0002-4829-9369	NIH [RO1DK070332, 5R01 DK082884-03, R01DK064265]; Vanderbilt Diabetes Research and Training Center [DK020593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070332, P60DK020593, R01DK064265, P30DK020593, F31DK102343, R01DK082884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank C. Zhang and A. M. Bradshaw for advice and technical assistance in performance of experiments in the zebrafish. We thank D. M. Parichy for providing the jaguar zebrafish strain. We thank B. S. Wulff and K. W. Conde-Frieboes and Novo Nordisk A/S for the contribution of MC4-NN2-0543. This work was supported by NIH RO1DK070332 (R.D.C.), NIH 5R01 DK082884-03 (J.S.D.), and NIH R01DK064265 (G.L.M.). R.D.C. is also supported by the Vanderbilt Diabetes Research and Training Center grant DK020593.	Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Conde-Frieboes K, 2012, J MED CHEM, V55, P1969, DOI 10.1021/jm201489a; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cox HM, 2010, CELL METAB, V11, P532, DOI 10.1016/j.cmet.2010.04.014; Doring F, 1998, J NEUROSCI, V18, P8625; Doronin SV, 2004, J BIOL CHEM, V279, P48231, DOI 10.1074/jbc.M405789200; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Ghamari-Langroudi M, 2011, P NATL ACAD SCI USA, V108, P355, DOI 10.1073/pnas.1016785108; Hida T, 2009, PIGM CELL MELANOMA R, V22, P623, DOI 10.1111/j.1755-148X.2009.00582.x; Huang CF, 2007, AM J PHYSIOL-RENAL, V292, pF1073, DOI 10.1152/ajprenal.00269.2006; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Madonna ME, 2012, ACS CHEM BIOL, V7, P394, DOI 10.1021/cb2003412; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Panaro BL, 2014, CELL METAB, V20, P1018, DOI 10.1016/j.cmet.2014.10.004; Shimura M, 2001, J PHYSIOL-LONDON, V531, P329, DOI 10.1111/j.1469-7793.2001.0329i.x; Smith MA, 2007, J PHYSIOL-LONDON, V578, P425, DOI 10.1113/jphysiol.2006.119479; Sohn JW, 2013, CELL, V152, P612, DOI 10.1016/j.cell.2012.12.022; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Swale DR, 2014, CURR OPIN PHARMACOL, V15, P7, DOI 10.1016/j.coph.2013.11.002; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Zhang C, 2012, CELL METAB, V15, P256, DOI 10.1016/j.cmet.2011.12.014	30	118	122	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 2	2015	520	7545					94	U223		10.1038/nature14051	http://dx.doi.org/10.1038/nature14051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE7NE	25600267	Green Accepted			2022-12-28	WOS:000352027700044
J	Giovannini, D; Romero, J; Potocek, V; Ferenczi, G; Speirits, F; Barnett, SM; Faccio, D; Padgett, MJ				Giovannini, Daniel; Romero, Jacquiline; Potocek, Vaclav; Ferenczi, Gergely; Speirits, Fiona; Barnett, Stephen M.; Faccio, Daniele; Padgett, Miles J.			Spatially structured photons that travel in free space slower than the speed of light	SCIENCE			English	Article							VELOCITY; BEAMS	That the speed of light in free space is constant is a cornerstone of modern physics. However, light beams have finite transverse size, which leads to a modification of their wave vectors resulting in a change to their phase and group velocities. We study the group velocity of single photons by measuring a change in their arrival time that results from changing the beam's transverse spatial structure. Using time-correlated photon pairs, we show a reduction in the group velocity of photons in both a Bessel beam and photons in a focused Gaussian beam. In both cases, the delay is several micrometers over a propagation distance of similar to 1 meter. Our work highlights that, even in free space, the invariance of the speed of light only applies to plane waves.	[Giovannini, Daniel; Romero, Jacquiline; Potocek, Vaclav; Ferenczi, Gergely; Speirits, Fiona; Barnett, Stephen M.; Padgett, Miles J.] Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland; [Potocek, Vaclav] Czech Tech Univ, Fac Nucl Sci & Phys Engn, CR-11519 Prague 1, Czech Republic; [Faccio, Daniele] Heriot Watt Univ, Sch Engn & Phys Sci, SUPA, Edinburgh EH14 4AS, Midlothian, Scotland	University of Glasgow; Czech Technical University Prague; Heriot Watt University; University of Edinburgh	Padgett, MJ (corresponding author), Univ Glasgow, Sch Phys & Astron, SUPA, Glasgow G12 8QQ, Lanark, Scotland.	miles.padgett@glasgow.ac.uk	Faccio, Daniele/K-5794-2018; Giovannini, Daniel/I-3646-2014; Potoček, Václav/GOE-4856-2022; Romero, Mary Jacquiline/A-1249-2013; Padgett, Miles J/B-7625-2008	Faccio, Daniele/0000-0001-8397-334X; Giovannini, Daniel/0000-0003-0191-7227; Romero, Mary Jacquiline/0000-0002-5840-2606; Padgett, Miles J/0000-0001-6643-0618; Barnett, Stephen/0000-0003-0733-4524; Speirits, Fiona/0000-0002-6460-5231; Potocek, Vaclav/0000-0002-6415-598X	Engineering and Physical Sciences Research Council through the COAM program; European Research Council (ERC) through the TWISTS grant; ERC through the MOLIGHT project; Hamamatsu; EPSRC [EP/J00443X/1, EP/M01326X/1, EP/I012451/1, EP/M006514/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M006514/1, EP/I012451/1, EP/J00443X/1, EP/M01326X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council through the COAM program(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (ERC) through the TWISTS grant(European Research Council (ERC)); ERC through the MOLIGHT project; Hamamatsu; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Franke-Arnold for useful discussions. This work was supported by the Engineering and Physical Sciences Research Council through the COAM program, and by the European Research Council (ERC) through the TWISTS grant; D.F. acknowledges support from ERC through the MOLIGHT project. We thank Hamamatsu for their support. M.J.P. thanks the Royal Society. M.J.P., D.F. and S.M.B. conceived the experiment and supervised the work; M.J.P., D.G., and J.R. designed the experiment; D.G. and J.R. constructed the experiment, acquired the data, and carried out the data analysis; V.P., J.R., G.F., F.S., and S.M.B. further developed the theoretical model; J.R., D.G., and M.J.P. wrote the text with input from all coauthors.	Alexeev I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.073901; Boyd R. W., 2009, TUTORIALS COMPLEX PH; Boyd RW, 2009, SCIENCE, V326, P1074, DOI 10.1126/science.1170885; Feng SM, 2001, OPT LETT, V26, P485, DOI 10.1364/OL.26.000485; Grant I. S., 1980, ELECTROMAGNETISM; HERMAN RM, 1991, J OPT SOC AM A, V8, P932, DOI 10.1364/JOSAA.8.000932; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Horvath ZL, 1996, APPL PHYS B-LASERS O, V63, P481, DOI 10.1007/BF01828944; Kaltenbaek R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.240502; Klewitz S, 1998, OPT COMMUN, V154, P186, DOI 10.1016/S0030-4018(98)00317-4; Kuntz KB, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.043802; Lunardi JT, 2001, PHYS LETT A, V291, P66, DOI 10.1016/S0375-9601(01)00714-9; McLaren M, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033818; MCLEOD JH, 1954, J OPT SOC AM, V44, P592, DOI 10.1364/JOSA.44.000592; Milonni PW, 2002, J PHYS B-AT MOL OPT, V35, pR31, DOI 10.1088/0953-4075/35/6/201; Mugnai D, 2000, PHYS REV LETT, V84, P4830, DOI 10.1103/PhysRevLett.84.4830; NAGELBERG ER, 1965, BELL SYST TECH J, V44, P1321, DOI 10.1002/j.1538-7305.1965.tb04183.x; STEINBERG AM, 1992, PHYS REV LETT, V68, P2421, DOI 10.1103/PhysRevLett.68.2421; VASARA A, 1989, J OPT SOC AM A, V6, P1748, DOI 10.1364/JOSAA.6.001748; Yariv A., 1989, QUANTUM ELECT	20	101	103	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 20	2015	347	6224					857	860		10.1126/science.aaa3035	http://dx.doi.org/10.1126/science.aaa3035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6UB	25612608	Green Accepted, Green Submitted			2022-12-28	WOS:000349761100039
J	Adashi, EY; Kocher, RP				Adashi, Eli Y.; Kocher, Robert P.			Physician Self-referral Regulation by Exceptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHARGES		[Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Kocher, Robert P.] Venrock, Palo Alto, CA USA; [Kocher, Robert P.] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	Brown University; University of Southern California	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						Bipartisan Policy Center, BIP RX PAT CTR CAR S; Centers for Medicare & Medicaid Services, SELF REFERRAL DISCLO; Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901; HILLMAN BJ, 1992, JAMA-J AM MED ASSOC, V268, P2050, DOI 10.1001/jama.268.15.2050; MITCHELL JM, 1992, JAMA-J AM MED ASSOC, V268, P2055, DOI 10.1001/jama.268.15.2055; RELMAN AS, 1992, NEW ENGL J MED, V327, P1522, DOI 10.1056/NEJM199211193272112; Sutton PA, 2011, ANN HEALTH LAW, V20, P8; Sutton PA, 2011, ANN HEALTH LAW, V20, P1; Sutton Patrick A, 2011, Ann Health Law, V20, P15; US Department of Health and Human Services, FISCAL YEAR 2015 BUD	10	9	9	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					457	458		10.1001/jama.2014.16600	http://dx.doi.org/10.1001/jama.2014.16600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25580941				2022-12-28	WOS:000349070300004
J	Patel, MS; Asch, DA; Volpp, KG				Patel, Mitesh S.; Asch, David A.; Volpp, Kevin G.			Wearable Devices as Facilitators, Not Drivers, of Health Behavior Change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							APPS		[Patel, Mitesh S.; Asch, David A.; Volpp, Kevin G.] Univ Penn, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Patel, MS (corresponding author), 423 Guardian Dr,Blockley Hall,12th Floor, Philadelphia, PA 19104 USA.	mpatel@upenn.edu		Volpp, Kevin/0000-0003-1423-4599; Asch, David/0000-0002-7970-286X	NIA NIH HHS [P30 AG034546] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Conroy DE, 2014, AM J PREV MED, V46, P649, DOI 10.1016/j.amepre.2014.01.010; Loewenstein G, 2013, HEALTH AFFAIR, V32, P1244, DOI 10.1377/hlthaff.2012.1163; Mccaffrey, 2014, ENDEAVOUR PARTNERS R; Nielsen CLR, 2014, ARE CONSUMERS REALLY; Powell AC, 2014, JAMA-J AM MED ASSOC, V311, P1851, DOI 10.1001/jama.2014.2564; Wang T., 2014, THE FUTURE OF BIOSEN	6	433	438	2	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2015	313	5					459	460		10.1001/jama.2014.14781	http://dx.doi.org/10.1001/jama.2014.14781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7AV	25569175				2022-12-28	WOS:000349070300005
J	Soderblom, D				Soderblom, David			Stellar clocks	NATURE			English	Editorial Material								A link between rotation and age for Sun-like stars has long been known, but a stringent test of it for older stars has been lacking. The Kepler mission helps to fill this gap with observations of an old star cluster. SEE LETTER P.589	Space Telescope Sci Inst, Baltimore, MD 21218 USA	Space Telescope Science Institute	Soderblom, D (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	drs@stsci.edu						Chaussidon M, 2007, ADV ASTROBIOL BIOGEO, P45, DOI 10.1007/10913314_2; KRAFT RP, 1967, ASTROPHYS J, V150, P551, DOI 10.1086/149359; Meibom S, 2015, NATURE, V517, P589, DOI 10.1038/nature14118; SKUMANICH A, 1972, ASTROPHYS J, V171, P565, DOI 10.1086/151310; Soderblom DR, 2010, ANNU REV ASTRON ASTR, V48, P581, DOI 10.1146/annurev-astro-081309-130806	5	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					557	558		10.1038/517557a	http://dx.doi.org/10.1038/517557a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25631439				2022-12-28	WOS:000348775000027
J	Curley, MAQ; Wypij, D; Watson, RS; Grant, MJC; Asaro, LA; Cheifetz, IM; Dodson, BL; Franck, LS; Gedeit, RG; Angus, DC; Matthay, MA				Curley, Martha A. Q.; Wypij, David; Watson, R. Scott; Grant, Mary Jo C.; Asaro, Lisa A.; Cheifetz, Ira M.; Dodson, Brenda L.; Franck, Linda S.; Gedeit, Rainer G.; Angus, Derek C.; Matthay, Michael A.		Network	Protocolized Sedation vs Usual Care in Pediatric Patients Mechanically Ventilated for Acute Respiratory Failure A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; CHILDREN; DELIRIUM; UNIT; INFANTS; WITHDRAWAL; EFFICACY; OUTCOMES; INTERRUPTION; INSTRUMENT	IMPORTANCE Protocolized sedation improves clinical outcomes in critically ill adults, but its effect in children is unknown. OBJECTIVE To determine whether critically ill children managed with a nurse-implemented, goal-directed sedation protocol experience fewer days of mechanical ventilation than patients receiving usual care. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized trial conducted in 31 US pediatric intensive care units (PICUs). A total of 2449 children (mean age, 4.7 years; range, 2 weeks to 17 years) mechanically ventilated for acute respiratory failure were enrolled in 2009-2013 and followed up until 72 hours after opioids were discontinued, 28 days, or hospital discharge. INTERVENTION Intervention PICUs (17 sites; n = 1225 patients) used a protocol that included targeted sedation, arousal assessments, extubation readiness testing, sedation adjustment every 8 hours, and sedation weaning. Control PICUs (14 sites; n = 1224 patients) managed sedation per usual care. MAIN OUTCOMES AND MEASURES The primary outcome was duration of mechanical ventilation. Secondary outcomes included time to recovery from acute respiratory failure, duration of weaning from mechanical ventilation, neurological testing, PICU and hospital lengths of stay, in-hospital mortality, sedation-related adverse events, measures of sedative exposure (wakefulness, pain, and agitation), and occurrence of iatrogenic withdrawal. RESULTS Duration of mechanical ventilation was not different between the 2 groups (intervention: median, 6.5 [IQR, 4.1-11.2] days; control: median, 6.5 [IQR, 3.7-12.1] days). Sedation-related adverse events including inadequate pain and sedation management, clinically significant iatrogenic withdrawal, and unplanned endotracheal tube/invasive line removal were not significantly different between the 2 groups. Intervention patients experienced more postextubation stridor (7% vs 4%; P = .03) and fewer stage 2 or worse immobility-related pressure ulcers (<1% vs 2%; P = .001). In exploratory analyses, intervention patients had fewer days of opioid administration (median, 9 [IQR, 5-15] days vs 10 [IQR, 4-21] days; P = .01), were exposed to fewer sedative classes (median, 2 [IQR, 2-3] classes vs 3 [IQR, 2-4] classes; P < .001), andwere more often awake and calm while intubated (median, 86%[IQR, 67%-100%] of days vs 75%[IQR, 50%-100%] of days; P = .004) than control patients, respectively; however, intervention patients had more days with any report of a pain score >= 4 (median, 50%[IQR, 27%-67%] of days vs 23%[IQR, 0%-46%] of days; P < .001) and any report of agitation (median, 60%[IQR, 33%-80%] vs40%[IQR, 13%-67%]; P = .003), respectively. CONCLUSIONS AND RELEVANCE Among children undergoing mechanical ventilation for acute respiratory failure, the use of a sedation protocol compared with usual care did not reduce the duration of mechanical ventilation. Exploratory analyses of secondary outcomes suggest a complex relationship among wakefulness, pain, and agitation.	[Curley, Martha A. Q.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Curley, Martha A. Q.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Curley, Martha A. Q.] Boston Childrens Hosp, Crit Care & Cardiovasc Program, Boston, MA USA; [Wypij, David] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wypij, David] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wypij, David; Asaro, Lisa A.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Watson, R. Scott] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Watson, R. Scott; Angus, Derek C.] Clin Res Invest & Syst Modeling Acute Illness Ctr, Pittsburgh, PA USA; [Grant, Mary Jo C.] Primary Childrens Med Ctr, Salt Lake City, UT USA; [Cheifetz, Ira M.] Duke Univ, Med Ctr, Durham, NC USA; [Dodson, Brenda L.] Boston Childrens Hosp, Dept Pharm, Boston, MA USA; [Franck, Linda S.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Seattle Children's Hospital; Duke University; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco	Curley, MAQ (corresponding author), Univ Penn, Claire M Fagin Hall,418 Curie Blvd 425, Philadelphia, PA 19104 USA.	curley@nursing.upenn.edu	Curley, Martha A/F-3579-2016; Cheifetz, Ira/I-8692-2019; Angus, Derek C/E-9671-2012	Curley, Martha A/0000-0001-5228-6694; Cheifetz, Ira/0000-0002-1174-1571; Franck, Linda/0000-0003-4291-9181; Gedeit, Rainer/0000-0003-2420-9493; Faustino, Edward Vincent S./0000-0001-6155-2691; Watson, R. Scott/0000-0002-2581-7186; Wypij, David/0000-0001-8367-8711; Asaro, Lisa/0000-0001-5736-0304	National Heart, Lung, and Blood Institute; National Institute of Nursing Research, National Institutes of Health [U01 HL086622, U01 HL086649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL086649, U01HL086622] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Nursing Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Heart, Lung, and Blood Institute and the National Institute of Nursing Research, National Institutes of Health (grant U01 HL086622 to Dr Curley and grant U01 HL086649 to Dr Wypij).	Anand KJS, 2010, PEDIATRICS, V125, pE1208, DOI 10.1542/peds.2009-0489; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Batt J, 2013, AM J RESP CRIT CARE, V187, P238, DOI 10.1164/rccm.201205-0954SO; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Colville G, 2008, AM J RESP CRIT CARE, V177, P976, DOI 10.1164/rccm.200706-857OC; Creten C, 2011, MINERVA ANESTESIOL, V77, P1099; Curley MAQ, 2006, J CRIT CARE, V21, P23, DOI 10.1016/j.jcrc.2005.12.004; Curley MAQ, 2005, JAMA-J AM MED ASSOC, V294, P229, DOI 10.1001/jama.294.2.229; CURLEY MAQ, 2003, PEDIATR CRIT CARE ME, V4, pA158; Curley MAQ, 2006, PEDIATR CRIT CARE ME, V7, P107, DOI 10.1097/01.PCC.0000200955.40962.38; Donner A, 2010, DESIGN ANAL CLUSTER; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Franck LS, 2008, PEDIATR CRIT CARE ME, V9, P573, DOI 10.1097/PCC.0b013e31818c8328; Gangnon RE, 2004, BIOMETRIKA, V91, P263, DOI 10.1093/biomet/91.2.263; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Grant MJC, 2012, CRIT CARE MED, V40, P1317, DOI 10.1097/CCM.0b013e31823c8ae3; Hartman ME, 2009, PEDIATR CRIT CARE ME, V10, P246, DOI 10.1097/PCC.0b013e31819a3bb9; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Jackson JC, 2010, AM J RESP CRIT CARE, V182, P183, DOI 10.1164/rccm.200903-0442OC; Jenkins IA, 2007, PEDIATR ANESTH, V17, P675, DOI 10.1111/j.1460-9592.2006.02180.x; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Khemani RG, 2014, AM J RESP CRIT CARE, V189; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Kudchadkar SR, 2014, CRIT CARE MED, V42, P1592, DOI 10.1097/CCM.0000000000000326; Kudchadkar SR, 2014, SLEEP MED REV, V18, P103, DOI 10.1016/j.smrv.2013.02.002; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Merkel S I, 1997, Pediatr Nurs, V23, P293; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Randolph AG, 2002, JAMA-J AM MED ASSOC, V288, P2561, DOI 10.1001/jama.288.20.2561; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Smith HAB, 2011, CRIT CARE MED, V39, P150, DOI 10.1097/CCM.0b013e3181feb489; Solodiuk Jean, 2003, J Pediatr Nurs, V18, P295, DOI 10.1016/S0882-5963(03)00090-3; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Tobias JD, 2000, CRIT CARE MED, V28, P2122, DOI 10.1097/00003246-200006000-00079; Traube C, 2014, CRIT CARE MED, V42, P656, DOI 10.1097/CCM.0b013e3182a66b76; Twite Mark D, 2004, Pediatr Crit Care Med, V5, P521, DOI 10.1097/01.PCC.0000144710.13710.2E; van Zellem L, 2014, PEDIATR CRIT CARE ME, V15, P189, DOI 10.1097/PCC.0000000000000044; Wong D L, 1988, Pediatr Nurs, V14, P9; Xie TL, 2003, STAT MED, V22, P2835, DOI 10.1002/sim.1536	48	247	249	4	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					379	389		10.1001/jama.2014.18399	http://dx.doi.org/10.1001/jama.2014.18399			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25602358	Green Accepted, Bronze			2022-12-28	WOS:000349072600020
J	Hurley, R				Hurley, Richard			What will MSF do with your (sic)47 000 Christmas gift?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							APPEAL 2014		BMJ, London, England		Hurley, R (corresponding author), BMJ, London, England.	rhurley@bmj.com						Arie S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7737; Godlee F, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7402; Gulland A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h303	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2015	350								h478	10.1136/bmj.h478	http://dx.doi.org/10.1136/bmj.h478			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZR	25626891	Bronze			2022-12-28	WOS:000348775700011
J	Patel, RM; Kandefer, S; Walsh, MC; Bell, EF; Carlo, WA; Laptook, AR; Sanchez, PJ; Shankaran, S; Van Meurs, KP; Ball, MB; Hale, EC; Newman, NS; Das, A; Higgins, RD; Stoll, BJ				Patel, Ravi M.; Kandefer, Sarah; Walsh, Michele C.; Bell, Edward F.; Carlo, Waldemar A.; Laptook, Abbot R.; Sanchez, Pablo J.; Shankaran, Seetha; Van Meurs, Krisa P.; Ball, M. Bethany; Hale, Ellen C.; Newman, Nancy S.; Das, Abhik; Higgins, Rosemary D.; Stoll, Barbara J.		Eunice Kennedy Shriver Natl Inst	Causes and Timing of Death in Extremely Premature Infants from 2000 through 2011	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; PRETERM INFANTS; MORTALITY; MORBIDITY; OUTCOMES; TRENDS; BORN	BACKGROUND Understanding the causes and timing of death in extremely premature infants may guide research efforts and inform the counseling of families. METHODS We analyzed prospectively collected data on 6075 deaths among 22,248 live births, with gestational ages of 22 0/7 to 28 6/7 weeks, among infants born in study hospitals within the National Institute of Child Health and Human Development Neonatal Research Network. We compared overall and cause-specific in-hospital mortality across three periods from 2000 through 2011, with adjustment for baseline differences. RESULTS The number of deaths per 1000 live births was 275 (95% confidence interval [CI], 264 to 285) from 2000 through 2003 and 285 (95% CI, 275 to 295) from 2004 through 2007; the number decreased to 258 (95% CI, 248 to 268) in the 2008-2011 period (P = 0.003 for the comparison across three periods). There were fewer pulmonary-related deaths attributed to the respiratory distress syndrome and bronchopulmonary dysplasia in 2008-2011 than in 2000-2003 and 2004-2007 (68 [95% CI, 63 to 74] vs. 83 [95% CI, 77 to 90] and 84 [95% CI, 78 to 90] per 1000 live births, respectively; P = 0.002). Similarly, in 2008-2011, as compared with 2000-2003, there were decreases in deaths attributed to immaturity (P = 0.05) and deaths complicated by infection (P = 0.04) or central nervous system injury (P < 0.001); however, there were increases in deaths attributed to necrotizing enterocolitis (30 [95% CI, 27 to 34] vs. 23 [95% CI, 20 to 27], P = 0.03). Overall, 40.4% of deaths occurred within 12 hours after birth, and 17.3% occurred after 28 days. CONCLUSIONS We found that from 2000 through 2011, overall mortality declined among extremely premature infants. Deaths related to pulmonary causes, immaturity, infection, and central nervous system injury decreased, while necrotizing enterocolitis-related deaths increased.	[Patel, Ravi M.; Hale, Ellen C.; Stoll, Barbara J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Patel, Ravi M.; Hale, Ellen C.; Stoll, Barbara J.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Kandefer, Sarah] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Walsh, Michele C.; Newman, Nancy S.] Case Western Reserve Univ, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Sanchez, Pablo J.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Carlo, Waldemar A.] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Shankaran, Seetha] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Van Meurs, Krisa P.; Ball, M. Bethany] Stanford Univ, Dept Pediat, Div Neonatal & Dev Med, Sch Med, Palo Alto, CA 94304 USA; [Van Meurs, Krisa P.; Ball, M. Bethany] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Das, Abhik] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	Emory University; Children's Healthcare of Atlanta (CHOA); Research Triangle Institute; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Iowa; University of Alabama System; University of Alabama Birmingham; Brown University; Women & Infants Hospital Rhode Island; Wayne State University; Stanford University; Lucile Packard Children's Hospital (LPCH); Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Patel, RM (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, 2015 Uppergate Dr NE,3rd Fl, Atlanta, GA 30322 USA.	rmpatel@emory.edu	Patel, Ravi/B-7218-2011; Ambalavanan, Namasivayam/AAI-4088-2020; Das, Abhik/AAF-1883-2020	Patel, Ravi/0000-0002-7444-5550; Ambalavanan, Namasivayam/0000-0003-0731-9092; Das, Abhik/0000-0003-2722-0479; Bell, Edward/0000-0002-5568-0889; Alexander, Barbara/0000-0001-5868-0529; Parikh, Nehal/0000-0002-1375-1247; Lakshminrusimha, Satyan/0000-0001-6098-2155; Gantz, Marie/0000-0001-8528-0184	National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [HD27904, HD21364, HD68284, HD27853, HD40492, HD27851, HD27856, HD68278, HD36790, HD27880, HD53119, HD34216, HD68270, HD40461, HD53109, HD21397, HD27881, HD53089, HD68244, HD68263, HD40521, HD21415, HD40689, HD21373, HD53124, HD40498, HD21385, HD27871]; National Center for Advancing Translational Sciences, NIH [UL1TR000454, KL2TR000455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD053119, U10HD027904, U10HD068270, UG1HD087229, U10HD053109, UG1HD068278, U10HD040492, U10HD053089, U10HD027871, UG1HD068263, UG1HD053109, UG1HD027851, U10HD068278, UG1HD040492, U10HD027856, U10HD021385, UG1HD040689, UG1HD053089, U10HD040461, UG1HD021385, UG1HD027880, UG1HD027904, UG1HD027853, U10HD036790, U10HD068263, UG1HD021364, UG1HD068244, U10HD027880, UG1HD034216, U10HD068244, U10HD068284, U10HD053124, UG1HD068270, U10HD021373, U10HD027851, U10HD021364, UG1HD027856, U10HD034216, U10HD027853, U10HD040689, UG1HD068284] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021415, U10HD027881, U01HD036790, U10HD040498, U10HD021397, U10HD040521] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000455, UL1TR000454] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants from the National Institutes of Health (NIH), grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, for the Neonatal Research Network Generic Database Study (U10 awards HD27904, HD21364, HD68284, HD27853, HD40492, HD27851, HD27856, HD68278, HD36790, HD27880, HD53119, HD34216, HD68270, HD40461, HD53109, HD21397, HD27881, HD53089, HD68244, HD68263, HD40521, HD21415, HD40689, HD21373, HD53124, HD40498, HD21385, and HD27871), and grants from the National Center for Advancing Translational Sciences, NIH (UL1TR000454 and KL2TR000455, to Dr. Patel).	Ahle M, 2013, PEDIATRICS, V132, pE443, DOI 10.1542/peds.2012-3847; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Berrington JE, 2012, J PEDIATR-US, V160, P49, DOI 10.1016/j.jpeds.2011.06.046; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Gould JB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e37; Hintz SR, 2005, ARCH DIS CHILD-FETAL, V90, P128, DOI 10.1136/adc.2003.046268; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Mathews TJ, 2013, NATL VITAL STAT REP, V62, P8; Mohamed MA, 2010, PEDIATRICS, V126, pE360, DOI 10.1542/peds.2009-2810; Shah PS, 2012, J PERINATOL, V32, P132, DOI 10.1038/jp.2011.68; Shankaran S, 2002, AM J OBSTET GYNECOL, V186, P796, DOI 10.1067/mob.2002.121652; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059	18	420	439	3	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					331	340		10.1056/NEJMoa1403489	http://dx.doi.org/10.1056/NEJMoa1403489			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25607427	Bronze, Green Accepted			2022-12-28	WOS:000348204500008
J	Chen, FH; Dong, GH; Zhang, DJ; Liu, XY; Jia, X; An, CB; Ma, MM; Xie, YW; Barton, L; Ren, XY; Zhao, ZJ; Wu, XH; Jones, MK				Chen, F. H.; Dong, G. H.; Zhang, D. J.; Liu, X. Y.; Jia, X.; An, C. B.; Ma, M. M.; Xie, Y. W.; Barton, L.; Ren, X. Y.; Zhao, Z. J.; Wu, X. H.; Jones, M. K.			Agriculture facilitated permanent human occupation of the Tibetan Plateau after 3600 BP	SCIENCE			English	Article							WHEAT; ORIGINS; SPREAD; CHINA	Our understanding of when and how humans adapted to living on the Tibetan Plateau at altitudes above 2000 to 3000 meters has been constrained by a paucity of archaeological data. Here we report data sets from the northeastern Tibetan Plateau indicating that the first villages were established only by 5200 calendar years before the present (cal yr B.P.). Using these data, we tested the hypothesis that a novel agropastoral economy facilitated year-round living at higher altitudes since 3600 cal yr B.P. This successful subsistence strategy facilitated the adaptation of farmers-herders to the challenges of global temperature decline during the late Holocene.	[Chen, F. H.; Dong, G. H.; Zhang, D. J.; Jia, X.; An, C. B.; Ma, M. M.; Xie, Y. W.] Lanzhou Univ, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Peoples R China; [Jones, M. K.] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England; [Barton, L.] Univ Pittsburgh, Dept Anthropol, Ctr Comparat Archaeol, Pittsburgh, PA 15260 USA; [Ren, X. Y.] Qinghai Prov Inst Cultural Rel & Archaeol, Xining 810007, Peoples R China; [Zhao, Z. J.] Chinese Acad Social Sci, Inst Archaeol, Beijing 100710, Peoples R China; [Wu, X. H.] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China; [Liu, X. Y.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	Lanzhou University; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Social Sciences; Peking University; Washington University (WUSTL)	Chen, FH (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Peoples R China.	fhchen@lzu.edu.cn; ghdong@lzu.edu.cn	Dong, Guanghui/C-5985-2013; Fahu, Chen/B-2788-2011; liu, xinyi/GWZ-8739-2022; Zhang, Dongju/ABH-9307-2022; MA, MINMIN/GYE-2888-2022	MA, MINMIN/0000-0002-5054-5733; Barton, Loukas/0000-0003-1519-4226; Chen, Fahu/0000-0002-8874-1035; Dong, Guanghui/0000-0001-8005-759X	project Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences [XDA05130601]; National Natural Science Foundation of China [41271218, 41021091]; 111 Program of the Chinese State Administration of Foreign Experts Affairs [B06026]; European Research Council research project Food Globalisation in Prehistory [249642]	project Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Program of the Chinese State Administration of Foreign Experts Affairs; European Research Council research project Food Globalisation in Prehistory	This research was funded by the project Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences (grant no. XDA05130601), the National Natural Science Foundation of China (grant nos. 41271218 and 41021091), the 111 Program (grant no. B06026) of the Chinese State Administration of Foreign Experts Affairs, and the European Research Council research project Food Globalisation in Prehistory (grant no. 249642). We thank O. Bar-Yosef for helpful comments. The biological and archaeological materials used in this paper are housed in the Key Laboratory of Western China's Environmental Systems (Ministry of Education), Lanzhou University. Data are available in the supplementary materials.	Aldenderfer M, 2011, HIGH ALT MED BIOL, V12, P141, DOI 10.1089/ham.2010.1094; [Anonymous], 2010, ATL CHIN CULT REL FA; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Belay G., 2006, PROTA PLANT RESOURCE; BNCR (Bureau of National Cultural Relics), 1996, ATL CHIN CULT REL FA, P10; Brantingham PJ, 2006, WORLD ARCHAEOL, V38, P387, DOI 10.1080/00438240600813301; Brantingham PJ, 2013, GEOARCHAEOLOGY, V28, P413, DOI 10.1002/gea.21448; Bureau of National Cultural Relics, 2009, ATL CHIN CULT REL FA; Chai Y., 1999, MIZI; d'Alpoim Guedes J, 2014, ARCHAEOL ANTHROP SCI, V6, P255, DOI 10.1007/s12520-013-0153-4; Dodson JR, 2013, QUATERNARY SCI REV, V72, P108, DOI 10.1016/j.quascirev.2013.04.021; Dong GH, 2013, J ARCHAEOL SCI, V40, P2538, DOI 10.1016/j.jas.2012.10.002; Flad R, 2010, HOLOCENE, V20, P955, DOI 10.1177/0959683609358914; Fu D. X., 2001, KAOGU, V47, P66; Guedes JD, 2014, QUATERN INT, V349, P29, DOI 10.1016/j.quaint.2014.08.003; Jones M, 2011, WORLD ARCHAEOL, V43, P665, DOI 10.1080/00438243.2011.624764; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Paldi E, 2001, BIOL PLANTARUM, V44, P145, DOI 10.1023/A:1017907412945; [汤惠生 Tang Huisheng], 2013, [科学通报, Chinese Science Bulletin], V58, P247; Wang X.Y., 1994, ZHONGGUO SHUJI; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Xie DJ., 2002, PREHISTORIC ARCHAEOL; Zhang DD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013749; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhao ZJ, 2004, KAOGU YU WENWU, V2, P85	26	346	425	38	359	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					248	250		10.1126/science.1259172	http://dx.doi.org/10.1126/science.1259172			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AZ0DA	25593179				2022-12-28	WOS:000347915300029
J	Flynn, RL; Cox, KE; Jeitany, M; Wakimoto, H; Bryll, AR; Ganem, NJ; Bersani, F; Pineda, JR; Suva, ML; Benes, CH; Haber, DA; Boussin, FD; Zou, L				Flynn, Rachel Litman; Cox, Kelli E.; Jeitany, Maya; Wakimoto, Hiroaki; Bryll, Alysia R.; Ganem, Neil J.; Bersani, Francesca; Pineda, Jose R.; Suva, Mario L.; Benes, Cyril H.; Haber, Daniel A.; Boussin, Francois D.; Zou, Lee			Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors	SCIENCE			English	Article							REPEAT-CONTAINING RNA; SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; CHROMOSOME ENDS; PROTEIN-KINASE; MUTATIONS; GLIOBLASTOMA; TUMORS; POLYMERASE; DISCOVERY	Cancer cells rely on telomerase or the alternative lengthening of telomeres (ALT) pathway to overcome replicative mortality. ALT is mediated by recombination and is prevalent in a subset of human cancers, yet whether it can be exploited therapeutically remains unknown. Loss of the chromatin-remodeling protein ATRX associates with ALT in cancers. Here, we show that ATRX loss compromises cell-cycle regulation of the telomeric noncoding RNA TERRA and leads to persistent association of replication protein A (RPA) with telomeres after DNA replication, creating a recombinogenic nucleoprotein structure. Inhibition of the protein kinase ATR, a critical regulator of recombination recruited by RPA, disrupts ALT and triggers chromosome fragmentation and apoptosis in ALT cells. The cell death induced by ATR inhibitors is highly selective for cancer cells that rely on ALT, suggesting that such inhibitors may be useful for treatment of ALT-positive cancers.	[Flynn, Rachel Litman; Bersani, Francesca; Suva, Mario L.; Benes, Cyril H.; Haber, Daniel A.; Zou, Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Flynn, Rachel Litman; Cox, Kelli E.; Bryll, Alysia R.; Ganem, Neil J.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Ctr Canc, Boston, MA 02118 USA; [Flynn, Rachel Litman; Cox, Kelli E.; Bryll, Alysia R.; Ganem, Neil J.] Boston Univ, Sch Med, Dept Med, Ctr Canc, Boston, MA 02118 USA; [Jeitany, Maya; Pineda, Jose R.; Boussin, Francois D.] CEA Fontenay Aux Roses, Inst Radiobiol Cellulaire & Mol, Lab Radiopathol, UMR 967, Fontenay Aux Roses, France; [Wakimoto, Hiroaki] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA; [Wakimoto, Hiroaki] Massachusetts Gen Hosp, Brain Tumor Ctr, Boston, MA 02115 USA; [Bersani, Francesca; Haber, Daniel A.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Charlestown, MA 02129 USA; [Suva, Mario L.; Zou, Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Boston University; Boston University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Flynn, RL (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	rlflynn@bu.edu; zou.lee@mgh.harvard.edu	Suva, Mario/AAY-7798-2020; Wakimoto, Hiroaki/H-4533-2019; Pineda, Jose R./F-9710-2015	Suva, Mario/0000-0001-9898-5351; Wakimoto, Hiroaki/0000-0001-8225-241X; Pineda, Jose R./0000-0002-0900-7466; Ganem, Neil/0000-0003-0269-6585; Boussin, francois/0000-0003-3778-4403; Bersani, Francesca/0000-0002-0343-7078	Wellcome Trust [102696]; Irtelis CEA Ph.D. program; INCA "TetraTips" [PLBIO10-030]; NIH [CA166729, GM076388]; Karin Grunebaum Cancer Research Foundation; Foster Foundation; NATIONAL CANCER INSTITUTE [R00CA166729, R01CA129933, K99CA166729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388, T32GM008541] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Irtelis CEA Ph.D. program; INCA "TetraTips"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karin Grunebaum Cancer Research Foundation; Foster Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Artandi, W. Wright, H. Yu, M.P. Junier, and Q. Yang for reagents; A. Manning, A. Jimenez, D. Ramirez, and T. Kortulewski for technical assistance; and members of the Zou lab for helpful discussions. C.H.B. is supported by a grant from the Wellcome Trust (102696). M.J. has a fellowship from Irtelis CEA Ph.D. program. F.B. has a grant from INCA "TetraTips" (PLBIO10-030). R.L.F. is supported by the NIH K99/R00 Award (CA166729), the Karin Grunebaum Cancer Research Foundation, and the Foster Foundation. L.Z. is a Jim and Ann Orr Massachusetts General Hospital Research Scholar, a Senior Scholar of the Ellison Medical Foundation, and supported by the NIH grant GM076388.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Barr SM, 2003, CURR BIOL, V13, P1047, DOI 10.1016/S0960-9822(03)00376-2; Bechter OE, 2003, EMBO REP, V4, P1138, DOI 10.1038/sj.embor.7400027; Bower K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050062; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Fokas E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.181; Foote KM, 2013, J MED CHEM, V56, P2125, DOI 10.1021/jm301859s; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Scheel C, 2001, ONCOGENE, V20, P3835, DOI 10.1038/sj.onc.1204493; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wakimoto H, 2014, CLIN CANCER RES, V20, P2898, DOI 10.1158/1078-0432.CCR-13-3052; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yeager TR, 1999, CANCER RES, V59, P4175; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	302	313	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					273	277		10.1126/science.1257216	http://dx.doi.org/10.1126/science.1257216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593184	Green Accepted, Green Submitted			2022-12-28	WOS:000347915300036
J	Andersen, MB; Elliott, T; Freymuth, H; Sims, KWW; Niu, YL; Kelley, KA				Andersen, Morten B.; Elliott, Tim; Freymuth, Heye; Sims, Kenneth W. W.; Niu, Yaoling; Kelley, Katherine A.			The terrestrial uranium isotope cycle	NATURE			English	Article							ALTERED OCEANIC-CRUST; EAST PACIFIC RISE; TH-PB SYSTEMATICS; JUAN-DE-FUCA; SOLAR-SYSTEM; U-235-PA-231 DISEQUILIBRIA; HYDROTHERMAL ALTERATION; TEMPERATURE-DEPENDENCE; CONTINENTAL-CRUST; BENEATH HAWAII	Changing conditions on the Earth's surface can have a remarkable influence on the composition of its overwhelmingly more massive interior. The global distribution of uranium is a notable example. In early Earth history, the continental crust was enriched in uranium. Yet after the initial rise in atmospheric oxygen, about 2.4 billion years ago, the aqueous mobility of oxidized uranium resulted in its significant transport to the oceans and, ultimately, by means of subduction, back to the mantle(1-8). Here we explore the isotopic characteristics of this global uranium cycle. We show that the subducted flux of uranium is isotopically distinct, with high U-238/U-235 ratios, as a result of alteration processes at the bottom of an oxic ocean. We also find that mid-ocean-ridge basalts (MORB s) have U-238/U-235 ratios higher than does the bulk Earth, confirming the widespread pollution of the upper mantle with this recycled uranium. Although many ocean island basalts (OIBs) are argued to contain a recycled componene, their uranium isotopic compositions do not differ from those of the bulk Earth. Because subducted uranium was probably isotopically unfractionated before full oceanic oxidation, about 600 million years ago, this observation reflects the greater antiquity of OIB sources. Elemental and isotope systematics of uranium in OIBs are strikingly consistent with previous OIB lead model ages(10), indicating that these mantle reservoirs formed between 2.4 and 1.8 billion years ago. In contrast, the uranium isotopic composition of MORB requires the convective stirring of recycled uranium throughout the upper mantle within the past 600 million years.	[Andersen, Morten B.; Elliott, Tim; Freymuth, Heye] Univ Bristol, Sch Earth Sci, Bristol Isotope Grp, Bristol B58 1RJ, Avon, England; [Andersen, Morten B.] ETH, Dept Earth Sci, Inst Geochem & Petrol, CH-8092 Zurich, Switzerland; [Sims, Kenneth W. W.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; [Niu, Yaoling] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Kelley, Katherine A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Bristol; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Wyoming; Durham University; University of Rhode Island	Andersen, MB (corresponding author), Univ Bristol, Sch Earth Sci, Bristol Isotope Grp, Bristol B58 1RJ, Avon, England.	morten.andersen@erdw.ethz.ch	Niu, Yaoling/A-5448-2008; Niu, Yaoling/GPW-9211-2022; Kelley, Katherine A/J-3728-2013	Niu, Yaoling/0000-0001-9488-2304; Kelley, Katherine A/0000-0002-7516-2683; Elliott, Tim/0000-0002-0984-0191; Freymuth, Heye/0000-0001-6991-5709	NERC [NE/H023933/1]; Natural Environment Research Council [NE/H023933/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial support for this research was provided by NERC grant NE/H023933/1. We thank the Natural History Museum, London, and M. Anand for providing meteorite samples. H. Staudigel and T. Plank were instrumental in producing and curating AOC composite samples. We are grateful to C. Taylor for careful picking of MORB glasses, E. Melekhova for preparing the quenched glass, D. Vance for comments and C. Coath for maintenance of the mass spectrometers.	ALBAREDE F, 1986, CHEM GEOL, V57, P1, DOI 10.1016/0009-2541(86)90090-2; Alt JC, 2003, CHEM GEOL, V201, P191, DOI 10.1016/S0009-2541(03)00201-8; Alt JC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003144; Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Andersen MB, 2014, EARTH PLANET SC LETT, V400, P184, DOI 10.1016/j.epsl.2014.05.051; Andersen MB, 2013, CHEM GEOL, V354, P22, DOI 10.1016/j.chemgeo.2013.06.021; Avanzinelli R, 2012, GEOCHIM COSMOCHIM AC, V92, P308, DOI 10.1016/j.gca.2012.06.020; Bach W, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000419; Barrat JA, 2007, GEOCHIM COSMOCHIM AC, V71, P4108, DOI 10.1016/j.gca.2007.06.001; Bigeleisen J, 1996, P NATL ACAD SCI USA, V93, P9393, DOI 10.1073/pnas.93.18.9393; Bigeleisen J, 1996, J AM CHEM SOC, V118, P3676, DOI 10.1021/ja954076k; Blichert-Toft J, 2010, EARTH PLANET SC LETT, V300, P152, DOI 10.1016/j.epsl.2010.10.001; Bopp CJ, 2010, ENVIRON SCI TECHNOL, V44, P5927, DOI 10.1021/es100643v; Bopp CJ, 2009, GEOLOGY, V37, P611, DOI 10.1130/G25550A.1; Bosch D, 2008, EARTH PLANET SC LETT, V265, P748, DOI 10.1016/j.epsl.2007.11.018; Bourdon B, 2000, GEOCHEM GEOPHY GEOSY, V1; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Brennecka GA, 2012, P NATL ACAD SCI USA, V109, P9299, DOI 10.1073/pnas.1114043109; Brennecka GA, 2011, ENVIRON SCI TECHNOL, V45, P1370, DOI 10.1021/es103061v; Brennecka GA, 2010, EARTH PLANET SC LETT, V291, P228, DOI 10.1016/j.epsl.2010.01.023; CHASE CG, 1981, EARTH PLANET SC LETT, V52, P277, DOI 10.1016/0012-821X(81)90182-5; CHAUVEL C, 1992, EARTH PLANET SC LETT, V110, P99, DOI 10.1016/0012-821X(92)90042-T; Chauvel C, 2008, NAT GEOSCI, V1, P64, DOI 10.1038/ngeo.2007.51; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P2467, DOI 10.1016/0016-7037(86)90030-X; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Class C, 1997, EARTH PLANET SC LETT, V150, P245, DOI 10.1016/S0012-821X(97)00089-7; Collerson KD, 1999, SCIENCE, V283, P1519, DOI 10.1126/science.283.5407.1519; Dauphas N, 2002, ASTROPHYS J, V565, P640, DOI 10.1086/324597; Dunk RM, 2002, CHEM GEOL, V190, P45, DOI 10.1016/S0009-2541(02)00110-9; Elliott T, 1997, CHEM GEOL, V139, P165, DOI 10.1016/S0009-2541(97)00034-X; Elliott T, 1999, EARTH PLANET SC LETT, V169, P129, DOI 10.1016/S0012-821X(99)00077-1; Elliott T, 1997, J GEOPHYS RES-SOL EA, V102, P14991, DOI 10.1029/97JB00788; Elliott T., 1991, THESIS OPEN U, P29; Elliott T, 2007, GEOCHIM COSMOCHIM AC, V71, P219, DOI 10.1016/j.gca.2006.07.043; Farley KA, 1998, ANNU REV EARTH PL SC, V26, P189, DOI 10.1146/annurev.earth.26.1.189; FUJII Y, 1989, J NUCL SCI TECHNOL, V26, P1061, DOI [10.3327/jnst.26.1061, 10.1080/18811248.1989.9734427]; Fujii Y, 2006, J NUCL SCI TECHNOL, V43, P400, DOI 10.3327/jnst.43.400; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; GALER SJG, 1985, NATURE, V316, P778, DOI 10.1038/316778a0; Goldmann A, 2015, GEOCHIM COSMOCHIM AC, V148, P145, DOI 10.1016/j.gca.2014.09.008; GOLDSTEIN SJ, 1989, EARTH PLANET SC LETT, V96, P134, DOI 10.1016/0012-821X(89)90128-3; GRAHAM D, 1990, NATURE, V347, P545, DOI 10.1038/347545a0; Gutjahr M, 2007, CHEM GEOL, V242, P351, DOI 10.1016/j.chemgeo.2007.03.021; HART SR, 1992, SCIENCE, V256, P517, DOI 10.1126/science.256.5056.517; HAURI EH, 1993, NATURE, V365, P221, DOI 10.1038/365221a0; HEMOND C, 1994, CHEM GEOL, V115, P7, DOI 10.1016/0009-2541(94)90143-0; Hermann J, 2002, CHEM GEOL, V192, P289, DOI 10.1016/S0009-2541(02)00222-X; Hiess J, 2012, SCIENCE, V335, P1610, DOI 10.1126/science.1215507; Jackson MG, 2007, NATURE, V448, P684, DOI 10.1038/nature06048; Jenner FE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC004009; Kelley KA, 2005, EARTH PLANET SC LETT, V234, P369, DOI 10.1016/j.epsl.2005.03.005; Kelley KA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000435; Kokfelt TF, 2003, EARTH PLANET SC LETT, V214, P167, DOI 10.1016/S0012-821X(03)00306-6; Kokfelt TF, 2006, J PETROL, V47, P1705, DOI 10.1093/petrology/egl025; Kramers JD, 1997, CHEM GEOL, V139, P75, DOI 10.1016/S0009-2541(97)00027-2; Lundstrom CC, 2003, GEOCHIM COSMOCHIM AC, V67, P4153, DOI 10.1016/S0016-7037(03)00308-9; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; MANHES G, 1984, GEOCHIM COSMOCHIM AC, V48, P2247, DOI 10.1016/0016-7037(84)90221-7; MARCANTONIO F, 1995, EARTH PLANET SC LETT, V133, P397, DOI 10.1016/0012-821X(95)00092-Q; MCCULLOCH MT, 1993, EARTH PLANET SC LETT, V115, P89, DOI 10.1016/0012-821X(93)90215-U; MCLENNAN SM, 1980, NATURE, V285, P621, DOI 10.1038/285621a0; MILLER DM, 1994, NATURE, V368, P514, DOI 10.1038/368514a0; MORGAN JW, 1973, GEOCHIM COSMOCHIM AC, V37, P1697, DOI 10.1016/0016-7037(73)90157-9; Mottl MJ, 1998, GEOLOGY, V26, P51, DOI 10.1130/0091-7613(1998)026<0051:WSDOMO>2.3.CO;2; Murphy MJ, 2014, EARTH PLANET SC LETT, V388, P306, DOI 10.1016/j.epsl.2013.11.034; Noordmann J., 2012, GOLDSCHM C MONTR, VA1548; Partin CA, 2013, EARTH PLANET SC LETT, V369, P284, DOI 10.1016/j.epsl.2013.03.031; PATTERSON C, 1956, GEOCHIM COSMOCHIM AC, V10, P230, DOI 10.1016/0016-7037(56)90036-9; Pietruszka AJ, 1999, EARTH PLANET SC LETT, V167, P311, DOI 10.1016/S0012-821X(99)00036-9; PLANK T, 2000, P OCEAN DRILLING PRO, V185; Prytulak J, 2009, GEOCHIM COSMOCHIM AC, V73, P2103, DOI 10.1016/j.gca.2009.01.001; Prytulak J, 2014, CHEM GEOL, V381, P94, DOI 10.1016/j.chemgeo.2014.04.030; Regelous M, 1999, EARTH PLANET SC LETT, V168, P45, DOI 10.1016/S0012-821X(99)00048-5; Regelous M, 2009, LITHOS, V112, P57, DOI 10.1016/j.lithos.2008.10.012; REINITZ I, 1989, EARTH PLANET SC LETT, V94, P199, DOI 10.1016/0012-821X(89)90139-8; Richter S, 2008, INT J MASS SPECTROM, V269, P145, DOI 10.1016/j.ijms.2007.09.012; Robinson C.J., 1996, GEOL SOC LOND SPEC P, V118, P131, DOI [10.1144/GSL.SP.1996.118.01.07, DOI 10.1144/GSL.SP.1996.118.01.07]; ROCHOLL A, 1993, EARTH PLANET SC LETT, V117, P265, DOI 10.1016/0012-821X(93)90132-S; Romaniello S. J., 2009, EOS T AGU, V90, pV54C; Romaniello SJ, 2013, CHEM GEOL, V362, P305, DOI 10.1016/j.chemgeo.2013.10.002; Rudge JF, 2006, EARTH PLANET SC LETT, V249, P494, DOI 10.1016/j.epsl.2006.06.046; RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9; Shiel AE, 2013, ENVIRON SCI TECHNOL, V47, P2535, DOI 10.1021/es303913y; Sigmarsson G, 2005, EARTH PLANET SC LETT, V234, P223, DOI 10.1016/j.epsl.2005.02.015; Sims KWW, 2006, EARTH PLANET SC LETT, V245, P743, DOI 10.1016/j.epsl.2006.02.030; SIMS KWW, 1995, SCIENCE, V267, P508, DOI 10.1126/science.267.5197.508; Sims KWW, 2002, GEOCHIM COSMOCHIM AC, V66, P3481, DOI 10.1016/S0016-7037(02)00909-2; Sims KWW, 1999, GEOCHIM COSMOCHIM AC, V63, P4119, DOI 10.1016/S0016-7037(99)00313-0; STAUDIGEL H, 1983, GEOCHIM COSMOCHIM AC, V47, P337, DOI 10.1016/0016-7037(83)90257-0; STAUDIGEL H, 1995, EARTH PLANET SC LETT, V130, P169, DOI 10.1016/0012-821X(94)00263-X; Staudigel H., 2003, TREATISE GEOCHEM, V3, P511, DOI [10.1016/B0-08-043751-6/03032-2, DOI 10.1016/B0-08-043751-6/03032-2]; Staudigel H., 1996, GEOPHYS MONOGR SER, V96, P19, DOI DOI 10.1029/GM096P0019; Steele RCJ, 2011, GEOCHIM COSMOCHIM AC, V75, P7906, DOI 10.1016/j.gca.2011.08.030; Stirling CH, 2005, GEOCHIM COSMOCHIM AC, V69, P1059, DOI 10.1016/j.gca.2004.06.034; Stirling CH, 2007, EARTH PLANET SC LETT, V264, P208, DOI 10.1016/j.epsl.2007.09.019; Stirling CH, 2006, EARTH PLANET SC LETT, V251, P386, DOI 10.1016/j.epsl.2006.09.023; Trinquier A, 2009, SCIENCE, V324, P374, DOI 10.1126/science.1168221; Turner S, 1997, CHEM GEOL, V139, P145, DOI 10.1016/S0009-2541(97)00031-4; Waters CL, 2013, GEOCHEM GEOPHY GEOSY, V14, P2547, DOI 10.1002/ggge.20134; Weyer S, 2008, GEOCHIM COSMOCHIM AC, V72, P345, DOI 10.1016/j.gca.2007.11.012; WHITE WM, 1982, NATURE, V296, P821, DOI 10.1038/296821a0; Willbold M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001005; WRIGHT E, 1987, EARTH PLANET SC LETT, V81, P151, DOI 10.1016/0012-821X(87)90152-X; Zartman RE, 2005, CHEM GEOL, V220, P263, DOI 10.1016/j.chemgeo.2005.04.003; ZARTMAN RE, 1988, GEOCHIM COSMOCHIM AC, V52, P1327, DOI 10.1016/0016-7037(88)90204-9; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	107	111	115	4	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					356	U463		10.1038/nature14062	http://dx.doi.org/10.1038/nature14062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592542	Green Submitted			2022-12-28	WOS:000347810300043
J	Darrow, JJ; Sarpatwari, A; Avorn, J; Kesselheim, AS				Darrow, Jonathan J.; Sarpatwari, Ameet; Avorn, Jerry; Kesselheim, Aaron S.			Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							APPROVAL; CANCER; END; FDA		[Darrow, Jonathan J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Darrow, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017; Darrow, J J/R-8365-2019	Kesselheim, Aaron/0000-0002-8867-2666; Darrow, J J/0000-0002-7351-4243				Annas GJ, 2007, NEW ENGL J MED, V357, P408, DOI 10.1056/NEJMhle070625; [Anonymous], 1987, FED REG, V52, P19466; [Anonymous], 2006, FED REGISTER, V71, P75148; [Anonymous], 2014, NY TIMES; [Anonymous], 2009, FED REGISTER, V74, P40900; [Anonymous], 1983, FED REGISTER, V48, P26729; Arnst C., 2007, DYING PATIENTS FIGHT; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Black Lee, 2007, Virtual Mentor, V9, P34, DOI 10.1001/virtualmentor.2007.9.1.hlaw1-0701; Cohen E, 2014, COMPANY DENIES DRUG; Columbia University Medical Center Institutional Review Board, IRB FEE SCHED; Darrow JJ, 2014, NEW ENGL J MED, V370, P1252, DOI 10.1056/NEJMhle1311493; Dennis B., 2014, WASHINGTON POST; Dooren JC, 2012, WALL STREET J; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Falit BP, 2008, JAMA-J AM MED ASSOC, V300, P2793, DOI 10.1001/jama.2008.828; Food and Drug Administration, 2013, GUID IND EXP ACC INV; Freireich EJ, 2009, J CLIN ONCOL, V27, P304, DOI 10.1200/JCO.2008.19.6543; Gaffney Alexander, 2014, REGULATORY EXPLAINER; Government Accountability Office, 1980, FDA DRUG APPR LENGTH; Groopman Jerome, 2006, NEW YORKER; Hayes E., 2010, PINK SHEET, P31; Herper M, 2010, WORLDS MOST EXPENSIV; Herper M, 2014, COMPANY MAKES DRUG A; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Institute of Medicine, 2004, HLTH LITERACY PRESCR; Kaitin KI, 2011, CLIN PHARMACOL THER, V89, P183, DOI 10.1038/clpt.2010.286; Kolva E, 2014, GEN HOSP PSYCHIAT, V36, P392, DOI 10.1016/j.genhosppsych.2014.02.013; Kroll D, 2014, WHY EVERYONE HAS STA; Leonard EW, 2009, J LAW MED ETHICS, V37, P269, DOI 10.1111/j.1748-720X.2009.00371.x; Mack GS, 2009, NAT BIOTECHNOL, V27, P871, DOI 10.1038/nbt1009-871; Marcus A. D., 2014, WALL STREET J; McDiarmid J, 2014, TORONTO STAR; Mello MM, 2007, NEW ENGL J MED, V356, P2737, DOI 10.1056/NEJMhle067499; Okie S, 2006, NEW ENGL J MED, V355, P437, DOI 10.1056/NEJMp068132; ROBERTS BS, 1982, ARIZ ST LJ, P581; Sanghavi D, 2013, PHARM HAIL MARY; Silverman Ed, 2014, WALL STREET J; Tansey B., 2003, SAN FRANCISCO CHRONI; Woloshin S, 2005, J GEN INTERN MED, V20, P996, DOI 10.1007/s11606-005-0245-7	40	94	96	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					279	286		10.1056/NEJMhle1409465	http://dx.doi.org/10.1056/NEJMhle1409465			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3HX	25587952	Bronze			2022-12-28	WOS:000348119200015
J	Efeyan, A; Comb, WC; Sabatini, DM				Efeyan, Alejo; Comb, William C.; Sabatini, David M.			Nutrient-sensing mechanisms and pathways	NATURE			English	Review							ACTIVATING PROTEIN COMPLEX; GCN2 EIF2-ALPHA KINASE; AMINO-ACID DEPRIVATION; UNCHARGED TRANSFER-RNA; SWEET TASTE RECEPTORS; ADIPOSE-SPECIFIC GENE; RAG GTPASES; INSULIN-RESISTANCE; TUMOR-SUPPRESSOR; SCAP PROTEIN	The ability to sense and respond to fluctuations in environmental nutrient levels is a requisite for life. Nutrient scarcity is a selective pressure that has shaped the evolution of most cellular processes. Different pathways that detect intracellular and extracellular levels of sugars, amino acids, lipids and surrogate metabolites are integrated and coordinated at the organismal level through hormonal signals. During food abundance, nutrient-sensing pathways engage anabolism and storage, whereas scarcity triggers homeostatic mechanisms, such as the mobilization of internal stores through autophagy. Nutrient-sensing pathways are commonly deregulated in human metabolic diseases.	[Efeyan, Alejo; Comb, William C.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Efeyan, Alejo; Comb, William C.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Efeyan, Alejo; Comb, William C.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Efeyan, Alejo; Comb, William C.; Sabatini, David M.] Seven Cambridge Ctr, Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Efeyan, Alejo/J-8197-2016	Efeyan, Alejo/0000-0002-3806-6799; /0000-0002-1446-7256	National Institutes of Health [R01 CA129105, CA103866, AI047389, R21 AG042876]; American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation; Charles King's Trust Foundation/Simeon J. Fortin Fellowship; American Cancer Society- Ellison Foundation Postdoctoral Fellowship [PE-13-356-01-TBE]; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation(Lawrence Ellison Foundation); Charles King's Trust Foundation/Simeon J. Fortin Fellowship; American Cancer Society- Ellison Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	D.M.S. is supported by grants from the National Institutes of Health (R01 CA129105, CA103866 and AI047389; R21 AG042876) and awards from the American Federation for Aging, Starr Foundation, Koch Institute Frontier Research Program, and the Ellison Medical Foundation. A.E. is supported by the Charles King's Trust Foundation/Simeon J. Fortin Fellowship. W.C.C. is supported by American Cancer Society- Ellison Foundation Postdoctoral Fellowship (PE-13-356-01-TBE). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; HARMS E, 1981, BIOCHEM BIOPH RES CO, V99, P830, DOI 10.1016/0006-291X(81)91239-0; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Naito T, 2013, J BIOL CHEM, V288, P21074, DOI 10.1074/jbc.M113.456228; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; Neuhaus EM, 2002, MOL BIOL CELL, V13, P1390, DOI 10.1091/mbc.01-08-0392; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Ogunnowo-Bada EO, 2014, DIABETES OBES METAB, V16, P26, DOI 10.1111/dom.12334; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Reeds PJ, 2000, J NUTR, V130, p1835S; RICHIERI GV, 1995, J LIPID RES, V36, P229; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Takahashi M, 2000, INT J OBESITY, V24, P861, DOI 10.1038/sj.ijo.0801244; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wrann CD, 2012, J CLIN INVEST, V122, P1010, DOI 10.1172/JCI58431; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhang YX, 2013, J BIOL CHEM, V288, P14059, DOI 10.1074/jbc.M113.469528; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	112	645	670	18	326	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					302	310		10.1038/nature14190	http://dx.doi.org/10.1038/nature14190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592535	Green Accepted, Green Submitted			2022-12-28	WOS:000347810300034
J	Butterworth, S				Butterworth, Siobhain			MEDICINE AND THE MEDIA Libel law reform: a new era of free speech in science?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Butterworth, S (corresponding author), BMJ, London WC1H 9JR, England.	sbutterworth@bmj.com						Hurley R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4429	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2015	350								h94	10.1136/bmj.h94	http://dx.doi.org/10.1136/bmj.h94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3MB	25569688				2022-12-28	WOS:000348130500017
J	Sawhney, S				Sawhney, Simon			PERSONAL VIEW Automated alerts for acute kidney injury warrant caution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPACT		Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Sawhney, S (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland.	simon.sawhney@abdn.ac.uk		Sawhney, Simon/0000-0002-7960-4573				Bedford M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-95; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Kerr M, 2014, NEPHROL DIAL TRANSPL, V29, P1362, DOI 10.1093/ndt/gfu016; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; NHS England, AC KIDN INJ AKI PROG; Porter CJ, 2014, NEPHROL DIAL TRANSPL, V29, P1888, DOI 10.1093/ndt/gfu082; Stewart J, 2009, ADD INS INJ REV CAR, P1; Williamson T., 1997, PHILOS ISSUES, V8, P215	8	7	7	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2015	350								h19	10.1136/bmj.h19	http://dx.doi.org/10.1136/bmj.h19			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LZ	25567325				2022-12-28	WOS:000348130300005
J	Kar, P				Kar, Partha			IF I RULED THE NHS Improving diabetes care: six simple suggestions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	partha.kar@porthosp.nhs.uk	Kar, Partha/AAT-4839-2020						0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2015	350								g7848	10.1136/bmj.g7848	http://dx.doi.org/10.1136/bmj.g7848			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3LX	25569243				2022-12-28	WOS:000348130100006
J	Wasserman, D; Hoven, CW; Wasserman, C; Wall, M; Eisenberg, R; Hadlaczky, G; Kelleher, I; Sarchiapone, M; Apter, A; Balazs, J; Bobes, J; Brunner, R; Corcoran, P; Cosman, D; Guillemin, F; Haring, C; Iosue, M; Kaess, M; Kahn, JP; Keeley, H; Musa, GJ; Nemes, B; Postuvan, V; Saiz, P; Reiter-Theil, S; Varnik, A; Varnik, P; Carli, V				Wasserman, Danuta; Hoven, Christina W.; Wasserman, Camilla; Wall, Melanie; Eisenberg, Ruth; Hadlaczky, Gergoe; Kelleher, Ian; Sarchiapone, Marco; Apter, Alan; Balazs, Judit; Bobes, Julio; Brunner, Romuald; Corcoran, Paul; Cosman, Doina; Guillemin, Francis; Haring, Christian; Iosue, Miriam; Kaess, Michael; Kahn, Jean-Pierre; Keeley, Helen; Musa, George J.; Nemes, Bogdan; Postuvan, Vita; Saiz, Pilar; Reiter-Theil, Stella; Varnik, Airi; Varnik, Peeter; Carli, Vladimir			School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial	LANCET			English	Article							EMPOWERING YOUNG LIVES; DIFFICULTIES QUESTIONNAIRE; MENTAL-DISORDERS; EUROPE SEYLE; HEALTH; ADOLESCENTS; RISK; PREVALENCE; BEHAVIOR; PEOPLE	Background Suicidal behaviours in adolescents are a major public health problem and evidence-based prevention programmes are greatly needed. We aimed to investigate the efficacy of school-based preventive interventions of suicidal behaviours. Methods The Saving and Empowering Young Lives in Europe (SEYLE) study is a multicentre, cluster-randomised controlled trial. The SEYLE sample consisted of 11 110 adolescent pupils, median age 15 years (IQR 14-15), recruited from 168 schools in ten European Union countries. We randomly assigned the schools to one of three interventions or a control group. The interventions were: (1) Question, Persuade, and Refer (QPR), a gatekeeper training module targeting teachers and other school personnel, (2) the Youth Aware of Mental Health Programme (YAM) targeting pupils, and (3) screening by professionals (ProfScreen) with referral of at-risk pupils. Each school was randomly assigned by random number generator to participate in one intervention (or control) group only and was unaware of the interventions undertaken in the other three trial groups. The primary outcome measure was the number of suicide attempt(s) made by 3 month and 12 month follow-up. Analysis included all pupils with data available at each timepoint, excluding those who had ever attempted suicide or who had shown severe suicidal ideation during the 2 weeks before baseline. This study is registered with the German Clinical Trials Registry, number DRKS00000214. Findings Between Nov 1, 2009, and Dec 14, 2010, 168 schools (11 110 pupils) were randomly assigned to interventions (40 schools [2692 pupils] to QPR, 45 [2721] YAM, 43 [2764] ProfScreen, and 40 [2933] control). No significant differences between intervention groups and the control group were recorded at the 3 month follow-up. At the 12 month follow-up, YAM was associated with a significant reduction of incident suicide attempts (odds ratios [OR] 0.45, 95% CI 0.24-0.85; p=0.014) and severe suicidal ideation (0.50, 0.27-0.92; p=0.025), compared with the control group. 14 pupils (0.70%) reported incident suicide attempts at the 12 month follow-up in the YAM versus 34 (1.51%) in the control group, and 15 pupils (0.75%) reported incident severe suicidal ideation in the YAM group versus 31 (1.37%) in the control group. No participants completed suicide during the study period. Interpretation YAM was effective in reducing the number of suicide attempts and severe suicidal ideation in school-based adolescents. These findings underline the benefit of this universal suicide preventive intervention in schools.	[Wasserman, Danuta; Hadlaczky, Gergoe; Kelleher, Ian; Carli, Vladimir] Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, S-17177 Stockholm, Sweden; [Hoven, Christina W.; Wasserman, Camilla; Eisenberg, Ruth; Musa, George J.] Columbia Univ, New York State Psychiat Inst, Div Child & Adolescent Psychiat, New York, NY USA; [Hoven, Christina W.; Wall, Melanie] Columbia Univ, New York State Psychiat Inst, Dept Psychiat, New York, NY USA; [Hoven, Christina W.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Wall, Melanie] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Wasserman, Camilla; Sarchiapone, Marco; Iosue, Miriam] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy; [Sarchiapone, Marco] Natl Inst Hlth Migrat & Poverty, Rome, Italy; [Apter, Alan] Tel Aviv Univ, Schneider Childrens Med Ctr, Feinberg Child Study Ctr, IL-69978 Tel Aviv, Israel; [Balazs, Judit] Vadaskert Child & Adolescent Psychiat Hosp, Budapest, Hungary; [Balazs, Judit] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Bobes, Julio; Saiz, Pilar] Univ Oviedo, Ctr Invest Biomed Red Salud Mental, Dept Psychiat, Oviedo, Spain; [Brunner, Romuald; Kaess, Michael] Heidelberg Univ, Ctr Psychosocial Med, Clin Child & Adolescent Psychiat, Sect Disorders Personal Dev, Heidelberg, Germany; [Corcoran, Paul; Keeley, Helen] Natl Suicide Res Fdn, Cork, Ireland; [Cosman, Doina; Nemes, Bogdan] Iuliu Hatieganu Univ Med & Pharm, Dept Clin Psychol, Cluj Napoca, Romania; [Guillemin, Francis] Nancy Univ Hosp, Inserm CIC EC, Nancy, France; [Kahn, Jean-Pierre] Nancy Univ Hosp, Dept Psychiat, Nancy, France; [Haring, Christian] State Hosp Hall, Inst Clin Evaluat, Dept Psychiat & Psychotherapy B, Tyrol, Austria; [Postuvan, Vita] Univ Primorska, Andrej Marusic Inst, Slovene Ctr Suicide Res, Koper, Slovenia; [Reiter-Theil, Stella] Univ Basel, Univ Basel Hosp, Hosp Psychiat, Dept Clin Eth, Basel, Switzerland; [Varnik, Airi; Varnik, Peeter] Estonian Swedish Mental Hlth & Suicidol Inst, Tallinn, Estonia; [Varnik, Airi; Varnik, Peeter] Tallinn Univ, EE-10120 Tallinn, Estonia	Karolinska Institutet; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; University of Molise; Tel Aviv University; Eotvos Lorand University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Oviedo; Ruprecht Karls University Heidelberg; Iuliu Hatieganu University of Medicine & Pharmacy; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; University of Primorska; University of Basel; Tallinn University	Wasserman, D (corresponding author), Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, S-17177 Stockholm, Sweden.	danuta.wasserman@ki.se	Saiz, Pilar A./ABF-5814-2021; Bobes, Julio/AAH-4365-2019; Cosman, Doina/L-9087-2013; Wall, Melanie/AAE-7828-2019; Sarchiapone, Marco/F-6402-2018; Nemes, Bogdan/A-8446-2012; Hadlaczky, Gergö/GWC-1514-2022; Postuvan, Vita/AAI-6910-2020	Saiz, Pilar A./0000-0002-5705-4523; Bobes, Julio/0000-0003-2187-4033; Cosman, Doina/0000-0001-7102-2432; Sarchiapone, Marco/0000-0001-9583-3117; Nemes, Bogdan/0000-0002-1381-798X; Hoven, Christina/0000-0003-1274-2936; Kelleher, Ian/0000-0003-1484-651X; Iosue, Miriam/0000-0002-3703-1578	European Union	European Union(European Commission)	Coordination Theme 1 (Health) of the European Union Seventh Framework Programme.	Andriessen K, 2012, INT J ENV RES PUB HE, V9, P24, DOI 10.3390/ijerph9010024; [Anonymous], 2014, LANCET, V383, P1183, DOI 10.1016/S0140-6736(14)60587-0; [Anonymous], 2014, NATURE, V506, P131; Aseltine RH, 2004, AM J PUBLIC HEALTH, V94, P446, DOI 10.2105/AJPH.94.3.446; Aseltine RH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-161; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Carli V, 2014, WORLD PSYCHIATRY, V13, P78, DOI 10.1002/wps.20088; De Silva S, 2013, CRISIS, V34, P223, DOI 10.1027/0227-5910/a000190; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Eyre O, 2014, LANCET, V383, P1366, DOI 10.1016/S0140-6736(13)62633-1; Fleischmann A, 2008, B WORLD HEALTH ORGAN, V86, P703, DOI 10.2471/BLT.07.046995; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Gould MS, 2009, J AM ACAD CHILD PSY, V48, P1193, DOI 10.1097/CHI.0b013e3181bef6d5; Hawton K, 1998, J EPIDEMIOL COMMUN H, V52, P191, DOI 10.1136/jech.52.3.191; Hooven C, 2010, AM J HEALTH BEHAV, V34, P721; Hoven Christina W, 2009, Leg Med (Tokyo), V11 Suppl 1, pS13, DOI 10.1016/j.legalmed.2009.01.106; Isensee B, 2012, EUR ADDICT RES, V18, P110, DOI 10.1159/000335085; Kaess M, 2014, EUR CHILD ADOLES PSY, V23, P611, DOI 10.1007/s00787-013-0490-y; Katz C, 2013, DEPRESS ANXIETY, V30, P1030, DOI 10.1002/da.22114; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Langford R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008958.pub2; Little R.J.A., 2002, STAT ANAL MISSING DA; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mrazek P., 1994, REDUCING RISKS MENTA; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; Patel V, 2014, NEW ENGL J MED, V370, P498, DOI 10.1056/NEJMp1315214; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; PAYKEL ES, 1974, BRIT J PSYCHIAT, V124, P460, DOI 10.1192/bjp.124.5.460; Pisani AR, 2013, J YOUTH ADOLESCENCE, V42, P807, DOI 10.1007/s10964-012-9884-2; Sisask M, 2013, HLTH ED J, V73, P382; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Tompkins TL, 2010, SUICIDE LIFE-THREAT, V40, P506, DOI 10.1521/suli.2010.40.5.506; Ttofi MM, 2011, J EXP CRIMINOL, V7, P27, DOI 10.1007/s11292-010-9109-1; Wasserman, 2009, OXFORD TXB SUICIDOLO, P381; Wasserman C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-776; Wasserman D, 2012, EUR PSYCHIAT, V27, P129, DOI 10.1016/j.eurpsy.2011.06.003; Wasserman Danuta, 2005, World Psychiatry, V4, P114; Wasserman D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-192; Wilcox HC, 2008, DRUG ALCOHOL DEPEN, V95, pS60, DOI 10.1016/j.drugalcdep.2008.01.005; World Health Organization, 2014, PREV SUIC PREV SUIC; Yuan Y, 2011, J STAT SOFTW, V45, P1; Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20	48	286	287	7	157	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1536	1544		10.1016/S0140-6736(14)61213-7	http://dx.doi.org/10.1016/S0140-6736(14)61213-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25579833				2022-12-28	WOS:000353220000035
J	Berradi, S; Hafidi, Z; Lezrek, M; Daoudi, R				Berradi, Soufiane; Hafidi, Zouheir; Lezrek, Mounir; Daoudi, Rajae			Acute fulminant endophthalmitis complicating traditional lens couching	LANCET			English	Editorial Material									[Berradi, Soufiane; Hafidi, Zouheir; Lezrek, Mounir; Daoudi, Rajae] Mohammed V Souissi Univ, Dept Ophthalmol, Teaching Hosp Rabat, Rabat 10100, Morocco	Mohammed V University in Rabat	Berradi, S (corresponding author), Mohammed V Souissi Univ, Dept Ophthalmol, Teaching Hosp Rabat, Rabat 10100, Morocco.	soufiane.berradi@hotmail.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1229	1229		10.1016/S0140-6736(15)60033-2	http://dx.doi.org/10.1016/S0140-6736(15)60033-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25601788				2022-12-28	WOS:000351715100036
J	Marini, JJ; Vincent, JL; Annane, D				Marini, John J.; Vincent, Jean-Louis; Annane, Djillali			Critical Care Evidence-New Directions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY		[Marini, John J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Vincent, Jean-Louis] Univ Libre Bruxelles, Dept Intens Care Med, Brussels, Belgium; [Annane, Djillali] Univ Versailles SQY, Hop Raymond Poincare, AP HP, Dept Med, Garches, France	University of Minnesota System; University of Minnesota Twin Cities; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Marini, JJ (corresponding author), Reg Hosp, Dept Pulm & Crit Care Med, 640 Jackson St,MS11203B, St Paul, MN 55101 USA.	marin002@umn.edu	Annane, Djillali/R-7947-2019	Vincent, Jean-Louis/0000-0001-6011-6951				HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Tonelli AR, 2014, INTENS CARE MED, V40, P769, DOI 10.1007/s00134-014-3272-1; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600	6	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2015	313	9					893	894		10.1001/jama.2014.18484	http://dx.doi.org/10.1001/jama.2014.18484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC3FN	25602680				2022-12-28	WOS:000350231800008
J	Collins, FS; Varmus, H				Collins, Francis S.; Varmus, Harold			A New Initiative on Precision Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Collins, Francis S.] NIH, Bethesda, MD 20892 USA; [Varmus, Harold] NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Collins, FS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							ABRAMS J, 2014, AM SOC CLIN ONCOL ED, V34, P71; Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498	4	2899	3064	19	597	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 26	2015	372	9					793	795		10.1056/NEJMp1500523	http://dx.doi.org/10.1056/NEJMp1500523			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CB8SQ	25635347	Green Published, Bronze			2022-12-28	WOS:000349901700001
J	Rovner, AJ; Haimovich, AD; Katz, SR; Li, Z; Grome, MW; Gassaway, BM; Amiram, M; Patel, JR; Gallagher, RR; Rinehart, J; Isaacs, FJ				Rovner, Alexis J.; Haimovich, Adrian D.; Katz, Spencer R.; Li, Zhe; Grome, Michael W.; Gassaway, Brandon M.; Amiram, Miriam; Patel, Jaymin R.; Gallagher, Ryan R.; Rinehart, Jesse; Isaacs, Farren J.			Recoded organisms engineered to depend on synthetic amino acids	NATURE			English	Article							BIOLOGICAL CONTAINMENT; PROTEIN-SYNTHESIS; RNA; EXPRESSION; CONSTRUCTION; SALMONELLA; BACTERIA; SYSTEM	Genetically modified organisms (GMOs) are increasingly used in research and industrial systemsto produce high-value pharmaceuticals, fuels and chemicals(1). Genetic isolation and intrinsic biocontainment would provide essential biosafety measures to secure these closed systems and enable safe applications of GMOs in open systems(2,3), which include bioremediation(4) and probiotics(5). Although safeguards have been designed to control cell growth by essential gene regulation(6), inducible toxin switches(7) and engineered auxotrophies8, these approaches are compromised by cross-feeding of essential metabolites, leaked expression of essential genes, or genetic mutations(9,10). Here we describe the construction of a series of genomically recoded organisms (GROs)(11) whose growth is restricted by the expression of multiple essential genes that depend on exogenously supplied synthetic aminoacids (sAAs). We introduced a Methanocaldococcus jannaschii tRNA: aminoacyl-tRNA synthetase pair into the chromosome of a GRO derived from Escherichia coli that lacks all TAG codons and release factor 1, endowing this organism with the orthogonal translational components to convert TAG into a dedicated sense codon for sAAs. Using multiplex automated genome engineering(12), we introduced in-frame TAG codons into 22 essential genes, linking their expression to the incorporation of synthetic phenylalanine-derived amino acids. Of the 60 sAA-dependent variants isolated, a notable strain harbouring three TAG codons inconserved functional residues(13) of MurG, DnaA and SerS and containing targeted tRNA deletions maintained robust growth and exhibited undetectable escape frequencies upon culturing similar to 10(11) cells on solid media for 7 days or in liquid media for 20 days. This is a significant improvement over existing biocontainment approaches(2,3,6-10). We constructed synthetic auxotrophs dependent on sAAs that were not rescued by cross-feeding in environmental growth assays. These auxotrophic GROs possess alternative genetic codes that impart genetic isolation by impeding horizontal gene transfer(11) and now depend on the use of synthetic biochemical building blocks, advancing orthogonal barriers between engineered organisms and the environment.	[Rovner, Alexis J.; Haimovich, Adrian D.; Katz, Spencer R.; Li, Zhe; Grome, Michael W.; Amiram, Miriam; Patel, Jaymin R.; Gallagher, Ryan R.; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Rovner, Alexis J.; Haimovich, Adrian D.; Katz, Spencer R.; Li, Zhe; Grome, Michael W.; Gassaway, Brandon M.; Amiram, Miriam; Patel, Jaymin R.; Gallagher, Ryan R.; Rinehart, Jesse; Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Isaacs, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	farren.isaacs@yale.edu	Gassaway, Brandon Mark/AAU-7548-2021; , Miriam/ABF-6823-2020	Gassaway, Brandon Mark/0000-0002-6102-2356; Amiram, Miriam/0000-0001-5826-930X; Patel, Jaymin/0000-0002-4380-4805; Katz, Spencer/0000-0002-5586-3562	Defense Advanced Research Projects Agency [N66001-12-C-4020, N66001-12-C-4211]; DuPont Inc.; Arnold and Mabel Beckman Foundation;  [NIH-MSTP-TG-T32GM07205]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DuPont Inc.; Arnold and Mabel Beckman Foundation; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Soll and Y. S. Wang for discussion and for providing pTech-supU. We thank N. Carriero and R. Bjornson at the Yale Biomedical High Performance Computing Cluster for assistance with SIFT. Funding received was from the Defense Advanced Research Projects Agency (N66001-12-C-4020, N66001-12-C-4211); NIH-MSTP-TG-T32GM07205 (A.D.H.); DuPont Inc. and the Arnold and Mabel Beckman Foundation (F.J.I.).	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; BERG P, 1975, P NATL ACAD SCI USA, V72, P1981, DOI 10.1073/pnas.72.6.1981; BETENBAUGH MJ, 1989, BIOTECHNOL BIOENG, V33, P1425, DOI 10.1002/bit.260331110; BOSL M, 1991, NUCLEIC ACIDS RES, V19, P5863, DOI 10.1093/nar/19.21.5863; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; Fan CG, 2014, CHEMBIOCHEM, V15, P1805, DOI 10.1002/cbic.201402083; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hammerling MJ, 2014, NAT CHEM BIOL, V10, P178, DOI [10.1038/nchembio.1450, 10.1038/NCHEMBIO.1450]; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Holberger LE, 2009, J BIOL CHEM, V284, P32188, DOI 10.1074/jbc.M109.062745; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; JENSEN LB, 1993, APPL ENVIRON MICROB, V59, P3713, DOI 10.1128/AEM.59.11.3713-3717.1993; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Maisnier-Patin S, 2002, MOL MICROBIOL, V46, P355, DOI 10.1046/j.1365-2958.2002.03173.x; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; O'Donoghue P, 2013, NAT CHEM BIOL, V9, P594, DOI 10.1038/nchembio.1339; Pieper DH, 2000, CURR OPIN BIOTECH, V11, P262, DOI 10.1016/S0958-1669(00)00094-X; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Rinehart J, 2011, J BIOL CHEM, V286, P30171, DOI 10.1074/jbc.M111.222893; Ronchel MC, 2001, APPL ENVIRON MICROB, V67, P2649, DOI 10.1128/AEM.67.6.2649-2656.2001; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; Schmidt M, 2012, FEBS LETT, V586, P2199, DOI 10.1016/j.febslet.2012.02.022; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Steidler L, 2003, BEST PRACT RES CL GA, V17, P861, DOI 10.1016/S1521-6918(03)00072-6; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Szafranski P, 1997, P NATL ACAD SCI USA, V94, P1059, DOI 10.1073/pnas.94.4.1059; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	43	204	218	6	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					89	+		10.1038/nature14095	http://dx.doi.org/10.1038/nature14095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25607356	Green Accepted			2022-12-28	WOS:000349098000037
J	Asenjo, M; Angelina, M				Asenjo, Maria; Angelina, Maria			Lung Herniation with Coughing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asenjo, Maria; Angelina, Maria] Hosp Rey Juan Carlos, Madrid, Spain		Asenjo, M (corresponding author), Hosp Rey Juan Carlos, Madrid, Spain.	mariaasenjomartinez@gmail.com							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 29	2015	372	5					464	464		10.1056/NEJMicm1307677	http://dx.doi.org/10.1056/NEJMicm1307677			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA1CD	25629744				2022-12-28	WOS:000348649700011
J	Hofmann, JW; Zhao, XA; De Cecco, M; Peterson, AL; Pagliaroli, L; Manivannan, J; Hubbard, GB; Ikeno, Y; Zhang, YQ; Feng, B; Li, XX; Serre, T; Qi, WB; Van Remmen, H; Miller, RA; Bath, KG; de Cabo, R; Xu, HY; Neretti, N; Sedivy, JM				Hofmann, Jeffrey W.; Zhao, Xiaoai; De Cecco, Marco; Peterson, Abigail L.; Pagliaroli, Luca; Manivannan, Jayameenakshi; Hubbard, Gene B.; Ikeno, Yuji; Zhang, Yongqing; Feng, Bin; Li, Xiaxi; Serre, Thomas; Qi, Wenbo; Van Remmen, Holly; Miller, Richard A.; Bath, Kevin G.; de Cabo, Rafael; Xu, Haiyan; Neretti, Nicola; Sedivy, John M.			Reduced Expression of MYC Increases Longevity and Enhances Healthspan	CELL			English	Article							AMES DWARF MICE; LIFE-SPAN; C-MYC; CALORIC RESTRICTION; DIETARY RESTRICTION; OXIDATIVE STRESS; MODEL ORGANISMS; DNA-DAMAGE; CANCER; MITOCHONDRIA	MYC is a highly pleiotropic transcription factor whose deregulation promotes cancer. In contrast, we find that Myc haploinsufficient (Myc(+/-)) mice exhibit increased lifespan. They show resistance to several age-associated pathologies, including osteoporosis, cardiac fibrosis, and immunosenescence. They also appear to be more active, with a higher metabolic rate and healthier lipid metabolism. Transcriptomic analysis reveals a gene expression signature enriched for metabolic and immune processes. The ancestral role of MYC as a regulator of ribosome biogenesis is reflected in reduced protein translation, which is inversely correlated with longevity. We also observe changes in nutrient and energy sensing pathways, including reduced serum IGF-1, increased AMPK activity, and decreased AKT, TOR, and S6K activities. In contrast to observations in other longevity models, Myc(+/-) mice do not show improvements in stress management pathways. Our findings indicate that MYC activity has a significant impact on longevity and multiple aspects of mammalian healthspan.	[Hofmann, Jeffrey W.; Zhao, Xiaoai; De Cecco, Marco; Peterson, Abigail L.; Pagliaroli, Luca; Manivannan, Jayameenakshi; Neretti, Nicola; Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Hubbard, Gene B.; Ikeno, Yuji; Qi, Wenbo; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zhang, Yongqing; de Cabo, Rafael] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA; [Feng, Bin; Xu, Haiyan] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Hallett Ctr Diabet & Endocrinol, Providence, RI 02903 USA; [Li, Xiaxi; Serre, Thomas; Bath, Kevin G.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA	Brown University; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sedivy, JM (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.	john_sedivy@brown.edu	de Cabo, Rafael Carlos/J-5230-2016; FENG, BIN/E-9505-2017; pagliaroli, luca/AAM-6761-2021; de Cabo, Rafael/E-7996-2010; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; FENG, BIN/0000-0001-6258-2729; pagliaroli, luca/0000-0001-5539-4789; de Cabo, Rafael/0000-0003-2830-5693; Neretti, Nicola/0000-0002-9552-1663; de Cabo, Rafael/0000-0002-3354-2442	NIH [R37 AG016694, P42 ES013660, P30 GM103410]; Intramural Research Program of the National Institute on Aging (NIH);  [F30 AG035592]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824, F30AG035592, R37AG016694, P01AG031736, U01AG022303, R01AG016694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute on Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant R37 AG016694 to J.M.S. J.W.H. was supported in part by grant F30 AG035592. J.M.S. was a Senior Scholar of the Ellison Medical Foundation and a recipient of the Glenn Award for Research on the Biological Mechanisms of Aging. The Brown Molecular Pathology and Genomics core facilities were supported by NIH grants P42 ES013660 and P30 GM103410. R.dC. is funded by the Intramural Research Program of the National Institute on Aging (NIH).	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Anisimov VN, 2004, EXP GERONTOL, V39, P305, DOI 10.1016/j.exger.2003.12.007; Bartke Andrzej, 2012, Frontiers in Genetics, V3, P288, DOI 10.3389/fgene.2012.00288; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Brown-Borg HM, 2012, AGE, V34, P43, DOI 10.1007/s11357-011-9212-x; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Dey S, 2013, AUTOPHAGY, V9, P612, DOI 10.4161/auto.23486; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Greer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074641; Heiman ML, 2003, ENDOCRINE, V20, P149, DOI 10.1385/ENDO:20:1-2:149; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x; Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Li XN, 2013, AM J PHYSIOL-ENDOC M, V305, pE942, DOI 10.1152/ajpendo.00304.2013; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Peck B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00096; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; Syed Farhan A, 2011, Curr Osteoporos Rep, V9, P219, DOI 10.1007/s11914-011-0074-z; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang JW, 2011, CURR OPIN IMMUNOL, V23, P532, DOI 10.1016/j.coi.2011.05.004; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Whitfield JR, 2012, CELL MOL LIFE SCI, V69, P931, DOI 10.1007/s00018-011-0860-x; Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	47	164	168	3	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					477	488		10.1016/j.cell.2014.12.016	http://dx.doi.org/10.1016/j.cell.2014.12.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25619689	Bronze, Green Accepted			2022-12-28	WOS:000349208000013
J	Machtens, JP; Kortzak, D; Lansche, C; Leinenweber, A; Kilian, P; Begemann, B; Zachariae, U; Ewers, D; de Groot, BL; Briones, R; Fahlke, C				Machtens, Jan-Philipp; Kortzak, Daniel; Lansche, Christine; Leinenweber, Ariane; Kilian, Petra; Begemann, Birgit; Zachariae, Ulrich; Ewers, David; de Groot, Bert L.; Briones, Rodolfo; Fahlke, Christoph			Mechanisms of Anion Conduction by Coupled Glutamate Transporters	CELL			English	Article							AMINO-ACID TRANSPORTER; EXTRACELLULAR GATE; SUBSTRATE; CHANNEL; EFFICIENT; DYNAMICS; HOMOLOG; BINDING	Excitatory amino acid transporters (EAATs) are essential for terminating glutamatergic synaptic transmission. They are not only coupled glutamate/Na+/H+/K+ transporters but also function as an channels. EAAT anion channels regulate neuronal excitability, and gain-of-function mutations in these proteins result in ataxia and epilepsy. We have combined molecular dynamics simulations with fluorescence spectroscopy of the prokaryotic homolog Glt(Ph) and patch-clamp recordings of mammalian EAATs to determine how these transporters conduct anions. Whereas outward-and inward-facing Glt(Ph) conformations are nonconductive, lateral movement of the glutamate transport domain from intermediate transporter conformations results in formation of an anion-selective conduction pathway. Fluorescence quenching of inserted tryptophan residues indicated the entry of anions into this pathway, and mutations of homologous pore-forming residues had analogous effects on Glt(Ph) simulations and EAAT2/EAAT4 measurements of single-channel currents and anion/cation selectivities. These findings provide a mechanistic framework of how neurotransmitter transporters can operate as anion-selective and ligand-gated ion channels.	[Machtens, Jan-Philipp; Kortzak, Daniel; Lansche, Christine; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst Zellulare Biophys ICS 4, D-52428 Julich, Germany; [Machtens, Jan-Philipp; Leinenweber, Ariane; Kilian, Petra; Begemann, Birgit; Ewers, David] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Machtens, Jan-Philipp; de Groot, Bert L.; Briones, Rodolfo] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany; [Zachariae, Ulrich] Univ Dundee, Coll Life Sci, Sch Engn Phys & Math, Dundee DD1 5EH, Scotland; [Zachariae, Ulrich] Univ Dundee, Coll Life Sci, Div Computat Biol, Dundee DD1 5EH, Scotland	Helmholtz Association; Research Center Julich; Hannover Medical School; Max Planck Society; University of Dundee; University of Dundee	Machtens, JP (corresponding author), Forschungszentrum Julich, Inst Complex Syst Zellulare Biophys ICS 4, D-52428 Julich, Germany.	jan-philipp.machtens@gmx.de; c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013; Machtens, Jan-Philipp/M-8659-2013; Ewers, David/AAG-8478-2021	Fahlke, Christoph/0000-0001-8602-9952; Machtens, Jan-Philipp/0000-0003-1673-8571; Ewers, David/0000-0003-1037-1027; Kortzak, Daniel/0000-0001-9098-3466; Zachariae, Ulrich/0000-0003-3287-8494	Deutsche Forschungsgemeinschaft [FA301/9, SFB803]; supercomputer JUROPA at Julich Supercomputing Centre (JSC); HLRN-II supercomputer of the North-German Supercomputing Alliance (HLRN)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); supercomputer JUROPA at Julich Supercomputing Centre (JSC); HLRN-II supercomputer of the North-German Supercomputing Alliance (HLRN)	These studies were supported by the Deutsche Forschungsgemeinschaft (FA301/9 to Ch.F.; SFB803 to B.L.d.G. and R.B.). The authors gratefully acknowledge the computing time granted on the supercomputer JUROPA at Julich Supercomputing Centre (JSC) and on the HLRN-II supercomputer of the North-German Supercomputing Alliance (HLRN). We thank A. Alekov, K. Benndorf, H. Grubmuller, and P. Hidalgo for critically reading the manuscript; T. Becher, R.E. Guzman, P. Kovermann, G. Stolting, B. Wilhelm, T. Gensch, I. Weyand, D. Kopfer, D. Wojciechowski, and D.J. Slotboom for helpful discussions; and T. Wassmann for preliminary simulations.	Akyuz N, 2013, NATURE, V502, P114, DOI 10.1038/nature12265; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Cater RJ, 2014, BIOPHYS J, V107, P621, DOI 10.1016/j.bpj.2014.05.046; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Erkens GB, 2013, NATURE, V502, P119, DOI 10.1038/nature12538; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Kutzner C, 2011, BIOPHYS J, V101, P809, DOI 10.1016/j.bpj.2011.06.010; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Machtens JP, 2011, J BIOL CHEM, V286, P23780, DOI 10.1074/jbc.M110.207514; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Otis TS, 2000, J NEUROSCI, V20, P2749; PICAUD SA, 1995, J NEUROPHYSIOL, V74, P1760, DOI 10.1152/jn.1995.74.4.1760; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Schneider N, 2014, J BIOL CHEM, V289, P1815, DOI 10.1074/jbc.M113.517177; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Vaitheeswaran S, 2004, J CHEM PHYS, V121, P7955, DOI 10.1063/1.1796271; Vazquez-Ibar JL, 2004, J BIOL CHEM, V279, P49214, DOI 10.1074/jbc.M407408200; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Wersinger E, 2006, J PHYSIOL-LONDON, V577, P221, DOI 10.1113/jphysiol.2006.118281; Winter N, 2012, BRAIN, V135, P3416, DOI 10.1093/brain/aws255; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	37	96	96	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 29	2015	160	3					542	553		10.1016/j.cell.2014.12.035	http://dx.doi.org/10.1016/j.cell.2014.12.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CA8YX	25635461	Green Published, Bronze			2022-12-28	WOS:000349208000018
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Direct to consumer genetic testing-is all knowledge power?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Food and Drug Administration, INSP COMPL ENF CRIM; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Kmietowicz Z, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7564; van Vlijmen EFW, 2011, BLOOD, V118, P2055, DOI 10.1182/blood-2011-03-345678; Walker K, 2013, LANCET, V382, P1674, DOI 10.1016/S0140-6736(13)61491-9; Wojcicki A, 2014, FUTURE GENETICS OUR	6	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2015	350								h439	10.1136/bmj.h439	http://dx.doi.org/10.1136/bmj.h439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA2ZM	25622591	Bronze			2022-12-28	WOS:000348775100010
J	Sibley, CH				Sibley, Carol Hopkins			Understanding artemisinin resistance	SCIENCE			English	Editorial Material							MALARIA; SPREAD		Univ Washington, Dept Genome Sci, Worldwide Antimalarial Resistance Network, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Worldwide Antimalarial Resistance Network (WWARN)	Sibley, CH (corresponding author), Univ Washington, Dept Genome Sci, Worldwide Antimalarial Resistance Network, Seattle, WA 98195 USA.	carol.sibley@wwarn.org						Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Dondorp AM, 2013, TRENDS PARASITOL, V29, P359, DOI 10.1016/j.pt.2013.05.005; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Klonis N, 2013, P NATL ACAD SCI USA, V110, P5157, DOI 10.1073/pnas.1217452110; Mok S, 2015, SCIENCE, V347, P431, DOI 10.1126/science.1260403; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4	14	23	24	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					373	374		10.1126/science.aaa4102	http://dx.doi.org/10.1126/science.aaa4102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25613877				2022-12-28	WOS:000348225800017
J	Cole, TB				Cole, Thomas B.			Canadian stairs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					226	227		10.1001/jama.2014.11527	http://dx.doi.org/10.1001/jama.2014.11527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25602982				2022-12-28	WOS:000348145000001
J	Ford, HL; Ravelo, AC; Polissar, PJ				Ford, Heather L.; Ravelo, A. Christina; Polissar, Pratigya J.			Reduced El Nino-Southern Oscillation during the Last Glacial Maximum	SCIENCE			English	Article							TROPICAL PACIFIC-OCEAN; SEA-SURFACE TEMPERATURES; LAYER HEAT-BALANCE; THERMOCLINE; RECONSTRUCTIONS; HYDROGRAPHY; ENSO	El Nino-Southern Oscillation (ENSO) is a major source of global interannual variability, but its response to climate change is uncertain. Paleoclimate records from the Last Glacial Maximum (LGM) provide insight into ENSO behavior when global boundary conditions (ice sheet extent, atmospheric partial pressure of CO2) were different from those today. In this work, we reconstruct LGM temperature variability at equatorial Pacific sites using measurements of individual planktonic foraminifera shells. A deep equatorial thermocline altered the dynamics in the eastern equatorial cold tongue, resulting in reduced ENSO variability during the LGM compared to the Late Holocene. These results suggest that ENSO was not tied directly to the east-west temperature gradient, as previously suggested. Rather, the thermocline of the eastern equatorial Pacific played a decisive role in the ENSO response to LGM climate.	[Ford, Heather L.; Ravelo, A. Christina] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Ford, Heather L.; Polissar, Pratigya J.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California Santa Cruz; Columbia University	Ford, HL (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	hford@ldeo.columbia.edu	Ford, Heather/CAG-7894-2022	Polissar, Pratigya/0000-0001-5483-1625; Ravelo, Ana Christina/0000-0003-3929-677X	NSF [OCE-1204254]; Achievement Rewards for College Scientists Foundation; Schlanger Fellowship, NSF; Directorate For Geosciences [1405178] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Achievement Rewards for College Scientists Foundation(General Electric); Schlanger Fellowship, NSF; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank P. DiNezio, A. Fedorov, B. Honisch, G. Manucharyan, A. Moore, A. Paytan, J. Zachos, and two anonymous reviewers for comments on the manuscript. R. Franks, E. Chen, J. Hourigan, and N. Movshovitz provided analytical support. For this research, we used samples provided by the Integrated Ocean Drilling Program (IODP). Funding for this research was provided by NSF grant OCE-1204254 (A.C.R.), the Achievement Rewards for College Scientists Foundation (H.L.F.), and the Schlanger Fellowship (H.L.F), which is part of the NSF-sponsored U.S. Science Support Program for IODP that is administered by the Consortium for Ocean Leadership. Our data are deposited at the National Oceanic and Atmospheric Administration National Climatic Data Center and Pangaea.	An SI, 2001, J CLIMATE, V14, P3421, DOI 10.1175/1520-0442(2001)014<3421:CROTAZ>2.0.CO;2; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Andreasen DJ, 1997, PALEOCEANOGRAPHY, V12, P395, DOI 10.1029/97PA00822; Benway HM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001208; Boucharel J, 2011, CLIM DYNAM, V37, P2045, DOI 10.1007/s00382-011-1119-9; Brady EC, 2013, J CLIMATE, V26, P1901, DOI 10.1175/JCLI-D-11-00416.1; Choi J, 2012, CLIM DYNAM, V38, P2631, DOI 10.1007/s00382-011-1186-y; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; DiNezio PN, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002083; Fedorov AV, 2001, J CLIMATE, V14, P3086, DOI 10.1175/1520-0442(2001)014<3086:ASAOTO>2.0.CO;2; Fiedler PC, 2006, PROG OCEANOGR, V69, P143, DOI 10.1016/j.pocean.2006.03.008; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hu ZZ, 2013, J CLIMATE, V26, P2601, DOI 10.1175/JCLI-D-12-00265.1; Jin FF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027221; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Koutavas A, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002378; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; Leduc G, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001701; Manucharyan GE, 2014, J CLIMATE, V27, P5836, DOI 10.1175/JCLI-D-13-00759.1; Otto-Bliesner BL, 2009, CLIM DYNAM, V32, P799, DOI 10.1007/s00382-008-0509-0; Patrick A, 1997, PALEOCEANOGRAPHY, V12, P649, DOI 10.1029/97PA01553; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rincon-Martinez D, 2011, MAR MICROPALEONTOL, V79, P24, DOI 10.1016/j.marmicro.2011.01.001; Sadekov AY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3692; Sagawa T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045827; Schmidt GA, 2014, CLIM PAST, V10, P221, DOI 10.5194/cp-10-221-2014; Spero HJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000814; Thirumalai K, 2013, PALEOCEANOGRAPHY, V28, P401, DOI 10.1002/palo.20037; Wang WM, 1999, J PHYS OCEANOGR, V29, P1812, DOI 10.1175/1520-0485(1999)029<1812:TSLHBI>2.0.CO;2; Wang WM, 2000, J PHYS OCEANOGR, V30, P2989, DOI 10.1175/1520-0485(2001)031<2989:TSLHBI>2.0.CO;2; Wit JC, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001857; Xu JA, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001934	32	70	73	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					255	258		10.1126/science.1258437	http://dx.doi.org/10.1126/science.1258437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25593181	Green Published			2022-12-28	WOS:000347915300031
J	Chandra, A; Khullar, D; Lee, TH				Chandra, Amitabh; Khullar, Dhruv; Lee, Thomas H.			Addressing the Challenge of Gray-Zone Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE; PCI		[Chandra, Amitabh] Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; [Khullar, Dhruv] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Lee, Thomas H.] Press Ganey Associates, Boston, MA USA	Harvard University; Harvard University; Massachusetts General Hospital	Chandra, A (corresponding author), Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA.							Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chandra A, 2012, J ECON LIT, V50, P645, DOI 10.1257/jel.50.3.645; Chandra A, 2011, J ECON PERSPECT, V25, P27, DOI 10.1257/jep.25.2.27; De Bruyne B, 2014, NEW ENGL J MED, V371, P1208, DOI 10.1056/NEJMoa1408758; Selby JV, 2014, NEW ENGL J MED, V370, P592, DOI 10.1056/NEJMp1313061	5	15	16	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					203	205		10.1056/NEJMp1409696	http://dx.doi.org/10.1056/NEJMp1409696			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3HX	25587945				2022-12-28	WOS:000348119200002
J	Janak, PH; Tye, KM				Janak, Patricia H.; Tye, Kay M.			From circuits to behaviour in the amygdala	NATURE			English	Review							PAVLOVIAN-INSTRUMENTAL TRANSFER; STIMULUS REWARD ASSOCIATIONS; BASOLATERAL AMYGDALA; CONDITIONED FEAR; LATERAL AMYGDALA; ORBITOFRONTAL CORTEX; NUCLEUS-ACCUMBENS; PRIMATE AMYGDALA; INHIBITORY CIRCUITS; DOUBLE DISSOCIATION	The amygdala has long been associated with emotion and motivation, playing an essential part in processing both fearful and rewarding environmental stimuli. How can a single structure be crucial for such different functions? With recent technological advances that allow for causal investigations of specific neural circuit elements, we can now begin to map the complex anatomical connections of the amygdala onto behavioural function. Understanding how the amygdala contributes to a wide array of behaviours requires the study of distinct amygdala circuits.	[Janak, Patricia H.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Janak, Patricia H.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Tye, Kay M.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Johns Hopkins University; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Northwell Health	Janak, PH (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	patricia.janak@jhu.edu; kaytye@mit.edu		Janak, Patricia/0000-0002-3333-9049	US National Institutes of Health [DA015096, AA014925, AA17072]; JPB Foundation; PIIF PNDRF; NARSAD Young Investigator Award; Whitehead Career Development Chair; NIH [MH102441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014925, R01AA016835, P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035943, R01DA015096] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; PIIF PNDRF; NARSAD Young Investigator Award(NARSAD); Whitehead Career Development Chair; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	R.H.J. acknowledges funding from US National Institutes of Health grants DA015096, AA014925, AA17072. K.M.T. is a New York Stem Cell Foundation-Robertson Investigator and acknowledges funding from the JPB Foundation, PIIF PNDRF, NARSAD Young Investigator Award, Whitehead Career Development Chair, and NIH grant MH102441. We thank K Vitale for input regarding interneurons and network selection, G. Calhoon and P Namburi for input on Fig 5, R. Keiflin for assistance with Fig 3, B. Saunders for comments on our text J. Gabrieli for input on human arnygdala research, I. Choi for assistance illustrating Fig. 1 and all the members of our laboratories for valuable discussion.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Allsop SA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00241; Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Barak S, 2013, NAT NEUROSCI, V16, P1111, DOI 10.1038/nn.3439; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Brown S., 1888, PHILOS T R SOC LON B, V179, P303; Buffalari DM, 2010, CURR TOP BEHAV NEURO, V3, P73, DOI 10.1007/7854_2009_18; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Chareyron LJ, 2011, J COMP NEUROL, V519, P3218, DOI 10.1002/cne.22677; Chaudhri N, 2013, EUR J NEUROSCI, V38, P2751, DOI 10.1111/ejn.12278; Cho JH, 2013, NEURON, V80, P1491, DOI 10.1016/j.neuron.2013.09.025; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Corbit LH, 2005, J NEUROSCI, V25, P962, DOI 10.1523/JNEUROSCI.4507-04.2005; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; EVERITT BJ, 1989, NEUROSCIENCE, V30, P63, DOI 10.1016/0306-4522(89)90353-9; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Freese JL, 2005, J COMP NEUROL, V486, P295, DOI 10.1002/cne.20520; GALLAGHER M, 1990, J NEUROSCI, V10, P1906; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Han JS, 1997, J NEUROSCI, V17, P3913; Hatfield T, 1996, J NEUROSCI, V16, P5256; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; HIROI N, 1991, J NEUROSCI, V11, P2107; HITCHCOCK J, 1986, BEHAV NEUROSCI, V100, P11, DOI 10.1037/0735-7044.100.1.11; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Holland PC, 2003, EUR J NEUROSCI, V17, P1680, DOI 10.1046/j.1460-9568.2003.02585.x; Hsiang HL, 2014, J NEUROSCI, V34, P14115, DOI 10.1523/JNEUROSCI.3327-14.2014; Huff ML, 2013, P NATL ACAD SCI USA, V110, P3597, DOI 10.1073/pnas.1219593110; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Johnston JB, 1923, J COMP NEUROL, V35, P337, DOI 10.1002/cne.900350502; KAPP BS, 1979, PHYSIOL BEHAV, V23, P1109, DOI 10.1016/0031-9384(79)90304-4; Kappers CUA, 1936, COMP ANATOMY NERVOUS; KELLEY AE, 1982, NEUROSCIENCE, V7, P615, DOI 10.1016/0306-4522(82)90067-7; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kluaver H., 1937, AM J PHYSIOL, V119, P352; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Land BB, 2014, NAT NEUROSCI, V17, P248, DOI 10.1038/nn.3625; Lanuza E, 1998, EUR J NEUROSCI, V10, P3517, DOI 10.1046/j.1460-9568.1998.00363.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Malkova L, 1997, J NEUROSCI, V17, P6011; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morrison SE, 2011, NEURON, V71, P1127, DOI 10.1016/j.neuron.2011.07.016; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Peck CJ, 2014, ELIFE, V3, DOI 10.7554/eLife.04478; Penzo MA, 2014, J NEUROSCI, V34, P2432, DOI 10.1523/JNEUROSCI.4166-13.2014; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Popescu AT, 2007, P NATL ACAD SCI USA, V104, P341, DOI 10.1073/pnas.0609831104; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roesch MR, 2012, EUR J NEUROSCI, V35, P1190, DOI 10.1111/j.1460-9568.2011.07986.x; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Sangha S, 2013, J NEUROSCI, V33, P3744, DOI 10.1523/JNEUROSCI.3302-12.2013; SANGHERA MK, 1979, EXP NEUROL, V63, P610, DOI 10.1016/0014-4886(79)90175-4; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Seymour B, 2008, NEURON, V58, P662, DOI 10.1016/j.neuron.2008.05.020; Shabel SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027797; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Siggins G. R., COLD SPRING HARB PER, V2; Sparta DR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00129; Stamatakis AM, 2014, NEUROPHARMACOLOGY, V76, P320, DOI 10.1016/j.neuropharm.2013.05.046; Stefanik MT, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00213; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Trouche S, 2013, NEURON, V80, P1054, DOI 10.1016/j.neuron.2013.07.047; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Xiu JB, 2014, NAT NEUROSCI, V17, P1552, DOI 10.1038/nn.3813; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhang WJ, 2013, J NEUROSCI, V33, P722, DOI 10.1523/JNEUROSCI.2970-12.2013	122	969	991	25	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					284	292		10.1038/nature14188	http://dx.doi.org/10.1038/nature14188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592533	Green Submitted, Green Accepted			2022-12-28	WOS:000347810300032
J	Pasparakis, M; Vandenabeele, P				Pasparakis, Manolis; Vandenabeele, Peter			Necroptosis and its role in inflammation	NATURE			English	Review							RECEPTOR-INTERACTING PROTEIN; MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; NF-KAPPA-B; CELL-DEATH; PROGRAMMED NECROSIS; RIP1 KINASE; EPIDERMAL-KERATINOCYTES; IN-VIVO; CASPASE-8	Regulated cell death has essential functions in development and in adult tissue homeostasis. Necroptosis is a newly discovered pathway of regulated necrosis that requires the proteins RIPK3 and MLKL and is induced by death receptors, interferons, toll-like receptors, intracellular RNA and DNA sensors, and probably other mediators. RIPK1 has important kinase-dependent and scaffolding functions that inhibit or trigger necroptosis and apoptosis. Mouse-model studies have revealed important functions for necroptosis in inflammation and suggested that it could be implicated in the pathogenesis of many human inflammatory diseases. We discuss the mechanisms regulating necroptosis and its potential role in inflammation and disease.	[Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med, D-50674 Cologne, Germany; [Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Vandenabeele, Peter] Univ Ghent VIB, VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, B-9052 Ghent, Belgium	University of Cologne; University of Cologne; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Ctr Mol Med, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de; Peter.Vandenabeele@irc.vib-ugent.be	Pasparakis, Manolis/N-4350-2019; Vandenabeele, Peter/AAD-5793-2022; Pasparakis, Manolis/H-9292-2017; Vandenabeele, Peter/C-8597-2009	Pasparakis, Manolis/0000-0002-9870-0966; Vandenabeele, Peter/0000-0002-6669-8822; Pasparakis, Manolis/0000-0002-9870-0966; 	European Research Council [2012-ADG_20120314]; German Research Foundation [SFB670, SFB829, SPP1656]; European Commission [223404, 223151]; Deutsche Krebshilfe; Else Kroner-Fresenius-Stiftung; Helmholtz Alliance (PCCC); Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11 N, FWO G.0A45.12 N, FWO G.0172.12, FWO G.0787.13N, G0C3114N, FWO KAN 31528711, 2012-188]; Gent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Flemish Government [B0F09/01M00709]	European Research Council(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe(Deutsche Krebshilfe); Else Kroner-Fresenius-Stiftung; Helmholtz Alliance (PCCC); Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grants (Research Foundation Flanders)(FWO); Gent University grants (MRP, GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Flemish Government(European Commission)	We apologise to all the authors whose work we could not cite in this Review due to space limitations M.P. acknowledges funding from the European Research Council (2012-ADG_20120314), the German Research Foundation (SFB670, SFB829, SPP1656), the European Commission (Grants 223404 (Masterswitch) and 223151 (InflaCare)), the Deutsche Krebshilfe, the Else Kroner-Fresenius-Stiftung and the Helmholtz Alliance (PCCC). Research in the Vandenabeele unit is supported by Belgian grants (Interuniversity Attraction Poles, IAP 7/32), Flemish grants (Research Foundation Flanders, FWO G.0875.11, FWO G.0973.11 N, FWO G.0A45.12 N, FWO G.0172.12, FWO G.0787.13N. G0C3114N, FWO KAN 31528711 and Foundation against Cancer 2012-188), Gent University grants (MRP, GROUP-ID consortium) and grants from Flanders Institute for Biotechnology (VIB). P.V. holds a Methusalem grant (B0F09/01M00709) from the Flemish Government.	Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Colbert LE, 2013, CANCER-AM CANCER SOC, V119, P3148, DOI 10.1002/cncr.28144; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gautheron J, 2014, EMBO MOL MED, V6, P1062, DOI 10.15252/emmm.201403856; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang H, 2014, HEPATOLOGY, V59, P1984, DOI 10.1002/hep.26976; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kang R, 2014, GASTROENTEROLOGY, V146, P1097, DOI 10.1053/j.gastro.2013.12.015; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lau A, 2013, AM J TRANSPLANT, V13, P2805, DOI 10.1111/ajt.12447; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Lu JV, 2011, P NATL ACAD SCI USA, V108, P15312, DOI 10.1073/pnas.1102779108; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Nunes T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/218493; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Panayotova-Dimitrova D, 2013, CELL REP, V5, P397, DOI 10.1016/j.celrep.2013.09.035; Pavlosky A, 2014, AM J TRANSPLANT, V14, P1778, DOI 10.1111/ajt.12779; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Roderick JE, 2014, P NATL ACAD SCI USA, V111, P14436, DOI 10.1073/pnas.1409389111; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Saito N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008227; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Sharma A, 2014, CRIT CARE, V18, DOI 10.1186/cc13970; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Su LJ, 2014, STRUCTURE, V22, P1489, DOI 10.1016/j.str.2014.07.014; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weinlich R, 2013, CELL REP, V5, P340, DOI 10.1016/j.celrep.2013.08.045; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Wickman GR, 2013, CELL DEATH DIFFER, V20, P1293, DOI 10.1038/cdd.2013.69; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wittkopf N, 2013, GASTROENTEROLOGY, V145, P1369, DOI 10.1053/j.gastro.2013.08.059; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Yang S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3583; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	125	1127	1183	21	381	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					311	320		10.1038/nature14191	http://dx.doi.org/10.1038/nature14191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592536				2022-12-28	WOS:000347810300035
J	Rodriguez, AR; Larrazabal, R				Rodriguez, Amadeo R.; Larrazabal, Ramiro			Intracranial Arteriovenous Malformation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rodriguez, Amadeo R.; Larrazabal, Ramiro] McMaster Univ, Hamilton, ON, Canada	McMaster University	Rodriguez, AR (corresponding author), McMaster Univ, Hamilton, ON, Canada.	arodrig@mcmaster.ca							0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3							e4	10.1056/NEJMicm1313525	http://dx.doi.org/10.1056/NEJMicm1313525			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25587971				2022-12-28	WOS:000348119200011
J	You, HZ; Rideau, E; Sidera, M; Fletcher, SP				You, Hengzhi; Rideau, Emeline; Sidera, Mireia; Fletcher, Stephen P.			Non-stabilized nucleophiles in Cu-catalysed dynamic kinetic asymmetric allylic alkylation	NATURE			English	Article							CONJUGATE ADDITION; SUBSTITUTION-REACTIONS; GRIGNARD-REAGENTS; ACID; IDENTIFICATION; RESOLUTION; LIGANDS	The development of new reactions forming asymmetric carbon-carbon bonds has enabled chemists to synthesize a broad range of important carbon-containing molecules, including pharmaceutical agents, fragrances and polymers(1). Most strategies to obtain enantiomerically enriched molecules rely on either generating new stereogenic centres from prochiral substrates or resolving racemic mixtures of enantiomers. An alternative strategy dynamic kinetic asymmetric transformation involves the transformation of a racemic starting material into a single enantiomer product, with greater than 50 per cent maximum yield(2,3). The use of stabilized nudeophiles (pK(a) < 25, where K-a is the acid dissociation constant) in palladium-catalysed asymmetric allylic alkylation reactions has proved to be extremely versatile in these processes(4,5). Conversely, the use of non-stabilized nudeophiles in such reactions is difficult and remains a key challenge'. Here we report a copper-catalysed dynamic kinetic asymmetric transformation using racemic substrates and alkyl nudeophiles. These nudeophiles have a pK(a) of >= 50, more than 25 orders of magnitude more basic than the nudeophiles that are typically used in such transformations. Organometallic reagents are generated in situ from alkenes by hydrometallation and give highly enantioenriched products under mild reaction conditions. The method is used to synthesize natural products that possess activity against tuberculosis and leprosy, and an inhibitor of para-aminobenzoate biosynthesis. Mechanistic studies indicate that the reaction proceeds through a rapidly isomerizing intermediate. We anticipate that this approach will be a valuable complement to existing asymmetric catalytic methods.	[You, Hengzhi; Rideau, Emeline; Sidera, Mireia; Fletcher, Stephen P.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford	Fletcher, SP (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	stephen.fletcher@chem.ox.ac.uk	Rideau, Emeline/AAR-1123-2020; Sidera, Mireia/N-3309-2015	Sidera, Mireia/0000-0002-7238-8433; Rideau, Emeline/0000-0003-2940-1169; You, Hengzhi/0000-0001-8904-5050	EPSRC [EP/H003711/1]; Engineering and Physical Sciences Research Council [EP/H003711/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the EPSRC (EP/H003711/1, a Career Acceleration Fellowship to S.P.F.). B. Odell and T. Claridge are thanked for assistance with the NMR experiments.	Alexakis A, 2008, CHEM REV, V108, P2796, DOI 10.1021/cr0683515; CABOT MC, 1981, LIPIDS, V16, P146, DOI 10.1007/BF02535690; Geurts K, 2008, PURE APPL CHEM, V80, P1025, DOI 10.1351/pac200880051025; Giacomina F, 2013, EUR J ORG CHEM, V2013, P6710, DOI 10.1002/ejoc.201300971; Harutyunyan SR, 2008, CHEM REV, V108, P2824, DOI 10.1021/cr068424k; Huerta FF, 2001, CHEM SOC REV, V30, P321, DOI 10.1039/b105464n; Jacobsen E. N., 2004, COMPREHENSIVE ASY S2; JACOBSEN PL, 1973, ANTIMICROB AGENTS CH, V3, P373, DOI 10.1128/AAC.3.3.373; Langlois JB, 2012, CHEM SCI, V3, P1062, DOI 10.1039/c2sc00868h; Langlois JB, 2012, TOP ORGANOMETAL CHEM, V38, P235, DOI 10.1007/3418_2011_12; Langlois JB, 2009, CHEM COMMUN, P3868, DOI 10.1039/b907722g; Lu Z, 2008, ANGEW CHEM INT EDIT, V47, P258, DOI 10.1002/anie.200605113; Maksymowicz RM, 2012, NAT CHEM, V4, P649, DOI [10.1038/NCHEM.1394, 10.1038/nchem.1394]; MATSUSHITA H, 1982, CHEM COMMUN, P160; Misale A, 2014, ANGEW CHEM INT EDIT, V53, P7068, DOI 10.1002/anie.201309074; Norinder J, 2007, CHEM-EUR J, V13, P4094, DOI 10.1002/chem.200601684; Pfaltz A., 1999, COMPREHENSIVE ASYMME, P833, DOI DOI 10.1021/CR0683515; Seemann M, 2003, EUR J ORG CHEM, V2003, P2122, DOI 10.1002/ejoc.200200700; Sha SC, 2013, J AM CHEM SOC, V135, P17602, DOI 10.1021/ja409511n; Sidera M, 2013, ANGEW CHEM INT EDIT, V52, P7995, DOI 10.1002/anie.201303202; Streitwieser A, 2008, J ORG CHEM, V73, P9426, DOI 10.1021/jo8020743; Teichert JF, 2010, ANGEW CHEM INT EDIT, V49, P2486, DOI 10.1002/anie.200904948; Trost BM, 2008, J AM CHEM SOC, V130, P14092, DOI 10.1021/ja806781u; Trost BM, 2007, ALDRICHIM ACTA, V40, P59; Trost BM, 1996, CHEM REV, V96, P395, DOI 10.1021/cr9409804; TROST BM, 1976, J ORG CHEM, V41, P3215, DOI 10.1021/jo00881a039; TROST BM, 1994, J AM CHEM SOC, V116, P4089, DOI 10.1021/ja00088a059; Vedejs E, 2005, ANGEW CHEM INT EDIT, V44, P3974, DOI 10.1002/anie.200460842; Wang JF, 2010, CHEM BIODIVERS, V7, P2046, DOI 10.1002/cbdv.201000072; Zhang HX, 2006, ANGEW CHEM INT EDIT, V45, P6391, DOI 10.1002/anie.200601880	30	76	76	5	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					351	355		10.1038/nature14089	http://dx.doi.org/10.1038/nature14089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25592541				2022-12-28	WOS:000347810300042
J	Iqbal, J; Ginsburg, O; Rochon, PA; Sun, P; Narod, SA				Iqbal, Javaid; Ginsburg, Ophira; Rochon, Paula A.; Sun, Ping; Narod, Steven A.			Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AFRICAN-AMERICAN WOMEN; JAPANESE WOMEN; GREEN TEA; ASIAN-AMERICANS; RISK; DISPARITIES; POPULATION; CARCINOMA; PATHOLOGY; MORTALITY	IMPORTANCE Women with early-stage breast cancers are expected to have excellent survival rates. It is important to identify factors that predict diagnosis of early-stage breast cancers. OBJECTIVE To determine the proportion of breast cancers that were identified at an early stage (stage I) in different racial/ethnic groups and whether ethnic differences may be better explained by early detection or by intrinsic biological differences in tumor aggressiveness. DESIGN, SETTING, AND PARTICIPANTS Observational study of women diagnosed with invasive breast cancer from 2004 to 2011 who were identified in the Surveillance, Epidemiology, and End Results (SEER) 18 registries database (N = 452 215). For each of 8 racial/ethnic groups, biological aggressiveness (triple-negative cancers, lymph node metastases, and distant metastases) of small-sized tumors of 2.0 cm or less was estimated. The odds ratio (OR) for being diagnosed at stage I compared with a later stage and the hazard ratio (HR) for death from stage I breast cancer by racial/ethnic group were determined. The date of final follow-up was December 31, 2011. MAIN OUTCOMES AND MEASURES Breast cancer stage at diagnosis and 7-year breast cancer-specific survival, adjusted for age at diagnosis, income, and estrogen receptor status. RESULTS Of 373 563 women with invasive breast cancer, 268 675 (71.9%) were non-Hispanic white; 34 928 (9.4%), Hispanic white; 38 751 (10.4%), black; 25 211 (6.7%), Asian; and 5998 (1.6%), other ethnicities. Mean follow-up time was 40.6 months (median, 38 months). Compared with non-Hispanic white women diagnosed with stage I breast cancer (50.8%), Japanese women (56.1%) were more likely to be diagnosed (OR, 1.23 [95% CI, 1.15-1.31], P <. 001) and black women (37.0%) were less likely to be diagnosed (OR, 0.65 [95% CI, 0.64-0.67], P <. 001). Actuarial risk of death from stage I breast cancer at 7 years was higher among black women (6.2%) than non-Hispanic white women (3.0%) (HR, 1.57 [95% CI, 1.40-1.75]; P <. 001), and lower among South Asian women (1.7%) (HR, 0.48 [95% CI, 0.20-1.15]; P = .10). Black women were more likely to die of breast cancer with small-sized tumors (9.0%) than non-Hispanic white women (4.6%) (HR, 1.96 [95% CI, 1.82-2.12]; P <. 001); the difference remained after adjustment for income and estrogen receptor status (HR, 1.56 [95% CI, 1.45-1.69]; P <. 001). CONCLUSIONS AND RELEVANCE Among US women diagnosed with invasive breast cancer, the likelihood of diagnosis at an early stage, and survival after stage I diagnosis, varied by race and ethnicity. Much of the difference could be statistically accounted for by intrinsic biological differences such as lymph node metastasis, distant metastasis, and triple-negative behavior of tumors.	[Iqbal, Javaid; Ginsburg, Ophira; Rochon, Paula A.; Sun, Ping; Narod, Steven A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Ginsburg, Ophira] Univ Toronto, Dept Med, Fac Med, Toronto, ON, Canada; [Ginsburg, Ophira; Rochon, Paula A.; Narod, Steven A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto	Narod, SA (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Familial Breast Canc Res Unit, 790 Bay St, Toronto, ON M5G 1N8, Canada.	steven.narod@wchospital.ca	Rochon, Paula A/J-2918-2016; Narod, Steven A/AAA-6112-2022	Rochon, Paula A/0000-0002-5973-4151; Ginsburg, Ophira/0000-0002-1384-2675	Canadian Institute of Health Research; Canada Research chair in breast cancer	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research chair in breast cancer	Dr Iqbal received a Canadian graduate scholarship from the Canadian Institute of Health Research. Dr Narod holds a Canada Research chair in breast cancer.	Agency for Healthcare Research and Quality, 2010, TABL 3 2 RAC ETHN CA; Agency for Healthcare Research and Quality, DEF CAT NEEDS RAC ET; Aiken L S, 1995, Womens Health, V1, P27; [Anonymous], SEER STAT DAT INC TO; Aziz H, 1999, AM J CLIN ONCOL-CANC, V22, P436, DOI 10.1097/00000421-199910000-00002; Cunningham JE, 2004, BREAST CANCER RES TR, V88, P161, DOI 10.1007/s10549-004-0592-9; Danforth DN, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3429; Fuhrman BJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-25; Gomez SL, 2013, JNCI-J NATL CANCER I, V105, P1096, DOI 10.1093/jnci/djt157; Howlader N, SEER CANC STAT REV; Iwasaki M, 2008, J CLIN ONCOL, V26, P1677, DOI 10.1200/JCO.2007.13.9964; Johnson C, 2008, SEER PROGRAM CODING, V07; Kamineni A, 2013, CANCER CAUSE CONTROL, V24, P305, DOI 10.1007/s10552-012-0115-7; Kwan ML, 2014, AM J EPIDEMIOL, V179, P95, DOI 10.1093/aje/kwt233; Maskarinec G, 2011, WOMENS HEALTH, V7, P677, DOI [10.2217/WHE.11.67, 10.2217/whe.11.67]; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; McDonald P A, 1999, Ethn Dis, V9, P81; Middleton Lavinia P., 2003, Cancer, V97, P253, DOI 10.1002/cncr.11021; Nakachi K, 1998, JPN J CANCER RES, V89, P254, DOI 10.1111/j.1349-7006.1998.tb00556.x; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; SAKAMOTO G, 1991, BREAST CANCER RES TR, V18, pS81, DOI 10.1007/BF02633534; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; STEMMERMANN GN, 1991, BREAST CANCER RES TR, V18, pS67, DOI 10.1007/BF02633531; STEMMERMANN GN, 1969, GANN, V60, P181; Surveillance Epidemiology and End Results Program, DAT US AGR 1973 2011; Svendsen RP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-686; U. S. Census Bureau, 2007 2011 AM COMM SU; VERNON SW, 1993, BREAST CANCER RES TR, V28, P137, DOI 10.1007/BF00666426; Wu AH, 2003, INT J CANCER, V106, P574, DOI 10.1002/ijc.11259; WYNDER EL, 1963, SURG GYNECOL OBSTET, V117, P196; Yamamoto S, 2003, J NATL CANCER I, V95, P906, DOI 10.1093/jnci/95.12.906; Yu JB, 2009, ONCOLOGY-NY, V23, P288	32	384	394	2	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					165	173		10.1001/jama.2014.17322	http://dx.doi.org/10.1001/jama.2014.17322			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585328				2022-12-28	WOS:000347679300016
J	Tjian, R				Tjian, Robert			Supporting Biomedical Research Meeting Challenges and Opportunities at HHMI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Howard Hughes Medical Institute	Tjian, R (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	jianr@hhmi.org			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665	9	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2015	313	2					133	134		10.1001/jama.2014.16543	http://dx.doi.org/10.1001/jama.2014.16543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY6MC	25585319	Bronze			2022-12-28	WOS:000347679300007
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Clinical trials: outcome measures	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Crump JA, 2005, BMJ-BRIT MED J, V331, P478, DOI 10.1136/bmj.38512.618681.E0; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7513; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041	4	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2015	350								h121	10.1136/bmj.h121	http://dx.doi.org/10.1136/bmj.h121			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3MT	25583733				2022-12-28	WOS:000348132400003
J	Kirshenbaum, K; Bock, DC; Lee, CY; Zhong, Z; Takeuchi, KJ; Marschilok, AC; Takeuchi, ES				Kirshenbaum, Kevin; Bock, David C.; Lee, Chia-Ying; Zhong, Zhong; Takeuchi, Kenneth J.; Marschilok, Amy C.; Takeuchi, Esther S.			In situ visualization of Li/Ag2VP2O8 batteries revealing rate-dependent discharge mechanism	SCIENCE			English	Article							X-RAY-ABSORPTION; SILVER VANADIUM-OXIDE; LI-ION BATTERIES; ELECTRODE MATERIALS; CATHODE; ELECTROCHEMISTRY; SPECTROSCOPY; DIFFRACTION; INSIGHTS; PHASES	The functional capacity of a battery is observed to decrease, often quite dramatically, as discharge rate demands increase. These capacity losses have been attributed to limited ion access and low electrical conductivity, resulting in incomplete electrode use. A strategy to improve electronic conductivity is the design of bimetallic materials that generate a silver matrix in situ during cathode reduction. Ex situ x-ray absorption spectroscopy coupled with in situ energy-dispersive x-ray diffraction measurements on intact lithium/silver vanadium diphosphate (Li/Ag2VP2O8) electrochemical cells demonstrate that the metal center preferentially reduced and its location in the bimetallic cathode are rate-dependent, affecting cell impedance. This work illustrates that spatial imaging as a function of discharge rate can provide needed insights toward improving realizable capacity of bimetallic cathode systems.	[Kirshenbaum, Kevin; Zhong, Zhong; Takeuchi, Esther S.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Bock, David C.; Takeuchi, Kenneth J.; Marschilok, Amy C.; Takeuchi, Esther S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Lee, Chia-Ying] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Takeuchi, Kenneth J.; Marschilok, Amy C.; Takeuchi, Esther S.] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Takeuchi, KJ (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	kenneth.takeuchi.1@stonybrook.edu; amy.marschilok@stonybrook.edu; esther.takeuchi@stonybrook.edu		Marschilok, Amy/0000-0001-9174-0474; Takeuchi, Kenneth/0000-0001-8129-444X	U.S. Department of Energy (DOE), Office of Basic Energy Sciences [DE-SC0008512]; DOE [DE-AC02-98CH10886]; Brookhaven National Laboratory; Gertrude and Maurice Goldhaber Distinguished Fellowship Program	U.S. Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Brookhaven National Laboratory(United States Department of Energy (DOE)); Gertrude and Maurice Goldhaber Distinguished Fellowship Program	E.S.T., K.J.T., A.C.M., C.-Y.L., and D.C.B. acknowledge funding from the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, under grant DE-SC0008512. Use of the National Synchrotron Light Source beamline X17B1 was supported by DOE contract DE-AC02-98CH10886. K.K. acknowledges postdoctoral support from Brookhaven National Laboratory and the Gertrude and Maurice Goldhaber Distinguished Fellowship Program. We thank M. C. Croft for helpful discussions and Y. Belyavina for assistance with the conceptual schematics shown in Fig 1.	Bock DC, 2013, DALTON T, V42, P13981, DOI 10.1039/c3dt51544c; Calvin S., 2013, XAFS EVERYONE, pxxvi; Chaurand P, 2007, J PHYS CHEM B, V111, P5101, DOI 10.1021/jp063186i; Ebner M, 2013, SCIENCE, V342, P716, DOI 10.1126/science.1241882; Huang H, 2001, ELECTROCHEM SOLID ST, V4, pA170, DOI 10.1149/1.1396695; Kirshenbaum KC, 2014, PHYS CHEM CHEM PHYS, V16, P9138, DOI 10.1039/c4cp01220h; LEISING RA, 1994, INORG CHEM, V33, P5733, DOI 10.1021/ic00103a021; Liu XS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3568; Marschilok AC, 2010, J POWER SOURCES, V195, P6839, DOI 10.1016/j.jpowsour.2010.04.033; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Patridge CJ, 2011, J PHYS CHEM C, V115, P14437, DOI 10.1021/jp203924w; Reynaud M, 2013, ECS TRANSACTIONS, V50, P11, DOI 10.1149/05024.0011ecst; Rousse G, 2014, CHEM MATER, V26, P394, DOI 10.1021/cm4022358; Russenbeek J, 2011, J POWER SOURCES, V196, P2332, DOI 10.1016/j.jpowsour.2010.10.023; Sauvage F, 2010, INORG CHEM, V49, P6461, DOI 10.1021/ic100125v; Sauvage F, 2008, INORG CHEM, V47, P8464, DOI 10.1021/ic800793e; Stallworth PE, 1998, J APPL PHYS, V83, P1247, DOI 10.1063/1.366822; Takeuchi ES, 2013, ENERG ENVIRON SCI, V6, P1465, DOI 10.1039/c3ee40152a; Takeuchi ES, 2013, J SOLID STATE CHEM, V200, P232, DOI 10.1016/j.jssc.2013.01.020; Takeuchi ES, 2009, CHEM MATER, V21, P4934, DOI 10.1021/cm902102k; WONG J, 1984, PHYS REV B, V30, P5596, DOI 10.1103/PhysRevB.30.5596; Zhou JG, 2014, PHYS CHEM CHEM PHYS, V16, P13838, DOI 10.1039/c4cp01436g; Zhou X, 2014, J POWER SOURCES, V265, P223, DOI 10.1016/j.jpowsour.2014.04.049	23	97	97	7	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					149	154		10.1126/science.1257289	http://dx.doi.org/10.1126/science.1257289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574017				2022-12-28	WOS:000347918900037
J	Sandholm, T				Sandholm, Tuomas			Solving imperfect-information games	SCIENCE			English	Editorial Material									Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Sandholm, T (corresponding author), Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA.							Bowling, 2013, P 12 INT C AUT AG MU, P255; Brown N., 2015, AAAI WORKSH COMP POK; Brown N, 2014, AAAI CONF ARTIF INTE, P594; Ganzfried O. S., 2011, P 10 INT C AUT AG MU, P781; Ganzfried S, 2012, P EC EC 12 ACM NEW Y, P587; Ganzfried Sam, 2013, P 23 INT JOINT C ART, P120; Gilpin A, 2012, MATH PROGRAM, V133, P279, DOI 10.1007/s10107-010-0430-2; Gilpin A, 2007, J ACM, V54, DOI 10.1145/1284320.1284324; Hawkin J. A., 2012, P 26 AAAI C ART INT, P1924; Hoda S, 2010, MATH OPER RES, V35, P494, DOI 10.1287/moor.1100.0452; Jackson E., 2013, WORKSH COMP POK IMP, P35; Kroer C., 2014, P 15 ACM C EC COMPUT, P621; Sandholm T., 2015, P AAAI C ART INT; Sandholm T, 2010, AI MAG, V31, P13, DOI 10.1609/aimag.v31i4.2311; Zinkevich M., 2008, ADV NEURAL INFORM PR, V20, P905	16	13	15	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 9	2015	347	6218					122	123		10.1126/science.aaa4614	http://dx.doi.org/10.1126/science.aaa4614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0EK	25574004				2022-12-28	WOS:000347918900020
J	McMurray, JJV; van Veldhuisen, DJ				McMurray, John J. V.; van Veldhuisen, Dirk J.			beta blockers, atrial fibrillation, and heart failure	LANCET			English	Editorial Material							TASK-FORCE; ASSOCIATION; CARVEDILOL; GUIDELINES; MANAGEMENT; TRIALS		[McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	University of Glasgow; University of Groningen; University of Groningen	McMurray, JJV (corresponding author), Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland.	john.mcmurray@glasgow.ac.uk	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				Castagno D, 2012, J AM COLL CARDIOL, V59, P1785, DOI 10.1016/j.jacc.2011.12.044; Hjalmarson A, 1999, LANCET, V353, P2001; Houghton T, 2000, EUR J HEART FAIL, V2, P333, DOI 10.1016/S1388-9842(00)00100-8; Khand AU, 2003, J AM COLL CARDIOL, V42, P1944, DOI 10.1016/j.jacc.2003.07.020; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; Lechat P, 1999, LANCET, V353, P9; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Rienstra M, 2013, JACC-HEART FAIL, V1, P21, DOI 10.1016/j.jchf.2012.09.002; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	12	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 20	2014	384	9961					2181	2183		10.1016/S0140-6736(14)62340-0	http://dx.doi.org/10.1016/S0140-6736(14)62340-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX0QC	25625384				2022-12-28	WOS:000346655700010
J	Dart, RC; Surratt, HL; Cicero, TJ; Parrino, MW; Severtson, SG; Bucher-Bartelson, B; Green, JL				Dart, Richard C.; Surratt, Hilary L.; Cicero, Theodore J.; Parrino, Mark W.; Severtson, S. Geoff; Bucher-Bartelson, Becki; Green, Jody L.			Trends in Opioid Analgesic Abuse and Mortality in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXTENDED-RELEASE OXYCODONE; COLLEGE-STUDENTS; NONMEDICAL USE; PRESCRIPTION; DIVERSION; IMPACT	Background The use of prescription opioid medications has increased greatly in the United States during the past two decades; in 2010, there were 16,651 opioid-related deaths. In response, hundreds of federal, state, and local interventions have been implemented. We describe trends in the diversion and abuse of prescription opioid analgesics using data through 2013. Methods We used five programs from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System to describe trends between 2002 and 2013 in the diversion and abuse of all products and formulations of six prescription opioid analgesics: oxycodone, hydrocodone, hydromorphone, fentanyl, morphine, and tramadol. The programs gather data from drug-diversion investigators, poison centers, substance-abuse treatment centers, and college students. Results Prescriptions for opioid analgesics increased substantially from 2002 through 2010 in the United States but then decreased slightly from 2011 through 2013. In general, RADARS System programs reported large increases in the rates of opioid diversion and abuse from 2002 to 2010, but then the rates flattened or decreased from 2011 through 2013. The rate of opioid-related deaths rose and fell in a similar pattern. Reported nonmedical use did not change significantly among college students. Conclusions Postmarketing surveillance indicates that the diversion and abuse of prescription opioid medications increased between 2002 and 2010 and plateaued or decreased between 2011 and 2013. These findings suggest that the United States may be making progress in controlling the abuse of opioid analgesics. Copyright (C) 2015 Massachusetts Medical Society.	[Dart, Richard C.; Severtson, S. Geoff; Bucher-Bartelson, Becki; Green, Jody L.] Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, Denver, CO 80204 USA; [Surratt, Hilary L.] Nova SE Univ, Ctr Appl Res Subst Use & Hlth Dispar, Ft Lauderdale, FL 33314 USA; [Cicero, Theodore J.] Washington Univ, Dept Psychiat, Sch Med, St Louis, MO 63130 USA; [Parrino, Mark W.] Amer Assoc Treatment Opioid Dependence, New York, NY USA	Denver Health Medical Center; Nova Southeastern University; Washington University (WUSTL)	Dart, RC (corresponding author), Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, 777 Bannock St,Mailcode 0180, Denver, CO 80204 USA.	richard.dart@rmpdc.org		Dart, Richard/0000-0001-5989-9354; Surratt, Hilary/0000-0003-4027-7840	Denver Health and Hospital Authority	Denver Health and Hospital Authority	Funded by the Denver Health and Hospital Authority.	[Anonymous], 2012, MULT CAUS DEATH FIL; [Anonymous], HOM RECR SAF LAWS ST; [Anonymous], 2013, BHSIS SER S; [Anonymous], 2002, PRESCR DRUGS STAT MO; Cicero TJ, 2007, DRUG ALCOHOL DEPEN, V91, P115, DOI 10.1016/j.drugalcdep.2007.05.008; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; Dart RC, 2014, CLIN J PAIN, V30, P685, DOI 10.1097/AJP.0000000000000001; Dart RC, 2009, DRUG ALCOHOL DEPEN, V105, pS26, DOI 10.1016/j.drugalcdep.2009.08.011; Dasgupta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041181; Davis JM, 2014, PHARMACOEPIDEM DR S, V23, P18, DOI 10.1002/pds.3533; Doherty C, 2013, AM SEE US LOSING GRO; Drug Abuse Warning Network, 2013, 2011 NAT EST DRUG RE; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; IMS Institute for Healthcare Informatics, 2011, HSRN DAT BRIEF XPON; Inciardi James A, 2009, J Opioid Manag, V5, P81; McCabe SE, 2014, ADDICT BEHAV, V39, P1176, DOI 10.1016/j.addbeh.2014.03.008; Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906; Muhuri PK, 2013, CBHSQ CTR BEHAV HLTH; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Reifler LM, 2012, PAIN MED, V13, P434, DOI 10.1111/j.1526-4637.2012.01327.x; Rosenblum A, 2007, DRUG ALCOHOL DEPEN, V90, P64, DOI 10.1016/j.drugalcdep.2007.02.012; Severtson SG, 2013, J PAIN, V14, P1122, DOI 10.1016/j.jpain.2013.04.011; Substance Abuse and Mental Health Services Administration, 2013, NSDUH SER H, VH-46; Substance Abuse and Mental Health Services Administration, 2013, NAT SURV DRUG US HLT; Substance Abuse Mental Health Services Administration, 2012, NSDUH SER H, V44; Surratt HL, 2014, PHARMACOEPIDEM DR S, V23, P314, DOI 10.1002/pds.3553; Unick GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054496	27	867	868	5	222	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					241	248		10.1056/NEJMsa1406143	http://dx.doi.org/10.1056/NEJMsa1406143			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AZ3HX	25875268	Bronze, Green Published			2022-12-28	WOS:000348119200008
J	Gewin, V				Gewin, Virginia			OUTREACH Speak up for science	NATURE			English	Article																		Jamieson KH, 2014, P NATL ACAD SCI USA, V111, P13598, DOI 10.1073/pnas.1320868111; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Scott-Phillips TC, 2014, EVOLUTION, V68, P1231, DOI 10.1111/evo.12332; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	5	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					231	233		10.1038/nj7533-231a	http://dx.doi.org/10.1038/nj7533-231a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25767845	Bronze			2022-12-28	WOS:000347477600043
J	[Anonymous]				[Anonymous]			Antiviral Drugs for Seasonal Influenza 2014-2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							NEURAMINIDASE INHIBITORS; CHEMOPROPHYLAXIS; OSELTAMIVIR; MANAGEMENT; PREGNANCY; CHILDREN											[Anonymous], MED LETT DRUGS THER; Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127; CDC, INFL ANT MED SUMM CL; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Louie JK, 2013, PEDIATRICS, V132, pE1539, DOI 10.1542/peds.2013-2149; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Toovey S, 2012, ADV THER, V29, P826, DOI 10.1007/s12325-012-0050-8; Wollenhaupt M, 2014, PHARMACOEPIDEM DR S, V23, P1035, DOI 10.1002/pds.3673; Yudin MH, 2014, INT J WOMENS HEALTH, V6, P681, DOI 10.2147/IJWH.S47235	13	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					413	414		10.1001/jama.2014.18380	http://dx.doi.org/10.1001/jama.2014.18380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25626039				2022-12-28	WOS:000349072600025
J	[Anonymous]				[Anonymous]			Antiviral Drugs for Seasonal Influenza 2014-2015	MEDICAL LETTER ON DRUGS AND THERAPEUTICS			English	Article							NEURAMINIDASE INHIBITORS; CHEMOPROPHYLAXIS; OSELTAMIVIR; MANAGEMENT; PREGNANCY; CHILDREN											[Anonymous], MED LETT DRUGS THER; [Anonymous], N ENGL J MED; Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127; CDC, INFL ANT MED SUMM CL; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Louie JK, 2013, PEDIATRICS, V132, pE1539, DOI 10.1542/peds.2013-2149; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Toovey S, 2012, ADV THER, V29, P826, DOI 10.1007/s12325-012-0050-8; Wollenhaupt M, 2014, PHARMACOEPIDEM DR S, V23, P1035, DOI 10.1002/pds.3673; Yudin MH, 2014, INT J WOMENS HEALTH, V6, P681, DOI 10.2147/IJWH.S47235	13	4	4	0	4	MED LETTER INC	NEW ROCHELLE	145 HUGUENOT ST, SUITE 312, NEW ROCHELLE, NY 10801-7537 USA	0025-732X	1523-2859		MED LETT DRUGS THER	Med. Lett. Drugs Ther.	DEC 8	2014	56	1457					121	123						3	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AU7WP	25626039				2022-12-28	WOS:000345809500001
J	Shah, ASV				Shah, Anoop S., V			High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study (vol 350, g7873, 2015)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction													Fox, keith A A/I-3742-2013; Newby, David Ernest/AAB-1364-2019	Shah, Anoop/0000-0002-2825-3419; Mills, Nicholas/0000-0003-0533-7991; Fox, Keith/0000-0002-0140-2752; McAllister, David/0000-0003-3550-1764				Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h626, 10.1136/bmj.g7873]	1	273	277	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2015	350								h626	10.1136/bmj.h626	http://dx.doi.org/10.1136/bmj.h626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB0IL	25646958	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000349309100013
J	Shah, ASV; Griffiths, M; Lee, KK; McAllister, DA; Hunter, AL; Ferry, AV; Cruikshank, A; Reid, A; Stoddart, M; Strachan, F; Walker, S; Collinson, PO; Apple, FS; Gray, AJ; Fox, KAA; Newby, DE; Mills, NL				Shah, Anoop S. V.; Griffiths, Megan; Lee, Kuan Ken; McAllister, David A.; Hunter, Amanda L.; Ferry, Amy V.; Cruikshank, Anne; Reid, Alan; Stoddart, Mary; Strachan, Fiona; Walker, Simon; Collinson, Paul O.; Apple, Fred S.; Gray, Alasdair J.; Fox, Keith A. A.; Newby, David E.; Mills, Nicholas L.			High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE CORONARY SYNDROME; SYMPTOM PRESENTATION; GENDER-DIFFERENCES; SEX-DIFFERENCES; I ASSAY; MORTALITY; RISK; ASSOCIATION; MARKER; DEATH	Objective To evaluate the diagnosis of myocardial infarction using a high sensitivity troponin I assay and sex specific diagnostic thresholds in men and women with suspected acute coronary syndrome. Design Prospective cohort study. Setting Regional cardiac centre, United Kingdom. Participants Consecutive patients with suspected acute coronary syndrome (n = 1126, 46% women). Two cardiologists independently adjudicated the diagnosis of myocardial infarction by using a high sensitivity troponin I assay with sex specific diagnostic thresholds (men 34 ng/L, women 16 ng/L) and compared with current practice where a contemporary assay (50 ng/L, single threshold) was used to guide care. Main outcome measure Diagnosis of myocardial infarction. Results The high sensitivity troponin I assay noticeably increased the diagnosis of myocardial infarction in women (from 11% to 22%; P < 0.001) but had a minimal effect in men (from 19% to 21%, P = 0.002). Women were less likely than men to be referred to a cardiologist or undergo coronary revascularisation (P < 0.05 for both). At 12 months, women with undisclosed increases in troponin concentration (17-49 ng/L) and those with myocardial infarction (>= 50 ng/L) had the highest rate of death or reinfarction compared with women without (<= 16 ng/L) myocardial infarction (25%, 24%, and 4%, respectively; P < 0.001). Conclusions Although having little effect in men, a high sensitivity troponin assay with sex specific diagnostic thresholds may double the diagnosis of myocardial infarction in women and identify those at high risk of reinfarction and death. Whether use of sex specific diagnostic thresholds will improve outcomes and tackle inequalities in the treatment of women with suspected acute coronary syndrome requires urgent attention.	[Shah, Anoop S. V.; Griffiths, Megan; Lee, Kuan Ken; Hunter, Amanda L.; Ferry, Amy V.; Strachan, Fiona; Fox, Keith A. A.; Newby, David E.; Mills, Nicholas L.] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [McAllister, David A.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Cruikshank, Anne; Reid, Alan] So Gen Hosp, Dept Biochem, Glasgow, Lanark, Scotland; [Stoddart, Mary; Walker, Simon] Royal Infirm Edinburgh NHS Trust, Dept Biochem, Edinburgh, Midlothian, Scotland; [Collinson, Paul O.] St Georges Hosp & Med Sch, Dept Cardiol, London, England; [Apple, Fred S.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Gray, Alasdair J.] Royal Infirm Edinburgh NHS Trust, Dept Emergency Med, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow; Royal Infirmary of Edinburgh; University of Edinburgh; St Georges University London; University of Minnesota System; University of Minnesota Twin Cities; Royal Infirmary of Edinburgh; University of Edinburgh	Mills, NL (corresponding author), Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh EH16 4SB, Midlothian, Scotland.	nick.mills@ed.ac.uk	Fox, keith A A/I-3742-2013; Newby, David Ernest/AAB-1364-2019	Shah, Anoop/0000-0002-2825-3419; Mills, Nicholas/0000-0003-0533-7991; Fox, Keith/0000-0002-0140-2752; McAllister, David/0000-0003-3550-1764	British Heart Foundation [SP/12/10/29922, SS/CH/09/002, FS/10/024/28266, CH/09/002]; legacy of Violet Kemlo	British Heart Foundation(British Heart Foundation); legacy of Violet Kemlo	This research was funded by a special project grant from the British Heart Foundation (SP/12/10/29922) with support from the legacy of Violet Kemlo. ASVS, NLM, and DEN are supported by clinical research scholarship (SS/CH/09/002), intermediate clinical research fellowship (FS/10/024/28266), and chair (CH/09/002) awards, respectively, from the British Heart Foundation. Abbott Laboratories provided the ARCHITECT<INF>STAT</INF> high sensitive troponin I assay reagents, calibrators, and controls without charge. The study sponsors had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report or in the decision to submit the manuscript for publication.	Anderson RD, 2007, CIRCULATION, V115, P823, DOI 10.1161/CIRCULATIONAHA.106.685859; Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Aw TC, 2013, CLIN CHIM ACTA, V422, P26, DOI 10.1016/j.cca.2013.03.034; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Canto JG, 2012, JAMA-J AM MED ASSOC, V307, P813, DOI 10.1001/jama.2012.199; Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189; Collinson PO, 2012, CLIN CHEM, V58, P305, DOI 10.1373/clinchem.2011.171439; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Elsaesser A, 2004, CIRCULATION, V109, P565, DOI 10.1161/01.CIR.0000116022.77781.26; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Gan SC, 2000, NEW ENGL J MED, V343, P8, DOI 10.1056/NEJM200007063430102; Glasziou P, 2008, ANN INTERN MED, V149, P816, DOI 10.7326/0003-4819-149-11-200812020-00009; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Mills NL, 2011, JAMA-J AM MED ASSOC, V305, P1210, DOI 10.1001/jama.2011.338; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; National Institute for Health and Care Excellence, 2014, MYOC INF AC EARL RUL; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Salton CJ, 2002, J AM COLL CARDIOL, V39, P1055, DOI 10.1016/S0735-1097(02)01712-6; Shah A, 2014, AM J MED; Shah ASV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4222; Shah ASV, 2014, CIRCULATION, V130, P1607, DOI 10.1161/CIRCULATIONAHA.114.011085; Shah ASV, 2013, HEART, V99, P1549, DOI 10.1136/heartjnl-2013-304033; Shah ASV, 2013, HEART, V99, P1225, DOI 10.1136/heartjnl-2013-303733; Silverman B.W., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Skinner JS, 2010, HEART, V96, P974, DOI 10.1136/hrt.2009.190066; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Wenger NK, 2012, CIRCULATION, V126, P604, DOI 10.1161/CIRCULATIONAHA.111.086892; Wiviott SD, 2004, CIRCULATION, V109, P580, DOI 10.1161/01.CIR.0000109491.66226.26	37	273	277	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2015	350								g7873	10.1136/bmj.g7873	http://dx.doi.org/10.1136/bmj.g7873			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ7ZG	25646958	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000348433700001
J	Collins, GS; Reitsma, JB; Altman, DG; Moons, KGM				Collins, Gary S.; Reitsma, Johannes B.; Altman, Douglas G.; Moons, Karel G. M.			Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article							GENETIC RISK PREDICTION; EXTERNAL VALIDATION; INTERNAL VALIDATION; RULES; IMPACT; EXPLANATION; RECOMMENDATIONS; ASSOCIATION; DISEASE; HEART	Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. The Transparent Reporting of a multivatiable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statementorg). (C) 2015 Elsevier Inc. All rights reserved.	[Collins, Gary S.; Altman, Douglas G.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Ctr Stat Med, Oxford, England; [Reitsma, Johannes B.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Oxford; Utrecht University; Utrecht University Medical Center	Collins, GS (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Ctr Stat Med, Oxford, England.	gary.collins@csm.ox.ac.uk	Knottnerus, Johannes A/A-3829-2009; Collins, Gary Stephen/A-2258-2014; Groves, Trish/A-9119-2009	Collins, Gary Stephen/0000-0002-2772-2316; Reitsma, Johannes/0000-0003-4026-4345; Vickers, Andrew/0000-0003-1525-6503; Groves, Trish/0000-0001-7915-6419; Macaskill, Petra/0000-0001-5879-6193; Barbour, Virginia/0000-0002-2358-2440	National Institute for Health Research Senior Investigator Award; Cancer Research UK [C5529]; Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]; Medical Research Council [G1100513]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10259, NF-SI-0513-10131] Funding Source: researchfish	National Institute for Health Research Senior Investigator Award; Cancer Research UK(Cancer Research UK); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Grant Support: There was no explicit funding for the development of this checklist and guidance document. The consensus meeting in June 2011 was partially funded by a National Institute for Health Research Senior Investigator Award held by Dr. Altman, Cancer Research UK (grant C5529), and the Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). Drs. Collins and Altman are funded in part by the Medical Research Council (grant G1100513). Dr. Altman is a member of the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558).	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P185; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P84; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Ettema RGA, 2010, CIRCULATION, V122, P682, DOI 10.1161/CIRCULATIONAHA.109.926808; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1010, DOI 10.1111/j.1365-2362.2011.02493.x; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moher D, 2010, PLOS MED, V16; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Williams Rebecca J, 2010, CMAJ, V182, P1638, DOI 10.1503/cmaj.092252	56	3212	3264	20	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	FEB	2015	68	2					112	121		10.1016/j.jclinepi.2014.11.010	http://dx.doi.org/10.1016/j.jclinepi.2014.11.010			10	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	CA5UX	25569120	Green Published, hybrid			2022-12-28	WOS:000348974400002
J	Collins, GS; Reitsma, JB; Altman, DG; Moons, KGM				Collins, Gary S.; Reitsma, Johannes B.; Altman, Douglas G.; Moons, Karel G. M.			Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement	ANNALS OF INTERNAL MEDICINE			English	Article							GENETIC RISK PREDICTION; EXTERNAL VALIDATION; INTERNAL VALIDATION; RULES; EXPLANATION; IMPACT; RECOMMENDATIONS; ASSOCIATION; DISEASE; HEART	Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).	[Collins, Gary S.; Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Botnar Res Ctr, Oxford OX3 7LD, England; [Reitsma, Johannes B.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	University of Oxford; Utrecht University; Utrecht University Medical Center	Collins, GS (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Botnar Res Ctr, Oxford OX3 7LD, England.	gary.collins@csm.ox.ac.uk	Knottnerus, Johannes A/A-3829-2009; Collins, Gary Stephen/A-2258-2014; Groves, Trish/A-9119-2009	Collins, Gary Stephen/0000-0002-2772-2316; Reitsma, Johannes/0000-0003-4026-4345; Vickers, Andrew/0000-0003-1525-6503; Groves, Trish/0000-0001-7915-6419; Macaskill, Petra/0000-0001-5879-6193; Barbour, Virginia/0000-0002-2358-2440	National Institute for Health Research Senior Investigator Award [C5529]; Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]; Medical Research Council [G1100513]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10259, NF-SI-0513-10131] Funding Source: researchfish	National Institute for Health Research Senior Investigator Award; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	There was no explicit funding for the development of this checklist and guidance document. The consensus meeting in June 2011 was partially funded by a National Institute for Health Research Senior Investigator Award held by Dr. Altman, Cancer Research UK (grant C5529), and the Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). Drs. Collins and Altman are funded in part by the Medical Research Council (grant G1100513). Dr. Altman is a member of the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558).	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P185; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P84; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Ettema RGA, 2010, CIRCULATION, V122, P682, DOI 10.1161/CIRCULATIONAHA.109.926808; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1010, DOI 10.1111/j.1365-2362.2011.02493.x; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moher D, 2010, PLOS MED, V16; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Williams Rebecca J, 2010, CMAJ, V182, P1638, DOI 10.1503/cmaj.092252	56	3212	3264	20	71	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 6	2015	162	1					55	U103		10.7326/M14-0697	http://dx.doi.org/10.7326/M14-0697			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1LU	25569120	Green Submitted			2022-12-28	WOS:000350103000007
J	Collins, GS; Reitsma, JB; Altman, DG; Moons, KGM				Collins, Gary S.; Reitsma, Johannes B.; Altman, Douglas G.; Moons, Karel G. M.			Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) The TRIPOD Statement	CIRCULATION			English	Article						diagnosis; epidemiology; prognosis; research design; risk; statistics	GENETIC RISK PREDICTION; INTERNAL VALIDATION; EXTERNAL VALIDATION; EXPLANATION; RULES; IMPACT; RECOMMENDATIONS; ASSOCIATION; DISEASE; HEART	Background-Prediction models are developed to aid health care providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed. Methods-The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) Initiative developed a set of recommendations for the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, health care professionals, and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors. Results-The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document. Conclusions-To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).	[Collins, Gary S.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Oxford; Utrecht University; Utrecht University Medical Center	Collins, GS (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England.	gary.collins@csm.ox.ac.uk	Knottnerus, Johannes A/A-3829-2009; Collins, Gary Stephen/A-2258-2014; Groves, Trish/A-9119-2009	Collins, Gary Stephen/0000-0002-2772-2316; Reitsma, Johannes/0000-0003-4026-4345; Vickers, Andrew/0000-0003-1525-6503; Groves, Trish/0000-0001-7915-6419; Macaskill, Petra/0000-0001-5879-6193; Barbour, Virginia/0000-0002-2358-2440	National Institute for Health Research Senior Investigator Award; Cancer Research UK [C5529]; Netherlands Organization for Scientific Research [ZONMW 918.10.615, 91208004]; Medical Research Council [G1100513]; Cancer Research UK [16895] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10259, NF-SI-0513-10131] Funding Source: researchfish	National Institute for Health Research Senior Investigator Award; Cancer Research UK(Cancer Research UK); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	There was no explicit funding for the development of this checklist and guidance document. The consensus meeting in June 2011 was partially funded by a National Institute for Health Research Senior Investigator Award held by Dr. Altman, Cancer Research UK (grant C5529), and the Netherlands Organization for Scientific Research (ZONMW 918.10.615 and 91208004). Drs. Collins and Altman are funded in part by the Medical Research Council (grant G1100513). Dr. Altman is a member of the Medical Research Council Prognosis Research Strategy (PROGRESS) Partnership (G0902393/99558).	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P185; Canadian CT Head and C-Spine (CCC) Study Group, 2002, CJEM, V4, P84; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; Collins GS, 2013, J CLIN EPIDEMIOL, V66, P268, DOI 10.1016/j.jclinepi.2012.06.020; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Ettema RGA, 2010, CIRCULATION, V122, P682, DOI 10.1161/CIRCULATIONAHA.109.926808; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1010, DOI 10.1111/j.1365-2362.2011.02493.x; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KNOTTNERUS JA, 1995, PRIMARY CARE, V22, P341; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moher D, 2010, PLOS MED, V16; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher David, 2009, Open Med, V3, pe123; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Williams Rebecca J, 2010, CMAJ, V182, P1638, DOI 10.1503/cmaj.092252	56	3212	3264	20	71	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7322	1524-4539		CIRCULATION	Circulation	JAN 13	2015	131	2					211	219		10.1161/CIRCULATIONAHA.114.014508	http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014508			9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	AY8FY	25569120	Green Published, hybrid			2022-12-28	WOS:000347791000018
